Citrus Sinensis ID: 021490
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 311 | 2.2.26 [Sep-21-2011] | |||||||
| Q9FE20 | 456 | Serine/threonine-protein | no | no | 0.932 | 0.635 | 0.707 | 1e-122 | |
| Q9LQQ8 | 423 | Probable serine/threonine | no | no | 0.935 | 0.687 | 0.684 | 1e-118 | |
| Q9SFT7 | 414 | Serine/threonine-protein | no | no | 0.816 | 0.613 | 0.688 | 1e-105 | |
| O49840 | 426 | Protein kinase 2B, chloro | no | no | 0.874 | 0.638 | 0.527 | 5e-79 | |
| O49839 | 426 | Protein kinase 2A, chloro | no | no | 0.807 | 0.589 | 0.559 | 1e-76 | |
| Q8GXZ3 | 410 | Serine/threonine-protein | no | no | 0.790 | 0.6 | 0.578 | 2e-76 | |
| Q9LFP7 | 493 | Probable receptor-like pr | no | no | 0.800 | 0.505 | 0.559 | 3e-76 | |
| P43293 | 389 | Probable serine/threonine | no | no | 0.855 | 0.683 | 0.516 | 1e-75 | |
| Q9SRH7 | 490 | Receptor-like serine/thre | no | no | 0.790 | 0.502 | 0.550 | 1e-73 | |
| Q9FM85 | 408 | Probable receptor-like pr | no | no | 0.823 | 0.627 | 0.542 | 1e-73 |
| >sp|Q9FE20|PBS1_ARATH Serine/threonine-protein kinase PBS1 OS=Arabidopsis thaliana GN=PBS1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 437 bits (1124), Expect = e-122, Method: Compositional matrix adjust.
Identities = 208/294 (70%), Positives = 240/294 (81%), Gaps = 4/294 (1%)
Query: 10 QDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVE 69
Q VA+KQLDRNG+QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE+MPLGS+E
Sbjct: 110 QVVAVKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLGSLE 169
Query: 70 DHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKL 129
DHLHDL P K+ LDWN RMKIAAGAA+GLE+LHDKA PPVIYRD K SNILLD G+HPKL
Sbjct: 170 DHLHDLPPDKEALDWNMRMKIAAGAAKGLEFLHDKANPPVIYRDFKSSNILLDEGFHPKL 229
Query: 130 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKA 189
SDFGLAKLGP GD +HVSTRVMGTYGYCAPEYA TGQLT+KSDVYSFGVV LE+++GRKA
Sbjct: 230 SDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKA 289
Query: 190 VDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDM 249
+D+ EQ+LVAWARPLF DR + +ADP L+G++P R YQALAVA+MC+ EQ
Sbjct: 290 IDSEMPHGEQNLVAWARPLFNDRRKFIKLADPRLKGRFPTRALYQALAVASMCIQEQAAT 349
Query: 250 RPVIADVVTALAYLASQKYESDAEKVQSPCLDPGTPTRTKGDKERKLNGGRGSE 303
RP+IADVVTAL+YLA+Q Y+ + + + G T+ D GG GS+
Sbjct: 350 RPLIADVVTALSYLANQAYDPSKDDSRRNRDERGARLITRNDD----GGGSGSK 399
|
Protein kinase required for plant defense mechanism mediated by the disease resistance (R) protein RPS5. In case of infection by Pseudomonas syringae, RPS5 specifically recognizes the avrPphB type III effector avirulence protein and triggers a defense reaction. AvrPphB may trigger RPS5-mediated defense mechanism via the cleavage of PBS1. Both kinase activity and cleavage by avrPphB are independently required to trigger the RPS5-mediated resistance. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9LQQ8|RLCK7_ARATH Probable serine/threonine-protein kinase RLCKVII OS=Arabidopsis thaliana GN=At1g07870 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 424 bits (1091), Expect = e-118, Method: Compositional matrix adjust.
Identities = 208/304 (68%), Positives = 236/304 (77%), Gaps = 13/304 (4%)
Query: 8 LLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGS 67
L Q VAIKQLDRNGVQG REF+VEVL LSL HPNLV LIG+CA+GDQRLLVYEYMP GS
Sbjct: 125 LDQVVAIKQLDRNGVQGIREFVVEVLTLSLADHPNLVKLIGFCAEGDQRLLVYEYMPQGS 184
Query: 68 VEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP 127
+EDHLH L GKKPLDWNTRMKIAAGAARGLEYLHD+ PPVIYRDLKCSNILL Y P
Sbjct: 185 LEDHLHVLPSGKKPLDWNTRMKIAAGAARGLEYLHDRMTPPVIYRDLKCSNILLGEDYQP 244
Query: 128 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 187
KLSDFGLAK+GP GD THVSTRVMGTYGYCAP+YA TGQLT KSD+YSFGVVLLE+++GR
Sbjct: 245 KLSDFGLAKVGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGR 304
Query: 188 KAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQP 247
KA+D +K +Q+LV WARPLF+DR + DP LQGQYP RG YQALA++AMCV EQP
Sbjct: 305 KAIDNTKTRKDQNLVGWARPLFKDRRNFPKMVDPLLQGQYPVRGLYQALAISAMCVQEQP 364
Query: 248 DMRPVIADVVTALAYLASQKYESDAEKVQSPCLDPGTPTRTKGDKERKLNGGRGSERERT 307
MRPV++DVV AL +LAS KY DP +P+ + G K + R E +R
Sbjct: 365 TMRPVVSDVVLALNFLASSKY------------DPNSPSSSSG-KNPSFHRDRDDEEKRP 411
Query: 308 RKLK 311
+K
Sbjct: 412 HLVK 415
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SFT7|Y3707_ARATH Serine/threonine-protein kinase At3g07070 OS=Arabidopsis thaliana GN=At3g07070 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 382 bits (980), Expect = e-105, Method: Compositional matrix adjust.
Identities = 175/254 (68%), Positives = 217/254 (85%)
Query: 12 VAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDH 71
VA+KQLDRNG+QGN+EF+VEVLMLSLLHH +LVNLIGYCADGDQRLLVYEYM GS+EDH
Sbjct: 105 VAVKQLDRNGLQGNKEFIVEVLMLSLLHHKHLVNLIGYCADGDQRLLVYEYMSRGSLEDH 164
Query: 72 LHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSD 131
L DL+P + PLDW+TR++IA GAA GLEYLHDKA PPVIYRDLK +NILLD ++ KLSD
Sbjct: 165 LLDLTPDQIPLDWDTRIRIALGAAMGLEYLHDKANPPVIYRDLKAANILLDGEFNAKLSD 224
Query: 132 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVD 191
FGLAKLGPVGD HVS+RVMGTYGYCAPEY +TGQLT KSDVYSFGVVLLE+++GR+ +D
Sbjct: 225 FGLAKLGPVGDKQHVSSRVMGTYGYCAPEYQRTGQLTTKSDVYSFGVVLLELITGRRVID 284
Query: 192 TSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRP 251
T++ EQ+LV WA+P+F++ +R +ADP L+G +P + QA+AVAAMC+ E+ +RP
Sbjct: 285 TTRPKDEQNLVTWAQPVFKEPSRFPELADPSLEGVFPEKALNQAVAVAAMCLQEEATVRP 344
Query: 252 VIADVVTALAYLAS 265
+++DVVTAL +L +
Sbjct: 345 LMSDVVTALGFLGT 358
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49840|APK2B_ARATH Protein kinase 2B, chloroplastic OS=Arabidopsis thaliana GN=APK2B PE=1 SV=1 | Back alignment and function description |
|---|
Score = 294 bits (753), Expect = 5e-79, Method: Compositional matrix adjust.
Identities = 154/292 (52%), Positives = 195/292 (66%), Gaps = 20/292 (6%)
Query: 12 VAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDH 71
VA+K+L G QG++E+L EV L L HPNLV L+GYC +G+ RLLVYE+MP GS+E+H
Sbjct: 118 VAVKKLKTEGYQGHKEWLTEVNYLGQLSHPNLVKLVGYCVEGENRLLVYEFMPKGSLENH 177
Query: 72 LHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSD 131
L G +PL W RMK+A GAA+GL +LHD AK VIYRD K +NILLD ++ KLSD
Sbjct: 178 L--FRRGAQPLTWAIRMKVAIGAAKGLTFLHD-AKSQVIYRDFKAANILLDAEFNSKLSD 234
Query: 132 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVD 191
FGLAK GP GD THVST+VMGT+GY APEY TG+LT KSDVYSFGVVLLE+LSGR+AVD
Sbjct: 235 FGLAKAGPTGDKTHVSTQVMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVD 294
Query: 192 TSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRP 251
SK EQSLV WA P D+ + I D L GQYP +G Y A ++A C++ +RP
Sbjct: 295 KSKVGMEQSLVDWATPYLGDKRKLFRIMDTRLGGQYPQKGAYTAASLALQCLNPDAKLRP 354
Query: 252 VIADVVTALAYLASQKYESDAEKVQSPCLDPGTPTRTKGDKERKLNGGRGSE 303
+++V+ L L S K PGT G+++ +++ RGS
Sbjct: 355 KMSEVLAKLDQLESTK--------------PGTGV---GNRQAQIDSPRGSN 389
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49839|APK2A_ARATH Protein kinase 2A, chloroplastic OS=Arabidopsis thaliana GN=APK2A PE=2 SV=1 | Back alignment and function description |
|---|
Score = 286 bits (733), Expect = 1e-76, Method: Compositional matrix adjust.
Identities = 142/254 (55%), Positives = 181/254 (71%), Gaps = 3/254 (1%)
Query: 12 VAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDH 71
VA+KQL G QG++E+L EV L L HPNLV L+GYCA+G+ RLLVYE+MP GS+E+H
Sbjct: 121 VAVKQLKPEGFQGHKEWLTEVNYLGQLSHPNLVLLVGYCAEGENRLLVYEFMPKGSLENH 180
Query: 72 LHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSD 131
L G +PL W RMK+A GAA+GL +LH+ AK VIYRD K +NILLD ++ KLSD
Sbjct: 181 L--FRRGAQPLTWAIRMKVAVGAAKGLTFLHE-AKSQVIYRDFKAANILLDADFNAKLSD 237
Query: 132 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVD 191
FGLAK GP GDNTHVST+V+GT+GY APEY TG+LT KSDVYSFGVVLLE++SGR+A+D
Sbjct: 238 FGLAKAGPTGDNTHVSTKVIGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELISGRRAMD 297
Query: 192 TSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRP 251
S E SLV WA P D+ + I D +L GQYP +G + A +A C++ +RP
Sbjct: 298 NSNGGNEYSLVDWATPYLGDKRKLFRIMDTKLGGQYPQKGAFTAANLALQCLNPDAKLRP 357
Query: 252 VIADVVTALAYLAS 265
+++V+ L L S
Sbjct: 358 KMSEVLVTLEQLES 371
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GXZ3|Y5102_ARATH Serine/threonine-protein kinase At5g01020 OS=Arabidopsis thaliana GN=At5g01020 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 286 bits (731), Expect = 2e-76, Method: Compositional matrix adjust.
Identities = 144/249 (57%), Positives = 178/249 (71%), Gaps = 3/249 (1%)
Query: 12 VAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDH 71
VA+K L++ G+QG+RE+L EV L L HPNLV LIGYC + D RLLVYE+M GS+E+H
Sbjct: 101 VAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMLRGSLENH 160
Query: 72 LHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSD 131
L PL W+ RM IA GAA+GL +LH+ A+ PVIYRD K SNILLD Y KLSD
Sbjct: 161 L--FRKTTAPLSWSRRMMIALGAAKGLAFLHN-AERPVIYRDFKTSNILLDSDYTAKLSD 217
Query: 132 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVD 191
FGLAK GP GD THVSTRVMGTYGY APEY TG LT +SDVYSFGVVLLE+L+GRK+VD
Sbjct: 218 FGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLEMLTGRKSVD 277
Query: 192 TSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRP 251
++ + EQ+LV WARP D+ + I DP L+ QY R +A ++A C+ + P RP
Sbjct: 278 KTRPSKEQNLVDWARPKLNDKRKLLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARP 337
Query: 252 VIADVVTAL 260
+++DVV L
Sbjct: 338 LMSDVVETL 346
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LFP7|Y5158_ARATH Probable receptor-like protein kinase At5g15080 OS=Arabidopsis thaliana GN=At5g15080 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 285 bits (728), Expect = 3e-76, Method: Compositional matrix adjust.
Identities = 141/252 (55%), Positives = 179/252 (71%), Gaps = 3/252 (1%)
Query: 12 VAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDH 71
VA+K L+ +G+QG++E+L E+ L L HPNLV L+GYC + DQRLLVYE+MP GS+E+H
Sbjct: 177 VAVKTLNPDGLQGHKEWLAEINFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENH 236
Query: 72 LHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSD 131
L S PL W+ RMKIA GAA+GL +LH++A PVIYRD K SNILLD Y+ KLSD
Sbjct: 237 LFRRS---LPLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDADYNAKLSD 293
Query: 132 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVD 191
FGLAK P THVSTRVMGTYGY APEY TG LT KSDVYSFGVVLLE+L+GR+++D
Sbjct: 294 FGLAKDAPDEGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMD 353
Query: 192 TSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRP 251
++ E +LV WARP D+ R + DP L+G + +G + +AA C+ P +RP
Sbjct: 354 KNRPNGEHNLVEWARPHLLDKRRFYRLLDPRLEGHFSIKGAQKVTQLAAQCLSRDPKIRP 413
Query: 252 VIADVVTALAYL 263
++DVV AL L
Sbjct: 414 KMSDVVEALKPL 425
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P43293|NAK_ARATH Probable serine/threonine-protein kinase NAK OS=Arabidopsis thaliana GN=NAK PE=2 SV=2 | Back alignment and function description |
|---|
Score = 283 bits (724), Expect = 1e-75, Method: Compositional matrix adjust.
Identities = 141/273 (51%), Positives = 187/273 (68%), Gaps = 7/273 (2%)
Query: 12 VAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDH 71
+A+K+L++ G QG+RE+L E+ L L HPNLV LIGYC + + RLLVYE+M GS+E+H
Sbjct: 103 IAVKRLNQEGFQGHREWLAEINYLGQLDHPNLVKLIGYCLEEEHRLLVYEFMTRGSLENH 162
Query: 72 LHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSD 131
L +PL WNTR+++A GAARGL +LH+ A+P VIYRD K SNILLD Y+ KLSD
Sbjct: 163 LFRRGTFYQPLSWNTRVRMALGAARGLAFLHN-AQPQVIYRDFKASNILLDSNYNAKLSD 221
Query: 132 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVD 191
FGLA+ GP+GDN+HVSTRVMGT GY APEY TG L++KSDVYSFGVVLLE+LSGR+A+D
Sbjct: 222 FGLARDGPMGDNSHVSTRVMGTQGYAAPEYLATGHLSVKSDVYSFGVVLLELLSGRRAID 281
Query: 192 TSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAM---CVHEQPD 248
++ E +LV WARP ++ R + DP LQGQY +AL +A + C+
Sbjct: 282 KNQPVGEHNLVDWARPYLTNKRRLLRVMDPRLQGQY---SLTRALKIAVLALDCISIDAK 338
Query: 249 MRPVIADVVTALAYLASQKYESDAEKVQSPCLD 281
RP + ++V + L QK S ++ +D
Sbjct: 339 SRPTMNEIVKTMEELHIQKEASKEQQNPQISID 371
|
May play a role in the regulation of plant growth and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SRH7|Y3130_ARATH Receptor-like serine/threonine-protein kinase At3g01300 OS=Arabidopsis thaliana GN=At3g01300 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 276 bits (707), Expect = 1e-73, Method: Compositional matrix adjust.
Identities = 137/249 (55%), Positives = 176/249 (70%), Gaps = 3/249 (1%)
Query: 12 VAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDH 71
VA+K L+ +G+QG++E+L E+ L L HPNLV L+GYC + DQRLLVYE+MP GS+E+H
Sbjct: 171 VAVKTLNPDGLQGHKEWLAEINYLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENH 230
Query: 72 LHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSD 131
L S PL W+ RMKIA GAA+GL +LH++A PVIYRD K SNILLD Y+ KLSD
Sbjct: 231 LFRRS---LPLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDGEYNAKLSD 287
Query: 132 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVD 191
FGLAK P THVSTRVMGTYGY APEY TG LT KSDVYSFGVVLLE+L+GR+++D
Sbjct: 288 FGLAKDAPDEGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMD 347
Query: 192 TSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRP 251
++ E +LV WARP D+ R + DP L+G + +G + +AA C+ +RP
Sbjct: 348 KNRPNGEHNLVEWARPHLLDKRRFYRLLDPRLEGHFSVKGAQKVTQLAAQCLSRDSKIRP 407
Query: 252 VIADVVTAL 260
+++VV L
Sbjct: 408 KMSEVVEVL 416
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FM85|Y5564_ARATH Probable receptor-like protein kinase At5g56460 OS=Arabidopsis thaliana GN=At5g56460 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 276 bits (707), Expect = 1e-73, Method: Compositional matrix adjust.
Identities = 141/260 (54%), Positives = 183/260 (70%), Gaps = 4/260 (1%)
Query: 12 VAIKQLD-RNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVED 70
VA+K D N QG+RE+L EV+ L L HPNLV LIGYC + + R+L+YEYM GSVE+
Sbjct: 110 VAVKVHDGDNSFQGHREWLAEVIFLGQLSHPNLVKLIGYCCEDNHRVLIYEYMARGSVEN 169
Query: 71 HLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLS 130
+L S PL W RMKIA GAA+GL +LH+ AK PVIYRD K SNILLD Y+ KLS
Sbjct: 170 NL--FSRVLLPLSWAIRMKIAFGAAKGLAFLHE-AKKPVIYRDFKTSNILLDMDYNAKLS 226
Query: 131 DFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAV 190
DFGLAK GPVGD +HVSTR+MGTYGY APEY TG LT SDVYSFGVVLLE+L+GRK++
Sbjct: 227 DFGLAKDGPVGDKSHVSTRIMGTYGYAAPEYIMTGHLTPGSDVYSFGVVLLELLTGRKSL 286
Query: 191 DTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMR 250
D S+ EQ+L+ WA PL +++ + I DP++ +YP + +A +A C++ P R
Sbjct: 287 DKSRPTREQNLIDWALPLLKEKKKVLNIVDPKMNCEYPVKAVQKAAMLAYHCLNRNPKAR 346
Query: 251 PVIADVVTALAYLASQKYES 270
P++ D+V +L L + + E+
Sbjct: 347 PLMRDIVDSLEPLQATEEEA 366
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 311 | ||||||
| 225439781 | 396 | PREDICTED: serine/threonine-protein kina | 0.967 | 0.760 | 0.797 | 1e-139 | |
| 356548196 | 383 | PREDICTED: serine/threonine-protein kina | 0.900 | 0.731 | 0.846 | 1e-139 | |
| 351721314 | 383 | protein kinase-like protein [Glycine max | 0.900 | 0.731 | 0.846 | 1e-138 | |
| 217074768 | 417 | unknown [Medicago truncatula] gi|3885097 | 0.900 | 0.671 | 0.842 | 1e-138 | |
| 449440049 | 395 | PREDICTED: serine/threonine-protein kina | 0.958 | 0.754 | 0.789 | 1e-138 | |
| 255568454 | 389 | receptor serine-threonine protein kinase | 0.913 | 0.730 | 0.821 | 1e-138 | |
| 356505176 | 379 | PREDICTED: serine/threonine-protein kina | 0.900 | 0.738 | 0.832 | 1e-135 | |
| 357510543 | 377 | Serine/threonine protein kinase PBS1 [Me | 0.893 | 0.737 | 0.839 | 1e-135 | |
| 7413555 | 395 | protein kinase-like [Arabidopsis thalian | 0.909 | 0.716 | 0.809 | 1e-135 | |
| 30679773 | 378 | protein kinase family protein [Arabidops | 0.900 | 0.740 | 0.817 | 1e-135 |
| >gi|225439781|ref|XP_002276042.1| PREDICTED: serine/threonine-protein kinase PBS1 [Vitis vinifera] gi|297741502|emb|CBI32634.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 499 bits (1286), Expect = e-139, Method: Compositional matrix adjust.
Identities = 240/301 (79%), Positives = 264/301 (87%)
Query: 10 QDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVE 69
Q VAIKQLDRNG+QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGS+E
Sbjct: 95 QAVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLE 154
Query: 70 DHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKL 129
DHLHD+S GKK LDWNTRMKIAAGAA+GLEYLHDKA PPVIYRDLKCSNILL +HPKL
Sbjct: 155 DHLHDVSLGKKRLDWNTRMKIAAGAAKGLEYLHDKASPPVIYRDLKCSNILLGEDFHPKL 214
Query: 130 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKA 189
SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA TGQLTLKSDVYSFGVVLLEI++GRKA
Sbjct: 215 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKA 274
Query: 190 VDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDM 249
+D SKAA E +LVAWARPLF+DR + +ADP LQGQYP RG YQALAVAAMCV EQP++
Sbjct: 275 IDNSKAAGEHNLVAWARPLFKDRRKFLHMADPMLQGQYPLRGLYQALAVAAMCVQEQPNL 334
Query: 250 RPVIADVVTALAYLASQKYESDAEKVQSPCLDPGTPTRTKGDKERKLNGGRGSERERTRK 309
RP+I DVVTAL YLA+Q Y+ D + VQS + P TP R K D +RKL GS+++RTR+
Sbjct: 335 RPLIVDVVTALTYLAAQTYDPDTQPVQSSRVAPSTPPRAKKDGDRKLPSSAGSQKDRTRR 394
Query: 310 L 310
L
Sbjct: 395 L 395
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356548196|ref|XP_003542489.1| PREDICTED: serine/threonine-protein kinase PBS1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 499 bits (1285), Expect = e-139, Method: Compositional matrix adjust.
Identities = 237/280 (84%), Positives = 257/280 (91%)
Query: 10 QDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVE 69
Q VAIKQLDRNG+QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE+M LGS+E
Sbjct: 101 QIVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSLGSLE 160
Query: 70 DHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKL 129
DHLHD+SPGKK LDWNTRMKIAAGAARGLEYLHDKA PPVIYRDLKCSNILL GYHPKL
Sbjct: 161 DHLHDISPGKKRLDWNTRMKIAAGAARGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKL 220
Query: 130 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKA 189
SDFGLAKLGPVG+NTHVSTRVMGTYGYCAPEYA TGQLTLKSDVYSFGVVLLEI++GRKA
Sbjct: 221 SDFGLAKLGPVGENTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKA 280
Query: 190 VDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDM 249
+D SKAA EQ+LVAWARPLF+DR + S +ADP LQGQYPPRG +QALAVAAMCV EQ +M
Sbjct: 281 IDNSKAAGEQNLVAWARPLFKDRRKFSQMADPMLQGQYPPRGLFQALAVAAMCVQEQANM 340
Query: 250 RPVIADVVTALAYLASQKYESDAEKVQSPCLDPGTPTRTK 289
RPVIADVVTAL+YLASQKY+ + + +QS L PGTP R+K
Sbjct: 341 RPVIADVVTALSYLASQKYDPNTQTLQSSRLAPGTPPRSK 380
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|351721314|ref|NP_001237717.1| protein kinase-like protein [Glycine max] gi|223452496|gb|ACM89575.1| protein kinase-like protein [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 497 bits (1280), Expect = e-138, Method: Compositional matrix adjust.
Identities = 237/280 (84%), Positives = 255/280 (91%)
Query: 10 QDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVE 69
Q VAIKQLDRNG+QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE+M LGS+E
Sbjct: 101 QIVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSLGSLE 160
Query: 70 DHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKL 129
DHLHD+SPGKK LDWNTRMKIAAGAARGLEYLHDKA PPVIYRDLKCSNILL GYHPKL
Sbjct: 161 DHLHDISPGKKELDWNTRMKIAAGAARGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKL 220
Query: 130 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKA 189
SDFGLAKLGPVG+NTHVSTRVMGTYGYCAPEYA TGQLTLKSDVYSFGVVLLEI++GRKA
Sbjct: 221 SDFGLAKLGPVGENTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKA 280
Query: 190 VDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDM 249
+D SKAA EQ+LVAWARPLF+DR + S +ADP LQGQYP RG YQALAVAAMCV EQ +M
Sbjct: 281 IDNSKAAGEQNLVAWARPLFKDRRKFSQMADPMLQGQYPSRGLYQALAVAAMCVQEQANM 340
Query: 250 RPVIADVVTALAYLASQKYESDAEKVQSPCLDPGTPTRTK 289
RPVIADVVTAL+YLA QKY+ + + VQS L PGTP R+K
Sbjct: 341 RPVIADVVTALSYLALQKYDPNTQTVQSSRLAPGTPPRSK 380
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|217074768|gb|ACJ85744.1| unknown [Medicago truncatula] gi|388509798|gb|AFK42965.1| unknown [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 496 bits (1278), Expect = e-138, Method: Compositional matrix adjust.
Identities = 236/280 (84%), Positives = 257/280 (91%)
Query: 10 QDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVE 69
Q VAIKQLDRNG+QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGS+E
Sbjct: 98 QTVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLE 157
Query: 70 DHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKL 129
DHLHD+SPGKK LDW+TRMKIAAGAA+GLEYLHDKA PPVIYRDLKCSNILL GYHPKL
Sbjct: 158 DHLHDISPGKKRLDWSTRMKIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKL 217
Query: 130 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKA 189
SDFGLAK+GPVG+NTHVSTRVMGTYGYCAPEYA TGQLTLKSDVYSFGVVLLEI++GRKA
Sbjct: 218 SDFGLAKVGPVGENTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKA 277
Query: 190 VDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDM 249
+D SK AAEQ+LVAWARPLF+DR + + +ADP LQGQYP RG YQALAVAAMCV EQ +M
Sbjct: 278 IDNSKCAAEQNLVAWARPLFKDRRKFTQMADPMLQGQYPSRGIYQALAVAAMCVQEQANM 337
Query: 250 RPVIADVVTALAYLASQKYESDAEKVQSPCLDPGTPTRTK 289
RPVIADVVTAL+YLASQ+YE + + VQS L PGTP RT+
Sbjct: 338 RPVIADVVTALSYLASQRYEPNTQTVQSSRLGPGTPPRTR 377
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449440049|ref|XP_004137797.1| PREDICTED: serine/threonine-protein kinase PBS1-like [Cucumis sativus] gi|449519164|ref|XP_004166605.1| PREDICTED: serine/threonine-protein kinase PBS1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 496 bits (1277), Expect = e-138, Method: Compositional matrix adjust.
Identities = 240/304 (78%), Positives = 267/304 (87%), Gaps = 6/304 (1%)
Query: 10 QDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVE 69
Q VAIKQLDRNG+QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL+YEYMPLGS++
Sbjct: 95 QVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLIYEYMPLGSLD 154
Query: 70 DHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKL 129
DHLHD+SPG K +DWNTRM+IAAGAARGLEYLHDKA PPVIYRDLK SNILLD+GYHPKL
Sbjct: 155 DHLHDISPGTKFIDWNTRMRIAAGAARGLEYLHDKASPPVIYRDLKSSNILLDKGYHPKL 214
Query: 130 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKA 189
SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA TGQLTLKSDVYSFGVVLLEI++GRKA
Sbjct: 215 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKA 274
Query: 190 VDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDM 249
+D SKAA EQ+LV+WARPLF+DR R + +ADP L+GQYP RG YQALA+AAMCV EQP+M
Sbjct: 275 IDDSKAAGEQNLVSWARPLFKDRLRFAQMADPMLRGQYPSRGLYQALAIAAMCVQEQPNM 334
Query: 250 RPVIADVVTALAYLASQKYESDAEKVQSPCLDPG---TPTRTKGDKERKLNGGRGSERER 306
RPVIADVVTAL+YLASQ+Y+ + P PG TP R D +RKLNGGR +R
Sbjct: 335 RPVIADVVTALSYLASQRYDPG---IILPNDSPGSAYTPPRANRDSDRKLNGGRRYDRNP 391
Query: 307 TRKL 310
T++L
Sbjct: 392 TKRL 395
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255568454|ref|XP_002525201.1| receptor serine-threonine protein kinase, putative [Ricinus communis] gi|223535498|gb|EEF37167.1| receptor serine-threonine protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 496 bits (1276), Expect = e-138, Method: Compositional matrix adjust.
Identities = 234/285 (82%), Positives = 259/285 (90%), Gaps = 1/285 (0%)
Query: 10 QDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVE 69
Q VAIKQL+RNG+QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGS+E
Sbjct: 101 QVVAIKQLNRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLE 160
Query: 70 DHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKL 129
DHL+++SPG K LDWNTRMKIAAGAA+GLEYLHDKA PPVIYRDLKCSNILL +GYHPKL
Sbjct: 161 DHLYEISPGVKTLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGQGYHPKL 220
Query: 130 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKA 189
SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA TGQLTLKSDVYS GVVLLEI++GR+A
Sbjct: 221 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSLGVVLLEIITGRRA 280
Query: 190 VDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDM 249
+D SKA EQ+LVAWARPLF+DR + L+ADP LQGQYPPRG YQALA+AAMCV EQP++
Sbjct: 281 IDNSKATGEQNLVAWARPLFKDRKKFKLMADPMLQGQYPPRGLYQALAIAAMCVQEQPNL 340
Query: 250 RPVIADVVTALAYLASQKYESDAEKVQSPCLDPGTPTRTKGDKER 294
RPVIADVVTAL+YLASQKY+ + + QSP PGTP RTK + +R
Sbjct: 341 RPVIADVVTALSYLASQKYDPEVQTAQSPRWTPGTP-RTKREAKR 384
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356505176|ref|XP_003521368.1| PREDICTED: serine/threonine-protein kinase PBS1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 488 bits (1257), Expect = e-135, Method: Compositional matrix adjust.
Identities = 233/280 (83%), Positives = 252/280 (90%)
Query: 10 QDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVE 69
Q VAIKQLDRNG+QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLG +E
Sbjct: 97 QVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGCLE 156
Query: 70 DHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKL 129
DHLHD+ PGKK LDWNTRMKIAAGAA+GLEYLHDKA PPVIYRDLKCSNILL GYHPKL
Sbjct: 157 DHLHDIPPGKKRLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKL 216
Query: 130 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKA 189
SDFGLAKLGPVG+NTHVSTRVMGTYGYCAPEYA TGQLTLKSDVYSFGVVLLEI++GRKA
Sbjct: 217 SDFGLAKLGPVGENTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKA 276
Query: 190 VDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDM 249
+D SK+A EQ+LVAWARPLF+DR + S +ADP L GQYPPRG YQALAVAAMCV EQ ++
Sbjct: 277 IDNSKSAGEQNLVAWARPLFKDRRKFSQMADPTLHGQYPPRGLYQALAVAAMCVQEQANL 336
Query: 250 RPVIADVVTALAYLASQKYESDAEKVQSPCLDPGTPTRTK 289
RPVIADVVTAL+YLASQKY+ + VQS P TP RT+
Sbjct: 337 RPVIADVVTALSYLASQKYDPNTHTVQSSRHAPSTPPRTR 376
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357510543|ref|XP_003625560.1| Serine/threonine protein kinase PBS1 [Medicago truncatula] gi|355500575|gb|AES81778.1| Serine/threonine protein kinase PBS1 [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 488 bits (1255), Expect = e-135, Method: Compositional matrix adjust.
Identities = 235/280 (83%), Positives = 253/280 (90%), Gaps = 2/280 (0%)
Query: 10 QDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVE 69
Q VAIKQLDRNG+QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLG +E
Sbjct: 97 QVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGCLE 156
Query: 70 DHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKL 129
DHLHD+SP KK LDWNTRMKIAAGAA+GLEYLHDKA PPVIYRDLKCSNILL GYHPKL
Sbjct: 157 DHLHDISPAKKRLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKL 216
Query: 130 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKA 189
SDFGLAKLGPVG+NTHVSTRVMGTYGYCAPEYA TGQLTLKSDVYSFGVVLLEI++GRKA
Sbjct: 217 SDFGLAKLGPVGENTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKA 276
Query: 190 VDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDM 249
+D SK+AAEQ+LVAWARPLF+DR + S +ADP LQGQYP RG YQALAVAAMCV EQ +M
Sbjct: 277 IDYSKSAAEQNLVAWARPLFKDRRKFSQMADPMLQGQYPSRGLYQALAVAAMCVQEQANM 336
Query: 250 RPVIADVVTALAYLASQKYESDAEKVQSPCLDPGTPTRTK 289
RPVIADVVTAL+YLA QK+ D VQ+ L P TPTRT+
Sbjct: 337 RPVIADVVTALSYLALQKH--DPNTVQNSRLAPSTPTRTR 374
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|7413555|emb|CAB86034.1| protein kinase-like [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 487 bits (1253), Expect = e-135, Method: Compositional matrix adjust.
Identities = 229/283 (80%), Positives = 255/283 (90%)
Query: 10 QDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVE 69
Q AIKQLD NG+QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGS+E
Sbjct: 97 QTAAIKQLDHNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLE 156
Query: 70 DHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKL 129
DHLHD+SPGK+PLDWNTRMKIAAGAA+GLEYLHDK PPVIYRDLKCSNILLD Y PKL
Sbjct: 157 DHLHDISPGKQPLDWNTRMKIAAGAAKGLEYLHDKTMPPVIYRDLKCSNILLDDDYFPKL 216
Query: 130 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKA 189
SDFGLAKLGPVGD +HVSTRVMGTYGYCAPEYA TGQLTLKSDVYSFGVVLLEI++GRKA
Sbjct: 217 SDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKA 276
Query: 190 VDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDM 249
+D+S++ EQ+LVAWARPLF+DR + S +ADP LQGQYPPRG YQALAVAAMCV EQP++
Sbjct: 277 IDSSRSTGEQNLVAWARPLFKDRRKFSQMADPMLQGQYPPRGLYQALAVAAMCVQEQPNL 336
Query: 250 RPVIADVVTALAYLASQKYESDAEKVQSPCLDPGTPTRTKGDK 292
RP+IADVVTAL+YLASQK++ A+ VQ PGTP R+K ++
Sbjct: 337 RPLIADVVTALSYLASQKFDPLAQPVQGSLFAPGTPPRSKRER 379
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|30679773|ref|NP_195900.2| protein kinase family protein [Arabidopsis thaliana] gi|110736288|dbj|BAF00114.1| protein kinase like protein [Arabidopsis thaliana] gi|332003136|gb|AED90519.1| protein kinase family protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 486 bits (1251), Expect = e-135, Method: Compositional matrix adjust.
Identities = 229/280 (81%), Positives = 253/280 (90%)
Query: 10 QDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVE 69
Q AIKQLD NG+QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGS+E
Sbjct: 97 QTAAIKQLDHNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLE 156
Query: 70 DHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKL 129
DHLHD+SPGK+PLDWNTRMKIAAGAA+GLEYLHDK PPVIYRDLKCSNILLD Y PKL
Sbjct: 157 DHLHDISPGKQPLDWNTRMKIAAGAAKGLEYLHDKTMPPVIYRDLKCSNILLDDDYFPKL 216
Query: 130 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKA 189
SDFGLAKLGPVGD +HVSTRVMGTYGYCAPEYA TGQLTLKSDVYSFGVVLLEI++GRKA
Sbjct: 217 SDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKA 276
Query: 190 VDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDM 249
+D+S++ EQ+LVAWARPLF+DR + S +ADP LQGQYPPRG YQALAVAAMCV EQP++
Sbjct: 277 IDSSRSTGEQNLVAWARPLFKDRRKFSQMADPMLQGQYPPRGLYQALAVAAMCVQEQPNL 336
Query: 250 RPVIADVVTALAYLASQKYESDAEKVQSPCLDPGTPTRTK 289
RP+IADVVTAL+YLASQK++ A+ VQ PGTP R+K
Sbjct: 337 RPLIADVVTALSYLASQKFDPLAQPVQGSLFAPGTPPRSK 376
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 311 | ||||||
| TAIR|locus:2151191 | 378 | CDL1 "CDG1-like 1" [Arabidopsi | 0.900 | 0.740 | 0.817 | 3e-124 | |
| TAIR|locus:2183018 | 513 | AT5G18610 [Arabidopsis thalian | 0.929 | 0.563 | 0.756 | 9.7e-118 | |
| TAIR|locus:2179857 | 456 | PBS1 "avrPphB susceptible 1" [ | 0.932 | 0.635 | 0.707 | 2.3e-110 | |
| TAIR|locus:2056613 | 424 | AT2G28590 [Arabidopsis thalian | 0.903 | 0.662 | 0.707 | 7.5e-105 | |
| TAIR|locus:2085720 | 386 | AT3G20530 [Arabidopsis thalian | 0.858 | 0.691 | 0.712 | 2.6e-102 | |
| TAIR|locus:2087263 | 363 | AT3G24790 [Arabidopsis thalian | 0.842 | 0.721 | 0.721 | 3.3e-102 | |
| TAIR|locus:2034344 | 381 | ASG5 "ALTERED SEED GERMINATION | 0.893 | 0.729 | 0.648 | 8.4e-97 | |
| TAIR|locus:2098580 | 414 | AT3G07070 [Arabidopsis thalian | 0.816 | 0.613 | 0.688 | 2e-95 | |
| TAIR|locus:2119350 | 389 | AT4G13190 [Arabidopsis thalian | 0.900 | 0.719 | 0.618 | 2.3e-94 | |
| TAIR|locus:2036818 | 389 | AT1G61860 [Arabidopsis thalian | 0.887 | 0.709 | 0.619 | 1.2e-90 |
| TAIR|locus:2151191 CDL1 "CDG1-like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1221 (434.9 bits), Expect = 3.0e-124, P = 3.0e-124
Identities = 229/280 (81%), Positives = 253/280 (90%)
Query: 10 QDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVE 69
Q AIKQLD NG+QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGS+E
Sbjct: 97 QTAAIKQLDHNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLE 156
Query: 70 DHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKL 129
DHLHD+SPGK+PLDWNTRMKIAAGAA+GLEYLHDK PPVIYRDLKCSNILLD Y PKL
Sbjct: 157 DHLHDISPGKQPLDWNTRMKIAAGAAKGLEYLHDKTMPPVIYRDLKCSNILLDDDYFPKL 216
Query: 130 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKA 189
SDFGLAKLGPVGD +HVSTRVMGTYGYCAPEYA TGQLTLKSDVYSFGVVLLEI++GRKA
Sbjct: 217 SDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKA 276
Query: 190 VDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDM 249
+D+S++ EQ+LVAWARPLF+DR + S +ADP LQGQYPPRG YQALAVAAMCV EQP++
Sbjct: 277 IDSSRSTGEQNLVAWARPLFKDRRKFSQMADPMLQGQYPPRGLYQALAVAAMCVQEQPNL 336
Query: 250 RPVIADVVTALAYLASQKYESDAEKVQSPCLDPGTPTRTK 289
RP+IADVVTAL+YLASQK++ A+ VQ PGTP R+K
Sbjct: 337 RPLIADVVTALSYLASQKFDPLAQPVQGSLFAPGTPPRSK 376
|
|
| TAIR|locus:2183018 AT5G18610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1141 (406.7 bits), Expect = 9.7e-118, Sum P(2) = 9.7e-118
Identities = 220/291 (75%), Positives = 245/291 (84%)
Query: 10 QDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVE 69
Q VA+KQLDRNG+QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGS+E
Sbjct: 107 QIVAVKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLE 166
Query: 70 DHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKL 129
DHLHDL P K+PLDW+TRM IAAGAA+GLEYLHDKA PPVIYRDLK SNILL GYHPKL
Sbjct: 167 DHLHDLPPDKEPLDWSTRMTIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLGDGYHPKL 226
Query: 130 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKA 189
SDFGLAKLGPVGD THVSTRVMGTYGYCAPEYA TGQLTLKSDVYSFGVV LE+++GRKA
Sbjct: 227 SDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKA 286
Query: 190 VDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDM 249
+D ++A E +LVAWARPLF+DR + +ADP LQG+YP RG YQALAVAAMC+ EQ
Sbjct: 287 IDNARAPGEHNLVAWARPLFKDRRKFPKMADPSLQGRYPMRGLYQALAVAAMCLQEQAAT 346
Query: 250 RPVIADVVTALAYLASQKYESDAEKVQSPCLDPGTP-TRTKGDKERKLNGG 299
RP+I DVVTAL YLASQ ++ +A Q+ G P RT+ D+ R L G
Sbjct: 347 RPLIGDVVTALTYLASQTFDPNAPSGQNSRSGSGPPFIRTRDDR-RSLGDG 396
|
|
| TAIR|locus:2179857 PBS1 "avrPphB susceptible 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1090 (388.8 bits), Expect = 2.3e-110, P = 2.3e-110
Identities = 208/294 (70%), Positives = 240/294 (81%)
Query: 10 QDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVE 69
Q VA+KQLDRNG+QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE+MPLGS+E
Sbjct: 110 QVVAVKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLGSLE 169
Query: 70 DHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKL 129
DHLHDL P K+ LDWN RMKIAAGAA+GLE+LHDKA PPVIYRD K SNILLD G+HPKL
Sbjct: 170 DHLHDLPPDKEALDWNMRMKIAAGAAKGLEFLHDKANPPVIYRDFKSSNILLDEGFHPKL 229
Query: 130 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKA 189
SDFGLAKLGP GD +HVSTRVMGTYGYCAPEYA TGQLT+KSDVYSFGVV LE+++GRKA
Sbjct: 230 SDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKA 289
Query: 190 VDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDM 249
+D+ EQ+LVAWARPLF DR + +ADP L+G++P R YQALAVA+MC+ EQ
Sbjct: 290 IDSEMPHGEQNLVAWARPLFNDRRKFIKLADPRLKGRFPTRALYQALAVASMCIQEQAAT 349
Query: 250 RPVIADVVTALAYLASQKYESDAEKVQSPCLDPGTPTRTKGDKERKLNGGRGSE 303
RP+IADVVTAL+YLA+Q Y+ + + + G T+ D GG GS+
Sbjct: 350 RPLIADVVTALSYLANQAYDPSKDDSRRNRDERGARLITRNDD----GGGSGSK 399
|
|
| TAIR|locus:2056613 AT2G28590 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1038 (370.5 bits), Expect = 7.5e-105, P = 7.5e-105
Identities = 203/287 (70%), Positives = 226/287 (78%)
Query: 10 QDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVE 69
Q VAIKQLDRNG QG REF+VEVL LSL HPNLV LIG+CA+G QRLLVYEYMPLGS++
Sbjct: 122 QVVAIKQLDRNGAQGIREFVVEVLTLSLADHPNLVKLIGFCAEGVQRLLVYEYMPLGSLD 181
Query: 70 DHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKL 129
+HLHDL GK PL WNTRMKIAAGAARGLEYLHD KPPVIYRDLKCSNIL+D GYH KL
Sbjct: 182 NHLHDLPSGKNPLAWNTRMKIAAGAARGLEYLHDTMKPPVIYRDLKCSNILIDEGYHAKL 241
Query: 130 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKA 189
SDFGLAK+GP G THVSTRVMGTYGYCAP+YA TGQLT KSDVYSFGVVLLE+++GRKA
Sbjct: 242 SDFGLAKVGPRGSETHVSTRVMGTYGYCAPDYALTGQLTFKSDVYSFGVVLLELITGRKA 301
Query: 190 VDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDM 249
D ++ QSLV WA PLF+DR + DP L+G YP RG YQALA+AAMCV EQP M
Sbjct: 302 YDNTRTRNHQSLVEWANPLFKDRKNFKKMVDPLLEGDYPVRGLYQALAIAAMCVQEQPSM 361
Query: 250 RPVIADVVTALAYLASQKYESDAEKVQSPCLDPGTPTRTKGDKERKL 296
RPVIADVV AL +LAS KY+ + Q T TK D+E+ L
Sbjct: 362 RPVIADVVMALDHLASSKYDRSHRQKQD------NVTETKVDEEKTL 402
|
|
| TAIR|locus:2085720 AT3G20530 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1014 (362.0 bits), Expect = 2.6e-102, P = 2.6e-102
Identities = 191/268 (71%), Positives = 226/268 (84%)
Query: 10 QDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVE 69
Q VA+KQLDRNG QGNREFLVEV+MLSLLHH NLVNL+GYCADGDQR+LVYEYM GS+E
Sbjct: 106 QVVAVKQLDRNGYQGNREFLVEVMMLSLLHHQNLVNLVGYCADGDQRILVYEYMQNGSLE 165
Query: 70 DHLHDLSPGKK-PLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK 128
DHL +L+ KK PLDW+TRMK+AAGAARGLEYLH+ A PPVIYRD K SNILLD ++PK
Sbjct: 166 DHLLELARNKKKPLDWDTRMKVAAGAARGLEYLHETADPPVIYRDFKASNILLDEEFNPK 225
Query: 129 LSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRK 188
LSDFGLAK+GP G THVSTRVMGTYGYCAPEYA TGQLT+KSDVYSFGVV LE+++GR+
Sbjct: 226 LSDFGLAKVGPTGGETHVSTRVMGTYGYCAPEYALTGQLTVKSDVYSFGVVFLEMITGRR 285
Query: 189 AVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPD 248
+DT+K EQ+LV WA PLF+DR + +L+ADP L+G+YP +G YQALAVAAMC+ E+
Sbjct: 286 VIDTTKPTEEQNLVTWASPLFKDRRKFTLMADPLLEGKYPIKGLYQALAVAAMCLQEEAA 345
Query: 249 MRPVIADVVTALAYLASQKYESDAEKVQ 276
RP+++DVVTAL YLA K E D + V+
Sbjct: 346 TRPMMSDVVTALEYLAVTKTEEDGQTVE 373
|
|
| TAIR|locus:2087263 AT3G24790 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1013 (361.7 bits), Expect = 3.3e-102, P = 3.3e-102
Identities = 189/262 (72%), Positives = 224/262 (85%)
Query: 10 QDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVE 69
Q VA+KQLDRNG+QG REFLVEVLMLSLLHH NLVNLIGYCADGDQRLLVYEYMPLGS+E
Sbjct: 71 QVVAVKQLDRNGLQGQREFLVEVLMLSLLHHRNLVNLIGYCADGDQRLLVYEYMPLGSLE 130
Query: 70 DHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKL 129
DHL DL PG+KPLDWNTR+KIA GAA+G+EYLHD+A PPVIYRDLK SNILLD Y KL
Sbjct: 131 DHLLDLEPGQKPLDWNTRIKIALGAAKGIEYLHDEADPPVIYRDLKSSNILLDPEYVAKL 190
Query: 130 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKA 189
SDFGLAKLGPVGD HVS+RVMGTYGYCAPEY +TG LT KSDVYSFGVVLLE++SGR+
Sbjct: 191 SDFGLAKLGPVGDTLHVSSRVMGTYGYCAPEYQRTGYLTNKSDVYSFGVVLLELISGRRV 250
Query: 190 VDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDM 249
+DT + + EQ+LV WA P+F+D TR+ +ADP L+G YP + QA+AVAAMC+HE+P +
Sbjct: 251 IDTMRPSHEQNLVTWALPIFRDPTRYWQLADPLLRGDYPEKSLNQAIAVAAMCLHEEPTV 310
Query: 250 RPVIADVVTALAYLASQKYESD 271
RP+++DV+TAL++L + S+
Sbjct: 311 RPLMSDVITALSFLGASSNSSN 332
|
|
| TAIR|locus:2034344 ASG5 "ALTERED SEED GERMINATION 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 962 (343.7 bits), Expect = 8.4e-97, P = 8.4e-97
Identities = 181/279 (64%), Positives = 219/279 (78%)
Query: 10 QDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVE 69
Q VAIKQL+ +G+QGNREF+VEVLMLSLLHHPNLV LIGYC GDQRLLVYEYMP+GS+E
Sbjct: 101 QVVAIKQLNPDGLQGNREFIVEVLMLSLLHHPNLVTLIGYCTSGDQRLLVYEYMPMGSLE 160
Query: 70 DHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKL 129
DHL DL ++PL WNTRMKIA GAARG+EYLH A PPVIYRDLK +NILLD+ + PKL
Sbjct: 161 DHLFDLESNQEPLSWNTRMKIAVGAARGIEYLHCTANPPVIYRDLKSANILLDKEFSPKL 220
Query: 130 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKA 189
SDFGLAKLGPVGD THVSTRVMGTYGYCAPEYA +G+LT+KSD+Y FGVVLLE+++GRKA
Sbjct: 221 SDFGLAKLGPVGDRTHVSTRVMGTYGYCAPEYAMSGKLTVKSDIYCFGVVLLELITGRKA 280
Query: 190 VDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDM 249
+D + EQ+LV W+RP +D+ + + DP L+G+YP R A+A+ AMC++E+
Sbjct: 281 IDLGQKQGEQNLVTWSRPYLKDQKKFGHLVDPSLRGKYPRRCLNYAIAIIAMCLNEEAHY 340
Query: 250 RPVIADVVTALAYLASQKYESDAEKVQSPCLDPG-TPTR 287
RP I D+V AL YLA+Q +A V SP + TP R
Sbjct: 341 RPFIGDIVVALEYLAAQSRSHEARNVSSPSPEISRTPRR 379
|
|
| TAIR|locus:2098580 AT3G07070 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 949 (339.1 bits), Expect = 2.0e-95, P = 2.0e-95
Identities = 175/254 (68%), Positives = 217/254 (85%)
Query: 12 VAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDH 71
VA+KQLDRNG+QGN+EF+VEVLMLSLLHH +LVNLIGYCADGDQRLLVYEYM GS+EDH
Sbjct: 105 VAVKQLDRNGLQGNKEFIVEVLMLSLLHHKHLVNLIGYCADGDQRLLVYEYMSRGSLEDH 164
Query: 72 LHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSD 131
L DL+P + PLDW+TR++IA GAA GLEYLHDKA PPVIYRDLK +NILLD ++ KLSD
Sbjct: 165 LLDLTPDQIPLDWDTRIRIALGAAMGLEYLHDKANPPVIYRDLKAANILLDGEFNAKLSD 224
Query: 132 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVD 191
FGLAKLGPVGD HVS+RVMGTYGYCAPEY +TGQLT KSDVYSFGVVLLE+++GR+ +D
Sbjct: 225 FGLAKLGPVGDKQHVSSRVMGTYGYCAPEYQRTGQLTTKSDVYSFGVVLLELITGRRVID 284
Query: 192 TSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRP 251
T++ EQ+LV WA+P+F++ +R +ADP L+G +P + QA+AVAAMC+ E+ +RP
Sbjct: 285 TTRPKDEQNLVTWAQPVFKEPSRFPELADPSLEGVFPEKALNQAVAVAAMCLQEEATVRP 344
Query: 252 VIADVVTALAYLAS 265
+++DVVTAL +L +
Sbjct: 345 LMSDVVTALGFLGT 358
|
|
| TAIR|locus:2119350 AT4G13190 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 939 (335.6 bits), Expect = 2.3e-94, P = 2.3e-94
Identities = 175/283 (61%), Positives = 230/283 (81%)
Query: 10 QDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVE 69
Q VA+KQLDRNG+QGNREFLVE+ LSLLHHPNL NLIGYC DGDQRLLV+E+MPLGS+E
Sbjct: 95 QVVAVKQLDRNGLQGNREFLVEIFRLSLLHHPNLANLIGYCLDGDQRLLVHEFMPLGSLE 154
Query: 70 DHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKL 129
DHL D+ G++PLDWN+R++IA GAA+GLEYLH+KA PPVIYRD K SNILL+ + KL
Sbjct: 155 DHLLDVVVGQQPLDWNSRIRIALGAAKGLEYLHEKANPPVIYRDFKSSNILLNVDFDAKL 214
Query: 130 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKA 189
SDFGLAKLG VGD +VS+RV+GTYGYCAPEY KTGQLT+KSDVYSFGVVLLE+++G++
Sbjct: 215 SDFGLAKLGSVGDTQNVSSRVVGTYGYCAPEYHKTGQLTVKSDVYSFGVVLLELITGKRV 274
Query: 190 VDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDM 249
+DT++ EQ+LV WA+P+F++ R +ADP LQG++P + QA+A+AAMC+ E+P +
Sbjct: 275 IDTTRPCHEQNLVTWAQPIFREPNRFPELADPLLQGEFPEKSLNQAVAIAAMCLQEEPIV 334
Query: 250 RPVIADVVTALAYLASQKYESDAEKVQSPCLDPGTPTRTKGDK 292
RP+I+DVVTAL++++++ + L+P +P +T D+
Sbjct: 335 RPLISDVVTALSFMSTET--GSPSGLTGTALNPLSP-KTVEDQ 374
|
|
| TAIR|locus:2036818 AT1G61860 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 904 (323.3 bits), Expect = 1.2e-90, P = 1.2e-90
Identities = 174/281 (61%), Positives = 210/281 (74%)
Query: 8 LLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGS 67
L Q VA+K+LDRNG+QG REF EV++LSL HPNLVNLIGYC + +QR+LVYE+MP GS
Sbjct: 107 LNQVVAVKRLDRNGLQGTREFFAEVMVLSLAQHPNLVNLIGYCVEDEQRVLVYEFMPNGS 166
Query: 68 VEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP 127
+EDHL DL G LDW TRM+I GAA+GLEYLHD A PPVIYRD K SNILL ++
Sbjct: 167 LEDHLFDLPEGSPSLDWFTRMRIVHGAAKGLEYLHDYADPPVIYRDFKASNILLQSDFNS 226
Query: 128 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 187
KLSDFGLA+LGP HVSTRVMGTYGYCAPEYA TGQLT KSDVYSFGVVLLEI+SGR
Sbjct: 227 KLSDFGLARLGPTEGKDHVSTRVMGTYGYCAPEYAMTGQLTAKSDVYSFGVVLLEIISGR 286
Query: 188 KAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQP 247
+A+D + EQ+L++WA PL +DR + I DP L G YP +G +QALA+AAMC+ E+
Sbjct: 287 RAIDGDRPTEEQNLISWAEPLLKDRRMFAQIVDPNLDGNYPVKGLHQALAIAAMCLQEEA 346
Query: 248 DMRPVIADVVTALAYLASQKYESDAEKVQSPCLDPGTPTRT 288
+ RP++ DVVTAL +LA E V + P +PT+T
Sbjct: 347 ETRPLMGDVVTALEFLAKP-----IEVVDNTNTTPASPTQT 382
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.914 |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 311 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-49 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 7e-48 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 9e-48 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-47 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-45 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-43 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-43 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-30 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 5e-28 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 6e-28 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 8e-28 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-26 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-26 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 5e-26 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 6e-26 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 6e-26 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-25 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-25 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-25 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-23 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-22 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-22 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-22 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-22 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-22 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-21 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-21 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-21 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-21 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-21 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-21 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 5e-21 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 9e-21 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-20 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-20 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-20 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-20 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-20 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-20 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 6e-20 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 6e-20 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 7e-20 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-19 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-19 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-19 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-19 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-19 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 6e-19 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 6e-19 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-18 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-18 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-18 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-18 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-18 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-18 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-18 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-18 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 7e-18 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 9e-18 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-17 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-17 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-17 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-17 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-17 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-17 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-17 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 4e-17 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-17 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 5e-17 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 5e-17 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 5e-17 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 6e-17 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 6e-17 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 7e-17 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 8e-17 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 8e-17 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 9e-17 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-16 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-16 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-16 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-16 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-16 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-16 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-16 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-16 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 5e-16 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 7e-16 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 7e-16 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 8e-16 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-15 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-15 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-15 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-15 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-15 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-15 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-15 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-15 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-15 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-15 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-15 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-15 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 5e-15 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-15 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 5e-15 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 8e-15 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-14 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-14 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-14 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-14 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-14 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-14 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-14 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-14 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-14 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-14 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-14 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-14 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-14 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-14 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 5e-14 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 5e-14 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 6e-14 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 6e-14 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 7e-14 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 8e-14 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 8e-14 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-13 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-13 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-13 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-13 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-13 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-13 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-13 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-13 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-13 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-13 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-13 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-13 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-13 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-13 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-13 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 4e-13 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 5e-13 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 5e-13 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 6e-13 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 6e-13 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 9e-13 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-12 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-12 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-12 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-12 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-12 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-12 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-12 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-12 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-12 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-12 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-12 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 4e-12 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-12 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 5e-12 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 5e-12 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 6e-12 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 7e-12 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 7e-12 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 8e-12 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-11 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-11 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-11 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-11 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-11 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-11 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-11 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-11 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-11 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-11 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-11 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-11 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-11 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 4e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-11 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 5e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 6e-11 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 6e-11 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 6e-11 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 7e-11 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 7e-11 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-10 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-10 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-10 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-10 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-10 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-10 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-10 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-10 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-10 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-10 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-10 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-10 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-10 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-10 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-10 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 5e-10 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 6e-10 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 6e-10 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 8e-10 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 8e-10 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 9e-10 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-09 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-09 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-09 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-09 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-09 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-09 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-09 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-09 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-09 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-09 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-09 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-09 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 4e-09 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-09 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 4e-09 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 5e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 5e-09 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 6e-09 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 8e-09 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 8e-09 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-08 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-08 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-08 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-08 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-08 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-08 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-08 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-08 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 6e-08 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 8e-08 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 9e-08 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 9e-08 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-07 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-07 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-07 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-07 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-07 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-07 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-07 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 5e-07 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 5e-07 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 6e-07 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 8e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 9e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 9e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 9e-07 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-06 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-06 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-06 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 4e-06 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 5e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 5e-06 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 6e-06 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 6e-06 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 7e-06 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 7e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 8e-06 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 9e-06 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-05 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-05 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-05 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-05 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-05 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-05 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 4e-05 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 4e-05 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 5e-05 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 6e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 7e-05 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-04 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-04 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-04 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-04 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-04 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-04 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 3e-04 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 0.001 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 0.002 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 0.002 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.003 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 0.003 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 163 bits (415), Expect = 2e-49
Identities = 65/177 (36%), Positives = 94/177 (53%), Gaps = 11/177 (6%)
Query: 10 QDVAIKQLDRNGVQGNRE-FLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSV 68
+ VAIK + + E L E+ +L L+HPN+V L G D + LV EY GS+
Sbjct: 19 KKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78
Query: 69 EDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG-YHP 127
+D L + + L + ++I GLEYLH +I+RDLK NILLD
Sbjct: 79 KDLLKEN---EGKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKV 132
Query: 128 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK-TGQLTLKSDVYSFGVVLLEI 183
KL+DFGL+KL + + + ++GT Y APE G + KSD++S GV+L E+
Sbjct: 133 KLADFGLSKL--LTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 160 bits (408), Expect = 7e-48
Identities = 67/177 (37%), Positives = 93/177 (52%), Gaps = 7/177 (3%)
Query: 10 QDVAIKQLDRN-GVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSV 68
+VA+K L + Q EFL E ++ L HPN+V L+G C + + ++V EYMP G +
Sbjct: 29 VEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDL 88
Query: 69 EDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK 128
D+L P K L + + A ARG+EYL K I+RDL N L+ K
Sbjct: 89 LDYLRKNRP--KELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVK 143
Query: 129 LSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 185
+SDFGL++ D V + APE K G+ T KSDV+SFGV+L EI +
Sbjct: 144 ISDFGLSRDLYDDDYYKVKGG-KLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFT 199
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 9e-48
Identities = 63/178 (35%), Positives = 89/178 (50%), Gaps = 7/178 (3%)
Query: 10 QDVAIKQLDRNGVQGNR-EFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSV 68
VA+K L + R EFL E ++ L HPN+V L+G C G+ +V EYMP G +
Sbjct: 29 TKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDL 88
Query: 69 EDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK 128
D L + L +++A A+G+EYL K ++RDL N L+ K
Sbjct: 89 LDFLRKH---GEKLTLKDLLQMALQIAKGMEYLESK---NFVHRDLAARNCLVTENLVVK 142
Query: 129 LSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG 186
+SDFGL++ D + APE K G+ T KSDV+SFGV+L EI +
Sbjct: 143 ISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTL 200
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 159 bits (405), Expect = 2e-47
Identities = 61/177 (34%), Positives = 88/177 (49%), Gaps = 8/177 (4%)
Query: 10 QDVAIKQLDRNGVQGNR-EFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSV 68
+VA+K L + + EFL E ++ L HPN+V L+G C + + +V EYM G +
Sbjct: 29 VEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDL 88
Query: 69 EDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK 128
+L + L + + A ARG+EYL K I+RDL N L+ K
Sbjct: 89 LSYLRKN---RPKLSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVK 142
Query: 129 LSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 185
+SDFGL++ D + APE K G+ T KSDV+SFGV+L EI +
Sbjct: 143 ISDFGLSRDLYDDDYYRKRGG-KLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFT 198
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 2e-45
Identities = 78/264 (29%), Positives = 114/264 (43%), Gaps = 39/264 (14%)
Query: 11 DVAIKQLDRNGVQGNR-EFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVE 69
+VA+K L + + R +FL E ++ L HPN+V L+G C + + LV EYM G +
Sbjct: 25 EVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLL 84
Query: 70 DHL-----HDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG 124
D+L SP K L + A A+G+EYL K ++RDL N L+
Sbjct: 85 DYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGED 141
Query: 125 YHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEIL 184
K+SDFGL++ D T + APE K G T KSDV+SFGV+L EI
Sbjct: 142 LVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIF 201
Query: 185 S-------GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALA 237
+ G + + + R + PE Y P Y+
Sbjct: 202 TLGATPYPGLSNEEVLEY-------------LRKGYR---LPKPE----YCPDELYE--- 238
Query: 238 VAAMCVHEQPDMRPVIADVVTALA 261
+ C P+ RP +++V L
Sbjct: 239 LMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 149 bits (379), Expect = 1e-43
Identities = 70/253 (27%), Positives = 107/253 (42%), Gaps = 35/253 (13%)
Query: 10 QDVAIKQLDRNGVQGNRE-FLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSV 68
+ VAIK + + ++ +RE L E+ +L L HPN+V L D D+ LV EY G +
Sbjct: 25 KLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDL 84
Query: 69 EDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK 128
D L + L + LEYLH K +++RDLK NILLD H K
Sbjct: 85 FDLLKK----RGRLSEDEARFYLRQILSALEYLHSK---GIVHRDLKPENILLDEDGHVK 137
Query: 129 LSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRK 188
L+DFGLA+ + ++T V GT Y APE D++S GV+L E+L+G
Sbjct: 138 LADFGLARQ--LDPGEKLTTFV-GTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTG-- 192
Query: 189 AVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAM-----CV 243
+P F + + + + P ++ A +
Sbjct: 193 -----------------KPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLL 235
Query: 244 HEQPDMRPVIADV 256
+ P+ R +
Sbjct: 236 VKDPEKRLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 3e-43
Identities = 70/179 (39%), Positives = 92/179 (51%), Gaps = 12/179 (6%)
Query: 12 VAIKQL--DRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVE 69
VA+K L + ++ E+ +L L HPN+V LI D D LV EY G
Sbjct: 27 VAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGD-- 84
Query: 70 DHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKL 129
L D PL + KIA RGLEYLH +I+RDLK NILLD K+
Sbjct: 85 --LFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNG---IIHRDLKPENILLDENGVVKI 139
Query: 130 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQL-TLKSDVYSFGVVLLEILSGR 187
+DFGLAK + ++ ++T V GT Y APE G K DV+S GV+L E+L+G+
Sbjct: 140 ADFGLAKKL-LKSSSSLTTFV-GTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 114 bits (289), Expect = 2e-30
Identities = 56/201 (27%), Positives = 92/201 (45%), Gaps = 31/201 (15%)
Query: 3 QVILCLLQD----VAIKQLDRNGVQGNREFLVEVL-----MLSLLHHPNLVNLIGYC--A 51
V L L +D +A+K ++ + G+ E +E L +LS L HPN+V G
Sbjct: 15 SVYLALDKDTGELMAVKSVE---LSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDE 71
Query: 52 DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN-----TRMKIAAGAARGLEYLHDKAK 106
+ + + EY+ GS+ L L TR + GL YLH
Sbjct: 72 EKNTLNIFLEYVSGGSLSSLLKK----FGKLPEPVIRKYTRQIL-----EGLAYLHSNG- 121
Query: 107 PPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ 166
+++RD+K +NIL+D KL+DFG AK + + V GT + APE + +
Sbjct: 122 --IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEE 179
Query: 167 LTLKSDVYSFGVVLLEILSGR 187
+D++S G ++E+ +G+
Sbjct: 180 YGRAADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 5e-28
Identities = 51/178 (28%), Positives = 85/178 (47%), Gaps = 9/178 (5%)
Query: 10 QDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVE 69
++VAIK + + + + E+ +L HPN+V G D+ +V E+ GS++
Sbjct: 26 KEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLK 85
Query: 70 DHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKL 129
D L + L + + +GLEYLH +I+RD+K +NILL KL
Sbjct: 86 DLLKST---NQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKL 139
Query: 130 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 187
DFGL+ +T ++GT + APE K+D++S G+ +E+ G+
Sbjct: 140 IDFGLSA---QLSDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 6e-28
Identities = 57/179 (31%), Positives = 91/179 (50%), Gaps = 12/179 (6%)
Query: 12 VAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR--LLVYEYMPLGSV 68
VA+K L+ +G Q +F E+ +L L H N+V G C R L+ EY+P GS+
Sbjct: 36 VAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSL 95
Query: 69 EDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK 128
D+L ++ + ++ +G++YL + I+RDL NIL++ K
Sbjct: 96 RDYLQRHRD---QINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVK 149
Query: 129 LSDFGLAKLGPVGDNTHVST--RVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 185
+SDFGLAK+ P + + + Y APE +T + + SDV+SFGV L E+ +
Sbjct: 150 ISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 8e-28
Identities = 64/179 (35%), Positives = 95/179 (53%), Gaps = 12/179 (6%)
Query: 10 QDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVE 69
Q VA+K L + + FL E +++ L HPNLV L+G G+ +V EYM GS+
Sbjct: 30 QKVAVKCLKDDS-TAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLV 88
Query: 70 DHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKL 129
D+L S G+ + ++ A G+EYL +K ++RDL N+L+ K+
Sbjct: 89 DYLR--SRGRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKV 143
Query: 130 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GR 187
SDFGLAK G S ++ + APE + + + KSDV+SFG++L EI S GR
Sbjct: 144 SDFGLAKEASQG---QDSGKL--PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 1e-26
Identities = 59/198 (29%), Positives = 102/198 (51%), Gaps = 17/198 (8%)
Query: 11 DVAIKQL-DRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVE 69
VAIK L + + N+E L E +++ + HP++V L+G C Q L+ + MPLG +
Sbjct: 38 PVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICL-SSQVQLITQLMPLGCLL 96
Query: 70 DHLHD----LSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY 125
D++ + + + L+W ++ A+G+ YL +K +++RDL N+L+
Sbjct: 97 DYVRNHKDNIGS-QYLLNWCVQI------AKGMSYLEEKR---LVHRDLAARNVLVKTPQ 146
Query: 126 HPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 185
H K++DFGLAKL V + + + + A E T KSDV+S+GV + E+++
Sbjct: 147 HVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMT 206
Query: 186 -GRKAVDTSKAAAEQSLV 202
G K + A L+
Sbjct: 207 FGAKPYEGIPAVEIPDLL 224
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 3e-26
Identities = 63/189 (33%), Positives = 93/189 (49%), Gaps = 16/189 (8%)
Query: 10 QDVAIKQLDRNG-VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSV 68
VAIK L N + +EF E ++S L HPN+V L+G C +++EY+ G +
Sbjct: 36 TSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDL 95
Query: 69 EDHLHDLSP------------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKC 116
+ L SP K LD + + IA A G+EYL + ++RDL
Sbjct: 96 HEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYL---SSHHFVHRDLAA 152
Query: 117 SNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSF 176
N L+ G K+SDFGL++ D V ++ + + PE G+ T +SD++SF
Sbjct: 153 RNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSF 212
Query: 177 GVVLLEILS 185
GVVL EI S
Sbjct: 213 GVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 5e-26
Identities = 57/180 (31%), Positives = 87/180 (48%), Gaps = 16/180 (8%)
Query: 12 VAIKQLDRNGVQGN-REFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVED 70
VA+K L + + +FL E ++ L H NL+ L G ++V E PLGS+ D
Sbjct: 26 VAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLGSLLD 84
Query: 71 HLHDLSPGKKPLD--WNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK 128
L + G + + ++IA G + YL K I+RDL NILL K
Sbjct: 85 RLRKDALGHFLISTLCDYAVQIANG----MRYLESKR---FIHRDLAARNILLASDDKVK 137
Query: 129 LSDFGLAKLGPVGDNTHVST---RVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 185
+ DFGL + P ++ +V +V + +CAPE +T + SDV+ FGV L E+ +
Sbjct: 138 IGDFGLMRALPQNEDHYVMEEHLKV--PFAWCAPESLRTRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 6e-26
Identities = 73/190 (38%), Positives = 98/190 (51%), Gaps = 16/190 (8%)
Query: 10 QDVAIKQLDRNGVQGNRE---FLVEVLML-SLLHHPNLVNLIGYCADGDQRLLVYEYMPL 65
+ VA+K L + ++E FL E+ +L SL H PN+V L + D LV EY+
Sbjct: 23 KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDG 82
Query: 66 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR-G 124
GS+ED L K PL + + I A LEYLH K +I+RD+K NILLDR G
Sbjct: 83 GSLEDLLKK-IGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDG 138
Query: 125 YHPKLSDFGLAKL----GPVGDNTHVSTRVMGTYGYCAPEYAK---TGQLTLKSDVYSFG 177
KL DFGLAKL G + + +GT GY APE + SD++S G
Sbjct: 139 RVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLG 198
Query: 178 VVLLEILSGR 187
+ L E+L+G
Sbjct: 199 ITLYELLTGL 208
|
Length = 384 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 6e-26
Identities = 58/174 (33%), Positives = 95/174 (54%), Gaps = 7/174 (4%)
Query: 12 VAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDH 71
VAIK L + + ++F EV L L H +L++L C+ G+ ++ E M GS+
Sbjct: 33 VAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAF 92
Query: 72 LHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSD 131
L SP + L + + +A A G+ YL ++ I+RDL NIL+ K++D
Sbjct: 93 LR--SPEGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVAD 147
Query: 132 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 185
FGLA+L + ++ ++S+ Y + APE A G + KSDV+SFG++L E+ +
Sbjct: 148 FGLARL--IKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 2e-25
Identities = 64/181 (35%), Positives = 94/181 (51%), Gaps = 14/181 (7%)
Query: 11 DVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVED 70
VA+K L + G FL E ++ L H LV L C++ + +V EYM GS+ D
Sbjct: 32 KVAVKTL-KPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLD 90
Query: 71 HLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLS 130
L K L + +AA A G+ YL + I+RDL NIL+ K++
Sbjct: 91 FLKS--GEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIA 145
Query: 131 DFGLAKLGPVGDNTHVSTRVMGT---YGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-G 186
DFGLA+L + D+ + + G + APE A G+ T+KSDV+SFG++L EI++ G
Sbjct: 146 DFGLARL--IEDDEYTAR--EGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYG 201
Query: 187 R 187
R
Sbjct: 202 R 202
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 3e-25
Identities = 65/180 (36%), Positives = 88/180 (48%), Gaps = 16/180 (8%)
Query: 13 AIKQLDRNGVQGNREF---LVEVLMLSLLHHPNLVNLIGYCADGDQR--LLVYEYMPLGS 67
A+K L + + +E L E +LS ++HP +V L + A + LV EY P G
Sbjct: 22 AMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL--HYAFQTEEKLYLVLEYAPGGE 79
Query: 68 VEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP 127
+ HL G+ + R AA LEYLH +IYRDLK NILLD H
Sbjct: 80 LFSHLSKE--GRFSEER-ARF-YAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHI 132
Query: 128 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 187
KL+DFGLAK + + +T GT Y APE D +S GV+L E+L+G+
Sbjct: 133 KLTDFGLAKELSS-EGSRTNTFC-GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 4e-25
Identities = 70/229 (30%), Positives = 104/229 (45%), Gaps = 26/229 (11%)
Query: 38 LHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARG 97
L HPN+V LIG C L++EY+ ++ + L +LS W R KIA G A+
Sbjct: 740 LQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRNLS-------WERRRKIAIGIAKA 792
Query: 98 LEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG----DNTHVSTRVMGT 153
L +LH + P V+ +L I++D P L +L G D +
Sbjct: 793 LRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL------RLSLPGLLCTDTKCFISS---- 842
Query: 154 YGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRT 213
Y APE +T +T KSD+Y FG++L+E+L+G+ D S+V WAR + D
Sbjct: 843 -AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHG-SIVEWARYCYSDCH 900
Query: 214 RHSLIADPELQGQYP--PRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 260
I DP ++G + + +A C P RP DV+ L
Sbjct: 901 LDMWI-DPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTL 948
|
Length = 968 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 96.0 bits (240), Expect = 2e-23
Identities = 57/226 (25%), Positives = 93/226 (41%), Gaps = 39/226 (17%)
Query: 12 VAIKQLD-RNGVQGNREFLV-EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVE 69
+K++D N + RE + EV +L L+HPN++ + + +V EY G +
Sbjct: 28 YVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLS 87
Query: 70 DHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKL 129
+ KP + L+YLH + +++RD+K NI L KL
Sbjct: 88 QKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKL 144
Query: 130 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE------YAKTGQLTLKSDVYSFGVVLLEI 183
DFG++K+ + ++ V+GT Y +PE Y KSD++S G VL E+
Sbjct: 145 GDFGISKV--LSSTVDLAKTVVGTPYYLSPELCQNKPYNY------KSDIWSLGCVLYEL 196
Query: 184 LSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPP 229
+ + F+ L L+GQYPP
Sbjct: 197 CTLKHP-------------------FEGENLLELA-LKILKGQYPP 222
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 2e-22
Identities = 56/185 (30%), Positives = 82/185 (44%), Gaps = 14/185 (7%)
Query: 12 VAIKQLDRNGVQGNRE-FLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVED 70
VA+K L R+ F E +L+ H N+V G C +GD ++V+EYM G +
Sbjct: 38 VAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNK 97
Query: 71 HLHDLSP----------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNIL 120
L P L + ++IA A G+ YL A ++RDL N L
Sbjct: 98 FLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYL---ASQHFVHRDLATRNCL 154
Query: 121 LDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVL 180
+ K+ DFG+++ D V M + PE + T +SDV+SFGVVL
Sbjct: 155 VGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVL 214
Query: 181 LEILS 185
EI +
Sbjct: 215 WEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 94.2 bits (234), Expect = 2e-22
Identities = 62/178 (34%), Positives = 89/178 (50%), Gaps = 12/178 (6%)
Query: 12 VAIKQLDRNGVQGNRE-FLVEVLMLSLLHHPNLVNLIGYCADGDQR--LLVYEYMPLGSV 68
VA+K L R Q N + E+ +L L+H N+V G C++ + L+ EY+PLGS+
Sbjct: 36 VAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSL 95
Query: 69 EDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK 128
D+L K L+ + A G+ YLH + I+RDL N+LLD K
Sbjct: 96 RDYL-----PKHKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVK 147
Query: 129 LSDFGLAKLGPVGDNTH-VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 185
+ DFGLAK P G + V + A E K + + SDV+SFGV L E+L+
Sbjct: 148 IGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 3e-22
Identities = 54/188 (28%), Positives = 92/188 (48%), Gaps = 21/188 (11%)
Query: 6 LCLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPL 65
+++V++ + G + ++ E+ +LS L HPN+V +G + D + E +P
Sbjct: 27 FFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPG 86
Query: 66 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY 125
GS+ L +P+ +I G LEYLHD+ ++RD+K +NIL+D
Sbjct: 87 GSLAKLLKKYGSFPEPVIRLYTRQILLG----LEYLHDRN---TVHRDIKGANILVDTNG 139
Query: 126 HPKLSDFGLAKLGPVGDNTHVSTRVM-----GTYGYCAPEY-AKTGQLTLKSDVYSFGVV 179
KL+DFG+AK V G+ + APE A+ G L +D++S G
Sbjct: 140 VVKLADFGMAK--------QVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCT 191
Query: 180 LLEILSGR 187
+LE+ +G+
Sbjct: 192 VLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 4e-22
Identities = 75/264 (28%), Positives = 126/264 (47%), Gaps = 38/264 (14%)
Query: 12 VAIKQLDR-NGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD-QRLLVYEYMPLGSVE 69
A+K L+R ++ +FL E +++ HPN+++L+G C + L+V YM G +
Sbjct: 26 CAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLR 85
Query: 70 DHLHDLS--PGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP 127
+ + + P K L + A+G+EYL A ++RDL N +LD +
Sbjct: 86 NFIRSETHNPTVKDL-----IGFGLQVAKGMEYL---ASKKFVHRDLAARNCMLDESFTV 137
Query: 128 KLSDFGLAK------LGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLL 181
K++DFGLA+ V ++T V + A E +T + T KSDV+SFGV+L
Sbjct: 138 KVADFGLARDIYDKEYYSVHNHTGAKLPVK----WMALESLQTQKFTTKSDVWSFGVLLW 193
Query: 182 EILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAM 241
E++ T A + ++ D T + L LQ +Y P Y+ V
Sbjct: 194 ELM-------TRGAPPYPDVDSF------DITVYLLQGRRLLQPEYCPDPLYE---VMLS 237
Query: 242 CVHEQPDMRPVIADVVTALAYLAS 265
C H +P+MRP +++V+ + + S
Sbjct: 238 CWHPKPEMRPTFSELVSRIEQIFS 261
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 4e-22
Identities = 65/187 (34%), Positives = 97/187 (51%), Gaps = 18/187 (9%)
Query: 9 LQD-----VAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR--LLVYE 61
LQD VA+K+L + + R+F E+ +L L H N+V G C +R LV E
Sbjct: 28 LQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVME 87
Query: 62 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL 121
Y+P GS+ D+L ++ LD + A+ +G+EYL K ++RDL NIL+
Sbjct: 88 YLPYGSLRDYL---QKHRERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILV 141
Query: 122 DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMG---TYGYCAPEYAKTGQLTLKSDVYSFGV 178
+ K+ DFGL K+ P D + R G + Y APE + ++ SDV+SFGV
Sbjct: 142 ESENRVKIGDFGLTKVLPQ-DKEYYKVREPGESPIFWY-APESLTESKFSVASDVWSFGV 199
Query: 179 VLLEILS 185
VL E+ +
Sbjct: 200 VLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 1e-21
Identities = 56/180 (31%), Positives = 94/180 (52%), Gaps = 14/180 (7%)
Query: 12 VAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDH 71
VA+K L + G ++FL E ++ L HP L+ L C + +V E M GS+ ++
Sbjct: 33 VAVKTL-KPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEY 91
Query: 72 LHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSD 131
L + L + +AA A G+ YL + I+RDL N+L+ K++D
Sbjct: 92 LQG--GAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVAD 146
Query: 132 FGLAKLGPVGDNTHVSTRVMGT---YGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GR 187
FGLA++ + ++ + + G + APE A + ++KSDV+SFG++L EI++ GR
Sbjct: 147 FGLARV--IKEDIYEARE--GAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 1e-21
Identities = 74/248 (29%), Positives = 112/248 (45%), Gaps = 36/248 (14%)
Query: 10 QDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVE 69
VAIK L + G FL E ++ L HP LV L + ++ EYM GS+
Sbjct: 31 TKVAIKSL-KQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQ-EPIYIITEYMENGSLV 88
Query: 70 DHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKL 129
D L +P L N + +AA A G+ ++ K I+RDL+ +NIL+ K+
Sbjct: 89 DFLK--TPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKI 143
Query: 130 SDFGLAKLGPVGDNTHVSTR-VMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRK 188
+DFGLA+L + DN + + + APE G T+KSDV+SFG++L EI
Sbjct: 144 ADFGLARL--IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEI----- 196
Query: 189 AVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYP-----PRGFYQALAVAAMCV 243
V + R + T +I + E + P P Y+ + +C
Sbjct: 197 -------------VTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYE---LMRLCW 240
Query: 244 HEQPDMRP 251
E+P+ RP
Sbjct: 241 KEKPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 2e-21
Identities = 56/177 (31%), Positives = 82/177 (46%), Gaps = 7/177 (3%)
Query: 11 DVAIKQLDRNGVQGNRE-FLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVE 69
+VA+K + FL E +L HPN+V LIG C +V E +P GS+
Sbjct: 21 EVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80
Query: 70 DHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKL 129
L K L ++++ AA G+EYL K I+RDL N L+ K+
Sbjct: 81 TFLRK---KKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKI 134
Query: 130 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG 186
SDFG+++ G T + APE G+ T +SDV+S+G++L E S
Sbjct: 135 SDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 2e-21
Identities = 54/178 (30%), Positives = 90/178 (50%), Gaps = 11/178 (6%)
Query: 12 VAIKQLDRNGVQGN--REFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVE 69
VAIKQ+ ++ + + E+ +L L HPN+V IG D ++ EY GS+
Sbjct: 28 VAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLR 87
Query: 70 DHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKL 129
+ P + L ++ +GL YLH++ VI+RD+K +NIL + KL
Sbjct: 88 QIIKKFGPFPESLVAVYVYQVL----QGLAYLHEQG---VIHRDIKAANILTTKDGVVKL 140
Query: 130 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 187
+DFG+A + D + V+GT + APE + + SD++S G ++E+L+G
Sbjct: 141 ADFGVA--TKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 91.1 bits (227), Expect = 2e-21
Identities = 60/213 (28%), Positives = 89/213 (41%), Gaps = 37/213 (17%)
Query: 3 QVILCLLQD----VAIKQLDRNGVQGNRE-----FLVEVLMLSLL-HHPNLVNLIGYCAD 52
V+L ++ AIK LD+ Q +E +E +L+ L HP ++ L D
Sbjct: 16 TVVLAKEKETNKEYAIKILDK--RQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQD 73
Query: 53 GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYR 112
+ V EY P G + ++ LD AA LEYLH K +I+R
Sbjct: 74 EENLYFVLEYAPNGELLQYIRKYGS----LDEKCTRFYAAEILLALEYLHSKG---IIHR 126
Query: 113 DLKCSNILLDRGYHPKLSDFGLAK-LGPVGDNTHVSTRVM-----------------GTY 154
DLK NILLD+ H K++DFG AK L P GT
Sbjct: 127 DLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTA 186
Query: 155 GYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 187
Y +PE SD+++ G ++ ++L+G+
Sbjct: 187 EYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 3e-21
Identities = 62/183 (33%), Positives = 89/183 (48%), Gaps = 14/183 (7%)
Query: 12 VAIKQLDRNGVQGNREFLV-EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVED 70
VAIK++D Q + + L EV +S +HPN+V GD+ LV Y+ GS
Sbjct: 29 VAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGS--- 85
Query: 71 HLHDLSPGKKPLDWNTRMKIAA---GAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP 127
L D+ P IA +GLEYLH + I+RD+K NILL
Sbjct: 86 -LLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ---IHRDIKAGNILLGEDGSV 141
Query: 128 KLSDFGL-AKLGPVGDNTH-VSTRVMGTYGYCAPEYAKTGQ-LTLKSDVYSFGVVLLEIL 184
K++DFG+ A L GD T V +GT + APE + K+D++SFG+ +E+
Sbjct: 142 KIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELA 201
Query: 185 SGR 187
+G
Sbjct: 202 TGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 90.0 bits (224), Expect = 5e-21
Identities = 52/160 (32%), Positives = 80/160 (50%), Gaps = 19/160 (11%)
Query: 35 LSLLH---HPNLVNLIG-YCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRM-- 88
L L P +V G + +G+ + V EYM GS+ D L KK +
Sbjct: 50 LKTLRSCESPYVVKCYGAFYKEGEISI-VLEYMDGGSLADLL------KKVGKIPEPVLA 102
Query: 89 KIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK-LGPVGDNTHVS 147
IA +GL+YLH K +I+RD+K SN+L++ K++DFG++K L D +
Sbjct: 103 YIARQILKGLDYLHTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCN-- 158
Query: 148 TRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 187
T V GT Y +PE + + +D++S G+ LLE G+
Sbjct: 159 TFV-GTVTYMSPERIQGESYSYAADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 9e-21
Identities = 59/181 (32%), Positives = 91/181 (50%), Gaps = 18/181 (9%)
Query: 11 DVAIKQLDRNG-VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVE 69
+VA+K L + G +EFL E +++ L HP +V LIG C G+ +LV E PLG +
Sbjct: 25 EVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVC-KGEPLMLVMELAPLGPLL 83
Query: 70 DHLHDLS--PGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP 127
+L P + ++ A G+ YL K ++RDL N+LL +
Sbjct: 84 KYLKKRREIPVSDLKELAHQV------AMGMAYLESKH---FVHRDLAARNVLLVNRHQA 134
Query: 128 KLSDFGLAK-LGPVGDNTHVSTRVMGTY--GYCAPEYAKTGQLTLKSDVYSFGVVLLEIL 184
K+SDFG+++ LG + + G + + APE G+ + KSDV+S+GV L E
Sbjct: 135 KISDFGMSRALGA--GSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAF 192
Query: 185 S 185
S
Sbjct: 193 S 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 1e-20
Identities = 78/265 (29%), Positives = 116/265 (43%), Gaps = 33/265 (12%)
Query: 10 QDVAIKQL-DRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSV 68
Q VAIK L D N Q EF E +++ LHHPN+V L+G +++EY+ G +
Sbjct: 35 QLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDL 94
Query: 69 EDHLHDLSPG-------------KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLK 115
+ L SP K LD + IA A G+EYL + +++DL
Sbjct: 95 HEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYL---SSHFFVHKDLA 151
Query: 116 CSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYS 175
NIL+ H K+SD GL++ D V + + + PE G+ + SD++S
Sbjct: 152 ARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWS 211
Query: 176 FGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQA 235
FGVVL EI S + + Q ++ R + L+ E PPR +
Sbjct: 212 FGVVLWEIFS--FGLQPYYGFSNQEVIEMVR-------KRQLLPCSE---DCPPRMY--- 256
Query: 236 LAVAAMCVHEQPDMRPVIADVVTAL 260
++ C E P RP D+ T L
Sbjct: 257 -SLMTECWQEGPSRRPRFKDIHTRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 88.8 bits (221), Expect = 2e-20
Identities = 63/187 (33%), Positives = 94/187 (50%), Gaps = 29/187 (15%)
Query: 10 QDVAIKQLDRNGVQGNREFLV-EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSV 68
++VAIK++ + N+E ++ E+L++ HPN+V+ GD+ +V EYM GS
Sbjct: 45 KEVAIKKMRLR--KQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGS- 101
Query: 69 EDHLHDLSPGKKPLDWN-TRMK---IAAGAA---RGLEYLHDKAKPPVIYRDLKCSNILL 121
L D+ + N RM IA +GLEYLH + VI+RD+K NILL
Sbjct: 102 ---LTDI------ITQNFVRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILL 149
Query: 122 DRGYHPKLSDFGLAKLGPVGDNTHVSTR--VMGTYGYCAPEYAKTGQLTLKSDVYSFGVV 179
+ KL+DFG A S R V+GT + APE K K D++S G++
Sbjct: 150 SKDGSVKLADFGFAAQL----TKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIM 205
Query: 180 LLEILSG 186
+E+ G
Sbjct: 206 CIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 2e-20
Identities = 62/244 (25%), Positives = 107/244 (43%), Gaps = 32/244 (13%)
Query: 13 AIKQLDRNGVQG--NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVED 70
A+KQ+D + + E + E +L+ L ++ D + +V EY G +
Sbjct: 29 AMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHK 88
Query: 71 HLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLS 130
L +PL + + GL +LH K +++RD+K N+ LD + K+
Sbjct: 89 LLK--MQRGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIG 143
Query: 131 DFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAV 190
D G+AKL + DNT+ + ++GT Y +PE + KSDV++ GVVL E +G+
Sbjct: 144 DLGVAKL--LSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPF 201
Query: 191 DTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPP--RGFYQALA-VAAMCVHEQP 247
D + A + ++G +PP + + Q LA + C+ +
Sbjct: 202 DA------NNQGALILKI--------------IRGVFPPVSQMYSQQLAQLIDQCLTKDY 241
Query: 248 DMRP 251
RP
Sbjct: 242 RQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 4e-20
Identities = 50/165 (30%), Positives = 79/165 (47%), Gaps = 27/165 (16%)
Query: 31 EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI 90
++L + P +V G + + EYM GS++ L + + KI
Sbjct: 51 DILHKC--NSPYIVGFYGAFYNNGDISICMEYMDGGSLDKIL---KEVQGRIPERILGKI 105
Query: 91 AAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRV 150
A +GL YLH+K K +I+RD+K SNIL++ KL DFG VS ++
Sbjct: 106 AVAVLKGLTYLHEKHK--IIHRDVKPSNILVNSRGQIKLCDFG------------VSGQL 151
Query: 151 M--------GTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 187
+ GT Y APE + ++KSD++S G+ L+E+ +GR
Sbjct: 152 VNSLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 4e-20
Identities = 54/171 (31%), Positives = 77/171 (45%), Gaps = 23/171 (13%)
Query: 26 REFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL--VYEYMPLGSVEDHLHDLSPGKKPLD 83
++ L E+ + P +V G D + EY GS++ S KK
Sbjct: 44 KQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLD------SIYKKVKK 97
Query: 84 WNTRM------KIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA-K 136
R+ KIA +GL YLH + +I+RD+K SNILL R KL DFG++ +
Sbjct: 98 RGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGE 154
Query: 137 LGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 187
L T GT Y APE + ++ SDV+S G+ LLE+ R
Sbjct: 155 LVNSLAGTFT-----GTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 88.0 bits (219), Expect = 4e-20
Identities = 64/196 (32%), Positives = 91/196 (46%), Gaps = 31/196 (15%)
Query: 4 VILCLLQD----VAIKQLDRNGVQGNRE---FLVEVLMLSLLHHPNLVNLIGYCADGDQR 56
V+L + A+K L + + ++ L E +L + HP LVNL G D
Sbjct: 17 VMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNL 76
Query: 57 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKC 116
LV EY+P G + HL G+ P R AA LEYLH ++YRDLK
Sbjct: 77 YLVMEYVPGGELFSHLR--KSGRFPEPV-ARF-YAAQVVLALEYLHSLD---IVYRDLKP 129
Query: 117 SNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE------YAKTGQLTLK 170
N+LLD + K++DFG AK V T+ + GT Y APE Y K
Sbjct: 130 ENLLLDSDGYIKITDFGFAKR--VKGRTYT---LCGTPEYLAPEIILSKGYGKA------ 178
Query: 171 SDVYSFGVVLLEILSG 186
D ++ G+++ E+L+G
Sbjct: 179 VDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 6e-20
Identities = 73/266 (27%), Positives = 120/266 (45%), Gaps = 27/266 (10%)
Query: 12 VAIKQLDRNGVQGNR-EFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVED 70
VA+K L + + R +FL EV +LS L PN++ L+G C D D ++ EYM G +
Sbjct: 49 VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108
Query: 71 HL--HDLSPGKKP-------------LDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLK 115
L H L ++ + +++ + +A A G++YL + ++RDL
Sbjct: 109 FLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLA 165
Query: 116 CSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYS 175
N L+ K++DFG+++ GD + R + + A E G+ T SDV++
Sbjct: 166 TRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWA 225
Query: 176 FGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQA 235
FGV L EIL K + EQ ++ A F+D+ R + P P+G Y+
Sbjct: 226 FGVTLWEILMLCKEQPYGELTDEQ-VIENAGEFFRDQGRQVYLFRPPP----CPQGLYEL 280
Query: 236 LAVAAMCVHEQPDMRPVIADVVTALA 261
+ C RP +D+ L
Sbjct: 281 M---LQCWSRDCRERPSFSDIHAFLT 303
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 86.9 bits (216), Expect = 6e-20
Identities = 61/185 (32%), Positives = 87/185 (47%), Gaps = 18/185 (9%)
Query: 12 VAIKQLDRNGVQGNREF---LVEVLMLSLLHHPNLVNLIGYCADGDQRL-LVYEYMPLGS 67
AIK + + + + L E +LS P +V L Y G + L LV EY+P G
Sbjct: 21 YAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY-YSFQGKKNLYLVMEYLPGGD 79
Query: 68 VEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP 127
+ L ++ LD + A LEYLH +I+RDLK NIL+D H
Sbjct: 80 LASLLENVGS----LDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHL 132
Query: 128 KLSDFGLAKLGPVGDNTHVS------TRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLL 181
KL+DFGL+K+G V +++ R++GT Y APE + D +S G +L
Sbjct: 133 KLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILY 192
Query: 182 EILSG 186
E L G
Sbjct: 193 EFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 7e-20
Identities = 59/182 (32%), Positives = 88/182 (48%), Gaps = 11/182 (6%)
Query: 12 VAIKQLDRNGVQGNR-EFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVED 70
VA+K L + R +FL EV +LS L PN+ L+G C ++ EYM G +
Sbjct: 49 VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQ 108
Query: 71 HLH-------DLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR 123
L L+ K L ++T + +A A G+ YL ++RDL N L+ +
Sbjct: 109 FLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRNCLVGK 165
Query: 124 GYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEI 183
Y K++DFG+++ D V R + A E G+ T KSDV++FGV L EI
Sbjct: 166 NYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEI 225
Query: 184 LS 185
L+
Sbjct: 226 LT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 2e-19
Identities = 53/172 (30%), Positives = 90/172 (52%), Gaps = 7/172 (4%)
Query: 12 VAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDH 71
VA+K L + ++ EFL E ++ + HPNLV L+G C ++ E+M G++ D+
Sbjct: 34 VAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 92
Query: 72 LHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSD 131
L + ++ ++ + +A + +EYL K I+RDL N L+ + K++D
Sbjct: 93 LREC--NRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVAD 147
Query: 132 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEI 183
FGL++L GD + APE + ++KSDV++FGV+L EI
Sbjct: 148 FGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 2e-19
Identities = 56/205 (27%), Positives = 98/205 (47%), Gaps = 23/205 (11%)
Query: 4 VILCLLQD----VAIKQLDRNGVQGNREFLV--EVLMLSLLHHPNLVNLIGYCADGDQRL 57
V LC + V IKQ+ + + E +L LL HPN++ + +
Sbjct: 16 VHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALM 75
Query: 58 LVYEYMPLGSVEDHLHD----LSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRD 113
+V EY P G++ +++ L L + ++ +A L ++H K +++RD
Sbjct: 76 IVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLA------LHHVHTKL---ILHRD 126
Query: 114 LKCSNILLDRGYHP-KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSD 172
LK NILLD+ K+ DFG++K+ + + T V+GT Y +PE + KSD
Sbjct: 127 LKTQNILLDKHKMVVKIGDFGISKI--LSSKSKAYT-VVGTPCYISPELCEGKPYNQKSD 183
Query: 173 VYSFGVVLLEILSGRKAVDTSKAAA 197
+++ G VL E+ S ++A + + A
Sbjct: 184 IWALGCVLYELASLKRAFEAANLPA 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 2e-19
Identities = 62/181 (34%), Positives = 89/181 (49%), Gaps = 14/181 (7%)
Query: 11 DVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVED 70
DVAIK + R G +F+ E ++ L HPNLV L G C +V EYM G + +
Sbjct: 30 DVAIKMI-REGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLN 88
Query: 71 HLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLS 130
+L + GK +W M + +EYL I+RDL N L+ K+S
Sbjct: 89 YLRE-RKGKLGTEWLLDM--CSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVS 142
Query: 131 DFGLAKLGPVGDNTHVSTRVMGT---YGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 187
DFGLA+ V D+ + S+ GT + PE + + KSDV+SFGV++ E+ S
Sbjct: 143 DFGLARY--VLDDQYTSS--QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEG 198
Query: 188 K 188
K
Sbjct: 199 K 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 4e-19
Identities = 56/181 (30%), Positives = 88/181 (48%), Gaps = 10/181 (5%)
Query: 12 VAIKQLDRNGVQGNR-EFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVED 70
VAIK ++ N R EFL E ++ + ++V L+G + G L+V E M G ++
Sbjct: 39 VAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKS 98
Query: 71 HLH------DLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG 124
+L + +PG P +++AA A G+ YL K ++RDL N ++
Sbjct: 99 YLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAED 155
Query: 125 YHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEIL 184
K+ DFG+ + D + + + APE K G T KSDV+SFGVVL E+
Sbjct: 156 LTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMA 215
Query: 185 S 185
+
Sbjct: 216 T 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 4e-19
Identities = 68/256 (26%), Positives = 115/256 (44%), Gaps = 36/256 (14%)
Query: 11 DVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVED 70
DVAIK + + G EF+ E ++ L H LV L G C +V EYM G + +
Sbjct: 30 DVAIKMI-KEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLN 88
Query: 71 HLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLS 130
+L + +P +++ G+ YL K I+RDL N L+D K+S
Sbjct: 89 YLREHGKRFQPSQL---LEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVS 142
Query: 131 DFGLAKLGPVGDNTHVSTRVMGT---YGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 187
DFGL++ V D+ + S+ +G+ + PE + + KSDV++FGV++ E+ S
Sbjct: 143 DFGLSRY--VLDDEYTSS--VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLG 198
Query: 188 KAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQ--YPPRGFYQAL-AVAAMCVH 244
K + +R +S + QG Y P + + A+ C H
Sbjct: 199 K-------------------MPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMYSCWH 239
Query: 245 EQPDMRPVIADVVTAL 260
E+ + RP +++++
Sbjct: 240 EKAEERPTFQQLLSSI 255
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 6e-19
Identities = 59/221 (26%), Positives = 103/221 (46%), Gaps = 13/221 (5%)
Query: 12 VAIKQLDRNGVQGNR-EFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVED 70
VA+K L + + R +FL E+ ++S L +PN++ L+G C D ++ EYM G +
Sbjct: 47 VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQ 106
Query: 71 HLHD--------LSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD 122
L + + + +A A G++YL A ++RDL N L+
Sbjct: 107 FLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVG 163
Query: 123 RGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLE 182
Y K++DFG+++ GD + R + + A E G+ T SDV++FGV L E
Sbjct: 164 NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWE 223
Query: 183 ILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPEL 223
+ + K S + EQ ++ F+++ R ++ L
Sbjct: 224 MFTLCKEQPYSLLSDEQ-VIENTGEFFRNQGRQIYLSQTPL 263
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 6e-19
Identities = 57/185 (30%), Positives = 86/185 (46%), Gaps = 14/185 (7%)
Query: 12 VAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDH 71
VA+K L ++F E +L++L H ++V G C +G L+V+EYM G +
Sbjct: 38 VAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRF 97
Query: 72 LHDLSPGKK-----------PLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNIL 120
L P K L + IA+ A G+ YL A ++RDL N L
Sbjct: 98 LRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYL---ASLHFVHRDLATRNCL 154
Query: 121 LDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVL 180
+ +G K+ DFG+++ D V R M + PE + T +SD++SFGVVL
Sbjct: 155 VGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVL 214
Query: 181 LEILS 185
EI +
Sbjct: 215 WEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 1e-18
Identities = 60/180 (33%), Positives = 98/180 (54%), Gaps = 16/180 (8%)
Query: 10 QDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVE 69
Q VA+K + + + FL E +++ LHH NLV L+G + +V E M G++
Sbjct: 30 QKVAVKNIKCDVTA--QAFLEETAVMTKLHHKNLVRLLGVILH-NGLYIVMELMSKGNLV 86
Query: 70 DHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKL 129
+ L + G+ + ++ + A G+EYL K +++RDL NIL+ K+
Sbjct: 87 NFLR--TRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKV 141
Query: 130 SDFGLAKLGPVG-DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GR 187
SDFGLA++G +G DN+ + + + APE K + + KSDV+S+GV+L E+ S GR
Sbjct: 142 SDFGLARVGSMGVDNSKLPVK------WTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGR 195
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 1e-18
Identities = 49/161 (30%), Positives = 86/161 (53%), Gaps = 12/161 (7%)
Query: 31 EVLMLSLLHHPNLVNLIG-YCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMK 89
E+ +++ L+HP+++ ++G C D L V E+M GSV L K+ + N +
Sbjct: 53 EIRLMARLNHPHIIRMLGATCEDSHFNLFV-EWMAGGSVSHLLSKYGAFKEAVIINYTEQ 111
Query: 90 IAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR-GYHPKLSDFGLA-KLGPVGDNT-HV 146
+ RGL YLH+ +I+RD+K +N+L+D G +++DFG A +L G
Sbjct: 112 LL----RGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEF 164
Query: 147 STRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 187
+++GT + APE + Q DV+S G V++E+ + +
Sbjct: 165 QGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 2e-18
Identities = 56/184 (30%), Positives = 89/184 (48%), Gaps = 23/184 (12%)
Query: 11 DVAIKQLDRNGVQGN--REFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSV 68
DVAIK L + G +FL E ++ HPN++ L G +++ EYM GS+
Sbjct: 34 DVAIKTL-KAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSL 92
Query: 69 EDHL--HDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH 126
+ L +D GK + + G A G++YL + ++RDL NIL++
Sbjct: 93 DKFLREND---GK--FTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLV 144
Query: 127 PKLSDFGLAKLGPVGDNTHVSTRVMGTYG-----YCAPEYAKTGQLTLKSDVYSFGVVLL 181
K+SDFG L +++ + G G + APE + T SDV+SFG+V+
Sbjct: 145 CKVSDFG---LSRRLEDSEATYTTKG--GKIPIRWTAPEAIAYRKFTSASDVWSFGIVMW 199
Query: 182 EILS 185
E++S
Sbjct: 200 EVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 2e-18
Identities = 52/162 (32%), Positives = 87/162 (53%), Gaps = 13/162 (8%)
Query: 31 EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI 90
E+ +L L H N+V +G D D + EY+P GSV L++ ++ L N +I
Sbjct: 56 EIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQI 115
Query: 91 AAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK-----LGPVGDNTH 145
+GL YLH++ +I+RD+K +NIL+D K+SDFG++K N
Sbjct: 116 L----KGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGA 168
Query: 146 VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 187
+ + G+ + APE K T K+D++S G +++E+L+G+
Sbjct: 169 RPS-LQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 3e-18
Identities = 58/199 (29%), Positives = 88/199 (44%), Gaps = 34/199 (17%)
Query: 12 VAIKQL-DRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVED 70
VA+K L + +F E +++ HPN+V L+G CA G L++EYM G + +
Sbjct: 38 VAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNE 97
Query: 71 HLHDLSP------------------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYR 112
L SP PL ++ IA A G+ YL ++ ++R
Sbjct: 98 FLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHR 154
Query: 113 DLKCSNILLDRGYHPKLSDFGLAKLGPVGD------NTHVSTRVMGTYGYCAPEYAKTGQ 166
DL N L+ K++DFGL++ D N + R M PE +
Sbjct: 155 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWM------PPESIFYNR 208
Query: 167 LTLKSDVYSFGVVLLEILS 185
T +SDV+++GVVL EI S
Sbjct: 209 YTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 3e-18
Identities = 58/179 (32%), Positives = 91/179 (50%), Gaps = 13/179 (7%)
Query: 12 VAIKQLDRNGVQGNREFLV-EVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPLGSVE 69
VA+K L RE L+ E+ ++S L +H N+VNL+G C G L++ EY G +
Sbjct: 68 VAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLL 127
Query: 70 DHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKL 129
+ L + L + + A+G+ +L K I+RDL N+LL G K+
Sbjct: 128 NFLR--RKRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKI 182
Query: 130 SDFGLAKLGPVGDNTHV---STRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 185
DFGLA+ + D+ +V + R+ + APE T +SDV+S+G++L EI S
Sbjct: 183 CDFGLAR-DIMNDSNYVVKGNARL--PVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 3e-18
Identities = 57/179 (31%), Positives = 93/179 (51%), Gaps = 16/179 (8%)
Query: 12 VAIKQL-DRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVED 70
VAIK + DR+G Q +E +L + L H +V L+G C G LV + PLGS+ D
Sbjct: 39 VAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQLVTQLSPLGSLLD 97
Query: 71 HLH----DLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH 126
H+ L P ++ L+W ++ A+G+ YL + +++R+L NILL
Sbjct: 98 HVRQHRDSLDP-QRLLNWCVQI------AKGMYYLEEHR---MVHRNLAARNILLKSDSI 147
Query: 127 PKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 185
+++DFG+A L D + + + A E G+ T +SDV+S+GV + E++S
Sbjct: 148 VQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.6 bits (205), Expect = 4e-18
Identities = 54/197 (27%), Positives = 85/197 (43%), Gaps = 45/197 (22%)
Query: 12 VAIKQLDRNGVQGNREFLV----EVLMLSLLHHPNLVNLIGYCADGDQR--LLVYEYMPL 65
VA+K++ F + E+ +L L HPN+V L + +V+EYM
Sbjct: 27 VALKKI--RMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMD- 83
Query: 66 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR--------GLEYLHDKAKPPVIYRDLKCS 117
HDL+ G L + +K + GL+YLH +++RD+K S
Sbjct: 84 -------HDLT-G---LLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGS 129
Query: 118 NILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE-------YAKTGQLTLK 170
NIL++ KL+DFGLA+ N+ T + T Y PE Y +
Sbjct: 130 NILINNDGVLKLADFGLARP-YTKRNSADYTNRVITLWYRPPELLLGATRY------GPE 182
Query: 171 SDVYSFGVVLLEILSGR 187
D++S G +L E+ G+
Sbjct: 183 VDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 7e-18
Identities = 56/178 (31%), Positives = 86/178 (48%), Gaps = 14/178 (7%)
Query: 11 DVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVED 70
VAIK + R G +F+ E ++ L HP LV L G C + LV+E+M G + D
Sbjct: 30 KVAIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSD 88
Query: 71 HLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLS 130
+L + T + + G+ YL VI+RDL N L+ K+S
Sbjct: 89 YLR---AQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVS 142
Query: 131 DFGLAKLGPVGDNTHVSTRVMGT---YGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 185
DFG+ + V D+ + S+ GT + +PE + + KSDV+SFGV++ E+ S
Sbjct: 143 DFGMTRF--VLDDQYTSST--GTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 9e-18
Identities = 67/250 (26%), Positives = 111/250 (44%), Gaps = 26/250 (10%)
Query: 12 VAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDH 71
VAIK + G +F+ E ++ L HP LV L G C +V E+M G +
Sbjct: 31 VAIKAI-NEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCL--- 86
Query: 72 LHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSD 131
L+ L + L + + + G+EYL + I+RDL N L+ K+SD
Sbjct: 87 LNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSD 143
Query: 132 FGLAKLGPVGDNTHVSTR-VMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAV 190
FG+ + V D+ + S+ + PE + + KSDV+SFGV++ E+ + K
Sbjct: 144 FGMTRY--VLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMP 201
Query: 191 DTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMR 250
K+ E + + +R + P+L Y+ V C HE+P+ R
Sbjct: 202 FEKKSNYE---------VVEMISRGFRLYRPKLASMT----VYE---VMYSCWHEKPEGR 245
Query: 251 PVIADVVTAL 260
P A+++ A+
Sbjct: 246 PTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 1e-17
Identities = 68/257 (26%), Positives = 117/257 (45%), Gaps = 19/257 (7%)
Query: 12 VAIKQLDRNGVQGNR-EFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVED 70
VA+K L + + R +FL E+ ++S L PN++ L+ C D ++ EYM G +
Sbjct: 49 VAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQ 108
Query: 71 HLHDLSPGKKPLD-------WNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR 123
L P + ++T + +A A G++YL + ++RDL N L+ +
Sbjct: 109 FLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGK 165
Query: 124 GYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEI 183
Y K++DFG+++ GD + R + + + E G+ T SDV++FGV L EI
Sbjct: 166 NYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEI 225
Query: 184 LSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCV 243
L+ K S+ + EQ ++ F+D+ R + P L P Y+ + C
Sbjct: 226 LTLCKEQPYSQLSDEQ-VIENTGEFFRDQGRQVYLPKPAL----CPDSLYK---LMLSCW 277
Query: 244 HEQPDMRPVIADVVTAL 260
RP ++ L
Sbjct: 278 RRNAKERPSFQEIHATL 294
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 1e-17
Identities = 60/186 (32%), Positives = 88/186 (47%), Gaps = 20/186 (10%)
Query: 5 ILCLLQDVAIKQLDRNGVQGNREFLVEVLMLSL-LHHPNLVNLIGYCA--DGDQRLLVYE 61
I L +DV ++ D +VE +L+L HP L +L +C + V E
Sbjct: 25 IKALKKDVVLEDDDVECT------MVERRVLALAWEHPFLTHL--FCTFQTKEHLFFVME 76
Query: 62 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL 121
Y+ G + H+ D AA GL++LH K +IYRDLK N+LL
Sbjct: 77 YLNGGDLMFHIQS----SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLL 129
Query: 122 DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLL 181
D+ H K++DFG+ K G+ ++ GT Y APE K + D +SFGV+L
Sbjct: 130 DKDGHIKIADFGMCKENMNGEGK--ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLY 187
Query: 182 EILSGR 187
E+L G+
Sbjct: 188 EMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 1e-17
Identities = 60/179 (33%), Positives = 91/179 (50%), Gaps = 13/179 (7%)
Query: 13 AIKQLDRNGVQGNREF---LVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPLGSV 68
A+K L ++ V + + +VE +L+L +P L +L + V E++ G +
Sbjct: 24 AVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDL 83
Query: 69 EDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK 128
H+ D K D AA GL++LH K +IYRDLK N++LDR H K
Sbjct: 84 MFHIQD----KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIK 136
Query: 129 LSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 187
++DFG+ K GDN ++ GT Y APE + + T D +SFGV+L E+L G+
Sbjct: 137 IADFGMCKENVFGDNR--ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 1e-17
Identities = 56/186 (30%), Positives = 85/186 (45%), Gaps = 15/186 (8%)
Query: 12 VAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDH 71
VA+K L + ++F E +L+ L H ++V G C DGD ++V+EYM G +
Sbjct: 38 VAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKF 97
Query: 72 LHDLSP------------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNI 119
L P K L + + IA+ A G+ YL A ++RDL N
Sbjct: 98 LRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNC 154
Query: 120 LLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVV 179
L+ K+ DFG+++ D V M + PE + T +SDV+SFGV+
Sbjct: 155 LVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVI 214
Query: 180 LLEILS 185
L EI +
Sbjct: 215 LWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 2e-17
Identities = 57/185 (30%), Positives = 86/185 (46%), Gaps = 12/185 (6%)
Query: 10 QDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSV 68
VA+K L + Q +EFL E ++S +HPN+V L+G C + + ++ E M G +
Sbjct: 27 IRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDL 86
Query: 69 EDHLHDLSPGKKP---LDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL---- 121
+L D + L + I A+G YL I+RDL N L+
Sbjct: 87 LSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKG 143
Query: 122 -DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVL 180
D K+ DFGLA+ D + + APE G+ T +SDV+SFGV++
Sbjct: 144 YDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLM 203
Query: 181 LEILS 185
EIL+
Sbjct: 204 WEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 3e-17
Identities = 52/178 (29%), Positives = 83/178 (46%), Gaps = 11/178 (6%)
Query: 13 AIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVE 69
A K+LD+ + +G + L E +L + +V+L D LV M G ++
Sbjct: 22 ACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLK 81
Query: 70 DHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKL 129
H++++ G+ + AA GLE+LH + ++YRDLK N+LLD + ++
Sbjct: 82 YHIYNV--GEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRI 136
Query: 130 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 187
SD GLA G GT GY APE + D ++ G L E+++GR
Sbjct: 137 SDLGLAVELKGGKKIKGRA---GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 4e-17
Identities = 63/178 (35%), Positives = 98/178 (55%), Gaps = 11/178 (6%)
Query: 12 VAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDH 71
VA+K L + G FL E ++ L H LV L ++ + +V EYM GS+ D
Sbjct: 33 VAVKTL-KPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYMSKGSLLDF 90
Query: 72 LHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSD 131
L D G+ L + +AA A G+ Y+ + I+RDL+ +NIL+ G K++D
Sbjct: 91 LKD-GEGRA-LKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIAD 145
Query: 132 FGLAKLGPVGDNTHVSTR-VMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GR 187
FGLA+L + DN + + + + APE A G+ T+KSDV+SFG++L E+++ GR
Sbjct: 146 FGLARL--IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 4e-17
Identities = 65/194 (33%), Positives = 94/194 (48%), Gaps = 24/194 (12%)
Query: 8 LLQDVAIKQLDRNGVQGN-REFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPL 65
L D AIK++ + + R+F E+ +L L HHPN++NL+G C L EY P
Sbjct: 21 LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80
Query: 66 GSVEDHLH-----DLSPG-------KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRD 113
G++ D L + P L + AA ARG++YL K I+RD
Sbjct: 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRD 137
Query: 114 LKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG--YCAPEYAKTGQLTLKS 171
L NIL+ Y K++DFGL++ G +V + MG + A E T S
Sbjct: 138 LAARNILVGENYVAKIADFGLSR----GQEVYVK-KTMGRLPVRWMAIESLNYSVYTTNS 192
Query: 172 DVYSFGVVLLEILS 185
DV+S+GV+L EI+S
Sbjct: 193 DVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 4e-17
Identities = 51/159 (32%), Positives = 71/159 (44%), Gaps = 12/159 (7%)
Query: 31 EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI 90
E +L L+HP LVNL D + LV + + G + HL + ++K
Sbjct: 50 ERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSE-----EQVKF 104
Query: 91 -AAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTR 149
LEYLH K +I+RD+K NILLD H ++DF +A T T
Sbjct: 105 WICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT---TS 158
Query: 150 VMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRK 188
GT GY APE ++ D +S GV E L G++
Sbjct: 159 TSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 5e-17
Identities = 61/191 (31%), Positives = 95/191 (49%), Gaps = 24/191 (12%)
Query: 11 DVAIKQLDRNGVQGN-REFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPLGSV 68
+ AIK L + + R+F E+ +L L HHPN++NL+G C + + EY P G++
Sbjct: 31 NAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNL 90
Query: 69 EDHLH-----DLSPG-------KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKC 116
D L + P L ++ A+ A G++YL +K I+RDL
Sbjct: 91 LDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAA 147
Query: 117 SNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG--YCAPEYAKTGQLTLKSDVY 174
N+L+ K++DFGL++ G+ +V + MG + A E T KSDV+
Sbjct: 148 RNVLVGENLASKIADFGLSR----GEEVYVK-KTMGRLPVRWMAIESLNYSVYTTKSDVW 202
Query: 175 SFGVVLLEILS 185
SFGV+L EI+S
Sbjct: 203 SFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 5e-17
Identities = 68/252 (26%), Positives = 114/252 (45%), Gaps = 32/252 (12%)
Query: 10 QDVAIKQLD-RNGVQGNREFLV-EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGS 67
Q A+K++D + Q RE V E+ +L+ ++HPN+++ DG++ +V EY P G
Sbjct: 26 QFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGD 85
Query: 68 VEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP 127
+ + +K + +I RGL+ LH++ +++RDLK +NILL
Sbjct: 86 LSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLV 142
Query: 128 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 187
K+ D G++K V T +GT Y APE K + KSD++S G +L E+ +
Sbjct: 143 KIGDLGISK---VLKKNMAKT-QIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATF- 197
Query: 188 KAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYP--PRGFYQALAVAAM-CVH 244
P F+ R+ L +G+YP P + Q L +
Sbjct: 198 ------------------APPFEARSMQDL-RYKVQRGKYPPIPPIYSQDLQNFIRSMLQ 238
Query: 245 EQPDMRPVIADV 256
+P +RP +
Sbjct: 239 VKPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 5e-17
Identities = 51/165 (30%), Positives = 78/165 (47%), Gaps = 16/165 (9%)
Query: 31 EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI 90
E+ +L LL HPNLV G ++ + EY G++E+ L + LD +
Sbjct: 49 EMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLE----HGRILDEHVIRVY 104
Query: 91 AAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRV 150
GL YLH +++RD+K +NI LD KL DFG A + +NT
Sbjct: 105 TLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVK--LKNNTTTMGEE 159
Query: 151 M----GTYGYCAPEYAKTGQLTLK---SDVYSFGVVLLEILSGRK 188
+ GT Y APE G+ +D++S G V+LE+ +G++
Sbjct: 160 VQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 6e-17
Identities = 57/175 (32%), Positives = 89/175 (50%), Gaps = 9/175 (5%)
Query: 12 VAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDH 71
VA+K L + G + FL E ++ L H LV L + ++ EYM GS+ D
Sbjct: 33 VAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDF 91
Query: 72 LHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSD 131
L GK L + +A A G+ Y+ K I+RDL+ +N+L+ K++D
Sbjct: 92 LKSDEGGKVLLP--KLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIAD 146
Query: 132 FGLAKLGPVGDNTHVSTR-VMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 185
FGLA++ + DN + + + APE G T+KSDV+SFG++L EI++
Sbjct: 147 FGLARV--IEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 6e-17
Identities = 55/195 (28%), Positives = 92/195 (47%), Gaps = 24/195 (12%)
Query: 12 VAIKQLDRNGVQGN-REFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVED 70
VA+K L N R+ L E +L ++HP+++ L G C+ LL+ EY GS+
Sbjct: 33 VAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRS 92
Query: 71 HL--------------------HDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVI 110
L + +P ++ L + A +RG++YL A+ ++
Sbjct: 93 FLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYL---AEMKLV 149
Query: 111 YRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLK 170
+RDL N+L+ G K+SDFGL++ D+ ++ + A E T +
Sbjct: 150 HRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQ 209
Query: 171 SDVYSFGVVLLEILS 185
SDV+SFGV+L EI++
Sbjct: 210 SDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 7e-17
Identities = 52/150 (34%), Positives = 75/150 (50%), Gaps = 13/150 (8%)
Query: 40 HPNLVNLIGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAARG 97
HP L L C RL V EY+ G + H+ +P R + AA G
Sbjct: 55 HPFLTQLHS-CFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEP-----RARFYAAEIVLG 108
Query: 98 LEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 157
L++LH++ +IYRDLK N+LLD H K++DFG+ K G +G T ++ GT Y
Sbjct: 109 LQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTFCGTPDYI 163
Query: 158 APEYAKTGQLTLKSDVYSFGVVLLEILSGR 187
APE D ++ GV+L E+L+G+
Sbjct: 164 APEILSYQPYGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 78.0 bits (193), Expect = 8e-17
Identities = 55/157 (35%), Positives = 72/157 (45%), Gaps = 18/157 (11%)
Query: 35 LSLLHHPNLVNLIGYCADGDQRLLVY---EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIA 91
L +HP +V L Y D++ +Y EY G + L D G ++ R
Sbjct: 47 LEECNHPFIVKL--YRTFKDKKY-IYMLMEYCLGGELWTILRDR--GLFD-EYTARF-YI 99
Query: 92 AGAARGLEYLHDKAKPPVIYRDLKCSNILLD-RGYHPKLSDFGLAKLGPVGDNTHVSTRV 150
A EYLH++ +IYRDLK N+LLD GY KL DFG AK G T
Sbjct: 100 ACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGY-VKLVDFGFAKKLKSGQKTWT---F 152
Query: 151 MGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 187
GT Y APE D +S G++L E+L+GR
Sbjct: 153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 8e-17
Identities = 56/193 (29%), Positives = 93/193 (48%), Gaps = 19/193 (9%)
Query: 10 QDVAIKQLDRNGVQGNRE---FLVEVLMLSLLHHPNLVNLIGYCADGDQRLL-VYEYMPL 65
+VAIK L + + + F E + + L+HPN+V L+ L V+EY+P
Sbjct: 4 HEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPG 63
Query: 66 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL---D 122
++ + L L ++ L H++ +++RDLK NI++
Sbjct: 64 RTLREVLA----ADGALPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQTG 116
Query: 123 RGYHPKLSDFGLAKLGP-VGDNTHV----STRVMGTYGYCAPEYAKTGQLTLKSDVYSFG 177
H K+ DFG+ L P V D +T V+GT YCAPE + +T SD+Y++G
Sbjct: 117 VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWG 176
Query: 178 VVLLEILSGRKAV 190
++ LE L+G++ V
Sbjct: 177 LIFLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 9e-17
Identities = 58/179 (32%), Positives = 89/179 (49%), Gaps = 16/179 (8%)
Query: 12 VAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL-LVYEYMPLGSVED 70
VA+K + + + FL E +++ L H NLV L+G + L +V EYM GS+ D
Sbjct: 32 VAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVD 89
Query: 71 HLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLS 130
+L S G+ L + +K + +EYL ++RDL N+L+ K+S
Sbjct: 90 YLR--SRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVS 144
Query: 131 DFGLAK-LGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GR 187
DFGL K D + + + APE + + + KSDV+SFG++L EI S GR
Sbjct: 145 DFGLTKEASSTQDTGKLPVK------WTAPEALREKKFSTKSDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 1e-16
Identities = 63/186 (33%), Positives = 84/186 (45%), Gaps = 28/186 (15%)
Query: 13 AIKQLDRNGVQGNREFLVEVLM--------LSLLHHPNLVNLIGYCADGDQRL-LVYEYM 63
AIK L + + E VE LM + HP LVNL C + + V EY
Sbjct: 28 AIKALKKGDIIARDE--VESLMCEKRIFETANSERHPFLVNLFA-CFQTEDHVCFVMEYA 84
Query: 64 PLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAARGLEYLHDKAKPPVIYRDLKCSNILLD 122
G + H+H + R AA GL+YLH+ ++YRDLK N+LLD
Sbjct: 85 AGGDLMMHIHTDVFSEP------RAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLD 135
Query: 123 RGYHPKLSDFGLAK--LGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVL 180
K++DFGL K +G GD T ST GT + APE T D + GV++
Sbjct: 136 TEGFVKIADFGLCKEGMGF-GDRT--ST-FCGTPEFLAPEVLTETSYTRAVDWWGLGVLI 191
Query: 181 LEILSG 186
E+L G
Sbjct: 192 YEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-16
Identities = 60/192 (31%), Positives = 88/192 (45%), Gaps = 15/192 (7%)
Query: 6 LCLLQD---VAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 62
LC QD VA+K L ++F E +L+ L H ++V G C +GD ++V+EY
Sbjct: 29 LCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEY 88
Query: 63 MPLGSVEDHLHDLSP-------GKKP--LDWNTRMKIAAGAARGLEYLHDKAKPPVIYRD 113
M G + L P G +P L + + IA A G+ YL A ++RD
Sbjct: 89 MKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYL---ASQHFVHRD 145
Query: 114 LKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDV 173
L N L+ K+ DFG+++ D V M + PE + T +SDV
Sbjct: 146 LATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDV 205
Query: 174 YSFGVVLLEILS 185
+S GVVL EI +
Sbjct: 206 WSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 2e-16
Identities = 67/265 (25%), Positives = 106/265 (40%), Gaps = 40/265 (15%)
Query: 10 QDVAIKQLDRNGVQG--NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGS 67
+ VAIK++ + L E+ +L L+HPN++ L+ LV+E+M
Sbjct: 25 EIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMD--- 81
Query: 68 VEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP 127
D + ++ L + +GL + H +++RDLK N+L++
Sbjct: 82 -TDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVL 137
Query: 128 KLSDFGLAKL--GPVGDNTH-VSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEI 183
KL+DFGLA+ PV TH V TR Y APE + D++S G + E+
Sbjct: 138 KLADFGLARSFGSPVRPYTHYVVTR-----WYRAPELLLGDKGYSTPVDIWSVGCIFAEL 192
Query: 184 LSGR-------------KAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPR 230
LS R K T + P F R+ + P+ G P+
Sbjct: 193 LSRRPLFPGKSEIDQLFKIFRTLGTPDPEVW-----PKFTSLARNYKFSFPKKAGMPLPK 247
Query: 231 GF----YQALAVAAMCVHEQPDMRP 251
F QAL + + +H P R
Sbjct: 248 LFPNASPQALDLLSQMLHYDPHKRI 272
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 76.9 bits (190), Expect = 2e-16
Identities = 57/179 (31%), Positives = 85/179 (47%), Gaps = 16/179 (8%)
Query: 12 VAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDH 71
VAIK + +E + E+ +L P +V G +V EY GSV D
Sbjct: 31 VAIKVVPVEE--DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDI 88
Query: 72 LHDLSPGKKPLDWNTRMKIAA---GAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK 128
+ + K L T +IAA +GLEYLH K I+RD+K NILL+ K
Sbjct: 89 MKITN---KTL---TEEEIAAILYQTLKGLEYLHSNKK---IHRDIKAGNILLNEEGQAK 139
Query: 129 LSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 187
L+DFG++ G + D V+GT + APE + K+D++S G+ +E+ G+
Sbjct: 140 LADFGVS--GQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-16
Identities = 48/154 (31%), Positives = 70/154 (45%), Gaps = 13/154 (8%)
Query: 33 LMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAA 92
+M+ P + L D LV EY+ G + L G P DW + A
Sbjct: 49 IMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTL--GGLPEDWAK--QYIA 104
Query: 93 GAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMG 152
G+E LH + +I+RD+K N+L+D+ H KL+DFGL++ G + + +G
Sbjct: 105 EVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNG------LENKKFVG 155
Query: 153 TYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG 186
T Y APE SD +S G V+ E L G
Sbjct: 156 TPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-16
Identities = 70/186 (37%), Positives = 89/186 (47%), Gaps = 22/186 (11%)
Query: 10 QDVAIKQLDRNGVQGN---REFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLG 66
+ VAIK++ +G Q N ++ + EV L L HPN + G LV EY LG
Sbjct: 41 EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYC-LG 99
Query: 67 SVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH 126
S D L KKPL I GA +GL YLH + I+RD+K NILL
Sbjct: 100 SASDILEVH---KKPLQEVEIAAICHGALQGLAYLHSHER---IHRDIKAGNILLTEPGT 153
Query: 127 PKLSDFGLAKL-GPVGDNTHVSTRVMGTYGYCAPEY---AKTGQLTLKSDVYSFGVVLLE 182
KL+DFG A L P N+ V GT + APE GQ K DV+S G+ +E
Sbjct: 154 VKLADFGSASLVSPA--NSFV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE 206
Query: 183 ILSGRK 188
L+ RK
Sbjct: 207 -LAERK 211
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 4e-16
Identities = 58/179 (32%), Positives = 94/179 (52%), Gaps = 14/179 (7%)
Query: 10 QDVAIKQLDRNGVQGNREFLV-EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSV 68
Q+VAIKQ++ Q +E ++ E+L++ HPN+VN + GD+ +V EY+ GS+
Sbjct: 45 QEVAIKQMNLQQ-QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSL 103
Query: 69 EDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK 128
D + + +D + + LE+LH VI+RD+K NILL K
Sbjct: 104 TDVVTETC-----MDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVK 155
Query: 129 LSDFGL-AKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG 186
L+DFG A++ P + + ST V GT + APE K D++S G++ +E++ G
Sbjct: 156 LTDFGFCAQITP--EQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 4e-16
Identities = 50/184 (27%), Positives = 95/184 (51%), Gaps = 9/184 (4%)
Query: 12 VAIKQLD--RNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVE 69
V K+++ R + R+ L E+++LSLL HPN++ + D + L+ EY G++
Sbjct: 28 VVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLY 87
Query: 70 DHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKL 129
D + + + + + + Y+H K +++RD+K NI L + KL
Sbjct: 88 DKI--VRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKL 142
Query: 130 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKA 189
DFG++K+ +G ++ V+GT Y +PE + + KSD+++ G VL E+L+ ++
Sbjct: 143 GDFGISKI--LGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRT 200
Query: 190 VDTS 193
D +
Sbjct: 201 FDAT 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 5e-16
Identities = 59/234 (25%), Positives = 104/234 (44%), Gaps = 34/234 (14%)
Query: 35 LSLLHH---PNLVNLIG-YCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI 90
L ++H P +V+ G + + + + E+M GS++ P + KI
Sbjct: 54 LQIMHECRSPYIVSFYGAFLNENNI-CMCMEFMDCGSLDRIYKKGGP----IPVEILGKI 108
Query: 91 AAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD--NTHVST 148
A GL YL++ + +++RD+K SNIL++ KL DFG++ G+ N+ T
Sbjct: 109 AVAVVEGLTYLYNVHR--IMHRDIKPSNILVNSRGQIKLCDFGVS-----GELINSIADT 161
Query: 149 RVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPL 208
V GT Y +PE + G+ T+KSDV+S G+ ++E+ G+ A + P+
Sbjct: 162 FV-GTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPF----AFSNIDDDGQDDPM 216
Query: 209 FQDRTRHSLIADPELQ---GQYPP--RGFYQALAVAAMCVHEQPDMRPVIADVV 257
++ +P + +P R F A C+ + P RP +
Sbjct: 217 GILDLLQQIVQEPPPRLPSSDFPEDLRDFVDA------CLLKDPTERPTPQQLC 264
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 7e-16
Identities = 57/181 (31%), Positives = 86/181 (47%), Gaps = 10/181 (5%)
Query: 12 VAIKQL-DRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVED 70
VA+K L + Q +FL+E L++S +H N+V LIG + R ++ E M G ++
Sbjct: 39 VAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKS 98
Query: 71 HLHDLSPGKK---PLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR---G 124
L + P + L + A A+G +YL + I+RD+ N LL G
Sbjct: 99 FLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPG 155
Query: 125 YHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEIL 184
K++DFG+A+ R M + PE G T K+DV+SFGV+L EI
Sbjct: 156 RVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIF 215
Query: 185 S 185
S
Sbjct: 216 S 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 7e-16
Identities = 46/167 (27%), Positives = 77/167 (46%), Gaps = 15/167 (8%)
Query: 27 EFLVEVLMLSLLHHPNLVNLI-GYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN 85
+F+VE+ +LS HPN+V L Y + +L+ E+ G+++ + +L ++ L
Sbjct: 48 DFMVEIDILSECKHPNIVGLYEAYFYENKLWILI-EFCDGGALDSIMLEL---ERGLTEP 103
Query: 86 TRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 145
+ L +LH VI+RDLK NILL KL+DFG++
Sbjct: 104 QIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKR 160
Query: 146 VSTRVMGTYGYCAPEYA-----KTGQLTLKSDVYSFGVVLLEILSGR 187
+ +GT + APE K K+D++S G+ L+E+
Sbjct: 161 DT--FIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQME 205
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 8e-16
Identities = 65/194 (33%), Positives = 94/194 (48%), Gaps = 24/194 (12%)
Query: 8 LLQDVAIKQLDRNGVQGN-REFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPL 65
L D AIK++ + + R+F E+ +L L HHPN++NL+G C L EY P
Sbjct: 33 LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 92
Query: 66 GSVEDHLH-----DLSPG-------KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRD 113
G++ D L + P L + AA ARG++YL K I+RD
Sbjct: 93 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRD 149
Query: 114 LKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG--YCAPEYAKTGQLTLKS 171
L NIL+ Y K++DFGL++ G +V + MG + A E T S
Sbjct: 150 LAARNILVGENYVAKIADFGLSR----GQEVYVK-KTMGRLPVRWMAIESLNYSVYTTNS 204
Query: 172 DVYSFGVVLLEILS 185
DV+S+GV+L EI+S
Sbjct: 205 DVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 1e-15
Identities = 70/249 (28%), Positives = 109/249 (43%), Gaps = 32/249 (12%)
Query: 12 VAIKQLDRNGVQGNREFLV-EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVED 70
VAIK +D + E + E+ +LS P + G G + ++ EY+ GS D
Sbjct: 32 VAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALD 91
Query: 71 HLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLS 130
L PG PL+ I +GL+YLH + K I+RD+K +N+LL KL+
Sbjct: 92 LL---KPG--PLEETYIATILREILKGLDYLHSERK---IHRDIKAANVLLSEQGDVKLA 143
Query: 131 DFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAV 190
DFG+A G + D +GT + APE K K+D++S G+ +E+ G
Sbjct: 144 DFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPN 201
Query: 191 DTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQY--PPRGFYQALAVAAMCVHEQPD 248
L+ P P L+GQY P + F +A C+++ P
Sbjct: 202 SDLHPMRVLFLIPKNSP-------------PTLEGQYSKPFKEFVEA------CLNKDPR 242
Query: 249 MRPVIADVV 257
RP +++
Sbjct: 243 FRPTAKELL 251
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-15
Identities = 56/178 (31%), Positives = 92/178 (51%), Gaps = 11/178 (6%)
Query: 12 VAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDH 71
VA+K + + G FL E ++ L H LV L + ++ E+M GS+ D
Sbjct: 33 VAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDF 90
Query: 72 LHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSD 131
L K+PL + +A A G+ ++ + I+RDL+ +NIL+ K++D
Sbjct: 91 LKSDEGSKQPLP--KLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIAD 145
Query: 132 FGLAKLGPVGDNTHVSTR-VMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GR 187
FGLA++ + DN + + + APE G T+KSDV+SFG++L+EI++ GR
Sbjct: 146 FGLARV--IEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.8 bits (185), Expect = 1e-15
Identities = 57/195 (29%), Positives = 89/195 (45%), Gaps = 44/195 (22%)
Query: 12 VAIKQL----DRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGS 67
VA+K++ + G+ L E+ +L L HPN+V L+ + LV+EY
Sbjct: 27 VALKKIRLDNEEEGIPSTA--LREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD--- 81
Query: 68 VEDHLHDLSPGKKPLDWNTRMKIAAGAA--------RGLEYLHDKAKPPVIYRDLKCSNI 119
DL KK LD ++ RGL Y H +++RDLK NI
Sbjct: 82 -----MDL---KKYLD-KRPGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNI 129
Query: 120 LLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKS-------D 172
L++R KL+DFGLA+ + T+ + V+ T Y APE + L S D
Sbjct: 130 LINRDGVLKLADFGLARAFGIPLRTY-THEVV-TLWYRAPE------ILLGSKHYSTAVD 181
Query: 173 VYSFGVVLLEILSGR 187
++S G + E+++G+
Sbjct: 182 IWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 2e-15
Identities = 57/165 (34%), Positives = 81/165 (49%), Gaps = 12/165 (7%)
Query: 29 LVEVLMLSLLHHPNLVNLIGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTR 87
+VE +L+L P + + C RL V EY+ G + H+ + K+P
Sbjct: 48 MVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEP----HA 103
Query: 88 MKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVS 147
+ AA A GL +LH K +IYRDLK N++LD H K++DFG+ K G T
Sbjct: 104 VFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT--- 157
Query: 148 TRVM-GTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVD 191
TR GT Y APE D ++FGV+L E+L+G+ D
Sbjct: 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 74.2 bits (183), Expect = 2e-15
Identities = 52/182 (28%), Positives = 84/182 (46%), Gaps = 8/182 (4%)
Query: 12 VAIKQLD-RNGVQGNREFLV-EVLMLSLLHHPNLVNLIGYCADGDQRLL--VYEYMPLGS 67
+ K++D N + ++ LV EV +L L HPN+V D + L V EY G
Sbjct: 28 LVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGD 87
Query: 68 VEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH--DKAKPPVIYRDLKCSNILLDRGY 125
+ + +K ++ +I L H V++RDLK +NI LD
Sbjct: 88 LAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANN 147
Query: 126 HPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 185
+ KL DFGLAK+ +G ++ + +GT Y +PE KSD++S G ++ E+ +
Sbjct: 148 NVKLGDFGLAKI--LGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCA 205
Query: 186 GR 187
Sbjct: 206 LS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 2e-15
Identities = 63/184 (34%), Positives = 88/184 (47%), Gaps = 17/184 (9%)
Query: 10 QDVAIKQLDRNGVQGNREF---LVEVLMLSLL-HHPNLVNLIGYCA--DGDQRLLVYEYM 63
Q AIK L ++ V + + +VE +LSL HP L +L YC + V EY+
Sbjct: 21 QFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL--YCTFQTKENLFFVMEYL 78
Query: 64 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR 123
G + H+ D AA GL++LH K ++YRDLK NILLD
Sbjct: 79 NGGDLMFHIQSC----HKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDT 131
Query: 124 GYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEI 183
H K++DFG+ K +GD + GT Y APE + D +SFGV+L E+
Sbjct: 132 DGHIKIADFGMCKENMLGDAK--TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEM 189
Query: 184 LSGR 187
L G+
Sbjct: 190 LIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-15
Identities = 55/161 (34%), Positives = 78/161 (48%), Gaps = 10/161 (6%)
Query: 27 EFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNT 86
+FL E +L HPN+V LIG C Q+ +Y M L D L L L
Sbjct: 39 KFLQEARILKQYSHPNIVRLIGVCT---QKQPIYIVMELVQGGDFLTFLRTEGPRLKVKE 95
Query: 87 RMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHV 146
+++ AA G+EYL K I+RDL N L+ K+SDFG+++ D +
Sbjct: 96 LIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSR--EEEDGVYA 150
Query: 147 STRVMGT--YGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 185
ST M + APE G+ + +SDV+SFG++L E S
Sbjct: 151 STGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 3e-15
Identities = 48/163 (29%), Positives = 82/163 (50%), Gaps = 15/163 (9%)
Query: 31 EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI 90
E+ L L H N+V +G+ + + EY+P GS+ L ++ L ++
Sbjct: 58 EIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQV 117
Query: 91 AAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRV 150
GL YLH K +++RDLK N+L+D K+SDFG++K D+ + + +
Sbjct: 118 L----EGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKK---SDDIYDNDQN 167
Query: 151 M---GTYGYCAPEYAKTGQ--LTLKSDVYSFGVVLLEILSGRK 188
M G+ + APE + + K D++S G V+LE+ +GR+
Sbjct: 168 MSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 3e-15
Identities = 65/183 (35%), Positives = 85/183 (46%), Gaps = 20/183 (10%)
Query: 12 VAIKQLDRNGVQGN---REFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSV 68
VA+K++ +G Q N ++ + EV L L HPN + G LV EY LGS
Sbjct: 49 VAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYC-LGSA 107
Query: 69 EDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK 128
D L KKPL I GA +GL YLH I+RD+K NILL K
Sbjct: 108 SDLLE---VHKKPLQEVEIAAITHGALQGLAYLHSHNM---IHRDIKAGNILLTEPGQVK 161
Query: 129 LSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY---AKTGQLTLKSDVYSFGVVLLEILS 185
L+DFG A ++ +GT + APE GQ K DV+S G+ +E L+
Sbjct: 162 LADFGSASKSSPANS------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE-LA 214
Query: 186 GRK 188
RK
Sbjct: 215 ERK 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-15
Identities = 54/159 (33%), Positives = 77/159 (48%), Gaps = 7/159 (4%)
Query: 27 EFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNT 86
+FL E +L HPN+V LIG C QR +Y M L D L L K L
Sbjct: 38 KFLSEARILKQYDHPNIVKLIGVCT---QRQPIYIVMELVPGGDFLSFLRKKKDELKTKQ 94
Query: 87 RMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHV 146
+K A AA G+ YL K I+RDL N L+ K+SDFG+++ G +
Sbjct: 95 LVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSS 151
Query: 147 STRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 185
+ + + APE G+ + +SDV+S+G++L E S
Sbjct: 152 GLKQI-PIKWTAPEALNYGRYSSESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 3e-15
Identities = 58/185 (31%), Positives = 100/185 (54%), Gaps = 15/185 (8%)
Query: 12 VAIKQLDRN-GVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVED 70
VAIK L+ G + N EF+ E L+++ + HP+LV L+G C + LV + MP G + D
Sbjct: 39 VAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLD 97
Query: 71 HLH---DLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP 127
++H D + L+W ++ A+G+ YL ++ +++RDL N+L+ H
Sbjct: 98 YVHEHKDNIGSQLLLNWCVQI------AKGMMYLEERR---LVHRDLAARNVLVKSPNHV 148
Query: 128 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-G 186
K++DFGLA+L + + + + A E + T +SDV+S+GV + E+++ G
Sbjct: 149 KITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFG 208
Query: 187 RKAVD 191
K D
Sbjct: 209 GKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 3e-15
Identities = 51/155 (32%), Positives = 74/155 (47%), Gaps = 20/155 (12%)
Query: 89 KIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST 148
KIA + LEYLH K VI+RD+K SN+L++R KL DFG++ G + D+ T
Sbjct: 107 KIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGIS--GYLVDSV-AKT 161
Query: 149 RVMGTYGYCAPEY----AKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ--SLV 202
G Y APE +KSDV+S G+ ++E+ +GR D+ K +Q +V
Sbjct: 162 IDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVV 221
Query: 203 AWARPL---------FQDRTRHSLIADPELQGQYP 228
P FQD L + + + YP
Sbjct: 222 EEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYP 256
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 5e-15
Identities = 53/189 (28%), Positives = 86/189 (45%), Gaps = 16/189 (8%)
Query: 10 QDVAIKQL-DRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSV 68
Q VAIK L D+ EF E +M S L HPN+V L+G +++ Y +
Sbjct: 36 QAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDL 95
Query: 69 EDHLHDLSPG------------KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKC 116
+ L SP K L+ + I A G+E+L + V+++DL
Sbjct: 96 HEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFL---SSHHVVHKDLAT 152
Query: 117 SNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSF 176
N+L+ + K+SD GL + D + + + +PE G+ ++ SD++S+
Sbjct: 153 RNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSY 212
Query: 177 GVVLLEILS 185
GVVL E+ S
Sbjct: 213 GVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 5e-15
Identities = 57/183 (31%), Positives = 96/183 (52%), Gaps = 14/183 (7%)
Query: 6 LCLLQDVAIKQLDRNGVQGNREFLV-EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMP 64
+ Q+VAIKQ++ Q +E ++ E+L++ L +PN+VN + GD+ +V EY+
Sbjct: 41 VATGQEVAIKQINLQK-QPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLA 99
Query: 65 LGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG 124
GS+ D + + +D + + LE+LH VI+RD+K N+LL
Sbjct: 100 GGSLTDVVTETC-----MDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMD 151
Query: 125 YHPKLSDFGL-AKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEI 183
KL+DFG A++ P + + ST V GT + APE K D++S G++ +E+
Sbjct: 152 GSVKLTDFGFCAQITP--EQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEM 208
Query: 184 LSG 186
+ G
Sbjct: 209 VEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 5e-15
Identities = 69/249 (27%), Positives = 108/249 (43%), Gaps = 32/249 (12%)
Query: 12 VAIKQLDRNGVQGNREFLV-EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVED 70
VAIK +D + E + E+ +LS P + G + ++ EY+ GS D
Sbjct: 32 VAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD 91
Query: 71 HLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLS 130
L PG PLD I +GL+YLH + K I+RD+K +N+LL KL+
Sbjct: 92 LLE---PG--PLDETQIATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLA 143
Query: 131 DFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAV 190
DFG+A G + D +GT + APE K K+D++S G+ +E+ G
Sbjct: 144 DFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPH 201
Query: 191 DTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQY--PPRGFYQALAVAAMCVHEQPD 248
L+ P P L+G Y P + F +A C++++P
Sbjct: 202 SELHPMKVLFLIPKNNP-------------PTLEGNYSKPLKEFVEA------CLNKEPS 242
Query: 249 MRPVIADVV 257
RP +++
Sbjct: 243 FRPTAKELL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 8e-15
Identities = 60/194 (30%), Positives = 92/194 (47%), Gaps = 19/194 (9%)
Query: 3 QVILCLLQD----VAIKQL--DRNGVQGNRE---FLVEVLMLSLLHHPNLVNLIGYCADG 53
+V LC D +A+KQ+ D + + +E E+ +L L H +V G C
Sbjct: 17 RVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYG-CLRD 75
Query: 54 DQRLLVY-EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYR 112
D+ L ++ EYMP GSV+D L L K G+EYLH +++R
Sbjct: 76 DETLSIFMEYMPGGSVKDQLKAYG----ALTETVTRKYTRQILEGVEYLHSNM---IVHR 128
Query: 113 DLKCSNILLDRGYHPKLSDFGLAK-LGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKS 171
D+K +NIL D + KL DFG +K L + + V GT + +PE K+
Sbjct: 129 DIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKA 188
Query: 172 DVYSFGVVLLEILS 185
DV+S G ++E+L+
Sbjct: 189 DVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.6 bits (179), Expect = 1e-14
Identities = 57/178 (32%), Positives = 82/178 (46%), Gaps = 11/178 (6%)
Query: 10 QDVAIKQLDRNGVQGNREFLV-EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSV 68
Q VAIK +D + E + E+ LS P + G G + ++ EY GS
Sbjct: 27 QVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSC 86
Query: 69 EDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK 128
L L PG LD I GLEYLH++ K I+RD+K +NILL K
Sbjct: 87 ---LDLLKPG--KLDETYIAFILREVLLGLEYLHEEGK---IHRDIKAANILLSEEGDVK 138
Query: 129 LSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG 186
L+DFG++ G + +GT + APE K K+D++S G+ +E+ G
Sbjct: 139 LADFGVS--GQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-14
Identities = 59/173 (34%), Positives = 91/173 (52%), Gaps = 10/173 (5%)
Query: 12 VAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDH 71
VAIK L + G FL E ++ L H LV L ++ + +V EYM GS+ D
Sbjct: 33 VAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDF 90
Query: 72 LHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSD 131
L K L + +AA A G+ Y+ + ++RDL+ +NIL+ K++D
Sbjct: 91 LKGEM--GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVAD 145
Query: 132 FGLAKLGPVGDNTHVSTR-VMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEI 183
FGLA+L + DN + + + + APE A G+ T+KSDV+SFG++L E+
Sbjct: 146 FGLARL--IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL 196
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 1e-14
Identities = 56/160 (35%), Positives = 75/160 (46%), Gaps = 12/160 (7%)
Query: 29 LVEVLMLSLLH-HPNLVNLIGYCADGDQRLL-VYEYMPLGSVEDHLHDLSPGKKPLDWNT 86
+ E +LSL HP L L C RL V E++ G + H+ + D
Sbjct: 43 MTEKRILSLARNHPFLTQLY-CCFQTPDRLFFVMEFVNGGDLMFHIQK----SRRFDEAR 97
Query: 87 RMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHV 146
AA L +LHDK +IYRDLK N+LLD H KL+DFG+ K G + +
Sbjct: 98 ARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG-IFNGKTT 153
Query: 147 STRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG 186
ST GT Y APE + D ++ GV+L E+L G
Sbjct: 154 ST-FCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-14
Identities = 59/175 (33%), Positives = 94/175 (53%), Gaps = 10/175 (5%)
Query: 12 VAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDH 71
VAIK L + G FL E ++ L H LV L ++ + +V E+M GS+ D
Sbjct: 33 VAIKTL-KPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMGKGSLLDF 90
Query: 72 LHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSD 131
L + K L + +AA A G+ Y+ + I+RDL+ +NIL+ K++D
Sbjct: 91 LKE--GDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIAD 145
Query: 132 FGLAKLGPVGDNTHVSTR-VMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 185
FGLA+L + DN + + + + APE A G+ T+KSDV+SFG++L E+++
Sbjct: 146 FGLARL--IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 1e-14
Identities = 57/184 (30%), Positives = 96/184 (52%), Gaps = 16/184 (8%)
Query: 11 DVAIKQLDRNGVQGNR-EFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVE 69
DVAIK L + R E + E ++ L +P +V +IG C + + +LV E G
Sbjct: 24 DVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVC-EAEALMLVMEMASGGP-- 80
Query: 70 DHLHDLSPGKK-PLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK 128
L+ GKK + + +++ + G++YL K ++RDL N+LL ++ K
Sbjct: 81 --LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAK 135
Query: 129 LSDFGLAK-LGPVGDNTHVSTRVMGTY--GYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 185
+SDFGL+K LG D+++ R G + + APE + + +SDV+S+G+ + E S
Sbjct: 136 ISDFGLSKALG--ADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFS 193
Query: 186 -GRK 188
G+K
Sbjct: 194 YGQK 197
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 2e-14
Identities = 57/164 (34%), Positives = 80/164 (48%), Gaps = 20/164 (12%)
Query: 29 LVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDH--LHDLSPGKKPLDWNT 86
L E+ ML L HPNLVNLI + LV+EY DH L++L + + +
Sbjct: 48 LREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYC------DHTVLNELEKNPRGVPEHL 101
Query: 87 RMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL--GPVGDNT 144
KI + + + H K I+RD+K NIL+ + KL DFG A++ GP D T
Sbjct: 102 IKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYT 158
Query: 145 -HVSTRVMGTYGYCAPEY-AKTGQLTLKSDVYSFGVVLLEILSG 186
+V+TR Y APE Q DV++ G V E+L+G
Sbjct: 159 DYVATR-----WYRAPELLVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 2e-14
Identities = 53/161 (32%), Positives = 81/161 (50%), Gaps = 23/161 (14%)
Query: 31 EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI 90
E+ ML HPN+V G D+ +V EY GS++D + PL + ++I
Sbjct: 50 EISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVT---RGPL---SELQI 103
Query: 91 A---AGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL-AKLGPVGDNTHV 146
A +GL YLH+ K I+RD+K +NILL KL+DFG+ A+L T +
Sbjct: 104 AYVCRETLKGLAYLHETGK---IHRDIKGANILLTEDGDVKLADFGVSAQL----TAT-I 155
Query: 147 STR--VMGTYGYCAPEYA---KTGQLTLKSDVYSFGVVLLE 182
+ R +GT + APE A + G K D+++ G+ +E
Sbjct: 156 AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 2e-14
Identities = 53/155 (34%), Positives = 82/155 (52%), Gaps = 16/155 (10%)
Query: 34 MLSLLHHPNLVNLIGYCADGDQRLL--VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIA 91
+L + HP ++ L + + DQR L + EY+P G + +L + G+ +T + A
Sbjct: 54 VLKEVSHPFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLR--NSGR--FSNSTGLFYA 107
Query: 92 AGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVM 151
+ LEYLH K ++YRDLK NILLD+ H KL+DFG AK + D T +
Sbjct: 108 SEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAK--KLRDRTWT---LC 159
Query: 152 GTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG 186
GT Y APE ++ D ++ G+++ E+L G
Sbjct: 160 GTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-14
Identities = 51/179 (28%), Positives = 85/179 (47%), Gaps = 10/179 (5%)
Query: 12 VAIKQLDRNGVQGNR-EFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVED 70
VAIK ++ R EFL E ++ + ++V L+G + G L++ E M G ++
Sbjct: 39 VAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKS 98
Query: 71 HLHDL------SPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG 124
+L L +P + P +++A A G+ YL+ ++RDL N ++
Sbjct: 99 YLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAED 155
Query: 125 YHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEI 183
+ K+ DFG+ + D + + + +PE K G T SDV+SFGVVL EI
Sbjct: 156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 3e-14
Identities = 54/165 (32%), Positives = 82/165 (49%), Gaps = 12/165 (7%)
Query: 29 LVEVLMLSLLHHPNLVNLIGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTR 87
+VE +L+L P + + C RL V EY+ G + H+ + K+P
Sbjct: 48 MVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEP----QA 103
Query: 88 MKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVS 147
+ AA + GL +LH + +IYRDLK N++LD H K++DFG+ K V V+
Sbjct: 104 VFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV---DGVT 157
Query: 148 TRVM-GTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVD 191
TR GT Y APE D +++GV+L E+L+G+ D
Sbjct: 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 3e-14
Identities = 62/178 (34%), Positives = 82/178 (46%), Gaps = 19/178 (10%)
Query: 12 VAIKQLDRNGVQGN---REFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSV 68
VAIK++ +G Q N ++ + EV L L HPN + G LV EY LGS
Sbjct: 43 VAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC-LGSA 101
Query: 69 EDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK 128
D L KKPL + GA +GL YLH +I+RD+K NILL K
Sbjct: 102 SDLLE---VHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVK 155
Query: 129 LSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY---AKTGQLTLKSDVYSFGVVLLEI 183
L DFG A + + +GT + APE GQ K DV+S G+ +E+
Sbjct: 156 LGDFGSASI------MAPANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 3e-14
Identities = 59/197 (29%), Positives = 94/197 (47%), Gaps = 23/197 (11%)
Query: 12 VAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDH 71
V +K L + + F ++S L H +LV L G C D+ ++V EY+ G ++
Sbjct: 33 VVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCV-RDENIMVEEYVKFGPLDVF 90
Query: 72 LHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR-----GYH 126
LH L W ++ +A A L YL DK +++ ++ NIL+ R GY
Sbjct: 91 LH-REKNNVSLHW--KLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYV 144
Query: 127 P--KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ--LTLKSDVYSFGVVLLE 182
P KLSD G+ V R+ + APE + GQ LT+ +D +SFG LLE
Sbjct: 145 PFIKLSDPGIPI--TVLSREERVERI----PWIAPECIRNGQASLTIAADKWSFGTTLLE 198
Query: 183 ILSGRKAVDTSKAAAEQ 199
I S + ++ +++E+
Sbjct: 199 ICSNGEEPLSTLSSSEK 215
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 4e-14
Identities = 46/180 (25%), Positives = 80/180 (44%), Gaps = 10/180 (5%)
Query: 12 VAIKQLDRNGVQG-NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVED 70
V +K L + + EF E+ M L H N+V L+G C + + ++ EY LG ++
Sbjct: 38 VLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQ 97
Query: 71 HL-----HDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY 125
L D PL ++ + A G+++L + ++RDL N L+
Sbjct: 98 FLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHL---SNARFVHRDLAARNCLVSSQR 154
Query: 126 HPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 185
K+S L+K + + + APE + + KSDV+SFGV++ E+ +
Sbjct: 155 EVKVSLLSLSK-DVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 4e-14
Identities = 65/183 (35%), Positives = 87/183 (47%), Gaps = 20/183 (10%)
Query: 12 VAIKQLDRNGVQGN---REFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSV 68
VAIK++ +G Q N ++ + EV L + HPN + G LV EY LGS
Sbjct: 53 VAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYC-LGSA 111
Query: 69 EDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK 128
D L KKPL I GA +GL YLH +I+RD+K NILL K
Sbjct: 112 SDLLE---VHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVK 165
Query: 129 LSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY---AKTGQLTLKSDVYSFGVVLLEILS 185
L+DFG A + ++ +GT + APE GQ K DV+S G+ +E L+
Sbjct: 166 LADFGSASIASPANS------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE-LA 218
Query: 186 GRK 188
RK
Sbjct: 219 ERK 221
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 5e-14
Identities = 55/163 (33%), Positives = 79/163 (48%), Gaps = 22/163 (13%)
Query: 31 EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDH--LHDLSPGKKPLDWNTRM 88
E+ ML L H NLVNLI + LV+E++ DH L DL LD +
Sbjct: 50 EIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFV------DHTVLDDLEKYPNGLDESRVR 103
Query: 89 KIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK-LGPVGDNTHVS 147
K RG+E+ H +I+RD+K NIL+ + KL DFG A+ L G+ V
Sbjct: 104 KYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE---VY 157
Query: 148 TRVMGTYGYCAPEY----AKTGQLTLKSDVYSFGVVLLEILSG 186
T + T Y APE K G+ D+++ G ++ E+L+G
Sbjct: 158 TDYVATRWYRAPELLVGDTKYGRAV---DIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 5e-14
Identities = 54/188 (28%), Positives = 86/188 (45%), Gaps = 17/188 (9%)
Query: 12 VAIKQLDRNGVQGN-REFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPLGSVE 69
VA+K L + + + + + E+ M+ ++ H N++NL+G C +V EY G++
Sbjct: 45 VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLR 104
Query: 70 DHLHDLSP----GKKPLDWNTRMKI--------AAGAARGLEYLHDKAKPPVIYRDLKCS 117
D L P + A ARG+E+L K I+RDL
Sbjct: 105 DFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAAR 161
Query: 118 NILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFG 177
N+L+ + K++DFGLA+ D +T + APE T +SDV+SFG
Sbjct: 162 NVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 221
Query: 178 VVLLEILS 185
V+L EI +
Sbjct: 222 VLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 6e-14
Identities = 54/159 (33%), Positives = 77/159 (48%), Gaps = 14/159 (8%)
Query: 29 LVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRM 88
E +L L HP +VN++ D ++ + E++ G + HL G+ P N
Sbjct: 66 AQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLR--KAGRFP---NDVA 120
Query: 89 KI-AAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVS 147
K A EYLH K +IYRDLK N+LLD H K++DFG AK V D T
Sbjct: 121 KFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAK--KVPDRTFT- 174
Query: 148 TRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG 186
+ GT Y APE ++ D ++ GV+L E ++G
Sbjct: 175 --LCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 6e-14
Identities = 56/188 (29%), Positives = 93/188 (49%), Gaps = 17/188 (9%)
Query: 10 QDVAIKQ--LDRNGVQGN----REFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 63
Q +A+KQ LD + V + EV +L L H N+V +G C D + + E++
Sbjct: 25 QLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFV 84
Query: 64 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR 123
P GS+ L+ P +P+ +I G A YLH+ V++RD+K +N++L
Sbjct: 85 PGGSISSILNRFGPLPEPVFCKYTKQILDGVA----YLHNNC---VVHRDIKGNNVMLMP 137
Query: 124 GYHPKLSDFGLAK----LGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVV 179
KL DFG A+ +G G ++++ + GT + APE KSD++S G
Sbjct: 138 NGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCT 197
Query: 180 LLEILSGR 187
+ E+ +G+
Sbjct: 198 VFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 7e-14
Identities = 53/184 (28%), Positives = 89/184 (48%), Gaps = 24/184 (13%)
Query: 10 QDVAIKQLDRNGVQGNREFLV-EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSV 68
+ VA+K++D Q RE L EV+++ HPN+V + GD+ +V E++ G++
Sbjct: 45 RQVAVKKMDLRK-QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGAL 103
Query: 69 EDHLHDLSPGKKPLDWNTRM---KIAA---GAARGLEYLHDKAKPPVIYRDLKCSNILLD 122
D + +TRM +IA + L +LH + VI+RD+K +ILL
Sbjct: 104 TDIVT-----------HTRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLT 149
Query: 123 RGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLE 182
KLSDFG V ++GT + APE + D++S G++++E
Sbjct: 150 SDGRVKLSDFGFC--AQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIE 207
Query: 183 ILSG 186
++ G
Sbjct: 208 MVDG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 8e-14
Identities = 56/180 (31%), Positives = 90/180 (50%), Gaps = 16/180 (8%)
Query: 12 VAIKQLDRNGVQGNR-EFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVED 70
VAIK L + R +FL E ++ HPN+++L G ++V EYM GS++
Sbjct: 35 VAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDA 94
Query: 71 HL--HDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK 128
L HD L + + G A G++YL D ++RDL NIL++ K
Sbjct: 95 FLRKHDGQFTVIQL-----VGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCK 146
Query: 129 LSDFGLAKLGPVGDNTHVSTRVMG---TYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 185
+SDFGL+++ + D+ + G + APE + T SDV+S+G+V+ E++S
Sbjct: 147 VSDFGLSRV--LEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 8e-14
Identities = 45/166 (27%), Positives = 67/166 (40%), Gaps = 21/166 (12%)
Query: 29 LVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRM 88
L EV +L L H N+VNL + LV+EY+ L L L +
Sbjct: 48 LREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVE----RTLLELLEASPGGLPPDAVR 103
Query: 89 KIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST 148
+ + Y H +I+RD+K NIL+ KL DFG A+ + ++
Sbjct: 104 SYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTD 160
Query: 149 RVMGTYGYCAPEYAKTGQLTLKS-------DVYSFGVVLLEILSGR 187
V T Y APE L + DV++ G ++ E+L G
Sbjct: 161 YV-ATRWYRAPE------LLVGDTNYGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 1e-13
Identities = 50/189 (26%), Positives = 80/189 (42%), Gaps = 19/189 (10%)
Query: 10 QDVAIKQLDRNGVQGN--REFLVEVLMLSLLHHPNLVNLIGYCADGDQR------LLVYE 61
VA+K + + + EFL E + HPN++ LIG C + +++
Sbjct: 28 LKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILP 87
Query: 62 YMPLGSVEDHLHDLSPGKKPLDWNTRM--KIAAGAARGLEYLHDKAKPPVIYRDLKCSNI 119
+M G + L G P + K A G+EYL ++ I+RDL N
Sbjct: 88 FMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNC 144
Query: 120 LLDRGYHPKLSDFGLAKLGPVGD---NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSF 176
+L ++DFGL+K GD ++ + + A E T KSDV++F
Sbjct: 145 MLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK---WIAIESLADRVYTSKSDVWAF 201
Query: 177 GVVLLEILS 185
GV + EI +
Sbjct: 202 GVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 1e-13
Identities = 52/176 (29%), Positives = 87/176 (49%), Gaps = 8/176 (4%)
Query: 12 VAIKQLDRNGVQGNR-EFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVED 70
VAIK L + R +FL E ++ H N++ L G +++ EYM G+++
Sbjct: 36 VAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDK 95
Query: 71 HLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLS 130
+L D ++ G A G++YL D ++RDL NIL++ K+S
Sbjct: 96 YLRDHDGEFSSYQLVGMLR---GIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVS 149
Query: 131 DFGLAK-LGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 185
DFGL++ L + T+ ++ + APE + T SDV+SFG+V+ E++S
Sbjct: 150 DFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 1e-13
Identities = 51/155 (32%), Positives = 79/155 (50%), Gaps = 15/155 (9%)
Query: 40 HPNLVNLIGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGL 98
HP LV L C + RL V E++ G + H+ +K + + R +A + L
Sbjct: 55 HPFLVGLHS-CFQTESRLFFVIEFVSGGDLMFHMQR---QRKLPEEHARF-YSAEISLAL 109
Query: 99 EYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK--LGPVGDNTHVSTRVMGTYGY 156
+LH++ +IYRDLK N+LLD H KL+D+G+ K + P GD T + GT Y
Sbjct: 110 NFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GDTT---STFCGTPNY 162
Query: 157 CAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVD 191
APE + D ++ GV++ E+++GR D
Sbjct: 163 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 1e-13
Identities = 55/181 (30%), Positives = 89/181 (49%), Gaps = 10/181 (5%)
Query: 12 VAIKQLDRNGVQGNR-EFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVED 70
VA+K ++ + R EFL E ++ ++V L+G + G L+V E M G ++
Sbjct: 39 VAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKS 98
Query: 71 HLHDL------SPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG 124
+L L +PG+ P +++AA A G+ YL+ K ++RDL N ++
Sbjct: 99 YLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHD 155
Query: 125 YHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEIL 184
+ K+ DFG+ + D + + + APE K G T SD++SFGVVL EI
Sbjct: 156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEIT 215
Query: 185 S 185
S
Sbjct: 216 S 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 69.4 bits (169), Expect = 1e-13
Identities = 56/179 (31%), Positives = 94/179 (52%), Gaps = 14/179 (7%)
Query: 10 QDVAIKQLDRNGVQGNREFLV-EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSV 68
Q+VAIKQ++ Q +E ++ E+L++ +PN+VN + GD+ +V EY+ GS+
Sbjct: 45 QEVAIKQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL 103
Query: 69 EDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK 128
D + + +D + + L++LH VI+RD+K NILL K
Sbjct: 104 TDVVTETC-----MDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVK 155
Query: 129 LSDFGL-AKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG 186
L+DFG A++ P + + ST V GT + APE K D++S G++ +E++ G
Sbjct: 156 LTDFGFCAQITP--EQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 69.4 bits (169), Expect = 1e-13
Identities = 53/179 (29%), Positives = 92/179 (51%), Gaps = 14/179 (7%)
Query: 10 QDVAIKQLDRNGVQGNREFLV-EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSV 68
Q+VAI+Q++ Q +E ++ E+L++ +PN+VN + GD+ +V EY+ GS+
Sbjct: 46 QEVAIRQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL 104
Query: 69 EDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK 128
D + + +D + + LE+LH VI+RD+K NILL K
Sbjct: 105 TDVVTETC-----MDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVK 156
Query: 129 LSDFGL-AKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG 186
L+DFG A++ P + ++GT + APE K D++S G++ +E++ G
Sbjct: 157 LTDFGFCAQITP---EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 2e-13
Identities = 52/155 (33%), Positives = 77/155 (49%), Gaps = 13/155 (8%)
Query: 39 HHPNLVNLIGYCADGDQRLL-VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARG 97
+HP LV L C + RL V EY+ G + H+ ++ L +A +
Sbjct: 54 NHPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLA 108
Query: 98 LEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG-PVGDNTHVSTRVMGTYGY 156
L YLH++ +IYRDLK N+LLD H KL+D+G+ K G GD T + GT Y
Sbjct: 109 LNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFCGTPNY 162
Query: 157 CAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVD 191
APE + D ++ GV++ E+++GR D
Sbjct: 163 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 2e-13
Identities = 54/155 (34%), Positives = 78/155 (50%), Gaps = 15/155 (9%)
Query: 40 HPNLVNLIGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGL 98
+P LV L C RL LV EY+ G + H+ ++ L AA L
Sbjct: 55 NPFLVGLHS-CFQTTSRLFLVIEYVNGGDLMFHMQR----QRKLPEEHARFYAAEICIAL 109
Query: 99 EYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK--LGPVGDNTHVSTRVMGTYGY 156
+LH++ +IYRDLK N+LLD H KL+D+G+ K LGP GD T + GT Y
Sbjct: 110 NFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP-GDTT---STFCGTPNY 162
Query: 157 CAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVD 191
APE + + D ++ GV++ E+++GR D
Sbjct: 163 IAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 2e-13
Identities = 54/181 (29%), Positives = 93/181 (51%), Gaps = 16/181 (8%)
Query: 12 VAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVE 69
VAIK L ++G + R+FL E ++ HPN+++L G +++ E+M G+++
Sbjct: 35 VAIKTL-KSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALD 93
Query: 70 DHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKL 129
L + G+ + M G A G++YL + ++RDL NIL++ K+
Sbjct: 94 SFLR-QNDGQFTVIQLVGM--LRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKV 147
Query: 130 SDFGLAKLGPVGDNTHVSTRVMGTYG-----YCAPEYAKTGQLTLKSDVYSFGVVLLEIL 184
SDFGL++ + D+T T G + APE + T SDV+S+G+V+ E++
Sbjct: 148 SDFGLSRF--LEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVM 205
Query: 185 S 185
S
Sbjct: 206 S 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 2e-13
Identities = 56/178 (31%), Positives = 87/178 (48%), Gaps = 11/178 (6%)
Query: 13 AIKQLDRNGVQ---GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVE 69
A K+L++ ++ G L E +L ++ +V+L D LV M G ++
Sbjct: 29 ACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLK 88
Query: 70 DHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKL 129
H++++ D + AA GLE LH + ++YRDLK NILLD H ++
Sbjct: 89 FHIYNMGNPG--FDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRI 143
Query: 130 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 187
SD GLA P G+ + RV GT GY APE K + T D + G ++ E++ G+
Sbjct: 144 SDLGLAVEIPEGET--IRGRV-GTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 2e-13
Identities = 54/179 (30%), Positives = 92/179 (51%), Gaps = 13/179 (7%)
Query: 13 AIKQLDRNGVQ---GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL-LVYEYMPLGSV 68
A K+LD+ ++ G + L+E +L ++ P +VNL Y + L LV M G +
Sbjct: 22 ACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNL-AYAFESKTHLCLVMSLMNGGDL 80
Query: 69 EDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK 128
+ H++++ G++ L+ + +A G+ +LH ++YRD+K N+LLD + +
Sbjct: 81 KYHIYNV--GERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCR 135
Query: 129 LSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 187
LSD GLA G T+ GT GY APE K + D ++ G + E+++GR
Sbjct: 136 LSDLGLAVELKDGKTI---TQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-13
Identities = 53/188 (28%), Positives = 88/188 (46%), Gaps = 17/188 (9%)
Query: 12 VAIKQLDRNGVQGNREFLV-EVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPLGSVE 69
VA+K L + + + LV E+ M+ ++ H N++NL+G C ++ EY G++
Sbjct: 50 VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 109
Query: 70 DHLHDLSP------------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCS 117
++L P + + + + ARG+EYL A I+RDL
Sbjct: 110 EYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAAR 166
Query: 118 NILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFG 177
N+L+ K++DFGLA+ D +T + APE T +SDV+SFG
Sbjct: 167 NVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 226
Query: 178 VVLLEILS 185
V++ EI +
Sbjct: 227 VLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 3e-13
Identities = 53/160 (33%), Positives = 88/160 (55%), Gaps = 21/160 (13%)
Query: 35 LSLLHHPNLVNLIGY----CADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI 90
L +LH N ++G+ +DG+ + + E+M GS++ L G+ P + ++ I
Sbjct: 50 LKVLHECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLK--KAGRIPENILGKISI 106
Query: 91 AAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD---NTHVS 147
A RGL YL +K K +++RD+K SNIL++ KL DFG++ G + D N+ V
Sbjct: 107 AV--LRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDSMANSFVG 160
Query: 148 TRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 187
TR Y +PE + T++SD++S G+ L+E+ GR
Sbjct: 161 TR-----SYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-13
Identities = 50/165 (30%), Positives = 74/165 (44%), Gaps = 11/165 (6%)
Query: 27 EFLVEVLMLSLLHHPNLVNLIGYCADGDQR------LLVYEYMPLGSVEDHLHDLSPGKK 80
+FL E + + HPN++ LIG C + +++ +M G + L G
Sbjct: 46 DFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDC 105
Query: 81 PLDWNTRM--KIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 138
P T+M K A G+EYL K+ I+RDL N +L+ + ++DFGL+K
Sbjct: 106 PQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGLSKKI 162
Query: 139 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEI 183
GD + A E T KSDV+SFGV + EI
Sbjct: 163 YNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEI 207
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-13
Identities = 64/258 (24%), Positives = 112/258 (43%), Gaps = 32/258 (12%)
Query: 12 VAIKQLDRN-GVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVED 70
VAIK L N + N+E L E +++ + P + L+G C +L V + MP G + D
Sbjct: 39 VAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTSTVQL-VTQLMPYGCLLD 97
Query: 71 HLH---DLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP 127
++ D + L+W ++ A+G+ YL + +++RDL N+L+ H
Sbjct: 98 YVRENKDRIGSQDLLNWCVQI------AKGMSYLEEVR---LVHRDLAARNVLVKSPNHV 148
Query: 128 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-G 186
K++DFGLA+L + + + + + A E + T +SDV+S+GV + E+++ G
Sbjct: 149 KITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFG 208
Query: 187 RKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQ 246
K D R L+ E Q PP + C
Sbjct: 209 AKPYDG----------------IPAREIPDLLEKGERLPQ-PPICTIDVYMIMVKCWMID 251
Query: 247 PDMRPVIADVVTALAYLA 264
+ RP ++V + +A
Sbjct: 252 SECRPRFRELVDEFSRMA 269
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 4e-13
Identities = 52/185 (28%), Positives = 96/185 (51%), Gaps = 15/185 (8%)
Query: 12 VAIKQL-DRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVED 70
VAIK+L + + N+E L E +++ + +P++ L+G C +L + + MP G + D
Sbjct: 39 VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLD 97
Query: 71 HLH---DLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP 127
++ D + L+W ++ A+G+ YL ++ +++RDL N+L+ H
Sbjct: 98 YVREHKDNIGSQYLLNWCVQI------AKGMNYLEERR---LVHRDLAARNVLVKTPQHV 148
Query: 128 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-G 186
K++DFGLAKL + + + + A E T +SDV+S+GV + E+++ G
Sbjct: 149 KITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFG 208
Query: 187 RKAVD 191
K D
Sbjct: 209 SKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 5e-13
Identities = 57/178 (32%), Positives = 88/178 (49%), Gaps = 11/178 (6%)
Query: 13 AIKQLDRNGVQ---GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVE 69
A K+L++ ++ G L E +L ++ +VNL D LV M G ++
Sbjct: 29 ACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLK 88
Query: 70 DHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKL 129
H++++ G + + AA GLE LH + +YRDLK NILLD H ++
Sbjct: 89 FHIYNM--GNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRI 143
Query: 130 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 187
SD GLA P G++ + RV GT GY APE + TL D + G ++ E++ G+
Sbjct: 144 SDLGLAVKIPEGES--IRGRV-GTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 5e-13
Identities = 50/148 (33%), Positives = 70/148 (47%), Gaps = 9/148 (6%)
Query: 40 HPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLE 99
HP L L D+ V EY+ G D + + +K D AA L
Sbjct: 55 HPFLTALHCCFQTKDRLFFVMEYVNGG---DLMFQIQRSRK-FDEPRSRFYAAEVTLALM 110
Query: 100 YLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 159
+LH VIYRDLK NILLD H KL+DFG+ K G + T +T GT Y AP
Sbjct: 111 FLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT--TTTFCGTPDYIAP 165
Query: 160 EYAKTGQLTLKSDVYSFGVVLLEILSGR 187
E + + D ++ GV++ E+++G+
Sbjct: 166 EILQELEYGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 6e-13
Identities = 51/181 (28%), Positives = 89/181 (49%), Gaps = 16/181 (8%)
Query: 12 VAIKQLD-RNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR--LLVYEYMPLGSV 68
VA+K L +G + E+ +L L+H N+V G C + L+ E++P GS+
Sbjct: 36 VAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSL 95
Query: 69 EDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK 128
+++L K ++ ++K A +G++YL + ++RDL N+L++ + K
Sbjct: 96 KEYL---PRNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVK 149
Query: 129 LSDFGLAKLGPVGDNTHVST----RVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEIL 184
+ DFGL K + + T + Y APE + + SDV+SFGV L E+L
Sbjct: 150 IGDFGLTK--AIETDKEYYTVKDDLDSPVFWY-APECLIQSKFYIASDVWSFGVTLYELL 206
Query: 185 S 185
+
Sbjct: 207 T 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 6e-13
Identities = 64/260 (24%), Positives = 101/260 (38%), Gaps = 24/260 (9%)
Query: 12 VAIKQL-DRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVED 70
V +K+L FL EV L+HPN++ +G C + LLV E+ PLG +++
Sbjct: 25 VVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKN 84
Query: 71 HLHDLSPGKKPL-DWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKL 129
+L + + ++A A GL +LH + I+ DL N L K+
Sbjct: 85 YLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKI 141
Query: 130 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA-------KTGQLTLKSDVYSFGVVLLE 182
D+GLA D + APE T KS+++S GV + E
Sbjct: 142 GDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWE 201
Query: 183 ILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMC 242
L + EQ L R + + P+L +Y R +Y+ + +
Sbjct: 202 -LFTAADQPYPDLSDEQVLKQVV------REQDIKLPKPQLDLKYSDR-WYEVMQFCWL- 252
Query: 243 VHEQPDMRPVIADVVTALAY 262
P+ RP +V L Y
Sbjct: 253 ---DPETRPTAEEVHELLTY 269
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 9e-13
Identities = 39/103 (37%), Positives = 58/103 (56%), Gaps = 10/103 (9%)
Query: 89 KIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA-KLGPVGDNTHVS 147
KIA + L YL ++ K +I+RD+K SNILLDR + KL DFG++ +L ++
Sbjct: 111 KIAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQL----VDSIAK 164
Query: 148 TRVMGTYGYCAPEYAKTGQLT---LKSDVYSFGVVLLEILSGR 187
TR G Y APE ++SDV+S G+ L E+ +G+
Sbjct: 165 TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 1e-12
Identities = 51/180 (28%), Positives = 85/180 (47%), Gaps = 13/180 (7%)
Query: 12 VAIKQLDRNGVQGN--REFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVE 69
VA+K++ ++G + L E+ L HP +V L+ G +LV EYMP +
Sbjct: 28 VALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYMP-SDLS 86
Query: 70 DHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKL 129
+ L D +PL +G+ Y+H +++RDLK +N+L+ K+
Sbjct: 87 EVLRDEE---RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKI 140
Query: 130 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE--YAKTGQLTLKSDVYSFGVVLLEILSGR 187
+DFGLA+L + S +V T Y APE Y + D+++ G + E+L+G
Sbjct: 141 ADFGLARLFSEEEPRLYSHQV-ATRWYRAPELLYGAR-KYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.5 bits (163), Expect = 1e-12
Identities = 63/198 (31%), Positives = 86/198 (43%), Gaps = 36/198 (18%)
Query: 10 QDVAIKQLDRNGVQGNREFLVEVLML-SLLHHPNLVNLIG------YCADGDQRLLVYEY 62
Q VAIK +D + E E +L +HPN+ G + DQ LV E
Sbjct: 32 QLVAIKIMDIIEDE-EEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMEL 90
Query: 63 MPLGSVEDHLHDLSPGKKPLDWNTRMK------IAAGAARGLEYLHDKAKPPVIYRDLKC 116
GSV D + K R+K I RGL YLH+ VI+RD+K
Sbjct: 91 CGGGSVTDLV------KGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKG 141
Query: 117 SNILLDRGYHPKLSDFGL-AKLGPVGDNTHVSTR--VMGTYGYCAPE-----YAKTGQLT 168
NILL + KL DFG+ A+L D+T + R +GT + APE
Sbjct: 142 QNILLTKNAEVKLVDFGVSAQL----DST-LGRRNTFIGTPYWMAPEVIACDEQPDASYD 196
Query: 169 LKSDVYSFGVVLLEILSG 186
+SDV+S G+ +E+ G
Sbjct: 197 ARSDVWSLGITAIELADG 214
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 1e-12
Identities = 56/188 (29%), Positives = 89/188 (47%), Gaps = 17/188 (9%)
Query: 12 VAIKQLDRNGVQGNREFLV-EVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPLGSVE 69
VA+K L + + LV E+ M+ ++ H N++NL+G C ++ EY G++
Sbjct: 47 VAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLR 106
Query: 70 DHLHDLSP------------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCS 117
++L P ++ L + + A ARG+EYL A I+RDL
Sbjct: 107 EYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAAR 163
Query: 118 NILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFG 177
N+L+ K++DFGLA+ D +T + APE T +SDV+SFG
Sbjct: 164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 223
Query: 178 VVLLEILS 185
V+L EI +
Sbjct: 224 VLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 1e-12
Identities = 58/233 (24%), Positives = 101/233 (43%), Gaps = 29/233 (12%)
Query: 29 LVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRM 88
L E+ +L L HPN++ + + ++ +V E G + + K+ + T
Sbjct: 50 LKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIW 109
Query: 89 KIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST 148
K LE++H K +++RD+K +N+ + KL D GL + T +
Sbjct: 110 KYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAH 164
Query: 149 RVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPL 208
++GT Y +PE KSD++S G +L E+ AA QS P
Sbjct: 165 SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM------------AALQS------PF 206
Query: 209 FQDRTR-HSLIADPELQGQYPP---RGFYQAL-AVAAMCVHEQPDMRPVIADV 256
+ D+ +SL E + YPP + + L + + C++ P+ RP I+ V
Sbjct: 207 YGDKMNLYSLCKKIE-KCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 2e-12
Identities = 51/176 (28%), Positives = 82/176 (46%), Gaps = 11/176 (6%)
Query: 12 VAIKQLDRNGVQGNRE-FLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVED 70
VA+K RE FL E ++ HP++V LIG + + +V E PLG +
Sbjct: 37 VAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVMELAPLGELRS 95
Query: 71 HLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLS 130
+L K LD + + + + L YL K ++RD+ N+L+ KL
Sbjct: 96 YLQV---NKYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLG 149
Query: 131 DFGLAKLGPVGDNTHV-STRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 185
DFGL++ + D ++ +++ + APE + T SDV+ FGV + EIL
Sbjct: 150 DFGLSRY--LEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM 203
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 2e-12
Identities = 57/193 (29%), Positives = 94/193 (48%), Gaps = 27/193 (13%)
Query: 12 VAIKQLDRNGVQGN-REFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPLGSVE 69
VA+K L + + + + + E+ M+ ++ H N++NL+G C ++ EY G++
Sbjct: 53 VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 112
Query: 70 DHL---------HDLSPGKKP---LDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCS 117
++L + +P + P L + + A ARG+EYL K I+RDL
Sbjct: 113 EYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAAR 169
Query: 118 NILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG-----YCAPEYAKTGQLTLKSD 172
N+L+ K++DFGLA+ D H+ T G + APE T +SD
Sbjct: 170 NVLVTEDNVMKIADFGLAR-----DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSD 224
Query: 173 VYSFGVVLLEILS 185
V+SFGV+L EI +
Sbjct: 225 VWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-12
Identities = 62/260 (23%), Positives = 113/260 (43%), Gaps = 32/260 (12%)
Query: 6 LCLL--QDVAIKQL---DRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 60
CLL + VA+K++ + + ++ + E+ +L L+HPN++ + + ++ +V
Sbjct: 22 TCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81
Query: 61 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNIL 120
E G + + K+ + T K +E++H + V++RD+K +N+
Sbjct: 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVF 138
Query: 121 LDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVL 180
+ KL D GL + T + ++GT Y +PE KSD++S G +L
Sbjct: 139 ITATGVVKLGDLGLGRF--FSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLL 196
Query: 181 LEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPP---RGFYQAL- 236
E+ AA QS P + D+ + Q YPP + + L
Sbjct: 197 YEM------------AALQS------PFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLR 238
Query: 237 AVAAMCVHEQPDMRPVIADV 256
+ +MC++ PD RP I V
Sbjct: 239 ELVSMCIYPDPDQRPDIGYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-12
Identities = 49/141 (34%), Positives = 71/141 (50%), Gaps = 8/141 (5%)
Query: 54 DQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRD 113
D LV M G ++ H++ + G+ + + AA GLE LH + ++YRD
Sbjct: 73 DALCLVLTLMNGGDLKFHIYHM--GEAGFEEGRAVFYAAEICCGLEDLH---QERIVYRD 127
Query: 114 LKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDV 173
LK NILLD H ++SD GLA P G + RV GT GY APE K + T D
Sbjct: 128 LKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRV-GTVGYMAPEVVKNERYTFSPDW 184
Query: 174 YSFGVVLLEILSGRKAVDTSK 194
++ G +L E+++G+ K
Sbjct: 185 WALGCLLYEMIAGQSPFQQRK 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 2e-12
Identities = 40/95 (42%), Positives = 52/95 (54%), Gaps = 5/95 (5%)
Query: 92 AGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVM 151
A A L++LH +IYRDLK NILLD H KL+DFGL+K + S
Sbjct: 105 AELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FC 159
Query: 152 GTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG 186
GT Y APE T +D +SFGV++ E+L+G
Sbjct: 160 GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 3e-12
Identities = 55/177 (31%), Positives = 82/177 (46%), Gaps = 37/177 (20%)
Query: 31 EVLMLSLLHHPNLVNLIGYCADGDQRL----------LVYEYMP---LGSVEDHL----- 72
E+ +L L+H N+VNL D L LV+EYM +G +E L
Sbjct: 56 EIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSE 115
Query: 73 -HDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSD 131
H S K+ L+ GL Y H K ++RD+KCSNILL+ KL+D
Sbjct: 116 DHIKSFMKQLLE-------------GLNYCHKKN---FLHRDIKCSNILLNNKGQIKLAD 159
Query: 132 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKS-DVYSFGVVLLEILSGR 187
FGLA+L ++ + +V+ T Y PE + + DV+S G +L E+ + +
Sbjct: 160 FGLARLYNSEESRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 3e-12
Identities = 54/167 (32%), Positives = 82/167 (49%), Gaps = 16/167 (9%)
Query: 29 LVEVLMLSLLHHPNLVNLIGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTR 87
+VE +L+L P + + C RL V EY+ G + + + K+P
Sbjct: 48 MVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEP----HA 103
Query: 88 MKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT--H 145
+ AA A GL +LH K +IYRDLK N++LD H K++DFG+ K +N
Sbjct: 104 VFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK-----ENMWDG 155
Query: 146 VSTRVM-GTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVD 191
V+T+ GT Y APE D ++FGV+L E+L+G+ +
Sbjct: 156 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 4e-12
Identities = 53/178 (29%), Positives = 83/178 (46%), Gaps = 11/178 (6%)
Query: 10 QDVAIKQLDRNGVQGNREFLV-EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSV 68
Q VAIK +D + E + E+ +LS P + G G + ++ EY+ GS
Sbjct: 30 QVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSA 89
Query: 69 EDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK 128
D L P D + +GL+YLH + K I+RD+K +N+LL K
Sbjct: 90 LDLLR-----AGPFDEFQIATMLKEILKGLDYLHSEKK---IHRDIKAANVLLSEQGDVK 141
Query: 129 LSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG 186
L+DFG+A G + D +GT + APE + K+D++S G+ +E+ G
Sbjct: 142 LADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 4e-12
Identities = 47/134 (35%), Positives = 67/134 (50%), Gaps = 8/134 (5%)
Query: 54 DQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRD 113
D LV M G ++ H++++ G D + AA GLE L + ++YRD
Sbjct: 73 DALCLVLTIMNGGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRD 127
Query: 114 LKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDV 173
LK NILLD H ++SD GLA P G+ V RV GT GY APE + T D
Sbjct: 128 LKPENILLDDRGHIRISDLGLAVQIPEGET--VRGRV-GTVGYMAPEVINNEKYTFSPDW 184
Query: 174 YSFGVVLLEILSGR 187
+ G ++ E++ G+
Sbjct: 185 WGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 4e-12
Identities = 45/182 (24%), Positives = 94/182 (51%), Gaps = 19/182 (10%)
Query: 7 CLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLG 66
C+++++ + ++ + +++ EV++L+ + HPN+V + + +V EY G
Sbjct: 28 CVIKEIDLTKMPVKEKEASKK---EVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGG 84
Query: 67 SVEDHLHD----LSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD 122
+ ++ L + L W ++ + GL+++HD+ +++RD+K NI L
Sbjct: 85 DLMKRINRQRGVLFSEDQILSWFVQISL------GLKHIHDRK---ILHRDIKSQNIFLS 135
Query: 123 R-GYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLL 181
+ G KL DFG+A+ + D+ ++ +GT Y +PE + K+D++S G VL
Sbjct: 136 KNGMVAKLGDFGIARQ--LNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLY 193
Query: 182 EI 183
E+
Sbjct: 194 EL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 5e-12
Identities = 36/108 (33%), Positives = 53/108 (49%), Gaps = 6/108 (5%)
Query: 98 LEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 157
L++LH + +IYRD+K NILLD H L+DFGL+K + + + GT Y
Sbjct: 118 LDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEF-LAEEEERAYSFCGTIEYM 173
Query: 158 APEYAKTGQLTLKS--DVYSFGVVLLEILSGRKAVDTSKAAAEQSLVA 203
APE + G D +S GV+ E+L+G QS ++
Sbjct: 174 APEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEIS 221
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 5e-12
Identities = 55/179 (30%), Positives = 88/179 (49%), Gaps = 15/179 (8%)
Query: 12 VAIKQL--DRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVE 69
VA+K L D N E L E ++ L +P +V +IG C + + +LV E LG
Sbjct: 25 VAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGIC-EAESWMLVMELAELGP-- 81
Query: 70 DHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKL 129
L+ K + ++ + G++YL + ++RDL N+LL ++ K+
Sbjct: 82 --LNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKI 136
Query: 130 SDFGLAK-LGPVGDNTHVSTRVMGTY--GYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 185
SDFGL+K LG D + + G + + APE + + KSDV+SFGV++ E S
Sbjct: 137 SDFGLSKALG--ADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 6e-12
Identities = 52/188 (27%), Positives = 89/188 (47%), Gaps = 17/188 (9%)
Query: 12 VAIKQLDRNGVQGNREFLV-EVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPLGSVE 69
VA+K L N + L+ E+ ++ L+ H N++NL+G C ++ EY G++
Sbjct: 47 VAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLR 106
Query: 70 DHLH-------DLSPG-----KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCS 117
+ L D + ++ L + + A ARG+EYL + I+RDL
Sbjct: 107 EFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAAR 163
Query: 118 NILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFG 177
N+L+ K++DFGLA+ D ++ + APE T +SDV+SFG
Sbjct: 164 NVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFG 223
Query: 178 VVLLEILS 185
+++ EI +
Sbjct: 224 ILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 7e-12
Identities = 48/172 (27%), Positives = 81/172 (47%), Gaps = 32/172 (18%)
Query: 29 LVEVLMLSLLHHPNLVNL--IGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNT 86
L E+ +L L HPN+V + + ++ D+ +V EY+ HDL K ++
Sbjct: 52 LREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVE--------HDL---KSLME--- 97
Query: 87 RMKIAAGAA----------RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 136
MK + G+ +LHD +++RDLK SN+LL+ K+ DFGLA+
Sbjct: 98 TMKQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAR 154
Query: 137 LGPVGDNTHVSTRVMGTYGYCAPE-YAKTGQLTLKSDVYSFGVVLLEILSGR 187
G T+++ T Y APE + + D++S G + E+L+ +
Sbjct: 155 --EYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 7e-12
Identities = 45/163 (27%), Positives = 82/163 (50%), Gaps = 15/163 (9%)
Query: 31 EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHD----LSPGKKPLDWNT 86
EV +LS + HPN+V + +V +Y G + ++ L P + LDW
Sbjct: 49 EVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFV 108
Query: 87 RMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHV 146
++ +A L+++HD+ +++RD+K NI L + KL DFG+A++ + +
Sbjct: 109 QICLA------LKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARV--LNSTVEL 157
Query: 147 STRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKA 189
+ +GT Y +PE + KSD+++ G VL E+ + + A
Sbjct: 158 ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHA 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 64.1 bits (157), Expect = 8e-12
Identities = 58/194 (29%), Positives = 93/194 (47%), Gaps = 39/194 (20%)
Query: 12 VAIKQL-------DRNGVQGNREFLVEVLMLSLLHHPNLVNLIG-YCADGDQRL-LVYEY 62
VAIK++ ++G+ N L E+ +L L HPN++ L+ + + LV+E+
Sbjct: 28 VAIKKIKLGERKEAKDGI--NFTALREIKLLQELKHPNIIGLLDVFGH--KSNINLVFEF 83
Query: 63 MPLGSVEDHLHD----LSPG-KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCS 117
M +E + D L+P K T RGLEYLH +++RDLK +
Sbjct: 84 ME-TDLEKVIKDKSIVLTPADIKSYMLMT--------LRGLEYLHSNW---ILHRDLKPN 131
Query: 118 NILLDRGYHPKLSDFGLAKLGPVGD-NTHVSTRVMGTYGYCAPEY---AKTGQLTLKSDV 173
N+L+ KL+DFGLA+ G N ++ +V+ T Y APE A+ + D+
Sbjct: 132 NLLIASDGVLKLADFGLARS--FGSPNRKMTHQVV-TRWYRAPELLFGAR--HYGVGVDM 186
Query: 174 YSFGVVLLEILSGR 187
+S G + E+L
Sbjct: 187 WSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-11
Identities = 50/183 (27%), Positives = 86/183 (46%), Gaps = 22/183 (12%)
Query: 10 QDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVE 69
+ VA+K++D Q EV+++ HH N+V++ GD+ +V E++ G++
Sbjct: 48 KQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALT 107
Query: 70 DHLHDLSPGKKPLDWNTRMK------IAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR 123
D + +TRM + R L YLH++ VI+RD+K +ILL
Sbjct: 108 D-----------IVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTS 153
Query: 124 GYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEI 183
KLSDFG V ++GT + APE + D++S G++++E+
Sbjct: 154 DGRIKLSDFGFC--AQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEM 211
Query: 184 LSG 186
+ G
Sbjct: 212 IDG 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 1e-11
Identities = 38/94 (40%), Positives = 55/94 (58%), Gaps = 5/94 (5%)
Query: 96 RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG-PVGDNTHVSTRVMGTY 154
RGL+Y+H V++RDLK SN+LL+ K+ DFGLA++ P D+T T + T
Sbjct: 117 RGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATR 173
Query: 155 GYCAPEYAKTGQLTLKS-DVYSFGVVLLEILSGR 187
Y APE + K+ D++S G +L E+LS R
Sbjct: 174 WYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.7 bits (156), Expect = 1e-11
Identities = 57/198 (28%), Positives = 85/198 (42%), Gaps = 50/198 (25%)
Query: 12 VAIKQLDRNGVQGNREF--------LVEVLML-SLLHHPNLVNLIGYCADGDQRLLVYEY 62
VAIK++ ++F L EV L L HPN+V L + D+ V+EY
Sbjct: 27 VAIKKM-------KKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEY 79
Query: 63 MPLGSVEDHLHDL--SPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNIL 120
M E +L+ L KP + I +GL ++H K +RDLK N+L
Sbjct: 80 M-----EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLL 131
Query: 121 LDRGYHPKLSDFGLAKLGPVGDN----THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYS- 175
+ K++DFGLA+ + +VSTR Y APE + L+S YS
Sbjct: 132 VSGPEVVKIADFGLAR--EIRSRPPYTDYVSTR-----WYRAPE------ILLRSTSYSS 178
Query: 176 ------FGVVLLEILSGR 187
G ++ E+ + R
Sbjct: 179 PVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 1e-11
Identities = 51/196 (26%), Positives = 93/196 (47%), Gaps = 23/196 (11%)
Query: 3 QVILCLLQDVAIKQLDRNG--VQGNREFLVEVLMLSLLHHPNLVNLIGYCA-DGDQRLLV 59
++V +K + + +Q L E +L L H N++ ++ C DG+ ++
Sbjct: 29 DEKPGKEEEVFVKTVKDHASEIQVTL-LLQESCLLYGLSHQNILPILHVCIEDGEPPFVL 87
Query: 60 YEYMPLGSVEDHLHD--LSPGKKPLDWNTR--MKIAAGAARGLEYLHDKAKPPVIYRDLK 115
Y YM G+++ L L P +T+ + +A A G+ YLH + VI++D+
Sbjct: 88 YPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIA 144
Query: 116 CSNILLDRGYHPKLSDFGLAK-LGP-----VGDNTHVSTRVMGTYGYCAPEYAKTGQLTL 169
N ++D K++D L++ L P +GDN + + M A E + +
Sbjct: 145 ARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWM------ALESLVNKEYSS 198
Query: 170 KSDVYSFGVVLLEILS 185
SDV+SFGV+L E+++
Sbjct: 199 ASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 2e-11
Identities = 53/165 (32%), Positives = 77/165 (46%), Gaps = 18/165 (10%)
Query: 29 LVEVLMLSLLHHPNLVNLIGYCADG--DQRLLVYEY--MPLGSVEDHLHDLSPGKKPLDW 84
L E+ +L L HPN+V L D LV EY L S+ D++ P
Sbjct: 54 LREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNM------PTPFSE 107
Query: 85 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT 144
+ + RGL+YLH+ +I+RDLK SN+LL K++DFGLA+ G
Sbjct: 108 SQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLAR--TYGLPA 162
Query: 145 HVSTRVMGTYGYCAPE--YAKTGQLTLKSDVYSFGVVLLEILSGR 187
T + T Y APE T T D+++ G +L E+L+ +
Sbjct: 163 KPMTPKVVTLWYRAPELLLGCTTY-TTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 2e-11
Identities = 59/185 (31%), Positives = 90/185 (48%), Gaps = 21/185 (11%)
Query: 12 VAIKQLDRNGVQGNREFLVEVLM---LSLLHH--PNLVNLIGYCADGDQRLLVYEYMPLG 66
+A+KQ+ R G N+E +LM + L H P +V GY + E M
Sbjct: 43 MAVKQMRRTG---NKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELM--S 97
Query: 67 SVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH 126
+ D L L + P+ + K+ + L YL K K VI+RD+K SNILLD +
Sbjct: 98 TCLDKL--LKRIQGPIPEDILGKMTVAIVKALHYL--KEKHGVIHRDVKPSNILLDASGN 153
Query: 127 PKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY----AKTGQLTLKSDVYSFGVVLLE 182
KL DFG++ G + D + TR G Y APE + +++DV+S G+ L+E
Sbjct: 154 VKLCDFGIS--GRLVD-SKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVE 210
Query: 183 ILSGR 187
+ +G+
Sbjct: 211 LATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 2e-11
Identities = 69/262 (26%), Positives = 102/262 (38%), Gaps = 29/262 (11%)
Query: 9 LQDVAIKQL--DRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYC--ADGDQRL----LVY 60
Q VA+K L D EFL E + HPN++ LIG + RL ++
Sbjct: 27 FQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVIL 86
Query: 61 EYMPLGSVEDHLHDLSPGKKP--LDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSN 118
+M G + L G++P L T ++ A G+EYL K I+RDL N
Sbjct: 87 PFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARN 143
Query: 119 ILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGV 178
+L+ ++DFGL+K GD + A E T SDV++FGV
Sbjct: 144 CMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGV 203
Query: 179 VLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAV 238
+ EI++ + T A E S + + LI L + PP +
Sbjct: 204 TMWEIMTRGQ---TPYAGVENSEI-----------YNYLIKGNRL--KQPPDCLEDVYEL 247
Query: 239 AAMCVHEQPDMRPVIADVVTAL 260
C +P RP + L
Sbjct: 248 MCQCWSPEPKCRPSFQHLRDQL 269
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 3e-11
Identities = 42/150 (28%), Positives = 73/150 (48%), Gaps = 13/150 (8%)
Query: 38 LHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLD----WNTRMKIAAG 93
L HPN+V + D+ +V + + + +H + L K+ WN +++
Sbjct: 66 LRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA 125
Query: 94 AARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT 153
L YLH + + +++RDL +NI+L ++DFGLAK + + T V+GT
Sbjct: 126 ----LRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK--QKQPESKL-TSVVGT 176
Query: 154 YGYCAPEYAKTGQLTLKSDVYSFGVVLLEI 183
Y PE K K+DV++FG +L ++
Sbjct: 177 ILYSCPEIVKNEPYGEKADVWAFGCILYQM 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 3e-11
Identities = 48/169 (28%), Positives = 77/169 (45%), Gaps = 8/169 (4%)
Query: 19 RNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPG 78
R G +G +VE +L+ +H +V+L LV M G + H++++
Sbjct: 34 RKGYEGA---MVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEE 90
Query: 79 KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 138
A GLE+LH + +IYRDLK N+LLD + ++SD GLA
Sbjct: 91 NPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAV-- 145
Query: 139 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 187
+ D + GT G+ APE + + D ++ GV L E+++ R
Sbjct: 146 ELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 3e-11
Identities = 53/187 (28%), Positives = 86/187 (45%), Gaps = 25/187 (13%)
Query: 12 VAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDH 71
+AIK++ + + E+ + S L H N+V +G ++ + E +P GS
Sbjct: 36 IAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGS---- 91
Query: 72 LHDLSPGK-KPLDWNTRMKIAAGAA--RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP- 127
L L K PL N + I GL+YLHD +++RD+K N+L++ Y
Sbjct: 92 LSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNT-YSGV 147
Query: 128 -KLSDFG----LAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ--LTLKSDVYSFGVVL 180
K+SDFG LA + P + GT Y APE G +D++S G +
Sbjct: 148 VKISDFGTSKRLAGINPCTET------FTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTI 201
Query: 181 LEILSGR 187
+E+ +G+
Sbjct: 202 VEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 3e-11
Identities = 40/96 (41%), Positives = 47/96 (48%), Gaps = 5/96 (5%)
Query: 91 AAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRV 150
AA A L YLH +IYRDLK NILLD H L+DFGL K G T ++
Sbjct: 102 AAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT--TSTF 156
Query: 151 MGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG 186
GT Y APE + D + G VL E+L G
Sbjct: 157 CGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 3e-11
Identities = 51/160 (31%), Positives = 74/160 (46%), Gaps = 11/160 (6%)
Query: 29 LVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRM 88
+ E +L HP L L D+ V EY G + HL ++ + R
Sbjct: 43 VTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL-----SRERVFTEERA 97
Query: 89 KI-AAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVS 147
+ A LEYLH + V+YRD+K N++LD+ H K++DFGL K G + D +
Sbjct: 98 RFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEG-ISDGATMK 153
Query: 148 TRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 187
T GT Y APE + D + GVV+ E++ GR
Sbjct: 154 T-FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 62.6 bits (153), Expect = 4e-11
Identities = 67/210 (31%), Positives = 95/210 (45%), Gaps = 68/210 (32%)
Query: 12 VAIKQL-D--RNGVQGNREFLVEVLMLS-LLHHPNLVNLIG-YCADGDQRL-LVYEYMPL 65
VA+K++ D RN R F E++ L L HPN+V L+ A+ D+ + LV+EYM
Sbjct: 35 VALKKIFDAFRNATDAQRTFR-EIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYM-- 91
Query: 66 GSVEDHLHDLSPGKKPLDWNTRMKIAAGA-------------ARGLEYLHDKAKPPVIYR 112
E LH + I A + L+Y+H VI+R
Sbjct: 92 ---ETDLHAV--------------IRANILEDVHKRYIMYQLLKALKYIHSGN---VIHR 131
Query: 113 DLKCSNILLDRGYHPKLSDFGLAK-LGPVGDNT-------HVSTRVMGTYGYCAPEYAKT 164
DLK SNILL+ KL+DFGLA+ L + +N +V+TR Y APE
Sbjct: 132 DLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATR-----WYRAPE---- 182
Query: 165 GQLTLKSDVYSFGV-------VLLEILSGR 187
+ L S Y+ GV +L E+L G+
Sbjct: 183 --ILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 4e-11
Identities = 53/159 (33%), Positives = 75/159 (47%), Gaps = 9/159 (5%)
Query: 29 LVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRM 88
L E +L HP L +L D+ V EY+ G + HL S + + TR
Sbjct: 43 LTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHL---SRERVFSEDRTRF 99
Query: 89 KIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST 148
A L+YLH ++YRDLK N++LD+ H K++DFGL K G + D + T
Sbjct: 100 -YGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEG-ITDAATMKT 154
Query: 149 RVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 187
GT Y APE + D + GVV+ E++ GR
Sbjct: 155 -FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 4e-11
Identities = 62/186 (33%), Positives = 91/186 (48%), Gaps = 28/186 (15%)
Query: 13 AIKQLDRNGV---QGNREFLVEVLMLSLLHH---PNLVNLIGYCADGDQRLLVYEYMPLG 66
A+K LD+ + QG L E +MLSL+ P +V + D+ + + M G
Sbjct: 23 AMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGG 82
Query: 67 SVEDHLHDLSPGKKPLDWNTRMKI-AAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY 125
+ HL + + M+ AA GLE++H++ V+YRDLK +NILLD
Sbjct: 83 DLHYHL-----SQHGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHG 134
Query: 126 HPKLSDFGLA----KLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKS-DVYSFGVVL 180
H ++SD GLA K P H S +GT+GY APE + G S D +S G +L
Sbjct: 135 HVRISDLGLACDFSKKKP-----HAS---VGTHGYMAPEVLQKGVAYDSSADWFSLGCML 186
Query: 181 LEILSG 186
++L G
Sbjct: 187 FKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 5e-11
Identities = 63/253 (24%), Positives = 109/253 (43%), Gaps = 32/253 (12%)
Query: 12 VAIKQL---DRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSV 68
VA+K++ D + + + E+ +L L+HPN++ + ++ +V E G +
Sbjct: 30 VALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDL 89
Query: 69 EDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK 128
+ K+ + T K LE++H + V++RD+K +N+ + K
Sbjct: 90 SRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVK 146
Query: 129 LSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRK 188
L D GL + T + ++GT Y +PE KSD++S G +L E+
Sbjct: 147 LGDLGLGRF--FSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM----- 199
Query: 189 AVDTSKAAAEQSLVAWARPLFQDRTR-HSLIADPELQGQYPP---RGFYQAL-AVAAMCV 243
AA QS P + D+ +SL E Q YPP + + L + MC+
Sbjct: 200 -------AALQS------PFYGDKMNLYSLCKKIE-QCDYPPLPSDHYSEELRQLVNMCI 245
Query: 244 HEQPDMRPVIADV 256
+ P+ RP I V
Sbjct: 246 NPDPEKRPDITYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 6e-11
Identities = 62/187 (33%), Positives = 93/187 (49%), Gaps = 30/187 (16%)
Query: 13 AIKQLDRNGV---QGNREFLVEVLMLSLLHH---PNLVNLIGYCADGDQRLLVYEYMPLG 66
A+K LD+ + QG L E +MLSL+ P +V + D+ + + M G
Sbjct: 23 AMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGG 82
Query: 67 SVEDHL--HDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG 124
+ HL H + K+ + T + + GLE++H++ V+YRDLK +NILLD
Sbjct: 83 DLHYHLSQHGVFSEKEMRFYATEIIL------GLEHMHNRF---VVYRDLKPANILLDEH 133
Query: 125 YHPKLSDFGLA----KLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKS-DVYSFGVV 179
H ++SD GLA K P H S +GT+GY APE + G S D +S G +
Sbjct: 134 GHVRISDLGLACDFSKKKP-----HAS---VGTHGYMAPEVLQKGTAYDSSADWFSLGCM 185
Query: 180 LLEILSG 186
L ++L G
Sbjct: 186 LFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 6e-11
Identities = 52/160 (32%), Positives = 75/160 (46%), Gaps = 10/160 (6%)
Query: 29 LVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRM 88
L E +L HP L L D+ V EY G + HL ++ + R
Sbjct: 43 LTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHL-----SRERVFSEDRA 97
Query: 89 KI-AAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVS 147
+ A L+YLH ++ V+YRDLK N++LD+ H K++DFGL K G + D +
Sbjct: 98 RFYGAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEG-IKDGATMK 154
Query: 148 TRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 187
T GT Y APE + D + GVV+ E++ GR
Sbjct: 155 T-FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 6e-11
Identities = 63/244 (25%), Positives = 106/244 (43%), Gaps = 27/244 (11%)
Query: 11 DVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVED 70
+V +K LD++ + F M+S L H +LV G C GD+ ++V EY+ GS++
Sbjct: 29 EVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDT 88
Query: 71 HLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLS 130
+L + + W ++++A A L +L DK + + ++ N+LL R K
Sbjct: 89 YLKK-NKNLINISW--KLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTG 142
Query: 131 DFGLAKLGPVGDNTHVSTRVMGT--YGYCAPEYAKTGQ-LTLKSDVYSFGVVLLEILSGR 187
+ KL G + V + + + PE + Q L+L +D +SFG L EI SG
Sbjct: 143 NPPFIKLSDPGISITVLPKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSG- 201
Query: 188 KAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQP 247
D +A + + L RH Q P + + + C+ +P
Sbjct: 202 --GDKPLSALDS-----QKKLQFYEDRH----------QLPAPKWTELANLINQCMDYEP 244
Query: 248 DMRP 251
D RP
Sbjct: 245 DFRP 248
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 7e-11
Identities = 58/180 (32%), Positives = 80/180 (44%), Gaps = 16/180 (8%)
Query: 8 LLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGS 67
L + +K+ ++N + R L L L HP LV L ++ V +Y+ G
Sbjct: 28 LQKKTILKKKEQNHIMAERNVL-----LKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGE 82
Query: 68 VEDHLHDLSPGKKPLDWNTRMKI-AAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH 126
+ HL +P R + AA A + YLH +IYRDLK NILLD H
Sbjct: 83 LFFHLQRERCFLEP-----RARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGH 134
Query: 127 PKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG 186
L+DFGL K G + T ++ GT Y APE + D + G VL E+L G
Sbjct: 135 VVLTDFGLCKEGVEPEET--TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 7e-11
Identities = 36/90 (40%), Positives = 49/90 (54%), Gaps = 5/90 (5%)
Query: 98 LEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 157
L YLH V+YRDLK N++LD+ H K++DFGL K G + D + T GT Y
Sbjct: 108 LGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEG-ISDGATMKT-FCGTPEYL 162
Query: 158 APEYAKTGQLTLKSDVYSFGVVLLEILSGR 187
APE + D + GVV+ E++ GR
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 1e-10
Identities = 49/160 (30%), Positives = 75/160 (46%), Gaps = 10/160 (6%)
Query: 31 EVLMLSLLHHPNLVNLIGYCADGDQRLLV--YEYMPLGSVEDHLHDLSPGKKPLDWNTRM 88
E+ +L L H +V G D ++ L EYMP GSV+D L L +
Sbjct: 54 EIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGA----LTESVTR 109
Query: 89 KIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK-LGPVGDNTHVS 147
K G+ YLH +++RD+K +NIL D + KL DFG +K L + +
Sbjct: 110 KYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGI 166
Query: 148 TRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 187
V GT + +PE K+DV+S G ++E+L+ +
Sbjct: 167 RSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-10
Identities = 54/198 (27%), Positives = 104/198 (52%), Gaps = 19/198 (9%)
Query: 35 LSLLHHPNLVNLIGYC----ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI 90
L +LH N ++G+ +DG+ + + E+M GS++ L + K + K+
Sbjct: 54 LQVLHECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKE----AKRIPEEILGKV 108
Query: 91 AAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRV 150
+ RGL YL +K + +++RD+K SNIL++ KL DFG++ G + D+ ++
Sbjct: 109 SIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSF 162
Query: 151 MGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLF- 209
+GT Y +PE + +++SD++S G+ L+E+ GR + A +++ + RP+
Sbjct: 163 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAI--FGRPVVD 220
Query: 210 -QDRTRHSLIADPELQGQ 226
++ HS+ P G+
Sbjct: 221 GEEGEPHSISPRPRPPGR 238
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-10
Identities = 58/179 (32%), Positives = 81/179 (45%), Gaps = 15/179 (8%)
Query: 13 AIKQLDRNGVQGNRE---FLVEV-LMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSV 68
A+K L + V +E + E ++L + HP LV L ++ V +++ G +
Sbjct: 24 AVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGEL 83
Query: 69 EDHLHDLSPGKKPLDWNTRMKI-AAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP 127
HL +P R + AA A L YLH ++YRDLK NILLD H
Sbjct: 84 FFHLQRERSFPEP-----RARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHV 135
Query: 128 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG 186
L+DFGL K G +T +T GT Y APE + D + G VL E+L G
Sbjct: 136 VLTDFGLCKEGIAQSDT--TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 2e-10
Identities = 54/204 (26%), Positives = 86/204 (42%), Gaps = 37/204 (18%)
Query: 12 VAIKQLDRNGVQGN----REFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMP--- 64
VA+K++ R + N + FL E + + L HP +V + C+DGD VY MP
Sbjct: 30 VALKKI-REDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGD---PVYYTMPYIE 85
Query: 65 ---LGSVEDHLHDLSPGKKPLDWNTRMK----IAAGAARGLEYLHDKAKPPVIYRDLKCS 117
L S+ + K L T + I +EY+H K V++RDLK
Sbjct: 86 GYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPD 142
Query: 118 NILLDRGYHPKLSDFGLAKL----------------GPVGDNTHVSTRVMGTYGYCAPEY 161
NILL + D+G A + + +++GT Y APE
Sbjct: 143 NILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPER 202
Query: 162 AKTGQLTLKSDVYSFGVVLLEILS 185
+ +D+Y+ GV+L ++L+
Sbjct: 203 LLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-10
Identities = 62/204 (30%), Positives = 97/204 (47%), Gaps = 45/204 (22%)
Query: 10 QDVAIKQLD------RNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL--VYE 61
Q A+K+++ RN +Q + VE +L+ +P +V++ +C+ +R L V E
Sbjct: 27 QRFAMKKINKQNLILRNQIQ---QVFVERDILTFAENPFVVSM--FCSFETKRHLCMVME 81
Query: 62 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL 121
Y+ G L ++ P+D RM A LEYLH+ +++RDLK N+L+
Sbjct: 82 YVEGGDCATLLKNIGA--LPVDM-ARMYFAE-TVLALEYLHNYG---IVHRDLKPDNLLI 134
Query: 122 DRGYHPKLSDFGLAKLGPVGDNTHV-------STR------VMGTYGYCAPE------YA 162
H KL+DFGL+K+G + T++ TR V GT Y APE Y
Sbjct: 135 TSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYG 194
Query: 163 KTGQLTLKSDVYSFGVVLLEILSG 186
K D ++ G++L E L G
Sbjct: 195 KP------VDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-10
Identities = 47/168 (27%), Positives = 75/168 (44%), Gaps = 37/168 (22%)
Query: 31 EVLMLSLLHHPNLVN-------------LIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP 77
E ++L+ + HPN+V ++ YC GD + ++ L P
Sbjct: 48 EAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDL---------MQKIKLQRGKLFP 98
Query: 78 GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 137
L W +M + G++++H+K V++RD+K NI L + KL DFG A+L
Sbjct: 99 EDTILQWFVQMCL------GVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARL 149
Query: 138 --GPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEI 183
P + T V GT Y PE + KSD++S G +L E+
Sbjct: 150 LTSPG---AYACTYV-GTPYYVPPEIWENMPYNNKSDIWSLGCILYEL 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 2e-10
Identities = 65/222 (29%), Positives = 82/222 (36%), Gaps = 47/222 (21%)
Query: 4 VILCLLQDV----AIKQLDRNGVQGNREFLVEVL----MLSLLHHPNLVNLIGYCADGDQ 55
V L L+ A+K LD+ + R + VL +L+ L HP L L
Sbjct: 17 VFLVRLKGTGKLFALKVLDKKEMI-KRNKVKRVLTEQEILATLDHPFLPTLYASFQTETY 75
Query: 56 RLLVYEYMPLGSVEDHLHDL---SPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYR 112
LV +Y P G L L PGK + R AA LEYLH ++YR
Sbjct: 76 LCLVMDYCPGGE----LFRLLQRQPGKCLSEEVARF-YAAEVLLALEYLHLLG---IVYR 127
Query: 113 DLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHV------------------------ST 148
DLK NILL H LSDF L+K V S
Sbjct: 128 DLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSF 187
Query: 149 RVM---GTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 187
R GT Y APE D ++ G++L E+L G
Sbjct: 188 RSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGT 229
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-10
Identities = 50/179 (27%), Positives = 85/179 (47%), Gaps = 19/179 (10%)
Query: 13 AIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHL 72
A K +D + +++VE+ +L+ HPN+V L+ + ++ E+ G+V+ +
Sbjct: 34 AAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVM 93
Query: 73 HDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDF 132
+L ++PL + L YLH+ +I+RDLK NIL KL+DF
Sbjct: 94 LEL---ERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADF 147
Query: 133 GLAKLGPVGDNTHVSTR---VMGTYGYCAPEY-----AKTGQLTLKSDVYSFGVVLLEI 183
G++ NT R +GT + APE +K K+DV+S G+ L+E+
Sbjct: 148 GVS-----AKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 3e-10
Identities = 44/156 (28%), Positives = 74/156 (47%), Gaps = 12/156 (7%)
Query: 31 EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI 90
E++M+ H N+V G D+ + E+ GS++D H P L + +
Sbjct: 56 EIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGP----LSESQIAYV 111
Query: 91 AAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRV 150
+ +GL YLH K K ++RD+K +NILL H KL+DFG++ +
Sbjct: 112 SRETLQGLYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVS--AQITATIAKRKSF 166
Query: 151 MGTYGYCAPEYA---KTGQLTLKSDVYSFGVVLLEI 183
+GT + APE A + G D+++ G+ +E+
Sbjct: 167 IGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 3e-10
Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 38/213 (17%)
Query: 98 LEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK--LGPVGDNTHVSTRVMGTYG 155
LE+LH K ++YRD+K NILLD H L+DFGL+K L + T+ GT
Sbjct: 118 LEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTY---SFCGTIE 171
Query: 156 YCAPEY--AKTGQLTLKSDVYSFGVVLLEILSG------------RKAVDTSKAAAEQSL 201
Y APE K G D +S G+++ E+L+G + V +
Sbjct: 172 YMAPEIIRGKGGHGKA-VDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPF 230
Query: 202 VAWARPLFQDRTRHSLIADPELQGQYPPRG--------FYQALAVAAMCVHE-QPDMRPV 252
++ P QD L DP+ + P+G F++ L A+ + + P RP
Sbjct: 231 PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALALRKVNPPFRPS 290
Query: 253 IADVVTALAYLASQKYESDAEKVQSPCLDPGTP 285
I + + + ++++ ++ E V SP GTP
Sbjct: 291 IRNELDVGNF--AEEF-TNLEPVYSP---AGTP 317
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 3e-10
Identities = 49/157 (31%), Positives = 88/157 (56%), Gaps = 15/157 (9%)
Query: 35 LSLLHHPNLVNLIGYC----ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI 90
L +LH N ++G+ +DG+ + + E+M GS++ L G+ P ++ I
Sbjct: 54 LQVLHECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLK--KAGRIPEQILGKVSI 110
Query: 91 AAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRV 150
A +GL YL +K K +++RD+K SNIL++ KL DFG++ G + D+ ++
Sbjct: 111 AV--IKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSF 162
Query: 151 MGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 187
+GT Y +PE + +++SD++S G+ L+E+ GR
Sbjct: 163 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-10
Identities = 46/158 (29%), Positives = 75/158 (47%), Gaps = 10/158 (6%)
Query: 31 EVLMLSLLHHPNLVNLIGYCADGDQRLL--VYEYMPLGSVEDHLHDLSPGKKPLDWNTRM 88
E+ +L L H +V G D +++ L EYMP GS++D L L N
Sbjct: 54 EIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGA----LTENVTR 109
Query: 89 KIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK-LGPVGDNTHVS 147
+ +G+ YLH +++RD+K +NIL D + KL DFG +K + + +
Sbjct: 110 RYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGI 166
Query: 148 TRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 185
V GT + +PE K+DV+S ++E+L+
Sbjct: 167 KSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 3e-10
Identities = 42/161 (26%), Positives = 74/161 (45%), Gaps = 13/161 (8%)
Query: 31 EVLMLSLLHHPNLVNLIGYCADGDQRL----LVYEYMPLGSVEDHLHDLSPGKKPLDWNT 86
E+ L + N++ + G+ D L L+ EY G + + L +K L + T
Sbjct: 68 EIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDK----EKDLSFKT 123
Query: 87 RMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHV 146
++ +A +GL L+ P Y++L + L+ Y K+ GL K+ +V
Sbjct: 124 KLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNV 181
Query: 147 STRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 187
+ V +Y +++ T+K D+YS GVVL EI +G+
Sbjct: 182 NFMVYFSYKMLNDIFSE---YTIKDDIYSLGVVLWEIFTGK 219
|
Length = 283 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-10
Identities = 48/160 (30%), Positives = 75/160 (46%), Gaps = 10/160 (6%)
Query: 31 EVLMLSLLHHPNLVNLIGYCADGDQRLL--VYEYMPLGSVEDHLHDLSPGKKPLDWNTRM 88
E+ +L L H +V G D +R L E+MP GS++D L L N
Sbjct: 54 EIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGA----LTENVTR 109
Query: 89 KIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK-LGPVGDNTHVS 147
K G+ YLH +++RD+K +NIL D + KL DFG +K L + +
Sbjct: 110 KYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGM 166
Query: 148 TRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 187
V GT + +PE K+D++S G ++E+L+ +
Sbjct: 167 KSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 3e-10
Identities = 36/93 (38%), Positives = 53/93 (56%), Gaps = 9/93 (9%)
Query: 96 RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG 155
RGL+Y+H V++RDLK SNIL++ K+ DFGLA++ +VSTR
Sbjct: 119 RGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY----- 170
Query: 156 YCAPEYAKTGQ-LTLKSDVYSFGVVLLEILSGR 187
Y APE T Q ++ D++S G + E+L G+
Sbjct: 171 YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 4e-10
Identities = 45/173 (26%), Positives = 84/173 (48%), Gaps = 34/173 (19%)
Query: 31 EVLMLSLLHHPNLVN--------------LIGYCADGDQRLLVYEYMPLGSVEDHLHDLS 76
E +LS L HPN+V ++G+C GD +Y +++ L
Sbjct: 49 EAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGD----LYH-----KLKEQKGKLL 99
Query: 77 PGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 136
P + ++W ++ +A L+YLH+K +++RDLK N+ L R K+ D G+A+
Sbjct: 100 PENQVVEWFVQIAMA------LQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIAR 150
Query: 137 LGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKA 189
+ + + +++ ++GT Y +PE KSDV++ G + E+ + + A
Sbjct: 151 V--LENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHA 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 4e-10
Identities = 61/225 (27%), Positives = 99/225 (44%), Gaps = 32/225 (14%)
Query: 31 EVLMLSLLHH---PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTR 87
EV +LS L PN+ G G + ++ EY GSV + +K + R
Sbjct: 49 EVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIR 108
Query: 88 MKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVS 147
+ A L+Y+H K VI+RD+K +NIL+ + KL DFG+A L + N+
Sbjct: 109 EVLVA-----LKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAAL--LNQNSSKR 158
Query: 148 TRVMGTYGYCAPEYAKTGQL-TLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWAR 206
+ +GT + APE G+ K+D++S G+ + E+ +G A L+ ++
Sbjct: 159 STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSK 218
Query: 207 PLFQDRTRHSLIADPELQGQYPPRGFYQALA-VAAMCVHEQPDMR 250
P P L+ G+ + L A C+ E+P R
Sbjct: 219 P-------------PRLED----NGYSKLLREFVAACLDEEPKER 246
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 5e-10
Identities = 67/265 (25%), Positives = 112/265 (42%), Gaps = 34/265 (12%)
Query: 12 VAIKQLDRN-GVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVED 70
V +K+L + VQ +FL E L H NL+ +G C + LLV E+ PLG ++
Sbjct: 25 VVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKG 84
Query: 71 HLH------DLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG 124
+L ++P D T ++A A GL +LH K I+ DL N LL
Sbjct: 85 YLRSCRKAELMTP-----DPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTAD 136
Query: 125 YHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT--GQL-----TLKSDVYSFG 177
K+ D+GL+ D ++ + APE G L T +S+V+S G
Sbjct: 137 LTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLG 196
Query: 178 VVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALA 237
V + E+ + +++ ++ + R + + P L+ R +Y+ +
Sbjct: 197 VTIWELF--ELGSQPYRHLSDEQVLT-----YTVREQQLKLPKPRLKLPLSDR-WYEVMQ 248
Query: 238 VAAMCVHEQPDMRPVIADVVTALAY 262
+ QP+ RP +V L+Y
Sbjct: 249 FCWL----QPEQRPSAEEVHLLLSY 269
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 6e-10
Identities = 51/179 (28%), Positives = 87/179 (48%), Gaps = 11/179 (6%)
Query: 6 LCLLQDVAIKQLDRN-GVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMP 64
L +L+++ + +L+ N VQ N E +LS L HP +V + D ++ EY
Sbjct: 30 LKVLKEIPVGELNPNETVQAN----QEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCE 85
Query: 65 LGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG 124
++ L +L K L N + G+ Y+H + +++RDLK NI L +
Sbjct: 86 GRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFL-KN 141
Query: 125 YHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEI 183
K+ DFG+++L + + ++T GT Y +PE K KSD++S G +L E+
Sbjct: 142 NLLKIGDFGVSRL--LMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.1 bits (144), Expect = 6e-10
Identities = 56/198 (28%), Positives = 85/198 (42%), Gaps = 39/198 (19%)
Query: 10 QDVAIKQL---DRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR-----LLVYE 61
+ VAIK++ + + R L E+ +L L H N++ L+ +V E
Sbjct: 26 RKVAIKKISNVFDDLIDAKR-ILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTE 84
Query: 62 YMPLGSVEDHLHDLSPGKKPLDWNTRMK-IAAGAARGLEYLHDKAKPPVIYRDLKCSNIL 120
M E LH + +PL + ++ RGL+YLH A VI+RDLK SNIL
Sbjct: 85 LM-----ETDLHKVIKSPQPLT-DDHIQYFLYQILRGLKYLH-SAN--VIHRDLKPSNIL 135
Query: 121 LDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTY----GYCAPE-------YAKTGQLTL 169
++ K+ DFGLA+ D + Y Y APE Y T
Sbjct: 136 VNSNCDLKICDFGLAR---GVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRY------TK 186
Query: 170 KSDVYSFGVVLLEILSGR 187
D++S G + E+L+ +
Sbjct: 187 AIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 8e-10
Identities = 47/181 (25%), Positives = 81/181 (44%), Gaps = 22/181 (12%)
Query: 12 VAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDH 71
VA+K++D Q EV+++ H N+V + GD+ +V E++ G++ D
Sbjct: 48 VAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTD- 106
Query: 72 LHDLSPGKKPLDWNTRMK------IAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY 125
+ +TRM + + L LH + VI+RD+K +ILL
Sbjct: 107 ----------IVTHTRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDG 153
Query: 126 HPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 185
KLSDFG V ++GT + APE + D++S G++++E++
Sbjct: 154 RVKLSDFGFC--AQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVD 211
Query: 186 G 186
G
Sbjct: 212 G 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 8e-10
Identities = 40/89 (44%), Positives = 47/89 (52%), Gaps = 5/89 (5%)
Query: 98 LEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 157
LE LH K VIYRDLK NILLD H L DFGL KL D+ + GT Y
Sbjct: 106 LENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK--TNTFCGTPEYL 160
Query: 158 APEYAKTGQLTLKSDVYSFGVVLLEILSG 186
APE T D ++ GV+L E+L+G
Sbjct: 161 APELLLGHGYTKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 9e-10
Identities = 50/180 (27%), Positives = 86/180 (47%), Gaps = 21/180 (11%)
Query: 13 AIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIG-YCADGDQRLLVYEYMPLGSVEDH 71
A K ++ + +++VE+ +L+ +HP +V L+G + DG +++ E+ P G+V+
Sbjct: 41 AAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMI-EFCPGGAVDAI 99
Query: 72 LHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSD 131
+ +L G I L+YLH +I+RDLK N+LL KL+D
Sbjct: 100 MLELDRGLTEPQIQV---ICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLAD 153
Query: 132 FGLAKLGPVGDNTHVSTR---VMGTYGYCAPEYA-----KTGQLTLKSDVYSFGVVLLEI 183
FG++ N R +GT + APE K K+D++S G+ L+E+
Sbjct: 154 FGVS-----AKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 1e-09
Identities = 47/181 (25%), Positives = 74/181 (40%), Gaps = 19/181 (10%)
Query: 41 PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLS--PGKKPLDWNTRMKIAAGAARGL 98
PN+V L Y D LV ++ G + H+ P + W M +A L
Sbjct: 45 PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVA------L 98
Query: 99 EYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFG-LAKLGPVGDNTHVSTRVMGTYGYC 157
+ LH + ++ RDL +NILLD H +L+ F +++ D V YC
Sbjct: 99 DALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM------YC 149
Query: 158 APEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSL 217
APE + T D +S G +L E+L+G K + + + P + SL
Sbjct: 150 APEVGGISEETEACDWWSLGAILFELLTG-KTLVECHPSGINTHTTLNIPEWVSEEARSL 208
Query: 218 I 218
+
Sbjct: 209 L 209
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 1e-09
Identities = 49/161 (30%), Positives = 73/161 (45%), Gaps = 15/161 (9%)
Query: 34 MLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAG 93
+LS+ + P + L D D LV EY P G D L L+ + D + A
Sbjct: 54 ILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGG---DLLSLLNRYEDQFDEDMAQFYLAE 110
Query: 94 AARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFG-LAKLGPVGDNTHVSTRVMG 152
+ +H ++RD+K N+L+DR H KL+DFG A+L + S +G
Sbjct: 111 LVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLT--ANKMVNSKLPVG 165
Query: 153 TYGYCAPEYAKT------GQLTLKSDVYSFGVVLLEILSGR 187
T Y APE T G ++ D +S GV+ E++ GR
Sbjct: 166 TPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-09
Identities = 45/162 (27%), Positives = 68/162 (41%), Gaps = 26/162 (16%)
Query: 97 GLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY 156
LE+LH K +IYRD+K NILLD H L+DFGL+K D + GT Y
Sbjct: 117 ALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSK-EFHEDEVERAYSFCGTIEY 172
Query: 157 CAPEYAKTGQLTLKS--DVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAW---------- 204
AP+ + G D +S GV++ E+L+G Q+ ++
Sbjct: 173 MAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP 232
Query: 205 --ARPLFQDRTRHSLIADPELQGQYPPRG--------FYQAL 236
L +D + L+ DP+ + P F+Q +
Sbjct: 233 QEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKI 274
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 2e-09
Identities = 52/191 (27%), Positives = 87/191 (45%), Gaps = 20/191 (10%)
Query: 10 QDVAIKQLDR--NGVQGNREFLVEVLMLSLLHHPNLVN----LIGYCADGDQRLLVYEYM 63
+ VAIK++ + + L E+ +L H N++ L AD +V + M
Sbjct: 31 KKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLM 90
Query: 64 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR 123
E LH + +PL RGL+Y+H VI+RDLK SN+L++
Sbjct: 91 -----ESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNE 142
Query: 124 GYHPKLSDFGLAKL---GPVGDNTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVV 179
++ DFG+A+ P ++ + T + T Y APE + + T D++S G +
Sbjct: 143 DCELRIGDFGMARGLSSSPT-EHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCI 201
Query: 180 LLEILSGRKAV 190
E+L GR+ +
Sbjct: 202 FAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 2e-09
Identities = 47/159 (29%), Positives = 83/159 (52%), Gaps = 10/159 (6%)
Query: 31 EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI 90
E+ ++ L H N+V L ++ +LV+EYM ++ ++ D + LD NT
Sbjct: 48 EISLMKELKHENIVRLHDVIHTENKLMLVFEYMD-KDLKKYM-DTHGVRGALDPNTVKSF 105
Query: 91 AAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRV 150
+G+ + H+ V++RDLK N+L+++ KL+DFGLA+ + NT + V
Sbjct: 106 TYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV 162
Query: 151 MGTYGYCAPEYAKTGQLTLKS--DVYSFGVVLLEILSGR 187
T Y AP+ G T + D++S G ++ E+++GR
Sbjct: 163 --TLWYRAPD-VLLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-09
Identities = 55/164 (33%), Positives = 71/164 (43%), Gaps = 13/164 (7%)
Query: 24 GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLD 83
G R LV L+ P +V L LV +YM G + HL G+ D
Sbjct: 42 GERNILVRTLLDE---SPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQ--KEGRFSED 96
Query: 84 WNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 143
+ IA LE+LH K ++YRDLK NILLD H L DFGL+K +
Sbjct: 97 -RAKFYIAE-LVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK 151
Query: 144 THVSTRVMGTYGYCAPE-YAKTGQLTLKSDVYSFGVVLLEILSG 186
T + GT Y APE T D +S GV++ E+ G
Sbjct: 152 T--TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 2e-09
Identities = 50/154 (32%), Positives = 72/154 (46%), Gaps = 11/154 (7%)
Query: 34 MLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAG 93
+L + HP +V+LI G + L+ EY+ G + HL + +T +
Sbjct: 53 ILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLER----EGIFMEDTACFYLSE 108
Query: 94 AARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN-THVSTRVMG 152
+ LE+LH + +IYRDLK NILLD H KL+DFGL K TH G
Sbjct: 109 ISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT---FCG 162
Query: 153 TYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG 186
T Y APE D +S G ++ ++L+G
Sbjct: 163 TIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 2e-09
Identities = 56/188 (29%), Positives = 76/188 (40%), Gaps = 38/188 (20%)
Query: 28 FLVEVLMLSLLHHPNLVNLIGYCADGDQRLL--VYEYMPLGSVEDHLHDLSPGKKPLDWN 85
E +L+ P +V L Y + D+ L V EYMP G + + L P +
Sbjct: 48 VRAERDILADADSPWIVKL--YYSFQDEEHLYLVMEYMPGGDLMNLLIRK--DVFPEET- 102
Query: 86 TRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK--------- 136
R IA L+ +H I+RD+K NIL+D H KL+DFGL K
Sbjct: 103 ARFYIAELVL-ALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDRE 158
Query: 137 -------LGPVGDNTHVSTR-----------VMGTYGYCAPEYAKTGQLTLKSDVYSFGV 178
DN V R +GT Y APE + L+ D +S GV
Sbjct: 159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGV 218
Query: 179 VLLEILSG 186
+L E+L G
Sbjct: 219 ILYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-09
Identities = 51/182 (28%), Positives = 81/182 (44%), Gaps = 22/182 (12%)
Query: 12 VAIKQLDRNGVQGN--REFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVE 69
VAI L R G R FL E L L H N+V L G G+ ++V EYM G+++
Sbjct: 36 VAIHTL-RAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALD 94
Query: 70 D----HLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY 125
H L G+ M + G A G++YL + +++ L +L++
Sbjct: 95 SFLRKHEGQLVAGQ-------LMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDL 144
Query: 126 HPKLSDFGLAKLGPVGDNTHVSTRVMGTYG--YCAPEYAKTGQLTLKSDVYSFGVVLLEI 183
K+S F + + T + G + APE + + SDV+SFG+V+ E+
Sbjct: 145 VCKISGFR---RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEV 201
Query: 184 LS 185
+S
Sbjct: 202 MS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 3e-09
Identities = 52/182 (28%), Positives = 78/182 (42%), Gaps = 35/182 (19%)
Query: 29 LVEVLMLSLLHHPNLVNLIGYCAD-----GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLD 83
L E+ +L L HPN+V LI + +R VY P HDLS L
Sbjct: 55 LREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMD-----HDLSG----LL 105
Query: 84 WNTRMKIAAGAAR--------GLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA 135
N +K+ + G+ YLH+ +++RD+K +NIL+D K++DFGLA
Sbjct: 106 ENPSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLA 162
Query: 136 KL---------GPVGDNTHVSTRVMGTYGYCAPEY-AKTGQLTLKSDVYSFGVVLLEILS 185
+ G G T T ++ T Y PE + T D++ G V E+ +
Sbjct: 163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFT 222
Query: 186 GR 187
R
Sbjct: 223 RR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 3e-09
Identities = 56/197 (28%), Positives = 86/197 (43%), Gaps = 45/197 (22%)
Query: 10 QDVAIKQ----LDRNGVQGNREFLVEVLMLSLL---HHPNLVNLIGYCA--DGDQRL--- 57
+ VA+K+ L G+ + L E+ +L L HPN+V L+ C D+ L
Sbjct: 25 RFVALKKVRVPLSEEGIPLST--LREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLT 82
Query: 58 LVYEYMPLGSVEDHLHDL-----SPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYR 112
LV+E+ V+ L PG L T + RG+++LH +++R
Sbjct: 83 LVFEH-----VDQDLATYLSKCPKPG---LPPETIKDLMRQLLRGVDFLHSHR---IVHR 131
Query: 113 DLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE------YAKTGQ 166
DLK NIL+ K++DFGLA+ + T V+ T Y APE YA
Sbjct: 132 DLKPQNILVTSDGQVKIADFGLAR---IYSFEMALTSVVVTLWYRAPEVLLQSSYATP-- 186
Query: 167 LTLKSDVYSFGVVLLEI 183
D++S G + E+
Sbjct: 187 ----VDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 3e-09
Identities = 59/185 (31%), Positives = 81/185 (43%), Gaps = 23/185 (12%)
Query: 49 YCADGDQRLL--VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAK 106
+ A D + L V EYMP G D ++ +S P W R A L+ +H
Sbjct: 109 HYAFQDDKYLYMVMEYMPGG---DLVNLMSNYDIPEKW-ARFYTAE-VVLALDAIHSMG- 162
Query: 107 PPVIYRDLKCSNILLDRGYHPKLSDFGLA-KLGPVGDNTHVSTRVMGTYGYCAPEYAKT- 164
I+RD+K N+LLD+ H KL+DFG K+ G T V GT Y +PE K+
Sbjct: 163 --FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG-MVRCDTAV-GTPDYISPEVLKSQ 218
Query: 165 ---GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADP 221
G + D +S GV L E+L G DT A SLV + + + D
Sbjct: 219 GGDGYYGRECDWWSVGVFLYEMLVG----DTPFYA--DSLVGTYSKIMDHKNSLTFPDDI 272
Query: 222 ELQGQ 226
E+ Q
Sbjct: 273 EISKQ 277
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 4e-09
Identities = 41/135 (30%), Positives = 69/135 (51%), Gaps = 17/135 (12%)
Query: 61 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNIL 120
EYM GS+ D L+ + + + +I +GL++L ++ +I+RD+K +N+L
Sbjct: 79 EYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIHRDVKPTNVL 135
Query: 121 LDRGYHPKLSDFGLAKLGPVGDN--THVSTRVMGTYGYCAPEYAKTGQL------TLKSD 172
++ KL DFG V N ++ +G Y APE K+G T++SD
Sbjct: 136 VNGNGQVKLCDFG------VSGNLVASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSD 189
Query: 173 VYSFGVVLLEILSGR 187
V+S G+ +LE+ GR
Sbjct: 190 VWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 4e-09
Identities = 32/99 (32%), Positives = 51/99 (51%), Gaps = 7/99 (7%)
Query: 89 KIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST 148
+IA +GL YL +++RD+K SN+L++ KL DFG++ ++
Sbjct: 99 RIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV----NSIAK 151
Query: 149 RVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 187
+GT Y APE Q + SDV+S G+ +E+ GR
Sbjct: 152 TYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 4e-09
Identities = 54/178 (30%), Positives = 86/178 (48%), Gaps = 20/178 (11%)
Query: 31 EVLMLSLLH---HPNLVNLIGYCADG--DQRL---LVYEYMPLGSVEDHLHDLSPGKKPL 82
EV +L L HPN+V L+ CA D+ LV+E++ + +L + P P
Sbjct: 49 EVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVD-QDLRTYLDKVPPPGLPA 107
Query: 83 DWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 142
+ T + RGL++LH +++RDLK NIL+ G KL+DFGLA++
Sbjct: 108 E--TIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIY---- 158
Query: 143 NTHVS-TRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ 199
+ ++ T V+ T Y APE D++S G + E+ RK + + A+Q
Sbjct: 159 SCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPLFCGNSEADQ 215
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 4e-09
Identities = 41/157 (26%), Positives = 73/157 (46%), Gaps = 10/157 (6%)
Query: 29 LVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRM 88
L+E ++L ++HP+++ + G +V + D L+ +PL + +
Sbjct: 105 LIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS----SDLYTYLTKRSRPLPIDQAL 160
Query: 89 KIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST 148
I GL YLH + +I+RD+K NI ++ + D G A+ PV +
Sbjct: 161 IIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQF-PVVAPAFLG- 215
Query: 149 RVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 185
+ GT APE + K+D++S G+VL E+L+
Sbjct: 216 -LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 5e-09
Identities = 41/127 (32%), Positives = 62/127 (48%), Gaps = 7/127 (5%)
Query: 60 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNI 119
Y+ V++ L D G + L + ARG+E+L K ++RDL N+
Sbjct: 214 YKGSNDSEVKNLLSD--DGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNV 268
Query: 120 LLDRGYHPKLSDFGLAKLGPVGDNTHVST-RVMGTYGYCAPEYAKTGQLTLKSDVYSFGV 178
LL +G K+ DFGLA+ + D+ +VS + APE T SDV+S+G+
Sbjct: 269 LLAQGKIVKICDFGLAR-DIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGI 327
Query: 179 VLLEILS 185
+L EI S
Sbjct: 328 LLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 5e-09
Identities = 54/155 (34%), Positives = 69/155 (44%), Gaps = 11/155 (7%)
Query: 33 LMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-A 91
++L + HP LV L D+ V +Y+ G + HL +P R + A
Sbjct: 48 VLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEP-----RARFYA 102
Query: 92 AGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVM 151
A A L YLH ++YRDLK NILLD H L+DFGL K + N ST
Sbjct: 103 AEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKEN-IEHNGTTST-FC 157
Query: 152 GTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG 186
GT Y APE D + G VL E+L G
Sbjct: 158 GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 6e-09
Identities = 48/189 (25%), Positives = 89/189 (47%), Gaps = 18/189 (9%)
Query: 5 ILCLLQD------VAIKQLDRNGVQGNREFLV-EVLMLSLLHHPNLVNLIGYCADGDQRL 57
I+C+ ++ VA+K +D Q RE L EV+++ H N+V + G++
Sbjct: 36 IVCIAREKHSGRQVAVKMMDLRK-QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELW 94
Query: 58 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCS 117
++ E++ G++ D + L+ + + L YLH + VI+RD+K
Sbjct: 95 VLMEFLQGGALTDIVSQTR-----LNEEQIATVCESVLQALCYLHSQG---VIHRDIKSD 146
Query: 118 NILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFG 177
+ILL KLSDFG + + ++GT + APE + D++S G
Sbjct: 147 SILLTLDGRVKLSDFGFC--AQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLG 204
Query: 178 VVLLEILSG 186
++++E++ G
Sbjct: 205 IMVIEMVDG 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 8e-09
Identities = 58/170 (34%), Positives = 82/170 (48%), Gaps = 27/170 (15%)
Query: 33 LMLSLLHHPNLVNLIG--YCAD---GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTR 87
++ SL +HPN+V G Y AD G Q LV E GSV + + L + LD
Sbjct: 71 ILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMI 130
Query: 88 MKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL-AKLGPVGDNTHV 146
I GA GL++LH+ +I+RD+K +NILL KL DFG+ A+L
Sbjct: 131 SYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLVDFGVSAQL--------T 179
Query: 147 STRV-----MGTYGYCAPEYAKTGQ-----LTLKSDVYSFGVVLLEILSG 186
STR+ +GT + APE Q + DV+S G+ +E+ G
Sbjct: 180 STRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 8e-09
Identities = 52/194 (26%), Positives = 90/194 (46%), Gaps = 31/194 (15%)
Query: 7 CLLQDVAIKQLDR---NGVQGNREFLVEVLMLSLLHHPNLVNLIG-YCADGDQRLL--VY 60
+ VAIK+L R + + R + E+ +L + H N++ L+ + VY
Sbjct: 38 KTGRKVAIKKLSRPFQSAIHAKRTYR-ELRLLKHMDHENVIGLLDVFTPASSLEDFQDVY 96
Query: 61 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNIL 120
L + L+++ +K D + + + RGL+Y+H +I+RDLK SNI
Sbjct: 97 LVTHLMGAD--LNNIVKCQKLSDDHIQF-LVYQILRGLKYIHSAG---IIHRDLKPSNIA 150
Query: 121 LDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE-------YAKTGQLTLKSDV 173
++ K+ DFGLA+ +V+TR Y APE Y +T D+
Sbjct: 151 VNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQT------VDI 199
Query: 174 YSFGVVLLEILSGR 187
+S G ++ E+L+G+
Sbjct: 200 WSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 1e-08
Identities = 55/166 (33%), Positives = 79/166 (47%), Gaps = 19/166 (11%)
Query: 28 FLVEVLMLSLLHHPNLVNLIGYCADGDQRLL--VYEYMPLGSVEDHLHDLSPGKKPLDWN 85
F E +++ + P +V L +CA D + L V EYMP G D ++ +S P W
Sbjct: 90 FWEERDIMAFANSPWVVQL--FCAFQDDKYLYMVMEYMPGG---DLVNLMSNYDVPEKWA 144
Query: 86 TRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA-KLGPVGDNT 144
A L+ +H +I+RD+K N+LLD+ H KL+DFG K+ G
Sbjct: 145 KFY--TAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG-MV 198
Query: 145 HVSTRVMGTYGYCAPEYAKT----GQLTLKSDVYSFGVVLLEILSG 186
T V GT Y +PE K+ G + D +S GV L E+L G
Sbjct: 199 RCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 1e-08
Identities = 54/181 (29%), Positives = 81/181 (44%), Gaps = 21/181 (11%)
Query: 12 VAIKQLDRNGVQGNREF---LVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSV 68
VAIK+ +++ + ++ E +L+ ++HP VNL G D LV E++ G
Sbjct: 59 VAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEF 118
Query: 69 EDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK 128
L K + AA EYL ++YRDLK N+LLD+ K
Sbjct: 119 FTFLRR----NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIK 171
Query: 129 LSDFGLAKLGPVGDNTHVSTR---VMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 185
++DFG AK+ V TR + GT Y APE +D ++ G+ + EIL
Sbjct: 172 MTDFGFAKV--------VDTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILV 223
Query: 186 G 186
G
Sbjct: 224 G 224
|
Length = 340 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (132), Expect = 1e-08
Identities = 50/163 (30%), Positives = 74/163 (45%), Gaps = 28/163 (17%)
Query: 33 LMLSLLHHPNLVNLIGYCADGDQ-RL-LVYEYMPLGSVEDHLHDLSPGKK-PLDWNTRMK 89
+ L HPN++ LI D RL LV+E M + +L++L G+K PL
Sbjct: 50 ALRRLSPHPNILRLIEVLFDRKTGRLALVFELM-----DMNLYELIKGRKRPLPEKRVKS 104
Query: 90 IAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH---- 145
+ L+++H + +RD+K NIL+ KL+DFG + G +
Sbjct: 105 YMYQLLKSLDHMHRNG---IFHRDIKPENILIK-DDILKLADFGSCR----GIYSKPPYT 156
Query: 146 --VSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILS 185
+STR Y APE T G K D+++ G V EILS
Sbjct: 157 EYISTR-----WYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 3e-08
Identities = 43/158 (27%), Positives = 75/158 (47%), Gaps = 8/158 (5%)
Query: 31 EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI 90
E+ +L L HPN+V L + L++E++ + ++ +L D P + +D
Sbjct: 49 EISLLKELQHPNIVCLQDVLMQESRLYLIFEFLSM-DLKKYL-DSLPKGQYMDAELVKSY 106
Query: 91 AAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRV 150
+G+ + H + V++RDLK N+L+D KL+DFGLA+ G V T
Sbjct: 107 LYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLAR--AFGIPVRVYTHE 161
Query: 151 MGTYGYCAPEYAKTGQL-TLKSDVYSFGVVLLEILSGR 187
+ T Y APE + D++S G + E+ + +
Sbjct: 162 VVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 4e-08
Identities = 47/168 (27%), Positives = 80/168 (47%), Gaps = 20/168 (11%)
Query: 26 REFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN 85
R+ E+ +L ++HPN+V + ++ E+M GS+E G D
Sbjct: 117 RQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLE--------GTHIADEQ 168
Query: 86 TRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK-LGPVGDNT 144
+A G+ YLH + +++RD+K SN+L++ + K++DFG+++ L D
Sbjct: 169 FLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPC 225
Query: 145 HVSTRVMGTYGYCAPEYAKT----GQLT-LKSDVYSFGVVLLEILSGR 187
+ S +GT Y +PE T G D++S GV +LE GR
Sbjct: 226 NSS---VGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 4e-08
Identities = 50/168 (29%), Positives = 77/168 (45%), Gaps = 23/168 (13%)
Query: 28 FLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLS-PGKKPLDWNT 86
F E +++ + P +V L D +V EYMP G + + + + P K +
Sbjct: 90 FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTA 149
Query: 87 RMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFG----LAKLGPVGD 142
+ +A A + ++H RD+K N+LLD+ H KL+DFG + K G V
Sbjct: 150 EVVLALDAIHSMGFIH---------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRC 200
Query: 143 NTHVSTRVMGTYGYCAPEYAKT----GQLTLKSDVYSFGVVLLEILSG 186
+T V GT Y +PE K+ G + D +S GV L E+L G
Sbjct: 201 DTAV-----GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 4e-08
Identities = 46/159 (28%), Positives = 73/159 (45%), Gaps = 18/159 (11%)
Query: 31 EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI 90
E+ M+ H N+V G ++ + EY GS++D H P + ++I
Sbjct: 56 EIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGP-------LSELQI 108
Query: 91 A---AGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVS 147
A +GL YLH K K ++RD+K +NILL KL+DFG+A +
Sbjct: 109 AYVCRETLQGLAYLHSKGK---MHRDIKGANILLTDNGDVKLADFGVA--AKITATIAKR 163
Query: 148 TRVMGTYGYCAPEYA---KTGQLTLKSDVYSFGVVLLEI 183
+GT + APE A K G D+++ G+ +E+
Sbjct: 164 KSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 4e-08
Identities = 47/151 (31%), Positives = 67/151 (44%), Gaps = 35/151 (23%)
Query: 29 LVEVLMLSLLHHPNLVNLIGYC---ADGDQR-----LLVYEYMPLGSVEDHLHDLSPGKK 80
L E+ +L LL H N+VNLI C A R LV+E+ HDL+
Sbjct: 59 LREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCE--------HDLAG--- 107
Query: 81 PLDWNTRMKIAAGAAR--------GLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDF 132
L N +K + GL Y+H +++RD+K +NIL+ + KL+DF
Sbjct: 108 -LLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADF 163
Query: 133 GLAK---LGPVGDNTHVSTRVMGTYGYCAPE 160
GLA+ L + RV+ T Y PE
Sbjct: 164 GLARAFSLSKNSKPNRYTNRVV-TLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 6e-08
Identities = 48/160 (30%), Positives = 72/160 (45%), Gaps = 18/160 (11%)
Query: 35 LSLLHHPNLVNLIGYCA----DGDQRL-LVYEYMP--LGSVEDHLHDLSPGKKPLDWNTR 87
L HPN+V L C D + +L LV+E++ L + D + + PG T
Sbjct: 58 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPE--PGVPT---ETI 112
Query: 88 MKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVS 147
+ RGL++LH V++RDLK NIL+ KL+DFGLA++
Sbjct: 113 KDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMAL 166
Query: 148 TRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 187
T V+ T Y APE D++S G + E+ +
Sbjct: 167 TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 8e-08
Identities = 30/77 (38%), Positives = 40/77 (51%), Gaps = 5/77 (6%)
Query: 110 IYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTL 169
I+RDLK N L+D H KL+DFGL+K N+ V+G+ Y APE +
Sbjct: 123 IHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANS-----VVGSPDYMAPEVLRGKGYDF 177
Query: 170 KSDVYSFGVVLLEILSG 186
D +S G +L E L G
Sbjct: 178 TVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 9e-08
Identities = 55/189 (29%), Positives = 78/189 (41%), Gaps = 20/189 (10%)
Query: 10 QDVAIKQLDRNGVQGNREFLVEVLMLSLL-HHPNLVNLIGYCAD------GDQRLLVYEY 62
Q AIK +D G + E E+ ML HH N+ G DQ LV E+
Sbjct: 32 QLAAIKVMDVTGDE-EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEF 90
Query: 63 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD 122
GSV D + + +W I RGL +LH VI+RD+K N+LL
Sbjct: 91 CGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGLSHLHQHK---VIHRDIKGQNVLLT 145
Query: 123 RGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ-----LTLKSDVYSFG 177
KL DFG++ + +GT + APE + KSD++S G
Sbjct: 146 ENAEVKLVDFGVS--AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLG 203
Query: 178 VVLLEILSG 186
+ +E+ G
Sbjct: 204 ITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 9e-08
Identities = 32/94 (34%), Positives = 52/94 (55%), Gaps = 7/94 (7%)
Query: 96 RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG 155
RGL+YLH +++RD+K N+L++ K+ DFGLA++ ++ H++ V+ Y
Sbjct: 114 RGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY- 169
Query: 156 YCAPEYAKTG--QLTLKSDVYSFGVVLLEILSGR 187
Y APE G T D++S G + E+L R
Sbjct: 170 YRAPEIL-MGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 1e-07
Identities = 37/113 (32%), Positives = 61/113 (53%), Gaps = 11/113 (9%)
Query: 77 PGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 136
PLD + ++ ++ A+G+++L K I+RD+ N+LL G K+ DFGLA+
Sbjct: 204 EDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLAR 260
Query: 137 LGPVGDNTHVSTRVMGT----YGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 185
+ D+ +V V G + APE T++SDV+S+G++L EI S
Sbjct: 261 -DIMNDSNYV---VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 1e-07
Identities = 34/91 (37%), Positives = 46/91 (50%), Gaps = 3/91 (3%)
Query: 95 ARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTY 154
A+G+ +L K I+RDL NILL G K+ DFGLA+ N V
Sbjct: 224 AKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPV 280
Query: 155 GYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 185
+ APE T +SDV+S+G++L EI S
Sbjct: 281 KWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 1e-07
Identities = 61/235 (25%), Positives = 91/235 (38%), Gaps = 65/235 (27%)
Query: 12 VAIKQLDRNGVQGN--REFLVEV-LMLSLLHHPNLVNLIGYCADGDQRLLV-YEYMPLGS 67
VA+K L + G + + + E+ +++ + HH N+VNL+G C L+V EY G+
Sbjct: 40 VAVKML-KEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGN 98
Query: 68 VEDHL----HDLSPGKKPLDWNTRMKIAAGAARGL------------------------- 98
+ ++L SP + MK G + L
Sbjct: 99 LSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEE 158
Query: 99 -EYLHDKAKPPV------------------------IYRDLKCSNILLDRGYHPKLSDFG 133
E + K P+ I+RDL NILL K+ DFG
Sbjct: 159 DEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFG 218
Query: 134 LAKLGPVGDNTHV---STRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 185
LA+ D +V R+ + APE T +SDV+SFGV+L EI S
Sbjct: 219 LAR-DIYKDPDYVRKGDARL--PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 1e-07
Identities = 53/188 (28%), Positives = 83/188 (44%), Gaps = 18/188 (9%)
Query: 10 QDVAIKQLDR--NGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR-----LLVYEY 62
+ VAIK+++ V L E+ +L LL HP++V + +R +V+E
Sbjct: 26 EKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFEL 85
Query: 63 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD 122
M E LH + L R L+Y+H V +RDLK NIL +
Sbjct: 86 M-----ESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILAN 137
Query: 123 RGYHPKLSDFGLAKLGPVGDNTHVS-TRVMGTYGYCAPEYAKT--GQLTLKSDVYSFGVV 179
K+ DFGLA++ T + T + T Y APE + + T D++S G +
Sbjct: 138 ADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCI 197
Query: 180 LLEILSGR 187
E+L+G+
Sbjct: 198 FAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 1e-07
Identities = 30/83 (36%), Positives = 47/83 (56%)
Query: 109 VIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLT 168
+I+RD+K +NILL KL DFG +K+ + V GT Y APE + +
Sbjct: 164 MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYS 223
Query: 169 LKSDVYSFGVVLLEILSGRKAVD 191
K+D++S GV+L E+L+ ++ D
Sbjct: 224 KKADMFSLGVLLYELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 2e-07
Identities = 50/171 (29%), Positives = 80/171 (46%), Gaps = 30/171 (17%)
Query: 31 EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI 90
E+ +L L+HPN+V L+ ++ LV+E++ DL KK +D + I
Sbjct: 49 EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH--------QDL---KKFMDASPLSGI 97
Query: 91 AAGAAR--------GLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK-LG-PV 140
+ GL + H V++RDLK N+L++ KL+DFGLA+ G PV
Sbjct: 98 PLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 154
Query: 141 GDNTHVSTRVMGTYGYCAPE-YAKTGQLTLKSDVYSFGVVLLEILSGRKAV 190
TH T Y APE + D++S G + E+++ R+A+
Sbjct: 155 RTYTHEVV----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 39/99 (39%), Positives = 55/99 (55%), Gaps = 9/99 (9%)
Query: 96 RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK---LGPVGDNTHVSTRVMG 152
GL+Y+H V++RDLK N+L++ K+ DFGLA+ P G+N T +
Sbjct: 116 CGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENP-GENAGFMTEYVA 171
Query: 153 TYGYCAPEYAKTGQLTLKS-DVYSFGVVLLEILSGRKAV 190
T Y APE + Q K+ DV+S G +L E+L GRK V
Sbjct: 172 TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 2e-07
Identities = 47/167 (28%), Positives = 68/167 (40%), Gaps = 16/167 (9%)
Query: 22 VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP---G 78
V G + E+ +L + H ++NLI +V MP + DL
Sbjct: 127 VTGGKTPGREIDILKTISHRAIINLIHAYRWKSTVCMV---MP-----KYKCDLFTYVDR 178
Query: 79 KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA-KL 137
PL + I L YLH + +I+RD+K NI LD + L DFG A KL
Sbjct: 179 SGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKL 235
Query: 138 GPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEIL 184
+T GT +PE K+D++S G+VL E+
Sbjct: 236 D-AHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMS 281
|
Length = 392 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 2e-07
Identities = 55/161 (34%), Positives = 77/161 (47%), Gaps = 40/161 (24%)
Query: 31 EVLMLSLLHHPNLVNL--IGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKK-----PL 82
E+ +L L+HPN+V L + + + +L LV+E++ L DL KK PL
Sbjct: 48 EISLLKELNHPNIVRLLDVVHS---ENKLYLVFEFLDL--------DL---KKYMDSSPL 93
Query: 83 DWNTRMKIAA---GAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK-LG 138
I + +G+ Y H V++RDLK N+L+DR KL+DFGLA+ G
Sbjct: 94 TGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFG 150
Query: 139 -PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGV 178
PV TH V+ T Y APE + L S YS V
Sbjct: 151 VPVRTYTH---EVV-TLWYRAPE------ILLGSRQYSTPV 181
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 2e-07
Identities = 39/94 (41%), Positives = 50/94 (53%), Gaps = 9/94 (9%)
Query: 95 ARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHV---STRVM 151
ARG+E+L A I+RDL NILL K+ DFGLA+ D +V S R+
Sbjct: 184 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLAR-DIYKDPDYVRKGSARL- 238
Query: 152 GTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 185
+ APE T +SDV+SFGV+L EI S
Sbjct: 239 -PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-07
Identities = 53/170 (31%), Positives = 74/170 (43%), Gaps = 27/170 (15%)
Query: 33 LMLSLLHHPNLVNLIG--YCAD---GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTR 87
++ +L HPN+V G Y D GDQ LV E GSV D + K L R
Sbjct: 67 ILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLV------KGFLKRGER 120
Query: 88 MK------IAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG 141
M+ I A GL++LH I+RD+K +NILL KL DFG++ +
Sbjct: 121 MEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLVDFGVS--AQLT 175
Query: 142 DNTHVSTRVMGTYGYCAPEYAKTGQ-----LTLKSDVYSFGVVLLEILSG 186
+GT + APE Q + DV+S G+ +E+ G
Sbjct: 176 STRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 3e-07
Identities = 52/168 (30%), Positives = 85/168 (50%), Gaps = 28/168 (16%)
Query: 31 EVLMLSLLHHPNLVNL--IGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTR 87
E+ +L + H N+V L + + ++RL LV+EY+ L ++ H+ D SP D+
Sbjct: 51 EISLLKEMQHGNIVRLQDVVHS---EKRLYLVFEYLDL-DLKKHM-DSSP-----DFAKN 100
Query: 88 MKIAAG----AARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP-KLSDFGLAK-LG-PV 140
++ RG+ Y H V++RDLK N+L+DR + KL+DFGLA+ G PV
Sbjct: 101 PRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157
Query: 141 GDNTHVSTRVMGTYGYCAPE-YAKTGQLTLKSDVYSFGVVLLEILSGR 187
TH T Y APE + + D++S G + E+++ +
Sbjct: 158 RTFTHEVV----TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 5e-07
Identities = 53/217 (24%), Positives = 89/217 (41%), Gaps = 59/217 (27%)
Query: 10 QDVAIKQLD----RNGVQGNREF----------LVEVLMLSLLHHPNLVNLIGYCADGDQ 55
+ VAIK++ N V +R+ L E+ +++ + H N++ L+ +GD
Sbjct: 35 KIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDF 94
Query: 56 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMK------IAAGAARGLEYLHDKAKPPV 109
LV + M DL KK +D R+ I GL LH K
Sbjct: 95 INLVMDIMA--------SDL---KKVVDRKIRLTESQVKCILLQILNGLNVLH---KWYF 140
Query: 110 IYRDLKCSNILLDRGYHPKLSDFGLAK-------LGPVGDNTHVSTRVMGTYG-----YC 157
++RDL +NI ++ K++DFGLA+ + + + R T Y
Sbjct: 141 MHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYR 200
Query: 158 APEYAKTGQLTLKS-------DVYSFGVVLLEILSGR 187
APE L + + D++S G + E+L+G+
Sbjct: 201 APE------LLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 5e-07
Identities = 60/192 (31%), Positives = 83/192 (43%), Gaps = 26/192 (13%)
Query: 10 QDVAIKQLDRNGVQGNREFLVEVLMLSLL-HHPNLVNLIGY------CADGDQRLLVYEY 62
Q AIK +D + E +E+ ML HH N+ G DQ LV E+
Sbjct: 42 QLAAIKVMDVTEDE-EEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEF 100
Query: 63 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD 122
GSV D + + DW I RGL +LH VI+RD+K N+LL
Sbjct: 101 CGAGSVTDLVKNTKGNALKEDWIAY--ICREILRGLAHLHAHK---VIHRDIKGQNVLLT 155
Query: 123 RGYHPKLSDFGL-AKLGPVGDNTHVSTR--VMGTYGYCAPEYAKTGQ-----LTLKSDVY 174
KL DFG+ A+L D T V R +GT + APE + +SD++
Sbjct: 156 ENAEVKLVDFGVSAQL----DRT-VGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIW 210
Query: 175 SFGVVLLEILSG 186
S G+ +E+ G
Sbjct: 211 SLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 6e-07
Identities = 37/100 (37%), Positives = 50/100 (50%), Gaps = 19/100 (19%)
Query: 96 RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG 155
RGL+Y+H V++RDLK SN+LL+ K+ DFGLA+ + T + T
Sbjct: 119 RGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR--TTSEKGDFMTEYVVTRW 173
Query: 156 YCAPEYAKTGQLTLKS-------DVYSFGVVLLEILSGRK 188
Y APE L L DV+S G + E+L GRK
Sbjct: 174 YRAPE------LLLNCSEYTTAIDVWSVGCIFAELL-GRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 8e-07
Identities = 49/173 (28%), Positives = 80/173 (46%), Gaps = 10/173 (5%)
Query: 31 EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI 90
EV +L L H N+V L LV+EY+ ++ ++ D G N ++ +
Sbjct: 54 EVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLD-KDLKQYMDDC--GNIMSMHNVKIFL 110
Query: 91 AAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRV 150
RGL Y H + V++RDLK N+L++ KL+DFGLA+ V T+ + V
Sbjct: 111 YQ-ILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV 166
Query: 151 MGTYGYCAPE-YAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLV 202
T Y P+ + + + + D++ G + E+ SGR S E L+
Sbjct: 167 --TLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLI 217
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 9e-07
Identities = 59/190 (31%), Positives = 82/190 (43%), Gaps = 28/190 (14%)
Query: 79 KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 138
KK L + + A+G+E+L A I+RDL NILL K+ DFGLA+
Sbjct: 173 KKVLTLEDLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLAR-D 228
Query: 139 PVGDNTHV---STRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSK 194
D +V R+ + APE T++SDV+SFGV+L EI S G K
Sbjct: 229 IYKDPDYVRKGDARL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 286
Query: 195 AAAEQSLVAWARPLFQ-DRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVI 253
E + R L + R R PE+ YQ + C H +P RP
Sbjct: 287 IDEE-----FCRRLKEGTRMRAPDYTTPEM---------YQTM---LDCWHGEPSQRPTF 329
Query: 254 ADVVTALAYL 263
+++V L L
Sbjct: 330 SELVEHLGNL 339
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 9e-07
Identities = 55/200 (27%), Positives = 91/200 (45%), Gaps = 31/200 (15%)
Query: 10 QDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGY----CADGDQRLL----VYE 61
+ VAIK++ ++ NRE L+ + L+H N++ L Y C +++ + V E
Sbjct: 92 EKVAIKKVLQDPQYKNRELLI----MKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVME 147
Query: 62 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL 121
++P +V ++ + L + R L Y+H K + +RDLK N+L+
Sbjct: 148 FIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLI 203
Query: 122 DRGYHP-KLSDFGLAK--LGPVGDNTHVSTRVMGTYGYCAPEYA-KTGQLTLKSDVYSFG 177
D H KL DFG AK L +++ +R Y APE T D++S G
Sbjct: 204 DPNTHTLKLCDFGSAKNLLAGQRSVSYICSRF-----YRAPELMLGATNYTTHIDLWSLG 258
Query: 178 VVLLE------ILSGRKAVD 191
++ E I SG+ +VD
Sbjct: 259 CIIAEMILGYPIFSGQSSVD 278
|
Length = 440 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 9e-07
Identities = 30/80 (37%), Positives = 42/80 (52%), Gaps = 7/80 (8%)
Query: 58 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCS 117
LV EY+ G V+ LH D +K + A L+YLH +I+RDLK
Sbjct: 81 LVMEYLIGGDVKSLLHIYGY----FDEEMAVKYISEVALALDYLHRHG---IIHRDLKPD 133
Query: 118 NILLDRGYHPKLSDFGLAKL 137
N+L+ H KL+DFGL+K+
Sbjct: 134 NMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.4 bits (116), Expect = 2e-06
Identities = 45/183 (24%), Positives = 76/183 (41%), Gaps = 51/183 (27%)
Query: 31 EVLMLSLLHHPNLVNLIGYC-ADGDQRL-LVYEYMPLGSVEDHLHDL--------SPGKK 80
E+ +L L H N+V+L+ D+ + L+++Y HDL +
Sbjct: 52 EIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAE--------HDLWQIIKFHRQAKRV 103
Query: 81 PLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL-----DRGYHPKLSDFGLA 135
+ + + G+ YLH V++RDLK +NIL+ +RG K+ D GLA
Sbjct: 104 SIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERG-VVKIGDLGLA 159
Query: 136 KL------GPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKS-------DVYSFGVVLLE 182
+L + V+ T Y APE L L + D+++ G + E
Sbjct: 160 RLFNAPLKPLADLD-----PVVVTIWYRAPE------LLLGARHYTKAIDIWAIGCIFAE 208
Query: 183 ILS 185
+L+
Sbjct: 209 LLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 2e-06
Identities = 51/179 (28%), Positives = 77/179 (43%), Gaps = 18/179 (10%)
Query: 31 EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVE---DHLHDLSPGKKPLDWNTR 87
E +L L H N+V L + V+EYM + H L P +N R
Sbjct: 53 EASLLKGLKHANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHP------YNVR 106
Query: 88 MKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVS 147
+ + RGL Y+H + +++RDLK N+L+ KL+DFGLA+ + T+ S
Sbjct: 107 LFMFQ-LLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSS 162
Query: 148 TRVMGTYGYCAPEYAKTGQLTLKS--DVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAW 204
V T Y P+ G S D++ G + +E+L G+ A EQ W
Sbjct: 163 EVV--TLWYRPPD-VLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIW 218
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 49/186 (26%), Positives = 78/186 (41%), Gaps = 42/186 (22%)
Query: 19 RNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE---YMPLGSVEDHLH-- 73
+ G + + E+L L L+H N++ + + +L E YM + L+
Sbjct: 201 KAGSRAAIQLENEILALGRLNHENILKI--------EEILRSEANTYMITQKYDFDLYSF 252
Query: 74 ----DLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKL 129
+PL TR I +EY+HDK +I+RD+K NI L+ L
Sbjct: 253 MYDEAFDWKDRPLLKQTR-AIMKQLLCAVEYIHDKK---LIHRDIKLENIFLNCDGKIVL 308
Query: 130 SDFGLA----------KLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVV 179
DFG A G VG S ++ GYC ++T D++S G++
Sbjct: 309 GDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYC--------EIT---DIWSCGLI 357
Query: 180 LLEILS 185
LL++LS
Sbjct: 358 LLDMLS 363
|
Length = 501 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 4e-06
Identities = 37/112 (33%), Positives = 54/112 (48%), Gaps = 20/112 (17%)
Query: 96 RGLEYLHDKAKPPVIYRDLKCSNILL-DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTY 154
RGL Y H + V++RDLK N+L+ +RG KL+DFGLA+ V T+ + V T
Sbjct: 114 RGLAYCHQRR---VLHRDLKPQNLLISERG-ELKLADFGLARAKSVPSKTYSNEVV--TL 167
Query: 155 GYCAP-------EYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ 199
Y P EY + L D++ G + E+ +GR S +Q
Sbjct: 168 WYRPPDVLLGSTEY--STSL----DMWGVGCIFYEMATGRPLFPGSTDVEDQ 213
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 4e-06
Identities = 45/150 (30%), Positives = 68/150 (45%), Gaps = 25/150 (16%)
Query: 42 NLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYL 101
NL ++ Y GD L+ ++ ED L P + M IA + L Y+
Sbjct: 75 NLYLVMDYYVGGDLLTLLSKF------EDRL----PEDMARFYLAEMVIAIDSVHQLHYV 124
Query: 102 HDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 161
H RD+K NIL+D H +L+DFG + L + D T S+ +GT Y +PE
Sbjct: 125 H---------RDIKPDNILMDMNGHIRLADFG-SCLKLMEDGTVQSSVAVGTPDYISPEI 174
Query: 162 AKT-----GQLTLKSDVYSFGVVLLEILSG 186
+ G+ + D +S GV + E+L G
Sbjct: 175 LQAMEDGKGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 5e-06
Identities = 28/77 (36%), Positives = 45/77 (58%)
Query: 109 VIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLT 168
+++RDLK +NI L KL DFG +K + V++ GT Y APE + + +
Sbjct: 190 MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYS 249
Query: 169 LKSDVYSFGVVLLEILS 185
K+D++S GV+L E+L+
Sbjct: 250 KKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 5e-06
Identities = 34/106 (32%), Positives = 52/106 (49%), Gaps = 15/106 (14%)
Query: 86 TRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 145
M +A + L Y+H RD+K N+LLD+ H +L+DFG + L + D T
Sbjct: 109 AEMVLAIDSVHQLGYVH---------RDIKPDNVLLDKNGHIRLADFG-SCLRLLADGTV 158
Query: 146 VSTRVMGTYGYCAPEYAK-----TGQLTLKSDVYSFGVVLLEILSG 186
S +GT Y +PE + G+ + D +S GV + E+L G
Sbjct: 159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 6e-06
Identities = 48/175 (27%), Positives = 77/175 (44%), Gaps = 14/175 (8%)
Query: 31 EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMP--LGSVEDHLHDLSPGKKPLDWNTRM 88
EV +L L H N+V L LV+EY+ L D+ +L + +
Sbjct: 53 EVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNL------MSMHNVK 106
Query: 89 KIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST 148
RGL Y H + +++RDLK N+L++ KL+DFGLA+ V T+ +
Sbjct: 107 IFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNE 163
Query: 149 RVMGTYGYCAPE-YAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLV 202
V T Y P+ + + + D++ G +L E+ +GR S E L+
Sbjct: 164 VV--TLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLI 216
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 6e-06
Identities = 45/181 (24%), Positives = 76/181 (41%), Gaps = 11/181 (6%)
Query: 12 VAIKQLDRN-GVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVED 70
V +K+L N + EFL + +L HPN++ +G C + LLV+EY LG ++
Sbjct: 25 VVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKS 84
Query: 71 HLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLS 130
+L ++ ++A A G+ ++H K ++ DL N L K+
Sbjct: 85 YLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVG 141
Query: 131 DFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK-------TGQLTLKSDVYSFGVVLLEI 183
D+G+ D + APE T + T S+V++ GV L E+
Sbjct: 142 DYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWEL 201
Query: 184 L 184
Sbjct: 202 F 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 7e-06
Identities = 32/93 (34%), Positives = 49/93 (52%), Gaps = 9/93 (9%)
Query: 96 RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG 155
RGL+Y+H +I+RDLK SN+ ++ K+ DFGLA+ +V+TR
Sbjct: 131 RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 182
Query: 156 YCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGR 187
Y APE D++S G ++ E+L+GR
Sbjct: 183 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 7e-06
Identities = 47/158 (29%), Positives = 77/158 (48%), Gaps = 20/158 (12%)
Query: 34 MLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAG 93
++S + H +L + G C G + ++V E++ G ++ L G+ P+ W ++ +A
Sbjct: 69 LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRK-EKGRVPVAW--KITVAQQ 125
Query: 94 AARGLEYLHDKAKPPVIYRDLKCSNILLDR-----GYHP--KLSDFGLAKLGPVGDNTHV 146
A L YL DK +++ ++ NILL R G P KLSD G++ + V
Sbjct: 126 LASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS-FTALSREERV 181
Query: 147 STRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEI 183
R+ + APE G L+ +D +SFG LLEI
Sbjct: 182 E-RI----PWIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 8e-06
Identities = 47/184 (25%), Positives = 76/184 (41%), Gaps = 21/184 (11%)
Query: 10 QDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVE 69
+ V IK R G E +L ++HP+++ L G L+ L +
Sbjct: 118 EHVVIKAGQRGGT------ATEAHILRAINHPSIIQLKGTFTYNKFTCLI-----LPRYK 166
Query: 70 DHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK- 128
L+ K+ + + I R ++YLH+ +I+RD+K NI ++ HP
Sbjct: 167 TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFIN---HPGD 220
Query: 129 --LSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG 186
L DFG A PV N + GT APE D++S G+VL E+ +
Sbjct: 221 VCLGDFGAACF-PVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATC 279
Query: 187 RKAV 190
++
Sbjct: 280 HDSL 283
|
Length = 391 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 9e-06
Identities = 41/137 (29%), Positives = 61/137 (44%), Gaps = 29/137 (21%)
Query: 12 VAIKQL----DRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGS 67
VA+K++ D GV + L E+ +L L H N+V L + LV+EY
Sbjct: 28 VALKRVRLDDDDEGVPSSA--LREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCD--- 82
Query: 68 VEDHLHDLSPGKKPLDWNTRMKIAAGAA--------RGLEYLHDKAKPPVIYRDLKCSNI 119
DL KK D + I +GL + H V++RDLK N+
Sbjct: 83 -----QDL---KKYFD-SCNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNL 130
Query: 120 LLDRGYHPKLSDFGLAK 136
L+++ KL+DFGLA+
Sbjct: 131 LINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 1e-05
Identities = 29/82 (35%), Positives = 45/82 (54%), Gaps = 6/82 (7%)
Query: 110 IYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT----- 164
++RD+K N+LLD H +L+DFG + L D T S+ +GT Y +PE +
Sbjct: 124 VHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGM 182
Query: 165 GQLTLKSDVYSFGVVLLEILSG 186
G+ + D +S GV + E+L G
Sbjct: 183 GKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 1e-05
Identities = 32/92 (34%), Positives = 49/92 (53%), Gaps = 5/92 (5%)
Query: 95 ARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST-RVMGT 153
A G+E+L K ++RDL N+L+ G K+ DFGLA+ + D+ ++S
Sbjct: 249 ANGMEFLASKN---CVHRDLAARNVLICEGKLVKICDFGLAR-DIMRDSNYISKGSTFLP 304
Query: 154 YGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 185
+ APE T SDV+SFG++L EI +
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 1e-05
Identities = 54/186 (29%), Positives = 88/186 (47%), Gaps = 21/186 (11%)
Query: 10 QDVAIKQLDR---NGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL-----VYE 61
Q+VAIK+L R N R + VLM L++H N++ L+ Q+ L VY
Sbjct: 42 QNVAIKKLSRPFQNVTHAKRAYRELVLM-KLVNHKNIIGLLN--VFTPQKSLEEFQDVYL 98
Query: 62 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL 121
M L ++ +L + + LD + G+++LH +I+RDLK SNI++
Sbjct: 99 VMEL--MDANLCQVI--QMDLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVV 151
Query: 122 DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLL 181
K+ DFGLA+ G + ++ V+ Y Y APE D++S G ++
Sbjct: 152 KSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMG 208
Query: 182 EILSGR 187
E++ G
Sbjct: 209 EMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 45.5 bits (107), Expect = 2e-05
Identities = 46/170 (27%), Positives = 79/170 (46%), Gaps = 10/170 (5%)
Query: 31 EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI 90
E +L L H N+V L + LV+EY+ + D PG + N ++ +
Sbjct: 53 EASLLKGLKHANIVLLHDIIHTKETLTLVFEYVHTDLCQ--YMDKHPGGLHPE-NVKLFL 109
Query: 91 AAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRV 150
RGL Y+H + +++RDLK N+L+ KL+DFGLA+ V +T+ + V
Sbjct: 110 FQ-LLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV 165
Query: 151 MGTYGYCAPE-YAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ 199
T Y P+ + + + D++ G + +E++ G A K +Q
Sbjct: 166 --TLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQ 213
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 2e-05
Identities = 45/158 (28%), Positives = 75/158 (47%), Gaps = 10/158 (6%)
Query: 31 EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI 90
EV +L L H N+V L LV+EY+ ++ +L D G N ++ +
Sbjct: 54 EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDC--GNSINMHNVKLFL 110
Query: 91 AAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRV 150
RGL Y H + V++RDLK N+L++ KL+DFGLA+ + T+ + V
Sbjct: 111 FQ-LLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV 166
Query: 151 MGTYGYCAPE-YAKTGQLTLKSDVYSFGVVLLEILSGR 187
T Y P+ + + + D++ G + E+ +GR
Sbjct: 167 --TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 3e-05
Identities = 32/114 (28%), Positives = 44/114 (38%), Gaps = 38/114 (33%)
Query: 110 IYRDLKCSNILLDRGYHPKLSDFGLAK-----------------LGPVGDNTHVSTR--- 149
I+RD+K N+LLD H KLSDFGL L +
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSK 182
Query: 150 ----------------VMGTYGYCAPE-YAKTGQLTLKSDVYSFGVVLLEILSG 186
+GT Y APE + +TG + D +S GV++ E+L G
Sbjct: 183 RKAETWKRNRRALAYSTVGTPDYIAPEVFLQTG-YNKECDWWSLGVIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 4e-05
Identities = 52/192 (27%), Positives = 88/192 (45%), Gaps = 29/192 (15%)
Query: 8 LLQDVAIKQLDR--NGVQGNREFLVEVLMLSLLHHPNLVNLIGY---CADGDQRLLVYEY 62
L Q VA+K+L R + R E+ +L + H N++ L+ + VY
Sbjct: 39 LRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLV 98
Query: 63 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD 122
L + L+++ +K D + + I RGL+Y+H +I+RDLK SN+ ++
Sbjct: 99 TNLMGAD--LNNIVKCQKLSDEHVQFLIYQ-LLRGLKYIHSAG---IIHRDLKPSNVAVN 152
Query: 123 RGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE-------YAKTGQLTLKSDVYS 175
++ DFGLA+ +V+TR Y APE Y +T D++S
Sbjct: 153 EDCELRILDFGLARQADDEMTGYVATR-----WYRAPEIMLNWMHYNQT------VDIWS 201
Query: 176 FGVVLLEILSGR 187
G ++ E+L G+
Sbjct: 202 VGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 4e-05
Identities = 42/169 (24%), Positives = 66/169 (39%), Gaps = 24/169 (14%)
Query: 31 EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI 90
E++ L HPN++ + + +V M GS ED L P P + I
Sbjct: 49 EIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLP-----ELAI 103
Query: 91 A---AGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA--------KLGP 139
A L+Y+H K I+R +K S+ILL LS + +
Sbjct: 104 AFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160
Query: 140 VGDNTHVSTRVMGTYGYCAPEYAKTGQL--TLKSDVYSFGVVLLEILSG 186
V D S + + + +PE + KSD+YS G+ E+ +G
Sbjct: 161 VHDFPKSSVKNLP---WLSPEVLQQNLQGYNEKSDIYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 4e-05
Identities = 42/154 (27%), Positives = 61/154 (39%), Gaps = 47/154 (30%)
Query: 98 LEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL----------------------- 134
+E +H K I+RD+K NIL+DR H KL+DFGL
Sbjct: 114 IESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDS 170
Query: 135 ------------AKLGPVGD-NTHVSTRVM-----GTYGYCAPE-YAKTGQLTLKSDVYS 175
+L P+ R + GT Y APE +TG L D +S
Sbjct: 171 MEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL-CDWWS 229
Query: 176 FGVVLLEILSGRKA-VDTSKAAAEQSLVAWARPL 208
GV+L E+L G+ + + A + ++ W L
Sbjct: 230 VGVILYEMLVGQPPFLADTPAETQLKVINWETTL 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 5e-05
Identities = 54/201 (26%), Positives = 95/201 (47%), Gaps = 43/201 (21%)
Query: 10 QDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIG-YCADGDQRL-LVYEYMPLGS 67
+D A+KQ++ G+ + E+ +L L HPN+++L + + D+++ L+++Y
Sbjct: 29 RDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE--- 83
Query: 68 VEDHLHDL----------SPGKKPLDWNTRM--KIAAGAARGLEYLHDKAKPPVIYRDLK 115
HDL KKP+ M + G+ YLH V++RDLK
Sbjct: 84 -----HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLK 135
Query: 116 CSNILL-----DRGYHPKLSDFGLAK-----LGPVGDNTHVSTRVMGTYGYCAPEYAKTG 165
+NIL+ +RG K++D G A+ L P+ D V+ T+ Y APE
Sbjct: 136 PANILVMGEGPERG-RVKIADMGFARLFNSPLKPLAD----LDPVVVTFWYRAPELLLGA 190
Query: 166 QLTLKS-DVYSFGVVLLEILS 185
+ K+ D+++ G + E+L+
Sbjct: 191 RHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 6e-05
Identities = 49/180 (27%), Positives = 81/180 (45%), Gaps = 14/180 (7%)
Query: 12 VAIKQLDRNGVQGNREF----LVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGS 67
VAIK+ + + N E L E+ ML L N+V L + LV+EY+
Sbjct: 29 VAIKKFKDS--EENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNM 86
Query: 68 VEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP 127
+E L + P P + K+ + + ++ +H K +++RD+K N+L+
Sbjct: 87 LE--LLEEMPNGVPPE-----KVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVL 139
Query: 128 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 187
KL DFG A+ G N + T + T Y +PE D++S G +L E+ G+
Sbjct: 140 KLCDFGFARNLSEGSNANY-TEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 7e-05
Identities = 18/26 (69%), Positives = 22/26 (84%)
Query: 110 IYRDLKCSNILLDRGYHPKLSDFGLA 135
I+RD+K NIL+DRG H KLSDFGL+
Sbjct: 123 IHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 1e-04
Identities = 31/99 (31%), Positives = 49/99 (49%), Gaps = 21/99 (21%)
Query: 96 RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG 155
GL+Y+H +I+RDLK N+ ++ K+ DFGLA+ +V TR
Sbjct: 128 CGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----W 179
Query: 156 YCAPE-------YAKTGQLTLKSDVYSFGVVLLEILSGR 187
Y APE Y +T D++S G ++ E+L+G+
Sbjct: 180 YRAPEVILNWMHYNQT------VDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 1e-04
Identities = 46/167 (27%), Positives = 71/167 (42%), Gaps = 18/167 (10%)
Query: 31 EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI 90
EV++ HPN++ G ++ +M GS L P + + I
Sbjct: 49 EVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFP--EGMSEALIGNI 106
Query: 91 AAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSD----FGLAKLGP----VGD 142
GA RGL YLH I+R++K S+IL+ LS + L + G V D
Sbjct: 107 LFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYD 163
Query: 143 NTHVSTRVMGTYGYCAPEYAKTG--QLTLKSDVYSFGVVLLEILSGR 187
ST V+ + +PE + +KSD+YS G+ E+ +GR
Sbjct: 164 FPQFSTSVLP---WLSPELLRQDLYGYNVKSDIYSVGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 1e-04
Identities = 30/93 (32%), Positives = 48/93 (51%), Gaps = 9/93 (9%)
Query: 96 RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG 155
+GL+Y+H +I+RDLK N+ ++ K+ DFGLA+ +V TR
Sbjct: 129 KGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR-----W 180
Query: 156 YCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGR 187
Y APE T D++S G ++ E+L+G+
Sbjct: 181 YRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 42.2 bits (100), Expect = 2e-04
Identities = 47/164 (28%), Positives = 67/164 (40%), Gaps = 23/164 (14%)
Query: 27 EFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNT 86
E +V LM +PN + L +L+ +Y+ G L DL + L
Sbjct: 58 EPMVHQLMK---DNPNFIKLYYSVTTLKGHVLIMDYIKDGD----LFDLLKKEGKLSEAE 110
Query: 87 RMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG-YHPKLSDFGLAKLGPVGDNTH 145
KI L LH K +I+ D+K N+L DR L D+GL K
Sbjct: 111 VKKIIRQLVEALNDLH-KHN--IIHNDIKLENVLYDRAKDRIYLCDYGLCK--------I 159
Query: 146 VSTRVM--GTYGYCAPEYAKTGQLTLKS-DVYSFGVVLLEILSG 186
+ T GT Y +PE K G S D ++ GV+ E+L+G
Sbjct: 160 IGTPSCYDGTLDYFSPEKIK-GHNYDVSFDWWAVGVLTYELLTG 202
|
Length = 267 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 2e-04
Identities = 50/195 (25%), Positives = 89/195 (45%), Gaps = 35/195 (17%)
Query: 8 LLQDVAIKQLDR---NGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMP 64
L ++VAIK+L R N R + E++++ ++H N++ L+ + P
Sbjct: 48 LERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNV------------FTP 94
Query: 65 LGSVEDHLHDLSPGKKPLDWN-----------TRMK-IAAGAARGLEYLHDKAKPPVIYR 112
S+E+ D+ + +D N RM + G+++LH +I+R
Sbjct: 95 QKSLEE-FQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHR 150
Query: 113 DLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSD 172
DLK SNI++ K+ DFGLA+ G + ++ V+ Y Y APE D
Sbjct: 151 DLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-YRAPEVILGMGYKENVD 207
Query: 173 VYSFGVVLLEILSGR 187
++S G ++ E++ G
Sbjct: 208 IWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 2e-04
Identities = 49/191 (25%), Positives = 87/191 (45%), Gaps = 35/191 (18%)
Query: 11 DVAIKQLDR---NGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGS 67
+VA+K+L R N R + E+++L ++H N+++L+ + P S
Sbjct: 48 NVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNIISLLNV------------FTPQKS 94
Query: 68 VEDHLHDLSPGKKPLDWN-----------TRMK-IAAGAARGLEYLHDKAKPPVIYRDLK 115
+E+ D+ + +D N RM + G+++LH +I+RDLK
Sbjct: 95 LEE-FQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLK 150
Query: 116 CSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYS 175
SNI++ K+ DFGLA+ N ++ V+ Y Y APE D++S
Sbjct: 151 PSNIVVKSDCTLKILDFGLARTACT--NFMMTPYVVTRY-YRAPEVILGMGYKENVDIWS 207
Query: 176 FGVVLLEILSG 186
G ++ E++ G
Sbjct: 208 VGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 2e-04
Identities = 53/201 (26%), Positives = 94/201 (46%), Gaps = 43/201 (21%)
Query: 10 QDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIG-YCADGDQRL-LVYEYMPLGS 67
++ A+KQ++ G+ + E+ +L L HPN++ L + + D+++ L+++Y
Sbjct: 29 KEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE--- 83
Query: 68 VEDHLHDL----------SPGKKPLDWNTRM--KIAAGAARGLEYLHDKAKPPVIYRDLK 115
HDL KKP+ M + G+ YLH V++RDLK
Sbjct: 84 -----HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLK 135
Query: 116 CSNILL-----DRGYHPKLSDFGLAK-----LGPVGDNTHVSTRVMGTYGYCAPEYAKTG 165
+NIL+ +RG K++D G A+ L P+ D V+ T+ Y APE
Sbjct: 136 PANILVMGEGPERG-RVKIADMGFARLFNSPLKPLAD----LDPVVVTFWYRAPELLLGA 190
Query: 166 QLTLKS-DVYSFGVVLLEILS 185
+ K+ D+++ G + E+L+
Sbjct: 191 RHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 3e-04
Identities = 45/186 (24%), Positives = 80/186 (43%), Gaps = 28/186 (15%)
Query: 27 EFLVEVLMLSLLHHPNLVNLIG-YCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDW 84
+ ++EV ++ L H N+V I + +Q+L ++ E+ G + ++ ++
Sbjct: 58 QLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEE 117
Query: 85 NTRMKIAAGAARGLEYLHDKAKPP----VIYRDLKCSNILLDRGYH-------------- 126
+ + I L Y H+ P V++RDLK NI L G
Sbjct: 118 HAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNG 177
Query: 127 ---PKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA--KTGQLTLKSDVYSFGVVLL 181
K+ DFGL+K + H +GT Y +PE +T KSD+++ G ++
Sbjct: 178 RPIAKIGDFGLSKNIGIESMAH---SCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIY 234
Query: 182 EILSGR 187
E+ SG+
Sbjct: 235 ELCSGK 240
|
Length = 1021 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 3e-04
Identities = 55/206 (26%), Positives = 96/206 (46%), Gaps = 27/206 (13%)
Query: 8 LLQDVAIKQLDR---NGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL-----V 59
L ++VAIK+L R N R + E++++ ++H N+++L+ Q+ L V
Sbjct: 41 LDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFTP--QKSLEEFQDV 97
Query: 60 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNI 119
Y M L ++ +L + + LD + G+++LH +I+RDLK SNI
Sbjct: 98 YLVMEL--MDANLCQVI--QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNI 150
Query: 120 LLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVV 179
++ K+ DFGLA+ G + ++ V+ Y Y APE D++S G +
Sbjct: 151 VVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCI 207
Query: 180 LLEILS------GRKAVDTSKAAAEQ 199
+ E++ GR +D EQ
Sbjct: 208 MGEMVRHKILFPGRDYIDQWNKVIEQ 233
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 38.2 bits (89), Expect = 0.001
Identities = 29/131 (22%), Positives = 44/131 (33%), Gaps = 15/131 (11%)
Query: 11 DVAIKQLDRNGVQGNREFLVEVLMLSLLH-HPNLV-NLIGYCADGDQRLLVYEYMPLGSV 68
D +K +RE EV +L LL V ++ L+ E++ G
Sbjct: 23 DYVLKINPSREKGADRER--EVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIE-GET 79
Query: 69 EDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK 128
D + + A L LH + + DL NIL+D G
Sbjct: 80 LDEVSEEEKEDIAEQ----------LAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILG 129
Query: 129 LSDFGLAKLGP 139
+ D+ A GP
Sbjct: 130 IIDWEYAGYGP 140
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.002
Identities = 46/195 (23%), Positives = 80/195 (41%), Gaps = 30/195 (15%)
Query: 12 VAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL-------------- 57
VA+K++ Q + L E+ ++ L H N+V + L
Sbjct: 33 VAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVY 92
Query: 58 LVYEYMP--LGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLK 115
+V EYM L +V + PL RGL+Y+H V++RDLK
Sbjct: 93 IVQEYMETDLANVLEQ--------GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLK 141
Query: 116 CSNILLD-RGYHPKLSDFGLAK-LGPVGDNTHVSTRVMGTYGYCAPEYA-KTGQLTLKSD 172
+N+ ++ K+ DFGLA+ + P + + + T Y +P T D
Sbjct: 142 PANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAID 201
Query: 173 VYSFGVVLLEILSGR 187
+++ G + E+L+G+
Sbjct: 202 MWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.002
Identities = 39/135 (28%), Positives = 60/135 (44%), Gaps = 15/135 (11%)
Query: 58 LVYEYMP--LGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLK 115
LV+EY+ L D + PG+ PL T +G+ + H K V++RDLK
Sbjct: 83 LVFEYLDSDLKKFMD-SNGRGPGR-PLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLK 137
Query: 116 CSNILLDR-GYHPKLSDFGLAKLG--PVGDNTHVSTRVMGTYGYCAPEYAKTG-QLTLKS 171
N+L+D+ K++D GL + PV TH + T Y APE +
Sbjct: 138 PQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTH----EIVTLWYRAPEVLLGSTHYSTPV 193
Query: 172 DVYSFGVVLLEILSG 186
D++S G + E+
Sbjct: 194 DIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 38.7 bits (90), Expect = 0.003
Identities = 23/57 (40%), Positives = 32/57 (56%), Gaps = 2/57 (3%)
Query: 12 VAIKQLDRNGVQGNREFLV-EVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPLG 66
VA+K L + RE L+ E+ +LS L H N+VNL+G C G L++ EY G
Sbjct: 71 VAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYG 127
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.003
Identities = 36/145 (24%), Positives = 55/145 (37%), Gaps = 46/145 (31%)
Query: 110 IYRDLKCSNILLDRGYHPKLSDFGL---------AKLGPVGDNTH--------------- 145
I+RD+K NIL+DR H KL+DFGL +K GD+
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182
Query: 146 ---------------------VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEIL 184
++ ++GT Y APE T D +S GV+L E+L
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242
Query: 185 SGRKA-VDTSKAAAEQSLVAWARPL 208
G+ + + + ++ W L
Sbjct: 243 VGQPPFLAQTPLETQMKVINWQTSL 267
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 38.1 bits (88), Expect = 0.004
Identities = 34/111 (30%), Positives = 46/111 (41%), Gaps = 35/111 (31%)
Query: 110 IYRDLKCSNILLDRGYHPKLSDFGLA---------------KLGPVGD------------ 142
I+RD+K N+LLD H KLSDFGL P D
Sbjct: 123 IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKA 182
Query: 143 ------NTHVSTRVMGTYGYCAPE-YAKTGQLTLKSDVYSFGVVLLEILSG 186
++ +GT Y APE + +TG L D +S GV++ E+L G
Sbjct: 183 ETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKL-CDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 311 | |||
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.98 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.98 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.95 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.91 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.91 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.89 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.87 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.86 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.86 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.84 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.83 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.82 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.82 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.82 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.82 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.81 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.79 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.79 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.78 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.77 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.75 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.72 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.67 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.66 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.64 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.64 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.63 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.61 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.6 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.58 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.57 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.55 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.5 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.44 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.38 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.34 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.28 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.22 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.19 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.19 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.17 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.12 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.12 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.08 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.08 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.06 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.05 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.03 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.03 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.92 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.76 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.75 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.6 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.5 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.32 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.3 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.23 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.22 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.18 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.17 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.14 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.06 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.96 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.87 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.69 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.68 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.61 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.54 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.41 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.22 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.16 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.15 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 97.1 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.01 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.96 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.84 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.83 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.79 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.77 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.74 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.73 | |
| PLN02236 | 344 | choline kinase | 96.69 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.63 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 96.56 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.46 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.43 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.22 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.17 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.14 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 95.82 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.77 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.75 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.36 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.0 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 95.0 | |
| PF04655 | 253 | APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r | 94.17 | |
| PTZ00384 | 383 | choline kinase; Provisional | 94.06 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 93.82 |
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-48 Score=325.79 Aligned_cols=232 Identities=26% Similarity=0.348 Sum_probs=189.6
Q ss_pred cCCcEEEEEEeecCCCcc-------hhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCC
Q 021490 7 CLLQDVAIKQLDRNGVQG-------NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGK 79 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~ 79 (311)
.+|+.||||++++..... ...+.+|+++|++|+|||||+++++|...+..||||||++||+|.+++.. +
T Consensus 195 ~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~YmVlE~v~GGeLfd~vv~----n 270 (475)
T KOG0615|consen 195 KTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSYMVLEYVEGGELFDKVVA----N 270 (475)
T ss_pred ccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceEEEEEEecCccHHHHHHh----c
Confidence 479999999998864433 22456999999999999999999999999999999999999999999987 7
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCC---CceEEccccccccCCCCCCceeeeeccccccc
Q 021490 80 KPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG---YHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY 156 (311)
Q Consensus 80 ~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~---~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y 156 (311)
+.+.+.....+++|++.|+.|||++| |+||||||+|||++.+ ..+||+|||++.... .........||+.|
T Consensus 271 k~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g---~~sfm~TlCGTpsY 344 (475)
T KOG0615|consen 271 KYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFGLAKVSG---EGSFMKTLCGTPSY 344 (475)
T ss_pred cccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccchhhccc---cceehhhhcCCccc
Confidence 88999999999999999999999999 9999999999999866 678999999998532 44555667899999
Q ss_pred cCccccccCCC---ccccceeehhHHHHHHHhCCCccCcchhHH-HHHHHHHhhhhhccccccccccCccccCCCChHhH
Q 021490 157 CAPEYAKTGQL---TLKSDVYSFGVVLLEILSGRKAVDTSKAAA-EQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGF 232 (311)
Q Consensus 157 ~aPE~~~~~~~---~~~~DiwslG~l~~~ll~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (311)
.|||++.+... ..++|+||+||++|-+++|.+||....... ...-+..+ ... +......+.+
T Consensus 345 vAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G----------~y~----f~p~~w~~Is 410 (475)
T KOG0615|consen 345 VAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKG----------RYA----FGPLQWDRIS 410 (475)
T ss_pred cChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcC----------ccc----ccChhhhhhh
Confidence 99999987544 347899999999999999999997654322 11111000 000 1112234567
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 021490 233 YQALAVAAMCVHEQPDMRPVIADVVTALAY 262 (311)
Q Consensus 233 ~~l~~li~~~l~~~p~~Rps~~~vl~~l~~ 262 (311)
++..+||.+||..||+.|||+.|+++..+.
T Consensus 411 eea~dlI~~mL~VdP~~R~s~~eaL~hpW~ 440 (475)
T KOG0615|consen 411 EEALDLINWMLVVDPENRPSADEALNHPWF 440 (475)
T ss_pred HHHHHHHHHhhEeCcccCcCHHHHhcChhh
Confidence 799999999999999999999999988653
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-47 Score=334.16 Aligned_cols=235 Identities=24% Similarity=0.358 Sum_probs=203.3
Q ss_pred Ccchhc-cCCcEEEEEEeecCC---CcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccC
Q 021490 1 MMQVIL-CLLQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLS 76 (311)
Q Consensus 1 ~~~~~~-~~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 76 (311)
||++.. ..|..||+|++.+.. ....+.+.+|+++.+.|+|||||+++++|++.++.|||.|+|..++|..+++.
T Consensus 34 cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLELC~~~sL~el~Kr-- 111 (592)
T KOG0575|consen 34 CYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLELCHRGSLMELLKR-- 111 (592)
T ss_pred EEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEecCCccHHHHHHh--
Confidence 466666 789999999998753 34457888999999999999999999999999999999999999999999986
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccc
Q 021490 77 PGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY 156 (311)
Q Consensus 77 ~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y 156 (311)
.+.+++.++..+++||+.||.|||+.+ |+|||||..|+|++++.+|||+|||++.... ...+......||+.|
T Consensus 112 --rk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le--~~~Erk~TlCGTPNY 184 (592)
T KOG0575|consen 112 --RKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLE--YDGERKKTLCGTPNY 184 (592)
T ss_pred --cCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeec--CcccccceecCCCcc
Confidence 789999999999999999999999999 9999999999999999999999999997643 222334456799999
Q ss_pred cCccccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHH
Q 021490 157 CAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQAL 236 (311)
Q Consensus 157 ~aPE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 236 (311)
+|||++.....+..+||||+||++|.||.|++||+.....+....+..... .+|...+.+..
T Consensus 185 IAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y------------------~~P~~ls~~A~ 246 (592)
T KOG0575|consen 185 IAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEY------------------SMPSHLSAEAK 246 (592)
T ss_pred cChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCc------------------ccccccCHHHH
Confidence 999999999999999999999999999999999999877666554432211 12334556889
Q ss_pred HHHHHccccCCCCCCCHHHHHHHHHH
Q 021490 237 AVAAMCVHEQPDMRPVIADVVTALAY 262 (311)
Q Consensus 237 ~li~~~l~~~p~~Rps~~~vl~~l~~ 262 (311)
+||.++|+.||.+|||+.+|+..--+
T Consensus 247 dLI~~lL~~~P~~Rpsl~~vL~h~Ff 272 (592)
T KOG0575|consen 247 DLIRKLLRPNPSERPSLDEVLDHPFF 272 (592)
T ss_pred HHHHHHhcCCcccCCCHHHHhcCHhh
Confidence 99999999999999999999987443
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-47 Score=317.67 Aligned_cols=235 Identities=25% Similarity=0.330 Sum_probs=192.6
Q ss_pred CCcEEEEEEeecCC-CcchhHHHHHHHHHhcCCCCcccceeeEeeeCC-eeEEEEecCCCCChhhhhcccCCCCCCCCHH
Q 021490 8 LLQDVAIKQLDRNG-VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD-QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN 85 (311)
Q Consensus 8 ~g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~ 85 (311)
+++-+|+|++..+. ....+++.+|+++++..+|||||.+|++|..+. ..+++||||+||+|++.+.. .+.+++.
T Consensus 103 t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgGSLd~~~k~----~g~i~E~ 178 (364)
T KOG0581|consen 103 TGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGGSLDDILKR----VGRIPEP 178 (364)
T ss_pred CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCCCHHHHHhh----cCCCCHH
Confidence 57889999995553 345579999999999999999999999999988 59999999999999999987 5789999
Q ss_pred HHHHHHHHHHHHHHHhhc-CCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccccc
Q 021490 86 TRMKIAAGAARGLEYLHD-KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT 164 (311)
Q Consensus 86 ~~~~~~~~i~~~l~~lh~-~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 164 (311)
..-.++.+|++||.|||+ .+ |+||||||+|+|++..|.|||+|||.+...... ......||..|||||.+.+
T Consensus 179 ~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS----~a~tfvGT~~YMsPERi~g 251 (364)
T KOG0581|consen 179 VLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS----IANTFVGTSAYMSPERISG 251 (364)
T ss_pred HHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh----hcccccccccccChhhhcC
Confidence 999999999999999996 77 999999999999999999999999998753222 3455679999999999999
Q ss_pred CCCccccceeehhHHHHHHHhCCCccCcch--hHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHc
Q 021490 165 GQLTLKSDVYSFGVVLLEILSGRKAVDTSK--AAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMC 242 (311)
Q Consensus 165 ~~~~~~~DiwslG~l~~~ll~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 242 (311)
..|+.++||||||+.++|+.+|+.||.... ......+..+. ..+. .|.+... ..+.++.+++..|
T Consensus 252 ~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~I---v~~p-------pP~lP~~---~fS~ef~~FV~~C 318 (364)
T KOG0581|consen 252 ESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAI---VDEP-------PPRLPEG---EFSPEFRSFVSCC 318 (364)
T ss_pred CcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHH---hcCC-------CCCCCcc---cCCHHHHHHHHHH
Confidence 999999999999999999999999997751 11111111111 1110 1222111 2566899999999
Q ss_pred cccCCCCCCCHHHHHHHHHHhhhc
Q 021490 243 VHEQPDMRPVIADVVTALAYLASQ 266 (311)
Q Consensus 243 l~~~p~~Rps~~~vl~~l~~~~~~ 266 (311)
|++||.+|||+.++++.-......
T Consensus 319 L~Kdp~~R~s~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 319 LRKDPSERPSAKQLLQHPFIKKFE 342 (364)
T ss_pred hcCCcccCCCHHHHhcCHHHhhcc
Confidence 999999999999999886544433
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-46 Score=327.13 Aligned_cols=262 Identities=57% Similarity=0.936 Sum_probs=221.6
Q ss_pred CcchhccCCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCC-eeEEEEecCCCCChhhhhcccCCCC
Q 021490 1 MMQVILCLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD-QRLLVYEYMPLGSVEDHLHDLSPGK 79 (311)
Q Consensus 1 ~~~~~~~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~ 79 (311)
||+..+.+|..||||+++........+|.+|+.++.+++|||+++++|+|.+.+ +.+||+||+++|+|.+++......
T Consensus 91 VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~- 169 (361)
T KOG1187|consen 91 VYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE- 169 (361)
T ss_pred EEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCC-
Confidence 477788899999999886554331456999999999999999999999999988 599999999999999999874322
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCc
Q 021490 80 KPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 159 (311)
Q Consensus 80 ~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aP 159 (311)
.++|..+++|+.++|.||+|||....++|+|||||+.|||++++.+.||+|||++...+.. .........||..|++|
T Consensus 170 -~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~-~~~~~~~~~gt~gY~~P 247 (361)
T KOG1187|consen 170 -PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEG-DTSVSTTVMGTFGYLAP 247 (361)
T ss_pred -CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCcc-ccceeeecCCCCccCCh
Confidence 8999999999999999999999988788999999999999999999999999999654331 11111111789999999
Q ss_pred cccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCcccc-CCCCh-HhHHHHHH
Q 021490 160 EYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQ-GQYPP-RGFYQALA 237 (311)
Q Consensus 160 E~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~l~~ 237 (311)
|....+..+.++||||||+++.||++|+.+.+.........+..|..+.+.+. ....+.|+.+. ..++. .....+..
T Consensus 248 Ey~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~-~~~eiiD~~l~~~~~~~~~~~~~~~~ 326 (361)
T KOG1187|consen 248 EYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEG-KLREIVDPRLKEGEYPDEKEVKKLAE 326 (361)
T ss_pred hhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCc-chhheeCCCccCCCCChHHHHHHHHH
Confidence 99988999999999999999999999999988766555556888887777666 77788899987 66665 57778899
Q ss_pred HHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 021490 238 VAAMCVHEQPDMRPVIADVVTALAYLASQ 266 (311)
Q Consensus 238 li~~~l~~~p~~Rps~~~vl~~l~~~~~~ 266 (311)
+..+|++.+|.+||+|.+|++.|+.+...
T Consensus 327 ~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 327 LALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred HHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 99999999999999999999999655433
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-46 Score=325.35 Aligned_cols=233 Identities=31% Similarity=0.443 Sum_probs=200.8
Q ss_pred CcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHHHH
Q 021490 9 LQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRM 88 (311)
Q Consensus 9 g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~ 88 (311)
..+||+|.++.. .-..+.|.+|+.+|++|+|++||++++++..+..+||||||++.|+|.++|.. ..+..+...+.+
T Consensus 230 ~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~--~~~~~l~~~~Ll 306 (468)
T KOG0197|consen 230 STKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRT--REGGLLNLPQLL 306 (468)
T ss_pred CCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhh--cCCCccchHHHH
Confidence 349999999654 45668899999999999999999999999998899999999999999999987 346789999999
Q ss_pred HHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccCCCc
Q 021490 89 KIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLT 168 (311)
Q Consensus 89 ~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 168 (311)
.++.|||+|++||++++ +|||||.++||||++++.+||+|||+++.. ............-+..|.|||.+....++
T Consensus 307 ~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~-~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS 382 (468)
T KOG0197|consen 307 DFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLI-GDDEYTASEGGKFPIKWTAPEALNYGKFS 382 (468)
T ss_pred HHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEccccccccc-CCCceeecCCCCCCceecCHHHHhhCCcc
Confidence 99999999999999999 999999999999999999999999999942 23333445556678899999999999999
Q ss_pred cccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCC
Q 021490 169 LKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQP 247 (311)
Q Consensus 169 ~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p 247 (311)
.++||||||+++|||+| |+.||.+....+....+... .+-..|..++..+.+++..||+.+|
T Consensus 383 ~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~G-----------------yRlp~P~~CP~~vY~lM~~CW~~~P 445 (468)
T KOG0197|consen 383 SKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERG-----------------YRLPRPEGCPDEVYELMKSCWHEDP 445 (468)
T ss_pred cccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhcc-----------------CcCCCCCCCCHHHHHHHHHHhhCCc
Confidence 99999999999999999 99999888776655544332 2223455566799999999999999
Q ss_pred CCCCCHHHHHHHHHHhhh
Q 021490 248 DMRPVIADVVTALAYLAS 265 (311)
Q Consensus 248 ~~Rps~~~vl~~l~~~~~ 265 (311)
++|||++.+...|+.+..
T Consensus 446 ~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 446 EDRPTFETLREVLEDFFT 463 (468)
T ss_pred ccCCCHHHHHHHHHHhhh
Confidence 999999999999887654
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-45 Score=318.76 Aligned_cols=238 Identities=35% Similarity=0.517 Sum_probs=194.0
Q ss_pred CCcE-EEEEEeecCCCcc--hhHHHHHHHHHhcCCCCcccceeeEeeeCC-eeEEEEecCCCCChhhhhcccCCCCCCCC
Q 021490 8 LLQD-VAIKQLDRNGVQG--NREFLVEVLMLSLLHHPNLVNLIGYCADGD-QRLLVYEYMPLGSVEDHLHDLSPGKKPLD 83 (311)
Q Consensus 8 ~g~~-vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~l~ 83 (311)
.|+. ||+|++....... .+.|.+|+.+|..++|||||.+++++.+.. .+++||||+++|+|.+++... ....++
T Consensus 63 ~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~--~~~~l~ 140 (362)
T KOG0192|consen 63 RGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKK--RKRKLP 140 (362)
T ss_pred CCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhc--ccCCCC
Confidence 3566 9999997654322 459999999999999999999999998887 799999999999999999874 357899
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCC-ceEEccccccccCCCCCCceeeeeccccccccCcccc
Q 021490 84 WNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY-HPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 162 (311)
Q Consensus 84 ~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 162 (311)
+..++.|+.||+.|+.|||+++. |+|||||++|||++.++ ++||+|||+++...... .......||+.|||||++
T Consensus 141 ~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~~~~~~~GT~~wMAPEv~ 216 (362)
T KOG0192|consen 141 LKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--TSMTSVAGTYRWMAPEVL 216 (362)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc--ccccCCCCCccccChhhh
Confidence 99999999999999999999873 89999999999999998 99999999997533221 223335799999999999
Q ss_pred c--cCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHH
Q 021490 163 K--TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAA 240 (311)
Q Consensus 163 ~--~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 240 (311)
. ...++.++||||||+++|||+||..||...........+. .. ..+..++......+..|+.
T Consensus 217 ~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~-----~~-----------~~Rp~~p~~~~~~l~~l~~ 280 (362)
T KOG0192|consen 217 RGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVV-----VG-----------GLRPPIPKECPPHLSSLME 280 (362)
T ss_pred cCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHH-----hc-----------CCCCCCCccCCHHHHHHHH
Confidence 9 6699999999999999999999999998876522211110 00 0111122224458888999
Q ss_pred HccccCCCCCCCHHHHHHHHHHhhhcc
Q 021490 241 MCVHEQPDMRPVIADVVTALAYLASQK 267 (311)
Q Consensus 241 ~~l~~~p~~Rps~~~vl~~l~~~~~~~ 267 (311)
.||..||..||++.+++..|+.+....
T Consensus 281 ~CW~~dp~~RP~f~ei~~~l~~~~~~~ 307 (362)
T KOG0192|consen 281 RCWLVDPSRRPSFLEIVSRLESIMSHI 307 (362)
T ss_pred HhCCCCCCcCCCHHHHHHHHHHHHHhh
Confidence 999999999999999999999877543
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-45 Score=309.99 Aligned_cols=225 Identities=27% Similarity=0.359 Sum_probs=182.7
Q ss_pred CCcEEEEEEeecC--CCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHH
Q 021490 8 LLQDVAIKQLDRN--GVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN 85 (311)
Q Consensus 8 ~g~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~ 85 (311)
+|..||||.+.+. .....+.+..|+.+|+.++|||||.+++++..++.+|||||||+||+|.++++. .+.+++.
T Consensus 34 ~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGDLs~yi~~----~~~l~e~ 109 (429)
T KOG0595|consen 34 SGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGDLSDYIRR----RGRLPEA 109 (429)
T ss_pred CCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCCCHHHHHHH----cCCCCHH
Confidence 6899999999877 456667889999999999999999999999999999999999999999999998 6789999
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCC------CceEEccccccccCCCCCCceeeeeccccccccCc
Q 021490 86 TRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG------YHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 159 (311)
Q Consensus 86 ~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~------~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aP 159 (311)
++..++.||+.||++||+++ |+||||||+|||++.. ..+||+|||+++... .........|++-||||
T Consensus 110 t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~---~~~~a~tlcGSplYMAP 183 (429)
T KOG0595|consen 110 TARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ---PGSMAETLCGSPLYMAP 183 (429)
T ss_pred HHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhhhCC---chhHHHHhhCCccccCH
Confidence 99999999999999999999 9999999999999864 468999999998654 33334456799999999
Q ss_pred cccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHH
Q 021490 160 EYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVA 239 (311)
Q Consensus 160 E~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 239 (311)
|++....|+.++|+||+|+++|+|++|..||+.....+-...+.... ......+...+..+.+|+
T Consensus 184 EV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~---------------~~~~~~~~~~s~~~~~Ll 248 (429)
T KOG0595|consen 184 EVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGN---------------EIVPVLPAELSNPLRELL 248 (429)
T ss_pred HHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccc---------------cccCchhhhccCchhhhh
Confidence 99999999999999999999999999999998766544433221111 111112222233445566
Q ss_pred HHccccCCCCCCCHHHHH
Q 021490 240 AMCVHEQPDMRPVIADVV 257 (311)
Q Consensus 240 ~~~l~~~p~~Rps~~~vl 257 (311)
...++.+|.+|-++.+-.
T Consensus 249 ~~ll~~~~~~~~~~~~~~ 266 (429)
T KOG0595|consen 249 ISLLQRNPKDRISFEDFF 266 (429)
T ss_pred hHHHhcCccccCchHHhh
Confidence 667777777776665543
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=309.24 Aligned_cols=235 Identities=26% Similarity=0.313 Sum_probs=192.2
Q ss_pred CCcEEEEEEeecCCCc---chhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCH
Q 021490 8 LLQDVAIKQLDRNGVQ---GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 84 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~ 84 (311)
.|+-+|+|++++.... .....+.|..+|..++||+||+++..|++.+.+|+|+||+.||.|..+|++ .+.+++
T Consensus 49 t~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~GGeLf~hL~~----eg~F~E 124 (357)
T KOG0598|consen 49 TGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLNGGELFYHLQR----EGRFSE 124 (357)
T ss_pred cCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccCCccHHHHHHh----cCCcch
Confidence 5889999999887543 346788899999999999999999999999999999999999999999997 788999
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccccc
Q 021490 85 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT 164 (311)
Q Consensus 85 ~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 164 (311)
..+..++.+|+.||.|||++| |+||||||+|||++.+|.++|+|||++...-.. ........||+.|||||++.+
T Consensus 125 ~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~--~~~t~tfcGT~eYmAPEil~~ 199 (357)
T KOG0598|consen 125 DRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD--GDATRTFCGTPEYMAPEILLG 199 (357)
T ss_pred hHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcccC--CCccccccCCccccChHHHhc
Confidence 999999999999999999999 999999999999999999999999999852221 122333679999999999999
Q ss_pred CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccc
Q 021490 165 GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVH 244 (311)
Q Consensus 165 ~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 244 (311)
..++.++|+||||+++|+|++|.+||...+.....+.+.... ....+.-.+.+..+++.++|+
T Consensus 200 ~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k-----------------~~~~p~~ls~~ardll~~LL~ 262 (357)
T KOG0598|consen 200 KGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK-----------------LPLPPGYLSEEARDLLKKLLK 262 (357)
T ss_pred CCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc-----------------CCCCCccCCHHHHHHHHHHhc
Confidence 999999999999999999999999999877654433332111 011122245588899999999
Q ss_pred cCCCCCC----CHHHHHHHHHHhhhccCC
Q 021490 245 EQPDMRP----VIADVVTALAYLASQKYE 269 (311)
Q Consensus 245 ~~p~~Rp----s~~~vl~~l~~~~~~~~~ 269 (311)
.||.+|. ++.++ +.-.++....++
T Consensus 263 rdp~~RLg~~~d~~~i-k~HpfF~~inW~ 290 (357)
T KOG0598|consen 263 RDPRQRLGGPGDAEEI-KRHPFFKGINWE 290 (357)
T ss_pred cCHHHhcCCCCChHHh-hcCcccccCCHH
Confidence 9999995 44443 333344444333
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-45 Score=296.29 Aligned_cols=243 Identities=26% Similarity=0.288 Sum_probs=194.6
Q ss_pred CCcEEEEEEeecCCC--cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHH
Q 021490 8 LLQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN 85 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~ 85 (311)
.|+-||||++..... .-.+-.++|+++|++|+|+|+|.++++|.....++||+|||+. ++.+-+... ..+++..
T Consensus 26 TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dh-TvL~eLe~~---p~G~~~~ 101 (396)
T KOG0593|consen 26 TGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDH-TVLHELERY---PNGVPSE 101 (396)
T ss_pred cccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecch-HHHHHHHhc---cCCCCHH
Confidence 599999999854322 2235788999999999999999999999999999999999985 444445543 5779999
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccccc-
Q 021490 86 TRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT- 164 (311)
Q Consensus 86 ~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~- 164 (311)
.+.+++.|++.|+.|+|+++ ++||||||+|||++.+|.+||||||.++.... .....+..+.|.+|.|||.+.+
T Consensus 102 ~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~--pgd~YTDYVATRWYRaPELLvGD 176 (396)
T KOG0593|consen 102 LVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA--PGDNYTDYVATRWYRAPELLVGD 176 (396)
T ss_pred HHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC--CcchhhhhhhhhhccChhhhccc
Confidence 99999999999999999999 99999999999999999999999999986432 4455666789999999998876
Q ss_pred CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHh--------hhhhccccccccccCccccCCCC-----hHh
Q 021490 165 GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWA--------RPLFQDRTRHSLIADPELQGQYP-----PRG 231 (311)
Q Consensus 165 ~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~-----~~~ 231 (311)
..|+..+||||+||++.||++|.+.|.+.+..+....+.-. +..|.....+....-|+....-+ +..
T Consensus 177 tqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~ 256 (396)
T KOG0593|consen 177 TQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKI 256 (396)
T ss_pred CcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccc
Confidence 78999999999999999999999999998877765443221 23333333333333333222111 334
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 021490 232 FYQALAVAAMCVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 232 ~~~l~~li~~~l~~~p~~Rps~~~vl~~ 259 (311)
+..++++++.||+.||++|+|-++++..
T Consensus 257 s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 257 SNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred hHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 5688999999999999999999999854
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=297.46 Aligned_cols=235 Identities=23% Similarity=0.304 Sum_probs=189.8
Q ss_pred cCCcEEEEEEeecCCC--cchhHHHHHHHHHhcCCCCcccceee-EeeeCC-eeEEEEecCCCCChhhhhcccCCCCCCC
Q 021490 7 CLLQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIG-YCADGD-QRLLVYEYMPLGSVEDHLHDLSPGKKPL 82 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~-~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~l 82 (311)
.+|..||.|.++-... ...++...|+.+|++|+|||||++++ .|.++. -++||||+|++|+|...++.....+..+
T Consensus 42 ~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~i 121 (375)
T KOG0591|consen 42 LDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLI 121 (375)
T ss_pred cCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhhcccCHHHHHHHHHhccccC
Confidence 4789999999864332 34468889999999999999999999 444444 4899999999999999999888888999
Q ss_pred CHHHHHHHHHHHHHHHHHhhcCC-CCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccc
Q 021490 83 DWNTRMKIAAGAARGLEYLHDKA-KPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 161 (311)
Q Consensus 83 ~~~~~~~~~~~i~~~l~~lh~~~-~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 161 (311)
++..+|+++.|++.||..+|++- .+.+.||||||.|||++.+|.|||+|||+++.... ........+||+.||+||+
T Consensus 122 pE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s--~~tfA~S~VGTPyYMSPE~ 199 (375)
T KOG0591|consen 122 PEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSS--KTTFAHSLVGTPYYMSPER 199 (375)
T ss_pred chHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcc--hhHHHHhhcCCCcccCHHH
Confidence 99999999999999999999831 12399999999999999999999999999986432 2333344689999999999
Q ss_pred cccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCC-hHhHHHHHHHHH
Q 021490 162 AKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYP-PRGFYQALAVAA 240 (311)
Q Consensus 162 ~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~ 240 (311)
+.+.+|+.++||||+||++|||+.-++||.+..-......+... .. ..+| ...+..+..|+.
T Consensus 200 i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qg--------d~---------~~~p~~~YS~~l~~li~ 262 (375)
T KOG0591|consen 200 IHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQG--------DY---------PPLPDEHYSTDLRELIN 262 (375)
T ss_pred HhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcC--------CC---------CCCcHHHhhhHHHHHHH
Confidence 99999999999999999999999999999987543333222211 00 1122 345678999999
Q ss_pred HccccCCCCCCCHHHHHHHH
Q 021490 241 MCVHEQPDMRPVIADVVTAL 260 (311)
Q Consensus 241 ~~l~~~p~~Rps~~~vl~~l 260 (311)
.|+.+||..||+...++..+
T Consensus 263 ~ci~vd~~~RP~t~~~v~di 282 (375)
T KOG0591|consen 263 MCIAVDPEQRPDTVPYVQDI 282 (375)
T ss_pred HHccCCcccCCCcchHHHHH
Confidence 99999999999965555444
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=306.78 Aligned_cols=228 Identities=27% Similarity=0.341 Sum_probs=191.9
Q ss_pred CCcEEEEEEeecCCC---cchhHHHHHHHHHhcC-CCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCC
Q 021490 8 LLQDVAIKQLDRNGV---QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLD 83 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~ 83 (311)
.++.+|||++.+... ...+.+.+|-..|.+| .||.|++++..|.++..+|+|+||+++|+|.+++.. .+.|+
T Consensus 97 t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~nGdll~~i~K----~Gsfd 172 (604)
T KOG0592|consen 97 TGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYAPNGDLLDLIKK----YGSFD 172 (604)
T ss_pred CCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEecCCCcHHHHHHH----hCcch
Confidence 689999999977543 3345777899999999 799999999999999999999999999999999998 68899
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCc---------eee--eeccc
Q 021490 84 WNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT---------HVS--TRVMG 152 (311)
Q Consensus 84 ~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~---------~~~--~~~~~ 152 (311)
+..+..++.+|+.||+|||++| |+||||||+|||++++++++|+|||.+...+..... ... ...+|
T Consensus 173 e~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVG 249 (604)
T KOG0592|consen 173 ETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVG 249 (604)
T ss_pred HHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccCChhhccccCccCcccccCcccceee
Confidence 9999999999999999999999 999999999999999999999999999875432221 111 23679
Q ss_pred cccccCccccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhH
Q 021490 153 TYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGF 232 (311)
Q Consensus 153 ~~~y~aPE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (311)
|..|.+||++.+...+..+|+|+|||++|+|+.|.+||...+.--..+.+... + -.+++..+
T Consensus 250 TAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l--------------~----y~fp~~fp 311 (604)
T KOG0592|consen 250 TAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQAL--------------D----YEFPEGFP 311 (604)
T ss_pred eecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHh--------------c----ccCCCCCC
Confidence 99999999999999999999999999999999999999887653322222111 1 13344445
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHH
Q 021490 233 YQALAVAAMCVHEQPDMRPVIADVVTAL 260 (311)
Q Consensus 233 ~~l~~li~~~l~~~p~~Rps~~~vl~~l 260 (311)
+.+.+|+++.|..||.+|+|+.+|-+..
T Consensus 312 ~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 312 EDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred HHHHHHHHHHHccCccccccHHHHhhCc
Confidence 6889999999999999999998887664
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=307.65 Aligned_cols=229 Identities=26% Similarity=0.363 Sum_probs=195.4
Q ss_pred cCCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHH
Q 021490 7 CLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNT 86 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~ 86 (311)
..++.||||.+........+-+++|+.+|+.++|+|||++++.|..++.+++||||++||+|.+.+.. ..+++.+
T Consensus 296 ~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLTDvVt~-----~~~~E~q 370 (550)
T KOG0578|consen 296 STKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLTDVVTK-----TRMTEGQ 370 (550)
T ss_pred cCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchhhhhhc-----ccccHHH
Confidence 36788999999887777778899999999999999999999999999999999999999999999985 5699999
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccCC
Q 021490 87 RMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ 166 (311)
Q Consensus 87 ~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 166 (311)
+..++.+++.||+|||.++ |+|||||.+|||++.+|.+||+|||+|...... .......+||+.|||||+.....
T Consensus 371 IA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~--~~KR~TmVGTPYWMAPEVvtrk~ 445 (550)
T KOG0578|consen 371 IAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE--QSKRSTMVGTPYWMAPEVVTRKP 445 (550)
T ss_pred HHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccc--cCccccccCCCCccchhhhhhcc
Confidence 9999999999999999999 999999999999999999999999999764332 23455678999999999999999
Q ss_pred CccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccC
Q 021490 167 LTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQ 246 (311)
Q Consensus 167 ~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 246 (311)
|++++||||||++++||+.|.+||-.........++.. ... ..-..+...+..+.+++.+||..|
T Consensus 446 YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~-------ng~--------P~lk~~~klS~~~kdFL~~cL~~d 510 (550)
T KOG0578|consen 446 YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-------NGT--------PKLKNPEKLSPELKDFLDRCLVVD 510 (550)
T ss_pred cCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhh-------cCC--------CCcCCccccCHHHHHHHHHHhhcc
Confidence 99999999999999999999999976444333222211 111 111223445668899999999999
Q ss_pred CCCCCCHHHHHHHH
Q 021490 247 PDMRPVIADVVTAL 260 (311)
Q Consensus 247 p~~Rps~~~vl~~l 260 (311)
+.+|+|+.|+|+.-
T Consensus 511 v~~RasA~eLL~Hp 524 (550)
T KOG0578|consen 511 VEQRASAKELLEHP 524 (550)
T ss_pred hhcCCCHHHHhcCh
Confidence 99999999999774
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=320.54 Aligned_cols=240 Identities=30% Similarity=0.446 Sum_probs=206.8
Q ss_pred CCcEEEEEEeecCCCc-chhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCC--------
Q 021490 8 LLQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPG-------- 78 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-------- 78 (311)
+.+-||||.++..... .+.+|.+|+++|..|+|||||+++|++.+++.+|||+|||..|+|.+||....+.
T Consensus 515 ~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~ 594 (774)
T KOG1026|consen 515 DEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQ 594 (774)
T ss_pred cceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCC
Confidence 4588999999887655 6689999999999999999999999999999999999999999999999765211
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccc
Q 021490 79 --KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY 156 (311)
Q Consensus 79 --~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y 156 (311)
...|+..+.+.++.|||.|++||-++. +|||||..+|+||+++..|||+|||+++.....+..........+.+|
T Consensus 595 ~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRW 671 (774)
T KOG1026|consen 595 DTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRW 671 (774)
T ss_pred CCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeec
Confidence 234889999999999999999999999 999999999999999999999999999875555555555556678899
Q ss_pred cCccccccCCCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHH
Q 021490 157 CAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQA 235 (311)
Q Consensus 157 ~aPE~~~~~~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 235 (311)
||||.+..+.++.++|||||||++||+++ |..||.+....+....+....- -.+|...+.++
T Consensus 672 MppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~l-----------------L~~Pe~CP~~v 734 (774)
T KOG1026|consen 672 MPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQL-----------------LSCPENCPTEV 734 (774)
T ss_pred CCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCCc-----------------ccCCCCCCHHH
Confidence 99999999999999999999999999999 9999988877665554432211 24456667799
Q ss_pred HHHHHHccccCCCCCCCHHHHHHHHHHhhhcc
Q 021490 236 LAVAAMCVHEQPDMRPVIADVVTALAYLASQK 267 (311)
Q Consensus 236 ~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~~ 267 (311)
.+|+..||+.+|++||++.||-.+|+......
T Consensus 735 Y~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 735 YSLMLECWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred HHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 99999999999999999999999998776543
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=302.72 Aligned_cols=247 Identities=23% Similarity=0.258 Sum_probs=194.5
Q ss_pred CCcEEEEEEeecCCCcchh-HHHHHHHHHhcCC-CCcccceeeEeeeCC-eeEEEEecCCCCChhhhhcccCCCCCCCCH
Q 021490 8 LLQDVAIKQLDRNGVQGNR-EFLVEVLMLSLLH-HPNLVNLIGYCADGD-QRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 84 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~~~~-~~~~e~~~l~~l~-h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~ 84 (311)
.|..||||.++.....+.+ .=.||+..|++|+ ||||+++.+++.+++ .+|+|||||+ .+|.++++.. +..|++
T Consensus 34 ~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~Md-~NLYqLmK~R---~r~fse 109 (538)
T KOG0661|consen 34 TGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFMD-CNLYQLMKDR---NRLFSE 109 (538)
T ss_pred CCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhhh-hhHHHHHhhc---CCcCCH
Confidence 5788999999877655444 2347999999998 999999999998888 9999999996 7999999873 688999
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccc-c
Q 021490 85 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA-K 163 (311)
Q Consensus 85 ~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~ 163 (311)
..+..|+.||+.||+|+|.+| +.|||+||+|||+..+..+||+|||+++... .....+..+.|.+|.|||++ +
T Consensus 110 ~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~---SkpPYTeYVSTRWYRAPEvLLr 183 (538)
T KOG0661|consen 110 SDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVR---SKPPYTEYVSTRWYRAPEVLLR 183 (538)
T ss_pred HHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccc---cCCCcchhhhcccccchHHhhh
Confidence 999999999999999999999 9999999999999988899999999998543 33445566789999999977 4
Q ss_pred cCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhh-hhcccccc-------ccccCccc----cCCCChHh
Q 021490 164 TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARP-LFQDRTRH-------SLIADPEL----QGQYPPRG 231 (311)
Q Consensus 164 ~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~-------~~~~~~~~----~~~~~~~~ 231 (311)
...|+.+.|+||+|||++|+.+-++.|.+.+..+....+-.+.. .-.+.... ..+.-|.. ....-+..
T Consensus 184 s~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~ 263 (538)
T KOG0661|consen 184 SGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNA 263 (538)
T ss_pred ccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCccc
Confidence 57889999999999999999999999999887766543322211 00000000 00011111 01112336
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHHHhh
Q 021490 232 FYQALAVAAMCVHEQPDMRPVIADVVTALAYLA 264 (311)
Q Consensus 232 ~~~l~~li~~~l~~~p~~Rps~~~vl~~l~~~~ 264 (311)
+.++.++|..||++||++|||+.++++..-+-.
T Consensus 264 s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~ 296 (538)
T KOG0661|consen 264 SSEAASLIERLLAWDPDKRPTASQALQHPFFQV 296 (538)
T ss_pred CHHHHHHHHHHhcCCCccCccHHHHhcCccccc
Confidence 678999999999999999999999998864433
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=294.72 Aligned_cols=230 Identities=20% Similarity=0.317 Sum_probs=186.3
Q ss_pred CCcEEEEEEeecCCCcc---hhHHHHHHHHHhcCCCCcccceeeEeee----CCeeEEEEecCCCCChhhhhcccCCCCC
Q 021490 8 LLQDVAIKQLDRNGVQG---NREFLVEVLMLSLLHHPNLVNLIGYCAD----GDQRLLVYEYMPLGSVEDHLHDLSPGKK 80 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 80 (311)
+|+.||||.++...... .+.|.+|+.+|.+++||||+++++++.+ ....++||||+++|+|.+++.. ..
T Consensus 42 ~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~----~~ 117 (283)
T PHA02988 42 NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDK----EK 117 (283)
T ss_pred CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHhh----CC
Confidence 68899999997654333 4678899999999999999999999876 3468999999999999999986 56
Q ss_pred CCCHHHHHHHHHHHHHHHHHhhcC-CCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCc
Q 021490 81 PLDWNTRMKIAAGAARGLEYLHDK-AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 159 (311)
Q Consensus 81 ~l~~~~~~~~~~~i~~~l~~lh~~-~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aP 159 (311)
.+++.....++.+++.||.|||+. + ++||||+|+||++++++.+||+|||++....... ....++..|+||
T Consensus 118 ~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aP 189 (283)
T PHA02988 118 DLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-----FKNVNFMVYFSY 189 (283)
T ss_pred CCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcccc-----ccccCcccccCH
Confidence 789999999999999999999985 7 8899999999999999999999999986432211 123577899999
Q ss_pred ccccc--CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHH
Q 021490 160 EYAKT--GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALA 237 (311)
Q Consensus 160 E~~~~--~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 237 (311)
|++.+ ..++.++|||||||++|+|++|..||...........+ ...... + ..+...+..+.+
T Consensus 190 E~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i------~~~~~~------~----~~~~~~~~~l~~ 253 (283)
T PHA02988 190 KMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLI------INKNNS------L----KLPLDCPLEIKC 253 (283)
T ss_pred HHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHH------HhcCCC------C----CCCCcCcHHHHH
Confidence 99876 67899999999999999999999999876543322211 000000 0 112233457889
Q ss_pred HHHHccccCCCCCCCHHHHHHHHHHhhh
Q 021490 238 VAAMCVHEQPDMRPVIADVVTALAYLAS 265 (311)
Q Consensus 238 li~~~l~~~p~~Rps~~~vl~~l~~~~~ 265 (311)
++.+||+.||++|||+.++++.|+++.+
T Consensus 254 li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 254 IVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred HHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999998764
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=272.94 Aligned_cols=248 Identities=25% Similarity=0.306 Sum_probs=196.7
Q ss_pred ccCCcEEEEEEeecCCCc-c-hhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCC
Q 021490 6 LCLLQDVAIKQLDRNGVQ-G-NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLD 83 (311)
Q Consensus 6 ~~~g~~vaiK~~~~~~~~-~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~ 83 (311)
...|+.||||+++..... . .....+|++.|+.++|+||+.++++|.+.+.+.||+||++ .+|+..+++ ....++
T Consensus 24 ~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~-tdLe~vIkd---~~i~l~ 99 (318)
T KOG0659|consen 24 TETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMP-TDLEVVIKD---KNIILS 99 (318)
T ss_pred cCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEecc-ccHHHHhcc---cccccC
Confidence 347999999999765432 2 3467899999999999999999999999999999999996 799999987 357899
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccc
Q 021490 84 WNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 163 (311)
Q Consensus 84 ~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 163 (311)
...+..|+.++++||+|||++. |+||||||.|+|++.+|.+||+|||+++........ ....+.|.+|.|||.+.
T Consensus 100 pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~--~~~~V~TRWYRAPELLf 174 (318)
T KOG0659|consen 100 PADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI--QTHQVVTRWYRAPELLF 174 (318)
T ss_pred HHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCCcc--cccceeeeeccChHHhc
Confidence 9999999999999999999999 999999999999999999999999999875443332 33336789999999887
Q ss_pred c-CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhh--hhccccccccccC---------ccccCCCChHh
Q 021490 164 T-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARP--LFQDRTRHSLIAD---------PELQGQYPPRG 231 (311)
Q Consensus 164 ~-~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~---------~~~~~~~~~~~ 231 (311)
+ ..|+..+|+||.||++.||+-|.+.|.+.+..+....+-.... ..........+.| +..+. .-+..
T Consensus 175 Gsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~-lf~aa 253 (318)
T KOG0659|consen 175 GSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNN-LFPAA 253 (318)
T ss_pred cchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCcccc-ccccc
Confidence 6 6899999999999999999999999988877766655432211 1111111111111 11222 22334
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 021490 232 FYQALAVAAMCVHEQPDMRPVIADVVTALAYL 263 (311)
Q Consensus 232 ~~~l~~li~~~l~~~p~~Rps~~~vl~~l~~~ 263 (311)
+..+++|+.+||.+||.+|+|+.|+++.-.+.
T Consensus 254 s~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~ 285 (318)
T KOG0659|consen 254 SSDALDLLSKMLTYNPKKRITASQALKHPYFK 285 (318)
T ss_pred cHHHHHHHHhhhccCchhcccHHHHhcchhhh
Confidence 55679999999999999999999999886543
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=300.40 Aligned_cols=230 Identities=27% Similarity=0.374 Sum_probs=189.4
Q ss_pred CCcEEEEEEeecC----CC-cchhHHHHHHHHHhcCC-CCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCC
Q 021490 8 LLQDVAIKQLDRN----GV-QGNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKP 81 (311)
Q Consensus 8 ~g~~vaiK~~~~~----~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 81 (311)
+|..||+|+++.. .. ...+.+.+|+.+++.++ ||||+++++++......|+|||||.||+|.+++.+ .++
T Consensus 41 t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy~~gGdL~~~i~~----~g~ 116 (370)
T KOG0583|consen 41 TGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVMEYCSGGDLFDYIVN----KGR 116 (370)
T ss_pred CCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEEecCCccHHHHHHH----cCC
Confidence 6799999987664 22 23456778999999998 99999999999999999999999999999999997 688
Q ss_pred CCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCC-CceEEccccccccCCCCCCceeeeeccccccccCcc
Q 021490 82 LDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG-YHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 160 (311)
Q Consensus 82 l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE 160 (311)
+.+..+..++.|+++|++|+|+.| |+||||||+|++++.+ +++||+|||++.... ..........|++.|+|||
T Consensus 117 l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~--~~~~~l~t~cGsp~Y~aPE 191 (370)
T KOG0583|consen 117 LKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLSAISP--GEDGLLKTFCGSPAYAAPE 191 (370)
T ss_pred CChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccccccC--CCCCcccCCCCCcccCCHH
Confidence 999999999999999999999999 9999999999999999 999999999998642 2233445567999999999
Q ss_pred ccccCC-Cc-cccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHh-HHHHHH
Q 021490 161 YAKTGQ-LT-LKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRG-FYQALA 237 (311)
Q Consensus 161 ~~~~~~-~~-~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~ 237 (311)
++.+.. |+ .++||||+|+++|.|++|..||+..........+ .... -.+|... +.++.+
T Consensus 192 vl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki------~~~~------------~~~p~~~~S~~~~~ 253 (370)
T KOG0583|consen 192 VLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKI------RKGE------------FKIPSYLLSPEARS 253 (370)
T ss_pred HhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHH------hcCC------------ccCCCCcCCHHHHH
Confidence 999877 75 7899999999999999999999985443322211 1110 0122222 568899
Q ss_pred HHHHccccCCCCCCCHHHHHHHHHHhhh
Q 021490 238 VAAMCVHEQPDMRPVIADVVTALAYLAS 265 (311)
Q Consensus 238 li~~~l~~~p~~Rps~~~vl~~l~~~~~ 265 (311)
|+.+||..||.+|+|+.+++.. .++..
T Consensus 254 Li~~mL~~~P~~R~t~~~i~~h-~w~~~ 280 (370)
T KOG0583|consen 254 LIEKMLVPDPSTRITLLEILEH-PWFQK 280 (370)
T ss_pred HHHHHcCCCcccCCCHHHHhhC-hhhcc
Confidence 9999999999999999999944 44443
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=305.79 Aligned_cols=228 Identities=25% Similarity=0.333 Sum_probs=192.8
Q ss_pred CCcEEEEEEeecCCCcc---hhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCH
Q 021490 8 LLQDVAIKQLDRNGVQG---NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 84 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~ 84 (311)
.|+.+|||++.+..... ...+.+|+-+|+.+.|||++.+|++++++.++|+|.||++||.|++++.. .+++++
T Consensus 36 TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~gGELFdylv~----kG~l~e 111 (786)
T KOG0588|consen 36 TGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVPGGELFDYLVR----KGPLPE 111 (786)
T ss_pred ccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecCCchhHHHHHh----hCCCCC
Confidence 58999999997764322 34677899999999999999999999999999999999999999999987 789999
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccccc
Q 021490 85 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT 164 (311)
Q Consensus 85 ~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 164 (311)
.++..++.||+.|+.|+|..+ ||||||||+|+|++..+.|||+|||.+..-. +.......+|.++|.+||++.+
T Consensus 112 ~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~---~gklLeTSCGSPHYA~PEIV~G 185 (786)
T KOG0588|consen 112 REAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEV---PGKLLETSCGSPHYAAPEIVSG 185 (786)
T ss_pred HHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeeccc---CCccccccCCCcccCCchhhcC
Confidence 999999999999999999999 9999999999999999899999999997422 2333445679999999999999
Q ss_pred CCC-ccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHcc
Q 021490 165 GQL-TLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCV 243 (311)
Q Consensus 165 ~~~-~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 243 (311)
.+| +.++||||.|||+|.||+|..||++.+.......+..+. + +.|...+.++.+|+.+||
T Consensus 186 ~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~-----------f-------~MPs~Is~eaQdLLr~ml 247 (786)
T KOG0588|consen 186 RPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGV-----------F-------EMPSNISSEAQDLLRRML 247 (786)
T ss_pred CCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCc-----------c-------cCCCcCCHHHHHHHHHHh
Confidence 888 578999999999999999999999765544333332211 1 123334458899999999
Q ss_pred ccCCCCCCCHHHHHHHHHHh
Q 021490 244 HEQPDMRPVIADVVTALAYL 263 (311)
Q Consensus 244 ~~~p~~Rps~~~vl~~l~~~ 263 (311)
.+||..|.|++||++...-.
T Consensus 248 ~VDp~~RiT~~eI~kHP~l~ 267 (786)
T KOG0588|consen 248 DVDPSTRITTEEILKHPFLS 267 (786)
T ss_pred ccCccccccHHHHhhCchhh
Confidence 99999999999999987533
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=282.34 Aligned_cols=213 Identities=28% Similarity=0.337 Sum_probs=183.7
Q ss_pred CCcEEEEEEeecCCCcch---hHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCH
Q 021490 8 LLQDVAIKQLDRNGVQGN---REFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 84 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~ 84 (311)
+|.-+|+|++++...-.. +...+|..+|+.+.||+++++++.+.+...+||||||++||.|.+++.. .+++++
T Consensus 68 ~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~GGElFS~Lrk----~~rF~e 143 (355)
T KOG0616|consen 68 SGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPGGELFSYLRK----SGRFSE 143 (355)
T ss_pred CCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEeccCCccHHHHHHh----cCCCCc
Confidence 689999999987755333 5677899999999999999999999999999999999999999999997 688999
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccccc
Q 021490 85 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT 164 (311)
Q Consensus 85 ~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 164 (311)
+.+..++.||+.||+|||+.+ |++|||||+|||++.+|.+||+|||.+...... .....||+.|+|||+++.
T Consensus 144 ~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r-----T~TlCGTPeYLAPEii~s 215 (355)
T KOG0616|consen 144 PHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR-----TWTLCGTPEYLAPEIIQS 215 (355)
T ss_pred hhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecCc-----EEEecCCccccChHHhhc
Confidence 999999999999999999999 999999999999999999999999999753221 334579999999999999
Q ss_pred CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccc
Q 021490 165 GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVH 244 (311)
Q Consensus 165 ~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 244 (311)
.+++.++|+||||+++|||+.|.+||...........+ .... -.+|.-.+.++.+|+.+.|+
T Consensus 216 k~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI------~~~~------------v~fP~~fs~~~kdLl~~LL~ 277 (355)
T KOG0616|consen 216 KGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKI------LEGK------------VKFPSYFSSDAKDLLKKLLQ 277 (355)
T ss_pred CCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHH------HhCc------------ccCCcccCHHHHHHHHHHHh
Confidence 99999999999999999999999999877664433222 1111 12344555688999999999
Q ss_pred cCCCCC
Q 021490 245 EQPDMR 250 (311)
Q Consensus 245 ~~p~~R 250 (311)
.|-.+|
T Consensus 278 vD~t~R 283 (355)
T KOG0616|consen 278 VDLTKR 283 (355)
T ss_pred hhhHhh
Confidence 999999
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=291.62 Aligned_cols=232 Identities=28% Similarity=0.405 Sum_probs=183.9
Q ss_pred CcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCC--eeEEEEecCCCCChhhhhcccCCCCCCCCHHH
Q 021490 9 LQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD--QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNT 86 (311)
Q Consensus 9 g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~ 86 (311)
|...|||.+........+.+.+|+.+|.+|+|||||++++...... .++++|||+++|+|.+++... ++.|++..
T Consensus 42 g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~~---g~~l~E~~ 118 (313)
T KOG0198|consen 42 GELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKRY---GGKLPEPL 118 (313)
T ss_pred CcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCCCcHHHHHHHc---CCCCCHHH
Confidence 7899999987664333677899999999999999999999755444 689999999999999999873 22799999
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcC-CCceEEccccccccCCC-CCCceeeeeccccccccCcccccc
Q 021490 87 RMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR-GYHPKLSDFGLAKLGPV-GDNTHVSTRVMGTYGYCAPEYAKT 164 (311)
Q Consensus 87 ~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~-~~~~~l~df~~~~~~~~-~~~~~~~~~~~~~~~y~aPE~~~~ 164 (311)
+..+..||+.||+|||++| ++|+||||+|||++. ++.+||+|||++..... ...........||+.|+|||++..
T Consensus 119 v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~ 195 (313)
T KOG0198|consen 119 VRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRN 195 (313)
T ss_pred HHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccccccccccccccCCccccCchhhcC
Confidence 9999999999999999999 999999999999999 79999999998875432 111122233579999999999985
Q ss_pred C-CCccccceeehhHHHHHHHhCCCccCcc-hhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHc
Q 021490 165 G-QLTLKSDVYSFGVVLLEILSGRKAVDTS-KAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMC 242 (311)
Q Consensus 165 ~-~~~~~~DiwslG~l~~~ll~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 242 (311)
+ ....++|||||||++.||+||..||... ..... +. ...... ..| .+|...+.++.+++.+|
T Consensus 196 g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~--~~-------~ig~~~---~~P----~ip~~ls~~a~~Fl~~C 259 (313)
T KOG0198|consen 196 GEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEA--LL-------LIGRED---SLP----EIPDSLSDEAKDFLRKC 259 (313)
T ss_pred CCcCCccchhhhcCCEEEeccCCCCcchhhcchHHH--HH-------HHhccC---CCC----CCCcccCHHHHHHHHHH
Confidence 3 3345999999999999999999999874 11111 11 000000 112 44555666899999999
Q ss_pred cccCCCCCCCHHHHHHHHHH
Q 021490 243 VHEQPDMRPVIADVVTALAY 262 (311)
Q Consensus 243 l~~~p~~Rps~~~vl~~l~~ 262 (311)
|..||++|||+.+++.....
T Consensus 260 ~~~~p~~Rpta~eLL~hpf~ 279 (313)
T KOG0198|consen 260 FKRDPEKRPTAEELLEHPFL 279 (313)
T ss_pred hhcCcccCcCHHHHhhChhh
Confidence 99999999999999988643
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=289.89 Aligned_cols=240 Identities=23% Similarity=0.300 Sum_probs=191.4
Q ss_pred CCcEEEEEEeecCCCcch-hHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHH
Q 021490 8 LLQDVAIKQLDRNGVQGN-REFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNT 86 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~~~-~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~ 86 (311)
-|..||||+++-+.+... +.+.+|+..|+.++||||++++..|..+..+++||+||.+||+.+.+.... ...+.+..
T Consensus 50 ~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~--~~Gl~E~~ 127 (516)
T KOG0582|consen 50 TNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGSLLDIIKTYY--PDGLEEAS 127 (516)
T ss_pred cCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhcCCcHHHHHHHHc--cccccHHH
Confidence 468999999988776544 889999999999999999999999999999999999999999999998754 45699999
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCC-Cceee-eeccccccccCcccccc
Q 021490 87 RMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD-NTHVS-TRVMGTYGYCAPEYAKT 164 (311)
Q Consensus 87 ~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~-~~~~~~~~y~aPE~~~~ 164 (311)
+..++.++++||.|||.+| .+|||||+.|||++.+|.|+|+|||.+....... ..... ....++++|+|||++..
T Consensus 128 Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q 204 (516)
T KOG0582|consen 128 IATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQ 204 (516)
T ss_pred HHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhh
Confidence 9999999999999999999 9999999999999999999999999875433322 11222 44579999999999533
Q ss_pred --CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHc
Q 021490 165 --GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMC 242 (311)
Q Consensus 165 --~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 242 (311)
..|+.++||||||++..||.+|..||.........-+--...+.... -..+...-.........+++..|
T Consensus 205 ~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~--------t~~~~~d~~k~~~ksf~e~i~~C 276 (516)
T KOG0582|consen 205 QLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLL--------TSGLDKDEDKKFSKSFREMIALC 276 (516)
T ss_pred cccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcc--------cccCChHHhhhhcHHHHHHHHHH
Confidence 68999999999999999999999999887665443222111111111 00111111122334777899999
Q ss_pred cccCCCCCCCHHHHHHHH
Q 021490 243 VHEQPDMRPVIADVVTAL 260 (311)
Q Consensus 243 l~~~p~~Rps~~~vl~~l 260 (311)
|..||.+|||++++++.-
T Consensus 277 L~kDP~kRptAskLlkh~ 294 (516)
T KOG0582|consen 277 LVKDPSKRPTASKLLKHA 294 (516)
T ss_pred hhcCcccCCCHHHHhccH
Confidence 999999999999999653
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=288.07 Aligned_cols=246 Identities=22% Similarity=0.240 Sum_probs=192.1
Q ss_pred cCCcEEEEEEeecCCC--cchhHHHHHHHHHhcCCCCcccceeeEeeeC--CeeEEEEecCCCCChhhhhcccCCCCCCC
Q 021490 7 CLLQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADG--DQRLLVYEYMPLGSVEDHLHDLSPGKKPL 82 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~l 82 (311)
..|+-||+|++..... ....-..+|+.+|++|+||||+++.+...+. ..+|||+|||+ -+|.-++.. .+-.|
T Consensus 140 ~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMd-hDL~GLl~~---p~vkf 215 (560)
T KOG0600|consen 140 ETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMD-HDLSGLLSS---PGVKF 215 (560)
T ss_pred ccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEeccc-chhhhhhcC---CCccc
Confidence 3689999999877653 3345667899999999999999999998776 68999999997 588888875 24579
Q ss_pred CHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccc
Q 021490 83 DWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 162 (311)
Q Consensus 83 ~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 162 (311)
++.++..++.||+.||+|+|++| ++|||||..|||++.+|.+||+|||+++.+....... .+..+-|.+|.|||++
T Consensus 216 t~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~-~T~rVvTLWYRpPELL 291 (560)
T KOG0600|consen 216 TEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAP-YTSRVVTLWYRPPELL 291 (560)
T ss_pred ChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeeccCCCCcc-cccceEEeeccChHHh
Confidence 99999999999999999999999 9999999999999999999999999998654443332 4456789999999988
Q ss_pred cc-CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccc-cccccccCcc-c--cCCCC-------hH
Q 021490 163 KT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDR-TRHSLIADPE-L--QGQYP-------PR 230 (311)
Q Consensus 163 ~~-~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-~--~~~~~-------~~ 230 (311)
.+ ..|+.++|+||.|||+.||++|+++|.+....+....+........+. +....+.... + ...+. ..
T Consensus 292 LG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~ 371 (560)
T KOG0600|consen 292 LGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKD 371 (560)
T ss_pred cCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhcc
Confidence 76 689999999999999999999999999988777665543322111111 1111111000 0 01111 12
Q ss_pred hHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 021490 231 GFYQALAVAAMCVHEQPDMRPVIADVVTAL 260 (311)
Q Consensus 231 ~~~~l~~li~~~l~~~p~~Rps~~~vl~~l 260 (311)
.+...++|+..+|..||.+|.|+.+++..=
T Consensus 372 ~~~~~l~Ll~~lL~ldP~kR~tA~~aL~se 401 (560)
T KOG0600|consen 372 FPASALDLLEKLLSLDPDKRGTASSALQSE 401 (560)
T ss_pred CCHHHHHHHHHHhccCccccccHHHHhcCc
Confidence 245778999999999999999999998763
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=296.43 Aligned_cols=236 Identities=30% Similarity=0.434 Sum_probs=194.4
Q ss_pred EEEEEeecCC---CcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHHHH
Q 021490 12 VAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRM 88 (311)
Q Consensus 12 vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~ 88 (311)
||+|..+... .....+|++|+++|++++||||++++|+....+.+++|||+|.||+|.++|+.. +..++..+..
T Consensus 189 VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~---~~~v~~~ek~ 265 (474)
T KOG0194|consen 189 VAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKN---KKSLPTLEKL 265 (474)
T ss_pred eEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhC---CCCCCHHHHH
Confidence 8999987532 345579999999999999999999999999999999999999999999999983 2369999999
Q ss_pred HHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccCCCc
Q 021490 89 KIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLT 168 (311)
Q Consensus 89 ~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 168 (311)
.++.+.|.||+|||+++ ++||||..+|||++.++.+||+|||++.... ...........+..|+|||.+....++
T Consensus 266 ~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~~~~--~~~~~~~~~klPirWLAPEtl~~~~~s 340 (474)
T KOG0194|consen 266 RFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSRAGS--QYVMKKFLKKLPIRWLAPETLNTGIFS 340 (474)
T ss_pred HHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccccCCc--ceeeccccccCcceecChhhhccCccc
Confidence 99999999999999999 9999999999999999999999999987532 111111123467899999999999999
Q ss_pred cccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCC
Q 021490 169 LKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQP 247 (311)
Q Consensus 169 ~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p 247 (311)
.++|||||||++||+++ |..||.+.........+. . ...+...+...+..+..++.+||..||
T Consensus 341 ~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~------~----------~~~r~~~~~~~p~~~~~~~~~c~~~~p 404 (474)
T KOG0194|consen 341 FKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIV------K----------NGYRMPIPSKTPKELAKVMKQCWKKDP 404 (474)
T ss_pred cccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHH------h----------cCccCCCCCCCHHHHHHHHHHhccCCh
Confidence 99999999999999999 788998876653322220 0 011122333445577889999999999
Q ss_pred CCCCCHHHHHHHHHHhhhccCCcc
Q 021490 248 DMRPVIADVVTALAYLASQKYESD 271 (311)
Q Consensus 248 ~~Rps~~~vl~~l~~~~~~~~~~~ 271 (311)
++||||.++.+.++.+.......+
T Consensus 405 ~~R~tm~~i~~~l~~~~~~~~~~~ 428 (474)
T KOG0194|consen 405 EDRPTMSTIKKKLEALEKKKEAFD 428 (474)
T ss_pred hhccCHHHHHHHHHHHHhcccccc
Confidence 999999999999999887766543
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=295.38 Aligned_cols=239 Identities=28% Similarity=0.396 Sum_probs=183.6
Q ss_pred CCcEEEEEEeecCCC-cchhHHHHHHHHHhcC-CCCcccceeeEeeeC-CeeEEEEecCCCCChhhhhcccCC-------
Q 021490 8 LLQDVAIKQLDRNGV-QGNREFLVEVLMLSLL-HHPNLVNLIGYCADG-DQRLLVYEYMPLGSVEDHLHDLSP------- 77 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~------- 77 (311)
.+..||+|+++.... .....+.+|+.++..+ +||||+++++++... ...++||||+++|+|.+++.....
T Consensus 36 ~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~ 115 (338)
T cd05102 36 SCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYRE 115 (338)
T ss_pred cchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccc
Confidence 457899999865432 2346789999999999 899999999988654 458999999999999998865211
Q ss_pred ---------------------------------------------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCC
Q 021490 78 ---------------------------------------------------GKKPLDWNTRMKIAAGAARGLEYLHDKAK 106 (311)
Q Consensus 78 ---------------------------------------------------~~~~l~~~~~~~~~~~i~~~l~~lh~~~~ 106 (311)
....+++..+..++.|++.||+|||+.+
T Consensus 116 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~- 194 (338)
T cd05102 116 KSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRK- 194 (338)
T ss_pred cchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 0235788899999999999999999999
Q ss_pred CCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccCCCccccceeehhHHHHHHHh-
Q 021490 107 PPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS- 185 (311)
Q Consensus 107 ~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~l~~~ll~- 185 (311)
++||||||+||+++.++.++|+|||++................++..|+|||++.+..++.++|||||||++|+|++
T Consensus 195 --ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~ 272 (338)
T cd05102 195 --CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSL 272 (338)
T ss_pred --EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhC
Confidence 99999999999999999999999999875322211111222345678999999988899999999999999999997
Q ss_pred CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhh
Q 021490 186 GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLAS 265 (311)
Q Consensus 186 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l~~~~~ 265 (311)
|..||......... .. ....... . ..+...+..+.+|+.+||+.||.+|||+.++++.|+.+..
T Consensus 273 g~~pf~~~~~~~~~--~~----~~~~~~~------~----~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 273 GASPYPGVQINEEF--CQ----RLKDGTR------M----RAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred CCCCCCCCCccHHH--HH----HHhcCCC------C----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99999764432111 00 0111000 0 1122334578899999999999999999999999987764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=285.16 Aligned_cols=226 Identities=23% Similarity=0.350 Sum_probs=189.5
Q ss_pred cCCcEEEEEEeecCCCcchh---HHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCC
Q 021490 7 CLLQDVAIKQLDRNGVQGNR---EFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLD 83 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~~~~---~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~ 83 (311)
.+|+.||||.+++....+.. .+.+|+++|..|+||||+.++++|++.+...+||||..+|.|.+++.. .+.|+
T Consensus 76 ~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivMEYaS~GeLYDYiSe----r~~Ls 151 (668)
T KOG0611|consen 76 KSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEYASGGELYDYISE----RGSLS 151 (668)
T ss_pred cCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEecCCccHHHHHHH----hcccc
Confidence 57999999999887655544 566899999999999999999999999999999999999999999998 78899
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccc
Q 021490 84 WNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 163 (311)
Q Consensus 84 ~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 163 (311)
+.++..++.||.+|+.|+|.++ ++|||||.+|||++.|+++||.|||++..+... .......|++-|.+||++.
T Consensus 152 ErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~~---kfLqTFCGSPLYASPEIvN 225 (668)
T KOG0611|consen 152 EREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYADK---KFLQTFCGSPLYASPEIVN 225 (668)
T ss_pred HHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhccc---cHHHHhcCCcccCCccccC
Confidence 9999999999999999999999 999999999999999999999999998754322 2233457999999999999
Q ss_pred cCCC-ccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHc
Q 021490 164 TGQL-TLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMC 242 (311)
Q Consensus 164 ~~~~-~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 242 (311)
+.+| ++.+|.||||+++|.|+.|..||++.+-.....-+ ... ....| ..+-...-||.+|
T Consensus 226 G~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQI-------s~G----aYrEP--------~~PSdA~gLIRwm 286 (668)
T KOG0611|consen 226 GTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQI-------SRG----AYREP--------ETPSDASGLIRWM 286 (668)
T ss_pred CCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHh-------hcc----cccCC--------CCCchHHHHHHHH
Confidence 9888 57899999999999999999999987653322111 110 00111 1122556699999
Q ss_pred cccCCCCCCCHHHHHHHHH
Q 021490 243 VHEQPDMRPVIADVVTALA 261 (311)
Q Consensus 243 l~~~p~~Rps~~~vl~~l~ 261 (311)
|.+||..|.|+++|....+
T Consensus 287 LmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 287 LMVNPERRATIEDIASHWW 305 (668)
T ss_pred HhcCcccchhHHHHhhhhe
Confidence 9999999999999998764
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=292.18 Aligned_cols=226 Identities=26% Similarity=0.324 Sum_probs=185.0
Q ss_pred cCCcEEEEEEeecCCC---cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCC
Q 021490 7 CLLQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLD 83 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~ 83 (311)
.+|+.||+|+++.... .....+.+|+.++..++||||+++++++..+...|+||||+++++|.+++.. ...++
T Consensus 18 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~ 93 (323)
T cd05571 18 ATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSR----ERVFS 93 (323)
T ss_pred CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCcHHHHHHH----cCCCC
Confidence 3689999999976432 2335678899999999999999999999999999999999999999999876 56799
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccc
Q 021490 84 WNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 163 (311)
Q Consensus 84 ~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 163 (311)
+..+..++.||+.||+|||+.| ++||||||+||+++.++.++|+|||++...... ........|+..|+|||++.
T Consensus 94 ~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~ 168 (323)
T cd05571 94 EDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYLAPEVLE 168 (323)
T ss_pred HHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccC--CCcccceecCccccChhhhc
Confidence 9999999999999999999999 999999999999999999999999998642111 11122345899999999999
Q ss_pred cCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHcc
Q 021490 164 TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCV 243 (311)
Q Consensus 164 ~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 243 (311)
+..++.++|||||||++|+|++|..||...+.......+. .. +. .++...+..+.+++.+||
T Consensus 169 ~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~------~~--------~~----~~p~~~~~~~~~li~~~L 230 (323)
T cd05571 169 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL------ME--------EI----RFPRTLSPEAKSLLAGLL 230 (323)
T ss_pred CCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHH------cC--------CC----CCCCCCCHHHHHHHHHHc
Confidence 8899999999999999999999999997655433222111 00 01 122334457889999999
Q ss_pred ccCCCCCC-----CHHHHHHH
Q 021490 244 HEQPDMRP-----VIADVVTA 259 (311)
Q Consensus 244 ~~~p~~Rp-----s~~~vl~~ 259 (311)
..||++|| ++.++++.
T Consensus 231 ~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 231 KKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred cCCHHHcCCCCCCCHHHHHcC
Confidence 99999999 78888865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=287.57 Aligned_cols=229 Identities=25% Similarity=0.339 Sum_probs=194.4
Q ss_pred CCcEEEEEEeecCCCcch--hHHHHHHHHHhcCCCCcccceeeEeeeCCe-eEEEEecCCCCChhhhhcccCCCCCCCCH
Q 021490 8 LLQDVAIKQLDRNGVQGN--REFLVEVLMLSLLHHPNLVNLIGYCADGDQ-RLLVYEYMPLGSVEDHLHDLSPGKKPLDW 84 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~~~--~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~lv~e~~~~~~L~~~l~~~~~~~~~l~~ 84 (311)
++..+|+|.+........ +..+.|+.++++++||||+.+.+.|.+++. .+|||+||+||+|.+.+.... +..+++
T Consensus 28 ~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~k--~~~f~E 105 (426)
T KOG0589|consen 28 DDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEGGDLAQLIKEQK--GVLFPE 105 (426)
T ss_pred CCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecCCCCHHHHHHHHh--hccccH
Confidence 678899999877655443 467889999999999999999999998888 999999999999999998754 578999
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccccc
Q 021490 85 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT 164 (311)
Q Consensus 85 ~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 164 (311)
..+..|+.|++.|+.|||++. |+|||||+.|||++.++.|+|+|||+++...... .......||+.|+.||.+.+
T Consensus 106 ~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~--~~a~tvvGTp~YmcPEil~d 180 (426)
T KOG0589|consen 106 ERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED--SLASTVVGTPYYMCPEILSD 180 (426)
T ss_pred HHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCch--hhhheecCCCcccCHHHhCC
Confidence 999999999999999999998 9999999999999999999999999998754432 23445679999999999999
Q ss_pred CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccc
Q 021490 165 GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVH 244 (311)
Q Consensus 165 ~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 244 (311)
.+|+.++|||||||++|||++-+++|...+.......+... .....+...+.++..++..||+
T Consensus 181 ~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~-----------------~~~Plp~~ys~el~~lv~~~l~ 243 (426)
T KOG0589|consen 181 IPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRG-----------------LYSPLPSMYSSELRSLVKSMLR 243 (426)
T ss_pred CCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhc-----------------cCCCCCccccHHHHHHHHHHhh
Confidence 99999999999999999999999999877654332221111 1123344556688999999999
Q ss_pred cCCCCCCCHHHHHHHH
Q 021490 245 EQPDMRPVIADVVTAL 260 (311)
Q Consensus 245 ~~p~~Rps~~~vl~~l 260 (311)
.+|..||++.+++...
T Consensus 244 ~~P~~RPsa~~LL~~P 259 (426)
T KOG0589|consen 244 KNPEHRPSALELLRRP 259 (426)
T ss_pred cCCccCCCHHHHhhCh
Confidence 9999999999999774
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=287.28 Aligned_cols=223 Identities=26% Similarity=0.320 Sum_probs=182.6
Q ss_pred CCcEEEEEEeecCCC---cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCH
Q 021490 8 LLQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 84 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~ 84 (311)
+|+.||+|+++.... ...+.+.+|+.++..++||||+++++++.++...++||||+.|++|.+++.. ...+++
T Consensus 42 ~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~ 117 (329)
T PTZ00263 42 TGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRK----AGRFPN 117 (329)
T ss_pred CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCCCCChHHHHHHH----cCCCCH
Confidence 689999999975432 3346788999999999999999999999999999999999999999999986 567899
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccccc
Q 021490 85 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT 164 (311)
Q Consensus 85 ~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 164 (311)
..+..++.|++.||+|||+.+ ++||||||+|||++.++.++|+|||++...... .....+++.|+|||++.+
T Consensus 118 ~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~ 189 (329)
T PTZ00263 118 DVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR-----TFTLCGTPEYLAPEVIQS 189 (329)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC-----cceecCChhhcCHHHHcC
Confidence 999999999999999999999 999999999999999999999999998753221 112358899999999999
Q ss_pred CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccc
Q 021490 165 GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVH 244 (311)
Q Consensus 165 ~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 244 (311)
..++.++|||||||++|+|++|..||...........+ .... . .++...+..+.+|+.+||+
T Consensus 190 ~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i------~~~~--------~----~~p~~~~~~~~~li~~~L~ 251 (329)
T PTZ00263 190 KGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKI------LAGR--------L----KFPNWFDGRARDLVKGLLQ 251 (329)
T ss_pred CCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHH------hcCC--------c----CCCCCCCHHHHHHHHHHhh
Confidence 88999999999999999999999999765433221111 0000 0 1122233467889999999
Q ss_pred cCCCCCCC-----HHHHHHHH
Q 021490 245 EQPDMRPV-----IADVVTAL 260 (311)
Q Consensus 245 ~~p~~Rps-----~~~vl~~l 260 (311)
.||.+||+ +.+++...
T Consensus 252 ~dP~~R~~~~~~~~~~ll~hp 272 (329)
T PTZ00263 252 TDHTKRLGTLKGGVADVKNHP 272 (329)
T ss_pred cCHHHcCCCCCCCHHHHhcCC
Confidence 99999997 67877653
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=280.87 Aligned_cols=240 Identities=26% Similarity=0.318 Sum_probs=192.3
Q ss_pred CCcEEEEEEeecCCCcch---hHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCH
Q 021490 8 LLQDVAIKQLDRNGVQGN---REFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 84 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~ 84 (311)
++...|+|++.+...... .+...|-+||..++||++..+|..|+.+...|+|||||+||+|..+++... ++.|++
T Consensus 101 t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~LrqkQp--~~~fse 178 (459)
T KOG0610|consen 101 TNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQKQP--GKRFSE 178 (459)
T ss_pred CCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCCccHHHHHhhCC--CCccch
Confidence 358999999988765444 466779999999999999999999999999999999999999999998855 688999
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCC-------C---------------
Q 021490 85 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG-------D--------------- 142 (311)
Q Consensus 85 ~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~-------~--------------- 142 (311)
..+..++.+|+.||+|||-.| ||+|||||+||||.++|.|.|+||+++...... .
T Consensus 179 ~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~ 255 (459)
T KOG0610|consen 179 SAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQP 255 (459)
T ss_pred hhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccc
Confidence 999999999999999999999 999999999999999999999999987542110 0
Q ss_pred ---------C-c----------------------eeeeeccccccccCccccccCCCccccceeehhHHHHHHHhCCCcc
Q 021490 143 ---------N-T----------------------HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAV 190 (311)
Q Consensus 143 ---------~-~----------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf 190 (311)
. . ......+||-.|+|||++.+...+.++|+|+||+++|||+.|..||
T Consensus 256 s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPF 335 (459)
T KOG0610|consen 256 SCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPF 335 (459)
T ss_pred cccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence 0 0 0001246899999999999999999999999999999999999999
Q ss_pred CcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCC----HHHHHHHHHHhhhc
Q 021490 191 DTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPV----IADVVTALAYLASQ 266 (311)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps----~~~vl~~l~~~~~~ 266 (311)
.+........-+. . ..+.-...+..+..+.+||++.|.+||.+|.- +.||-+. .++...
T Consensus 336 KG~~~~~Tl~NIv------~----------~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~H-pFF~gV 398 (459)
T KOG0610|consen 336 KGSNNKETLRNIV------G----------QPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRH-PFFEGV 398 (459)
T ss_pred CCCCchhhHHHHh------c----------CCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhcC-ccccCC
Confidence 9877654432111 1 11111112255678999999999999999987 6676654 344444
Q ss_pred cCC
Q 021490 267 KYE 269 (311)
Q Consensus 267 ~~~ 269 (311)
.+.
T Consensus 399 nWa 401 (459)
T KOG0610|consen 399 NWA 401 (459)
T ss_pred Chh
Confidence 443
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=265.08 Aligned_cols=242 Identities=24% Similarity=0.303 Sum_probs=193.3
Q ss_pred cCCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCC-----eeEEEEecCCCCChhhhhcccCCCCCC
Q 021490 7 CLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD-----QRLLVYEYMPLGSVEDHLHDLSPGKKP 81 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~ 81 (311)
.++.-+|+|++...+.++.+..++|++..++++|||+++++++...+. ..|++++|+..|+|.+.++.....+..
T Consensus 44 s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~ 123 (302)
T KOG2345|consen 44 STGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNF 123 (302)
T ss_pred CcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCc
Confidence 467889999998888888999999999999999999999999875443 489999999999999999988777789
Q ss_pred CCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceee-------eeccccc
Q 021490 82 LDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVS-------TRVMGTY 154 (311)
Q Consensus 82 l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~-------~~~~~~~ 154 (311)
+++.+++.|+.+|++||.+||+.. +|+.||||||.||++++.+.++++|||.+............ .....+.
T Consensus 124 ~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~ 202 (302)
T KOG2345|consen 124 VSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTI 202 (302)
T ss_pred cCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCC
Confidence 999999999999999999999984 67999999999999999999999999998753221111100 1134678
Q ss_pred cccCccccc---cCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHh
Q 021490 155 GYCAPEYAK---TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRG 231 (311)
Q Consensus 155 ~y~aPE~~~---~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (311)
.|.|||.+. +...++++|||||||++|.|+.|..||+..-. +..........+.+...-....
T Consensus 203 pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~--------------~GgSlaLAv~n~q~s~P~~~~y 268 (302)
T KOG2345|consen 203 PYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ--------------QGGSLALAVQNAQISIPNSSRY 268 (302)
T ss_pred cccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh--------------cCCeEEEeeeccccccCCCCCc
Confidence 999999885 35678999999999999999999999975321 0011111111222211112236
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 021490 232 FYQALAVAAMCVHEQPDMRPVIADVVTALAYL 263 (311)
Q Consensus 232 ~~~l~~li~~~l~~~p~~Rps~~~vl~~l~~~ 263 (311)
++.+.+++++||++||.+||++.+++..+..+
T Consensus 269 se~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 269 SEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred cHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 67899999999999999999999999988755
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=287.45 Aligned_cols=225 Identities=26% Similarity=0.293 Sum_probs=181.6
Q ss_pred CCcEEEEEEeecCC---CcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCH
Q 021490 8 LLQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 84 (311)
Q Consensus 8 ~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~ 84 (311)
+|+.||+|+++... ......+.+|+.++..++||||+++++++.+....++||||+++++|.+++.. ...+++
T Consensus 17 ~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~ 92 (312)
T cd05585 17 TQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQR----EGRFDL 92 (312)
T ss_pred CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcHHHHHHh----cCCCCH
Confidence 58899999987542 23345788899999999999999999999999999999999999999999976 567999
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccccc
Q 021490 85 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT 164 (311)
Q Consensus 85 ~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 164 (311)
..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++....... .......|+..|+|||++.+
T Consensus 93 ~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~ 167 (312)
T cd05585 93 SRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNTFCGTPEYLAPELLLG 167 (312)
T ss_pred HHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC--CccccccCCcccCCHHHHcC
Confidence 999999999999999999999 9999999999999999999999999986422111 11223458899999999999
Q ss_pred CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccc
Q 021490 165 GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVH 244 (311)
Q Consensus 165 ~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 244 (311)
..++.++|||||||++|+|++|..||............ .... . .++...+..+.+++.+||.
T Consensus 168 ~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~------~~~~--------~----~~~~~~~~~~~~li~~~L~ 229 (312)
T cd05585 168 HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKI------LQEP--------L----RFPDGFDRDAKDLLIGLLS 229 (312)
T ss_pred CCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHH------HcCC--------C----CCCCcCCHHHHHHHHHHcC
Confidence 89999999999999999999999999765443221111 1110 0 1222334578899999999
Q ss_pred cCCCCCCC---HHHHHHH
Q 021490 245 EQPDMRPV---IADVVTA 259 (311)
Q Consensus 245 ~~p~~Rps---~~~vl~~ 259 (311)
.||.+||+ +.+++..
T Consensus 230 ~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 230 RDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred CCHHHcCCCCCHHHHHcC
Confidence 99999986 4555544
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=288.28 Aligned_cols=248 Identities=21% Similarity=0.263 Sum_probs=189.1
Q ss_pred CCcEEEEEEeecCCC-cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHH
Q 021490 8 LLQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNT 86 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~ 86 (311)
+|..||+|++..... .....+.+|+++++.++||||+++++++..+...++||||+++++|.+++.. ...+++..
T Consensus 29 ~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~ 104 (331)
T cd06649 29 SGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKE----AKRIPEEI 104 (331)
T ss_pred CCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCCCcHHHHHHH----cCCCCHHH
Confidence 578899999875432 2346799999999999999999999999999999999999999999999976 56789999
Q ss_pred HHHHHHHHHHHHHHhhcC-CCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccC
Q 021490 87 RMKIAAGAARGLEYLHDK-AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG 165 (311)
Q Consensus 87 ~~~~~~~i~~~l~~lh~~-~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 165 (311)
+..++.|++.||.|||+. + ++|+||||+||+++.++.++|+|||++...... ......++..|+|||++.+.
T Consensus 105 ~~~~~~~i~~~l~~lH~~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~----~~~~~~g~~~y~aPE~~~~~ 177 (331)
T cd06649 105 LGKVSIAVLRGLAYLREKHQ---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGT 177 (331)
T ss_pred HHHHHHHHHHHHHHHhhcCC---EEcCCCChhhEEEcCCCcEEEccCccccccccc----ccccCCCCcCcCCHhHhcCC
Confidence 999999999999999985 5 999999999999999999999999998643221 12234588999999999988
Q ss_pred CCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhcccccc-c-c--------------------------
Q 021490 166 QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRH-S-L-------------------------- 217 (311)
Q Consensus 166 ~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~-~-------------------------- 217 (311)
.++.++|||||||++|+|++|..||.............. +........ . .
T Consensus 178 ~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (331)
T cd06649 178 HYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGR--PVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFE 255 (331)
T ss_pred CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcc--cccccccCCccccCcccccccccccccccccccchhHHH
Confidence 899999999999999999999999976554332221110 000000000 0 0
Q ss_pred ----ccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhccC
Q 021490 218 ----IADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQKY 268 (311)
Q Consensus 218 ----~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~~~ 268 (311)
..............+.++.+|+.+||+.||++|||+.++++....-.....
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~~~ 310 (331)
T cd06649 256 LLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSEVE 310 (331)
T ss_pred HHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcccc
Confidence 000000000011235678999999999999999999999988765444433
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=297.06 Aligned_cols=232 Identities=28% Similarity=0.409 Sum_probs=189.9
Q ss_pred CCcEEEEEEeecCCC---cchhHHHHHHHHHhcC-CCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCC
Q 021490 8 LLQDVAIKQLDRNGV---QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLD 83 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~ 83 (311)
+++-+|||++++... +..+..+.|.+++... +||+++.++..|++.+++|+||||+.||++....+ ...|+
T Consensus 392 ~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~~Ggdm~~~~~-----~~~F~ 466 (694)
T KOG0694|consen 392 TNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYVAGGDLMHHIH-----TDVFS 466 (694)
T ss_pred CCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEecCCCcEEEEEe-----ccccc
Confidence 588999999988754 4557888899999888 59999999999999999999999999999443333 47899
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccc
Q 021490 84 WNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 163 (311)
Q Consensus 84 ~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 163 (311)
+..+..+++.|+.||+|||++| |+|||||.+|||++.+|.+||+|||+++.... .........||+.|+|||+++
T Consensus 467 e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~--~g~~TsTfCGTpey~aPEil~ 541 (694)
T KOG0694|consen 467 EPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG--QGDRTSTFCGTPEFLAPEVLT 541 (694)
T ss_pred HHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccccCC--CCCccccccCChhhcChhhhc
Confidence 9999999999999999999999 99999999999999999999999999985321 122344567999999999999
Q ss_pred cCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHcc
Q 021490 164 TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCV 243 (311)
Q Consensus 164 ~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 243 (311)
+..|+.++|+|||||++||||.|+.||.+.+..+.-+-+. .+ + ..+|...+.+..+|++++|
T Consensus 542 e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~------~d--------~----~~yP~~ls~ea~~il~~ll 603 (694)
T KOG0694|consen 542 EQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIV------ND--------E----VRYPRFLSKEAIAIMRRLL 603 (694)
T ss_pred cCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh------cC--------C----CCCCCcccHHHHHHHHHHh
Confidence 9999999999999999999999999999877665543331 11 1 1334455668899999999
Q ss_pred ccCCCCCCCH----HHHHHHHHHhhhcc
Q 021490 244 HEQPDMRPVI----ADVVTALAYLASQK 267 (311)
Q Consensus 244 ~~~p~~Rps~----~~vl~~l~~~~~~~ 267 (311)
+.||.+|.-+ ++.+..--++..+.
T Consensus 604 ~k~p~kRLG~~e~d~~~i~~hpFFr~i~ 631 (694)
T KOG0694|consen 604 RKNPEKRLGSGERDAEDIKKHPFFRSID 631 (694)
T ss_pred ccCcccccCCCCCCchhhhhCCccccCC
Confidence 9999999765 44444433444443
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=312.03 Aligned_cols=239 Identities=31% Similarity=0.405 Sum_probs=197.5
Q ss_pred cEEEEEEeecCC-CcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccC---CCCCCCCHH
Q 021490 10 QDVAIKQLDRNG-VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLS---PGKKPLDWN 85 (311)
Q Consensus 10 ~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~l~~~ 85 (311)
..||||.++... .....+|.+|+.+|+.++||||++++|++.+....++++|||+||+|..+|.+.. .....++..
T Consensus 723 ~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~ 802 (1025)
T KOG1095|consen 723 IQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMR 802 (1025)
T ss_pred eEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHH
Confidence 459999997654 3445799999999999999999999999999999999999999999999998852 124678999
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccC
Q 021490 86 TRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG 165 (311)
Q Consensus 86 ~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 165 (311)
..+.++.+||+|+.||+++. +|||||..+|+|+++...|||+|||+++................+..|||||.+...
T Consensus 803 dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~ 879 (1025)
T KOG1095|consen 803 DLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDG 879 (1025)
T ss_pred HHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhc
Confidence 99999999999999999999 999999999999999999999999999843333333322333456899999999999
Q ss_pred CCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccc
Q 021490 166 QLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVH 244 (311)
Q Consensus 166 ~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 244 (311)
.++.++|||||||++||+++ |..||...++.+........ . +-..|+.++..+.++|..||+
T Consensus 880 iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~g-------g----------RL~~P~~CP~~ly~lM~~CW~ 942 (1025)
T KOG1095|consen 880 IFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEG-------G----------RLDPPSYCPEKLYQLMLQCWK 942 (1025)
T ss_pred ccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhC-------C----------ccCCCCCCChHHHHHHHHHcc
Confidence 99999999999999999999 88999887765543322111 0 112345556688899999999
Q ss_pred cCCCCCCCHHHHHHHHHHhhhccC
Q 021490 245 EQPDMRPVIADVVTALAYLASQKY 268 (311)
Q Consensus 245 ~~p~~Rps~~~vl~~l~~~~~~~~ 268 (311)
.+|++||++..+++.+..+.+...
T Consensus 943 ~~pe~RP~F~~i~~q~~~i~~~~~ 966 (1025)
T KOG1095|consen 943 HDPEDRPSFRTIVEQDPAISNAAL 966 (1025)
T ss_pred CChhhCccHHHHHhhhhhhhhhhc
Confidence 999999999999998887776543
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=288.25 Aligned_cols=238 Identities=24% Similarity=0.261 Sum_probs=189.3
Q ss_pred cchhcc-CCcEEEEEEeecCCC---cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCC
Q 021490 2 MQVILC-LLQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP 77 (311)
Q Consensus 2 ~~~~~~-~g~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 77 (311)
|.+... +|+.||+|+++.... .....+.+|+.++..++||||+++++++.+....|+||||++|++|.+++..
T Consensus 18 y~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~--- 94 (333)
T cd05600 18 FLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNN--- 94 (333)
T ss_pred EEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCCCCCHHHHHHH---
Confidence 334433 589999999976432 2345788999999999999999999999999999999999999999999976
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeecccccccc
Q 021490 78 GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 157 (311)
Q Consensus 78 ~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~ 157 (311)
...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++..... ......++..|+
T Consensus 95 -~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-----~~~~~~gt~~y~ 165 (333)
T cd05600 95 -LGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-----YANSVVGSPDYM 165 (333)
T ss_pred -cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-----ccCCcccCcccc
Confidence 567999999999999999999999999 99999999999999999999999999864322 223346889999
Q ss_pred CccccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHH
Q 021490 158 APEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALA 237 (311)
Q Consensus 158 aPE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 237 (311)
|||++.+..++.++|||||||++|+|++|..||...........+......+. .....++ ....+.++.+
T Consensus 166 aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~------~~~~s~~~~~ 235 (333)
T cd05600 166 APEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQ----RPVYDDP------RFNLSDEAWD 235 (333)
T ss_pred ChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcccccc----CCCCCcc------ccccCHHHHH
Confidence 99999988999999999999999999999999987654433221111100000 0000000 0223457889
Q ss_pred HHHHccccCCCCCCCHHHHHHHHH
Q 021490 238 VAAMCVHEQPDMRPVIADVVTALA 261 (311)
Q Consensus 238 li~~~l~~~p~~Rps~~~vl~~l~ 261 (311)
++.+||..+|.+|||+.+++....
T Consensus 236 li~~~l~~~~~rr~s~~~ll~h~~ 259 (333)
T cd05600 236 LITKLINDPSRRFGSLEDIKNHPF 259 (333)
T ss_pred HHHHHhhChhhhcCCHHHHHhCcc
Confidence 999999999999999999997743
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-41 Score=292.63 Aligned_cols=224 Identities=25% Similarity=0.387 Sum_probs=183.2
Q ss_pred CcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHHHH
Q 021490 9 LQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRM 88 (311)
Q Consensus 9 g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~ 88 (311)
+..||||+++... ..+++-|++|+||||+.+.++|.....+|||||||..|-|...|+. +..++.....
T Consensus 147 netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLka----~~~itp~llv 215 (904)
T KOG4721|consen 147 NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLKA----GRPITPSLLV 215 (904)
T ss_pred CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHHHhc----cCccCHHHHH
Confidence 5678888775332 2468889999999999999999999999999999999999999998 7889999999
Q ss_pred HHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccCCCc
Q 021490 89 KIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLT 168 (311)
Q Consensus 89 ~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 168 (311)
.|..+||.|+.|||.+. |+|||||.-||||+.+..|||+|||.++..... ...-...||..|||||++...+.+
T Consensus 216 ~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMSFaGTVaWMAPEvIrnePcs 289 (904)
T KOG4721|consen 216 DWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKMSFAGTVAWMAPEVIRNEPCS 289 (904)
T ss_pred HHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh---hhhhhhhhhHhhhCHHHhhcCCcc
Confidence 99999999999999998 999999999999999999999999988742221 222234699999999999999999
Q ss_pred cccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCC
Q 021490 169 LKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPD 248 (311)
Q Consensus 169 ~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~ 248 (311)
+++|||||||++||||||..||...+.... +++-..+... -..|...+..+.-|+++||+..|.
T Consensus 290 EKVDIwSfGVVLWEmLT~EiPYkdVdssAI---------IwGVGsNsL~-------LpvPstcP~GfklL~Kqcw~sKpR 353 (904)
T KOG4721|consen 290 EKVDIWSFGVVLWEMLTGEIPYKDVDSSAI---------IWGVGSNSLH-------LPVPSTCPDGFKLLLKQCWNSKPR 353 (904)
T ss_pred cccceehhHHHHHHHHhcCCCccccchhee---------EEeccCCccc-------ccCcccCchHHHHHHHHHHhcCCC
Confidence 999999999999999999999987654222 1111112111 122333444556689999999999
Q ss_pred CCCCHHHHHHHHHHhhh
Q 021490 249 MRPVIADVVTALAYLAS 265 (311)
Q Consensus 249 ~Rps~~~vl~~l~~~~~ 265 (311)
.|||+.+++..|..+..
T Consensus 354 NRPSFrqil~HldIa~p 370 (904)
T KOG4721|consen 354 NRPSFRQILLHLDIASP 370 (904)
T ss_pred CCccHHHHHHHHhhcCH
Confidence 99999999999965443
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=304.30 Aligned_cols=243 Identities=24% Similarity=0.258 Sum_probs=194.8
Q ss_pred cchhccCC-cEEEEEEeecCCCcchhHHHHHHHHHhcCC-CCcccceeeEe-ee------CCeeEEEEecCCCCChhhhh
Q 021490 2 MQVILCLL-QDVAIKQLDRNGVQGNREFLVEVLMLSLLH-HPNLVNLIGYC-AD------GDQRLLVYEYMPLGSVEDHL 72 (311)
Q Consensus 2 ~~~~~~~g-~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~-~~------~~~~~lv~e~~~~~~L~~~l 72 (311)
|-|-...+ ..+|+|++-..+....+.+.+|+.+|++|+ |+|||.+++.. .. ..+++|.||||.||.|-+++
T Consensus 54 Yla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~m 133 (738)
T KOG1989|consen 54 YLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFM 133 (738)
T ss_pred EEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEeehhhccCCcHHHHH
Confidence 44444455 899999987788788889999999999996 99999999932 11 13678999999999999999
Q ss_pred cccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCc-e------
Q 021490 73 HDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT-H------ 145 (311)
Q Consensus 73 ~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~------ 145 (311)
.... ...|++.++++|+++++.|+++||.. ++||+|||||-+|||++.+|..||||||.+......... .
T Consensus 134 n~Rl--q~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve 210 (738)
T KOG1989|consen 134 NTRL--QTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVE 210 (738)
T ss_pred HHHH--hccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccccccCCCccHHHHHHHH
Confidence 8744 45599999999999999999999998 688999999999999999999999999998642221111 0
Q ss_pred eeeeccccccccCcccc---ccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCcc
Q 021490 146 VSTRVMGTYGYCAPEYA---KTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPE 222 (311)
Q Consensus 146 ~~~~~~~~~~y~aPE~~---~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (311)
..-....|+.|++||.+ .+.++++|+|||||||++|.||....||+....... .+..
T Consensus 211 ~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laI--------------------lng~ 270 (738)
T KOG1989|consen 211 EEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAI--------------------LNGN 270 (738)
T ss_pred HHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeE--------------------Eecc
Confidence 01124579999999976 468899999999999999999999999987633221 1111
Q ss_pred ccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhcc
Q 021490 223 LQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQK 267 (311)
Q Consensus 223 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~~ 267 (311)
+.-.-.+..+..+.+||..||+.||.+||++.+++..+-.+....
T Consensus 271 Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 271 YSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred ccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 111122467789999999999999999999999999997777553
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=286.65 Aligned_cols=227 Identities=25% Similarity=0.334 Sum_probs=185.1
Q ss_pred cCCcEEEEEEeecCCC---cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCC
Q 021490 7 CLLQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLD 83 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~ 83 (311)
.+|+.||+|++..... .....+.+|+.+++.++||||+++++++.++...++||||+++++|..++.. ...++
T Consensus 18 ~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~----~~~l~ 93 (328)
T cd05593 18 ASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSR----ERVFS 93 (328)
T ss_pred CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCCHHHHHHh----cCCCC
Confidence 3689999999976432 3345788899999999999999999999999999999999999999998876 56799
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccc
Q 021490 84 WNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 163 (311)
Q Consensus 84 ~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 163 (311)
+..+..++.||+.||+|||+.+ ++||||||+|||++.++.++|+|||++...... ........++..|+|||++.
T Consensus 94 ~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~~~~~gt~~y~aPE~~~ 168 (328)
T cd05593 94 EDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITD--AATMKTFCGTPEYLAPEVLE 168 (328)
T ss_pred HHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCc--ccccccccCCcCccChhhhc
Confidence 9999999999999999999999 999999999999999999999999998642111 11122345889999999998
Q ss_pred cCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHcc
Q 021490 164 TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCV 243 (311)
Q Consensus 164 ~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 243 (311)
+..++.++|||||||++|+|++|..||...+.......+. .. .. .++...+..+.+++.+||
T Consensus 169 ~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~------~~--------~~----~~p~~~~~~~~~li~~~L 230 (328)
T cd05593 169 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL------ME--------DI----KFPRTLSADAKSLLSGLL 230 (328)
T ss_pred CCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhc------cC--------Cc----cCCCCCCHHHHHHHHHHc
Confidence 8889999999999999999999999997654432221110 00 11 122334457889999999
Q ss_pred ccCCCCCC-----CHHHHHHHH
Q 021490 244 HEQPDMRP-----VIADVVTAL 260 (311)
Q Consensus 244 ~~~p~~Rp-----s~~~vl~~l 260 (311)
..||++|+ ++.++++..
T Consensus 231 ~~dP~~R~~~~~~~~~~il~h~ 252 (328)
T cd05593 231 IKDPNKRLGGGPDDAKEIMRHS 252 (328)
T ss_pred CCCHHHcCCCCCCCHHHHhcCC
Confidence 99999997 899988663
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-40 Score=282.22 Aligned_cols=244 Identities=21% Similarity=0.222 Sum_probs=183.4
Q ss_pred CCcEEEEEEeecCCC--cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHH
Q 021490 8 LLQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN 85 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~ 85 (311)
+|+.||+|+++.... ...+.+.+|+.+++.++||||+++++++..+...++||||++++.+..+... ...+++.
T Consensus 25 ~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~ 100 (287)
T cd07848 25 TKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEM----PNGVPPE 100 (287)
T ss_pred CCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCCCCHHHHHHhc----CCCCCHH
Confidence 678999999875432 2346788999999999999999999999999999999999998777655443 4579999
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccC
Q 021490 86 TRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG 165 (311)
Q Consensus 86 ~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 165 (311)
.+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++........ .......++..|+|||++.+.
T Consensus 101 ~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~ 176 (287)
T cd07848 101 KVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN-ANYTEYVATRWYRSPELLLGA 176 (287)
T ss_pred HHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCccccccccc-ccccccccccccCCcHHHcCC
Confidence 99999999999999999999 99999999999999999999999999875322211 112234578899999999888
Q ss_pred CCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhh-h-------hhccccccccccCccc------cCCCChHh
Q 021490 166 QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWAR-P-------LFQDRTRHSLIADPEL------QGQYPPRG 231 (311)
Q Consensus 166 ~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~-~-------~~~~~~~~~~~~~~~~------~~~~~~~~ 231 (311)
.++.++|||||||++|+|++|+.||......+....+.... + .+...........+.. ........
T Consensus 177 ~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (287)
T cd07848 177 PYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGIL 256 (287)
T ss_pred CCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhccc
Confidence 89999999999999999999999998655433322111110 0 0000000000000100 01111224
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 021490 232 FYQALAVAAMCVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 232 ~~~l~~li~~~l~~~p~~Rps~~~vl~~ 259 (311)
+..+.+|+.+||+.||++|||++++++.
T Consensus 257 s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 257 SGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred CHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 5678999999999999999999998864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=300.84 Aligned_cols=231 Identities=22% Similarity=0.253 Sum_probs=185.5
Q ss_pred CcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHHHH
Q 021490 9 LQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRM 88 (311)
Q Consensus 9 g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~ 88 (311)
+..||+|.+..........+.+|+.+++.++||||+++++++..+...|+||||++||+|.+++.+.......+++..+.
T Consensus 93 ~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~ 172 (478)
T PTZ00267 93 KEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVG 172 (478)
T ss_pred CeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHH
Confidence 67788887755544444577889999999999999999999999999999999999999999886543335678999999
Q ss_pred HHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccCCCc
Q 021490 89 KIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLT 168 (311)
Q Consensus 89 ~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 168 (311)
.++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++................|+..|+|||++.+..++
T Consensus 173 ~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 249 (478)
T PTZ00267 173 LLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYS 249 (478)
T ss_pred HHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCC
Confidence 99999999999999999 999999999999999999999999998754332222223334589999999999988999
Q ss_pred cccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCC
Q 021490 169 LKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPD 248 (311)
Q Consensus 169 ~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~ 248 (311)
.++|||||||++|+|++|..||...........+.. .. . ...+...+..+.+++.+||..||+
T Consensus 250 ~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~-----~~-~-----------~~~~~~~s~~~~~li~~~L~~dP~ 312 (478)
T PTZ00267 250 KKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLY-----GK-Y-----------DPFPCPVSSGMKALLDPLLSKNPA 312 (478)
T ss_pred cHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-----CC-C-----------CCCCccCCHHHHHHHHHHhccChh
Confidence 999999999999999999999976544322211110 00 0 011223345788999999999999
Q ss_pred CCCCHHHHHHH
Q 021490 249 MRPVIADVVTA 259 (311)
Q Consensus 249 ~Rps~~~vl~~ 259 (311)
+|||+.+++..
T Consensus 313 ~Rps~~~~l~~ 323 (478)
T PTZ00267 313 LRPTTQQLLHT 323 (478)
T ss_pred hCcCHHHHHhC
Confidence 99999998753
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=287.64 Aligned_cols=227 Identities=26% Similarity=0.325 Sum_probs=184.2
Q ss_pred cCCcEEEEEEeecCCC---cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCC
Q 021490 7 CLLQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLD 83 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~ 83 (311)
.+|..||+|+++.... .....+.+|+.+++.++||||+++++++..+...|+||||+++++|..++.. ...++
T Consensus 18 ~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~----~~~~~ 93 (323)
T cd05595 18 ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR----ERVFT 93 (323)
T ss_pred CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCcHHHHHHH----cCCCC
Confidence 3689999999976432 2345677899999999999999999999999999999999999999998876 56799
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccc
Q 021490 84 WNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 163 (311)
Q Consensus 84 ~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 163 (311)
+..+..++.|++.||+|||+++ ++||||||+|||++.++.++|+|||++...... ........++..|+|||++.
T Consensus 94 ~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~ 168 (323)
T cd05595 94 EERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYLAPEVLE 168 (323)
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCC--CCccccccCCcCcCCccccc
Confidence 9999999999999999999999 999999999999999999999999987642111 11122345889999999998
Q ss_pred cCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHcc
Q 021490 164 TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCV 243 (311)
Q Consensus 164 ~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 243 (311)
+..++.++|||||||++|+|++|..||...+......... .. .. .++...+..+.+++.+||
T Consensus 169 ~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~------~~--------~~----~~p~~~~~~~~~li~~~L 230 (323)
T cd05595 169 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL------ME--------EI----RFPRTLSPEAKSLLAGLL 230 (323)
T ss_pred CCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHh------cC--------CC----CCCCCCCHHHHHHHHHHc
Confidence 8899999999999999999999999997655432221111 00 00 122233457889999999
Q ss_pred ccCCCCCC-----CHHHHHHHH
Q 021490 244 HEQPDMRP-----VIADVVTAL 260 (311)
Q Consensus 244 ~~~p~~Rp-----s~~~vl~~l 260 (311)
..||.+|| ++.++++.-
T Consensus 231 ~~dP~~R~~~~~~~~~~~l~h~ 252 (323)
T cd05595 231 KKDPKQRLGGGPSDAKEVMEHR 252 (323)
T ss_pred cCCHHHhCCCCCCCHHHHHcCC
Confidence 99999998 888888653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=281.53 Aligned_cols=232 Identities=27% Similarity=0.344 Sum_probs=183.6
Q ss_pred cCCcEEEEEEeecCCC---cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCC
Q 021490 7 CLLQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLD 83 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~ 83 (311)
.+|+.||+|.+..... .....+.+|+.++..++|+||+++++++.++...++||||+++|+|.+++.... ...++
T Consensus 23 ~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~--~~~~~ 100 (285)
T cd05631 23 ATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMG--NPGFD 100 (285)
T ss_pred cCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCCCcHHHHHHhhC--CCCCC
Confidence 4789999999865432 223467889999999999999999999999999999999999999988876421 34689
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccc
Q 021490 84 WNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 163 (311)
Q Consensus 84 ~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 163 (311)
+..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++...... .......++..|+|||++.
T Consensus 101 ~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~---~~~~~~~g~~~y~aPE~~~ 174 (285)
T cd05631 101 EQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEG---ETVRGRVGTVGYMAPEVIN 174 (285)
T ss_pred HHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC---CeecCCCCCCCccCHhhhc
Confidence 9999999999999999999999 999999999999999999999999998753221 1122346889999999999
Q ss_pred cCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHcc
Q 021490 164 TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCV 243 (311)
Q Consensus 164 ~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 243 (311)
+..++.++|||||||++|+|++|..||.............. .... ....++...+..+.+|+.+||
T Consensus 175 ~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~---~~~~-----------~~~~~~~~~s~~~~~li~~~l 240 (285)
T cd05631 175 NEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDR---RVKE-----------DQEEYSEKFSEDAKSICRMLL 240 (285)
T ss_pred CCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHH---Hhhc-----------ccccCCccCCHHHHHHHHHHh
Confidence 88999999999999999999999999976543211111100 0000 001122334457889999999
Q ss_pred ccCCCCCCC-----HHHHHHHH
Q 021490 244 HEQPDMRPV-----IADVVTAL 260 (311)
Q Consensus 244 ~~~p~~Rps-----~~~vl~~l 260 (311)
+.||.+||+ ++++++.-
T Consensus 241 ~~~P~~R~~~~~~~~~~~~~h~ 262 (285)
T cd05631 241 TKNPKERLGCRGNGAAGVKQHP 262 (285)
T ss_pred hcCHHHhcCCCCCCHHHHhcCH
Confidence 999999997 78888653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=275.35 Aligned_cols=245 Identities=24% Similarity=0.287 Sum_probs=193.3
Q ss_pred CCcEEEEEEeec--CCCcchhHHHHHHHHHhcCCCCcccceeeEeee-----CCeeEEEEecCCCCChhhhhcccCCCCC
Q 021490 8 LLQDVAIKQLDR--NGVQGNREFLVEVLMLSLLHHPNLVNLIGYCAD-----GDQRLLVYEYMPLGSVEDHLHDLSPGKK 80 (311)
Q Consensus 8 ~g~~vaiK~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 80 (311)
+|..||||++.. ......++-.+|+++|+.++|+||+.+++++.. -...|+|+|+| +.+|...+++ +.
T Consensus 46 t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~elM-etDL~~iik~----~~ 120 (359)
T KOG0660|consen 46 TGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFELM-ETDLHQIIKS----QQ 120 (359)
T ss_pred CCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhHH-hhHHHHHHHc----Cc
Confidence 689999999974 344556788999999999999999999999855 24679999999 5789999987 66
Q ss_pred CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcc
Q 021490 81 PLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 160 (311)
Q Consensus 81 ~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE 160 (311)
.++...+.-+++|++.||.|+|+.+ ++||||||.|++++.+..+||+|||+++...........+..+.|.+|.|||
T Consensus 121 ~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPE 197 (359)
T KOG0660|consen 121 DLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPE 197 (359)
T ss_pred cccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccceeeccccCcccchhcceeeeeecCHH
Confidence 6999999999999999999999999 9999999999999999999999999998754332334446677899999999
Q ss_pred ccc-cCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccc---------ccc---ccccC--ccccC
Q 021490 161 YAK-TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDR---------TRH---SLIAD--PELQG 225 (311)
Q Consensus 161 ~~~-~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~---------~~~---~~~~~--~~~~~ 225 (311)
++. ...|+.+.||||.|||+.||++|++.|.+.+......++....+..... ... ..... ..+..
T Consensus 198 lll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~ 277 (359)
T KOG0660|consen 198 LLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSS 277 (359)
T ss_pred HHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHH
Confidence 774 4789999999999999999999999999988776665543322111100 000 00000 00011
Q ss_pred CCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 021490 226 QYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 261 (311)
Q Consensus 226 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l~ 261 (311)
.+ +......++|+.+||..||.+|+|++|+++...
T Consensus 278 ~f-p~a~p~AidLlekmL~fdP~kRita~eAL~hPY 312 (359)
T KOG0660|consen 278 IF-PNANPLAIDLLEKMLVFDPKKRITAEEALAHPY 312 (359)
T ss_pred Hc-CCCCHHHHHHHHHHhccCccccCCHHHHhcChh
Confidence 11 234558899999999999999999999998754
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=283.97 Aligned_cols=240 Identities=27% Similarity=0.394 Sum_probs=182.9
Q ss_pred CcEEEEEEeecCCC-cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCC----------
Q 021490 9 LQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP---------- 77 (311)
Q Consensus 9 g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------- 77 (311)
+..||+|++..... .....|.+|+.++..++||||+++++++.+....++||||+++++|.+++.....
T Consensus 46 ~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 125 (304)
T cd05096 46 PLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDA 125 (304)
T ss_pred ceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccc
Confidence 45799999875432 2345799999999999999999999999999999999999999999998865311
Q ss_pred -----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccc
Q 021490 78 -----GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMG 152 (311)
Q Consensus 78 -----~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~ 152 (311)
....+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++................+
T Consensus 126 ~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~ 202 (304)
T cd05096 126 VPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVL 202 (304)
T ss_pred cccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCC
Confidence 1234788899999999999999999999 99999999999999999999999999875332222222223345
Q ss_pred cccccCccccccCCCccccceeehhHHHHHHHh--CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChH
Q 021490 153 TYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS--GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPR 230 (311)
Q Consensus 153 ~~~y~aPE~~~~~~~~~~~DiwslG~l~~~ll~--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (311)
+..|+|||++....++.++||||||+++|+|++ +..||......... ............... ...++.
T Consensus 203 ~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~---~~~~~~~~~~~~~~~-------~~~~~~ 272 (304)
T cd05096 203 PIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVI---ENAGEFFRDQGRQVY-------LFRPPP 272 (304)
T ss_pred CccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHH---HHHHHHhhhcccccc-------ccCCCC
Confidence 778999999988889999999999999999987 56777665433221 111111111100000 011223
Q ss_pred hHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 021490 231 GFYQALAVAAMCVHEQPDMRPVIADVVTALA 261 (311)
Q Consensus 231 ~~~~l~~li~~~l~~~p~~Rps~~~vl~~l~ 261 (311)
.+..+.+|+.+||+.||.+|||+.++.+.|+
T Consensus 273 ~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 273 CPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 3457889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=276.40 Aligned_cols=237 Identities=27% Similarity=0.392 Sum_probs=192.8
Q ss_pred cchhccCCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCC
Q 021490 2 MQVILCLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKP 81 (311)
Q Consensus 2 ~~~~~~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 81 (311)
|.+...++..+++|++..........+.+|+.+++.++|+||+++++++.+....++||||+++++|.+++.... +..
T Consensus 23 y~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~ 100 (261)
T cd05148 23 WEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPE--GQV 100 (261)
T ss_pred EEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccCCHHHHHhcCC--CCC
Confidence 455666789999999977666567789999999999999999999999999999999999999999999997632 457
Q ss_pred CCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccc
Q 021490 82 LDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 161 (311)
Q Consensus 82 l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 161 (311)
+++..++.++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||.+....... .......++..|++||.
T Consensus 101 ~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~--~~~~~~~~~~~~~~PE~ 175 (261)
T cd05148 101 LPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDV--YLSSDKKIPYKWTAPEA 175 (261)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCcc--ccccCCCCceEecCHHH
Confidence 899999999999999999999999 9999999999999999999999999986532211 11112335678999999
Q ss_pred cccCCCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHH
Q 021490 162 AKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAA 240 (311)
Q Consensus 162 ~~~~~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 240 (311)
+....++.++||||||+++|+|++ |..||............. . . .....+...+..+.+++.
T Consensus 176 ~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~---~----~----------~~~~~~~~~~~~~~~~i~ 238 (261)
T cd05148 176 ASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT---A----G----------YRMPCPAKCPQEIYKIML 238 (261)
T ss_pred HccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH---h----C----------CcCCCCCCCCHHHHHHHH
Confidence 988889999999999999999998 899997655332221111 0 0 001112334457889999
Q ss_pred HccccCCCCCCCHHHHHHHHHH
Q 021490 241 MCVHEQPDMRPVIADVVTALAY 262 (311)
Q Consensus 241 ~~l~~~p~~Rps~~~vl~~l~~ 262 (311)
+||+.||.+|||+.++++.|+.
T Consensus 239 ~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 239 ECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred HHcCCCchhCcCHHHHHHHHhc
Confidence 9999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=283.29 Aligned_cols=227 Identities=26% Similarity=0.321 Sum_probs=183.4
Q ss_pred cCCcEEEEEEeecCC----CcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCC
Q 021490 7 CLLQDVAIKQLDRNG----VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPL 82 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l 82 (311)
.+|+.||+|+++... ......+.+|+.+++.++||||+++++++.++...|+||||++|++|.+++.. .+.+
T Consensus 22 ~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~ 97 (323)
T cd05584 22 DTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLER----EGIF 97 (323)
T ss_pred CCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeCCCCchHHHHHHH----cCCC
Confidence 368899999997532 12335677899999999999999999999999999999999999999999976 5678
Q ss_pred CHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccc
Q 021490 83 DWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 162 (311)
Q Consensus 83 ~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 162 (311)
.+..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++...... ........++..|+|||++
T Consensus 98 ~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~ 172 (323)
T cd05584 98 MEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHE--GTVTHTFCGTIEYMAPEIL 172 (323)
T ss_pred CHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccC--CCcccccCCCccccChhhc
Confidence 89999999999999999999999 999999999999999999999999998632111 1112234588999999999
Q ss_pred ccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHc
Q 021490 163 KTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMC 242 (311)
Q Consensus 163 ~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 242 (311)
.+..++.++|||||||++|+|++|..||...........+ .... ..+++..+..+.+++.+|
T Consensus 173 ~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~------~~~~------------~~~~~~~~~~~~~li~~~ 234 (323)
T cd05584 173 MRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKI------LKGK------------LNLPPYLTPEARDLLKKL 234 (323)
T ss_pred cCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHH------HcCC------------CCCCCCCCHHHHHHHHHH
Confidence 8888899999999999999999999999876543221111 1100 012233345788999999
Q ss_pred cccCCCCCC-----CHHHHHHHH
Q 021490 243 VHEQPDMRP-----VIADVVTAL 260 (311)
Q Consensus 243 l~~~p~~Rp-----s~~~vl~~l 260 (311)
|+.||.+|| ++.+++...
T Consensus 235 l~~~p~~R~~~~~~~~~~l~~h~ 257 (323)
T cd05584 235 LKRNPSSRLGAGPGDAAEVQSHP 257 (323)
T ss_pred cccCHhHcCCCCCCCHHHHhcCC
Confidence 999999999 788887653
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=277.91 Aligned_cols=234 Identities=27% Similarity=0.398 Sum_probs=186.7
Q ss_pred CCcEEEEEEeecCCCc-chhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccC----------
Q 021490 8 LLQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLS---------- 76 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------- 76 (311)
++..||+|+++..... ..+.|.+|++++..++|+||+++++++......++||||+++++|.+++....
T Consensus 34 ~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~ 113 (280)
T cd05049 34 DKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPD 113 (280)
T ss_pred CcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccc
Confidence 3578999999765543 45789999999999999999999999999999999999999999999987531
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccc
Q 021490 77 PGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY 156 (311)
Q Consensus 77 ~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y 156 (311)
.....+++..+..++.|++.||++||+.+ ++|+||+|+||+++.++.++|+|||++................++..|
T Consensus 114 ~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y 190 (280)
T cd05049 114 SPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRW 190 (280)
T ss_pred cccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeEEECCcccceecccCcceecCCCCccccee
Confidence 12345889999999999999999999999 999999999999999999999999998643222111112233456789
Q ss_pred cCccccccCCCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHH
Q 021490 157 CAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQA 235 (311)
Q Consensus 157 ~aPE~~~~~~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 235 (311)
+|||++.+..++.++||||||+++|+|++ |..||...........+. .. .. ...+...+..+
T Consensus 191 ~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~-------~~-~~---------~~~~~~~~~~~ 253 (280)
T cd05049 191 MPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT-------QG-RL---------LQRPRTCPSEV 253 (280)
T ss_pred cChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-------cC-Cc---------CCCCCCCCHHH
Confidence 99999999999999999999999999998 999997655443322211 00 00 01112234578
Q ss_pred HHHHHHccccCCCCCCCHHHHHHHHH
Q 021490 236 LAVAAMCVHEQPDMRPVIADVVTALA 261 (311)
Q Consensus 236 ~~li~~~l~~~p~~Rps~~~vl~~l~ 261 (311)
.+++.+||..||++|||+.|+++.|+
T Consensus 254 ~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 254 YDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 89999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=281.37 Aligned_cols=243 Identities=21% Similarity=0.255 Sum_probs=182.1
Q ss_pred CCcEEEEEEeecCCC-cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHH
Q 021490 8 LLQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNT 86 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~ 86 (311)
+|..||+|+++.... .....+.+|+.+++.++||||+++++++.++...++||||++ ++|.+++... +..+++..
T Consensus 29 ~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~---~~~~~~~~ 104 (288)
T cd07871 29 TENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLD-SDLKQYLDNC---GNLMSMHN 104 (288)
T ss_pred CCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCC-cCHHHHHHhc---CCCCCHHH
Confidence 689999999865433 234577899999999999999999999999999999999997 4899888652 34588999
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccccc-C
Q 021490 87 RMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT-G 165 (311)
Q Consensus 87 ~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~ 165 (311)
+..++.|++.||+|||+++ ++||||||+||+++.++.++|+|||++....... .......++..|+|||++.+ .
T Consensus 105 ~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~ 179 (288)
T cd07871 105 VKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT--KTYSNEVVTLWYRPPDVLLGST 179 (288)
T ss_pred HHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCC--ccccCceecccccChHHhcCCc
Confidence 9999999999999999999 9999999999999999999999999986432211 11223457889999998865 5
Q ss_pred CCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhh-hhcccc-------ccccccCccccC----CCChHhHH
Q 021490 166 QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARP-LFQDRT-------RHSLIADPELQG----QYPPRGFY 233 (311)
Q Consensus 166 ~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~-------~~~~~~~~~~~~----~~~~~~~~ 233 (311)
.++.++||||+||++|+|++|..||................. ...... .......+.... ...+....
T Consensus 180 ~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (288)
T cd07871 180 EYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDT 259 (288)
T ss_pred ccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCH
Confidence 688999999999999999999999987665443322211110 000000 000000011000 01122345
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHH
Q 021490 234 QALAVAAMCVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 234 ~l~~li~~~l~~~p~~Rps~~~vl~~ 259 (311)
++.+|+.+||+.||.+|||++|+++.
T Consensus 260 ~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 260 DGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred HHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 78899999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=284.63 Aligned_cols=224 Identities=25% Similarity=0.276 Sum_probs=184.0
Q ss_pred CCcEEEEEEeecCCC---cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCH
Q 021490 8 LLQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 84 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~ 84 (311)
+|+.||+|++..... ...+.+.+|+.+++.++||||+++++++.++...++||||+++++|.+++.. .+.+++
T Consensus 25 ~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~ 100 (291)
T cd05612 25 SEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRN----SGRFSN 100 (291)
T ss_pred CCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCCCCCHHHHHHH----cCCCCH
Confidence 689999999865432 2345788999999999999999999999999999999999999999999976 567999
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccccc
Q 021490 85 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT 164 (311)
Q Consensus 85 ~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 164 (311)
..+..++.|++.||+|||++| ++||||+|+||+++.++.++|+|||++...... .....++..|+|||++.+
T Consensus 101 ~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~ 172 (291)
T cd05612 101 STGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-----TWTLCGTPEYLAPEVIQS 172 (291)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC-----cccccCChhhcCHHHHcC
Confidence 999999999999999999999 999999999999999999999999998653221 112357899999999998
Q ss_pred CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccc
Q 021490 165 GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVH 244 (311)
Q Consensus 165 ~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 244 (311)
..++.++|||||||++|+|++|..||...........+.. .. . .++...+..+.+|+.+||.
T Consensus 173 ~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~------~~--------~----~~~~~~~~~~~~li~~~l~ 234 (291)
T cd05612 173 KGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILA------GK--------L----EFPRHLDLYAKDLIKKLLV 234 (291)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh------CC--------c----CCCccCCHHHHHHHHHHcC
Confidence 8899999999999999999999999977654332221110 00 0 1222234578899999999
Q ss_pred cCCCCCCC-----HHHHHHHHH
Q 021490 245 EQPDMRPV-----IADVVTALA 261 (311)
Q Consensus 245 ~~p~~Rps-----~~~vl~~l~ 261 (311)
.||.+||+ +.++++..+
T Consensus 235 ~dp~~R~~~~~~~~~~~l~h~~ 256 (291)
T cd05612 235 VDRTRRLGNMKNGADDVKNHRW 256 (291)
T ss_pred CCHHHccCCccCCHHHHhcCcc
Confidence 99999995 888887644
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=274.04 Aligned_cols=237 Identities=26% Similarity=0.333 Sum_probs=184.9
Q ss_pred cchhcc-CCcEEEEEEeecCC-CcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCC
Q 021490 2 MQVILC-LLQDVAIKQLDRNG-VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGK 79 (311)
Q Consensus 2 ~~~~~~-~g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~ 79 (311)
|.+... +|+.||+|.+.... ......+.+|+++++.++||||+++++++......++||||+++++|.+++... .
T Consensus 12 y~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~ 88 (252)
T cd05084 12 FSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTE---G 88 (252)
T ss_pred EEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHHHHHHhC---C
Confidence 444443 78999999876443 233467999999999999999999999999999999999999999999998652 3
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCc
Q 021490 80 KPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 159 (311)
Q Consensus 80 ~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aP 159 (311)
..+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.................+..|+||
T Consensus 89 ~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 165 (252)
T cd05084 89 PRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAP 165 (252)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCceeecCc
Confidence 46899999999999999999999999 999999999999999999999999998643211111111111234569999
Q ss_pred cccccCCCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHH
Q 021490 160 EYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAV 238 (311)
Q Consensus 160 E~~~~~~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 238 (311)
|.+.+..++.++|+||||+++|+|++ |..||............... .....+...+..+.++
T Consensus 166 E~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~l 228 (252)
T cd05084 166 EALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQG-----------------VRLPCPELCPDAVYRL 228 (252)
T ss_pred hhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcC-----------------CCCCCcccCCHHHHHH
Confidence 99988889999999999999999998 88888755443222211100 0001122334578899
Q ss_pred HHHccccCCCCCCCHHHHHHHHH
Q 021490 239 AAMCVHEQPDMRPVIADVVTALA 261 (311)
Q Consensus 239 i~~~l~~~p~~Rps~~~vl~~l~ 261 (311)
+.+||..+|++|||+.++++.|+
T Consensus 229 i~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 229 MERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HHHHcCCChhhCcCHHHHHHHHh
Confidence 99999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=287.34 Aligned_cols=225 Identities=28% Similarity=0.366 Sum_probs=192.5
Q ss_pred CCcEEEEEEeecCCC--cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHH
Q 021490 8 LLQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN 85 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~ 85 (311)
+++-||+|.+.+... ...+.+.+|+++++.|+||||+.++++|++..++++|+|||.| +|..++.+ .+.++++
T Consensus 26 t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g-~L~~il~~----d~~lpEe 100 (808)
T KOG0597|consen 26 TIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG-DLFTILEQ----DGKLPEE 100 (808)
T ss_pred ceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh-hHHHHHHh----ccCCCHH
Confidence 578999999866543 3456788999999999999999999999999999999999976 99999998 7899999
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccC
Q 021490 86 TRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG 165 (311)
Q Consensus 86 ~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 165 (311)
.+..++.++++||.|||+.+ |.|||+||+|||+..+|.+|++|||+++.+. .+..+.....||+-|||||+..+.
T Consensus 101 ~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~--~~t~vltsikGtPlYmAPElv~e~ 175 (808)
T KOG0597|consen 101 QVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMS--TNTSVLTSIKGTPLYMAPELVEEQ 175 (808)
T ss_pred HHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcc--cCceeeeeccCcccccCHHHHcCC
Confidence 99999999999999999999 9999999999999999999999999998743 355666778899999999999999
Q ss_pred CCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHcccc
Q 021490 166 QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHE 245 (311)
Q Consensus 166 ~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 245 (311)
+|+..+|.||+||++||+++|++||...........+ ..+.. ..|...+.....+++..|.+
T Consensus 176 pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I------~~d~v------------~~p~~~S~~f~nfl~gLL~k 237 (808)
T KOG0597|consen 176 PYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSI------LKDPV------------KPPSTASSSFVNFLQGLLIK 237 (808)
T ss_pred CccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHH------hcCCC------------CCcccccHHHHHHHHHHhhc
Confidence 9999999999999999999999999765543322222 22211 11234445778899999999
Q ss_pred CCCCCCCHHHHHHHH
Q 021490 246 QPDMRPVIADVVTAL 260 (311)
Q Consensus 246 ~p~~Rps~~~vl~~l 260 (311)
||.+|.|-.+++..-
T Consensus 238 dP~~RltW~~Ll~Hp 252 (808)
T KOG0597|consen 238 DPAQRLTWTDLLGHP 252 (808)
T ss_pred ChhhcccHHHHhcCh
Confidence 999999999998664
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=285.89 Aligned_cols=236 Identities=24% Similarity=0.243 Sum_probs=190.5
Q ss_pred cchhcc----CCcEEEEEEeecCCCcc---hhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcc
Q 021490 2 MQVILC----LLQDVAIKQLDRNGVQG---NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHD 74 (311)
Q Consensus 2 ~~~~~~----~g~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 74 (311)
++|.|+ .|.-+|+|++++..... .+.+..|-.+|...++|+||+++..|++.+.+||||||++||++..+|..
T Consensus 155 GeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPGGD~mTLL~~ 234 (550)
T KOG0605|consen 155 GEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPGGDMMTLLMR 234 (550)
T ss_pred eeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCCccHHHHHHh
Confidence 455555 69999999998865533 35677799999999999999999999999999999999999999999987
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCC-------------
Q 021490 75 LSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG------------- 141 (311)
Q Consensus 75 ~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~------------- 141 (311)
...|++..+..++.+++.||..+|+.| ++||||||+|+||+..|++||+|||++.-....
T Consensus 235 ----~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~ 307 (550)
T KOG0605|consen 235 ----KDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQ 307 (550)
T ss_pred ----cCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhhhhhhhhhhcchhhhh
Confidence 789999999999999999999999999 999999999999999999999999998421100
Q ss_pred ------C--Cce-----ee-------------------eeccccccccCccccccCCCccccceeehhHHHHHHHhCCCc
Q 021490 142 ------D--NTH-----VS-------------------TRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKA 189 (311)
Q Consensus 142 ------~--~~~-----~~-------------------~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~l~~~ll~g~~p 189 (311)
. ... .. ...+||+.|+|||++.+..|+..+|+||||||+||||.|.+|
T Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPP 387 (550)
T KOG0605|consen 308 INLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPP 387 (550)
T ss_pred hhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHHHHhCCCC
Confidence 0 000 00 124699999999999999999999999999999999999999
Q ss_pred cCcchhHHHH-HHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCC---CHHHHHHHH
Q 021490 190 VDTSKAAAEQ-SLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRP---VIADVVTAL 260 (311)
Q Consensus 190 f~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---s~~~vl~~l 260 (311)
|......... .+..|...+.... ....+.+..+||.+||. ||+.|. .++||-+..
T Consensus 388 F~s~tp~~T~rkI~nwr~~l~fP~---------------~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HP 446 (550)
T KOG0605|consen 388 FCSETPQETYRKIVNWRETLKFPE---------------EVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHP 446 (550)
T ss_pred CCCCCHHHHHHHHHHHhhhccCCC---------------cCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCC
Confidence 9887766554 3444442221110 11123588899999999 999996 466666553
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=278.42 Aligned_cols=239 Identities=26% Similarity=0.379 Sum_probs=189.0
Q ss_pred CCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccC---------CC
Q 021490 8 LLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLS---------PG 78 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------~~ 78 (311)
++..+|+|.+........+.+.+|+.++.+++||||+++++++......++||||+++++|.+++.... ..
T Consensus 34 ~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~ 113 (288)
T cd05093 34 DKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNR 113 (288)
T ss_pred cceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCC
Confidence 356689999876555556789999999999999999999999999999999999999999999987532 11
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccC
Q 021490 79 KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCA 158 (311)
Q Consensus 79 ~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~a 158 (311)
...+++..++.++.|++.||+|||+.+ ++||||+|+||++++++.++|+|||++................++..|+|
T Consensus 114 ~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~a 190 (288)
T cd05093 114 PAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMP 190 (288)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccC
Confidence 235899999999999999999999999 99999999999999999999999999864322211111222334678999
Q ss_pred ccccccCCCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHH
Q 021490 159 PEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALA 237 (311)
Q Consensus 159 PE~~~~~~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 237 (311)
||++.+..++.++||||||+++|+|++ |..||...........+... . ... .+...+..+.+
T Consensus 191 PE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~------~-------~~~----~~~~~~~~l~~ 253 (288)
T cd05093 191 PESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQG------R-------VLQ----RPRTCPKEVYD 253 (288)
T ss_pred HHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC------C-------cCC----CCCCCCHHHHH
Confidence 999988889999999999999999998 89999766543322111100 0 000 11123347899
Q ss_pred HHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 021490 238 VAAMCVHEQPDMRPVIADVVTALAYLASQ 266 (311)
Q Consensus 238 li~~~l~~~p~~Rps~~~vl~~l~~~~~~ 266 (311)
|+.+||+.||.+|||+.++++.|+.+...
T Consensus 254 li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 254 LMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred HHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 99999999999999999999999887743
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=270.34 Aligned_cols=248 Identities=20% Similarity=0.260 Sum_probs=191.3
Q ss_pred cCCcEEEEEEeecCCC-c-chhHHHHHHHHHhcCCCCc-ccceeeEeeeCC------eeEEEEecCCCCChhhhhcccCC
Q 021490 7 CLLQDVAIKQLDRNGV-Q-GNREFLVEVLMLSLLHHPN-LVNLIGYCADGD------QRLLVYEYMPLGSVEDHLHDLSP 77 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~-~-~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~ 77 (311)
.+|+.||+|++.-... + .-....+|+.+++.|+|+| |+.+++++.... .+++|+||++ .+|..++.....
T Consensus 34 ~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~d-~DL~~ymd~~~~ 112 (323)
T KOG0594|consen 34 RTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFLD-RDLKKYMDSLPK 112 (323)
T ss_pred cCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEEEeec-ccHHHHHHhccc
Confidence 3789999999876654 2 2356789999999999999 999999998777 7899999995 799999988653
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeecccccccc
Q 021490 78 GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 157 (311)
Q Consensus 78 ~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~ 157 (311)
....++...+..++.|++.||+|||+++ |+||||||+||+++++|.+||+|||+++..... .......+.|.+|.
T Consensus 113 ~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip--~~~yt~evvTlWYR 187 (323)
T KOG0594|consen 113 KPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGLARAFSIP--MRTYTPEVVTLWYR 187 (323)
T ss_pred cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccchHHHhcCC--cccccccEEEeecc
Confidence 3357888999999999999999999999 999999999999999999999999999853322 22244456889999
Q ss_pred CccccccC-CCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCC--------
Q 021490 158 APEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYP-------- 228 (311)
Q Consensus 158 aPE~~~~~-~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 228 (311)
|||++.+. .|+...||||+|||+.||+++++-|.+....+....+-................-+.....++
T Consensus 188 aPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l 267 (323)
T KOG0594|consen 188 APEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDL 267 (323)
T ss_pred CHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccch
Confidence 99998775 789999999999999999999999998887555443322211111111111111111111111
Q ss_pred ----hHhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 021490 229 ----PRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 260 (311)
Q Consensus 229 ----~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l 260 (311)
+.......+++.+||+++|+.|.|+..++..-
T Consensus 268 ~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~ 303 (323)
T KOG0594|consen 268 SSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHP 303 (323)
T ss_pred HHhccccCccHHHHHHHHhccCcccCcCHHHHhcCh
Confidence 11124788899999999999999999999873
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=277.97 Aligned_cols=233 Identities=32% Similarity=0.467 Sum_probs=186.0
Q ss_pred cEEEEEEeecCCC-cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCC-----------
Q 021490 10 QDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP----------- 77 (311)
Q Consensus 10 ~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----------- 77 (311)
..||+|.++.... .....|.+|+.++..++||||+++++++......+++|||+++++|.+++.....
T Consensus 36 ~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 115 (283)
T cd05048 36 TSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDE 115 (283)
T ss_pred eeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccc
Confidence 6799999865443 2345789999999999999999999999988899999999999999999876321
Q ss_pred -CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccc
Q 021490 78 -GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY 156 (311)
Q Consensus 78 -~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y 156 (311)
....+++..++.++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++................++..|
T Consensus 116 ~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y 192 (283)
T cd05048 116 TVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRW 192 (283)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccc
Confidence 1156889999999999999999999999 999999999999999999999999998653222222222334467889
Q ss_pred cCccccccCCCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHH
Q 021490 157 CAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQA 235 (311)
Q Consensus 157 ~aPE~~~~~~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 235 (311)
+|||.+....++.++|||||||++|+|++ |..||......+....+.. .. ....+...+..+
T Consensus 193 ~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~-------~~----------~~~~~~~~~~~~ 255 (283)
T cd05048 193 MPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRS-------RQ----------LLPCPEDCPARV 255 (283)
T ss_pred cCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc-------CC----------cCCCcccCCHHH
Confidence 99999988889999999999999999998 9999976554332221110 00 001123344688
Q ss_pred HHHHHHccccCCCCCCCHHHHHHHHHH
Q 021490 236 LAVAAMCVHEQPDMRPVIADVVTALAY 262 (311)
Q Consensus 236 ~~li~~~l~~~p~~Rps~~~vl~~l~~ 262 (311)
.+|+.+||+.||++|||+.++++.|+.
T Consensus 256 ~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 256 YALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=273.45 Aligned_cols=233 Identities=26% Similarity=0.396 Sum_probs=186.4
Q ss_pred cCCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHH
Q 021490 7 CLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNT 86 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~ 86 (311)
..+..||+|+++.. ......+.+|+++++.++|+||+++++++..+...+++|||+++++|.+++.... ...+++..
T Consensus 29 ~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~l~~~~ 105 (263)
T cd05052 29 KYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN--RQEVNAVV 105 (263)
T ss_pred cCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcHHHHHHhCC--CCCCCHHH
Confidence 35889999998643 3456789999999999999999999999999999999999999999999987532 35689999
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccCC
Q 021490 87 RMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ 166 (311)
Q Consensus 87 ~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 166 (311)
++.++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++........ ........+..|+|||.+.+..
T Consensus 106 ~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~ 181 (263)
T cd05052 106 LLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNK 181 (263)
T ss_pred HHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccccee-eccCCCCCccccCCHHHhccCC
Confidence 9999999999999999999 99999999999999999999999999875322111 1111122356799999998889
Q ss_pred CccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHcccc
Q 021490 167 LTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHE 245 (311)
Q Consensus 167 ~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 245 (311)
++.++||||||+++|+|++ |..||............. .. .....+...+..+.+++.+||..
T Consensus 182 ~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~-------~~----------~~~~~~~~~~~~~~~li~~cl~~ 244 (263)
T cd05052 182 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-------KG----------YRMERPEGCPPKVYELMRACWQW 244 (263)
T ss_pred CCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-------CC----------CCCCCCCCCCHHHHHHHHHHccC
Confidence 9999999999999999998 899997655433221111 00 00111223345788999999999
Q ss_pred CCCCCCCHHHHHHHHHHh
Q 021490 246 QPDMRPVIADVVTALAYL 263 (311)
Q Consensus 246 ~p~~Rps~~~vl~~l~~~ 263 (311)
||++|||+.++++.|+.+
T Consensus 245 ~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 245 NPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CcccCCCHHHHHHHHHhh
Confidence 999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=279.28 Aligned_cols=231 Identities=35% Similarity=0.517 Sum_probs=179.9
Q ss_pred CCcEEEEEEeecCCC-cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHH
Q 021490 8 LLQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNT 86 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~ 86 (311)
.+..|+||.++.... ...+.|.+|++.+++++||||+++++++......++|+||+++|+|.+++... ....+++..
T Consensus 27 ~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~~~g~L~~~L~~~--~~~~~~~~~ 104 (259)
T PF07714_consen 27 KNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYCPGGSLDDYLKSK--NKEPLSEQQ 104 (259)
T ss_dssp SEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--TTEBHHHHHHHT--CTTTSBHHH
T ss_pred CCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccccccccccccccc--ccccccccc
Confidence 578999999965433 33689999999999999999999999999888899999999999999999883 136799999
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccCC
Q 021490 87 RMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ 166 (311)
Q Consensus 87 ~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 166 (311)
++.|+.|++.||+|||+.+ ++|++|+++||+++.++.+||+|||++....................|+|||.+....
T Consensus 105 ~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~ 181 (259)
T PF07714_consen 105 RLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGE 181 (259)
T ss_dssp HHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSE
T ss_pred ccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999999999999 9999999999999999999999999987642222222233345678899999999888
Q ss_pred CccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHcccc
Q 021490 167 LTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHE 245 (311)
Q Consensus 167 ~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 245 (311)
++.++||||||+++|||++ |..||...........+.... . ...+...+..+.+++..||..
T Consensus 182 ~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~-------~----------~~~~~~~~~~~~~li~~C~~~ 244 (259)
T PF07714_consen 182 YTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQ-------R----------LPIPDNCPKDIYSLIQQCWSH 244 (259)
T ss_dssp ESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTE-------E----------TTSBTTSBHHHHHHHHHHT-S
T ss_pred ccccccccccccccccccccccccccccccccccccccccc-------c----------ceeccchhHHHHHHHHHHcCC
Confidence 9999999999999999999 679987765433222111110 0 011222344788899999999
Q ss_pred CCCCCCCHHHHHHHH
Q 021490 246 QPDMRPVIADVVTAL 260 (311)
Q Consensus 246 ~p~~Rps~~~vl~~l 260 (311)
||.+|||+.++++.|
T Consensus 245 ~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 245 DPEKRPSFQEILQEL 259 (259)
T ss_dssp SGGGS--HHHHHHHH
T ss_pred ChhhCcCHHHHHhcC
Confidence 999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=290.45 Aligned_cols=238 Identities=26% Similarity=0.405 Sum_probs=184.1
Q ss_pred CCcEEEEEEeecCCC-cchhHHHHHHHHHhcC-CCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccC---------
Q 021490 8 LLQDVAIKQLDRNGV-QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLS--------- 76 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------- 76 (311)
++..||+|+++.... ...+.+.+|+++++.+ +|+||+++++++......++||||+++|+|.+++....
T Consensus 67 ~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~ 146 (374)
T cd05106 67 NVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMA 146 (374)
T ss_pred ccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhcccccc
Confidence 456899999975432 3346788999999999 89999999999999999999999999999999885421
Q ss_pred ---------------------------------------------------------CCCCCCCHHHHHHHHHHHHHHHH
Q 021490 77 ---------------------------------------------------------PGKKPLDWNTRMKIAAGAARGLE 99 (311)
Q Consensus 77 ---------------------------------------------------------~~~~~l~~~~~~~~~~~i~~~l~ 99 (311)
.....+++..++.++.|++.||+
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~ 226 (374)
T cd05106 147 LPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMD 226 (374)
T ss_pred ccccccccccccccchhcccccccccccccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHH
Confidence 01235788899999999999999
Q ss_pred HhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccCCCccccceeehhHH
Q 021490 100 YLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVV 179 (311)
Q Consensus 100 ~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~l 179 (311)
|||+++ ++||||||+||++++++.++|+|||++................++..|+|||++.+..++.++|||||||+
T Consensus 227 yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvi 303 (374)
T cd05106 227 FLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGIL 303 (374)
T ss_pred HHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHH
Confidence 999999 99999999999999999999999999865332221111222234567999999988889999999999999
Q ss_pred HHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 021490 180 LLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 258 (311)
Q Consensus 180 ~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~ 258 (311)
+|+|++ |..||......... ... ..... . ...+...+.++.+++.+||+.||++|||+.++++
T Consensus 304 l~ellt~G~~Pf~~~~~~~~~--~~~----~~~~~------~----~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 304 LWEIFSLGKSPYPGILVNSKF--YKM----VKRGY------Q----MSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred HHHHHhCCCCCCccccccHHH--HHH----HHccc------C----ccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 999997 99999765432211 000 00000 0 0111122357889999999999999999999999
Q ss_pred HHHHhh
Q 021490 259 ALAYLA 264 (311)
Q Consensus 259 ~l~~~~ 264 (311)
.|+.+.
T Consensus 368 ~l~~~~ 373 (374)
T cd05106 368 LIQRQL 373 (374)
T ss_pred HHHHHh
Confidence 998753
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=276.46 Aligned_cols=238 Identities=26% Similarity=0.401 Sum_probs=189.4
Q ss_pred CCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCC----------
Q 021490 8 LLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP---------- 77 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------- 77 (311)
++..+++|.++.......+.+.+|+.+++.++|+||+++++++......++||||+++++|.+++.....
T Consensus 34 ~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~ 113 (291)
T cd05094 34 DKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQP 113 (291)
T ss_pred cceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEecCCCCcHHHHHHhcCccccccccccc
Confidence 4567899988655555557899999999999999999999999999999999999999999999875321
Q ss_pred --CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeecccccc
Q 021490 78 --GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG 155 (311)
Q Consensus 78 --~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~ 155 (311)
....+++..++.++.|++.||+|||+++ ++|+||+|+||+++.++.++|+|||++................++..
T Consensus 114 ~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~ 190 (291)
T cd05094 114 RQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 190 (291)
T ss_pred ccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCccee
Confidence 1245899999999999999999999999 99999999999999999999999999864322221112223345778
Q ss_pred ccCccccccCCCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHH
Q 021490 156 YCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQ 234 (311)
Q Consensus 156 y~aPE~~~~~~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
|+|||.+.+..++.++||||||+++|+|++ |..||............ ...... ..+...+..
T Consensus 191 y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~-------~~~~~~----------~~~~~~~~~ 253 (291)
T cd05094 191 WMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECI-------TQGRVL----------ERPRVCPKE 253 (291)
T ss_pred ecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-------hCCCCC----------CCCccCCHH
Confidence 999999988889999999999999999998 99998765543322111 000000 011123447
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHHHHHhhh
Q 021490 235 ALAVAAMCVHEQPDMRPVIADVVTALAYLAS 265 (311)
Q Consensus 235 l~~li~~~l~~~p~~Rps~~~vl~~l~~~~~ 265 (311)
+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus 254 ~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 254 VYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred HHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 8899999999999999999999999998854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=272.29 Aligned_cols=237 Identities=28% Similarity=0.388 Sum_probs=188.8
Q ss_pred cchhccCCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCC
Q 021490 2 MQVILCLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKP 81 (311)
Q Consensus 2 ~~~~~~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 81 (311)
|.+...+++.||+|.++... ...+.+.+|+.+++.++||||+++++++......++||||+++++|.+++.... +..
T Consensus 23 ~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~ 99 (261)
T cd05068 23 WEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGA--GRA 99 (261)
T ss_pred EEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCCcHHHHHhccC--CCC
Confidence 44556677889999986443 346789999999999999999999999999999999999999999999997632 356
Q ss_pred CCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccc
Q 021490 82 LDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 161 (311)
Q Consensus 82 l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 161 (311)
+++..+..++.+++.||.+||+.+ ++|+||+|+||+++.++.++|+|||++....... .........+..|+|||.
T Consensus 100 ~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~ 175 (261)
T cd05068 100 LKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDI-YEAREGAKFPIKWTAPEA 175 (261)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCc-ccccCCCcCceeccCccc
Confidence 899999999999999999999999 9999999999999999999999999987543211 111111223457999999
Q ss_pred cccCCCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHH
Q 021490 162 AKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAA 240 (311)
Q Consensus 162 ~~~~~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 240 (311)
+.+..++.++|+||||+++|+|++ |..||...........+. .... ...+...+..+.+++.
T Consensus 176 ~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~-------~~~~----------~~~~~~~~~~~~~li~ 238 (261)
T cd05068 176 ALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD-------QGYR----------MPCPPGCPKELYDIML 238 (261)
T ss_pred cccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-------cCCC----------CCCCCcCCHHHHHHHH
Confidence 988889999999999999999999 999997654332221110 0000 0112233457889999
Q ss_pred HccccCCCCCCCHHHHHHHHHH
Q 021490 241 MCVHEQPDMRPVIADVVTALAY 262 (311)
Q Consensus 241 ~~l~~~p~~Rps~~~vl~~l~~ 262 (311)
+||+.+|.+||++.++++.|+.
T Consensus 239 ~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 239 DCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred HHhhcCcccCCCHHHHHHHHhc
Confidence 9999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=282.77 Aligned_cols=224 Identities=29% Similarity=0.387 Sum_probs=178.1
Q ss_pred cCCcEEEEEEeecCC---CcchhHHHHHHHHHhcC-CCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCC
Q 021490 7 CLLQDVAIKQLDRNG---VQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPL 82 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l 82 (311)
.+|+.||+|+++... ....+.+..|..++..+ +||||+++++++..+...++||||++|++|..++.. ...+
T Consensus 18 ~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~~~~----~~~~ 93 (316)
T cd05592 18 GTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQS----SGRF 93 (316)
T ss_pred CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCcHHHHHHH----cCCC
Confidence 357889999997542 22334566677777654 899999999999999999999999999999999876 5679
Q ss_pred CHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccc
Q 021490 83 DWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 162 (311)
Q Consensus 83 ~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 162 (311)
++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++....... .......|+..|+|||++
T Consensus 94 ~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~ 168 (316)
T cd05592 94 DEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKASTFCGTPDYIAPEIL 168 (316)
T ss_pred CHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--CccccccCCccccCHHHH
Confidence 99999999999999999999999 9999999999999999999999999986422211 222334589999999999
Q ss_pred ccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHc
Q 021490 163 KTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMC 242 (311)
Q Consensus 163 ~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 242 (311)
.+..++.++|||||||++|+|++|..||...........+. .. .+ .++...+..+.+++.+|
T Consensus 169 ~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~------~~--------~~----~~~~~~~~~~~~ll~~~ 230 (316)
T cd05592 169 KGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSIL------ND--------RP----HFPRWISKEAKDCLSKL 230 (316)
T ss_pred cCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHH------cC--------CC----CCCCCCCHHHHHHHHHH
Confidence 98889999999999999999999999998765432221111 00 01 12223345778899999
Q ss_pred cccCCCCCCCHHHHH
Q 021490 243 VHEQPDMRPVIADVV 257 (311)
Q Consensus 243 l~~~p~~Rps~~~vl 257 (311)
|..||.+||++.+.+
T Consensus 231 l~~~P~~R~~~~~~l 245 (316)
T cd05592 231 FERDPTKRLGVDGDI 245 (316)
T ss_pred ccCCHHHcCCChHHH
Confidence 999999999986433
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=284.60 Aligned_cols=227 Identities=26% Similarity=0.324 Sum_probs=184.1
Q ss_pred cCCcEEEEEEeecCCC---cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCC
Q 021490 7 CLLQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLD 83 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~ 83 (311)
.+|..||+|+++.... .....+.+|++++..++||||+++++++.++...|+||||+++++|..++.. ...++
T Consensus 18 ~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~----~~~l~ 93 (325)
T cd05594 18 ATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSR----ERVFS 93 (325)
T ss_pred CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCcHHHHHHh----cCCCC
Confidence 4789999999976432 2345678899999999999999999999999999999999999999998876 56799
Q ss_pred HHHHHHHHHHHHHHHHHhhc-CCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccc
Q 021490 84 WNTRMKIAAGAARGLEYLHD-KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 162 (311)
Q Consensus 84 ~~~~~~~~~~i~~~l~~lh~-~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 162 (311)
+..+..++.|++.||+|||+ .+ ++||||||+|||++.++.++|+|||++...... ........++..|+|||++
T Consensus 94 ~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~ 168 (325)
T cd05594 94 EDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--GATMKTFCGTPEYLAPEVL 168 (325)
T ss_pred HHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCC--CcccccccCCcccCCHHHH
Confidence 99999999999999999997 78 999999999999999999999999998642111 1112234588999999999
Q ss_pred ccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHc
Q 021490 163 KTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMC 242 (311)
Q Consensus 163 ~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 242 (311)
.+..++.++|||||||++|+|++|..||...........+... .. .++...+..+.+++.+|
T Consensus 169 ~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~--------------~~----~~p~~~~~~~~~li~~~ 230 (325)
T cd05594 169 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME--------------EI----RFPRTLSPEAKSLLSGL 230 (325)
T ss_pred ccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcC--------------CC----CCCCCCCHHHHHHHHHH
Confidence 8889999999999999999999999999765543322221100 00 11223345788999999
Q ss_pred cccCCCCCC-----CHHHHHHHH
Q 021490 243 VHEQPDMRP-----VIADVVTAL 260 (311)
Q Consensus 243 l~~~p~~Rp-----s~~~vl~~l 260 (311)
|..||++|+ ++.++++..
T Consensus 231 L~~dP~~R~~~~~~~~~~il~h~ 253 (325)
T cd05594 231 LKKDPKQRLGGGPDDAKEIMQHK 253 (325)
T ss_pred hhcCHHHhCCCCCCCHHHHhcCC
Confidence 999999996 899988663
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=277.74 Aligned_cols=234 Identities=24% Similarity=0.320 Sum_probs=183.6
Q ss_pred cCCcEEEEEEeecCCCc---chhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCC
Q 021490 7 CLLQDVAIKQLDRNGVQ---GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLD 83 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~ 83 (311)
.+|+.||+|++...... ..+.+..|+++++.++|+||+++.+++..+...++||||++|++|..++.........++
T Consensus 16 ~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~ 95 (280)
T cd05608 16 ATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFP 95 (280)
T ss_pred cCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCHHHHHHhccccCCCCC
Confidence 36889999998654322 235677899999999999999999999999999999999999999988755433356799
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccc
Q 021490 84 WNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 163 (311)
Q Consensus 84 ~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 163 (311)
+..+..++.|++.||+|||+.+ ++||||+|+||+++.++.++|+|||++....... .......++..|+|||++.
T Consensus 96 ~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~ 170 (280)
T cd05608 96 EPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ--SKTKGYAGTPGFMAPELLQ 170 (280)
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCC--ccccccCCCcCccCHHHhc
Confidence 9999999999999999999999 9999999999999999999999999986432221 1122345788999999999
Q ss_pred cCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHcc
Q 021490 164 TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCV 243 (311)
Q Consensus 164 ~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 243 (311)
+..++.++|+||||+++|+|++|..||............ ....... ...++...+..+.+++.+||
T Consensus 171 ~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~--~~~~~~~------------~~~~~~~~~~~~~~li~~~l 236 (280)
T cd05608 171 GEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL--KQRILND------------SVTYPDKFSPASKSFCEALL 236 (280)
T ss_pred CCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHH--HHhhccc------------CCCCcccCCHHHHHHHHHHh
Confidence 999999999999999999999999999754322111100 0000000 01122334557889999999
Q ss_pred ccCCCCCC-----CHHHHHHH
Q 021490 244 HEQPDMRP-----VIADVVTA 259 (311)
Q Consensus 244 ~~~p~~Rp-----s~~~vl~~ 259 (311)
+.||++|| ++++++..
T Consensus 237 ~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 237 AKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred cCCHHHhcCCCCCCHHHHhcC
Confidence 99999999 66777765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=270.90 Aligned_cols=234 Identities=25% Similarity=0.396 Sum_probs=185.9
Q ss_pred cchhccCCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCC
Q 021490 2 MQVILCLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKP 81 (311)
Q Consensus 2 ~~~~~~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 81 (311)
|.+...++..+|+|.+... ......|.+|+.+++.++||||+++++++.+....++||||+++++|.+++... ...
T Consensus 21 y~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~---~~~ 96 (256)
T cd05114 21 HLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQR---QGK 96 (256)
T ss_pred EEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHHHHHHhC---ccC
Confidence 5556667788999988543 344578899999999999999999999999999999999999999999998752 246
Q ss_pred CCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccc
Q 021490 82 LDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 161 (311)
Q Consensus 82 l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 161 (311)
+++..++.++.+++.||+|||+.+ ++|+||+|+||+++.++.++|+|||.+........ .......++..|+|||.
T Consensus 97 ~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~-~~~~~~~~~~~y~aPE~ 172 (256)
T cd05114 97 LSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-TSSSGAKFPVKWSPPEV 172 (256)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCce-eccCCCCCchhhCChhh
Confidence 899999999999999999999999 99999999999999999999999998865322111 11112234567999999
Q ss_pred cccCCCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHH
Q 021490 162 AKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAA 240 (311)
Q Consensus 162 ~~~~~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 240 (311)
+.+..++.++|+||||+++|+|++ |..||...........+... . .... +...+..+.+++.
T Consensus 173 ~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~-------~---~~~~-------~~~~~~~~~~li~ 235 (256)
T cd05114 173 FNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRG-------F---RLYR-------PKLASMTVYEVMY 235 (256)
T ss_pred cccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC-------C---CCCC-------CCCCCHHHHHHHH
Confidence 988889999999999999999999 89999766543322221110 0 0001 1112347889999
Q ss_pred HccccCCCCCCCHHHHHHHH
Q 021490 241 MCVHEQPDMRPVIADVVTAL 260 (311)
Q Consensus 241 ~~l~~~p~~Rps~~~vl~~l 260 (311)
+||..+|.+|||+.++++.|
T Consensus 236 ~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 236 SCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred HHccCCcccCcCHHHHHHhh
Confidence 99999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=279.15 Aligned_cols=233 Identities=26% Similarity=0.418 Sum_probs=184.6
Q ss_pred EEEEEEeecCCC-cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHHHHH
Q 021490 11 DVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMK 89 (311)
Q Consensus 11 ~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~ 89 (311)
.||+|+++.... ...+.+.+|+.+++.++||||+++++++... ..++|++|+++|+|.+++... ...+++..++.
T Consensus 38 ~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~e~~~~g~l~~~l~~~---~~~~~~~~~~~ 113 (316)
T cd05108 38 PVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREH---KDNIGSQYLLN 113 (316)
T ss_pred eEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-CceeeeecCCCCCHHHHHHhc---cccCCHHHHHH
Confidence 489999865432 3456889999999999999999999998764 578999999999999998862 34688999999
Q ss_pred HHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccCCCcc
Q 021490 90 IAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTL 169 (311)
Q Consensus 90 ~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 169 (311)
++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++.................+..|++||.+.+..++.
T Consensus 114 ~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~ 190 (316)
T cd05108 114 WCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTH 190 (316)
T ss_pred HHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccccCCCcceeccCCccceeecChHHhccCCCCc
Confidence 9999999999999999 9999999999999999999999999997643322222222233456899999998889999
Q ss_pred ccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCC
Q 021490 170 KSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPD 248 (311)
Q Consensus 170 ~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~ 248 (311)
++||||||+++|+|++ |..||............. .... ...++.....+.+++.+||..||.
T Consensus 191 ~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~-------~~~~----------~~~~~~~~~~~~~li~~cl~~~p~ 253 (316)
T cd05108 191 QSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-------KGER----------LPQPPICTIDVYMIMVKCWMIDAD 253 (316)
T ss_pred hhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh-------CCCC----------CCCCCCCCHHHHHHHHHHccCChh
Confidence 9999999999999998 999997654433222111 0000 011122334788899999999999
Q ss_pred CCCCHHHHHHHHHHhhhcc
Q 021490 249 MRPVIADVVTALAYLASQK 267 (311)
Q Consensus 249 ~Rps~~~vl~~l~~~~~~~ 267 (311)
+|||+.+++..+..+....
T Consensus 254 ~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 254 SRPKFRELIIEFSKMARDP 272 (316)
T ss_pred hCcCHHHHHHHHHHHHcCC
Confidence 9999999999998877554
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=289.41 Aligned_cols=236 Identities=28% Similarity=0.406 Sum_probs=183.2
Q ss_pred CCcEEEEEEeecCC-CcchhHHHHHHHHHhcC-CCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCC--------
Q 021490 8 LLQDVAIKQLDRNG-VQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP-------- 77 (311)
Q Consensus 8 ~g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-------- 77 (311)
.+..||+|+++... ....+.+.+|+.++..+ +||||+++++++.+....++||||++||+|.+++.....
T Consensus 64 ~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~ 143 (375)
T cd05104 64 AAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHE 143 (375)
T ss_pred cceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcceeeehhccCCcHHHHHHhccccccccccc
Confidence 46789999996543 23346788999999999 899999999999999999999999999999999865210
Q ss_pred ---------------------------------------------------------------CCCCCCHHHHHHHHHHH
Q 021490 78 ---------------------------------------------------------------GKKPLDWNTRMKIAAGA 94 (311)
Q Consensus 78 ---------------------------------------------------------------~~~~l~~~~~~~~~~~i 94 (311)
....+++..+..++.|+
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi 223 (375)
T cd05104 144 DHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQV 223 (375)
T ss_pred chhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHH
Confidence 11257888999999999
Q ss_pred HHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccCCCcccccee
Q 021490 95 ARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVY 174 (311)
Q Consensus 95 ~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diw 174 (311)
+.||+|||+.+ ++||||||+||+++.++.++|+|||++................++..|+|||++.+..++.++|||
T Consensus 224 ~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~ 300 (375)
T cd05104 224 AKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVW 300 (375)
T ss_pred HHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHH
Confidence 99999999999 999999999999999999999999998754322221112223345679999999988999999999
Q ss_pred ehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCH
Q 021490 175 SFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVI 253 (311)
Q Consensus 175 slG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~ 253 (311)
||||++|+|++ |..||........ .... ....... ..+...+.++.+|+.+||..||++|||+
T Consensus 301 slG~~l~ellt~g~~p~~~~~~~~~--~~~~----~~~~~~~----------~~~~~~~~~l~~li~~cl~~dP~~RPs~ 364 (375)
T cd05104 301 SYGILLWEIFSLGSSPYPGMPVDSK--FYKM----IKEGYRM----------LSPECAPSEMYDIMKSCWDADPLKRPTF 364 (375)
T ss_pred HHHHHHHHHHhcCCCCCCCCCchHH--HHHH----HHhCccC----------CCCCCCCHHHHHHHHHHccCChhHCcCH
Confidence 99999999998 8889876432211 1111 1111000 0111223478899999999999999999
Q ss_pred HHHHHHHHH
Q 021490 254 ADVVTALAY 262 (311)
Q Consensus 254 ~~vl~~l~~ 262 (311)
.++++.|+.
T Consensus 365 ~eil~~l~~ 373 (375)
T cd05104 365 KQIVQLIEQ 373 (375)
T ss_pred HHHHHHHHh
Confidence 999999974
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=282.44 Aligned_cols=223 Identities=28% Similarity=0.401 Sum_probs=178.8
Q ss_pred CCcEEEEEEeecCC---CcchhHHHHHHHHHhcC-CCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCC
Q 021490 8 LLQDVAIKQLDRNG---VQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLD 83 (311)
Q Consensus 8 ~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~ 83 (311)
+|..||+|+++... ......+..|..++..+ +||||+++++++.++...|+||||+.|++|..++.. ...++
T Consensus 19 ~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~----~~~~~ 94 (316)
T cd05620 19 KGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQD----KGRFD 94 (316)
T ss_pred CCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCCcHHHHHHH----cCCCC
Confidence 68899999997642 23345667788888755 899999999999999999999999999999999876 56789
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccc
Q 021490 84 WNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 163 (311)
Q Consensus 84 ~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 163 (311)
+..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++...... ........|+..|+|||++.
T Consensus 95 ~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~ 169 (316)
T cd05620 95 LYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG--DNRASTFCGTPDYIAPEILQ 169 (316)
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccC--CCceeccCCCcCccCHHHHc
Confidence 9999999999999999999999 999999999999999999999999987632111 11223346899999999999
Q ss_pred cCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHcc
Q 021490 164 TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCV 243 (311)
Q Consensus 164 ~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 243 (311)
+..++.++|||||||++|+|++|..||...........+... .+ .++...+.++.+++.+||
T Consensus 170 ~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~--------------~~----~~~~~~~~~~~~li~~~l 231 (316)
T cd05620 170 GLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD--------------TP----HYPRWITKESKDILEKLF 231 (316)
T ss_pred CCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--------------CC----CCCCCCCHHHHHHHHHHc
Confidence 889999999999999999999999999765543222111100 01 112223457888999999
Q ss_pred ccCCCCCCCHH-HHH
Q 021490 244 HEQPDMRPVIA-DVV 257 (311)
Q Consensus 244 ~~~p~~Rps~~-~vl 257 (311)
..||.+||++. +++
T Consensus 232 ~~dP~~R~~~~~~~~ 246 (316)
T cd05620 232 ERDPTRRLGVVGNIR 246 (316)
T ss_pred cCCHHHcCCChHHHH
Confidence 99999999985 444
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=282.39 Aligned_cols=222 Identities=25% Similarity=0.294 Sum_probs=180.1
Q ss_pred cCCcEEEEEEeecCCC--cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCH
Q 021490 7 CLLQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 84 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~ 84 (311)
.+|+.||+|+++.... .....+.+|++++.+++||||+++++++.++...|+||||+++++|.+++.. ...+++
T Consensus 22 ~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~ 97 (318)
T cd05582 22 DAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSK----EVMFTE 97 (318)
T ss_pred CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCCCCcHHHHHHH----cCCCCH
Confidence 3689999999976432 2335677899999999999999999999999999999999999999999876 567999
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccccc
Q 021490 85 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT 164 (311)
Q Consensus 85 ~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 164 (311)
..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++....... .......++..|+|||.+.+
T Consensus 98 ~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~ 172 (318)
T cd05582 98 EDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KKAYSFCGTVEYMAPEVVNR 172 (318)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--CceecccCChhhcCHHHHcC
Confidence 999999999999999999999 9999999999999999999999999986432211 11223458899999999988
Q ss_pred CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccc
Q 021490 165 GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVH 244 (311)
Q Consensus 165 ~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 244 (311)
..++.++|||||||++|+|++|..||...........+ .... ..++...+..+.+++.+||+
T Consensus 173 ~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i------~~~~------------~~~p~~~~~~~~~li~~~l~ 234 (318)
T cd05582 173 RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMI------LKAK------------LGMPQFLSPEAQSLLRALFK 234 (318)
T ss_pred CCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHH------HcCC------------CCCCCCCCHHHHHHHHHHhh
Confidence 88899999999999999999999999865543222111 1100 01222334578889999999
Q ss_pred cCCCCCCCHHH
Q 021490 245 EQPDMRPVIAD 255 (311)
Q Consensus 245 ~~p~~Rps~~~ 255 (311)
.||.+|||+.+
T Consensus 235 ~~P~~R~~a~~ 245 (318)
T cd05582 235 RNPANRLGAGP 245 (318)
T ss_pred cCHhHcCCCCC
Confidence 99999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=283.22 Aligned_cols=219 Identities=28% Similarity=0.382 Sum_probs=178.1
Q ss_pred CCcEEEEEEeecCC---CcchhHHHHHHHHHhcC-CCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCC
Q 021490 8 LLQDVAIKQLDRNG---VQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLD 83 (311)
Q Consensus 8 ~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~ 83 (311)
+|+.||+|+++... ....+.+..|..++..+ +||||+++++++.+....|+||||++|++|.+++.. ...++
T Consensus 19 ~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g~L~~~i~~----~~~l~ 94 (320)
T cd05590 19 SGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQK----SRRFD 94 (320)
T ss_pred CCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCchHHHHHHH----cCCCC
Confidence 58899999997542 23445677888888877 699999999999999999999999999999998876 56799
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccc
Q 021490 84 WNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 163 (311)
Q Consensus 84 ~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 163 (311)
+..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++...... ........|+..|+|||++.
T Consensus 95 ~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~--~~~~~~~~gt~~y~aPE~~~ 169 (320)
T cd05590 95 EARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN--GKTTSTFCGTPDYIAPEILQ 169 (320)
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC--CCcccccccCccccCHHHHc
Confidence 9999999999999999999999 999999999999999999999999998642111 11223346899999999999
Q ss_pred cCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHcc
Q 021490 164 TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCV 243 (311)
Q Consensus 164 ~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 243 (311)
+..++.++|||||||++|+|++|..||...........+ .... . ..+...+..+.+++.+||
T Consensus 170 ~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i------~~~~--------~----~~~~~~~~~~~~li~~~L 231 (320)
T cd05590 170 EMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAI------LNDE--------V----VYPTWLSQDAVDILKAFM 231 (320)
T ss_pred CCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHH------hcCC--------C----CCCCCCCHHHHHHHHHHc
Confidence 888999999999999999999999999876543322211 1110 0 112223457889999999
Q ss_pred ccCCCCCCCH
Q 021490 244 HEQPDMRPVI 253 (311)
Q Consensus 244 ~~~p~~Rps~ 253 (311)
+.||.+||++
T Consensus 232 ~~dP~~R~~~ 241 (320)
T cd05590 232 TKNPTMRLGS 241 (320)
T ss_pred ccCHHHCCCC
Confidence 9999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=285.21 Aligned_cols=230 Identities=23% Similarity=0.314 Sum_probs=176.8
Q ss_pred CCcEEEEEEeecCCC-cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHH
Q 021490 8 LLQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNT 86 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~ 86 (311)
+|+.||||++..... .....+.+|+++++.++|+||+++++++.++...++||||+++++|... ....+..
T Consensus 98 ~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~--------~~~~~~~ 169 (353)
T PLN00034 98 TGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGT--------HIADEQF 169 (353)
T ss_pred CCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCCccccc--------ccCCHHH
Confidence 689999999865433 2346788999999999999999999999999999999999999998543 2356778
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccccc--
Q 021490 87 RMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT-- 164 (311)
Q Consensus 87 ~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-- 164 (311)
+..++.||+.||+|||+.+ ++||||||+|||++.++.++|+|||++....... .......|+..|+|||++..
T Consensus 170 ~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~ 244 (353)
T PLN00034 170 LADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM--DPCNSSVGTIAYMSPERINTDL 244 (353)
T ss_pred HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccccc--ccccccccCccccCcccccccc
Confidence 8899999999999999999 9999999999999999999999999986532211 11223468899999998743
Q ss_pred ---CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHH
Q 021490 165 ---GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAM 241 (311)
Q Consensus 165 ---~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 241 (311)
...+.++|||||||++|+|++|..||................ ... . ...+...+..+.+||.+
T Consensus 245 ~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~--~~~--------~----~~~~~~~~~~l~~li~~ 310 (353)
T PLN00034 245 NHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAIC--MSQ--------P----PEAPATASREFRHFISC 310 (353)
T ss_pred ccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHh--ccC--------C----CCCCCccCHHHHHHHHH
Confidence 234568999999999999999999997433222111111100 000 0 11122334578999999
Q ss_pred ccccCCCCCCCHHHHHHHHHHhh
Q 021490 242 CVHEQPDMRPVIADVVTALAYLA 264 (311)
Q Consensus 242 ~l~~~p~~Rps~~~vl~~l~~~~ 264 (311)
||+.||++|||+.|+++.-....
T Consensus 311 ~l~~~P~~Rpt~~ell~hp~~~~ 333 (353)
T PLN00034 311 CLQREPAKRWSAMQLLQHPFILR 333 (353)
T ss_pred HccCChhhCcCHHHHhcCccccc
Confidence 99999999999999998754333
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=265.60 Aligned_cols=253 Identities=22% Similarity=0.223 Sum_probs=194.9
Q ss_pred Ccchhcc-CCcEEEEEEeecCCC-cch-hHHHHHHHHHhcCCCCcccceeeEee--eCCeeEEEEecCCCCChhhhhccc
Q 021490 1 MMQVILC-LLQDVAIKQLDRNGV-QGN-REFLVEVLMLSLLHHPNLVNLIGYCA--DGDQRLLVYEYMPLGSVEDHLHDL 75 (311)
Q Consensus 1 ~~~~~~~-~g~~vaiK~~~~~~~-~~~-~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~~~L~~~l~~~ 75 (311)
||++..+ ++.-||+|+++.... ... .-.++|+.+|.+.+|||||.+-.+.. +-+..|||||||+ -+|.+++...
T Consensus 92 VYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~E-hDLksl~d~m 170 (419)
T KOG0663|consen 92 VYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVE-HDLKSLMETM 170 (419)
T ss_pred EEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHH-hhHHHHHHhc
Confidence 3555444 688999999976542 222 35678999999999999999988764 3456899999997 6899999874
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeecccccc
Q 021490 76 SPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG 155 (311)
Q Consensus 76 ~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~ 155 (311)
.++|...++..++.|+++|++|||.+. |+|||||++|+|++..|.+||+|||+++.+... .......+-|.+
T Consensus 171 ---~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp--~k~~T~lVVTLW 242 (419)
T KOG0663|consen 171 ---KQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGSP--LKPYTPLVVTLW 242 (419)
T ss_pred ---cCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcCC--cccCcceEEEee
Confidence 468999999999999999999999998 999999999999999999999999999864332 233445567999
Q ss_pred ccCcccccc-CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhcccc-------------ccccccCc
Q 021490 156 YCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRT-------------RHSLIADP 221 (311)
Q Consensus 156 y~aPE~~~~-~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~ 221 (311)
|.|||++.+ ..|+.+.|+||+|||+.||+++.+.|.+....+..+.+-.......+.. ........
T Consensus 243 YRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn 322 (419)
T KOG0663|consen 243 YRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYN 322 (419)
T ss_pred ecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCch
Confidence 999998876 5789999999999999999999999998887776654432221111110 11111111
Q ss_pred cccCCCChH-hHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 021490 222 ELQGQYPPR-GFYQALAVAAMCVHEQPDMRPVIADVVTALAY 262 (311)
Q Consensus 222 ~~~~~~~~~-~~~~l~~li~~~l~~~p~~Rps~~~vl~~l~~ 262 (311)
.+...++.. .++..++|+..+|.+||++|.|++|.++.-.+
T Consensus 323 ~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F 364 (419)
T KOG0663|consen 323 NLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYF 364 (419)
T ss_pred hhhhhccccccchhHHHHHHHHhccCccccccHHHhhccccc
Confidence 122233332 45788999999999999999999999987443
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=284.83 Aligned_cols=244 Identities=20% Similarity=0.252 Sum_probs=183.6
Q ss_pred CCcEEEEEEeecCCC-cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHH
Q 021490 8 LLQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNT 86 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~ 86 (311)
+|..+|+|++..... .....+.+|++++..++||||+++++++.++...++||||+++++|.+++.. .+.+++..
T Consensus 29 ~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~ 104 (333)
T cd06650 29 SGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQI 104 (333)
T ss_pred CCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecCCCCcHHHHHHH----cCCCCHHH
Confidence 578899998865432 2346789999999999999999999999999999999999999999999976 46789999
Q ss_pred HHHHHHHHHHHHHHhhcC-CCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccC
Q 021490 87 RMKIAAGAARGLEYLHDK-AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG 165 (311)
Q Consensus 87 ~~~~~~~i~~~l~~lh~~-~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 165 (311)
+..++.+++.||+|||+. + ++|+||||+||+++.++.++|+|||++...... ......++..|+|||++.+.
T Consensus 105 ~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~ 177 (333)
T cd06650 105 LGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGT 177 (333)
T ss_pred HHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCcchhhhhh----ccccCCCCccccCHHHhcCC
Confidence 999999999999999974 6 999999999999999999999999998643211 11223578899999999888
Q ss_pred CCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhh-hcccc--cc-------ccccCcc-------------
Q 021490 166 QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPL-FQDRT--RH-------SLIADPE------------- 222 (311)
Q Consensus 166 ~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~--~~-------~~~~~~~------------- 222 (311)
.++.++|+|||||++|+|++|..||.................. ..... .. .....+.
T Consensus 178 ~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (333)
T cd06650 178 HYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDY 257 (333)
T ss_pred CCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHH
Confidence 8999999999999999999999999765543222211100000 00000 00 0000000
Q ss_pred -cc---CCCC-hHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 021490 223 -LQ---GQYP-PRGFYQALAVAAMCVHEQPDMRPVIADVVTALAY 262 (311)
Q Consensus 223 -~~---~~~~-~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l~~ 262 (311)
.. ...+ .....++.+|+.+||+.||++|||+.+++..-..
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~ 302 (333)
T cd06650 258 IVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFI 302 (333)
T ss_pred HhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHH
Confidence 00 0000 1124568899999999999999999999977543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=282.75 Aligned_cols=226 Identities=27% Similarity=0.349 Sum_probs=190.2
Q ss_pred CCcEEEEEEeecCCC-cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHH
Q 021490 8 LLQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNT 86 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~ 86 (311)
.++.||+|++..... ...++...|+.+|.+++++||.++|+.+..+..++++||||.||++.+.++. +..+.+..
T Consensus 37 t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv~~lL~~----~~~~~E~~ 112 (467)
T KOG0201|consen 37 TKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSVLDLLKS----GNILDEFE 112 (467)
T ss_pred ccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcchhhhhcc----CCCCccce
Confidence 589999999977654 4457889999999999999999999999999999999999999999999987 56668999
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccCC
Q 021490 87 RMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ 166 (311)
Q Consensus 87 ~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 166 (311)
+..++.+++.|+.|||.++ .+|||||+.||++..+|.++++|||.+-...... ......+||+.|||||++....
T Consensus 113 i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~--~rr~tfvGTPfwMAPEVI~~~~ 187 (467)
T KOG0201|consen 113 IAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTV--KRRKTFVGTPFWMAPEVIKQSG 187 (467)
T ss_pred eeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechh--hccccccccccccchhhhcccc
Confidence 9999999999999999999 9999999999999999999999999986533322 2235578999999999999999
Q ss_pred CccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccC
Q 021490 167 LTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQ 246 (311)
Q Consensus 167 ~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 246 (311)
|+.++||||||++.+||.+|.+|+........ .........|.+.+ ..+..+.+++..||..|
T Consensus 188 Y~~KADIWSLGITaiEla~GePP~s~~hPmrv-------------lflIpk~~PP~L~~----~~S~~~kEFV~~CL~k~ 250 (467)
T KOG0201|consen 188 YDTKADIWSLGITAIELAKGEPPHSKLHPMRV-------------LFLIPKSAPPRLDG----DFSPPFKEFVEACLDKN 250 (467)
T ss_pred ccchhhhhhhhHHHHHHhcCCCCCcccCcceE-------------EEeccCCCCCcccc----ccCHHHHHHHHHHhhcC
Confidence 99999999999999999999999987654111 11111122233333 34457889999999999
Q ss_pred CCCCCCHHHHHHH
Q 021490 247 PDMRPVIADVVTA 259 (311)
Q Consensus 247 p~~Rps~~~vl~~ 259 (311)
|+.|||+.++++.
T Consensus 251 P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 251 PEFRPSAKELLKH 263 (467)
T ss_pred cccCcCHHHHhhh
Confidence 9999999999865
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=283.35 Aligned_cols=222 Identities=24% Similarity=0.280 Sum_probs=182.2
Q ss_pred CcEEEEEEeecCC---CcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHH
Q 021490 9 LQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN 85 (311)
Q Consensus 9 g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~ 85 (311)
+..||+|++.... ....+.+.+|+.++..++||||+++++++.++...++||||++||+|.+++.. ...+++.
T Consensus 56 ~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~----~~~~~~~ 131 (340)
T PTZ00426 56 FPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRR----NKRFPND 131 (340)
T ss_pred CeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHH----cCCCCHH
Confidence 3689999986542 23346788999999999999999999999999999999999999999999986 5679999
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccC
Q 021490 86 TRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG 165 (311)
Q Consensus 86 ~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 165 (311)
.+..++.|++.||+|||+.+ ++||||||+|||++.++.++|+|||++...... .....|++.|+|||++.+.
T Consensus 132 ~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~ 203 (340)
T PTZ00426 132 VGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR-----TYTLCGTPEYIAPEILLNV 203 (340)
T ss_pred HHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCCC-----cceecCChhhcCHHHHhCC
Confidence 99999999999999999999 999999999999999999999999998753221 1234588999999999888
Q ss_pred CCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHcccc
Q 021490 166 QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHE 245 (311)
Q Consensus 166 ~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 245 (311)
.++.++|||||||++|+|++|..||...........+. ... ..++...+..+.+++.+||+.
T Consensus 204 ~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~------~~~------------~~~p~~~~~~~~~li~~~l~~ 265 (340)
T PTZ00426 204 GHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKIL------EGI------------IYFPKFLDNNCKHLMKKLLSH 265 (340)
T ss_pred CCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHh------cCC------------CCCCCCCCHHHHHHHHHHccc
Confidence 89999999999999999999999998655432222111 100 011222344678899999999
Q ss_pred CCCCCC-----CHHHHHHHH
Q 021490 246 QPDMRP-----VIADVVTAL 260 (311)
Q Consensus 246 ~p~~Rp-----s~~~vl~~l 260 (311)
||.+|+ |++++++..
T Consensus 266 dp~~R~~~~~~~~~~~~~hp 285 (340)
T PTZ00426 266 DLTKRYGNLKKGAQNVKEHP 285 (340)
T ss_pred CHHHcCCCCCCCHHHHHcCC
Confidence 999995 888888764
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=286.31 Aligned_cols=236 Identities=27% Similarity=0.406 Sum_probs=190.8
Q ss_pred cEEEEEEeecCCCcc--hhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHHH
Q 021490 10 QDVAIKQLDRNGVQG--NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTR 87 (311)
Q Consensus 10 ~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~ 87 (311)
.+||||+++...... .+.|.+|+..+++-+|-||+-+.|++..... .||+-||+|.+|+.+++.. ...|...+.
T Consensus 415 GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv~---etkfdm~~~ 490 (678)
T KOG0193|consen 415 GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEGSSLYTHLHVQ---ETKFDMNTT 490 (678)
T ss_pred cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhccCchhhhhccch---hhhhhHHHH
Confidence 579999998876544 4689999999999999999999999988776 9999999999999999873 467999999
Q ss_pred HHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccc---c
Q 021490 88 MKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK---T 164 (311)
Q Consensus 88 ~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~ 164 (311)
+.|+.||+.|+.|||.++ |+|+|||..|||+.++++|||+|||++................+...|||||++. .
T Consensus 491 idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~ 567 (678)
T KOG0193|consen 491 IDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDD 567 (678)
T ss_pred HHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhccc
Confidence 999999999999999999 9999999999999999999999999987544443333344456888999999985 3
Q ss_pred CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccc
Q 021490 165 GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVH 244 (311)
Q Consensus 165 ~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 244 (311)
.+|++++||||||+++|||++|..||........ +.-.+......|... ......+++.+|+..||.
T Consensus 568 nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqI----------ifmVGrG~l~pd~s~---~~s~~pk~mk~Ll~~C~~ 634 (678)
T KOG0193|consen 568 NPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQI----------IFMVGRGYLMPDLSK---IRSNCPKAMKRLLSDCWK 634 (678)
T ss_pred CCCCcccchhhhhHHHHHHHhCcCCcCCCChhhe----------EEEecccccCccchh---hhccCHHHHHHHHHHHHh
Confidence 6889999999999999999999999983222111 111111111112111 122345588889999999
Q ss_pred cCCCCCCCHHHHHHHHHHhhh
Q 021490 245 EQPDMRPVIADVVTALAYLAS 265 (311)
Q Consensus 245 ~~p~~Rps~~~vl~~l~~~~~ 265 (311)
+++++||++.+|+..|+.+..
T Consensus 635 ~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 635 FDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred cCcccCccHHHHHHHHHHhhh
Confidence 999999999999999887775
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=262.37 Aligned_cols=234 Identities=25% Similarity=0.334 Sum_probs=190.7
Q ss_pred ccCCcEEEEEEeecCCCcc----h----hHHHHHHHHHhcC-CCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccC
Q 021490 6 LCLLQDVAIKQLDRNGVQG----N----REFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLS 76 (311)
Q Consensus 6 ~~~g~~vaiK~~~~~~~~~----~----~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 76 (311)
.+.|+..|+|++....... . +.-..|+.+|+++ .||+|+.+.++++.+...++|+|.|+.|.|++++.+
T Consensus 39 k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlVFdl~prGELFDyLts-- 116 (411)
T KOG0599|consen 39 KETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLVFDLMPRGELFDYLTS-- 116 (411)
T ss_pred cccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhhhhhcccchHHHHhhh--
Confidence 3468889999986643221 1 2344699999999 699999999999999999999999999999999998
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccc
Q 021490 77 PGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY 156 (311)
Q Consensus 77 ~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y 156 (311)
.-.+++.....++.|+..|++|||.++ ||||||||+|||++++-+++|+|||.+.....+ .......||++|
T Consensus 117 --~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGFa~~l~~G---ekLrelCGTPgY 188 (411)
T KOG0599|consen 117 --KVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGFACQLEPG---EKLRELCGTPGY 188 (411)
T ss_pred --heeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccceeeccCCc---hhHHHhcCCCcc
Confidence 678999999999999999999999999 999999999999999999999999999754332 233446799999
Q ss_pred cCcccccc------CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChH
Q 021490 157 CAPEYAKT------GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPR 230 (311)
Q Consensus 157 ~aPE~~~~------~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (311)
+|||.+.. ..|+..+|+||+|+|+|.|+.|.+||-.....-...++..+...+. .|+ ..+
T Consensus 189 LAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~---------spe-----Wad 254 (411)
T KOG0599|consen 189 LAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFR---------SPE-----WAD 254 (411)
T ss_pred cChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccC---------Ccc-----hhh
Confidence 99998853 4678889999999999999999999987665555444433322222 222 223
Q ss_pred hHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 021490 231 GFYQALAVAAMCVHEQPDMRPVIADVVTALAYL 263 (311)
Q Consensus 231 ~~~~l~~li~~~l~~~p~~Rps~~~vl~~l~~~ 263 (311)
.+....+||.+||++||.+|.|++|+++.-.++
T Consensus 255 is~~~KdLIsrlLqVdp~~Ritake~LaHpff~ 287 (411)
T KOG0599|consen 255 ISATVKDLISRLLQVDPTKRITAKEALAHPFFI 287 (411)
T ss_pred ccccHHHHHHHHHeeCchhcccHHHHhcChHHH
Confidence 445778899999999999999999999876543
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=271.10 Aligned_cols=237 Identities=25% Similarity=0.349 Sum_probs=188.4
Q ss_pred cchhccCCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCC
Q 021490 2 MQVILCLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKP 81 (311)
Q Consensus 2 ~~~~~~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 81 (311)
|.+...++..||+|.+.... ...+.+.+|+.+++.++|+||+++++.+.+....+++|||+++++|.+++.... ...
T Consensus 23 ~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~ 99 (261)
T cd05072 23 WMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDE--GGK 99 (261)
T ss_pred EEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHHHHHHHhc--CCC
Confidence 44555677889999986433 346789999999999999999999999999999999999999999999987532 456
Q ss_pred CCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccc
Q 021490 82 LDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 161 (311)
Q Consensus 82 l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 161 (311)
+++..++.++.+++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++........ .......++..|+|||.
T Consensus 100 ~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~ 175 (261)
T cd05072 100 VLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY-TAREGAKFPIKWTAPEA 175 (261)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCce-eccCCCccceecCCHHH
Confidence 889999999999999999999999 99999999999999999999999999875432211 11122335668999999
Q ss_pred cccCCCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHH
Q 021490 162 AKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAA 240 (311)
Q Consensus 162 ~~~~~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 240 (311)
+....++.++||||||+++|+|++ |..||............. .... .+ .....+..+.+++.
T Consensus 176 ~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~-------~~~~-----~~-----~~~~~~~~~~~li~ 238 (261)
T cd05072 176 INFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQ-------RGYR-----MP-----RMENCPDELYDIMK 238 (261)
T ss_pred hccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHH-------cCCC-----CC-----CCCCCCHHHHHHHH
Confidence 988888999999999999999998 999997654433221111 0000 00 11123347888999
Q ss_pred HccccCCCCCCCHHHHHHHHHH
Q 021490 241 MCVHEQPDMRPVIADVVTALAY 262 (311)
Q Consensus 241 ~~l~~~p~~Rps~~~vl~~l~~ 262 (311)
+||..+|++|||+.++.+.|+.
T Consensus 239 ~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 239 TCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred HHccCCcccCcCHHHHHHHHhc
Confidence 9999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=272.52 Aligned_cols=232 Identities=24% Similarity=0.330 Sum_probs=183.6
Q ss_pred CCcEEEEEEeecCCC-cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHH
Q 021490 8 LLQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNT 86 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~ 86 (311)
.+..||+|+++.... .....|.+|+..+.+++||||+++++++..+...++||||+++++|.+++... ...+++..
T Consensus 32 ~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~l~~~~ 108 (266)
T cd05064 32 RELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKH---EGQLVAGQ 108 (266)
T ss_pred ceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEEeCCCCcHHHHHHhC---CCCCCHHH
Confidence 467899999876533 22357889999999999999999999999999999999999999999998752 35789999
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccCC
Q 021490 87 RMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ 166 (311)
Q Consensus 87 ~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 166 (311)
++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++++|||.......... .......++..|+|||.+.+..
T Consensus 109 ~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~ 184 (266)
T cd05064 109 LMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAI-YTTMSGKSPVLWAAPEAIQYHH 184 (266)
T ss_pred HHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccccccch-hcccCCCCceeecCHHHHhhCC
Confidence 9999999999999999999 99999999999999999999999998754211111 1111123456899999999899
Q ss_pred CccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHcccc
Q 021490 167 LTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHE 245 (311)
Q Consensus 167 ~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 245 (311)
++.++|||||||++|++++ |..||...........+ ..... . ..+...+..+.+++.+||+.
T Consensus 185 ~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~-------~~~~~------~----~~~~~~~~~~~~li~~c~~~ 247 (266)
T cd05064 185 FSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAV-------EDGFR------L----PAPRNCPNLLHQLMLDCWQK 247 (266)
T ss_pred ccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH-------HCCCC------C----CCCCCCCHHHHHHHHHHcCC
Confidence 9999999999999999875 99999765543322211 11000 0 11222344788899999999
Q ss_pred CCCCCCCHHHHHHHHHHh
Q 021490 246 QPDMRPVIADVVTALAYL 263 (311)
Q Consensus 246 ~p~~Rps~~~vl~~l~~~ 263 (311)
+|.+|||+.++.+.|..+
T Consensus 248 ~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 248 ERGERPRFSQIHSILSKM 265 (266)
T ss_pred CchhCCCHHHHHHHHHhh
Confidence 999999999999988643
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=280.93 Aligned_cols=226 Identities=27% Similarity=0.343 Sum_probs=182.3
Q ss_pred CCcEEEEEEeecCC---CcchhHHHHHHHHHhcC-CCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCC
Q 021490 8 LLQDVAIKQLDRNG---VQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLD 83 (311)
Q Consensus 8 ~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~ 83 (311)
+|+.||+|+++... ....+.+..|.+++..+ +||||+++++++.++...|+||||+++++|..++.. ...++
T Consensus 19 ~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~----~~~~~ 94 (321)
T cd05591 19 TDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQR----SRKFD 94 (321)
T ss_pred CCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCCcHHHHHHH----cCCCC
Confidence 57899999997642 23345677899998876 799999999999999999999999999999998876 56799
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccc
Q 021490 84 WNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 163 (311)
Q Consensus 84 ~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 163 (311)
+..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++...... ........++..|+|||++.
T Consensus 95 ~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~ 169 (321)
T cd05591 95 EPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILN--GVTTTTFCGTPDYIAPEILQ 169 (321)
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccC--CccccccccCccccCHHHHc
Confidence 9999999999999999999999 999999999999999999999999988642211 11122345889999999999
Q ss_pred cCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHcc
Q 021490 164 TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCV 243 (311)
Q Consensus 164 ~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 243 (311)
+..++.++|||||||++|+|++|..||...........+ .... . ..+...+.++.+++.+||
T Consensus 170 ~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i------~~~~--------~----~~p~~~~~~~~~ll~~~L 231 (321)
T cd05591 170 ELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESI------LHDD--------V----LYPVWLSKEAVSILKAFM 231 (321)
T ss_pred CCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHH------HcCC--------C----CCCCCCCHHHHHHHHHHh
Confidence 889999999999999999999999999876543322211 1110 0 112223457889999999
Q ss_pred ccCCCCCC-------CHHHHHHHH
Q 021490 244 HEQPDMRP-------VIADVVTAL 260 (311)
Q Consensus 244 ~~~p~~Rp-------s~~~vl~~l 260 (311)
+.||++|| ++.++++..
T Consensus 232 ~~dp~~R~~~~~~~~~~~~~~~hp 255 (321)
T cd05591 232 TKNPNKRLGCVASQGGEDAIKQHP 255 (321)
T ss_pred ccCHHHcCCCCCCCCCHHHHhcCC
Confidence 99999999 788887663
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=279.83 Aligned_cols=224 Identities=30% Similarity=0.399 Sum_probs=179.3
Q ss_pred CCcEEEEEEeecCC---CcchhHHHHHHHHHhcC-CCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCC
Q 021490 8 LLQDVAIKQLDRNG---VQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLD 83 (311)
Q Consensus 8 ~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~ 83 (311)
+|+.||+|+++... ......+..|..++..+ +||||+++++++.+....++||||++||+|.+++.. ...++
T Consensus 19 ~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~----~~~~~ 94 (316)
T cd05619 19 TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQS----CHKFD 94 (316)
T ss_pred CCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHH----cCCCC
Confidence 57899999997642 23345667788888764 899999999999999999999999999999999976 46789
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccc
Q 021490 84 WNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 163 (311)
Q Consensus 84 ~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 163 (311)
+..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++....... .......++..|+|||++.
T Consensus 95 ~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~ 169 (316)
T cd05619 95 LPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AKTCTFCGTPDYIAPEILL 169 (316)
T ss_pred HHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--CceeeecCCccccCHHHHc
Confidence 9999999999999999999999 9999999999999999999999999986421111 1223345889999999999
Q ss_pred cCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHcc
Q 021490 164 TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCV 243 (311)
Q Consensus 164 ~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 243 (311)
+..++.++|||||||++|+|++|..||...........+... .+ .++...+..+.+++.+||
T Consensus 170 ~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~--------------~~----~~~~~~~~~~~~li~~~l 231 (316)
T cd05619 170 GQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD--------------NP----CYPRWLTREAKDILVKLF 231 (316)
T ss_pred CCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--------------CC----CCCccCCHHHHHHHHHHh
Confidence 889999999999999999999999999866543322211110 01 112223447888999999
Q ss_pred ccCCCCCCCHH-HHHH
Q 021490 244 HEQPDMRPVIA-DVVT 258 (311)
Q Consensus 244 ~~~p~~Rps~~-~vl~ 258 (311)
+.||.+||++. ++++
T Consensus 232 ~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 232 VREPERRLGVKGDIRQ 247 (316)
T ss_pred ccCHhhcCCChHHHHc
Confidence 99999999997 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=281.94 Aligned_cols=246 Identities=23% Similarity=0.289 Sum_probs=180.1
Q ss_pred cCCcEEEEEEeecCC--CcchhHHHHHHHHHhcCCCCcccceeeEeeeC-----CeeEEEEecCCCCChhhhhcccCCCC
Q 021490 7 CLLQDVAIKQLDRNG--VQGNREFLVEVLMLSLLHHPNLVNLIGYCADG-----DQRLLVYEYMPLGSVEDHLHDLSPGK 79 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~ 79 (311)
.+|+.||||+++... ......+.+|+++++.++||||+++++++... ...|+||||++ ++|.+++.. .
T Consensus 23 ~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~----~ 97 (338)
T cd07859 23 HTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKA----N 97 (338)
T ss_pred CCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEecCC-CCHHHHHHh----c
Confidence 478999999986532 23345788999999999999999999987543 24799999995 689998876 5
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCc-eeeeeccccccccC
Q 021490 80 KPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT-HVSTRVMGTYGYCA 158 (311)
Q Consensus 80 ~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~y~a 158 (311)
..+++..+..++.|++.||+|||+.+ ++||||||+|||++.++.++|+|||++......... .......++..|+|
T Consensus 98 ~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~a 174 (338)
T cd07859 98 DDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 174 (338)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCccccccccccCccccccCCCCCCCcCC
Confidence 67999999999999999999999999 999999999999999999999999998643221111 11223468899999
Q ss_pred cccccc--CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhh--------hhcccc------ccccccCcc
Q 021490 159 PEYAKT--GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARP--------LFQDRT------RHSLIADPE 222 (311)
Q Consensus 159 PE~~~~--~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~--------~~~~~~------~~~~~~~~~ 222 (311)
||++.+ ..++.++|||||||++|+|++|+.||................. .+.... .........
T Consensus 175 PE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 254 (338)
T cd07859 175 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVP 254 (338)
T ss_pred HHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCc
Confidence 999865 6788999999999999999999999976554332211110000 000000 000000000
Q ss_pred ccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 021490 223 LQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 261 (311)
Q Consensus 223 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l~ 261 (311)
+... -+.....+.+++.+||+.||++|||++++++.-.
T Consensus 255 ~~~~-~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~ 292 (338)
T cd07859 255 FSQK-FPNADPLALRLLERLLAFDPKDRPTAEEALADPY 292 (338)
T ss_pred hHHh-cCCCChHHHHHHHHHcCcCcccCCCHHHHhcCch
Confidence 0000 0122346789999999999999999999998744
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=278.19 Aligned_cols=225 Identities=27% Similarity=0.364 Sum_probs=178.1
Q ss_pred cCCcEEEEEEeecCC---CcchhHHHHHHHHH---hcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCC
Q 021490 7 CLLQDVAIKQLDRNG---VQGNREFLVEVLML---SLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKK 80 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~---~~~~~~~~~e~~~l---~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 80 (311)
.+|+.||||+++... ....+.+.+|++++ ..++||||+++++++.++...|+||||++|++|..++.. .
T Consensus 22 ~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~-----~ 96 (324)
T cd05589 22 KTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT-----D 96 (324)
T ss_pred CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcCCCCCcHHHHhhc-----C
Confidence 368999999997543 22335666676655 566799999999999999999999999999999988864 5
Q ss_pred CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcc
Q 021490 81 PLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 160 (311)
Q Consensus 81 ~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE 160 (311)
.+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++...... ........++..|+|||
T Consensus 97 ~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~--~~~~~~~~g~~~y~aPE 171 (324)
T cd05589 97 VFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF--GDRTSTFCGTPEFLAPE 171 (324)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCCC--CCcccccccCccccCHh
Confidence 6999999999999999999999999 999999999999999999999999987642111 11122345889999999
Q ss_pred ccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHH
Q 021490 161 YAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAA 240 (311)
Q Consensus 161 ~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 240 (311)
.+.+..++.++|||||||++|+|++|..||...........+. ... + .++...+..+.+++.
T Consensus 172 ~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~------~~~--------~----~~p~~~~~~~~~li~ 233 (324)
T cd05589 172 VLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIV------NDE--------V----RYPRFLSREAISIMR 233 (324)
T ss_pred HhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHH------hCC--------C----CCCCCCCHHHHHHHH
Confidence 9998889999999999999999999999998765433222111 000 0 112233457889999
Q ss_pred HccccCCCCCC-----CHHHHHHH
Q 021490 241 MCVHEQPDMRP-----VIADVVTA 259 (311)
Q Consensus 241 ~~l~~~p~~Rp-----s~~~vl~~ 259 (311)
+||+.||.+|| ++.++++.
T Consensus 234 ~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 234 RLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred HHhhcCHhHcCCCCCCCHHHHhhC
Confidence 99999999999 56676654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=277.97 Aligned_cols=225 Identities=27% Similarity=0.390 Sum_probs=181.9
Q ss_pred CCcEEEEEEeecCC---CcchhHHHHHHHHHhcC-CCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCC
Q 021490 8 LLQDVAIKQLDRNG---VQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLD 83 (311)
Q Consensus 8 ~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~ 83 (311)
+++.||+|+++... ......+.+|.+++..+ +||||+++++++.+....|+||||++|++|..++.. ...++
T Consensus 19 ~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~l~ 94 (318)
T cd05570 19 TDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQR----SGRFD 94 (318)
T ss_pred CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHH----cCCCC
Confidence 57899999997642 23345677899999888 699999999999999999999999999999999876 56799
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccc
Q 021490 84 WNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 163 (311)
Q Consensus 84 ~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 163 (311)
+..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++....... .......++..|+|||++.
T Consensus 95 ~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~ 169 (318)
T cd05570 95 EPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VTTSTFCGTPDYIAPEILS 169 (318)
T ss_pred HHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC--CcccceecCccccCHHHhc
Confidence 9999999999999999999999 9999999999999999999999999886421111 1122235789999999999
Q ss_pred cCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHcc
Q 021490 164 TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCV 243 (311)
Q Consensus 164 ~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 243 (311)
+..++.++|+|||||++|+|++|..||...........+ ... .. .++...+..+.+|+.+||
T Consensus 170 ~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i------~~~--------~~----~~~~~~~~~~~~li~~~l 231 (318)
T cd05570 170 YQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSI------LED--------EV----RYPRWLSKEAKSILKSFL 231 (318)
T ss_pred CCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHH------HcC--------CC----CCCCcCCHHHHHHHHHHc
Confidence 999999999999999999999999999765543222111 100 00 112233457889999999
Q ss_pred ccCCCCCCCH-----HHHHHH
Q 021490 244 HEQPDMRPVI-----ADVVTA 259 (311)
Q Consensus 244 ~~~p~~Rps~-----~~vl~~ 259 (311)
..||++|||+ .++++.
T Consensus 232 ~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 232 TKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred cCCHHHcCCCCCCCHHHHhcC
Confidence 9999999999 777755
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=276.74 Aligned_cols=233 Identities=28% Similarity=0.330 Sum_probs=182.3
Q ss_pred CCcEEEEEEeecCCC--------------cchhHHHHHHHHHhcCCCCcccceeeEeeeC--CeeEEEEecCCCCChhhh
Q 021490 8 LLQDVAIKQLDRNGV--------------QGNREFLVEVLMLSLLHHPNLVNLIGYCADG--DQRLLVYEYMPLGSVEDH 71 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~--------------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~ 71 (311)
+|+.||||++.+... ...+...+|+.+|++++|||||+++++..+. ..+|||+|||..|.+..-
T Consensus 121 ~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~ 200 (576)
T KOG0585|consen 121 DGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWC 200 (576)
T ss_pred CCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeecCcccCceEEEEEeccCCccccC
Confidence 689999999976322 1125788999999999999999999999654 578999999998886543
Q ss_pred hcccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCC---Cceeee
Q 021490 72 LHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD---NTHVST 148 (311)
Q Consensus 72 l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~---~~~~~~ 148 (311)
-.. ...+.+.++++++.+++.||+|||.+| |+||||||.|+|++++|+|||+|||.+....... ......
T Consensus 201 p~d----~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~ 273 (576)
T KOG0585|consen 201 PPD----KPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLS 273 (576)
T ss_pred CCC----cccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCCcEEeeccceeeecccCCccccHHHHh
Confidence 332 333999999999999999999999999 9999999999999999999999999987543221 112233
Q ss_pred eccccccccCccccccC----CCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCcccc
Q 021490 149 RVMGTYGYCAPEYAKTG----QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQ 224 (311)
Q Consensus 149 ~~~~~~~y~aPE~~~~~----~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (311)
...||+.|+|||...+. ..+.+.||||+||++|-|+.|+.||-.....+....+ ..+. +.
T Consensus 274 ~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KI------vn~p----------L~ 337 (576)
T KOG0585|consen 274 RTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKI------VNDP----------LE 337 (576)
T ss_pred hcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHH------hcCc----------cc
Confidence 47899999999987663 2367899999999999999999999765543332211 1111 11
Q ss_pred CCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 021490 225 GQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYL 263 (311)
Q Consensus 225 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l~~~ 263 (311)
-...+...+.+.+||.+||.+||..|.++.+|....+.-
T Consensus 338 fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt 376 (576)
T KOG0585|consen 338 FPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVT 376 (576)
T ss_pred CCCcccccHHHHHHHHHHhhcChhheeehhhheecceec
Confidence 111224566889999999999999999999999887643
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=280.75 Aligned_cols=232 Identities=24% Similarity=0.354 Sum_probs=181.0
Q ss_pred CCcEEEEEEeecCCC---cchhHHHHHHHHHhcC-CCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCC
Q 021490 8 LLQDVAIKQLDRNGV---QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLD 83 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~ 83 (311)
+|+.||+|+++.... .....+.+|..++..+ +||||+++++++.+....|+||||++|++|.+++.. .+.++
T Consensus 19 ~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~----~~~l~ 94 (329)
T cd05588 19 TRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQR----QRKLP 94 (329)
T ss_pred CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCCCHHHHHHH----cCCCC
Confidence 688999999976432 2335678899999998 799999999999999999999999999999998876 56799
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccc
Q 021490 84 WNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 163 (311)
Q Consensus 84 ~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 163 (311)
+..+..++.|++.||+|||+++ ++||||||+||+++.++.++|+|||++...... ........|+..|+|||++.
T Consensus 95 ~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~ 169 (329)
T cd05588 95 EEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--GDTTSTFCGTPNYIAPEILR 169 (329)
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccC--CCccccccCCccccCHHHHc
Confidence 9999999999999999999999 999999999999999999999999988632111 11222346889999999999
Q ss_pred cCCCccccceeehhHHHHHHHhCCCccCcchhHH--HHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHH
Q 021490 164 TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA--EQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAM 241 (311)
Q Consensus 164 ~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 241 (311)
+..++.++|+|||||++|+|++|..||....... ......+....+... . ..++...+..+.+++.+
T Consensus 170 ~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-------~----~~~p~~~~~~~~~li~~ 238 (329)
T cd05588 170 GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEK-------Q----IRIPRSLSVKASSVLKG 238 (329)
T ss_pred CCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcC-------C----CCCCCCCCHHHHHHHHH
Confidence 9899999999999999999999999996432111 000000000001000 0 11233344578899999
Q ss_pred ccccCCCCCCC------HHHHHHH
Q 021490 242 CVHEQPDMRPV------IADVVTA 259 (311)
Q Consensus 242 ~l~~~p~~Rps------~~~vl~~ 259 (311)
||..||.+|+| +.++++.
T Consensus 239 ~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 239 FLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred HhccCHHHcCCCCCCCCHHHHhcC
Confidence 99999999997 6677655
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=270.36 Aligned_cols=238 Identities=21% Similarity=0.296 Sum_probs=186.9
Q ss_pred CCcEEEEEEeecCCC---cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCH
Q 021490 8 LLQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 84 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~ 84 (311)
+|..||||.++.... .....+.+|+++++.++||||+++++++.+....++|+||+++++|.+++.........+++
T Consensus 26 ~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~ 105 (267)
T cd08228 26 DRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPE 105 (267)
T ss_pred CCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEecCCCcHHHHHHHhhhccCCCCH
Confidence 689999998865332 23357889999999999999999999999999999999999999999988654433566899
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccccc
Q 021490 85 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT 164 (311)
Q Consensus 85 ~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 164 (311)
..+..++.|++.||+|||+++ ++|+||+|+||+++.++.++|+|||++....... .......++..|+|||.+.+
T Consensus 106 ~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~ 180 (267)
T cd08228 106 RTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT--TAAHSLVGTPYYMSPERIHE 180 (267)
T ss_pred HHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccchh--HHHhcCCCCccccChhhhcc
Confidence 999999999999999999999 9999999999999999999999999886532211 11122357788999999988
Q ss_pred CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccc
Q 021490 165 GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVH 244 (311)
Q Consensus 165 ~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 244 (311)
..++.++|+||||+++|+|++|..||........ ...... .... .+ .......+..+.+++.+||.
T Consensus 181 ~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~-~~~~~~----~~~~------~~---~~~~~~~~~~~~~li~~cl~ 246 (267)
T cd08228 181 NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLF-SLCQKI----EQCD------YP---PLPTEHYSEKLRELVSMCIY 246 (267)
T ss_pred CCCCchhhHHHHHHHHHHHhcCCCCCccccccHH-HHHHHH----hcCC------CC---CCChhhcCHHHHHHHHHHCC
Confidence 8889999999999999999999999865432111 111110 0000 00 01111234578899999999
Q ss_pred cCCCCCCCHHHHHHHHHHhh
Q 021490 245 EQPDMRPVIADVVTALAYLA 264 (311)
Q Consensus 245 ~~p~~Rps~~~vl~~l~~~~ 264 (311)
.+|.+|||+.++++.++++.
T Consensus 247 ~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 247 PDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred CCcccCcCHHHHHHHHHHhc
Confidence 99999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=268.55 Aligned_cols=232 Identities=31% Similarity=0.442 Sum_probs=188.7
Q ss_pred CcEEEEEEeecCCCcc-hhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCC-----CCCC
Q 021490 9 LQDVAIKQLDRNGVQG-NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPG-----KKPL 82 (311)
Q Consensus 9 g~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-----~~~l 82 (311)
+..|++|.++...... .+.+.+|++.+..++|+||+++++++.++...++||||+++++|.+++...... ...+
T Consensus 23 ~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 102 (262)
T cd00192 23 TTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTL 102 (262)
T ss_pred CceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccCCcHHHHHhhccccccccccccC
Confidence 8899999997655433 578999999999999999999999999999999999999999999999874211 3779
Q ss_pred CHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccc
Q 021490 83 DWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 162 (311)
Q Consensus 83 ~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 162 (311)
++..++.++.|++.||+|||+++ ++|+||+|+||+++.++.++|+|||.+................++..|+|||.+
T Consensus 103 ~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 179 (262)
T cd00192 103 SLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESL 179 (262)
T ss_pred CHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEcccccccccccccccccccCCCcCccccCHHHh
Confidence 99999999999999999999999 999999999999999999999999998764433222222334567889999999
Q ss_pred ccCCCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHH
Q 021490 163 KTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAM 241 (311)
Q Consensus 163 ~~~~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 241 (311)
....++.++||||||+++|+|++ |..||............. .. .....+...+..+.+++.+
T Consensus 180 ~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-------~~----------~~~~~~~~~~~~~~~li~~ 242 (262)
T cd00192 180 KDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLR-------KG----------YRLPKPEYCPDELYELMLS 242 (262)
T ss_pred ccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-------cC----------CCCCCCccCChHHHHHHHH
Confidence 88889999999999999999999 699998764432221111 00 0011222335588899999
Q ss_pred ccccCCCCCCCHHHHHHHH
Q 021490 242 CVHEQPDMRPVIADVVTAL 260 (311)
Q Consensus 242 ~l~~~p~~Rps~~~vl~~l 260 (311)
||..||.+|||+.+++..|
T Consensus 243 ~l~~~p~~Rps~~~l~~~l 261 (262)
T cd00192 243 CWQLDPEDRPTFSELVERL 261 (262)
T ss_pred HccCCcccCcCHHHHHHhh
Confidence 9999999999999999886
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=269.10 Aligned_cols=234 Identities=27% Similarity=0.382 Sum_probs=184.3
Q ss_pred cchhccCCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCC
Q 021490 2 MQVILCLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKP 81 (311)
Q Consensus 2 ~~~~~~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 81 (311)
|.+...++..+|+|++.... .....|.+|+++++.++||||+++++++......++||||++|++|.+++... ...
T Consensus 21 ~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~ 96 (256)
T cd05059 21 HLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRER---KGK 96 (256)
T ss_pred EEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHHHHHHhc---ccC
Confidence 44445567789999985433 34567889999999999999999999999999999999999999999998752 346
Q ss_pred CCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccc
Q 021490 82 LDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 161 (311)
Q Consensus 82 l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 161 (311)
+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++....... ........++..|+|||.
T Consensus 97 ~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~~y~~Pe~ 172 (256)
T cd05059 97 LGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ-YTSSQGTKFPVKWAPPEV 172 (256)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccccc-ccccCCCCCCccccCHHH
Confidence 899999999999999999999999 9999999999999999999999999886532111 111111223457999999
Q ss_pred cccCCCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHH
Q 021490 162 AKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAA 240 (311)
Q Consensus 162 ~~~~~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 240 (311)
+.+..++.++|+||||+++|+|++ |..||............... .....+...+..+.+++.
T Consensus 173 ~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~li~ 235 (256)
T cd05059 173 FDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAG-----------------YRLYRPKLAPTEVYTIMY 235 (256)
T ss_pred hccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcC-----------------CcCCCCCCCCHHHHHHHH
Confidence 988889999999999999999999 88999765443222111100 000112223457889999
Q ss_pred HccccCCCCCCCHHHHHHHH
Q 021490 241 MCVHEQPDMRPVIADVVTAL 260 (311)
Q Consensus 241 ~~l~~~p~~Rps~~~vl~~l 260 (311)
+||..+|++|||+.++++.|
T Consensus 236 ~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 236 SCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred HHhcCChhhCcCHHHHHHHh
Confidence 99999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=283.38 Aligned_cols=231 Identities=26% Similarity=0.285 Sum_probs=185.2
Q ss_pred CCcEEEEEEeecCCC---cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCH
Q 021490 8 LLQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 84 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~ 84 (311)
+|+.||||+++.... .....+.+|+.++..++||||+++++++.++...++||||+++++|.+++.. ...+++
T Consensus 25 ~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~ 100 (350)
T cd05573 25 TGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIR----KDVFPE 100 (350)
T ss_pred CCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCCCCCHHHHHHH----cCCCCH
Confidence 689999999976432 3346788999999999999999999999999999999999999999999987 467999
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCC----------------------
Q 021490 85 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD---------------------- 142 (311)
Q Consensus 85 ~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~---------------------- 142 (311)
..+..++.|++.||+|||+.| ++||||||+||+++.++.++|+|||++.......
T Consensus 101 ~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (350)
T cd05573 101 ETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRR 177 (350)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcccCcccccccccccccccccccccc
Confidence 999999999999999999999 9999999999999999999999999987533222
Q ss_pred -----CceeeeeccccccccCccccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhcccccccc
Q 021490 143 -----NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSL 217 (311)
Q Consensus 143 -----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 217 (311)
.........++..|+|||++.+..++.++|||||||++|+|++|..||...........+. .....
T Consensus 178 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~------~~~~~--- 248 (350)
T cd05573 178 RDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKII------NWKES--- 248 (350)
T ss_pred cccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHHHHHHh------ccCCc---
Confidence 0011223458899999999999999999999999999999999999998765433221111 00000
Q ss_pred ccCccccCCCChHhHHHHHHHHHHccccCCCCCCC-HHHHHHHH
Q 021490 218 IADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPV-IADVVTAL 260 (311)
Q Consensus 218 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-~~~vl~~l 260 (311)
...+. ....+..+.+++.+||. ||.+||+ +.++++..
T Consensus 249 ~~~p~-----~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp 286 (350)
T cd05573 249 LRFPP-----DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHP 286 (350)
T ss_pred ccCCC-----CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCC
Confidence 00000 01134578889999998 9999999 99999764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=271.58 Aligned_cols=236 Identities=28% Similarity=0.394 Sum_probs=185.8
Q ss_pred CcEEEEEEeecCCC-cchhHHHHHHHHHhcC-CCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccC----------
Q 021490 9 LQDVAIKQLDRNGV-QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLS---------- 76 (311)
Q Consensus 9 g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------- 76 (311)
...+|+|.+..... .....+.+|+.++..+ +|+||+++++++..+...+++|||+++++|.+++....
T Consensus 42 ~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~ 121 (293)
T cd05053 42 TSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDD 121 (293)
T ss_pred ceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCcccccccc
Confidence 46799998865432 3335788999999999 89999999999999999999999999999999986531
Q ss_pred --CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccc
Q 021490 77 --PGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTY 154 (311)
Q Consensus 77 --~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~ 154 (311)
.....+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++................++.
T Consensus 122 ~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~ 198 (293)
T cd05053 122 PRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPV 198 (293)
T ss_pred ccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCc
Confidence 22457899999999999999999999999 9999999999999999999999999987532221111112223456
Q ss_pred cccCccccccCCCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHH
Q 021490 155 GYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFY 233 (311)
Q Consensus 155 ~y~aPE~~~~~~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
.|+|||++.+..++.++|||||||++|+|++ |..||.............. .. ....+.....
T Consensus 199 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~-------~~----------~~~~~~~~~~ 261 (293)
T cd05053 199 KWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKE-------GY----------RMEKPQNCTQ 261 (293)
T ss_pred cccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHHc-------CC----------cCCCCCCCCH
Confidence 7999999988889999999999999999998 9999976554333221110 00 0011223345
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHHHHHhh
Q 021490 234 QALAVAAMCVHEQPDMRPVIADVVTALAYLA 264 (311)
Q Consensus 234 ~l~~li~~~l~~~p~~Rps~~~vl~~l~~~~ 264 (311)
.+.+|+.+||..||++|||+.++++.|+.+.
T Consensus 262 ~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 262 ELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 7889999999999999999999999998664
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=267.11 Aligned_cols=231 Identities=28% Similarity=0.379 Sum_probs=183.5
Q ss_pred cCCcEEEEEEeecCCC--cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCH
Q 021490 7 CLLQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 84 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~ 84 (311)
.++..+|+|+++.... ...+.+.+|+.++..++||||+++++++. ....++||||+++++|.+++.. ...+++
T Consensus 20 ~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~----~~~~~~ 94 (257)
T cd05116 20 KSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELGPLNKFLQK----NKHVTE 94 (257)
T ss_pred CCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCCcHHHHHHh----cCCCCH
Confidence 4678999999865443 23467899999999999999999999875 4567899999999999999976 467899
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCcee-eeeccccccccCccccc
Q 021490 85 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHV-STRVMGTYGYCAPEYAK 163 (311)
Q Consensus 85 ~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~ 163 (311)
..+..++.|++.||+|||+++ ++|+||+|.||+++.++.++|+|||++........... .....++..|+|||.+.
T Consensus 95 ~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 171 (257)
T cd05116 95 KNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMN 171 (257)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhc
Confidence 999999999999999999999 99999999999999999999999999875432221111 11123357899999998
Q ss_pred cCCCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHc
Q 021490 164 TGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMC 242 (311)
Q Consensus 164 ~~~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 242 (311)
...++.++|+||||+++|+|++ |..||...........+... .. ...+...+.++.++|.+|
T Consensus 172 ~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~-------~~----------~~~~~~~~~~l~~li~~~ 234 (257)
T cd05116 172 YYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESG-------ER----------MECPQRCPPEMYDLMKLC 234 (257)
T ss_pred cCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCC-------CC----------CCCCCCCCHHHHHHHHHH
Confidence 8888999999999999999998 99999765543322222110 00 012223445788999999
Q ss_pred cccCCCCCCCHHHHHHHHHH
Q 021490 243 VHEQPDMRPVIADVVTALAY 262 (311)
Q Consensus 243 l~~~p~~Rps~~~vl~~l~~ 262 (311)
|+.||++|||+.+|.+.|+.
T Consensus 235 ~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 235 WTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred hccCchhCcCHHHHHHHHhc
Confidence 99999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=279.29 Aligned_cols=220 Identities=27% Similarity=0.321 Sum_probs=175.5
Q ss_pred CCcEEEEEEeecCCC---cchhHHHHHHH-HHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCC
Q 021490 8 LLQDVAIKQLDRNGV---QGNREFLVEVL-MLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLD 83 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~---~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~ 83 (311)
+|+.||+|++..... .....+++|.. +++.++||||+++++.+.+....++||||+++++|..++.. ...++
T Consensus 19 ~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~ 94 (323)
T cd05575 19 DGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQR----ERSFP 94 (323)
T ss_pred CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCCCHHHHHHh----cCCCC
Confidence 689999999975422 22345555554 56788999999999999999999999999999999999876 56799
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccc
Q 021490 84 WNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 163 (311)
Q Consensus 84 ~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 163 (311)
+..+..++.||+.||+|||+++ ++||||||+|||++.++.++|+|||++...... ........|+..|+|||++.
T Consensus 95 ~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~ 169 (323)
T cd05575 95 EPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH--SKTTSTFCGTPEYLAPEVLR 169 (323)
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccC--CCccccccCChhhcChhhhc
Confidence 9999999999999999999999 999999999999999999999999998642111 11222345889999999999
Q ss_pred cCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHcc
Q 021490 164 TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCV 243 (311)
Q Consensus 164 ~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 243 (311)
+..++.++|||||||++|+|++|..||...+.......+ .... . ..++..+..+.+++.+||
T Consensus 170 ~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i------~~~~--------~----~~~~~~~~~~~~li~~~l 231 (323)
T cd05575 170 KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNI------LNKP--------L----RLKPNISVSARHLLEGLL 231 (323)
T ss_pred CCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHH------HcCC--------C----CCCCCCCHHHHHHHHHHh
Confidence 889999999999999999999999999765543221111 1100 0 112223457889999999
Q ss_pred ccCCCCCCCHH
Q 021490 244 HEQPDMRPVIA 254 (311)
Q Consensus 244 ~~~p~~Rps~~ 254 (311)
+.||.+||++.
T Consensus 232 ~~~p~~R~~~~ 242 (323)
T cd05575 232 QKDRTKRLGAK 242 (323)
T ss_pred hcCHHhCCCCC
Confidence 99999999984
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=271.23 Aligned_cols=247 Identities=23% Similarity=0.271 Sum_probs=187.4
Q ss_pred cchhcc-CCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCC-----eeEEEEecCCCCChhhhhccc
Q 021490 2 MQVILC-LLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD-----QRLLVYEYMPLGSVEDHLHDL 75 (311)
Q Consensus 2 ~~~~~~-~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~ 75 (311)
|++++. ++..||||++-.... .-.+|+.+|+.++|||||++..+|.... ...+||||++ .+|.+.+...
T Consensus 41 yq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP-~tL~~~~r~~ 115 (364)
T KOG0658|consen 41 YQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMP-ETLYRVIRHY 115 (364)
T ss_pred EEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhch-HHHHHHHHHH
Confidence 444444 469999999854332 2235999999999999999999886432 3468999997 7999999876
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCC-CceEEccccccccCCCCCCceeeeeccccc
Q 021490 76 SPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG-YHPKLSDFGLAKLGPVGDNTHVSTRVMGTY 154 (311)
Q Consensus 76 ~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~ 154 (311)
...+..++.-.+.-+..||++||+|||+.| ||||||||+|+|++.+ |.+||+|||.+........ ......+.
T Consensus 116 ~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~ep---niSYicSR 189 (364)
T KOG0658|consen 116 TRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEP---NISYICSR 189 (364)
T ss_pred hhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceeeccCCC---ceeEEEec
Confidence 556788999999999999999999999999 9999999999999965 8999999999986433222 23334677
Q ss_pred cccCcccccc-CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccc------cccccccCccccC--
Q 021490 155 GYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDR------TRHSLIADPELQG-- 225 (311)
Q Consensus 155 ~y~aPE~~~~-~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~-- 225 (311)
-|.|||.+.+ ..|+.+.||||.||++.||+.|++.|.+.+..+....+-......... ........|.+..
T Consensus 190 yYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~ 269 (364)
T KOG0658|consen 190 YYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHP 269 (364)
T ss_pred cccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCccccccc
Confidence 8999998876 689999999999999999999999999987766654432221111100 0101112222221
Q ss_pred ---CCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 021490 226 ---QYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 226 ---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~ 259 (311)
-+......++++|+.++|+++|.+|.++.+++..
T Consensus 270 ~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 270 WHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred ceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 1334456789999999999999999999999955
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=283.26 Aligned_cols=247 Identities=28% Similarity=0.420 Sum_probs=203.1
Q ss_pred cchhcc---CCcEEEEEEeecCCCcch-hHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCC
Q 021490 2 MQVILC---LLQDVAIKQLDRNGVQGN-REFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP 77 (311)
Q Consensus 2 ~~~~~~---~g~~vaiK~~~~~~~~~~-~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 77 (311)
++|.+| .+..||+|+++....... ..|.+|+++|.+|+||||+.++++|..++.+++|+||++.|+|.+++....
T Consensus 552 GEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnGDLnqFl~ahe- 630 (807)
T KOG1094|consen 552 GEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENGDLNQFLSAHE- 630 (807)
T ss_pred ceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcCcHHHHHHhcc-
Confidence 445555 358999999988766554 799999999999999999999999999999999999999999999998732
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeecccccccc
Q 021490 78 GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 157 (311)
Q Consensus 78 ~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~ 157 (311)
...+.......++.||++|++||.+.+ +|||||.+.|||++.++++||+|||.++-...+.......+.+.+..|+
T Consensus 631 -apt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwm 706 (807)
T KOG1094|consen 631 -LPTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWM 706 (807)
T ss_pred -CcccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCceeeecceeeeeeeh
Confidence 122466677889999999999999999 9999999999999999999999999998665666666777778899999
Q ss_pred CccccccCCCccccceeehhHHHHHHHh--CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHH
Q 021490 158 APEYAKTGQLTLKSDVYSFGVVLLEILS--GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQA 235 (311)
Q Consensus 158 aPE~~~~~~~~~~~DiwslG~l~~~ll~--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 235 (311)
|+|.+.-+.++.++|+|+||+++||+++ ...||.....+. +++....++........+ .-|+-++..+
T Consensus 707 awEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~---vven~~~~~~~~~~~~~l-------~~P~~cp~~l 776 (807)
T KOG1094|consen 707 AWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ---VVENAGEFFRDQGRQVVL-------SRPPACPQGL 776 (807)
T ss_pred hHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH---HHHhhhhhcCCCCcceec-------cCCCcCcHHH
Confidence 9999999999999999999999999754 789987655433 233333334433333222 2244556688
Q ss_pred HHHHHHccccCCCCCCCHHHHHHHHHHh
Q 021490 236 LAVAAMCVHEQPDMRPVIADVVTALAYL 263 (311)
Q Consensus 236 ~~li~~~l~~~p~~Rps~~~vl~~l~~~ 263 (311)
.+++..||..|..+|||++++...|+..
T Consensus 777 yelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 777 YELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred HHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 8999999999999999999999988653
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=271.56 Aligned_cols=234 Identities=28% Similarity=0.430 Sum_probs=185.3
Q ss_pred CCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCC----------
Q 021490 8 LLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP---------- 77 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------- 77 (311)
++..+|+|.++.........|.+|+++++.++|+||+++++++.++...+++|||+++++|.+++.....
T Consensus 34 ~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~ 113 (280)
T cd05092 34 DKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGED 113 (280)
T ss_pred CceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhccccc
Confidence 4668999988766655667899999999999999999999999999999999999999999999875321
Q ss_pred -CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccc
Q 021490 78 -GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY 156 (311)
Q Consensus 78 -~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y 156 (311)
....+++..++.++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++................++..|
T Consensus 114 ~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y 190 (280)
T cd05092 114 VAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRW 190 (280)
T ss_pred CCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccc
Confidence 1135889999999999999999999999 999999999999999999999999998643222211112223346789
Q ss_pred cCccccccCCCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHH
Q 021490 157 CAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQA 235 (311)
Q Consensus 157 ~aPE~~~~~~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 235 (311)
+|||.+.+..++.++|||||||++|+|++ |..||............... .. .. .+...+..+
T Consensus 191 ~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-------~~------~~----~~~~~~~~~ 253 (280)
T cd05092 191 MPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQG-------RE------LE----RPRTCPPEV 253 (280)
T ss_pred cCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcC-------cc------CC----CCCCCCHHH
Confidence 99999988889999999999999999998 89998665443322211100 00 00 111223467
Q ss_pred HHHHHHccccCCCCCCCHHHHHHHHH
Q 021490 236 LAVAAMCVHEQPDMRPVIADVVTALA 261 (311)
Q Consensus 236 ~~li~~~l~~~p~~Rps~~~vl~~l~ 261 (311)
.+++.+||+.||.+||++.++++.|+
T Consensus 254 ~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 254 YAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HHHHHHHccCChhhCCCHHHHHHHHh
Confidence 89999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=267.21 Aligned_cols=232 Identities=26% Similarity=0.391 Sum_probs=184.8
Q ss_pred CcEEEEEEeecCCC-cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHHH
Q 021490 9 LQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTR 87 (311)
Q Consensus 9 g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~ 87 (311)
...||+|+++.... .....|.+|+.++..++||||+++++++..+...++||||+++++|.+++... .+.+++..+
T Consensus 32 ~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~---~~~~~~~~~ 108 (266)
T cd05033 32 EIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLREN---DGKFTVGQL 108 (266)
T ss_pred cceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEcCCCCCHHHHHHhc---cCCCCHHHH
Confidence 45799999865443 23457899999999999999999999999999999999999999999998762 347899999
Q ss_pred HHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccCCC
Q 021490 88 MKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQL 167 (311)
Q Consensus 88 ~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 167 (311)
+.++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++................++..|+|||.+.+..+
T Consensus 109 ~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~ 185 (266)
T cd05033 109 VGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKF 185 (266)
T ss_pred HHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccccccceeccCCCCCccccChhhhccCCC
Confidence 999999999999999999 99999999999999999999999999876432222222222334578999999988889
Q ss_pred ccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccC
Q 021490 168 TLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQ 246 (311)
Q Consensus 168 ~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 246 (311)
+.++||||||+++|+|++ |..||...........+. ..... ..+...+..+.+++.+||+.+
T Consensus 186 ~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~-------~~~~~----------~~~~~~~~~l~~li~~cl~~~ 248 (266)
T cd05033 186 TSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVE-------DGYRL----------PPPMDCPSALYQLMLDCWQKD 248 (266)
T ss_pred ccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH-------cCCCC----------CCCCCCCHHHHHHHHHHcCCC
Confidence 999999999999999998 999996554332211111 00000 011223457889999999999
Q ss_pred CCCCCCHHHHHHHHHHh
Q 021490 247 PDMRPVIADVVTALAYL 263 (311)
Q Consensus 247 p~~Rps~~~vl~~l~~~ 263 (311)
|++||++.++++.|+.+
T Consensus 249 p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 249 RNERPTFSQIVSTLDKM 265 (266)
T ss_pred cccCcCHHHHHHHHHhh
Confidence 99999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=267.24 Aligned_cols=243 Identities=21% Similarity=0.301 Sum_probs=190.3
Q ss_pred cchhcc-CCcEEEEEEeecCCC---cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCC
Q 021490 2 MQVILC-LLQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP 77 (311)
Q Consensus 2 ~~~~~~-~g~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 77 (311)
|.+... +|+.||+|.++.... ...+.+.+|++++++++|+|++++++.+..+...++||||+++++|.+++.....
T Consensus 19 ~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 98 (267)
T cd08224 19 YKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKK 98 (267)
T ss_pred EEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecCCCCCHHHHHHHhcc
Confidence 344444 789999999864322 2346888999999999999999999999999999999999999999999876444
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeecccccccc
Q 021490 78 GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 157 (311)
Q Consensus 78 ~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~ 157 (311)
....+++..++.++.+++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++....... .......++..|+
T Consensus 99 ~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~y~ 173 (267)
T cd08224 99 QKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT--TAAHSLVGTPYYM 173 (267)
T ss_pred cCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccCCC--cccceecCCcccc
Confidence 4566899999999999999999999999 9999999999999999999999999886432221 1112235778899
Q ss_pred CccccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCC-hHhHHHHH
Q 021490 158 APEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYP-PRGFYQAL 236 (311)
Q Consensus 158 aPE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~ 236 (311)
|||.+.+..++.++|+||||+++|+|++|..||........ ...... ... . . ...+ ...+..+.
T Consensus 174 apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~----~~~-~-----~----~~~~~~~~~~~~~ 238 (267)
T cd08224 174 SPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY-SLCKKI----EKC-D-----Y----PPLPADHYSEELR 238 (267)
T ss_pred CHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHH-HHHhhh----hcC-C-----C----CCCChhhcCHHHH
Confidence 99999888899999999999999999999999965432111 111000 000 0 0 0111 13345788
Q ss_pred HHHHHccccCCCCCCCHHHHHHHHHHhh
Q 021490 237 AVAAMCVHEQPDMRPVIADVVTALAYLA 264 (311)
Q Consensus 237 ~li~~~l~~~p~~Rps~~~vl~~l~~~~ 264 (311)
+++.+||..+|++|||+.++++.|+.+.
T Consensus 239 ~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 239 DLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred HHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 9999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=275.63 Aligned_cols=245 Identities=21% Similarity=0.216 Sum_probs=178.9
Q ss_pred CCcEEEEEEeecCCCc-chhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHH
Q 021490 8 LLQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNT 86 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~ 86 (311)
+|+.||+|+++..... ....+.+|+.+++.++||||+++++++.++...++||||++ ++|.+++... ...+++..
T Consensus 29 ~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~---~~~~~~~~ 104 (303)
T cd07869 29 NGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH-TDLCQYMDKH---PGGLHPEN 104 (303)
T ss_pred CCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC-cCHHHHHHhC---CCCCCHHH
Confidence 6889999998755432 23467889999999999999999999999999999999996 6788777652 45689999
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccccc-C
Q 021490 87 RMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT-G 165 (311)
Q Consensus 87 ~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~ 165 (311)
+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++....... .......++..|+|||++.+ .
T Consensus 105 ~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~ 179 (303)
T cd07869 105 VKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS--HTYSNEVVTLWYRPPDVLLGST 179 (303)
T ss_pred HHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC--ccCCCCcccCCCCChHHHcCCC
Confidence 9999999999999999999 9999999999999999999999999986422111 11223457889999998865 4
Q ss_pred CCccccceeehhHHHHHHHhCCCccCcchhHHH-HHHHHHhh-hhhccccc---cccccCcc-ccCCCCh---------H
Q 021490 166 QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE-QSLVAWAR-PLFQDRTR---HSLIADPE-LQGQYPP---------R 230 (311)
Q Consensus 166 ~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~-~~~~~~~~-~~~~~~~~---~~~~~~~~-~~~~~~~---------~ 230 (311)
.++.++|||||||++|+|++|..||........ ........ ........ ......+. +....+. .
T Consensus 180 ~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (303)
T cd07869 180 EYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLS 259 (303)
T ss_pred CCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccC
Confidence 578899999999999999999999976433211 11111100 00000000 00000000 0000000 1
Q ss_pred hHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 021490 231 GFYQALAVAAMCVHEQPDMRPVIADVVTALA 261 (311)
Q Consensus 231 ~~~~l~~li~~~l~~~p~~Rps~~~vl~~l~ 261 (311)
.+..+.+|+.+||+.||++|||+.++++.-.
T Consensus 260 ~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~ 290 (303)
T cd07869 260 YVNHAEDLASKLLQCFPKNRLSAQAALSHEY 290 (303)
T ss_pred CChHHHHHHHHHhccCchhccCHHHHhcCcc
Confidence 1246778999999999999999999997643
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=280.55 Aligned_cols=233 Identities=25% Similarity=0.360 Sum_probs=180.0
Q ss_pred cCCcEEEEEEeecCCC---cchhHHHHHHHHHhcC-CCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCC
Q 021490 7 CLLQDVAIKQLDRNGV---QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPL 82 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l 82 (311)
.+|+.||+|+++.... .....+.+|+.++.++ +||||+++++++.++...++||||+++++|..++.. ...+
T Consensus 18 ~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~----~~~l 93 (329)
T cd05618 18 KTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR----QRKL 93 (329)
T ss_pred CCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCCCHHHHHHH----cCCC
Confidence 3678999999976432 2335677899988877 799999999999999999999999999999988876 5679
Q ss_pred CHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccc
Q 021490 83 DWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 162 (311)
Q Consensus 83 ~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 162 (311)
++..+..++.|++.||+|||+++ ++||||||+||+++.++.++|+|||++...... ........|+..|+|||++
T Consensus 94 ~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~--~~~~~~~~gt~~y~aPE~~ 168 (329)
T cd05618 94 PEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP--GDTTSTFCGTPNYIAPEIL 168 (329)
T ss_pred CHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCC--CCccccccCCccccCHHHH
Confidence 99999999999999999999999 999999999999999999999999998642111 1112234688999999999
Q ss_pred ccCCCccccceeehhHHHHHHHhCCCccCcchhHH--HHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHH
Q 021490 163 KTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA--EQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAA 240 (311)
Q Consensus 163 ~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 240 (311)
.+..++.++|||||||++|+|++|..||....... ......+....+... ...++...+..+.+++.
T Consensus 169 ~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~-----------~~~~p~~~~~~~~~ll~ 237 (329)
T cd05618 169 RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK-----------QIRIPRSLSVKAASVLK 237 (329)
T ss_pred cCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcC-----------CCCCCCCCCHHHHHHHH
Confidence 99899999999999999999999999996322110 000000000000000 01123334557889999
Q ss_pred HccccCCCCCCCH------HHHHHH
Q 021490 241 MCVHEQPDMRPVI------ADVVTA 259 (311)
Q Consensus 241 ~~l~~~p~~Rps~------~~vl~~ 259 (311)
+||..||++||++ .+++..
T Consensus 238 ~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 238 SFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred HHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 9999999999984 666654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=267.34 Aligned_cols=232 Identities=27% Similarity=0.384 Sum_probs=183.5
Q ss_pred hhccCCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCC
Q 021490 4 VILCLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLD 83 (311)
Q Consensus 4 ~~~~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~ 83 (311)
+...++..||+|.+.... ...+.|.+|+.++..++||||+++++++.+....++||||+.+++|.+++... ...++
T Consensus 23 ~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~---~~~~~ 98 (256)
T cd05113 23 GKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREH---GKRFQ 98 (256)
T ss_pred EEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHHHHHhc---CCCCC
Confidence 334455679999986433 34578999999999999999999999999888899999999999999998762 23689
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccc
Q 021490 84 WNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 163 (311)
Q Consensus 84 ~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 163 (311)
+..++.++.|++.||+|||+.+ ++|+||+|.||+++.++.++|+|||.+....... ........++..|++||.+.
T Consensus 99 ~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~-~~~~~~~~~~~~y~~pe~~~ 174 (256)
T cd05113 99 PSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLL 174 (256)
T ss_pred HHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCc-eeecCCCccChhhCCHHHHh
Confidence 9999999999999999999999 9999999999999999999999999886532211 11112233557899999998
Q ss_pred cCCCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHc
Q 021490 164 TGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMC 242 (311)
Q Consensus 164 ~~~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 242 (311)
+..++.++||||||+++|+|++ |..||............. ... .. ..+...+..+.+++.+|
T Consensus 175 ~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~------~~~-~~----------~~~~~~~~~~~~li~~c 237 (256)
T cd05113 175 YSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVS------QGL-RL----------YRPHLASEKVYAIMYSC 237 (256)
T ss_pred cCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHh------cCC-CC----------CCCCCCCHHHHHHHHHH
Confidence 8889999999999999999998 999997655432221111 000 00 00111245788999999
Q ss_pred cccCCCCCCCHHHHHHHH
Q 021490 243 VHEQPDMRPVIADVVTAL 260 (311)
Q Consensus 243 l~~~p~~Rps~~~vl~~l 260 (311)
|..||.+|||+.+++..|
T Consensus 238 l~~~p~~Rp~~~~ll~~~ 255 (256)
T cd05113 238 WHEKAEERPTFQQLLSSI 255 (256)
T ss_pred cCCCcccCCCHHHHHHhh
Confidence 999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=277.53 Aligned_cols=229 Identities=26% Similarity=0.249 Sum_probs=194.2
Q ss_pred CCcEEEEEEeecCCCc---chhHHHHHHHHHhcCC-CCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCC
Q 021490 8 LLQDVAIKQLDRNGVQ---GNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLD 83 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~ 83 (311)
+|+.+|+|++++.... +.+.+.+|+.+|+++. ||||+.++++|++....++|||+|.||.|.+.+... .++
T Consensus 59 tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~GGeLfd~i~~~-----~~s 133 (382)
T KOG0032|consen 59 TGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELCEGGELFDRIVKK-----HYS 133 (382)
T ss_pred CCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEecCCchHHHHHHHc-----cCC
Confidence 3999999999877553 3468999999999998 999999999999999999999999999999999873 399
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcC----CCceEEccccccccCCCCCCceeeeeccccccccCc
Q 021490 84 WNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR----GYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 159 (311)
Q Consensus 84 ~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~----~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aP 159 (311)
+..+..++.|++.++.|||+.| ++||||||+|+|+.. ++.++++|||++..... ........||+.|+||
T Consensus 134 E~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~---~~~~~~~~Gtp~y~AP 207 (382)
T KOG0032|consen 134 ERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP---GERLHTIVGTPEYVAP 207 (382)
T ss_pred HHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC---CceEeeecCCccccCc
Confidence 9999999999999999999999 999999999999964 35799999999986433 4455667899999999
Q ss_pred cccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHH
Q 021490 160 EYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVA 239 (311)
Q Consensus 160 E~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 239 (311)
|++....++..+|+||+|+++|.|++|.+||...........+... +..+.....+..+..+-+++
T Consensus 208 Evl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~--------------~~~f~~~~w~~is~~akd~i 273 (382)
T KOG0032|consen 208 EVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRG--------------DFDFTSEPWDDISESAKDFI 273 (382)
T ss_pred hhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcC--------------CCCCCCCCccccCHHHHHHH
Confidence 9999999999999999999999999999999876654433322111 11333344455577899999
Q ss_pred HHccccCCCCCCCHHHHHHHHH
Q 021490 240 AMCVHEQPDMRPVIADVVTALA 261 (311)
Q Consensus 240 ~~~l~~~p~~Rps~~~vl~~l~ 261 (311)
..||..||..|+|+.++++..+
T Consensus 274 ~~ll~~dp~~R~ta~~~L~HpW 295 (382)
T KOG0032|consen 274 RKLLEFDPRKRLTAAQALQHPW 295 (382)
T ss_pred HHhcccCcccCCCHHHHhcCcc
Confidence 9999999999999999999643
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=265.25 Aligned_cols=236 Identities=28% Similarity=0.374 Sum_probs=186.5
Q ss_pred cchhccCCcEEEEEEeecCCCc-chhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCC
Q 021490 2 MQVILCLLQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKK 80 (311)
Q Consensus 2 ~~~~~~~g~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 80 (311)
|.+...+++.||+|.++..... ....+.+|+++++.++||||+++++++......++||||+++++|.+++... ..
T Consensus 12 y~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~ 88 (250)
T cd05085 12 FKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKK---KD 88 (250)
T ss_pred EEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHHHHHhc---CC
Confidence 4555678899999998655432 2347889999999999999999999999999999999999999999988652 34
Q ss_pred CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcc
Q 021490 81 PLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 160 (311)
Q Consensus 81 ~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE 160 (311)
.+++..++.++.+++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||++....... ........++..|+|||
T Consensus 89 ~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~~y~aPE 164 (250)
T cd05085 89 ELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI-YSSSGLKQIPIKWTAPE 164 (250)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccc-cccCCCCCCcccccCHH
Confidence 6889999999999999999999999 9999999999999999999999999886422111 11111123456799999
Q ss_pred ccccCCCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHH
Q 021490 161 YAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVA 239 (311)
Q Consensus 161 ~~~~~~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 239 (311)
++....++.++||||||+++|+|++ |..||............. . . .....+...+..+.+++
T Consensus 165 ~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~---~----~----------~~~~~~~~~~~~~~~li 227 (250)
T cd05085 165 ALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVE---K----G----------YRMSCPQKCPDDVYKVM 227 (250)
T ss_pred HhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH---c----C----------CCCCCCCCCCHHHHHHH
Confidence 9988889999999999999999998 999997654432211110 0 0 00111223345788999
Q ss_pred HHccccCCCCCCCHHHHHHHHH
Q 021490 240 AMCVHEQPDMRPVIADVVTALA 261 (311)
Q Consensus 240 ~~~l~~~p~~Rps~~~vl~~l~ 261 (311)
.+||..+|++|||+.++++.|.
T Consensus 228 ~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 228 QRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHcccCcccCCCHHHHHHHhc
Confidence 9999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=265.61 Aligned_cols=237 Identities=27% Similarity=0.381 Sum_probs=187.4
Q ss_pred cchhccCCcEEEEEEeecCCCc-chhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCC
Q 021490 2 MQVILCLLQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKK 80 (311)
Q Consensus 2 ~~~~~~~g~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 80 (311)
|.+...+|+.||+|++...... ....+.+|++++++++|+||+++++++.+....++||||+.+++|.+++... ..
T Consensus 12 ~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~---~~ 88 (251)
T cd05041 12 YKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKK---KN 88 (251)
T ss_pred EEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHHHHHhc---CC
Confidence 4455556999999998765443 4568999999999999999999999999999999999999999999998652 34
Q ss_pred CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcc
Q 021490 81 PLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 160 (311)
Q Consensus 81 ~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE 160 (311)
.+++..+..++.+++.+|+|||+++ ++|+||+|+||+++.++.++|+|||.+.................+..|+|||
T Consensus 89 ~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE 165 (251)
T cd05041 89 RLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPE 165 (251)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcceeccCChH
Confidence 6889999999999999999999999 9999999999999999999999999986432111111111122356799999
Q ss_pred ccccCCCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHH
Q 021490 161 YAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVA 239 (311)
Q Consensus 161 ~~~~~~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 239 (311)
.+.+..++.++|+||||+++|+|++ |..||............... . ....+...+..+.+++
T Consensus 166 ~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~---~--------------~~~~~~~~~~~~~~li 228 (251)
T cd05041 166 ALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESG---Y--------------RMPAPQLCPEEIYRLM 228 (251)
T ss_pred hhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcC---C--------------CCCCCccCCHHHHHHH
Confidence 9988889999999999999999999 88888765543322221100 0 0011222345788999
Q ss_pred HHccccCCCCCCCHHHHHHHHH
Q 021490 240 AMCVHEQPDMRPVIADVVTALA 261 (311)
Q Consensus 240 ~~~l~~~p~~Rps~~~vl~~l~ 261 (311)
.+||..+|.+|||+.++++.|.
T Consensus 229 ~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 229 LQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHHhccChhhCcCHHHHHHHhh
Confidence 9999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=266.12 Aligned_cols=232 Identities=25% Similarity=0.354 Sum_probs=182.6
Q ss_pred CCcEEEEEEeecCCC-cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHH
Q 021490 8 LLQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNT 86 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~ 86 (311)
.+..||+|+++.... ...+.|.+|+.+++.++||||+++++++. ....++||||+++++|.+++... ...+++..
T Consensus 21 ~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~ 96 (257)
T cd05115 21 KQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGPLNKFLSGK---KDEITVSN 96 (257)
T ss_pred CceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCCHHHHHHhC---CCCCCHHH
Confidence 356799999866543 23467899999999999999999999875 45789999999999999998752 35789999
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCcee-eeeccccccccCccccccC
Q 021490 87 RMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHV-STRVMGTYGYCAPEYAKTG 165 (311)
Q Consensus 87 ~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~ 165 (311)
++.++.|++.||+|||+++ ++|+||+|+||+++.++.++|+|||++........... .....++..|+|||.+...
T Consensus 97 ~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 173 (257)
T cd05115 97 VVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFR 173 (257)
T ss_pred HHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHccC
Confidence 9999999999999999999 99999999999999999999999999864322221111 1112235689999999888
Q ss_pred CCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccc
Q 021490 166 QLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVH 244 (311)
Q Consensus 166 ~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 244 (311)
.++.++||||||+++|+|++ |..||...........+... . ....+...+.++.+++.+||.
T Consensus 174 ~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-------~----------~~~~~~~~~~~l~~li~~c~~ 236 (257)
T cd05115 174 KFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQG-------K----------RLDCPAECPPEMYALMKDCWI 236 (257)
T ss_pred CCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCC-------C----------CCCCCCCCCHHHHHHHHHHcC
Confidence 88999999999999999996 99999766543322211100 0 011223345588899999999
Q ss_pred cCCCCCCCHHHHHHHHHHh
Q 021490 245 EQPDMRPVIADVVTALAYL 263 (311)
Q Consensus 245 ~~p~~Rps~~~vl~~l~~~ 263 (311)
.||++||++.++.+.|+.+
T Consensus 237 ~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 237 YKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CChhhCcCHHHHHHHHhhh
Confidence 9999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=270.45 Aligned_cols=234 Identities=27% Similarity=0.383 Sum_probs=182.1
Q ss_pred CCcEEEEEEeecCCCc-chhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCC---CCCCCC
Q 021490 8 LLQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP---GKKPLD 83 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~l~ 83 (311)
.+..||+|.++..... ....|.+|+.+++.++|+||+++++++.+....++||||++|++|.+++..... ....++
T Consensus 35 ~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~ 114 (277)
T cd05036 35 VELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLT 114 (277)
T ss_pred CceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCC
Confidence 4678999988654322 345789999999999999999999999988899999999999999999876421 123589
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCC---ceEEccccccccCCCCCCceeeeeccccccccCcc
Q 021490 84 WNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY---HPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 160 (311)
Q Consensus 84 ~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~---~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE 160 (311)
+..++.++.|++.||+|||+.+ ++|+||+|+||+++.++ .++|+|||++.................+..|+|||
T Consensus 115 ~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 191 (277)
T cd05036 115 MKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPE 191 (277)
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHH
Confidence 9999999999999999999999 99999999999998754 58999999987542211111111222356799999
Q ss_pred ccccCCCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHH
Q 021490 161 YAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVA 239 (311)
Q Consensus 161 ~~~~~~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 239 (311)
++.+..++.++|||||||++|+|++ |..||...........+.. . .. ...+...+..+.+++
T Consensus 192 ~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~------~-~~----------~~~~~~~~~~~~~~i 254 (277)
T cd05036 192 AFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTG------G-GR----------LDPPKGCPGPVYRIM 254 (277)
T ss_pred HHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc------C-Cc----------CCCCCCCCHHHHHHH
Confidence 9988889999999999999999997 9999986554433222110 0 00 011223345788999
Q ss_pred HHccccCCCCCCCHHHHHHHHH
Q 021490 240 AMCVHEQPDMRPVIADVVTALA 261 (311)
Q Consensus 240 ~~~l~~~p~~Rps~~~vl~~l~ 261 (311)
.+||+.+|++|||+.++++.|.
T Consensus 255 ~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 255 TDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HHHcCCCcccCcCHHHHHHHhh
Confidence 9999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=270.02 Aligned_cols=234 Identities=25% Similarity=0.394 Sum_probs=182.1
Q ss_pred CCcEEEEEEeecCCC-cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCC------CC
Q 021490 8 LLQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPG------KK 80 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~------~~ 80 (311)
.+..||+|+++.... .....|.+|+.+++.++||||+++++++.++...++||||+++++|.+++...... ..
T Consensus 35 ~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~ 114 (277)
T cd05062 35 PETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQA 114 (277)
T ss_pred ceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCcccccccccc
Confidence 457799999864332 23457889999999999999999999999999999999999999999998753211 13
Q ss_pred CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcc
Q 021490 81 PLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 160 (311)
Q Consensus 81 ~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE 160 (311)
.+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++................++..|+|||
T Consensus 115 ~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 191 (277)
T cd05062 115 PPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE 191 (277)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChh
Confidence 4678889999999999999999999 9999999999999999999999999986432222111111223467899999
Q ss_pred ccccCCCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHH
Q 021490 161 YAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVA 239 (311)
Q Consensus 161 ~~~~~~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 239 (311)
.+.+..++.++||||||+++|+|++ |..||.............. . .. + ..+...+..+.+++
T Consensus 192 ~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~------~-~~------~----~~~~~~~~~~~~li 254 (277)
T cd05062 192 SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVME------G-GL------L----DKPDNCPDMLFELM 254 (277)
T ss_pred HhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc------C-Cc------C----CCCCCCCHHHHHHH
Confidence 9988889999999999999999999 7889876554332221110 0 00 0 11122334788899
Q ss_pred HHccccCCCCCCCHHHHHHHHH
Q 021490 240 AMCVHEQPDMRPVIADVVTALA 261 (311)
Q Consensus 240 ~~~l~~~p~~Rps~~~vl~~l~ 261 (311)
.+||+.||++|||+.++++.|+
T Consensus 255 ~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 255 RMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HHHcCCChhhCcCHHHHHHHhh
Confidence 9999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=267.99 Aligned_cols=238 Identities=21% Similarity=0.296 Sum_probs=187.8
Q ss_pred cCCcEEEEEEeecCCC---cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCC
Q 021490 7 CLLQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLD 83 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~ 83 (311)
.+|..+|||.+..... .....+.+|+.+++.++|+||+++++++.++...+++|||+++++|.+++.........++
T Consensus 25 ~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~ 104 (267)
T cd08229 25 LDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIP 104 (267)
T ss_pred CCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEecCCCCHHHHHHHhhccCCCCC
Confidence 4789999998865432 2335788999999999999999999999999999999999999999998875443456789
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccc
Q 021490 84 WNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 163 (311)
Q Consensus 84 ~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 163 (311)
+..++.++.+++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++....... .......++..|+|||.+.
T Consensus 105 ~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~ape~~~ 179 (267)
T cd08229 105 EKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT--TAAHSLVGTPYYMSPERIH 179 (267)
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhccccCC--cccccccCCcCccCHHHhc
Confidence 9999999999999999999999 9999999999999999999999999886532221 1112235778899999998
Q ss_pred cCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHcc
Q 021490 164 TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCV 243 (311)
Q Consensus 164 ~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 243 (311)
+..++.++|+||||+++|+|++|..||........ ...... .. ...+. ..+...+..+.+++.+||
T Consensus 180 ~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~----~~------~~~~~---~~~~~~~~~~~~li~~~l 245 (267)
T cd08229 180 ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY-SLCKKI----EQ------CDYPP---LPSDHYSEELRQLVNMCI 245 (267)
T ss_pred CCCccchhhHHHHHHHHHHHHhCCCCcccccchHH-HHhhhh----hc------CCCCC---CCcccccHHHHHHHHHhc
Confidence 88899999999999999999999999965432211 111000 00 00010 011224457889999999
Q ss_pred ccCCCCCCCHHHHHHHHHHh
Q 021490 244 HEQPDMRPVIADVVTALAYL 263 (311)
Q Consensus 244 ~~~p~~Rps~~~vl~~l~~~ 263 (311)
..||.+|||+.+|.+.++.+
T Consensus 246 ~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 246 NPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred CCCcccCCCHHHHHHHHhhh
Confidence 99999999999999988764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=270.83 Aligned_cols=235 Identities=26% Similarity=0.345 Sum_probs=184.3
Q ss_pred CCcEEEEEEeecCCCcc-hhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccC----------
Q 021490 8 LLQDVAIKQLDRNGVQG-NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLS---------- 76 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------- 76 (311)
.++.||+|+++...... .+.+.+|+.++..++||||+++++++.+....++++||+.+++|.+++....
T Consensus 34 ~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~ 113 (283)
T cd05091 34 QTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDD 113 (283)
T ss_pred ceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCcccccccc
Confidence 35889999997554322 3578899999999999999999999999999999999999999999985321
Q ss_pred --CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccc
Q 021490 77 --PGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTY 154 (311)
Q Consensus 77 --~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~ 154 (311)
.....+++..+..++.|++.||+|||+.+ ++||||||.||++++++.++|+|||++................++.
T Consensus 114 ~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~ 190 (283)
T cd05091 114 DKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPI 190 (283)
T ss_pred ccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCceEecccccccccccchheeeccCccCCc
Confidence 11245888999999999999999999999 9999999999999999999999999987533222222222334567
Q ss_pred cccCccccccCCCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHH
Q 021490 155 GYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFY 233 (311)
Q Consensus 155 ~y~aPE~~~~~~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
.|+|||.+....++.++||||||+++|+|++ |..||...........+... .. ..++...+.
T Consensus 191 ~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~-------~~----------~~~~~~~~~ 253 (283)
T cd05091 191 RWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNR-------QV----------LPCPDDCPA 253 (283)
T ss_pred cccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-------Cc----------CCCCCCCCH
Confidence 8999999988889999999999999999998 88888765443322211110 00 011223344
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 021490 234 QALAVAAMCVHEQPDMRPVIADVVTALAY 262 (311)
Q Consensus 234 ~l~~li~~~l~~~p~~Rps~~~vl~~l~~ 262 (311)
.+.+++..||+.+|.+|||+.+++..|+.
T Consensus 254 ~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 254 WVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 78899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=269.83 Aligned_cols=248 Identities=27% Similarity=0.386 Sum_probs=185.0
Q ss_pred cCCcEEEEEEeecCCC-cchhHHHHHHHHHhcCCCCcccceeeEeeeC--CeeEEEEecCCCCChhhhhcccCCCCCCCC
Q 021490 7 CLLQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADG--DQRLLVYEYMPLGSVEDHLHDLSPGKKPLD 83 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~ 83 (311)
.++..||+|.++.... .....|.+|+++++.++||||+++++++... ...++||||+++++|.+++.. ..++
T Consensus 31 ~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-----~~l~ 105 (283)
T cd05080 31 GTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPK-----HKLN 105 (283)
T ss_pred CCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEecCCCCCCHHHHHHH-----cCCC
Confidence 4688999999865532 2456788999999999999999999987653 467999999999999999975 4599
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCce-eeeeccccccccCcccc
Q 021490 84 WNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH-VSTRVMGTYGYCAPEYA 162 (311)
Q Consensus 84 ~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~ 162 (311)
+..++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++.......... ......++..|+|||.+
T Consensus 106 ~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~ 182 (283)
T cd05080 106 LAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECL 182 (283)
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHh
Confidence 9999999999999999999999 9999999999999999999999999987543221111 11122345679999999
Q ss_pred ccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHc
Q 021490 163 KTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMC 242 (311)
Q Consensus 163 ~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 242 (311)
....++.++||||||+++|+|++|..||........ ............ .......+.......+...+..+.+++.+|
T Consensus 183 ~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~c 260 (283)
T cd05080 183 KENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQGQMTV-VRLIELLERGMRLPCPKNCPQEVYILMKNC 260 (283)
T ss_pred cccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-hhhcccccccch-hhhhhhhhcCCCCCCCCCCCHHHHHHHHHH
Confidence 888899999999999999999999999865432111 000000000000 000000011111122333456889999999
Q ss_pred cccCCCCCCCHHHHHHHHHHhh
Q 021490 243 VHEQPDMRPVIADVVTALAYLA 264 (311)
Q Consensus 243 l~~~p~~Rps~~~vl~~l~~~~ 264 (311)
|+.+|++|||+.++++.|+.+.
T Consensus 261 l~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 261 WETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hccChhhCCCHHHHHHHHHHhh
Confidence 9999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=281.64 Aligned_cols=230 Identities=23% Similarity=0.275 Sum_probs=181.4
Q ss_pred CCcEEEEEEeecCCC---cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCH
Q 021490 8 LLQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 84 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~ 84 (311)
+|+.||||+++.... .....+.+|+.++..++||||+++++++.++...++||||++||+|.+++.. ...+++
T Consensus 25 ~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~----~~~l~~ 100 (364)
T cd05599 25 TGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMK----KDTFTE 100 (364)
T ss_pred CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCCCcHHHHHHHH----cCCCCH
Confidence 689999999975422 2335678899999999999999999999999999999999999999999976 567999
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCce-------------------
Q 021490 85 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH------------------- 145 (311)
Q Consensus 85 ~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~------------------- 145 (311)
..+..++.|++.||+|||+.+ ++||||||+|||++.++.++|+|||++..........
T Consensus 101 ~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (364)
T cd05599 101 EETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISK 177 (364)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceeccccccccccccccccccccccccccc
Confidence 999999999999999999999 9999999999999999999999999886432111000
Q ss_pred -----------------eeeeccccccccCccccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHH-HHHHhhh
Q 021490 146 -----------------VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQS-LVAWARP 207 (311)
Q Consensus 146 -----------------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~-~~~~~~~ 207 (311)
......||+.|+|||++....++.++|||||||++|+|++|..||.......... +..|..
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i~~~~~- 256 (364)
T cd05599 178 PMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKE- 256 (364)
T ss_pred cccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCCCCCHHHHHHHHHcCCC-
Confidence 0012358999999999998899999999999999999999999998665432211 111100
Q ss_pred hhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCC---HHHHHHHH
Q 021490 208 LFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPV---IADVVTAL 260 (311)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps---~~~vl~~l 260 (311)
. ...+. ....+..+.++|.+|+. +|.+|++ +.++++.-
T Consensus 257 ------~---~~~~~-----~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~ 297 (364)
T cd05599 257 ------T---LQFPD-----EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHP 297 (364)
T ss_pred ------c---cCCCC-----CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCC
Confidence 0 00000 01234477889999997 9999998 88888753
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=280.93 Aligned_cols=232 Identities=25% Similarity=0.256 Sum_probs=180.3
Q ss_pred cCCcEEEEEEeecCCC---cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCC
Q 021490 7 CLLQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLD 83 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~ 83 (311)
.+|+.||||++..... .....+.+|+.+++.++||||+++++++.+....++||||++||+|.+++.. ...++
T Consensus 24 ~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~ 99 (381)
T cd05626 24 DTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIR----MEVFP 99 (381)
T ss_pred CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHh----cCCCC
Confidence 3688999999976432 2335788999999999999999999999999999999999999999999976 56789
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCc-------------------
Q 021490 84 WNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT------------------- 144 (311)
Q Consensus 84 ~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~------------------- 144 (311)
+..+..++.|++.||+|||+.+ |+||||||+|||++.++.++|+|||++.........
T Consensus 100 e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (381)
T cd05626 100 EVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDL 176 (381)
T ss_pred HHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccccccccccccccCcccc
Confidence 9999999999999999999999 999999999999999999999999987532100000
Q ss_pred --------------------------eeeeeccccccccCccccccCCCccccceeehhHHHHHHHhCCCccCcchhHHH
Q 021490 145 --------------------------HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE 198 (311)
Q Consensus 145 --------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~ 198 (311)
.......|+..|+|||++.+..++.++|||||||++|+|++|..||........
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~ 256 (381)
T cd05626 177 WDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTET 256 (381)
T ss_pred cccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHHHHhCCCCCcCCCHHHH
Confidence 001123589999999999888899999999999999999999999976554332
Q ss_pred HH-HHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHH--ccccCCCCCCCHHHHHHHH
Q 021490 199 QS-LVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAM--CVHEQPDMRPVIADVVTAL 260 (311)
Q Consensus 199 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~--~l~~~p~~Rps~~~vl~~l 260 (311)
.. +..+... .. .+ .....+.++.+|+.+ |+..++..||++.+++..-
T Consensus 257 ~~~i~~~~~~--------~~--~~-----~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp 306 (381)
T cd05626 257 QLKVINWENT--------LH--IP-----PQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHP 306 (381)
T ss_pred HHHHHccccc--------cC--CC-----CCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCc
Confidence 21 1111100 00 00 011234477888887 5556666799999999764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=269.40 Aligned_cols=235 Identities=30% Similarity=0.403 Sum_probs=183.5
Q ss_pred CCcEEEEEEeecCCC-cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCC---------
Q 021490 8 LLQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP--------- 77 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------- 77 (311)
.+..|++|.+..... .....+.+|+.+++.++||||+++++++..+...++||||+++++|.+++.....
T Consensus 33 ~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 112 (283)
T cd05090 33 HAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSD 112 (283)
T ss_pred CcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccc
Confidence 568899999865433 2336788999999999999999999999999999999999999999999853210
Q ss_pred ----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeecccc
Q 021490 78 ----GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT 153 (311)
Q Consensus 78 ----~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~ 153 (311)
....+++..+..++.|++.||+|||+++ ++|+||+|+||+++.++.++|+|||++................++
T Consensus 113 ~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 189 (283)
T cd05090 113 EDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189 (283)
T ss_pred cccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCCcEEeccccccccccCCcceecccCCCcc
Confidence 1235788999999999999999999999 999999999999999999999999998753222211222223356
Q ss_pred ccccCccccccCCCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhH
Q 021490 154 YGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGF 232 (311)
Q Consensus 154 ~~y~aPE~~~~~~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (311)
..|+|||.+.+..++.++|+||||+++|+|++ |..||............... .. . ..+...+
T Consensus 190 ~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-------~~------~----~~~~~~~ 252 (283)
T cd05090 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKR-------QL------L----PCSEDCP 252 (283)
T ss_pred ceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-------Cc------C----CCCCCCC
Confidence 67999999988889999999999999999998 88999765433222211100 00 0 0112233
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 021490 233 YQALAVAAMCVHEQPDMRPVIADVVTALAY 262 (311)
Q Consensus 233 ~~l~~li~~~l~~~p~~Rps~~~vl~~l~~ 262 (311)
..+.+++.+||+.||.+||++.++++.|..
T Consensus 253 ~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 253 PRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 478889999999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=269.78 Aligned_cols=231 Identities=24% Similarity=0.339 Sum_probs=179.0
Q ss_pred cCCcEEEEEEeecCCC---cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCC
Q 021490 7 CLLQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLD 83 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~ 83 (311)
.+|+.||+|.+..... .....+..|+++++.++||||+++++++.++...++||||++|++|.+++.... ...++
T Consensus 16 ~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~~--~~~~~ 93 (277)
T cd05607 16 NTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVG--ERGLE 93 (277)
T ss_pred cCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCHHHHHHhcc--ccCCC
Confidence 3689999999865322 223456679999999999999999999999999999999999999998886522 34688
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccc
Q 021490 84 WNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 163 (311)
Q Consensus 84 ~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 163 (311)
+..+..++.|++.||+|||+.+ ++||||+|+||+++.++.++|+|||++...... .......++..|+|||++.
T Consensus 94 ~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~ 167 (277)
T cd05607 94 MERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG---KTITQRAGTNGYMAPEILK 167 (277)
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCC---ceeeccCCCCCccCHHHHc
Confidence 9999999999999999999999 999999999999999999999999998653221 1223345788999999998
Q ss_pred cCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHcc
Q 021490 164 TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCV 243 (311)
Q Consensus 164 ~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 243 (311)
+..++.++|+|||||++|+|++|..||............ ......... .. .....+.++.+++.+||
T Consensus 168 ~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~--~~~~~~~~~--------~~---~~~~~~~~~~~li~~~L 234 (277)
T cd05607 168 EEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEEL--KRRTLEDEV--------KF---EHQNFTEESKDICRLFL 234 (277)
T ss_pred cCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHH--HHHhhcccc--------cc---ccccCCHHHHHHHHHHh
Confidence 888999999999999999999999999754321111100 011111000 00 00123447889999999
Q ss_pred ccCCCCCCCHHHHHH
Q 021490 244 HEQPDMRPVIADVVT 258 (311)
Q Consensus 244 ~~~p~~Rps~~~vl~ 258 (311)
+.||.+||++.|+++
T Consensus 235 ~~~P~~R~~~~~~~~ 249 (277)
T cd05607 235 AKKPEDRLGSREKND 249 (277)
T ss_pred ccCHhhCCCCccchh
Confidence 999999999976653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=266.65 Aligned_cols=237 Identities=29% Similarity=0.407 Sum_probs=188.6
Q ss_pred cchhccCCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCC
Q 021490 2 MQVILCLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKP 81 (311)
Q Consensus 2 ~~~~~~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 81 (311)
|.+...+++.||+|.+.... ...+.+.+|+.+++.++|+||+++++++......++||||+++++|.+++.... +..
T Consensus 23 ~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~--~~~ 99 (261)
T cd05034 23 WMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGE--GKK 99 (261)
T ss_pred EEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCCHHHHHhccc--cCC
Confidence 45566778899999986443 456789999999999999999999999998889999999999999999997632 356
Q ss_pred CCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccc
Q 021490 82 LDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 161 (311)
Q Consensus 82 l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 161 (311)
+++..+..++.+++.||+|||+++ ++|+||+|+||+++.++.++|+|||++....... .........+..|+|||.
T Consensus 100 ~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~~y~~PE~ 175 (261)
T cd05034 100 LRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDE-YTAREGAKFPIKWTAPEA 175 (261)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchh-hhhhhccCCCccccCHHH
Confidence 899999999999999999999999 9999999999999999999999999986533211 111112234568999999
Q ss_pred cccCCCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHH
Q 021490 162 AKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAA 240 (311)
Q Consensus 162 ~~~~~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 240 (311)
+.+..++.++|+||||+++|+|++ |..||............... +. ...+...+..+.+++.
T Consensus 176 ~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~---~~--------------~~~~~~~~~~~~~~i~ 238 (261)
T cd05034 176 ANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERG---YR--------------MPRPPNCPEELYDLML 238 (261)
T ss_pred hccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC---CC--------------CCCCCCCCHHHHHHHH
Confidence 988889999999999999999998 99999765433222111000 00 0111122347889999
Q ss_pred HccccCCCCCCCHHHHHHHHHH
Q 021490 241 MCVHEQPDMRPVIADVVTALAY 262 (311)
Q Consensus 241 ~~l~~~p~~Rps~~~vl~~l~~ 262 (311)
+||+.+|.+||++.++.+.|+.
T Consensus 239 ~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 239 QCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred HHcccCcccCCCHHHHHHHHhc
Confidence 9999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=278.94 Aligned_cols=232 Identities=24% Similarity=0.251 Sum_probs=182.7
Q ss_pred cCCcEEEEEEeecCCC---cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCC
Q 021490 7 CLLQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLD 83 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~ 83 (311)
.+|+.||+|+++.... ...+.+.+|+.++..++||||+++++++.++...++||||+++++|.+++... ...++
T Consensus 24 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~l~ 100 (330)
T cd05601 24 ATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRY---EDQFD 100 (330)
T ss_pred CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCCCCCHHHHHHHh---cCCCC
Confidence 3689999999976432 23457888999999999999999999999999999999999999999999762 35799
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccc
Q 021490 84 WNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 163 (311)
Q Consensus 84 ~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 163 (311)
+..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++........ .......++..|+|||++.
T Consensus 101 ~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~ 176 (330)
T cd05601 101 EDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM-VNSKLPVGTPDYIAPEVLT 176 (330)
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCCCc-eeeecccCCccccCHHHhc
Confidence 9999999999999999999999 99999999999999999999999999875332221 1222346889999999986
Q ss_pred ------cCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHH
Q 021490 164 ------TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALA 237 (311)
Q Consensus 164 ------~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 237 (311)
...++.++|||||||++|+|++|..||...........+ .... .... .+ ..+..+..+.+
T Consensus 177 ~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i------~~~~-~~~~--~~-----~~~~~~~~~~~ 242 (330)
T cd05601 177 TMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNI------MNFQ-RFLK--FP-----EDPKVSSDFLD 242 (330)
T ss_pred cccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHH------HcCC-CccC--CC-----CCCCCCHHHHH
Confidence 456788999999999999999999999765543321111 1000 0000 00 11223457888
Q ss_pred HHHHccccCCCCCCCHHHHHHHH
Q 021490 238 VAAMCVHEQPDMRPVIADVVTAL 260 (311)
Q Consensus 238 li~~~l~~~p~~Rps~~~vl~~l 260 (311)
|+.+||+ +|.+|||+.+++..-
T Consensus 243 li~~ll~-~p~~R~t~~~l~~h~ 264 (330)
T cd05601 243 LIQSLLC-GQKERLGYEGLCCHP 264 (330)
T ss_pred HHHHHcc-ChhhCCCHHHHhCCC
Confidence 9999998 999999999998653
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=265.56 Aligned_cols=227 Identities=31% Similarity=0.454 Sum_probs=184.9
Q ss_pred CCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHHH
Q 021490 8 LLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTR 87 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~ 87 (311)
.|+.||+|.++.... ..+++.+|+.+++.++|+||+++++++.+....++||||+++++|.+++.... ...+++..+
T Consensus 28 ~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~--~~~~~~~~~ 104 (256)
T cd05039 28 RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRG--RAVITLAQQ 104 (256)
T ss_pred cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHHHHHHhcC--CCCCCHHHH
Confidence 478999999976543 56789999999999999999999999998899999999999999999997622 236999999
Q ss_pred HHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccCCC
Q 021490 88 MKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQL 167 (311)
Q Consensus 88 ~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 167 (311)
..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+....... .....+..|+|||.+....+
T Consensus 105 ~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~-----~~~~~~~~~~ape~~~~~~~ 176 (256)
T cd05039 105 LGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ-----DSGKLPVKWTAPEALREKKF 176 (256)
T ss_pred HHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEccccccccccccc-----ccCCCcccccCchhhcCCcC
Confidence 999999999999999999 9999999999999999999999999987532111 12234567999999988888
Q ss_pred ccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccC
Q 021490 168 TLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQ 246 (311)
Q Consensus 168 ~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 246 (311)
+.++|+||||+++|+|++ |..||............. .... ...+...+..+.+++.+||..+
T Consensus 177 ~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-------~~~~----------~~~~~~~~~~~~~li~~~l~~~ 239 (256)
T cd05039 177 STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVE-------KGYR----------MEAPEGCPPEVYKVMKDCWELD 239 (256)
T ss_pred CcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh-------cCCC----------CCCccCCCHHHHHHHHHHhccC
Confidence 999999999999999997 999997664433221111 0000 0112223457889999999999
Q ss_pred CCCCCCHHHHHHHHHH
Q 021490 247 PDMRPVIADVVTALAY 262 (311)
Q Consensus 247 p~~Rps~~~vl~~l~~ 262 (311)
|++|||+.++++.|+.
T Consensus 240 p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 240 PAKRPTFKQLREQLAL 255 (256)
T ss_pred hhhCcCHHHHHHHHhc
Confidence 9999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=269.06 Aligned_cols=232 Identities=23% Similarity=0.284 Sum_probs=182.3
Q ss_pred cCCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHH
Q 021490 7 CLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNT 86 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~ 86 (311)
.+|+.||+|++..........+.+|+.++..++||||+++++++..+...++||||+++++|.+++.. ...+++..
T Consensus 32 ~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~----~~~~~~~~ 107 (267)
T cd06646 32 HTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHV----TGPLSELQ 107 (267)
T ss_pred CCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcHHHHHHh----cCCCCHHH
Confidence 46889999999766555566788999999999999999999999999999999999999999999876 46789999
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccc---
Q 021490 87 RMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK--- 163 (311)
Q Consensus 87 ~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--- 163 (311)
+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++....... .......++..|+|||.+.
T Consensus 108 ~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~ 182 (267)
T cd06646 108 IAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATI--AKRKSFIGTPYWMAPEVAAVEK 182 (267)
T ss_pred HHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccc--cccCccccCccccCHhHccccc
Confidence 9999999999999999999 9999999999999999999999999987532211 1112235778899999874
Q ss_pred cCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHcc
Q 021490 164 TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCV 243 (311)
Q Consensus 164 ~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 243 (311)
...++.++|+||||+++|+|++|..||........... .. ......+... .....+..+.+++.+||
T Consensus 183 ~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~-------~~----~~~~~~~~~~--~~~~~~~~~~~li~~~l 249 (267)
T cd06646 183 NGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL-------MS----KSNFQPPKLK--DKTKWSSTFHNFVKISL 249 (267)
T ss_pred CCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhee-------ee----cCCCCCCCCc--cccccCHHHHHHHHHHh
Confidence 34578899999999999999999999865432211000 00 0000011110 01123457889999999
Q ss_pred ccCCCCCCCHHHHHHHH
Q 021490 244 HEQPDMRPVIADVVTAL 260 (311)
Q Consensus 244 ~~~p~~Rps~~~vl~~l 260 (311)
+.+|++|||++++++.|
T Consensus 250 ~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 250 TKNPKKRPTAERLLTHL 266 (267)
T ss_pred hCChhhCcCHHHHhcCC
Confidence 99999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=271.04 Aligned_cols=240 Identities=25% Similarity=0.386 Sum_probs=188.7
Q ss_pred CCcEEEEEEeecCC-CcchhHHHHHHHHHhcC-CCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCC--------
Q 021490 8 LLQDVAIKQLDRNG-VQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP-------- 77 (311)
Q Consensus 8 ~g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-------- 77 (311)
.+..||+|.++... ......+.+|+.++..+ +||||+++++++......++||||+++++|.+++.....
T Consensus 46 ~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 125 (304)
T cd05101 46 EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD 125 (304)
T ss_pred cceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccc
Confidence 35679999986543 23456789999999999 899999999999999999999999999999999876321
Q ss_pred ----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeecccc
Q 021490 78 ----GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT 153 (311)
Q Consensus 78 ----~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~ 153 (311)
....+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++................++
T Consensus 126 ~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~ 202 (304)
T cd05101 126 IARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLP 202 (304)
T ss_pred cccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCC
Confidence 1245788899999999999999999999 999999999999999999999999998754332222212223355
Q ss_pred ccccCccccccCCCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhH
Q 021490 154 YGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGF 232 (311)
Q Consensus 154 ~~y~aPE~~~~~~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (311)
..|+|||++.+..++.++||||||+++|+|++ |..||............. .... ...+...+
T Consensus 203 ~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-------~~~~----------~~~~~~~~ 265 (304)
T cd05101 203 VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK-------EGHR----------MDKPANCT 265 (304)
T ss_pred ceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH-------cCCc----------CCCCCCCC
Confidence 68999999988889999999999999999998 788887654433222111 0000 01122334
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhcc
Q 021490 233 YQALAVAAMCVHEQPDMRPVIADVVTALAYLASQK 267 (311)
Q Consensus 233 ~~l~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~~ 267 (311)
..+.+++.+||..+|++|||+.++++.|+.+....
T Consensus 266 ~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~ 300 (304)
T cd05101 266 NELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLT 300 (304)
T ss_pred HHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhh
Confidence 57888999999999999999999999998877553
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=274.44 Aligned_cols=220 Identities=27% Similarity=0.310 Sum_probs=175.1
Q ss_pred CCcEEEEEEeecCCC---cchhHHHHHHH-HHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCC
Q 021490 8 LLQDVAIKQLDRNGV---QGNREFLVEVL-MLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLD 83 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~---~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~ 83 (311)
+|+.||+|++..... .....+..|.. +++.++||||+++++++.+....++||||++|++|...+.. ...++
T Consensus 19 ~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~ 94 (321)
T cd05603 19 DGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQR----ERCFL 94 (321)
T ss_pred CCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHH----cCCCC
Confidence 688999999875432 22344555554 67889999999999999999999999999999999988876 56789
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccc
Q 021490 84 WNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 163 (311)
Q Consensus 84 ~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 163 (311)
+..+..++.||+.||+|||+.+ ++||||||+||+++.++.++|+|||++...... ........++..|+|||++.
T Consensus 95 ~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~ 169 (321)
T cd05603 95 EPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP--EETTSTFCGTPEYLAPEVLR 169 (321)
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCC--CCccccccCCcccCCHHHhc
Confidence 9999999999999999999999 999999999999999999999999998642111 11223345889999999998
Q ss_pred cCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHcc
Q 021490 164 TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCV 243 (311)
Q Consensus 164 ~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 243 (311)
+..++.++|||||||++|+|++|..||...+.......+ ... ...+++.....+.+++.+||
T Consensus 170 ~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i------~~~------------~~~~~~~~~~~~~~li~~~l 231 (321)
T cd05603 170 KEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNI------LHK------------PLQLPGGKTVAACDLLVGLL 231 (321)
T ss_pred CCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHH------hcC------------CCCCCCCCCHHHHHHHHHHc
Confidence 888999999999999999999999999776533221111 110 01123334557889999999
Q ss_pred ccCCCCCCCHH
Q 021490 244 HEQPDMRPVIA 254 (311)
Q Consensus 244 ~~~p~~Rps~~ 254 (311)
+.||.+||++.
T Consensus 232 ~~~p~~R~~~~ 242 (321)
T cd05603 232 HKDQRRRLGAK 242 (321)
T ss_pred cCCHhhcCCCC
Confidence 99999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=270.66 Aligned_cols=231 Identities=27% Similarity=0.370 Sum_probs=182.7
Q ss_pred CCcEEEEEEeecCCC---cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCH
Q 021490 8 LLQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 84 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~ 84 (311)
+|..||+|++..... .....+.+|+.+++.++||||+++++.+.++...++||||+++++|.+++... ....+++
T Consensus 24 ~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~ 101 (285)
T cd05605 24 TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNM--GNPGFDE 101 (285)
T ss_pred CCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccCCCcHHHHHHhc--CcCCCCH
Confidence 588999999865432 22346788999999999999999999999999999999999999999888652 1356899
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccccc
Q 021490 85 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT 164 (311)
Q Consensus 85 ~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 164 (311)
..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++....... ......++..|+|||++.+
T Consensus 102 ~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~ 175 (285)
T cd05605 102 ERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE---TIRGRVGTVGYMAPEVVKN 175 (285)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC---ccccccCCCCccCcHHhcC
Confidence 999999999999999999999 9999999999999999999999999987532211 1123457889999999988
Q ss_pred CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccc
Q 021490 165 GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVH 244 (311)
Q Consensus 165 ~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 244 (311)
..++.++||||+|+++|+|++|..||............... +... ...++...+..+.+|+.+||.
T Consensus 176 ~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~---~~~~-----------~~~~~~~~~~~~~~li~~~l~ 241 (285)
T cd05605 176 ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERR---VKED-----------QEEYSEKFSEAARSICRQLLT 241 (285)
T ss_pred CCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHH---hhhc-----------ccccCcccCHHHHHHHHHHcc
Confidence 88999999999999999999999999865432221111100 0000 011222344578889999999
Q ss_pred cCCCCCC-----CHHHHHHHH
Q 021490 245 EQPDMRP-----VIADVVTAL 260 (311)
Q Consensus 245 ~~p~~Rp-----s~~~vl~~l 260 (311)
.||++|| ++.+++...
T Consensus 242 ~~P~~R~~~~~~~~~~l~~~~ 262 (285)
T cd05605 242 KDPGFRLGCRGEGAEEVKAHP 262 (285)
T ss_pred CCHHHhcCCCCCCHHHHhcCc
Confidence 9999999 888887764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=277.10 Aligned_cols=231 Identities=24% Similarity=0.302 Sum_probs=179.9
Q ss_pred CCcEEEEEEeecCC----CcchhHHHHHHHHHhcC-CCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCC
Q 021490 8 LLQDVAIKQLDRNG----VQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPL 82 (311)
Q Consensus 8 ~g~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l 82 (311)
.|..||+|++.... ....+.+.+|+.++..+ .||||+++++++..+...++||||+++++|.+++.. ...+
T Consensus 27 ~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~ 102 (332)
T cd05614 27 TGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQ----RDNF 102 (332)
T ss_pred CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEEEeCCCCCcHHHHHHH----cCCC
Confidence 68899999986532 22345778899999999 589999999999999999999999999999999876 5679
Q ss_pred CHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccc
Q 021490 83 DWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 162 (311)
Q Consensus 83 ~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 162 (311)
++..+..++.|++.||+|||+.+ ++||||||+|||++.++.++|+|||++........ .......|+..|+|||++
T Consensus 103 ~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~ 178 (332)
T cd05614 103 SEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEK-ERTYSFCGTIEYMAPEII 178 (332)
T ss_pred CHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCccccccCC-CccccccCCccccCHHHh
Confidence 99999999999999999999999 99999999999999999999999999864322211 112234589999999998
Q ss_pred ccC-CCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHH
Q 021490 163 KTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAM 241 (311)
Q Consensus 163 ~~~-~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 241 (311)
.+. .++.++|||||||++|+|++|..||............. ..... .++. ++...+..+.+++.+
T Consensus 179 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~--~~~~~--------~~~~----~~~~~~~~~~~li~~ 244 (332)
T cd05614 179 RGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVS--RRILK--------CDPP----FPSFIGPEAQDLLHK 244 (332)
T ss_pred cCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHH--HHHhc--------CCCC----CCCCCCHHHHHHHHH
Confidence 764 47889999999999999999999996433211111110 00010 0111 222334578889999
Q ss_pred ccccCCCCCC-----CHHHHHHHH
Q 021490 242 CVHEQPDMRP-----VIADVVTAL 260 (311)
Q Consensus 242 ~l~~~p~~Rp-----s~~~vl~~l 260 (311)
||..||++|| +++++++..
T Consensus 245 ~l~~dp~~R~~~~~~~~~~~l~h~ 268 (332)
T cd05614 245 LLRKDPKKRLGAGPQGASEIKEHP 268 (332)
T ss_pred HcCCCHHHcCCCCCCCHHHHHcCC
Confidence 9999999999 777887653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=264.94 Aligned_cols=236 Identities=28% Similarity=0.383 Sum_probs=185.5
Q ss_pred cchhccCCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCC
Q 021490 2 MQVILCLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKP 81 (311)
Q Consensus 2 ~~~~~~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 81 (311)
|.+...++..||+|.+.... ...+.|.+|+.+++.++|+|++++++++.. ...+++|||+++++|.+++.... ...
T Consensus 23 ~~~~~~~~~~~~~k~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~--~~~ 98 (260)
T cd05070 23 WMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKDGE--GRA 98 (260)
T ss_pred EEEEecCCceeEEEEecCCC-CCHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEecCCCcHHHHHHhcC--CCC
Confidence 45556678889999986543 345689999999999999999999998754 56799999999999999987522 346
Q ss_pred CCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccc
Q 021490 82 LDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 161 (311)
Q Consensus 82 l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 161 (311)
+++..++.++.+++.||+|||+.+ ++|+||+|.||++++++.++|+|||++........ .......++..|+|||.
T Consensus 99 ~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~ 174 (260)
T cd05070 99 LKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY-TARQGAKFPIKWTAPEA 174 (260)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCccc-ccccCCCCCccccChHH
Confidence 899999999999999999999999 99999999999999999999999999865322111 11112234567999999
Q ss_pred cccCCCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHH
Q 021490 162 AKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAA 240 (311)
Q Consensus 162 ~~~~~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 240 (311)
+.+..++.++|+||||+++|+|++ |..||............. .... ...+...+..+.+++.
T Consensus 175 ~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~-------~~~~----------~~~~~~~~~~~~~li~ 237 (260)
T cd05070 175 ALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVE-------RGYR----------MPCPQDCPISLHELML 237 (260)
T ss_pred HhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-------cCCC----------CCCCCcCCHHHHHHHH
Confidence 988889999999999999999999 889997654433222111 0000 0112233457889999
Q ss_pred HccccCCCCCCCHHHHHHHHHH
Q 021490 241 MCVHEQPDMRPVIADVVTALAY 262 (311)
Q Consensus 241 ~~l~~~p~~Rps~~~vl~~l~~ 262 (311)
+||..+|++|||+.++.+.|++
T Consensus 238 ~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 238 QCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred HHcccCcccCcCHHHHHHHHhc
Confidence 9999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=267.99 Aligned_cols=237 Identities=24% Similarity=0.352 Sum_probs=185.6
Q ss_pred CcEEEEEEeecCCC-cchhHHHHHHHHHhcCCCCcccceeeEeee-CCeeEEEEecCCCCChhhhhcccCCC----CCCC
Q 021490 9 LQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCAD-GDQRLLVYEYMPLGSVEDHLHDLSPG----KKPL 82 (311)
Q Consensus 9 g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~----~~~l 82 (311)
+..|++|++..... .....+.+|+.+++.++|+||+++++++.. +...+++++|+++++|.+++...... +..+
T Consensus 35 ~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l 114 (280)
T cd05043 35 EEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQAL 114 (280)
T ss_pred eeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCC
Confidence 78899999864432 334678899999999999999999998765 46789999999999999998764322 2568
Q ss_pred CHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccc
Q 021490 83 DWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 162 (311)
Q Consensus 83 ~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 162 (311)
++..++.++.+++.||+|||+.+ ++|+||+|+||++++++.++|+|||+++...............++..|+|||++
T Consensus 115 ~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~ 191 (280)
T cd05043 115 STQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESL 191 (280)
T ss_pred CHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHH
Confidence 99999999999999999999999 999999999999999999999999998753222211111223356779999999
Q ss_pred ccCCCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHH
Q 021490 163 KTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAM 241 (311)
Q Consensus 163 ~~~~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 241 (311)
.+..++.++||||||+++|++++ |..||............. .... . ..+...+..+.+++.+
T Consensus 192 ~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-------~~~~------~----~~~~~~~~~~~~li~~ 254 (280)
T cd05043 192 VNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLK-------DGYR------L----AQPINCPDELFAVMAC 254 (280)
T ss_pred hcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHH-------cCCC------C----CCCCcCCHHHHHHHHH
Confidence 88889999999999999999999 999997654433221111 0000 0 0111223478899999
Q ss_pred ccccCCCCCCCHHHHHHHHHHhhh
Q 021490 242 CVHEQPDMRPVIADVVTALAYLAS 265 (311)
Q Consensus 242 ~l~~~p~~Rps~~~vl~~l~~~~~ 265 (311)
||..||++|||+.++++.|+.+..
T Consensus 255 ~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 255 CWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred HcCCChhhCCCHHHHHHHHHHHHh
Confidence 999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=275.43 Aligned_cols=219 Identities=28% Similarity=0.356 Sum_probs=176.5
Q ss_pred CCcEEEEEEeecCC---CcchhHHHHHHHHHhcCCC-CcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCC
Q 021490 8 LLQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHH-PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLD 83 (311)
Q Consensus 8 ~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~ 83 (311)
+++.||+|++.... ....+.+..|++++..++| ++|+.+++++.+.+..|+||||++|++|.+++.. ...++
T Consensus 24 ~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~----~~~~~ 99 (324)
T cd05587 24 TDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ----VGKFK 99 (324)
T ss_pred CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCCCCcHHHHHHH----cCCCC
Confidence 57889999997542 2344678889999999976 4688899999999999999999999999999876 56789
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccc
Q 021490 84 WNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 163 (311)
Q Consensus 84 ~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 163 (311)
+..+..++.|++.||+|||+.+ ++||||||+|||++.++.++|+|||++...... ........|+..|+|||++.
T Consensus 100 ~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~ 174 (324)
T cd05587 100 EPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG--GKTTRTFCGTPDYIAPEIIA 174 (324)
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC--CCceeeecCCccccChhhhc
Confidence 9999999999999999999999 999999999999999999999999988642111 11222345889999999999
Q ss_pred cCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHcc
Q 021490 164 TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCV 243 (311)
Q Consensus 164 ~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 243 (311)
+..++.++|||||||++|+|++|..||...........+. .. . ..++...+..+.+++.+||
T Consensus 175 ~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~------~~--------~----~~~~~~~~~~~~~li~~~l 236 (324)
T cd05587 175 YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIM------EH--------N----VSYPKSLSKEAVSICKGLL 236 (324)
T ss_pred CCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH------cC--------C----CCCCCCCCHHHHHHHHHHh
Confidence 8889999999999999999999999998665433221111 00 0 1112233457889999999
Q ss_pred ccCCCCCCCH
Q 021490 244 HEQPDMRPVI 253 (311)
Q Consensus 244 ~~~p~~Rps~ 253 (311)
..||.+|++.
T Consensus 237 ~~~P~~R~~~ 246 (324)
T cd05587 237 TKHPAKRLGC 246 (324)
T ss_pred hcCHHHcCCC
Confidence 9999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=270.89 Aligned_cols=243 Identities=22% Similarity=0.254 Sum_probs=177.6
Q ss_pred CCcEEEEEEeecCCCc--chhHHHHHHHHHhcC---CCCcccceeeEee-----eCCeeEEEEecCCCCChhhhhcccCC
Q 021490 8 LLQDVAIKQLDRNGVQ--GNREFLVEVLMLSLL---HHPNLVNLIGYCA-----DGDQRLLVYEYMPLGSVEDHLHDLSP 77 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l---~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~ 77 (311)
+|..||+|+++..... ....+.+|+.+++.+ +||||+++++++. .....++||||++ ++|.+++....
T Consensus 26 ~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~- 103 (290)
T cd07862 26 GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVP- 103 (290)
T ss_pred CCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEEEEEccCC-CCHHHHHHhCC-
Confidence 4688999998654322 234667788777766 6999999999885 2456899999996 68999887532
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeecccccccc
Q 021490 78 GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 157 (311)
Q Consensus 78 ~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~ 157 (311)
...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++...... .......++..|+
T Consensus 104 -~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~~~~y~ 176 (290)
T cd07862 104 -EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTSVVVTLWYR 176 (290)
T ss_pred -CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccccceEeccCC---ccccccccccccc
Confidence 356899999999999999999999999 999999999999999999999999998653222 1223345788999
Q ss_pred CccccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHH-HHHhhhhhccccccc-cccCccc-------cCCCC
Q 021490 158 APEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSL-VAWARPLFQDRTRHS-LIADPEL-------QGQYP 228 (311)
Q Consensus 158 aPE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~-------~~~~~ 228 (311)
|||++.+..++.++|||||||++|+|++|.+||........... ............... ......+ .....
T Consensus 177 aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (290)
T cd07862 177 APEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFV 256 (290)
T ss_pred ChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHc
Confidence 99999888899999999999999999999999987654433222 111100000000000 0000000 00111
Q ss_pred hHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 021490 229 PRGFYQALAVAAMCVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 229 ~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~ 259 (311)
+..+..+.+++.+||+.||++|||+.++++.
T Consensus 257 ~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 257 TDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred cCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 2334567889999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=270.64 Aligned_cols=241 Identities=25% Similarity=0.402 Sum_probs=183.5
Q ss_pred CCcEEEEEEeecCCC-cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCC-------C
Q 021490 8 LLQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPG-------K 79 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-------~ 79 (311)
++..||+|++..... .....|.+|+.+++.++|+||+++++++.++...++||||+++++|.+++...... .
T Consensus 45 ~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 124 (296)
T cd05095 45 QPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADV 124 (296)
T ss_pred ceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccc
Confidence 455799999865432 33468999999999999999999999999999999999999999999998763211 2
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCc
Q 021490 80 KPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 159 (311)
Q Consensus 80 ~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aP 159 (311)
..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++................++..|++|
T Consensus 125 ~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p 201 (296)
T cd05095 125 VTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSW 201 (296)
T ss_pred cccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCH
Confidence 34778899999999999999999999 999999999999999999999999998653222221222223346789999
Q ss_pred cccccCCCccccceeehhHHHHHHHh--CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHH
Q 021490 160 EYAKTGQLTLKSDVYSFGVVLLEILS--GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALA 237 (311)
Q Consensus 160 E~~~~~~~~~~~DiwslG~l~~~ll~--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 237 (311)
|......++.++|+|||||++|+|++ |..||........... ....+......... ..+...+..+.+
T Consensus 202 e~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~-------~~~~~~~~~~~~ 271 (296)
T cd05095 202 ESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIEN---TGEFFRDQGRQVYL-------PKPALCPDSLYK 271 (296)
T ss_pred HHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHHHHH---HHHHHhhccccccC-------CCCCCCCHHHHH
Confidence 98888889999999999999999998 7788865543322111 11111111000000 011223357889
Q ss_pred HHHHccccCCCCCCCHHHHHHHHH
Q 021490 238 VAAMCVHEQPDMRPVIADVVTALA 261 (311)
Q Consensus 238 li~~~l~~~p~~Rps~~~vl~~l~ 261 (311)
++.+||+.||.+|||+.++++.|+
T Consensus 272 li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 272 LMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HHHHHcCCCcccCCCHHHHHHHHh
Confidence 999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=264.41 Aligned_cols=237 Identities=28% Similarity=0.394 Sum_probs=187.2
Q ss_pred CcchhccCCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCC
Q 021490 1 MMQVILCLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKK 80 (311)
Q Consensus 1 ~~~~~~~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 80 (311)
||.+...+++.||+|.+.... .....+.+|+.+++.++|+||+++++++. ....+++|||+.+++|.+++.... +.
T Consensus 22 v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~--~~ 97 (260)
T cd05067 22 VWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPE--GI 97 (260)
T ss_pred EEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCCCCCHHHHHHhcC--CC
Confidence 355667788999999986443 45578999999999999999999999874 456899999999999999986532 45
Q ss_pred CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcc
Q 021490 81 PLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 160 (311)
Q Consensus 81 ~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE 160 (311)
.+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++....... ........++..|+|||
T Consensus 98 ~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~y~~pe 173 (260)
T cd05067 98 KLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPE 173 (260)
T ss_pred CCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCC-cccccCCcccccccCHH
Confidence 7899999999999999999999999 9999999999999999999999999986532111 11112233567899999
Q ss_pred ccccCCCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHH
Q 021490 161 YAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVA 239 (311)
Q Consensus 161 ~~~~~~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 239 (311)
.+....++.++||||||+++|+|++ |..||............. .... ...+...+.++.+++
T Consensus 174 ~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-------~~~~----------~~~~~~~~~~~~~li 236 (260)
T cd05067 174 AINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLE-------RGYR----------MPRPDNCPEELYELM 236 (260)
T ss_pred HhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHH-------cCCC----------CCCCCCCCHHHHHHH
Confidence 9988888999999999999999999 999997655433222110 0000 011122334788999
Q ss_pred HHccccCCCCCCCHHHHHHHHHH
Q 021490 240 AMCVHEQPDMRPVIADVVTALAY 262 (311)
Q Consensus 240 ~~~l~~~p~~Rps~~~vl~~l~~ 262 (311)
.+||..+|++|||+++++..|+.
T Consensus 237 ~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 237 RLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred HHHccCChhhCCCHHHHHHHhhc
Confidence 99999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=266.38 Aligned_cols=231 Identities=31% Similarity=0.434 Sum_probs=179.6
Q ss_pred EEEEEEeecCC-CcchhHHHHHHHHHhcC-CCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCC-----------
Q 021490 11 DVAIKQLDRNG-VQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP----------- 77 (311)
Q Consensus 11 ~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----------- 77 (311)
.+++|.++... ....+.+.+|++++.++ +||||+++++++......++||||+++++|.+++.....
T Consensus 24 ~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~ 103 (270)
T cd05047 24 DAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 103 (270)
T ss_pred EEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCCcHHHHHHhcccccccccccccc
Confidence 56888886433 23446888999999999 799999999999999999999999999999999875321
Q ss_pred -CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccc
Q 021490 78 -GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY 156 (311)
Q Consensus 78 -~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y 156 (311)
....+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++...... ........+..|
T Consensus 104 ~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfgl~~~~~~~---~~~~~~~~~~~y 177 (270)
T cd05047 104 STASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVY---VKKTMGRLPVRW 177 (270)
T ss_pred CCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCCCccccchh---hhccCCCCcccc
Confidence 1235889999999999999999999999 999999999999999999999999987531110 011112235579
Q ss_pred cCccccccCCCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHH
Q 021490 157 CAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQA 235 (311)
Q Consensus 157 ~aPE~~~~~~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 235 (311)
+|||++....++.++|+||||+++|+|++ |..||............ ..... ...+...+..+
T Consensus 178 ~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~-------~~~~~----------~~~~~~~~~~~ 240 (270)
T cd05047 178 MAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL-------PQGYR----------LEKPLNCDDEV 240 (270)
T ss_pred CChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHH-------hCCCC----------CCCCCcCCHHH
Confidence 99999988889999999999999999997 99999765433221111 00000 01111233478
Q ss_pred HHHHHHccccCCCCCCCHHHHHHHHHHhh
Q 021490 236 LAVAAMCVHEQPDMRPVIADVVTALAYLA 264 (311)
Q Consensus 236 ~~li~~~l~~~p~~Rps~~~vl~~l~~~~ 264 (311)
.+++.+||..||.+|||+.+++..|..+.
T Consensus 241 ~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 241 YDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred HHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 89999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=271.78 Aligned_cols=229 Identities=24% Similarity=0.331 Sum_probs=185.1
Q ss_pred cCCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHH
Q 021490 7 CLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNT 86 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~ 86 (311)
.+|+.|++|.+........+.+.+|+.+++.++|+||+++++.+..+...++||||+++++|.+++.. ..+++..
T Consensus 43 ~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~ 117 (296)
T cd06654 43 ATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQ 117 (296)
T ss_pred CCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCHHHHHHh-----cCCCHHH
Confidence 47899999999776666667899999999999999999999999999999999999999999999864 4588999
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccCC
Q 021490 87 RMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ 166 (311)
Q Consensus 87 ~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 166 (311)
+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++....... .......++..|+|||.+.+..
T Consensus 118 ~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~ 192 (296)
T cd06654 118 IAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSTMVGTPYWMAPEVVTRKA 192 (296)
T ss_pred HHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccc--cccCcccCCccccCHHHHcCCC
Confidence 9999999999999999999 9999999999999999999999999876432211 1112235778999999998888
Q ss_pred CccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccC
Q 021490 167 LTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQ 246 (311)
Q Consensus 167 ~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 246 (311)
++.++|+|||||++|+|++|..||.......... .. .... . +. ...+......+.+++.+||..|
T Consensus 193 ~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~--~~----~~~~--~-----~~--~~~~~~~~~~l~~li~~~l~~~ 257 (296)
T cd06654 193 YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY--LI----ATNG--T-----PE--LQNPEKLSAIFRDFLNRCLDMD 257 (296)
T ss_pred CCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHH--HH----hcCC--C-----CC--CCCccccCHHHHHHHHHHCcCC
Confidence 8999999999999999999999997654322111 00 0000 0 00 0112233457888999999999
Q ss_pred CCCCCCHHHHHHHH
Q 021490 247 PDMRPVIADVVTAL 260 (311)
Q Consensus 247 p~~Rps~~~vl~~l 260 (311)
|++|||+.+++..-
T Consensus 258 p~~Rpt~~eil~~~ 271 (296)
T cd06654 258 VEKRGSAKELLQHQ 271 (296)
T ss_pred cccCcCHHHHhhCh
Confidence 99999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=265.18 Aligned_cols=231 Identities=26% Similarity=0.308 Sum_probs=183.3
Q ss_pred cCCcEEEEEEeecCCCc-----chhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCC
Q 021490 7 CLLQDVAIKQLDRNGVQ-----GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKP 81 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 81 (311)
.+|+.||+|.+...... ....+.+|+++++.++||||+++++++.++...++|+||+++++|.+++.. ...
T Consensus 25 ~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~----~~~ 100 (263)
T cd06625 25 DTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKA----YGA 100 (263)
T ss_pred CCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEECCCCcHHHHHHH----hCC
Confidence 36899999998654321 234688899999999999999999999999999999999999999999876 467
Q ss_pred CCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCcee-eeeccccccccCcc
Q 021490 82 LDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHV-STRVMGTYGYCAPE 160 (311)
Q Consensus 82 l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~-~~~~~~~~~y~aPE 160 (311)
+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++........... .....++..|+|||
T Consensus 101 ~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE 177 (263)
T cd06625 101 LTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPE 177 (263)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceeccccccccccccCCCcCccccCcc
Confidence 899999999999999999999999 99999999999999999999999999864322111111 12234677899999
Q ss_pred ccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHH
Q 021490 161 YAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAA 240 (311)
Q Consensus 161 ~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 240 (311)
.+.+..++.++||||||+++|+|++|..||............ ... ......+......+.+++.
T Consensus 178 ~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~------~~~----------~~~~~~~~~~~~~~~~li~ 241 (263)
T cd06625 178 VISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKI------ATQ----------PTNPQLPSHVSPDARNFLR 241 (263)
T ss_pred eeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHH------hcc----------CCCCCCCccCCHHHHHHHH
Confidence 999888999999999999999999999999765432221100 000 0011223334457889999
Q ss_pred HccccCCCCCCCHHHHHHHH
Q 021490 241 MCVHEQPDMRPVIADVVTAL 260 (311)
Q Consensus 241 ~~l~~~p~~Rps~~~vl~~l 260 (311)
+||..+|.+|||+.+++...
T Consensus 242 ~~l~~~p~~Rpt~~~ll~~~ 261 (263)
T cd06625 242 RTFVENAKKRPSAEELLRHF 261 (263)
T ss_pred HHhhcCcccCCCHHHHhhCC
Confidence 99999999999999998753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=276.72 Aligned_cols=222 Identities=27% Similarity=0.303 Sum_probs=175.5
Q ss_pred CCcEEEEEEeecCCC---cchhHHHHHH-HHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCC
Q 021490 8 LLQDVAIKQLDRNGV---QGNREFLVEV-LMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLD 83 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~---~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~ 83 (311)
+++.||+|++..... .....+..|. .+++.++||||+++++++.+....++||||++|++|.+++.. ...+.
T Consensus 19 ~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~ 94 (325)
T cd05602 19 EEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQR----ERCFL 94 (325)
T ss_pred CCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCCcHHHHHHh----cCCCC
Confidence 578899999875432 2223444444 456788999999999999999999999999999999999976 56788
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccc
Q 021490 84 WNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 163 (311)
Q Consensus 84 ~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 163 (311)
+..+..++.|++.||+|||+.| ++||||||+||+++.++.++|+|||++...... ........|+..|+|||++.
T Consensus 95 ~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~ 169 (325)
T cd05602 95 EPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH--NGTTSTFCGTPEYLAPEVLH 169 (325)
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccC--CCCcccccCCccccCHHHHc
Confidence 9999999999999999999999 999999999999999999999999998642111 11223345899999999999
Q ss_pred cCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHcc
Q 021490 164 TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCV 243 (311)
Q Consensus 164 ~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 243 (311)
+..++.++|||||||++|+|++|..||...........+ .... ...++..+..+.+++.+||
T Consensus 170 ~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i------~~~~------------~~~~~~~~~~~~~li~~~l 231 (325)
T cd05602 170 KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI------LNKP------------LQLKPNITNSARHLLEGLL 231 (325)
T ss_pred CCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHH------HhCC------------cCCCCCCCHHHHHHHHHHc
Confidence 989999999999999999999999999765543321111 0000 0112233457888999999
Q ss_pred ccCCCCCCCHHHH
Q 021490 244 HEQPDMRPVIADV 256 (311)
Q Consensus 244 ~~~p~~Rps~~~v 256 (311)
+.||.+||++.+.
T Consensus 232 ~~~p~~R~~~~~~ 244 (325)
T cd05602 232 QKDRTKRLGAKDD 244 (325)
T ss_pred ccCHHHCCCCCCC
Confidence 9999999998743
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=272.73 Aligned_cols=235 Identities=26% Similarity=0.387 Sum_probs=184.7
Q ss_pred CCcEEEEEEeecCCC-cchhHHHHHHHHHhcC-CCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHH
Q 021490 8 LLQDVAIKQLDRNGV-QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN 85 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~ 85 (311)
.+..||+|.++.... ...+.+.+|+.+++++ +||||+++++++......++||||+.+++|.+++.... ...+++.
T Consensus 64 ~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~--~~~l~~~ 141 (302)
T cd05055 64 AVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKR--ESFLTLE 141 (302)
T ss_pred ceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEEEEEcCCCCcHHHHHHhCC--CCCCCHH
Confidence 456899999865432 3346788999999999 79999999999999999999999999999999997522 2348999
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccC
Q 021490 86 TRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG 165 (311)
Q Consensus 86 ~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 165 (311)
++..++.+++.||+|||+++ ++|+||+|+||+++.++.++++|||++................++..|+|||.+...
T Consensus 142 ~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 218 (302)
T cd05055 142 DLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNC 218 (302)
T ss_pred HHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccC
Confidence 99999999999999999999 999999999999999999999999998754332221122223456789999999888
Q ss_pred CCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccc
Q 021490 166 QLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVH 244 (311)
Q Consensus 166 ~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 244 (311)
.++.++||||||+++|+|++ |..||............ ...... ...+...+..+.+++.+||.
T Consensus 219 ~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~------~~~~~~----------~~~~~~~~~~~~~li~~cl~ 282 (302)
T cd05055 219 VYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKL------IKEGYR----------MAQPEHAPAEIYDIMKTCWD 282 (302)
T ss_pred CCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHH------HHcCCc----------CCCCCCCCHHHHHHHHHHcC
Confidence 89999999999999999998 99998765432221100 000000 01111223478899999999
Q ss_pred cCCCCCCCHHHHHHHHHHh
Q 021490 245 EQPDMRPVIADVVTALAYL 263 (311)
Q Consensus 245 ~~p~~Rps~~~vl~~l~~~ 263 (311)
.+|++|||+.++++.|+.+
T Consensus 283 ~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 283 ADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred CCchhCcCHHHHHHHHHhh
Confidence 9999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=264.16 Aligned_cols=228 Identities=24% Similarity=0.307 Sum_probs=184.5
Q ss_pred CCcEEEEEEeecCC--CcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHH
Q 021490 8 LLQDVAIKQLDRNG--VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN 85 (311)
Q Consensus 8 ~g~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~ 85 (311)
+|..|++|.+.... ......+.+|+++++.++||||+++++++.++...++||||++|++|.+++.... ...+++.
T Consensus 24 ~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~ 101 (256)
T cd08529 24 DKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQR--GRPLPED 101 (256)
T ss_pred CCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCCCcHHHHHHHhc--CCCCCHH
Confidence 68999999986543 2345688899999999999999999999999999999999999999999997632 4678999
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccC
Q 021490 86 TRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG 165 (311)
Q Consensus 86 ~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 165 (311)
.++.++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .......++..|+|||++.+.
T Consensus 102 ~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~ 176 (256)
T cd08529 102 QVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT--NFANTIVGTPYYLSPELCEDK 176 (256)
T ss_pred HHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCcc--chhhccccCccccCHHHhcCC
Confidence 99999999999999999999 9999999999999999999999999886533221 112223577889999999888
Q ss_pred CCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHcccc
Q 021490 166 QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHE 245 (311)
Q Consensus 166 ~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 245 (311)
.++.++|+||||+++|+|++|..||............ .... .+ ..+......+.+++.+||+.
T Consensus 177 ~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~------~~~~-------~~----~~~~~~~~~~~~~i~~~l~~ 239 (256)
T cd08529 177 PYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKI------IRGV-------FP----PVSQMYSQQLAQLIDQCLTK 239 (256)
T ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------HcCC-------CC----CCccccCHHHHHHHHHHccC
Confidence 8999999999999999999999999766533221111 0000 00 11113345788999999999
Q ss_pred CCCCCCCHHHHHHH
Q 021490 246 QPDMRPVIADVVTA 259 (311)
Q Consensus 246 ~p~~Rps~~~vl~~ 259 (311)
+|++||++.++++.
T Consensus 240 ~p~~Rp~~~~ll~~ 253 (256)
T cd08529 240 DYRQRPDTFQLLRN 253 (256)
T ss_pred CcccCcCHHHHhhC
Confidence 99999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=282.87 Aligned_cols=237 Identities=26% Similarity=0.376 Sum_probs=183.7
Q ss_pred CcEEEEEEeecCCC-cchhHHHHHHHHHhcCC-CCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCC---------
Q 021490 9 LQDVAIKQLDRNGV-QGNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP--------- 77 (311)
Q Consensus 9 g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------- 77 (311)
+..||||+++.... ...+.+.+|++++..+. ||||+++++++.+....|+|||||++|+|.+++.....
T Consensus 67 ~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~ 146 (400)
T cd05105 67 VMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEK 146 (400)
T ss_pred ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhcccccc
Confidence 34699999965433 23467999999999996 99999999999999999999999999999988764210
Q ss_pred --------------------------------------------------------------------------------
Q 021490 78 -------------------------------------------------------------------------------- 77 (311)
Q Consensus 78 -------------------------------------------------------------------------------- 77 (311)
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 226 (400)
T cd05105 147 PKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLL 226 (400)
T ss_pred ccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHH
Confidence
Q ss_pred ---CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccc
Q 021490 78 ---GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTY 154 (311)
Q Consensus 78 ---~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~ 154 (311)
....+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++................++.
T Consensus 227 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~ 303 (400)
T cd05105 227 SDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPV 303 (400)
T ss_pred HhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCc
Confidence 0135788899999999999999999999 9999999999999999999999999986532222212222234667
Q ss_pred cccCccccccCCCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHH
Q 021490 155 GYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFY 233 (311)
Q Consensus 155 ~y~aPE~~~~~~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
.|+|||++.+..++.++|||||||++|+|++ |..||......... ... ...... . ..+...+.
T Consensus 304 ~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~--~~~----~~~~~~------~----~~~~~~~~ 367 (400)
T cd05105 304 KWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF--YNK----IKSGYR------M----AKPDHATQ 367 (400)
T ss_pred ceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHH--HHH----HhcCCC------C----CCCccCCH
Confidence 8999999988889999999999999999997 88998754322111 000 000000 0 11122345
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHHHHHhh
Q 021490 234 QALAVAAMCVHEQPDMRPVIADVVTALAYLA 264 (311)
Q Consensus 234 ~l~~li~~~l~~~p~~Rps~~~vl~~l~~~~ 264 (311)
.+.+++.+||..||++|||+.++.+.|+.+.
T Consensus 368 ~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 368 EVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred HHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 7889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=273.08 Aligned_cols=226 Identities=22% Similarity=0.333 Sum_probs=191.0
Q ss_pred CCcEEEEEEeecCCCcc--hhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHH
Q 021490 8 LLQDVAIKQLDRNGVQG--NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN 85 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~ 85 (311)
.|..||||++.+...+. ...++.|++.|+.++|||||++|+++.....+|||+|+-++|+|++|+-.. ...+.+.
T Consensus 42 TGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD~GDl~DyImKH---e~Gl~E~ 118 (864)
T KOG4717|consen 42 TGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGDGGDLFDYIMKH---EEGLNED 118 (864)
T ss_pred ccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecCCchHHHHHHhh---hccccHH
Confidence 58999999998765433 358888999999999999999999999999999999999999999998762 5789999
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEE-cCCCceEEccccccccCCCCCCceeeeeccccccccCcccccc
Q 021490 86 TRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL-DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT 164 (311)
Q Consensus 86 ~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~-~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 164 (311)
.+.+++.||+.||.|+|... +|||||||+|+.+ ..-|-|||+|||++..+..+ .......|...|.|||++.+
T Consensus 119 La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG---~kL~TsCGSLAYSAPEILLG 192 (864)
T KOG4717|consen 119 LAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG---KKLTTSCGSLAYSAPEILLG 192 (864)
T ss_pred HHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCc---chhhcccchhhccCchhhhc
Confidence 99999999999999999999 9999999999766 46788999999998754333 23344578999999999988
Q ss_pred CCCc-cccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHcc
Q 021490 165 GQLT-LKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCV 243 (311)
Q Consensus 165 ~~~~-~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 243 (311)
..|+ +++||||||+|+|.|++|++||+..+..+...++. ...-..|...+.++.+||..||
T Consensus 193 DsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmIm------------------DCKYtvPshvS~eCrdLI~sML 254 (864)
T KOG4717|consen 193 DSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIM------------------DCKYTVPSHVSKECRDLIQSML 254 (864)
T ss_pred CccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhh------------------cccccCchhhhHHHHHHHHHHH
Confidence 7764 78999999999999999999998877655544331 1112346677889999999999
Q ss_pred ccCCCCCCCHHHHHHHH
Q 021490 244 HEQPDMRPVIADVVTAL 260 (311)
Q Consensus 244 ~~~p~~Rps~~~vl~~l 260 (311)
..||++|.|.++|...-
T Consensus 255 vRdPkkRAslEeI~s~~ 271 (864)
T KOG4717|consen 255 VRDPKKRASLEEIVSTS 271 (864)
T ss_pred hcCchhhccHHHHhccc
Confidence 99999999999988653
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=264.12 Aligned_cols=237 Identities=28% Similarity=0.361 Sum_probs=185.3
Q ss_pred cchhccCCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCC
Q 021490 2 MQVILCLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKP 81 (311)
Q Consensus 2 ~~~~~~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 81 (311)
|.+...++..||+|+++... ...+.|.+|+.+++.++||||+++++.+.. ...++||||+++++|.+++.... +..
T Consensus 23 ~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~--~~~ 98 (262)
T cd05071 23 WMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEM--GKY 98 (262)
T ss_pred EEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCCCCcHHHHHhhcc--ccC
Confidence 44555566779999986533 345689999999999999999999998754 55799999999999999997522 346
Q ss_pred CCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccc
Q 021490 82 LDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 161 (311)
Q Consensus 82 l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 161 (311)
+++..+..++.+++.||+|||+.+ ++|+||+|+||++++++.++|+|||.+........ .......++..|+|||.
T Consensus 99 ~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~ 174 (262)
T cd05071 99 LRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAPEA 174 (262)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccccc-ccccCCcccceecCHhH
Confidence 889999999999999999999999 99999999999999999999999999865332221 11122345678999999
Q ss_pred cccCCCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHH
Q 021490 162 AKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAA 240 (311)
Q Consensus 162 ~~~~~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 240 (311)
..+..++.++|+||||+++|+|++ |..||.............. ... ...+...+..+.+++.
T Consensus 175 ~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~-------~~~----------~~~~~~~~~~l~~li~ 237 (262)
T cd05071 175 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER-------GYR----------MPCPPECPESLHDLMC 237 (262)
T ss_pred hccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhc-------CCC----------CCCccccCHHHHHHHH
Confidence 988889999999999999999999 8888876543322211110 000 0112233457889999
Q ss_pred HccccCCCCCCCHHHHHHHHHHh
Q 021490 241 MCVHEQPDMRPVIADVVTALAYL 263 (311)
Q Consensus 241 ~~l~~~p~~Rps~~~vl~~l~~~ 263 (311)
+||+.||++|||+.++++.|+..
T Consensus 238 ~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 238 QCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred HHccCCcccCCCHHHHHHHHHHh
Confidence 99999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=288.73 Aligned_cols=233 Identities=22% Similarity=0.286 Sum_probs=184.9
Q ss_pred cCCcEEEEEEeecCCC--cchhHHHHHHHHHhcCCCCcccceeeEeeeCC--------eeEEEEecCCCCChhhhhcccC
Q 021490 7 CLLQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGD--------QRLLVYEYMPLGSVEDHLHDLS 76 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--------~~~lv~e~~~~~~L~~~l~~~~ 76 (311)
.+|+.||||++..... .....+.+|+..+..++|+||+++++.+.... ..++||||+++|+|.+++....
T Consensus 55 ~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~ 134 (496)
T PTZ00283 55 SDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRA 134 (496)
T ss_pred CCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhh
Confidence 4789999999876543 23357888999999999999999988775432 3689999999999999987644
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccc
Q 021490 77 PGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY 156 (311)
Q Consensus 77 ~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y 156 (311)
.....+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.++|+|||++................|+..|
T Consensus 135 ~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y 211 (496)
T PTZ00283 135 KTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYY 211 (496)
T ss_pred ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEEecccCeeccccccccccccccCCcce
Confidence 44567999999999999999999999999 999999999999999999999999998754322222222334688999
Q ss_pred cCccccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHH
Q 021490 157 CAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQAL 236 (311)
Q Consensus 157 ~aPE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 236 (311)
+|||++.+..++.++|||||||++|+|++|..||............ .... ....++..+..+.
T Consensus 212 ~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~------~~~~-----------~~~~~~~~~~~l~ 274 (496)
T PTZ00283 212 VAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKT------LAGR-----------YDPLPPSISPEMQ 274 (496)
T ss_pred eCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH------hcCC-----------CCCCCCCCCHHHH
Confidence 9999999889999999999999999999999999865543221111 1000 0012233445788
Q ss_pred HHHHHccccCCCCCCCHHHHHHH
Q 021490 237 AVAAMCVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 237 ~li~~~l~~~p~~Rps~~~vl~~ 259 (311)
+++.+||+.||.+|||+.+++..
T Consensus 275 ~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 275 EIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HHHHHHcccChhhCcCHHHHHhC
Confidence 99999999999999999999864
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=280.96 Aligned_cols=230 Identities=24% Similarity=0.255 Sum_probs=178.2
Q ss_pred cCCcEEEEEEeecCCC---cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCC
Q 021490 7 CLLQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLD 83 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~ 83 (311)
.+++.||+|++..... .....+.+|+.+++.++||||+++++.+.++...|+||||++||+|.+++.. .+.++
T Consensus 24 ~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~ 99 (382)
T cd05625 24 DTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIR----MGIFP 99 (382)
T ss_pred CCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHh----cCCCC
Confidence 3688999999975432 2335788899999999999999999999999999999999999999999976 46789
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCC---------------------
Q 021490 84 WNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD--------------------- 142 (311)
Q Consensus 84 ~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~--------------------- 142 (311)
+..+..++.|++.||+|||+.+ |+||||||+|||++.+|.++|+|||++.......
T Consensus 100 e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (382)
T cd05625 100 EDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNE 176 (382)
T ss_pred HHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCcccccccccccccccccccccccccccc
Confidence 9999999999999999999999 9999999999999999999999999864211000
Q ss_pred ------------------------CceeeeeccccccccCccccccCCCccccceeehhHHHHHHHhCCCccCcchhHHH
Q 021490 143 ------------------------NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE 198 (311)
Q Consensus 143 ------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~ 198 (311)
.........|+..|+|||++.+..++.++|||||||++|+|++|..||........
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~ 256 (382)
T cd05625 177 WGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLET 256 (382)
T ss_pred ccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHHHHhCCCCCCCCCHHHH
Confidence 00001123588999999999988999999999999999999999999986554332
Q ss_pred HH-HHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCC---HHHHHHH
Q 021490 199 QS-LVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPV---IADVVTA 259 (311)
Q Consensus 199 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps---~~~vl~~ 259 (311)
.. +..+.. . ...+ .....+.++.+++.+|+ .+|.+|++ +.+++..
T Consensus 257 ~~~i~~~~~-------~---~~~p-----~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 305 (382)
T cd05625 257 QMKVINWQT-------S---LHIP-----PQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAH 305 (382)
T ss_pred HHHHHccCC-------C---cCCC-----CcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcC
Confidence 21 111100 0 0000 01123446778888876 49999987 7777754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=265.49 Aligned_cols=231 Identities=25% Similarity=0.369 Sum_probs=181.8
Q ss_pred cEEEEEEeecCC-CcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHHHH
Q 021490 10 QDVAIKQLDRNG-VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRM 88 (311)
Q Consensus 10 ~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~ 88 (311)
..||||+++... ......|.+|+.+++.++||||+++++++.++...++||||+++++|.+++... .+.+++..++
T Consensus 33 ~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~ 109 (269)
T cd05065 33 IFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQN---DGQFTVIQLV 109 (269)
T ss_pred eeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEecCCCCcHHHHHhhC---CCCCCHHHHH
Confidence 369999986543 233468999999999999999999999999999999999999999999998763 3568999999
Q ss_pred HHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeec---cccccccCccccccC
Q 021490 89 KIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRV---MGTYGYCAPEYAKTG 165 (311)
Q Consensus 89 ~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~---~~~~~y~aPE~~~~~ 165 (311)
.++.|++.||+|||+++ ++|+||+|+||+++.++.++|+|||++............... ..+..|+|||.+.+.
T Consensus 110 ~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~ 186 (269)
T cd05065 110 GMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYR 186 (269)
T ss_pred HHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhccC
Confidence 99999999999999999 999999999999999999999999988653222211111111 123579999999888
Q ss_pred CCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccc
Q 021490 166 QLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVH 244 (311)
Q Consensus 166 ~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 244 (311)
.++.++||||||+++|||++ |..||...........+. . . .. ...+...+..+.+++.+||.
T Consensus 187 ~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~---~---~-~~----------~~~~~~~~~~~~~li~~~l~ 249 (269)
T cd05065 187 KFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIE---Q---D-YR----------LPPPMDCPTALHQLMLDCWQ 249 (269)
T ss_pred cccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHH---c---C-Cc----------CCCcccCCHHHHHHHHHHcC
Confidence 89999999999999999886 999997655433222111 0 0 00 00112223467889999999
Q ss_pred cCCCCCCCHHHHHHHHHHh
Q 021490 245 EQPDMRPVIADVVTALAYL 263 (311)
Q Consensus 245 ~~p~~Rps~~~vl~~l~~~ 263 (311)
.+|.+||++.+++..|+.+
T Consensus 250 ~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 250 KDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred CChhhCcCHHHHHHHHHhh
Confidence 9999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=279.79 Aligned_cols=231 Identities=22% Similarity=0.250 Sum_probs=179.9
Q ss_pred cCCcEEEEEEeecCC---CcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCC
Q 021490 7 CLLQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLD 83 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~ 83 (311)
.+|+.||||++.... ......+.+|++++..++||||+++++++.++...|+||||++|++|.+++.. ...++
T Consensus 24 ~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~ 99 (377)
T cd05629 24 DTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIK----YDTFS 99 (377)
T ss_pred CCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCCCCcHHHHHHh----cCCCC
Confidence 378999999986542 22345788899999999999999999999999999999999999999999976 56789
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCc------------e------
Q 021490 84 WNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT------------H------ 145 (311)
Q Consensus 84 ~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~------------~------ 145 (311)
+..+..++.|++.||+|||+.+ ++||||||+|||++.++.++|+|||++......... .
T Consensus 100 ~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (377)
T cd05629 100 EDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNR 176 (377)
T ss_pred HHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccccccccccccccccccccccccc
Confidence 9999999999999999999999 999999999999999999999999988532110000 0
Q ss_pred ---------------------------eeeeccccccccCccccccCCCccccceeehhHHHHHHHhCCCccCcchhHHH
Q 021490 146 ---------------------------VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE 198 (311)
Q Consensus 146 ---------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~ 198 (311)
......|+..|+|||++.+..++.++|||||||++|+|++|..||........
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~ 256 (377)
T cd05629 177 NSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHET 256 (377)
T ss_pred cccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhhhhhcCCCCCCCCCHHHH
Confidence 00013588999999999988999999999999999999999999976554322
Q ss_pred HH-HHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCC---CCHHHHHHHH
Q 021490 199 QS-LVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMR---PVIADVVTAL 260 (311)
Q Consensus 199 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R---ps~~~vl~~l 260 (311)
.. +..|.. . ...+. ....+.++.+++.+||. +|.+| +|+.+++...
T Consensus 257 ~~~i~~~~~-------~---~~~p~-----~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp 306 (377)
T cd05629 257 YRKIINWRE-------T---LYFPD-----DIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHP 306 (377)
T ss_pred HHHHHccCC-------c---cCCCC-----CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCC
Confidence 11 111100 0 00000 01234578889999998 77765 5999988764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=270.04 Aligned_cols=241 Identities=28% Similarity=0.402 Sum_probs=185.0
Q ss_pred CCcEEEEEEeecCCC-cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCC-------CC
Q 021490 8 LLQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP-------GK 79 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-------~~ 79 (311)
.+..||+|.+..... ...+.+.+|++++..++||||+++++++..+...++|||++.+++|.+++..... ..
T Consensus 45 ~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 124 (296)
T cd05051 45 APVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNS 124 (296)
T ss_pred CceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccC
Confidence 356799999865543 3356888999999999999999999999999999999999999999999876321 12
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCc
Q 021490 80 KPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 159 (311)
Q Consensus 80 ~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aP 159 (311)
..+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++................++..|+||
T Consensus 125 ~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 201 (296)
T cd05051 125 KSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAW 201 (296)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCH
Confidence 36899999999999999999999999 999999999999999999999999998643222222222233456789999
Q ss_pred cccccCCCccccceeehhHHHHHHHh--CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHH
Q 021490 160 EYAKTGQLTLKSDVYSFGVVLLEILS--GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALA 237 (311)
Q Consensus 160 E~~~~~~~~~~~DiwslG~l~~~ll~--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 237 (311)
|.+.+..++.++||||||+++|+|++ +..||......... ......+........ ...+...+.++.+
T Consensus 202 E~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~---~~~~~~~~~~~~~~~-------~~~~~~~~~~l~~ 271 (296)
T cd05051 202 ESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVI---ENAGHFFRDDGRQIY-------LPRPPNCPKDIYE 271 (296)
T ss_pred HHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHHH---HHHHhcccccccccc-------CCCccCCCHHHHH
Confidence 99988889999999999999999998 67788654432221 111111111000000 1112233458899
Q ss_pred HHHHccccCCCCCCCHHHHHHHHH
Q 021490 238 VAAMCVHEQPDMRPVIADVVTALA 261 (311)
Q Consensus 238 li~~~l~~~p~~Rps~~~vl~~l~ 261 (311)
++.+||+.||.+|||+.++++.|+
T Consensus 272 li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 272 LMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred HHHHHhccChhcCCCHHHHHHHhc
Confidence 999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=264.55 Aligned_cols=235 Identities=24% Similarity=0.341 Sum_probs=182.8
Q ss_pred CcEEEEEEeecCCC--cchhHHHHHHHHHhcCCCCcccceeeEeeeCCe------eEEEEecCCCCChhhhhcccC--CC
Q 021490 9 LQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ------RLLVYEYMPLGSVEDHLHDLS--PG 78 (311)
Q Consensus 9 g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~------~~lv~e~~~~~~L~~~l~~~~--~~ 78 (311)
+..||+|.++.... .....+.+|+..++.++||||+++++++..... .++++||+++++|..++.... ..
T Consensus 27 ~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~ 106 (273)
T cd05035 27 QLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGL 106 (273)
T ss_pred cceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCC
Confidence 47799999875433 234688999999999999999999998866554 799999999999999885532 12
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccC
Q 021490 79 KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCA 158 (311)
Q Consensus 79 ~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~a 158 (311)
...+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++.................+..|+|
T Consensus 107 ~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~ 183 (273)
T cd05035 107 PEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA 183 (273)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCccceeeccccccccccccccCCccccC
Confidence 346899999999999999999999999 99999999999999999999999999875432221111112234568999
Q ss_pred ccccccCCCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHH
Q 021490 159 PEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALA 237 (311)
Q Consensus 159 PE~~~~~~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 237 (311)
||.+.+..++.++|||||||++|+|++ |..||............. .. . . ...+...+..+.+
T Consensus 184 pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~------~~-~------~----~~~~~~~~~~~~~ 246 (273)
T cd05035 184 IESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLR------HG-N------R----LKQPEDCLDELYD 246 (273)
T ss_pred HhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH------cC-C------C----CCCCcCCCHHHHH
Confidence 999988889999999999999999999 889987654332211110 00 0 0 0112234457899
Q ss_pred HHHHccccCCCCCCCHHHHHHHHHHh
Q 021490 238 VAAMCVHEQPDMRPVIADVVTALAYL 263 (311)
Q Consensus 238 li~~~l~~~p~~Rps~~~vl~~l~~~ 263 (311)
++.+||+.||++|||+.++++.|+.+
T Consensus 247 li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 247 LMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred HHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 99999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=263.46 Aligned_cols=230 Identities=28% Similarity=0.406 Sum_probs=183.8
Q ss_pred cEEEEEEeecCCC-cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHHHH
Q 021490 10 QDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRM 88 (311)
Q Consensus 10 ~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~ 88 (311)
..||+|.+..... ...+.+.+|+..+++++||||+++++++.. ...++||||+++++|.+++.... ...+++..++
T Consensus 24 ~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~ 100 (257)
T cd05040 24 IPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDA--LGHFLISTLC 100 (257)
T ss_pred eEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCCcHHHHHHhcc--cccCcHHHHH
Confidence 3699999977665 456789999999999999999999999988 88999999999999999997632 1568999999
Q ss_pred HHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCc-eeeeeccccccccCccccccCCC
Q 021490 89 KIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT-HVSTRVMGTYGYCAPEYAKTGQL 167 (311)
Q Consensus 89 ~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~ 167 (311)
.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++......... .......++..|+|||.+.+..+
T Consensus 101 ~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~ 177 (257)
T cd05040 101 DYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTF 177 (257)
T ss_pred HHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccceecccCCCCCceecCHHHhcccCc
Confidence 99999999999999999 999999999999999999999999998764332111 11112346678999999988889
Q ss_pred ccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccC
Q 021490 168 TLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQ 246 (311)
Q Consensus 168 ~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 246 (311)
+.++||||||+++|+|++ |..||.............. .. ... ..+...+..+.+++.+||..+
T Consensus 178 ~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~------~~---~~~-------~~~~~~~~~~~~li~~~l~~~ 241 (257)
T cd05040 178 SHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDK------EG---ERL-------ERPEACPQDIYNVMLQCWAHN 241 (257)
T ss_pred CchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh------cC---CcC-------CCCccCCHHHHHHHHHHCCCC
Confidence 999999999999999998 9999976544332211110 00 000 011123347889999999999
Q ss_pred CCCCCCHHHHHHHHH
Q 021490 247 PDMRPVIADVVTALA 261 (311)
Q Consensus 247 p~~Rps~~~vl~~l~ 261 (311)
|++|||+.++++.|.
T Consensus 242 p~~Rps~~~~~~~l~ 256 (257)
T cd05040 242 PADRPTFAALREFLP 256 (257)
T ss_pred cccCCCHHHHHHHhc
Confidence 999999999999874
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=270.64 Aligned_cols=239 Identities=27% Similarity=0.397 Sum_probs=186.7
Q ss_pred CcEEEEEEeecCC-CcchhHHHHHHHHHhcC-CCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCC---------
Q 021490 9 LQDVAIKQLDRNG-VQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP--------- 77 (311)
Q Consensus 9 g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------- 77 (311)
+..+|+|.++... ......+.+|+.++..+ +||||+++++++..+...++||||+++++|.+++.....
T Consensus 50 ~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~ 129 (307)
T cd05098 50 VTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNP 129 (307)
T ss_pred cceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCccccccccc
Confidence 3579999987543 23446788899999999 799999999999999999999999999999999976321
Q ss_pred ---CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccc
Q 021490 78 ---GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTY 154 (311)
Q Consensus 78 ---~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~ 154 (311)
....+++.++..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++................++.
T Consensus 130 ~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~ 206 (307)
T cd05098 130 TQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPV 206 (307)
T ss_pred ccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCcc
Confidence 1235889999999999999999999999 9999999999999999999999999986432211111111122346
Q ss_pred cccCccccccCCCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHH
Q 021490 155 GYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFY 233 (311)
Q Consensus 155 ~y~aPE~~~~~~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
.|+|||.+.+..++.++|+|||||++|+|++ |..||............... . ....+...+.
T Consensus 207 ~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-------~----------~~~~~~~~~~ 269 (307)
T cd05098 207 KWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEG-------H----------RMDKPSNCTN 269 (307)
T ss_pred ceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHcC-------C----------CCCCCCcCCH
Confidence 7999999988889999999999999999998 88888765443322221110 0 0011223345
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHHHHHhhhcc
Q 021490 234 QALAVAAMCVHEQPDMRPVIADVVTALAYLASQK 267 (311)
Q Consensus 234 ~l~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~~ 267 (311)
++.+++.+||..+|.+|||+.++++.|+.+....
T Consensus 270 ~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~ 303 (307)
T cd05098 270 ELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT 303 (307)
T ss_pred HHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence 8888999999999999999999999999877553
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=267.95 Aligned_cols=236 Identities=27% Similarity=0.409 Sum_probs=185.4
Q ss_pred cEEEEEEeecCCC-cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCC-----------
Q 021490 10 QDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP----------- 77 (311)
Q Consensus 10 ~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----------- 77 (311)
..+++|.+..... .....+.+|+.+++.++||||+++++.+..+...++++||+.+++|.+++.....
T Consensus 31 ~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 110 (290)
T cd05045 31 TTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGN 110 (290)
T ss_pred eeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccc
Confidence 5688888865432 2346788999999999999999999999999999999999999999998865311
Q ss_pred ---------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeee
Q 021490 78 ---------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST 148 (311)
Q Consensus 78 ---------~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~ 148 (311)
....+++..++.++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++.............
T Consensus 111 ~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~ 187 (290)
T cd05045 111 RNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRS 187 (290)
T ss_pred cccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhheEEEcCCCcEEeccccccccccCccchhccc
Confidence 1245889999999999999999999999 9999999999999999999999999986532222111122
Q ss_pred eccccccccCccccccCCCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCC
Q 021490 149 RVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQY 227 (311)
Q Consensus 149 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (311)
...++..|+|||.+.+..++.++||||||+++|+|++ |..||............. ... ....
T Consensus 188 ~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~-------~~~----------~~~~ 250 (290)
T cd05045 188 KGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLK-------TGY----------RMER 250 (290)
T ss_pred CCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh-------CCC----------CCCC
Confidence 2345678999999988889999999999999999998 999997655433222111 000 0011
Q ss_pred ChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhh
Q 021490 228 PPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLAS 265 (311)
Q Consensus 228 ~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l~~~~~ 265 (311)
+...+..+.+++.+||+.+|++||++.++++.|+.+..
T Consensus 251 ~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 251 PENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 22234578899999999999999999999999987753
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=255.70 Aligned_cols=230 Identities=20% Similarity=0.237 Sum_probs=188.8
Q ss_pred cCCcEEEEEEeecCC--CcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCH
Q 021490 7 CLLQDVAIKQLDRNG--VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 84 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~ 84 (311)
.+|+..|+|+++-+. ..+.+.+.+|+++-+.|+||||+++.+.+.+....|+|+|+++|++|..-+.+ ...+++
T Consensus 34 ~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~dl~~eIV~----R~~ySE 109 (355)
T KOG0033|consen 34 TTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA----REFYSE 109 (355)
T ss_pred cchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecccchHHHHHHHH----HHHHHH
Confidence 368888998876543 34567889999999999999999999999999999999999999999887766 467888
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEc---CCCceEEccccccccCCCCCCceeeeeccccccccCccc
Q 021490 85 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD---RGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 161 (311)
Q Consensus 85 ~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~---~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 161 (311)
..+-.++.||+.+|.|+|.++ |+|||+||+|+++. ...-+||+|||++...+ .........|++.|+|||+
T Consensus 110 a~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~---~g~~~~G~~GtP~fmaPEv 183 (355)
T KOG0033|consen 110 ADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN---DGEAWHGFAGTPGYLSPEV 183 (355)
T ss_pred HHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEeC---CccccccccCCCcccCHHH
Confidence 999999999999999999999 99999999999995 34458999999998644 3344556789999999999
Q ss_pred cccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHH
Q 021490 162 AKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAM 241 (311)
Q Consensus 162 ~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 241 (311)
+...+++..+|||+.|+++|-|+.|.+||.+.+......-+... +-.++....+..+++..+|+.+
T Consensus 184 vrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g--------------~yd~~~~~w~~is~~Ak~Lvrr 249 (355)
T KOG0033|consen 184 LKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAG--------------AYDYPSPEWDTVTPEAKSLIRR 249 (355)
T ss_pred hhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhcc--------------ccCCCCcccCcCCHHHHHHHHH
Confidence 99999999999999999999999999999885554432222111 1111122233455688999999
Q ss_pred ccccCCCCCCCHHHHHHHH
Q 021490 242 CVHEQPDMRPVIADVVTAL 260 (311)
Q Consensus 242 ~l~~~p~~Rps~~~vl~~l 260 (311)
||..||++|.|+.|.+..-
T Consensus 250 ML~~dP~kRIta~EAL~Hp 268 (355)
T KOG0033|consen 250 MLTVNPKKRITADEALKHP 268 (355)
T ss_pred HhccChhhhccHHHHhCCc
Confidence 9999999999999988654
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=275.71 Aligned_cols=222 Identities=27% Similarity=0.328 Sum_probs=176.4
Q ss_pred cCCcEEEEEEeecCCC---cchhHHHHHHH-HHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCC
Q 021490 7 CLLQDVAIKQLDRNGV---QGNREFLVEVL-MLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPL 82 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~---~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l 82 (311)
.+|+.||+|++..... .....+..|.. +++.++||||+++++++..+...++||||++|++|..++.. ...+
T Consensus 18 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~ 93 (325)
T cd05604 18 LDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQR----ERSF 93 (325)
T ss_pred CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCCCHHHHHHH----cCCC
Confidence 3689999999975422 23345555554 56778999999999999999999999999999999988876 5679
Q ss_pred CHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccc
Q 021490 83 DWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 162 (311)
Q Consensus 83 ~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 162 (311)
++..+..++.||+.||+|||+.| ++||||||+|||++.++.++|+|||++...... ........|+..|+|||++
T Consensus 94 ~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~~~~~gt~~y~aPE~~ 168 (325)
T cd05604 94 PEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--SDTTTTFCGTPEYLAPEVI 168 (325)
T ss_pred CHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCC--CCCcccccCChhhCCHHHH
Confidence 99999999999999999999999 999999999999999999999999998642111 1122334588999999999
Q ss_pred ccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHc
Q 021490 163 KTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMC 242 (311)
Q Consensus 163 ~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 242 (311)
.+..++.++|||||||++|+|++|..||...+........ ... .. ..++..+..+.+++.+|
T Consensus 169 ~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~------~~~----~~--------~~~~~~~~~~~~ll~~l 230 (325)
T cd05604 169 RKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNI------LHK----PL--------VLRPGASLTAWSILEEL 230 (325)
T ss_pred cCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHH------HcC----Cc--------cCCCCCCHHHHHHHHHH
Confidence 9889999999999999999999999999766543321111 110 00 11223345778899999
Q ss_pred cccCCCCCCCHHH
Q 021490 243 VHEQPDMRPVIAD 255 (311)
Q Consensus 243 l~~~p~~Rps~~~ 255 (311)
|..||.+||++.+
T Consensus 231 l~~~p~~R~~~~~ 243 (325)
T cd05604 231 LEKDRQRRLGAKE 243 (325)
T ss_pred hccCHHhcCCCCC
Confidence 9999999998863
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=270.56 Aligned_cols=239 Identities=24% Similarity=0.362 Sum_probs=181.2
Q ss_pred cEEEEEEeecCCC-cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCC--------CCC
Q 021490 10 QDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP--------GKK 80 (311)
Q Consensus 10 ~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~ 80 (311)
..||+|.++.... .....|.+|+++++.++|+|++++++++......++||||+++++|.+++..... ...
T Consensus 45 ~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 124 (295)
T cd05097 45 VLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIP 124 (295)
T ss_pred eEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCC
Confidence 3589999865432 3345799999999999999999999999999999999999999999999865210 112
Q ss_pred CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcc
Q 021490 81 PLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 160 (311)
Q Consensus 81 ~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE 160 (311)
.+++..++.++.+++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++................++..|+|||
T Consensus 125 ~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 201 (295)
T cd05097 125 SVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWE 201 (295)
T ss_pred cccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChh
Confidence 4788999999999999999999999 9999999999999999999999999986532222112222234567899999
Q ss_pred ccccCCCccccceeehhHHHHHHHh--CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHH
Q 021490 161 YAKTGQLTLKSDVYSFGVVLLEILS--GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAV 238 (311)
Q Consensus 161 ~~~~~~~~~~~DiwslG~l~~~ll~--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 238 (311)
.+....++.++|+||||+++|+|++ +..||............ ...+........ ...++..+..+.+|
T Consensus 202 ~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~---~~~~~~~~~~~~-------~~~~~~~~~~l~~l 271 (295)
T cd05097 202 SILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENT---GEFFRNQGRQIY-------LSQTPLCPSPVFKL 271 (295)
T ss_pred hhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHHHH---HHhhhhcccccc-------CCCCCCCCHHHHHH
Confidence 9988889999999999999999988 66788765433221111 111111000000 01122234589999
Q ss_pred HHHccccCCCCCCCHHHHHHHHH
Q 021490 239 AAMCVHEQPDMRPVIADVVTALA 261 (311)
Q Consensus 239 i~~~l~~~p~~Rps~~~vl~~l~ 261 (311)
+.+||+.||++|||+.++++.|+
T Consensus 272 i~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 272 MMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHHcCCCchhCcCHHHHHHHHh
Confidence 99999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=274.25 Aligned_cols=227 Identities=25% Similarity=0.323 Sum_probs=177.0
Q ss_pred cCCcEEEEEEeecCCC---cchhHHHHHHHHHhcC-CCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCC
Q 021490 7 CLLQDVAIKQLDRNGV---QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPL 82 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l 82 (311)
.+++.||+|+++.... ...+.+.+|+.++.++ +||||+.+++++.+....|+||||++|++|..++.. ...+
T Consensus 18 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~l 93 (327)
T cd05617 18 KNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQR----QRKL 93 (327)
T ss_pred CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHH----cCCC
Confidence 3678999999976532 2345688899999888 699999999999999999999999999999998876 5679
Q ss_pred CHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccc
Q 021490 83 DWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 162 (311)
Q Consensus 83 ~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 162 (311)
++..+..++.|++.||+|||+++ ++||||||+||+++.++.++|+|||++...... ........|+..|+|||++
T Consensus 94 ~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~ 168 (327)
T cd05617 94 PEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP--GDTTSTFCGTPNYIAPEIL 168 (327)
T ss_pred CHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCC--CCceecccCCcccCCHHHH
Confidence 99999999999999999999999 999999999999999999999999988642111 1122334688999999999
Q ss_pred ccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHc
Q 021490 163 KTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMC 242 (311)
Q Consensus 163 ~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 242 (311)
.+..++.++|||||||++|+|++|..||...................... ...++...+..+.+++.+|
T Consensus 169 ~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-----------~~~~p~~~~~~~~~li~~~ 237 (327)
T cd05617 169 RGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK-----------PIRIPRFLSVKASHVLKGF 237 (327)
T ss_pred CCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC-----------CCCCCCCCCHHHHHHHHHH
Confidence 98899999999999999999999999996432211110000010001000 0112223345778899999
Q ss_pred cccCCCCCCCH
Q 021490 243 VHEQPDMRPVI 253 (311)
Q Consensus 243 l~~~p~~Rps~ 253 (311)
|..||++|+++
T Consensus 238 L~~dP~~R~~~ 248 (327)
T cd05617 238 LNKDPKERLGC 248 (327)
T ss_pred hccCHHHcCCC
Confidence 99999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=264.97 Aligned_cols=233 Identities=25% Similarity=0.353 Sum_probs=178.7
Q ss_pred EEEEEEeecCC--CcchhHHHHHHHHHhcCCCCcccceeeEeeeC------CeeEEEEecCCCCChhhhhcccC--CCCC
Q 021490 11 DVAIKQLDRNG--VQGNREFLVEVLMLSLLHHPNLVNLIGYCADG------DQRLLVYEYMPLGSVEDHLHDLS--PGKK 80 (311)
Q Consensus 11 ~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~--~~~~ 80 (311)
.||+|.++... ....+.+.+|+.+++.++|+||+++++++... ...+++|||+.+++|.+++.... ....
T Consensus 28 ~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~ 107 (272)
T cd05075 28 KVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQ 107 (272)
T ss_pred eEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcc
Confidence 68999886543 23346788999999999999999999976432 24689999999999998874321 1234
Q ss_pred CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcc
Q 021490 81 PLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 160 (311)
Q Consensus 81 ~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE 160 (311)
.+++..+..++.|++.||+|||+++ ++|+||||+||++++++.++|+|||++................++..|++||
T Consensus 108 ~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe 184 (272)
T cd05075 108 YLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIE 184 (272)
T ss_pred cCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHH
Confidence 5899999999999999999999999 9999999999999999999999999987543222111112223567899999
Q ss_pred ccccCCCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHH
Q 021490 161 YAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVA 239 (311)
Q Consensus 161 ~~~~~~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 239 (311)
...+..++.++||||||+++|+|++ |..||............. ..... ..++..+..+.+++
T Consensus 185 ~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~-------~~~~~----------~~~~~~~~~~~~li 247 (272)
T cd05075 185 SLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLR-------QGNRL----------KQPPDCLDGLYSLM 247 (272)
T ss_pred HccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-------cCCCC----------CCCCCCCHHHHHHH
Confidence 9988889999999999999999999 889997654432211111 10000 11223345788999
Q ss_pred HHccccCCCCCCCHHHHHHHHHHh
Q 021490 240 AMCVHEQPDMRPVIADVVTALAYL 263 (311)
Q Consensus 240 ~~~l~~~p~~Rps~~~vl~~l~~~ 263 (311)
.+||..||++|||+.++++.|+.+
T Consensus 248 ~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 248 SSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred HHHcCCCcccCcCHHHHHHHHHhh
Confidence 999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=269.10 Aligned_cols=239 Identities=26% Similarity=0.406 Sum_probs=186.5
Q ss_pred CCcEEEEEEeecCCC-cchhHHHHHHHHHhcC-CCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCC--------
Q 021490 8 LLQDVAIKQLDRNGV-QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP-------- 77 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-------- 77 (311)
.+..||+|.++.... .....+.+|+.+++.+ +||||+++++++.++...++||||+++++|.+++.....
T Consensus 43 ~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~ 122 (314)
T cd05099 43 QTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFD 122 (314)
T ss_pred cceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCccccccc
Confidence 356799999865432 3345788999999999 699999999999988899999999999999999976321
Q ss_pred ----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeecccc
Q 021490 78 ----GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT 153 (311)
Q Consensus 78 ----~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~ 153 (311)
....+++..+..++.|++.||.|||++| ++|+||+|+||+++.++.++|+|||++................++
T Consensus 123 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~ 199 (314)
T cd05099 123 ITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLP 199 (314)
T ss_pred ccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCC
Confidence 1245889999999999999999999999 999999999999999999999999998753322111111112234
Q ss_pred ccccCccccccCCCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhH
Q 021490 154 YGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGF 232 (311)
Q Consensus 154 ~~y~aPE~~~~~~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (311)
..|+|||++.+..++.++||||||+++|+|++ |..||............. .... ...+...+
T Consensus 200 ~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~-------~~~~----------~~~~~~~~ 262 (314)
T cd05099 200 VKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLR-------EGHR----------MDKPSNCT 262 (314)
T ss_pred ccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------cCCC----------CCCCCCCC
Confidence 57999999988889999999999999999999 889997655433322211 0000 01122334
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 021490 233 YQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 266 (311)
Q Consensus 233 ~~l~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~ 266 (311)
..+.+++.+||..||++|||+.++++.|+.+...
T Consensus 263 ~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 296 (314)
T cd05099 263 HELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA 296 (314)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence 4788999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=266.38 Aligned_cols=233 Identities=28% Similarity=0.417 Sum_probs=183.7
Q ss_pred CcEEEEEEeecCCC-cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCC------CCC
Q 021490 9 LQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPG------KKP 81 (311)
Q Consensus 9 g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~------~~~ 81 (311)
+..||+|.+..... .....+.+|+.++..++||||+++++++......++||||+++++|.+++...... ...
T Consensus 36 ~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 115 (277)
T cd05032 36 ETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGP 115 (277)
T ss_pred ceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCC
Confidence 47899999865432 33457889999999999999999999999999999999999999999998753211 234
Q ss_pred CCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccc
Q 021490 82 LDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 161 (311)
Q Consensus 82 l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 161 (311)
+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++................++..|+|||.
T Consensus 116 ~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 192 (277)
T cd05032 116 PTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPES 192 (277)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHH
Confidence 788999999999999999999999 99999999999999999999999999865322221111222345678999999
Q ss_pred cccCCCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHH
Q 021490 162 AKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAA 240 (311)
Q Consensus 162 ~~~~~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 240 (311)
+....++.++|||||||++|+|++ |..||............. ... .+ ..+...+..+.+++.
T Consensus 193 ~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~-------~~~------~~----~~~~~~~~~~~~li~ 255 (277)
T cd05032 193 LKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI-------DGG------HL----DLPENCPDKLLELMR 255 (277)
T ss_pred HhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh-------cCC------CC----CCCCCCCHHHHHHHH
Confidence 988889999999999999999998 899997655433222111 000 00 112223457889999
Q ss_pred HccccCCCCCCCHHHHHHHHH
Q 021490 241 MCVHEQPDMRPVIADVVTALA 261 (311)
Q Consensus 241 ~~l~~~p~~Rps~~~vl~~l~ 261 (311)
+||..+|++|||+.++++.|+
T Consensus 256 ~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 256 MCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred HHcCCChhhCCCHHHHHHHhc
Confidence 999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=262.36 Aligned_cols=236 Identities=28% Similarity=0.363 Sum_probs=184.0
Q ss_pred cchhccCCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCC
Q 021490 2 MQVILCLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKP 81 (311)
Q Consensus 2 ~~~~~~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 81 (311)
|.+...++..+|+|.+.... ...+.+.+|+.+++.++|+|++++++++.. ...++||||+.+++|.+++.... ...
T Consensus 23 ~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~--~~~ 98 (260)
T cd05069 23 WMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMGKGSLLDFLKEGD--GKY 98 (260)
T ss_pred EEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcCCCCCHHHHHhhCC--CCC
Confidence 44555566789999885433 345678899999999999999999998754 56789999999999999997632 345
Q ss_pred CCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccc
Q 021490 82 LDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 161 (311)
Q Consensus 82 l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 161 (311)
+++..+..++.+++.||+|||+.+ ++|+||+|+||++++++.++|+|||++........ .......++..|+|||.
T Consensus 99 ~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~~Pe~ 174 (260)
T cd05069 99 LKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY-TARQGAKFPIKWTAPEA 174 (260)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcc-cccCCCccchhhCCHHH
Confidence 889999999999999999999999 99999999999999999999999999865322211 11122235677999999
Q ss_pred cccCCCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHH
Q 021490 162 AKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAA 240 (311)
Q Consensus 162 ~~~~~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 240 (311)
..+..++.++|+||||+++|+|++ |..||............ ..... ...+...+..+.+++.
T Consensus 175 ~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~-------~~~~~----------~~~~~~~~~~~~~li~ 237 (260)
T cd05069 175 ALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQV-------ERGYR----------MPCPQGCPESLHELMK 237 (260)
T ss_pred hccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-------HcCCC----------CCCCcccCHHHHHHHH
Confidence 988889999999999999999999 89999765433221111 00000 0112233457889999
Q ss_pred HccccCCCCCCCHHHHHHHHHH
Q 021490 241 MCVHEQPDMRPVIADVVTALAY 262 (311)
Q Consensus 241 ~~l~~~p~~Rps~~~vl~~l~~ 262 (311)
+||..||.+||++.++++.|+.
T Consensus 238 ~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 238 LCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred HHccCCcccCcCHHHHHHHHhc
Confidence 9999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=262.35 Aligned_cols=231 Identities=29% Similarity=0.473 Sum_probs=183.1
Q ss_pred CcEEEEEEeecCCCc-chhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHHH
Q 021490 9 LQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTR 87 (311)
Q Consensus 9 g~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~ 87 (311)
+..+|+|.+...... ..+.+.+|+.+++.++|+||+++++++. ....++||||+++++|.+++.. ...+++..+
T Consensus 23 ~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~----~~~~~~~~~ 97 (257)
T cd05060 23 EVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPLGPLLKYLKK----RREIPVSDL 97 (257)
T ss_pred cceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCCCcHHHHHHh----CCCCCHHHH
Confidence 378999998765442 4568899999999999999999999876 4568999999999999999986 457899999
Q ss_pred HHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCcee-eeeccccccccCccccccCC
Q 021490 88 MKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHV-STRVMGTYGYCAPEYAKTGQ 166 (311)
Q Consensus 88 ~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~ 166 (311)
..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++........... .....++..|+|||.+.+..
T Consensus 98 ~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 174 (257)
T cd05060 98 KELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGK 174 (257)
T ss_pred HHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccccccCccccccccCHHHhcCCC
Confidence 999999999999999999 99999999999999999999999999875432221111 11122345799999998888
Q ss_pred CccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHcccc
Q 021490 167 LTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHE 245 (311)
Q Consensus 167 ~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 245 (311)
++.++||||||+++|+|++ |..||...........+.... . ...+...+..+.+++.+||..
T Consensus 175 ~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~-------~----------~~~~~~~~~~l~~li~~cl~~ 237 (257)
T cd05060 175 FSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGE-------R----------LPRPEECPQEIYSIMLSCWKY 237 (257)
T ss_pred CCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC-------c----------CCCCCCCCHHHHHHHHHHhcC
Confidence 9999999999999999998 999997655433222111100 0 011222345788999999999
Q ss_pred CCCCCCCHHHHHHHHHHhh
Q 021490 246 QPDMRPVIADVVTALAYLA 264 (311)
Q Consensus 246 ~p~~Rps~~~vl~~l~~~~ 264 (311)
+|++|||+.++++.|+.+.
T Consensus 238 ~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 238 RPEDRPTFSELESTFRRDP 256 (257)
T ss_pred ChhhCcCHHHHHHHHHhcc
Confidence 9999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=277.81 Aligned_cols=230 Identities=23% Similarity=0.239 Sum_probs=177.6
Q ss_pred CCcEEEEEEeecCCC---cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCH
Q 021490 8 LLQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 84 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~ 84 (311)
+|+.||||+++.... .....+.+|+.++..++|+||+++++.+.++...|+||||++||+|.+++.. .+.+++
T Consensus 25 ~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~l~~ 100 (363)
T cd05628 25 TGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMK----KDTLTE 100 (363)
T ss_pred CCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCCCCcHHHHHHh----cCCCCH
Confidence 589999999975432 2335678899999999999999999999999999999999999999999986 567999
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCc--------------------
Q 021490 85 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT-------------------- 144 (311)
Q Consensus 85 ~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~-------------------- 144 (311)
..+..++.|++.||+|||+.| |+||||||+|||++.++.++|+|||++.........
T Consensus 101 ~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (363)
T cd05628 101 EETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMN 177 (363)
T ss_pred HHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCcccccccccccccccccccccccccccccc
Confidence 999999999999999999999 999999999999999999999999998643211000
Q ss_pred -------------eeeeeccccccccCccccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHH-HHhhhhhc
Q 021490 145 -------------HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLV-AWARPLFQ 210 (311)
Q Consensus 145 -------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~-~~~~~~~~ 210 (311)
.......||..|+|||++.+..++.++|||||||++|+|++|..||...........+ .+...
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~--- 254 (363)
T cd05628 178 SKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKET--- 254 (363)
T ss_pred cccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCc---
Confidence 0011246899999999999889999999999999999999999999765543322211 11000
Q ss_pred cccccccccCccccCCCChHhHHHHHHHHHHccc--cCCCCCCCHHHHHHH
Q 021490 211 DRTRHSLIADPELQGQYPPRGFYQALAVAAMCVH--EQPDMRPVIADVVTA 259 (311)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~--~~p~~Rps~~~vl~~ 259 (311)
...+. ....+.++.+++.+++. .++..||+++++++.
T Consensus 255 -------~~~p~-----~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 255 -------LIFPP-----EVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred -------ccCCC-----cCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 00000 01133467778777554 233356899999876
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=262.52 Aligned_cols=228 Identities=22% Similarity=0.292 Sum_probs=183.5
Q ss_pred CCcEEEEEEeecCC-CcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHH
Q 021490 8 LLQDVAIKQLDRNG-VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNT 86 (311)
Q Consensus 8 ~g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~ 86 (311)
+|+.+|+|.++... ....+.+.+|+.+++.++|+||+++++.+.++...++||||+++++|.+++.... ...+++..
T Consensus 24 ~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~ 101 (255)
T cd08219 24 SDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQR--GKLFPEDT 101 (255)
T ss_pred CCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCCcHHHHHHhcc--CCCCCHHH
Confidence 68899999986543 3345678899999999999999999999999999999999999999999886522 45689999
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccCC
Q 021490 87 RMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ 166 (311)
Q Consensus 87 ~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 166 (311)
++.++.|++.||.+||+.+ ++|+||+|.||+++.++.++++|||.+...... ........++..|+|||++.+..
T Consensus 102 ~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~ 176 (255)
T cd08219 102 ILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP--GAYACTYVGTPYYVPPEIWENMP 176 (255)
T ss_pred HHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccc--ccccccccCCccccCHHHHccCC
Confidence 9999999999999999999 999999999999999999999999998653221 11122345788899999998888
Q ss_pred CccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccC
Q 021490 167 LTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQ 246 (311)
Q Consensus 167 ~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 246 (311)
++.++|+||||+++|+|++|..||............. .. .. ...+...+..+.+++.+||..|
T Consensus 177 ~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~------~~--~~---------~~~~~~~~~~~~~li~~~l~~~ 239 (255)
T cd08219 177 YNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVC------QG--SY---------KPLPSHYSYELRSLIKQMFKRN 239 (255)
T ss_pred cCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHh------cC--CC---------CCCCcccCHHHHHHHHHHHhCC
Confidence 9999999999999999999999997654332211110 00 00 0112223446888999999999
Q ss_pred CCCCCCHHHHHHH
Q 021490 247 PDMRPVIADVVTA 259 (311)
Q Consensus 247 p~~Rps~~~vl~~ 259 (311)
|++|||+.+++.+
T Consensus 240 P~~Rp~~~~il~~ 252 (255)
T cd08219 240 PRSRPSATTILSR 252 (255)
T ss_pred cccCCCHHHHhhc
Confidence 9999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=279.71 Aligned_cols=230 Identities=24% Similarity=0.250 Sum_probs=179.8
Q ss_pred CCcEEEEEEeecCCC---cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCH
Q 021490 8 LLQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 84 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~ 84 (311)
+|+.||+|++..... .....+.+|+.++..++||||+++++.+.++...|+||||++||+|.+++.. .+.+++
T Consensus 25 ~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~----~~~~~~ 100 (376)
T cd05598 25 TNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIR----LGIFEE 100 (376)
T ss_pred CCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCCCCcHHHHHHh----cCCCCH
Confidence 589999999865422 2345688899999999999999999999999999999999999999999976 567899
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCC---------------------
Q 021490 85 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN--------------------- 143 (311)
Q Consensus 85 ~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--------------------- 143 (311)
..+..++.||+.||+|||+.+ |+||||||+|||++.++.++|+|||++........
T Consensus 101 ~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (376)
T cd05598 101 DLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEW 177 (376)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccccccccccccccccccccc
Confidence 999999999999999999999 99999999999999999999999998742110000
Q ss_pred --------------------ceeeeeccccccccCccccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHH-H
Q 021490 144 --------------------THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSL-V 202 (311)
Q Consensus 144 --------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~-~ 202 (311)
........|+..|+|||++.+..++.++|||||||++|+|++|..||........... .
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~ 257 (376)
T cd05598 178 SEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVI 257 (376)
T ss_pred cccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhCCCCCCCCCHHHHHHHHh
Confidence 0000123588999999999999999999999999999999999999987654332211 1
Q ss_pred HHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCC---CHHHHHHHH
Q 021490 203 AWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRP---VIADVVTAL 260 (311)
Q Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---s~~~vl~~l 260 (311)
.|.. . ...+ .....+..+.+++.+|+ .+|.+|+ |+.+++...
T Consensus 258 ~~~~--------~--~~~~-----~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~ 302 (376)
T cd05598 258 NWET--------T--LHIP-----SQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHP 302 (376)
T ss_pred ccCc--------c--ccCC-----CCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCC
Confidence 1100 0 0000 01123446777888876 5999999 899998764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=264.66 Aligned_cols=231 Identities=26% Similarity=0.400 Sum_probs=179.7
Q ss_pred EEEEEEeecCCC-cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHHHHH
Q 021490 11 DVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMK 89 (311)
Q Consensus 11 ~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~ 89 (311)
.+++|.+..... .....+..|+.++..++||||+++++++. +...++++||+++|+|.+++... ...+++..+..
T Consensus 38 ~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~i~e~~~~gsL~~~l~~~---~~~~~~~~~~~ 113 (279)
T cd05111 38 PVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQLVTQLSPLGSLLDHVRQH---RDSLDPQRLLN 113 (279)
T ss_pred EEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEEEEEeCCCCcHHHHHHhc---ccCCCHHHHHH
Confidence 578887754322 22356778888999999999999999875 45578999999999999999752 35689999999
Q ss_pred HHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccCCCcc
Q 021490 90 IAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTL 169 (311)
Q Consensus 90 ~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 169 (311)
++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++................++..|++||.+.+..++.
T Consensus 114 i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~ 190 (279)
T cd05111 114 WCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTH 190 (279)
T ss_pred HHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCc
Confidence 9999999999999999 9999999999999999999999999987543222222222334667899999998888999
Q ss_pred ccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCC
Q 021490 170 KSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPD 248 (311)
Q Consensus 170 ~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~ 248 (311)
++||||||+++|+|++ |..||............... . ....+ ......+.+++.+||..||+
T Consensus 191 ~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~-------~---~~~~~-------~~~~~~~~~li~~c~~~~p~ 253 (279)
T cd05111 191 QSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKG-------E---RLAQP-------QICTIDVYMVMVKCWMIDEN 253 (279)
T ss_pred hhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC-------C---cCCCC-------CCCCHHHHHHHHHHcCCCcc
Confidence 9999999999999998 99999766543322222110 0 00011 11223677899999999999
Q ss_pred CCCCHHHHHHHHHHhhh
Q 021490 249 MRPVIADVVTALAYLAS 265 (311)
Q Consensus 249 ~Rps~~~vl~~l~~~~~ 265 (311)
+|||+.++++.|..+..
T Consensus 254 ~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 254 VRPTFKELANEFTRMAR 270 (279)
T ss_pred cCcCHHHHHHHHHHHHh
Confidence 99999999999987764
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=274.56 Aligned_cols=238 Identities=29% Similarity=0.439 Sum_probs=182.8
Q ss_pred CcEEEEEEeecCCC-cchhHHHHHHHHHhcC-CCCcccceeeEeee-CCeeEEEEecCCCCChhhhhcccCCC-------
Q 021490 9 LQDVAIKQLDRNGV-QGNREFLVEVLMLSLL-HHPNLVNLIGYCAD-GDQRLLVYEYMPLGSVEDHLHDLSPG------- 78 (311)
Q Consensus 9 g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~------- 78 (311)
++.||+|+++.... ...+.+.+|+.++..+ +|+||+++++++.. +...+++|||+++++|.+++......
T Consensus 37 ~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~ 116 (337)
T cd05054 37 CRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNK 116 (337)
T ss_pred cceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccc
Confidence 57899999865432 2345788899999999 89999999998764 45688999999999999988642110
Q ss_pred --------------------------------------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 021490 79 --------------------------------------------------KKPLDWNTRMKIAAGAARGLEYLHDKAKPP 108 (311)
Q Consensus 79 --------------------------------------------------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~ 108 (311)
...+++..+..++.|++.||+|||+.+
T Consensus 117 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--- 193 (337)
T cd05054 117 STRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRK--- 193 (337)
T ss_pred cccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 136889999999999999999999999
Q ss_pred eEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccCCCccccceeehhHHHHHHHh-CC
Q 021490 109 VIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GR 187 (311)
Q Consensus 109 i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~l~~~ll~-g~ 187 (311)
++||||||+||+++.++.++|+|||++................++..|+|||++.+..++.++|||||||++|+|++ |.
T Consensus 194 ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~ 273 (337)
T cd05054 194 CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGA 273 (337)
T ss_pred eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCC
Confidence 99999999999999999999999999875422221111222345678999999999999999999999999999998 99
Q ss_pred CccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhh
Q 021490 188 KAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLAS 265 (311)
Q Consensus 188 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l~~~~~ 265 (311)
.||......... . ..+...... ..+......+.+++.+||+.+|++|||+.++++.|+.+.+
T Consensus 274 ~p~~~~~~~~~~--~----~~~~~~~~~----------~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 274 SPYPGVQIDEEF--C----RRLKEGTRM----------RAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred CCCCCCCccHHH--H----HHHhccCCC----------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 999754322110 0 011111000 1122234578899999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=262.37 Aligned_cols=226 Identities=27% Similarity=0.377 Sum_probs=179.3
Q ss_pred CCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEee-eCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHH
Q 021490 8 LLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA-DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNT 86 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~ 86 (311)
.|..||+|.++.. ...+.|.+|+.+++.++|+|++++++++. .+...++||||+++++|.+++.... ...+++..
T Consensus 28 ~~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~ 103 (256)
T cd05082 28 RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG--RSVLGGDC 103 (256)
T ss_pred cCCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHHHHHHhcC--CCCCCHHH
Confidence 4778999988543 23567899999999999999999999764 5567899999999999999987622 34588999
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccCC
Q 021490 87 RMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ 166 (311)
Q Consensus 87 ~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 166 (311)
++.++.|++.||+|||+++ ++|+||+|+||+++.++.++|+|||++....... .....+..|+|||++....
T Consensus 104 ~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~ 175 (256)
T cd05082 104 LLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREKK 175 (256)
T ss_pred HHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC-----CCCccceeecCHHHHccCC
Confidence 9999999999999999999 9999999999999999999999999886432211 1122456799999998888
Q ss_pred CccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHcccc
Q 021490 167 LTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHE 245 (311)
Q Consensus 167 ~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 245 (311)
++.++|||||||++|+|++ |..||...........+ .... .+ ..+...+..+.+++.+||+.
T Consensus 176 ~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~-------~~~~------~~----~~~~~~~~~~~~li~~~l~~ 238 (256)
T cd05082 176 FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV-------EKGY------KM----DAPDGCPPVVYDVMKQCWHL 238 (256)
T ss_pred CCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-------hcCC------CC----CCCCCCCHHHHHHHHHHhcC
Confidence 9999999999999999998 99998765432221111 0000 01 11223345788999999999
Q ss_pred CCCCCCCHHHHHHHHHH
Q 021490 246 QPDMRPVIADVVTALAY 262 (311)
Q Consensus 246 ~p~~Rps~~~vl~~l~~ 262 (311)
+|++|||+.++++.|+.
T Consensus 239 ~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 239 DAATRPSFLQLREQLEH 255 (256)
T ss_pred ChhhCcCHHHHHHHHhc
Confidence 99999999999999874
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=261.71 Aligned_cols=247 Identities=27% Similarity=0.352 Sum_probs=200.1
Q ss_pred Ccchhcc----CCcEEEEEEeecCCCcchhH---HHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhc
Q 021490 1 MMQVILC----LLQDVAIKQLDRNGVQGNRE---FLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLH 73 (311)
Q Consensus 1 ~~~~~~~----~g~~vaiK~~~~~~~~~~~~---~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 73 (311)
|++|+|+ .|+-+|||++++...-..++ -..|-++|...+||++..+...|+.++++|+||||..||.|..+|.
T Consensus 181 FGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyanGGeLf~HLs 260 (516)
T KOG0690|consen 181 FGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYANGGELFFHLS 260 (516)
T ss_pred cceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEccCceEeeehh
Confidence 3566666 68999999998876544443 3458999999999999999999999999999999999999999998
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeecccc
Q 021490 74 DLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT 153 (311)
Q Consensus 74 ~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~ 153 (311)
. ...+++.....+-..|++||.|||+++ ||+||||.+|.|++.+|.+||+|||++... ...........||
T Consensus 261 r----er~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~--I~~g~t~kTFCGT 331 (516)
T KOG0690|consen 261 R----ERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEE--IKYGDTTKTFCGT 331 (516)
T ss_pred h----hhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhc--ccccceeccccCC
Confidence 7 678999999999999999999999999 999999999999999999999999999752 2222334456799
Q ss_pred ccccCccccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHH
Q 021490 154 YGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFY 233 (311)
Q Consensus 154 ~~y~aPE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
+.|+|||++....|+.++|+|.+|+++|||++|+.||...+......++... + -.+|...+.
T Consensus 332 PEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~e--------------d----~kFPr~ls~ 393 (516)
T KOG0690|consen 332 PEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILME--------------D----LKFPRTLSP 393 (516)
T ss_pred hhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhh--------------h----ccCCccCCH
Confidence 9999999999999999999999999999999999999877655443333211 1 134555566
Q ss_pred HHHHHHHHccccCCCCCC-----CHHHHHHHHHHhhhccCCcccccc
Q 021490 234 QALAVAAMCVHEQPDMRP-----VIADVVTALAYLASQKYESDAEKV 275 (311)
Q Consensus 234 ~l~~li~~~l~~~p~~Rp-----s~~~vl~~l~~~~~~~~~~~~~~~ 275 (311)
+...|+...|..||++|. .+.||.+. .+++...++..-.+-
T Consensus 394 eAktLLsGLL~kdP~kRLGgGpdDakEi~~h-~FF~~v~W~~~~~Kk 439 (516)
T KOG0690|consen 394 EAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH-RFFASVDWEATYRKK 439 (516)
T ss_pred HHHHHHHHHhhcChHhhcCCCchhHHHHHhh-hhhccCCHHHHHHhc
Confidence 888899999999999993 44555443 566666554444333
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=273.65 Aligned_cols=219 Identities=27% Similarity=0.342 Sum_probs=176.4
Q ss_pred CCcEEEEEEeecCCC---cchhHHHHHHHHHhcC-CCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCC
Q 021490 8 LLQDVAIKQLDRNGV---QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLD 83 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~ 83 (311)
+++.||+|+++.... .....+..|..++..+ .|++|+.+++++.+....++||||+++|+|.+++.. ...++
T Consensus 24 ~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~----~~~~~ 99 (323)
T cd05616 24 TDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQ----VGRFK 99 (323)
T ss_pred CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCCCCCHHHHHHH----cCCCC
Confidence 578999999976432 2234567788888877 578999999999999999999999999999999876 56799
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccc
Q 021490 84 WNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 163 (311)
Q Consensus 84 ~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 163 (311)
+..+..++.|++.||+|||+.+ ++||||||+|||++.++.++|+|||++....... .......|+..|+|||++.
T Consensus 100 ~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~ 174 (323)
T cd05616 100 EPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG--VTTKTFCGTPDYIAPEIIA 174 (323)
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCCC--CccccCCCChhhcCHHHhc
Confidence 9999999999999999999999 9999999999999999999999999986422111 1122345889999999999
Q ss_pred cCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHcc
Q 021490 164 TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCV 243 (311)
Q Consensus 164 ~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 243 (311)
+..++.++|||||||++|+|++|..||...........+. ... ..++...+.++.+++.+||
T Consensus 175 ~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~------~~~------------~~~p~~~s~~~~~li~~~l 236 (323)
T cd05616 175 YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM------EHN------------VAYPKSMSKEAVAICKGLM 236 (323)
T ss_pred CCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHH------hCC------------CCCCCcCCHHHHHHHHHHc
Confidence 9999999999999999999999999998765433222111 100 0122334457889999999
Q ss_pred ccCCCCCCCH
Q 021490 244 HEQPDMRPVI 253 (311)
Q Consensus 244 ~~~p~~Rps~ 253 (311)
+.||.+|++.
T Consensus 237 ~~~p~~R~~~ 246 (323)
T cd05616 237 TKHPGKRLGC 246 (323)
T ss_pred ccCHHhcCCC
Confidence 9999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=268.03 Aligned_cols=230 Identities=24% Similarity=0.339 Sum_probs=186.6
Q ss_pred cCCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHH
Q 021490 7 CLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNT 86 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~ 86 (311)
.+|+.|++|.+........+.+.+|+.+++.++||||+++++++..+...++|+||+++++|.+++.. ..+++..
T Consensus 42 ~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~l~~~~ 116 (296)
T cd06655 42 ATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTE-----TCMDEAQ 116 (296)
T ss_pred CCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCcHHHHHHh-----cCCCHHH
Confidence 57899999999766655667889999999999999999999999999999999999999999998864 4689999
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccCC
Q 021490 87 RMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ 166 (311)
Q Consensus 87 ~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 166 (311)
+..++.+++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++....... .......++..|+|||.+.+..
T Consensus 117 ~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~ 191 (296)
T cd06655 117 IAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ--SKRSTMVGTPYWMAPEVVTRKA 191 (296)
T ss_pred HHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccccc--ccCCCcCCCccccCcchhcCCC
Confidence 9999999999999999999 9999999999999999999999999876432221 1112235778999999998888
Q ss_pred CccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccC
Q 021490 167 LTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQ 246 (311)
Q Consensus 167 ~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 246 (311)
++.++|+|||||++|+|++|..||...+......... ... . .. ...+...+..+.+++.+||..|
T Consensus 192 ~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~------~~~-~-~~-------~~~~~~~~~~~~~li~~~l~~d 256 (296)
T cd06655 192 YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA------TNG-T-PE-------LQNPEKLSPIFRDFLNRCLEMD 256 (296)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH------hcC-C-cc-------cCCcccCCHHHHHHHHHHhhcC
Confidence 9999999999999999999999997765433221110 000 0 00 0111223347888999999999
Q ss_pred CCCCCCHHHHHHHHH
Q 021490 247 PDMRPVIADVVTALA 261 (311)
Q Consensus 247 p~~Rps~~~vl~~l~ 261 (311)
|.+|||+.+++..-.
T Consensus 257 p~~Rpt~~~il~~~~ 271 (296)
T cd06655 257 VEKRGSAKELLQHPF 271 (296)
T ss_pred hhhCCCHHHHhhChH
Confidence 999999999997644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=265.36 Aligned_cols=233 Identities=28% Similarity=0.400 Sum_probs=183.2
Q ss_pred CcEEEEEEeecCCC-cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCC---CCCCCCH
Q 021490 9 LQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP---GKKPLDW 84 (311)
Q Consensus 9 g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~l~~ 84 (311)
++.+|+|.+..... .....+.+|+.+++.++||||+++++++......++||||+++++|.+++..... ....+++
T Consensus 26 ~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 105 (269)
T cd05044 26 PIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTL 105 (269)
T ss_pred ceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccH
Confidence 36799998855432 3456889999999999999999999999998999999999999999999875321 1245889
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCC-----ceEEccccccccCCCCCCceeeeeccccccccCc
Q 021490 85 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY-----HPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 159 (311)
Q Consensus 85 ~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~-----~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aP 159 (311)
..+..++.|++.||+|||+.+ ++|+||+|+||+++.++ .++++|||++................++..|+||
T Consensus 106 ~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 182 (269)
T cd05044 106 KELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAP 182 (269)
T ss_pred HHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCH
Confidence 999999999999999999999 99999999999999877 8999999998643222211112223456789999
Q ss_pred cccccCCCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHH
Q 021490 160 EYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAV 238 (311)
Q Consensus 160 E~~~~~~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 238 (311)
|.+.+..++.++||||||+++|+|++ |..||...........+. ... ....+...+..+.++
T Consensus 183 E~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~-------~~~----------~~~~~~~~~~~~~~l 245 (269)
T cd05044 183 ESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVT-------AGG----------RLQKPENCPDKIYQL 245 (269)
T ss_pred HHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHh-------cCC----------ccCCcccchHHHHHH
Confidence 99998899999999999999999998 999997654432221110 000 001122334578899
Q ss_pred HHHccccCCCCCCCHHHHHHHHH
Q 021490 239 AAMCVHEQPDMRPVIADVVTALA 261 (311)
Q Consensus 239 i~~~l~~~p~~Rps~~~vl~~l~ 261 (311)
+.+||..+|.+|||+.++++.|+
T Consensus 246 i~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 246 MTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred HHHHcCCCcccCCCHHHHHHHHh
Confidence 99999999999999999999885
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=264.60 Aligned_cols=233 Identities=26% Similarity=0.407 Sum_probs=182.9
Q ss_pred EEEEEEeecCCC-cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHHHHH
Q 021490 11 DVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMK 89 (311)
Q Consensus 11 ~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~ 89 (311)
+||+|+++.... .....+.+|+.++..+.||||+++++++.. ...+++++|+++|+|.+++... ...+++..++.
T Consensus 38 ~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l~~~~~~~g~l~~~l~~~---~~~~~~~~~~~ 113 (279)
T cd05109 38 PVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQLVTQLMPYGCLLDYVREN---KDRIGSQDLLN 113 (279)
T ss_pred EEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEEEEEcCCCCCHHHHHhhc---cCCCCHHHHHH
Confidence 589999865433 334678899999999999999999999875 4578999999999999998752 35689999999
Q ss_pred HHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccCCCcc
Q 021490 90 IAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTL 169 (311)
Q Consensus 90 ~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 169 (311)
++.|++.||+|||+++ ++|+||||+||++++++.++|+|||++................++..|+|||...+..++.
T Consensus 114 ~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~ 190 (279)
T cd05109 114 WCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTH 190 (279)
T ss_pred HHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCc
Confidence 9999999999999999 9999999999999999999999999987543222211122223467899999998888999
Q ss_pred ccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCC
Q 021490 170 KSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPD 248 (311)
Q Consensus 170 ~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~ 248 (311)
++|||||||++|||++ |..||...........+... ... ..+...+..+.+++.+||..||+
T Consensus 191 ~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-------~~~----------~~~~~~~~~~~~li~~~l~~dp~ 253 (279)
T cd05109 191 QSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKG-------ERL----------PQPPICTIDVYMIMVKCWMIDSE 253 (279)
T ss_pred hhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC-------CcC----------CCCccCCHHHHHHHHHHcCCChh
Confidence 9999999999999998 89999765543322211110 000 01122344788899999999999
Q ss_pred CCCCHHHHHHHHHHhhhcc
Q 021490 249 MRPVIADVVTALAYLASQK 267 (311)
Q Consensus 249 ~Rps~~~vl~~l~~~~~~~ 267 (311)
+||++.+++..|+.+....
T Consensus 254 ~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 254 CRPRFRELVDEFSRMARDP 272 (279)
T ss_pred hCcCHHHHHHHHHHhhcCC
Confidence 9999999999998776443
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=262.96 Aligned_cols=238 Identities=26% Similarity=0.331 Sum_probs=178.0
Q ss_pred CCcEEEEEEeecCCC-cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCC-CCCCCCHH
Q 021490 8 LLQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP-GKKPLDWN 85 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~l~~~ 85 (311)
.+..+|+|.++.... .....+.+|+.+++.++||||+++++++.+....++||||+++++|.+++..... ....+++.
T Consensus 21 ~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 100 (269)
T cd05087 21 TPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPT 100 (269)
T ss_pred CceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCcHHHHHHHhhhcccccccHH
Confidence 346799998865543 2335788999999999999999999999988899999999999999999875321 12356677
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccC
Q 021490 86 TRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG 165 (311)
Q Consensus 86 ~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 165 (311)
.+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||.+................++..|+|||++...
T Consensus 101 ~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 177 (269)
T cd05087 101 TLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEV 177 (269)
T ss_pred HHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhccc
Confidence 88899999999999999999 999999999999999999999999998643222111112223467789999988642
Q ss_pred -------CCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHH
Q 021490 166 -------QLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALA 237 (311)
Q Consensus 166 -------~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 237 (311)
.++.++|+||||+++|+|++ |..||............. . .......++.+.. .....+.+
T Consensus 178 ~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~-----~---~~~~~~~~~~~~~----~~~~~~~~ 245 (269)
T cd05087 178 HGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTV-----R---EQQLKLPKPRLKL----PLSDRWYE 245 (269)
T ss_pred cccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHh-----h---cccCCCCCCccCC----CCChHHHH
Confidence 35789999999999999996 999997655433221110 0 0111111222211 22336777
Q ss_pred HHHHccccCCCCCCCHHHHHHHHH
Q 021490 238 VAAMCVHEQPDMRPVIADVVTALA 261 (311)
Q Consensus 238 li~~~l~~~p~~Rps~~~vl~~l~ 261 (311)
++..|| .+|.+|||+.+|++.|+
T Consensus 246 l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 246 VMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred HHHHHh-cCcccCCCHHHHHHHhc
Confidence 999999 68999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=267.67 Aligned_cols=234 Identities=29% Similarity=0.411 Sum_probs=181.6
Q ss_pred EEEEEEeecCC-CcchhHHHHHHHHHhcC-CCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCC-----------
Q 021490 11 DVAIKQLDRNG-VQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP----------- 77 (311)
Q Consensus 11 ~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----------- 77 (311)
.+++|.++... ....+.|.+|+.++.++ +||||+++++++......++|+||+++++|.+++.....
T Consensus 31 ~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 110 (297)
T cd05089 31 NAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEH 110 (297)
T ss_pred eeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEecCCCcHHHHHHhcccccccccccccc
Confidence 57888876432 23346789999999999 799999999999998899999999999999999865221
Q ss_pred -CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccc
Q 021490 78 -GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY 156 (311)
Q Consensus 78 -~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y 156 (311)
....+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++...... ........+..|
T Consensus 111 ~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y 184 (297)
T cd05089 111 GTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLASKIADFGLSRGEEVY---VKKTMGRLPVRW 184 (297)
T ss_pred CccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeEEECCcCCCccccce---eccCCCCcCccc
Confidence 1235889999999999999999999999 999999999999999999999999987532111 011111234579
Q ss_pred cCccccccCCCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHH
Q 021490 157 CAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQA 235 (311)
Q Consensus 157 ~aPE~~~~~~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 235 (311)
+|||++.+..++.++|||||||++|+|++ |..||............ ... .....+...+..+
T Consensus 185 ~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~------~~~-----------~~~~~~~~~~~~~ 247 (297)
T cd05089 185 MAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKL------PQG-----------YRMEKPRNCDDEV 247 (297)
T ss_pred cCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH------hcC-----------CCCCCCCCCCHHH
Confidence 99999988889999999999999999997 99999765443221111 000 0001122234578
Q ss_pred HHHHHHccccCCCCCCCHHHHHHHHHHhhhcc
Q 021490 236 LAVAAMCVHEQPDMRPVIADVVTALAYLASQK 267 (311)
Q Consensus 236 ~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~~ 267 (311)
.+|+.+||..+|.+|||++++++.|..+....
T Consensus 248 ~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 248 YELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred HHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 89999999999999999999999998777544
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=267.06 Aligned_cols=234 Identities=28% Similarity=0.427 Sum_probs=182.8
Q ss_pred CCcEEEEEEeecCCC-cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCC---------
Q 021490 8 LLQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP--------- 77 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------- 77 (311)
++..||+|++..... .....+.+|+.+++.++||||+++++++.++...++||||+++++|.+++.....
T Consensus 34 ~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 113 (288)
T cd05050 34 PFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHS 113 (288)
T ss_pred cceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEEecCCCCCHHHHHHHcCcccccccccc
Confidence 568899999865433 3346788999999999999999999999999999999999999999999875321
Q ss_pred ---------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeee
Q 021490 78 ---------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST 148 (311)
Q Consensus 78 ---------~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~ 148 (311)
....+++..++.++.|++.||+|||+.+ ++|+||+|.||+++.++.++|+|||++.............
T Consensus 114 ~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 190 (288)
T cd05050 114 TSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASE 190 (288)
T ss_pred ccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhheEecCCCceEECccccceecccCccccccC
Confidence 1235788999999999999999999999 9999999999999999999999999886432221111122
Q ss_pred eccccccccCccccccCCCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCC
Q 021490 149 RVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQY 227 (311)
Q Consensus 149 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (311)
....+..|+|||.+.+..++.++|||||||++|+|++ |..||...........+. .... ...
T Consensus 191 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~~~~~-------~~~~----------~~~ 253 (288)
T cd05050 191 NDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVR-------DGNV----------LSC 253 (288)
T ss_pred CCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-------cCCC----------CCC
Confidence 2234567999999988889999999999999999998 888886554332211111 0000 011
Q ss_pred ChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 021490 228 PPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 261 (311)
Q Consensus 228 ~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l~ 261 (311)
+...+..+.+++.+||+.+|.+|||+.|+++.|+
T Consensus 254 ~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 254 PDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 1223457889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=284.36 Aligned_cols=244 Identities=21% Similarity=0.245 Sum_probs=177.4
Q ss_pred cCCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeC--------CeeEEEEecCCCCChhhhhcccCCC
Q 021490 7 CLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADG--------DQRLLVYEYMPLGSVEDHLHDLSPG 78 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~~~~ 78 (311)
.+|+.||||++.... ....+|+.+++.++||||+++++++... ..+++||||++ ++|.+++......
T Consensus 89 ~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~-~~l~~~~~~~~~~ 163 (440)
T PTZ00036 89 DTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIP-QTVHKYMKHYARN 163 (440)
T ss_pred CCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEEEecCC-ccHHHHHHHHhhc
Confidence 368899999885432 2345799999999999999999886432 24679999997 5787777654334
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCC-ceEEccccccccCCCCCCceeeeecccccccc
Q 021490 79 KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY-HPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 157 (311)
Q Consensus 79 ~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~ 157 (311)
...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++ .+||+|||++....... ......++..|+
T Consensus 164 ~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~---~~~~~~~t~~y~ 237 (440)
T PTZ00036 164 NHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQ---RSVSYICSRFYR 237 (440)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeeccccchhccCCC---CcccCCCCcCcc
Confidence 577999999999999999999999999 99999999999998664 79999999997532221 112345788999
Q ss_pred Ccccccc-CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHh-hhhh----ccc------cccccccCccccC
Q 021490 158 APEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWA-RPLF----QDR------TRHSLIADPELQG 225 (311)
Q Consensus 158 aPE~~~~-~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~-~~~~----~~~------~~~~~~~~~~~~~ 225 (311)
|||++.+ ..++.++|||||||++|+|++|.+||...........+... .... ... ..........+..
T Consensus 238 aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~ 317 (440)
T PTZ00036 238 APELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKK 317 (440)
T ss_pred CHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHH
Confidence 9998865 46899999999999999999999999876543332211110 0000 000 0000001111222
Q ss_pred CCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 021490 226 QYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 261 (311)
Q Consensus 226 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l~ 261 (311)
.++...+.++.+|+.+||++||.+|||+.|+++.-.
T Consensus 318 ~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~ 353 (440)
T PTZ00036 318 VFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPF 353 (440)
T ss_pred HhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChh
Confidence 233344568899999999999999999999997754
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=274.90 Aligned_cols=230 Identities=22% Similarity=0.232 Sum_probs=180.6
Q ss_pred CCcEEEEEEeecCC---CcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCH
Q 021490 8 LLQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 84 (311)
Q Consensus 8 ~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~ 84 (311)
+|..||+|+++... ......+.+|+.+++.++||||+++++++.++...++||||++||+|.+++.. ..+++
T Consensus 67 ~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~-----~~l~~ 141 (370)
T cd05596 67 SKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSN-----YDIPE 141 (370)
T ss_pred CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcCCCCCcHHHHHHh-----cCCCH
Confidence 68899999996532 12334677899999999999999999999999999999999999999999875 45889
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccccc
Q 021490 85 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT 164 (311)
Q Consensus 85 ~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 164 (311)
..+..++.|++.||+|||+.+ ++||||||+|||++.++.++|+|||++....... ........|++.|+|||++.+
T Consensus 142 ~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~ 217 (370)
T cd05596 142 KWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG-MVRCDTAVGTPDYISPEVLKS 217 (370)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeeccCCC-cccCCCCCCCcCeECHHHhcc
Confidence 999999999999999999999 9999999999999999999999999986532211 111223458999999998865
Q ss_pred C----CCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHH
Q 021490 165 G----QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAA 240 (311)
Q Consensus 165 ~----~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 240 (311)
. .++.++|||||||++|+|++|..||...........+ ...... ...+ .....+..+.+++.
T Consensus 218 ~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i------~~~~~~---~~~~-----~~~~~s~~~~~li~ 283 (370)
T cd05596 218 QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI------MDHKNS---LTFP-----DDIEISKQAKDLIC 283 (370)
T ss_pred CCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHH------HcCCCc---CCCC-----CcCCCCHHHHHHHH
Confidence 3 4788999999999999999999999865543221111 110000 0000 01123458889999
Q ss_pred HccccCCCC--CCCHHHHHHHH
Q 021490 241 MCVHEQPDM--RPVIADVVTAL 260 (311)
Q Consensus 241 ~~l~~~p~~--Rps~~~vl~~l 260 (311)
+||+.+|.+ |+|+.+++...
T Consensus 284 ~~L~~~p~r~~R~s~~ell~h~ 305 (370)
T cd05596 284 AFLTDREVRLGRNGVDEIKSHP 305 (370)
T ss_pred HHccChhhccCCCCHHHHhcCc
Confidence 999999987 99999998774
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=262.92 Aligned_cols=231 Identities=23% Similarity=0.302 Sum_probs=181.6
Q ss_pred cCCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHH
Q 021490 7 CLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNT 86 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~ 86 (311)
.+++.||+|+++.........+.+|+.+++.++||||+++++.+......++||||+++++|.+++.. .+.+++..
T Consensus 32 ~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~ 107 (267)
T cd06645 32 NTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHV----TGPLSESQ 107 (267)
T ss_pred CCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcHHHHHHh----cCCCCHHH
Confidence 36899999998766555556788999999999999999999999999999999999999999999876 56799999
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccc---
Q 021490 87 RMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK--- 163 (311)
Q Consensus 87 ~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--- 163 (311)
+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++...... ........++..|+|||++.
T Consensus 108 ~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~ 182 (267)
T cd06645 108 IAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITAT--IAKRKSFIGTPYWMAPEVAAVER 182 (267)
T ss_pred HHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCc--ccccccccCcccccChhhhcccc
Confidence 9999999999999999999 999999999999999999999999998643221 11122345788999999874
Q ss_pred cCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHcc
Q 021490 164 TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCV 243 (311)
Q Consensus 164 ~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 243 (311)
...++.++|+|||||++|+|++|..||............. ..... .+.... ....+..+.+++.+||
T Consensus 183 ~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~------~~~~~-----~~~~~~--~~~~~~~~~~li~~~l 249 (267)
T cd06645 183 KGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMT------KSNFQ-----PPKLKD--KMKWSNSFHHFVKMAL 249 (267)
T ss_pred CCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhh------ccCCC-----CCcccc--cCCCCHHHHHHHHHHc
Confidence 4567889999999999999999999986543222111000 00000 000000 0112346788999999
Q ss_pred ccCCCCCCCHHHHHHH
Q 021490 244 HEQPDMRPVIADVVTA 259 (311)
Q Consensus 244 ~~~p~~Rps~~~vl~~ 259 (311)
+.+|++|||+.++++.
T Consensus 250 ~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 250 TKNPKKRPTAEKLLQH 265 (267)
T ss_pred cCCchhCcCHHHHhcC
Confidence 9999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=261.07 Aligned_cols=234 Identities=25% Similarity=0.396 Sum_probs=184.5
Q ss_pred cchhccCCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCC
Q 021490 2 MQVILCLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKP 81 (311)
Q Consensus 2 ~~~~~~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 81 (311)
|.+...++..+|+|.+... ......|.+|+++++.++|||++++++++......++||||+++++|.+++... ...
T Consensus 21 ~~~~~~~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~---~~~ 96 (256)
T cd05112 21 WLGYWLEKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQ---RGK 96 (256)
T ss_pred EEEEEeCCCeEEEEECCCC-CCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHHHHHHhC---ccC
Confidence 4444556889999998543 334568999999999999999999999999999999999999999999998752 346
Q ss_pred CCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccc
Q 021490 82 LDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 161 (311)
Q Consensus 82 l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 161 (311)
+++..++.++.+++.+|++||+.+ ++|+||+|.||+++.++.++|+|||.+....... .........+..|+|||.
T Consensus 97 ~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~~~~aPe~ 172 (256)
T cd05112 97 FSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWSSPEV 172 (256)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCc-ccccCCCccchhhcCHhH
Confidence 889999999999999999999999 9999999999999999999999999886432211 111112234568999999
Q ss_pred cccCCCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHH
Q 021490 162 AKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAA 240 (311)
Q Consensus 162 ~~~~~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 240 (311)
+.+..++.++|+||||+++|+|++ |..||............. ... .. ..+...+..+.+|+.
T Consensus 173 ~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-------~~~---~~-------~~~~~~~~~~~~l~~ 235 (256)
T cd05112 173 FSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETIN-------AGF---RL-------YKPRLASQSVYELMQ 235 (256)
T ss_pred hccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHh-------CCC---CC-------CCCCCCCHHHHHHHH
Confidence 988889999999999999999998 999997654332211110 000 00 011123457889999
Q ss_pred HccccCCCCCCCHHHHHHHH
Q 021490 241 MCVHEQPDMRPVIADVVTAL 260 (311)
Q Consensus 241 ~~l~~~p~~Rps~~~vl~~l 260 (311)
+||..+|++|||+.++++.|
T Consensus 236 ~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 236 HCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred HHcccChhhCCCHHHHHHhh
Confidence 99999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=249.86 Aligned_cols=229 Identities=26% Similarity=0.333 Sum_probs=192.9
Q ss_pred cCCcEEEEEEeecCCC---cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCC
Q 021490 7 CLLQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLD 83 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~ 83 (311)
+++--||+|++.+... ...+++.+|+++-..|+||||+++|++|-++...||++||...|+|...|+... ...++
T Consensus 45 ks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya~~gel~k~L~~~~--~~~f~ 122 (281)
T KOG0580|consen 45 KSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYAPRGELYKDLQEGR--MKRFD 122 (281)
T ss_pred cCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEecCCchHHHHHHhcc--ccccc
Confidence 3788999999866432 334689999999999999999999999999999999999999999999998532 67799
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccc
Q 021490 84 WNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 163 (311)
Q Consensus 84 ~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 163 (311)
+.....+..|+|.|+.|+|.++ ++||||||+|+|++..|.+|++|||-+...+ ........||..|++||...
T Consensus 123 e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p----~~kR~tlcgt~dyl~pEmv~ 195 (281)
T KOG0580|consen 123 EQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP----SNKRKTLCGTLDYLPPEMVE 195 (281)
T ss_pred ccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC----CCCceeeecccccCCHhhcC
Confidence 9999999999999999999999 9999999999999999999999999886422 23344467999999999999
Q ss_pred cCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHcc
Q 021490 164 TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCV 243 (311)
Q Consensus 164 ~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 243 (311)
+...+..+|+|++|++.||++.|.+||......+....+.... -.+|...+....++|.+|+
T Consensus 196 ~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~------------------~~~p~~is~~a~dlI~~ll 257 (281)
T KOG0580|consen 196 GRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVD------------------LKFPSTISGGAADLISRLL 257 (281)
T ss_pred CCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHcc------------------ccCCcccChhHHHHHHHHh
Confidence 9999999999999999999999999998765433333222211 1223445558889999999
Q ss_pred ccCCCCCCCHHHHHHHHHH
Q 021490 244 HEQPDMRPVIADVVTALAY 262 (311)
Q Consensus 244 ~~~p~~Rps~~~vl~~l~~ 262 (311)
..+|.+|.+..|++...+-
T Consensus 258 ~~~p~~r~~l~~v~~hpwI 276 (281)
T KOG0580|consen 258 VKNPIERLALTEVMDHPWI 276 (281)
T ss_pred ccCccccccHHHHhhhHHH
Confidence 9999999999999987653
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=262.41 Aligned_cols=230 Identities=27% Similarity=0.384 Sum_probs=181.3
Q ss_pred EEEEEEeecCC-CcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHHHHH
Q 021490 11 DVAIKQLDRNG-VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMK 89 (311)
Q Consensus 11 ~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~ 89 (311)
.+|+|.++... ....+.+.+|+++++.++||||+++++++.+....++||||+++++|.+++... ...+++..+..
T Consensus 35 ~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~ 111 (268)
T cd05063 35 AVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDH---DGEFSSYQLVG 111 (268)
T ss_pred EEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcCCCCCHHHHHHhc---CCCCCHHHHHH
Confidence 79999986543 233467889999999999999999999999999999999999999999998752 35689999999
Q ss_pred HHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceee-eeccccccccCccccccCCCc
Q 021490 90 IAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVS-TRVMGTYGYCAPEYAKTGQLT 168 (311)
Q Consensus 90 ~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~ 168 (311)
++.+++.||+|||+.+ ++|+||+|+||+++.++.++++|||++............ .....+..|+|||++....++
T Consensus 112 ~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~ 188 (268)
T cd05063 112 MLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFT 188 (268)
T ss_pred HHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcC
Confidence 9999999999999999 999999999999999999999999998653322111111 111234579999999888889
Q ss_pred cccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCC
Q 021490 169 LKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQP 247 (311)
Q Consensus 169 ~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p 247 (311)
.++||||||+++|+|++ |..||...........+. .... .+ .+...+..+.+++.+||+.+|
T Consensus 189 ~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~-------~~~~-----~~-----~~~~~~~~~~~li~~c~~~~p 251 (268)
T cd05063 189 SASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIN-------DGFR-----LP-----APMDCPSAVYQLMLQCWQQDR 251 (268)
T ss_pred hHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHh-------cCCC-----CC-----CCCCCCHHHHHHHHHHcCCCc
Confidence 99999999999999997 999997654332211111 0000 00 011223477899999999999
Q ss_pred CCCCCHHHHHHHHHHh
Q 021490 248 DMRPVIADVVTALAYL 263 (311)
Q Consensus 248 ~~Rps~~~vl~~l~~~ 263 (311)
++||++.++++.|+.+
T Consensus 252 ~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 252 ARRPRFVDIVNLLDKL 267 (268)
T ss_pred ccCcCHHHHHHHHHhh
Confidence 9999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=267.60 Aligned_cols=234 Identities=30% Similarity=0.431 Sum_probs=180.7
Q ss_pred EEEEEEeecCC-CcchhHHHHHHHHHhcC-CCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccC------------
Q 021490 11 DVAIKQLDRNG-VQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLS------------ 76 (311)
Q Consensus 11 ~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------ 76 (311)
.+++|.++... ......+.+|+.++.++ +|+||+++++++.++...++||||+++++|.+++....
T Consensus 36 ~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 115 (303)
T cd05088 36 DAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 115 (303)
T ss_pred eEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccc
Confidence 45777765432 23345788999999999 89999999999999999999999999999999986532
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccc
Q 021490 77 PGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY 156 (311)
Q Consensus 77 ~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y 156 (311)
.....+++..++.++.|++.||+|||+.+ ++||||+|+||+++.++.++|+|||++...... ........+..|
T Consensus 116 ~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y 189 (303)
T cd05088 116 STASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVY---VKKTMGRLPVRW 189 (303)
T ss_pred cccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcEEeCccccCcccchh---hhcccCCCcccc
Confidence 11246889999999999999999999999 999999999999999999999999998531110 111112235679
Q ss_pred cCccccccCCCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHH
Q 021490 157 CAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQA 235 (311)
Q Consensus 157 ~aPE~~~~~~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 235 (311)
+|||.+.+..++.++||||||+++|+|++ |..||............ .... . ...+...+..+
T Consensus 190 ~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~-------~~~~------~----~~~~~~~~~~~ 252 (303)
T cd05088 190 MAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL-------PQGY------R----LEKPLNCDDEV 252 (303)
T ss_pred cCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHH-------hcCC------c----CCCCCCCCHHH
Confidence 99999988888999999999999999998 99999765443221111 0000 0 00111223468
Q ss_pred HHHHHHccccCCCCCCCHHHHHHHHHHhhhcc
Q 021490 236 LAVAAMCVHEQPDMRPVIADVVTALAYLASQK 267 (311)
Q Consensus 236 ~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~~ 267 (311)
.+|+.+||+.+|++|||+.++++.|..+....
T Consensus 253 ~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~ 284 (303)
T cd05088 253 YDLMRQCWREKPYERPSFAQILVSLNRMLEER 284 (303)
T ss_pred HHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 88999999999999999999999998766544
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=270.30 Aligned_cols=246 Identities=21% Similarity=0.290 Sum_probs=182.8
Q ss_pred CCcEEEEEEeecCCCc-chhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHH
Q 021490 8 LLQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNT 86 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~ 86 (311)
++..||+|.++..... ....+.+|+.+++.++||||+++++++..+...++||||++ ++|.+++... +..+++..
T Consensus 30 ~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~---~~~~~~~~ 105 (309)
T cd07872 30 TENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLD-KDLKQYMDDC---GNIMSMHN 105 (309)
T ss_pred CCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCC-CCHHHHHHhc---CCCCCHHH
Confidence 6788999998755432 33567889999999999999999999999999999999997 4888887652 35689999
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccccc-C
Q 021490 87 RMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT-G 165 (311)
Q Consensus 87 ~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~ 165 (311)
+..++.|++.||+|||+.+ ++||||+|+||+++.++.++|+|||++....... .......++..|+|||++.+ .
T Consensus 106 ~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~ 180 (309)
T cd07872 106 VKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPT--KTYSNEVVTLWYRPPDVLLGSS 180 (309)
T ss_pred HHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCc--cccccccccccccCCHHHhCCC
Confidence 9999999999999999999 9999999999999999999999999986422211 11222356889999998865 5
Q ss_pred CCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhh-h----hccccccccccC---cccc----CCCChHhHH
Q 021490 166 QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARP-L----FQDRTRHSLIAD---PELQ----GQYPPRGFY 233 (311)
Q Consensus 166 ~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~-~----~~~~~~~~~~~~---~~~~----~~~~~~~~~ 233 (311)
.++.++||||||+++|+|++|..||......+.......... . +..........+ +... ....+..+.
T Consensus 181 ~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (309)
T cd07872 181 EYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDT 260 (309)
T ss_pred CCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCH
Confidence 678999999999999999999999987665443322211100 0 000000000000 0000 001122345
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 021490 234 QALAVAAMCVHEQPDMRPVIADVVTALAY 262 (311)
Q Consensus 234 ~l~~li~~~l~~~p~~Rps~~~vl~~l~~ 262 (311)
.+.+++.+||+.||.+|||+.|+++....
T Consensus 261 ~~~~li~~~L~~dp~~R~t~~e~l~h~~~ 289 (309)
T cd07872 261 EGIELLTKFLQYESKKRISAEEAMKHAYF 289 (309)
T ss_pred HHHHHHHHhccCChhhCCCHHHHhcChhh
Confidence 78899999999999999999999986543
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=262.75 Aligned_cols=229 Identities=26% Similarity=0.382 Sum_probs=182.3
Q ss_pred cCCcEEEEEEeecCCCcc---------hhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCC
Q 021490 7 CLLQDVAIKQLDRNGVQG---------NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP 77 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~~---------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 77 (311)
.+++.||+|.+....... .+.+.+|+.+++.++||||+++++++.+....++||||+++++|.+++..
T Consensus 23 ~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--- 99 (267)
T cd06628 23 SSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNN--- 99 (267)
T ss_pred CCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEEEEEecCCCCHHHHHHh---
Confidence 367899999886544322 14678899999999999999999999999999999999999999999976
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCc----eeeeecccc
Q 021490 78 GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT----HVSTRVMGT 153 (311)
Q Consensus 78 ~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~----~~~~~~~~~ 153 (311)
.+.+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||.+......... .......++
T Consensus 100 -~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ 175 (267)
T cd06628 100 -YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGS 175 (267)
T ss_pred -ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCcccccccccCCccccccccCCC
Confidence 467899999999999999999999999 999999999999999999999999988754321111 111123467
Q ss_pred ccccCccccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHH
Q 021490 154 YGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFY 233 (311)
Q Consensus 154 ~~y~aPE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
..|+|||.+.+..++.++|+||||+++|+|++|..||.......... . . . . ...+ ..+...+.
T Consensus 176 ~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~--~-~---~-~------~~~~----~~~~~~~~ 238 (267)
T cd06628 176 VFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIF--K-I---G-E------NASP----EIPSNISS 238 (267)
T ss_pred cCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHH--H-H---h-c------cCCC----cCCcccCH
Confidence 88999999988888999999999999999999999997654322110 0 0 0 0 0011 12223345
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHH
Q 021490 234 QALAVAAMCVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 234 ~l~~li~~~l~~~p~~Rps~~~vl~~ 259 (311)
.+.+++.+||+.||.+||++.++++.
T Consensus 239 ~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 239 EAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred HHHHHHHHHccCCchhCcCHHHHhhC
Confidence 78899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=276.21 Aligned_cols=243 Identities=21% Similarity=0.219 Sum_probs=187.0
Q ss_pred cCCcEEEEEEeecCCCcchhHHHHHHHHHhcCC-C-----CcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCC
Q 021490 7 CLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLH-H-----PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKK 80 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h-----~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 80 (311)
+.|+.||||+++. ...-..+-..|+.+|..|+ | -|+|+++++|....+.|||+|.+ +.+|.++++... ..
T Consensus 209 ~T~e~VAIKIiKN-~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfELL-~~NLYellK~n~--f~ 284 (586)
T KOG0667|consen 209 KTGEIVAIKIIKN-KKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFELL-STNLYELLKNNK--FR 284 (586)
T ss_pred CCCcEEEEEeecc-ChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeeehhh-hhhHHHHHHhcC--CC
Confidence 3689999999954 3344566777999999997 3 37999999999999999999999 589999999844 56
Q ss_pred CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCC--CceEEccccccccCCCCCCceeeeeccccccccC
Q 021490 81 PLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG--YHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCA 158 (311)
Q Consensus 81 ~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~--~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~a 158 (311)
+|+...+..++.||+.||.+||+.+ |+|+||||+|||+.+. ..|||+|||.+........ ...-+..|.|
T Consensus 285 Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~vy-----tYiQSRfYRA 356 (586)
T KOG0667|consen 285 GLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQRVY-----TYIQSRFYRA 356 (586)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccccCCcce-----eeeecccccc
Confidence 7999999999999999999999999 9999999999999753 3699999999976433322 3345667999
Q ss_pred ccccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhh-----ccccccccccCc------------
Q 021490 159 PEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLF-----QDRTRHSLIADP------------ 221 (311)
Q Consensus 159 PE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~------------ 221 (311)
||++.+.+|+.+.||||||||+.||++|.+.|.+.+..+....+....... ....+...+.+.
T Consensus 357 PEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~ 436 (586)
T KOG0667|consen 357 PEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETS 436 (586)
T ss_pred chhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeec
Confidence 999999999999999999999999999999999888777664443221100 000000000000
Q ss_pred -----------------ccc-----------CCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 021490 222 -----------------ELQ-----------GQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 261 (311)
Q Consensus 222 -----------------~~~-----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l~ 261 (311)
... ..........+.+++++||.+||.+|+|..++++.-.
T Consensus 437 ~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~Hpf 504 (586)
T KOG0667|consen 437 APRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALNHPF 504 (586)
T ss_pred ccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhcCcc
Confidence 000 0111123456789999999999999999999997753
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=262.79 Aligned_cols=221 Identities=23% Similarity=0.364 Sum_probs=175.1
Q ss_pred CcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHHHH
Q 021490 9 LQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRM 88 (311)
Q Consensus 9 g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~ 88 (311)
...|++|++..........|.+|+.++..++||||+++++++..+...++||||+++++|..++... ...+++..++
T Consensus 32 ~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~---~~~~~~~~~~ 108 (262)
T cd05077 32 EIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRK---SDVLTTPWKF 108 (262)
T ss_pred ceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEEEEecccCCCHHHHHHhc---CCCCCHHHHH
Confidence 3468999886655555568889999999999999999999999988999999999999999888652 3568999999
Q ss_pred HHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCc-------eEEccccccccCCCCCCceeeeeccccccccCccc
Q 021490 89 KIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH-------PKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 161 (311)
Q Consensus 89 ~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~-------~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 161 (311)
.++.|++.||+|||+++ ++|+||+|+||+++.++. ++++|||++..... .....++..|+|||.
T Consensus 109 ~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~------~~~~~~~~~y~aPE~ 179 (262)
T cd05077 109 KVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLS------RQECVERIPWIAPEC 179 (262)
T ss_pred HHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCCCCCCccccC------cccccccccccChhh
Confidence 99999999999999999 999999999999987654 89999998764221 112346778999998
Q ss_pred cc-cCCCccccceeehhHHHHHHH-hCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHH
Q 021490 162 AK-TGQLTLKSDVYSFGVVLLEIL-SGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVA 239 (311)
Q Consensus 162 ~~-~~~~~~~~DiwslG~l~~~ll-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 239 (311)
+. +..++.++|||||||++|+|+ +|..||............ ... . .........+.+|+
T Consensus 180 ~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~-------~~~---~---------~~~~~~~~~~~~li 240 (262)
T cd05077 180 VEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFY-------EGQ---C---------MLVTPSCKELADLM 240 (262)
T ss_pred hcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHH-------hcC---c---------cCCCCChHHHHHHH
Confidence 86 467889999999999999998 588888654332221111 000 0 00111234788899
Q ss_pred HHccccCCCCCCCHHHHHHHH
Q 021490 240 AMCVHEQPDMRPVIADVVTAL 260 (311)
Q Consensus 240 ~~~l~~~p~~Rps~~~vl~~l 260 (311)
.+||+.||.+||++.++++.+
T Consensus 241 ~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 241 THCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred HHHcCCChhhCcCHHHHHHhc
Confidence 999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=273.41 Aligned_cols=231 Identities=22% Similarity=0.243 Sum_probs=178.7
Q ss_pred CCcEEEEEEeecCC---CcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCH
Q 021490 8 LLQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 84 (311)
Q Consensus 8 ~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~ 84 (311)
+|+.||+|++.... ......+.+|+.+++.++||||+++++++.++...|+||||++||+|.+++.. ..+++
T Consensus 67 ~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~-----~~~~~ 141 (370)
T cd05621 67 SQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSN-----YDVPE 141 (370)
T ss_pred CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCCCCCcHHHHHHh-----cCCCH
Confidence 57899999986532 22335678899999999999999999999999999999999999999999965 45899
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccccc
Q 021490 85 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT 164 (311)
Q Consensus 85 ~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 164 (311)
..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++....... ........|+..|+|||++.+
T Consensus 142 ~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~ 217 (370)
T cd05621 142 KWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG-MVRCDTAVGTPDYISPEVLKS 217 (370)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceecccCC-ceecccCCCCcccCCHHHHhc
Confidence 999999999999999999999 9999999999999999999999999987532211 111223468999999999865
Q ss_pred C----CCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHH
Q 021490 165 G----QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAA 240 (311)
Q Consensus 165 ~----~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 240 (311)
. .++.++|+|||||++|+|++|..||...........+ ...... ...+ .....+..+.+++.
T Consensus 218 ~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i------~~~~~~---~~~p-----~~~~~s~~~~~li~ 283 (370)
T cd05621 218 QGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKI------MDHKNS---LNFP-----EDVEISKHAKNLIC 283 (370)
T ss_pred cCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHH------HhCCcc---cCCC-----CcccCCHHHHHHHH
Confidence 4 3788999999999999999999999765543221111 110000 0000 01123456778999
Q ss_pred HccccCCCC--CCCHHHHHHHHH
Q 021490 241 MCVHEQPDM--RPVIADVVTALA 261 (311)
Q Consensus 241 ~~l~~~p~~--Rps~~~vl~~l~ 261 (311)
.||..++.. |+|+.++++...
T Consensus 284 ~~L~~~~~r~~R~~~~e~l~hp~ 306 (370)
T cd05621 284 AFLTDREVRLGRNGVEEIKQHPF 306 (370)
T ss_pred HHccCchhccCCCCHHHHhcCcc
Confidence 999865543 899999998754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=262.19 Aligned_cols=227 Identities=26% Similarity=0.336 Sum_probs=183.3
Q ss_pred CCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHHH
Q 021490 8 LLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTR 87 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~ 87 (311)
+++.+++|.++.... .+.+.+|+.+++.++|+||+++++.+.++...++++||+++++|.+++... ...+++..+
T Consensus 27 ~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~---~~~l~~~~~ 101 (256)
T cd06612 27 TGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKIT---NKTLTEEEI 101 (256)
T ss_pred CCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcHHHHHHhC---ccCCCHHHH
Confidence 478999999865432 678999999999999999999999999999999999999999999998652 457899999
Q ss_pred HHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccCCC
Q 021490 88 MKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQL 167 (311)
Q Consensus 88 ~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 167 (311)
..++.|++.||.|||+.+ ++|+||+|.||+++.++.++|+|||++........ ......++..|+|||.+.+..+
T Consensus 102 ~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~ 176 (256)
T cd06612 102 AAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA--KRNTVIGTPFWMAPEVIQEIGY 176 (256)
T ss_pred HHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc--ccccccCCccccCHHHHhcCCC
Confidence 999999999999999999 99999999999999999999999999875332211 1222346788999999988889
Q ss_pred ccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCC
Q 021490 168 TLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQP 247 (311)
Q Consensus 168 ~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p 247 (311)
+.++||||||+++|+|++|..||............ ... . .+ ....+......+.+++.+||+.||
T Consensus 177 ~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~-------~~~-~-----~~--~~~~~~~~~~~~~~~i~~~l~~~P 241 (256)
T cd06612 177 NNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI-------PNK-P-----PP--TLSDPEKWSPEFNDFVKKCLVKDP 241 (256)
T ss_pred CchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhh-------ccC-C-----CC--CCCchhhcCHHHHHHHHHHHhcCh
Confidence 99999999999999999999999765432221100 000 0 00 011122334578899999999999
Q ss_pred CCCCCHHHHHHH
Q 021490 248 DMRPVIADVVTA 259 (311)
Q Consensus 248 ~~Rps~~~vl~~ 259 (311)
++|||+.++++.
T Consensus 242 ~~Rps~~~il~~ 253 (256)
T cd06612 242 EERPSAIQLLQH 253 (256)
T ss_pred hhCcCHHHHhcC
Confidence 999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=260.45 Aligned_cols=236 Identities=24% Similarity=0.359 Sum_probs=185.8
Q ss_pred cchhccCCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCC
Q 021490 2 MQVILCLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKP 81 (311)
Q Consensus 2 ~~~~~~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 81 (311)
|.+...++..+|+|.+... ....+.|.+|+++++.++|+||+++++.+.+ ...+++|||+++++|.+++.... ...
T Consensus 23 y~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~--~~~ 98 (260)
T cd05073 23 WMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDE--GSK 98 (260)
T ss_pred EEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcHHHHHHhCC--ccc
Confidence 4455567788999988643 2345688999999999999999999999887 67899999999999999997632 456
Q ss_pred CCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccc
Q 021490 82 LDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 161 (311)
Q Consensus 82 l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 161 (311)
+++..+..++.+++.||+|||+.+ ++|+||+|+||+++.++.++|+|||.+....... ........++..|+|||.
T Consensus 99 ~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~y~~PE~ 174 (260)
T cd05073 99 QPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPEA 174 (260)
T ss_pred cCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCC-cccccCCcccccccCHhH
Confidence 888999999999999999999999 9999999999999999999999999886432211 111222335567999999
Q ss_pred cccCCCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHH
Q 021490 162 AKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAA 240 (311)
Q Consensus 162 ~~~~~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 240 (311)
+....++.++|+||||+++|++++ |..||............... .. ...+...+..+.+++.
T Consensus 175 ~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~-------~~----------~~~~~~~~~~~~~~i~ 237 (260)
T cd05073 175 INFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG-------YR----------MPRPENCPEELYNIMM 237 (260)
T ss_pred hccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC-------CC----------CCCcccCCHHHHHHHH
Confidence 988889999999999999999998 89999765443322211100 00 0111233457889999
Q ss_pred HccccCCCCCCCHHHHHHHHHH
Q 021490 241 MCVHEQPDMRPVIADVVTALAY 262 (311)
Q Consensus 241 ~~l~~~p~~Rps~~~vl~~l~~ 262 (311)
+||+.+|++||++.++.+.|+.
T Consensus 238 ~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 238 RCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred HHcccCcccCcCHHHHHHHHhc
Confidence 9999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=259.09 Aligned_cols=230 Identities=24% Similarity=0.294 Sum_probs=184.8
Q ss_pred CCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHHH
Q 021490 8 LLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTR 87 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~ 87 (311)
++..+++|++........+.+.+|+.+++.++||||+++++++.++...+++|||+++++|.+++... ...+++..+
T Consensus 27 ~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~~~~~~~---~~~l~~~~~ 103 (262)
T cd06613 27 TGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVT---RGPLSELQI 103 (262)
T ss_pred CCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcHHHHHHhh---ccCCCHHHH
Confidence 57889999997766666788999999999999999999999999999999999999999999998762 257999999
Q ss_pred HHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccC--
Q 021490 88 MKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG-- 165 (311)
Q Consensus 88 ~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-- 165 (311)
..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||.+....... .......++..|+|||.+...
T Consensus 104 ~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~y~~Pe~~~~~~~ 178 (262)
T cd06613 104 AYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI--AKRKSFIGTPYWMAPEVAAVERK 178 (262)
T ss_pred HHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh--hccccccCCccccCchhhccccc
Confidence 999999999999999999 9999999999999999999999999886532211 112234567789999998766
Q ss_pred -CCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccc
Q 021490 166 -QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVH 244 (311)
Q Consensus 166 -~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 244 (311)
.++.++|+||||+++|+|++|..||.............. .. ...+. .......+..+.+++.+||.
T Consensus 179 ~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~------~~-----~~~~~--~~~~~~~~~~~~~li~~~l~ 245 (262)
T cd06613 179 GGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISK------SN-----FPPPK--LKDKEKWSPVFHDFIKKCLT 245 (262)
T ss_pred CCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh------cc-----CCCcc--ccchhhhhHHHHHHHHHHcC
Confidence 788999999999999999999999976553322111100 00 00000 01123345678899999999
Q ss_pred cCCCCCCCHHHHHH
Q 021490 245 EQPDMRPVIADVVT 258 (311)
Q Consensus 245 ~~p~~Rps~~~vl~ 258 (311)
.+|.+|||+.+++.
T Consensus 246 ~~p~~Rpt~~~il~ 259 (262)
T cd06613 246 KDPKKRPTATKLLQ 259 (262)
T ss_pred CChhhCCCHHHHhc
Confidence 99999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=285.36 Aligned_cols=236 Identities=25% Similarity=0.362 Sum_probs=200.1
Q ss_pred CcEEEEEEeecCCCcch-hHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHHH
Q 021490 9 LQDVAIKQLDRNGVQGN-REFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTR 87 (311)
Q Consensus 9 g~~vaiK~~~~~~~~~~-~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~ 87 (311)
-..||||.|+.-..+.+ .+|+.|+.+|-+++||||+++.++........||+|||++|+|+.||... .+.|+.-+.
T Consensus 657 e~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~---DGqftviQL 733 (996)
T KOG0196|consen 657 EITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQN---DGQFTVIQL 733 (996)
T ss_pred ceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhc---CCceEeehH
Confidence 37899999987765554 58999999999999999999999999999999999999999999999873 466999999
Q ss_pred HHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCce-eeeeccccccccCccccccCC
Q 021490 88 MKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH-VSTRVMGTYGYCAPEYAKTGQ 166 (311)
Q Consensus 88 ~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~ 166 (311)
..++..|+.|+.||-+.+ +|||||...||||+.+..+|++|||+++......... ......-+.+|.|||.+..+.
T Consensus 734 VgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RK 810 (996)
T KOG0196|consen 734 VGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRK 810 (996)
T ss_pred HHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcc
Confidence 999999999999999999 9999999999999999999999999998654443222 222345678999999999999
Q ss_pred CccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHcccc
Q 021490 167 LTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHE 245 (311)
Q Consensus 167 ~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 245 (311)
++.++||||+|+++||.++ |..||-.-.+.+....++.. ++-..|..++..|.+|+..||++
T Consensus 811 FTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~g-----------------yRLPpPmDCP~aL~qLMldCWqk 873 (996)
T KOG0196|consen 811 FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQG-----------------YRLPPPMDCPAALYQLMLDCWQK 873 (996)
T ss_pred cCchhhccccceEEEEecccCCCcccccchHHHHHHHHhc-----------------cCCCCCCCCcHHHHHHHHHHHHH
Confidence 9999999999999999887 99999776665544433222 11223455667999999999999
Q ss_pred CCCCCCCHHHHHHHHHHhhhcc
Q 021490 246 QPDMRPVIADVVTALAYLASQK 267 (311)
Q Consensus 246 ~p~~Rps~~~vl~~l~~~~~~~ 267 (311)
|-.+||++.+|+..|..+....
T Consensus 874 dR~~RP~F~qiV~~lDklIrnP 895 (996)
T KOG0196|consen 874 DRNRRPKFAQIVSTLDKLIRNP 895 (996)
T ss_pred HhhcCCCHHHHHHHHHHHhcCc
Confidence 9999999999999999887654
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=278.21 Aligned_cols=234 Identities=26% Similarity=0.374 Sum_probs=197.5
Q ss_pred CcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHHHH
Q 021490 9 LQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRM 88 (311)
Q Consensus 9 g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~ 88 (311)
.-.||||.++ .+.-..++|+.|+.+|+.+.|||+|.++++|..+...|||+|||..|+|.++|.++. ...++....+
T Consensus 292 slTvAVKtLK-EDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRecn--r~ev~avvLl 368 (1157)
T KOG4278|consen 292 SLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYLRECN--RSEVPAVVLL 368 (1157)
T ss_pred ceeeehhhhh-hcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccHHHHHHHhc--hhhcchhHHH
Confidence 3468999995 444567899999999999999999999999999999999999999999999999854 4567888889
Q ss_pred HHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccCCCc
Q 021490 89 KIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLT 168 (311)
Q Consensus 89 ~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 168 (311)
.++.||++|++||..++ ++||||...|+||.++..||+.|||+++.+..... .......-+..|.|||-+..+.++
T Consensus 369 yMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTY-TAHAGAKFPIKWTAPEsLAyNtFS 444 (1157)
T KOG4278|consen 369 YMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNTFS 444 (1157)
T ss_pred HHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCce-ecccCccCcccccCcccccccccc
Confidence 99999999999999999 99999999999999999999999999987644332 223334567889999999999999
Q ss_pred cccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCC
Q 021490 169 LKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQP 247 (311)
Q Consensus 169 ~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p 247 (311)
.++|||+||+++||+.| |-.||.+.+......+++. .++..-|..++....+|+..||+++|
T Consensus 445 iKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEk-----------------gyRM~~PeGCPpkVYeLMraCW~WsP 507 (1157)
T KOG4278|consen 445 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEK-----------------GYRMDGPEGCPPKVYELMRACWNWSP 507 (1157)
T ss_pred cchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhc-----------------cccccCCCCCCHHHHHHHHHHhcCCc
Confidence 99999999999999998 9999999876555444432 22223344455588999999999999
Q ss_pred CCCCCHHHHHHHHHHhhhc
Q 021490 248 DMRPVIADVVTALAYLASQ 266 (311)
Q Consensus 248 ~~Rps~~~vl~~l~~~~~~ 266 (311)
.+||++.|+-+.++.+.+.
T Consensus 508 sDRPsFaeiHqafEtmf~~ 526 (1157)
T KOG4278|consen 508 SDRPSFAEIHQAFETMFSS 526 (1157)
T ss_pred ccCccHHHHHHHHHHHhcc
Confidence 9999999999999866543
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=270.58 Aligned_cols=220 Identities=26% Similarity=0.340 Sum_probs=176.2
Q ss_pred cCCcEEEEEEeecCC---CcchhHHHHHHHHHhcCC-CCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCC
Q 021490 7 CLLQDVAIKQLDRNG---VQGNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPL 82 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l 82 (311)
.+|+.||+|+++... ....+.+..|..++..+. |++|+++++++.+....|+||||++|++|.+++.. ...+
T Consensus 23 ~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~----~~~l 98 (323)
T cd05615 23 GTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQ----VGKF 98 (323)
T ss_pred CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCCCCcHHHHHHH----cCCC
Confidence 368999999997542 233456788999998886 57788899999999999999999999999999876 5679
Q ss_pred CHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccc
Q 021490 83 DWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 162 (311)
Q Consensus 83 ~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 162 (311)
++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++....... .......|+..|+|||++
T Consensus 99 ~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~ 173 (323)
T cd05615 99 KEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG--VTTRTFCGTPDYIAPEII 173 (323)
T ss_pred CHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCCC--ccccCccCCccccCHHHH
Confidence 99999999999999999999999 9999999999999999999999999986422111 112234588999999999
Q ss_pred ccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHc
Q 021490 163 KTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMC 242 (311)
Q Consensus 163 ~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 242 (311)
.+..++.++|||||||++|+|++|..||...........+ .... ..++...+..+.+++.+|
T Consensus 174 ~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i------~~~~------------~~~p~~~~~~~~~li~~~ 235 (323)
T cd05615 174 AYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSI------MEHN------------VSYPKSLSKEAVSICKGL 235 (323)
T ss_pred cCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH------HhCC------------CCCCccCCHHHHHHHHHH
Confidence 9888999999999999999999999999876543222111 1100 011223345788899999
Q ss_pred cccCCCCCCCH
Q 021490 243 VHEQPDMRPVI 253 (311)
Q Consensus 243 l~~~p~~Rps~ 253 (311)
|+.||.+|++.
T Consensus 236 l~~~p~~R~~~ 246 (323)
T cd05615 236 MTKHPSKRLGC 246 (323)
T ss_pred cccCHhhCCCC
Confidence 99999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=274.05 Aligned_cols=227 Identities=23% Similarity=0.248 Sum_probs=175.5
Q ss_pred cCCcEEEEEEeecCCCc---chhHHHHHHHHHhcC---CCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCC
Q 021490 7 CLLQDVAIKQLDRNGVQ---GNREFLVEVLMLSLL---HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKK 80 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 80 (311)
.+|+.||+|++...... ....+..|..++..+ +||||+++++++.+....|+||||+++++|.+++.. ..
T Consensus 16 ~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~----~~ 91 (330)
T cd05586 16 DTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQK----EG 91 (330)
T ss_pred CCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCCChHHHHHHh----cC
Confidence 36899999998654321 223455677777655 699999999999999999999999999999999876 56
Q ss_pred CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcc
Q 021490 81 PLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 160 (311)
Q Consensus 81 ~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE 160 (311)
.+++..+..++.|++.||+|||+++ ++||||||+|||++.++.++|+|||++....... .......|+..|+|||
T Consensus 92 ~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE 166 (330)
T cd05586 92 RFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KTTNTFCGTTEYLAPE 166 (330)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CCccCccCCccccCHH
Confidence 7999999999999999999999999 9999999999999999999999999986422111 1122345889999999
Q ss_pred ccccC-CCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHH
Q 021490 161 YAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVA 239 (311)
Q Consensus 161 ~~~~~-~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 239 (311)
++.+. .++.++|||||||++|+|++|..||...........+... . ..+.. ...+..+.+++
T Consensus 167 ~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~-----~---------~~~~~---~~~~~~~~~li 229 (330)
T cd05586 167 VLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFG-----K---------VRFPK---NVLSDEGRQFV 229 (330)
T ss_pred HHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcC-----C---------CCCCC---ccCCHHHHHHH
Confidence 88654 5789999999999999999999999765543322111100 0 00000 11234778899
Q ss_pred HHccccCCCCCC----CHHHHHHH
Q 021490 240 AMCVHEQPDMRP----VIADVVTA 259 (311)
Q Consensus 240 ~~~l~~~p~~Rp----s~~~vl~~ 259 (311)
.+||..||.+|| ++.++++.
T Consensus 230 ~~~L~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 230 KGLLNRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred HHHcCCCHHHCCCCCCCHHHHhcC
Confidence 999999999998 56776654
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=268.05 Aligned_cols=228 Identities=21% Similarity=0.318 Sum_probs=183.7
Q ss_pred CCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHHH
Q 021490 8 LLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTR 87 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~ 87 (311)
.|..||||.+........+.+.+|+..++.++|+||+++++.+..+...++||||+++++|.+++.. +.+++..+
T Consensus 46 ~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~l~~~~~ 120 (292)
T cd06658 46 TGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTH-----TRMNEEQI 120 (292)
T ss_pred CCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHHHHHhc-----CCCCHHHH
Confidence 5889999998765555567899999999999999999999999999999999999999999998864 45899999
Q ss_pred HHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccCCC
Q 021490 88 MKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQL 167 (311)
Q Consensus 88 ~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 167 (311)
..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++....... .......++..|+|||.+.+..+
T Consensus 121 ~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~ 195 (292)
T cd06658 121 ATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV--PKRKSLVGTPYWMAPEVISRLPY 195 (292)
T ss_pred HHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccc--ccCceeecCccccCHHHHccCCC
Confidence 999999999999999999 9999999999999999999999999886432211 11223457889999999988888
Q ss_pred ccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCC
Q 021490 168 TLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQP 247 (311)
Q Consensus 168 ~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p 247 (311)
+.++|+||||+++|+|++|..||.............. .+ .+.+. .....+..+.+++.+||..||
T Consensus 196 ~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~---~~----------~~~~~--~~~~~~~~~~~li~~~l~~~P 260 (292)
T cd06658 196 GTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRD---NL----------PPRVK--DSHKVSSVLRGFLDLMLVREP 260 (292)
T ss_pred CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---cC----------CCccc--cccccCHHHHHHHHHHccCCh
Confidence 9999999999999999999999976544322111110 00 00000 011233467789999999999
Q ss_pred CCCCCHHHHHHHH
Q 021490 248 DMRPVIADVVTAL 260 (311)
Q Consensus 248 ~~Rps~~~vl~~l 260 (311)
.+|||++++++.-
T Consensus 261 ~~Rpt~~~il~~~ 273 (292)
T cd06658 261 SQRATAQELLQHP 273 (292)
T ss_pred hHCcCHHHHhhCh
Confidence 9999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=277.51 Aligned_cols=236 Identities=26% Similarity=0.382 Sum_probs=183.9
Q ss_pred CCcEEEEEEeecCCCcc-hhHHHHHHHHHhcCC-CCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCC--------
Q 021490 8 LLQDVAIKQLDRNGVQG-NREFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP-------- 77 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-------- 77 (311)
.+..||+|+++...... .+.+.+|+.++..+. ||||+++++++......++||||+++|+|.+++.....
T Consensus 66 ~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~ 145 (401)
T cd05107 66 STMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLD 145 (401)
T ss_pred CceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcc
Confidence 45689999997653322 357889999999997 99999999999998999999999999999999865311
Q ss_pred --------------------------------------------------------------------------------
Q 021490 78 -------------------------------------------------------------------------------- 77 (311)
Q Consensus 78 -------------------------------------------------------------------------------- 77 (311)
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (401)
T cd05107 146 KNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTR 225 (401)
T ss_pred cccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcc
Confidence
Q ss_pred ------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeecc
Q 021490 78 ------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVM 151 (311)
Q Consensus 78 ------~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~ 151 (311)
....+++..++.++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++................
T Consensus 226 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~ 302 (401)
T cd05107 226 RDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTF 302 (401)
T ss_pred hhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcC
Confidence 1124677888999999999999999999 9999999999999999999999999986532221111122234
Q ss_pred ccccccCccccccCCCccccceeehhHHHHHHHh-CCCccCcchhHHHH-HHHHHhhhhhccccccccccCccccCCCCh
Q 021490 152 GTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQ-SLVAWARPLFQDRTRHSLIADPELQGQYPP 229 (311)
Q Consensus 152 ~~~~y~aPE~~~~~~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (311)
++..|+|||.+....++.++||||||+++|+|++ |..||......... ..+. .. .....+.
T Consensus 303 ~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~-------~~----------~~~~~p~ 365 (401)
T cd05107 303 LPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIK-------RG----------YRMAKPA 365 (401)
T ss_pred CCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHH-------cC----------CCCCCCC
Confidence 6778999999988889999999999999999998 88998764432221 1110 00 0001122
Q ss_pred HhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 021490 230 RGFYQALAVAAMCVHEQPDMRPVIADVVTALAYL 263 (311)
Q Consensus 230 ~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l~~~ 263 (311)
..+.++.+|+.+||..+|.+||++.+++..|+.+
T Consensus 366 ~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 366 HASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 3345888999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=263.97 Aligned_cols=249 Identities=25% Similarity=0.263 Sum_probs=183.9
Q ss_pred cchhcc-CCcEEEEEEeecCCC--cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCC
Q 021490 2 MQVILC-LLQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPG 78 (311)
Q Consensus 2 ~~~~~~-~g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~ 78 (311)
|.+... +|+.||+|++..... ...+.+.+|+.+++.++|+|++++++++......++||||+++++|..++..
T Consensus 18 ~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~---- 93 (286)
T cd07847 18 FKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKN---- 93 (286)
T ss_pred EEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCccHHHHHHhC----
Confidence 334443 689999999865432 2335688999999999999999999999999999999999999888887654
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccC
Q 021490 79 KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCA 158 (311)
Q Consensus 79 ~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~a 158 (311)
...+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++........ ......++..|+|
T Consensus 94 ~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~a 168 (286)
T cd07847 94 PRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGD--DYTDYVATRWYRA 168 (286)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCcc--cccCcccccccCC
Confidence 456999999999999999999999999 99999999999999999999999999875432211 1122346788999
Q ss_pred cccccc-CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHH-hhhhhc-------cccccccccCccccCCC--
Q 021490 159 PEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAW-ARPLFQ-------DRTRHSLIADPELQGQY-- 227 (311)
Q Consensus 159 PE~~~~-~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~-~~~~~~-------~~~~~~~~~~~~~~~~~-- 227 (311)
||.+.+ ..++.++|+||||+++|+|++|..||.+....+....... ...... ..........+......
T Consensus 169 PE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (286)
T cd07847 169 PELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPL 248 (286)
T ss_pred HHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCH
Confidence 998865 4578899999999999999999999986654433221111 000000 00000000001100000
Q ss_pred ---ChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 021490 228 ---PPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 228 ---~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~ 259 (311)
-+..+..+.+++.+||..+|++|||+.+++..
T Consensus 249 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 249 ESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred HHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 01234678899999999999999999998864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=263.38 Aligned_cols=231 Identities=23% Similarity=0.320 Sum_probs=181.9
Q ss_pred CCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHHH
Q 021490 8 LLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTR 87 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~ 87 (311)
.+..+++|.+........+.+.+|+++++.++||||+++++++..+...++|+||+++++|..++... ...+++..+
T Consensus 29 ~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~---~~~l~~~~~ 105 (282)
T cd06643 29 TGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLEL---ERPLTEPQI 105 (282)
T ss_pred CCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcHHHHHHhc---CCCCCHHHH
Confidence 47788999986655555678899999999999999999999999999999999999999998887641 356899999
Q ss_pred HHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccc----
Q 021490 88 MKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK---- 163 (311)
Q Consensus 88 ~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---- 163 (311)
..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++...... ........++..|+|||++.
T Consensus 106 ~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~ 180 (282)
T cd06643 106 RVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQRRDSFIGTPYWMAPEVVMCETS 180 (282)
T ss_pred HHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccccc--ccccccccccccccCHhhccccCC
Confidence 999999999999999999 999999999999999999999999998643211 11122345788999999874
Q ss_pred -cCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHc
Q 021490 164 -TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMC 242 (311)
Q Consensus 164 -~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 242 (311)
+..++.++|+|||||++|+|++|..||............ .... . +.. ..+...+..+.+++.+|
T Consensus 181 ~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~------~~~~--~-----~~~--~~~~~~~~~~~~li~~~ 245 (282)
T cd06643 181 KDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKI------AKSE--P-----PTL--AQPSRWSSEFKDFLKKC 245 (282)
T ss_pred CCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHH------hhcC--C-----CCC--CCccccCHHHHHHHHHH
Confidence 345778999999999999999999999765432211111 0000 0 000 01122345788999999
Q ss_pred cccCCCCCCCHHHHHHHHH
Q 021490 243 VHEQPDMRPVIADVVTALA 261 (311)
Q Consensus 243 l~~~p~~Rps~~~vl~~l~ 261 (311)
|..||.+|||+.++++...
T Consensus 246 l~~~p~~Rp~~~~il~~~~ 264 (282)
T cd06643 246 LEKNVDARWTTTQLLQHPF 264 (282)
T ss_pred ccCChhhCcCHHHHhcCCC
Confidence 9999999999999987653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=266.72 Aligned_cols=245 Identities=22% Similarity=0.269 Sum_probs=184.7
Q ss_pred CCcEEEEEEeecCCC-cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHH
Q 021490 8 LLQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNT 86 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~ 86 (311)
+|..+|+|.++.... ....++.+|++++..++||||+++++++.++...++||||+++++|.+++.. ...+++..
T Consensus 25 ~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~L~~~l~~----~~~~~~~~ 100 (308)
T cd06615 25 SGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPENI 100 (308)
T ss_pred CCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCcHHHHHHh----cCCCCHHH
Confidence 678899998865432 2335788999999999999999999999999999999999999999999976 46789999
Q ss_pred HHHHHHHHHHHHHHhhc-CCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccC
Q 021490 87 RMKIAAGAARGLEYLHD-KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG 165 (311)
Q Consensus 87 ~~~~~~~i~~~l~~lh~-~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 165 (311)
+..++.|++.||.|||+ .+ ++|+||+|+||+++.++.++|+|||++...... ......++..|+|||++.+.
T Consensus 101 ~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~~~aPE~~~~~ 173 (308)
T cd06615 101 LGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGT 173 (308)
T ss_pred HHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccccccc----ccccCCCCcCccChhHhcCC
Confidence 99999999999999997 57 999999999999999999999999987643211 11224578899999999888
Q ss_pred CCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhcccccc-----ccc-----------cC---ccccCC
Q 021490 166 QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRH-----SLI-----------AD---PELQGQ 226 (311)
Q Consensus 166 ~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~-----------~~---~~~~~~ 226 (311)
.++.++|+||||+++|+|++|..||...+..................... ... .+ ......
T Consensus 174 ~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (308)
T cd06615 174 HYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPK 253 (308)
T ss_pred CCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCcc
Confidence 88999999999999999999999997654332221111100000000000 000 00 000000
Q ss_pred CC-hHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 021490 227 YP-PRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYL 263 (311)
Q Consensus 227 ~~-~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l~~~ 263 (311)
.+ .....++.+++.+||..||++|||+.+++......
T Consensus 254 ~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~ 291 (308)
T cd06615 254 LPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIK 291 (308)
T ss_pred CcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhh
Confidence 01 11345688999999999999999999999887653
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=261.19 Aligned_cols=232 Identities=25% Similarity=0.359 Sum_probs=183.1
Q ss_pred cEEEEEEeecCC-CcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHHHH
Q 021490 10 QDVAIKQLDRNG-VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRM 88 (311)
Q Consensus 10 ~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~ 88 (311)
..|++|...... ....+.+.+|+.+++.++||||+++++++.+ ...++||||+++++|.+++... ...+++..++
T Consensus 35 ~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~ 110 (270)
T cd05056 35 IAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQVN---KYSLDLASLI 110 (270)
T ss_pred cceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEEEcCCCCcHHHHHHhC---CCCCCHHHHH
Confidence 568999886554 3345689999999999999999999998875 4578999999999999999762 3458999999
Q ss_pred HHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccCCCc
Q 021490 89 KIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLT 168 (311)
Q Consensus 89 ~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 168 (311)
.++.+++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++........ .......++..|+|||.+....++
T Consensus 111 ~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~ 186 (270)
T cd05056 111 LYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESY-YKASKGKLPIKWMAPESINFRRFT 186 (270)
T ss_pred HHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecccccc-eecCCCCccccccChhhhccCCCC
Confidence 99999999999999999 99999999999999999999999999865322211 111122345679999999888899
Q ss_pred cccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCC
Q 021490 169 LKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQP 247 (311)
Q Consensus 169 ~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p 247 (311)
.++||||||+++|+|++ |..||............... .. . ..+...+..+.+++.+||..+|
T Consensus 187 ~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~-------~~------~----~~~~~~~~~~~~li~~~l~~~P 249 (270)
T cd05056 187 SASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENG-------ER------L----PMPPNCPPTLYSLMTKCWAYDP 249 (270)
T ss_pred chhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC-------Cc------C----CCCCCCCHHHHHHHHHHcCCCh
Confidence 99999999999999986 99999766543332211110 00 0 1122334578889999999999
Q ss_pred CCCCCHHHHHHHHHHhhhc
Q 021490 248 DMRPVIADVVTALAYLASQ 266 (311)
Q Consensus 248 ~~Rps~~~vl~~l~~~~~~ 266 (311)
.+|||+.++++.|+.+...
T Consensus 250 ~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 250 SKRPRFTELKAQLSDILQE 268 (270)
T ss_pred hhCcCHHHHHHHHHHHHhc
Confidence 9999999999999887643
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=276.34 Aligned_cols=242 Identities=21% Similarity=0.282 Sum_probs=183.0
Q ss_pred cCCcEEEEEEeecCC--CcchhHHHHHHHHHhcCCCCcccceeeEeeeCC-----eeEEEEecCCCCChhhhhcccCCCC
Q 021490 7 CLLQDVAIKQLDRNG--VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD-----QRLLVYEYMPLGSVEDHLHDLSPGK 79 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~ 79 (311)
.+|+.||||++.... ....+.+.+|+.+++.++||||+++++++.... ..|+||||+. ++|.+.+.. .
T Consensus 23 ~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~ 97 (372)
T cd07853 23 RDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQ-SDLHKIIVS----P 97 (372)
T ss_pred CCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEeeccc-cCHHHHHhc----C
Confidence 478999999986542 234467889999999999999999999998766 7899999996 678887765 5
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCc
Q 021490 80 KPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 159 (311)
Q Consensus 80 ~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aP 159 (311)
..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++....... ........++..|+||
T Consensus 98 ~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~-~~~~~~~~~~~~y~aP 173 (372)
T cd07853 98 QPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDE-SKHMTQEVVTQYYRAP 173 (372)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeecccCc-cccCCCCCcCCCcCCH
Confidence 67999999999999999999999999 9999999999999999999999999986532221 1112223567889999
Q ss_pred cccccC-CCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhh----------------hhhccccccccccCcc
Q 021490 160 EYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWAR----------------PLFQDRTRHSLIADPE 222 (311)
Q Consensus 160 E~~~~~-~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~ 222 (311)
|++.+. .++.++|||||||++|+|++|..||...........+.... ..+..... ..+.
T Consensus 174 E~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~----~~~~ 249 (372)
T cd07853 174 EILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPH----KPPS 249 (372)
T ss_pred HHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCC----CCCc
Confidence 998764 57899999999999999999999998766543332221110 00000000 0000
Q ss_pred c--cCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 021490 223 L--QGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 261 (311)
Q Consensus 223 ~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l~ 261 (311)
. ........+.++.+|+.+||+.||.+|||+.+++....
T Consensus 250 ~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~ 290 (372)
T cd07853 250 LPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPY 290 (372)
T ss_pred hHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHh
Confidence 0 00112223557889999999999999999999998754
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=264.60 Aligned_cols=232 Identities=23% Similarity=0.318 Sum_probs=184.6
Q ss_pred cCCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHH
Q 021490 7 CLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNT 86 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~ 86 (311)
.++..||+|+++.......+.|.+|+++++.++||||+++++++..+...++||||+++++|.+++... ...+++..
T Consensus 28 ~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~l~~~~ 104 (280)
T cd06611 28 ETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLEL---ERGLTEPQ 104 (280)
T ss_pred CCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCCcHHHHHHHh---cCCCCHHH
Confidence 368999999997665556678999999999999999999999999999999999999999999998762 35699999
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccc---
Q 021490 87 RMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK--- 163 (311)
Q Consensus 87 ~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--- 163 (311)
+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++...... ........++..|++||.+.
T Consensus 105 ~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~ 179 (280)
T cd06611 105 IRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKST--LQKRDTFIGTPYWMAPEVVACET 179 (280)
T ss_pred HHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccc--ccccceeecchhhcCHHHHhhcc
Confidence 9999999999999999999 999999999999999999999999987643221 11122345788899999874
Q ss_pred --cCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHH
Q 021490 164 --TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAM 241 (311)
Q Consensus 164 --~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 241 (311)
...++.++|+||||+++|+|++|..||...+........ ... .. +.+ ..+...+..+.+++.+
T Consensus 180 ~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~------~~~--~~-----~~~--~~~~~~~~~~~~li~~ 244 (280)
T cd06611 180 FKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKI------LKS--EP-----PTL--DQPSKWSSSFNDFLKS 244 (280)
T ss_pred cCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHH------hcC--CC-----CCc--CCcccCCHHHHHHHHH
Confidence 345678999999999999999999999765433221111 000 00 000 1122234478889999
Q ss_pred ccccCCCCCCCHHHHHHHHH
Q 021490 242 CVHEQPDMRPVIADVVTALA 261 (311)
Q Consensus 242 ~l~~~p~~Rps~~~vl~~l~ 261 (311)
||..+|.+|||+.++++.-.
T Consensus 245 ~l~~~p~~Rps~~~il~~~~ 264 (280)
T cd06611 245 CLVKDPDDRPTAAELLKHPF 264 (280)
T ss_pred HhccChhhCcCHHHHhcChh
Confidence 99999999999999997743
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=267.19 Aligned_cols=229 Identities=25% Similarity=0.347 Sum_probs=184.7
Q ss_pred cCCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHH
Q 021490 7 CLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNT 86 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~ 86 (311)
.+|+.||+|.+........+.+.+|+.+++.++|+||+++++++..+...++||||+++++|.+++.. ..+++..
T Consensus 42 ~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~ 116 (297)
T cd06656 42 ATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQ 116 (297)
T ss_pred CCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCCCHHHHHHh-----CCCCHHH
Confidence 47999999999776666667888999999999999999999999999999999999999999999864 4588999
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccCC
Q 021490 87 RMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ 166 (311)
Q Consensus 87 ~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 166 (311)
+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .......++..|+|||.+.+..
T Consensus 117 ~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~ 191 (297)
T cd06656 117 IAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSTMVGTPYWMAPEVVTRKA 191 (297)
T ss_pred HHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCc--cCcCcccCCccccCHHHHcCCC
Confidence 9999999999999999999 9999999999999999999999999886432221 1122335778899999998888
Q ss_pred CccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccC
Q 021490 167 LTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQ 246 (311)
Q Consensus 167 ~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 246 (311)
++.++|+||||+++|+|++|..||...+....... .... . .+. ...+......+.+++.+||..+
T Consensus 192 ~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~-------~~~~-~-----~~~--~~~~~~~~~~~~~li~~~l~~~ 256 (297)
T cd06656 192 YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-------IATN-G-----TPE--LQNPERLSAVFRDFLNRCLEMD 256 (297)
T ss_pred CCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee-------eccC-C-----CCC--CCCccccCHHHHHHHHHHccCC
Confidence 89999999999999999999999976443111000 0000 0 000 0112233456788999999999
Q ss_pred CCCCCCHHHHHHHH
Q 021490 247 PDMRPVIADVVTAL 260 (311)
Q Consensus 247 p~~Rps~~~vl~~l 260 (311)
|++|||+.++++.-
T Consensus 257 p~~Rps~~~il~~~ 270 (297)
T cd06656 257 VDRRGSAKELLQHP 270 (297)
T ss_pred hhhCcCHHHHhcCc
Confidence 99999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=260.19 Aligned_cols=232 Identities=26% Similarity=0.374 Sum_probs=183.0
Q ss_pred CcEEEEEEeecCCC-cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHHH
Q 021490 9 LQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTR 87 (311)
Q Consensus 9 g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~ 87 (311)
+..+|+|.++.... ...+.|.+|+.++..++||||+++++++.++...++||||+++++|.+++... ...+++..+
T Consensus 32 ~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~ 108 (267)
T cd05066 32 EIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKH---DGQFTVIQL 108 (267)
T ss_pred ceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHhc---CCCCCHHHH
Confidence 34799999865432 23468899999999999999999999999999999999999999999999762 356899999
Q ss_pred HHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCcee-eeeccccccccCccccccCC
Q 021490 88 MKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHV-STRVMGTYGYCAPEYAKTGQ 166 (311)
Q Consensus 88 ~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~ 166 (311)
+.++.|++.||++||+.+ ++|+||+|+||+++.++.++|+|||++........... .....++..|++||.+.+..
T Consensus 109 ~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~ 185 (267)
T cd05066 109 VGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 185 (267)
T ss_pred HHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCc
Confidence 999999999999999999 99999999999999999999999999875432221111 11122346799999998888
Q ss_pred CccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHcccc
Q 021490 167 LTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHE 245 (311)
Q Consensus 167 ~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 245 (311)
++.++|+||||+++|++++ |..||...........+. ..... ..+...+..+.+++.+||+.
T Consensus 186 ~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~-------~~~~~----------~~~~~~~~~~~~li~~~l~~ 248 (267)
T cd05066 186 FTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIE-------EGYRL----------PAPMDCPAALHQLMLDCWQK 248 (267)
T ss_pred cCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHh-------CCCcC----------CCCCCCCHHHHHHHHHHccc
Confidence 9999999999999999886 999997655433222111 00000 01112334778899999999
Q ss_pred CCCCCCCHHHHHHHHHHh
Q 021490 246 QPDMRPVIADVVTALAYL 263 (311)
Q Consensus 246 ~p~~Rps~~~vl~~l~~~ 263 (311)
+|.+|||+.++++.|..+
T Consensus 249 ~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 249 DRNERPKFEQIVSILDKL 266 (267)
T ss_pred CchhCCCHHHHHHHHHhh
Confidence 999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=266.32 Aligned_cols=245 Identities=20% Similarity=0.251 Sum_probs=182.4
Q ss_pred CCcEEEEEEeecCCC-cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHH
Q 021490 8 LLQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNT 86 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~ 86 (311)
+++.||+|.++.... .....+.+|+.+++.++||||+++++++......++||||++ ++|.+++... ...+++..
T Consensus 30 ~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~---~~~~~~~~ 105 (301)
T cd07873 30 TDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDC---GNSINMHN 105 (301)
T ss_pred CCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc-cCHHHHHHhc---CCCCCHHH
Confidence 688999999865433 233577889999999999999999999999999999999997 5898888652 35689999
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccccc-C
Q 021490 87 RMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT-G 165 (311)
Q Consensus 87 ~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~ 165 (311)
+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++....... .......++..|+|||++.+ .
T Consensus 106 ~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~ 180 (301)
T cd07873 106 VKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT--KTYSNEVVTLWYRPPDILLGST 180 (301)
T ss_pred HHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCC--CcccccceeecccCcHHHhCCC
Confidence 9999999999999999999 9999999999999999999999999986432211 11122346788999998765 4
Q ss_pred CCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhh-hhcccc-------ccccccCccccC----CCChHhHH
Q 021490 166 QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARP-LFQDRT-------RHSLIADPELQG----QYPPRGFY 233 (311)
Q Consensus 166 ~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~-------~~~~~~~~~~~~----~~~~~~~~ 233 (311)
.++.++||||||+++|+|++|..||...+............. ...... .......+.... ...+..+.
T Consensus 181 ~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (301)
T cd07873 181 DYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDS 260 (301)
T ss_pred CCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCH
Confidence 578899999999999999999999987655433221111100 000000 000000011110 11123345
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHHHH
Q 021490 234 QALAVAAMCVHEQPDMRPVIADVVTALA 261 (311)
Q Consensus 234 ~l~~li~~~l~~~p~~Rps~~~vl~~l~ 261 (311)
.+.+|+.+||+.||.+|||+.++++.-.
T Consensus 261 ~~~~li~~ml~~dp~~R~t~~eil~h~~ 288 (301)
T cd07873 261 DGAELLSKLLQFEGRKRISAEEAMKHPY 288 (301)
T ss_pred HHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 7889999999999999999999997644
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=264.52 Aligned_cols=233 Identities=27% Similarity=0.334 Sum_probs=182.5
Q ss_pred cCCcEEEEEEeecCCCcc---hhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCC
Q 021490 7 CLLQDVAIKQLDRNGVQG---NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLD 83 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~ 83 (311)
.+|+.||+|.+....... ...+.+|+.+++.++|++|+.+++.+.++...++||||++|++|.+++.... ...++
T Consensus 23 ~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~~~l~ 100 (285)
T cd05630 23 ATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMG--EAGFE 100 (285)
T ss_pred CCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCCCcHHHHHHHhc--ccCCC
Confidence 368899999986543222 2457789999999999999999999999999999999999999999886522 34689
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccc
Q 021490 84 WNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 163 (311)
Q Consensus 84 ~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 163 (311)
+..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... ......++..|+|||++.
T Consensus 101 ~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~---~~~~~~g~~~y~aPE~~~ 174 (285)
T cd05630 101 EGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGRVGTVGYMAPEVVK 174 (285)
T ss_pred HHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc---cccCCCCCccccChHHHc
Confidence 9999999999999999999999 9999999999999999999999999886432211 112345889999999998
Q ss_pred cCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHcc
Q 021490 164 TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCV 243 (311)
Q Consensus 164 ~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 243 (311)
+..++.++|+||+|+++|+|++|..||.................... ...+...+..+.+|+.+||
T Consensus 175 ~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~li~~~l 240 (285)
T cd05630 175 NERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQ--------------EEYSEKFSPDARSLCKMLL 240 (285)
T ss_pred CCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhh--------------hhcCccCCHHHHHHHHHHh
Confidence 88899999999999999999999999976432111111100000000 0112223446888999999
Q ss_pred ccCCCCCCC-----HHHHHHHHH
Q 021490 244 HEQPDMRPV-----IADVVTALA 261 (311)
Q Consensus 244 ~~~p~~Rps-----~~~vl~~l~ 261 (311)
+.||.+||| +.+++..-.
T Consensus 241 ~~~p~~R~s~~~~~~~~~~~h~~ 263 (285)
T cd05630 241 CKDPKERLGCQGGGAREVKEHPL 263 (285)
T ss_pred hcCHHHccCCCCCchHHHHcChh
Confidence 999999999 888887643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=263.37 Aligned_cols=229 Identities=23% Similarity=0.336 Sum_probs=181.2
Q ss_pred CCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHHH
Q 021490 8 LLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTR 87 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~ 87 (311)
+|+.|++|++........+.+.+|+.+++.++||||+++++.+..+...++||||+++++|..++.+. ...+++..+
T Consensus 36 ~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~---~~~l~~~~~ 112 (292)
T cd06644 36 TGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLEL---DRGLTEPQI 112 (292)
T ss_pred CCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcHHHHHHhh---cCCCCHHHH
Confidence 58999999997666566678999999999999999999999999999999999999999998887652 356899999
Q ss_pred HHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccc----
Q 021490 88 MKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK---- 163 (311)
Q Consensus 88 ~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---- 163 (311)
..++.|++.+|+|||+.+ ++|+||+|+||+++.++.++|+|||++...... ........++..|+|||++.
T Consensus 113 ~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~ 187 (292)
T cd06644 113 QVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT--LQRRDSFIGTPYWMAPEVVMCETM 187 (292)
T ss_pred HHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccc--ccccceecCCccccCceeeccccc
Confidence 999999999999999999 999999999999999999999999987642211 11122334778899999884
Q ss_pred -cCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHc
Q 021490 164 -TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMC 242 (311)
Q Consensus 164 -~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 242 (311)
...++.++|+|||||++|+|++|..||......... ... .... .+.. ..+...+..+.+++.+|
T Consensus 188 ~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~--~~~----~~~~-------~~~~--~~~~~~~~~~~~li~~~ 252 (292)
T cd06644 188 KDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL--LKI----AKSE-------PPTL--SQPSKWSMEFRDFLKTA 252 (292)
T ss_pred cCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHH--HHH----hcCC-------CccC--CCCcccCHHHHHHHHHH
Confidence 345678999999999999999999999765432211 110 0000 0000 11223344788899999
Q ss_pred cccCCCCCCCHHHHHHH
Q 021490 243 VHEQPDMRPVIADVVTA 259 (311)
Q Consensus 243 l~~~p~~Rps~~~vl~~ 259 (311)
|..||++||++.++++.
T Consensus 253 l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 253 LDKHPETRPSAAQLLEH 269 (292)
T ss_pred hcCCcccCcCHHHHhcC
Confidence 99999999999999875
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=268.80 Aligned_cols=250 Identities=18% Similarity=0.201 Sum_probs=180.1
Q ss_pred cCCcEEEEEEeecCCC--cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCH
Q 021490 7 CLLQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 84 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~ 84 (311)
.+|+.||+|+++.... ...+.+.+|+.+++.++||||+++++++..+...++||||+++++|.+++.... ...+++
T Consensus 23 ~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~--~~~l~~ 100 (327)
T cd08227 23 PTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHF--MDGMSE 100 (327)
T ss_pred ccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccCCCcHHHHHHhhc--cCCCCH
Confidence 3689999999965533 223567789999999999999999999999999999999999999999986522 345899
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCC-c----eeeeeccccccccCc
Q 021490 85 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN-T----HVSTRVMGTYGYCAP 159 (311)
Q Consensus 85 ~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~----~~~~~~~~~~~y~aP 159 (311)
..+..++.|++.||+|||+++ ++||||||+||+++.++.++++||+.......... . .......++..|+||
T Consensus 101 ~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aP 177 (327)
T cd08227 101 LAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSP 177 (327)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhccccccccccccccccccccceecccCh
Confidence 999999999999999999999 99999999999999999999999986532211100 0 001122456779999
Q ss_pred ccccc--CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHH-HHHhhhhhcccc----------ccccccCc-----
Q 021490 160 EYAKT--GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSL-VAWARPLFQDRT----------RHSLIADP----- 221 (311)
Q Consensus 160 E~~~~--~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~----------~~~~~~~~----- 221 (311)
|++.+ ..++.++|||||||++|+|++|..||........... .....+...+.. ......+.
T Consensus 178 E~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (327)
T cd08227 178 EVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGES 257 (327)
T ss_pred HHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhhcccCCcccCCcCCCCcc
Confidence 99875 4688999999999999999999999975433221100 000000000000 00000000
Q ss_pred ------------cccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 021490 222 ------------ELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 261 (311)
Q Consensus 222 ------------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l~ 261 (311)
.............+.+++.+||+.||++|||+.++++...
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~ 309 (327)
T cd08227 258 TTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSF 309 (327)
T ss_pred cccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChh
Confidence 0000111223457889999999999999999999997654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=275.94 Aligned_cols=233 Identities=26% Similarity=0.388 Sum_probs=196.2
Q ss_pred CcEEEEEEeecCC-CcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHHH
Q 021490 9 LQDVAIKQLDRNG-VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTR 87 (311)
Q Consensus 9 g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~ 87 (311)
.-.||||..+.+. .++.+.|+.|+.+|++++||||++++|++.+. ..++|||+++-|.|..+++.. ...++....
T Consensus 418 ~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~WivmEL~~~GELr~yLq~n---k~sL~l~tL 493 (974)
T KOG4257|consen 418 RIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVMELAPLGELREYLQQN---KDSLPLRTL 493 (974)
T ss_pred ceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEEecccchhHHHHHHhc---cccchHHHH
Confidence 4679999997643 45568999999999999999999999999764 689999999999999999983 467999999
Q ss_pred HHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccCCC
Q 021490 88 MKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQL 167 (311)
Q Consensus 88 ~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 167 (311)
..++.||+.||+|||+.. +|||||..+||||....-|||+|||+++......... ......+..|||||-+.-+.+
T Consensus 494 ~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYk-aS~~kLPIKWmaPESINfRrF 569 (974)
T KOG4257|consen 494 TLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYK-ASRGKLPIKWMAPESINFRRF 569 (974)
T ss_pred HHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhccccchhh-ccccccceeecCccccchhcc
Confidence 999999999999999999 9999999999999999999999999998765444333 235567889999999999999
Q ss_pred ccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccC
Q 021490 168 TLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQ 246 (311)
Q Consensus 168 ~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 246 (311)
+.++|||-||+.+||++. |..||.+-.+.+....+ ...-+..+|+.++..|..|+.+||.+|
T Consensus 570 TtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~i-----------------EnGeRlP~P~nCPp~LYslmskcWaye 632 (974)
T KOG4257|consen 570 TTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHI-----------------ENGERLPCPPNCPPALYSLMSKCWAYE 632 (974)
T ss_pred cchhhHHHHHHHHHHHHHhcCCccccccccceEEEe-----------------cCCCCCCCCCCCChHHHHHHHHHhccC
Confidence 999999999999999877 99999876543321111 112233456677779999999999999
Q ss_pred CCCCCCHHHHHHHHHHhhhc
Q 021490 247 PDMRPVIADVVTALAYLASQ 266 (311)
Q Consensus 247 p~~Rps~~~vl~~l~~~~~~ 266 (311)
|.+||.+.++...|..+.+.
T Consensus 633 P~kRPrftei~~~lsdv~qe 652 (974)
T KOG4257|consen 633 PSKRPRFTEIKAILSDVLQE 652 (974)
T ss_pred cccCCcHHHHHHHHHHHHHH
Confidence 99999999999999877764
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=265.20 Aligned_cols=242 Identities=27% Similarity=0.395 Sum_probs=182.4
Q ss_pred ccCCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeee--CCeeEEEEecCCCCChhhhhcccCCCCCCCC
Q 021490 6 LCLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCAD--GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLD 83 (311)
Q Consensus 6 ~~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~ 83 (311)
..+|..||+|.++.......+.|.+|++++..++||||+++++++.. ....++||||+++++|.+++... ...++
T Consensus 30 ~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~l~ 106 (284)
T cd05081 30 DNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKH---RERLD 106 (284)
T ss_pred CCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEEecCCCCHHHHHHhc---CcCCC
Confidence 34688999999876655556789999999999999999999998643 34689999999999999999752 34689
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCcee-eeeccccccccCcccc
Q 021490 84 WNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHV-STRVMGTYGYCAPEYA 162 (311)
Q Consensus 84 ~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~ 162 (311)
+..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++........... .....++..|+|||.+
T Consensus 107 ~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 183 (284)
T cd05081 107 HRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESL 183 (284)
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHh
Confidence 9999999999999999999999 99999999999999999999999999875432221111 1111234569999999
Q ss_pred ccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHH---------HHhhhhhccccccccccCccccCCCChHhHH
Q 021490 163 KTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLV---------AWARPLFQDRTRHSLIADPELQGQYPPRGFY 233 (311)
Q Consensus 163 ~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
.+..++.++||||||+++|+|++|..++............ ......... ......+...+.
T Consensus 184 ~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~ 253 (284)
T cd05081 184 TESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKN----------NGRLPAPPGCPA 253 (284)
T ss_pred ccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhc----------CCcCCCCCCCCH
Confidence 8888999999999999999999987765433211100000 000000000 000011223345
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 021490 234 QALAVAAMCVHEQPDMRPVIADVVTALAYL 263 (311)
Q Consensus 234 ~l~~li~~~l~~~p~~Rps~~~vl~~l~~~ 263 (311)
.+.+|+.+||..+|++|||+.++++.|+.+
T Consensus 254 ~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 254 EIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=266.72 Aligned_cols=231 Identities=20% Similarity=0.281 Sum_probs=185.8
Q ss_pred CCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHHH
Q 021490 8 LLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTR 87 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~ 87 (311)
+|+.||+|++........+.+.+|+.++..++||||+++++.+..+...++|+||+++++|.+++.. ..+++..+
T Consensus 45 ~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~-----~~~~~~~~ 119 (297)
T cd06659 45 SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-----TRLNEEQI 119 (297)
T ss_pred CCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHHHHhh-----cCCCHHHH
Confidence 6899999999766655667889999999999999999999999999999999999999999988754 56899999
Q ss_pred HHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccCCC
Q 021490 88 MKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQL 167 (311)
Q Consensus 88 ~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 167 (311)
+.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++....... .......++..|+|||.+.+..+
T Consensus 120 ~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~ 194 (297)
T cd06659 120 ATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--PKRKSLVGTPYWMAPEVISRTPY 194 (297)
T ss_pred HHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccc--ccccceecCccccCHHHHccCCC
Confidence 999999999999999999 9999999999999999999999999886432211 11223457889999999988889
Q ss_pred ccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCC
Q 021490 168 TLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQP 247 (311)
Q Consensus 168 ~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p 247 (311)
+.++|+||||+++|+|++|..||............. ..... . .......+..+.+++.+||+.+|
T Consensus 195 ~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~-------~~~~~------~--~~~~~~~~~~l~~~i~~~l~~~P 259 (297)
T cd06659 195 GTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLR-------DSPPP------K--LKNAHKISPVLRDFLERMLTREP 259 (297)
T ss_pred CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh-------ccCCC------C--ccccCCCCHHHHHHHHHHhcCCc
Confidence 999999999999999999999997654332211111 00000 0 00111233468889999999999
Q ss_pred CCCCCHHHHHHHHHHh
Q 021490 248 DMRPVIADVVTALAYL 263 (311)
Q Consensus 248 ~~Rps~~~vl~~l~~~ 263 (311)
.+||++.++++.-...
T Consensus 260 ~~Rps~~~ll~~~~~~ 275 (297)
T cd06659 260 QERATAQELLDHPFLL 275 (297)
T ss_pred ccCcCHHHHhhChhhc
Confidence 9999999999875433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=275.66 Aligned_cols=240 Identities=18% Similarity=0.193 Sum_probs=176.5
Q ss_pred cCCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHH
Q 021490 7 CLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNT 86 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~ 86 (311)
..++.||+|... ...+.+|+++++.|+||||+++++++..+...++|+|++. ++|..++.. ...+++..
T Consensus 115 ~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~----~~~l~~~~ 183 (391)
T PHA03212 115 KTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-TDLYCYLAA----KRNIAICD 183 (391)
T ss_pred CCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-CCHHHHHHh----cCCCCHHH
Confidence 367889999653 2457789999999999999999999999999999999995 788888876 46789999
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccCC
Q 021490 87 RMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ 166 (311)
Q Consensus 87 ~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 166 (311)
++.++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++....... ........|+..|+|||++.+..
T Consensus 184 ~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~ 259 (391)
T PHA03212 184 ILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-ANKYYGWAGTIATNAPELLARDP 259 (391)
T ss_pred HHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccc-ccccccccCccCCCChhhhcCCC
Confidence 9999999999999999999 9999999999999999999999999986421111 11122346899999999999889
Q ss_pred CccccceeehhHHHHHHHhCCCccCcchh-------HHHH-HHHHHhhhhhcccc--------------ccccccCcccc
Q 021490 167 LTLKSDVYSFGVVLLEILSGRKAVDTSKA-------AAEQ-SLVAWARPLFQDRT--------------RHSLIADPELQ 224 (311)
Q Consensus 167 ~~~~~DiwslG~l~~~ll~g~~pf~~~~~-------~~~~-~~~~~~~~~~~~~~--------------~~~~~~~~~~~ 224 (311)
++.++|||||||++|+|++|..||..... .... .++........... .......+...
T Consensus 260 ~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 339 (391)
T PHA03212 260 YGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSR 339 (391)
T ss_pred CCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCC
Confidence 99999999999999999999987643221 0000 01100000000000 00000000000
Q ss_pred CCC--ChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 021490 225 GQY--PPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 261 (311)
Q Consensus 225 ~~~--~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l~ 261 (311)
... ....+.++.+|+.+||+.||.+|||+.|+++.-.
T Consensus 340 ~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~ 378 (391)
T PHA03212 340 PLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAA 378 (391)
T ss_pred CCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChh
Confidence 000 0123457889999999999999999999997654
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=261.41 Aligned_cols=236 Identities=25% Similarity=0.339 Sum_probs=185.2
Q ss_pred cchhccCCcEEEEEEeecCCCc------chhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhccc
Q 021490 2 MQVILCLLQDVAIKQLDRNGVQ------GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDL 75 (311)
Q Consensus 2 ~~~~~~~g~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 75 (311)
|.+...+|+.+|+|.++..... ....+.+|+++++.++|+||+++++++.+....++|+||+++++|.+++.+
T Consensus 17 ~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~- 95 (265)
T cd06631 17 YCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNR- 95 (265)
T ss_pred EEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecCCCCcHHHHHHh-
Confidence 3444567889999998654321 124688899999999999999999999999999999999999999999976
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCC----Cceeeeecc
Q 021490 76 SPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD----NTHVSTRVM 151 (311)
Q Consensus 76 ~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~~ 151 (311)
...+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++....... .........
T Consensus 96 ---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ 169 (265)
T cd06631 96 ---FGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMH 169 (265)
T ss_pred ---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhhccccccccccccccC
Confidence 456899999999999999999999999 9999999999999999999999999886432111 111112245
Q ss_pred ccccccCccccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHh
Q 021490 152 GTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRG 231 (311)
Q Consensus 152 ~~~~y~aPE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (311)
++..|+|||++.+..++.++|+||||+++|+|++|..||...+........... .. ..+ ..+...
T Consensus 170 ~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~------~~-----~~~----~~~~~~ 234 (265)
T cd06631 170 GTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAH------RG-----LMP----RLPDSF 234 (265)
T ss_pred CCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhc------cC-----CCC----CCCCCC
Confidence 788999999998888899999999999999999999999765433221111000 00 011 112234
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 021490 232 FYQALAVAAMCVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 232 ~~~l~~li~~~l~~~p~~Rps~~~vl~~ 259 (311)
+..+.+++.+||..+|.+|||+.+++..
T Consensus 235 ~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 235 SAAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred CHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 4578899999999999999999998863
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=262.63 Aligned_cols=220 Identities=24% Similarity=0.370 Sum_probs=174.2
Q ss_pred cEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHHHHH
Q 021490 10 QDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMK 89 (311)
Q Consensus 10 ~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~ 89 (311)
..|++|++..........|.+|+.+++.++||||+++++++.++...++||||+++++|..++... .+.+++..+..
T Consensus 45 ~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~---~~~~~~~~~~~ 121 (274)
T cd05076 45 LRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKE---KGRVPVAWKIT 121 (274)
T ss_pred eeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhc---CCCCCHHHHHH
Confidence 568999986555444568889999999999999999999999999999999999999999988652 45789999999
Q ss_pred HHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCC-------ceEEccccccccCCCCCCceeeeeccccccccCcccc
Q 021490 90 IAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY-------HPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 162 (311)
Q Consensus 90 ~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~-------~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 162 (311)
++.|++.||+|||+++ ++||||||+||+++..+ .++++|||.+..... .....++..|+|||.+
T Consensus 122 i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~------~~~~~~~~~~~aPe~~ 192 (274)
T cd05076 122 VAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALS------REERVERIPWIAPECV 192 (274)
T ss_pred HHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcccCccceeeecCCcccccccc------ccccccCCcccCchhh
Confidence 9999999999999999 99999999999997643 489999998753211 1122466789999988
Q ss_pred cc-CCCccccceeehhHHHHHHH-hCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHH
Q 021490 163 KT-GQLTLKSDVYSFGVVLLEIL-SGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAA 240 (311)
Q Consensus 163 ~~-~~~~~~~DiwslG~l~~~ll-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 240 (311)
.+ ..++.++||||||+++|+|+ +|..||............. ... ..+......+.+++.
T Consensus 193 ~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-------~~~------------~~~~~~~~~~~~li~ 253 (274)
T cd05076 193 PGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYE-------KKH------------RLPEPSCKELATLIS 253 (274)
T ss_pred cCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHHHH-------hcc------------CCCCCCChHHHHHHH
Confidence 65 56789999999999999985 6899997654332221111 000 011112236888999
Q ss_pred HccccCCCCCCCHHHHHHHH
Q 021490 241 MCVHEQPDMRPVIADVVTAL 260 (311)
Q Consensus 241 ~~l~~~p~~Rps~~~vl~~l 260 (311)
+||+.+|++|||+.++++.|
T Consensus 254 ~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 254 QCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HHcccChhhCcCHHHHHHhh
Confidence 99999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=260.42 Aligned_cols=232 Identities=28% Similarity=0.440 Sum_probs=184.3
Q ss_pred EEEEEEeecCCC-cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHHHHH
Q 021490 11 DVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMK 89 (311)
Q Consensus 11 ~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~ 89 (311)
.||+|.++.... .....+.+|+.++..++||||+++++++.. ...++||||+++++|.+++... ...+++..+..
T Consensus 38 ~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~g~L~~~l~~~---~~~~~~~~~~~ 113 (279)
T cd05057 38 PVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRNH---KDNIGSQYLLN 113 (279)
T ss_pred EEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEEecCCCCcHHHHHHhc---cCCCCHHHHHH
Confidence 689998865543 234688899999999999999999999877 7889999999999999998762 34589999999
Q ss_pred HHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccCCCcc
Q 021490 90 IAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTL 169 (311)
Q Consensus 90 ~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 169 (311)
++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||.+.................+..|+|||.+....++.
T Consensus 114 ~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~ 190 (279)
T cd05057 114 WCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTH 190 (279)
T ss_pred HHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCc
Confidence 9999999999999999 9999999999999999999999999987543222211111222356799999998888999
Q ss_pred ccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCC
Q 021490 170 KSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPD 248 (311)
Q Consensus 170 ~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~ 248 (311)
++|+||||+++|++++ |..||...........+. .... ...+......+.+++.+||..||+
T Consensus 191 ~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-------~~~~----------~~~~~~~~~~~~~~~~~~l~~~p~ 253 (279)
T cd05057 191 KSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE-------KGER----------LPQPPICTIDVYMVLVKCWMIDAE 253 (279)
T ss_pred hhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh-------CCCC----------CCCCCCCCHHHHHHHHHHcCCChh
Confidence 9999999999999998 999998765433222111 0000 011122334788899999999999
Q ss_pred CCCCHHHHHHHHHHhhhc
Q 021490 249 MRPVIADVVTALAYLASQ 266 (311)
Q Consensus 249 ~Rps~~~vl~~l~~~~~~ 266 (311)
+|||+.++++.|..+...
T Consensus 254 ~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 254 SRPTFKELINEFSKMARD 271 (279)
T ss_pred hCCCHHHHHHHHHHHHhC
Confidence 999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=263.26 Aligned_cols=243 Identities=23% Similarity=0.261 Sum_probs=176.7
Q ss_pred CCcEEEEEEeecCCCc--chhHHHHHHHHHhcC---CCCcccceeeEeee-----CCeeEEEEecCCCCChhhhhcccCC
Q 021490 8 LLQDVAIKQLDRNGVQ--GNREFLVEVLMLSLL---HHPNLVNLIGYCAD-----GDQRLLVYEYMPLGSVEDHLHDLSP 77 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~ 77 (311)
+|+.||+|.++..... ....+.+|+.+++.+ +||||+++++++.. ....++|||+++ ++|.+++....
T Consensus 24 ~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~- 101 (288)
T cd07863 24 SGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVD-QDLRTYLDKVP- 101 (288)
T ss_pred CCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEEEEcccc-cCHHHHHHhcC-
Confidence 6899999998754322 224566777777665 69999999998754 245799999997 58888887532
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeecccccccc
Q 021490 78 GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 157 (311)
Q Consensus 78 ~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~ 157 (311)
...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++....... ......++..|+
T Consensus 102 -~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~ 174 (288)
T cd07863 102 -PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQM---ALTPVVVTLWYR 174 (288)
T ss_pred -CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCccccccCcc---cCCCcccccccc
Confidence 345899999999999999999999999 9999999999999999999999999986532211 112235788999
Q ss_pred CccccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHH-HHHhhhhhcccccc-ccc-------cCccccCCCC
Q 021490 158 APEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSL-VAWARPLFQDRTRH-SLI-------ADPELQGQYP 228 (311)
Q Consensus 158 aPE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~-~~~-------~~~~~~~~~~ 228 (311)
|||++.+..++.++|||||||++|+|++|.+||........... .............. ... ..+.....+.
T Consensus 175 aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (288)
T cd07863 175 APEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVV 254 (288)
T ss_pred CchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhC
Confidence 99999888899999999999999999999999976554333221 11110000000000 000 0000001112
Q ss_pred hHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 021490 229 PRGFYQALAVAAMCVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 229 ~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~ 259 (311)
+.....+.+++.+||+.||++|||+.+++..
T Consensus 255 ~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 255 PEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred cCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 2345578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=265.77 Aligned_cols=239 Identities=27% Similarity=0.400 Sum_probs=186.6
Q ss_pred cEEEEEEeecCCC-cchhHHHHHHHHHhcC-CCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCC----------
Q 021490 10 QDVAIKQLDRNGV-QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP---------- 77 (311)
Q Consensus 10 ~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------- 77 (311)
..||+|.++.... ...+.+.+|+++++++ +||||+++++++..+...++++||+++++|.+++.....
T Consensus 45 ~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 124 (334)
T cd05100 45 VTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTC 124 (334)
T ss_pred eeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccc
Confidence 4689998865432 3346889999999999 799999999999998899999999999999999875321
Q ss_pred --CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeecccccc
Q 021490 78 --GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG 155 (311)
Q Consensus 78 --~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~ 155 (311)
....+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++................++..
T Consensus 125 ~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~ 201 (334)
T cd05100 125 KLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVK 201 (334)
T ss_pred cCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCce
Confidence 1235788999999999999999999999 99999999999999999999999999865322211111112233467
Q ss_pred ccCccccccCCCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHH
Q 021490 156 YCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQ 234 (311)
Q Consensus 156 y~aPE~~~~~~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
|+|||++.+..++.++||||||+++|+|++ |..||...........+. .... ...+...+..
T Consensus 202 y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~-------~~~~----------~~~~~~~~~~ 264 (334)
T cd05100 202 WMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLK-------EGHR----------MDKPANCTHE 264 (334)
T ss_pred EcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-------cCCC----------CCCCCCCCHH
Confidence 999999988889999999999999999998 889987655433322211 0000 0112223447
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHHHHHhhhccC
Q 021490 235 ALAVAAMCVHEQPDMRPVIADVVTALAYLASQKY 268 (311)
Q Consensus 235 l~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~~~ 268 (311)
+.+++.+||+.+|.+|||+.+++..|+.+.....
T Consensus 265 l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~ 298 (334)
T cd05100 265 LYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTS 298 (334)
T ss_pred HHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcC
Confidence 8899999999999999999999999998875443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=264.32 Aligned_cols=244 Identities=21% Similarity=0.217 Sum_probs=180.0
Q ss_pred CCcEEEEEEeecCCC--cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHH
Q 021490 8 LLQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN 85 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~ 85 (311)
+|..||+|+++.... ...+.+.+|+.+++.++||||+++++++.++...++||||++ ++|.+++.... .+..+++.
T Consensus 24 ~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~-~~~~~~~~ 101 (285)
T cd07861 24 TGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-MDLKKYLDSLP-KGQYMDAE 101 (285)
T ss_pred CCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-CCHHHHHhcCC-CCCcCCHH
Confidence 689999999865432 234678899999999999999999999999999999999997 68888886533 23578999
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccccc-
Q 021490 86 TRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT- 164 (311)
Q Consensus 86 ~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~- 164 (311)
.++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++...... ........++..|+|||++.+
T Consensus 102 ~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~ 176 (285)
T cd07861 102 LVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP--VRVYTHEVVTLWYRAPEVLLGS 176 (285)
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCC--cccccCCcccccccChHHhcCC
Confidence 99999999999999999999 999999999999999999999999998643221 111222346788999998765
Q ss_pred CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHH-HHHhhhhhccc----c-------ccccccCccccCCCChHhH
Q 021490 165 GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSL-VAWARPLFQDR----T-------RHSLIADPELQGQYPPRGF 232 (311)
Q Consensus 165 ~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~-~~~~~~~~~~~----~-------~~~~~~~~~~~~~~~~~~~ 232 (311)
..++.++|+||||+++|+|++|..||........... ........... . .........+ .......+
T Consensus 177 ~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 255 (285)
T cd07861 177 PRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSL-RSAVKNLD 255 (285)
T ss_pred CCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchh-HHhcCCCC
Confidence 4568899999999999999999999976544322111 10000000000 0 0000000000 00111234
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHH
Q 021490 233 YQALAVAAMCVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 233 ~~l~~li~~~l~~~p~~Rps~~~vl~~ 259 (311)
.++.+++.+||..||.+|||+.+++..
T Consensus 256 ~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 256 EDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred HHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 577899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=262.79 Aligned_cols=220 Identities=28% Similarity=0.453 Sum_probs=175.5
Q ss_pred cEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHHHHH
Q 021490 10 QDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMK 89 (311)
Q Consensus 10 ~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~ 89 (311)
.+|++|.+........+.+.+|+.+++.++||||+++++++..+...++||||+++|+|.+++... ...+++..+..
T Consensus 28 ~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~ 104 (258)
T cd05078 28 TEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKN---KNLINISWKLE 104 (258)
T ss_pred chhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecCCCCcHHHHHhcC---CCCCCHHHHHH
Confidence 458888886555455578899999999999999999999999989999999999999999999762 34689999999
Q ss_pred HHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCc--------eEEccccccccCCCCCCceeeeeccccccccCccc
Q 021490 90 IAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH--------PKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 161 (311)
Q Consensus 90 ~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~--------~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 161 (311)
++.|++.||+|||+.+ ++|+||||+||+++.++. ++++|||++..... .....++..|+|||+
T Consensus 105 ~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~------~~~~~~~~~y~aPE~ 175 (258)
T cd05078 105 VAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLP------KEILLERIPWVPPEC 175 (258)
T ss_pred HHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccccccCC------chhccccCCccCchh
Confidence 9999999999999999 999999999999987665 69999998754221 112346778999999
Q ss_pred ccc-CCCccccceeehhHHHHHHHhCC-CccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHH
Q 021490 162 AKT-GQLTLKSDVYSFGVVLLEILSGR-KAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVA 239 (311)
Q Consensus 162 ~~~-~~~~~~~DiwslG~l~~~ll~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 239 (311)
+.+ ..++.++||||||+++|+|++|. .||............ ... ..++.....++.+++
T Consensus 176 ~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~-------~~~------------~~~~~~~~~~~~~li 236 (258)
T cd05078 176 IENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFY-------EDR------------HQLPAPKWTELANLI 236 (258)
T ss_pred ccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHH-------Hcc------------ccCCCCCcHHHHHHH
Confidence 976 45789999999999999999984 666554433222111 000 112223345788999
Q ss_pred HHccccCCCCCCCHHHHHHHH
Q 021490 240 AMCVHEQPDMRPVIADVVTAL 260 (311)
Q Consensus 240 ~~~l~~~p~~Rps~~~vl~~l 260 (311)
.+||+.||++|||+.++++.|
T Consensus 237 ~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 237 NQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred HHHhccChhhCCCHHHHHHhc
Confidence 999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=261.23 Aligned_cols=228 Identities=24% Similarity=0.320 Sum_probs=184.7
Q ss_pred cCCcEEEEEEeecCCC-cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHH
Q 021490 7 CLLQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN 85 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~ 85 (311)
.+|..||+|+++.... .....+.+|+.+++.++|+||+++++++.++...++||||++|++|.+++.. ..+++.
T Consensus 27 ~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~-----~~l~~~ 101 (277)
T cd06640 27 RTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRA-----GPFDEF 101 (277)
T ss_pred cCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCCcHHHHHhc-----CCCCHH
Confidence 3688999999875532 3446788999999999999999999999999999999999999999998864 468899
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccC
Q 021490 86 TRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG 165 (311)
Q Consensus 86 ~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 165 (311)
.+..++.+++.||+|||+.+ ++|+||+|+||+++.++.++++|||++....... .......++..|+|||.+.+.
T Consensus 102 ~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~apE~~~~~ 176 (277)
T cd06640 102 QIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IKRNTFVGTPFWMAPEVIQQS 176 (277)
T ss_pred HHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCc--cccccccCcccccCHhHhccC
Confidence 99999999999999999999 9999999999999999999999999986532221 112223467789999999888
Q ss_pred CCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHcccc
Q 021490 166 QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHE 245 (311)
Q Consensus 166 ~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 245 (311)
.++.++|+||||+++|+|++|..||............ . .......+...+..+.+++.+||..
T Consensus 177 ~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~-------~----------~~~~~~~~~~~~~~~~~li~~~l~~ 239 (277)
T cd06640 177 AYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI-------P----------KNNPPTLTGEFSKPFKEFIDACLNK 239 (277)
T ss_pred CCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhh-------h----------cCCCCCCchhhhHHHHHHHHHHccc
Confidence 8999999999999999999999999765432211110 0 0001122334556788999999999
Q ss_pred CCCCCCCHHHHHHHHH
Q 021490 246 QPDMRPVIADVVTALA 261 (311)
Q Consensus 246 ~p~~Rps~~~vl~~l~ 261 (311)
+|++||++.+++....
T Consensus 240 ~p~~Rp~~~~il~~~~ 255 (277)
T cd06640 240 DPSFRPTAKELLKHKF 255 (277)
T ss_pred CcccCcCHHHHHhChH
Confidence 9999999999987754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=257.70 Aligned_cols=230 Identities=23% Similarity=0.342 Sum_probs=185.5
Q ss_pred cCCcEEEEEEeecCC--CcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCH
Q 021490 7 CLLQDVAIKQLDRNG--VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 84 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~ 84 (311)
.+|..+++|.+.... ......+.+|+.++++++|+||+++++++.+....+++|||+++++|.+++.... ...+++
T Consensus 23 ~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~~~~~~--~~~~~~ 100 (256)
T cd08221 23 EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQK--GQLFEE 100 (256)
T ss_pred CCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCCCcHHHHHHhcc--ccCCCH
Confidence 368899999986553 3445678899999999999999999999999999999999999999999997632 356899
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccccc
Q 021490 85 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT 164 (311)
Q Consensus 85 ~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 164 (311)
..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||.+........ ......++..|+|||.+.+
T Consensus 101 ~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~--~~~~~~~~~~y~ape~~~~ 175 (256)
T cd08221 101 EMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS--MAETVVGTPYYMSPELCQG 175 (256)
T ss_pred HHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc--cccccCCCccccCHhhcCC
Confidence 999999999999999999999 99999999999999999999999998865322221 2223457889999999988
Q ss_pred CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccc
Q 021490 165 GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVH 244 (311)
Q Consensus 165 ~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 244 (311)
..++.++|+||||+++|+|++|..||...........+. .. ... ..+...+..+.+++.+||.
T Consensus 176 ~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~------~~--~~~---------~~~~~~~~~~~~~i~~~l~ 238 (256)
T cd08221 176 VKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIV------QG--NYT---------PVVSVYSSELISLVHSLLQ 238 (256)
T ss_pred CCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH------cC--CCC---------CCccccCHHHHHHHHHHcc
Confidence 888999999999999999999999997654432221111 00 000 0112234578889999999
Q ss_pred cCCCCCCCHHHHHHHH
Q 021490 245 EQPDMRPVIADVVTAL 260 (311)
Q Consensus 245 ~~p~~Rps~~~vl~~l 260 (311)
.+|.+|||+.++++.+
T Consensus 239 ~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 239 QDPEKRPTADEVLDQP 254 (256)
T ss_pred cCcccCCCHHHHhhCc
Confidence 9999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=275.66 Aligned_cols=242 Identities=21% Similarity=0.216 Sum_probs=180.1
Q ss_pred CCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHHH
Q 021490 8 LLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTR 87 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~ 87 (311)
.+..||+|.+... ..+.+|+++++.++||||+++++++......++|||++. ++|.+++.. ...+++..+
T Consensus 118 ~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~----~~~l~~~~~ 187 (392)
T PHA03207 118 QRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK-CDLFTYVDR----SGPLPLEQA 187 (392)
T ss_pred cceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcC-CCHHHHHHh----cCCCCHHHH
Confidence 4578899987532 345689999999999999999999999999999999995 688888854 567999999
Q ss_pred HHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccCCC
Q 021490 88 MKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQL 167 (311)
Q Consensus 88 ~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 167 (311)
+.++.|++.||+|||+.+ |+||||||+|||++.++.++|+|||++................++..|+|||++.+..+
T Consensus 188 ~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 264 (392)
T PHA03207 188 ITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPY 264 (392)
T ss_pred HHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcccccccccccccccCccCHhHhcCCCC
Confidence 999999999999999999 99999999999999999999999999865433322222234568999999999998899
Q ss_pred ccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhcccccccc------------ccCccccCCC--C-----
Q 021490 168 TLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSL------------IADPELQGQY--P----- 228 (311)
Q Consensus 168 ~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~--~----- 228 (311)
+.++|||||||++|+|++|..||.+................++....... .........+ +
T Consensus 265 ~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (392)
T PHA03207 265 CAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRK 344 (392)
T ss_pred CchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhc
Confidence 99999999999999999999999654322111111000000000000000 0000000000 0
Q ss_pred hHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 021490 229 PRGFYQALAVAAMCVHEQPDMRPVIADVVTALAY 262 (311)
Q Consensus 229 ~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l~~ 262 (311)
.....++.++|.+||+.||++|||+.+++..-.+
T Consensus 345 ~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f 378 (392)
T PHA03207 345 YGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLF 378 (392)
T ss_pred cCcchhHHHHHHHHhccChhhCCCHHHHhhCchh
Confidence 0123467889999999999999999999988654
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=270.02 Aligned_cols=231 Identities=22% Similarity=0.239 Sum_probs=178.2
Q ss_pred CCcEEEEEEeecCCC---cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCH
Q 021490 8 LLQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 84 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~ 84 (311)
+++.||+|++..... .....+.+|+.+++.++||||+++++++.++...++||||++|++|.+++.. ..+++
T Consensus 67 ~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~-----~~~~~ 141 (371)
T cd05622 67 TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN-----YDVPE 141 (371)
T ss_pred CCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHh-----cCCCH
Confidence 578999999865321 2335678899999999999999999999999999999999999999999875 45899
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccccc
Q 021490 85 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT 164 (311)
Q Consensus 85 ~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 164 (311)
..+..++.|++.||+|||+.+ ++||||||+|||++.++.++|+|||++....... ........|++.|+|||++..
T Consensus 142 ~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~-~~~~~~~~gt~~y~aPE~l~~ 217 (371)
T cd05622 142 KWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG-MVRCDTAVGTPDYISPEVLKS 217 (371)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCC-cccccCcccCccccCHHHHhc
Confidence 999999999999999999999 9999999999999999999999999987532211 111223468999999999865
Q ss_pred C----CCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHH
Q 021490 165 G----QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAA 240 (311)
Q Consensus 165 ~----~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 240 (311)
. .++.++|||||||++|+|++|..||...+.......+ .... ....+ ......+..+.+++.
T Consensus 218 ~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i------~~~~-~~~~~-------~~~~~~s~~~~~li~ 283 (371)
T cd05622 218 QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI------MNHK-NSLTF-------PDDNDISKEAKNLIC 283 (371)
T ss_pred cCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHH------HcCC-CcccC-------CCcCCCCHHHHHHHH
Confidence 3 3788999999999999999999999876543221111 1100 00000 011234457888999
Q ss_pred HccccCCCC--CCCHHHHHHHHH
Q 021490 241 MCVHEQPDM--RPVIADVVTALA 261 (311)
Q Consensus 241 ~~l~~~p~~--Rps~~~vl~~l~ 261 (311)
.||..++.. |++++++++...
T Consensus 284 ~~L~~~~~r~~r~~~~ei~~h~~ 306 (371)
T cd05622 284 AFLTDREVRLGRNGVEEIKRHLF 306 (371)
T ss_pred HHcCChhhhcCCCCHHHHhcCcc
Confidence 999844433 789999998763
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=263.01 Aligned_cols=233 Identities=24% Similarity=0.335 Sum_probs=184.4
Q ss_pred cchhc-cCCcEEEEEEeecCC-CcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCC
Q 021490 2 MQVIL-CLLQDVAIKQLDRNG-VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGK 79 (311)
Q Consensus 2 ~~~~~-~~g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~ 79 (311)
|.++. .+|..||+|.++... ....+.+.+|+.+++.++||||+++++.+..+...++||||+++++|.+++..
T Consensus 21 y~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----- 95 (277)
T cd06642 21 YKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKP----- 95 (277)
T ss_pred EEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCCcHHHHhhc-----
Confidence 34433 357899999986443 23346788999999999999999999999999999999999999999998864
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCc
Q 021490 80 KPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 159 (311)
Q Consensus 80 ~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aP 159 (311)
..+++..+..++.+++.|++|||+++ ++|+||+|+||++++++.++++|||++....... .......++..|+||
T Consensus 96 ~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aP 170 (277)
T cd06642 96 GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IKRNTFVGTPFWMAP 170 (277)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcc--hhhhcccCcccccCH
Confidence 56899999999999999999999999 9999999999999999999999999986532211 111123467889999
Q ss_pred cccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHH
Q 021490 160 EYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVA 239 (311)
Q Consensus 160 E~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 239 (311)
|.+.+..++.++|+||||+++|+|++|..||........... .... ..+ ..+...+..+.+++
T Consensus 171 E~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~-------~~~~------~~~----~~~~~~~~~~~~li 233 (277)
T cd06642 171 EVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFL-------IPKN------SPP----TLEGQYSKPFKEFV 233 (277)
T ss_pred HHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhh-------hhcC------CCC----CCCcccCHHHHHHH
Confidence 999888899999999999999999999999875433211110 0000 011 11223345788999
Q ss_pred HHccccCCCCCCCHHHHHHHHH
Q 021490 240 AMCVHEQPDMRPVIADVVTALA 261 (311)
Q Consensus 240 ~~~l~~~p~~Rps~~~vl~~l~ 261 (311)
.+||+.+|++|||+.+++....
T Consensus 234 ~~~l~~~p~~Rp~~~~il~~~~ 255 (277)
T cd06642 234 EACLNKDPRFRPTAKELLKHKF 255 (277)
T ss_pred HHHccCCcccCcCHHHHHHhHH
Confidence 9999999999999999998643
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=258.43 Aligned_cols=235 Identities=23% Similarity=0.339 Sum_probs=174.0
Q ss_pred EEEEEEeecCCC-cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHHHHH
Q 021490 11 DVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMK 89 (311)
Q Consensus 11 ~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~ 89 (311)
.+++|.++.... ...+.|.+|+.+++.++||||+++++.+.+....++||||+++++|.+++.........++...+..
T Consensus 24 ~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 103 (268)
T cd05086 24 RVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQR 103 (268)
T ss_pred eEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCcHHHHHHhhhcccccccHHHHHH
Confidence 456666654332 3456899999999999999999999999999999999999999999999976433334577788899
Q ss_pred HHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccccc-----
Q 021490 90 IAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT----- 164 (311)
Q Consensus 90 ~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----- 164 (311)
++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++................++..|+|||++..
T Consensus 104 ~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 180 (268)
T cd05086 104 MACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGL 180 (268)
T ss_pred HHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCcc
Confidence 9999999999999999 99999999999999999999999998753211111111223456788999998753
Q ss_pred --CCCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHH
Q 021490 165 --GQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAM 241 (311)
Q Consensus 165 --~~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 241 (311)
..++.++||||||+++|+|++ |..||............ ... ......++.+. ......+.+++..
T Consensus 181 ~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~------~~~--~~~~~~~~~~~----~~~~~~~~~l~~~ 248 (268)
T cd05086 181 ITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHV------IKD--QQVKLFKPQLE----LPYSERWYEVLQF 248 (268)
T ss_pred ccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH------Hhh--cccccCCCccC----CCCcHHHHHHHHH
Confidence 235778999999999999997 56788654432221111 100 00111122222 2233467789999
Q ss_pred ccccCCCCCCCHHHHHHHHH
Q 021490 242 CVHEQPDMRPVIADVVTALA 261 (311)
Q Consensus 242 ~l~~~p~~Rps~~~vl~~l~ 261 (311)
|| .+|++|||+.++++.|.
T Consensus 249 c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 249 CW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred Hh-hCcccCCCHHHHHHHhc
Confidence 99 67999999999998873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=257.34 Aligned_cols=229 Identities=32% Similarity=0.448 Sum_probs=182.3
Q ss_pred CcEEEEEEeecCCCc-chhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHHH
Q 021490 9 LQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTR 87 (311)
Q Consensus 9 g~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~ 87 (311)
+..||+|+++..... ..+.+.+|+.++..++|+||+++++++.+....+++|||+++++|.+++.... ...+++..+
T Consensus 28 ~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~~~~~l~~~~~~~~--~~~~~~~~~ 105 (258)
T smart00219 28 EVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMEGGDLLDYLRKNR--PKELSLSDL 105 (258)
T ss_pred CceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEeccCCCCHHHHHHhhh--hccCCHHHH
Confidence 488999999665443 46789999999999999999999999999999999999999999999997621 122899999
Q ss_pred HHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccCCC
Q 021490 88 MKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQL 167 (311)
Q Consensus 88 ~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 167 (311)
+.++.|++.||++||+.+ ++|+||+|+||+++.++.++|+|||++........... ....++..|+|||.+....+
T Consensus 106 ~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~-~~~~~~~~y~~Pe~~~~~~~ 181 (258)
T smart00219 106 LSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKK-KGGKLPIRWMAPESLKDGKF 181 (258)
T ss_pred HHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceeccccccccc-ccCCCcccccChHHhccCCC
Confidence 999999999999999999 99999999999999999999999999875433211111 12236678999999988889
Q ss_pred ccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccC
Q 021490 168 TLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQ 246 (311)
Q Consensus 168 ~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 246 (311)
+.++|+||||+++|+|++ |..||............... .. ...+...+..+.+++.+||..|
T Consensus 182 ~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~-------~~----------~~~~~~~~~~~~~~i~~~l~~~ 244 (258)
T smart00219 182 TSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKG-------YR----------LPKPENCPPEIYKLMLQCWAED 244 (258)
T ss_pred CcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC-------CC----------CCCCCcCCHHHHHHHHHHCcCC
Confidence 999999999999999998 78888764433222211100 00 0111123457888999999999
Q ss_pred CCCCCCHHHHHHHH
Q 021490 247 PDMRPVIADVVTAL 260 (311)
Q Consensus 247 p~~Rps~~~vl~~l 260 (311)
|.+|||+.++++.|
T Consensus 245 p~~Rpt~~~ll~~l 258 (258)
T smart00219 245 PEDRPTFSELVEIL 258 (258)
T ss_pred hhhCcCHHHHHhhC
Confidence 99999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=261.10 Aligned_cols=231 Identities=29% Similarity=0.448 Sum_probs=184.2
Q ss_pred CCcEEEEEEeecCCCcchh--HHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHH
Q 021490 8 LLQDVAIKQLDRNGVQGNR--EFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN 85 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~~~~--~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~ 85 (311)
+|+.||+|++......... ...+|+.+++.++||||+++++++.+....++|||++++++|.+++.. ...+++.
T Consensus 23 ~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~L~~~l~~----~~~~~~~ 98 (260)
T PF00069_consen 23 NGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPGGSLQDYLQK----NKPLSEE 98 (260)
T ss_dssp TTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETTEBHHHHHHH----HSSBBHH
T ss_pred CCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccccccccccccccccccccccc----ccccccc
Confidence 4678999999776543332 345699999999999999999999999999999999999999999984 5779999
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccc-c
Q 021490 86 TRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK-T 164 (311)
Q Consensus 86 ~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~ 164 (311)
.++.++.|++.||++||+.+ ++|+||+|+||+++.++.++|+|||.+... ...........++..|.|||++. +
T Consensus 99 ~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~--~~~~~~~~~~~~~~~y~aPE~~~~~ 173 (260)
T PF00069_consen 99 EILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKL--SENNENFNPFVGTPEYMAPEVLQQG 173 (260)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEES--TSTTSEBSSSSSSGGGSCHHHHTTT
T ss_pred cccccccccccccccccccc---cccccccccccccccccccccccccccccc--ccccccccccccccccccccccccc
Confidence 99999999999999999999 999999999999999999999999998643 11222334456788999999998 7
Q ss_pred CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhh-hhccccccccccCccccCCCChHhHHHHHHHHHHcc
Q 021490 165 GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARP-LFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCV 243 (311)
Q Consensus 165 ~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 243 (311)
..++.++|+||||+++|+|++|..||................. ....... ........+.+++.+||
T Consensus 174 ~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~l~~li~~~l 241 (260)
T PF00069_consen 174 KKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQ------------QSREKSEELRDLIKKML 241 (260)
T ss_dssp SSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTT------------SHTTSHHHHHHHHHHHS
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhhccccccccccc------------ccchhHHHHHHHHHHHc
Confidence 8899999999999999999999999987633333222221111 0000000 00011258899999999
Q ss_pred ccCCCCCCCHHHHHHH
Q 021490 244 HEQPDMRPVIADVVTA 259 (311)
Q Consensus 244 ~~~p~~Rps~~~vl~~ 259 (311)
+.||++|||+.++++.
T Consensus 242 ~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 242 SKDPEQRPSAEELLKH 257 (260)
T ss_dssp SSSGGGSTTHHHHHTS
T ss_pred cCChhHCcCHHHHhcC
Confidence 9999999999999864
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=259.06 Aligned_cols=217 Identities=28% Similarity=0.444 Sum_probs=173.1
Q ss_pred EEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHHHHHH
Q 021490 11 DVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI 90 (311)
Q Consensus 11 ~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~ 90 (311)
.|++|.+...... ...|.+|+.+++.++||||+++++++.. ...++||||+++++|.+++... ...+++..+..+
T Consensus 32 ~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~ 106 (259)
T cd05037 32 SVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHRE---KNNVSLHWKLDV 106 (259)
T ss_pred eeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEEEcCCCCcHHHHHHhh---ccCCCHHHHHHH
Confidence 5788887544433 6789999999999999999999999887 7789999999999999999862 237899999999
Q ss_pred HHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCC-------ceEEccccccccCCCCCCceeeeeccccccccCccccc
Q 021490 91 AAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY-------HPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 163 (311)
Q Consensus 91 ~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~-------~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 163 (311)
+.|++.||+|||+.+ ++|+||||+||+++.++ .++|+|||++..... .....++..|+|||++.
T Consensus 107 ~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~------~~~~~~~~~y~aPE~~~ 177 (259)
T cd05037 107 AKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS------REERVERIPWIAPECIR 177 (259)
T ss_pred HHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCCccccccc------ccccccCCCccChhhhc
Confidence 999999999999999 99999999999999887 799999999874322 11234567899999987
Q ss_pred cC--CCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHH
Q 021490 164 TG--QLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAA 240 (311)
Q Consensus 164 ~~--~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 240 (311)
.. .++.++|+||||+++|+|++ |..||............. .. . ..+......+.+++.
T Consensus 178 ~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-------~~---~---------~~~~~~~~~~~~li~ 238 (259)
T cd05037 178 NGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-------DQ---H---------RLPMPDCAELANLIN 238 (259)
T ss_pred CCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-------cC---C---------CCCCCCchHHHHHHH
Confidence 76 78899999999999999999 577776654222111110 00 0 001111257889999
Q ss_pred HccccCCCCCCCHHHHHHHH
Q 021490 241 MCVHEQPDMRPVIADVVTAL 260 (311)
Q Consensus 241 ~~l~~~p~~Rps~~~vl~~l 260 (311)
+||..+|.+|||+.++++.|
T Consensus 239 ~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 239 QCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred HHhccChhhCCCHHHHHHhc
Confidence 99999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=258.75 Aligned_cols=236 Identities=25% Similarity=0.341 Sum_probs=174.9
Q ss_pred CcEEEEEEeecCCC-cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCC-CCCCCHHH
Q 021490 9 LQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPG-KKPLDWNT 86 (311)
Q Consensus 9 g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~l~~~~ 86 (311)
...+|+|.+..... .....|.+|+..++.++|+||+++++.+.+....++||||+++++|.+++...... ...+++..
T Consensus 22 ~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 101 (269)
T cd05042 22 KARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDV 101 (269)
T ss_pred CeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCcHHHHHHhccccccccccHHH
Confidence 45788887754432 23457889999999999999999999999999999999999999999998764321 23456788
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccccc--
Q 021490 87 RMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT-- 164 (311)
Q Consensus 87 ~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-- 164 (311)
+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++................++..|+|||++..
T Consensus 102 ~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 178 (269)
T cd05042 102 LQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRG 178 (269)
T ss_pred HHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhcc
Confidence 8999999999999999999 99999999999999999999999999864222111111122335667999998743
Q ss_pred -----CCCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHH
Q 021490 165 -----GQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAV 238 (311)
Q Consensus 165 -----~~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 238 (311)
..++.++|||||||++|+|++ |..||............ ... .......+.+ +...+..+.++
T Consensus 179 ~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~------~~~--~~~~~~~~~~----~~~~~~~~~~~ 246 (269)
T cd05042 179 QDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQV------VRE--QDIKLPKPQL----DLKYSDRWYEV 246 (269)
T ss_pred ccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHH------hhc--cCccCCCCcc----cccCCHHHHHH
Confidence 356789999999999999999 78888765433221111 000 0011112222 22233466778
Q ss_pred HHHccccCCCCCCCHHHHHHHH
Q 021490 239 AAMCVHEQPDMRPVIADVVTAL 260 (311)
Q Consensus 239 i~~~l~~~p~~Rps~~~vl~~l 260 (311)
+..|| .||++|||+.+|++.|
T Consensus 247 ~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 247 MQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred HHHHh-cCcccccCHHHHHHHh
Confidence 88898 5999999999999886
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=261.03 Aligned_cols=231 Identities=27% Similarity=0.356 Sum_probs=181.4
Q ss_pred cCCcEEEEEEeecCCC---cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCC
Q 021490 7 CLLQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLD 83 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~ 83 (311)
.+|+.||+|.+..... .....+.+|+++++.++|+||+.+.+.+.+++..++||||+++++|.+++.... ...++
T Consensus 23 ~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~ 100 (285)
T cd05632 23 ATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMG--NPGFE 100 (285)
T ss_pred CCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccCccHHHHHHHhc--CCCCC
Confidence 4688999999865432 223467889999999999999999999999999999999999999998886522 34699
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccc
Q 021490 84 WNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 163 (311)
Q Consensus 84 ~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 163 (311)
+..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++....... ......++..|+|||++.
T Consensus 101 ~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~---~~~~~~g~~~~~aPE~~~ 174 (285)
T cd05632 101 EERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE---SIRGRVGTVGYMAPEVLN 174 (285)
T ss_pred HHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC---cccCCCCCcCccChHHhc
Confidence 9999999999999999999999 9999999999999999999999999886432211 112345789999999998
Q ss_pred cCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHcc
Q 021490 164 TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCV 243 (311)
Q Consensus 164 ~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 243 (311)
+..++.++|+||||+++|+|++|..||............... .... . ..++...+..+.+|+..||
T Consensus 175 ~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~---~~~~-------~----~~~~~~~~~~~~~li~~~l 240 (285)
T cd05632 175 NQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRR---VLET-------E----EVYSAKFSEEAKSICKMLL 240 (285)
T ss_pred CCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh---hhcc-------c----cccCccCCHHHHHHHHHHc
Confidence 888999999999999999999999999765432221111100 0000 0 0112223447788999999
Q ss_pred ccCCCCCCC-----HHHHHHH
Q 021490 244 HEQPDMRPV-----IADVVTA 259 (311)
Q Consensus 244 ~~~p~~Rps-----~~~vl~~ 259 (311)
+.||++||+ +.+++..
T Consensus 241 ~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 241 TKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred cCCHhHcCCCcccChHHHHcC
Confidence 999999999 6666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=260.53 Aligned_cols=228 Identities=26% Similarity=0.353 Sum_probs=183.7
Q ss_pred CCcEEEEEEeecCC-CcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHH
Q 021490 8 LLQDVAIKQLDRNG-VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNT 86 (311)
Q Consensus 8 ~g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~ 86 (311)
+|..||+|++.... ......+.+|+.+++.++|+||+++++++.++...++|+||+++++|.+++.. ..+++..
T Consensus 25 ~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~-----~~~~~~~ 99 (274)
T cd06609 25 TNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKP-----GKLDETY 99 (274)
T ss_pred CCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCcHHHHHhh-----cCCCHHH
Confidence 68999999986553 23346788999999999999999999999999999999999999999999875 3789999
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccCC
Q 021490 87 RMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ 166 (311)
Q Consensus 87 ~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 166 (311)
+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++....... .......++..|+|||.+.+..
T Consensus 100 ~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~ 174 (274)
T cd06609 100 IAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--SKRNTFVGTPFWMAPEVIKQSG 174 (274)
T ss_pred HHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc--cccccccCCccccChhhhccCC
Confidence 9999999999999999999 9999999999999999999999999987543221 1122345777899999998888
Q ss_pred CccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccC
Q 021490 167 LTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQ 246 (311)
Q Consensus 167 ~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 246 (311)
++.++|+||||+++|+|++|..||...........+. .. ..+.+... ..+..+.+++.+||..+
T Consensus 175 ~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~-------~~------~~~~~~~~---~~~~~~~~~l~~~l~~~ 238 (274)
T cd06609 175 YDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIP-------KN------NPPSLEGN---KFSKPFKDFVSLCLNKD 238 (274)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhh-------hc------CCCCCccc---ccCHHHHHHHHHHhhCC
Confidence 9999999999999999999999997654322111110 00 00111110 03347888999999999
Q ss_pred CCCCCCHHHHHHHHH
Q 021490 247 PDMRPVIADVVTALA 261 (311)
Q Consensus 247 p~~Rps~~~vl~~l~ 261 (311)
|++|||++++++.-.
T Consensus 239 p~~Rpt~~~il~~~~ 253 (274)
T cd06609 239 PKERPSAKELLKHKF 253 (274)
T ss_pred hhhCcCHHHHhhChh
Confidence 999999999988644
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=261.56 Aligned_cols=230 Identities=22% Similarity=0.308 Sum_probs=178.5
Q ss_pred cCCcEEEEEEeecCC-CcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHH
Q 021490 7 CLLQDVAIKQLDRNG-VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN 85 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~ 85 (311)
.+++.||+|++.... ......+.+|++++.+++||||+++++.+......++||||+++++|..+ ..+++.
T Consensus 24 ~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~--------~~~~~~ 95 (279)
T cd06619 24 LTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVY--------RKIPEH 95 (279)
T ss_pred CCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCCChHHh--------hcCCHH
Confidence 478999999986542 23346789999999999999999999999999999999999999998654 236788
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccC
Q 021490 86 TRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG 165 (311)
Q Consensus 86 ~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 165 (311)
.+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++...... ......++..|+|||++.+.
T Consensus 96 ~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~ 168 (279)
T cd06619 96 VLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----IAKTYVGTNAYMAPERISGE 168 (279)
T ss_pred HHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc----cccCCCCChhhcCceeecCC
Confidence 99999999999999999999 999999999999999999999999998643211 12234578899999999988
Q ss_pred CCccccceeehhHHHHHHHhCCCccCcchhHHHHH-HHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccc
Q 021490 166 QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQS-LVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVH 244 (311)
Q Consensus 166 ~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 244 (311)
.++.++|+||||+++|+|++|..||.......... ............ .+.+ .....+.++.+++.+||+
T Consensus 169 ~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-------~~~~---~~~~~~~~~~~li~~~l~ 238 (279)
T cd06619 169 QYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED-------PPVL---PVGQFSEKFVHFITQCMR 238 (279)
T ss_pred CCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC-------CCCC---CCCcCCHHHHHHHHHHhh
Confidence 89999999999999999999999996533211110 000000000000 0000 011233478899999999
Q ss_pred cCCCCCCCHHHHHHHHH
Q 021490 245 EQPDMRPVIADVVTALA 261 (311)
Q Consensus 245 ~~p~~Rps~~~vl~~l~ 261 (311)
.||++||++.++++...
T Consensus 239 ~~P~~Rp~~~eil~~~~ 255 (279)
T cd06619 239 KQPKERPAPENLMDHPF 255 (279)
T ss_pred CChhhCCCHHHHhcCcc
Confidence 99999999999997643
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=261.87 Aligned_cols=236 Identities=27% Similarity=0.408 Sum_probs=182.4
Q ss_pred CCcEEEEEEeecCCC-cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCC------CCC
Q 021490 8 LLQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP------GKK 80 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~------~~~ 80 (311)
.+..||+|.++.... .....+.+|+..++.++||||+++++++.++...++||||+++|+|.+++..... ...
T Consensus 35 ~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 114 (288)
T cd05061 35 AETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRP 114 (288)
T ss_pred cceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCC
Confidence 356899998864432 2335688899999999999999999999999999999999999999999975321 123
Q ss_pred CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcc
Q 021490 81 PLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 160 (311)
Q Consensus 81 ~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE 160 (311)
.++...+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++................++..|+|||
T Consensus 115 ~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE 191 (288)
T cd05061 115 PPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPE 191 (288)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHH
Confidence 4567788999999999999999999 9999999999999999999999999986432222111112223466799999
Q ss_pred ccccCCCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHH
Q 021490 161 YAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVA 239 (311)
Q Consensus 161 ~~~~~~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 239 (311)
.+.+..++.++|+|||||++|+|++ |..||............ .... . + ..+...+..+.+++
T Consensus 192 ~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~------~~~~-~------~----~~~~~~~~~~~~li 254 (288)
T cd05061 192 SLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV------MDGG-Y------L----DQPDNCPERVTDLM 254 (288)
T ss_pred HhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH------HcCC-C------C----CCCCCCCHHHHHHH
Confidence 9988889999999999999999998 78898765543322211 0000 0 0 01112235788999
Q ss_pred HHccccCCCCCCCHHHHHHHHHHh
Q 021490 240 AMCVHEQPDMRPVIADVVTALAYL 263 (311)
Q Consensus 240 ~~~l~~~p~~Rps~~~vl~~l~~~ 263 (311)
.+||+.||++|||+.++++.|+..
T Consensus 255 ~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 255 RMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred HHHcCCChhHCcCHHHHHHHHHhh
Confidence 999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=272.49 Aligned_cols=230 Identities=21% Similarity=0.216 Sum_probs=178.7
Q ss_pred CCcEEEEEEeecCC---CcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCH
Q 021490 8 LLQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 84 (311)
Q Consensus 8 ~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~ 84 (311)
+|+.||+|+++... ......+.+|+.++..++||||+++++.+.++...|+||||++||+|.+++.. ...+++
T Consensus 25 ~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~l~~ 100 (360)
T cd05627 25 TGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMK----KDTLSE 100 (360)
T ss_pred CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCccHHHHHHh----cCCCCH
Confidence 68999999997543 23345778899999999999999999999999999999999999999999976 567999
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCc--------------------
Q 021490 85 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT-------------------- 144 (311)
Q Consensus 85 ~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~-------------------- 144 (311)
..+..++.|++.||+|||+.| ++||||||+||+++.++.++|+|||++.........
T Consensus 101 ~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (360)
T cd05627 101 EATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMN 177 (360)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccccccccccccccCCcccccccccc
Confidence 999999999999999999999 999999999999999999999999987643211000
Q ss_pred -------------eeeeeccccccccCccccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhcc
Q 021490 145 -------------HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQD 211 (311)
Q Consensus 145 -------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 211 (311)
.......|+..|+|||++.+..++.++|||||||++|+|++|..||...........+. ..
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~~~i~------~~ 251 (360)
T cd05627 178 SKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVM------NW 251 (360)
T ss_pred cccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCCHHHHHHHHH------cC
Confidence 00112358999999999999999999999999999999999999997665433222111 00
Q ss_pred ccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCC---HHHHHHH
Q 021490 212 RTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPV---IADVVTA 259 (311)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps---~~~vl~~ 259 (311)
... . .+.. ....+..+.+++.+++. ||.+|++ +.++++.
T Consensus 252 --~~~-~---~~p~--~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 252 --KET-L---VFPP--EVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSH 293 (360)
T ss_pred --CCc-e---ecCC--CCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence 000 0 0000 01134477888888774 9999985 5666655
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=259.69 Aligned_cols=230 Identities=24% Similarity=0.363 Sum_probs=180.1
Q ss_pred cCCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCC--CH
Q 021490 7 CLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPL--DW 84 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l--~~ 84 (311)
.++..|++|.+........+.+.+|+.++..++|+||+++++++..+...++|+||+++++|.+++... ...+ ++
T Consensus 31 ~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~ 107 (268)
T cd06624 31 STQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSK---WGPLKDNE 107 (268)
T ss_pred CCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHHHHHHHh---cccCCCcH
Confidence 357889999987666556678999999999999999999999999999999999999999999998752 2344 78
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcC-CCceEEccccccccCCCCCCceeeeeccccccccCccccc
Q 021490 85 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR-GYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 163 (311)
Q Consensus 85 ~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 163 (311)
..+..++.|++.||+|||+.+ ++|+||+|+||+++. ++.++|+|||.+....... .......++..|+|||.+.
T Consensus 108 ~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~aPE~~~ 182 (268)
T cd06624 108 QTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN--PCTETFTGTLQYMAPEVID 182 (268)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecccCC--CccccCCCCccccChhhhc
Confidence 889999999999999999999 999999999999976 6789999999886432211 1122234788999999886
Q ss_pred cC--CCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHH
Q 021490 164 TG--QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAM 241 (311)
Q Consensus 164 ~~--~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 241 (311)
.. .++.++|+||||+++|+|++|..||.......... +...... ..+ .++......+.+++.+
T Consensus 183 ~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~---~~~~~~~--------~~~----~~~~~~~~~~~~li~~ 247 (268)
T cd06624 183 KGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM---FKVGMFK--------IHP----EIPESLSAEAKNFILR 247 (268)
T ss_pred cccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhH---hhhhhhc--------cCC----CCCcccCHHHHHHHHH
Confidence 54 37889999999999999999999996543211110 0000000 011 1233344578899999
Q ss_pred ccccCCCCCCCHHHHHHH
Q 021490 242 CVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 242 ~l~~~p~~Rps~~~vl~~ 259 (311)
||+.+|.+|||+.+++..
T Consensus 248 ~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 248 CFEPDPDKRASAHDLLQD 265 (268)
T ss_pred HcCCCchhCCCHHHHHhC
Confidence 999999999999999864
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=261.86 Aligned_cols=240 Identities=23% Similarity=0.374 Sum_probs=181.8
Q ss_pred cCCcEEEEEEeecCC-CcchhHHHHHHHHHhcCCCCcccceeeEeeeC--CeeEEEEecCCCCChhhhhcccCCCCCCCC
Q 021490 7 CLLQDVAIKQLDRNG-VQGNREFLVEVLMLSLLHHPNLVNLIGYCADG--DQRLLVYEYMPLGSVEDHLHDLSPGKKPLD 83 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~ 83 (311)
.++..||+|.++... ......+.+|+.+++.++||||+++++++.+. ...++||||++|++|.+++... ...++
T Consensus 31 ~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~---~~~~~ 107 (284)
T cd05079 31 NTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRN---KNKIN 107 (284)
T ss_pred CccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEEEEEccCCCCHHHHHHhc---cCCCC
Confidence 368889999986553 23346889999999999999999999998765 5689999999999999998652 34689
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCc-eeeeeccccccccCcccc
Q 021490 84 WNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT-HVSTRVMGTYGYCAPEYA 162 (311)
Q Consensus 84 ~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~ 162 (311)
+..+..++.|++.||+|||+++ ++|+||+|+||+++.++.++|+|||++......... .......++..|+|||++
T Consensus 108 ~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~ 184 (284)
T cd05079 108 LKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECL 184 (284)
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHh
Confidence 9999999999999999999999 999999999999999999999999998754322211 111223456789999999
Q ss_pred ccCCCccccceeehhHHHHHHHhCCCccCcchhHHH---------HHHHHHhhhhhccccccccccCccccCCCChHhHH
Q 021490 163 KTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE---------QSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFY 233 (311)
Q Consensus 163 ~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
.+..++.++||||||+++|+|+++..|+........ ....... ...... .....+...+.
T Consensus 185 ~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~----------~~~~~~~~~~~ 253 (284)
T cd05079 185 IQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV-RVLEEG----------KRLPRPPNCPE 253 (284)
T ss_pred ccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHH-HHHHcC----------ccCCCCCCCCH
Confidence 888899999999999999999997765432111000 0000000 000000 00111223456
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 021490 234 QALAVAAMCVHEQPDMRPVIADVVTALAYL 263 (311)
Q Consensus 234 ~l~~li~~~l~~~p~~Rps~~~vl~~l~~~ 263 (311)
.+.+|+.+||+.||++|||+.++++.|+.+
T Consensus 254 ~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 254 EVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 899999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=257.05 Aligned_cols=233 Identities=27% Similarity=0.405 Sum_probs=177.5
Q ss_pred CcEEEEEEeecCC-CcchhHHHHHHHHHhcCCCCcccceeeEee-eCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHH
Q 021490 9 LQDVAIKQLDRNG-VQGNREFLVEVLMLSLLHHPNLVNLIGYCA-DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNT 86 (311)
Q Consensus 9 g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~ 86 (311)
+..||+|.+.... ....+.+.+|+.+++.++||||+++++++. .+...++||||+.+++|.+++... ...+++..
T Consensus 23 ~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~ 99 (262)
T cd05058 23 KIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSE---THNPTVKD 99 (262)
T ss_pred eEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCCCCHHHHHHhc---CCCCCHHH
Confidence 4679999885433 234568889999999999999999999765 455679999999999999998752 24467788
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCce--eeeeccccccccCcccccc
Q 021490 87 RMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH--VSTRVMGTYGYCAPEYAKT 164 (311)
Q Consensus 87 ~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~ 164 (311)
+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.......... ......++..|+|||.+..
T Consensus 100 ~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 176 (262)
T cd05058 100 LIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQT 176 (262)
T ss_pred HHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcceeecccccCcCCccccChhHhcc
Confidence 8999999999999999999 9999999999999999999999999986432211101 1112235668999999988
Q ss_pred CCCccccceeehhHHHHHHHhC-CCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHcc
Q 021490 165 GQLTLKSDVYSFGVVLLEILSG-RKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCV 243 (311)
Q Consensus 165 ~~~~~~~DiwslG~l~~~ll~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 243 (311)
..++.++||||||+++|+|++| .+||............ .... .+.. +...+..+.+++.+||
T Consensus 177 ~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~------~~~~-------~~~~----~~~~~~~~~~li~~cl 239 (262)
T cd05058 177 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYL------LQGR-------RLLQ----PEYCPDPLYEVMLSCW 239 (262)
T ss_pred CccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH------hcCC-------CCCC----CCcCCHHHHHHHHHHc
Confidence 8899999999999999999995 5666654332221111 0000 0000 1112347889999999
Q ss_pred ccCCCCCCCHHHHHHHHHHhh
Q 021490 244 HEQPDMRPVIADVVTALAYLA 264 (311)
Q Consensus 244 ~~~p~~Rps~~~vl~~l~~~~ 264 (311)
..+|++||++.+++..|+.+.
T Consensus 240 ~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 240 HPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred CCChhhCCCHHHHHHHHHHHh
Confidence 999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=256.89 Aligned_cols=232 Identities=25% Similarity=0.342 Sum_probs=185.1
Q ss_pred cchhcc-CCcEEEEEEeecCCC-----cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhccc
Q 021490 2 MQVILC-LLQDVAIKQLDRNGV-----QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDL 75 (311)
Q Consensus 2 ~~~~~~-~g~~vaiK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 75 (311)
|.+... +|..|++|.+..... ...+.+.+|+.+++.++|+||+++++++..+...++++||+++++|.+++..
T Consensus 17 y~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~- 95 (258)
T cd06632 17 YEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKK- 95 (258)
T ss_pred EEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEecCCCcHHHHHHh-
Confidence 444554 789999999865442 2346788999999999999999999999999999999999999999999976
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeecccccc
Q 021490 76 SPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG 155 (311)
Q Consensus 76 ~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~ 155 (311)
...+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||.+....... ......++..
T Consensus 96 ---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~---~~~~~~~~~~ 166 (258)
T cd06632 96 ---YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS---FAKSFKGSPY 166 (258)
T ss_pred ---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccccc---cccccCCCcc
Confidence 456899999999999999999999999 9999999999999999999999999886532221 1223457888
Q ss_pred ccCccccccCC-CccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHH
Q 021490 156 YCAPEYAKTGQ-LTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQ 234 (311)
Q Consensus 156 y~aPE~~~~~~-~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
|++||.+.... ++.++|+||||+++|+|++|..||............ . .. .. ....+......
T Consensus 167 y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~--~----~~-~~---------~~~~~~~~~~~ 230 (258)
T cd06632 167 WMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKI--G----RS-KE---------LPPIPDHLSDE 230 (258)
T ss_pred eeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHH--H----hc-cc---------CCCcCCCcCHH
Confidence 99999887666 889999999999999999999999765532211111 0 00 00 01122334457
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHH
Q 021490 235 ALAVAAMCVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 235 l~~li~~~l~~~p~~Rps~~~vl~~ 259 (311)
+.+++.+||+.+|++|||+.+++..
T Consensus 231 ~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 231 AKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred HHHHHHHHhhcCcccCcCHHHHhcC
Confidence 8889999999999999999999864
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=260.17 Aligned_cols=240 Identities=28% Similarity=0.448 Sum_probs=184.1
Q ss_pred CCcEEEEEEeecCCCc-chhHHHHHHHHHhcCCCCcccceeeEeee--CCeeEEEEecCCCCChhhhhcccCCCCCCCCH
Q 021490 8 LLQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCAD--GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 84 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~ 84 (311)
++..||+|+++..... ..+.|.+|+.+++.++|+||+++++++.. ....++||||+++++|.+++... ...+++
T Consensus 32 ~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~---~~~~~~ 108 (284)
T cd05038 32 TGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRH---RDQINL 108 (284)
T ss_pred CceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEecCCCCCHHHHHHhC---ccccCH
Confidence 5789999999766543 46789999999999999999999999877 55789999999999999999762 236999
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCcee-eeeccccccccCccccc
Q 021490 85 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHV-STRVMGTYGYCAPEYAK 163 (311)
Q Consensus 85 ~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~ 163 (311)
..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||.+........... .....++..|++||.+.
T Consensus 109 ~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~ 185 (284)
T cd05038 109 KRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLR 185 (284)
T ss_pred HHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHc
Confidence 999999999999999999999 99999999999999999999999999875432211111 11123455699999998
Q ss_pred cCCCccccceeehhHHHHHHHhCCCccCcchhHHHH--------HHHHHhhhhhccccccccccCccccCCCChHhHHHH
Q 021490 164 TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ--------SLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQA 235 (311)
Q Consensus 164 ~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 235 (311)
...++.++|+||||+++|+|++|..||......... ............. .....+...+.++
T Consensus 186 ~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~ 255 (284)
T cd05038 186 TSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEG----------ERLPRPPSCPDEV 255 (284)
T ss_pred cCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHcC----------CcCCCCccCCHHH
Confidence 888999999999999999999999998654322100 0000000000000 0001112233578
Q ss_pred HHHHHHccccCCCCCCCHHHHHHHHHHh
Q 021490 236 LAVAAMCVHEQPDMRPVIADVVTALAYL 263 (311)
Q Consensus 236 ~~li~~~l~~~p~~Rps~~~vl~~l~~~ 263 (311)
.+++.+||..+|.+|||+.++++.|+.+
T Consensus 256 ~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 256 YDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 8999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=260.60 Aligned_cols=228 Identities=21% Similarity=0.316 Sum_probs=183.8
Q ss_pred cCCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHH
Q 021490 7 CLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNT 86 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~ 86 (311)
.+|+.+++|+++.......+.+.+|+.+++.++||||+++++++......++|+||++|++|.+++.. ..+++..
T Consensus 42 ~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~-----~~~~~~~ 116 (285)
T cd06648 42 STGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTH-----TRMNEEQ 116 (285)
T ss_pred CCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHHHHHHh-----CCCCHHH
Confidence 46889999998765555567789999999999999999999999999999999999999999999875 4589999
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccCC
Q 021490 87 RMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ 166 (311)
Q Consensus 87 ~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 166 (311)
+..++.|++.||+|||+.+ ++||||+|+||+++.++.++|+|||.+....... .......++..|+|||.+.+..
T Consensus 117 ~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~ 191 (285)
T cd06648 117 IATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV--PRRKSLVGTPYWMAPEVISRLP 191 (285)
T ss_pred HHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCC--cccccccCCccccCHHHhcCCC
Confidence 9999999999999999999 9999999999999999999999999876432211 1122245788999999998888
Q ss_pred CccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccC
Q 021490 167 LTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQ 246 (311)
Q Consensus 167 ~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 246 (311)
++.++|+||||+++|+|++|..||............... . .+... .+...+..+.+++.+||+.+
T Consensus 192 ~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~-------~------~~~~~--~~~~~~~~l~~li~~~l~~~ 256 (285)
T cd06648 192 YGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN-------L------PPKLK--NLHKVSPRLRSFLDRMLVRD 256 (285)
T ss_pred CCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc-------C------CCCCc--ccccCCHHHHHHHHHHcccC
Confidence 999999999999999999999999765432221111100 0 00000 01123347889999999999
Q ss_pred CCCCCCHHHHHHH
Q 021490 247 PDMRPVIADVVTA 259 (311)
Q Consensus 247 p~~Rps~~~vl~~ 259 (311)
|++|||+.++++.
T Consensus 257 p~~Rpt~~~il~~ 269 (285)
T cd06648 257 PAQRATAAELLNH 269 (285)
T ss_pred hhhCcCHHHHccC
Confidence 9999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=269.29 Aligned_cols=243 Identities=23% Similarity=0.272 Sum_probs=177.6
Q ss_pred cCCcEEEEEEeecCC--CcchhHHHHHHHHHhcCCCCcccceeeEeeeCC------eeEEEEecCCCCChhhhhcccCCC
Q 021490 7 CLLQDVAIKQLDRNG--VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD------QRLLVYEYMPLGSVEDHLHDLSPG 78 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~ 78 (311)
..|..||+|++.... ......+.+|+.+++.++||||+++++++.... ..|+||||+++ +|.+.+..
T Consensus 44 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---- 118 (359)
T cd07876 44 VLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIHM---- 118 (359)
T ss_pred CCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEEEeCCCc-CHHHHHhc----
Confidence 358999999986542 233467889999999999999999999986443 47999999974 66666542
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccC
Q 021490 79 KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCA 158 (311)
Q Consensus 79 ~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~a 158 (311)
.+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++...... .......++..|+|
T Consensus 119 --~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~~t~~y~a 190 (359)
T cd07876 119 --ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTN---FMMTPYVVTRYYRA 190 (359)
T ss_pred --cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCCccccccC---ccCCCCcccCCCCC
Confidence 4788999999999999999999999 999999999999999999999999998642211 11223457889999
Q ss_pred ccccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHH-H---------------Hhhhhhcccccccccc---
Q 021490 159 PEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLV-A---------------WARPLFQDRTRHSLIA--- 219 (311)
Q Consensus 159 PE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~-~---------------~~~~~~~~~~~~~~~~--- 219 (311)
||++.+..++.++|||||||++|+|++|..||...+........ . ................
T Consensus 191 PE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (359)
T cd07876 191 PEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEE 270 (359)
T ss_pred chhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhh
Confidence 99999889999999999999999999999999866543221100 0 0000000000000000
Q ss_pred -Cccc----cCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 021490 220 -DPEL----QGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAY 262 (311)
Q Consensus 220 -~~~~----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l~~ 262 (311)
.+.. ...........+.+|+.+||..||++|||+.|++.....
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~ 318 (359)
T cd07876 271 LFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYI 318 (359)
T ss_pred hccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchh
Confidence 0000 000111224567899999999999999999999987543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=255.42 Aligned_cols=228 Identities=22% Similarity=0.312 Sum_probs=180.7
Q ss_pred CCcEEEEEEeecCCC--cchhHHHHHHHHHhcCCCCcccceeeEeee-CCeeEEEEecCCCCChhhhhcccCCCCCCCCH
Q 021490 8 LLQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCAD-GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 84 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~ 84 (311)
+|+.||+|.+..... ...+.+.+|+++++.++|+|++++++.+.. +...+++|||+++++|.+++.... ...+++
T Consensus 24 ~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~--~~~l~~ 101 (257)
T cd08223 24 DGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQK--GKLLPE 101 (257)
T ss_pred CCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccCCCcHHHHHHHhc--CCCCCH
Confidence 578899999865432 234578889999999999999999998764 446799999999999999987632 456899
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccccc
Q 021490 85 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT 164 (311)
Q Consensus 85 ~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 164 (311)
.+++.++.+++.||++||+.+ ++|+||+|+||+++.++.++|+|||++....... .......++..|+|||++.+
T Consensus 102 ~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~ 176 (257)
T cd08223 102 NQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC--DMASTLIGTPYYMSPELFSN 176 (257)
T ss_pred HHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC--CccccccCCcCccChhHhcC
Confidence 999999999999999999999 9999999999999999999999999986532211 12223457889999999998
Q ss_pred CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccc
Q 021490 165 GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVH 244 (311)
Q Consensus 165 ~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 244 (311)
..++.++|+||||+++|+|++|..||...+........ .... . ...+...+..+.+++.+||+
T Consensus 177 ~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~------~~~~-------~----~~~~~~~~~~~~~li~~~l~ 239 (257)
T cd08223 177 KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRI------IEGK-------L----PPMPKDYSPELGELIATMLS 239 (257)
T ss_pred CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHH------HhcC-------C----CCCccccCHHHHHHHHHHhc
Confidence 88999999999999999999999999765432221111 1000 0 01122344578899999999
Q ss_pred cCCCCCCCHHHHHHH
Q 021490 245 EQPDMRPVIADVVTA 259 (311)
Q Consensus 245 ~~p~~Rps~~~vl~~ 259 (311)
.||.+|||+.+++..
T Consensus 240 ~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 240 KRPEKRPSVKSILRQ 254 (257)
T ss_pred cCcccCCCHHHHhcC
Confidence 999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=268.51 Aligned_cols=240 Identities=29% Similarity=0.421 Sum_probs=181.4
Q ss_pred cCCcEEEEEEeecCCC-cchhHHHHHHHHHhcC-CCCcccceeeEeee-CCeeEEEEecCCCCChhhhhcccCC------
Q 021490 7 CLLQDVAIKQLDRNGV-QGNREFLVEVLMLSLL-HHPNLVNLIGYCAD-GDQRLLVYEYMPLGSVEDHLHDLSP------ 77 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~------ 77 (311)
.+++.||||+++.... .....+.+|+.++..+ +||||+++++++.. +...++||||+++|+|.+++.....
T Consensus 35 ~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~ 114 (343)
T cd05103 35 ATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYK 114 (343)
T ss_pred ccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCceEEEEeccCCCcHHHHHHhcCCcccccc
Confidence 4678999999975432 2345788999999999 68999999998754 4467899999999999999865210
Q ss_pred ---------------------------------------------------------CCCCCCHHHHHHHHHHHHHHHHH
Q 021490 78 ---------------------------------------------------------GKKPLDWNTRMKIAAGAARGLEY 100 (311)
Q Consensus 78 ---------------------------------------------------------~~~~l~~~~~~~~~~~i~~~l~~ 100 (311)
....+++..+..++.|++.||+|
T Consensus 115 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~ 194 (343)
T cd05103 115 TKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEF 194 (343)
T ss_pred ccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHH
Confidence 01246788889999999999999
Q ss_pred hhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccCCCccccceeehhHHH
Q 021490 101 LHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVL 180 (311)
Q Consensus 101 lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~l~ 180 (311)
||+.+ ++||||||+||+++.++.++|+|||++................++..|+|||.+.+..++.++||||||+++
T Consensus 195 lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l 271 (343)
T cd05103 195 LASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 271 (343)
T ss_pred HHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHH
Confidence 99999 999999999999999999999999998653222111111223345679999999888899999999999999
Q ss_pred HHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 021490 181 LEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 181 ~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~ 259 (311)
|+|++ |..||......... .. ....... . ..+...+..+.+++..||+.||++|||+.++++.
T Consensus 272 ~el~~~g~~p~~~~~~~~~~--~~----~~~~~~~---~-------~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 272 WEIFSLGASPYPGVKIDEEF--CR----RLKEGTR---M-------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred HHHHHCCCCCCCCccccHHH--HH----HHhccCC---C-------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 99997 89998754322111 00 0100000 0 0011123468889999999999999999999999
Q ss_pred HHHhhh
Q 021490 260 LAYLAS 265 (311)
Q Consensus 260 l~~~~~ 265 (311)
|+.+.+
T Consensus 336 l~~~~~ 341 (343)
T cd05103 336 LGNLLQ 341 (343)
T ss_pred HHHHHh
Confidence 988764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=261.67 Aligned_cols=244 Identities=24% Similarity=0.286 Sum_probs=183.0
Q ss_pred CCcEEEEEEeecCC--CcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHH
Q 021490 8 LLQDVAIKQLDRNG--VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN 85 (311)
Q Consensus 8 ~g~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~ 85 (311)
+|+.||+|+++... ....+.+.+|+++++.++|+||+++++++..+...++||||++++.+..+... ...+++.
T Consensus 25 ~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~----~~~~~~~ 100 (288)
T cd07833 25 TGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEAS----PGGLPPD 100 (288)
T ss_pred CCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCCCCHHHHHHhc----CCCCCHH
Confidence 58899999986543 23346889999999999999999999999999999999999998777666554 4568999
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccC
Q 021490 86 TRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG 165 (311)
Q Consensus 86 ~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 165 (311)
.++.++.+++.||+|||+.+ ++|+||+|+||++++++.++|+|||++........ .......++..|+|||++.+.
T Consensus 101 ~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~ 176 (288)
T cd07833 101 AVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPA-SPLTDYVATRWYRAPELLVGD 176 (288)
T ss_pred HHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-ccccCcccccCCcCCchhcCC
Confidence 99999999999999999999 99999999999999999999999999875433221 112234567889999999877
Q ss_pred -CCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhcc--------ccccc--cccCcc----ccCCCChH
Q 021490 166 -QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQD--------RTRHS--LIADPE----LQGQYPPR 230 (311)
Q Consensus 166 -~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~--------~~~~~--~~~~~~----~~~~~~~~ 230 (311)
.++.++|+||||+++|+|++|..||......+.............. ..... ...+.. ....++..
T Consensus 177 ~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (288)
T cd07833 177 TNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGK 256 (288)
T ss_pred CCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCc
Confidence 7889999999999999999999999765543322211111000000 00000 000000 00112222
Q ss_pred hHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 021490 231 GFYQALAVAAMCVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 231 ~~~~l~~li~~~l~~~p~~Rps~~~vl~~ 259 (311)
.+..+.+++.+||..+|++|||+.++++.
T Consensus 257 ~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 257 VSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred cchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 35688999999999999999999998864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=260.08 Aligned_cols=232 Identities=23% Similarity=0.319 Sum_probs=181.2
Q ss_pred CCcEEEEEEeecCC-CcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHH
Q 021490 8 LLQDVAIKQLDRNG-VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNT 86 (311)
Q Consensus 8 ~g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~ 86 (311)
+|..||+|.++... ......+.+|+.++..++||||+++++.+..+...++||||+++++|..++.... ....+++..
T Consensus 25 ~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~ 103 (286)
T cd06622 25 TGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGV-ATEGIPEDV 103 (286)
T ss_pred CCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCCCCHHHHHHhcc-ccCCCCHHH
Confidence 68999999986543 2334688999999999999999999999999999999999999999999887521 134789999
Q ss_pred HHHHHHHHHHHHHHhhc-CCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccC
Q 021490 87 RMKIAAGAARGLEYLHD-KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG 165 (311)
Q Consensus 87 ~~~~~~~i~~~l~~lh~-~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 165 (311)
+..++.+++.||.|||+ .+ ++|+||+|+||+++.++.++|+|||++...... ......++..|+|||.+.+.
T Consensus 104 ~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~ 176 (286)
T cd06622 104 LRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS----LAKTNIGCQSYMAPERIKSG 176 (286)
T ss_pred HHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCC----ccccCCCccCccCcchhcCC
Confidence 99999999999999997 47 999999999999999999999999988643211 11223467789999988543
Q ss_pred ------CCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHH
Q 021490 166 ------QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVA 239 (311)
Q Consensus 166 ------~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 239 (311)
.++.++|+|||||++|+|++|..||............... ... .....++..+.++.+++
T Consensus 177 ~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~---~~~-----------~~~~~~~~~~~~~~~li 242 (286)
T cd06622 177 GPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAI---VDG-----------DPPTLPSGYSDDAQDFV 242 (286)
T ss_pred CCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHH---hhc-----------CCCCCCcccCHHHHHHH
Confidence 3478999999999999999999999754332221111100 000 00122333556788999
Q ss_pred HHccccCCCCCCCHHHHHHHHH
Q 021490 240 AMCVHEQPDMRPVIADVVTALA 261 (311)
Q Consensus 240 ~~~l~~~p~~Rps~~~vl~~l~ 261 (311)
.+||..+|++||++.+++....
T Consensus 243 ~~~l~~~p~~Rp~~~~l~~~~~ 264 (286)
T cd06622 243 AKCLNKIPNRRPTYAQLLEHPW 264 (286)
T ss_pred HHHcccCcccCCCHHHHhcChh
Confidence 9999999999999999998654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=287.44 Aligned_cols=232 Identities=19% Similarity=0.292 Sum_probs=177.0
Q ss_pred CCcEEEEEEeecCCC--cchhHHHHHHHHHhcCCCCcccceeeEeee--CCeeEEEEecCCCCChhhhhcccCCCCCCCC
Q 021490 8 LLQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCAD--GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLD 83 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~ 83 (311)
++..||+|++..... .....|..|+.++..|+||||++++++|.+ ...+||||||+++++|.+++.........++
T Consensus 37 tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~ 116 (1021)
T PTZ00266 37 TQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIE 116 (1021)
T ss_pred CCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCC
Confidence 578899999865432 234678899999999999999999998854 3568999999999999999976433346799
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCC----CCeEeeccCCCeEEEcC-----------------CCceEEccccccccCCCCC
Q 021490 84 WNTRMKIAAGAARGLEYLHDKAK----PPVIYRDLKCSNILLDR-----------------GYHPKLSDFGLAKLGPVGD 142 (311)
Q Consensus 84 ~~~~~~~~~~i~~~l~~lh~~~~----~~i~h~dl~p~nil~~~-----------------~~~~~l~df~~~~~~~~~~ 142 (311)
+..++.|+.||+.||+|||+.+. .+|+|+||||+|||++. .+.++|+|||++.......
T Consensus 117 E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s 196 (1021)
T PTZ00266 117 EHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES 196 (1021)
T ss_pred HHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCccccccccc
Confidence 99999999999999999998431 22999999999999964 3458999999987532211
Q ss_pred CceeeeeccccccccCcccccc--CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccC
Q 021490 143 NTHVSTRVMGTYGYCAPEYAKT--GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD 220 (311)
Q Consensus 143 ~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (311)
......+++.|+|||++.+ ..++.++|||||||++|+|++|..||......... ... +...
T Consensus 197 ---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~ql--i~~----lk~~-------- 259 (1021)
T PTZ00266 197 ---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQL--ISE----LKRG-------- 259 (1021)
T ss_pred ---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHHH--HHH----HhcC--------
Confidence 1223468999999999854 45789999999999999999999999754432211 110 1000
Q ss_pred ccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 021490 221 PELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 221 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~ 259 (311)
+.+. ....+..+.+||..||..+|.+|||+.+++..
T Consensus 260 p~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 260 PDLP---IKGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred CCCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 0000 01123578899999999999999999999964
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=257.82 Aligned_cols=234 Identities=24% Similarity=0.341 Sum_probs=182.2
Q ss_pred CCcEEEEEEeecCCCc-chhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCC-----CCC
Q 021490 8 LLQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPG-----KKP 81 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-----~~~ 81 (311)
..+.|++|.+...... ..+.+.+|+++++.++|+||+++++++.+....++||||+++++|.+++...... ...
T Consensus 34 ~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~ 113 (275)
T cd05046 34 GETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPP 113 (275)
T ss_pred CcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEecCCCcHHHHHHhcccccccccccC
Confidence 4567999988654433 3568999999999999999999999999888999999999999999999763211 126
Q ss_pred CCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccc
Q 021490 82 LDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 161 (311)
Q Consensus 82 l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 161 (311)
+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++++|||++....... ........++..|+|||.
T Consensus 114 l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~-~~~~~~~~~~~~y~~PE~ 189 (275)
T cd05046 114 LSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSE-YYKLRNALIPLRWLAPEA 189 (275)
T ss_pred CCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEcccccccccCccc-ccccCCceeEEeecChhh
Confidence 899999999999999999999999 9999999999999999999999999876422111 111122345677999999
Q ss_pred cccCCCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHH
Q 021490 162 AKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAA 240 (311)
Q Consensus 162 ~~~~~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 240 (311)
+.+..++.++||||||+++|+|++ |..||.............. . ......+...+..+.+++.
T Consensus 190 ~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~------~----------~~~~~~~~~~~~~l~~~i~ 253 (275)
T cd05046 190 VQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQA------G----------KLELPVPEGCPSRLYKLMT 253 (275)
T ss_pred hccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHc------C----------CcCCCCCCCCCHHHHHHHH
Confidence 988888999999999999999998 7889865443222111100 0 0000011223347889999
Q ss_pred HccccCCCCCCCHHHHHHHHH
Q 021490 241 MCVHEQPDMRPVIADVVTALA 261 (311)
Q Consensus 241 ~~l~~~p~~Rps~~~vl~~l~ 261 (311)
+||+.+|.+|||+.+++..|.
T Consensus 254 ~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 254 RCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred HHcCCCcccCCCHHHHHHHhc
Confidence 999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=262.06 Aligned_cols=250 Identities=20% Similarity=0.251 Sum_probs=185.5
Q ss_pred CCcEEEEEEeecC--CCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHH
Q 021490 8 LLQDVAIKQLDRN--GVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN 85 (311)
Q Consensus 8 ~g~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~ 85 (311)
+|+.||||+++.. .....+.+.+|+.+++.++|+||+++++++.++...+++|||+++++|.+++.... ...+++.
T Consensus 24 ~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~--~~~~~~~ 101 (314)
T cd08216 24 TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHF--PEGLPEL 101 (314)
T ss_pred CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhc--ccCCCHH
Confidence 6899999998765 23445689999999999999999999999999999999999999999999997632 3468999
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCC-----ceeeeeccccccccCcc
Q 021490 86 TRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN-----THVSTRVMGTYGYCAPE 160 (311)
Q Consensus 86 ~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-----~~~~~~~~~~~~y~aPE 160 (311)
.+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++++||+.+........ ........++..|+|||
T Consensus 102 ~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE 178 (314)
T cd08216 102 AIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPE 178 (314)
T ss_pred HHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccccccccCHH
Confidence 99999999999999999999 99999999999999999999999998754321111 01112234667899999
Q ss_pred cccc--CCCccccceeehhHHHHHHHhCCCccCcchhHHHH-HHHHHh-hhhhcccc------ccc----cccCcc----
Q 021490 161 YAKT--GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ-SLVAWA-RPLFQDRT------RHS----LIADPE---- 222 (311)
Q Consensus 161 ~~~~--~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~-~~~~~~-~~~~~~~~------~~~----~~~~~~---- 222 (311)
++.. ..++.++|+|||||++|+|++|..||......... ...... ...+.... ... ...++.
T Consensus 179 ~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (314)
T cd08216 179 VLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDS 258 (314)
T ss_pred HhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccccccchhhh
Confidence 9865 45788999999999999999999999765432211 100000 00000000 000 000000
Q ss_pred ccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 021490 223 LQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAY 262 (311)
Q Consensus 223 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l~~ 262 (311)
.........+..+.+++.+||..||++|||+.++++....
T Consensus 259 ~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~ 298 (314)
T cd08216 259 VDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFF 298 (314)
T ss_pred hhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchH
Confidence 1112223445678899999999999999999999987553
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=259.87 Aligned_cols=245 Identities=23% Similarity=0.291 Sum_probs=183.5
Q ss_pred cCCcEEEEEEeecCCC--cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCH
Q 021490 7 CLLQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 84 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~ 84 (311)
.+|..||+|++..... .....+.+|+.+++.++||||+++++++..+...++|+||+ +++|.+++... ...+++
T Consensus 23 ~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~L~~~~~~~---~~~~~~ 98 (286)
T cd07832 23 ETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDE---ERPLPE 98 (286)
T ss_pred CCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-CCCHHHHHHhc---CCCCCH
Confidence 4789999999876542 33468999999999999999999999999999999999999 99999998752 366999
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccccc
Q 021490 85 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT 164 (311)
Q Consensus 85 ~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 164 (311)
..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++........ .......++..|+|||.+.+
T Consensus 99 ~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~ 174 (286)
T cd07832 99 AQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-RLYSHQVATRWYRAPELLYG 174 (286)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-CccccccCcccccCceeeec
Confidence 999999999999999999999 99999999999999999999999999875432221 11223457889999998865
Q ss_pred -CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHH-hhh-------hhccccccccccCccc----cCCCChHh
Q 021490 165 -GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAW-ARP-------LFQDRTRHSLIADPEL----QGQYPPRG 231 (311)
Q Consensus 165 -~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~-~~~-------~~~~~~~~~~~~~~~~----~~~~~~~~ 231 (311)
..++.++||||+|+++|+|++|.++|.............. ... .+...........+.. .....+..
T Consensus 175 ~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (286)
T cd07832 175 ARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDA 254 (286)
T ss_pred cccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCc
Confidence 4468999999999999999999888876554332211110 000 0000000000000000 00111223
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 021490 232 FYQALAVAAMCVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 232 ~~~l~~li~~~l~~~p~~Rps~~~vl~~ 259 (311)
...+.+++.+||..||.+|||+++++..
T Consensus 255 ~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 255 SPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred cHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 4688999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=256.71 Aligned_cols=236 Identities=25% Similarity=0.369 Sum_probs=181.1
Q ss_pred CCcEEEEEEeecCCC--cchhHHHHHHHHHhcCCCCcccceeeEeeeCC------eeEEEEecCCCCChhhhhcccC--C
Q 021490 8 LLQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGD------QRLLVYEYMPLGSVEDHLHDLS--P 77 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~--~ 77 (311)
.|+.||||++..... ...+++.+|+.+++.++||||+++++++.... ..+++++|+.+++|.+++.... .
T Consensus 26 ~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 105 (273)
T cd05074 26 SFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGE 105 (273)
T ss_pred CceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccC
Confidence 578999999865432 33467889999999999999999999886432 2478899999999988875321 1
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeecccccccc
Q 021490 78 GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 157 (311)
Q Consensus 78 ~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~ 157 (311)
....+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++................++..|+
T Consensus 106 ~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~ 182 (273)
T cd05074 106 EPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWL 182 (273)
T ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhc
Confidence 1235789999999999999999999999 9999999999999999999999999987532222111112233557899
Q ss_pred CccccccCCCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHH
Q 021490 158 APEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQAL 236 (311)
Q Consensus 158 aPE~~~~~~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 236 (311)
+||.+....++.++||||||+++|+|++ |..||............. .... . ..++..+..+.
T Consensus 183 ~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~-------~~~~------~----~~~~~~~~~~~ 245 (273)
T cd05074 183 ALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLI-------KGNR------L----KQPPDCLEDVY 245 (273)
T ss_pred CHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHH-------cCCc------C----CCCCCCCHHHH
Confidence 9999988888999999999999999999 889987655433221111 0000 0 01122345788
Q ss_pred HHHHHccccCCCCCCCHHHHHHHHHHh
Q 021490 237 AVAAMCVHEQPDMRPVIADVVTALAYL 263 (311)
Q Consensus 237 ~li~~~l~~~p~~Rps~~~vl~~l~~~ 263 (311)
+++.+||+.+|++|||+.++++.|+.+
T Consensus 246 ~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 246 ELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred HHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=272.55 Aligned_cols=228 Identities=25% Similarity=0.389 Sum_probs=191.5
Q ss_pred cEEEEEEeecCCCc-chhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHHHH
Q 021490 10 QDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRM 88 (311)
Q Consensus 10 ~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~ 88 (311)
..||||++...... ...+|++|+.+|.+|+|+|++++|++..+ ...-||||+++.|+|.+.|... ....|......
T Consensus 139 V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELaplGSLldrLrka--~~~~llv~~Lc 215 (1039)
T KOG0199|consen 139 VNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAPLGSLLDRLRKA--KKAILLVSRLC 215 (1039)
T ss_pred EeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcccchHHHHHhhc--cccceeHHHHH
Confidence 67899999766544 55899999999999999999999999887 6788999999999999999872 35678888999
Q ss_pred HHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceee-eeccccccccCccccccCCC
Q 021490 89 KIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVS-TRVMGTYGYCAPEYAKTGQL 167 (311)
Q Consensus 89 ~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~ 167 (311)
.++.|||.|++||.+++ +|||||...|+++.....|||+|||+.+........+.. ....-...|+|||.+....+
T Consensus 216 dya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kF 292 (1039)
T KOG0199|consen 216 DYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKF 292 (1039)
T ss_pred HHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccc
Confidence 99999999999999999 999999999999999989999999999875544433332 33456789999999999999
Q ss_pred ccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccC
Q 021490 168 TLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQ 246 (311)
Q Consensus 168 ~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 246 (311)
+.++|+|+|||++|||++ |..||.+.........+.. .-+-.-+..+++.+.++++.||..+
T Consensus 293 ShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~-----------------~erLpRPk~csedIY~imk~cWah~ 355 (1039)
T KOG0199|consen 293 SHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDA-----------------GERLPRPKYCSEDIYQIMKNCWAHN 355 (1039)
T ss_pred cccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccc-----------------cccCCCCCCChHHHHHHHHHhccCC
Confidence 999999999999999999 8899988776554443321 1111234567789999999999999
Q ss_pred CCCCCCHHHHHHHH
Q 021490 247 PDMRPVIADVVTAL 260 (311)
Q Consensus 247 p~~Rps~~~vl~~l 260 (311)
|++|||+..|.+.+
T Consensus 356 paDRptFsair~~~ 369 (1039)
T KOG0199|consen 356 PADRPTFSAIREDL 369 (1039)
T ss_pred ccccccHHHHHHhH
Confidence 99999999998554
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=260.97 Aligned_cols=232 Identities=28% Similarity=0.440 Sum_probs=180.5
Q ss_pred EEEEEEeecCCC-cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHHHHH
Q 021490 11 DVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMK 89 (311)
Q Consensus 11 ~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~ 89 (311)
.||+|.+..... .....+.+|+.++..++||||+++++++... ..+++++|+++|+|.+++... ...+++..++.
T Consensus 38 ~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~~~~g~l~~~~~~~---~~~~~~~~~~~ 113 (303)
T cd05110 38 PVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLDYVHEH---KDNIGSQLLLN 113 (303)
T ss_pred eEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-CceeeehhcCCCCHHHHHHhc---ccCCCHHHHHH
Confidence 578898865433 2234788999999999999999999988654 467999999999999998762 34689999999
Q ss_pred HHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccCCCcc
Q 021490 90 IAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTL 169 (311)
Q Consensus 90 ~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 169 (311)
++.|++.||+|||+++ ++|+||+|+||+++.++.++|+|||++................++..|++||.+.+..++.
T Consensus 114 ~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~ 190 (303)
T cd05110 114 WCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTH 190 (303)
T ss_pred HHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccccCcccccccCCCccccccCCHHHhccCCCCh
Confidence 9999999999999999 9999999999999999999999999987543222111122233567899999998888999
Q ss_pred ccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCC
Q 021490 170 KSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPD 248 (311)
Q Consensus 170 ~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~ 248 (311)
++||||||+++|+|++ |..||............. ..... ..++..+..+.+++..||..+|+
T Consensus 191 ~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~-------~~~~~----------~~~~~~~~~~~~li~~c~~~~p~ 253 (303)
T cd05110 191 QSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLE-------KGERL----------PQPPICTIDVYMVMVKCWMIDAD 253 (303)
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------CCCCC----------CCCCCCCHHHHHHHHHHcCCChh
Confidence 9999999999999997 899997654333222211 10000 01112334788899999999999
Q ss_pred CCCCHHHHHHHHHHhhhc
Q 021490 249 MRPVIADVVTALAYLASQ 266 (311)
Q Consensus 249 ~Rps~~~vl~~l~~~~~~ 266 (311)
+||++.++++.|+.+...
T Consensus 254 ~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 254 SRPKFKELAAEFSRMARD 271 (303)
T ss_pred hCcCHHHHHHHHHHHHhc
Confidence 999999999999876533
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=270.02 Aligned_cols=241 Identities=22% Similarity=0.255 Sum_probs=178.0
Q ss_pred CCcEEEEEEeecCCC--cchhHHHHHHHHHhcCCCCcccceeeEeeeC------CeeEEEEecCCCCChhhhhcccCCCC
Q 021490 8 LLQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADG------DQRLLVYEYMPLGSVEDHLHDLSPGK 79 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~ 79 (311)
.|+.||+|++..... .....+.+|+.+++.++||||+++++++... ...++||||+++ +|.+.+..
T Consensus 41 ~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~----- 114 (355)
T cd07874 41 LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQM----- 114 (355)
T ss_pred CCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEEhhhhcc-cHHHHHhh-----
Confidence 588999999865432 3346788899999999999999999988643 357999999974 67666643
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCc
Q 021490 80 KPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 159 (311)
Q Consensus 80 ~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aP 159 (311)
.+++..+..++.|++.||+|||+.| ++||||||+||+++.++.++|+|||++...... .......++..|+||
T Consensus 115 -~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~t~~y~aP 187 (355)
T cd07874 115 -ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAP 187 (355)
T ss_pred -cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcccccCCCc---cccCCccccCCccCH
Confidence 4888999999999999999999999 999999999999999999999999998753221 112234578899999
Q ss_pred cccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHH-HH---------------hhhhhccccccccccCcc-
Q 021490 160 EYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLV-AW---------------ARPLFQDRTRHSLIADPE- 222 (311)
Q Consensus 160 E~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~-~~---------------~~~~~~~~~~~~~~~~~~- 222 (311)
|++.+..++.++|||||||++|+|++|..||...+........ .. ................+.
T Consensus 188 E~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (355)
T cd07874 188 EVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKL 267 (355)
T ss_pred HHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhh
Confidence 9999889999999999999999999999999766543322111 00 000000000000000000
Q ss_pred -----c--cCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 021490 223 -----L--QGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 261 (311)
Q Consensus 223 -----~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l~ 261 (311)
. ....+......+.+|+.+||..||++|||+.|+++...
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~ 313 (355)
T cd07874 268 FPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPY 313 (355)
T ss_pred ccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcc
Confidence 0 01111223457789999999999999999999998743
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=261.60 Aligned_cols=249 Identities=23% Similarity=0.231 Sum_probs=183.2
Q ss_pred cchhc-cCCcEEEEEEeecCCCc-----chhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhccc
Q 021490 2 MQVIL-CLLQDVAIKQLDRNGVQ-----GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDL 75 (311)
Q Consensus 2 ~~~~~-~~g~~vaiK~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 75 (311)
|.+.. .+|+.||+|.++..... ....+.+|+.+++.++|+||+++++++.++...++||||+ +++|.+++...
T Consensus 17 y~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~i~~~ 95 (298)
T cd07841 17 YKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDK 95 (298)
T ss_pred EEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEccc-CCCHHHHHhcc
Confidence 34443 36899999999765433 2346778999999999999999999999999999999999 89999999762
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeecccccc
Q 021490 76 SPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG 155 (311)
Q Consensus 76 ~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~ 155 (311)
...+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++....... .......++..
T Consensus 96 ---~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~ 167 (298)
T cd07841 96 ---SIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN--RKMTHQVVTRW 167 (298)
T ss_pred ---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccCCC--cccccccccee
Confidence 137999999999999999999999999 9999999999999999999999999987543221 11122345678
Q ss_pred ccCcccccc-CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHH-HHhhhhhccc-cccccccCc---cc-----c
Q 021490 156 YCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLV-AWARPLFQDR-TRHSLIADP---EL-----Q 224 (311)
Q Consensus 156 y~aPE~~~~-~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~---~~-----~ 224 (311)
|+|||.+.+ ..++.++|+|||||++|+|++|.+||............ .......... .......+. .. .
T Consensus 168 y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (298)
T cd07841 168 YRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPL 247 (298)
T ss_pred eeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccccccCCcch
Confidence 999998854 46788999999999999999998888655433222111 1000000000 000000000 00 0
Q ss_pred CCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 021490 225 GQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 225 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~ 259 (311)
.......+..+.+++.+||+.||++|||+.+++..
T Consensus 248 ~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 248 KQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred hhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 11112345688899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=254.68 Aligned_cols=229 Identities=21% Similarity=0.303 Sum_probs=183.5
Q ss_pred cCCcEEEEEEeecCC--CcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCH
Q 021490 7 CLLQDVAIKQLDRNG--VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 84 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~ 84 (311)
.+|+.||+|.+.... ....+.+.+|+.+++.++||||+++++++......++|+||+.+++|.+++.... ...+++
T Consensus 23 ~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~ 100 (256)
T cd08218 23 EDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQR--GVLFPE 100 (256)
T ss_pred CCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCCCcHHHHHHhcc--CCCCCH
Confidence 368999999987543 2334588999999999999999999999999999999999999999999887521 346889
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccccc
Q 021490 85 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT 164 (311)
Q Consensus 85 ~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 164 (311)
..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||.+....... .......++..|+|||++.+
T Consensus 101 ~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~ 175 (256)
T cd08218 101 DQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV--ELARTCIGTPYYLSPEICEN 175 (256)
T ss_pred HHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcch--hhhhhccCCccccCHHHhCC
Confidence 999999999999999999999 9999999999999999999999999886432211 11122347788999999988
Q ss_pred CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccc
Q 021490 165 GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVH 244 (311)
Q Consensus 165 ~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 244 (311)
..++.++|+||||+++|+|++|..||............ .... .+ ..+......+.+++.+||+
T Consensus 176 ~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~------~~~~-------~~----~~~~~~~~~~~~li~~~l~ 238 (256)
T cd08218 176 RPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKI------IRGS-------YP----PVSSHYSYDLRNLVSQLFK 238 (256)
T ss_pred CCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHH------hcCC-------CC----CCcccCCHHHHHHHHHHhh
Confidence 88899999999999999999999999765443221111 1000 00 1122334578899999999
Q ss_pred cCCCCCCCHHHHHHH
Q 021490 245 EQPDMRPVIADVVTA 259 (311)
Q Consensus 245 ~~p~~Rps~~~vl~~ 259 (311)
.+|.+||++.++++.
T Consensus 239 ~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 239 RNPRDRPSVNSILEK 253 (256)
T ss_pred CChhhCcCHHHHhhC
Confidence 999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=257.70 Aligned_cols=233 Identities=23% Similarity=0.334 Sum_probs=183.2
Q ss_pred cCCcEEEEEEeecCCCc------chhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCC
Q 021490 7 CLLQDVAIKQLDRNGVQ------GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKK 80 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 80 (311)
.+|..||+|++...... ..+.+.+|+.+++.++|+||+++++++.+....++|+||++|++|.+++.. ..
T Consensus 23 ~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~----~~ 98 (268)
T cd06630 23 KTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSK----YG 98 (268)
T ss_pred CCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEeccCCCcHHHHHHH----hC
Confidence 57899999998654321 235788999999999999999999999999999999999999999999976 46
Q ss_pred CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCC-ceEEccccccccCCCCCC--ceeeeecccccccc
Q 021490 81 PLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY-HPKLSDFGLAKLGPVGDN--THVSTRVMGTYGYC 157 (311)
Q Consensus 81 ~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~-~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~y~ 157 (311)
.+++..+..++.|++.||+|||+++ ++|+||+|.||+++.++ .++|+|||.+........ ........++..|+
T Consensus 99 ~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (268)
T cd06630 99 AFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFM 175 (268)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccccccccccccccCCcccccccccccee
Confidence 7899999999999999999999999 99999999999998775 599999999865332211 11112235778999
Q ss_pred CccccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHH
Q 021490 158 APEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALA 237 (311)
Q Consensus 158 aPE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 237 (311)
|||.+.+..++.++|+||+|+++|+|++|..||................. . ......+......+.+
T Consensus 176 ~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---~----------~~~~~~~~~~~~~~~~ 242 (268)
T cd06630 176 APEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIAS---A----------TTAPSIPEHLSPGLRD 242 (268)
T ss_pred CHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhc---c----------CCCCCCchhhCHHHHH
Confidence 99999888889999999999999999999999965443221111111000 0 0011233344568889
Q ss_pred HHHHccccCCCCCCCHHHHHHH
Q 021490 238 VAAMCVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 238 li~~~l~~~p~~Rps~~~vl~~ 259 (311)
++.+||..+|.+|||+.+++..
T Consensus 243 ~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 243 VTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred HHHHHcCCCcccCcCHHHHhcC
Confidence 9999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=257.81 Aligned_cols=237 Identities=25% Similarity=0.338 Sum_probs=187.5
Q ss_pred chhcc-CCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCC
Q 021490 3 QVILC-LLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKP 81 (311)
Q Consensus 3 ~~~~~-~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 81 (311)
.+... ++..|++|+++.... ..+.+.+|+++++.++|+|++++++.+......++|+||+++++|.+++... ...
T Consensus 37 ~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~ 112 (286)
T cd06614 37 KATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQN---FVR 112 (286)
T ss_pred EEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHHHHHHHh---ccC
Confidence 34444 688999999975544 5678899999999999999999999999999999999999999999999872 137
Q ss_pred CCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccc
Q 021490 82 LDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 161 (311)
Q Consensus 82 l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 161 (311)
+++..+..++.+++.||+|||+.| ++|+||+|+||+++.++.++|+|||++....... .......++..|++||.
T Consensus 113 l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~y~~PE~ 187 (286)
T cd06614 113 MNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK--SKRNSVVGTPYWMAPEV 187 (286)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccch--hhhccccCCcccCCHhH
Confidence 999999999999999999999999 9999999999999999999999999876432211 11122346778999999
Q ss_pred cccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHH
Q 021490 162 AKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAM 241 (311)
Q Consensus 162 ~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 241 (311)
+.+..++.++|+||||+++|+|++|..||............. ... . ... ..+...+..+.+++.+
T Consensus 188 ~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~------~~~-~-~~~-------~~~~~~~~~l~~li~~ 252 (286)
T cd06614 188 IKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLIT------TKG-I-PPL-------KNPEKWSPEFKDFLNK 252 (286)
T ss_pred hcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH------hcC-C-CCC-------cchhhCCHHHHHHHHH
Confidence 988889999999999999999999999997654432211110 000 0 000 0111134578889999
Q ss_pred ccccCCCCCCCHHHHHHHHHHh
Q 021490 242 CVHEQPDMRPVIADVVTALAYL 263 (311)
Q Consensus 242 ~l~~~p~~Rps~~~vl~~l~~~ 263 (311)
||+.+|.+|||+.+++......
T Consensus 253 ~l~~~p~~Rpt~~~il~~~~~~ 274 (286)
T cd06614 253 CLVKDPEKRPSAEELLQHPFLK 274 (286)
T ss_pred HhccChhhCcCHHHHhhChHhh
Confidence 9999999999999999765433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=262.84 Aligned_cols=236 Identities=28% Similarity=0.298 Sum_probs=184.6
Q ss_pred chhcc-CCcEEEEEEeecCCCc---chhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCC
Q 021490 3 QVILC-LLQDVAIKQLDRNGVQ---GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPG 78 (311)
Q Consensus 3 ~~~~~-~g~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~ 78 (311)
.+... +|+.||+|.+...... ..+.+.+|++++..++|+||+++++.+.++...++||||+.|++|.+++....
T Consensus 19 ~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-- 96 (316)
T cd05574 19 LVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQP-- 96 (316)
T ss_pred EEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCCCCHHHHHHhCC--
Confidence 33343 5899999999765433 34578899999999999999999999999999999999999999999987532
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCce-------------
Q 021490 79 KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH------------- 145 (311)
Q Consensus 79 ~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~------------- 145 (311)
...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++..........
T Consensus 97 ~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (316)
T cd05574 97 GKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSV 173 (316)
T ss_pred CCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhcccccccccccccccccccccc
Confidence 457999999999999999999999999 9999999999999999999999999876432211100
Q ss_pred --------------eeeeccccccccCccccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhcc
Q 021490 146 --------------VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQD 211 (311)
Q Consensus 146 --------------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 211 (311)
......++..|+|||++.+..++.++||||||+++|+|++|..||...+........ ...
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~------~~~ 247 (316)
T cd05574 174 NSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNI------LKK 247 (316)
T ss_pred cccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHHHHHH------hcC
Confidence 011235778899999998888999999999999999999999999765543221111 100
Q ss_pred ccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCC----HHHHHHH
Q 021490 212 RTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPV----IADVVTA 259 (311)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps----~~~vl~~ 259 (311)
.. .+. .....+..+.+++.+||..||++||| +++++..
T Consensus 248 ~~--------~~~--~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 248 EV--------TFP--GSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred Cc--------cCC--CccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 00 000 01113558899999999999999999 7777764
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=253.32 Aligned_cols=225 Identities=29% Similarity=0.425 Sum_probs=179.5
Q ss_pred cCCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHH
Q 021490 7 CLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNT 86 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~ 86 (311)
.+|..||+|.++... ..+.+.+|+.++..++|||++++++++..+ ..++||||+.+++|.+++.... ...+++..
T Consensus 27 ~~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~ 101 (254)
T cd05083 27 YTGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKGNLVNFLRTRG--RALVSVIQ 101 (254)
T ss_pred cCCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCCHHHHHHhcC--cCCCCHHH
Confidence 367889999985432 346789999999999999999999998654 4799999999999999997632 34689999
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccCC
Q 021490 87 RMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ 166 (311)
Q Consensus 87 ~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 166 (311)
++.++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++...... ......+..|+|||.+.+..
T Consensus 102 ~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-----~~~~~~~~~y~~pe~~~~~~ 173 (254)
T cd05083 102 LLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-----VDNSKLPVKWTAPEALKHKK 173 (254)
T ss_pred HHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecccc-----CCCCCCCceecCHHHhccCC
Confidence 9999999999999999999 999999999999999999999999988642211 11223456799999998888
Q ss_pred CccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHcccc
Q 021490 167 LTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHE 245 (311)
Q Consensus 167 ~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 245 (311)
++.++|+||||+++|+|++ |..||.............. ... ...+...+..+.+++.+||+.
T Consensus 174 ~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-------~~~----------~~~~~~~~~~~~~li~~~l~~ 236 (254)
T cd05083 174 FSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEK-------GYR----------MEPPEGCPADVYVLMTSCWET 236 (254)
T ss_pred cCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhC-------CCC----------CCCCCcCCHHHHHHHHHHcCC
Confidence 9999999999999999998 9999976654332221110 000 011122345788999999999
Q ss_pred CCCCCCCHHHHHHHHH
Q 021490 246 QPDMRPVIADVVTALA 261 (311)
Q Consensus 246 ~p~~Rps~~~vl~~l~ 261 (311)
+|++||++.+++..|+
T Consensus 237 ~p~~Rp~~~~l~~~l~ 252 (254)
T cd05083 237 EPKKRPSFHKLREKLE 252 (254)
T ss_pred ChhhCcCHHHHHHHHc
Confidence 9999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=255.67 Aligned_cols=229 Identities=24% Similarity=0.348 Sum_probs=186.1
Q ss_pred CCcEEEEEEeecCCC-cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHH
Q 021490 8 LLQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNT 86 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~ 86 (311)
+|+.|++|++..... .....+.+|+..+..++|+||+++++++......++||||+++++|.+++.. ...+++..
T Consensus 25 ~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~ 100 (264)
T cd06623 25 TGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKK----VGKIPEPV 100 (264)
T ss_pred CCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCCcHHHHHHH----cCCCCHHH
Confidence 589999999876654 3457899999999999999999999999999999999999999999999986 46799999
Q ss_pred HHHHHHHHHHHHHHhhc-CCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccC
Q 021490 87 RMKIAAGAARGLEYLHD-KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG 165 (311)
Q Consensus 87 ~~~~~~~i~~~l~~lh~-~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 165 (311)
++.++.|++.|++|||+ .+ ++|+||+|+||+++.++.++|+|||.+......... .....++..|+|||.+...
T Consensus 101 ~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~~pE~~~~~ 175 (264)
T cd06623 101 LAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ--CNTFVGTVTYMSPERIQGE 175 (264)
T ss_pred HHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCCCc--ccceeecccccCHhhhCCC
Confidence 99999999999999999 99 999999999999999999999999988753322211 1233577889999999888
Q ss_pred CCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChH-hHHHHHHHHHHccc
Q 021490 166 QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPR-GFYQALAVAAMCVH 244 (311)
Q Consensus 166 ~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~ 244 (311)
.++.++|+||||+++|+|++|..||................ .. ..+ ..+.. .+..+.+++.+||.
T Consensus 176 ~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~---~~-------~~~----~~~~~~~~~~l~~li~~~l~ 241 (264)
T cd06623 176 SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC---DG-------PPP----SLPAEEFSPEFRDFISACLQ 241 (264)
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh---cC-------CCC----CCCcccCCHHHHHHHHHHcc
Confidence 88999999999999999999999997664211111111111 00 001 11122 34588899999999
Q ss_pred cCCCCCCCHHHHHHH
Q 021490 245 EQPDMRPVIADVVTA 259 (311)
Q Consensus 245 ~~p~~Rps~~~vl~~ 259 (311)
.+|++|||+.++++.
T Consensus 242 ~~p~~R~~~~~ll~~ 256 (264)
T cd06623 242 KDPKKRPSAAELLQH 256 (264)
T ss_pred CChhhCCCHHHHHhC
Confidence 999999999999976
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=258.26 Aligned_cols=234 Identities=26% Similarity=0.356 Sum_probs=180.5
Q ss_pred cCCcEEEEEEeecCCCc----------chhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccC
Q 021490 7 CLLQDVAIKQLDRNGVQ----------GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLS 76 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~----------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 76 (311)
.+|+.||+|.++..... ..+.+.+|+.+++.++|||++++++++......++||||+++++|.+++..
T Consensus 24 ~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-- 101 (272)
T cd06629 24 TTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRT-- 101 (272)
T ss_pred CCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceEEEEecCCCCcHHHHHhh--
Confidence 36899999988542211 124677899999999999999999999999999999999999999999976
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccc
Q 021490 77 PGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY 156 (311)
Q Consensus 77 ~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y 156 (311)
...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++++|||++................++..|
T Consensus 102 --~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y 176 (272)
T cd06629 102 --YGRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFW 176 (272)
T ss_pred --ccCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeeccccccccccccccccccccCCccc
Confidence 467899999999999999999999999 999999999999999999999999998653221111112223477889
Q ss_pred cCccccccCC--CccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHH
Q 021490 157 CAPEYAKTGQ--LTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQ 234 (311)
Q Consensus 157 ~aPE~~~~~~--~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
+|||.+.... ++.++|+||||+++|++++|..||.......... . .... .. .+.+........+..
T Consensus 177 ~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~--~----~~~~--~~----~~~~~~~~~~~~~~~ 244 (272)
T cd06629 177 MAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMF--K----LGNK--RS----APPIPPDVSMNLSPV 244 (272)
T ss_pred cCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHH--H----hhcc--cc----CCcCCccccccCCHH
Confidence 9999887644 7899999999999999999999996543321110 0 0000 00 011111122233458
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHH
Q 021490 235 ALAVAAMCVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 235 l~~li~~~l~~~p~~Rps~~~vl~~ 259 (311)
+.+++.+||..+|.+|||+.++++.
T Consensus 245 ~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 245 ALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred HHHHHHHHhcCChhhCCCHHHHhhC
Confidence 8899999999999999999999865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=269.37 Aligned_cols=236 Identities=22% Similarity=0.245 Sum_probs=185.9
Q ss_pred CcchhccCCcEEEEEEeecCC--CcchhHHHHHHHHHhcC-CCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCC
Q 021490 1 MMQVILCLLQDVAIKQLDRNG--VQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP 77 (311)
Q Consensus 1 ~~~~~~~~g~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 77 (311)
||+|.-.+.+-+|+|++.... .....-|.+|+..|.+| .|.+|+.+++|-..++.+|||||+= ..+|...|++.
T Consensus 377 V~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~G-d~DL~kiL~k~-- 453 (677)
T KOG0596|consen 377 VFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECG-DIDLNKILKKK-- 453 (677)
T ss_pred eeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeecc-cccHHHHHHhc--
Confidence 466667777888888865432 33446899999999999 5899999999999999999999964 58999999873
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeecccccccc
Q 021490 78 GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 157 (311)
Q Consensus 78 ~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~ 157 (311)
...++...+..+..|++.++.++|..| |||.||||.|+|+- .|.+||+|||++..+............+||+.||
T Consensus 454 -~~~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYM 528 (677)
T KOG0596|consen 454 -KSIDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYM 528 (677)
T ss_pred -cCCCchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhcccCccccceeeccccCccccc
Confidence 234444589999999999999999999 99999999999885 4689999999998876666666667788999999
Q ss_pred CccccccC-----------CCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCC
Q 021490 158 APEYAKTG-----------QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQ 226 (311)
Q Consensus 158 aPE~~~~~-----------~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (311)
+||.+... .++.++||||||||+|+|+.|+.||........ ....+.+|...-.
T Consensus 529 sPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~a---------------Kl~aI~~P~~~Ie 593 (677)
T KOG0596|consen 529 SPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIA---------------KLHAITDPNHEIE 593 (677)
T ss_pred CHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHH---------------HHHhhcCCCcccc
Confidence 99988542 256789999999999999999999976543211 1222333432222
Q ss_pred CChHh-HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 021490 227 YPPRG-FYQALAVAAMCVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 227 ~~~~~-~~~l~~li~~~l~~~p~~Rps~~~vl~~ 259 (311)
++... ..+++++++.||..||++|||+.++++.
T Consensus 594 fp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 594 FPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred ccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 22211 2239999999999999999999999976
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=255.45 Aligned_cols=229 Identities=26% Similarity=0.333 Sum_probs=183.4
Q ss_pred CCcEEEEEEeecCCC---cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCH
Q 021490 8 LLQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 84 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~ 84 (311)
+|+.||+|++..... ...+.+.+|+.+++.++||||+++++.+.++...++|+||+++++|.+++.. ...+++
T Consensus 17 ~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~ 92 (262)
T cd05572 17 KNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRD----RGLFDE 92 (262)
T ss_pred CCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcHHHHHhh----cCCCCH
Confidence 589999999875443 2346789999999999999999999999999999999999999999999976 456899
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccccc
Q 021490 85 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT 164 (311)
Q Consensus 85 ~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 164 (311)
..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++....... ......++..|++||.+..
T Consensus 93 ~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~ 166 (262)
T cd05572 93 YTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVAPEIILN 166 (262)
T ss_pred HHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccccccCCcCccChhHhcC
Confidence 999999999999999999999 9999999999999999999999999987543221 1222357788999999988
Q ss_pred CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccc
Q 021490 165 GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVH 244 (311)
Q Consensus 165 ~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 244 (311)
..++.++|+||||+++|+|++|..||........ .... .... ......++...+..+.+++.+||.
T Consensus 167 ~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~---~~~~----------~~~~~~~~~~~~~~~~~~i~~~l~ 232 (262)
T cd05572 167 KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPM-EIYN---DILK----------GNGKLEFPNYIDKAAKDLIKQLLR 232 (262)
T ss_pred CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHH-HHHH---HHhc----------cCCCCCCCcccCHHHHHHHHHHcc
Confidence 8889999999999999999999999976652111 1110 0010 000111222335588999999999
Q ss_pred cCCCCCCC-----HHHHHHHH
Q 021490 245 EQPDMRPV-----IADVVTAL 260 (311)
Q Consensus 245 ~~p~~Rps-----~~~vl~~l 260 (311)
.||++||+ +.|+++.-
T Consensus 233 ~~p~~R~~~~~~~~~~l~~~~ 253 (262)
T cd05572 233 RNPEERLGNLKGGIKDIKKHK 253 (262)
T ss_pred CChhhCcCCcccCHHHHhcCh
Confidence 99999999 78887643
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=268.91 Aligned_cols=241 Identities=21% Similarity=0.244 Sum_probs=178.1
Q ss_pred CCcEEEEEEeecCC--CcchhHHHHHHHHHhcCCCCcccceeeEeeeC------CeeEEEEecCCCCChhhhhcccCCCC
Q 021490 8 LLQDVAIKQLDRNG--VQGNREFLVEVLMLSLLHHPNLVNLIGYCADG------DQRLLVYEYMPLGSVEDHLHDLSPGK 79 (311)
Q Consensus 8 ~g~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~ 79 (311)
.++.||||++.... ......+.+|+.+++.++||||+++++++... ...|+||||++ ++|.+.+..
T Consensus 48 ~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----- 121 (364)
T cd07875 48 LERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQM----- 121 (364)
T ss_pred CCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEEEEeCCC-CCHHHHHHh-----
Confidence 68899999986543 23346788999999999999999999987543 35799999996 577777643
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCc
Q 021490 80 KPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 159 (311)
Q Consensus 80 ~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aP 159 (311)
.+++..+..++.|++.||+|||+++ ++||||||+||+++.++.++|+|||++...... .......++..|+||
T Consensus 122 -~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~---~~~~~~~~t~~y~aP 194 (364)
T cd07875 122 -ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAP 194 (364)
T ss_pred -cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCccccCCC---CcccCCcccCCcCCH
Confidence 4788999999999999999999999 999999999999999999999999998753221 112234578899999
Q ss_pred cccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHH-hh---------------hhhccccccccc----c
Q 021490 160 EYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAW-AR---------------PLFQDRTRHSLI----A 219 (311)
Q Consensus 160 E~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~-~~---------------~~~~~~~~~~~~----~ 219 (311)
|++.+..++.++|||||||++|+|++|..||...+.......+.. .. ............ .
T Consensus 195 E~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (364)
T cd07875 195 EVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKL 274 (364)
T ss_pred HHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhh
Confidence 999998999999999999999999999999987654333221100 00 000000000000 0
Q ss_pred Cccc----cCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 021490 220 DPEL----QGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 261 (311)
Q Consensus 220 ~~~~----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l~ 261 (311)
.+.. ...........+.+|+.+||+.||.+|||+.++++.-.
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~ 320 (364)
T cd07875 275 FPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 320 (364)
T ss_pred CccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcc
Confidence 0000 00111122457889999999999999999999998744
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=256.24 Aligned_cols=232 Identities=23% Similarity=0.333 Sum_probs=182.3
Q ss_pred CCcEEEEEEeecCCC----------cchhHHHHHHHHHhc-CCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccC
Q 021490 8 LLQDVAIKQLDRNGV----------QGNREFLVEVLMLSL-LHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLS 76 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~----------~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 76 (311)
.++.+|+|.+..... .....+..|+.++.. ++||||+++++++.++...+++|||++|++|.+++....
T Consensus 25 ~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~ 104 (269)
T cd08528 25 GQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLK 104 (269)
T ss_pred CCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCeEEEEEecCCCCcHHHHHHHHH
Confidence 378899998764321 223457778888875 699999999999999999999999999999999886544
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeecccccc
Q 021490 77 PGKKPLDWNTRMKIAAGAARGLEYLHD-KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG 155 (311)
Q Consensus 77 ~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~ 155 (311)
.....+++..++.++.|++.||.|||+ .+ ++|+||+|.||+++.++.++|+|||.+....... ......++..
T Consensus 105 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~ 178 (269)
T cd08528 105 EKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES---KLTSVVGTIL 178 (269)
T ss_pred hccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEecccceeeccccc---ccccccCccc
Confidence 345679999999999999999999996 67 9999999999999999999999999987532221 2233457888
Q ss_pred ccCccccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHH
Q 021490 156 YCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQA 235 (311)
Q Consensus 156 y~aPE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 235 (311)
|++||.+.+..++.++|+||||+++|+|++|..||.............. .. . .+.. ....+..+
T Consensus 179 ~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~------~~-~-----~~~~----~~~~~~~l 242 (269)
T cd08528 179 YSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVE------AV-Y-----EPLP----EGMYSEDV 242 (269)
T ss_pred CcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhh------cc-C-----CcCC----cccCCHHH
Confidence 9999999888889999999999999999999999976554332211110 00 0 0000 01223478
Q ss_pred HHHHHHccccCCCCCCCHHHHHHHHH
Q 021490 236 LAVAAMCVHEQPDMRPVIADVVTALA 261 (311)
Q Consensus 236 ~~li~~~l~~~p~~Rps~~~vl~~l~ 261 (311)
.+++.+||+.||++|||+.++..+++
T Consensus 243 ~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 243 TDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred HHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 89999999999999999999998874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=258.05 Aligned_cols=239 Identities=23% Similarity=0.351 Sum_probs=187.1
Q ss_pred cCCcEEEEEEeecCCC-cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHH
Q 021490 7 CLLQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN 85 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~ 85 (311)
.+|+.||+|++..... ...+.+.+|++++..++||||+++++.+......++||||+++++|.+++.. .+.+++.
T Consensus 28 ~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~ 103 (284)
T cd06620 28 PTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKK----GGPIPVE 103 (284)
T ss_pred CCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCCCCCHHHHHHh----ccCCCHH
Confidence 3588999999865432 3457899999999999999999999999999999999999999999998876 4679999
Q ss_pred HHHHHHHHHHHHHHHhhc-CCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccccc
Q 021490 86 TRMKIAAGAARGLEYLHD-KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT 164 (311)
Q Consensus 86 ~~~~~~~~i~~~l~~lh~-~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 164 (311)
.+..++.+++.+|.|||+ .+ ++|+||+|+||+++.++.++|+|||++...... ......++..|+|||++.+
T Consensus 104 ~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~----~~~~~~~~~~~~aPE~~~~ 176 (284)
T cd06620 104 ILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINS----IADTFVGTSTYMSPERIQG 176 (284)
T ss_pred HHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhh----ccCccccCcccCCHHHHcc
Confidence 999999999999999997 57 999999999999999999999999987542111 1123457889999999988
Q ss_pred CCCccccceeehhHHHHHHHhCCCccCcchhHHH-----HHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHH
Q 021490 165 GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE-----QSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVA 239 (311)
Q Consensus 165 ~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 239 (311)
..++.++|+|||||++|+|++|..||........ .............. .+.+. ....+..+.+++
T Consensus 177 ~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~---~~~~~~~~~~li 246 (284)
T cd06620 177 GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP-------PPRLP---SSDFPEDLRDFV 246 (284)
T ss_pred CCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc-------CCCCC---chhcCHHHHHHH
Confidence 8889999999999999999999999975443211 11111111111110 00000 011334788999
Q ss_pred HHccccCCCCCCCHHHHHHHHHHhhhc
Q 021490 240 AMCVHEQPDMRPVIADVVTALAYLASQ 266 (311)
Q Consensus 240 ~~~l~~~p~~Rps~~~vl~~l~~~~~~ 266 (311)
.+||..||.+|||+.++++...++...
T Consensus 247 ~~~l~~dp~~Rpt~~e~~~~~~~~~~~ 273 (284)
T cd06620 247 DACLLKDPTERPTPQQLCAMPPFIQAL 273 (284)
T ss_pred HHHhcCCcccCcCHHHHhcCccccccc
Confidence 999999999999999999987665543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=253.08 Aligned_cols=228 Identities=25% Similarity=0.350 Sum_probs=182.4
Q ss_pred cCCcEEEEEEeecCCC--cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCH
Q 021490 7 CLLQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 84 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~ 84 (311)
.+++.+|+|.+..... .....+.+|+++++.++||||+++++.+..+...++||||+++++|.+++.... ...+++
T Consensus 23 ~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~ 100 (256)
T cd08220 23 ADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRC--NSLLDE 100 (256)
T ss_pred CCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCCCCHHHHHHHhc--ccCCCH
Confidence 3689999999876532 334688899999999999999999999999999999999999999999997632 346899
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCC-CceEEccccccccCCCCCCceeeeeccccccccCccccc
Q 021490 85 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG-YHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 163 (311)
Q Consensus 85 ~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 163 (311)
..+..++.+++.+|+|||+++ ++|+||+|+||+++.+ +.++|+|||.+....... ......++..|+|||.+.
T Consensus 101 ~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~ 174 (256)
T cd08220 101 DTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS---KAYTVVGTPCYISPELCE 174 (256)
T ss_pred HHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc---cccccccCCcccCchhcc
Confidence 999999999999999999999 9999999999999854 467999999987532221 122245778999999998
Q ss_pred cCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHcc
Q 021490 164 TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCV 243 (311)
Q Consensus 164 ~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 243 (311)
+..++.++|+||||+++|+|++|..||...+......... .. .. ...+...+..+.+++.+||
T Consensus 175 ~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~------~~--~~---------~~~~~~~~~~l~~li~~~l 237 (256)
T cd08220 175 GKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIM------SG--TF---------APISDRYSPDLRQLILSML 237 (256)
T ss_pred CCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHH------hc--CC---------CCCCCCcCHHHHHHHHHHc
Confidence 8888999999999999999999999997655432211110 00 00 0112223457889999999
Q ss_pred ccCCCCCCCHHHHHHH
Q 021490 244 HEQPDMRPVIADVVTA 259 (311)
Q Consensus 244 ~~~p~~Rps~~~vl~~ 259 (311)
..+|++|||+.++++.
T Consensus 238 ~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 238 NLDPSKRPQLSQIMAQ 253 (256)
T ss_pred cCChhhCCCHHHHhhC
Confidence 9999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=255.45 Aligned_cols=229 Identities=26% Similarity=0.325 Sum_probs=177.6
Q ss_pred cCCcEEEEEEeecCCCcchhHHHHHHHHHhcC-CCCcccceeeEeeeC------CeeEEEEecCCCCChhhhhcccCCCC
Q 021490 7 CLLQDVAIKQLDRNGVQGNREFLVEVLMLSLL-HHPNLVNLIGYCADG------DQRLLVYEYMPLGSVEDHLHDLSPGK 79 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~ 79 (311)
.+++.||+|++.... .....+..|+.++..+ +|+||+++++++... ...++||||+.+++|.+++.... .
T Consensus 29 ~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~--~ 105 (272)
T cd06637 29 KTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK--G 105 (272)
T ss_pred CCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhcc--C
Confidence 368899999986443 4556788999999998 699999999998653 46899999999999999987622 3
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCc
Q 021490 80 KPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 159 (311)
Q Consensus 80 ~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aP 159 (311)
..+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++....... .......++..|+||
T Consensus 106 ~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~g~~~y~aP 180 (272)
T cd06637 106 NTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAP 180 (272)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCceeccccc--ccCCcccccccccCH
Confidence 56899999999999999999999999 9999999999999999999999999986432211 112234578899999
Q ss_pred cccc-----cCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHH
Q 021490 160 EYAK-----TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQ 234 (311)
Q Consensus 160 E~~~-----~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
|++. +..++.++|+|||||++|+|++|..||............ ... . .+. ......+..
T Consensus 181 E~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~------~~~--~-----~~~---~~~~~~~~~ 244 (272)
T cd06637 181 EVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI------PRN--P-----APR---LKSKKWSKK 244 (272)
T ss_pred hHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHH------hcC--C-----CCC---CCCCCcCHH
Confidence 9885 345788999999999999999999999754432221111 000 0 000 011123347
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHH
Q 021490 235 ALAVAAMCVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 235 l~~li~~~l~~~p~~Rps~~~vl~~ 259 (311)
+.+|+.+||..||.+|||+.++++.
T Consensus 245 ~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 245 FQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred HHHHHHHHcCCChhhCCCHHHHhhC
Confidence 8899999999999999999999864
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=263.10 Aligned_cols=234 Identities=21% Similarity=0.188 Sum_probs=178.2
Q ss_pred CCcEEEEEEeecCC---CcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCH
Q 021490 8 LLQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 84 (311)
Q Consensus 8 ~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~ 84 (311)
+|+.||+|++.... ....+.+.+|+.++..++|+||+.+++++.++...|+||||++|++|.+++... ...+++
T Consensus 25 ~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~---~~~~~~ 101 (331)
T cd05597 25 TGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKF---EDRLPE 101 (331)
T ss_pred CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCCCCcHHHHHHHh---cCCCCH
Confidence 58999999996532 223456888999999999999999999999999999999999999999999752 356899
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccccc
Q 021490 85 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT 164 (311)
Q Consensus 85 ~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 164 (311)
..+..++.|++.||+|||+++ ++||||||+|||++.++.++|+|||++........ .......++..|+|||++..
T Consensus 102 ~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~ 177 (331)
T cd05597 102 DMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT-VQSNVAVGTPDYISPEILQA 177 (331)
T ss_pred HHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCCCC-ccccceeccccccCHHHHhh
Confidence 999999999999999999999 99999999999999999999999999864322211 11222458899999999863
Q ss_pred -----CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHH
Q 021490 165 -----GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVA 239 (311)
Q Consensus 165 -----~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 239 (311)
..++.++|||||||++|+|++|..||...........+ ........ .+. ..+..+..+.+++
T Consensus 178 ~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i------~~~~~~~~---~~~----~~~~~~~~~~~li 244 (331)
T cd05597 178 MEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI------MNHKEHFQ---FPP----DVTDVSEEAKDLI 244 (331)
T ss_pred ccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHH------HcCCCccc---CCC----ccCCCCHHHHHHH
Confidence 45788999999999999999999999765443222111 11000000 000 0112345778899
Q ss_pred HHccccCCC--CCCCHHHHHHHHH
Q 021490 240 AMCVHEQPD--MRPVIADVVTALA 261 (311)
Q Consensus 240 ~~~l~~~p~--~Rps~~~vl~~l~ 261 (311)
.+||..+++ .|+++.+++..-.
T Consensus 245 ~~ll~~~~~r~~r~~~~~~l~hp~ 268 (331)
T cd05597 245 RRLICSPETRLGRNGLQDFKDHPF 268 (331)
T ss_pred HHHccCcccccCCCCHHHHhcCCC
Confidence 887765443 4789999998743
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=262.22 Aligned_cols=249 Identities=26% Similarity=0.295 Sum_probs=183.3
Q ss_pred cchhcc-CCcEEEEEEeecCCCc--chhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCC
Q 021490 2 MQVILC-LLQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPG 78 (311)
Q Consensus 2 ~~~~~~-~g~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~ 78 (311)
|.+... +|+.||+|++...... ..+.+.+|+++++.++||||+++++++..+...++|+||+++++|.++...
T Consensus 18 y~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---- 93 (286)
T cd07846 18 MKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKY---- 93 (286)
T ss_pred EEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCccHHHHHHhc----
Confidence 334443 5899999997654332 346788999999999999999999999999999999999999888887664
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccC
Q 021490 79 KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCA 158 (311)
Q Consensus 79 ~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~a 158 (311)
...+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++....... .......++..|+|
T Consensus 94 ~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~a 168 (286)
T cd07846 94 PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG--EVYTDYVATRWYRA 168 (286)
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc--cccCcccceeeccC
Confidence 456899999999999999999999999 9999999999999999999999999986532221 11222356788999
Q ss_pred cccccc-CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhh--------ccccccccccCcccc-----
Q 021490 159 PEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLF--------QDRTRHSLIADPELQ----- 224 (311)
Q Consensus 159 PE~~~~-~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~----- 224 (311)
||.+.+ ..++.++||||||+++|+|++|..||......+....+......+ ...........+...
T Consensus 169 PE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (286)
T cd07846 169 PELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPL 248 (286)
T ss_pred cHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchH
Confidence 998865 456789999999999999999999997554332211111100000 000000000001000
Q ss_pred CCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 021490 225 GQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 225 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~ 259 (311)
....+..+..+.+++.+||..+|.+||++.++++.
T Consensus 249 ~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 249 EKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred HHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 01112345678899999999999999999998864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=274.75 Aligned_cols=240 Identities=20% Similarity=0.207 Sum_probs=174.2
Q ss_pred CCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHHH
Q 021490 8 LLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTR 87 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~ 87 (311)
.++.||||... ...+.+|++++++|+|+||+++++++..+...++|||++. ++|.+++... ...+++..+
T Consensus 193 ~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~L~~~l~~~---~~~l~~~~~ 262 (461)
T PHA03211 193 YPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-SDLYTYLGAR---LRPLGLAQV 262 (461)
T ss_pred CCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-CCHHHHHHhc---CCCCCHHHH
Confidence 46788998532 2346789999999999999999999999999999999995 7888887652 346999999
Q ss_pred HHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccCCC
Q 021490 88 MKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQL 167 (311)
Q Consensus 88 ~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 167 (311)
+.++.|++.||+|||+.+ |+||||||+|||++.++.++|+|||++................|+..|+|||++.+..+
T Consensus 263 ~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~ 339 (461)
T PHA03211 263 TAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPY 339 (461)
T ss_pred HHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcCCCC
Confidence 999999999999999999 99999999999999999999999999875432222222233468999999999998899
Q ss_pred ccccceeehhHHHHHHHhCCCccCcchh--------HHHHHHHHHhhhhhcccccc-------------ccccCccccCC
Q 021490 168 TLKSDVYSFGVVLLEILSGRKAVDTSKA--------AAEQSLVAWARPLFQDRTRH-------------SLIADPELQGQ 226 (311)
Q Consensus 168 ~~~~DiwslG~l~~~ll~g~~pf~~~~~--------~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~ 226 (311)
+.++|||||||++|||++|..++-.... .....++............. .....+.....
T Consensus 340 ~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 419 (461)
T PHA03211 340 TPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRP 419 (461)
T ss_pred CchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCc
Confidence 9999999999999999998765422111 11111221111000000000 00000000000
Q ss_pred CCh---HhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 021490 227 YPP---RGFYQALAVAAMCVHEQPDMRPVIADVVTAL 260 (311)
Q Consensus 227 ~~~---~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l 260 (311)
... .....+.+|+.+||+.||.+|||+.|+++.-
T Consensus 420 ~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp 456 (461)
T PHA03211 420 AWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLP 456 (461)
T ss_pred chhhhccccchHHHHHHHHcccChhhCcCHHHHhhCc
Confidence 000 1223678899999999999999999999864
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=254.65 Aligned_cols=231 Identities=24% Similarity=0.309 Sum_probs=184.2
Q ss_pred cCCcEEEEEEeecCCC--cchhHHHHHHHHHhcCCCCcccceeeEeee--CCeeEEEEecCCCCChhhhhcccCCCCCCC
Q 021490 7 CLLQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCAD--GDQRLLVYEYMPLGSVEDHLHDLSPGKKPL 82 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l 82 (311)
.+|..||+|.++.... ...+.+.+|+.+++.++|+||+++++++.. +...+++|||+++++|.+++.........+
T Consensus 23 ~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l 102 (265)
T cd08217 23 SDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYI 102 (265)
T ss_pred CCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhccCCCHHHHHHHHhhcccCC
Confidence 3678999999865433 334578899999999999999999997753 456799999999999999997654445679
Q ss_pred CHHHHHHHHHHHHHHHHHhh-----cCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeecccccccc
Q 021490 83 DWNTRMKIAAGAARGLEYLH-----DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 157 (311)
Q Consensus 83 ~~~~~~~~~~~i~~~l~~lh-----~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~ 157 (311)
++..++.++.+++.||++|| +.+ ++|+||+|+||+++.++.++|+|||++........ ......++..|+
T Consensus 103 ~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~--~~~~~~~~~~~~ 177 (265)
T cd08217 103 EEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSS--FAKTYVGTPYYM 177 (265)
T ss_pred CHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEecccccccccCCcc--cccccccCCCcc
Confidence 99999999999999999999 777 99999999999999999999999999875432221 122235788999
Q ss_pred CccccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHH
Q 021490 158 APEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALA 237 (311)
Q Consensus 158 aPE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 237 (311)
|||.+.+..++.++|+||||+++|+|++|..||...+........ .... ....+...+..+.+
T Consensus 178 ~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~-------~~~~----------~~~~~~~~~~~~~~ 240 (265)
T cd08217 178 SPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKI-------KEGK----------FRRIPYRYSSELNE 240 (265)
T ss_pred ChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHH-------hcCC----------CCCCccccCHHHHH
Confidence 999998888899999999999999999999999876532221111 0000 01223344558889
Q ss_pred HHHHccccCCCCCCCHHHHHHH
Q 021490 238 VAAMCVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 238 li~~~l~~~p~~Rps~~~vl~~ 259 (311)
++.+||..+|++|||+.++++.
T Consensus 241 l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 241 VIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred HHHHHccCCcccCCCHHHHhhC
Confidence 9999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=262.76 Aligned_cols=253 Identities=18% Similarity=0.230 Sum_probs=183.6
Q ss_pred cCCcEEEEEEeecCCC--cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCH
Q 021490 7 CLLQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 84 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~ 84 (311)
.+|+.||+|++..... ...+.+.+|+.+++.++||||++++++|..+...++|+||+.+++|.+++.... ...+++
T Consensus 23 ~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~--~~~~~~ 100 (328)
T cd08226 23 PTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYF--PEGMSE 100 (328)
T ss_pred CCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCCCHHHHHHhhc--ccCCCH
Confidence 3789999999865432 234678899999999999999999999999999999999999999999988632 345899
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCC-Cce----eeeeccccccccCc
Q 021490 85 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD-NTH----VSTRVMGTYGYCAP 159 (311)
Q Consensus 85 ~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~----~~~~~~~~~~y~aP 159 (311)
..+..++.|++.||+|||+.+ ++||||||+||+++.++.++++||+.+....... ... ......++..|++|
T Consensus 101 ~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aP 177 (328)
T cd08226 101 ALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSP 177 (328)
T ss_pred HHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccccccccccCccCccCh
Confidence 999999999999999999999 9999999999999999999999997543211110 000 00112345679999
Q ss_pred ccccc--CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccc-------------------------
Q 021490 160 EYAKT--GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDR------------------------- 212 (311)
Q Consensus 160 E~~~~--~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~------------------------- 212 (311)
|++.+ ..++.++|||||||++|+|++|..||................+.....
T Consensus 178 E~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (328)
T cd08226 178 ELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGES 257 (328)
T ss_pred hhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccc
Confidence 99866 347899999999999999999999997654332211000000000000
Q ss_pred c----ccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhh
Q 021490 213 T----RHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLA 264 (311)
Q Consensus 213 ~----~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l~~~~ 264 (311)
. ......+..+....+...+..+.+|+.+||+.||++|||+.++++......
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~ 313 (328)
T cd08226 258 VVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQ 313 (328)
T ss_pred hhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHH
Confidence 0 000000111111222345678899999999999999999999997765444
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=284.54 Aligned_cols=241 Identities=21% Similarity=0.242 Sum_probs=183.4
Q ss_pred CCcEEEEEEeecCCC---cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCC-------
Q 021490 8 LLQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP------- 77 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~------- 77 (311)
.|+.||+|++..... ...++|.+|++++..++||||+++++++.++...++||||++|++|.+++.....
T Consensus 26 tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~ 105 (932)
T PRK13184 26 CSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKE 105 (932)
T ss_pred CCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCCCCCHHHHHHHhhhccccchh
Confidence 589999999965432 2235789999999999999999999999999999999999999999998865211
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCC--------------
Q 021490 78 GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN-------------- 143 (311)
Q Consensus 78 ~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-------------- 143 (311)
....++...++.++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++........
T Consensus 106 ~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~ 182 (932)
T PRK13184 106 LAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICY 182 (932)
T ss_pred hhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecCcceecccccccccccccccccccc
Confidence 1234567788999999999999999999 99999999999999999999999999875311100
Q ss_pred --ceeeeeccccccccCccccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCc
Q 021490 144 --THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADP 221 (311)
Q Consensus 144 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (311)
........|++.|+|||++.+..++.++|||||||++|+|++|..||............ ... ++
T Consensus 183 s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~~~-----~i~---------~P 248 (932)
T PRK13184 183 SSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISYRD-----VIL---------SP 248 (932)
T ss_pred cccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhhhh-----hcc---------Ch
Confidence 00112245899999999999889999999999999999999999999764332111000 000 00
Q ss_pred cccCCCChHhHHHHHHHHHHccccCCCCCC-CHHHHHHHHHHhhhc
Q 021490 222 ELQGQYPPRGFYQALAVAAMCVHEQPDMRP-VIADVVTALAYLASQ 266 (311)
Q Consensus 222 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-s~~~vl~~l~~~~~~ 266 (311)
... ......+..+.+++.+||+.||++|| +++++++.|+...+.
T Consensus 249 ~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 249 IEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred hhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 000 00012234678899999999999996 566777888776554
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=265.29 Aligned_cols=241 Identities=21% Similarity=0.269 Sum_probs=176.7
Q ss_pred cCCcEEEEEEeecCCC--cchhHHHHHHHHHhcCCCCcccceeeEeeeC------CeeEEEEecCCCCChhhhhcccCCC
Q 021490 7 CLLQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADG------DQRLLVYEYMPLGSVEDHLHDLSPG 78 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~ 78 (311)
.+++.||+|++..... .....+.+|+.+++.++||||+++++++... ...|++++++ +++|.+++..
T Consensus 38 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~~---- 112 (343)
T cd07878 38 RLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVKC---- 112 (343)
T ss_pred CCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEeecC-CCCHHHHHhc----
Confidence 3678999999865432 2345678899999999999999999987543 3468999988 7899888763
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccC
Q 021490 79 KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCA 158 (311)
Q Consensus 79 ~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~a 158 (311)
..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++...... .....++..|+|
T Consensus 113 -~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~t~~y~a 183 (343)
T cd07878 113 -QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDE-----MTGYVATRWYRA 183 (343)
T ss_pred -CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCccceecCCC-----cCCccccccccC
Confidence 56999999999999999999999999 999999999999999999999999998753221 123357889999
Q ss_pred cccccc-CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHH-hhh----hhccccc---------cccccCccc
Q 021490 159 PEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAW-ARP----LFQDRTR---------HSLIADPEL 223 (311)
Q Consensus 159 PE~~~~-~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~-~~~----~~~~~~~---------~~~~~~~~~ 223 (311)
||++.+ ..++.++|||||||++|+|++|..||.............. ... ....... ........+
T Consensus 184 PE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (343)
T cd07878 184 PEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDL 263 (343)
T ss_pred chHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhH
Confidence 999876 5688999999999999999999999976544322211100 000 0000000 000000000
Q ss_pred cCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 021490 224 QGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAY 262 (311)
Q Consensus 224 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l~~ 262 (311)
. .........+.+|+.+||..||.+|||+.+++..-..
T Consensus 264 ~-~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~ 301 (343)
T cd07878 264 K-KIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYF 301 (343)
T ss_pred H-HhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcch
Confidence 0 0001122357889999999999999999999987544
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=258.91 Aligned_cols=233 Identities=25% Similarity=0.287 Sum_probs=177.8
Q ss_pred cCCcEEEEEEeecCCCcchhHHHHHHHHHhcC-CCCcccceeeEee-----eCCeeEEEEecCCCCChhhhhcccCCCCC
Q 021490 7 CLLQDVAIKQLDRNGVQGNREFLVEVLMLSLL-HHPNLVNLIGYCA-----DGDQRLLVYEYMPLGSVEDHLHDLSPGKK 80 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 80 (311)
..|..+|+|++.... .....+.+|+.++..+ +||||+++++++. .+...++||||++|++|.+++........
T Consensus 41 ~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 119 (286)
T cd06638 41 KNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGE 119 (286)
T ss_pred CCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCc
Confidence 357899999885432 3346788899999999 6999999999874 34568999999999999998765333356
Q ss_pred CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcc
Q 021490 81 PLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 160 (311)
Q Consensus 81 ~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE 160 (311)
.+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .......++..|+|||
T Consensus 120 ~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE 194 (286)
T cd06638 120 RMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR--LRRNTSVGTPFWMAPE 194 (286)
T ss_pred cccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEEccCCceeecccCC--CccccccCCCcccChh
Confidence 7899999999999999999999999 9999999999999999999999999986532211 1122235788999999
Q ss_pred cccc-----CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHH
Q 021490 161 YAKT-----GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQA 235 (311)
Q Consensus 161 ~~~~-----~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 235 (311)
++.. ..++.++|||||||++|+|++|..||........... ... ........ +......+
T Consensus 195 ~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~-------~~~-~~~~~~~~-------~~~~~~~~ 259 (286)
T cd06638 195 VIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFK-------IPR-NPPPTLHQ-------PELWSNEF 259 (286)
T ss_pred hhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhh-------ccc-cCCCcccC-------CCCcCHHH
Confidence 8753 4578899999999999999999999976543221100 000 00000001 11123468
Q ss_pred HHHHHHccccCCCCCCCHHHHHHHH
Q 021490 236 LAVAAMCVHEQPDMRPVIADVVTAL 260 (311)
Q Consensus 236 ~~li~~~l~~~p~~Rps~~~vl~~l 260 (311)
.+++.+||+.||++|||+.++++.+
T Consensus 260 ~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 260 NDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred HHHHHHHccCCcccCCCHHHHhhcc
Confidence 8899999999999999999999764
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=259.19 Aligned_cols=222 Identities=27% Similarity=0.328 Sum_probs=182.0
Q ss_pred CCcEEEEEEeecCCC---cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCH
Q 021490 8 LLQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 84 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~ 84 (311)
+++.||+|+++.... ...+.+.+|+++++.++||||+++++++.++...++||||+++++|.+++.. ...+++
T Consensus 25 ~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~----~~~l~~ 100 (290)
T cd05580 25 SGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRK----SGRFPE 100 (290)
T ss_pred CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCCCCCHHHHHHH----cCCCCH
Confidence 689999999865432 2346788999999999999999999999999999999999999999999987 567999
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccccc
Q 021490 85 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT 164 (311)
Q Consensus 85 ~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 164 (311)
..+..++.|++.||.|||+.+ ++|+||+|.||+++.++.++|+|||++...... .....++..|+|||.+.+
T Consensus 101 ~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~ 172 (290)
T cd05580 101 PVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-----TYTLCGTPEYLAPEIILS 172 (290)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC-----CCCCCCCccccChhhhcC
Confidence 999999999999999999999 999999999999999999999999998753222 222357889999999988
Q ss_pred CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccc
Q 021490 165 GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVH 244 (311)
Q Consensus 165 ~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 244 (311)
...+.++|+||||+++|+|++|..||............ ... .. .++......+.+++.+||.
T Consensus 173 ~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~------~~~--------~~----~~~~~~~~~l~~li~~~l~ 234 (290)
T cd05580 173 KGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKI------LEG--------KV----RFPSFFSPDAKDLIRNLLQ 234 (290)
T ss_pred CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------hcC--------Cc----cCCccCCHHHHHHHHHHcc
Confidence 88899999999999999999999999766532221111 000 00 1122234578889999999
Q ss_pred cCCCCCC-----CHHHHHHH
Q 021490 245 EQPDMRP-----VIADVVTA 259 (311)
Q Consensus 245 ~~p~~Rp-----s~~~vl~~ 259 (311)
.||.+|+ ++++++..
T Consensus 235 ~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 235 VDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred CCHHHccCcccCCHHHHHcC
Confidence 9999998 77777754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=262.53 Aligned_cols=180 Identities=24% Similarity=0.299 Sum_probs=144.0
Q ss_pred CCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeee--CCeeEEEEecCCCCChhhhhcccC-----CCCC
Q 021490 8 LLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCAD--GDQRLLVYEYMPLGSVEDHLHDLS-----PGKK 80 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~ 80 (311)
+++.||+|.++... ....+.+|+.+++.++||||+++++++.. +...+++|||+. ++|.+++.... ....
T Consensus 27 ~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~ 103 (317)
T cd07868 27 DDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPV 103 (317)
T ss_pred CCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-CCHHHHHHhcccccccCCcc
Confidence 56889999986432 33467889999999999999999998854 456899999985 58887765321 1123
Q ss_pred CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEE----cCCCceEEccccccccCCCCCC-ceeeeecccccc
Q 021490 81 PLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL----DRGYHPKLSDFGLAKLGPVGDN-THVSTRVMGTYG 155 (311)
Q Consensus 81 ~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~----~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~ 155 (311)
.+++..+..++.|++.||+|||+++ ++||||||+|||+ +.++.+||+|||++........ ........++..
T Consensus 104 ~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~ 180 (317)
T cd07868 104 QLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 180 (317)
T ss_pred cCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCcccccc
Confidence 5899999999999999999999999 9999999999999 4567899999999875332211 111223467889
Q ss_pred ccCcccccc-CCCccccceeehhHHHHHHHhCCCccCcc
Q 021490 156 YCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTS 193 (311)
Q Consensus 156 y~aPE~~~~-~~~~~~~DiwslG~l~~~ll~g~~pf~~~ 193 (311)
|+|||++.+ ..++.++||||+||++|+|++|.+||...
T Consensus 181 y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 999998876 45889999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=257.65 Aligned_cols=232 Identities=25% Similarity=0.274 Sum_probs=178.2
Q ss_pred cCCcEEEEEEeecCCCcchhHHHHHHHHHhcC-CCCcccceeeEeeeC-----CeeEEEEecCCCCChhhhhcccCCCCC
Q 021490 7 CLLQDVAIKQLDRNGVQGNREFLVEVLMLSLL-HHPNLVNLIGYCADG-----DQRLLVYEYMPLGSVEDHLHDLSPGKK 80 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~ 80 (311)
.+|+.+|+|++.... .....+.+|+.++..+ +|||++++++++... ...++||||+++++|.+++........
T Consensus 45 ~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~ 123 (291)
T cd06639 45 KDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQ 123 (291)
T ss_pred CCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCC
Confidence 468899999985432 3456778899999999 799999999998653 358999999999999998865433456
Q ss_pred CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcc
Q 021490 81 PLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 160 (311)
Q Consensus 81 ~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE 160 (311)
.+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++........ ......++..|+|||
T Consensus 124 ~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE 198 (291)
T cd06639 124 RLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPE 198 (291)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEeecccchhcccccc--cccCccCCccccChh
Confidence 7899999999999999999999999 99999999999999999999999999865322111 112235778899999
Q ss_pred ccccC-----CCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHH
Q 021490 161 YAKTG-----QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQA 235 (311)
Q Consensus 161 ~~~~~-----~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 235 (311)
.+... .++.++|||||||++|+|++|..||.......... ... .. ..... ..+......+
T Consensus 199 ~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~--~~~----~~--~~~~~-------~~~~~~~~~l 263 (291)
T cd06639 199 VIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLF--KIP----RN--PPPTL-------LHPEKWCRSF 263 (291)
T ss_pred hhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHH--HHh----cC--CCCCC-------CcccccCHHH
Confidence 87543 36789999999999999999999997654322211 100 00 00000 0112233478
Q ss_pred HHHHHHccccCCCCCCCHHHHHHH
Q 021490 236 LAVAAMCVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 236 ~~li~~~l~~~p~~Rps~~~vl~~ 259 (311)
.+++.+||+.+|++|||+.++++.
T Consensus 264 ~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 264 NHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred HHHHHHHhhcChhhCcCHHHHhcC
Confidence 899999999999999999999875
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=258.33 Aligned_cols=245 Identities=24% Similarity=0.280 Sum_probs=185.3
Q ss_pred chhc-cCCcEEEEEEeecCCC-cchhHHHHHHHHHhcCCCCcccceeeEeeeC--CeeEEEEecCCCCChhhhhcccCCC
Q 021490 3 QVIL-CLLQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADG--DQRLLVYEYMPLGSVEDHLHDLSPG 78 (311)
Q Consensus 3 ~~~~-~~g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~ 78 (311)
.+.. .+++.+|+|.+..... .....+.+|+++++.++||||+++++++.+. ...++||||+++++|.+++......
T Consensus 19 ~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~ 98 (287)
T cd06621 19 KCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKR 98 (287)
T ss_pred EEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCCCHHHHHHHHHhc
Confidence 3344 3689999999875433 3446789999999999999999999988653 4689999999999999887654334
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccC
Q 021490 79 KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCA 158 (311)
Q Consensus 79 ~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~a 158 (311)
...+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++....... .....++..|++
T Consensus 99 ~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~y~~ 171 (287)
T cd06621 99 GGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL----AGTFTGTSFYMA 171 (287)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccccc----cccccCCccccC
Confidence 567899999999999999999999999 9999999999999999999999999976432211 112346778999
Q ss_pred ccccccCCCccccceeehhHHHHHHHhCCCccCcchh--HHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHH
Q 021490 159 PEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKA--AAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQAL 236 (311)
Q Consensus 159 PE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 236 (311)
||.+.+..++.++|+||||+++|+|++|..||..... ........+... .........+.. ....+..+.
T Consensus 172 pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~----~~~~~~~~~ 243 (287)
T cd06621 172 PERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN----MPNPELKDEPGN----GIKWSEEFK 243 (287)
T ss_pred HHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc----CCchhhccCCCC----CCchHHHHH
Confidence 9999888899999999999999999999999976532 111111111111 000000000000 012345788
Q ss_pred HHHHHccccCCCCCCCHHHHHHHHHH
Q 021490 237 AVAAMCVHEQPDMRPVIADVVTALAY 262 (311)
Q Consensus 237 ~li~~~l~~~p~~Rps~~~vl~~l~~ 262 (311)
+++.+||..+|.+|||+.|+++.-..
T Consensus 244 ~li~~~l~~~p~~Rpt~~eil~~~~~ 269 (287)
T cd06621 244 DFIKQCLEKDPTRRPTPWDMLEHPWI 269 (287)
T ss_pred HHHHHHcCCCcccCCCHHHHHhCccc
Confidence 99999999999999999999987543
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=258.21 Aligned_cols=242 Identities=22% Similarity=0.266 Sum_probs=176.6
Q ss_pred CCcEEEEEEeecCCCc-chhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHH
Q 021490 8 LLQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNT 86 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~ 86 (311)
+|..||+|.+...... ....+.+|+++++.++|+||+++++++.++...++||||+. ++|.+++... ...+++..
T Consensus 29 ~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~ 104 (291)
T cd07844 29 TGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLD-TDLKQYMDDC---GGGLSMHN 104 (291)
T ss_pred CCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCC-CCHHHHHHhC---CCCCCHHH
Confidence 6899999998654332 23467789999999999999999999999999999999997 5899888752 34789999
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccccc-C
Q 021490 87 RMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT-G 165 (311)
Q Consensus 87 ~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~ 165 (311)
+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .......++..|+|||++.+ .
T Consensus 105 ~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~ 179 (291)
T cd07844 105 VRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPS--KTYSNEVVTLWYRPPDVLLGST 179 (291)
T ss_pred HHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCC--ccccccccccccCCcHHhhcCc
Confidence 9999999999999999999 9999999999999999999999999886422111 11112235778999998865 5
Q ss_pred CCccccceeehhHHHHHHHhCCCccCcchh-HHHHHHHHHhh-hhhcc----ccc---ccc-----ccCccccCCCChHh
Q 021490 166 QLTLKSDVYSFGVVLLEILSGRKAVDTSKA-AAEQSLVAWAR-PLFQD----RTR---HSL-----IADPELQGQYPPRG 231 (311)
Q Consensus 166 ~~~~~~DiwslG~l~~~ll~g~~pf~~~~~-~~~~~~~~~~~-~~~~~----~~~---~~~-----~~~~~~~~~~~~~~ 231 (311)
.++.++||||+|+++|+|++|..||..... ........... ..... ... ... .....+.... +..
T Consensus 180 ~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 258 (291)
T cd07844 180 EYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHA-PRL 258 (291)
T ss_pred ccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhC-cCC
Confidence 578899999999999999999999975542 11111111000 00000 000 000 0000000000 011
Q ss_pred --HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 021490 232 --FYQALAVAAMCVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 232 --~~~l~~li~~~l~~~p~~Rps~~~vl~~ 259 (311)
...+.+++.+||+.+|.+|||+.+++..
T Consensus 259 ~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 259 DRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred CCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 2577889999999999999999998764
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=256.35 Aligned_cols=225 Identities=27% Similarity=0.329 Sum_probs=182.9
Q ss_pred CCcEEEEEEeecCCC---cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCH
Q 021490 8 LLQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 84 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~ 84 (311)
+|..||+|++..... ...+.+.+|++++++++||||+++++.+.++...++|+||+.|++|.+++.. ...+++
T Consensus 24 ~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~ 99 (258)
T cd05578 24 TKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQ----KVKFSE 99 (258)
T ss_pred CCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCCCCCHHHHHHh----cCCcCH
Confidence 589999999976543 3356889999999999999999999999999999999999999999999986 457999
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccccc
Q 021490 85 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT 164 (311)
Q Consensus 85 ~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 164 (311)
..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||.+....... ......++..|+|||.+..
T Consensus 100 ~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~ 173 (258)
T cd05578 100 EQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTTSTSGTPGYMAPEVLCR 173 (258)
T ss_pred HHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc---cccccCCChhhcCHHHHcc
Confidence 999999999999999999999 9999999999999999999999999987533221 1223457788999999988
Q ss_pred CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccc
Q 021490 165 GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVH 244 (311)
Q Consensus 165 ~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 244 (311)
..++.++|+||||+++|+|++|..||............... .. .....+...+..+.+++.+||+
T Consensus 174 ~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~----~~-----------~~~~~~~~~~~~~~~~i~~~l~ 238 (258)
T cd05578 174 QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQ----ET-----------ADVLYPATWSTEAIDAINKLLE 238 (258)
T ss_pred cCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHh----cc-----------ccccCcccCcHHHHHHHHHHcc
Confidence 88999999999999999999999999866532111111100 00 0112223344688899999999
Q ss_pred cCCCCCCCH--HHHH
Q 021490 245 EQPDMRPVI--ADVV 257 (311)
Q Consensus 245 ~~p~~Rps~--~~vl 257 (311)
.||.+||++ .|++
T Consensus 239 ~~p~~R~~~~~~~l~ 253 (258)
T cd05578 239 RDPQKRLGDNLKDLK 253 (258)
T ss_pred CChhHcCCccHHHHh
Confidence 999999999 6654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=258.34 Aligned_cols=228 Identities=21% Similarity=0.294 Sum_probs=183.2
Q ss_pred cCCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHH
Q 021490 7 CLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNT 86 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~ 86 (311)
.+|..||+|++..........+.+|+.+++.++|+||+++++.+..+...++||||+++++|.+++.. ..+++..
T Consensus 43 ~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~ 117 (292)
T cd06657 43 SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH-----TRMNEEQ 117 (292)
T ss_pred CCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHHHHHhc-----CCCCHHH
Confidence 47899999998655545567899999999999999999999999999999999999999999998754 4589999
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccCC
Q 021490 87 RMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ 166 (311)
Q Consensus 87 ~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 166 (311)
+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||.+....... .......++..|++||.+.+..
T Consensus 118 ~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~~pE~~~~~~ 192 (292)
T cd06657 118 IAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKSLVGTPYWMAPELISRLP 192 (292)
T ss_pred HHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccc--ccccccccCccccCHHHhcCCC
Confidence 9999999999999999999 9999999999999999999999999876432211 1122245778899999988888
Q ss_pred CccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccC
Q 021490 167 LTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQ 246 (311)
Q Consensus 167 ~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 246 (311)
++.++|+||+|+++|+|++|..||............... .. +.+. .....+..+.+++.+||..|
T Consensus 193 ~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~---~~----------~~~~--~~~~~~~~l~~li~~~l~~~ 257 (292)
T cd06657 193 YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN---LP----------PKLK--NLHKVSPSLKGFLDRLLVRD 257 (292)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhh---CC----------cccC--CcccCCHHHHHHHHHHHhCC
Confidence 899999999999999999999999765443322221110 00 0000 01122336788999999999
Q ss_pred CCCCCCHHHHHHH
Q 021490 247 PDMRPVIADVVTA 259 (311)
Q Consensus 247 p~~Rps~~~vl~~ 259 (311)
|.+||++.+++..
T Consensus 258 P~~R~~~~~ll~~ 270 (292)
T cd06657 258 PAQRATAAELLKH 270 (292)
T ss_pred cccCcCHHHHhcC
Confidence 9999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=256.16 Aligned_cols=229 Identities=26% Similarity=0.325 Sum_probs=176.0
Q ss_pred cCCcEEEEEEeecCCC-----cchhHHHHHHHHHhcCCCCcccceeeEeee--CCeeEEEEecCCCCChhhhhcccCCCC
Q 021490 7 CLLQDVAIKQLDRNGV-----QGNREFLVEVLMLSLLHHPNLVNLIGYCAD--GDQRLLVYEYMPLGSVEDHLHDLSPGK 79 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~ 79 (311)
..|..|++|++..... .....+.+|+.+++.++||||+++++++.+ ....++++||+++++|.+++.. .
T Consensus 25 ~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~----~ 100 (266)
T cd06651 25 DTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKA----Y 100 (266)
T ss_pred CCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEeCCCCCcHHHHHHH----c
Confidence 3588999999865432 123568889999999999999999998865 3567899999999999999976 4
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCC-ceeeeeccccccccC
Q 021490 80 KPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN-THVSTRVMGTYGYCA 158 (311)
Q Consensus 80 ~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~y~a 158 (311)
..+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++........ ........++..|+|
T Consensus 101 ~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~a 177 (266)
T cd06651 101 GALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMS 177 (266)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccccccccccCCccccCCccccccC
Confidence 56899999999999999999999999 99999999999999999999999999864322111 111122347788999
Q ss_pred ccccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHH
Q 021490 159 PEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAV 238 (311)
Q Consensus 159 PE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 238 (311)
||.+.+..++.++|+|||||++|+|++|..||............ .... ..+ .++......+.++
T Consensus 178 PE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~------~~~~------~~~----~~~~~~~~~~~~l 241 (266)
T cd06651 178 PEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKI------ATQP------TNP----QLPSHISEHARDF 241 (266)
T ss_pred HHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHH------hcCC------CCC----CCchhcCHHHHHH
Confidence 99998888899999999999999999999999765432211100 0000 011 1222333456667
Q ss_pred HHHccccCCCCCCCHHHHHHH
Q 021490 239 AAMCVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 239 i~~~l~~~p~~Rps~~~vl~~ 259 (311)
+ .||..+|++|||+.+++..
T Consensus 242 i-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 242 L-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred H-HHhcCChhhCcCHHHHhcC
Confidence 7 6888999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=254.89 Aligned_cols=232 Identities=25% Similarity=0.354 Sum_probs=182.9
Q ss_pred cCCcEEEEEEeecCCCc--chhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCH
Q 021490 7 CLLQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 84 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~ 84 (311)
.+++.|++|.++..... ....+.+|+.+++.++|+||+++++++.+....++|+||+++++|.+++.. +..+++
T Consensus 23 ~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~ 98 (264)
T cd06626 23 DTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEH----GRILDE 98 (264)
T ss_pred CCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCCCcHHHHHhh----cCCCCh
Confidence 47899999999766553 457889999999999999999999999999999999999999999999976 456899
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCcee--eeeccccccccCcccc
Q 021490 85 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHV--STRVMGTYGYCAPEYA 162 (311)
Q Consensus 85 ~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~--~~~~~~~~~y~aPE~~ 162 (311)
..+..++.+++.||+|||+.+ ++|+||+|+||++++++.++|+|||++........... .....++..|+|||.+
T Consensus 99 ~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~ 175 (264)
T cd06626 99 HVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVI 175 (264)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhc
Confidence 999999999999999999999 99999999999999999999999999875433222111 1123567899999998
Q ss_pred ccCC---CccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHH
Q 021490 163 KTGQ---LTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVA 239 (311)
Q Consensus 163 ~~~~---~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 239 (311)
.+.. .+.++||||||+++|+|++|..||...+....... ... ... .+.+.. .......+.+++
T Consensus 176 ~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~--~~~--~~~--------~~~~~~--~~~~~~~~~~li 241 (264)
T cd06626 176 TGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMF--HVG--AGH--------KPPIPD--SLQLSPEGKDFL 241 (264)
T ss_pred cCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHH--HHh--cCC--------CCCCCc--ccccCHHHHHHH
Confidence 7765 78999999999999999999999976532211110 000 000 001100 011244778899
Q ss_pred HHccccCCCCCCCHHHHHHH
Q 021490 240 AMCVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 240 ~~~l~~~p~~Rps~~~vl~~ 259 (311)
.+||+.+|.+|||+.+++..
T Consensus 242 ~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 242 DRCLESDPKKRPTASELLQH 261 (264)
T ss_pred HHHccCCcccCCCHHHHhcC
Confidence 99999999999999998753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=256.74 Aligned_cols=231 Identities=27% Similarity=0.326 Sum_probs=178.8
Q ss_pred CCcEEEEEEeecCCCcchhHHHHHHHHHhcC-CCCcccceeeEeeeCC------eeEEEEecCCCCChhhhhcccCCCCC
Q 021490 8 LLQDVAIKQLDRNGVQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGD------QRLLVYEYMPLGSVEDHLHDLSPGKK 80 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~ 80 (311)
+++.+++|++.... ...+.+.+|+.+++.+ .|+||+++++++.+.. ..++||||+++++|.+++......+.
T Consensus 30 ~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~ 108 (275)
T cd06608 30 TGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGK 108 (275)
T ss_pred CCcEEEEEEEecCc-hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCC
Confidence 57899999986543 3457899999999999 7999999999986544 48999999999999998876433356
Q ss_pred CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcc
Q 021490 81 PLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 160 (311)
Q Consensus 81 ~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE 160 (311)
.+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++...... ........++..|+|||
T Consensus 109 ~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~--~~~~~~~~~~~~y~aPE 183 (275)
T cd06608 109 RLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDST--LGRRNTFIGTPYWMAPE 183 (275)
T ss_pred CCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCccceecccc--hhhhcCccccccccCHh
Confidence 7999999999999999999999999 999999999999999999999999988643221 11222345788899999
Q ss_pred cccc-----CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHH
Q 021490 161 YAKT-----GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQA 235 (311)
Q Consensus 161 ~~~~-----~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 235 (311)
++.. ..++.++||||||+++|+|++|..||............ ... . .+. ...+...+..+
T Consensus 184 ~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~------~~~--~-----~~~--~~~~~~~~~~~ 248 (275)
T cd06608 184 VIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKI------PRN--P-----PPT--LKSPENWSKKF 248 (275)
T ss_pred HhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHh------hcc--C-----CCC--CCchhhcCHHH
Confidence 8753 34678899999999999999999999754332211100 000 0 000 01112234578
Q ss_pred HHHHHHccccCCCCCCCHHHHHHH
Q 021490 236 LAVAAMCVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 236 ~~li~~~l~~~p~~Rps~~~vl~~ 259 (311)
.+++.+||..||.+|||+.++++.
T Consensus 249 ~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 249 NDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred HHHHHHHhhcChhhCcCHHHHhcC
Confidence 899999999999999999999864
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=259.53 Aligned_cols=242 Identities=19% Similarity=0.201 Sum_probs=177.4
Q ss_pred cCCcEEEEEEeecCCC--cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCH
Q 021490 7 CLLQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 84 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~ 84 (311)
.+|..||+|.++.... .....+.+|+.+++.++||||+++++++.+....++|+||++ ++|.+++... ...+++
T Consensus 23 ~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~---~~~~~~ 98 (284)
T cd07839 23 ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCD-QDLKKYFDSC---NGDIDP 98 (284)
T ss_pred CCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCC-CCHHHHHHhc---CCCCCH
Confidence 3689999999865432 223567889999999999999999999999999999999997 5788877642 456999
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccccc
Q 021490 85 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT 164 (311)
Q Consensus 85 ~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 164 (311)
..++.++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .......++..|+|||++.+
T Consensus 99 ~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~ 173 (284)
T cd07839 99 EIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPV--RCYSAEVVTLWYRPPDVLFG 173 (284)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCC--CCcCCCccccCCcChHHHhC
Confidence 999999999999999999999 9999999999999999999999999986432211 11122346788999998866
Q ss_pred C-CCccccceeehhHHHHHHHhCCCccC-cchhHHHHHHHHHhh--------hhhccccccccccCcccc-----CCCCh
Q 021490 165 G-QLTLKSDVYSFGVVLLEILSGRKAVD-TSKAAAEQSLVAWAR--------PLFQDRTRHSLIADPELQ-----GQYPP 229 (311)
Q Consensus 165 ~-~~~~~~DiwslG~l~~~ll~g~~pf~-~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~-----~~~~~ 229 (311)
. .++.++|||||||++|+|++|..||. ..+.......+.... +......... ..+... ....+
T Consensus 174 ~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 251 (284)
T cd07839 174 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYK--PYPMYPATTSLVNVVP 251 (284)
T ss_pred CcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccccc--ccCCCCCcchhhhhcc
Confidence 4 46889999999999999999988853 332222211110000 0000000000 000000 11122
Q ss_pred HhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 021490 230 RGFYQALAVAAMCVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 230 ~~~~~l~~li~~~l~~~p~~Rps~~~vl~~ 259 (311)
..+..+.+++.+||+.||.+|||+++++..
T Consensus 252 ~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 252 KLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred cCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 345688899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=255.62 Aligned_cols=237 Identities=24% Similarity=0.360 Sum_probs=185.2
Q ss_pred chhcc-CCcEEEEEEeecCCC-cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCC
Q 021490 3 QVILC-LLQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKK 80 (311)
Q Consensus 3 ~~~~~-~g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 80 (311)
.+... +|+.||+|.+..... .....+.+|+++++.++||||+++++.+..+...++++||+++++|.+++... ..
T Consensus 19 ~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~ 95 (265)
T cd06605 19 KVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEV---QG 95 (265)
T ss_pred EEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCCcHHHHHHHc---cC
Confidence 33343 689999999876543 34467899999999999999999999999999999999999999999999862 26
Q ss_pred CCCHHHHHHHHHHHHHHHHHhhc-CCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCc
Q 021490 81 PLDWNTRMKIAAGAARGLEYLHD-KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 159 (311)
Q Consensus 81 ~l~~~~~~~~~~~i~~~l~~lh~-~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aP 159 (311)
.+++..+..++.|++.||+|||+ .+ ++|+||+|+||+++.++.++|+|||.+........ ....++..|+||
T Consensus 96 ~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~----~~~~~~~~y~~P 168 (265)
T cd06605 96 RIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA----KTFVGTSSYMAP 168 (265)
T ss_pred CCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHHh----hcccCChhccCH
Confidence 78999999999999999999999 88 99999999999999999999999998764321111 114577889999
Q ss_pred cccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChH-hHHHHHHH
Q 021490 160 EYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPR-GFYQALAV 238 (311)
Q Consensus 160 E~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~l 238 (311)
|.+.+..++.++|+||||+++|+|++|..||........ ............. .+. .+.. .+..+.++
T Consensus 169 E~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~-------~~~----~~~~~~~~~~~~l 236 (265)
T cd06605 169 ERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD-GIFELLQYIVNEP-------PPR----LPSGKFSPDFQDF 236 (265)
T ss_pred HHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc-cHHHHHHHHhcCC-------CCC----CChhhcCHHHHHH
Confidence 999888999999999999999999999999975431111 0011111111100 001 1111 44578899
Q ss_pred HHHccccCCCCCCCHHHHHHHHH
Q 021490 239 AAMCVHEQPDMRPVIADVVTALA 261 (311)
Q Consensus 239 i~~~l~~~p~~Rps~~~vl~~l~ 261 (311)
|.+||..||.+|||+.+++..-.
T Consensus 237 i~~~l~~~p~~Rpt~~~ll~~~~ 259 (265)
T cd06605 237 VNLCLIKDPRERPSYKELLEHPF 259 (265)
T ss_pred HHHHcCCCchhCcCHHHHhhCch
Confidence 99999999999999999987643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=258.27 Aligned_cols=229 Identities=26% Similarity=0.364 Sum_probs=183.6
Q ss_pred cCCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHH
Q 021490 7 CLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNT 86 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~ 86 (311)
.+|..||+|.+........+.+.+|+.+++.++||||+++++.+......++|+||+++++|.+++.. ..+++..
T Consensus 42 ~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~l~~~~ 116 (293)
T cd06647 42 ATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQ 116 (293)
T ss_pred CCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCCcHHHHHhh-----cCCCHHH
Confidence 36789999998765555667889999999999999999999999999999999999999999999875 4588999
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccCC
Q 021490 87 RMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ 166 (311)
Q Consensus 87 ~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 166 (311)
+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .......++..|++||.+....
T Consensus 117 ~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~ 191 (293)
T cd06647 117 IAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSTMVGTPYWMAPEVVTRKA 191 (293)
T ss_pred HHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceecccccc--cccccccCChhhcCchhhccCC
Confidence 9999999999999999999 9999999999999999999999999876432211 1122235778899999998888
Q ss_pred CccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccC
Q 021490 167 LTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQ 246 (311)
Q Consensus 167 ~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 246 (311)
++.++|+||||+++|++++|..||............ .... .+.+ ..+......+.+++.+||..+
T Consensus 192 ~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~------~~~~-------~~~~--~~~~~~~~~l~~li~~~l~~~ 256 (293)
T cd06647 192 YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI------ATNG-------TPEL--QNPEKLSAIFRDFLNRCLEMD 256 (293)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeeh------hcCC-------CCCC--CCccccCHHHHHHHHHHccCC
Confidence 899999999999999999999999764432111000 0000 0000 111223446888999999999
Q ss_pred CCCCCCHHHHHHHH
Q 021490 247 PDMRPVIADVVTAL 260 (311)
Q Consensus 247 p~~Rps~~~vl~~l 260 (311)
|.+||++.+++..-
T Consensus 257 p~~Rp~~~~il~h~ 270 (293)
T cd06647 257 VEKRGSAKELLQHP 270 (293)
T ss_pred hhhCcCHHHHhcCH
Confidence 99999999999774
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=265.19 Aligned_cols=167 Identities=25% Similarity=0.384 Sum_probs=140.9
Q ss_pred CCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHHH
Q 021490 8 LLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTR 87 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~ 87 (311)
.+..||+|+.... ....|+.+++.++||||+++++++.+....++|||++. ++|.+++.. ....+++..+
T Consensus 90 ~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~ 159 (357)
T PHA03209 90 QPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS-SDLYTYLTK---RSRPLPIDQA 159 (357)
T ss_pred CCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC-CcHHHHHHh---ccCCCCHHHH
Confidence 5678999875322 23569999999999999999999999999999999995 688888765 2467999999
Q ss_pred HHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccCCC
Q 021490 88 MKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQL 167 (311)
Q Consensus 88 ~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 167 (311)
..++.|++.||+|||+.+ |+||||||+|||++.++.++|+|||++...... .......++..|+|||++.+..+
T Consensus 160 ~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~ 233 (357)
T PHA03209 160 LIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA---PAFLGLAGTVETNAPEVLARDKY 233 (357)
T ss_pred HHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC---cccccccccccccCCeecCCCCC
Confidence 999999999999999999 999999999999999999999999998642111 11223458899999999998899
Q ss_pred ccccceeehhHHHHHHHhCCCcc
Q 021490 168 TLKSDVYSFGVVLLEILSGRKAV 190 (311)
Q Consensus 168 ~~~~DiwslG~l~~~ll~g~~pf 190 (311)
+.++|||||||++|+|+++..++
T Consensus 234 ~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 234 NSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred CchhhHHHHHHHHHHHHHcCCcc
Confidence 99999999999999999855443
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=258.68 Aligned_cols=244 Identities=20% Similarity=0.234 Sum_probs=179.0
Q ss_pred cCCcEEEEEEeecCCC--cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCH
Q 021490 7 CLLQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 84 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~ 84 (311)
.+|+.||||.++.... .....+.+|++++++++||||+++++++.++...++||||+. ++|.+++.... ...+++
T Consensus 23 ~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~--~~~l~~ 99 (284)
T cd07860 23 LTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASP--LSGIPL 99 (284)
T ss_pred CCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-cCHHHHHHhCC--CCCCCH
Confidence 3789999999865432 223578899999999999999999999999999999999996 68988886532 456899
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccccc
Q 021490 85 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT 164 (311)
Q Consensus 85 ~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 164 (311)
..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++....... .......++..|+|||.+.+
T Consensus 100 ~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~ 174 (284)
T cd07860 100 PLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV--RTYTHEVVTLWYRAPEILLG 174 (284)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCc--cccccccccccccCCeEEec
Confidence 999999999999999999999 9999999999999999999999999886432211 11122345778999998865
Q ss_pred C-CCccccceeehhHHHHHHHhCCCccCcchhHHHH-HHHHHhhhhhcc-----------ccccccccCccccCCCChHh
Q 021490 165 G-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ-SLVAWARPLFQD-----------RTRHSLIADPELQGQYPPRG 231 (311)
Q Consensus 165 ~-~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~-~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~ 231 (311)
. .++.++||||||+++|+|++|..||......... ............ ...........+ ....+..
T Consensus 175 ~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 253 (284)
T cd07860 175 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDF-SKVVPPL 253 (284)
T ss_pred CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCH-HHHcccC
Confidence 4 4588899999999999999999999765433221 111111000000 000000000000 0011223
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 021490 232 FYQALAVAAMCVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 232 ~~~l~~li~~~l~~~p~~Rps~~~vl~~ 259 (311)
...+.++|.+||+.||.+|||+++++..
T Consensus 254 ~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 254 DEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred CHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 4567889999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=253.59 Aligned_cols=236 Identities=27% Similarity=0.398 Sum_probs=185.1
Q ss_pred cCCcEEEEEEeecCCC-cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHH
Q 021490 7 CLLQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN 85 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~ 85 (311)
.+|..+|+|++..... .....+.+|+.+++.++|+||+++++.+..+...++|+|++++++|.+++..... ...+++.
T Consensus 24 ~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~-~~~~~~~ 102 (267)
T cd06610 24 PNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYP-RGGLDEA 102 (267)
T ss_pred CCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCcHHHHHHHhcc-cCCCCHH
Confidence 3688999999865442 3457889999999999999999999999999999999999999999999976321 2468999
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCce--eeeeccccccccCccccc
Q 021490 86 TRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH--VSTRVMGTYGYCAPEYAK 163 (311)
Q Consensus 86 ~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~ 163 (311)
.+..++.|++.||++||+.+ ++|+||+|+||++++++.++|+|||++.......... ......++..|++||.+.
T Consensus 103 ~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~ 179 (267)
T cd06610 103 IIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVME 179 (267)
T ss_pred HHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHc
Confidence 99999999999999999999 9999999999999999999999999986543322221 223345788999999987
Q ss_pred cC-CCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCC-ChHhHHHHHHHHHH
Q 021490 164 TG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQY-PPRGFYQALAVAAM 241 (311)
Q Consensus 164 ~~-~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~ 241 (311)
.. .++.++|+||||+++|+|++|..||............ .... .+.+.... ....+..+.+++.+
T Consensus 180 ~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~------~~~~-------~~~~~~~~~~~~~~~~~~~li~~ 246 (267)
T cd06610 180 QVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLT------LQND-------PPSLETGADYKKYSKSFRKMISL 246 (267)
T ss_pred cccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHH------hcCC-------CCCcCCccccccccHHHHHHHHH
Confidence 76 7899999999999999999999999765443211110 0000 00111100 12334578899999
Q ss_pred ccccCCCCCCCHHHHHHH
Q 021490 242 CVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 242 ~l~~~p~~Rps~~~vl~~ 259 (311)
||..||++|||+.+++..
T Consensus 247 ~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 247 CLQKDPSKRPTAEELLKH 264 (267)
T ss_pred HcCCChhhCcCHHHHhhC
Confidence 999999999999999864
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=259.06 Aligned_cols=232 Identities=25% Similarity=0.293 Sum_probs=179.1
Q ss_pred CCcEEEEEEeecCCC---cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCH
Q 021490 8 LLQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 84 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~ 84 (311)
.++.|++|.+..... .....+.+|+++++.++||||+++++.+..+...++||||++|++|.+++.. ...+++
T Consensus 25 ~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~----~~~~~~ 100 (305)
T cd05609 25 TRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKN----IGALPV 100 (305)
T ss_pred CCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHH----cCCCCH
Confidence 578999999865532 2335788999999999999999999999999999999999999999999976 467899
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCc-------------eeeeecc
Q 021490 85 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT-------------HVSTRVM 151 (311)
Q Consensus 85 ~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~-------------~~~~~~~ 151 (311)
..+..++.+++.||+|||+.+ ++|+||+|.||+++.++.++|+|||++......... .......
T Consensus 101 ~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (305)
T cd05609 101 DMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVC 177 (305)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcCccccccccccccchhhccccCCc
Confidence 999999999999999999999 999999999999999999999999987631111000 0011134
Q ss_pred ccccccCccccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHh
Q 021490 152 GTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRG 231 (311)
Q Consensus 152 ~~~~y~aPE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (311)
++..|+|||.+....++.++|+||||+++|+|++|..||.+............ .. ...+... ...
T Consensus 178 ~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~------~~-----~~~~~~~----~~~ 242 (305)
T cd05609 178 GTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS------DD-----IEWPEGD----EAL 242 (305)
T ss_pred cCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh------cc-----cCCCCcc----ccC
Confidence 67789999999888899999999999999999999999976543322111100 00 0001110 123
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 021490 232 FYQALAVAAMCVHEQPDMRPVIADVVTALA 261 (311)
Q Consensus 232 ~~~l~~li~~~l~~~p~~Rps~~~vl~~l~ 261 (311)
+..+.+++.+||+.||++||++.++.+.|+
T Consensus 243 ~~~~~~li~~~l~~~P~~R~~~~~~~~ll~ 272 (305)
T cd05609 243 PADAQDLISRLLRQNPLERLGTGGAFEVKQ 272 (305)
T ss_pred CHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence 346889999999999999999655554443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=252.59 Aligned_cols=229 Identities=24% Similarity=0.277 Sum_probs=177.8
Q ss_pred cCCcEEEEEEeecCCC-----cchhHHHHHHHHHhcCCCCcccceeeEeeeC--CeeEEEEecCCCCChhhhhcccCCCC
Q 021490 7 CLLQDVAIKQLDRNGV-----QGNREFLVEVLMLSLLHHPNLVNLIGYCADG--DQRLLVYEYMPLGSVEDHLHDLSPGK 79 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~ 79 (311)
.+|..||||.+..... ...+.+.+|+.+++.++||||+++++++.+. ...++||||+++++|.+++.. .
T Consensus 25 ~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~----~ 100 (265)
T cd06652 25 DTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKS----Y 100 (265)
T ss_pred CCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEEecCCCcHHHHHHH----c
Confidence 3589999999864321 1235788899999999999999999988663 467899999999999999876 4
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCc-eeeeeccccccccC
Q 021490 80 KPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT-HVSTRVMGTYGYCA 158 (311)
Q Consensus 80 ~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~y~a 158 (311)
..+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++......... .......++..|+|
T Consensus 101 ~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~a 177 (265)
T cd06652 101 GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMS 177 (265)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccccccccccccccccCCCCccccC
Confidence 56889999999999999999999999 999999999999999999999999988643211110 11122347789999
Q ss_pred ccccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHH
Q 021490 159 PEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAV 238 (311)
Q Consensus 159 PE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 238 (311)
||++.+..++.++|+||||+++|+|++|..||............ .... .....+......+.++
T Consensus 178 PE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~------~~~~----------~~~~~~~~~~~~~~~~ 241 (265)
T cd06652 178 PEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKI------ATQP----------TNPVLPPHVSDHCRDF 241 (265)
T ss_pred hhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHH------hcCC----------CCCCCchhhCHHHHHH
Confidence 99998888899999999999999999999999765332221100 0000 0112334455678889
Q ss_pred HHHccccCCCCCCCHHHHHHH
Q 021490 239 AAMCVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 239 i~~~l~~~p~~Rps~~~vl~~ 259 (311)
+.+|+. +|++||+++++++.
T Consensus 242 i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 242 LKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred HHHHhc-ChhhCCCHHHHhcC
Confidence 999995 99999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=257.55 Aligned_cols=244 Identities=22% Similarity=0.233 Sum_probs=180.7
Q ss_pred cCCcEEEEEEeecCCC--cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCH
Q 021490 7 CLLQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 84 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~ 84 (311)
.+|..||+|++..... .....+.+|+.+++.++|||++++++++.++...+++|||++ ++|.+++.... ...+++
T Consensus 22 ~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~--~~~~~~ 98 (283)
T cd07835 22 LTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD-LDLKKYMDSSP--LTGLDP 98 (283)
T ss_pred CCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-cCHHHHHhhCC--CCCCCH
Confidence 3799999999865532 223578899999999999999999999999999999999995 68999887632 246899
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccccc
Q 021490 85 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT 164 (311)
Q Consensus 85 ~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 164 (311)
..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++....... .......++..|+|||++.+
T Consensus 99 ~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~ 173 (283)
T cd07835 99 PLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPV--RTYTHEVVTLWYRAPEILLG 173 (283)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCc--cccCccccccCCCCCceeec
Confidence 999999999999999999999 9999999999999999999999999986432211 11122245788999998765
Q ss_pred C-CCccccceeehhHHHHHHHhCCCccCcchhHHHH-HHHHHhhhhhccc-----------cccccccCccccCCCChHh
Q 021490 165 G-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ-SLVAWARPLFQDR-----------TRHSLIADPELQGQYPPRG 231 (311)
Q Consensus 165 ~-~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~-~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~ 231 (311)
. .++.++|+||||+++|+|++|..||......... ............. ........+ ......+..
T Consensus 174 ~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 252 (283)
T cd07835 174 SRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQ-DLSKVVPNL 252 (283)
T ss_pred CcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhccccccc-chhhhcCCC
Confidence 4 5688999999999999999999999765443221 1111100000000 000000000 001112334
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 021490 232 FYQALAVAAMCVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 232 ~~~l~~li~~~l~~~p~~Rps~~~vl~~ 259 (311)
+..+.+++.+||+.||.+|||+.++++.
T Consensus 253 ~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 253 DEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 4678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=249.80 Aligned_cols=234 Identities=24% Similarity=0.359 Sum_probs=187.4
Q ss_pred cchhcc-CCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCC
Q 021490 2 MQVILC-LLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKK 80 (311)
Q Consensus 2 ~~~~~~-~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 80 (311)
|.+... +|..+++|++..........+.+|+++++.++|+|++.+++++..+...++++||+++++|.+++... ..
T Consensus 17 ~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~---~~ 93 (253)
T cd05122 17 YKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKST---NQ 93 (253)
T ss_pred EEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcHHHHHhhc---CC
Confidence 334443 68999999997665556678999999999999999999999999999999999999999999998762 25
Q ss_pred CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcc
Q 021490 81 PLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 160 (311)
Q Consensus 81 ~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE 160 (311)
.+++..+..++.+++.+|++||+.+ ++|+||+|+||+++.++.++|+|||.+........ .....++..|++||
T Consensus 94 ~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~PE 167 (253)
T cd05122 94 TLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---RNTMVGTPYWMAPE 167 (253)
T ss_pred CCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc---ccceecCCcccCHH
Confidence 7999999999999999999999999 99999999999999999999999998875433221 23345788999999
Q ss_pred ccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHH
Q 021490 161 YAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAA 240 (311)
Q Consensus 161 ~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 240 (311)
.+.+...+.++|+||||+++|+|++|..||...+.......... ........ +...+..+.+++.
T Consensus 168 ~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--------~~~~~~~~-------~~~~~~~~~~~i~ 232 (253)
T cd05122 168 VINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT--------NGPPGLRN-------PEKWSDEFKDFLK 232 (253)
T ss_pred HHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh--------cCCCCcCc-------ccccCHHHHHHHH
Confidence 99888889999999999999999999999976543222111100 00000000 1112447889999
Q ss_pred HccccCCCCCCCHHHHHHH
Q 021490 241 MCVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 241 ~~l~~~p~~Rps~~~vl~~ 259 (311)
+||+.||++|||+.++++.
T Consensus 233 ~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 233 KCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred HHccCChhhCCCHHHHhcC
Confidence 9999999999999999863
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=255.99 Aligned_cols=231 Identities=25% Similarity=0.321 Sum_probs=180.6
Q ss_pred cCCcEEEEEEeecCCC---cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCC
Q 021490 7 CLLQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLD 83 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~ 83 (311)
.+|..||+|.+..... .....+.+|+++++.++||||+++++++......|+||||+++++|.+++.... ...++
T Consensus 16 ~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~ 93 (277)
T cd05577 16 ATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVG--EPGFP 93 (277)
T ss_pred CCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcHHHHHHHcC--cCCCC
Confidence 3689999999865432 234567789999999999999999999999999999999999999999987632 24689
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccc
Q 021490 84 WNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 163 (311)
Q Consensus 84 ~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 163 (311)
+..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||.+..... ........++..|+|||.+.
T Consensus 94 ~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~~~~~~y~~PE~~~ 167 (277)
T cd05577 94 EARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKGRAGTPGYMAPEVLQ 167 (277)
T ss_pred HHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhcc---CCccccccCCCCcCCHHHhc
Confidence 9999999999999999999999 99999999999999999999999998864322 11112234677899999998
Q ss_pred cCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHcc
Q 021490 164 TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCV 243 (311)
Q Consensus 164 ~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 243 (311)
+..++.++|+||||+++|+|++|..||............... ... .....+...+..+.+++.+||
T Consensus 168 ~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~------------~~~~~~~~~~~~~~~li~~~l 233 (277)
T cd05577 168 GEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRR--TLE------------MAVEYPDKFSPEAKDLCEALL 233 (277)
T ss_pred CCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhc--ccc------------ccccCCccCCHHHHHHHHHHc
Confidence 888899999999999999999999999765431111111000 000 011122233557889999999
Q ss_pred ccCCCCCC-----CHHHHHHH
Q 021490 244 HEQPDMRP-----VIADVVTA 259 (311)
Q Consensus 244 ~~~p~~Rp-----s~~~vl~~ 259 (311)
+.||.+|| ++.+++..
T Consensus 234 ~~~p~~R~~~~~~~~~~ll~h 254 (277)
T cd05577 234 QKDPEKRLGCRGGSADEVREH 254 (277)
T ss_pred cCChhHccCCCcccHHHHHhC
Confidence 99999999 66667654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=274.69 Aligned_cols=241 Identities=17% Similarity=0.192 Sum_probs=173.1
Q ss_pred CCcEEEEEEeecCCCcchhHHHHHHHHHhcCCC------CcccceeeEeeeC-CeeEEEEecCCCCChhhhhcccCCCCC
Q 021490 8 LLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHH------PNLVNLIGYCADG-DQRLLVYEYMPLGSVEDHLHDLSPGKK 80 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h------~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~ 80 (311)
.++.||||+++... .....+..|+.+++.++| .+++++++++..+ .+.|+||+++ |++|.+++.. .+
T Consensus 153 ~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~----~~ 226 (467)
T PTZ00284 153 RKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKY-GPCLLDWIMK----HG 226 (467)
T ss_pred CCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEEecc-CCCHHHHHHH----cC
Confidence 57889999996432 233455667777776654 4588888888654 5789999988 6889888876 56
Q ss_pred CCCHHHHHHHHHHHHHHHHHhhc-CCCCCeEeeccCCCeEEEcCCC----------------ceEEccccccccCCCCCC
Q 021490 81 PLDWNTRMKIAAGAARGLEYLHD-KAKPPVIYRDLKCSNILLDRGY----------------HPKLSDFGLAKLGPVGDN 143 (311)
Q Consensus 81 ~l~~~~~~~~~~~i~~~l~~lh~-~~~~~i~h~dl~p~nil~~~~~----------------~~~l~df~~~~~~~~~~~ 143 (311)
.+++..+..++.||+.||+|||+ .+ |+||||||+|||++.++ .+||+|||.+....
T Consensus 227 ~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~---- 299 (467)
T PTZ00284 227 PFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDER---- 299 (467)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccCc----
Confidence 79999999999999999999998 58 99999999999998765 49999999875321
Q ss_pred ceeeeeccccccccCccccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhh----------------
Q 021490 144 THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARP---------------- 207 (311)
Q Consensus 144 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~---------------- 207 (311)
.......++..|+|||++.+..++.++|||||||++|||++|+.||...........+.....
T Consensus 300 -~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~ 378 (467)
T PTZ00284 300 -HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEAR 378 (467)
T ss_pred -cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHH
Confidence 112234689999999999999999999999999999999999999987665443332211100
Q ss_pred -hhccccccccccCccc----cCC--C-ChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 021490 208 -LFQDRTRHSLIADPEL----QGQ--Y-PPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAY 262 (311)
Q Consensus 208 -~~~~~~~~~~~~~~~~----~~~--~-~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l~~ 262 (311)
.+..........++.. ... . .......+.+||.+||++||.+|||++|+++.-..
T Consensus 379 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~ 441 (467)
T PTZ00284 379 LLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYV 441 (467)
T ss_pred HHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCccc
Confidence 0000000000000000 000 0 00113457799999999999999999999987543
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=254.74 Aligned_cols=236 Identities=26% Similarity=0.306 Sum_probs=184.1
Q ss_pred cchhcc-CCcEEEEEEeecCCC---cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCC
Q 021490 2 MQVILC-LLQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP 77 (311)
Q Consensus 2 ~~~~~~-~g~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 77 (311)
|.+... +|+.+++|++..... ...+.+.+|++++..++||||+++++.+..+...++++||+++++|.+++..
T Consensus 10 y~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--- 86 (265)
T cd05579 10 FLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLEN--- 86 (265)
T ss_pred EEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcHHHHHHH---
Confidence 344444 489999999866544 3446788999999999999999999999999999999999999999999986
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCC------ceeeeecc
Q 021490 78 GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN------THVSTRVM 151 (311)
Q Consensus 78 ~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~------~~~~~~~~ 151 (311)
...+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++........ ........
T Consensus 87 -~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ 162 (265)
T cd05579 87 -VGSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIV 162 (265)
T ss_pred -cCCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccCcc
Confidence 457899999999999999999999999 99999999999999999999999998865322211 11222345
Q ss_pred ccccccCccccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHh
Q 021490 152 GTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRG 231 (311)
Q Consensus 152 ~~~~y~aPE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (311)
++..|++||.......+.++|+||||+++|+|++|..||.............. .... .+ .. ...
T Consensus 163 ~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~------~~~~-----~~---~~--~~~ 226 (265)
T cd05579 163 GTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILN------GKIE-----WP---ED--VEV 226 (265)
T ss_pred cCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc------CCcC-----CC---cc--ccC
Confidence 67889999999888889999999999999999999999976654332211110 0000 00 00 012
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 021490 232 FYQALAVAAMCVHEQPDMRPVIADVVTAL 260 (311)
Q Consensus 232 ~~~l~~li~~~l~~~p~~Rps~~~vl~~l 260 (311)
+..+.+++.+||+.+|++|||+..+.+.|
T Consensus 227 ~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 227 SDEAIDLISKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred CHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence 45788999999999999999994444433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=255.80 Aligned_cols=243 Identities=21% Similarity=0.257 Sum_probs=180.0
Q ss_pred CCcEEEEEEeecCCCcc--hhHHHHHHHHHhcCCCCcccceeeEeeeC--CeeEEEEecCCCCChhhhhcccCCCCCCCC
Q 021490 8 LLQDVAIKQLDRNGVQG--NREFLVEVLMLSLLHHPNLVNLIGYCADG--DQRLLVYEYMPLGSVEDHLHDLSPGKKPLD 83 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~ 83 (311)
+|+.+|+|.++...... ...+.+|+.++..++||||+++++++... ...|+||||++ ++|.+++... ...++
T Consensus 29 ~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~l~ 104 (293)
T cd07843 29 TGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVE-HDLKSLMETM---KQPFL 104 (293)
T ss_pred CCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcC-cCHHHHHHhc---cCCCC
Confidence 58899999997554322 24677899999999999999999998777 78999999997 5898888762 24689
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccc
Q 021490 84 WNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 163 (311)
Q Consensus 84 ~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 163 (311)
+..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++....... .......++..|+|||.+.
T Consensus 105 ~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~~aPE~~~ 179 (293)
T cd07843 105 QSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL--KPYTQLVVTLWYRAPELLL 179 (293)
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccCCc--cccccccccccccCchhhc
Confidence 9999999999999999999999 9999999999999999999999999887533221 1122234678899999886
Q ss_pred cC-CCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHh-hhh----------hccc--cccccccCccccCCCCh
Q 021490 164 TG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWA-RPL----------FQDR--TRHSLIADPELQGQYPP 229 (311)
Q Consensus 164 ~~-~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~-~~~----------~~~~--~~~~~~~~~~~~~~~~~ 229 (311)
+. .++.++|+||||+++|+|++|..||...........+... ... +... ..........+...++.
T Consensus 180 ~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (293)
T cd07843 180 GAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPA 259 (293)
T ss_pred CCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccc
Confidence 54 4688999999999999999999999765543322211100 000 0000 00000001111122222
Q ss_pred H-hHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 021490 230 R-GFYQALAVAAMCVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 230 ~-~~~~l~~li~~~l~~~p~~Rps~~~vl~~ 259 (311)
. ....+.+++.+||+.||++|||+.|++..
T Consensus 260 ~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 260 LSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred cCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 2 35678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=256.80 Aligned_cols=229 Identities=26% Similarity=0.317 Sum_probs=176.2
Q ss_pred cCCcEEEEEEeecCCCcchhHHHHHHHHHhcC-CCCcccceeeEeee------CCeeEEEEecCCCCChhhhhcccCCCC
Q 021490 7 CLLQDVAIKQLDRNGVQGNREFLVEVLMLSLL-HHPNLVNLIGYCAD------GDQRLLVYEYMPLGSVEDHLHDLSPGK 79 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~~~l~~~~~~~ 79 (311)
.+++.||+|++.... .....+..|+.++..+ +|+||+++++++.. ....+++|||+++++|.+++.... .
T Consensus 39 ~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~--~ 115 (282)
T cd06636 39 KTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTK--G 115 (282)
T ss_pred CCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHcc--C
Confidence 468899999985443 3446788899999998 69999999999853 457899999999999999987632 3
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCc
Q 021490 80 KPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 159 (311)
Q Consensus 80 ~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aP 159 (311)
..+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++....... .......++..|+||
T Consensus 116 ~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aP 190 (282)
T cd06636 116 NALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAP 190 (282)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCcchhhhhccc--cCCCcccccccccCH
Confidence 56889999999999999999999999 9999999999999999999999999876432111 112224578899999
Q ss_pred cccc-----cCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHH
Q 021490 160 EYAK-----TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQ 234 (311)
Q Consensus 160 E~~~-----~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
|.+. ...++.++|+||||+++|+|++|..||............. .. . .+.. .....+..
T Consensus 191 E~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~-------~~-~-----~~~~---~~~~~~~~ 254 (282)
T cd06636 191 EVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIP-------RN-P-----PPKL---KSKKWSKK 254 (282)
T ss_pred hhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHh-------hC-C-----CCCC---cccccCHH
Confidence 9875 3457889999999999999999999997554322211110 00 0 0000 01123347
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHH
Q 021490 235 ALAVAAMCVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 235 l~~li~~~l~~~p~~Rps~~~vl~~ 259 (311)
+.+++.+||+.||.+|||+.++++.
T Consensus 255 ~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 255 FIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred HHHHHHHHhCCChhhCcCHHHHhcC
Confidence 8899999999999999999999764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=250.58 Aligned_cols=236 Identities=24% Similarity=0.301 Sum_probs=188.6
Q ss_pred cchhcc-CCcEEEEEEeecCCC--cchhHHHHHHHHHhcCCCCcccceeeEeeeC--CeeEEEEecCCCCChhhhhcccC
Q 021490 2 MQVILC-LLQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADG--DQRLLVYEYMPLGSVEDHLHDLS 76 (311)
Q Consensus 2 ~~~~~~-~g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~ 76 (311)
|.+... +|..|++|++..... ...+.+.+|+..+++++||||+++++.+.+. ...++|+||+++++|.+++..
T Consensus 17 ~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-- 94 (260)
T cd06606 17 YLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKK-- 94 (260)
T ss_pred EEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecCCCcHHHHHHH--
Confidence 334444 689999999866543 3457889999999999999999999999888 889999999999999999987
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccc
Q 021490 77 PGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY 156 (311)
Q Consensus 77 ~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y 156 (311)
...+++..++.++.+++.||+|||+.+ ++|+||+|+||+++.++.++|+|||.+................++..|
T Consensus 95 --~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y 169 (260)
T cd06606 95 --FGKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYW 169 (260)
T ss_pred --cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccccccccccCCCCCccc
Confidence 348999999999999999999999999 999999999999999999999999998754333221112334578899
Q ss_pred cCccccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHH
Q 021490 157 CAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQAL 236 (311)
Q Consensus 157 ~aPE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 236 (311)
++||.+.....+.++|+||||+++|+|++|..||.......... . . .. ........+...+..+.
T Consensus 170 ~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~-~----~-~~---------~~~~~~~~~~~~~~~l~ 234 (260)
T cd06606 170 MAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAAL-Y----K-IG---------SSGEPPEIPEHLSEEAK 234 (260)
T ss_pred cCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHH-H----h-cc---------ccCCCcCCCcccCHHHH
Confidence 99999988889999999999999999999999998765111100 0 0 00 00111122333356889
Q ss_pred HHHHHccccCCCCCCCHHHHHHH
Q 021490 237 AVAAMCVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 237 ~li~~~l~~~p~~Rps~~~vl~~ 259 (311)
+++.+||..||.+||++.+++..
T Consensus 235 ~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 235 DFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred HHHHHhCcCChhhCCCHHHHhhC
Confidence 99999999999999999999865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=260.56 Aligned_cols=181 Identities=23% Similarity=0.300 Sum_probs=143.6
Q ss_pred CCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeee--CCeeEEEEecCCCCChhhhhcccC-----CCCC
Q 021490 8 LLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCAD--GDQRLLVYEYMPLGSVEDHLHDLS-----PGKK 80 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~ 80 (311)
.+..||+|.++... ....+.+|+.+++.++||||+++++++.. +...++||||++ ++|.+++.... ....
T Consensus 27 ~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~ 103 (317)
T cd07867 27 DEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE-HDLWHIIKFHRASKANKKPM 103 (317)
T ss_pred ccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-CcHHHHHHhhhccccCCCCc
Confidence 45789999886442 33567889999999999999999998853 457899999986 57777764321 1124
Q ss_pred CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEE----cCCCceEEccccccccCCCCCCc-eeeeecccccc
Q 021490 81 PLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL----DRGYHPKLSDFGLAKLGPVGDNT-HVSTRVMGTYG 155 (311)
Q Consensus 81 ~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~----~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~ 155 (311)
.+++..+..++.|++.||+|||+.+ ++||||||+||++ +.++.++|+|||++......... .......++..
T Consensus 104 ~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~ 180 (317)
T cd07867 104 QLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 180 (317)
T ss_pred cCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceeccc
Confidence 5889999999999999999999999 9999999999999 56678999999998754322111 11223457889
Q ss_pred ccCcccccc-CCCccccceeehhHHHHHHHhCCCccCcch
Q 021490 156 YCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSK 194 (311)
Q Consensus 156 y~aPE~~~~-~~~~~~~DiwslG~l~~~ll~g~~pf~~~~ 194 (311)
|+|||++.+ ..++.++|||||||++|+|++|.+||....
T Consensus 181 y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred ccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 999998876 457899999999999999999999996543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=256.68 Aligned_cols=226 Identities=31% Similarity=0.387 Sum_probs=178.1
Q ss_pred CCcEEEEEEeecCCCc---chhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCH
Q 021490 8 LLQDVAIKQLDRNGVQ---GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 84 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~ 84 (311)
+|+.||+|++...... ..+.+.+|+++++.++||||+++++++.++...++|+||+. ++|.+++... ...+++
T Consensus 39 ~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~~---~~~l~~ 114 (307)
T cd06607 39 TNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEVH---KKPLQE 114 (307)
T ss_pred CCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhhC-CCHHHHHHHc---ccCCCH
Confidence 6899999998654332 23578899999999999999999999999999999999997 5777766542 356899
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccc-
Q 021490 85 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK- 163 (311)
Q Consensus 85 ~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~- 163 (311)
..+..++.|++.||.|||+.+ ++|+||+|.||+++.++.++|+|||++...... ....++..|+|||++.
T Consensus 115 ~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~ 185 (307)
T cd06607 115 VEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA------NSFVGTPYWMAPEVILA 185 (307)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC------CCccCCccccCceeeec
Confidence 999999999999999999999 999999999999999999999999988643221 1234677899999874
Q ss_pred --cCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHH
Q 021490 164 --TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAM 241 (311)
Q Consensus 164 --~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 241 (311)
...++.++||||||+++|+|++|..||.............. . . .+.+ .+...+..+.+++.+
T Consensus 186 ~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~------~--~-----~~~~---~~~~~~~~~~~li~~ 249 (307)
T cd06607 186 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ------N--D-----SPTL---SSNDWSDYFRNFVDS 249 (307)
T ss_pred cCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhc------C--C-----CCCC---CchhhCHHHHHHHHH
Confidence 35678899999999999999999999976543322111100 0 0 0000 012234578899999
Q ss_pred ccccCCCCCCCHHHHHHHHHH
Q 021490 242 CVHEQPDMRPVIADVVTALAY 262 (311)
Q Consensus 242 ~l~~~p~~Rps~~~vl~~l~~ 262 (311)
||..||++||++.+++.....
T Consensus 250 ~l~~~p~~Rp~~~~il~~~~~ 270 (307)
T cd06607 250 CLQKIPQDRPSSEELLKHRFV 270 (307)
T ss_pred HhcCChhhCcCHHHHhcChhh
Confidence 999999999999999987543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=248.10 Aligned_cols=230 Identities=23% Similarity=0.357 Sum_probs=187.5
Q ss_pred CCcEEEEEEeecCCC--cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHH
Q 021490 8 LLQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN 85 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~ 85 (311)
+|..+++|++..... .....+.+|+++++.++|+|++++++.+..+...++|+||+++++|.+++......+..+++.
T Consensus 24 ~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 103 (258)
T cd08215 24 DGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEE 103 (258)
T ss_pred CCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCCCcHHHHHHHhhccCCCcCHH
Confidence 589999999876543 445678899999999999999999999999999999999999999999998743334789999
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccC
Q 021490 86 TRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG 165 (311)
Q Consensus 86 ~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 165 (311)
.+..++.+++.||++||+.+ ++|+||+|+||+++.++.++|+|||.+....... .......++..|+|||.+.+.
T Consensus 104 ~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~y~~pe~~~~~ 178 (258)
T cd08215 104 QILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV--DLAKTVVGTPYYLSPELCQNK 178 (258)
T ss_pred HHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc--ceecceeeeecccChhHhccC
Confidence 99999999999999999999 9999999999999999999999999986533222 122334578889999999888
Q ss_pred CCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHcccc
Q 021490 166 QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHE 245 (311)
Q Consensus 166 ~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 245 (311)
.++.++|+||+|+++|+|++|..||............ .... ....+...+..+.+++.+||..
T Consensus 179 ~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~------~~~~-----------~~~~~~~~~~~~~~~i~~~l~~ 241 (258)
T cd08215 179 PYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKI------LKGQ-----------YPPIPSQYSSELRNLVSSLLQK 241 (258)
T ss_pred CCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHH------hcCC-----------CCCCCCCCCHHHHHHHHHHcCC
Confidence 8999999999999999999999999766533221111 0000 0111223445788999999999
Q ss_pred CCCCCCCHHHHHHH
Q 021490 246 QPDMRPVIADVVTA 259 (311)
Q Consensus 246 ~p~~Rps~~~vl~~ 259 (311)
+|.+|||+.++++.
T Consensus 242 ~p~~Rp~~~~ll~~ 255 (258)
T cd08215 242 DPEERPSIAQILQS 255 (258)
T ss_pred ChhhCcCHHHHhcC
Confidence 99999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=253.15 Aligned_cols=228 Identities=25% Similarity=0.344 Sum_probs=181.1
Q ss_pred cCCcEEEEEEeecCC-CcchhHHHHHHHHHhcCC---CCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCC
Q 021490 7 CLLQDVAIKQLDRNG-VQGNREFLVEVLMLSLLH---HPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPL 82 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l 82 (311)
.+|..||+|.++... ......+.+|+.+++.++ |||++++++++..+...++||||+++++|.+++.. ..+
T Consensus 24 ~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~l 98 (277)
T cd06917 24 PTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKA-----GPI 98 (277)
T ss_pred CCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCCCCcHHHHHHc-----cCC
Confidence 578999999986543 234467889999999996 99999999999999999999999999999999865 368
Q ss_pred CHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccc
Q 021490 83 DWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 162 (311)
Q Consensus 83 ~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 162 (311)
++..++.++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .......++..|+|||.+
T Consensus 99 ~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~ 173 (277)
T cd06917 99 AEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS--SKRSTFVGTPYWMAPEVI 173 (277)
T ss_pred CHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCCc--cccccccCCcceeCHHHh
Confidence 99999999999999999999999 9999999999999999999999999886543222 112223577889999987
Q ss_pred cc-CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHH
Q 021490 163 KT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAM 241 (311)
Q Consensus 163 ~~-~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 241 (311)
.+ ..++.++|+||||+++|+|++|..||............ ... ..+.+... ..+.++.+++.+
T Consensus 174 ~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~-------~~~------~~~~~~~~---~~~~~~~~~i~~ 237 (277)
T cd06917 174 TEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLI-------PKS------KPPRLEDN---GYSKLLREFVAA 237 (277)
T ss_pred ccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcc-------ccC------CCCCCCcc---cCCHHHHHHHHH
Confidence 64 45688999999999999999999999765432211100 000 01111111 134578899999
Q ss_pred ccccCCCCCCCHHHHHHHH
Q 021490 242 CVHEQPDMRPVIADVVTAL 260 (311)
Q Consensus 242 ~l~~~p~~Rps~~~vl~~l 260 (311)
||..||++||++.+++..-
T Consensus 238 ~l~~~p~~R~~~~~il~~~ 256 (277)
T cd06917 238 CLDEEPKERLSAEELLKSK 256 (277)
T ss_pred HcCCCcccCcCHHHHhhCh
Confidence 9999999999999998753
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=250.20 Aligned_cols=229 Identities=25% Similarity=0.353 Sum_probs=191.4
Q ss_pred cCCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHH
Q 021490 7 CLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNT 86 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~ 86 (311)
.+|+.||||.+... .+.+++..|+.+|.+...|++|++|+.+..+..+++|||||..|++.+.+.. +.+.+++.+
T Consensus 56 EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSDI~R~---R~K~L~E~E 130 (502)
T KOG0574|consen 56 ESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSISDIMRA---RRKPLSEQE 130 (502)
T ss_pred ccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcHHHHHHH---hcCCccHHH
Confidence 47999999998543 4778899999999999999999999999999999999999999999998876 368899999
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccCC
Q 021490 87 RMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ 166 (311)
Q Consensus 87 ~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 166 (311)
+..++...++||+|||... =+|||||..|||++.+|..||.|||.+-.. .......+...||+.|+|||+++.-.
T Consensus 131 Is~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQL--TDTMAKRNTVIGTPFWMAPEVI~EIG 205 (502)
T KOG0574|consen 131 ISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQL--TDTMAKRNTVIGTPFWMAPEVIEEIG 205 (502)
T ss_pred HHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchh--hhhHHhhCccccCcccccHHHHHHhc
Confidence 9999999999999999988 899999999999999999999999998542 22233455678999999999999999
Q ss_pred CccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccC
Q 021490 167 LTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQ 246 (311)
Q Consensus 167 ~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 246 (311)
|+.++||||||++..||..|++||........ .+--... ..|.+ .-|...+.+.-+++++||-.+
T Consensus 206 Y~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA---------IFMIPT~----PPPTF--~KPE~WS~~F~DFi~~CLiK~ 270 (502)
T KOG0574|consen 206 YDTKADIWSLGITAIEMAEGRPPYSDIHPMRA---------IFMIPTK----PPPTF--KKPEEWSSEFNDFIRSCLIKK 270 (502)
T ss_pred cchhhhHhhhcchhhhhhcCCCCcccccccce---------eEeccCC----CCCCC--CChHhhhhHHHHHHHHHhcCC
Confidence 99999999999999999999999987554211 1111110 11112 234556778889999999999
Q ss_pred CCCCCCHHHHHHHH
Q 021490 247 PDMRPVIADVVTAL 260 (311)
Q Consensus 247 p~~Rps~~~vl~~l 260 (311)
|++|-|+.++++.-
T Consensus 271 PE~R~TA~~L~~H~ 284 (502)
T KOG0574|consen 271 PEERKTALRLCEHT 284 (502)
T ss_pred HHHHHHHHHHhhhh
Confidence 99999999988653
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=254.88 Aligned_cols=229 Identities=25% Similarity=0.293 Sum_probs=175.2
Q ss_pred cCCcEEEEEEeecCCCc---chhHHHHHHHHHhc---CCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCC
Q 021490 7 CLLQDVAIKQLDRNGVQ---GNREFLVEVLMLSL---LHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKK 80 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~---~~~~~~~e~~~l~~---l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 80 (311)
.+|+.+|+|.+...... ....+.+|..++.. .+||||+.+++++..++..++||||+++++|.+++.. .+
T Consensus 17 ~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~----~~ 92 (279)
T cd05633 17 DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQ----HG 92 (279)
T ss_pred CCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCCCCCHHHHHHh----cC
Confidence 35899999998654322 12334455544443 4799999999999988999999999999999998876 56
Q ss_pred CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcc
Q 021490 81 PLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 160 (311)
Q Consensus 81 ~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE 160 (311)
.+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++....... .....++..|+|||
T Consensus 93 ~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~y~aPE 165 (279)
T cd05633 93 VFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPE 165 (279)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC----ccCcCCCcCccCHH
Confidence 7999999999999999999999999 9999999999999999999999999986432211 12235788999999
Q ss_pred ccc-cCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHH
Q 021490 161 YAK-TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVA 239 (311)
Q Consensus 161 ~~~-~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 239 (311)
.+. +..++.++|+||+||++|+|++|..||............... . ......+...+..+.+++
T Consensus 166 ~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~---~------------~~~~~~~~~~~~~~~~li 230 (279)
T cd05633 166 VLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT---L------------TVNVELPDSFSPELKSLL 230 (279)
T ss_pred HhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHh---h------------cCCcCCccccCHHHHHHH
Confidence 886 456789999999999999999999999754322111111100 0 001122333455888999
Q ss_pred HHccccCCCCCC-----CHHHHHHHHH
Q 021490 240 AMCVHEQPDMRP-----VIADVVTALA 261 (311)
Q Consensus 240 ~~~l~~~p~~Rp-----s~~~vl~~l~ 261 (311)
.+||..||++|| |+.++++...
T Consensus 231 ~~~l~~~p~~R~~~~~~~~~~~~~h~~ 257 (279)
T cd05633 231 EGLLQRDVSKRLGCLGRGAQEVKEHVF 257 (279)
T ss_pred HHHhcCCHHHhcCCCCCCHHHHHhCcc
Confidence 999999999999 5988887653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=251.12 Aligned_cols=224 Identities=24% Similarity=0.239 Sum_probs=172.4
Q ss_pred cCCcEEEEEEeecCCCcc---hhHHHHHHHHH-hcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCC
Q 021490 7 CLLQDVAIKQLDRNGVQG---NREFLVEVLML-SLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPL 82 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~~---~~~~~~e~~~l-~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l 82 (311)
.+|+.||+|++....... ...+..|..++ ...+|+|++++++++..+...++|+||+++++|.+++.. ...+
T Consensus 19 ~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~ 94 (260)
T cd05611 19 STGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKT----LGGL 94 (260)
T ss_pred CCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCCCCHHHHHHH----cCCC
Confidence 368999999986543222 22344454444 455899999999999999999999999999999999976 4678
Q ss_pred CHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccc
Q 021490 83 DWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 162 (311)
Q Consensus 83 ~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 162 (311)
++..+..++.|++.||.|||+.+ ++|+||+|.||+++.++.++|+|||++..... .....++..|++||.+
T Consensus 95 ~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~~~~~~~~y~~pe~~ 165 (260)
T cd05611 95 PEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NKKFVGTPDYLAPETI 165 (260)
T ss_pred CHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------cccCCCCcCccChhhh
Confidence 99999999999999999999999 99999999999999999999999998864221 1223467889999999
Q ss_pred ccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHc
Q 021490 163 KTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMC 242 (311)
Q Consensus 163 ~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 242 (311)
.+..++.++||||||+++|+|++|..||............... ... .........+..+.+++.+|
T Consensus 166 ~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~------~~~--------~~~~~~~~~~~~~~~~i~~~ 231 (260)
T cd05611 166 LGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSR------RIN--------WPEEVKEFCSPEAVDLINRL 231 (260)
T ss_pred cCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc------ccC--------CCCcccccCCHHHHHHHHHH
Confidence 8877899999999999999999999999765543221111100 000 00111122345788999999
Q ss_pred cccCCCCCCCHHHHH
Q 021490 243 VHEQPDMRPVIADVV 257 (311)
Q Consensus 243 l~~~p~~Rps~~~vl 257 (311)
|+.||++|||+.++.
T Consensus 232 l~~~p~~R~~~~~~~ 246 (260)
T cd05611 232 LCMDPAKRLGANGYQ 246 (260)
T ss_pred ccCCHHHccCCCcHH
Confidence 999999999665433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=250.19 Aligned_cols=228 Identities=21% Similarity=0.328 Sum_probs=181.3
Q ss_pred CCcEEEEEEeecCCC--cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHH
Q 021490 8 LLQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN 85 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~ 85 (311)
+|..||+|.+..... ...+.+.+|+.+++.++|+||+++++.+.++...++|+||+++++|.+++.... ...+++.
T Consensus 24 ~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~ 101 (257)
T cd08225 24 DSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQR--GVLFSED 101 (257)
T ss_pred CCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCCCcHHHHHHhcc--CCCCCHH
Confidence 588999999865432 334678899999999999999999999999999999999999999999987632 3458999
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCc-eEEccccccccCCCCCCceeeeeccccccccCcccccc
Q 021490 86 TRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH-PKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT 164 (311)
Q Consensus 86 ~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~-~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 164 (311)
.+..++.+++.||+|||+.+ ++|+||+|.||++++++. ++|+|||.+...... ........++..|+|||++.+
T Consensus 102 ~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~--~~~~~~~~~~~~~~ape~~~~ 176 (257)
T cd08225 102 QILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS--MELAYTCVGTPYYLSPEICQN 176 (257)
T ss_pred HHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCC--cccccccCCCccccCHHHHcC
Confidence 99999999999999999999 999999999999998864 699999988653222 112222457888999999988
Q ss_pred CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccc
Q 021490 165 GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVH 244 (311)
Q Consensus 165 ~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 244 (311)
..++.++|+||||+++|+|++|..||.......... ....... ....+..+..+.+++.+||.
T Consensus 177 ~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~------~~~~~~~-----------~~~~~~~~~~~~~~i~~~l~ 239 (257)
T cd08225 177 RPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVL------KICQGYF-----------APISPNFSRDLRSLISQLFK 239 (257)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHH------HHhcccC-----------CCCCCCCCHHHHHHHHHHhc
Confidence 889999999999999999999999997654322111 0011000 01122334578899999999
Q ss_pred cCCCCCCCHHHHHHH
Q 021490 245 EQPDMRPVIADVVTA 259 (311)
Q Consensus 245 ~~p~~Rps~~~vl~~ 259 (311)
.+|++|||+.++++.
T Consensus 240 ~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 240 VSPRDRPSITSILKR 254 (257)
T ss_pred cChhhCcCHHHHhhC
Confidence 999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=254.78 Aligned_cols=235 Identities=24% Similarity=0.324 Sum_probs=176.8
Q ss_pred CCcEEEEEEeecCCC-cchhHHHHHHHH-HhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHH
Q 021490 8 LLQDVAIKQLDRNGV-QGNREFLVEVLM-LSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN 85 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~-~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~ 85 (311)
+|..||+|+++.... .....+..|+.. ++.++||||+++++++..+...++||||++ ++|.+++.........+++.
T Consensus 25 ~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~ 103 (283)
T cd06617 25 TGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD-TSLDKFYKKVYDKGLTIPED 103 (283)
T ss_pred CCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHH
Confidence 689999999876532 234456666665 566689999999999999999999999996 68888876544345679999
Q ss_pred HHHHHHHHHHHHHHHhhcC-CCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccccc
Q 021490 86 TRMKIAAGAARGLEYLHDK-AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT 164 (311)
Q Consensus 86 ~~~~~~~~i~~~l~~lh~~-~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 164 (311)
.++.++.|++.||+|||++ + ++|+||+|+||+++.++.++|+|||++...... .......++..|+|||.+.+
T Consensus 104 ~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~ 177 (283)
T cd06617 104 ILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS---VAKTIDAGCKPYMAPERINP 177 (283)
T ss_pred HHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecccccccccc---cccccccCCccccChhhcCC
Confidence 9999999999999999997 8 999999999999999999999999998643221 11222357788999998865
Q ss_pred ----CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHH
Q 021490 165 ----GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAA 240 (311)
Q Consensus 165 ----~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 240 (311)
..++.++|+||||+++|+|++|..||........ ..... ... . .+.+. ....+..+.+++.
T Consensus 178 ~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~----~~~--~-----~~~~~---~~~~~~~l~~li~ 242 (283)
T cd06617 178 ELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQ-QLKQV----VEE--P-----SPQLP---AEKFSPEFQDFVN 242 (283)
T ss_pred cccccccCccccchhhHHHHHHHHhCCCCCCccccCHH-HHHHH----Hhc--C-----CCCCC---ccccCHHHHHHHH
Confidence 4568899999999999999999999964322110 00000 000 0 00000 0123457889999
Q ss_pred HccccCCCCCCCHHHHHHHHHHhh
Q 021490 241 MCVHEQPDMRPVIADVVTALAYLA 264 (311)
Q Consensus 241 ~~l~~~p~~Rps~~~vl~~l~~~~ 264 (311)
+||..+|.+|||+.++++.-....
T Consensus 243 ~~l~~~p~~Rp~~~~il~~~~~~~ 266 (283)
T cd06617 243 KCLKKNYKERPNYPELLQHPFFEL 266 (283)
T ss_pred HHccCChhhCcCHHHHhcCchhhh
Confidence 999999999999999998654433
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=251.62 Aligned_cols=227 Identities=25% Similarity=0.351 Sum_probs=181.7
Q ss_pred cCCcEEEEEEeecCCC-cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHH
Q 021490 7 CLLQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN 85 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~ 85 (311)
.+|..||+|++..... .....+.+|+..+..++||||+++++++..+...++||||+++++|.+++.. ..+++.
T Consensus 27 ~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~-----~~~~~~ 101 (277)
T cd06641 27 RTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-----GPLDET 101 (277)
T ss_pred CCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCcHHHHHhc-----CCCCHH
Confidence 4688999999854432 2346788999999999999999999999999999999999999999999864 468999
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccC
Q 021490 86 TRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG 165 (311)
Q Consensus 86 ~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 165 (311)
.+..++.+++.++.+||+.+ ++|+||+|.||+++.++.++|+|||++........ ......++..|+|||.+...
T Consensus 102 ~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~ 176 (277)
T cd06641 102 QIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIKQS 176 (277)
T ss_pred HHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh--hhccccCCccccChhhhccC
Confidence 99999999999999999999 99999999999999999999999998764322111 11223467789999999888
Q ss_pred CCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHcccc
Q 021490 166 QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHE 245 (311)
Q Consensus 166 ~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 245 (311)
.++.++|+|||||++|+|++|..||...........+. .. . .+. .+...+..+.+++.+||+.
T Consensus 177 ~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~------~~-~------~~~----~~~~~~~~~~~~i~~~l~~ 239 (277)
T cd06641 177 AYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIP------KN-N------PPT----LEGNYSKPLKEFVEACLNK 239 (277)
T ss_pred CCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHh------cC-C------CCC----CCcccCHHHHHHHHHHccC
Confidence 88999999999999999999999997644322111110 00 0 011 1222344788899999999
Q ss_pred CCCCCCCHHHHHHHH
Q 021490 246 QPDMRPVIADVVTAL 260 (311)
Q Consensus 246 ~p~~Rps~~~vl~~l 260 (311)
+|.+||++.+++..-
T Consensus 240 ~p~~Rp~~~~~l~~~ 254 (277)
T cd06641 240 EPSFRPTAKELLKHK 254 (277)
T ss_pred ChhhCcCHHHHHhCH
Confidence 999999999999863
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=253.38 Aligned_cols=245 Identities=20% Similarity=0.268 Sum_probs=180.5
Q ss_pred CCcEEEEEEeecCCC-cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHH
Q 021490 8 LLQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNT 86 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~ 86 (311)
+|..||+|+++.... .....+.+|+.+++.++|+||+++++++.+....++||||++ ++|.+++.... ....+++..
T Consensus 24 ~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~ 101 (284)
T cd07836 24 TGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMD-KDLKKYMDTHG-VRGALDPNT 101 (284)
T ss_pred CCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCC-ccHHHHHHhcC-CCCCcCHHH
Confidence 688999999876543 234677889999999999999999999999999999999997 48888876532 135689999
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccccc-C
Q 021490 87 RMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT-G 165 (311)
Q Consensus 87 ~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~ 165 (311)
+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++....... .......++..|++||++.+ .
T Consensus 102 ~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~ 176 (284)
T cd07836 102 VKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPV--NTFSNEVVTLWYRAPDVLLGSR 176 (284)
T ss_pred HHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc--cccccccccccccChHHhcCCC
Confidence 9999999999999999999 9999999999999999999999999986432211 11122346778999998765 4
Q ss_pred CCccccceeehhHHHHHHHhCCCccCcchhHHHHHHH-HHhhhhhcccc----cccccc--Cc----cccCCCChHhHHH
Q 021490 166 QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLV-AWARPLFQDRT----RHSLIA--DP----ELQGQYPPRGFYQ 234 (311)
Q Consensus 166 ~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~----~~~~~~--~~----~~~~~~~~~~~~~ 234 (311)
.++.++|+||||+++|+|++|..||............ ........... ...... .+ .......+..+..
T Consensus 177 ~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (284)
T cd07836 177 TYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPL 256 (284)
T ss_pred CCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcH
Confidence 5688999999999999999999999766543322211 11000000000 000000 00 0001111233557
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHH
Q 021490 235 ALAVAAMCVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 235 l~~li~~~l~~~p~~Rps~~~vl~~ 259 (311)
+.+++.+||+.||.+||++.++++.
T Consensus 257 ~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 257 GIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred HHHHHHHHhcCCcccCCCHHHHhcC
Confidence 8899999999999999999999864
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=257.34 Aligned_cols=232 Identities=20% Similarity=0.190 Sum_probs=177.5
Q ss_pred CCcEEEEEEeecCC---CcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCH
Q 021490 8 LLQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 84 (311)
Q Consensus 8 ~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~ 84 (311)
+++.||+|++.... ......+.+|..++..++|+||+.+++++.++...|+||||++||+|.+++... ...+++
T Consensus 25 ~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~---~~~l~~ 101 (331)
T cd05624 25 TERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKF---EDRLPE 101 (331)
T ss_pred CCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHh---cCCCCH
Confidence 67889999986532 123346788999999999999999999999999999999999999999999752 356899
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccccc
Q 021490 85 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT 164 (311)
Q Consensus 85 ~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 164 (311)
..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++........ .......|+..|+|||++.+
T Consensus 102 ~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~ 177 (331)
T cd05624 102 DMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT-VQSSVAVGTPDYISPEILQA 177 (331)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCCCc-eeeccccCCcccCCHHHHhc
Confidence 999999999999999999999 99999999999999999999999999865322211 11223458999999998865
Q ss_pred -----CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHH
Q 021490 165 -----GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVA 239 (311)
Q Consensus 165 -----~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 239 (311)
..++.++||||||+++|+|++|..||...........+ ....... .-+. . ....+..+.+++
T Consensus 178 ~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i------~~~~~~~---~~p~---~-~~~~~~~~~~li 244 (331)
T cd05624 178 MEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI------MNHEERF---QFPS---H-ITDVSEEAKDLI 244 (331)
T ss_pred cccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHH------HcCCCcc---cCCC---c-cccCCHHHHHHH
Confidence 46788999999999999999999999765543221111 1100000 0000 0 112345788899
Q ss_pred HHccccCCCC--CCCHHHHHHH
Q 021490 240 AMCVHEQPDM--RPVIADVVTA 259 (311)
Q Consensus 240 ~~~l~~~p~~--Rps~~~vl~~ 259 (311)
.+||..++++ |++++++++.
T Consensus 245 ~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 245 QRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred HHHccCchhhcCCCCHHHHhcC
Confidence 9999876554 4688888765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=257.14 Aligned_cols=232 Identities=21% Similarity=0.189 Sum_probs=177.6
Q ss_pred CCcEEEEEEeecCC---CcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCH
Q 021490 8 LLQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 84 (311)
Q Consensus 8 ~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~ 84 (311)
.++.+|+|++.+.. ......+.+|+.++..++|+||+++++.+.+....++||||+++|+|.+++... ...+++
T Consensus 25 ~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~---~~~l~~ 101 (332)
T cd05623 25 ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKF---EDRLPE 101 (332)
T ss_pred CCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccCCCcHHHHHHHh---cCCCCH
Confidence 57889999986532 122345788999999999999999999999999999999999999999999752 356899
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccc-
Q 021490 85 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK- 163 (311)
Q Consensus 85 ~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~- 163 (311)
..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++....... ........|+..|+|||++.
T Consensus 102 ~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~ 177 (332)
T cd05623 102 DMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG-TVQSSVAVGTPDYISPEILQA 177 (332)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccCC-cceecccccCccccCHHHHhc
Confidence 999999999999999999999 9999999999999999999999999986432211 11222346899999999886
Q ss_pred ----cCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHH
Q 021490 164 ----TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVA 239 (311)
Q Consensus 164 ----~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 239 (311)
...++.++|||||||++|+|++|..||...+.......+. ...... ..+.. ....+..+.+|+
T Consensus 178 ~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~------~~~~~~---~~p~~----~~~~s~~~~~li 244 (332)
T cd05623 178 MEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM------NHKERF---QFPAQ----VTDVSEDAKDLI 244 (332)
T ss_pred cccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHh------CCCccc---cCCCc----cccCCHHHHHHH
Confidence 3467889999999999999999999998665433222111 100000 00110 112345788899
Q ss_pred HHccccCCC--CCCCHHHHHHH
Q 021490 240 AMCVHEQPD--MRPVIADVVTA 259 (311)
Q Consensus 240 ~~~l~~~p~--~Rps~~~vl~~ 259 (311)
.+||..+++ .|+++.++++.
T Consensus 245 ~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 245 RRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred HHHccChhhhcCCCCHHHHhCC
Confidence 998866544 36899999877
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=249.41 Aligned_cols=229 Identities=24% Similarity=0.365 Sum_probs=186.0
Q ss_pred cCCcEEEEEEeecCCC--cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCH
Q 021490 7 CLLQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 84 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~ 84 (311)
.+|+.+|+|.+..... .....+.+|+.+++.++|+||+++++++.+....++|+||+++++|.+++.........+++
T Consensus 23 ~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~ 102 (256)
T cd08530 23 SDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPE 102 (256)
T ss_pred CCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCCCCHHHHHHHHHhhcCCCCH
Confidence 4688999999875432 33457888999999999999999999999999999999999999999998764333467899
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccccc
Q 021490 85 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT 164 (311)
Q Consensus 85 ~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 164 (311)
..++.++.+++.||+|||+.+ ++|+||+|.||+++.++.++|+|||++...... ......++..|++||.+.+
T Consensus 103 ~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~~~~Pe~~~~ 175 (256)
T cd08530 103 QEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN----MAKTQIGTPHYMAPEVWKG 175 (256)
T ss_pred HHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC----CcccccCCccccCHHHHCC
Confidence 999999999999999999999 999999999999999999999999998754332 1222347788999999988
Q ss_pred CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccc
Q 021490 165 GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVH 244 (311)
Q Consensus 165 ~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 244 (311)
..++.++|+||||+++|+|++|..||...+......... .. . ....+.....++.+++.+||+
T Consensus 176 ~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~------~~--~---------~~~~~~~~~~~~~~li~~~l~ 238 (256)
T cd08530 176 RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQ------RG--K---------YPPIPPIYSQDLQNFIRSMLQ 238 (256)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh------cC--C---------CCCCchhhCHHHHHHHHHHcC
Confidence 888999999999999999999999998765432211110 00 0 011222445678999999999
Q ss_pred cCCCCCCCHHHHHHH
Q 021490 245 EQPDMRPVIADVVTA 259 (311)
Q Consensus 245 ~~p~~Rps~~~vl~~ 259 (311)
.+|++|||+.++++.
T Consensus 239 ~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 239 VKPKLRPNCDKILAS 253 (256)
T ss_pred CCcccCCCHHHHhcC
Confidence 999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=247.20 Aligned_cols=226 Identities=27% Similarity=0.386 Sum_probs=184.1
Q ss_pred CCcEEEEEEeecCCC--cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHH
Q 021490 8 LLQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN 85 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~ 85 (311)
+|+.|++|.+..... ...+.+.+|++++..++|+|++++++++.++...+++|||+++++|.+++.. ...+++.
T Consensus 24 ~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~----~~~l~~~ 99 (254)
T cd06627 24 TGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKK----FGPFPES 99 (254)
T ss_pred CCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCCCcHHHHHHh----ccCCCHH
Confidence 678999999976654 3456899999999999999999999999999999999999999999999976 4679999
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccC
Q 021490 86 TRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG 165 (311)
Q Consensus 86 ~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 165 (311)
.++.++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||.+......... .....++..|+|||...+.
T Consensus 100 ~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~y~~pe~~~~~ 174 (254)
T cd06627 100 LVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--DASVVGTPYWMAPEVIEMS 174 (254)
T ss_pred HHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCccc--ccccccchhhcCHhhhcCC
Confidence 99999999999999999999 999999999999999999999999998754332221 2234578889999998887
Q ss_pred CCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHcccc
Q 021490 166 QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHE 245 (311)
Q Consensus 166 ~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 245 (311)
..+.++|+||+|+++|+|++|..||............ ... . . ...+...+..+.+++.+||..
T Consensus 175 ~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~------~~~--~-----~----~~~~~~~~~~~~~~i~~~l~~ 237 (254)
T cd06627 175 GASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRI------VQD--D-----H----PPLPEGISPELKDFLMQCFQK 237 (254)
T ss_pred CCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH------hcc--C-----C----CCCCCCCCHHHHHHHHHHHhC
Confidence 7899999999999999999999999765432111100 000 0 0 112223345788999999999
Q ss_pred CCCCCCCHHHHHHH
Q 021490 246 QPDMRPVIADVVTA 259 (311)
Q Consensus 246 ~p~~Rps~~~vl~~ 259 (311)
+|++|||+.+++..
T Consensus 238 ~p~~R~~~~~~l~~ 251 (254)
T cd06627 238 DPNLRPTAKQLLKH 251 (254)
T ss_pred ChhhCcCHHHHhcC
Confidence 99999999998853
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=267.18 Aligned_cols=228 Identities=24% Similarity=0.347 Sum_probs=187.6
Q ss_pred CcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCC--CHHH
Q 021490 9 LQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPL--DWNT 86 (311)
Q Consensus 9 g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l--~~~~ 86 (311)
-..+|||.+........+-+++|+.+-++|+|.|||+++|.+.++...-+.||-++||+|.+++.+.. +++ .+.+
T Consensus 600 qvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSsLLrskW---GPlKDNEst 676 (1226)
T KOG4279|consen 600 QVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSSLLRSKW---GPLKDNEST 676 (1226)
T ss_pred eeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHHHHHhcc---CCCccchhH
Confidence 46789999977776677788999999999999999999999999999999999999999999998743 456 7888
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcC-CCceEEccccccccCCCCCCceeeeeccccccccCcccccc-
Q 021490 87 RMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR-GYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT- 164 (311)
Q Consensus 87 ~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~- 164 (311)
+-.+..||+.||.|||++. |||||||-+|+|++. .|.+||+|||.+...... .......-||..|||||++..
T Consensus 677 m~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi--nP~TETFTGTLQYMAPEvIDqG 751 (1226)
T KOG4279|consen 677 MNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI--NPCTETFTGTLQYMAPEVIDQG 751 (1226)
T ss_pred HHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccC--CccccccccchhhhChHhhccC
Confidence 9999999999999999999 999999999999974 789999999998764322 223334569999999999975
Q ss_pred -CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHcc
Q 021490 165 -GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCV 243 (311)
Q Consensus 165 -~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 243 (311)
..|+.++|||||||++.||.||++||-........ + +.-.. -.....+|...+.+...+|.+|+
T Consensus 752 ~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA-M-------FkVGm-------yKvHP~iPeelsaeak~FilrcF 816 (1226)
T KOG4279|consen 752 PRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA-M-------FKVGM-------YKVHPPIPEELSAEAKNFILRCF 816 (1226)
T ss_pred CcCCCchhhhhhccceeEeeccCCCCeeecCChhHh-h-------hhhcc-------eecCCCCcHHHHHHHHHHHHHHc
Confidence 57899999999999999999999999654322110 0 11000 01123456777889999999999
Q ss_pred ccCCCCCCCHHHHHHH
Q 021490 244 HEQPDMRPVIADVVTA 259 (311)
Q Consensus 244 ~~~p~~Rps~~~vl~~ 259 (311)
.+||.+||++.+++..
T Consensus 817 epd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 817 EPDPCDRPSAKDLLQD 832 (1226)
T ss_pred CCCcccCccHHHhccC
Confidence 9999999999999965
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=256.62 Aligned_cols=242 Identities=25% Similarity=0.307 Sum_probs=178.0
Q ss_pred CCcEEEEEEeecC--CCcchhHHHHHHHHHhcC-CCCcccceeeEeeeC--CeeEEEEecCCCCChhhhhcccCCCCCCC
Q 021490 8 LLQDVAIKQLDRN--GVQGNREFLVEVLMLSLL-HHPNLVNLIGYCADG--DQRLLVYEYMPLGSVEDHLHDLSPGKKPL 82 (311)
Q Consensus 8 ~g~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~l 82 (311)
+|..+|+|++... .......+.+|+.++.++ +||||+++++++... ...++||||++ ++|.+++.. ..+
T Consensus 31 ~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~ 104 (337)
T cd07852 31 TKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYME-TDLHAVIRA-----NIL 104 (337)
T ss_pred CCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEecccc-cCHHHHHhc-----CCC
Confidence 6889999998543 223445678899999999 999999999988643 46899999997 599988875 378
Q ss_pred CHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCc---eeeeeccccccccCc
Q 021490 83 DWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT---HVSTRVMGTYGYCAP 159 (311)
Q Consensus 83 ~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~~~y~aP 159 (311)
++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++......... .......++..|+||
T Consensus 105 ~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aP 181 (337)
T cd07852 105 EDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAP 181 (337)
T ss_pred CHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhccccccccccCcchhcccccccccCc
Confidence 89999999999999999999999 999999999999999999999999998754322211 122234578899999
Q ss_pred ccccc-CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhh------------hcc-ccc-cccccCcccc
Q 021490 160 EYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPL------------FQD-RTR-HSLIADPELQ 224 (311)
Q Consensus 160 E~~~~-~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~------------~~~-~~~-~~~~~~~~~~ 224 (311)
|.+.+ ..++.++|+||||+++|+|++|+.||.................. ... ... .........
T Consensus 182 E~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 260 (337)
T cd07852 182 EILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPL- 260 (337)
T ss_pred eeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccch-
Confidence 98754 55788999999999999999999999765544332211111000 000 000 000000000
Q ss_pred CCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 021490 225 GQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 225 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~ 259 (311)
....+..+..+.+++.+||+.||++|||+.++++.
T Consensus 261 ~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 261 DELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred hhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 01111245688999999999999999999999976
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=251.46 Aligned_cols=241 Identities=23% Similarity=0.233 Sum_probs=176.2
Q ss_pred cCCcEEEEEEeecCCC-cchhHHHHHHHHHhcCC-CCcccceeeEeeeC--CeeEEEEecCCCCChhhhhcccCCCCCCC
Q 021490 7 CLLQDVAIKQLDRNGV-QGNREFLVEVLMLSLLH-HPNLVNLIGYCADG--DQRLLVYEYMPLGSVEDHLHDLSPGKKPL 82 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~l 82 (311)
.+|+.||+|+++.... .......+|+.++..+. |+|++++++++.++ ...++||||++ ++|.+.+... ...+
T Consensus 22 ~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~---~~~~ 97 (282)
T cd07831 22 KTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMD-MNLYELIKGR---KRPL 97 (282)
T ss_pred CCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCC-ccHHHHHHhc---cCCC
Confidence 3689999999875432 22334567899999885 99999999999887 88999999997 5888877652 3568
Q ss_pred CHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccc
Q 021490 83 DWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 162 (311)
Q Consensus 83 ~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 162 (311)
++..++.++.|++.||+|||+.+ ++|+||+|+||+++. +.++|+|||++........ .....++..|+|||.+
T Consensus 98 ~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~ 170 (282)
T cd07831 98 PEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP---YTEYISTRWYRAPECL 170 (282)
T ss_pred CHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCCC---cCCCCCCcccCChhHh
Confidence 99999999999999999999999 999999999999999 9999999999875322211 1223467889999976
Q ss_pred cc-CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhh--------hhhccccccccccCcccc----CCCCh
Q 021490 163 KT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWAR--------PLFQDRTRHSLIADPELQ----GQYPP 229 (311)
Q Consensus 163 ~~-~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~----~~~~~ 229 (311)
.. ..++.++|||||||++|+|++|..||...+..+......... ........ .....+... ....+
T Consensus 171 ~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 249 (282)
T cd07831 171 LTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRH-MNYNFPSKKGTGLRKLLP 249 (282)
T ss_pred hcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccc-ccccCcccccccHHHHcc
Confidence 43 556889999999999999999999997655433221111000 00000000 000000000 00112
Q ss_pred HhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 021490 230 RGFYQALAVAAMCVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 230 ~~~~~l~~li~~~l~~~p~~Rps~~~vl~~ 259 (311)
..+..+.+++.+||.++|++|||+.++++.
T Consensus 250 ~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 250 NASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 346789999999999999999999999864
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=259.30 Aligned_cols=241 Identities=23% Similarity=0.255 Sum_probs=178.2
Q ss_pred CCcEEEEEEeecCC--CcchhHHHHHHHHHhcCCCCcccceeeEeeeC------CeeEEEEecCCCCChhhhhcccCCCC
Q 021490 8 LLQDVAIKQLDRNG--VQGNREFLVEVLMLSLLHHPNLVNLIGYCADG------DQRLLVYEYMPLGSVEDHLHDLSPGK 79 (311)
Q Consensus 8 ~g~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~ 79 (311)
+|..||+|++.... ......+.+|+.+++.++||||+++++++... ...|+||||+. ++|.+.+..
T Consensus 40 ~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----- 113 (353)
T cd07850 40 TGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQM----- 113 (353)
T ss_pred CCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEEeccC-CCHHHHHhh-----
Confidence 68999999986432 23345788899999999999999999988543 35799999996 588888764
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCc
Q 021490 80 KPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 159 (311)
Q Consensus 80 ~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aP 159 (311)
.++...+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++....... ......++..|+||
T Consensus 114 -~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aP 186 (353)
T cd07850 114 -DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAP 186 (353)
T ss_pred -cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCccceeCCCCC---CCCCCcccccccCH
Confidence 2889999999999999999999999 9999999999999999999999999987532211 12223467889999
Q ss_pred cccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHH-h---------------hhhhcccccc-----ccc
Q 021490 160 EYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAW-A---------------RPLFQDRTRH-----SLI 218 (311)
Q Consensus 160 E~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~-~---------------~~~~~~~~~~-----~~~ 218 (311)
|.+.+..++.++|||||||++|+|++|..||...+.......+.. . .......... ...
T Consensus 187 E~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (353)
T cd07850 187 EVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEEL 266 (353)
T ss_pred HHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhh
Confidence 999988999999999999999999999999976654322111100 0 0000000000 000
Q ss_pred c----CccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 021490 219 A----DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 261 (311)
Q Consensus 219 ~----~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l~ 261 (311)
. .+......+......+.+++.+||+.||++|||+.+++..-.
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~ 313 (353)
T cd07850 267 FPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPY 313 (353)
T ss_pred CcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChh
Confidence 0 000001112233557889999999999999999999997743
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=250.71 Aligned_cols=244 Identities=22% Similarity=0.226 Sum_probs=175.9
Q ss_pred cCCcEEEEEEeecCCCcc-hhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHH
Q 021490 7 CLLQDVAIKQLDRNGVQG-NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN 85 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~ 85 (311)
.+|..||+|++....... ...+.+|+.+++.++|+||+++++++.++...++||||+. ++|.+++... ...+++.
T Consensus 28 ~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~---~~~~~~~ 103 (291)
T cd07870 28 INGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-TDLAQYMIQH---PGGLHPY 103 (291)
T ss_pred CCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-CCHHHHHHhC---CCCCCHH
Confidence 368899999986554333 3467889999999999999999999999999999999996 6777766542 3567888
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccccc-
Q 021490 86 TRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT- 164 (311)
Q Consensus 86 ~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~- 164 (311)
.+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++....... .......++..|+|||.+.+
T Consensus 104 ~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~ 178 (291)
T cd07870 104 NVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPS--QTYSSEVVTLWYRPPDVLLGA 178 (291)
T ss_pred HHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCCC--CCCCCccccccccCCceeecC
Confidence 99999999999999999999 9999999999999999999999999886422211 11122346788999998865
Q ss_pred CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhh-hhhcc-----ccccccccCccccCCCC---------h
Q 021490 165 GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWAR-PLFQD-----RTRHSLIADPELQGQYP---------P 229 (311)
Q Consensus 165 ~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~-~~~~~-----~~~~~~~~~~~~~~~~~---------~ 229 (311)
..++.++|+||||+++|+|++|..||.............+.. ..... ................+ .
T Consensus 179 ~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (291)
T cd07870 179 TDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRL 258 (291)
T ss_pred CCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhcccc
Confidence 457889999999999999999999997655432211111100 00000 00000000000000000 0
Q ss_pred HhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 021490 230 RGFYQALAVAAMCVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 230 ~~~~~l~~li~~~l~~~p~~Rps~~~vl~~ 259 (311)
.....+.+++.+||..||.+|||+.+++..
T Consensus 259 ~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 259 SRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred CCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 113467889999999999999999998754
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=256.23 Aligned_cols=247 Identities=19% Similarity=0.211 Sum_probs=177.9
Q ss_pred CCcEEEEEEeecCC---CcchhHHHHHHHHHhcCCCCcccceeeEeeeC--CeeEEEEecCCCCChhhhhcccCCC-CCC
Q 021490 8 LLQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADG--DQRLLVYEYMPLGSVEDHLHDLSPG-KKP 81 (311)
Q Consensus 8 ~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~-~~~ 81 (311)
+|..||+|.+.... ....+.+.+|+.++..++||||+++++++.+. ...++||||++ ++|.+++...... ...
T Consensus 26 ~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~ 104 (316)
T cd07842 26 DGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAE-HDLWQIIKFHRQAKRVS 104 (316)
T ss_pred CCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEeCCC-cCHHHHHHhhccCCCcC
Confidence 57999999997643 33346788899999999999999999999888 78999999996 4777766543222 247
Q ss_pred CCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcC----CCceEEccccccccCCCCCC-ceeeeeccccccc
Q 021490 82 LDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR----GYHPKLSDFGLAKLGPVGDN-THVSTRVMGTYGY 156 (311)
Q Consensus 82 l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~----~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~y 156 (311)
+++..++.++.|++.||+|||+.+ ++|+||+|+||+++. ++.++|+|||++........ ........++..|
T Consensus 105 ~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y 181 (316)
T cd07842 105 IPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWY 181 (316)
T ss_pred cCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCCccccccCCCcccccccCCccccccc
Confidence 899999999999999999999999 999999999999999 99999999999875322221 1112233567889
Q ss_pred cCcccccc-CCCccccceeehhHHHHHHHhCCCccCcchhHHH-------HHHHHHhhhhhc-----------ccccccc
Q 021490 157 CAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE-------QSLVAWARPLFQ-----------DRTRHSL 217 (311)
Q Consensus 157 ~aPE~~~~-~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~-------~~~~~~~~~~~~-----------~~~~~~~ 217 (311)
+|||++.+ ..++.++|+||||+++|+|++|..||........ ..+.... ..+. .......
T Consensus 182 ~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~l~~~~~~~~~~~~~~~~~~~ 260 (316)
T cd07842 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIF-EVLGTPTEKDWPDIKKMPEYDT 260 (316)
T ss_pred cCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHH-HHhCCCchhHHHHHhhcccchh
Confidence 99998765 4578999999999999999999999975443220 0000000 0000 0000000
Q ss_pred ccCccccCCCC---------h--HhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 021490 218 IADPELQGQYP---------P--RGFYQALAVAAMCVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 218 ~~~~~~~~~~~---------~--~~~~~l~~li~~~l~~~p~~Rps~~~vl~~ 259 (311)
..+......++ . .....+.+++.+||+.||++|||+.+++..
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 261 LMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred hhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00000000011 0 234578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=246.14 Aligned_cols=216 Identities=23% Similarity=0.248 Sum_probs=167.6
Q ss_pred hHHHHHHHHHhcC-CCCcccceeeEeeeC----CeeEEEEecCCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHH
Q 021490 26 REFLVEVLMLSLL-HHPNLVNLIGYCADG----DQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEY 100 (311)
Q Consensus 26 ~~~~~e~~~l~~l-~h~~i~~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~ 100 (311)
....+|+++--.- .|||||.++++|.+. ..+.+|||.++||.|++.+++. +...+++.++-.|+.||+.|+.|
T Consensus 99 ~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~--g~~afTErea~eI~~qI~~Av~~ 176 (400)
T KOG0604|consen 99 PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDR--GDQAFTEREASEIMKQIGLAVRY 176 (400)
T ss_pred HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHHc--ccccchHHHHHHHHHHHHHHHHH
Confidence 4556787765554 599999999998643 4678999999999999999983 35679999999999999999999
Q ss_pred hhcCCCCCeEeeccCCCeEEEcC---CCceEEccccccccCCCCCCceeeeeccccccccCccccccCCCccccceeehh
Q 021490 101 LHDKAKPPVIYRDLKCSNILLDR---GYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFG 177 (311)
Q Consensus 101 lh~~~~~~i~h~dl~p~nil~~~---~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG 177 (311)
||+.+ |.||||||+|+|.+. |..+||+|||.+..... ........-|+.|.|||++....|+..+|+||+|
T Consensus 177 lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlg 250 (400)
T KOG0604|consen 177 LHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLG 250 (400)
T ss_pred HHhcc---hhhccCChhheeeecCCCCcceEecccccccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchh
Confidence 99999 999999999999964 55789999999975321 2223334578999999999999999999999999
Q ss_pred HHHHHHHhCCCccCcchhHHHHHHHHHhhhhhcccc--ccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHH
Q 021490 178 VVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRT--RHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIAD 255 (311)
Q Consensus 178 ~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 255 (311)
|++|-|++|.+||........ .+-+..+. ....+.+ .-....++...++|+.+|..+|.+|.|+++
T Consensus 251 VimYIlLCGyPPFYS~hg~ai-------spgMk~rI~~gqy~FP~-----pEWs~VSe~aKdlIR~LLkt~PteRlTI~~ 318 (400)
T KOG0604|consen 251 VIMYILLCGYPPFYSNHGLAI-------SPGMKRRIRTGQYEFPE-----PEWSCVSEAAKDLIRKLLKTEPTERLTIEE 318 (400)
T ss_pred HHHHHhhcCCCcccccCCccC-------ChhHHhHhhccCccCCC-----hhHhHHHHHHHHHHHHHhcCCchhheeHHH
Confidence 999999999999954322110 01111111 1111222 223456778889999999999999999999
Q ss_pred HHHHHH
Q 021490 256 VVTALA 261 (311)
Q Consensus 256 vl~~l~ 261 (311)
+...-+
T Consensus 319 ~m~hpw 324 (400)
T KOG0604|consen 319 VMDHPW 324 (400)
T ss_pred hhcCch
Confidence 997754
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=254.79 Aligned_cols=247 Identities=23% Similarity=0.270 Sum_probs=179.7
Q ss_pred cCCcEEEEEEeecCCCcc--hhHHHHHHHHHhcCCCCcccceeeEeeeC--CeeEEEEecCCCCChhhhhcccCCCCCCC
Q 021490 7 CLLQDVAIKQLDRNGVQG--NREFLVEVLMLSLLHHPNLVNLIGYCADG--DQRLLVYEYMPLGSVEDHLHDLSPGKKPL 82 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~l 82 (311)
.+|..||+|+++...... ...+.+|+.++++++|+||+++++++... ...++||||++ ++|.+++... ...+
T Consensus 30 ~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~---~~~l 105 (309)
T cd07845 30 TSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCE-QDLASLLDNM---PTPF 105 (309)
T ss_pred CCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCC-CCHHHHHHhc---ccCC
Confidence 368999999986543322 23567899999999999999999998654 46899999996 5888888752 3568
Q ss_pred CHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccc
Q 021490 83 DWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 162 (311)
Q Consensus 83 ~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 162 (311)
++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||.+....... .......++..|+|||++
T Consensus 106 ~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~ 180 (309)
T cd07845 106 SESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA--KPMTPKVVTLWYRAPELL 180 (309)
T ss_pred CHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecCCcc--CCCCcccccccccChhhh
Confidence 99999999999999999999999 9999999999999999999999999987543221 111223356789999988
Q ss_pred cc-CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhh-hhcccc-------c--cccccCcccc--CCCCh
Q 021490 163 KT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARP-LFQDRT-------R--HSLIADPELQ--GQYPP 229 (311)
Q Consensus 163 ~~-~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~-------~--~~~~~~~~~~--~~~~~ 229 (311)
.+ ..++.++||||||+++|+|++|..||...+.......+..... ...... . .......... .....
T Consensus 181 ~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (309)
T cd07845 181 LGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFP 260 (309)
T ss_pred cCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhcc
Confidence 65 5678999999999999999999999986655433322211100 000000 0 0000000000 00001
Q ss_pred HhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 021490 230 RGFYQALAVAAMCVHEQPDMRPVIADVVTALAY 262 (311)
Q Consensus 230 ~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l~~ 262 (311)
..+..+.++|.+||..||.+|||+.+++..-.+
T Consensus 261 ~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f 293 (309)
T cd07845 261 WLSEAGLRLLNFLLMYDPKKRATAEEALESSYF 293 (309)
T ss_pred ccCHHHHHHHHHHhcCChhhCcCHHHHhcChhh
Confidence 135577889999999999999999999987543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=252.40 Aligned_cols=243 Identities=19% Similarity=0.230 Sum_probs=176.8
Q ss_pred CCcEEEEEEeecCCC--cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHH
Q 021490 8 LLQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN 85 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~ 85 (311)
+|+.||+|.+..... ...+.+.+|+++++.++||||+++++++.++...++||||++ ++|.+++.... ...+++.
T Consensus 26 ~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~ 102 (294)
T PLN00009 26 TNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD-LDLKKHMDSSP--DFAKNPR 102 (294)
T ss_pred CCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEeccc-ccHHHHHHhCC--CCCcCHH
Confidence 688999999865432 223578899999999999999999999999999999999996 58888775522 3346888
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcC-CCceEEccccccccCCCCCCceeeeeccccccccCcccccc
Q 021490 86 TRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR-GYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT 164 (311)
Q Consensus 86 ~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 164 (311)
.+..++.|++.||+|||+++ ++|+||+|+||+++. ++.++|+|||++...... ........++..|+|||.+.+
T Consensus 103 ~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~~y~~PE~~~~ 177 (294)
T PLN00009 103 LIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP--VRTFTHEVVTLWYRAPEILLG 177 (294)
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC--ccccccCceeecccCHHHHhC
Confidence 99999999999999999999 999999999999985 567999999998643221 111122346788999998865
Q ss_pred -CCCccccceeehhHHHHHHHhCCCccCcchhHHHHH-HHHHhhhhhccccc-----------cccccCccccCCCChHh
Q 021490 165 -GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQS-LVAWARPLFQDRTR-----------HSLIADPELQGQYPPRG 231 (311)
Q Consensus 165 -~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~ 231 (311)
..++.++||||||+++|+|++|..||.......... .............. ........ .....+..
T Consensus 178 ~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 256 (294)
T PLN00009 178 SRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKD-LATVVPTL 256 (294)
T ss_pred CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhhcccCCCCC-HHHhCcCC
Confidence 457889999999999999999999997654432221 11110000000000 00000000 00112234
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 021490 232 FYQALAVAAMCVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 232 ~~~l~~li~~~l~~~p~~Rps~~~vl~~ 259 (311)
+..+.+++.+||+.+|.+||++.++++.
T Consensus 257 ~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 257 EPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred ChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 5578899999999999999999999975
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=252.93 Aligned_cols=244 Identities=23% Similarity=0.240 Sum_probs=183.4
Q ss_pred cCCcEEEEEEeecCCCc--chhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCH
Q 021490 7 CLLQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 84 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~ 84 (311)
.+|+.+++|.++..... ....+.+|+.+++.++|+||+++++++.++...++|+||+++ +|.+++... ...+++
T Consensus 22 ~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~~l~~~---~~~~~~ 97 (283)
T cd05118 22 LTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDR---QRGLPE 97 (283)
T ss_pred CCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC-CHHHHHHhh---cccCCH
Confidence 37899999998655432 356788899999999999999999999999999999999974 888887652 357899
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccccc
Q 021490 85 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT 164 (311)
Q Consensus 85 ~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 164 (311)
..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+....... .......++..|+|||.+.+
T Consensus 98 ~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~ 172 (283)
T cd05118 98 SLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RPYTHYVVTRWYRAPELLLG 172 (283)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--ccccCccCcccccCcHHHhc
Confidence 999999999999999999999 9999999999999999999999999886533222 11222346778999998876
Q ss_pred C-CCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHH-Hhhhhhcccc-------ccccccCcc----ccCCCChHh
Q 021490 165 G-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVA-WARPLFQDRT-------RHSLIADPE----LQGQYPPRG 231 (311)
Q Consensus 165 ~-~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~-------~~~~~~~~~----~~~~~~~~~ 231 (311)
. .++.++|+||||+++|+|++|+.||...+......... .......... .......+. ......+..
T Consensus 173 ~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (283)
T cd05118 173 DKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNA 252 (283)
T ss_pred CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhh
Confidence 6 78999999999999999999999997666543322111 1000000000 000000000 001112334
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 021490 232 FYQALAVAAMCVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 232 ~~~l~~li~~~l~~~p~~Rps~~~vl~~ 259 (311)
+..+.+++.+||..||.+||++.+++..
T Consensus 253 ~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 253 SPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred CHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 6788999999999999999999999864
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=258.83 Aligned_cols=249 Identities=22% Similarity=0.268 Sum_probs=182.0
Q ss_pred cCCcEEEEEEeecCCC--cchhHHHHHHHHHhcCCCCcccceeeEeee----CCeeEEEEecCCCCChhhhhcccCCCCC
Q 021490 7 CLLQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCAD----GDQRLLVYEYMPLGSVEDHLHDLSPGKK 80 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 80 (311)
.+|..||+|++..... .....+.+|+.+++.++||||+++++++.. ....++||||+. ++|.+++.. ..
T Consensus 28 ~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~ 102 (334)
T cd07855 28 RSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLME-SDLHHIIHS----DQ 102 (334)
T ss_pred CCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEehhh-hhHHHHhcc----CC
Confidence 3689999999876432 344678889999999999999999998753 346899999995 689888875 45
Q ss_pred CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCc--eeeeeccccccccC
Q 021490 81 PLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT--HVSTRVMGTYGYCA 158 (311)
Q Consensus 81 ~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~~y~a 158 (311)
.+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++......... .......++..|+|
T Consensus 103 ~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~ 179 (334)
T cd07855 103 PLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRA 179 (334)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceeecccCcCCCcccccccccccccC
Confidence 6999999999999999999999999 999999999999999999999999998653222111 11123457889999
Q ss_pred cccccc-CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhh-----hc----ccc----ccccccCcccc
Q 021490 159 PEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPL-----FQ----DRT----RHSLIADPELQ 224 (311)
Q Consensus 159 PE~~~~-~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~-----~~----~~~----~~~~~~~~~~~ 224 (311)
||.+.+ ..++.++||||||+++|+|++|..||...+.......+...... +. ... .......+...
T Consensus 180 PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (334)
T cd07855 180 PELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPW 259 (334)
T ss_pred hHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCH
Confidence 998765 46789999999999999999999999765543322211111000 00 000 00000000000
Q ss_pred CCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 021490 225 GQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYL 263 (311)
Q Consensus 225 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l~~~ 263 (311)
....+..+..+.+++.+||+.+|.+|||+.+++.....-
T Consensus 260 ~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~ 298 (334)
T cd07855 260 SKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLA 298 (334)
T ss_pred HHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhh
Confidence 001123356889999999999999999999999875543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=258.68 Aligned_cols=245 Identities=22% Similarity=0.275 Sum_probs=184.4
Q ss_pred CCcEEEEEEeecCC--CcchhHHHHHHHHHhcCCCCcccceeeEeeeCC-----eeEEEEecCCCCChhhhhcccCCCCC
Q 021490 8 LLQDVAIKQLDRNG--VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD-----QRLLVYEYMPLGSVEDHLHDLSPGKK 80 (311)
Q Consensus 8 ~g~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~ 80 (311)
+|..||+|++.... ....+.+.+|+.+++.++|+||+++++++.... ..|+||||++ ++|.+++.. ..
T Consensus 24 ~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~----~~ 98 (330)
T cd07834 24 TGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELME-TDLHKVIKS----PQ 98 (330)
T ss_pred CCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEecchh-hhHHHHHhC----CC
Confidence 48999999987654 334568999999999999999999999987765 7899999997 588888876 45
Q ss_pred CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCc-eeeeeccccccccCc
Q 021490 81 PLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT-HVSTRVMGTYGYCAP 159 (311)
Q Consensus 81 ~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~y~aP 159 (311)
.+++..++.++.+++.||++||+.| ++|+||+|.||+++.++.++|+|||++......... .......++..|+||
T Consensus 99 ~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aP 175 (330)
T cd07834 99 PLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAP 175 (330)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEeecccccccccccccccccCcCCc
Confidence 8999999999999999999999999 999999999999999999999999998754332210 112233567889999
Q ss_pred cccccC-CCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHh-hhhhccccc-------c-----ccccCccccC
Q 021490 160 EYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWA-RPLFQDRTR-------H-----SLIADPELQG 225 (311)
Q Consensus 160 E~~~~~-~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~-------~-----~~~~~~~~~~ 225 (311)
|.+.+. .++.++|+||||+++|+|++|..||...........+... ......... . .....+.-..
T Consensus 176 E~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (330)
T cd07834 176 ELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLS 255 (330)
T ss_pred eeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhH
Confidence 999877 7899999999999999999999999876654332211111 000000000 0 0000000000
Q ss_pred CCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 021490 226 QYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 260 (311)
Q Consensus 226 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l 260 (311)
...+..+..+.+++.+||+.+|.+|||+++++...
T Consensus 256 ~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 290 (330)
T cd07834 256 KLFPGASPEAIDLLEKMLVFDPKKRITADEALAHP 290 (330)
T ss_pred HhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCc
Confidence 11122456788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=252.16 Aligned_cols=247 Identities=19% Similarity=0.194 Sum_probs=177.2
Q ss_pred cCCcEEEEEEeecCCC--cchhHHHHHHHHHhcCC-CCcccceeeEeeeCCe-----eEEEEecCCCCChhhhhcccCCC
Q 021490 7 CLLQDVAIKQLDRNGV--QGNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQ-----RLLVYEYMPLGSVEDHLHDLSPG 78 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~-----~~lv~e~~~~~~L~~~l~~~~~~ 78 (311)
.+|+.||+|.++.... .....+.+|+.++..++ ||||+++++++..... .|+||||+++ +|.+++......
T Consensus 24 ~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~ 102 (295)
T cd07837 24 NTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRG 102 (295)
T ss_pred CCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEeeccCc-CHHHHHHHhccc
Confidence 3689999999765432 23357888999999995 6999999999877665 8999999985 888887653322
Q ss_pred -CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcC-CCceEEccccccccCCCCCCceeeeeccccccc
Q 021490 79 -KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR-GYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY 156 (311)
Q Consensus 79 -~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y 156 (311)
...+++..++.++.||+.||+|||+.+ ++|+||+|+||+++. ++.++|+|||++........ ......++..|
T Consensus 103 ~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~ 177 (295)
T cd07837 103 PGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVK--SYTHEIVTLWY 177 (295)
T ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecccceecCCCcc--ccCCcccccCC
Confidence 356899999999999999999999999 999999999999998 88999999998864322111 11122457789
Q ss_pred cCcccccc-CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHH-HHHhhh----hhccccccccc-cCcc----ccC
Q 021490 157 CAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSL-VAWARP----LFQDRTRHSLI-ADPE----LQG 225 (311)
Q Consensus 157 ~aPE~~~~-~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~-~~~~~~----~~~~~~~~~~~-~~~~----~~~ 225 (311)
+|||.+.+ ..++.++|+||||+++|+|++|..||........... ...... .+......... ..+. ...
T Consensus 178 ~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (295)
T cd07837 178 RAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLS 257 (295)
T ss_pred CChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHH
Confidence 99998764 4578999999999999999999999976544332211 111000 00000000000 0000 000
Q ss_pred CCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 021490 226 QYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 226 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~ 259 (311)
...+..+..+.++|.+||..||.+|||+.+++..
T Consensus 258 ~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 258 RAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred HhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 1112345678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=249.50 Aligned_cols=228 Identities=24% Similarity=0.274 Sum_probs=175.2
Q ss_pred cCCcEEEEEEeecCCCcc---hhHHHHHHH---HHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCC
Q 021490 7 CLLQDVAIKQLDRNGVQG---NREFLVEVL---MLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKK 80 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~~---~~~~~~e~~---~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 80 (311)
.+|+.||+|.+....... ...+..|.. .+....||+|+.+++++......++||||+.|++|.+++.. .+
T Consensus 17 ~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~g~~L~~~l~~----~~ 92 (278)
T cd05606 17 DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ----HG 92 (278)
T ss_pred cCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCCCCcHHHHHHh----cC
Confidence 368899999987653221 123444443 34445799999999999999999999999999999998875 56
Q ss_pred CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcc
Q 021490 81 PLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 160 (311)
Q Consensus 81 ~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE 160 (311)
.+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++....... .....++..|+|||
T Consensus 93 ~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE 165 (278)
T cd05606 93 VFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPE 165 (278)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC----CcCcCCCcCCcCcH
Confidence 7999999999999999999999999 9999999999999999999999999886432111 12235788999999
Q ss_pred ccccC-CCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHH
Q 021490 161 YAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVA 239 (311)
Q Consensus 161 ~~~~~-~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 239 (311)
++.+. .++.++||||+|+++|+|++|..||............... .. ..+ ..+...+..+.+++
T Consensus 166 ~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~---~~--------~~~----~~~~~~s~~~~~li 230 (278)
T cd05606 166 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT---LT--------MAV----ELPDSFSPELRSLL 230 (278)
T ss_pred HhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHh---hc--------cCC----CCCCcCCHHHHHHH
Confidence 98743 6889999999999999999999999765322111111000 00 011 12223345888999
Q ss_pred HHccccCCCCCC-----CHHHHHHHH
Q 021490 240 AMCVHEQPDMRP-----VIADVVTAL 260 (311)
Q Consensus 240 ~~~l~~~p~~Rp-----s~~~vl~~l 260 (311)
.+||..+|.+|| ++.++++.-
T Consensus 231 ~~~l~~~p~~R~~~~~~~~~~ll~~~ 256 (278)
T cd05606 231 EGLLQRDVNRRLGCLGRGAQEVKEHP 256 (278)
T ss_pred HHHhhcCHHhccCCCCCCHHHHHhCc
Confidence 999999999999 999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=252.20 Aligned_cols=231 Identities=29% Similarity=0.394 Sum_probs=180.0
Q ss_pred cCCcEEEEEEeecCCC---cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCC
Q 021490 7 CLLQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLD 83 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~ 83 (311)
.+|..||+|++..... .....+.+|+.+++.++|||++++++++.++...++||||+. |+|.+.+... ...++
T Consensus 48 ~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~~---~~~l~ 123 (317)
T cd06635 48 RTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLEVH---KKPLQ 123 (317)
T ss_pred CCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCC-CCHHHHHHHh---cCCCC
Confidence 3688999999865432 223578889999999999999999999999999999999997 4777776542 45689
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccc
Q 021490 84 WNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 163 (311)
Q Consensus 84 ~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 163 (311)
+..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..... .....++..|+|||.+.
T Consensus 124 ~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~------~~~~~~~~~y~aPE~~~ 194 (317)
T cd06635 124 EVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP------ANSFVGTPYWMAPEVIL 194 (317)
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC------cccccCCccccChhhhh
Confidence 9999999999999999999999 99999999999999999999999998764221 11234678899999873
Q ss_pred ---cCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHH
Q 021490 164 ---TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAA 240 (311)
Q Consensus 164 ---~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 240 (311)
...++.++|+||||+++|+|++|..||.............. ... +. ......+..+.+++.
T Consensus 195 ~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~------~~~-------~~---~~~~~~~~~l~~li~ 258 (317)
T cd06635 195 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ------NES-------PT---LQSNEWSDYFRNFVD 258 (317)
T ss_pred cCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh------ccC-------CC---CCCccccHHHHHHHH
Confidence 45678899999999999999999999876543222111100 000 00 001123346888999
Q ss_pred HccccCCCCCCCHHHHHHHHHHhhhc
Q 021490 241 MCVHEQPDMRPVIADVVTALAYLASQ 266 (311)
Q Consensus 241 ~~l~~~p~~Rps~~~vl~~l~~~~~~ 266 (311)
+||+.+|.+||++.++++.+..+...
T Consensus 259 ~~l~~~p~~Rpt~~~il~~~~~~~~~ 284 (317)
T cd06635 259 SCLQKIPQDRPTSEELLKHMFVLRER 284 (317)
T ss_pred HHccCCcccCcCHHHHHhChhhhccC
Confidence 99999999999999999887655533
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=244.92 Aligned_cols=237 Identities=23% Similarity=0.295 Sum_probs=187.2
Q ss_pred ccCCcEEEEEEeecCCCcchhHHHHHHHHHhcC-CCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCH
Q 021490 6 LCLLQDVAIKQLDRNGVQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 84 (311)
Q Consensus 6 ~~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~ 84 (311)
+.+|+.+|||++.+....+..++.+|++++.+. .|+||+.++++|+++...|||||.+.||+|..++++ ...|++
T Consensus 100 i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGplLshI~~----~~~F~E 175 (463)
T KOG0607|consen 100 IQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPLLSHIQK----RKHFNE 175 (463)
T ss_pred eccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchHHHHHHH----hhhccH
Confidence 457899999999999888889999999999999 599999999999999999999999999999999998 688999
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCc---eEEccccccccCCCCC-----Cceeeeeccccccc
Q 021490 85 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH---PKLSDFGLAKLGPVGD-----NTHVSTRVMGTYGY 156 (311)
Q Consensus 85 ~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~---~~l~df~~~~~~~~~~-----~~~~~~~~~~~~~y 156 (311)
.++..+..+|+.||.|||.+| |.||||||+|||-...+. |||+||++..-..... .........|+..|
T Consensus 176 ~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEf 252 (463)
T KOG0607|consen 176 REASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEF 252 (463)
T ss_pred HHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhh
Confidence 999999999999999999999 999999999999976543 7999998875321111 11112335688899
Q ss_pred cCccccc-----cCCCccccceeehhHHHHHHHhCCCccCcchhHH------------HHHHHHHhhhhhcccccccccc
Q 021490 157 CAPEYAK-----TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA------------EQSLVAWARPLFQDRTRHSLIA 219 (311)
Q Consensus 157 ~aPE~~~-----~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~ 219 (311)
||||+.. ...|+.++|.||||+|+|-|++|.+||.+....+ ...+... +++ ....+.
T Consensus 253 MAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFes----IQE--GkYeFP 326 (463)
T KOG0607|consen 253 MAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFES----IQE--GKYEFP 326 (463)
T ss_pred cchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHH----Hhc--cCCcCC
Confidence 9999763 3467899999999999999999999997544311 1111111 111 111122
Q ss_pred CccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 021490 220 DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 260 (311)
Q Consensus 220 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l 260 (311)
+.. ....+.+..+++...|..|+.+|.++.+++...
T Consensus 327 dkd-----WahIS~eakdlisnLlvrda~~rlsa~~vlnhP 362 (463)
T KOG0607|consen 327 DKD-----WAHISSEAKDLISNLLVRDAKQRLSAAQVLNHP 362 (463)
T ss_pred hhh-----hHHhhHHHHHHHHHHHhccHHhhhhhhhccCCc
Confidence 222 233456778899999999999999999988743
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=252.22 Aligned_cols=236 Identities=22% Similarity=0.284 Sum_probs=177.5
Q ss_pred cCCcEEEEEEeecCCC-cchhHHHHHHHHHhcCC-CCcccceeeEeeeCCeeEEEEecCCCCChhhhhccc-CCCCCCCC
Q 021490 7 CLLQDVAIKQLDRNGV-QGNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDL-SPGKKPLD 83 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~l~ 83 (311)
.+|+.||+|.+..... .....+.+|+.++.++. |+||+++++++..+...+++|||+. ++|.++.... ......++
T Consensus 27 ~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~-~~l~~l~~~~~~~~~~~l~ 105 (288)
T cd06616 27 PSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMD-ISLDKFYKYVYEVLKSVIP 105 (288)
T ss_pred CCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEeccc-CCHHHHHHHHHHhhcCCCC
Confidence 3689999999875443 34467889999999996 9999999999998889999999985 5665543211 11236799
Q ss_pred HHHHHHHHHHHHHHHHHhhcC-CCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccc
Q 021490 84 WNTRMKIAAGAARGLEYLHDK-AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 162 (311)
Q Consensus 84 ~~~~~~~~~~i~~~l~~lh~~-~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 162 (311)
+..+..++.+++.||+|||+. + ++||||+|+||+++.++.++|+|||++....... ......++..|+|||++
T Consensus 106 ~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~ 179 (288)
T cd06616 106 EEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI---AKTRDAGCRPYMAPERI 179 (288)
T ss_pred HHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhccCC---ccccccCccCccCHHHh
Confidence 999999999999999999975 7 9999999999999999999999999986432211 11223467889999998
Q ss_pred ccC---CCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHH
Q 021490 163 KTG---QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVA 239 (311)
Q Consensus 163 ~~~---~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 239 (311)
.+. .++.++||||||+++|+|++|..||........ ... ..... ..+.+....+...+..+.+|+
T Consensus 180 ~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~----~~~~~-------~~~~~~~~~~~~~~~~l~~li 247 (288)
T cd06616 180 DPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFD-QLT----QVVKG-------DPPILSNSEEREFSPSFVNFI 247 (288)
T ss_pred ccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHH-HHh----hhcCC-------CCCcCCCcCCCccCHHHHHHH
Confidence 765 688999999999999999999999976541110 000 00000 011111222233455789999
Q ss_pred HHccccCCCCCCCHHHHHHHHH
Q 021490 240 AMCVHEQPDMRPVIADVVTALA 261 (311)
Q Consensus 240 ~~~l~~~p~~Rps~~~vl~~l~ 261 (311)
.+||+.||++|||+.+++..-.
T Consensus 248 ~~~l~~~p~~Rpt~~~i~~~~~ 269 (288)
T cd06616 248 NLCLIKDESKRPKYKELLEHPF 269 (288)
T ss_pred HHHccCChhhCcCHHHHhcChh
Confidence 9999999999999999997643
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=290.05 Aligned_cols=230 Identities=25% Similarity=0.287 Sum_probs=186.7
Q ss_pred cCCcEEEEEEeecCCC--cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCH
Q 021490 7 CLLQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 84 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~ 84 (311)
.+|.-.|+|.++-... ...+...+|..+|..|+|||+|+++++-.+.+..+|.||||+||+|.+.+.. +...++
T Consensus 1258 ~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~GsLa~ll~~----gri~dE 1333 (1509)
T KOG4645|consen 1258 DTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGSLASLLEH----GRIEDE 1333 (1509)
T ss_pred CccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCcHHHHHHh----cchhhh
Confidence 3688889998765443 3346788999999999999999999999999999999999999999999987 666777
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCc--eeeeeccccccccCcccc
Q 021490 85 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT--HVSTRVMGTYGYCAPEYA 162 (311)
Q Consensus 85 ~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~ 162 (311)
.....+..|++.|++|||++| ||||||||.||+++.+|.+|++|||.+......... .......||+.|||||++
T Consensus 1334 ~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvi 1410 (1509)
T KOG4645|consen 1334 MVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVI 1410 (1509)
T ss_pred hHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhh
Confidence 788889999999999999999 999999999999999999999999999764333211 112346799999999999
Q ss_pred ccC---CCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHH
Q 021490 163 KTG---QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVA 239 (311)
Q Consensus 163 ~~~---~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 239 (311)
.+. .-..++|||||||++.||+||+.||...+..-..- ..+ -..-..++|...+.+..+++
T Consensus 1411 t~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIM--y~V--------------~~gh~Pq~P~~ls~~g~dFl 1474 (1509)
T KOG4645|consen 1411 TGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIM--YHV--------------AAGHKPQIPERLSSEGRDFL 1474 (1509)
T ss_pred cccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHH--hHH--------------hccCCCCCchhhhHhHHHHH
Confidence 764 45678999999999999999999998766421100 000 00111345666777899999
Q ss_pred HHccccCCCCCCCHHHHHHH
Q 021490 240 AMCVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 240 ~~~l~~~p~~Rps~~~vl~~ 259 (311)
..||..||++|+++.|+++.
T Consensus 1475 e~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1475 EHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred HHHHhcCchhhhHHHHHHHh
Confidence 99999999999999988765
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=251.34 Aligned_cols=245 Identities=23% Similarity=0.270 Sum_probs=175.9
Q ss_pred CCcEEEEEEeecCCCc--chhHHHHHHHHHhcCCCCcccceeeEeeeCC--------eeEEEEecCCCCChhhhhcccCC
Q 021490 8 LLQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGD--------QRLLVYEYMPLGSVEDHLHDLSP 77 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--------~~~lv~e~~~~~~L~~~l~~~~~ 77 (311)
+|+.||||.+...... ....+.+|+.+++.++||||+++++++.... ..++||||+. ++|.+.+...
T Consensus 36 ~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~-- 112 (310)
T cd07865 36 TKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCE-HDLAGLLSNK-- 112 (310)
T ss_pred CCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEEEEEcCCC-cCHHHHHHhc--
Confidence 6899999998654322 2345678999999999999999999886543 4599999996 5888877652
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCc--eeeeecccccc
Q 021490 78 GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT--HVSTRVMGTYG 155 (311)
Q Consensus 78 ~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~~ 155 (311)
...+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++......... .......++..
T Consensus 113 -~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~ 188 (310)
T cd07865 113 -NVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLW 188 (310)
T ss_pred -ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCcc
Confidence 346899999999999999999999999 999999999999999999999999998653222111 11122346788
Q ss_pred ccCccccccC-CCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhcccc-----ccccccCccccCCC--
Q 021490 156 YCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRT-----RHSLIADPELQGQY-- 227 (311)
Q Consensus 156 y~aPE~~~~~-~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~-- 227 (311)
|+|||.+.+. .++.++|+||||+++|+|++|..||...........+......+.... .........+....
T Consensus 189 y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (310)
T cd07865 189 YRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKR 268 (310)
T ss_pred ccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccch
Confidence 9999987654 468899999999999999999999977655433333222211110000 00000000000000
Q ss_pred -------ChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 021490 228 -------PPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 228 -------~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~ 259 (311)
+......+.+++.+||..||.+|||+.++++.
T Consensus 269 ~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 269 KVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred hhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 00123466789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=249.20 Aligned_cols=244 Identities=22% Similarity=0.216 Sum_probs=180.8
Q ss_pred CCcEEEEEEeecCC--CcchhHHHHHHHHHhcCCCCcccceeeEeeeC--CeeEEEEecCCCCChhhhhcccCCCCCCCC
Q 021490 8 LLQDVAIKQLDRNG--VQGNREFLVEVLMLSLLHHPNLVNLIGYCADG--DQRLLVYEYMPLGSVEDHLHDLSPGKKPLD 83 (311)
Q Consensus 8 ~g~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~ 83 (311)
+|..+|+|++.... ......+.+|+++++.++|+|++++++++.+. ...++|+||++ ++|.+++... ...++
T Consensus 23 ~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~---~~~~~ 98 (287)
T cd07840 23 TGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMD-HDLTGLLDSP---EVKFT 98 (287)
T ss_pred CCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecccc-ccHHHHHhcc---CCCCC
Confidence 58999999997663 23345788999999999999999999999887 78999999997 5888888652 25799
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccc
Q 021490 84 WNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 163 (311)
Q Consensus 84 ~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 163 (311)
+..++.++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++........ .......++..|+|||.+.
T Consensus 99 ~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~ 174 (287)
T cd07840 99 ESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-ADYTNRVITLWYRPPELLL 174 (287)
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCCc-ccccccccccccCCceeeE
Confidence 9999999999999999999999 99999999999999999999999999875433221 1122234577899999776
Q ss_pred c-CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhh-hhccccc-ccc-----------ccCccccCCCCh
Q 021490 164 T-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARP-LFQDRTR-HSL-----------IADPELQGQYPP 229 (311)
Q Consensus 164 ~-~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~-~~~-----------~~~~~~~~~~~~ 229 (311)
+ ..++.++||||||+++|+|++|..||................. ....... ... .....+...+..
T Consensus 175 ~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (287)
T cd07840 175 GATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKH 254 (287)
T ss_pred ccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcc
Confidence 4 4678999999999999999999999976654333222111100 0000000 000 000000000111
Q ss_pred HhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 021490 230 RGFYQALAVAAMCVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 230 ~~~~~l~~li~~~l~~~p~~Rps~~~vl~~ 259 (311)
..+..+.+++.+||..+|.+|||++++++.
T Consensus 255 ~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 255 LIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 125578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=255.12 Aligned_cols=252 Identities=19% Similarity=0.200 Sum_probs=183.5
Q ss_pred cchhc-cCCcEEEEEEeecCCCcc--------------hhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCC
Q 021490 2 MQVIL-CLLQDVAIKQLDRNGVQG--------------NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLG 66 (311)
Q Consensus 2 ~~~~~-~~g~~vaiK~~~~~~~~~--------------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 66 (311)
|.+.. .+|+.||||+++...... ...+.+|+.+++.++|+||+++++++..+...++||||+. +
T Consensus 26 y~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~ 104 (335)
T PTZ00024 26 EKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMA-S 104 (335)
T ss_pred EEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCCcEEEEEeccc-c
Confidence 34443 368999999986543222 1257789999999999999999999999999999999996 6
Q ss_pred ChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCC----
Q 021490 67 SVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD---- 142 (311)
Q Consensus 67 ~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~---- 142 (311)
+|.+++.. ...+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 105 ~l~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl~dfg~~~~~~~~~~~~~ 177 (335)
T PTZ00024 105 DLKKVVDR----KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDT 177 (335)
T ss_pred CHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEECCccceeeccccccccc
Confidence 89998876 567999999999999999999999999 9999999999999999999999999886533110
Q ss_pred --------CceeeeeccccccccCccccccC-CCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhh-hhhc--
Q 021490 143 --------NTHVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWAR-PLFQ-- 210 (311)
Q Consensus 143 --------~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~-~~~~-- 210 (311)
.........++..|+|||.+.+. .++.++|+||||+++|+|++|..||...........+.... ....
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~ 257 (335)
T PTZ00024 178 LSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDN 257 (335)
T ss_pred ccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCchhh
Confidence 00111122357789999988653 46889999999999999999999998665443322111110 0000
Q ss_pred --ccccc------ccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 021490 211 --DRTRH------SLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAY 262 (311)
Q Consensus 211 --~~~~~------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l~~ 262 (311)
..... .....+.+ .......+..+.+++.+||..+|++|||+++++....+
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~ 316 (335)
T PTZ00024 258 WPQAKKLPLYTEFTPRKPKDL-KTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYF 316 (335)
T ss_pred CcchhhcccccccCcCCcccH-HHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCccc
Confidence 00000 00000000 01112234578899999999999999999999986543
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=256.30 Aligned_cols=222 Identities=28% Similarity=0.367 Sum_probs=181.8
Q ss_pred CCcEEEEEEeecCCC---cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCH
Q 021490 8 LLQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 84 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~ 84 (311)
.|+-+|.|.+.++.. ......++|-.+|..++.++||.+-.+|.+.+.+|+|+..|+||+|.-++.+.. +..|++
T Consensus 209 TGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGGDLkfHiyn~g--~~gF~e 286 (591)
T KOG0986|consen 209 TGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGGDLKFHIYNHG--NPGFDE 286 (591)
T ss_pred chhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCCceeEEeeccC--CCCCch
Confidence 567777777766543 233567789999999999999999999999999999999999999999998743 468999
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccccc
Q 021490 85 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT 164 (311)
Q Consensus 85 ~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 164 (311)
..+..++.+|+.||++||+.+ ||+||+||+|||+++.|+|+|+|+|++..+... ......+||.+|||||++..
T Consensus 287 ~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g---~~~~~rvGT~GYMAPEvl~n 360 (591)
T KOG0986|consen 287 QRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPEG---KPIRGRVGTVGYMAPEVLQN 360 (591)
T ss_pred HHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCCC---CccccccCcccccCHHHHcC
Confidence 999999999999999999999 999999999999999999999999999754433 22334489999999999999
Q ss_pred CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccc
Q 021490 165 GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVH 244 (311)
Q Consensus 165 ~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 244 (311)
..|+...|+|||||++|+|+.|+.||..........-+.. ... .+ ...++...++++.+|+...|+
T Consensus 361 e~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdr--r~~---------~~---~~ey~~kFS~eakslc~~LL~ 426 (591)
T KOG0986|consen 361 EVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDR--RTL---------ED---PEEYSDKFSEEAKSLCEGLLT 426 (591)
T ss_pred CcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHH--HHh---------cc---hhhcccccCHHHHHHHHHHHc
Confidence 9999999999999999999999999976544322211110 001 11 123455667789999999999
Q ss_pred cCCCCCC
Q 021490 245 EQPDMRP 251 (311)
Q Consensus 245 ~~p~~Rp 251 (311)
.||.+|.
T Consensus 427 Kdp~~RL 433 (591)
T KOG0986|consen 427 KDPEKRL 433 (591)
T ss_pred cCHHHhc
Confidence 9999995
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=285.89 Aligned_cols=244 Identities=29% Similarity=0.502 Sum_probs=183.8
Q ss_pred cchhc-cCCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCC
Q 021490 2 MQVIL-CLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKK 80 (311)
Q Consensus 2 ~~~~~-~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 80 (311)
|++.. .+|..||+|.++.... ....|++.+++++||||+++++++.+....++||||+++|+|.+++..
T Consensus 707 y~~~~~~~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~------ 776 (968)
T PLN00113 707 YKGKSIKNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------ 776 (968)
T ss_pred EEEEECCCCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc------
Confidence 44444 5789999999864332 123468899999999999999999999999999999999999999963
Q ss_pred CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcc
Q 021490 81 PLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 160 (311)
Q Consensus 81 ~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE 160 (311)
+++..+..++.+++.||+|||....++++||||||+||+++.++..++. |+....... .....++..|+|||
T Consensus 777 -l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~------~~~~~~t~~y~aPE 848 (968)
T PLN00113 777 -LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT------DTKCFISSAYVAPE 848 (968)
T ss_pred -CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc------CCCccccccccCcc
Confidence 7899999999999999999994422339999999999999988877765 444322111 11225678999999
Q ss_pred ccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccC--CCChHhHHHHHHH
Q 021490 161 YAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQG--QYPPRGFYQALAV 238 (311)
Q Consensus 161 ~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~l 238 (311)
++.+..++.++|||||||++|||++|+.||+.... .......|........ ......++.+.. ..+.....++.++
T Consensus 849 ~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l 926 (968)
T PLN00113 849 TRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDC-HLDMWIDPSIRGDVSVNQNEIVEVMNL 926 (968)
T ss_pred cccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCcc-chhheeCccccCCCCccHHHHHHHHHH
Confidence 99989999999999999999999999999954321 1222333333222211 122233444322 2344566778899
Q ss_pred HHHccccCCCCCCCHHHHHHHHHHhhh
Q 021490 239 AAMCVHEQPDMRPVIADVVTALAYLAS 265 (311)
Q Consensus 239 i~~~l~~~p~~Rps~~~vl~~l~~~~~ 265 (311)
+.+||+.||++|||+.++++.|+.+.+
T Consensus 927 ~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 927 ALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred HHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 999999999999999999999987754
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=244.80 Aligned_cols=221 Identities=29% Similarity=0.336 Sum_probs=179.7
Q ss_pred CCcEEEEEEeecCCCc---chhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCH
Q 021490 8 LLQDVAIKQLDRNGVQ---GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 84 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~ 84 (311)
+|+.+|+|++...... ....+.+|+.+++.++|+||+++++.+..+...++||||+++++|.+++.. ...+++
T Consensus 17 ~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~----~~~l~~ 92 (250)
T cd05123 17 TGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSK----EGRFSE 92 (250)
T ss_pred CCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcHHHHHHh----cCCCCH
Confidence 5899999998765432 345788999999999999999999999999999999999999999999986 457899
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccccc
Q 021490 85 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT 164 (311)
Q Consensus 85 ~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 164 (311)
..+..++.|++.||.|||+.+ ++|+||+|.||+++.++.++|+|||.+....... .......++..|++||.+.+
T Consensus 93 ~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~Pe~~~~ 167 (250)
T cd05123 93 ERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFCGTPEYLAPEVLLG 167 (250)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCCcCCccccChHHhCC
Confidence 999999999999999999999 9999999999999999999999999986532221 11223456788999999988
Q ss_pred CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccc
Q 021490 165 GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVH 244 (311)
Q Consensus 165 ~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 244 (311)
...+.++|+||||+++|+|++|..||...+........ ... . ..++...+..+.+++.+||.
T Consensus 168 ~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~------~~~--------~----~~~~~~~~~~l~~~i~~~l~ 229 (250)
T cd05123 168 KGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKI------LKD--------P----LRFPEFLSPEARDLISGLLQ 229 (250)
T ss_pred CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH------hcC--------C----CCCCCCCCHHHHHHHHHHhc
Confidence 88899999999999999999999999765542221111 000 0 01222224578899999999
Q ss_pred cCCCCCCCHHH
Q 021490 245 EQPDMRPVIAD 255 (311)
Q Consensus 245 ~~p~~Rps~~~ 255 (311)
.||++||++.+
T Consensus 230 ~~p~~R~~~~~ 240 (250)
T cd05123 230 KDPTKRLGSGG 240 (250)
T ss_pred CCHhhCCCccc
Confidence 99999999943
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=263.56 Aligned_cols=226 Identities=23% Similarity=0.331 Sum_probs=186.0
Q ss_pred EEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHHHHHHH
Q 021490 12 VAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIA 91 (311)
Q Consensus 12 vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~ 91 (311)
.|.|++.-.+....++|+-|+++|...+||+|+++++.|..+..++++.|||.||-++..+-.. +..|+++++.-++
T Consensus 60 AAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDaimlEL---~r~LtE~QIqvvc 136 (1187)
T KOG0579|consen 60 AAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDAIMLEL---GRVLTEDQIQVVC 136 (1187)
T ss_pred hhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHhHHHHHh---ccccchHHHHHHH
Confidence 4567776667777889999999999999999999999999999999999999999999887763 6789999999999
Q ss_pred HHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccc-----ccCC
Q 021490 92 AGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA-----KTGQ 166 (311)
Q Consensus 92 ~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-----~~~~ 166 (311)
+|++.||.|||+++ |+|||||..|||++-+|.|+|.|||.+.. ............||+.|||||+. .+.+
T Consensus 137 ~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAK--n~~t~qkRDsFIGTPYWMAPEVvmCET~KD~P 211 (1187)
T KOG0579|consen 137 YQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAK--NKSTRQKRDSFIGTPYWMAPEVVMCETFKDQP 211 (1187)
T ss_pred HHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeeccccccc--chhHHhhhccccCCcccccchheeeccccCCC
Confidence 99999999999999 99999999999999999999999998753 22222334456899999999975 4678
Q ss_pred CccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccC
Q 021490 167 LTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQ 246 (311)
Q Consensus 167 ~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 246 (311)
|+.++||||||+++.+|..+.+|....+.....-.+.... .|.+ --|..++-...+++..||..|
T Consensus 212 YDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSe-------------PPTL--lqPS~Ws~~F~DfLk~cL~Kn 276 (1187)
T KOG0579|consen 212 YDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE-------------PPTL--LQPSHWSRSFSDFLKRCLVKN 276 (1187)
T ss_pred chhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcC-------------CCcc--cCcchhhhHHHHHHHHHHhcC
Confidence 9999999999999999999999987766543322221111 1111 113445567788999999999
Q ss_pred CCCCCCHHHHHHHH
Q 021490 247 PDMRPVIADVVTAL 260 (311)
Q Consensus 247 p~~Rps~~~vl~~l 260 (311)
|..||++.++++..
T Consensus 277 p~~Rp~aaqll~Hp 290 (1187)
T KOG0579|consen 277 PRNRPPAAQLLKHP 290 (1187)
T ss_pred CccCCCHHHHhhCc
Confidence 99999999998654
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=260.49 Aligned_cols=225 Identities=32% Similarity=0.400 Sum_probs=184.9
Q ss_pred cCCcEEEEEEeecCCCcc---hhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCC
Q 021490 7 CLLQDVAIKQLDRNGVQG---NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLD 83 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~ 83 (311)
.+...||||++.-....+ ..+++.|+..|++++|||++.+-+.|..+...+||||||- |+-.+.+.-. .+++.
T Consensus 49 ~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYCl-GSAsDlleVh---kKplq 124 (948)
T KOG0577|consen 49 RNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDLLEVH---KKPLQ 124 (948)
T ss_pred CccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHh-ccHHHHHHHH---hccch
Confidence 367889999986544433 3578889999999999999999999999999999999995 6777776542 57899
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccc
Q 021490 84 WNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 163 (311)
Q Consensus 84 ~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 163 (311)
+.++..|+.+.+.||+|||+.+ .+|||||..|||+++.|.|||+|||.+... ...+..+||+.|||||++.
T Consensus 125 EvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~------~PAnsFvGTPywMAPEVIL 195 (948)
T KOG0577|consen 125 EVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIM------APANSFVGTPYWMAPEVIL 195 (948)
T ss_pred HHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhc------CchhcccCCccccchhHhe
Confidence 9999999999999999999999 999999999999999999999999988643 2334567999999999884
Q ss_pred ---cCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHH
Q 021490 164 ---TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAA 240 (311)
Q Consensus 164 ---~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 240 (311)
.+.|+-++||||||++..||..+++|+-..+.......+.. +. .|.+. ....+.....++.
T Consensus 196 AMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQ------Ne-------sPtLq---s~eWS~~F~~Fvd 259 (948)
T KOG0577|consen 196 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ------NE-------SPTLQ---SNEWSDYFRNFVD 259 (948)
T ss_pred eccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHh------cC-------CCCCC---CchhHHHHHHHHH
Confidence 47899999999999999999999999876665444332211 11 12221 3456778889999
Q ss_pred HccccCCCCCCCHHHHHHHH
Q 021490 241 MCVHEQPDMRPVIADVVTAL 260 (311)
Q Consensus 241 ~~l~~~p~~Rps~~~vl~~l 260 (311)
.||++-|.+|||.++++..-
T Consensus 260 ~CLqKipqeRptse~ll~H~ 279 (948)
T KOG0577|consen 260 SCLQKIPQERPTSEELLKHR 279 (948)
T ss_pred HHHhhCcccCCcHHHHhhcc
Confidence 99999999999999988543
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=250.13 Aligned_cols=233 Identities=26% Similarity=0.350 Sum_probs=185.0
Q ss_pred cchhcc-CCcEEEEEEeecCCC---cchhHHHHHHHHHhcCC-CCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccC
Q 021490 2 MQVILC-LLQDVAIKQLDRNGV---QGNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLS 76 (311)
Q Consensus 2 ~~~~~~-~g~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 76 (311)
|.+... +|+.||+|++..... .....+.+|+.++..++ ||||+++++++.++...++|||++++++|.+++..
T Consensus 18 y~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-- 95 (280)
T cd05581 18 VLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRK-- 95 (280)
T ss_pred EEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCCCCcHHHHHHH--
Confidence 334443 799999999865332 23467888999999998 99999999999999999999999999999999986
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCc------------
Q 021490 77 PGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT------------ 144 (311)
Q Consensus 77 ~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~------------ 144 (311)
...+++..++.++.|++.||.+||+.+ ++|+||+|+||+++.++.++++|||++.........
T Consensus 96 --~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~ 170 (280)
T cd05581 96 --YGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDS 170 (280)
T ss_pred --cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCCccccccCCCCCccccc
Confidence 457999999999999999999999999 999999999999999999999999998653322210
Q ss_pred ------eeeeeccccccccCccccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccc
Q 021490 145 ------HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLI 218 (311)
Q Consensus 145 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 218 (311)
.......++..|++||+.....++.++|+||||+++|++++|..||............ ...
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~------~~~------- 237 (280)
T cd05581 171 QIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKI------LKL------- 237 (280)
T ss_pred cccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH------Hhc-------
Confidence 1112234678899999988888899999999999999999999999876532211111 000
Q ss_pred cCccccCCCChHhHHHHHHHHHHccccCCCCCCCH----HHHHHH
Q 021490 219 ADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVI----ADVVTA 259 (311)
Q Consensus 219 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~----~~vl~~ 259 (311)
....+...+..+.+++.+||+.+|.+|||+ ++++..
T Consensus 238 -----~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 238 -----EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred -----CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 011222334578899999999999999999 777653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=259.50 Aligned_cols=209 Identities=24% Similarity=0.404 Sum_probs=171.5
Q ss_pred chhHHHHHHHHHhcCCCCcccceeeEeeeCCe--eEEEEecCCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 021490 24 GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ--RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYL 101 (311)
Q Consensus 24 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~l 101 (311)
..++|..|+.+|+.|+||||+++|+++.+... ..+|+|++.+|+|..|+.. .+.+....+..|+.||++||.||
T Consensus 84 ~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y~kk----~~~vn~kaik~W~RQILkGL~yL 159 (632)
T KOG0584|consen 84 ELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELFTSGTLREYRKK----HRRVNIKAIKSWCRQILKGLVYL 159 (632)
T ss_pred HHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecccCCcHHHHHHH----hccCCHHHHHHHHHHHHHHhhhh
Confidence 34789999999999999999999999976554 7899999999999999998 67899999999999999999999
Q ss_pred hcCCCCCeEeeccCCCeEEEcC-CCceEEccccccccCCCCCCceeeeeccccccccCccccccCCCccccceeehhHHH
Q 021490 102 HDKAKPPVIYRDLKCSNILLDR-GYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVL 180 (311)
Q Consensus 102 h~~~~~~i~h~dl~p~nil~~~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~l~ 180 (311)
|++ .+||+|||||-+||||+. -|.|||+|+|++....... .....||+.|||||+.. ..|++.+||||||+.+
T Consensus 160 Hs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCm 233 (632)
T KOG0584|consen 160 HSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCM 233 (632)
T ss_pred hcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhccc----cceeccCccccChHHHh-hhcchhhhhhhhhHHH
Confidence 999 689999999999999986 5889999999997643322 22267999999999987 8999999999999999
Q ss_pred HHHHhCCCccCcchhHHHH--HHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 021490 181 LEILSGRKAVDTSKAAAEQ--SLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 258 (311)
Q Consensus 181 ~~ll~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~ 258 (311)
.||+|+..||......... .+.....|. ......| .++.+||.+||.. ..+|||+.|+|.
T Consensus 234 LEMvT~eYPYsEC~n~AQIYKKV~SGiKP~-----sl~kV~d------------Pevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 234 LEMVTSEYPYSECTNPAQIYKKVTSGIKPA-----ALSKVKD------------PEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred HHHHhccCChhhhCCHHHHHHHHHcCCCHH-----HhhccCC------------HHHHHHHHHHhcC-chhccCHHHHhh
Confidence 9999999999776554332 111111110 0111112 2677899999999 999999999997
Q ss_pred HH
Q 021490 259 AL 260 (311)
Q Consensus 259 ~l 260 (311)
.-
T Consensus 296 d~ 297 (632)
T KOG0584|consen 296 DP 297 (632)
T ss_pred Ch
Confidence 63
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=259.57 Aligned_cols=226 Identities=24% Similarity=0.307 Sum_probs=186.3
Q ss_pred CCcEEEEEEeecCCC--cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHH
Q 021490 8 LLQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN 85 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~ 85 (311)
.|..||||++++... .....+.+|+++|..|+||||++++.+......+|+||||+.+|.+++++.. .+...+.
T Consensus 80 t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~ge~~~yl~~----~gr~~e~ 155 (596)
T KOG0586|consen 80 TGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASGGELFDYLVK----HGRMKEK 155 (596)
T ss_pred CCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccCchhHHHHHh----cccchhh
Confidence 588999999977532 3345688999999999999999999999999999999999999999999998 6778889
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccC
Q 021490 86 TRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG 165 (311)
Q Consensus 86 ~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 165 (311)
.+..++.|+.+|++|||+++ |+|||||++|+|++.+-++||+|||++.... .........|++.|.|||++.+.
T Consensus 156 ~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~---~~~~lqt~cgsppyAaPEl~~g~ 229 (596)
T KOG0586|consen 156 EARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFD---YGLMLQTFCGSPPYAAPELFNGK 229 (596)
T ss_pred hhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeec---ccccccccCCCCCccChHhhcCc
Confidence 99999999999999999999 9999999999999999999999999998543 23334456799999999999886
Q ss_pred CC-ccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccc
Q 021490 166 QL-TLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVH 244 (311)
Q Consensus 166 ~~-~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 244 (311)
.+ ++.+|+||+|+++|.|+.|..||++...... ..+.....+ .++.-.+.++-++|+++|-
T Consensus 230 ~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~L-----------r~rvl~gk~-------rIp~~ms~dce~lLrk~lv 291 (596)
T KOG0586|consen 230 KYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKEL-----------RPRVLRGKY-------RIPFYMSCDCEDLLRKFLV 291 (596)
T ss_pred ccCCcceehhhhhhhheeeeecccccCCcccccc-----------cchheeeee-------cccceeechhHHHHHHhhc
Confidence 65 6899999999999999999999987543211 111111111 1122223466779999999
Q ss_pred cCCCCCCCHHHHHHHHH
Q 021490 245 EQPDMRPVIADVVTALA 261 (311)
Q Consensus 245 ~~p~~Rps~~~vl~~l~ 261 (311)
.+|.+|++..++.+.-+
T Consensus 292 l~Pskr~~~dqim~~~W 308 (596)
T KOG0586|consen 292 LNPSKRGPCDQIMKDRW 308 (596)
T ss_pred cCccccCCHHHhhhhcc
Confidence 99999999999886643
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=245.12 Aligned_cols=249 Identities=22% Similarity=0.258 Sum_probs=179.7
Q ss_pred cchhcc-CCcEEEEEEeecCCCcc--hhHHHHHHHHHhcC---CCCcccceeeEeeeCCe-----eEEEEecCCCCChhh
Q 021490 2 MQVILC-LLQDVAIKQLDRNGVQG--NREFLVEVLMLSLL---HHPNLVNLIGYCADGDQ-----RLLVYEYMPLGSVED 70 (311)
Q Consensus 2 ~~~~~~-~g~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~-----~~lv~e~~~~~~L~~ 70 (311)
|.+... +|+.||+|+++...... ...+.+|+.+++.+ +|+|++++++++..... .+++|||+. ++|.+
T Consensus 16 ~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~-~~l~~ 94 (287)
T cd07838 16 YKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVD-QDLAT 94 (287)
T ss_pred EEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEEEehhcc-cCHHH
Confidence 334444 58999999996543322 24566787777666 59999999999987776 899999997 58988
Q ss_pred hhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeec
Q 021490 71 HLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRV 150 (311)
Q Consensus 71 ~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~ 150 (311)
++.... ...+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 95 ~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~~---~~~~~ 166 (287)
T cd07838 95 YLSKCP--KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEM---ALTSV 166 (287)
T ss_pred HHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcceeccCCc---ccccc
Confidence 887632 236899999999999999999999999 9999999999999999999999999886532221 11223
Q ss_pred cccccccCccccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHH-hhhhhccccccccc-----cC---c
Q 021490 151 MGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAW-ARPLFQDRTRHSLI-----AD---P 221 (311)
Q Consensus 151 ~~~~~y~aPE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~-----~~---~ 221 (311)
.++..|+|||.+.+..++.++|+||||+++|+|++|.+||......+....+.. .............. .. +
T Consensus 167 ~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (287)
T cd07838 167 VVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTP 246 (287)
T ss_pred cccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchhhcccccc
Confidence 467889999999888899999999999999999999999976554332221110 00000000000000 00 0
Q ss_pred cccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 021490 222 ELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 222 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~ 259 (311)
.......+.....+.+++.+||+.||.+||++.+++..
T Consensus 247 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 247 RSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred cchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 00011112345678899999999999999999999854
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=241.86 Aligned_cols=229 Identities=23% Similarity=0.264 Sum_probs=178.3
Q ss_pred cCCcEEEEEEeecCC-----CcchhHHHHHHHHHhcCCCCcccceeeEeeeC--CeeEEEEecCCCCChhhhhcccCCCC
Q 021490 7 CLLQDVAIKQLDRNG-----VQGNREFLVEVLMLSLLHHPNLVNLIGYCADG--DQRLLVYEYMPLGSVEDHLHDLSPGK 79 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~ 79 (311)
.+|..||+|.+.... ......+.+|+++++.++|+||+++++.+.+. ...++++||+++++|.+++.. .
T Consensus 25 ~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~----~ 100 (264)
T cd06653 25 DTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKA----Y 100 (264)
T ss_pred CCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEEEeCCCCcHHHHHHH----c
Confidence 368999999875321 12335788999999999999999999998664 468899999999999999876 4
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCc-eeeeeccccccccC
Q 021490 80 KPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT-HVSTRVMGTYGYCA 158 (311)
Q Consensus 80 ~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~y~a 158 (311)
..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......... .......++..|+|
T Consensus 101 ~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~a 177 (264)
T cd06653 101 GALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMS 177 (264)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccccccccccCccccccCCcccccC
Confidence 56899999999999999999999999 999999999999999999999999998753221111 11122347888999
Q ss_pred ccccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHH
Q 021490 159 PEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAV 238 (311)
Q Consensus 159 PE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 238 (311)
||.+.+..++.++|+||||+++|+|++|..||......... ... ... ......+......+.++
T Consensus 178 PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~~~----~~~----------~~~~~~p~~~~~~~~~~ 241 (264)
T cd06653 178 PEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAI--FKI----ATQ----------PTKPMLPDGVSDACRDF 241 (264)
T ss_pred HhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHH--HHH----HcC----------CCCCCCCcccCHHHHHH
Confidence 99998888899999999999999999999999765332211 110 000 00112334455678899
Q ss_pred HHHccccCCCCCCCHHHHHHH
Q 021490 239 AAMCVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 239 i~~~l~~~p~~Rps~~~vl~~ 259 (311)
+.+||. +|..|||+.+++..
T Consensus 242 i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 242 LKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred HHHHhc-CcccCccHHHHhcC
Confidence 999999 57999999988753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=248.26 Aligned_cols=249 Identities=24% Similarity=0.261 Sum_probs=178.3
Q ss_pred chhcc-CCcEEEEEEeecCCC--cchhHHHHHHHHHhcCCCCcccceeeEeeeCC----------eeEEEEecCCCCChh
Q 021490 3 QVILC-LLQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGD----------QRLLVYEYMPLGSVE 69 (311)
Q Consensus 3 ~~~~~-~g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----------~~~lv~e~~~~~~L~ 69 (311)
.+... +|+.||+|+++.... .....+.+|+.+++.++||||+++++++.+.. ..++|+||+++ +|.
T Consensus 25 ~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~ 103 (302)
T cd07864 25 KARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLM 103 (302)
T ss_pred EEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcEEEEEcccCc-cHH
Confidence 33443 588999999975432 23356778999999999999999999987654 78999999975 777
Q ss_pred hhhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeee
Q 021490 70 DHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTR 149 (311)
Q Consensus 70 ~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~ 149 (311)
..+... ...+++..++.++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++........ .....
T Consensus 104 ~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~ 176 (302)
T cd07864 104 GLLESG---LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEES-RPYTN 176 (302)
T ss_pred HHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeCcccccccccCCcc-ccccc
Confidence 776652 356899999999999999999999999 99999999999999999999999999875432221 11122
Q ss_pred ccccccccCcccccc-CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhh-hhhc----cccccccc--cCc
Q 021490 150 VMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWAR-PLFQ----DRTRHSLI--ADP 221 (311)
Q Consensus 150 ~~~~~~y~aPE~~~~-~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~-~~~~----~~~~~~~~--~~~ 221 (311)
..++..|+|||.+.+ ..++.++|||||||++|+|++|..||...........+.... .... ........ .++
T Consensus 177 ~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (302)
T cd07864 177 KVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKP 256 (302)
T ss_pred ceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccccccccccc
Confidence 235678999998764 456889999999999999999999997655433322221110 0000 00000000 000
Q ss_pred --ccc---CCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 021490 222 --ELQ---GQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 222 --~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~ 259 (311)
... .......+..+.+++.+||+.||.+|||+.+++..
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 257 KKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred ccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000 00011224578899999999999999999998864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=246.27 Aligned_cols=243 Identities=24% Similarity=0.272 Sum_probs=181.2
Q ss_pred CCcEEEEEEeecCC--CcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHH
Q 021490 8 LLQDVAIKQLDRNG--VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN 85 (311)
Q Consensus 8 ~g~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~ 85 (311)
+|+.||+|+++... ....+.+.+|+.+++.++|+|++++++++.+....++|+||++ ++|.+++... ...+++.
T Consensus 23 ~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~i~~~---~~~~~~~ 98 (282)
T cd07829 23 TGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-MDLKKYLDKR---PGPLSPN 98 (282)
T ss_pred CCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-cCHHHHHHhh---ccCCCHH
Confidence 58999999997654 2334678889999999999999999999999999999999997 5899999862 1579999
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccC
Q 021490 86 TRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG 165 (311)
Q Consensus 86 ~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 165 (311)
.+..++.+++.||++||+.+ ++|+||+|+||++++++.++|+|||++........ .......+..|+|||.+...
T Consensus 99 ~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~ 173 (282)
T cd07829 99 LIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR--TYTHEVVTLWYRAPEILLGS 173 (282)
T ss_pred HHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc--ccCccccCcCcCChHHhcCC
Confidence 99999999999999999999 99999999999999999999999999865322211 11223356789999988765
Q ss_pred -CCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHh-h-------hhhcccc---ccccccCccccCCCChHhHH
Q 021490 166 -QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWA-R-------PLFQDRT---RHSLIADPELQGQYPPRGFY 233 (311)
Q Consensus 166 -~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~-~-------~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 233 (311)
.++.++|+||||+++|+|++|..||...........+... . ..+.... ...............+....
T Consensus 174 ~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (282)
T cd07829 174 KHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDP 253 (282)
T ss_pred cCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccH
Confidence 7889999999999999999999999766543322111100 0 0000000 00000000000001112255
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHH
Q 021490 234 QALAVAAMCVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 234 ~l~~li~~~l~~~p~~Rps~~~vl~~ 259 (311)
.+.+++.+||..||.+||++.+++..
T Consensus 254 ~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 254 EGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred HHHHHHHHhhccCcccCCCHHHHhhC
Confidence 78999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=246.53 Aligned_cols=242 Identities=20% Similarity=0.232 Sum_probs=182.5
Q ss_pred CCcEEEEEEeecCCCcchhHHHHHHHHHhcCC-C-Cc----ccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCC
Q 021490 8 LLQDVAIKQLDRNGVQGNREFLVEVLMLSLLH-H-PN----LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKP 81 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h-~~----i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 81 (311)
.+..||||+++.. ....+..+-|+++|.++. + |+ ++.+.++|....+.|+|+|.+ |-|+.+++... ...+
T Consensus 113 ~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivfell-G~S~~dFlk~N--~y~~ 188 (415)
T KOG0671|consen 113 TKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVFELL-GLSTFDFLKEN--NYIP 188 (415)
T ss_pred CCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEEecc-ChhHHHHhccC--Cccc
Confidence 4688999988533 344566677999999993 2 33 777888899999999999998 67999999873 3567
Q ss_pred CCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEc--------------------CCCceEEccccccccCCCC
Q 021490 82 LDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD--------------------RGYHPKLSDFGLAKLGPVG 141 (311)
Q Consensus 82 l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~--------------------~~~~~~l~df~~~~~~~~~ 141 (311)
++...+..+.+|++.+++|||+.+ ++|-||||+|||+. .+..|+++|||.+......
T Consensus 189 fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~ 265 (415)
T KOG0671|consen 189 FPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEH 265 (415)
T ss_pred cchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccC
Confidence 999999999999999999999999 99999999999993 1345899999999753322
Q ss_pred CCceeeeeccccccccCccccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhcccccccc----
Q 021490 142 DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSL---- 217 (311)
Q Consensus 142 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 217 (311)
. ...+.|..|.|||++.+.+++..+||||+|||++|+++|...|.+-+..+...+.+-....++.......
T Consensus 266 h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~K 340 (415)
T KOG0671|consen 266 H-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEK 340 (415)
T ss_pred c-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHh
Confidence 2 3456788999999999999999999999999999999999999887766654333222111111000000
Q ss_pred -----ccC-c------------------cccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 021490 218 -----IAD-P------------------ELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 261 (311)
Q Consensus 218 -----~~~-~------------------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l~ 261 (311)
..| + .........+..+|++|+.+||.+||.+|+|+.|++..--
T Consensus 341 yf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~HpF 408 (415)
T KOG0671|consen 341 YFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALSHPF 408 (415)
T ss_pred hhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhcCHH
Confidence 000 0 0001112344567999999999999999999999997743
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=253.73 Aligned_cols=245 Identities=24% Similarity=0.292 Sum_probs=176.4
Q ss_pred cCCcEEEEEEeecCCC-cchhHHHHHHHHHhcCCCCcccceeeEeeeC-----CeeEEEEecCCCCChhhhhcccCCCCC
Q 021490 7 CLLQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADG-----DQRLLVYEYMPLGSVEDHLHDLSPGKK 80 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~ 80 (311)
.+|+.||+|+++.... .....+.+|+.+++.++|+||+++++++... ...++|+||+. ++|.+.+.. .
T Consensus 28 ~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-----~ 101 (336)
T cd07849 28 PTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELME-TDLYKLIKT-----Q 101 (336)
T ss_pred CCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEehhcc-cCHHHHHhc-----C
Confidence 4789999999864332 3446788899999999999999999987544 35799999996 588877764 5
Q ss_pred CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCC-ceeeeeccccccccCc
Q 021490 81 PLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN-THVSTRVMGTYGYCAP 159 (311)
Q Consensus 81 ~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~y~aP 159 (311)
.+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++........ ........++..|+||
T Consensus 102 ~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aP 178 (336)
T cd07849 102 HLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAP 178 (336)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceeeccccccccCCcCCcCcCCCccCh
Confidence 6999999999999999999999999 99999999999999999999999999865322111 1111224578889999
Q ss_pred ccccc-CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhh-h--------hcccccc--ccc-cCcccc-C
Q 021490 160 EYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARP-L--------FQDRTRH--SLI-ADPELQ-G 225 (311)
Q Consensus 160 E~~~~-~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~-~--------~~~~~~~--~~~-~~~~~~-~ 225 (311)
|.+.+ ..++.++||||||+++|+|++|+.||...+............. . ....... ... ..+... .
T Consensus 179 E~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (336)
T cd07849 179 EIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWN 258 (336)
T ss_pred HHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHH
Confidence 98654 5688999999999999999999999976543222111100000 0 0000000 000 000000 0
Q ss_pred CCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 021490 226 QYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 260 (311)
Q Consensus 226 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l 260 (311)
...+..+..+.+++.+||+.||.+|||+.++++.-
T Consensus 259 ~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp 293 (336)
T cd07849 259 KLFPNADPKALDLLDKMLTFNPHKRITVEEALAHP 293 (336)
T ss_pred HHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCc
Confidence 00112345788999999999999999999999873
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=247.21 Aligned_cols=229 Identities=30% Similarity=0.373 Sum_probs=177.6
Q ss_pred cCCcEEEEEEeecCCC---cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCC
Q 021490 7 CLLQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLD 83 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~ 83 (311)
.+|..+|+|.+..... ....++.+|+++++.++|+|++++++++......++||||+. ++|.+.+... ...++
T Consensus 38 ~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~---~~~l~ 113 (308)
T cd06634 38 RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVH---KKPLQ 113 (308)
T ss_pred CCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccC-CCHHHHHHHc---CCCCC
Confidence 3678899999864322 233578889999999999999999999999999999999996 5777776541 35689
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccc
Q 021490 84 WNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 163 (311)
Q Consensus 84 ~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 163 (311)
+..+..++.+++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++..... .....++..|+|||.+.
T Consensus 114 ~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~------~~~~~~~~~y~aPE~~~ 184 (308)
T cd06634 114 EVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANXFVGTPYWMAPEVIL 184 (308)
T ss_pred HHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecC------cccccCCccccCHHHHh
Confidence 9999999999999999999999 99999999999999999999999998764321 11234678899999874
Q ss_pred ---cCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHH
Q 021490 164 ---TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAA 240 (311)
Q Consensus 164 ---~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 240 (311)
...++.++|||||||++|+|++|..||............. ... .+. ......+..+.+++.
T Consensus 185 ~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~------~~~-------~~~---~~~~~~~~~~~~li~ 248 (308)
T cd06634 185 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA------QNE-------SPA---LQSGHWSEYFRNFVD 248 (308)
T ss_pred hcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHh------hcC-------CCC---cCcccccHHHHHHHH
Confidence 3567889999999999999999999986654322211110 000 000 011223456888999
Q ss_pred HccccCCCCCCCHHHHHHHHHHhh
Q 021490 241 MCVHEQPDMRPVIADVVTALAYLA 264 (311)
Q Consensus 241 ~~l~~~p~~Rps~~~vl~~l~~~~ 264 (311)
+||..+|++||++.+++.......
T Consensus 249 ~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 249 SCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred HHhhCCcccCCCHHHHhhCccccc
Confidence 999999999999999998865444
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=252.96 Aligned_cols=244 Identities=22% Similarity=0.281 Sum_probs=179.6
Q ss_pred cCCcEEEEEEeecCC--CcchhHHHHHHHHHhcCCCCcccceeeEeeeC-----CeeEEEEecCCCCChhhhhcccCCCC
Q 021490 7 CLLQDVAIKQLDRNG--VQGNREFLVEVLMLSLLHHPNLVNLIGYCADG-----DQRLLVYEYMPLGSVEDHLHDLSPGK 79 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~ 79 (311)
.+|..||||.+.... ......+.+|+.+++.++|+||+++++++... ...++|+||+. ++|.+++.. .
T Consensus 28 ~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~----~ 102 (337)
T cd07858 28 ETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMD-TDLHQIIRS----S 102 (337)
T ss_pred CCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEeCCC-CCHHHHHhc----C
Confidence 468999999986542 23345778899999999999999999987644 34799999995 789888876 5
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCc
Q 021490 80 KPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 159 (311)
Q Consensus 80 ~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aP 159 (311)
..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .......++..|+||
T Consensus 103 ~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~~~~~y~aP 177 (337)
T cd07858 103 QTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG--DFMTEYVVTRWYRAP 177 (337)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccccccCCCc--ccccccccccCccCh
Confidence 67999999999999999999999999 9999999999999999999999999987532221 112223467889999
Q ss_pred ccccc-CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhh-hh-------hcccccc------ccccCcccc
Q 021490 160 EYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWAR-PL-------FQDRTRH------SLIADPELQ 224 (311)
Q Consensus 160 E~~~~-~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~-~~-------~~~~~~~------~~~~~~~~~ 224 (311)
|.+.. ..++.++|+||||+++|+|++|..||...+............ .. +...... .....+...
T Consensus 178 E~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (337)
T cd07858 178 ELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFA 257 (337)
T ss_pred HHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHH
Confidence 98764 568899999999999999999999997654332221111100 00 0000000 000000000
Q ss_pred CCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 021490 225 GQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 261 (311)
Q Consensus 225 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l~ 261 (311)
...+..+..+.+++.+||+.+|++|||+.++++.-.
T Consensus 258 -~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~ 293 (337)
T cd07858 258 -RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPY 293 (337)
T ss_pred -HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcc
Confidence 011234567889999999999999999999998743
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=246.16 Aligned_cols=224 Identities=31% Similarity=0.419 Sum_probs=175.6
Q ss_pred CCcEEEEEEeecCCC---cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCH
Q 021490 8 LLQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 84 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~ 84 (311)
+|..|++|++..... .....+.+|+.+++.++|||++++++++.+....++||||+. ++|.+++... ...+++
T Consensus 45 ~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~---~~~l~~ 120 (313)
T cd06633 45 TNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLEVH---KKPLQE 120 (313)
T ss_pred CCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-CCHHHHHHhc---CCCCCH
Confidence 688999999865433 223568889999999999999999999999999999999996 5777776542 456899
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccc-
Q 021490 85 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK- 163 (311)
Q Consensus 85 ~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~- 163 (311)
..+..++.|++.+|+|||+.+ ++|+||+|+||+++.++.++|+|||++..... .....++..|+|||++.
T Consensus 121 ~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~------~~~~~~~~~y~aPE~~~~ 191 (313)
T cd06633 121 VEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP------ANSFVGTPYWMAPEVILA 191 (313)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC------CCCccccccccChhhccc
Confidence 999999999999999999999 99999999999999999999999998753211 12335778899999874
Q ss_pred --cCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHH
Q 021490 164 --TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAM 241 (311)
Q Consensus 164 --~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 241 (311)
...++.++|+||||+++|+|++|..||............. ... .+.. .....+..+.+++.+
T Consensus 192 ~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~------~~~-------~~~~---~~~~~~~~l~~li~~ 255 (313)
T cd06633 192 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA------QND-------SPTL---QSNEWTDSFRGFVDY 255 (313)
T ss_pred cCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH------hcC-------CCCC---CccccCHHHHHHHHH
Confidence 3567889999999999999999999987654322221110 000 0000 111223468889999
Q ss_pred ccccCCCCCCCHHHHHHHH
Q 021490 242 CVHEQPDMRPVIADVVTAL 260 (311)
Q Consensus 242 ~l~~~p~~Rps~~~vl~~l 260 (311)
||+.+|.+||++.+++..-
T Consensus 256 ~l~~~P~~Rp~~~~~l~~~ 274 (313)
T cd06633 256 CLQKIPQERPASAELLRHD 274 (313)
T ss_pred HccCChhhCcCHHHHhcCc
Confidence 9999999999999999763
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=245.58 Aligned_cols=232 Identities=23% Similarity=0.291 Sum_probs=179.1
Q ss_pred cCCcEEEEEEeecCCC----cchhHHHHHHHHHhcC-CCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCC
Q 021490 7 CLLQDVAIKQLDRNGV----QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKP 81 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 81 (311)
.++..||||+++.... ...+.+.+|+.++..+ +||||+++++.+..+...++||||+++++|.+++.. ...
T Consensus 26 ~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~ 101 (288)
T cd05583 26 DAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQ----REH 101 (288)
T ss_pred cCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEEEecCCCCcHHHHHhh----cCC
Confidence 3578899999875322 2345788999999999 599999999999999999999999999999999875 456
Q ss_pred CCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccc
Q 021490 82 LDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 161 (311)
Q Consensus 82 l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 161 (311)
+++..+..++.|++.+|+|||+.+ ++|+||+|.||+++.++.++|+|||++......... ......++..|++||.
T Consensus 102 ~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~ 177 (288)
T cd05583 102 FTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE-RAYSFCGTIEYMAPEV 177 (288)
T ss_pred cCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECcccccccccccc-ccccccCCccccCHHH
Confidence 899999999999999999999999 999999999999999999999999988653222111 1122347889999998
Q ss_pred cccCC--CccccceeehhHHHHHHHhCCCccCcchhHHH-HHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHH
Q 021490 162 AKTGQ--LTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE-QSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAV 238 (311)
Q Consensus 162 ~~~~~--~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 238 (311)
+.+.. .+.++|+||||+++|+|++|..||........ ..... ..... .+ ..+......+.++
T Consensus 178 ~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~---~~~~~--------~~----~~~~~~~~~l~~l 242 (288)
T cd05583 178 IRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISR---RILKS--------KP----PFPKTMSAEARDF 242 (288)
T ss_pred hcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHH---HHHcc--------CC----CCCcccCHHHHHH
Confidence 87654 68899999999999999999999964322111 11111 11111 01 1122233478889
Q ss_pred HHHccccCCCCCCCHHHHHHHHH
Q 021490 239 AAMCVHEQPDMRPVIADVVTALA 261 (311)
Q Consensus 239 i~~~l~~~p~~Rps~~~vl~~l~ 261 (311)
+.+||+.||++|||+.++.+.|.
T Consensus 243 i~~~l~~~p~~R~t~~~~~~~l~ 265 (288)
T cd05583 243 IQKLLEKDPKKRLGANGADEIKN 265 (288)
T ss_pred HHHHhcCCHhhccCcchHHHHhc
Confidence 99999999999999888777664
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=241.99 Aligned_cols=221 Identities=20% Similarity=0.267 Sum_probs=169.8
Q ss_pred cCCcEEEEEEeecCCCcchhHHHHHHHHHhcC-CCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHH
Q 021490 7 CLLQDVAIKQLDRNGVQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN 85 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~ 85 (311)
.+|..+|+|.+........ |+.....+ +||||+++++.+......++||||+++++|.+++.. ...+++.
T Consensus 39 ~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~----~~~l~~~ 109 (267)
T PHA03390 39 PTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKK----EGKLSEA 109 (267)
T ss_pred CCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHHh----cCCCCHH
Confidence 3578899999865432221 22222222 799999999999999999999999999999999976 4589999
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCC-ceEEccccccccCCCCCCceeeeeccccccccCcccccc
Q 021490 86 TRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY-HPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT 164 (311)
Q Consensus 86 ~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 164 (311)
.+..++.|++.||.|||+.+ ++|+||+|+||+++.++ .++|+|||++...... ....++..|+|||++.+
T Consensus 110 ~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~ 180 (267)
T PHA03390 110 EVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP------SCYDGTLDYFSPEKIKG 180 (267)
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccceecCCC------ccCCCCCcccChhhhcC
Confidence 99999999999999999999 99999999999999988 9999999988643221 12347789999999988
Q ss_pred CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccc
Q 021490 165 GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVH 244 (311)
Q Consensus 165 ~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 244 (311)
..++.++|+||||+++|+|++|..||........ ....+.... .. . .......+..+.+++.+||+
T Consensus 181 ~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~-~~--------~----~~~~~~~~~~~~~li~~~l~ 246 (267)
T PHA03390 181 HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEEL-DLESLLKRQ-QK--------K----LPFIKNVSKNANDFVQSMLK 246 (267)
T ss_pred CCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchh-hHHHHHHhh-cc--------c----CCcccccCHHHHHHHHHHhc
Confidence 8899999999999999999999999974432211 111111100 00 0 01112344578899999999
Q ss_pred cCCCCCCC-HHHHHHH
Q 021490 245 EQPDMRPV-IADVVTA 259 (311)
Q Consensus 245 ~~p~~Rps-~~~vl~~ 259 (311)
.+|.+||+ ++++++.
T Consensus 247 ~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 247 YNINYRLTNYNEIIKH 262 (267)
T ss_pred cChhhCCchHHHHhcC
Confidence 99999996 6888754
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=252.02 Aligned_cols=244 Identities=21% Similarity=0.291 Sum_probs=176.8
Q ss_pred cCCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeC--------------CeeEEEEecCCCCChhhhh
Q 021490 7 CLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADG--------------DQRLLVYEYMPLGSVEDHL 72 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------------~~~~lv~e~~~~~~L~~~l 72 (311)
.+|..||+|++........+.+.+|+++++.++||||+++++++... ...++||||++ ++|.+++
T Consensus 28 ~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~ 106 (342)
T cd07854 28 DCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVL 106 (342)
T ss_pred CCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccccceEEEEeeccc-ccHHHHH
Confidence 36899999999777666667899999999999999999999876543 35789999997 5888888
Q ss_pred cccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEc-CCCceEEccccccccCCCCCC-ceeeeec
Q 021490 73 HDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD-RGYHPKLSDFGLAKLGPVGDN-THVSTRV 150 (311)
Q Consensus 73 ~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~-~~~~~~l~df~~~~~~~~~~~-~~~~~~~ 150 (311)
.. ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++ +++.++++|||.+........ .......
T Consensus 107 ~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 178 (342)
T cd07854 107 EQ-----GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEG 178 (342)
T ss_pred Hc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEECCcccceecCCccccccccccc
Confidence 64 46899999999999999999999999 99999999999997 456789999999864321111 1111223
Q ss_pred cccccccCcccccc-CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhcc--cc-----ccccccCcc
Q 021490 151 MGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQD--RT-----RHSLIADPE 222 (311)
Q Consensus 151 ~~~~~y~aPE~~~~-~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~-----~~~~~~~~~ 222 (311)
.++..|+|||.+.. ..++.++|||||||++|+|++|..||................+.... .. .........
T Consensus 179 ~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (342)
T cd07854 179 LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDG 258 (342)
T ss_pred cccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcc
Confidence 46778999997644 56788999999999999999999999766543332221111000000 00 000000000
Q ss_pred cc-----CCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 021490 223 LQ-----GQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 223 ~~-----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~ 259 (311)
.. ....+.....+.+++.+||..||.+|||+.+++..
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 259 GEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred cccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 00 00111234578899999999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=240.31 Aligned_cols=208 Identities=24% Similarity=0.264 Sum_probs=165.7
Q ss_pred cCCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHH
Q 021490 7 CLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNT 86 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~ 86 (311)
.+|+.||+|.+.... .+.+|...+....||||+++++++.++...++||||++|++|.+++.. ...+++..
T Consensus 16 ~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~ 86 (237)
T cd05576 16 RTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK----FLNIPEEC 86 (237)
T ss_pred cCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH----hcCCCHHH
Confidence 368999999986543 233455555666799999999999999999999999999999999876 45699999
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccCC
Q 021490 87 RMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ 166 (311)
Q Consensus 87 ~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 166 (311)
+..++.|++.||+|||+.+ ++|+||||+||+++.++.++++|||.+...... .....++..|+|||.+.+..
T Consensus 87 ~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~ 158 (237)
T cd05576 87 VKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENMYCAPEVGGISE 158 (237)
T ss_pred HHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCccccCCcccCCCC
Confidence 9999999999999999999 999999999999999999999999987543221 11223456799999998888
Q ss_pred CccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccC
Q 021490 167 LTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQ 246 (311)
Q Consensus 167 ~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 246 (311)
++.++|+||+|+++|+|++|..|+...... ... ......+...+..+.+++.+||+.|
T Consensus 159 ~~~~~DvwslG~il~el~~g~~~~~~~~~~------------~~~----------~~~~~~~~~~~~~~~~li~~~l~~d 216 (237)
T cd05576 159 ETEACDWWSLGAILFELLTGKTLVECHPSG------------INT----------HTTLNIPEWVSEEARSLLQQLLQFN 216 (237)
T ss_pred CCchhhHHHHHHHHHHHHHCcchhhcCchh------------ccc----------ccccCCcccCCHHHHHHHHHHccCC
Confidence 899999999999999999999887542210 000 0001122333457888999999999
Q ss_pred CCCCCCH
Q 021490 247 PDMRPVI 253 (311)
Q Consensus 247 p~~Rps~ 253 (311)
|++||++
T Consensus 217 p~~R~~~ 223 (237)
T cd05576 217 PTERLGA 223 (237)
T ss_pred HHHhcCC
Confidence 9999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=244.81 Aligned_cols=230 Identities=23% Similarity=0.324 Sum_probs=176.8
Q ss_pred cCCcEEEEEEeecCCC----cchhHHHHHHHHHhcC-CCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCC
Q 021490 7 CLLQDVAIKQLDRNGV----QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKP 81 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 81 (311)
.+|..||+|+++.... ...+.+.+|+.++..+ +|+||+.+++.+..+...++||||+++++|.+++.. ...
T Consensus 26 ~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~ 101 (290)
T cd05613 26 DSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQ----RER 101 (290)
T ss_pred CCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEEEecCCCCcHHHHHHH----cCC
Confidence 3789999999875432 2346788899999999 589999999999999999999999999999999976 467
Q ss_pred CCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccc
Q 021490 82 LDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 161 (311)
Q Consensus 82 l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 161 (311)
+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... ........++..|+|||.
T Consensus 102 l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~ 177 (290)
T cd05613 102 FKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE-VERAYSFCGTIEYMAPDI 177 (290)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccceeccccc-ccccccccCCcccCChhh
Confidence 899999999999999999999999 9999999999999999999999999886532211 111122347788999998
Q ss_pred ccc--CCCccccceeehhHHHHHHHhCCCccCcchhHHH-HHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHH
Q 021490 162 AKT--GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE-QSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAV 238 (311)
Q Consensus 162 ~~~--~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 238 (311)
+.. ..++.++||||||+++|+|++|..||........ ..... ..... .+ .++......+.++
T Consensus 178 ~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~---~~~~~--------~~----~~~~~~~~~~~~l 242 (290)
T cd05613 178 VRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISR---RILKS--------EP----PYPQEMSALAKDI 242 (290)
T ss_pred ccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHH---Hhhcc--------CC----CCCccCCHHHHHH
Confidence 865 3467899999999999999999999964322111 11111 00110 01 1122233477889
Q ss_pred HHHccccCCCCCC-----CHHHHHHH
Q 021490 239 AAMCVHEQPDMRP-----VIADVVTA 259 (311)
Q Consensus 239 i~~~l~~~p~~Rp-----s~~~vl~~ 259 (311)
+.+||+.||++|| ++.+++..
T Consensus 243 l~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 243 IQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred HHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 9999999999997 66776654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=244.15 Aligned_cols=243 Identities=23% Similarity=0.262 Sum_probs=178.3
Q ss_pred CCcEEEEEEeecCCCc-chhHHHHHHHHHhcCC-CCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHH
Q 021490 8 LLQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN 85 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~ 85 (311)
+|+.|+||.+...... ......+|+..+..++ |+||+++++++.++...++||||+ +++|.+++.... +..+++.
T Consensus 23 ~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~--~~~~~~~ 99 (283)
T cd07830 23 TGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRK--GKPFSES 99 (283)
T ss_pred CCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-CCCHHHHHHhcc--cccCCHH
Confidence 5788999998655332 2334567999999998 999999999999999999999999 789988887622 3478999
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccccc-
Q 021490 86 TRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT- 164 (311)
Q Consensus 86 ~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~- 164 (311)
.+..++.|++.+|.|||+++ ++|+||+|.||+++.++.++|+|||++....... ......++..|+|||++..
T Consensus 100 ~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~ 173 (283)
T cd07830 100 VIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP---PYTDYVSTRWYRAPEILLRS 173 (283)
T ss_pred HHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCC---CcCCCCCcccccCceeeecC
Confidence 99999999999999999999 9999999999999999999999999986432211 1122346788999998753
Q ss_pred CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHH-HHHhhhhhc----cccccccccCcccc-------CCCChHhH
Q 021490 165 GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSL-VAWARPLFQ----DRTRHSLIADPELQ-------GQYPPRGF 232 (311)
Q Consensus 165 ~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~-~~~~~~~~~----~~~~~~~~~~~~~~-------~~~~~~~~ 232 (311)
..++.++|+||||+++|+|++|..||......+.... ......... .........+..+. ....+...
T Consensus 174 ~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (283)
T cd07830 174 TSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNAS 253 (283)
T ss_pred cCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCC
Confidence 5578999999999999999999999976654332211 111000000 00000000000000 01111224
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHH
Q 021490 233 YQALAVAAMCVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 233 ~~l~~li~~~l~~~p~~Rps~~~vl~~ 259 (311)
..+.+++.+||+.||++|||+.|++..
T Consensus 254 ~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 254 PEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred HHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 578899999999999999999999764
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=244.52 Aligned_cols=236 Identities=24% Similarity=0.389 Sum_probs=175.6
Q ss_pred cchhcc-CCcEEEEEEeecCCC-cchhHHHHHHHHHhcC-CCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCC
Q 021490 2 MQVILC-LLQDVAIKQLDRNGV-QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPG 78 (311)
Q Consensus 2 ~~~~~~-~g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~ 78 (311)
|.+... +|+.||||.++.... .....+..|+.++... .||||+++++++.+....++||||+. ++|.+++...
T Consensus 32 ~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~l~~~~--- 107 (296)
T cd06618 32 YKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMS-TCLDKLLKRI--- 107 (296)
T ss_pred EEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccC-cCHHHHHHHh---
Confidence 334444 389999999975543 2345667777767666 59999999999999999999999985 5777776552
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeecccccccc
Q 021490 79 KKPLDWNTRMKIAAGAARGLEYLHD-KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 157 (311)
Q Consensus 79 ~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~ 157 (311)
...+++..+..++.+++.||+|||+ .+ ++|+||+|+||++++++.++|+|||++....... ......++..|+
T Consensus 108 ~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~---~~~~~~~~~~y~ 181 (296)
T cd06618 108 QGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK---AKTRSAGCAAYM 181 (296)
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccCCC---cccCCCCCcccc
Confidence 3478999999999999999999997 57 9999999999999999999999999986432211 112234677899
Q ss_pred CccccccCC----CccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHH
Q 021490 158 APEYAKTGQ----LTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFY 233 (311)
Q Consensus 158 aPE~~~~~~----~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
|||.+.+.. ++.++|+||||+++|+|++|..||........ ... ....... +.... ....+.
T Consensus 182 aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~---~~~~~~~-------~~~~~--~~~~~~ 247 (296)
T cd06618 182 APERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFE--VLT---KILQEEP-------PSLPP--NEGFSP 247 (296)
T ss_pred CHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHH--HHH---HHhcCCC-------CCCCC--CCCCCH
Confidence 999987543 78899999999999999999999976432211 110 0111100 00000 012344
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHHHH
Q 021490 234 QALAVAAMCVHEQPDMRPVIADVVTALA 261 (311)
Q Consensus 234 ~l~~li~~~l~~~p~~Rps~~~vl~~l~ 261 (311)
++.+++.+||..||.+|||+.+++....
T Consensus 248 ~l~~li~~~l~~~p~~Rp~~~~il~~~~ 275 (296)
T cd06618 248 DFCSFVDLCLTKDHRKRPKYRELLQHPF 275 (296)
T ss_pred HHHHHHHHHccCChhhCCCHHHHhcChh
Confidence 7889999999999999999999997754
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=247.19 Aligned_cols=245 Identities=27% Similarity=0.348 Sum_probs=194.7
Q ss_pred CCcEEEEEEeecCCC---cchhHHHHHHHHHhcC-CCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCC
Q 021490 8 LLQDVAIKQLDRNGV---QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLD 83 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~ 83 (311)
+..-+|||++++... ++.+.-+.|-++|... +-|+++.+...|++-+++|+||||+.||+|-..+++ -+.+.
T Consensus 373 tdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyvnGGDLMyhiQQ----~GkFK 448 (683)
T KOG0696|consen 373 TDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ----VGKFK 448 (683)
T ss_pred cchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEEEEecCchhhhHHHH----hcccC
Confidence 356789999977643 3345666788888877 578999999999999999999999999999999998 67899
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccc
Q 021490 84 WNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 163 (311)
Q Consensus 84 ~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 163 (311)
++.+..++.+|+-||-|||++| |++||||.+|||++.+|.+||.|||++...-.. ........||+.|+|||++.
T Consensus 449 Ep~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~--~~TTkTFCGTPdYiAPEIi~ 523 (683)
T KOG0696|consen 449 EPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD--GVTTKTFCGTPDYIAPEIIA 523 (683)
T ss_pred CchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccccccC--CcceeeecCCCcccccceEE
Confidence 9999999999999999999999 999999999999999999999999999742222 22233457999999999999
Q ss_pred cCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHcc
Q 021490 164 TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCV 243 (311)
Q Consensus 164 ~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 243 (311)
..+|+.++|+||+|+++|||+.|++||++.+..+.-+.+ +. -+-.+|...+.+..++++..|
T Consensus 524 YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI------~e------------hnvsyPKslSkEAv~ickg~l 585 (683)
T KOG0696|consen 524 YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAI------ME------------HNVSYPKSLSKEAVAICKGLL 585 (683)
T ss_pred ecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH------HH------------ccCcCcccccHHHHHHHHHHh
Confidence 999999999999999999999999999987765442222 11 112455667779999999999
Q ss_pred ccCCCCC----CCHHHHHHHHHHhhhccCCccccccCCCC
Q 021490 244 HEQPDMR----PVIADVVTALAYLASQKYESDAEKVQSPC 279 (311)
Q Consensus 244 ~~~p~~R----ps~~~vl~~l~~~~~~~~~~~~~~~~~~~ 279 (311)
..+|.+| |..++=+..--++..+.++.-+..-..|+
T Consensus 586 tK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~~eiqPP 625 (683)
T KOG0696|consen 586 TKHPGKRLGCGPEGERDIREHPFFRRIDWEKLERREIQPP 625 (683)
T ss_pred hcCCccccCCCCccccchhhCcchhhccHHHHhhccCCCC
Confidence 9999999 45554444444555555544444333333
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=258.17 Aligned_cols=219 Identities=25% Similarity=0.318 Sum_probs=174.9
Q ss_pred cCCcEEEEEEeecCCCcchhHHHHHHHHHhcC-CCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHH
Q 021490 7 CLLQDVAIKQLDRNGVQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN 85 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~ 85 (311)
.+++..++|++.+. ..+-.+|+.++... +||||+++.+++.++.+.|+|||.+.|+-|.+.+.. ...+. .
T Consensus 345 ~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~----~~~~~-~ 415 (612)
T KOG0603|consen 345 PTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRS----KPEFC-S 415 (612)
T ss_pred ccccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeeehhccccHHHHHHHh----cchhH-H
Confidence 35677788887654 12334567666665 799999999999999999999999999988888775 33333 7
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEE-cCCCceEEccccccccCCCCCCceeeeeccccccccCcccccc
Q 021490 86 TRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL-DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT 164 (311)
Q Consensus 86 ~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~-~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 164 (311)
.+..|+.+++.|+.|||++| ++||||||+|||+ +..|.++|+|||.+...... .....-|..|.|||++..
T Consensus 416 e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-----~~tp~~t~~y~APEvl~~ 487 (612)
T KOG0603|consen 416 EASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-----CDTPALTLQYVAPEVLAI 487 (612)
T ss_pred HHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh-----hcccchhhcccChhhhcc
Confidence 88899999999999999999 9999999999999 68899999999998753332 122345778999999999
Q ss_pred CCCccccceeehhHHHHHHHhCCCccCcchhHHH-HHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHcc
Q 021490 165 GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE-QSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCV 243 (311)
Q Consensus 165 ~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 243 (311)
..+++++||||||+++|+||+|..||........ ...+ + ...+....+.+..+|+.+||
T Consensus 488 ~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i-------~-------------~~~~s~~vS~~AKdLl~~LL 547 (612)
T KOG0603|consen 488 QEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRI-------Q-------------MPKFSECVSDEAKDLLQQLL 547 (612)
T ss_pred CCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhh-------c-------------CCccccccCHHHHHHHHHhc
Confidence 9999999999999999999999999976655411 1100 0 01122455668899999999
Q ss_pred ccCCCCCCCHHHHHHHHHH
Q 021490 244 HEQPDMRPVIADVVTALAY 262 (311)
Q Consensus 244 ~~~p~~Rps~~~vl~~l~~ 262 (311)
++||.+||++.++...-+.
T Consensus 548 ~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 548 QVDPALRLGADEIGAHPWF 566 (612)
T ss_pred cCChhhCcChhhhccCcch
Confidence 9999999999999987654
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=257.57 Aligned_cols=255 Identities=22% Similarity=0.238 Sum_probs=186.8
Q ss_pred Ccchh-ccCCcEEEEEEeecCC-CcchhHHHHHHHHHhcCCCCcccceeeEeeeCC------eeEEEEecCCCCChhhhh
Q 021490 1 MMQVI-LCLLQDVAIKQLDRNG-VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD------QRLLVYEYMPLGSVEDHL 72 (311)
Q Consensus 1 ~~~~~-~~~g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~l 72 (311)
||++. -.+|..||||.++... ....+...+|+++|++|+|+|||+++++-.+.. ...+|||||.||||...+
T Consensus 29 V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L 108 (732)
T KOG4250|consen 29 VYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRKVL 108 (732)
T ss_pred eeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEeecCCCcHHHHh
Confidence 34444 4579999999997754 345678889999999999999999999865543 458999999999999999
Q ss_pred cccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEc--CCC--ceEEccccccccCCCCCCceeee
Q 021490 73 HDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD--RGY--HPKLSDFGLAKLGPVGDNTHVST 148 (311)
Q Consensus 73 ~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~--~~~--~~~l~df~~~~~~~~~~~~~~~~ 148 (311)
.+.. ...+|++.+.+.++.++..||.|||++| |+||||||.||++- ++| .-||+|||.++..... ....
T Consensus 109 ~~PE-N~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~---s~~~ 181 (732)
T KOG4250|consen 109 NSPE-NAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDN---SLFT 181 (732)
T ss_pred cCcc-cccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccccccCCCC---Ceee
Confidence 8744 3467999999999999999999999999 99999999999984 334 3599999999854333 2455
Q ss_pred eccccccccCcccccc-CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhh---h----------hccccc
Q 021490 149 RVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARP---L----------FQDRTR 214 (311)
Q Consensus 149 ~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~---~----------~~~~~~ 214 (311)
..+||..|++||+... ..|+..+|.|||||++|+..||..||...........+.|... . ......
T Consensus 182 S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~~eNgpv~ 261 (732)
T KOG4250|consen 182 SLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQEEENGPVE 261 (732)
T ss_pred eecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEeeecccCCcee
Confidence 6789999999999984 8889999999999999999999999976554432221211110 0 000000
Q ss_pred cccccCccccCCCChHhHHHHHHHHHHccccCCCCCC--CHHHHHHHHHHhh
Q 021490 215 HSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRP--VIADVVTALAYLA 264 (311)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp--s~~~vl~~l~~~~ 264 (311)
..... | ......+.....+-.++..+|..+|.+|. .+.+.-..+..+.
T Consensus 262 ~s~~l-P-~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL 311 (732)
T KOG4250|consen 262 WSSTL-P-QPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDIL 311 (732)
T ss_pred eeccC-C-CcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHH
Confidence 00000 0 01222233334555688889999999998 5555444444333
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=246.56 Aligned_cols=245 Identities=22% Similarity=0.247 Sum_probs=174.9
Q ss_pred CCcEEEEEEeecCCCcc--hhHHHHHHHHHhcCCCCcccceeeEeeeC--------CeeEEEEecCCCCChhhhhcccCC
Q 021490 8 LLQDVAIKQLDRNGVQG--NREFLVEVLMLSLLHHPNLVNLIGYCADG--------DQRLLVYEYMPLGSVEDHLHDLSP 77 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~~~ 77 (311)
+|+.||+|++....... ...+.+|+++++.++||||+++++++.+. ...++|+||+. ++|...+...
T Consensus 32 ~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~-~~l~~~~~~~-- 108 (311)
T cd07866 32 TGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMD-HDLSGLLENP-- 108 (311)
T ss_pred CCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceEEEEEecCC-cCHHHHHhcc--
Confidence 68999999986654322 34678899999999999999999987543 34699999996 4677766542
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCce---------eee
Q 021490 78 GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH---------VST 148 (311)
Q Consensus 78 ~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~---------~~~ 148 (311)
...+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++.......... ...
T Consensus 109 -~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ 184 (311)
T cd07866 109 -SVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYT 184 (311)
T ss_pred -ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCccchhccCCCcccccCCcccccccc
Confidence 457999999999999999999999999 9999999999999999999999999886532221111 111
Q ss_pred eccccccccCcccccc-CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhh-----hccccccccccCcc
Q 021490 149 RVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPL-----FQDRTRHSLIADPE 222 (311)
Q Consensus 149 ~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~ 222 (311)
...++..|+|||.+.+ ..++.++||||||+++|+|++|.+||...........+...... +..........+..
T Consensus 185 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (311)
T cd07866 185 NLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVH 264 (311)
T ss_pred cceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccc
Confidence 2345778999998765 45789999999999999999999999766554332222111000 00000000000000
Q ss_pred ccCCCC-------hHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 021490 223 LQGQYP-------PRGFYQALAVAAMCVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 223 ~~~~~~-------~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~ 259 (311)
.....+ ......+.+++.+||+.||.+|||+.+++..
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 265 SFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred cCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 000111 1122568899999999999999999998864
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=235.36 Aligned_cols=232 Identities=29% Similarity=0.349 Sum_probs=185.0
Q ss_pred cchhcc-CCcEEEEEEeecCCCcc-hhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCC
Q 021490 2 MQVILC-LLQDVAIKQLDRNGVQG-NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGK 79 (311)
Q Consensus 2 ~~~~~~-~g~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~ 79 (311)
|.+... +|..+|+|++....... .+.+.+|++.++.++|+|++++++.+......++++|++++++|.+++.. .
T Consensus 6 ~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~----~ 81 (244)
T smart00220 6 YLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK----R 81 (244)
T ss_pred EEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh----c
Confidence 334444 58999999997665544 68999999999999999999999999998999999999999999999876 3
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCc
Q 021490 80 KPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 159 (311)
Q Consensus 80 ~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aP 159 (311)
..+++..++.++.+++.++.+||+.+ ++|+||+|.||+++.++.++++|||.+....... ......++..|++|
T Consensus 82 ~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~p 155 (244)
T smart00220 82 GRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYMAP 155 (244)
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCCCH
Confidence 34899999999999999999999999 9999999999999999999999999987543221 22334577889999
Q ss_pred cccccCCCccccceeehhHHHHHHHhCCCccCcc-hhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHH
Q 021490 160 EYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTS-KAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAV 238 (311)
Q Consensus 160 E~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 238 (311)
|.+....++.++|+||||+++|+|++|..||... .......... ...... . .........+.++
T Consensus 156 E~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~------~~~~~~----~-----~~~~~~~~~~~~~ 220 (244)
T smart00220 156 EVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIG------KPKPPF----P-----PPEWKISPEAKDL 220 (244)
T ss_pred HHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHh------ccCCCC----c-----cccccCCHHHHHH
Confidence 9998888899999999999999999999999763 2222111110 000000 0 0000033478889
Q ss_pred HHHccccCCCCCCCHHHHHH
Q 021490 239 AAMCVHEQPDMRPVIADVVT 258 (311)
Q Consensus 239 i~~~l~~~p~~Rps~~~vl~ 258 (311)
+.+||..+|++||++.++++
T Consensus 221 i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 221 IRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHccCCchhccCHHHHhh
Confidence 99999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=247.77 Aligned_cols=243 Identities=21% Similarity=0.222 Sum_probs=175.2
Q ss_pred CcEEEEEEeecCCC--cchhHHHHHHHHHhcC-CCCcccceeeEeeeC----CeeEEEEecCCCCChhhhhcccCCCCCC
Q 021490 9 LQDVAIKQLDRNGV--QGNREFLVEVLMLSLL-HHPNLVNLIGYCADG----DQRLLVYEYMPLGSVEDHLHDLSPGKKP 81 (311)
Q Consensus 9 g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 81 (311)
|..||+|++..... ...+.+.+|+.++..+ .||||+++++.+... ...+++++++. ++|.+++.. ...
T Consensus 27 ~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~----~~~ 101 (332)
T cd07857 27 EETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELME-ADLHQIIRS----GQP 101 (332)
T ss_pred CceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEEEeccc-CCHHHHHhc----CCC
Confidence 78899999864322 2346788999999999 599999999875322 45789999985 689988875 567
Q ss_pred CCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCc--eeeeeccccccccCc
Q 021490 82 LDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT--HVSTRVMGTYGYCAP 159 (311)
Q Consensus 82 l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~~y~aP 159 (311)
+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++......... .......++..|+||
T Consensus 102 ~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aP 178 (332)
T cd07857 102 LTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAP 178 (332)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCceecccccccccccccCcccCccccCc
Confidence 999999999999999999999999 999999999999999999999999998753321111 111234578899999
Q ss_pred ccccc-CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhh---------hhccc----c-ccccccCcccc
Q 021490 160 EYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARP---------LFQDR----T-RHSLIADPELQ 224 (311)
Q Consensus 160 E~~~~-~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~---------~~~~~----~-~~~~~~~~~~~ 224 (311)
|++.+ ..++.++|+||||+++|+|++|..||...+............. ..... . .........+.
T Consensus 179 E~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (332)
T cd07857 179 EIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFE 258 (332)
T ss_pred HHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchH
Confidence 98765 5678999999999999999999999976554322111100000 00000 0 00000000000
Q ss_pred CCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 021490 225 GQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 260 (311)
Q Consensus 225 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l 260 (311)
...+..+..+.+++.+||+.||.+|||+.+++..-
T Consensus 259 -~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~ 293 (332)
T cd07857 259 -SIFPNANPLALDLLEKLLAFDPTKRISVEEALEHP 293 (332)
T ss_pred -hhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 11112345788999999999999999999998664
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=262.78 Aligned_cols=233 Identities=20% Similarity=0.209 Sum_probs=163.7
Q ss_pred hhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCC-CCCCCCHHHHHHHHHHHHHHHHHhhc
Q 021490 25 NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP-GKKPLDWNTRMKIAAGAARGLEYLHD 103 (311)
Q Consensus 25 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~ 103 (311)
...+.+|+.+|..++||||+++++++.+....|+|++++. ++|.+++..... .........+..++.|++.||+|||+
T Consensus 207 ~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~ 285 (501)
T PHA03210 207 AIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD 285 (501)
T ss_pred HHHHHHHHHHHHhCCCCCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh
Confidence 4568899999999999999999999999999999999985 677777654211 12234466788999999999999999
Q ss_pred CCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccCCCccccceeehhHHHHHH
Q 021490 104 KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEI 183 (311)
Q Consensus 104 ~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~l~~~l 183 (311)
++ |+||||||+|||++.++.++|+|||++....... ........|+..|+|||++.+..++.++|||||||++|+|
T Consensus 286 ~g---IiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~el 361 (501)
T PHA03210 286 KK---LIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKER-EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDM 361 (501)
T ss_pred CC---eecCCCCHHHEEECCCCCEEEEeCCCceecCccc-ccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHH
Confidence 99 9999999999999999999999999987543221 1112234689999999999998999999999999999999
Q ss_pred HhCCCc-cCcchhHHHHHHHHHhhhh------hcccc-ccc-cccC---ccccCCCCh-----HhHHHHHHHHHHccccC
Q 021490 184 LSGRKA-VDTSKAAAEQSLVAWARPL------FQDRT-RHS-LIAD---PELQGQYPP-----RGFYQALAVAAMCVHEQ 246 (311)
Q Consensus 184 l~g~~p-f~~~~~~~~~~~~~~~~~~------~~~~~-~~~-~~~~---~~~~~~~~~-----~~~~~l~~li~~~l~~~ 246 (311)
++|..+ |..........+....... +.+.. ... .+.. .......+. .....+.+++.+||++|
T Consensus 362 l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~D 441 (501)
T PHA03210 362 LSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFD 441 (501)
T ss_pred HHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccC
Confidence 998754 4322211111111111000 00000 000 0000 000000000 11235677899999999
Q ss_pred CCCCCCHHHHHHHHHH
Q 021490 247 PDMRPVIADVVTALAY 262 (311)
Q Consensus 247 p~~Rps~~~vl~~l~~ 262 (311)
|++|||+.|++..-.+
T Consensus 442 P~~Rpsa~elL~hp~f 457 (501)
T PHA03210 442 WHLRPGAAELLALPLF 457 (501)
T ss_pred cccCcCHHHHhhChhh
Confidence 9999999999987544
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=246.15 Aligned_cols=239 Identities=23% Similarity=0.283 Sum_probs=175.8
Q ss_pred CCcEEEEEEeecCC--CcchhHHHHHHHHHhcCCCCcccceeeEeee-CCeeEEEEecCCCCChhhhhcccCCCCCCCCH
Q 021490 8 LLQDVAIKQLDRNG--VQGNREFLVEVLMLSLLHHPNLVNLIGYCAD-GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 84 (311)
Q Consensus 8 ~g~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~ 84 (311)
+|..||+|++.... ....+.+.+|+.+++.++||||+++++++.. ....++++||+ +++|.+++.. ..+++
T Consensus 34 ~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-----~~~~~ 107 (328)
T cd07856 34 TGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL-GTDLHRLLTS-----RPLEK 107 (328)
T ss_pred CCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh-ccCHHHHHhc-----CCCCH
Confidence 78999999885432 2234678889999999999999999999865 55789999998 5689888864 45888
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccccc
Q 021490 85 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT 164 (311)
Q Consensus 85 ~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 164 (311)
..+..++.|++.||+|||+.+ ++|+||+|.||+++.++.++|+|||.+...... .....++..|+|||.+.+
T Consensus 108 ~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~ 179 (328)
T cd07856 108 QFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQ-----MTGYVSTRYYRAPEIMLT 179 (328)
T ss_pred HHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccccCCC-----cCCCcccccccCceeeec
Confidence 899999999999999999999 999999999999999999999999998643211 112345778999998765
Q ss_pred -CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHh-hhh----h---ccccccccccCccccCCCC-----hH
Q 021490 165 -GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWA-RPL----F---QDRTRHSLIADPELQGQYP-----PR 230 (311)
Q Consensus 165 -~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~-~~~----~---~~~~~~~~~~~~~~~~~~~-----~~ 230 (311)
..++.++|+||||+++|+|++|..||............... ... . ..................+ +.
T Consensus 180 ~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (328)
T cd07856 180 WQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKN 259 (328)
T ss_pred cCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCC
Confidence 56889999999999999999999999765543222111110 000 0 0000000000000000011 12
Q ss_pred hHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 021490 231 GFYQALAVAAMCVHEQPDMRPVIADVVTAL 260 (311)
Q Consensus 231 ~~~~l~~li~~~l~~~p~~Rps~~~vl~~l 260 (311)
....+.+++.+||+.+|.+|||+.+++..-
T Consensus 260 ~~~~~~~li~~~l~~~P~~R~t~~ell~~~ 289 (328)
T cd07856 260 ADPSAIDLLEKMLVFDPQKRISAAEALAHP 289 (328)
T ss_pred CCHHHHHHHHHHcCCChhhCCCHHHHhcCC
Confidence 346788999999999999999999998774
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=260.61 Aligned_cols=234 Identities=28% Similarity=0.406 Sum_probs=200.8
Q ss_pred CcEEEEEEeecCC-CcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHHH
Q 021490 9 LQDVAIKQLDRNG-VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTR 87 (311)
Q Consensus 9 g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~ 87 (311)
+.+||||++.... ....+.+++|+.+|..|+|||++++++++.... +-||++|+++|+|.++++.. ...+.....
T Consensus 725 KipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~mP~G~LlDyvr~h---r~~igsq~l 800 (1177)
T KOG1025|consen 725 KIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLMPLGCLLDYVREH---RDNIGSQDL 800 (1177)
T ss_pred cceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhcccchHHHHHHHh---hccccHHHH
Confidence 4789999986653 455689999999999999999999999998765 78999999999999999873 567999999
Q ss_pred HHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccCCC
Q 021490 88 MKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQL 167 (311)
Q Consensus 88 ~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 167 (311)
+.|+.||++|+.|||.+. ++||||..+||||..-..+||.|||++................-.+.|+|-|.+....+
T Consensus 801 Lnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~ 877 (1177)
T KOG1025|consen 801 LNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKY 877 (1177)
T ss_pred HHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCC
Confidence 999999999999999999 99999999999999999999999999987655554444455566788999999999999
Q ss_pred ccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccC
Q 021490 168 TLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQ 246 (311)
Q Consensus 168 ~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 246 (311)
+.++|||||||++||++| |..|+.+....+..++++...+ -..|+....++..++.+||..|
T Consensus 878 thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geR-----------------LsqPpiCtiDVy~~mvkCwmid 940 (1177)
T KOG1025|consen 878 THQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGER-----------------LSQPPICTIDVYMVMVKCWMID 940 (1177)
T ss_pred CchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcccc-----------------CCCCCCccHHHHHHHHHHhccC
Confidence 999999999999999999 9999999887777665543221 2345667778899999999999
Q ss_pred CCCCCCHHHHHHHHHHhhhc
Q 021490 247 PDMRPVIADVVTALAYLASQ 266 (311)
Q Consensus 247 p~~Rps~~~vl~~l~~~~~~ 266 (311)
++.||+++++...+..++..
T Consensus 941 ~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 941 ADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred cccCccHHHHHHHHHHHhcC
Confidence 99999999999988766543
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=238.11 Aligned_cols=228 Identities=24% Similarity=0.338 Sum_probs=175.9
Q ss_pred CcEEEEEEeecCCC-----cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCC
Q 021490 9 LQDVAIKQLDRNGV-----QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLD 83 (311)
Q Consensus 9 g~~vaiK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~ 83 (311)
+..+++|+++.... ....++..|+.+++.++||||+++++++.+....++|+||+++++|.+++.........++
T Consensus 25 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~ 104 (260)
T cd08222 25 VAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLS 104 (260)
T ss_pred CCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEeCCCCCHHHHHHHHhhcccccC
Confidence 34456666544221 2234677899999999999999999999998999999999999999998875443456799
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccc
Q 021490 84 WNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 163 (311)
Q Consensus 84 ~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 163 (311)
+..++.++.|++.||.|||+.+ ++|+||+|+||+++. +.++|+|||.+...... ........++..|+|||...
T Consensus 105 ~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~~~pe~~~ 178 (260)
T cd08222 105 ENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGS--CDLATTFTGTPYYMSPEALK 178 (260)
T ss_pred HHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecCCC--cccccCCCCCcCccCHHHHc
Confidence 9999999999999999999999 999999999999975 56999999988653221 11222334678899999988
Q ss_pred cCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHcc
Q 021490 164 TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCV 243 (311)
Q Consensus 164 ~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 243 (311)
+..++.++|+||||+++|+|++|..||............ ... ..+ ..+...+..+.+++.+||
T Consensus 179 ~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~------~~~-------~~~----~~~~~~~~~~~~li~~~l 241 (260)
T cd08222 179 HQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRI------VEG-------PTP----SLPETYSRQLNSIMQSML 241 (260)
T ss_pred cCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH------HcC-------CCC----CCcchhcHHHHHHHHHHh
Confidence 888899999999999999999999999754432211110 000 011 112234457889999999
Q ss_pred ccCCCCCCCHHHHHHH
Q 021490 244 HEQPDMRPVIADVVTA 259 (311)
Q Consensus 244 ~~~p~~Rps~~~vl~~ 259 (311)
..+|++||++.++++.
T Consensus 242 ~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 242 NKDPSLRPSAAEILRN 257 (260)
T ss_pred cCChhhCcCHHHHhhC
Confidence 9999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=251.03 Aligned_cols=238 Identities=22% Similarity=0.268 Sum_probs=176.6
Q ss_pred CCcEEEEEEeecCC--CcchhHHHHHHHHHhcCCCCcccceeeEeeeCCe------eEEEEecCCCCChhhhhcccCCCC
Q 021490 8 LLQDVAIKQLDRNG--VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ------RLLVYEYMPLGSVEDHLHDLSPGK 79 (311)
Q Consensus 8 ~g~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~------~~lv~e~~~~~~L~~~l~~~~~~~ 79 (311)
+|+.||+|++.... ......+.+|+.+++.++||||+++++++..... .++|+||+ +++|.+++..
T Consensus 39 ~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~----- 112 (343)
T cd07851 39 TGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKC----- 112 (343)
T ss_pred CCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEEecC-CCCHHHHHhc-----
Confidence 57899999986532 2233567889999999999999999998866554 89999998 6799998875
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCc
Q 021490 80 KPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 159 (311)
Q Consensus 80 ~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aP 159 (311)
..+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++...... .....++..|+||
T Consensus 113 ~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~-----~~~~~~~~~y~aP 184 (343)
T cd07851 113 QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 184 (343)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccccccccccc-----ccCCcccccccCH
Confidence 56999999999999999999999999 999999999999999999999999998753221 1223467789999
Q ss_pred ccccc-CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhh----hccccccc----------cccCcccc
Q 021490 160 EYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPL----FQDRTRHS----------LIADPELQ 224 (311)
Q Consensus 160 E~~~~-~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~----~~~~~~~~----------~~~~~~~~ 224 (311)
|.+.+ ..++.++||||||+++|+|++|..||...........+...... +....... ....+.+.
T Consensus 185 E~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (343)
T cd07851 185 EIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFK 264 (343)
T ss_pred HHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHH
Confidence 98765 46788999999999999999999999765543322211110000 00000000 00000000
Q ss_pred CCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 021490 225 GQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 260 (311)
Q Consensus 225 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l 260 (311)
......+..+.+++.+||..||.+|||+.+++..-
T Consensus 265 -~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~ 299 (343)
T cd07851 265 -EVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHP 299 (343)
T ss_pred -HHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCC
Confidence 00112356889999999999999999999998763
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=230.53 Aligned_cols=230 Identities=27% Similarity=0.370 Sum_probs=178.5
Q ss_pred cCCcEEEEEEeecCCC-cchhHHHHHHHHHhcC-CCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCH
Q 021490 7 CLLQDVAIKQLDRNGV-QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 84 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~ 84 (311)
..|.-+|||.+..... +..+++++.+.++..- ++|+||+.+++|..+...++.||.| +..++.++.. ..+++++
T Consensus 115 s~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM-s~C~ekLlkr---ik~piPE 190 (391)
T KOG0983|consen 115 STGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM-STCAEKLLKR---IKGPIPE 190 (391)
T ss_pred ccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH-HHHHHHHHHH---hcCCchH
Confidence 3578899999876653 4456788888877766 4899999999999999999999998 3566666655 2567999
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccccc
Q 021490 85 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT 164 (311)
Q Consensus 85 ~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 164 (311)
..+-++...+++||.||.++.+ ++|||+||+|||+++.|++|++|||++-..... ....+..|-+.|||||.+..
T Consensus 191 ~ilGk~tva~v~AL~YLKeKH~--viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS---kAhtrsAGC~~YMaPERidp 265 (391)
T KOG0983|consen 191 RILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGNIKLCDFGISGRLVDS---KAHTRSAGCAAYMAPERIDP 265 (391)
T ss_pred HhhhhhHHHHHHHHHHHHHhcc--eeecccCccceEEccCCCEEeecccccceeecc---cccccccCCccccCccccCC
Confidence 9999999999999999998754 999999999999999999999999998643222 22344568889999999865
Q ss_pred ---CCCccccceeehhHHHHHHHhCCCccCcchhHHH-HHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHH
Q 021490 165 ---GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE-QSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAA 240 (311)
Q Consensus 165 ---~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 240 (311)
..|+..+||||||++++||.||+.||.+.+..-. ...+ ..+. .|.+... ...+....+++.
T Consensus 266 ~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkv------ln~e-------PP~L~~~--~gFSp~F~~fv~ 330 (391)
T KOG0983|consen 266 PDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKV------LNEE-------PPLLPGH--MGFSPDFQSFVK 330 (391)
T ss_pred CCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHH------HhcC-------CCCCCcc--cCcCHHHHHHHH
Confidence 4688999999999999999999999987554322 1111 1110 1112111 114557888999
Q ss_pred HccccCCCCCCCHHHHHHHH
Q 021490 241 MCVHEQPDMRPVIADVVTAL 260 (311)
Q Consensus 241 ~~l~~~p~~Rps~~~vl~~l 260 (311)
.||+.|+.+||...++++.-
T Consensus 331 ~CL~kd~r~RP~Y~~Ll~h~ 350 (391)
T KOG0983|consen 331 DCLTKDHRKRPKYNKLLEHP 350 (391)
T ss_pred HHhhcCcccCcchHHHhcCc
Confidence 99999999999999998653
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=247.72 Aligned_cols=237 Identities=22% Similarity=0.285 Sum_probs=172.8
Q ss_pred cCCcEEEEEEeecCCC--cchhHHHHHHHHHhcCCCCcccceeeEeeeCC------eeEEEEecCCCCChhhhhcccCCC
Q 021490 7 CLLQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGD------QRLLVYEYMPLGSVEDHLHDLSPG 78 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~ 78 (311)
..|+.||+|++..... .....+.+|+.+++.++||||+++++++.... ..++|+||+. .+|...+.
T Consensus 38 ~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~----- 111 (342)
T cd07879 38 RTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQ-TDLQKIMG----- 111 (342)
T ss_pred CCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEecccc-cCHHHHHc-----
Confidence 4689999999865422 22356889999999999999999999986542 4699999985 46766542
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccC
Q 021490 79 KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCA 158 (311)
Q Consensus 79 ~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~a 158 (311)
..+++..+..++.|++.||+|||+.+ ++||||+|+||+++.++.++|+|||++...... .....++..|+|
T Consensus 112 -~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~-----~~~~~~~~~y~a 182 (342)
T cd07879 112 -HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRA 182 (342)
T ss_pred -CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC-----CCCceeeecccC
Confidence 35899999999999999999999999 999999999999999999999999998643221 112346778999
Q ss_pred cccccc-CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhh----hhccccc----c------ccccCccc
Q 021490 159 PEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARP----LFQDRTR----H------SLIADPEL 223 (311)
Q Consensus 159 PE~~~~-~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~----~~~~~~~----~------~~~~~~~~ 223 (311)
||.+.+ ..++.++|+||||+++|+|++|+.||...+............. .+..... . .......+
T Consensus 183 PE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (342)
T cd07879 183 PEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDF 262 (342)
T ss_pred hhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchH
Confidence 998865 4678899999999999999999999987554332221111100 0000000 0 00000000
Q ss_pred cCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 021490 224 QGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 224 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~ 259 (311)
.. ..+..+..+.+++.+||+.||.+|||+.+++..
T Consensus 263 ~~-~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h 297 (342)
T cd07879 263 ST-LFPKASPQAVDLLEKMLELDVDKRLTATEALEH 297 (342)
T ss_pred HH-HhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 011234568899999999999999999999965
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=260.73 Aligned_cols=237 Identities=26% Similarity=0.403 Sum_probs=188.3
Q ss_pred CcEEEEEEeecCCC-cchhHHHHHHHHHhcC-CCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccC---CC-----
Q 021490 9 LQDVAIKQLDRNGV-QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLS---PG----- 78 (311)
Q Consensus 9 g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~----- 78 (311)
...||||.++.... ...+.+..|+++|..+ .|+||+.+++++......++|+||+..|+|.+++.... .-
T Consensus 328 ~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~ 407 (609)
T KOG0200|consen 328 YVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGV 407 (609)
T ss_pred eEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCC
Confidence 57899999876543 3457899999999999 69999999999999899999999999999999998744 00
Q ss_pred --C--CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceee-eecccc
Q 021490 79 --K--KPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVS-TRVMGT 153 (311)
Q Consensus 79 --~--~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~-~~~~~~ 153 (311)
. ..++....+.++.||+.|++||++.. ++||||..+|||++++..+||+|||+++........... .....+
T Consensus 408 ~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP 484 (609)
T KOG0200|consen 408 FPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLP 484 (609)
T ss_pred CccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccc
Confidence 0 13899999999999999999999999 999999999999999999999999999854333322211 111146
Q ss_pred ccccCccccccCCCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhH
Q 021490 154 YGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGF 232 (311)
Q Consensus 154 ~~y~aPE~~~~~~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (311)
..|||||.+....++.++||||||+++|||++ |..||.+...... +..+ ... ..+..-|....
T Consensus 485 ~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~--l~~~----l~~----------G~r~~~P~~c~ 548 (609)
T KOG0200|consen 485 VKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEE--LLEF----LKE----------GNRMEQPEHCS 548 (609)
T ss_pred eeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHH--HHHH----Hhc----------CCCCCCCCCCC
Confidence 67999999999999999999999999999999 8899987331111 1111 111 11112233445
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHHHHhh
Q 021490 233 YQALAVAAMCVHEQPDMRPVIADVVTALAYLA 264 (311)
Q Consensus 233 ~~l~~li~~~l~~~p~~Rps~~~vl~~l~~~~ 264 (311)
.++.++++.||+.+|++||++.++.+.+....
T Consensus 549 ~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 549 DEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred HHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 68889999999999999999999999998753
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=246.94 Aligned_cols=240 Identities=21% Similarity=0.243 Sum_probs=175.6
Q ss_pred cCCcEEEEEEeecCCC--cchhHHHHHHHHHhcCCCCcccceeeEeeeCC------eeEEEEecCCCCChhhhhcccCCC
Q 021490 7 CLLQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGD------QRLLVYEYMPLGSVEDHLHDLSPG 78 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~ 78 (311)
.+|..||||++..... .....+.+|+.+++.++||||+++++++..+. ..++||||+ |++|.+++..
T Consensus 38 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~---- 112 (343)
T cd07880 38 RTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKH---- 112 (343)
T ss_pred CCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEEEecC-CCCHHHHHhc----
Confidence 4689999999864322 22357889999999999999999999986553 358999998 7799888764
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccC
Q 021490 79 KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCA 158 (311)
Q Consensus 79 ~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~a 158 (311)
..+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++...... .....++..|++
T Consensus 113 -~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~a 183 (343)
T cd07880 113 -EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSE-----MTGYVVTRWYRA 183 (343)
T ss_pred -CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccccccccC-----ccccccCCcccC
Confidence 46899999999999999999999999 999999999999999999999999998743221 122346788999
Q ss_pred cccccc-CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHH-HHHhhh---hhcccc-----ccccccCccc----c
Q 021490 159 PEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSL-VAWARP---LFQDRT-----RHSLIADPEL----Q 224 (311)
Q Consensus 159 PE~~~~-~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~-~~~~~~---~~~~~~-----~~~~~~~~~~----~ 224 (311)
||.+.+ ..++.++|+||||+++|+|++|..||........... ...... .+.... ......-+.. .
T Consensus 184 PE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (343)
T cd07880 184 PEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDF 263 (343)
T ss_pred HHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchH
Confidence 998865 4578899999999999999999999976554322111 100000 000000 0000000000 0
Q ss_pred CCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 021490 225 GQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 260 (311)
Q Consensus 225 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l 260 (311)
....+.....+.+++.+||..||++|||+.+++..-
T Consensus 264 ~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~ 299 (343)
T cd07880 264 RSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHP 299 (343)
T ss_pred HHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence 011123344688999999999999999999999653
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=250.86 Aligned_cols=224 Identities=25% Similarity=0.291 Sum_probs=190.0
Q ss_pred EEEEEeecCCCc---chhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHHHH
Q 021490 12 VAIKQLDRNGVQ---GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRM 88 (311)
Q Consensus 12 vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~ 88 (311)
.|+|++++...- ..+.+..|-++|...+.|+||++|..|.++...|+.||-|-||.|...+.. .+.|+..++.
T Consensus 448 fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGElWTiLrd----Rg~Fdd~tar 523 (732)
T KOG0614|consen 448 FALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGGELWTILRD----RGSFDDYTAR 523 (732)
T ss_pred HHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCchhhhhhhh----cCCcccchhh
Confidence 788888776543 345778899999999999999999999999999999999999999999987 7889999999
Q ss_pred HHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccCCCc
Q 021490 89 KIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLT 168 (311)
Q Consensus 89 ~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 168 (311)
.++..++.|++|||++| |++|||||+|++++.+|.+||.|||.+.....+.. .-...||+.|.|||++.....+
T Consensus 524 F~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~K---TwTFcGTpEYVAPEIILnKGHD 597 (732)
T KOG0614|consen 524 FYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRK---TWTFCGTPEYVAPEIILNKGHD 597 (732)
T ss_pred hhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccCCc---eeeecCCcccccchhhhccCcc
Confidence 99999999999999999 99999999999999999999999999986543332 2335699999999999999999
Q ss_pred cccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCC
Q 021490 169 LKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPD 248 (311)
Q Consensus 169 ~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~ 248 (311)
.++|.||||+++|||++|.+||.+.+.....+.+-.....+ .+|........+|+++.++.+|.
T Consensus 598 ~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i----------------~~Pr~I~k~a~~Lik~LCr~~P~ 661 (732)
T KOG0614|consen 598 RAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKI----------------EFPRRITKTATDLIKKLCRDNPT 661 (732)
T ss_pred hhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhh----------------hcccccchhHHHHHHHHHhcCcH
Confidence 99999999999999999999999998877666553332111 23444555778899999999999
Q ss_pred CCCC-----HHHHHHHHH
Q 021490 249 MRPV-----IADVVTALA 261 (311)
Q Consensus 249 ~Rps-----~~~vl~~l~ 261 (311)
+|.- +.|+.+.-+
T Consensus 662 ERLG~~~~gI~DIkkH~W 679 (732)
T KOG0614|consen 662 ERLGYQKGGINDIKKHRW 679 (732)
T ss_pred hhhccccCChHHHHhhhh
Confidence 9964 666666543
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=243.92 Aligned_cols=240 Identities=21% Similarity=0.236 Sum_probs=175.5
Q ss_pred cCCcEEEEEEeecCCC--cchhHHHHHHHHHhcCCCCcccceeeEeeeC------CeeEEEEecCCCCChhhhhcccCCC
Q 021490 7 CLLQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADG------DQRLLVYEYMPLGSVEDHLHDLSPG 78 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~ 78 (311)
.+|+.||+|+++.... ...+.+.+|+.++..++||||+++++++... ...+++++++ |++|.+++..
T Consensus 40 ~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~---- 114 (345)
T cd07877 40 KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC---- 114 (345)
T ss_pred CCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEEehhc-ccCHHHHHhc----
Confidence 4789999999865432 2346788899999999999999999988543 3468888887 7899888764
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccC
Q 021490 79 KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCA 158 (311)
Q Consensus 79 ~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~a 158 (311)
..+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++..... ......++..|+|
T Consensus 115 -~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~-----~~~~~~~~~~y~a 185 (345)
T cd07877 115 -QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRWYRA 185 (345)
T ss_pred -CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEEecccccccccc-----cccccccCCCccC
Confidence 46899999999999999999999999 99999999999999999999999999864321 1122356788999
Q ss_pred cccccc-CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhh----h----hcccccc------ccccCccc
Q 021490 159 PEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARP----L----FQDRTRH------SLIADPEL 223 (311)
Q Consensus 159 PE~~~~-~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~----~----~~~~~~~------~~~~~~~~ 223 (311)
||.+.+ ..++.++|||||||++|+|++|..||...........+..... . +...... .......+
T Consensus 186 PE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (345)
T cd07877 186 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNF 265 (345)
T ss_pred HHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcch
Confidence 998765 5678899999999999999999999975543322111100000 0 0000000 00000000
Q ss_pred cCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 021490 224 QGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 261 (311)
Q Consensus 224 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l~ 261 (311)
. ......+..+.+++.+||+.||.+|||+.+++..-.
T Consensus 266 ~-~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~ 302 (345)
T cd07877 266 A-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 302 (345)
T ss_pred h-hhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChh
Confidence 0 000112457889999999999999999999998754
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=238.47 Aligned_cols=249 Identities=29% Similarity=0.375 Sum_probs=183.6
Q ss_pred CcEEEEEEeecCCCcchhHHHHHHHHHhcC--CCCcccceeeEeeeCC----eeEEEEecCCCCChhhhhcccCCCCCCC
Q 021490 9 LQDVAIKQLDRNGVQGNREFLVEVLMLSLL--HHPNLVNLIGYCADGD----QRLLVYEYMPLGSVEDHLHDLSPGKKPL 82 (311)
Q Consensus 9 g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l--~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~l 82 (311)
++.||||++... ....|.+|-++++.. .|+||+.++++-.... .+.||++|.+.|+|.++|+. ..+
T Consensus 233 ~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL~~-----nti 304 (534)
T KOG3653|consen 233 NRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPKGSLCDYLKA-----NTI 304 (534)
T ss_pred CceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeeccCCcHHHHHHh-----ccc
Confidence 599999999643 345777887777654 7999999999876555 78999999999999999996 679
Q ss_pred CHHHHHHHHHHHHHHHHHhhcCC------CCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccc
Q 021490 83 DWNTRMKIAAGAARGLEYLHDKA------KPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY 156 (311)
Q Consensus 83 ~~~~~~~~~~~i~~~l~~lh~~~------~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y 156 (311)
+|.....++..++.||+|||+.- +++|+|||||..||||.+++++.|+|||++............-..+||.+|
T Consensus 305 sw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RY 384 (534)
T KOG3653|consen 305 SWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRY 384 (534)
T ss_pred cHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhh
Confidence 99999999999999999999742 668999999999999999999999999999876655555545557899999
Q ss_pred cCccccccCC-C-----ccccceeehhHHHHHHHhCCCccCcchhHHHHH----------HHHHhhhhhccccccccccC
Q 021490 157 CAPEYAKTGQ-L-----TLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQS----------LVAWARPLFQDRTRHSLIAD 220 (311)
Q Consensus 157 ~aPE~~~~~~-~-----~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~ 220 (311)
||||++.+.. + -.+.||||+|.++|||+++-..+........+- -+...+........+..+.+
T Consensus 385 MAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~ 464 (534)
T KOG3653|consen 385 MAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPD 464 (534)
T ss_pred cCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChh
Confidence 9999997632 2 236899999999999998643332111100000 00000000111111111111
Q ss_pred ccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhccCC
Q 021490 221 PELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQKYE 269 (311)
Q Consensus 221 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~~~~ 269 (311)
.=..+ ....-+.+.+..||..||+-|.|+.=+.+++..+......
T Consensus 465 ~W~~h----~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~ 509 (534)
T KOG3653|consen 465 AWRKH----AGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED 509 (534)
T ss_pred hhhcC----ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence 10000 2344677899999999999999999999999988876655
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=246.69 Aligned_cols=228 Identities=24% Similarity=0.280 Sum_probs=182.7
Q ss_pred cCCcEEEEEEeecCCC--cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCH
Q 021490 7 CLLQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 84 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~ 84 (311)
++|++||||++.+... ...+++.+|+.+|.++.||.||.+-..|++.+..++|||.+.| +..+.+-+ ...+++++
T Consensus 587 ktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G-DMLEMILS--sEkgRL~e 663 (888)
T KOG4236|consen 587 KTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG-DMLEMILS--SEKGRLPE 663 (888)
T ss_pred ccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-hHHHHHHH--hhcccchH
Confidence 4799999999987643 3446889999999999999999999999999999999999965 55454433 23688999
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCC---CceEEccccccccCCCCCCceeeeeccccccccCccc
Q 021490 85 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG---YHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 161 (311)
Q Consensus 85 ~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~---~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 161 (311)
.....++.||+.||.|||-+| |+|+||||+|||+... ..+||+|||.++.++.. ......+||+.|+|||+
T Consensus 664 r~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk---sFRrsVVGTPAYLaPEV 737 (888)
T KOG4236|consen 664 RITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK---SFRRSVVGTPAYLAPEV 737 (888)
T ss_pred HHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchh---hhhhhhcCCccccCHHH
Confidence 999999999999999999999 9999999999999653 47999999999865433 33445679999999999
Q ss_pred cccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHH
Q 021490 162 AKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAM 241 (311)
Q Consensus 162 ~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 241 (311)
+....|...-|+||.|+|+|.-+.|..||...+....+ ++.. .++.| ..-..+.+...++||..
T Consensus 738 LrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQ--IQNA-----------aFMyP---p~PW~eis~~AidlIn~ 801 (888)
T KOG4236|consen 738 LRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQ--IQNA-----------AFMYP---PNPWSEISPEAIDLINN 801 (888)
T ss_pred HhhccccccccceeeeEEEEEEecccccCCCccchhHH--hhcc-----------ccccC---CCchhhcCHHHHHHHHH
Confidence 99999999999999999999999999999865532211 1101 11111 11123445588999999
Q ss_pred ccccCCCCCCCHHHHHHH
Q 021490 242 CVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 242 ~l~~~p~~Rps~~~vl~~ 259 (311)
.|++.-.+|-|+...+..
T Consensus 802 LLqVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 802 LLQVKMRKRYSVDKSLSH 819 (888)
T ss_pred HHHHHHHHhcchHhhccc
Confidence 999999999998876643
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=232.01 Aligned_cols=255 Identities=22% Similarity=0.234 Sum_probs=182.6
Q ss_pred cEEEEEEeecCCC-cch-hHHHHHHHHHhcCCCCcccceeeEeee-CCeeEEEEecCCCCChhhhhcccC-CCCCCCCHH
Q 021490 10 QDVAIKQLDRNGV-QGN-REFLVEVLMLSLLHHPNLVNLIGYCAD-GDQRLLVYEYMPLGSVEDHLHDLS-PGKKPLDWN 85 (311)
Q Consensus 10 ~~vaiK~~~~~~~-~~~-~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~l~~~ 85 (311)
+.+|||.++.... +.. ....+|+.+++.++|||++.+..+|.. +...++++||.+ -+|...++-.. .....++..
T Consensus 54 k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~ 132 (438)
T KOG0666|consen 54 KEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWLLFDYAE-HDLWHIIKFHRASKAKQLPRS 132 (438)
T ss_pred hhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEEehhhh-hhHHHHHHHhccchhccCCHH
Confidence 4689998866521 222 356789999999999999999999977 778999999997 57877765432 223579999
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCC----CceEEccccccccCCCCCC-ceeeeeccccccccCcc
Q 021490 86 TRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG----YHPKLSDFGLAKLGPVGDN-THVSTRVMGTYGYCAPE 160 (311)
Q Consensus 86 ~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~----~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~y~aPE 160 (311)
.+..++.||+.|+.|||++= ++||||||.|||+..+ |.|||+|||+++.....-. .......+-|.+|.|||
T Consensus 133 mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPE 209 (438)
T KOG0666|consen 133 MVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPE 209 (438)
T ss_pred HHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChH
Confidence 99999999999999999996 9999999999999877 9999999999987433221 22334456789999999
Q ss_pred cccc-CCCccccceeehhHHHHHHHhCCCccCcchhHHHHH---HHHHhhhhhc------cccccccccCccc-------
Q 021490 161 YAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQS---LVAWARPLFQ------DRTRHSLIADPEL------- 223 (311)
Q Consensus 161 ~~~~-~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~---~~~~~~~~~~------~~~~~~~~~~~~~------- 223 (311)
.+.+ ..||.+.|+||+|||+.||+|-.+.|.+........ -......++. +........-|+.
T Consensus 210 LLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f 289 (438)
T KOG0666|consen 210 LLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDF 289 (438)
T ss_pred HhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHh
Confidence 8876 678999999999999999999998887655432211 0000011110 0000000001111
Q ss_pred c-CCCCh-----------HhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhccC
Q 021490 224 Q-GQYPP-----------RGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQKY 268 (311)
Q Consensus 224 ~-~~~~~-----------~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~~~ 268 (311)
. ..+.. .-+...++|+.++|++||.+|.|+++.++...+....-+
T Consensus 290 ~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~d~lp 346 (438)
T KOG0666|consen 290 RRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFTEDPLP 346 (438)
T ss_pred HHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccccccCCCC
Confidence 0 00010 012347889999999999999999999998776655433
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=261.26 Aligned_cols=235 Identities=23% Similarity=0.264 Sum_probs=187.2
Q ss_pred CCcEEEEEEeecCC---CcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCH
Q 021490 8 LLQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 84 (311)
Q Consensus 8 ~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~ 84 (311)
.++-+|+|++++-. ......|..|-.+|..-+.+.|+.++.+|.++.++|+||||++||+|-.++.. ...+++
T Consensus 99 t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~pGGDlltLlSk----~~~~pE 174 (1317)
T KOG0612|consen 99 TEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYMPGGDLLTLLSK----FDRLPE 174 (1317)
T ss_pred cccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEecccCchHHHHHhh----cCCChH
Confidence 57889999987632 23446788899999888899999999999999999999999999999999987 347999
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccccc
Q 021490 85 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT 164 (311)
Q Consensus 85 ~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 164 (311)
..+..++..++.||..+|+.| +|||||||+|||++..|.+||.|||.|..+... +.-.....+|||.|++||+++.
T Consensus 175 ~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGsClkm~~d-G~V~s~~aVGTPDYISPEvLqs 250 (1317)
T KOG0612|consen 175 DWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGSCLKMDAD-GTVRSSVAVGTPDYISPEVLQS 250 (1317)
T ss_pred HHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchhHHhcCCC-CcEEeccccCCCCccCHHHHHh
Confidence 999999999999999999999 999999999999999999999999999765433 3344555789999999999853
Q ss_pred -----CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCC--hHhHHHHHH
Q 021490 165 -----GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYP--PRGFYQALA 237 (311)
Q Consensus 165 -----~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~ 237 (311)
+.|+..+|+||+||++|||+.|..||......... ..++...... .+| ...+.+..+
T Consensus 251 ~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY------~KIm~hk~~l----------~FP~~~~VSeeakd 314 (1317)
T KOG0612|consen 251 QGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETY------GKIMNHKESL----------SFPDETDVSEEAKD 314 (1317)
T ss_pred hcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHH------HHHhchhhhc----------CCCcccccCHHHHH
Confidence 56889999999999999999999999876544332 2223321111 112 235668888
Q ss_pred HHHHccccCCCCCCC---HHHHHHHHHHhhhccC
Q 021490 238 VAAMCVHEQPDMRPV---IADVVTALAYLASQKY 268 (311)
Q Consensus 238 li~~~l~~~p~~Rps---~~~vl~~l~~~~~~~~ 268 (311)
||...+. +|..|.. ++++-... ++....|
T Consensus 315 LI~~ll~-~~e~RLgrngiedik~Hp-FF~g~~W 346 (1317)
T KOG0612|consen 315 LIEALLC-DREVRLGRNGIEDIKNHP-FFEGIDW 346 (1317)
T ss_pred HHHHHhc-ChhhhcccccHHHHHhCc-cccCCCh
Confidence 9988765 5778877 88887664 3333443
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-32 Score=232.56 Aligned_cols=239 Identities=27% Similarity=0.336 Sum_probs=181.5
Q ss_pred ccCCcEEEEEEeecCCCc-c------hhHHHHHHHHHhcCCCCcccceeeEee-eCCeeEEEEecCCCCChhhhhcccCC
Q 021490 6 LCLLQDVAIKQLDRNGVQ-G------NREFLVEVLMLSLLHHPNLVNLIGYCA-DGDQRLLVYEYMPLGSVEDHLHDLSP 77 (311)
Q Consensus 6 ~~~g~~vaiK~~~~~~~~-~------~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~ 77 (311)
+...+-||+|+-..+..+ + .+...+|..+-+.|+||.||++|++|. +....|-|+|||+|.+|+.+|++
T Consensus 485 l~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYLKQ--- 561 (775)
T KOG1151|consen 485 LTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQ--- 561 (775)
T ss_pred cchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeeeeecCCCchhHHHHh---
Confidence 446788999984333211 1 135668999999999999999999995 45678999999999999999998
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEc---CCCceEEccccccccCCCCCCc-----eeeee
Q 021490 78 GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD---RGYHPKLSDFGLAKLGPVGDNT-----HVSTR 149 (311)
Q Consensus 78 ~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~---~~~~~~l~df~~~~~~~~~~~~-----~~~~~ 149 (311)
...+++.++..|+.||+.||.||-+. ++||+|-||||.|||+- ..|.+||+|||++..+...... .....
T Consensus 562 -hklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQ 639 (775)
T KOG1151|consen 562 -HKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQ 639 (775)
T ss_pred -hhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecc
Confidence 78899999999999999999999988 68899999999999995 4578999999999876543322 23344
Q ss_pred ccccccccCcccccc----CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccC
Q 021490 150 VMGTYGYCAPEYAKT----GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQG 225 (311)
Q Consensus 150 ~~~~~~y~aPE~~~~----~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (311)
..||.+|++||++.- ..++.++||||+|||+|..+.|+.||...-.. ++++. ...++.. .+..-
T Consensus 640 gAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ--QdILq-eNTIlkA---------tEVqF 707 (775)
T KOG1151|consen 640 GAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ--QDILQ-ENTILKA---------TEVQF 707 (775)
T ss_pred cCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH--HHHHh-hhchhcc---------eeccC
Confidence 679999999998743 45788999999999999999999999754321 11111 0000100 00111
Q ss_pred CCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 021490 226 QYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 261 (311)
Q Consensus 226 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l~ 261 (311)
..-|..+.+..++|.+||++.-++|..+.++...-.
T Consensus 708 P~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpy 743 (775)
T KOG1151|consen 708 PPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPY 743 (775)
T ss_pred CCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCcc
Confidence 112344557888999999999999988888776543
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=233.21 Aligned_cols=238 Identities=26% Similarity=0.340 Sum_probs=177.0
Q ss_pred CcEEEEEEeecCCCcchhHHHHHHHHHhcC--CCCcccceeeEeeeC----CeeEEEEecCCCCChhhhhcccCCCCCCC
Q 021490 9 LQDVAIKQLDRNGVQGNREFLVEVLMLSLL--HHPNLVNLIGYCADG----DQRLLVYEYMPLGSVEDHLHDLSPGKKPL 82 (311)
Q Consensus 9 g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l--~h~~i~~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~l 82 (311)
|..||||++... +...+.+|.++.+.. +|+||+.+++.-..+ .+++||++|.+.|||.++|.. ..+
T Consensus 234 Ge~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r-----~tv 305 (513)
T KOG2052|consen 234 GEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR-----NTV 305 (513)
T ss_pred CCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhh-----ccC
Confidence 789999999543 345677788888654 999999999875433 268999999999999999986 679
Q ss_pred CHHHHHHHHHHHHHHHHHhh-----cCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCc--eeeeecccccc
Q 021490 83 DWNTRMKIAAGAARGLEYLH-----DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT--HVSTRVMGTYG 155 (311)
Q Consensus 83 ~~~~~~~~~~~i~~~l~~lh-----~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~~ 155 (311)
+....++++..+|+||++|| .+|+++|.|||||..||||..+|.+.|+|+|++......... ...+..+||.+
T Consensus 306 ~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKR 385 (513)
T KOG2052|consen 306 TTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKR 385 (513)
T ss_pred CHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceee
Confidence 99999999999999999999 467889999999999999999999999999999764433222 23345689999
Q ss_pred ccCccccccCCC------ccccceeehhHHHHHHHhC----------CCccCcchhHHHHHHHHHhhhhhcccccccccc
Q 021490 156 YCAPEYAKTGQL------TLKSDVYSFGVVLLEILSG----------RKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA 219 (311)
Q Consensus 156 y~aPE~~~~~~~------~~~~DiwslG~l~~~ll~g----------~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 219 (311)
|||||++...-. -..+||||||.++||+..+ +.||...-..+.. .+.+... .+
T Consensus 386 YMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs--~eeMrkV--------VC- 454 (513)
T KOG2052|consen 386 YMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPS--FEEMRKV--------VC- 454 (513)
T ss_pred ccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCC--HHHHhcc--------ee-
Confidence 999999965321 2469999999999998753 2444321110000 0000000 00
Q ss_pred CccccCCCC-----hHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhh
Q 021490 220 DPELQGQYP-----PRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLAS 265 (311)
Q Consensus 220 ~~~~~~~~~-----~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l~~~~~ 265 (311)
...++..+| .+.+..+.+|++.||..||.-|.|+-.+-+.|..+.+
T Consensus 455 v~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 455 VQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred ecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 011111111 2445678889999999999999999999999988874
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-31 Score=232.53 Aligned_cols=209 Identities=14% Similarity=0.134 Sum_probs=154.3
Q ss_pred HHHHHhcCCCCcccceeeEeeeCC----eeEEEEecCCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC
Q 021490 31 EVLMLSLLHHPNLVNLIGYCADGD----QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAK 106 (311)
Q Consensus 31 e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~ 106 (311)
+...+..+.|+|++++++.+.... ..+++++++. .++.+.+.. ....++..+..++.|++.||+|||+.+
T Consensus 73 ~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~- 146 (294)
T PHA02882 73 LWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKR----IKCKNKKLIKNIMKDMLTTLEYIHEHG- 146 (294)
T ss_pred HHHHhccCCCCCCCcEEEeeeEecCCceEEEEEEehhc-cCHHHHHHh----hccCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 344556778999999998765443 3477888774 567666654 334678889999999999999999999
Q ss_pred CCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCc-----eeeeeccccccccCccccccCCCccccceeehhHHHH
Q 021490 107 PPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT-----HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLL 181 (311)
Q Consensus 107 ~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~l~~ 181 (311)
++||||||+|||++.++.++|+|||++......... .......++..|+|||++.+..++.++|||||||++|
T Consensus 147 --iiHrDiKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~ 224 (294)
T PHA02882 147 --ISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCML 224 (294)
T ss_pred --eecCCCCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHH
Confidence 999999999999999999999999998754221111 1112235899999999999999999999999999999
Q ss_pred HHHhCCCccCcchhHHHH-H--HHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 021490 182 EILSGRKAVDTSKAAAEQ-S--LVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 258 (311)
Q Consensus 182 ~ll~g~~pf~~~~~~~~~-~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~ 258 (311)
+|++|..||......... . ...+....... .. ..+..+..+.+++..||+.+|.+||++.++++
T Consensus 225 el~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~-----~~--------~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 225 KWAGIKLPWKGFGHNGNLIHAAKCDFIKRLHEG-----KI--------KIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HHHhCCCCCCccccchHHHHHhHHHHHHHhhhh-----hh--------ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 999999999766322111 1 01111111000 00 01112357889999999999999999999998
Q ss_pred HH
Q 021490 259 AL 260 (311)
Q Consensus 259 ~l 260 (311)
.+
T Consensus 292 ~~ 293 (294)
T PHA02882 292 IF 293 (294)
T ss_pred hh
Confidence 75
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-32 Score=256.24 Aligned_cols=122 Identities=31% Similarity=0.370 Sum_probs=110.6
Q ss_pred CCcEEEEEEeecCCCc---chhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCH
Q 021490 8 LLQDVAIKQLDRNGVQ---GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 84 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~ 84 (311)
+|..||||+++..... ....+..|+.++..++||||+++++++......|+||||+.|++|.+++.. .+.+++
T Consensus 28 ~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g~~L~~li~~----~~~l~~ 103 (669)
T cd05610 28 NSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHI----YGYFDE 103 (669)
T ss_pred CCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCCCCCHHHHHHh----cCCCCH
Confidence 6899999999754332 236788899999999999999999999999999999999999999999976 457899
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccc
Q 021490 85 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 136 (311)
Q Consensus 85 ~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~ 136 (311)
..++.++.||+.||.|||..+ |+||||||+|||++.++.++|+|||++.
T Consensus 104 ~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 104 EMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred HHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999999999999 9999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.3e-32 Score=206.21 Aligned_cols=244 Identities=21% Similarity=0.241 Sum_probs=189.8
Q ss_pred CCcEEEEEEeecCCC--cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHH
Q 021490 8 LLQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN 85 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~ 85 (311)
.+.-||+|.+..... .......+|+-+++.+.|.||++++++...+..+.+|+|||+ .+|..+..+. ++.++..
T Consensus 26 t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cd-qdlkkyfdsl---ng~~d~~ 101 (292)
T KOG0662|consen 26 THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD-QDLKKYFDSL---NGDLDPE 101 (292)
T ss_pred ccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhh-HHHHHHHHhc---CCcCCHH
Confidence 467899999866543 223578899999999999999999999999999999999995 6888888764 6789999
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccccc-
Q 021490 86 TRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT- 164 (311)
Q Consensus 86 ~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~- 164 (311)
.+..++.|+++||.|+|+++ +.|||+||+|.+++.+|++|+.|||+++..+. ........+-|.+|.+|.++.+
T Consensus 102 ~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgi--pvrcysaevvtlwyrppdvlfga 176 (292)
T KOG0662|consen 102 IVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGI--PVRCYSAEVVTLWYRPPDVLFGA 176 (292)
T ss_pred HHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCC--ceEeeeceeeeeeccCcceeeee
Confidence 99999999999999999999 99999999999999999999999999986432 3333444567899999999887
Q ss_pred CCCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhcccccc--ccccCccccCCCC---------hHhH
Q 021490 165 GQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRH--SLIADPELQGQYP---------PRGF 232 (311)
Q Consensus 165 ~~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~---------~~~~ 232 (311)
.-|+.+.|+||-||++.|+.. |.+.|.+.+..+....+-+......+.... ..+.|-.....++ +...
T Consensus 177 kly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~ln 256 (292)
T KOG0662|consen 177 KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLN 256 (292)
T ss_pred ehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhc
Confidence 457889999999999999987 777788888777766555543322222111 1112211111222 2233
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHH
Q 021490 233 YQALAVAAMCVHEQPDMRPVIADVVTAL 260 (311)
Q Consensus 233 ~~l~~li~~~l~~~p~~Rps~~~vl~~l 260 (311)
..-.+++++.|.-+|.+|.++++.++..
T Consensus 257 s~grdllqkll~cnp~qrisaeaalqhp 284 (292)
T KOG0662|consen 257 STGRDLLQKLLKCNPAQRISAEAALQHP 284 (292)
T ss_pred chhHHHHHHHhccCcccccCHHHHhcCc
Confidence 3456799999999999999999988764
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-32 Score=258.06 Aligned_cols=180 Identities=27% Similarity=0.407 Sum_probs=132.9
Q ss_pred eEEEEecCCCCChhhhhcccCCCCCCC-CHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccc
Q 021490 56 RLLVYEYMPLGSVEDHLHDLSPGKKPL-DWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL 134 (311)
Q Consensus 56 ~~lv~e~~~~~~L~~~l~~~~~~~~~l-~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~ 134 (311)
+||-||||+..+|.+.+.+ +... .....|.++.+|+.||+|+|++| ++||||||.|||+++++.|||+|||+
T Consensus 671 LYIQMEyCE~~ll~~iI~~----N~~~~~~d~~wrLFreIlEGLaYIH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGL 743 (1351)
T KOG1035|consen 671 LYIQMEYCEKTLLRDIIRR----NHFNSQRDEAWRLFREILEGLAYIHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGL 743 (1351)
T ss_pred EEEEHhhhhhhHHHHHHHh----cccchhhHHHHHHHHHHHHHHHHHHhCc---eeeccCCcceeEEcCCCCeeeccccc
Confidence 4778889987777777766 2322 57889999999999999999999 99999999999999999999999999
Q ss_pred cccCC----------------CCCCceeeeeccccccccCccccccC---CCccccceeehhHHHHHHHhCCCccCcchh
Q 021490 135 AKLGP----------------VGDNTHVSTRVMGTYGYCAPEYAKTG---QLTLKSDVYSFGVVLLEILSGRKAVDTSKA 195 (311)
Q Consensus 135 ~~~~~----------------~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~DiwslG~l~~~ll~g~~pf~~~~~ 195 (311)
+.... .+.+....+..+||.-|+|||++.+. .|+.++|+||||++++||+. ||.+...
T Consensus 744 At~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsME 820 (1351)
T KOG1035|consen 744 ATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSME 820 (1351)
T ss_pred chhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCchHH
Confidence 87511 01111223456899999999999764 49999999999999999984 4766543
Q ss_pred HHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 021490 196 AAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 258 (311)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~ 258 (311)
... .+.. .. ...+..+ ..+.......-..+|.+|++.||.+|||+.|++.
T Consensus 821 Ra~--iL~~----LR----~g~iP~~---~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 821 RAS--ILTN----LR----KGSIPEP---ADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHH--HHHh----cc----cCCCCCC---cccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 221 1111 11 0011111 2223334445677999999999999999999985
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-33 Score=227.15 Aligned_cols=236 Identities=24% Similarity=0.271 Sum_probs=179.4
Q ss_pred cCCcEEEEEEeecCCC-cchhHHHHHHHHHhcC-CCCcccceeeEeeeCCeeEEEEecCCCCChhhhhccc-CCCCCCCC
Q 021490 7 CLLQDVAIKQLDRNGV-QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDL-SPGKKPLD 83 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~l~ 83 (311)
.+|+.+|||.+..... .++++++.|.....+- ++||||+++++...+..++++||+|+ .||+.+.... ......++
T Consensus 87 ~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd-~SlDklYk~vy~vq~~~ip 165 (361)
T KOG1006|consen 87 PSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD-ISLDKLYKRVYSVQKSRIP 165 (361)
T ss_pred ccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-hhHHHHHHHHHHHHhccCc
Confidence 4799999999988765 5667899988877666 68999999999999999999999995 7776654321 11246799
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccc
Q 021490 84 WNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 163 (311)
Q Consensus 84 ~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 163 (311)
+..+-.+....+.||.||...-+ |+|||+||+|||++..|.|||+|||++-.... ....+...|-..|+|||.+.
T Consensus 166 E~Ilg~ItvatV~AL~yLK~~lk--iIHRDvKPSNILldr~G~vKLCDFGIcGqLv~---SiAkT~daGCrpYmAPERi~ 240 (361)
T KOG1006|consen 166 ENILGHITVATVDALDYLKEELK--IIHRDVKPSNILLDRHGDVKLCDFGICGQLVD---SIAKTVDAGCRPYMAPERID 240 (361)
T ss_pred HhhhhheeeeehhHHHHHHHHhh--hhhccCChhheEEecCCCEeeecccchHhHHH---HHHhhhccCCccccChhccC
Confidence 99999999999999999987643 99999999999999999999999999853211 12233345778899999986
Q ss_pred c--CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHH
Q 021490 164 T--GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAM 241 (311)
Q Consensus 164 ~--~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 241 (311)
. ..|+.++|+||||+++||+.||..||..-+..-++- .......... ... ..-..+.+..+..++..
T Consensus 241 p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql-----~~Vv~gdpp~---l~~---~~~~~~~s~~~~~fint 309 (361)
T KOG1006|consen 241 PSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQL-----CQVVIGDPPI---LLF---DKECVHYSFSMVRFINT 309 (361)
T ss_pred CccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHH-----HHHHcCCCCe---ecC---cccccccCHHHHHHHHH
Confidence 4 468999999999999999999999998765422211 1111110000 000 01112345688999999
Q ss_pred ccccCCCCCCCHHHHHHH
Q 021490 242 CVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 242 ~l~~~p~~Rps~~~vl~~ 259 (311)
||.+|-..||+..++...
T Consensus 310 Cl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 310 CLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred HhhcccccCcchhhhhcC
Confidence 999999999999998865
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=243.73 Aligned_cols=230 Identities=27% Similarity=0.342 Sum_probs=188.2
Q ss_pred cCCcEEEEEEeecCCCcchhHHHHHHHHHhcC-CCCcccceeeEeee-----CCeeEEEEecCCCCChhhhhcccCCCCC
Q 021490 7 CLLQDVAIKQLDRNGVQGNREFLVEVLMLSLL-HHPNLVNLIGYCAD-----GDQRLLVYEYMPLGSVEDHLHDLSPGKK 80 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 80 (311)
.+|+.+|+|++. ...+..++...|+++++.+ .|||++.++++|.. ++.++||||||.|||..++++... +.
T Consensus 42 ~~~~~aa~kI~~-~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~--g~ 118 (953)
T KOG0587|consen 42 KTGQLAAIKIMD-PTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTK--GN 118 (953)
T ss_pred ecCceeeeEeec-CCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhc--cc
Confidence 478899999884 4456667888899999998 69999999999853 468999999999999999999876 78
Q ss_pred CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcc
Q 021490 81 PLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 160 (311)
Q Consensus 81 ~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE 160 (311)
.+.|..+.-+++.++.|+++||.+. ++|||||-.|||++.++.|||.|||.+.... ..........||+.|||||
T Consensus 119 rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDFGvSaQld--sT~grRnT~iGtP~WMAPE 193 (953)
T KOG0587|consen 119 RLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLD--STVGRRNTFIGTPYWMAPE 193 (953)
T ss_pred chhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeeeeeeeeee--cccccccCcCCCcccccce
Confidence 8999999999999999999999998 9999999999999999999999999986532 2223345567999999999
Q ss_pred cccc-----CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHH
Q 021490 161 YAKT-----GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQA 235 (311)
Q Consensus 161 ~~~~-----~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 235 (311)
++.. ..|+..+|+||||++..||-.|.+|+........ +|.. ...|.....-+...+++.
T Consensus 194 Viac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmra---------LF~I------pRNPPPkLkrp~kWs~~F 258 (953)
T KOG0587|consen 194 VIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRA---------LFLI------PRNPPPKLKRPKKWSKKF 258 (953)
T ss_pred eeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhh---------hccC------CCCCCccccchhhHHHHH
Confidence 9853 3567889999999999999999999876544211 1111 112222223356678899
Q ss_pred HHHHHHccccCCCCCCCHHHHHHH
Q 021490 236 LAVAAMCVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 236 ~~li~~~l~~~p~~Rps~~~vl~~ 259 (311)
.++|..||.+|-..||++.++++.
T Consensus 259 ndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 259 NDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred HHHHHHHHhhccccCcchhhhccC
Confidence 999999999999999999998864
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-32 Score=224.85 Aligned_cols=223 Identities=24% Similarity=0.325 Sum_probs=177.6
Q ss_pred CCcEEEEEEeecCC---CcchhHHHHHHHHHhcC-CCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCC
Q 021490 8 LLQDVAIKQLDRNG---VQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLD 83 (311)
Q Consensus 8 ~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~ 83 (311)
..+-+|+|++++.- .++.+.+..|-.++.+- +||++|.+...|.++..+++|.||++||+|--++++ ...++
T Consensus 274 t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~ggdlmfhmqr----qrklp 349 (593)
T KOG0695|consen 274 TDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR----QRKLP 349 (593)
T ss_pred cceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEecCcceeeehhh----hhcCc
Confidence 46889999998753 34456677888888877 699999999999999999999999999999999887 67899
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccc
Q 021490 84 WNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 163 (311)
Q Consensus 84 ~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 163 (311)
++.+..+...|..||.|||++| |++||||.+|+|++..|.+||+|||.+... ...........||+.|.|||++.
T Consensus 350 eeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~--l~~gd~tstfcgtpnyiapeilr 424 (593)
T KOG0695|consen 350 EEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEG--LGPGDTTSTFCGTPNYIAPEILR 424 (593)
T ss_pred HHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcC--CCCCcccccccCCCcccchhhhc
Confidence 9999999999999999999999 999999999999999999999999999752 12223344567999999999999
Q ss_pred cCCCccccceeehhHHHHHHHhCCCccCcch--hHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHH
Q 021490 164 TGQLTLKSDVYSFGVVLLEILSGRKAVDTSK--AAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAM 241 (311)
Q Consensus 164 ~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 241 (311)
+..|..++|+|+||++++||+.|+.||+... +.+........+..... . -.+|...+.....+++.
T Consensus 425 geeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilek----------q--iriprslsvkas~vlkg 492 (593)
T KOG0695|consen 425 GEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEK----------Q--IRIPRSLSVKASHVLKG 492 (593)
T ss_pred ccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhh----------c--ccccceeehhhHHHHHH
Confidence 9999999999999999999999999996432 11111111111111111 1 12334444466679999
Q ss_pred ccccCCCCCC
Q 021490 242 CVHEQPDMRP 251 (311)
Q Consensus 242 ~l~~~p~~Rp 251 (311)
-|.+||.+|.
T Consensus 493 flnkdp~erl 502 (593)
T KOG0695|consen 493 FLNKDPKERL 502 (593)
T ss_pred hhcCCcHHhc
Confidence 9999999993
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-32 Score=219.07 Aligned_cols=253 Identities=23% Similarity=0.296 Sum_probs=186.5
Q ss_pred CCcEEEEEEeecCC-Ccc-hhHHHHHHHHHhcCCCCcccceeeEeeeC--------CeeEEEEecCCCCChhhhhcccCC
Q 021490 8 LLQDVAIKQLDRNG-VQG-NREFLVEVLMLSLLHHPNLVNLIGYCADG--------DQRLLVYEYMPLGSVEDHLHDLSP 77 (311)
Q Consensus 8 ~g~~vaiK~~~~~~-~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~~~ 77 (311)
.|+.||+|++-..+ .+. -....+|+.+|..|.|+|++.++++|... ...|+||++|+ -+|.-.+...
T Consensus 41 ~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~ce-hDLaGlLsn~-- 117 (376)
T KOG0669|consen 41 TGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLVFDFCE-HDLAGLLSNR-- 117 (376)
T ss_pred ccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeeeHHHhh-hhHHHHhcCc--
Confidence 46778888754432 222 24677899999999999999999887432 34799999997 5888888762
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCce--eeeecccccc
Q 021490 78 GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH--VSTRVMGTYG 155 (311)
Q Consensus 78 ~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~--~~~~~~~~~~ 155 (311)
...++..++..++.++..||.|+|+.. |+|||+|+.|+|++.+|.++|.|||+++......+.. .....+-|.+
T Consensus 118 -~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLw 193 (376)
T KOG0669|consen 118 -KVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLW 193 (376)
T ss_pred -cccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccccccceecccccCCCCcccceeeee
Confidence 467999999999999999999999998 9999999999999999999999999997543332221 1234567899
Q ss_pred ccCcccccc-CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccc--------cc-cCccccC
Q 021490 156 YCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHS--------LI-ADPELQG 225 (311)
Q Consensus 156 y~aPE~~~~-~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~-~~~~~~~ 225 (311)
|.+||.+.+ ..+++..|||+-||++.+|++|.+.+.+........++......+....... .+ ..|...+
T Consensus 194 YrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~ 273 (376)
T KOG0669|consen 194 YRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKG 273 (376)
T ss_pred cCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcc
Confidence 999997765 7889999999999999999999999988776666555544322111111000 00 0000000
Q ss_pred CC--------ChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhcc
Q 021490 226 QY--------PPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQK 267 (311)
Q Consensus 226 ~~--------~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~~ 267 (311)
++ |-.-..+.++|+.++|..||.+|+++.+++..-.+.....
T Consensus 274 ~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~ 323 (376)
T KOG0669|consen 274 QKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPM 323 (376)
T ss_pred hhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCc
Confidence 00 0111247889999999999999999999998876655443
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=225.46 Aligned_cols=237 Identities=22% Similarity=0.290 Sum_probs=190.3
Q ss_pred CcEEEEEEeecCCC-cchhHHHHHHHHHhcCCCCcccceeeEee-eCCeeEEEEecCCCCChhhhhcccC----CCCCCC
Q 021490 9 LQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCA-DGDQRLLVYEYMPLGSVEDHLHDLS----PGKKPL 82 (311)
Q Consensus 9 g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~l 82 (311)
-+.|-+|.++.... -....+..|.-++..+.|||++.+.++.. +....+.++.+..-|+|..++..+. ...+.+
T Consensus 314 ~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtv 393 (563)
T KOG1024|consen 314 CQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTV 393 (563)
T ss_pred HHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccch
Confidence 45566666644322 22356778999999999999999999874 4557788999999999999998442 223567
Q ss_pred CHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccc
Q 021490 83 DWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 162 (311)
Q Consensus 83 ~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 162 (311)
+..+...++.|++.|++|||+.+ ++|.||..+|+++++...+||+|=.+++..-..+..........+..||+||.+
T Consensus 394 tt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal 470 (563)
T KOG1024|consen 394 TTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEAL 470 (563)
T ss_pred hHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHH
Confidence 78889999999999999999999 999999999999999999999999998865444444444445567899999999
Q ss_pred ccCCCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHH
Q 021490 163 KTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAM 241 (311)
Q Consensus 163 ~~~~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 241 (311)
....++.++|+||||+++|||+| |+.|+...+..+....+.-+. +-.-|-+++.+|+.++.-
T Consensus 471 ~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGy-----------------RlaQP~NCPDeLf~vMac 533 (563)
T KOG1024|consen 471 QNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGY-----------------RLAQPFNCPDELFTVMAC 533 (563)
T ss_pred hhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccc-----------------eecCCCCCcHHHHHHHHH
Confidence 99999999999999999999999 999998887765544332111 112244566699999999
Q ss_pred ccccCCCCCCCHHHHHHHHHHhhh
Q 021490 242 CVHEQPDMRPVIADVVTALAYLAS 265 (311)
Q Consensus 242 ~l~~~p~~Rps~~~vl~~l~~~~~ 265 (311)
||+..|++|||++++...|..+-.
T Consensus 534 CWallpeeRPsf~Qlv~cLseF~~ 557 (563)
T KOG1024|consen 534 CWALLPEERPSFSQLVICLSEFHT 557 (563)
T ss_pred HHhcCcccCCCHHHHHHHHHHHHH
Confidence 999999999999999999987653
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-32 Score=246.78 Aligned_cols=227 Identities=24% Similarity=0.304 Sum_probs=170.8
Q ss_pred CCcEEEEEEeecCCCcchhHHHHHHHHHhcC-CCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHH
Q 021490 8 LLQDVAIKQLDRNGVQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNT 86 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~ 86 (311)
.|++||||.+-.. -.....+|+..|..- +||||+++++.-.+.+..|++.|.|. .+|.+++..............
T Consensus 532 e~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~-~sL~dlie~~~~d~~~~~~i~ 607 (903)
T KOG1027|consen 532 EGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA-CSLQDLIESSGLDVEMQSDID 607 (903)
T ss_pred CCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh-hhHHHHHhccccchhhccccc
Confidence 4789999987322 234566899999988 69999999999999999999999995 899999987311111112245
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcC---C--CceEEccccccccCCCCCCc-eeeeeccccccccCcc
Q 021490 87 RMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR---G--YHPKLSDFGLAKLGPVGDNT-HVSTRVMGTYGYCAPE 160 (311)
Q Consensus 87 ~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~---~--~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~y~aPE 160 (311)
.+.++.|+++||++||+.+ |+||||||+||||+. + ..++|+|||++......... .......|+.+|+|||
T Consensus 608 ~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE 684 (903)
T KOG1027|consen 608 PISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPE 684 (903)
T ss_pred HHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHH
Confidence 6889999999999999999 999999999999975 3 46899999999876544322 2234567999999999
Q ss_pred ccccCCCccccceeehhHHHHHHHhC-CCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHH
Q 021490 161 YAKTGQLTLKSDVYSFGVVLLEILSG-RKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVA 239 (311)
Q Consensus 161 ~~~~~~~~~~~DiwslG~l~~~ll~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 239 (311)
++....-+.++||||+||++||.++| .+||...-..+. ++.. . ..... ...+....+..+||
T Consensus 685 ~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~-NIl~-------~-~~~L~--------~L~~~~d~eA~dLI 747 (903)
T KOG1027|consen 685 QLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA-NILT-------G-NYTLV--------HLEPLPDCEAKDLI 747 (903)
T ss_pred HHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh-hhhc-------C-cccee--------eeccCchHHHHHHH
Confidence 99988888899999999999999985 899976433211 1110 0 00000 00111111778899
Q ss_pred HHccccCCCCCCCHHHHHH
Q 021490 240 AMCVHEQPDMRPVIADVVT 258 (311)
Q Consensus 240 ~~~l~~~p~~Rps~~~vl~ 258 (311)
.+|+.++|..||++.+|+.
T Consensus 748 ~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 748 SRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred HHhcCCCcccCCCHHHHhC
Confidence 9999999999999999983
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=235.30 Aligned_cols=179 Identities=27% Similarity=0.301 Sum_probs=150.5
Q ss_pred cEEEEEEeecCCCcchh---HHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHH
Q 021490 10 QDVAIKQLDRNGVQGNR---EFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNT 86 (311)
Q Consensus 10 ~~vaiK~~~~~~~~~~~---~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~ 86 (311)
..+|+|.|.+.+.-... .+..|-.||..-+++.||++|..|.+++.+|+||+|++||++-.+|.+ .+-|++..
T Consensus 655 ~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGGDmMSLLIr----mgIFeE~L 730 (1034)
T KOG0608|consen 655 ALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIR----MGIFEEDL 730 (1034)
T ss_pred hHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCccHHHHHHH----hccCHHHH
Confidence 45677777665543332 445688899999999999999999999999999999999999999987 68899999
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCC--CCCCc---------eee--------
Q 021490 87 RMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGP--VGDNT---------HVS-------- 147 (311)
Q Consensus 87 ~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~--~~~~~---------~~~-------- 147 (311)
+..++.++.+|+++.|..| ++||||||+||||+.+|.|||+|||+|.-+. ..... ...
T Consensus 731 ARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d 807 (1034)
T KOG0608|consen 731 ARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWAD 807 (1034)
T ss_pred HHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceeccccccccCCCccccccCCCchhhcc
Confidence 9999999999999999999 9999999999999999999999999986311 00000 000
Q ss_pred ---------------------eeccccccccCccccccCCCccccceeehhHHHHHHHhCCCccCcchh
Q 021490 148 ---------------------TRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKA 195 (311)
Q Consensus 148 ---------------------~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~ 195 (311)
-..+||..|+|||++....++..+|+||.|||+|||+.|++||-....
T Consensus 808 ~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp 876 (1034)
T KOG0608|consen 808 ISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADTP 876 (1034)
T ss_pred ccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCCccCCCC
Confidence 024589999999999999999999999999999999999999965444
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=214.48 Aligned_cols=241 Identities=22% Similarity=0.249 Sum_probs=183.1
Q ss_pred CCcEEEEEEeecC--CCcchhHHHHHHHHHhcCCCCcccceeeEeeeC------CeeEEEEecCCCCChhhhhcccCCCC
Q 021490 8 LLQDVAIKQLDRN--GVQGNREFLVEVLMLSLLHHPNLVNLIGYCADG------DQRLLVYEYMPLGSVEDHLHDLSPGK 79 (311)
Q Consensus 8 ~g~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~ 79 (311)
.+++||+|++... .....++..+|..++..+.|+||++++.+|.-. ...|+|||++. ++|...+..
T Consensus 40 ~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~-~nl~~vi~~----- 113 (369)
T KOG0665|consen 40 LGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELMD-ANLCQVILM----- 113 (369)
T ss_pred ccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhhh-hHHHHHHHH-----
Confidence 5789999997554 234557888999999999999999999998543 35699999995 788888763
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCc
Q 021490 80 KPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 159 (311)
Q Consensus 80 ~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aP 159 (311)
.++-.++..++.|++.|+.+||+.| |+||||||+||++..+..+||.|||++...... -..+..+.+..|.||
T Consensus 114 -elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~---~~mtpyVvtRyyrap 186 (369)
T KOG0665|consen 114 -ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD---FMMTPYVVTRYYRAP 186 (369)
T ss_pred -hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhcccCcc---cccCchhheeeccCc
Confidence 4677889999999999999999999 999999999999999999999999999753222 234445678889999
Q ss_pred cccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHH----------------hhhhhc------ccccccc
Q 021490 160 EYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAW----------------ARPLFQ------DRTRHSL 217 (311)
Q Consensus 160 E~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~----------------~~~~~~------~~~~~~~ 217 (311)
|++-+-.+.+.+||||+||++.||++|..-|.+.+..+....+.. +.-... ...-...
T Consensus 187 evil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~ 266 (369)
T KOG0665|consen 187 EVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSEL 266 (369)
T ss_pred hheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhh
Confidence 999988899999999999999999999999987765444321111 000000 0111112
Q ss_pred ccCccccC--CCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 021490 218 IADPELQG--QYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 261 (311)
Q Consensus 218 ~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l~ 261 (311)
+.|..+.. ..++..+..+.+++.+||-.||++|.|+.+++....
T Consensus 267 fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY 312 (369)
T KOG0665|consen 267 FPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPY 312 (369)
T ss_pred CCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCe
Confidence 22222211 111234556778999999999999999999998754
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=216.40 Aligned_cols=245 Identities=21% Similarity=0.277 Sum_probs=183.1
Q ss_pred cCCcEEEEEEeecC--CCcchhHHHHHHHHHhcCCCCcccceeeEeeeC-----CeeEEEEecCCCCChhhhhcccCCCC
Q 021490 7 CLLQDVAIKQLDRN--GVQGNREFLVEVLMLSLLHHPNLVNLIGYCADG-----DQRLLVYEYMPLGSVEDHLHDLSPGK 79 (311)
Q Consensus 7 ~~g~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~ 79 (311)
.+|+.||+|++..- +-.+.+.+.+|+++|..++|.|++..+++..-. ++.|+++|++. .+|...+.+ .
T Consensus 76 RdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TELmQ-SDLHKIIVS----P 150 (449)
T KOG0664|consen 76 RSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTELMQ-SDLHKIIVS----P 150 (449)
T ss_pred CCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHHHH-hhhhheecc----C
Confidence 47999999998653 235568999999999999999999999876433 25688999885 678887776 7
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCc
Q 021490 80 KPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 159 (311)
Q Consensus 80 ~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aP 159 (311)
..++.+.+.-+++||+.||.|||+.+ |.||||||.|.|++.|..+||+|||+++...... .......+-|..|.||
T Consensus 151 Q~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~-~~hMTqEVVTQYYRAP 226 (449)
T KOG0664|consen 151 QALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD-RLNMTHEVVTQYYRAP 226 (449)
T ss_pred CCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccchhh-hhhhHHHHHHHHhccH
Confidence 88999999999999999999999999 9999999999999999999999999998643222 2223344567889999
Q ss_pred ccccc-CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhh--h------hccccc----cccccCccccC-
Q 021490 160 EYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARP--L------FQDRTR----HSLIADPELQG- 225 (311)
Q Consensus 160 E~~~~-~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~--~------~~~~~~----~~~~~~~~~~~- 225 (311)
|++.+ ..|+.+.||||.|||+.|++.++..|.........+++-.... . .-+..+ +.....|.+..
T Consensus 227 EiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vL 306 (449)
T KOG0664|consen 227 ELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRL 306 (449)
T ss_pred HHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccce
Confidence 98876 6789999999999999999999998977666555444321110 0 000000 00111111110
Q ss_pred ---CCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 021490 226 ---QYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 260 (311)
Q Consensus 226 ---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l 260 (311)
..+.....+...++.++|.+||+.|.+.++.+..+
T Consensus 307 YtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 307 YKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred eeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 11112234567789999999999999999988765
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=225.52 Aligned_cols=242 Identities=21% Similarity=0.227 Sum_probs=182.6
Q ss_pred CCcEEEEEEeecCCCcchhHHHHHHHHHhcCCC------CcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCC
Q 021490 8 LLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHH------PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKP 81 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h------~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 81 (311)
-|+.||||++..+. .-.+.=+.|+++|++|+. -|+++++..|.+..++|||||-+ ..+|.+.|+... .+-+
T Consensus 456 r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG-~nvG 532 (752)
T KOG0670|consen 456 RGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYG-RNVG 532 (752)
T ss_pred CCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhC-cccc
Confidence 37899999996543 334455679999999962 47999999999999999999988 589999998753 2457
Q ss_pred CCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCC-CceEEccccccccCCCCCCceeeeeccccccccCcc
Q 021490 82 LDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG-YHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 160 (311)
Q Consensus 82 l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE 160 (311)
|....+..++.|++.||..|...| ++|.||||.||||++. ..+||||||.+........+. ..-+..|.|||
T Consensus 533 L~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~eneitP----YLVSRFYRaPE 605 (752)
T KOG0670|consen 533 LHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFGSASFASENEITP----YLVSRFYRAPE 605 (752)
T ss_pred eeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCccccccccccccH----HHHHHhccCcc
Confidence 889999999999999999999999 9999999999999975 467999999987532222111 12345799999
Q ss_pred ccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccc-cccccccCccccC--------------
Q 021490 161 YAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDR-TRHSLIADPELQG-------------- 225 (311)
Q Consensus 161 ~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~-------------- 225 (311)
++.+.+|+...|+||.||++|||+||+..|.+..+.....+..-....++.. .....+.+..+..
T Consensus 606 IiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~ 685 (752)
T KOG0670|consen 606 IILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTE 685 (752)
T ss_pred eeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEecccccc
Confidence 9999999999999999999999999999999888766654332221111111 1111111111111
Q ss_pred ------------------------CCC---hHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 021490 226 ------------------------QYP---PRGFYQALAVAAMCVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 226 ------------------------~~~---~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~ 259 (311)
.++ +....++.+|+.+||..||++|.|..++|+.
T Consensus 686 r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~H 746 (752)
T KOG0670|consen 686 REKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKH 746 (752)
T ss_pred ceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcC
Confidence 122 1234677889999999999999999998875
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-30 Score=200.50 Aligned_cols=182 Identities=25% Similarity=0.294 Sum_probs=150.9
Q ss_pred cCCcEEEEEEeecCCC-cchhHHHHHHHHHhcC-CCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCH
Q 021490 7 CLLQDVAIKQLDRNGV-QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 84 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~ 84 (311)
.+|+-+|+|.+...-. ..+++..+|+.+...- .+|++|.+++...+....+++||.++ .||+.+..+....++.+++
T Consensus 69 ~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~-tSldkfy~~v~~~g~~ipE 147 (282)
T KOG0984|consen 69 QSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMD-TSLDKFYRKVLKKGGTIPE 147 (282)
T ss_pred cCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhh-hhHHHHHHHHHhcCCcCch
Confidence 3799999999966533 4456778888877665 79999999999999999999999995 7888887666556889999
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccccc
Q 021490 85 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT 164 (311)
Q Consensus 85 ~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 164 (311)
..+-+++..+..||.|||++-. ++|||+||.|||++..|.+|++|||++-.....- ..+...|...|+|||.+..
T Consensus 148 ~vlGkIa~Svv~al~~L~~kL~--vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSi---Akt~daGCkpYmaPEri~~ 222 (282)
T KOG0984|consen 148 DVLGKIAVSVVHALEFLHSKLS--VIHRDVKPSNILINYDGQVKICDFGISGYLVDSI---AKTMDAGCKPYMAPERINP 222 (282)
T ss_pred HHhhHhHHHHHHHHHHHHHHhh--hhhccCCcceEEEccCCcEEEcccccceeehhhh---HHHHhcCCCccCChhhcCc
Confidence 9999999999999999999753 9999999999999999999999999985422211 1122346678999998753
Q ss_pred ----CCCccccceeehhHHHHHHHhCCCccCcch
Q 021490 165 ----GQLTLKSDVYSFGVVLLEILSGRKAVDTSK 194 (311)
Q Consensus 165 ----~~~~~~~DiwslG~l~~~ll~g~~pf~~~~ 194 (311)
..|+.++||||||+++.||.+++.||+.-.
T Consensus 223 e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 223 ELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred ccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 478999999999999999999999997543
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=8e-29 Score=202.96 Aligned_cols=195 Identities=34% Similarity=0.504 Sum_probs=167.7
Q ss_pred CCcEEEEEEeecCCCc-chhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHH
Q 021490 8 LLQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNT 86 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~ 86 (311)
+|+.+++|++...... ..+.+.+|+..++.++|++++++++++......++++|+++|++|.+++... ...+++..
T Consensus 17 ~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~~~---~~~~~~~~ 93 (215)
T cd00180 17 TGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKEN---EGKLSEDE 93 (215)
T ss_pred CCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHHHHHhc---cCCCCHHH
Confidence 4899999998655432 3578999999999999999999999999989999999999999999999862 14689999
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcC-CCceEEccccccccCCCCCCceeeeeccccccccCccccccC
Q 021490 87 RMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR-GYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG 165 (311)
Q Consensus 87 ~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 165 (311)
++.++.+++.++++||+.+ ++|+||+|.||+++. ++.++|+||+.+........ ......+...|.+||.....
T Consensus 94 ~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~ 168 (215)
T cd00180 94 ILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVGTPAYMAPEVLLGK 168 (215)
T ss_pred HHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccCCCCccChhHhccc
Confidence 9999999999999999999 999999999999999 89999999999875332211 12224467789999998776
Q ss_pred -CCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccc
Q 021490 166 -QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVH 244 (311)
Q Consensus 166 -~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 244 (311)
..+.++|+|++|+++++| ..+.+++..|+.
T Consensus 169 ~~~~~~~D~~~lg~~~~~l-------------------------------------------------~~~~~~l~~~l~ 199 (215)
T cd00180 169 GYYSEKSDIWSLGVILYEL-------------------------------------------------PELKDLIRKMLQ 199 (215)
T ss_pred CCCCchhhhHHHHHHHHHH-------------------------------------------------HHHHHHHHHHhh
Confidence 788999999999999999 256779999999
Q ss_pred cCCCCCCCHHHHHHH
Q 021490 245 EQPDMRPVIADVVTA 259 (311)
Q Consensus 245 ~~p~~Rps~~~vl~~ 259 (311)
.||.+||++.++++.
T Consensus 200 ~~p~~R~~~~~l~~~ 214 (215)
T cd00180 200 KDPEKRPSAKEILEH 214 (215)
T ss_pred CCcccCcCHHHHhhC
Confidence 999999999999865
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-29 Score=201.35 Aligned_cols=234 Identities=20% Similarity=0.303 Sum_probs=171.8
Q ss_pred CCcEEEEEEeecCCCcchhHHHHHHHHHhcCC-CCcccceeeE-eeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHH
Q 021490 8 LLQDVAIKQLDRNGVQGNREFLVEVLMLSLLH-HPNLVNLIGY-CADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN 85 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~-~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~ 85 (311)
++..+|+|-+. .......+|.+|...--.|. |.||+..|++ |+..+.+++++||++.|+|.+.+.. .++.+.
T Consensus 48 s~t~ivlKavp-~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv~~-----~GigE~ 121 (378)
T KOG1345|consen 48 SKTRIVLKAVP-RPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNVEA-----AGIGEA 121 (378)
T ss_pred CceEEEeeccC-cchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccCccchhhhhcCc-----ccccHH
Confidence 57889999885 44466789999998887784 8899998885 5677788899999999999998875 678899
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcC--CCceEEccccccccCCCCCCceeeeeccccccccCccccc
Q 021490 86 TRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR--GYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 163 (311)
Q Consensus 86 ~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~--~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 163 (311)
....++.|+++||.|||+++ +||||||.+|||+-. .-+|||+|||+++..+.. .........|.+||+..
T Consensus 122 ~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t-----V~~~~~~~~y~~pe~~~ 193 (378)
T KOG1345|consen 122 NTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT-----VKYLEYVNNYHAPELCD 193 (378)
T ss_pred HHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccCce-----ehhhhhhcccCCcHHHh
Confidence 99999999999999999999 999999999999953 448999999998753211 11223556799999764
Q ss_pred c-----CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHH
Q 021490 164 T-----GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAV 238 (311)
Q Consensus 164 ~-----~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 238 (311)
. ....+.+|+|+||+++|+++||..||..... .......|.. +.+... +.+...+. ..+..++.+
T Consensus 194 ~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~-~d~~Y~~~~~-w~~rk~-------~~~P~~F~-~fs~~a~r~ 263 (378)
T KOG1345|consen 194 TVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASI-MDKPYWEWEQ-WLKRKN-------PALPKKFN-PFSEKALRL 263 (378)
T ss_pred hccccceEecccccchheeeeeeeeecCCCcchhhhc-cCchHHHHHH-HhcccC-------ccCchhhc-ccCHHHHHH
Confidence 3 2346889999999999999999999984332 2222222221 111111 11111111 234478889
Q ss_pred HHHccccCCCCC---CCHHHHHHHHHHhhh
Q 021490 239 AAMCVHEQPDMR---PVIADVVTALAYLAS 265 (311)
Q Consensus 239 i~~~l~~~p~~R---ps~~~vl~~l~~~~~ 265 (311)
+++-|+.++++| .++......++.-+.
T Consensus 264 Fkk~lt~~~~drcki~~~kk~rk~~w~E~~ 293 (378)
T KOG1345|consen 264 FKKSLTPRFKDRCKIWTAKKMRKCLWKEKL 293 (378)
T ss_pred HHHhcCCcccccchhHHHHHHHHHHHHHhh
Confidence 999999999999 566555555543333
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.7e-29 Score=230.58 Aligned_cols=238 Identities=18% Similarity=0.185 Sum_probs=146.7
Q ss_pred CcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeE------eeeCCeeEEEEecCCCCChhhhhcccCC-----
Q 021490 9 LQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGY------CADGDQRLLVYEYMPLGSVEDHLHDLSP----- 77 (311)
Q Consensus 9 g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~------~~~~~~~~lv~e~~~~~~L~~~l~~~~~----- 77 (311)
|..||+|+++... ..+.+.++ .+....+.++..++.. ...+...++|+||+++++|.+++.....
T Consensus 161 ~~~vAvK~~~~~~--~~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~ 236 (566)
T PLN03225 161 EGKYVLKKATEYG--AVEIWMNE--RVRRACPNSCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVE 236 (566)
T ss_pred CcEEEEEEecccc--hhHHHHHH--HHHhhchhhHHHHHHhhhcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHH
Confidence 6899999885432 12222222 1222222222222221 2345678999999999999998875210
Q ss_pred -----------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcC-CCceEEccccccccCCCCCCce
Q 021490 78 -----------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR-GYHPKLSDFGLAKLGPVGDNTH 145 (311)
Q Consensus 78 -----------~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~-~~~~~l~df~~~~~~~~~~~~~ 145 (311)
.........+..++.|++.||+|||+++ |+||||||+|||++. ++.+||+|||++........ .
T Consensus 237 ~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~-~ 312 (566)
T PLN03225 237 PYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGIN-Y 312 (566)
T ss_pred HHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCCHHHEEEeCCCCcEEEEeCCCccccccccc-c
Confidence 0011123456789999999999999999 999999999999985 67899999999875322211 1
Q ss_pred eeeeccccccccCccccccC----------------------CCccccceeehhHHHHHHHhCCCccCcchhHHHHH---
Q 021490 146 VSTRVMGTYGYCAPEYAKTG----------------------QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQS--- 200 (311)
Q Consensus 146 ~~~~~~~~~~y~aPE~~~~~----------------------~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~--- 200 (311)
......+++.|+|||.+... .++.++|||||||++|+|+++..+++.....-...
T Consensus 313 ~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~ 392 (566)
T PLN03225 313 IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKR 392 (566)
T ss_pred CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHHHHHHHhCcCCCchHHHHHHHHHHh
Confidence 22334578899999965322 23456799999999999998776654321111100
Q ss_pred ----HHHHhhhhhccccccccccCccccCCC--ChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 021490 201 ----LVAWARPLFQDRTRHSLIADPELQGQY--PPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 261 (311)
Q Consensus 201 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l~ 261 (311)
...|....... ..+.+...+ .........+|+.+||++||.+|||+.++++.-.
T Consensus 393 ~~~~~~~~~~~~~~~-------~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~Hpf 452 (566)
T PLN03225 393 NDYDLVAWRKLVEPR-------ASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHPY 452 (566)
T ss_pred cCCcHHHHHHhhccc-------cchhhhhhhhhccccchHHHHHHHHHccCCcccCCCHHHHhCCcC
Confidence 11111000000 000000000 0011224558999999999999999999998743
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.1e-29 Score=196.23 Aligned_cols=242 Identities=17% Similarity=0.226 Sum_probs=174.8
Q ss_pred ccCCcEEEEEEeecCCCcchhHHHHHHHHHhcCC-CCcccceeeEeeeC--CeeEEEEecCCCCChhhhhcccCCCCCCC
Q 021490 6 LCLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLH-HPNLVNLIGYCADG--DQRLLVYEYMPLGSVEDHLHDLSPGKKPL 82 (311)
Q Consensus 6 ~~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~l 82 (311)
..++..++||+++... .+.+.+|+.+|.+|+ ||||++++++..+. ....||+||+++.+...+.. .+
T Consensus 60 ~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly~-------tl 129 (338)
T KOG0668|consen 60 ITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLYP-------TL 129 (338)
T ss_pred cCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhccccHHHHhh-------hh
Confidence 3578999999997543 356778999999997 99999999998664 45689999998877666554 48
Q ss_pred CHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcC-CCceEEccccccccCCCCCCceeeeeccccccccCccc
Q 021490 83 DWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR-GYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 161 (311)
Q Consensus 83 ~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 161 (311)
+...+..++.++++||.|+|+.| |.|||+||.|++++. .-.++|+|+|++...-.... .+..+.+..|--||.
T Consensus 130 ~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~e---YnVRVASRyfKGPEL 203 (338)
T KOG0668|consen 130 TDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPEL 203 (338)
T ss_pred chhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcCCCce---eeeeeehhhcCCchh
Confidence 88899999999999999999999 999999999999985 55799999999976433332 233446677889998
Q ss_pred ccc-CCCccccceeehhHHHHHHHhCCCcc-CcchhHHHHHHHHHhh---hhhccccccccccCccccC---CCC-----
Q 021490 162 AKT-GQLTLKSDVYSFGVVLLEILSGRKAV-DTSKAAAEQSLVAWAR---PLFQDRTRHSLIADPELQG---QYP----- 228 (311)
Q Consensus 162 ~~~-~~~~~~~DiwslG~l~~~ll~g~~pf-~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~---~~~----- 228 (311)
+.. ..++-+-|+|||||++..|+..+.|| .+.++.+..-.+.... ....-........+|.+.. ..+
T Consensus 204 LVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~ 283 (338)
T KOG0668|consen 204 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWS 283 (338)
T ss_pred eeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHH
Confidence 865 67888999999999999999988887 4444433332111110 0000000001111222111 000
Q ss_pred -------h-HhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 021490 229 -------P-RGFYQALAVAAMCVHEQPDMRPVIADVVTALAYL 263 (311)
Q Consensus 229 -------~-~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l~~~ 263 (311)
. -.+.+.++++.+.|.+|..+|+|+.|......+.
T Consensus 284 ~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~ 326 (338)
T KOG0668|consen 284 RFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFA 326 (338)
T ss_pred HhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHH
Confidence 0 1135889999999999999999999998775443
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=217.35 Aligned_cols=240 Identities=19% Similarity=0.220 Sum_probs=161.0
Q ss_pred cCCcEEEEEEeecCCCcchhH--------------HHHHHHHHhcCCCCcc-----cceeeEeee--------CCeeEEE
Q 021490 7 CLLQDVAIKQLDRNGVQGNRE--------------FLVEVLMLSLLHHPNL-----VNLIGYCAD--------GDQRLLV 59 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~~~~~--------------~~~e~~~l~~l~h~~i-----~~~~~~~~~--------~~~~~lv 59 (311)
.+++.||||.++.......++ +..|+.++.+++|.++ ++++++|.. ....++|
T Consensus 184 ~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV 263 (507)
T PLN03224 184 QKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLV 263 (507)
T ss_pred ccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEE
Confidence 356789999987544332233 3447777777766554 566666542 3467999
Q ss_pred EecCCCCChhhhhcccCC--------------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeE
Q 021490 60 YEYMPLGSVEDHLHDLSP--------------------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNI 119 (311)
Q Consensus 60 ~e~~~~~~L~~~l~~~~~--------------------~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~ni 119 (311)
+||+++++|.+++..... ....+++..+..++.|++.+|.|||+.+ ++||||||+||
T Consensus 264 ~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NI 340 (507)
T PLN03224 264 WKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENL 340 (507)
T ss_pred EEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhE
Confidence 999999999998864211 0123467788999999999999999999 99999999999
Q ss_pred EEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccCC--------------------C--ccccceeehh
Q 021490 120 LLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ--------------------L--TLKSDVYSFG 177 (311)
Q Consensus 120 l~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--------------------~--~~~~DiwslG 177 (311)
+++.++.++|+|||++.......... .....+++.|+|||.+.... + ....|+||+|
T Consensus 341 Ll~~~~~~kL~DFGla~~~~~~~~~~-~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlG 419 (507)
T PLN03224 341 LVTVDGQVKIIDFGAAVDMCTGINFN-PLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAG 419 (507)
T ss_pred EECCCCcEEEEeCcCccccccCCccC-ccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHH
Confidence 99999999999999986432221111 11123478999999875321 1 1247999999
Q ss_pred HHHHHHHhCCC-ccCcchhHHH------HHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCC---
Q 021490 178 VVLLEILSGRK-AVDTSKAAAE------QSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQP--- 247 (311)
Q Consensus 178 ~l~~~ll~g~~-pf~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p--- 247 (311)
|++|+|++|.. ||........ .....|.. ..... .+ -......+....+|+.++|..+|
T Consensus 420 vil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~--~~~~~-----~~----~~~~d~~s~~~~dLi~~LL~~~~~~~ 488 (507)
T PLN03224 420 VLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM--YKGQK-----YD----FSLLDRNKEAGWDLACKLITKRDQAN 488 (507)
T ss_pred HHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh--hcccC-----CC----cccccccChHHHHHHHHHhccCCCCc
Confidence 99999999875 6654321111 01111110 00000 00 01122335578889999999866
Q ss_pred CCCCCHHHHHHHHH
Q 021490 248 DMRPVIADVVTALA 261 (311)
Q Consensus 248 ~~Rps~~~vl~~l~ 261 (311)
.+|+|+.|+++.-.
T Consensus 489 ~~RlSa~eaL~Hp~ 502 (507)
T PLN03224 489 RGRLSVGQALSHRF 502 (507)
T ss_pred ccCCCHHHHhCCCC
Confidence 68999999997644
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.7e-28 Score=235.83 Aligned_cols=199 Identities=17% Similarity=0.251 Sum_probs=139.3
Q ss_pred hcCCC-CcccceeeEe-------eeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 021490 36 SLLHH-PNLVNLIGYC-------ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKP 107 (311)
Q Consensus 36 ~~l~h-~~i~~~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~ 107 (311)
+.++| +||++++++| ......++++|++ +++|.+++... ...+++..++.++.||+.||+|||++|
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~g-- 100 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP---DRSVDAFECFHVFRQIVEIVNAAHSQG-- 100 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc---cccccHHHHHHHHHHHHHHHHHHHhCC--
Confidence 34556 6888888877 2334567888887 57999999752 356999999999999999999999999
Q ss_pred CeEeeccCCCeEEEcCCCc-------------------eEEccccccccCCCCCC--------------ceeeeeccccc
Q 021490 108 PVIYRDLKCSNILLDRGYH-------------------PKLSDFGLAKLGPVGDN--------------THVSTRVMGTY 154 (311)
Q Consensus 108 ~i~h~dl~p~nil~~~~~~-------------------~~l~df~~~~~~~~~~~--------------~~~~~~~~~~~ 154 (311)
|+||||||+|||++..|. +|++|||+++....... ........+|.
T Consensus 101 -IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 179 (793)
T PLN00181 101 -IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMS 179 (793)
T ss_pred -eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCc
Confidence 999999999999965444 45555555542110000 00001134788
Q ss_pred cccCccccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHH
Q 021490 155 GYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQ 234 (311)
Q Consensus 155 ~y~aPE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
.|+|||++.+..++.++|||||||++|||++|..|+........ .+.. .. ..+.. ......
T Consensus 180 ~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~~-~~~~---~~----------~~~~~-----~~~~~~ 240 (793)
T PLN00181 180 WYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRTMS-SLRH---RV----------LPPQI-----LLNWPK 240 (793)
T ss_pred ceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHHHH-HHHH---hh----------cChhh-----hhcCHH
Confidence 89999999988999999999999999999998888754221100 0000 00 00000 011224
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHHH
Q 021490 235 ALAVAAMCVHEQPDMRPVIADVVTAL 260 (311)
Q Consensus 235 l~~li~~~l~~~p~~Rps~~~vl~~l 260 (311)
..+++.+||+.||.+|||+.++++..
T Consensus 241 ~~~~~~~~L~~~P~~Rps~~eil~h~ 266 (793)
T PLN00181 241 EASFCLWLLHPEPSCRPSMSELLQSE 266 (793)
T ss_pred HHHHHHHhCCCChhhCcChHHHhhch
Confidence 56788999999999999999998643
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-28 Score=215.95 Aligned_cols=175 Identities=24% Similarity=0.302 Sum_probs=149.3
Q ss_pred cCCcEEEEEEeecCCC---cch-----hHHHHHHHHHhcCC---CCcccceeeEeeeCCeeEEEEecC-CCCChhhhhcc
Q 021490 7 CLLQDVAIKQLDRNGV---QGN-----REFLVEVLMLSLLH---HPNLVNLIGYCADGDQRLLVYEYM-PLGSVEDHLHD 74 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~---~~~-----~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~-~~~~L~~~l~~ 74 (311)
.+...|+||.+.+... .+. -.+-.|+.+|..|+ |+||++++++|++++.+||+||.. +|.+|++++..
T Consensus 584 ~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yyl~te~hg~gIDLFd~IE~ 663 (772)
T KOG1152|consen 584 ENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYYYLETEVHGEGIDLFDFIEF 663 (772)
T ss_pred ccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCeeEEEecCCCCCcchhhhhhc
Confidence 3678999999876543 111 12336999999997 999999999999999999999964 57899999987
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccc
Q 021490 75 LSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTY 154 (311)
Q Consensus 75 ~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~ 154 (311)
...+++.++..++.||+.|+++||++| |+|||||-+|+.++.+|-+||+|||.+..... ......+||.
T Consensus 664 ----kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidfgsaa~~ks----gpfd~f~gtv 732 (772)
T KOG1152|consen 664 ----KPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDFGSAAYTKS----GPFDVFVGTV 732 (772)
T ss_pred ----cCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeeccchhhhcC----CCcceeeeec
Confidence 778999999999999999999999999 99999999999999999999999998864322 2233457999
Q ss_pred cccCccccccCCC-ccccceeehhHHHHHHHhCCCccCc
Q 021490 155 GYCAPEYAKTGQL-TLKSDVYSFGVVLLEILSGRKAVDT 192 (311)
Q Consensus 155 ~y~aPE~~~~~~~-~~~~DiwslG~l~~~ll~g~~pf~~ 192 (311)
.|.|||++.+..| +..-|||+||+++|.++...+||..
T Consensus 733 ~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 733 DYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred cccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 9999999999877 5568999999999999999999854
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=191.71 Aligned_cols=169 Identities=22% Similarity=0.204 Sum_probs=126.0
Q ss_pred CChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCce
Q 021490 66 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 145 (311)
Q Consensus 66 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~ 145 (311)
|+|.+++... +..+++..++.++.|++.||+|||+.+ ||+||+++.++.+++ ||++......
T Consensus 1 GsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~---- 62 (176)
T smart00750 1 VSLADILEVR---GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE---- 62 (176)
T ss_pred CcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc----
Confidence 6889988752 456999999999999999999999885 999999999999999 9988653221
Q ss_pred eeeeccccccccCccccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccC
Q 021490 146 VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQG 225 (311)
Q Consensus 146 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (311)
...++..|+|||++.+..++.++|||||||++|+|++|..||......... ....... .... .+.. .
T Consensus 63 ---~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~-~~~~~~~-~~~~-------~~~~-~ 129 (176)
T smart00750 63 ---QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAI-LEILLNG-MPAD-------DPRD-R 129 (176)
T ss_pred ---cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHH-HHHHHHH-hccC-------Cccc-c
Confidence 125789999999999999999999999999999999999999654321111 0000100 0000 0000 0
Q ss_pred CCChHhHH--HHHHHHHHccccCCCCCCCHHHHHHHHHHhhh
Q 021490 226 QYPPRGFY--QALAVAAMCVHEQPDMRPVIADVVTALAYLAS 265 (311)
Q Consensus 226 ~~~~~~~~--~l~~li~~~l~~~p~~Rps~~~vl~~l~~~~~ 265 (311)
..+..... .+.+++.+||..||.+|||+.++++.+..+..
T Consensus 130 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 130 SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 11122222 58899999999999999999999999876653
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.4e-27 Score=195.20 Aligned_cols=183 Identities=33% Similarity=0.384 Sum_probs=155.2
Q ss_pred cchhcc-CCcEEEEEEeecCCCc-chhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCC
Q 021490 2 MQVILC-LLQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGK 79 (311)
Q Consensus 2 ~~~~~~-~g~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~ 79 (311)
|.+... +++.+|+|.+...... ..+.+.+|++.+..++|+|++++++++......++++|++++++|.+++.. .
T Consensus 16 ~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~----~ 91 (225)
T smart00221 16 YLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGDLFDYLRK----K 91 (225)
T ss_pred EEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCCCHHHHHHh----c
Confidence 344444 3899999999765544 567899999999999999999999999988999999999999999999986 2
Q ss_pred CC-CCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccC
Q 021490 80 KP-LDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCA 158 (311)
Q Consensus 80 ~~-l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~a 158 (311)
.. +++..+..++.+++.++.+||+.+ ++|+|++|.||+++.++.++|+|||.+........ .......+...|++
T Consensus 92 ~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~~~ 167 (225)
T smart00221 92 GGKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-ALLKTVKGTPFYLA 167 (225)
T ss_pred ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-ccccceeccCCcCC
Confidence 33 899999999999999999999999 99999999999999999999999998875432210 01223356778999
Q ss_pred cccc-ccCCCccccceeehhHHHHHHHhCCCccCc
Q 021490 159 PEYA-KTGQLTLKSDVYSFGVVLLEILSGRKAVDT 192 (311)
Q Consensus 159 PE~~-~~~~~~~~~DiwslG~l~~~ll~g~~pf~~ 192 (311)
||.+ ....++.++|+|+||+++++|++|+.||..
T Consensus 168 pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 168 PEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred HhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 9988 667778899999999999999999999966
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-27 Score=214.32 Aligned_cols=229 Identities=24% Similarity=0.285 Sum_probs=184.2
Q ss_pred CCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHHH
Q 021490 8 LLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTR 87 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~ 87 (311)
+|...|+|+++........-...|+-+++..+||||+.+++.+...+.++++||||.||+|.+-.+- -+.+++.++
T Consensus 39 s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggslQdiy~~----Tgplselqi 114 (829)
T KOG0576|consen 39 SGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQDIYHV----TGPLSELQI 114 (829)
T ss_pred cCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCcccceeee----cccchhHHH
Confidence 6899999999888878888888899999999999999999999999999999999999999997775 578999999
Q ss_pred HHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccc---cc
Q 021490 88 MKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA---KT 164 (311)
Q Consensus 88 ~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---~~ 164 (311)
.-++...+.|++|||+.+ =+|||||-.||++++.|.+|+.|||.+-.+... ........||+.|+|||+. ..
T Consensus 115 ayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitat--i~KrksfiGtpywmapEvaaverk 189 (829)
T KOG0576|consen 115 AYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITAT--IAKRKSFIGTPYWMAPEVAAVERK 189 (829)
T ss_pred HHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhh--hhhhhcccCCccccchhHHHHHhc
Confidence 999999999999999999 899999999999999999999999987543221 1223345799999999976 45
Q ss_pred CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccc
Q 021490 165 GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVH 244 (311)
Q Consensus 165 ~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 244 (311)
..|...+|||++|+...|+-.-++|-.........-+ + ..+.+..|.+.. ....+..+.++++.+|.
T Consensus 190 ggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~L-------m----TkS~~qpp~lkD--k~kws~~fh~fvK~alt 256 (829)
T KOG0576|consen 190 GGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFL-------M----TKSGFQPPTLKD--KTKWSEFFHNFVKGALT 256 (829)
T ss_pred ccccccccccccccchhhhhhcCCcccccchHHHHHH-------h----hccCCCCCcccC--CccchHHHHHHHHHHhc
Confidence 7889999999999999999877776433322211111 1 111111222211 23455678889999999
Q ss_pred cCCCCCCCHHHHHH
Q 021490 245 EQPDMRPVIADVVT 258 (311)
Q Consensus 245 ~~p~~Rps~~~vl~ 258 (311)
.+|++|||++-++.
T Consensus 257 knpKkRptaeklL~ 270 (829)
T KOG0576|consen 257 KNPKKRPTAEKLLQ 270 (829)
T ss_pred CCCccCCChhhhee
Confidence 99999999998775
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=9e-26 Score=195.50 Aligned_cols=109 Identities=23% Similarity=0.296 Sum_probs=92.1
Q ss_pred cCCcEEEEEEeecCCCcchhHHHHHHHHHhcCC-----C---CcccceeeEeee----CCeeEEEEecCCCCChhhhhcc
Q 021490 7 CLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLH-----H---PNLVNLIGYCAD----GDQRLLVYEYMPLGSVEDHLHD 74 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-----h---~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~ 74 (311)
.+.+-||+|+++... .-.+..+.|+++|++++ | .+||++++.|.. +.+.|||+|++ |.+|..++..
T Consensus 101 q~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~ 178 (590)
T KOG1290|consen 101 QNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKY 178 (590)
T ss_pred cCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHH
Confidence 467889999996443 34467788999999884 3 359999999954 56899999998 7899999987
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEE
Q 021490 75 LSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL 121 (311)
Q Consensus 75 ~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~ 121 (311)
.. .+.++...+.+|+.||+.||.|||+..+ |+|-||||+|||+
T Consensus 179 s~--YrGlpl~~VK~I~~qvL~GLdYLH~ecg--IIHTDlKPENvLl 221 (590)
T KOG1290|consen 179 SN--YRGLPLSCVKEICRQVLTGLDYLHRECG--IIHTDLKPENVLL 221 (590)
T ss_pred hC--CCCCcHHHHHHHHHHHHHHHHHHHHhcC--ccccCCCcceeee
Confidence 43 5789999999999999999999998864 9999999999999
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.5e-24 Score=182.21 Aligned_cols=172 Identities=29% Similarity=0.337 Sum_probs=142.1
Q ss_pred CCcEEEEEEeecCCCcchhHHHHHHHHHhcC-CCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHH
Q 021490 8 LLQDVAIKQLDRNGVQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNT 86 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~ 86 (311)
.+..||+|.+...+ ...+..+|+++|..+ -+.||+++.+.+..++...+|+||++...-.++... ++...
T Consensus 63 ~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~H~~f~~l~~~-------l~~~~ 133 (418)
T KOG1167|consen 63 KRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFEHDRFRDLYRS-------LSLAE 133 (418)
T ss_pred ccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccCccCHHHHHhc-------CCHHH
Confidence 46789999985443 456788999999999 488999999999999999999999999888888875 67889
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcC-CCceEEccccccccCCC--------------CCC--------
Q 021490 87 RMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR-GYHPKLSDFGLAKLGPV--------------GDN-------- 143 (311)
Q Consensus 87 ~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~-~~~~~l~df~~~~~~~~--------------~~~-------- 143 (311)
+..+++.++.||+++|.+| |+||||||.|++.+. .+.-.|.|||++..... ...
T Consensus 134 i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~ 210 (418)
T KOG1167|consen 134 IRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHC 210 (418)
T ss_pred HHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccc
Confidence 9999999999999999999 999999999999985 45679999999872000 000
Q ss_pred ----------c----------eeeeeccccccccCcccccc-CCCccccceeehhHHHHHHHhCCCccC
Q 021490 144 ----------T----------HVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVD 191 (311)
Q Consensus 144 ----------~----------~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~l~~~ll~g~~pf~ 191 (311)
. .......||++|.|||++.. ...+.++||||.|+|+.-++++..||-
T Consensus 211 ~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf 279 (418)
T KOG1167|consen 211 QSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFF 279 (418)
T ss_pred cccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhccccccc
Confidence 0 00012458999999999875 456889999999999999999999984
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.5e-25 Score=178.23 Aligned_cols=226 Identities=23% Similarity=0.388 Sum_probs=178.1
Q ss_pred CcEEEEEEeecCCCcch--hHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHH
Q 021490 9 LQDVAIKQLDRNGVQGN--REFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNT 86 (311)
Q Consensus 9 g~~vaiK~~~~~~~~~~--~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~ 86 (311)
|.++++|+++...++.. .+|..|.-.|+-+.||||+.+++.+....++.++..|++.|+|+..++... +-..+..+
T Consensus 213 gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~t--~vvvd~sq 290 (448)
T KOG0195|consen 213 GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQT--SVVVDHSQ 290 (448)
T ss_pred CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcCc--cEEEecch
Confidence 56788899877765544 589999999999999999999999999999999999999999999998743 45678889
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCeEee-ccCCCeEEEcCCCceEEc--cccccccCCCCCCceeeeeccccccccCccccc
Q 021490 87 RMKIAAGAARGLEYLHDKAKPPVIYR-DLKCSNILLDRGYHPKLS--DFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 163 (311)
Q Consensus 87 ~~~~~~~i~~~l~~lh~~~~~~i~h~-dl~p~nil~~~~~~~~l~--df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 163 (311)
+.+++.+++.|++|||+... ++-+ .|....++++++-+.+|. |--.+.. .....-.+.|++||.++
T Consensus 291 av~faldiargmaflhslep--~ipr~~lns~hvmidedltarismad~kfsfq---------e~gr~y~pawmspealq 359 (448)
T KOG0195|consen 291 AVRFALDIARGMAFLHSLEP--MIPRFYLNSKHVMIDEDLTARISMADTKFSFQ---------EVGRAYSPAWMSPEALQ 359 (448)
T ss_pred HHHHHHHHHhhHHHHhhcch--hhhhhhcccceEEecchhhhheecccceeeee---------ccccccCcccCCHHHHh
Confidence 99999999999999999852 4433 588899999998887765 3222211 11223467899999998
Q ss_pred cCCCc---cccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHH
Q 021490 164 TGQLT---LKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAA 240 (311)
Q Consensus 164 ~~~~~---~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 240 (311)
..+-+ .++|+|||++++||+.|+..||......+-.-. +.-..++-.+||..+..+..|+.
T Consensus 360 rkped~n~raadmwsfaillwel~trevpfadlspmecgmk----------------ialeglrv~ippgis~hm~klm~ 423 (448)
T KOG0195|consen 360 RKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMK----------------IALEGLRVHIPPGISRHMNKLMN 423 (448)
T ss_pred cCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhh----------------hhhccccccCCCCccHHHHHHHH
Confidence 76543 579999999999999999999987654322111 11223445667777889999999
Q ss_pred HccccCCCCCCCHHHHHHHHHHh
Q 021490 241 MCVHEQPDMRPVIADVVTALAYL 263 (311)
Q Consensus 241 ~~l~~~p~~Rps~~~vl~~l~~~ 263 (311)
-|+..||.+||.+..++-.|+..
T Consensus 424 icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 424 ICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred HHhcCCCCcCCCcceehhhHHHh
Confidence 99999999999999998888753
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-24 Score=201.55 Aligned_cols=216 Identities=21% Similarity=0.247 Sum_probs=165.3
Q ss_pred HHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 021490 28 FLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKP 107 (311)
Q Consensus 28 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~ 107 (311)
+..|+-+-..|.|+|++..+..+.+....+-+||||++ +|..++.. ...+....+-.++.|++.|+.|+|+.|
T Consensus 368 i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~~----~~~~~~~e~~c~fKqL~~Gv~y~h~~G-- 440 (601)
T KOG0590|consen 368 ITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVMS----NGKLTPLEADCFFKQLLRGVKYLHSMG-- 440 (601)
T ss_pred hhhheeecccccCCchhhhHHHHhhcccchhhhhcccH-HHHHHHhc----ccccchhhhhHHHHHHHHHHHHHHhcC--
Confidence 33466666778999998888887776666666999998 99999987 467999999999999999999999999
Q ss_pred CeEeeccCCCeEEEcCCCceEEccccccccCCCCCCc--eeeeeccccccccCccccccCCCcc-ccceeehhHHHHHHH
Q 021490 108 PVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT--HVSTRVMGTYGYCAPEYAKTGQLTL-KSDVYSFGVVLLEIL 184 (311)
Q Consensus 108 ~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~-~~DiwslG~l~~~ll 184 (311)
+.|||+|++|++++.+|.+||+|||.+......... .......|+..|+|||++.+..|.+ ..||||.|+++..|.
T Consensus 441 -iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~ 519 (601)
T KOG0590|consen 441 -LAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMI 519 (601)
T ss_pred -ceeccCccccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEe
Confidence 999999999999999999999999998764433333 4556678999999999999988875 599999999999999
Q ss_pred hCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 021490 185 SGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 260 (311)
Q Consensus 185 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l 260 (311)
+|+.||......+..... ............ ...+....+.....+|.+||+.||.+|.|+++|++.-
T Consensus 520 ~~~~~Wk~a~~~~~~~~~------~~~~~~~~~~~~---~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~ 586 (601)
T KOG0590|consen 520 LGRFPWKVAKKSDNSFKT------NNYSDQRNIFEG---PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDE 586 (601)
T ss_pred cCCCccccccccccchhh------hccccccccccC---hHHHHHhchhhHHHHHHHHccCChhheecHHHHhhCh
Confidence 999999766544332100 000000000000 0011122234556799999999999999999999763
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-22 Score=191.31 Aligned_cols=231 Identities=21% Similarity=0.197 Sum_probs=166.3
Q ss_pred chhccCCcEEEEEEeecCC-CcchhHHH---HHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCC
Q 021490 3 QVILCLLQDVAIKQLDRNG-VQGNREFL---VEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPG 78 (311)
Q Consensus 3 ~~~~~~g~~vaiK~~~~~~-~~~~~~~~---~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~ 78 (311)
++...+|. |+||++-+.. .-+.+.|. .|++ +..+++||.+++.-+...+...|||-+|+. -+|.+++..
T Consensus 41 r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqyvk-hnLyDRlST---- 113 (1431)
T KOG1240|consen 41 RAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQYVK-HNLYDRLST---- 113 (1431)
T ss_pred hccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHHHh-hhhhhhhcc----
Confidence 34455677 9999986665 33444444 4444 555689999999888888888899999985 689999986
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEcccccccc--CCCCCCcee---eeecccc
Q 021490 79 KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL--GPVGDNTHV---STRVMGT 153 (311)
Q Consensus 79 ~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~--~~~~~~~~~---~~~~~~~ 153 (311)
...+...+...++.|++.||..+|..| |+|||||.+|||++.=+.+.|+||...+. .+..+.... .......
T Consensus 114 RPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRR 190 (1431)
T KOG1240|consen 114 RPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRR 190 (1431)
T ss_pred chHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCCCcccceEEEecCCce
Confidence 677888999999999999999999999 99999999999999999999999987642 222222221 1223345
Q ss_pred ccccCcccccc----------CC-CccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCc
Q 021490 154 YGYCAPEYAKT----------GQ-LTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADP 221 (311)
Q Consensus 154 ~~y~aPE~~~~----------~~-~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (311)
.+|+|||.+.. .. .+++-||||+||++.||++ |+++|+-........ .. ......
T Consensus 191 tCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~-----------~~--~~~~e~ 257 (1431)
T KOG1240|consen 191 TCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRS-----------GN--ADDPEQ 257 (1431)
T ss_pred eeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhc-----------cC--ccCHHH
Confidence 68999997743 12 5788999999999999988 788887543211110 00 000000
Q ss_pred cccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 021490 222 ELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 260 (311)
Q Consensus 222 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l 260 (311)
.+. .++ ...+..++..|++.||..|.|+++.++.-
T Consensus 258 ~Le-~Ie---d~~~Rnlil~Mi~rdPs~RlSAedyL~~y 292 (1431)
T KOG1240|consen 258 LLE-KIE---DVSLRNLILSMIQRDPSKRLSAEDYLQKY 292 (1431)
T ss_pred HHH-hCc---CccHHHHHHHHHccCchhccCHHHHHHhh
Confidence 000 000 11466799999999999999999999873
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.7e-21 Score=174.09 Aligned_cols=218 Identities=28% Similarity=0.418 Sum_probs=163.2
Q ss_pred HhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe-Eeec
Q 021490 35 LSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPV-IYRD 113 (311)
Q Consensus 35 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i-~h~d 113 (311)
|+.+.|.|+.++++.+.++...+.|.+||..|+|.+.+.. ....+++.....++.+++.||+|+|... | .|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s~---i~~hg~ 74 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNSP---IGYHGA 74 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcCc---ceeeee
Confidence 4678999999999999999999999999999999999986 3567899999999999999999999886 5 9999
Q ss_pred cCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccC-------CCccccceeehhHHHHHHHhC
Q 021490 114 LKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG-------QLTLKSDVYSFGVVLLEILSG 186 (311)
Q Consensus 114 l~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-------~~~~~~DiwslG~l~~~ll~g 186 (311)
++..|++++....+|++|||+.....................|.|||.+... ..+.+.||||+|++++|+++.
T Consensus 75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r 154 (484)
T KOG1023|consen 75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR 154 (484)
T ss_pred eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence 9999999999999999999998754321111112222345679999988653 146779999999999999999
Q ss_pred CCccCcchhHHH-HHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhh
Q 021490 187 RKAVDTSKAAAE-QSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLAS 265 (311)
Q Consensus 187 ~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l~~~~~ 265 (311)
..||+....... ..++..... .. .....|.+.... .....+..++..||..+|.+||++.++...++.+..
T Consensus 155 ~~~~~~~~~~~~~~eii~~~~~-~~-----~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 155 SGPFDLRNLVEDPDEIILRVKK-GG-----SNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred cCccccccccCChHHHHHHHHh-cC-----CCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 999976433222 222222111 00 001111111000 222378889999999999999999999988876554
Q ss_pred c
Q 021490 266 Q 266 (311)
Q Consensus 266 ~ 266 (311)
.
T Consensus 227 ~ 227 (484)
T KOG1023|consen 227 G 227 (484)
T ss_pred c
Confidence 3
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.9e-20 Score=162.40 Aligned_cols=237 Identities=32% Similarity=0.419 Sum_probs=178.1
Q ss_pred cEEEEEEeecCCCcc---hhHHHHHHHHHhcCCCC-cccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHH
Q 021490 10 QDVAIKQLDRNGVQG---NREFLVEVLMLSLLHHP-NLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN 85 (311)
Q Consensus 10 ~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~ 85 (311)
..+++|.+....... ...+.+|+..+..+.|+ +++++.+.+......+++++++.++++.+++...... ..++..
T Consensus 23 ~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~-~~~~~~ 101 (384)
T COG0515 23 KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRK-GPLSES 101 (384)
T ss_pred cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCCCcHHHHHHhcccc-cCCCHH
Confidence 568899987765433 57899999999999988 7999999997777789999999999999777652111 379999
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCC-ceEEccccccccCCCCCCce----eeeeccccccccCcc
Q 021490 86 TRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY-HPKLSDFGLAKLGPVGDNTH----VSTRVMGTYGYCAPE 160 (311)
Q Consensus 86 ~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~-~~~l~df~~~~~~~~~~~~~----~~~~~~~~~~y~aPE 160 (311)
....++.|++.++.++|+.+ ++|||+||+||+++..+ .++++|||.+.......... ......++..|++||
T Consensus 102 ~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe 178 (384)
T COG0515 102 EALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPE 178 (384)
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHH
Confidence 99999999999999999999 99999999999999988 79999999986433222211 234567899999999
Q ss_pred cccc---CCCccccceeehhHHHHHHHhCCCccCcchh----HHHHHHHHHhhhhhccccccccccCccccCCCChHhHH
Q 021490 161 YAKT---GQLTLKSDVYSFGVVLLEILSGRKAVDTSKA----AAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFY 233 (311)
Q Consensus 161 ~~~~---~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
.+.+ .......|+|++|++++++++|..||..... ........... .. ................
T Consensus 179 ~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~------~~---~~~~~~~~~~~~~~~~ 249 (384)
T COG0515 179 VLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELP------TP---SLASPLSPSNPELISK 249 (384)
T ss_pred HhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcC------Cc---ccccccCccccchhhH
Confidence 9987 5788999999999999999999999866553 11111111000 00 0000000000012234
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHH
Q 021490 234 QALAVAAMCVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 234 ~l~~li~~~l~~~p~~Rps~~~vl~~ 259 (311)
.+.+++..++..+|..|.+..+....
T Consensus 250 ~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 250 AASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred HHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 67789999999999999999887765
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.6e-20 Score=163.21 Aligned_cols=238 Identities=19% Similarity=0.172 Sum_probs=176.2
Q ss_pred cEEEEEEeecCCCcchhHHHHHHHHHhcCCC----CcccceeeEe-eeCCeeEEEEecCCCCChhhhhcccCCCCCCCCH
Q 021490 10 QDVAIKQLDRNGVQGNREFLVEVLMLSLLHH----PNLVNLIGYC-ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 84 (311)
Q Consensus 10 ~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h----~~i~~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~ 84 (311)
..+|+|............+..|..++..+.. +++..+++.+ ..+...++||+.+ |.+|.++..... .+.++.
T Consensus 45 ~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM~l~-G~sL~dl~~~~~--~~~fs~ 121 (322)
T KOG1164|consen 45 KEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVMSLL-GPSLEDLRKRNP--PGRFSR 121 (322)
T ss_pred eeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEEecc-CccHHHHHHhCC--CCCcCH
Confidence 4688888765543333377788888888862 5889999988 5777889999988 799999886643 578999
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCC-----CceEEccccccc--cCCCCCCc---ee---eeecc
Q 021490 85 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG-----YHPKLSDFGLAK--LGPVGDNT---HV---STRVM 151 (311)
Q Consensus 85 ~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~-----~~~~l~df~~~~--~~~~~~~~---~~---~~~~~ 151 (311)
.++..++.|++.+|.+||+.| ++||||||.|+++... ..+++.|||+++ ........ .. .....
T Consensus 122 ~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~r 198 (322)
T KOG1164|consen 122 KTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFR 198 (322)
T ss_pred hHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCC
Confidence 999999999999999999999 9999999999999764 469999999998 32111111 11 12345
Q ss_pred ccccccCccccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHH-HHHHhhhhhccccccccccCccccCCCChH
Q 021490 152 GTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQS-LVAWARPLFQDRTRHSLIADPELQGQYPPR 230 (311)
Q Consensus 152 ~~~~y~aPE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (311)
||..|.++.+..+...+.+.|+||++.++.+++.|..||.......... ........... . ....
T Consensus 199 GT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~~~~---------~-----~~~~ 264 (322)
T KOG1164|consen 199 GTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKLLTD---------R-----FGDL 264 (322)
T ss_pred CccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhhhccc---------c-----ccCC
Confidence 9999999999999999999999999999999999999996655332211 11111000000 0 1111
Q ss_pred hHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhcc
Q 021490 231 GFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQK 267 (311)
Q Consensus 231 ~~~~l~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~~ 267 (311)
.+..+.++...+-..+..++|....+...++......
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 265 KPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred ChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 2234555666666689999999999999987666544
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.8e-20 Score=164.36 Aligned_cols=140 Identities=16% Similarity=0.038 Sum_probs=104.4
Q ss_pred CCcEEEEEEeecCC-----CcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCC
Q 021490 8 LLQDVAIKQLDRNG-----VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPL 82 (311)
Q Consensus 8 ~g~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l 82 (311)
+|+.||||++.... ....+.|.+|+++|+.++|+|++..+.. ....|+||||++|++|... .. ..
T Consensus 43 ~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~~LVmE~~~G~~L~~~-~~----~~-- 112 (365)
T PRK09188 43 PGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGKDGLVRGWTEGVPLHLA-RP----HG-- 112 (365)
T ss_pred CCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCCcEEEEEccCCCCHHHh-Cc----cc--
Confidence 57778999875331 1224578899999999999999853322 2457999999999999632 11 11
Q ss_pred CHHHHHHHHHHHHHHHHHhhcCCCCCeEeecc-CCCeEEEcCCCceEEccccccccCCCCCCceee------eecccccc
Q 021490 83 DWNTRMKIAAGAARGLEYLHDKAKPPVIYRDL-KCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVS------TRVMGTYG 155 (311)
Q Consensus 83 ~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl-~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~------~~~~~~~~ 155 (311)
...++.+++.+|+|||+.| |+|||| ||+|||++.++.++|+|||++............ ....++..
T Consensus 113 ----~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~ 185 (365)
T PRK09188 113 ----DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKR 185 (365)
T ss_pred ----hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCc
Confidence 1467899999999999999 999999 999999999999999999999864332211111 23456778
Q ss_pred ccCcccccc
Q 021490 156 YCAPEYAKT 164 (311)
Q Consensus 156 y~aPE~~~~ 164 (311)
|++||.+..
T Consensus 186 ~~~pe~~~~ 194 (365)
T PRK09188 186 TYAPDALTP 194 (365)
T ss_pred cCCcccCCh
Confidence 999998864
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.4e-21 Score=173.58 Aligned_cols=209 Identities=25% Similarity=0.297 Sum_probs=168.2
Q ss_pred CCcEEEEEEeecCCCcc--hhHHHHHHHHHhcCC-CCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCH
Q 021490 8 LLQDVAIKQLDRNGVQG--NREFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 84 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~ 84 (311)
.|.-+|+|++++..... ......|..++...+ ||+++++...|+.+...++++++..||.|...+.. ...+++
T Consensus 21 a~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l~~----~~~f~~ 96 (612)
T KOG0603|consen 21 AGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRGGDLFTRLSK----EVMFDE 96 (612)
T ss_pred ccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcccchhhhcccc----CCchHH
Confidence 46778889887754322 124556788888886 99999999999999999999999999999998887 567888
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccccc
Q 021490 85 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT 164 (311)
Q Consensus 85 ~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 164 (311)
.....+...++.+++++|+.+ ++|+|+|++||+++.+|.+++.|||+++..-.... ..|+..|+|||++.
T Consensus 97 ~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~------~cgt~eymApEI~~- 166 (612)
T KOG0603|consen 97 LDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI------ACGTYEYRAPEIIN- 166 (612)
T ss_pred HHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhh------cccchhhhhhHhhh-
Confidence 889999999999999999999 99999999999999999999999999874222111 16899999999987
Q ss_pred CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccc
Q 021490 165 GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVH 244 (311)
Q Consensus 165 ~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 244 (311)
....++|.||||++.++|++|..||... ....+ .. .....|...+..+.+++..++.
T Consensus 167 -gh~~a~D~ws~gvl~felltg~~pf~~~----~~~~I------l~------------~~~~~p~~l~~~a~~~~~~l~~ 223 (612)
T KOG0603|consen 167 -GHLSAADWWSFGVLAFELLTGTLPFGGD----TMKRI------LK------------AELEMPRELSAEARSLFRQLFK 223 (612)
T ss_pred -ccCCcccchhhhhhHHHHhhCCCCCchH----HHHHH------hh------------hccCCchhhhHHHHHHHHHHHh
Confidence 6788999999999999999999999871 11111 00 0123445556677889999999
Q ss_pred cCCCCCCCH
Q 021490 245 EQPDMRPVI 253 (311)
Q Consensus 245 ~~p~~Rps~ 253 (311)
.+|..|.-.
T Consensus 224 r~p~nrLg~ 232 (612)
T KOG0603|consen 224 RNPENRLGA 232 (612)
T ss_pred hCHHHHhcc
Confidence 999999533
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=6.4e-20 Score=156.14 Aligned_cols=197 Identities=22% Similarity=0.204 Sum_probs=142.0
Q ss_pred CCCcccceeeEeee---------------------------CCeeEEEEecCCCCChhhhhcccCCCCCCCCHHHHHHHH
Q 021490 39 HHPNLVNLIGYCAD---------------------------GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIA 91 (311)
Q Consensus 39 ~h~~i~~~~~~~~~---------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~ 91 (311)
+||||+.+.++|.+ ...+|+||..++ .+|.+++-. ...+......++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~-----~~~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWT-----RHRSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhc-----CCCchHHHHHHH
Confidence 59999999988754 235799999885 799999975 446777888999
Q ss_pred HHHHHHHHHhhcCCCCCeEeeccCCCeEEEc--CC--CceEEccccccccCCCCCCc----eeeeeccccccccCccccc
Q 021490 92 AGAARGLEYLHDKAKPPVIYRDLKCSNILLD--RG--YHPKLSDFGLAKLGPVGDNT----HVSTRVMGTYGYCAPEYAK 163 (311)
Q Consensus 92 ~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~--~~--~~~~l~df~~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~ 163 (311)
.|++.|+.|||.+| +.|||+|.+|||+. ++ ..+.+.|||++.......-. .-....-|.-..+|||+..
T Consensus 348 aQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 348 AQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 99999999999999 99999999999994 22 35789999998653221111 1112234778899999886
Q ss_pred cCC------CccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHH
Q 021490 164 TGQ------LTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALA 237 (311)
Q Consensus 164 ~~~------~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 237 (311)
..+ .-.++|.|+.|.+.||+++..+||........ ..+. .....-|.+...+ +..+.+
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L-----------~~r~-Yqe~qLPalp~~v----pp~~rq 488 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLL-----------DTRT-YQESQLPALPSRV----PPVARQ 488 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhee-----------chhh-hhhhhCCCCcccC----ChHHHH
Confidence 422 24689999999999999999999976322110 0000 0111123333333 447888
Q ss_pred HHHHccccCCCCCCCHHHHHHHH
Q 021490 238 VAAMCVHEQPDMRPVIADVVTAL 260 (311)
Q Consensus 238 li~~~l~~~p~~Rps~~~vl~~l 260 (311)
++...|+.||++|+|..-....|
T Consensus 489 lV~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 489 LVFDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HHHHHhcCCccccCCccHHHhHH
Confidence 99999999999999877665555
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.6e-19 Score=149.06 Aligned_cols=241 Identities=19% Similarity=0.151 Sum_probs=178.5
Q ss_pred cCCcEEEEEEeecCCCcchhHHHHHHHHHhcC-CCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHH
Q 021490 7 CLLQDVAIKQLDRNGVQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN 85 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~ 85 (311)
-+|++||||.=. ......++..|++..+.| ..++|..++.+...+.+-.||+|++ |.||+++..-+ +..|+..
T Consensus 51 ~nne~VAIKfEP--rkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-GPSLEDLFD~C---gR~FSvK 124 (449)
T KOG1165|consen 51 YNNEPVAIKFEP--RKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-GPSLEDLFDLC---GRRFSVK 124 (449)
T ss_pred ccCceEEEEecc--ccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-CcCHHHHHHHh---cCcccHH
Confidence 368999999643 334667888999999999 4799999998888888889999998 79999988763 6789999
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcC-----CCceEEccccccccCCCCCC-----ceeeeecccccc
Q 021490 86 TRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR-----GYHPKLSDFGLAKLGPVGDN-----THVSTRVMGTYG 155 (311)
Q Consensus 86 ~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~-----~~~~~l~df~~~~~~~~~~~-----~~~~~~~~~~~~ 155 (311)
++..++.|++.-++++|++. +++|||||+|+||.. ...|.++|||++........ ........||..
T Consensus 125 TV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTAR 201 (449)
T KOG1165|consen 125 TVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTAR 201 (449)
T ss_pred hHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccccCcccccccccccee
Confidence 99999999999999999999 999999999999964 34689999999976432211 112223568999
Q ss_pred ccCccccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHH
Q 021490 156 YCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQA 235 (311)
Q Consensus 156 y~aPE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 235 (311)
||+--...+...+..-|+-|||-++++.|-|..||.+..........+- +++.... ..-. .+....+.++
T Consensus 202 YMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeK----IGe~Kr~--T~i~----~Lc~g~P~ef 271 (449)
T KOG1165|consen 202 YMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEK----IGETKRS--TPIE----VLCEGFPEEF 271 (449)
T ss_pred eeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHH----hcccccc--CCHH----HHHhcCHHHH
Confidence 9999998888889999999999999999999999987665333222111 1111000 0000 1112234456
Q ss_pred HHHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 021490 236 LAVAAMCVHEQPDMRPVIADVVTALAYLASQ 266 (311)
Q Consensus 236 ~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~ 266 (311)
...+.-.-..+-.+-|+..-+...+..+...
T Consensus 272 a~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr 302 (449)
T KOG1165|consen 272 ATYLRYVRRLDFFETPDYDYLRKLFDDVLDR 302 (449)
T ss_pred HHHHHHHHhcCcccCCCHHHHHHHHHHHHHh
Confidence 6666666677777888887766666554433
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=6e-20 Score=148.26 Aligned_cols=127 Identities=15% Similarity=0.073 Sum_probs=97.3
Q ss_pred CcchhccCCcEEEEEEeecCCCc--c-------hhHH-----------------HHHHHHHhcCCCCcccceeeEeeeCC
Q 021490 1 MMQVILCLLQDVAIKQLDRNGVQ--G-------NREF-----------------LVEVLMLSLLHHPNLVNLIGYCADGD 54 (311)
Q Consensus 1 ~~~~~~~~g~~vaiK~~~~~~~~--~-------~~~~-----------------~~e~~~l~~l~h~~i~~~~~~~~~~~ 54 (311)
||.+...+|++||||+++..... . ...| ..|++.+..+.++++.....+...
T Consensus 13 Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~~p~~~~~~-- 90 (190)
T cd05147 13 VYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIPCPEPILLK-- 90 (190)
T ss_pred EEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCcEEEec--
Confidence 45666678999999999764321 1 1122 349999999988877544333222
Q ss_pred eeEEEEecCCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHh-hcCCCCCeEeeccCCCeEEEcCCCceEEcccc
Q 021490 55 QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYL-HDKAKPPVIYRDLKCSNILLDRGYHPKLSDFG 133 (311)
Q Consensus 55 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~l-h~~~~~~i~h~dl~p~nil~~~~~~~~l~df~ 133 (311)
..++||||++|+++...... ...++...+..++.|++.+|.++ |+.| ++||||||+||+++ ++.++|+|||
T Consensus 91 ~~~iVmE~i~g~~l~~~~~~----~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-~~~v~LiDFG 162 (190)
T cd05147 91 SHVLVMEFIGDDGWAAPRLK----DAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-DGKLYIIDVS 162 (190)
T ss_pred CCEEEEEEeCCCCCcchhhh----cCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-CCcEEEEEcc
Confidence 23899999998777654332 35789999999999999999999 7889 99999999999998 4789999999
Q ss_pred cccc
Q 021490 134 LAKL 137 (311)
Q Consensus 134 ~~~~ 137 (311)
++..
T Consensus 163 ~a~~ 166 (190)
T cd05147 163 QSVE 166 (190)
T ss_pred cccc
Confidence 9864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.9e-20 Score=152.16 Aligned_cols=147 Identities=12% Similarity=0.152 Sum_probs=111.0
Q ss_pred CCcEEEEEEeecCCCcchhH---------HHHHHHHHhcCCCCcccceeeEeeeC--------CeeEEEEecCCCCChhh
Q 021490 8 LLQDVAIKQLDRNGVQGNRE---------FLVEVLMLSLLHHPNLVNLIGYCADG--------DQRLLVYEYMPLGSVED 70 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~~~~~---------~~~e~~~l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~ 70 (311)
++..+|||++.......... +.+|+..+.++.|++|..+.+++... ...++||||++|.+|.+
T Consensus 53 ~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~ 132 (232)
T PRK10359 53 DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELND 132 (232)
T ss_pred CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHH
Confidence 56789999997654433322 67899999999999999999886543 35789999999999977
Q ss_pred hhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeec
Q 021490 71 HLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRV 150 (311)
Q Consensus 71 ~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~ 150 (311)
+.. +++ ....+++.+|..+|+.| ++|||++|.||+++.+| ++|+|||...........
T Consensus 133 ~~~--------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~a~------ 190 (232)
T PRK10359 133 MPE--------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRKAK------ 190 (232)
T ss_pred hhh--------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-EEEEECCCcccccchhhH------
Confidence 632 222 34569999999999999 99999999999999988 999999987532111000
Q ss_pred cccccccCccccccCCCccccceeehhHHHHHHH
Q 021490 151 MGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEIL 184 (311)
Q Consensus 151 ~~~~~y~aPE~~~~~~~~~~~DiwslG~l~~~ll 184 (311)
........+..++|+|+||+++..+.
T Consensus 191 --------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 191 --------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred --------HHHHHHhHhcccccccceeEeehHHH
Confidence 00223345667999999999887654
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.5e-19 Score=144.37 Aligned_cols=240 Identities=20% Similarity=0.159 Sum_probs=175.2
Q ss_pred ccCCcEEEEEEeecCCCcchhHHHHHHHHHhcCCC-CcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCH
Q 021490 6 LCLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHH-PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 84 (311)
Q Consensus 6 ~~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~ 84 (311)
..+|..||||+=.. .....++..|..+.+.|++ ..|..+..++.+...-.+||++. |.||.++.+-+ ...++.
T Consensus 37 i~~ge~VAiK~Es~--~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-GPsLEdLfnfC---~R~ftm 110 (341)
T KOG1163|consen 37 ITSGEEVAIKLESS--KAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-GPSLEDLFNFC---SRRFTM 110 (341)
T ss_pred ccCCceEEEEeecc--cCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-CccHHHHHHHH---hhhhhH
Confidence 45899999997532 2345678889999999975 67888888888888889999998 79999998864 467999
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcC---CCceEEccccccccCCCCC-----Cceeeeeccccccc
Q 021490 85 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR---GYHPKLSDFGLAKLGPVGD-----NTHVSTRVMGTYGY 156 (311)
Q Consensus 85 ~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~---~~~~~l~df~~~~~~~~~~-----~~~~~~~~~~~~~y 156 (311)
.+++.++-|++.-++|+|.++ ++||||||+|+|..- ...+.++|||++....... .........||..|
T Consensus 111 kTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRY 187 (341)
T KOG1163|consen 111 KTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARY 187 (341)
T ss_pred HhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhccccccccCccccCCccceeeee
Confidence 999999999999999999999 999999999999964 3568999999997532211 11112234588888
Q ss_pred cCccccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHH
Q 021490 157 CAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQAL 236 (311)
Q Consensus 157 ~aPE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 236 (311)
.+--..-+-..+...|+-|+|.++.++.-|..||.+.......+..+-... . ..... -..+=.. .+.+..
T Consensus 188 ASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~E---k--K~s~~-ie~LC~G----~P~EF~ 257 (341)
T KOG1163|consen 188 ASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISE---K--KMSTP-IEVLCKG----FPAEFA 257 (341)
T ss_pred hhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHH---h--hcCCC-HHHHhCC----CcHHHH
Confidence 887766666667889999999999999999999998776554433221110 0 00000 0001112 223555
Q ss_pred HHHHHccccCCCCCCCHHHHHHHHHHhh
Q 021490 237 AVAAMCVHEQPDMRPVIADVVTALAYLA 264 (311)
Q Consensus 237 ~li~~~l~~~p~~Rps~~~vl~~l~~~~ 264 (311)
-.+..|-...-++-|...-+.+.+..+.
T Consensus 258 myl~Y~R~L~F~E~Pdy~ylrqlFriLf 285 (341)
T KOG1163|consen 258 MYLNYCRGLGFEEKPDYMYLRQLFRILF 285 (341)
T ss_pred HHHHHHhhcCCCCCCcHHHHHHHHHHHH
Confidence 6777888888888888887777665444
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=9.1e-19 Score=141.79 Aligned_cols=127 Identities=15% Similarity=0.056 Sum_probs=98.7
Q ss_pred CcchhccCCcEEEEEEeecCCCcc--------------------------hhHHHHHHHHHhcCCCCcccceeeEeeeCC
Q 021490 1 MMQVILCLLQDVAIKQLDRNGVQG--------------------------NREFLVEVLMLSLLHHPNLVNLIGYCADGD 54 (311)
Q Consensus 1 ~~~~~~~~g~~vaiK~~~~~~~~~--------------------------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 54 (311)
||.+...+|+.||||+++...... ...+.+|+..+..+.|+++.....+...
T Consensus 13 Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~-- 90 (190)
T cd05145 13 VYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVPVPEPILLK-- 90 (190)
T ss_pred EEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCCCceEEEec--
Confidence 355666689999999987653210 1123578999999999987655544333
Q ss_pred eeEEEEecCCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCeEeeccCCCeEEEcCCCceEEcccc
Q 021490 55 QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD-KAKPPVIYRDLKCSNILLDRGYHPKLSDFG 133 (311)
Q Consensus 55 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~~i~h~dl~p~nil~~~~~~~~l~df~ 133 (311)
..++||||++|+++...... ...++...+..++.+++.++.++|+ .| ++||||||+||+++ ++.++|+|||
T Consensus 91 ~~~lVmE~~~g~~~~~~~l~----~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-~~~~~liDFG 162 (190)
T cd05145 91 KNVLVMEFIGDDGSPAPRLK----DVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-DGKPYIIDVS 162 (190)
T ss_pred CCEEEEEEecCCCchhhhhh----hccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-CCCEEEEEcc
Confidence 24899999998865443222 3467888999999999999999999 99 99999999999998 7899999999
Q ss_pred cccc
Q 021490 134 LAKL 137 (311)
Q Consensus 134 ~~~~ 137 (311)
++..
T Consensus 163 ~a~~ 166 (190)
T cd05145 163 QAVE 166 (190)
T ss_pred ccee
Confidence 9874
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.1e-19 Score=150.38 Aligned_cols=218 Identities=18% Similarity=0.224 Sum_probs=133.5
Q ss_pred cchhcc-CCcEEEEEEeecCCC---cchhHHHHHHHHHhcCCC----------CcccceeeEeee---------CC----
Q 021490 2 MQVILC-LLQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHH----------PNLVNLIGYCAD---------GD---- 54 (311)
Q Consensus 2 ~~~~~~-~g~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h----------~~i~~~~~~~~~---------~~---- 54 (311)
++|... .|+++|+|++..... ...+.+.+|.-....+.+ -.++..++.... ..
T Consensus 29 ~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~~~~~~~~~~~~~ 108 (288)
T PF14531_consen 29 FEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGKPPFFERGPGQSI 108 (288)
T ss_dssp EEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS-SEEEECETTEE
T ss_pred EEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCCCcceecCCCCcc
Confidence 344444 489999999755442 233577777655555432 233333333221 11
Q ss_pred ----eeEEEEecCCCCChhhhhccc---CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCce
Q 021490 55 ----QRLLVYEYMPLGSVEDHLHDL---SPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP 127 (311)
Q Consensus 55 ----~~~lv~e~~~~~~L~~~l~~~---~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~ 127 (311)
..+++|+-+ .++|.+++... ......+.......+..|+++.+++||+.| ++|+||+|+|++++.+|.+
T Consensus 109 ~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHgdi~~~nfll~~~G~v 184 (288)
T PF14531_consen 109 YWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHGDIKPENFLLDQDGGV 184 (288)
T ss_dssp EEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEE-TTS-E
T ss_pred ceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEecccceeeEEEcCCCCE
Confidence 236788877 47888775432 111223444455677789999999999999 9999999999999999999
Q ss_pred EEccccccccCCCCCCceeeeeccccccccCcccccc--------CCCccccceeehhHHHHHHHhCCCccCcchhHHHH
Q 021490 128 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT--------GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ 199 (311)
Q Consensus 128 ~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~ 199 (311)
+|+||+.....+ ..... ...+..|.+||.... -.++.+.|.|+||+++|.|+++..||+........
T Consensus 185 ~Lg~F~~~~r~g----~~~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~ 259 (288)
T PF14531_consen 185 FLGDFSSLVRAG----TRYRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADP 259 (288)
T ss_dssp EE--GGGEEETT----EEEEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTS
T ss_pred EEcChHHHeecC----ceeec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccc
Confidence 999998775421 11111 345577999997643 24688899999999999999999999865432110
Q ss_pred HHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCC
Q 021490 200 SLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMR 250 (311)
Q Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 250 (311)
. . .-..|. +.++.+..||..+|+.||.+|
T Consensus 260 ~------------~---------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 260 E------------W---------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp G------------G---------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred c------------c---------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 0 0 112344 666788889999999999987
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.78 E-value=6e-20 Score=161.65 Aligned_cols=174 Identities=25% Similarity=0.372 Sum_probs=130.1
Q ss_pred eeEEEEecCCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccc
Q 021490 55 QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL 134 (311)
Q Consensus 55 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~ 134 (311)
.+|+.|++|.-.+|.+++.... .....++.....++.|++.|+.| ++ .+|+|+||.||++..+..++|+|||+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~-~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRR-TGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCC-cccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhh
Confidence 5789999999999999997533 24567888999999999999999 77 99999999999999999999999999
Q ss_pred cccCCCCC----CceeeeeccccccccCccccccCCCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhh
Q 021490 135 AKLGPVGD----NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLF 209 (311)
Q Consensus 135 ~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~ 209 (311)
........ .........||..|++||.+.+..|+.++||||||++++|++. -...|+....... +
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t~~d----------~ 472 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIATLTD----------I 472 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHhhhh----------h
Confidence 87543332 1223455679999999999999999999999999999999987 3333322221111 1
Q ss_pred ccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHH
Q 021490 210 QDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIAD 255 (311)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 255 (311)
. ....+|.+...+| .-..|+.+++...|.+||++.+
T Consensus 473 r-----~g~ip~~~~~d~p-----~e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 473 R-----DGIIPPEFLQDYP-----EEYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred h-----cCCCChHHhhcCc-----HHHHHHHHhcCCCcccCchHHH
Confidence 1 1111222222222 3346999999999999994443
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.1e-18 Score=138.46 Aligned_cols=167 Identities=19% Similarity=0.119 Sum_probs=120.6
Q ss_pred CCcEEEEEEeecCCCcch----hHHHHHHHHHhcCC-CCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCC
Q 021490 8 LLQDVAIKQLDRNGVQGN----REFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPL 82 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~~~----~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l 82 (311)
.+.+++.+.+........ ..|.+|+++|++|. |+++.+++++ ...+++|+|+.|.+|...+.. .
T Consensus 24 ~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G~~L~~~~~~-----~-- 92 (218)
T PRK12274 24 GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLAGAAMYQRPPR-----G-- 92 (218)
T ss_pred CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeecCccHHhhhhh-----h--
Confidence 577888777754433211 25889999999995 5789988886 346999999999998654321 1
Q ss_pred CHHHHHHHHHHHHHHHHHhhcCCCCCeEeecc-CCCeEEEcCCCceEEccccccccCCCCCCc----ee-------eeec
Q 021490 83 DWNTRMKIAAGAARGLEYLHDKAKPPVIYRDL-KCSNILLDRGYHPKLSDFGLAKLGPVGDNT----HV-------STRV 150 (311)
Q Consensus 83 ~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl-~p~nil~~~~~~~~l~df~~~~~~~~~~~~----~~-------~~~~ 150 (311)
...++.+++.+|.++|+.| ++|||| ||+||+++.+|.++|+|||++......... .. ....
T Consensus 93 ----~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~ 165 (218)
T PRK12274 93 ----DLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKR 165 (218)
T ss_pred ----hHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHH
Confidence 1357789999999999999 999999 799999999999999999999753322210 00 0112
Q ss_pred cccccccCcccccc--CCCccccceeehhHHHHHHHhCCCccCc
Q 021490 151 MGTYGYCAPEYAKT--GQLTLKSDVYSFGVVLLEILSGRKAVDT 192 (311)
Q Consensus 151 ~~~~~y~aPE~~~~--~~~~~~~DiwslG~l~~~ll~g~~pf~~ 192 (311)
..++.|+.|+...- ..--...++++.|+-+|.++|+..++-.
T Consensus 166 ~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 166 MYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred hcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 34666777764322 1222567888999999999999887643
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.75 E-value=6.9e-18 Score=161.19 Aligned_cols=234 Identities=17% Similarity=0.136 Sum_probs=168.0
Q ss_pred CcchhccCCcEEEEEEeecCCCcch---hHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCC
Q 021490 1 MMQVILCLLQDVAIKQLDRNGVQGN---REFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP 77 (311)
Q Consensus 1 ~~~~~~~~g~~vaiK~~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 77 (311)
||.+...+|+.||||+=+....... .+++..++ . . --+-|..+..++...+..+||++|.+.|+|.++++.
T Consensus 714 vy~a~~~~~~~~alK~e~P~~~WEfYI~~q~~~RLk-~-~-~~~~~~~~~~a~~~~~~S~lv~ey~~~Gtlld~~N~--- 787 (974)
T KOG1166|consen 714 VYVATHSNGKLVALKVEKPPNPWEFYICLQVMERLK-P-Q-MLPSIMHISSAHVFQNASVLVSEYSPYGTLLDLINT--- 787 (974)
T ss_pred EEEeecCCCcEEEEEeecCCCceeeeehHHHHHhhc-h-h-hhcchHHHHHHHccCCcceeeeeccccccHHHhhcc---
Confidence 4666777899999998766654332 33333332 1 1 123466666666667788999999999999999985
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEc-------CCCceEEccccccccCCCCCCceeeeec
Q 021490 78 GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD-------RGYHPKLSDFGLAKLGPVGDNTHVSTRV 150 (311)
Q Consensus 78 ~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~-------~~~~~~l~df~~~~~~~~~~~~~~~~~~ 150 (311)
.+.+++..++.+..|++..+..||..+ ||||||||+|+|+. ++..++|+|||.+..+............
T Consensus 788 -~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~ 863 (974)
T KOG1166|consen 788 -NKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAV 863 (974)
T ss_pred -CCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEecccceeeeEcCCCcEEeee
Confidence 788999999999999999999999999 99999999999994 3446899999998765554445556667
Q ss_pred cccccccCccccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChH
Q 021490 151 MGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPR 230 (311)
Q Consensus 151 ~~~~~y~aPE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (311)
.++..+-.+|...+..|+.++|.|.|+.+++-||.|+..- .. .......+..+.......
T Consensus 864 ~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q------------------~~--~g~~~~~~~~~~Ry~~~~ 923 (974)
T KOG1166|consen 864 WHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME------------------VK--NGSSWMVKTNFPRYWKRD 923 (974)
T ss_pred eccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH------------------hc--CCcceeccccchhhhhHH
Confidence 7899999999999999999999999999999999887421 00 001111111111111112
Q ss_pred hHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhcc
Q 021490 231 GFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQK 267 (311)
Q Consensus 231 ~~~~l~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~~ 267 (311)
-+-+++..+|..|-..=|...++...++......
T Consensus 924 ---~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~~ 957 (974)
T KOG1166|consen 924 ---MWNKFFDLLLNPDCDTLPNLQELRTELEEVLAEH 957 (974)
T ss_pred ---HHHHHHHHHhCcCcccchhHHHHHHHHHHHHHHH
Confidence 2334666677644444478888888777665544
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=8.3e-17 Score=131.30 Aligned_cols=113 Identities=19% Similarity=0.218 Sum_probs=90.9
Q ss_pred EEEEEeecCCCcchhHHHHHHHHHhcC-----CCCcccceeeEeeeCC---eeE-EEEec--CCCCChhhhhcccCCCCC
Q 021490 12 VAIKQLDRNGVQGNREFLVEVLMLSLL-----HHPNLVNLIGYCADGD---QRL-LVYEY--MPLGSVEDHLHDLSPGKK 80 (311)
Q Consensus 12 vaiK~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~---~~~-lv~e~--~~~~~L~~~l~~~~~~~~ 80 (311)
.+||++........+.+.+|+.+++.+ +||||+++++++.++. ..+ +|+|| +.+++|.+++.+ .
T Consensus 27 k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~-----~ 101 (210)
T PRK10345 27 RCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQ-----C 101 (210)
T ss_pred eEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHc-----c
Confidence 378888665555667899999999999 5799999999998874 333 78999 557999999975 2
Q ss_pred CCCHHHHHHHHHHHHHHH-HHhhcCCCCCeEeeccCCCeEEEcC----CCceEEccccc
Q 021490 81 PLDWNTRMKIAAGAARGL-EYLHDKAKPPVIYRDLKCSNILLDR----GYHPKLSDFGL 134 (311)
Q Consensus 81 ~l~~~~~~~~~~~i~~~l-~~lh~~~~~~i~h~dl~p~nil~~~----~~~~~l~df~~ 134 (311)
.+++. ..++.+++.++ +|||+++ |+||||||+||+++. ++.++|+|++.
T Consensus 102 ~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 102 RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 36655 35678888777 9999999 999999999999974 34799999543
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.67 E-value=4.2e-16 Score=128.45 Aligned_cols=117 Identities=23% Similarity=0.274 Sum_probs=99.1
Q ss_pred CCcEEEEEEeecCCCcc--------hhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCC
Q 021490 8 LLQDVAIKQLDRNGVQG--------NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGK 79 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~~--------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~ 79 (311)
.|..|++|+........ ...+.+|+.++..+.|+++.....++.+....++||||++|++|.+.+.. .
T Consensus 18 ~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~G~~L~~~~~~----~ 93 (211)
T PRK14879 18 LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYIEGEPLKDLINS----N 93 (211)
T ss_pred CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEeCCcCHHHHHHh----c
Confidence 67889999875443211 23577899999999999988877777777888999999999999999865 1
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccc
Q 021490 80 KPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 136 (311)
Q Consensus 80 ~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~ 136 (311)
. . ....++.+++.+|.++|+.+ ++|+|++|.||+++ ++.++++|||.+.
T Consensus 94 ~---~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~ 142 (211)
T PRK14879 94 G---M-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAE 142 (211)
T ss_pred c---H-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCccc
Confidence 1 2 88899999999999999999 99999999999999 7889999999875
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.4e-15 Score=138.03 Aligned_cols=168 Identities=15% Similarity=0.167 Sum_probs=133.8
Q ss_pred hhccCCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCC
Q 021490 4 VILCLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLD 83 (311)
Q Consensus 4 ~~~~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~ 83 (311)
....+|.+|.|+..+...........+-++-|+.|+||||+++++.+..+...|+|+|-+ ..|..++.+ +.
T Consensus 32 t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~-------l~ 102 (690)
T KOG1243|consen 32 TRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKE-------LG 102 (690)
T ss_pred ceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHH-------hH
Confidence 345689999999987776655667788899999999999999999999999999999988 478888876 33
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccc
Q 021490 84 WNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 163 (311)
Q Consensus 84 ~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 163 (311)
...+..-+.||+.||.|||+.+. ++|++|+...|+|+..|..+|++|.++........ .......-..|..|+.+.
T Consensus 103 ~~~v~~Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~ 178 (690)
T KOG1243|consen 103 KEEVCLGLFQILAALSFLNDDCN--LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEID 178 (690)
T ss_pred HHHHHHHHHHHHHHHHHHhccCC--eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcC
Confidence 66777788999999999985543 99999999999999999999999998754322221 112223334567777654
Q ss_pred cCCCccccceeehhHHHHHHHhC
Q 021490 164 TGQLTLKSDVYSFGVVLLEILSG 186 (311)
Q Consensus 164 ~~~~~~~~DiwslG~l~~~ll~g 186 (311)
... -..|.|.|||++|+++.|
T Consensus 179 ~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 179 PSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred ccc--cchhhhhHHHHHHHHhCc
Confidence 433 457999999999999998
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.1e-15 Score=127.52 Aligned_cols=125 Identities=13% Similarity=0.049 Sum_probs=94.3
Q ss_pred cchh--ccCCcEEEEEEeecCCCc------------------------chhHHHHHHHHHhcCCCCc--ccceeeEeeeC
Q 021490 2 MQVI--LCLLQDVAIKQLDRNGVQ------------------------GNREFLVEVLMLSLLHHPN--LVNLIGYCADG 53 (311)
Q Consensus 2 ~~~~--~~~g~~vaiK~~~~~~~~------------------------~~~~~~~e~~~l~~l~h~~--i~~~~~~~~~~ 53 (311)
|.+. ..+|+.||+|+++..... ....+.+|+..+..+.+.+ +.++++ .
T Consensus 45 y~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~~i~~p~~~~---~- 120 (237)
T smart00090 45 YHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEAGVPVPKPIA---W- 120 (237)
T ss_pred EEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCeeeE---e-
Confidence 4555 568999999998754311 0123567999999997533 333333 2
Q ss_pred CeeEEEEecCCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEcccc
Q 021490 54 DQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFG 133 (311)
Q Consensus 54 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~ 133 (311)
...++||||++|.+|...... ...+....+..++.|++.++++||+.|. ++|+||||+||+++ ++.++|+|||
T Consensus 121 ~~~~lV~E~~~g~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~g~--iiH~Dikp~NIli~-~~~i~LiDFg 193 (237)
T smart00090 121 RRNVLVMEFIGGDGLPAPRLK----DVEPEEEEEFELYDDILEEMRKLYKEGE--LVHGDLSEYNILVH-DGKVVIIDVS 193 (237)
T ss_pred cCceEEEEEecCCcccccccc----cCCcchHHHHHHHHHHHHHHHHHHhcCC--EEeCCCChhhEEEE-CCCEEEEECh
Confidence 235899999999888765533 3446666778999999999999998864 99999999999999 7899999999
Q ss_pred cccc
Q 021490 134 LAKL 137 (311)
Q Consensus 134 ~~~~ 137 (311)
.+..
T Consensus 194 ~a~~ 197 (237)
T smart00090 194 QSVE 197 (237)
T ss_pred hhhc
Confidence 8763
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.2e-15 Score=124.61 Aligned_cols=120 Identities=23% Similarity=0.255 Sum_probs=95.7
Q ss_pred cchhccCCcEEEEEEeecCCCc--------chhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhc
Q 021490 2 MQVILCLLQDVAIKQLDRNGVQ--------GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLH 73 (311)
Q Consensus 2 ~~~~~~~g~~vaiK~~~~~~~~--------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 73 (311)
|.+. -+|.+|++|+....... ...++.+|++++..++|+++.....++......++||||++|++|.+++.
T Consensus 11 y~~~-~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~g~~l~~~~~ 89 (199)
T TIGR03724 11 YLGD-FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIEGKPLKDVIE 89 (199)
T ss_pred EEee-cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEECCccHHHHHh
Confidence 4444 36789999996543211 12567789999999998876666556666677899999999999998876
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEcccccccc
Q 021490 74 DLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 137 (311)
Q Consensus 74 ~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~ 137 (311)
. ... .++.+++.+|.+||+.+ ++|+|++|.||+++ ++.++++|||++..
T Consensus 90 ~----~~~-------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 90 E----GND-------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred h----cHH-------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 5 111 78999999999999999 99999999999999 78999999998753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.5e-16 Score=131.39 Aligned_cols=203 Identities=23% Similarity=0.321 Sum_probs=142.4
Q ss_pred HHhcCCCCcccceeeEeeeCC-----eeEEEEecCCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 021490 34 MLSLLHHPNLVNLIGYCADGD-----QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPP 108 (311)
Q Consensus 34 ~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~ 108 (311)
-|.++-|.||++++.++.+.. +..+++||+..|+|..+|++.......+......+|+.||++||.|||+. .++
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~Pp 198 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CCc
Confidence 344557999999999986543 56899999999999999999887788899999999999999999999998 688
Q ss_pred eEeeccCCCeEEEcCCCceEEccccccccCCCC--CCceeeeeccccccccCccccccCCCccccceeehhHHHHHHHhC
Q 021490 109 VIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVG--DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG 186 (311)
Q Consensus 109 i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~l~~~ll~g 186 (311)
++|+++..+.|++..+|-||++--.-....... ..........+.+.|.+||.-.....+.++|||+||+...+|.-+
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail 278 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL 278 (458)
T ss_pred cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence 999999999999999988888632111110000 011111223467889999977667778899999999999999776
Q ss_pred CCccCc-chhHH-HHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 021490 187 RKAVDT-SKAAA-EQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 187 ~~pf~~-~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~ 259 (311)
..--.. ..... ..+... ....+.++. -.+++.+|+...|..||++.+++..
T Consensus 279 Eiq~tnseS~~~~ee~ia~----------~i~~len~l------------qr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 279 EIQSTNSESKVEVEENIAN----------VIIGLENGL------------QRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred eeccCCCcceeehhhhhhh----------heeeccCcc------------ccCcCcccccCCCCCCcchhhhhcC
Confidence 533111 11100 000000 000011111 1127788999999999999988754
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.61 E-value=1.5e-16 Score=148.61 Aligned_cols=214 Identities=25% Similarity=0.274 Sum_probs=163.5
Q ss_pred HHHHHHHhcCC-CCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHhh-cCCC
Q 021490 29 LVEVLMLSLLH-HPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH-DKAK 106 (311)
Q Consensus 29 ~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh-~~~~ 106 (311)
..|..+-..+. |+|++.+++...+.+..++++++..|+++.+.+.. ......+...+-.++.|+..++.|+| ..+
T Consensus 68 ~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~--~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~- 144 (601)
T KOG0590|consen 68 DTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISH--PDSTGTSSSSASRYLPQLNSGLSYLHPENG- 144 (601)
T ss_pred CccccccccccccccccccCCccCCCcccccccCccccccccccccc--CCccCCCCcchhhhhhhhccCccccCcccc-
Confidence 34666666675 99999999999999999999999999999998832 11226777888899999999999999 888
Q ss_pred CCeEeeccCCCeEEEcCCC-ceEEccccccccCCC-CCCceeeeeccc-cccccCccccccC-CCccccceeehhHHHHH
Q 021490 107 PPVIYRDLKCSNILLDRGY-HPKLSDFGLAKLGPV-GDNTHVSTRVMG-TYGYCAPEYAKTG-QLTLKSDVYSFGVVLLE 182 (311)
Q Consensus 107 ~~i~h~dl~p~nil~~~~~-~~~l~df~~~~~~~~-~~~~~~~~~~~~-~~~y~aPE~~~~~-~~~~~~DiwslG~l~~~ 182 (311)
+.|+|++|+|.+++..+ .+++.|||++..... ...........| +..|.|||...+. ...+..|+||.|+++..
T Consensus 145 --~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~ 222 (601)
T KOG0590|consen 145 --VTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSA 222 (601)
T ss_pred --cccCCCCCccchhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccc
Confidence 99999999999999999 999999999987655 333344455667 9999999998874 55788999999999999
Q ss_pred HHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 021490 183 ILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 260 (311)
Q Consensus 183 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l 260 (311)
+++|..|+.......... ..| ...... ..............+++.+++..+|..|.+.+++-..-
T Consensus 223 ~~~g~~p~~~~~~~~~~~-~~~----~~~~~~--------~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~ 287 (601)
T KOG0590|consen 223 MLTGELPWDFPSRKDGRY-SSW----KSNKGR--------FTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDN 287 (601)
T ss_pred cccCCCCccccccccccc-eee----cccccc--------cccCccccCChhhhhcccccccCCchhccccccccccc
Confidence 999999997765433110 000 011000 00111122334677799999999999999999877553
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.60 E-value=4.1e-16 Score=147.26 Aligned_cols=139 Identities=28% Similarity=0.328 Sum_probs=106.1
Q ss_pred HHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCce------------ee-eeccccccccCccc
Q 021490 95 ARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH------------VS-TRVMGTYGYCAPEY 161 (311)
Q Consensus 95 ~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~------------~~-~~~~~~~~y~aPE~ 161 (311)
+.+++|||+.+ |+|||+||+|.+|+.-|.+|++|||+++......... .. ....+|+.|.|||+
T Consensus 153 vla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeV 229 (1205)
T KOG0606|consen 153 VLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEV 229 (1205)
T ss_pred hHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhh
Confidence 78899999999 9999999999999999999999999987532221111 11 23479999999999
Q ss_pred cccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHH
Q 021490 162 AKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAM 241 (311)
Q Consensus 162 ~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 241 (311)
+....|+..+|+|++|+|+|+.+-|..||.+...++....+ +.+......- | .....++.+++.+
T Consensus 230 ilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~v------isd~i~wpE~-d--------ea~p~Ea~dli~~ 294 (1205)
T KOG0606|consen 230 ILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV------ISDDIEWPEE-D--------EALPPEAQDLIEQ 294 (1205)
T ss_pred hhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhh------hhhhcccccc-C--------cCCCHHHHHHHHH
Confidence 99999999999999999999999999999887655443222 2221111111 1 1122378889999
Q ss_pred ccccCCCCCC
Q 021490 242 CVHEQPDMRP 251 (311)
Q Consensus 242 ~l~~~p~~Rp 251 (311)
.|+.+|.+|.
T Consensus 295 LL~qnp~~Rl 304 (1205)
T KOG0606|consen 295 LLRQNPLCRL 304 (1205)
T ss_pred HHHhChHhhc
Confidence 9999999994
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.3e-14 Score=121.43 Aligned_cols=118 Identities=21% Similarity=0.206 Sum_probs=90.8
Q ss_pred CCcEEEEEEeecCCC-------------cchhHHHHHHHHHhcCCCCcc--cceeeEeeeCC----eeEEEEecCCC-CC
Q 021490 8 LLQDVAIKQLDRNGV-------------QGNREFLVEVLMLSLLHHPNL--VNLIGYCADGD----QRLLVYEYMPL-GS 67 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~i--~~~~~~~~~~~----~~~lv~e~~~~-~~ 67 (311)
+|..++||.+..... .....+.+|++++..|+|+++ ...+++..... ..++|||+++| .+
T Consensus 54 ~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~ 133 (239)
T PRK01723 54 PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHGLFYRADILIERIEGARD 133 (239)
T ss_pred CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecCcceeeeEEEEecCCCCC
Confidence 467889998754211 223567889999999998775 66666543322 23599999997 68
Q ss_pred hhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEcccccccc
Q 021490 68 VEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 137 (311)
Q Consensus 68 L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~ 137 (311)
|.+++.. ..++.. .+.+++.+|.+||+.| |+|+||+|.|||++.++.++|+|||.+..
T Consensus 134 L~~~l~~-----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 134 LVALLQE-----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred HHHHHhc-----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence 9888764 345543 3578999999999999 99999999999999988999999998864
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.4e-14 Score=118.15 Aligned_cols=119 Identities=15% Similarity=0.017 Sum_probs=91.2
Q ss_pred cchhccCCcEEEEEEeecCCCc----------------------chhHHHHHHHHHhcCCCCc--ccceeeEeeeCCeeE
Q 021490 2 MQVILCLLQDVAIKQLDRNGVQ----------------------GNREFLVEVLMLSLLHHPN--LVNLIGYCADGDQRL 57 (311)
Q Consensus 2 ~~~~~~~g~~vaiK~~~~~~~~----------------------~~~~~~~e~~~l~~l~h~~--i~~~~~~~~~~~~~~ 57 (311)
|.+...+|+.||||++...... ....+.+|+.++..+.|++ +...++ ....+
T Consensus 32 y~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~v~~~~~----~~~~~ 107 (198)
T cd05144 32 YLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFPVPKPID----WNRHA 107 (198)
T ss_pred EEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCCCCceee----cCCce
Confidence 4555668999999987643210 0123567899999887764 444443 23458
Q ss_pred EEEecCCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEcccccccc
Q 021490 58 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 137 (311)
Q Consensus 58 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~ 137 (311)
+||||++|++|...... .....++.+++.++.++|+.+ ++|+||+|.||++++++.++|+|||.+..
T Consensus 108 lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nill~~~~~~~liDfg~~~~ 174 (198)
T cd05144 108 VVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNILVDDDEKIYIIDWPQMVS 174 (198)
T ss_pred EEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEEEcCCCcEEEEECCcccc
Confidence 99999999998765431 235678899999999999999 99999999999999999999999999854
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.55 E-value=2.5e-14 Score=133.78 Aligned_cols=96 Identities=24% Similarity=0.328 Sum_probs=85.7
Q ss_pred hHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC
Q 021490 26 REFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKA 105 (311)
Q Consensus 26 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~ 105 (311)
+.+.+|++++..++|++++....++.+....++||||++|++|.+++. ....++.+++.+|.+||+.+
T Consensus 381 ~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~g 448 (535)
T PRK09605 381 ERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKAG 448 (535)
T ss_pred HHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhCC
Confidence 468899999999999999888777777777899999999999998885 24678999999999999999
Q ss_pred CCCeEeeccCCCeEEEcCCCceEEcccccccc
Q 021490 106 KPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 137 (311)
Q Consensus 106 ~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~ 137 (311)
++||||||+||++ .++.++|+|||++..
T Consensus 449 ---iiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 449 ---IVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred ---CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 9999999999999 677899999999863
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.9e-13 Score=105.96 Aligned_cols=116 Identities=21% Similarity=0.186 Sum_probs=95.0
Q ss_pred CcEEEEEEeecCCCcchhHHHHHHHHHhcCCC--CcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHH
Q 021490 9 LQDVAIKQLDRNGVQGNREFLVEVLMLSLLHH--PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNT 86 (311)
Q Consensus 9 g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~ 86 (311)
+..+++|....... ...+.+|+..++.++| .++.+++.++......+++|||++|+++..+ +...
T Consensus 21 ~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~~~-----------~~~~ 87 (155)
T cd05120 21 DEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDEV-----------SEEE 87 (155)
T ss_pred CCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecccC-----------CHHH
Confidence 47899998754433 5678899999999976 5888888888877889999999988766543 4566
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEcccccccc
Q 021490 87 RMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 137 (311)
Q Consensus 87 ~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~ 137 (311)
...++.+++.+++.||......++|+|++|.||+++..+.++++||+.+..
T Consensus 88 ~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 88 KEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred HHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 778899999999999985222299999999999999989999999998763
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.44 E-value=3.7e-13 Score=108.66 Aligned_cols=123 Identities=18% Similarity=0.144 Sum_probs=85.5
Q ss_pred CcchhccCCcEEEEEEeecCCCcch--hHH----------------------HHHHHHHhcCCCCc--ccceeeEeeeCC
Q 021490 1 MMQVILCLLQDVAIKQLDRNGVQGN--REF----------------------LVEVLMLSLLHHPN--LVNLIGYCADGD 54 (311)
Q Consensus 1 ~~~~~~~~g~~vaiK~~~~~~~~~~--~~~----------------------~~e~~~l~~l~h~~--i~~~~~~~~~~~ 54 (311)
||.+...+|++||||++........ ..+ ..|...+..+.+.+ +.++++. .
T Consensus 13 Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~----~ 88 (187)
T cd05119 13 VYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPVPKPIDL----N 88 (187)
T ss_pred EEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCCCceEec----C
Confidence 3566666899999999875432111 111 24566666664432 3444432 2
Q ss_pred eeEEEEecCCCCChhh-hhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCeEeeccCCCeEEEcCCCceEEccc
Q 021490 55 QRLLVYEYMPLGSVED-HLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD-KAKPPVIYRDLKCSNILLDRGYHPKLSDF 132 (311)
Q Consensus 55 ~~~lv~e~~~~~~L~~-~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~~i~h~dl~p~nil~~~~~~~~l~df 132 (311)
..++||||++|+++.. .+... .. ...+..++.+++.++.++|. .+ ++|+||+|+||+++ ++.++++||
T Consensus 89 ~~~lv~e~~~g~~~~~~~l~~~-----~~-~~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~-~~~~~liDf 158 (187)
T cd05119 89 RHVLVMEFIGGDGIPAPRLKDV-----RL-LEDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD-DGKVYIIDV 158 (187)
T ss_pred CCEEEEEEeCCCCccChhhhhh-----hh-cccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-CCcEEEEEC
Confidence 3589999999855432 12210 01 16678999999999999999 88 99999999999999 889999999
Q ss_pred ccccc
Q 021490 133 GLAKL 137 (311)
Q Consensus 133 ~~~~~ 137 (311)
|.+..
T Consensus 159 g~a~~ 163 (187)
T cd05119 159 PQAVE 163 (187)
T ss_pred ccccc
Confidence 99863
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.38 E-value=1.4e-12 Score=118.42 Aligned_cols=128 Identities=21% Similarity=0.124 Sum_probs=87.3
Q ss_pred CcchhccCCcEEEEEEeecCCCcch----------------------------------------hHHHHHHHHHhcCC-
Q 021490 1 MMQVILCLLQDVAIKQLDRNGVQGN----------------------------------------REFLVEVLMLSLLH- 39 (311)
Q Consensus 1 ~~~~~~~~g~~vaiK~~~~~~~~~~----------------------------------------~~~~~e~~~l~~l~- 39 (311)
||.+.+.+|+.||||+.+....... -+|.+|++.+.+++
T Consensus 133 Vh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~Ea~n~~~~~~ 212 (437)
T TIGR01982 133 VHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRREAANASELGE 212 (437)
T ss_pred eEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHHHHHHHHHHHH
Confidence 5778888999999999865321100 03455666666553
Q ss_pred ---CCcccceeeEe-eeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHH-HHHHhhcCCCCCeEeecc
Q 021490 40 ---HPNLVNLIGYC-ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR-GLEYLHDKAKPPVIYRDL 114 (311)
Q Consensus 40 ---h~~i~~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~-~l~~lh~~~~~~i~h~dl 114 (311)
|.+-+.+-.++ ......++||||++|++|.+..... ..... ...++..++. .+..+|..| ++|+|+
T Consensus 213 ~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~---~~~~~---~~~ia~~~~~~~l~ql~~~g---~~H~D~ 283 (437)
T TIGR01982 213 NFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALD---EAGLD---RKALAENLARSFLNQVLRDG---FFHADL 283 (437)
T ss_pred hcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHH---hcCCC---HHHHHHHHHHHHHHHHHhCC---ceeCCC
Confidence 32222322233 2344579999999999998876531 11222 2345555555 467889999 999999
Q ss_pred CCCeEEEcCCCceEEcccccccc
Q 021490 115 KCSNILLDRGYHPKLSDFGLAKL 137 (311)
Q Consensus 115 ~p~nil~~~~~~~~l~df~~~~~ 137 (311)
+|.||+++.++.++++|||++..
T Consensus 284 hPgNilv~~~g~i~liDfG~~~~ 306 (437)
T TIGR01982 284 HPGNIFVLKDGKIIALDFGIVGR 306 (437)
T ss_pred CcccEEECCCCcEEEEeCCCeeE
Confidence 99999999999999999999864
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.34 E-value=2e-12 Score=116.51 Aligned_cols=226 Identities=23% Similarity=0.212 Sum_probs=162.5
Q ss_pred CCcEEEEEEeecCCC--cchhHHHHHHHHHhcC-CCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCH
Q 021490 8 LLQDVAIKQLDRNGV--QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 84 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~ 84 (311)
++..+|+|.-+.... .....=.+|+.....+ .|++.++.+..+...+..++-+|+|. .+|.++.... ...++.
T Consensus 142 s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqtE~~~-~sl~~~~~~~---~~~~p~ 217 (524)
T KOG0601|consen 142 SPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFIQTELCG-ESLQSYCHTP---CNFLPD 217 (524)
T ss_pred CCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcceeeecccc-chhHHhhhcc---cccCCc
Confidence 567788887433222 2223445677777777 58999999999999999999999994 7888877762 345888
Q ss_pred HHHHHHHHHHHH----HHHHhhcCCCCCeEeeccCCCeEEEcCC-CceEEccccccccCCCCCCc---eeeeeccccccc
Q 021490 85 NTRMKIAAGAAR----GLEYLHDKAKPPVIYRDLKCSNILLDRG-YHPKLSDFGLAKLGPVGDNT---HVSTRVMGTYGY 156 (311)
Q Consensus 85 ~~~~~~~~~i~~----~l~~lh~~~~~~i~h~dl~p~nil~~~~-~~~~l~df~~~~~~~~~~~~---~~~~~~~~~~~y 156 (311)
..++..+.+... |+..+|+.+ ++|.+++|.||+...+ ..++++|||+........-. ....+..+...|
T Consensus 218 ~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y 294 (524)
T KOG0601|consen 218 NLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIY 294 (524)
T ss_pred hhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceE
Confidence 889999999888 999999999 9999999999999999 88999999998765443322 122223577889
Q ss_pred cCccccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHH
Q 021490 157 CAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQAL 236 (311)
Q Consensus 157 ~aPE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 236 (311)
++||..+ .-++...|+|++|.++.+-.++...+..... ..+.+.+.. .+...+....+-.+.
T Consensus 295 ~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~----------~~W~~~r~~-------~ip~e~~~~~s~~l~ 356 (524)
T KOG0601|consen 295 AAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKN----------SSWSQLRQG-------YIPLEFCEGGSSSLR 356 (524)
T ss_pred eChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCC----------CCccccccc-------cCchhhhcCcchhhh
Confidence 9999876 5668899999999999998887766543310 011111100 011112222233555
Q ss_pred HHHHHccccCCCCCCCHHHHHH
Q 021490 237 AVAAMCVHEQPDMRPVIADVVT 258 (311)
Q Consensus 237 ~li~~~l~~~p~~Rps~~~vl~ 258 (311)
..+.+|++.+|..|++...+..
T Consensus 357 ~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 357 SVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred hHHHHhcCcchhhhhHHHHHhc
Confidence 6899999999999998877653
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.28 E-value=1.3e-11 Score=97.93 Aligned_cols=113 Identities=17% Similarity=0.084 Sum_probs=81.3
Q ss_pred CCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCccc-ceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHH
Q 021490 8 LLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLV-NLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNT 86 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~-~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~ 86 (311)
.|..|++|+..... .....+.+|+.++..+.+.+++ +++... ....++||||++|.++... . . .
T Consensus 20 ~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~~~--~-------~---~ 84 (170)
T cd05151 20 ANKKYVVRIPGNGT-ELLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELLTE--D-------F---S 84 (170)
T ss_pred CCeEEEEEeCCCCc-ccccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccccc--c-------c---c
Confidence 47889999874432 2334567899999998665544 344332 3346899999999887543 1 0 1
Q ss_pred HHHHHHHHHHHHHHhhcCC--CCCeEeeccCCCeEEEcCCCceEEccccccc
Q 021490 87 RMKIAAGAARGLEYLHDKA--KPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 136 (311)
Q Consensus 87 ~~~~~~~i~~~l~~lh~~~--~~~i~h~dl~p~nil~~~~~~~~l~df~~~~ 136 (311)
...++.+++.+|+.||..+ ...++|+|++|.||+++ ++.++++||+.+.
T Consensus 85 ~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 85 DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred CHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 1345679999999999987 11149999999999999 6689999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.5e-10 Score=92.94 Aligned_cols=95 Identities=15% Similarity=0.105 Sum_probs=71.6
Q ss_pred HHHHHHhcCCC--CcccceeeEeeeCCeeEEEEecCCCCChh-hhhcccCCCCCCCCHHHHHHHHHHHHHHHHHh-hcCC
Q 021490 30 VEVLMLSLLHH--PNLVNLIGYCADGDQRLLVYEYMPLGSVE-DHLHDLSPGKKPLDWNTRMKIAAGAARGLEYL-HDKA 105 (311)
Q Consensus 30 ~e~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~~L~-~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~l-h~~~ 105 (311)
+|++.|.++.. -++..++++ ...++||||+.+..+. ..+.+ ..++......+..+++.+|..| |..|
T Consensus 75 kE~r~L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-----~~~~~~~~~~i~~~i~~~l~~l~H~~g 145 (197)
T cd05146 75 KEMHNLKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-----AKLNDEEMKNAYYQVLSMMKQLYKECN 145 (197)
T ss_pred HHHHHHHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-----cccCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 79999988853 345555543 3568999999765442 22332 2355566778889999999999 8898
Q ss_pred CCCeEeeccCCCeEEEcCCCceEEcccccccc
Q 021490 106 KPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 137 (311)
Q Consensus 106 ~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~ 137 (311)
++|+||++.||++++ +.++|+|||.+..
T Consensus 146 ---lVHGDLs~~NIL~~~-~~v~iIDF~qav~ 173 (197)
T cd05146 146 ---LVHADLSEYNMLWHD-GKVWFIDVSQSVE 173 (197)
T ss_pred ---eecCCCCHHHEEEEC-CcEEEEECCCcee
Confidence 999999999999974 6799999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.19 E-value=1.9e-10 Score=89.64 Aligned_cols=113 Identities=25% Similarity=0.290 Sum_probs=88.3
Q ss_pred CcEEEEEEeecCCC--cc------hhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCC
Q 021490 9 LQDVAIKQLDRNGV--QG------NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKK 80 (311)
Q Consensus 9 g~~vaiK~~~~~~~--~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 80 (311)
|.++++|.-.++.- .. .++-.+|++++..++--.|....-++.+.....|+|||++|..|.+.+.. .
T Consensus 19 g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~G~~lkd~l~~----~- 93 (204)
T COG3642 19 GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIEGELLKDALEE----A- 93 (204)
T ss_pred CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeCChhHHHHHHh----c-
Confidence 55677777444321 11 13455799999998766666666666677788999999999999989886 2
Q ss_pred CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccc
Q 021490 81 PLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 136 (311)
Q Consensus 81 ~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~ 136 (311)
...++..+-.-+.-||..| |+|+||+++||+++..+ +.++|||++.
T Consensus 94 ------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~ 139 (204)
T COG3642 94 ------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGE 139 (204)
T ss_pred ------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCccc
Confidence 2567788888899999999 99999999999998765 9999999986
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.19 E-value=3.6e-10 Score=98.27 Aligned_cols=203 Identities=16% Similarity=0.181 Sum_probs=131.6
Q ss_pred eeEEEEecCCCCC-hhhhhccc--CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEcc
Q 021490 55 QRLLVYEYMPLGS-VEDHLHDL--SPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSD 131 (311)
Q Consensus 55 ~~~lv~e~~~~~~-L~~~l~~~--~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~d 131 (311)
...+.|+.+.|.. ...++.-. ..+.....|...+.++..++.+.+.||..| .+-||+.++|+|+++++.|.|.|
T Consensus 84 ~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVd 160 (637)
T COG4248 84 VIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVD 160 (637)
T ss_pred eeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEc
Confidence 3678888887642 22222211 112345779999999999999999999999 99999999999999999999998
Q ss_pred ccccccCCCCCCceeeeeccccccccCccccc-----cCCCccccceeehhHHHHHHHhC-CCccCcchhHHHH-----H
Q 021490 132 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK-----TGQLTLKSDVYSFGVVLLEILSG-RKAVDTSKAAAEQ-----S 200 (311)
Q Consensus 132 f~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~l~~~ll~g-~~pf~~~~~~~~~-----~ 200 (311)
-+..... .+.......++...|.+||.-. +..-+...|.|.||+++++++.| ++||.+....... .
T Consensus 161 sDsfqi~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~ 237 (637)
T COG4248 161 SDSFQIN---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLET 237 (637)
T ss_pred ccceeec---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchh
Confidence 7655432 2333344457889999999654 33457789999999999998875 8999765432110 0
Q ss_pred HHHHhhhhhccccccccccCccccCCCCh-HhHHHHHHHHHHccccC--CCCCCCHHHHHHHHHHhhhc
Q 021490 201 LVAWARPLFQDRTRHSLIADPELQGQYPP-RGFYQALAVAAMCVHEQ--PDMRPVIADVVTALAYLASQ 266 (311)
Q Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~~l~~~--p~~Rps~~~vl~~l~~~~~~ 266 (311)
-+.... +........-..+. ....|- -....+..|+.+|+..- +.-|||++.++..|..+.+.
T Consensus 238 ~Ia~g~--f~ya~~~~~g~~p~-P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~ 303 (637)
T COG4248 238 DIAHGR--FAYASDQRRGLKPP-PRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQ 303 (637)
T ss_pred hhhcce--eeechhccCCCCCC-CCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence 010000 00000000000000 001111 11235666888998763 56899999999999776644
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.17 E-value=4.7e-11 Score=109.97 Aligned_cols=128 Identities=17% Similarity=0.081 Sum_probs=83.4
Q ss_pred CcchhccC-CcEEEEEEeecCCCcc----------------------------------h------hHHHHHHHHHhcCC
Q 021490 1 MMQVILCL-LQDVAIKQLDRNGVQG----------------------------------N------REFLVEVLMLSLLH 39 (311)
Q Consensus 1 ~~~~~~~~-g~~vaiK~~~~~~~~~----------------------------------~------~~~~~e~~~l~~l~ 39 (311)
|+.+.+.+ |+.||||++.+.-... . -+|.+|+..+.+++
T Consensus 135 Vh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~~Ea~N~~~~~ 214 (537)
T PRK04750 135 VHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLMREAANASQLR 214 (537)
T ss_pred EEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHHHHHHHHHHHH
Confidence 46677877 9999999997531100 0 13445665555553
Q ss_pred ----CCcccceeeEeee-CCeeEEEEecCCCCChhhh--hcccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEee
Q 021490 40 ----HPNLVNLIGYCAD-GDQRLLVYEYMPLGSVEDH--LHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYR 112 (311)
Q Consensus 40 ----h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~--l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~ 112 (311)
+.+.+.+-.++.+ ....+|||||++|+++.+. +.........+....+..++.|+. ..| ++|+
T Consensus 215 ~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif-------~~G---ffHa 284 (537)
T PRK04750 215 RNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF-------RDG---FFHA 284 (537)
T ss_pred HHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-------hCC---eeeC
Confidence 3334444444432 4567899999999999774 322100111344555555555554 477 9999
Q ss_pred ccCCCeEEEcCCC----ceEEccccccccC
Q 021490 113 DLKCSNILLDRGY----HPKLSDFGLAKLG 138 (311)
Q Consensus 113 dl~p~nil~~~~~----~~~l~df~~~~~~ 138 (311)
|++|.||+++.+| .++++|||++...
T Consensus 285 DpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 285 DMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred CCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 9999999999888 9999999998653
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.12 E-value=2.2e-09 Score=95.63 Aligned_cols=159 Identities=17% Similarity=0.187 Sum_probs=118.6
Q ss_pred cCCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEee----eCCeeEEEEecCCC-CChhhhhccc------
Q 021490 7 CLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA----DGDQRLLVYEYMPL-GSVEDHLHDL------ 75 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~----~~~~~~lv~e~~~~-~~L~~~l~~~------ 75 (311)
-+|..|++|+++-........-..-+++++++.|+|+|++.++|. .+..+++|++|+++ ++|.++--..
T Consensus 299 ~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~ 378 (655)
T KOG3741|consen 299 VDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKR 378 (655)
T ss_pred cCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCccccc
Confidence 379999999994433333323344688999999999999999886 34568999999875 5676643221
Q ss_pred -----CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeec
Q 021490 76 -----SPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRV 150 (311)
Q Consensus 76 -----~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~ 150 (311)
...+...++..+|.++.|+..||.++|+.| +..+-|.+.+|+++.+-+++|..+|.........
T Consensus 379 ~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~-------- 447 (655)
T KOG3741|consen 379 TNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP-------- 447 (655)
T ss_pred cccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecCCC--------
Confidence 122455788999999999999999999999 9999999999999999899999888764322211
Q ss_pred cccccccCccccccCCCccccceeehhHHHHHHHhCC
Q 021490 151 MGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 187 (311)
Q Consensus 151 ~~~~~y~aPE~~~~~~~~~~~DiwslG~l~~~ll~g~ 187 (311)
. +.+.. ..+-|.=.||.++..|.||.
T Consensus 448 ------~--~~le~---~Qq~D~~~lG~ll~aLAt~~ 473 (655)
T KOG3741|consen 448 ------T--EPLES---QQQNDLRDLGLLLLALATGT 473 (655)
T ss_pred ------C--cchhH---HhhhhHHHHHHHHHHHhhcc
Confidence 0 11111 23567778999999999985
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.12 E-value=6.4e-10 Score=94.22 Aligned_cols=124 Identities=16% Similarity=0.103 Sum_probs=91.5
Q ss_pred CCcEEEEEEeecCCCc-ch----------hHHHHHHHHHhcCCCCcc--cceeeEeee-----CCeeEEEEecCCCC-Ch
Q 021490 8 LLQDVAIKQLDRNGVQ-GN----------REFLVEVLMLSLLHHPNL--VNLIGYCAD-----GDQRLLVYEYMPLG-SV 68 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~-~~----------~~~~~e~~~l~~l~h~~i--~~~~~~~~~-----~~~~~lv~e~~~~~-~L 68 (311)
+|+.+.||........ .. ..+.+|...+..|...+| ..+++++.. ....++|||++++. +|
T Consensus 44 ~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL 123 (268)
T PRK15123 44 AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISL 123 (268)
T ss_pred CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccH
Confidence 5788999976433311 01 147789999988854333 344455543 23578999999876 79
Q ss_pred hhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcC-------CCceEEccccccc
Q 021490 69 EDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR-------GYHPKLSDFGLAK 136 (311)
Q Consensus 69 ~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~-------~~~~~l~df~~~~ 136 (311)
.+++.... ....+......++.+++..+.-||..| ++|+|+++.|||++. ++.+.++||+.+.
T Consensus 124 ~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 124 EDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred HHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 88886421 234566778899999999999999999 999999999999975 4689999999875
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.08 E-value=3.4e-10 Score=90.61 Aligned_cols=123 Identities=20% Similarity=0.151 Sum_probs=79.9
Q ss_pred CcchhccCCcEEEEEEeecCCC----------------------cc----hhHHHHHHHHHhcCCCC--cccceeeEeee
Q 021490 1 MMQVILCLLQDVAIKQLDRNGV----------------------QG----NREFLVEVLMLSLLHHP--NLVNLIGYCAD 52 (311)
Q Consensus 1 ~~~~~~~~g~~vaiK~~~~~~~----------------------~~----~~~~~~e~~~l~~l~h~--~i~~~~~~~~~ 52 (311)
||.++..+|.+||||+.+.... .. .....+|++.|..+..- ++.+++++.
T Consensus 2 Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-- 79 (188)
T PF01163_consen 2 VYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-- 79 (188)
T ss_dssp EEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE--
T ss_pred EEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe--
Confidence 4667788999999999654100 00 12345799999999765 455555442
Q ss_pred CCeeEEEEecCC--CCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHH-hhcCCCCCeEeeccCCCeEEEcCCCceEE
Q 021490 53 GDQRLLVYEYMP--LGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEY-LHDKAKPPVIYRDLKCSNILLDRGYHPKL 129 (311)
Q Consensus 53 ~~~~~lv~e~~~--~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~-lh~~~~~~i~h~dl~p~nil~~~~~~~~l 129 (311)
..++||||++ |..+..+... .++......++.+++..+.. +|..| ++||||++.||+++++ .+.+
T Consensus 80 --~~~ivME~I~~~G~~~~~l~~~------~~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 80 --RNVIVMEYIGEDGVPLPRLKDV------DLSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp --TTEEEEE--EETTEEGGCHHHC------GGGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred --CCEEEEEecCCCccchhhHHhc------cccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence 3479999998 6555544332 12244566777788875555 57998 9999999999999988 8999
Q ss_pred cccccccc
Q 021490 130 SDFGLAKL 137 (311)
Q Consensus 130 ~df~~~~~ 137 (311)
+|||.+..
T Consensus 148 IDf~qav~ 155 (188)
T PF01163_consen 148 IDFGQAVD 155 (188)
T ss_dssp --GTTEEE
T ss_pred EecCccee
Confidence 99998753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.08 E-value=9.5e-10 Score=91.04 Aligned_cols=130 Identities=18% Similarity=0.220 Sum_probs=95.7
Q ss_pred cchhccCCcEEEEEEeecCCC-cchhHHHHHHHHHhcCCCC--cccceeeEeeeCC---eeEEEEecCCCCChhhhhccc
Q 021490 2 MQVILCLLQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHP--NLVNLIGYCADGD---QRLLVYEYMPLGSVEDHLHDL 75 (311)
Q Consensus 2 ~~~~~~~g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~--~i~~~~~~~~~~~---~~~lv~e~~~~~~L~~~l~~~ 75 (311)
|.+...+|..+++|+...... .....+..|++++..+++. ++.+++.+..... ..++||||++|.++.+.+..
T Consensus 15 ~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~G~~l~~~~~~- 93 (223)
T cd05154 15 YLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVDGRVLRDRLLR- 93 (223)
T ss_pred EEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeCCEecCCCCCC-
Confidence 455555678999998754332 2456788999999999753 4566777665532 56899999999888776532
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHhhcCC--------------------------------------------------
Q 021490 76 SPGKKPLDWNTRMKIAAGAARGLEYLHDKA-------------------------------------------------- 105 (311)
Q Consensus 76 ~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~-------------------------------------------------- 105 (311)
..++......++.+++.+|..||+..
T Consensus 94 ----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (223)
T cd05154 94 ----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLRWLEAHLP 169 (223)
T ss_pred ----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHHHHHhhCC
Confidence 34667777778888888888888531
Q ss_pred ---CCCeEeeccCCCeEEEcC--CCceEEccccccc
Q 021490 106 ---KPPVIYRDLKCSNILLDR--GYHPKLSDFGLAK 136 (311)
Q Consensus 106 ---~~~i~h~dl~p~nil~~~--~~~~~l~df~~~~ 136 (311)
...++|+|+++.||+++. ++.+.|+||+.+.
T Consensus 170 ~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 170 ADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred CCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 112799999999999998 6678999998775
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.06 E-value=6.1e-11 Score=112.94 Aligned_cols=195 Identities=24% Similarity=0.244 Sum_probs=141.2
Q ss_pred CCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCC
Q 021490 38 LHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCS 117 (311)
Q Consensus 38 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~ 117 (311)
.++|.++.....+.-....+|+++|+.|++|...++. .+..+..-.......+..++++||... +.|+|++|.
T Consensus 861 p~~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~----~~~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~ 933 (1205)
T KOG0606|consen 861 PRSPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHN----SGCLSAEPARSPILERVQSLESLHSSL---RKHRDLKPD 933 (1205)
T ss_pred CCCCceecccCCCCCCCCcchhhHHhccCCchhhhhc----CCCcccccccchhHHHHhhhhccccch---hhccccccc
Confidence 3456666555555556678999999999999999987 345666677777888889999999998 999999999
Q ss_pred eEEEcCCCceEEccccccccCCCC----CC----c---------------------eeeeeccccccccCccccccCCCc
Q 021490 118 NILLDRGYHPKLSDFGLAKLGPVG----DN----T---------------------HVSTRVMGTYGYCAPEYAKTGQLT 168 (311)
Q Consensus 118 nil~~~~~~~~l~df~~~~~~~~~----~~----~---------------------~~~~~~~~~~~y~aPE~~~~~~~~ 168 (311)
|.+...+|...+.||+........ .. . .......+++.|.+||...+....
T Consensus 934 ~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hg 1013 (1205)
T KOG0606|consen 934 SLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHG 1013 (1205)
T ss_pred chhhcccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCC
Confidence 999999999999999733221100 00 0 001224589999999999999999
Q ss_pred cccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCC
Q 021490 169 LKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPD 248 (311)
Q Consensus 169 ~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~ 248 (311)
..+|+|+.|+++++.++|.+||......... ....... .-....+........+++...+..+|.
T Consensus 1014 s~ad~~~~g~~l~e~l~g~pp~na~tpq~~f----------~ni~~~~-----~~~p~g~~~~s~~aq~~~~~ll~~~~~ 1078 (1205)
T KOG0606|consen 1014 SAADWWSSGVCLFEVLTGIPPFNAETPQQIF----------ENILNRD-----IPWPEGPEEGSYEAQDLINRLLTEEPT 1078 (1205)
T ss_pred CcchhhhhhhhhhhhhcCCCCCCCcchhhhh----------hccccCC-----CCCCCCccccChhhhhhhhhhhccCch
Confidence 9999999999999999999999876543321 1110000 000122233445677799999999999
Q ss_pred CCCCHH
Q 021490 249 MRPVIA 254 (311)
Q Consensus 249 ~Rps~~ 254 (311)
+|..+.
T Consensus 1079 qr~~a~ 1084 (1205)
T KOG0606|consen 1079 QRLGAK 1084 (1205)
T ss_pred hccCcc
Confidence 997665
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.05 E-value=2.2e-09 Score=83.52 Aligned_cols=125 Identities=21% Similarity=0.175 Sum_probs=91.9
Q ss_pred CCcEEEEEEeecCCC--------cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCC-CChhhhhcccCCC
Q 021490 8 LLQDVAIKQLDRNGV--------QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPL-GSVEDHLHDLSPG 78 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~--------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~ 78 (311)
+|+..+||.-..+.- -...+-.+|++.|.+++--.|.-..-+|.+...-.++|||++| .++.+++....
T Consensus 29 ~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~~~g~~~vk~~i~~~~-- 106 (229)
T KOG3087|consen 29 SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEFIDGASTVKDFILSTM-- 106 (229)
T ss_pred CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEeccchhHHHHHHHHHc--
Confidence 578778876433211 1124566799999988766666655667777788999999987 47788887643
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCC---ceEEcccccccc
Q 021490 79 KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY---HPKLSDFGLAKL 137 (311)
Q Consensus 79 ~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~---~~~l~df~~~~~ 137 (311)
...........++..+-..+.-||..+ ++||||..+||++..++ .+.++|||++..
T Consensus 107 ~~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 107 EDESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred cCcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 222333344789999999999999999 99999999999996544 358999999863
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.03 E-value=2.5e-10 Score=103.10 Aligned_cols=223 Identities=19% Similarity=0.162 Sum_probs=153.9
Q ss_pred cCCcEEEEEEeecCCCcchh--HHHHHHHHHhcC-CCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCC
Q 021490 7 CLLQDVAIKQLDRNGVQGNR--EFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLD 83 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~~~~--~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~ 83 (311)
.++..+++|.+.+....... .-..|+.+...+ .|.+++..+..+......|+=.|||.++++.....- ...+.
T Consensus 289 ~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~~~----~~~~d 364 (524)
T KOG0601|consen 289 EGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEGGSSSLRSVT----SQMLD 364 (524)
T ss_pred CCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhcCcchhhhhHH----HHhcC
Confidence 35667777777554433322 233466666666 588899988888888888999999999988766633 46688
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCC-CceEEccccccccCCCCCCceeeeecccccccc--Ccc
Q 021490 84 WNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG-YHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC--APE 160 (311)
Q Consensus 84 ~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~--aPE 160 (311)
+...+.+..|++.++.++|+.. ++|.|++|.||++..+ +..+++||++.......... ..+...+. ++.
T Consensus 365 ~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~~~-----~~~~~r~~p~~~~ 436 (524)
T KOG0601|consen 365 EDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSSGV-----FHHIDRLYPIAEI 436 (524)
T ss_pred cchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccccccceeccc-----ccccccccccchh
Confidence 8899999999999999999999 9999999999999886 77899999987532111111 11222333 555
Q ss_pred ccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHH
Q 021490 161 YAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAA 240 (311)
Q Consensus 161 ~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 240 (311)
......+..++|+++||..+.+..++...-..... ........ -+ . .+.....+..+.+
T Consensus 437 ~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~-------------~~~i~~~~---~p----~-~~~~~~~~q~~~k 495 (524)
T KOG0601|consen 437 LLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ-------------SLTIRSGD---TP----N-LPGLKLQLQVLLK 495 (524)
T ss_pred hccccccccccccccccccccccccCcccCccccc-------------ceeeeccc---cc----C-CCchHHhhhhhhh
Confidence 55667788999999999999999887643222110 00000000 00 0 1112246667888
Q ss_pred HccccCCCCCCCHHHHHHHHHH
Q 021490 241 MCVHEQPDMRPVIADVVTALAY 262 (311)
Q Consensus 241 ~~l~~~p~~Rps~~~vl~~l~~ 262 (311)
.++..++..||++.++.....+
T Consensus 496 v~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 496 VMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred hhcCCccccchhhhhhcccchh
Confidence 9999999999999988766543
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.03 E-value=1.4e-10 Score=106.38 Aligned_cols=158 Identities=19% Similarity=0.202 Sum_probs=107.7
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceee-------eeccccccc
Q 021490 84 WNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVS-------TRVMGTYGY 156 (311)
Q Consensus 84 ~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~-------~~~~~~~~y 156 (311)
.+....=+.+++.|+.|+|..-+ +||++|.|++|.++.++..||+.|+.+.......+.... ........|
T Consensus 98 Te~~f~nl~~v~dgl~flh~sAk--~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f 175 (700)
T KOG2137|consen 98 TEDGFANLGNVADGLAFLHRSAK--VVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNF 175 (700)
T ss_pred ccHhhhhhhcccchhhhhccCcc--eeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCccc
Confidence 34445556677799999998755 999999999999999999999999987643221111111 112345689
Q ss_pred cCccccccCCCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHH
Q 021490 157 CAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQA 235 (311)
Q Consensus 157 ~aPE~~~~~~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 235 (311)
.|||++.....+.++|+||+|+++|.+.. |+..+.............. .+..-...++...+.++
T Consensus 176 ~apE~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~--------------~~~~~~~~~s~~~p~el 241 (700)
T KOG2137|consen 176 LAPEYLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRN--------------LLNAGAFGYSNNLPSEL 241 (700)
T ss_pred ccchhhccccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhc--------------ccccccccccccCcHHH
Confidence 99999998888999999999999999984 5555543322111110000 00000112223445588
Q ss_pred HHHHHHccccCCCCCCCHHHHH
Q 021490 236 LAVAAMCVHEQPDMRPVIADVV 257 (311)
Q Consensus 236 ~~li~~~l~~~p~~Rps~~~vl 257 (311)
.+-+.+++..++..||++..+.
T Consensus 242 ~~~l~k~l~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 242 RESLKKLLNGDSAVRPTLDLLL 263 (700)
T ss_pred HHHHHHHhcCCcccCcchhhhh
Confidence 8899999999999999776665
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.92 E-value=6.8e-09 Score=85.01 Aligned_cols=106 Identities=25% Similarity=0.243 Sum_probs=84.2
Q ss_pred hhHHHHHHHHHhcCCCC--cccceeeEeeeC----CeeEEEEecCCCC-ChhhhhcccCCCCCCCCHHHHHHHHHHHHHH
Q 021490 25 NREFLVEVLMLSLLHHP--NLVNLIGYCADG----DQRLLVYEYMPLG-SVEDHLHDLSPGKKPLDWNTRMKIAAGAARG 97 (311)
Q Consensus 25 ~~~~~~e~~~l~~l~h~--~i~~~~~~~~~~----~~~~lv~e~~~~~-~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~ 97 (311)
.....+|...+..|..- .+..++++.... ...++|+|++++. +|.+++.. ...++......++.+++..
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~----~~~~~~~~~~~ll~~l~~~ 130 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQ----WEQLDPSQRRELLRALARL 130 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHh----hcccchhhHHHHHHHHHHH
Confidence 34677888888887533 345555655542 2458999999874 79998886 2336777889999999999
Q ss_pred HHHhhcCCCCCeEeeccCCCeEEEcCCC---ceEEcccccccc
Q 021490 98 LEYLHDKAKPPVIYRDLKCSNILLDRGY---HPKLSDFGLAKL 137 (311)
Q Consensus 98 l~~lh~~~~~~i~h~dl~p~nil~~~~~---~~~l~df~~~~~ 137 (311)
++-||..| ++|+|+++.|||++.++ .+.++||+.+..
T Consensus 131 i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 131 IAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 99999999 99999999999999887 899999997764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.76 E-value=4.3e-08 Score=81.20 Aligned_cols=120 Identities=18% Similarity=0.061 Sum_probs=84.9
Q ss_pred CcchhccCCcEEEEEEeec------------------CCCcc----hhHHHHHHHHHhcCCCC--cccceeeEeeeCCee
Q 021490 1 MMQVILCLLQDVAIKQLDR------------------NGVQG----NREFLVEVLMLSLLHHP--NLVNLIGYCADGDQR 56 (311)
Q Consensus 1 ~~~~~~~~g~~vaiK~~~~------------------~~~~~----~~~~~~e~~~l~~l~h~--~i~~~~~~~~~~~~~ 56 (311)
||.++..+|.++|||.=+. ...++ .....+|.++|..|... .+.+.+++ +.-
T Consensus 107 VY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~VP~P~~~----nRH 182 (304)
T COG0478 107 VYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKVPKPIAW----NRH 182 (304)
T ss_pred EEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCCCCcccc----ccc
Confidence 4667788899999996221 00111 12445799999998644 56666654 345
Q ss_pred EEEEecCCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccc
Q 021490 57 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 136 (311)
Q Consensus 57 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~ 136 (311)
.+|||+++|..|...- +.....-.++..|+.-+.-+-..| ++|+|+++-||+++++|.++++||..+.
T Consensus 183 aVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~dg~~~vIDwPQ~v 250 (304)
T COG0478 183 AVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTEDGDIVVIDWPQAV 250 (304)
T ss_pred eeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEecCCCEEEEeCcccc
Confidence 8999999986664432 123344555666666666666788 9999999999999999999999998664
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.75 E-value=1.1e-08 Score=93.76 Aligned_cols=130 Identities=18% Similarity=0.153 Sum_probs=83.6
Q ss_pred CcchhccCCcEEEEEEeecCCCc---------------------c-------------------hhHHHHHHHHHhcCC-
Q 021490 1 MMQVILCLLQDVAIKQLDRNGVQ---------------------G-------------------NREFLVEVLMLSLLH- 39 (311)
Q Consensus 1 ~~~~~~~~g~~vaiK~~~~~~~~---------------------~-------------------~~~~~~e~~~l~~l~- 39 (311)
||.+++.+|+.||||+..+.-.. . .-+|.+|+..+.+++
T Consensus 141 VH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~EA~n~~~~~~ 220 (517)
T COG0661 141 VHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRREAANAERFRE 220 (517)
T ss_pred heeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHHHHHHHHHHHH
Confidence 67889999999999997661100 0 013445776666653
Q ss_pred ----CCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccC
Q 021490 40 ----HPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLK 115 (311)
Q Consensus 40 ----h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~ 115 (311)
.+++.-..-+.+......|+|||++|..+.+...-. ...++...+.....++. +..+-..| +.|.|.+
T Consensus 221 nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~---~~g~d~k~ia~~~~~~f--~~q~~~dg---ffHaDpH 292 (517)
T COG0661 221 NFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALK---SAGIDRKELAELLVRAF--LRQLLRDG---FFHADPH 292 (517)
T ss_pred HcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHH---hcCCCHHHHHHHHHHHH--HHHHHhcC---ccccCCC
Confidence 233332222334456679999999999998874221 13344333333222221 22223356 9999999
Q ss_pred CCeEEEcCCCceEEccccccccC
Q 021490 116 CSNILLDRGYHPKLSDFGLAKLG 138 (311)
Q Consensus 116 p~nil~~~~~~~~l~df~~~~~~ 138 (311)
|.||+++.+|.+.+.|||+....
T Consensus 293 pGNi~v~~~g~i~~lDfGi~g~l 315 (517)
T COG0661 293 PGNILVRSDGRIVLLDFGIVGRL 315 (517)
T ss_pred ccceEEecCCcEEEEcCcceecC
Confidence 99999999999999999998653
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.60 E-value=4.2e-07 Score=73.74 Aligned_cols=114 Identities=13% Similarity=0.088 Sum_probs=74.2
Q ss_pred cCCcEEEEEEeecCCCcchhHHH---------HHHHHHhcCC---CCcccceeeEee-----eCCeeEEEEecCCCCChh
Q 021490 7 CLLQDVAIKQLDRNGVQGNREFL---------VEVLMLSLLH---HPNLVNLIGYCA-----DGDQRLLVYEYMPLGSVE 69 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~~~~~~~---------~e~~~l~~l~---h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~ 69 (311)
-+|..+++|..........+.|. +.+..+..++ ...+..++.+.. .....+++|||++|..|.
T Consensus 52 i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~ 131 (229)
T PF06176_consen 52 IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKIFRYTSSYVLLMEYIEGVELN 131 (229)
T ss_pred ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeeeccceeEEEEEEEEecCeecc
Confidence 36788899987665443333333 2333333343 222333333322 223456899999998886
Q ss_pred hhhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccc
Q 021490 70 DHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 136 (311)
Q Consensus 70 ~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~ 136 (311)
+... +++ .+...+..++.-||+.| ++|+|.+|.|+++++++ ++++||+...
T Consensus 132 d~~~--------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~-i~iID~~~k~ 182 (229)
T PF06176_consen 132 DIED--------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG-IRIIDTQGKR 182 (229)
T ss_pred cchh--------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc-EEEEECcccc
Confidence 6543 222 24456777899999999 99999999999998665 9999997654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.50 E-value=7.9e-07 Score=71.87 Aligned_cols=122 Identities=15% Similarity=0.135 Sum_probs=88.7
Q ss_pred CcEEEEEEeecCC------CcchhHHHHHHHHHhcCCCCc--ccceeeEee-e----CCeeEEEEecCCC-CChhhhhcc
Q 021490 9 LQDVAIKQLDRNG------VQGNREFLVEVLMLSLLHHPN--LVNLIGYCA-D----GDQRLLVYEYMPL-GSVEDHLHD 74 (311)
Q Consensus 9 g~~vaiK~~~~~~------~~~~~~~~~e~~~l~~l~h~~--i~~~~~~~~-~----~~~~~lv~e~~~~-~~L~~~l~~ 74 (311)
|..+-+|.-.... +....-|.+|...+..|..-+ +..+. ++. . ....+||+|-++| .+|.+++.+
T Consensus 41 g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~ 119 (216)
T PRK09902 41 GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVTEDMAGFISIADWYAQ 119 (216)
T ss_pred CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEEEeCCCCccHHHHHhc
Confidence 3456677654211 335578999999999995322 44444 222 1 2346899997653 688888865
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCc--eEEccccccc
Q 021490 75 LSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH--PKLSDFGLAK 136 (311)
Q Consensus 75 ~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~--~~l~df~~~~ 136 (311)
.. -...+......++.+++..++-||+.| +.|+|+.+.||+++.+|. +.++||.-++
T Consensus 120 ~~--~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 120 HA--VSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred CC--cCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 21 234577778899999999999999999 999999999999986666 9999998665
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.32 E-value=1.2e-05 Score=66.66 Aligned_cols=126 Identities=10% Similarity=0.057 Sum_probs=72.6
Q ss_pred CCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCc--ccceeeEeeeCCeeEEEEecCCCCC-hhhhh------------
Q 021490 8 LLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPN--LVNLIGYCADGDQRLLVYEYMPLGS-VEDHL------------ 72 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~~~~~~~~~lv~e~~~~~~-L~~~l------------ 72 (311)
.|..+++|...... ......+|++++..+..-. +.+.+++........+|||+++|.+ +...+
T Consensus 21 ~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~~~~~~~~~~~~~~l~~ 98 (226)
T TIGR02172 21 KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSFSRIISDNPSRLEEIAK 98 (226)
T ss_pred cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccchhhhhcCCHHHHHHHHH
Confidence 46678888875422 3456788999999886433 4667777777777889999999863 21111
Q ss_pred ---------cccCCCCCCCCHH--HHHHHHH-------HHHH-HHHHhhcC-CCCCeEeeccCCCeEEEcCCCceEEccc
Q 021490 73 ---------HDLSPGKKPLDWN--TRMKIAA-------GAAR-GLEYLHDK-AKPPVIYRDLKCSNILLDRGYHPKLSDF 132 (311)
Q Consensus 73 ---------~~~~~~~~~l~~~--~~~~~~~-------~i~~-~l~~lh~~-~~~~i~h~dl~p~nil~~~~~~~~l~df 132 (311)
++.......++.. .....+. .+.. ...+|... ....++|+|++|.||++++++ +.++||
T Consensus 99 ~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~~Nii~~~~~-~~iIDw 177 (226)
T TIGR02172 99 IFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQIGNLITSGKG-TYWIDL 177 (226)
T ss_pred HHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCCCcEEEcCCC-cEEEec
Confidence 1111011111100 0000000 0001 11222111 122379999999999999888 999999
Q ss_pred cccc
Q 021490 133 GLAK 136 (311)
Q Consensus 133 ~~~~ 136 (311)
+.+.
T Consensus 178 e~a~ 181 (226)
T TIGR02172 178 GDFG 181 (226)
T ss_pred hhcC
Confidence 8765
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.30 E-value=7.5e-06 Score=67.37 Aligned_cols=123 Identities=17% Similarity=0.114 Sum_probs=80.2
Q ss_pred cchhccCCcEEEEEEeecCCCcch---------hH---------------HHHHHHHHhcCC--CCcccceeeEeeeCCe
Q 021490 2 MQVILCLLQDVAIKQLDRNGVQGN---------RE---------------FLVEVLMLSLLH--HPNLVNLIGYCADGDQ 55 (311)
Q Consensus 2 ~~~~~~~g~~vaiK~~~~~~~~~~---------~~---------------~~~e~~~l~~l~--h~~i~~~~~~~~~~~~ 55 (311)
|.+...++..+|+|+.+.....-. .+ ...|+.-|.++. +=.+.+.+++. .
T Consensus 65 y~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~Pi~~~----~ 140 (268)
T COG1718 65 YLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPEPIAFR----N 140 (268)
T ss_pred EeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCCceeec----C
Confidence 445557899999999865322110 11 124666666553 22334444433 3
Q ss_pred eEEEEecCCCCCh-hhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCeEeeccCCCeEEEcCCCceEEcccc
Q 021490 56 RLLVYEYMPLGSV-EDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD-KAKPPVIYRDLKCSNILLDRGYHPKLSDFG 133 (311)
Q Consensus 56 ~~lv~e~~~~~~L-~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~~i~h~dl~p~nil~~~~~~~~l~df~ 133 (311)
-.|||||+....+ .=.|. .-.+.......+..+++..+.-|-. .+ +||+||+..|||+. ++.+.++|++
T Consensus 141 nVLvMEfIg~~g~pAP~Lk-----Dv~~e~~e~~~~~~~~v~~~~~l~~~a~---LVHgDLSEyNiL~~-~~~p~iID~~ 211 (268)
T COG1718 141 NVLVMEFIGDDGLPAPRLK-----DVPLELEEAEGLYEDVVEYMRRLYKEAG---LVHGDLSEYNILVH-DGEPYIIDVS 211 (268)
T ss_pred CeEEEEeccCCCCCCCCcc-----cCCcCchhHHHHHHHHHHHHHHHHHhcC---cccccchhhheEEE-CCeEEEEECc
Confidence 4799999854311 11122 2334444677888888888888887 67 99999999999999 7789999999
Q ss_pred cccc
Q 021490 134 LAKL 137 (311)
Q Consensus 134 ~~~~ 137 (311)
.+..
T Consensus 212 QaV~ 215 (268)
T COG1718 212 QAVT 215 (268)
T ss_pred cccc
Confidence 8753
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.23 E-value=1.2e-05 Score=67.71 Aligned_cols=60 Identities=17% Similarity=0.114 Sum_probs=42.6
Q ss_pred CcEEEEEEeecCCCcchhHHHHHHHHHhcCC-CCcccceeeEeeeCCeeEEEEecCCCCChhhh
Q 021490 9 LQDVAIKQLDRNGVQGNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLVYEYMPLGSVEDH 71 (311)
Q Consensus 9 g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 71 (311)
+..+++|+..... ...+.+|+++++.+. +--+.+++++...+...++||++++|.+|...
T Consensus 22 ~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~ 82 (244)
T cd05150 22 NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL 82 (244)
T ss_pred CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence 4678888874432 345677999998884 43455667766666678999999999877643
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.22 E-value=4.6e-06 Score=76.66 Aligned_cols=129 Identities=18% Similarity=0.077 Sum_probs=81.0
Q ss_pred CcchhccCCcEEEEEEeecCCCcc-------------------------------------hhHHHHHHHHHhcC----C
Q 021490 1 MMQVILCLLQDVAIKQLDRNGVQG-------------------------------------NREFLVEVLMLSLL----H 39 (311)
Q Consensus 1 ~~~~~~~~g~~vaiK~~~~~~~~~-------------------------------------~~~~~~e~~~l~~l----~ 39 (311)
|+++.+++|+.||||+-++.-... .-+|.+|++-..++ .
T Consensus 177 VhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~Nae~~~~~f~ 256 (538)
T KOG1235|consen 177 VHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAKNAERFRENFK 256 (538)
T ss_pred eEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHHhHHHHHHHHH
Confidence 578899999999999976511100 01344565555444 3
Q ss_pred CCc---ccceeeEe-eeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccC
Q 021490 40 HPN---LVNLIGYC-ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLK 115 (311)
Q Consensus 40 h~~---i~~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~ 115 (311)
|-+ -+.+-.++ .......|+||||+|..+.+.-.- ....++...+..-+.+...-. +=..| ++|+|-+
T Consensus 257 ~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i---~~~gi~~~~i~~~l~~~~~~q--If~~G---ffHaDPH 328 (538)
T KOG1235|consen 257 DFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAI---DKRGISPHDILNKLVEAYLEQ--IFKTG---FFHADPH 328 (538)
T ss_pred hcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHH---HHcCCCHHHHHHHHHHHHHHH--HHhcC---CccCCCC
Confidence 444 12222333 223467999999999888765322 124566665544444433222 22346 9999999
Q ss_pred CCeEEEcC----CCceEEcccccccc
Q 021490 116 CSNILLDR----GYHPKLSDFGLAKL 137 (311)
Q Consensus 116 p~nil~~~----~~~~~l~df~~~~~ 137 (311)
|-||++.. ++.+.+.|||+...
T Consensus 329 PGNilv~~~~~~~~~ivllDhGl~~~ 354 (538)
T KOG1235|consen 329 PGNILVRPNPEGDEEIVLLDHGLYAV 354 (538)
T ss_pred CCcEEEecCCCCCccEEEEccccccc
Confidence 99999983 67899999999864
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.18 E-value=8e-06 Score=79.89 Aligned_cols=194 Identities=21% Similarity=0.195 Sum_probs=135.9
Q ss_pred HHHHHHhcCCCCcccceeeEeeeCCeeE----EEEecCCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC
Q 021490 30 VEVLMLSLLHHPNLVNLIGYCADGDQRL----LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKA 105 (311)
Q Consensus 30 ~e~~~l~~l~h~~i~~~~~~~~~~~~~~----lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~ 105 (311)
-|.+.+.++.|+|+..++.+........ +..++|...++...++. -..++....+.+..++.+|+.++|+..
T Consensus 231 ~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~----v~~i~~~~~r~~~~~~~~GL~~~h~~~ 306 (1351)
T KOG1035|consen 231 IELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS----VGSIPLETLRILHQKLLEGLAYLHSLS 306 (1351)
T ss_pred HHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh----ccccCHHHHHHHHHHHhhhHHHHHHhc
Confidence 4777888889999999999876654433 45667888888888887 678899999999999999999999997
Q ss_pred CCCeEeeccCCC---eEEEcCCCceEEc--cccccccCCCCCCceeeeeccccccccCccccccCCCccc--cceeehhH
Q 021490 106 KPPVIYRDLKCS---NILLDRGYHPKLS--DFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLK--SDVYSFGV 178 (311)
Q Consensus 106 ~~~i~h~dl~p~---nil~~~~~~~~l~--df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~--~DiwslG~ 178 (311)
+.|.-+... +..++..+.+.++ ||+......... .......+..+.++|.........+ .|+|.+|.
T Consensus 307 ---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~---~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgl 380 (1351)
T KOG1035|consen 307 ---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNE---KSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGL 380 (1351)
T ss_pred ---cceeEEecccccccccCccceeecchhhhcccccCCCcc---cchhhcCccccccccccccccchhhhhhHHHHHHH
Confidence 777777666 4445566667766 888765422211 1112234556778887766555444 79999999
Q ss_pred HHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHH
Q 021490 179 VLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVT 258 (311)
Q Consensus 179 l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~ 258 (311)
+...+..|..+-....... ..+. ......+.+...+|+.-++++|+++.+++.
T Consensus 381 l~~~~~~~~~i~~~~~~~~-----------------------~~l~----~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~ 433 (1351)
T KOG1035|consen 381 LLLQLSQGEDISEKSAVPV-----------------------SLLD----VLSTSELLDALPKCLDEDSEERLSALELLT 433 (1351)
T ss_pred HHhhhhhcCcccccccchh-----------------------hhhc----cccchhhhhhhhhhcchhhhhccchhhhhh
Confidence 9999888765432211100 0000 000114666888999999999999999997
Q ss_pred HH
Q 021490 259 AL 260 (311)
Q Consensus 259 ~l 260 (311)
..
T Consensus 434 ~~ 435 (1351)
T KOG1035|consen 434 HP 435 (1351)
T ss_pred ch
Confidence 75
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.17 E-value=1.6e-06 Score=79.73 Aligned_cols=168 Identities=20% Similarity=0.151 Sum_probs=116.7
Q ss_pred cEEEEEEeecCCCcchhHHHHHHHHHhcCCCCc-ccceeeEeeeCCeeEEEEecCCCC-ChhhhhcccCCCCCCCCHHHH
Q 021490 10 QDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPN-LVNLIGYCADGDQRLLVYEYMPLG-SVEDHLHDLSPGKKPLDWNTR 87 (311)
Q Consensus 10 ~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~l~~~~~ 87 (311)
++.|=|.+............-++++|.+++||| .+..++-+.-+....++++++.++ +....... ..-.+...+.
T Consensus 262 RptaeklL~h~fvs~~l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~~---se~~~~~~~~ 338 (829)
T KOG0576|consen 262 RPTAEKLLQHPFVSQTLSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEMTV---SEIALEQYQF 338 (829)
T ss_pred CCChhhheeceeeccchhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccccccCCh---hhHhhhhhhh
Confidence 445555554333333344556899999999999 666666666666778999999776 22211111 1234555556
Q ss_pred HHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccCCC
Q 021490 88 MKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQL 167 (311)
Q Consensus 88 ~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 167 (311)
...+..-+++++++|+.- =+|+| ||+.++ +..+.+||+......... ......+++.++|||+.+...+
T Consensus 339 ~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~~t~~~~~~~~~pev~~~~~~ 407 (829)
T KOG0576|consen 339 AYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---KPRTAIGTPEPLAPEVIQENTI 407 (829)
T ss_pred hhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc---ccccCCCCCCCCCchhhccccc
Confidence 667777788999999875 48888 666655 578999999876433222 2334568999999999999999
Q ss_pred ccccceeehhHHHHHHHhCCCccC
Q 021490 168 TLKSDVYSFGVVLLEILSGRKAVD 191 (311)
Q Consensus 168 ~~~~DiwslG~l~~~ll~g~~pf~ 191 (311)
..+.|.|++|.-..+|--|.+|-.
T Consensus 408 ~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 408 DGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred ccCCCccCCCcchhhcCCCCCCCC
Confidence 999999999987777777766643
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.14 E-value=1.6e-05 Score=63.87 Aligned_cols=101 Identities=28% Similarity=0.291 Sum_probs=81.3
Q ss_pred HHHHHHHhcCCC-CcccceeeEeeeCCeeEEEEecCCCCChhhh---hcccCCCCCCCCHHHHHHHHHHHHHHHHHhhcC
Q 021490 29 LVEVLMLSLLHH-PNLVNLIGYCADGDQRLLVYEYMPLGSVEDH---LHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK 104 (311)
Q Consensus 29 ~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~---l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~ 104 (311)
.+|.-++..+.+ +++.+++|+|- .++|+||...+++... +.+ -...+|..+.+++.+++..+.+|+..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~----~~~~~w~~R~~iA~~lL~~l~~l~~~ 78 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQ----FLQSPWEQRAKIALQLLELLEELDHG 78 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCcccccccccccc----ccccCHHHHHHHHHHHHHHHHHHhcC
Confidence 358888888876 69999999983 3789999987665421 111 23468999999999999999999986
Q ss_pred CCCCeEeeccCCCeEEEcCCCceEEcccccccc
Q 021490 105 AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 137 (311)
Q Consensus 105 ~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~ 137 (311)
-.+.+...|++++|+-++++|+++++|.+.+..
T Consensus 79 ~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 79 PLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred CCCcEEEeecchHHeEEeCCCcEEEEechhcch
Confidence 544599999999999999999999999987653
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.06 E-value=6.9e-05 Score=60.61 Aligned_cols=113 Identities=21% Similarity=0.187 Sum_probs=81.8
Q ss_pred cCCcEEEEEEeecCC----------------CcchhHHHHHHHHHhcCC------CCcccceeeEeeeCCeeEEEEecCC
Q 021490 7 CLLQDVAIKQLDRNG----------------VQGNREFLVEVLMLSLLH------HPNLVNLIGYCADGDQRLLVYEYMP 64 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~----------------~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~~~~lv~e~~~ 64 (311)
.++...+||+..... ....++..+|+.....+. +.+|.+++|+.+++....+|+|.+.
T Consensus 21 P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~veT~~G~Glv~e~I~ 100 (199)
T PF10707_consen 21 PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYGFVETNLGLGLVVELIR 100 (199)
T ss_pred CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeEEEecCCceEEEEEEEE
Confidence 356778999987665 233566777777777666 7889999999999999999999753
Q ss_pred ------CCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCC----ceEEcc
Q 021490 65 ------LGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY----HPKLSD 131 (311)
Q Consensus 65 ------~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~----~~~l~d 131 (311)
..+|.+++.+ +.++. ...+.+.+ -..+|-+.+ |+.+|++|.||++..+. .+.|+|
T Consensus 101 d~dG~~s~TL~~~l~~-----~~~~~-~~~~~L~~---f~~~l~~~~---Iv~~dl~~~NIv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 101 DADGNISPTLEDYLKE-----GGLTE-ELRQALDE---FKRYLLDHH---IVIRDLNPHNIVVQRRDSGEFRLVLID 165 (199)
T ss_pred CCCCCcCccHHHHHHc-----CCccH-HHHHHHHH---HHHHHHHcC---CeecCCCcccEEEEecCCCceEEEEEe
Confidence 2468888864 44665 44444444 456667777 99999999999996432 466665
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.96 E-value=6.8e-05 Score=62.27 Aligned_cols=65 Identities=15% Similarity=0.174 Sum_probs=42.4
Q ss_pred chhccCCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCC--cccceeeEe---eeCCeeEEEEecCCCCChhh
Q 021490 3 QVILCLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHP--NLVNLIGYC---ADGDQRLLVYEYMPLGSVED 70 (311)
Q Consensus 3 ~~~~~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~--~i~~~~~~~---~~~~~~~lv~e~~~~~~L~~ 70 (311)
.+...+ ..+++|..... .....+.+|+.+++.+... .+..++... ......+++|++++|.++..
T Consensus 15 ~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~~~~~ 84 (239)
T PF01636_consen 15 RVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGRPLDD 84 (239)
T ss_dssp EEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSEEHHH
T ss_pred EEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccccccc
Confidence 344444 58999986433 4556788899998888532 244555533 22335689999999987777
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.87 E-value=0.00013 Score=61.10 Aligned_cols=28 Identities=29% Similarity=0.373 Sum_probs=24.8
Q ss_pred eEeeccCCCeEEEcCCCceEEccccccc
Q 021490 109 VIYRDLKCSNILLDRGYHPKLSDFGLAK 136 (311)
Q Consensus 109 i~h~dl~p~nil~~~~~~~~l~df~~~~ 136 (311)
++|+|+++.||++++++..-|+||+.+.
T Consensus 166 l~HGD~~~~Nvlv~~~~i~giIDw~~a~ 193 (235)
T cd05155 166 WFHGDLAPGNLLVQDGRLSAVIDFGCLG 193 (235)
T ss_pred EEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence 8999999999999877666799999765
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.00053 Score=67.87 Aligned_cols=59 Identities=15% Similarity=0.270 Sum_probs=40.8
Q ss_pred cEEEEEEeecCC-CcchhHHHHHHHHHhcCC-CCcc--cceeeEeeeC---CeeEEEEecCCCCCh
Q 021490 10 QDVAIKQLDRNG-VQGNREFLVEVLMLSLLH-HPNL--VNLIGYCADG---DQRLLVYEYMPLGSV 68 (311)
Q Consensus 10 ~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i--~~~~~~~~~~---~~~~lv~e~~~~~~L 68 (311)
..+++|+..... ......+.+|+++++.+. |.++ .+++.++.+. ...|+||||++|..+
T Consensus 66 ~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVME~v~G~~~ 131 (822)
T PLN02876 66 KRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIMEYLEGRIF 131 (822)
T ss_pred eeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEEEecCCccc
Confidence 467777754322 123457889999999995 6654 6677776554 357899999998653
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.00046 Score=58.50 Aligned_cols=125 Identities=14% Similarity=0.016 Sum_probs=67.6
Q ss_pred cCCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcc-cceeeEeeeCCeeEEEEecCCCCChhhh--------------
Q 021490 7 CLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNL-VNLIGYCADGDQRLLVYEYMPLGSVEDH-------------- 71 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~~~~L~~~-------------- 71 (311)
.+|..+++|........-.-...+|.++++.+....+ .+++... . .++|+||++|.++...
T Consensus 17 ~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~~~~~~~~~~~~~~~la~~ 92 (256)
T TIGR02721 17 HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEVITLDQFVALDLLLELAAL 92 (256)
T ss_pred eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCcccccccccCchhHHHHHHH
Confidence 4677889987543221111245779999998864333 2333332 2 3689999998765421
Q ss_pred ---hcccCCCCCCCCHH-HHHHHHHHH---------HHHHHHhhcC-----CCCCeEeeccCCCeEEEcCCCceEEcccc
Q 021490 72 ---LHDLSPGKKPLDWN-TRMKIAAGA---------ARGLEYLHDK-----AKPPVIYRDLKCSNILLDRGYHPKLSDFG 133 (311)
Q Consensus 72 ---l~~~~~~~~~l~~~-~~~~~~~~i---------~~~l~~lh~~-----~~~~i~h~dl~p~nil~~~~~~~~l~df~ 133 (311)
+++.......+... .+..+..++ ...+..+-.. ....++|+|+.|.||++++++ +.++||.
T Consensus 93 l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Nil~~~~~-~~lIDwE 171 (256)
T TIGR02721 93 LHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNLVVTPQG-LKLIDWE 171 (256)
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcEEEeCCC-CEEEecc
Confidence 11111111222211 111211111 1112212111 012389999999999999877 7899998
Q ss_pred ccc
Q 021490 134 LAK 136 (311)
Q Consensus 134 ~~~ 136 (311)
.+.
T Consensus 172 ~a~ 174 (256)
T TIGR02721 172 YAS 174 (256)
T ss_pred ccC
Confidence 775
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.0012 Score=57.29 Aligned_cols=59 Identities=15% Similarity=0.035 Sum_probs=40.7
Q ss_pred cCCcEEEEEEeecCCCcchhHHHHHHHHHhcCCC---CcccceeeEeee---CCeeEEEEecCCCCCh
Q 021490 7 CLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHH---PNLVNLIGYCAD---GDQRLLVYEYMPLGSV 68 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h---~~i~~~~~~~~~---~~~~~lv~e~~~~~~L 68 (311)
.+| .+++|..+ . ......|..|++.|+.|.- -.+.++++++.+ ....++|||+++|.++
T Consensus 36 ~~~-~~~~k~~~-~-~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G~~~ 100 (297)
T PRK10593 36 SQG-NPMPLMAR-S-FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRGVSV 100 (297)
T ss_pred CCC-CEEEEEec-c-cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCCEec
Confidence 445 46777643 2 1234688899999998853 357777777654 3568999999998765
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.00065 Score=56.71 Aligned_cols=28 Identities=25% Similarity=0.318 Sum_probs=25.2
Q ss_pred eEeeccCCCeEEEcC-CCceEEccccccc
Q 021490 109 VIYRDLKCSNILLDR-GYHPKLSDFGLAK 136 (311)
Q Consensus 109 i~h~dl~p~nil~~~-~~~~~l~df~~~~ 136 (311)
++|+|+.+.||+++. ++.+.++||..+.
T Consensus 172 l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 172 FCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred EEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 999999999999998 5789999998764
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.00074 Score=58.49 Aligned_cols=126 Identities=17% Similarity=0.139 Sum_probs=68.9
Q ss_pred CCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCc--ccceeeE------eeeCCeeEEEEecCCCCChhh---------
Q 021490 8 LLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPN--LVNLIGY------CADGDQRLLVYEYMPLGSVED--------- 70 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~------~~~~~~~~lv~e~~~~~~L~~--------- 70 (311)
++..+++|+... ........|++++..|.+.+ +.+++.. ...+...++|++|++|.++..
T Consensus 36 ~~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i~G~~~~~~~~~~~~~l 112 (296)
T cd05153 36 DSGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFLAGEHLTRPTAAHCRQI 112 (296)
T ss_pred CCCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeCCCCCCCCCCHHHHHHH
Confidence 445788898754 23455666888888774322 3333331 123345689999999876532
Q ss_pred --h---hcccCCC-C------CCCCHHHHH----------HHHHHHHHHHHHhhcC----CCCCeEeeccCCCeEEEcCC
Q 021490 71 --H---LHDLSPG-K------KPLDWNTRM----------KIAAGAARGLEYLHDK----AKPPVIYRDLKCSNILLDRG 124 (311)
Q Consensus 71 --~---l~~~~~~-~------~~l~~~~~~----------~~~~~i~~~l~~lh~~----~~~~i~h~dl~p~nil~~~~ 124 (311)
. ++..... . ....+.... .....+..++.++... -...++|+|+.|.|++++++
T Consensus 113 g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~ 192 (296)
T cd05153 113 GEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRGVIHADLFRDNVLFDGD 192 (296)
T ss_pred HHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCcCCccCcCcccEEEeCC
Confidence 0 0100000 0 001111100 0111122334444431 01129999999999999998
Q ss_pred CceEEccccccc
Q 021490 125 YHPKLSDFGLAK 136 (311)
Q Consensus 125 ~~~~l~df~~~~ 136 (311)
+.+.|+||+.+.
T Consensus 193 ~~~~iIDfe~a~ 204 (296)
T cd05153 193 ELSGVIDFYFAC 204 (296)
T ss_pred ceEEEeehhhhc
Confidence 777899998765
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.22 E-value=0.0019 Score=56.12 Aligned_cols=56 Identities=16% Similarity=0.199 Sum_probs=36.2
Q ss_pred CcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcc-cceeeEeeeCCeeEEEEecCCCCChh
Q 021490 9 LQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNL-VNLIGYCADGDQRLLVYEYMPLGSVE 69 (311)
Q Consensus 9 g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~~~~L~ 69 (311)
+..+++|+..... .......+|++++..+...++ .+++.++. ..+|++|++|.++.
T Consensus 29 ~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~----~~~v~e~i~G~~l~ 85 (302)
T cd05156 29 PRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP----NGRIEEFIPSRTLT 85 (302)
T ss_pred CCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC----CCchhheeCCCcCC
Confidence 5889999864432 333556778888888854333 34444443 23689999987764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.0023 Score=54.96 Aligned_cols=57 Identities=19% Similarity=0.195 Sum_probs=37.5
Q ss_pred cCCcEEEEEEeecCCCcchhHHHHHHHHHhcCC---CCcccceeeEeeeCCeeEEEEecCCCC
Q 021490 7 CLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLH---HPNLVNLIGYCADGDQRLLVYEYMPLG 66 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~~ 66 (311)
.+++.+.||+-. ......|..|++-|+.|. .-.+.+++++...+...+|||||++.+
T Consensus 38 ~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 38 TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 578889999764 334567888999999884 345778888887777789999998765
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.15 E-value=0.0024 Score=55.68 Aligned_cols=28 Identities=36% Similarity=0.332 Sum_probs=25.6
Q ss_pred eEeeccCCCeEEEcCCCceEEccccccc
Q 021490 109 VIYRDLKCSNILLDRGYHPKLSDFGLAK 136 (311)
Q Consensus 109 i~h~dl~p~nil~~~~~~~~l~df~~~~ 136 (311)
++|+|+++.|++++.++.+.|+||+.+.
T Consensus 189 l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 189 VIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred cCCCCCCcCcEEEECCceEEEeeccccc
Confidence 9999999999999988877899999764
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=97.10 E-value=0.002 Score=52.90 Aligned_cols=28 Identities=36% Similarity=0.426 Sum_probs=20.1
Q ss_pred eEeeccCCCeEEE-cCCCceEEccccccc
Q 021490 109 VIYRDLKCSNILL-DRGYHPKLSDFGLAK 136 (311)
Q Consensus 109 i~h~dl~p~nil~-~~~~~~~l~df~~~~ 136 (311)
++|+|+.+.||++ +.++.++++||..+.
T Consensus 145 ~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 145 FCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred EeeccCccccEEeccCCCeEEEecHHHHh
Confidence 8999999999999 888999999998764
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.01 E-value=0.0096 Score=53.55 Aligned_cols=65 Identities=15% Similarity=0.034 Sum_probs=42.2
Q ss_pred CcchhccCC-cEEEEEEeecC------C-CcchhHHHHHHHHHhcCC-C--CcccceeeEeeeCCeeEEEEecCCCCC
Q 021490 1 MMQVILCLL-QDVAIKQLDRN------G-VQGNREFLVEVLMLSLLH-H--PNLVNLIGYCADGDQRLLVYEYMPLGS 67 (311)
Q Consensus 1 ~~~~~~~~g-~~vaiK~~~~~------~-~~~~~~~~~e~~~l~~l~-h--~~i~~~~~~~~~~~~~~lv~e~~~~~~ 67 (311)
||.|.+.+| +.|+||.-... . .-..+++..|++.|..+. + .++.+++.+ +....++|||++++..
T Consensus 42 VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lVME~L~~~~ 117 (401)
T PRK09550 42 VFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTVMEDLSDHK 117 (401)
T ss_pred EEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEEEecCCCcc
Confidence 356666777 48999984311 1 124467778999998873 2 345556655 3456789999997643
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.96 E-value=0.0048 Score=54.11 Aligned_cols=126 Identities=15% Similarity=0.081 Sum_probs=81.2
Q ss_pred CcchhccCCcEEEEEEeecCC--Ccchh------------------------HHHHHHHHHhcCCCCcccceeeEeeeCC
Q 021490 1 MMQVILCLLQDVAIKQLDRNG--VQGNR------------------------EFLVEVLMLSLLHHPNLVNLIGYCADGD 54 (311)
Q Consensus 1 ~~~~~~~~g~~vaiK~~~~~~--~~~~~------------------------~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 54 (311)
||-|...+|..+|||+.+-.- ..+.+ ....|++-|.+|....|.-.--+...
T Consensus 160 VYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP~PePIlLk-- 237 (520)
T KOG2270|consen 160 VYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIPCPEPILLK-- 237 (520)
T ss_pred eEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCCCCCceeee--
Confidence 566778899999999975310 00111 12247777777765443322222221
Q ss_pred eeEEEEecCCCCCh-hhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEcccc
Q 021490 55 QRLLVYEYMPLGSV-EDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFG 133 (311)
Q Consensus 55 ~~~lv~e~~~~~~L-~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~ 133 (311)
.-.|||+|+..... .-.|. .-.++...+..+-.+++.-+.-|..... +||.||.--|+|+.+ |.++++|-+
T Consensus 238 ~hVLVM~FlGrdgw~aPkLK-----d~~ls~~ka~~~Y~~~v~~MR~lY~~c~--LVHADLSEfN~Lyhd-G~lyiIDVS 309 (520)
T KOG2270|consen 238 NHVLVMEFLGRDGWAAPKLK-----DASLSTSKARELYQQCVRIMRRLYQKCR--LVHADLSEFNLLYHD-GKLYIIDVS 309 (520)
T ss_pred cceEeeeeccCCCCcCcccc-----cccCChHHHHHHHHHHHHHHHHHHHHhc--eeccchhhhhheEEC-CEEEEEEcc
Confidence 24799999953221 11222 3557777888888888888877766543 999999999998865 579999987
Q ss_pred ccc
Q 021490 134 LAK 136 (311)
Q Consensus 134 ~~~ 136 (311)
.+.
T Consensus 310 QSV 312 (520)
T KOG2270|consen 310 QSV 312 (520)
T ss_pred ccc
Confidence 664
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.84 E-value=0.0067 Score=52.90 Aligned_cols=27 Identities=26% Similarity=0.315 Sum_probs=24.1
Q ss_pred eEeeccCCCeEEEcCCCceEEccccccc
Q 021490 109 VIYRDLKCSNILLDRGYHPKLSDFGLAK 136 (311)
Q Consensus 109 i~h~dl~p~nil~~~~~~~~l~df~~~~ 136 (311)
++|||+.+.||+++. +.+.++||+.+.
T Consensus 189 liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 189 FCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred eEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 899999999999987 568999998664
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.83 E-value=0.015 Score=50.60 Aligned_cols=119 Identities=22% Similarity=0.272 Sum_probs=74.3
Q ss_pred CcEEEEEEeec--CCCcchhHHHHHHHHHhcCCC--CcccceeeEeeeCC--eeEEEEecCCCCChhhhhcccCCCCCCC
Q 021490 9 LQDVAIKQLDR--NGVQGNREFLVEVLMLSLLHH--PNLVNLIGYCADGD--QRLLVYEYMPLGSVEDHLHDLSPGKKPL 82 (311)
Q Consensus 9 g~~vaiK~~~~--~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~l 82 (311)
+++++++ ... ..........+|+..++.+.- --+-..++.+.+++ ..+.||+|++|..+.+.+... ..
T Consensus 48 ~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~-----~~ 121 (321)
T COG3173 48 GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPE-----SL 121 (321)
T ss_pred CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcc-----cc
Confidence 6777877 332 223444566678888887742 23444556666655 669999999985443332210 01
Q ss_pred CHHHHHHHH-HHHHHHHHHhhcCC-------------------------------------------------------C
Q 021490 83 DWNTRMKIA-AGAARGLEYLHDKA-------------------------------------------------------K 106 (311)
Q Consensus 83 ~~~~~~~~~-~~i~~~l~~lh~~~-------------------------------------------------------~ 106 (311)
. ..++ ..++..|+.||+-. .
T Consensus 122 ~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~ 197 (321)
T COG3173 122 G----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGP 197 (321)
T ss_pred h----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCC
Confidence 1 1112 24455555555321 1
Q ss_pred CCeEeeccCCCeEEEcCCCceEEcccccccc
Q 021490 107 PPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 137 (311)
Q Consensus 107 ~~i~h~dl~p~nil~~~~~~~~l~df~~~~~ 137 (311)
..++|||+++.|++++.++-+=+.||+++..
T Consensus 198 ~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 198 PVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred ceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 1289999999999999988899999999874
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.79 E-value=0.0084 Score=51.39 Aligned_cols=29 Identities=31% Similarity=0.425 Sum_probs=24.6
Q ss_pred eEeeccCCCeEEEcCCCc-eEEcccccccc
Q 021490 109 VIYRDLKCSNILLDRGYH-PKLSDFGLAKL 137 (311)
Q Consensus 109 i~h~dl~p~nil~~~~~~-~~l~df~~~~~ 137 (311)
++|+|+++.||++++++. .-|+||+.+..
T Consensus 187 lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 187 LVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 899999999999997554 57999998763
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.77 E-value=0.023 Score=49.74 Aligned_cols=28 Identities=32% Similarity=0.336 Sum_probs=24.8
Q ss_pred eEeeccCCCeEEEcCCCceEEccccccc
Q 021490 109 VIYRDLKCSNILLDRGYHPKLSDFGLAK 136 (311)
Q Consensus 109 i~h~dl~p~nil~~~~~~~~l~df~~~~ 136 (311)
+||+|+.+.||+++.+...-|+||+.+.
T Consensus 189 liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 189 VIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cCCCCCCCCcEEEECCceEEEEeccccc
Confidence 9999999999999877666899999775
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.74 E-value=0.0035 Score=57.18 Aligned_cols=49 Identities=24% Similarity=0.336 Sum_probs=39.2
Q ss_pred hhHHHHHHHHHhcCCCCcccceeeEeeeC-CeeEEEEecCCCCChhhhhcc
Q 021490 25 NREFLVEVLMLSLLHHPNLVNLIGYCADG-DQRLLVYEYMPLGSVEDHLHD 74 (311)
Q Consensus 25 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~ 74 (311)
..+..-...+++.+.|+|+...+++.... .+..+|+|++ +.+|.+.+..
T Consensus 26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~ 75 (725)
T KOG1093|consen 26 SIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKT 75 (725)
T ss_pred HHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHh
Confidence 35666778899999999999998876433 3578999999 5899998876
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.73 E-value=0.0029 Score=54.50 Aligned_cols=119 Identities=13% Similarity=-0.018 Sum_probs=79.7
Q ss_pred cchhccCCcEEEEEEeec----------C--------CCcch----hHHHHHHHHHhcC-CCCc-ccceeeEeeeCCeeE
Q 021490 2 MQVILCLLQDVAIKQLDR----------N--------GVQGN----REFLVEVLMLSLL-HHPN-LVNLIGYCADGDQRL 57 (311)
Q Consensus 2 ~~~~~~~g~~vaiK~~~~----------~--------~~~~~----~~~~~e~~~l~~l-~h~~-i~~~~~~~~~~~~~~ 57 (311)
|-|..++|++.++|.=.. + ...|. -...+|...|+.| .|.+ +.+.++ ...-+
T Consensus 109 Y~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfpVPkpiD----~~RH~ 184 (465)
T KOG2268|consen 109 YVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFPVPKPID----HNRHC 184 (465)
T ss_pred EEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCCCCCccc----cccee
Confidence 556677888888886211 0 01111 1334688888877 3443 444443 34568
Q ss_pred EEEecCCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEcccccccc
Q 021490 58 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 137 (311)
Q Consensus 58 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~ 137 (311)
+|||++.|..|...-+- ... ..+...+..-|.-|..+| ++|+|+.--||++.+++.++++||..+..
T Consensus 185 Vvmelv~g~Pl~~v~~v-------~d~---~~ly~~lm~~Iv~la~~G---lIHgDFNEFNimv~dd~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 185 VVMELVDGYPLRQVRHV-------EDP---PTLYDDLMGLIVRLANHG---LIHGDFNEFNIMVKDDDKIVVIDFPQMVS 251 (465)
T ss_pred eHHHhhcccceeeeeec-------CCh---HHHHHHHHHHHHHHHHcC---ceecccchheeEEecCCCEEEeechHhhc
Confidence 99999999887654322 122 234445555677778888 99999999999999999999999987654
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.69 E-value=0.015 Score=51.59 Aligned_cols=123 Identities=18% Similarity=0.188 Sum_probs=67.5
Q ss_pred CcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcc-cceeeEeeeCCeeEEEEecCCCCChhhh----------------
Q 021490 9 LQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNL-VNLIGYCADGDQRLLVYEYMPLGSVEDH---------------- 71 (311)
Q Consensus 9 g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~~~~L~~~---------------- 71 (311)
+..|++|+..... ...-...+|..+++.+...++ .++++.+..+ .|++|++|.+|...
T Consensus 65 ~~~~v~Ri~g~~t-~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g~~l~~~~l~~~~~~~~ia~~L~ 139 (344)
T PLN02236 65 GRKVLVRIYGEGV-ELFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHARTLSAADLRDPEISALIAAKLR 139 (344)
T ss_pred CCeEEEEEccCCC-CeeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCCCCCCHHHcCChHHHHHHHHHHH
Confidence 4678998775433 222233678889888854443 3455555332 58999987776421
Q ss_pred -hcccCCCCC--CCCHHHHHHHHHHHH--------------------HHHHH-hhcCC-CCCeEeeccCCCeEEEcC-CC
Q 021490 72 -LHDLSPGKK--PLDWNTRMKIAAGAA--------------------RGLEY-LHDKA-KPPVIYRDLKCSNILLDR-GY 125 (311)
Q Consensus 72 -l~~~~~~~~--~l~~~~~~~~~~~i~--------------------~~l~~-lh~~~-~~~i~h~dl~p~nil~~~-~~ 125 (311)
+++...... ...+..+..++.++. ..|.. +.... ..-++|+|+++.||++++ ++
T Consensus 140 ~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~ 219 (344)
T PLN02236 140 EFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDDQEIGFCHNDLQYGNIMIDEETR 219 (344)
T ss_pred HHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccCCCceEEeCCCCcCcEEEeCCCC
Confidence 111110111 112233333332221 11111 11111 112899999999999986 46
Q ss_pred ceEEccccccc
Q 021490 126 HPKLSDFGLAK 136 (311)
Q Consensus 126 ~~~l~df~~~~ 136 (311)
.+.++||..+.
T Consensus 220 ~~~lID~Eya~ 230 (344)
T PLN02236 220 AITIIDYEYAS 230 (344)
T ss_pred cEEEEeehhcc
Confidence 79999998765
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.63 E-value=0.0068 Score=49.41 Aligned_cols=104 Identities=13% Similarity=0.045 Sum_probs=69.4
Q ss_pred cEEEEEEeecCCCc-chhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHHHH
Q 021490 10 QDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRM 88 (311)
Q Consensus 10 ~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~ 88 (311)
.+..+|++..-.+. ....|.+++.++.++. .|+++..- +...+.++.|.|.-.. -.+.
T Consensus 86 G~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~-------------i~~~---- 144 (308)
T PF07387_consen 86 GPLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIK-------------INFS---- 144 (308)
T ss_pred chhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcc-------------cchh----
Confidence 34566777655554 4467788898888764 46776632 4456678999884221 1111
Q ss_pred HHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEcccccc
Q 021490 89 KIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA 135 (311)
Q Consensus 89 ~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~ 135 (311)
.++..=+++|.-.|+.. +..+|||..|+|||-+..|.+||.|-+.-
T Consensus 145 N~i~agi~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 145 NFITAGIKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred HHHHHhHHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhhh
Confidence 11112246788889552 33999999999999999999999997653
|
The function of this family is unknown. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.56 E-value=0.018 Score=45.26 Aligned_cols=108 Identities=17% Similarity=0.118 Sum_probs=71.1
Q ss_pred CcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccc-eeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHHH
Q 021490 9 LQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVN-LIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTR 87 (311)
Q Consensus 9 g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~-~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~ 87 (311)
|.++|+|+-... .....+..|+++|..+..-++.+ ++.+. ..++.|||+.|-.|.+.... .+...+
T Consensus 45 ~~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~~L~~~~~~-------~~rk~l 111 (201)
T COG2112 45 GGEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGRPLGKLEIG-------GDRKHL 111 (201)
T ss_pred CceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCcchhhhhhc-------ccHHHH
Confidence 568999876433 45678889999999998766544 33332 23456999998888776653 133333
Q ss_pred HHHHHHHHHHHHHhhcCCCCCeEeeccCC-CeEEEcCCCceEEccccccc
Q 021490 88 MKIAAGAARGLEYLHDKAKPPVIYRDLKC-SNILLDRGYHPKLSDFGLAK 136 (311)
Q Consensus 88 ~~~~~~i~~~l~~lh~~~~~~i~h~dl~p-~nil~~~~~~~~l~df~~~~ 136 (311)
. .++..---|-..| |-|+.|+- ...++..++.+.|+||..+.
T Consensus 112 ~----~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At 154 (201)
T COG2112 112 L----RVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSAT 154 (201)
T ss_pred H----HHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchh
Confidence 3 3344434455567 99998864 44444455589999999876
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.46 E-value=0.00023 Score=72.07 Aligned_cols=160 Identities=13% Similarity=-0.002 Sum_probs=112.6
Q ss_pred HHHHHhcCCCCcccceeeEee--eCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC--C
Q 021490 31 EVLMLSLLHHPNLVNLIGYCA--DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKA--K 106 (311)
Q Consensus 31 e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~--~ 106 (311)
|...++...|+++.....-.. ++...+.+++++.+|.+.+.+.........+...-+.....+......-.|+.. +
T Consensus 1279 e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg 1358 (2724)
T KOG1826|consen 1279 ERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLG 1358 (2724)
T ss_pred hhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCC
Confidence 444445557887776655443 234568899999999999998875544455555555554445466666666543 3
Q ss_pred CCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccCCCccccceeehhHHHHHHHhC
Q 021490 107 PPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG 186 (311)
Q Consensus 107 ~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~l~~~ll~g 186 (311)
...+|+++++-|.++..+-.++++++|+.+... .......-..+++-|+.|+....-.++.++|+|..|+.+|....|
T Consensus 1359 ~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIkn--p~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~ 1436 (2724)
T KOG1826|consen 1359 NTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKN--PVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDG 1436 (2724)
T ss_pred ccchhhhhhhhccceecCCcccccccccccccC--chHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcc
Confidence 447899999999999999999999999987311 111122234566778888888777788889999999999999888
Q ss_pred CCccCc
Q 021490 187 RKAVDT 192 (311)
Q Consensus 187 ~~pf~~ 192 (311)
..+|-.
T Consensus 1437 n~~fi~ 1442 (2724)
T KOG1826|consen 1437 NAYFIF 1442 (2724)
T ss_pred cHHHHH
Confidence 877643
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.43 E-value=0.02 Score=50.50 Aligned_cols=28 Identities=21% Similarity=0.282 Sum_probs=24.6
Q ss_pred eEeeccCCCeEEEcC-CCceEEccccccc
Q 021490 109 VIYRDLKCSNILLDR-GYHPKLSDFGLAK 136 (311)
Q Consensus 109 i~h~dl~p~nil~~~-~~~~~l~df~~~~ 136 (311)
++|+|+.+.||++++ ++.++++||..+-
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 799999999999975 5689999998764
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.22 E-value=0.069 Score=46.96 Aligned_cols=67 Identities=13% Similarity=0.006 Sum_probs=40.9
Q ss_pred CcchhccCCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCc--cccee---e--EeeeCCeeEEEEecCCCCCh
Q 021490 1 MMQVILCLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPN--LVNLI---G--YCADGDQRLLVYEYMPLGSV 68 (311)
Q Consensus 1 ~~~~~~~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~---~--~~~~~~~~~lv~e~~~~~~L 68 (311)
||++...+|..+++|+..... ........|.+.+..|.... ++... + +...+...+.++++++|...
T Consensus 41 vy~v~~~~~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~~ 114 (325)
T PRK11768 41 VYQFGDEDGRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRAP 114 (325)
T ss_pred EEEEecCCCCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCCC
Confidence 466677788889999874332 34566677888877773211 22211 1 12334567889999987643
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.17 E-value=0.04 Score=48.04 Aligned_cols=29 Identities=21% Similarity=0.246 Sum_probs=26.7
Q ss_pred eEeeccCCCeEEEcCCCceEEcccccccc
Q 021490 109 VIYRDLKCSNILLDRGYHPKLSDFGLAKL 137 (311)
Q Consensus 109 i~h~dl~p~nil~~~~~~~~l~df~~~~~ 137 (311)
+||+|+.+.|++++.++.+.++||..+..
T Consensus 198 lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 198 LVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 99999999999999998999999988753
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.14 E-value=0.02 Score=50.29 Aligned_cols=72 Identities=24% Similarity=0.220 Sum_probs=56.8
Q ss_pred CeeEEEEecCCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEcccc
Q 021490 54 DQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFG 133 (311)
Q Consensus 54 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~ 133 (311)
...|++|++- |+++.. + ....+.++..++.+.+..+.-+..+- ++-|||+...||+++ +|.|-|+||.
T Consensus 299 ~y~yl~~kdh-gt~is~-i-------k~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfk 366 (488)
T COG5072 299 LYLYLHFKDH-GTPISI-I-------KADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFK 366 (488)
T ss_pred eEEEEEEecC-Cceeee-e-------ecccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEee
Confidence 3557788865 454422 2 33567889999999999888888753 489999999999999 8999999999
Q ss_pred cccc
Q 021490 134 LAKL 137 (311)
Q Consensus 134 ~~~~ 137 (311)
+++.
T Consensus 367 lsRl 370 (488)
T COG5072 367 LSRL 370 (488)
T ss_pred eeec
Confidence 9984
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=95.82 E-value=0.039 Score=45.37 Aligned_cols=58 Identities=26% Similarity=0.306 Sum_probs=41.9
Q ss_pred CcEEEEEEeecCCCcchhHHHHHHHHHhcCCC---CcccceeeEeeeCCeeEEEEecCCCCChh
Q 021490 9 LQDVAIKQLDRNGVQGNREFLVEVLMLSLLHH---PNLVNLIGYCADGDQRLLVYEYMPLGSVE 69 (311)
Q Consensus 9 g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h---~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 69 (311)
..++.+|+- .......|..|+.-|+.|.- -.+.+++.+..+..+.|+|+||++-+.+.
T Consensus 39 ~~~~FvK~n---~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d 99 (286)
T COG3001 39 TDPFFVKCN---QREQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD 99 (286)
T ss_pred CcceEEEec---chhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence 356666642 22334677888888888843 45777888888889999999999876665
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.77 E-value=0.11 Score=45.90 Aligned_cols=29 Identities=21% Similarity=0.246 Sum_probs=24.6
Q ss_pred CeEeeccCCCeEEEcCCCceEEcccccccc
Q 021490 108 PVIYRDLKCSNILLDRGYHPKLSDFGLAKL 137 (311)
Q Consensus 108 ~i~h~dl~p~nil~~~~~~~~l~df~~~~~ 137 (311)
.++|||+.+.||++++++ ++++|+..+..
T Consensus 193 ~llHGDl~~gNi~~~~~~-~~~iD~e~~~~ 221 (370)
T TIGR01767 193 TLLHGDLHSGSIFVSEHE-TKVIDPEFAFY 221 (370)
T ss_pred eeeeccCCcccEEEcCCC-CEEEcCccccc
Confidence 389999999999998765 78999987654
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.75 E-value=0.11 Score=45.67 Aligned_cols=132 Identities=20% Similarity=0.271 Sum_probs=74.5
Q ss_pred cchhccCCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcc------cceee----EeeeCCeeEEEEecCCCCChhh-
Q 021490 2 MQVILCLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNL------VNLIG----YCADGDQRLLVYEYMPLGSVED- 70 (311)
Q Consensus 2 ~~~~~~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i------~~~~~----~~~~~~~~~lv~e~~~~~~L~~- 70 (311)
|++...+|+. ++|+.... ....+...|...|..|.-..| ...-| ........+-+++|++|..+..
T Consensus 42 f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~~~~~~ 118 (331)
T COG2334 42 FRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGRPLERD 118 (331)
T ss_pred EEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCcCcCCC
Confidence 5556667776 88988654 455666667788887732111 11111 1111136788999999887772
Q ss_pred hh------------------cccC----CCCCCCCHHH-------------HHHHHHHHHHHHHHhhcCC-------CCC
Q 021490 71 HL------------------HDLS----PGKKPLDWNT-------------RMKIAAGAARGLEYLHDKA-------KPP 108 (311)
Q Consensus 71 ~l------------------~~~~----~~~~~l~~~~-------------~~~~~~~i~~~l~~lh~~~-------~~~ 108 (311)
.. .... .......|.. -.....++...+..+.+.- +..
T Consensus 119 ~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp~~~~~ 198 (331)
T COG2334 119 DNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLPALGDQ 198 (331)
T ss_pred CcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCCcccce
Confidence 11 0000 0011122220 0112333444444444321 122
Q ss_pred eEeeccCCCeEEEcCCCc-eEEccccccc
Q 021490 109 VIYRDLKCSNILLDRGYH-PKLSDFGLAK 136 (311)
Q Consensus 109 i~h~dl~p~nil~~~~~~-~~l~df~~~~ 136 (311)
+||+|+.|.||+++.+.. +-++||+-+.
T Consensus 199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred eeecCCCccceeEcCCCCeeeEEEccccc
Confidence 899999999999998874 8999998764
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.36 E-value=0.23 Score=44.89 Aligned_cols=30 Identities=13% Similarity=0.221 Sum_probs=24.8
Q ss_pred CCeEeeccCCCeEEEcCCCceEEcccccccc
Q 021490 107 PPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 137 (311)
Q Consensus 107 ~~i~h~dl~p~nil~~~~~~~~l~df~~~~~ 137 (311)
+.++|||+++.|||++.++ .+++|...+..
T Consensus 230 ~~L~HGDl~~g~i~~~~~~-~~~id~ef~~~ 259 (418)
T PLN02756 230 QALVHGDLHTGSVMVTPDS-TQVIDPEFAFY 259 (418)
T ss_pred cceeecCCCCCcEEEcCCC-ceEecchhhcc
Confidence 3499999999999999876 88888776653
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.00 E-value=0.27 Score=50.12 Aligned_cols=28 Identities=43% Similarity=0.404 Sum_probs=24.1
Q ss_pred eEeeccCCCeEEEcCCC--ce-EEccccccc
Q 021490 109 VIYRDLKCSNILLDRGY--HP-KLSDFGLAK 136 (311)
Q Consensus 109 i~h~dl~p~nil~~~~~--~~-~l~df~~~~ 136 (311)
++|+|+.+.||+++.++ .+ =|+|||-+.
T Consensus 205 vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 205 VIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred eECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 99999999999999775 45 499999775
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=95.00 E-value=0.21 Score=40.44 Aligned_cols=85 Identities=29% Similarity=0.386 Sum_probs=57.8
Q ss_pred hHHHHHHHHHhcCC---CCcc--cceeeEeeeC------------------CeeEEEEecCCCCChhhhhcccCCCCCCC
Q 021490 26 REFLVEVLMLSLLH---HPNL--VNLIGYCADG------------------DQRLLVYEYMPLGSVEDHLHDLSPGKKPL 82 (311)
Q Consensus 26 ~~~~~e~~~l~~l~---h~~i--~~~~~~~~~~------------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~l 82 (311)
..|..|-+...+|+ +.++ ++++++..-. ....||.||++... .+
T Consensus 99 ~PF~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~ 165 (207)
T PF13095_consen 99 DPFNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PL 165 (207)
T ss_pred ChHHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------cc
Confidence 35778888887774 4456 8898887322 12356777665322 22
Q ss_pred CHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEcccccc
Q 021490 83 DWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLA 135 (311)
Q Consensus 83 ~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~ 135 (311)
.. .-+.++.+-+..+|..| |+-+|+++.|.. +| +|+|||.+
T Consensus 166 ~~----~~~~~~~~dl~~~~k~g---I~~~Dv~~~ny~---~G--~lvDfs~~ 206 (207)
T PF13095_consen 166 QI----RDIPQMLRDLKILHKLG---IVPRDVKPRNYR---GG--KLVDFSSS 206 (207)
T ss_pred ch----hHHHHHHHHHHHHHHCC---eeeccCcccccc---CC--EEEecccC
Confidence 22 33556677788899999 999999999975 33 88999854
|
|
| >PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties [] | Back alignment and domain information |
|---|
Probab=94.17 E-value=0.14 Score=43.12 Aligned_cols=67 Identities=15% Similarity=0.048 Sum_probs=43.4
Q ss_pred cchhccCCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecC-CCCChhhhh
Q 021490 2 MQVILCLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM-PLGSVEDHL 72 (311)
Q Consensus 2 ~~~~~~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~-~~~~L~~~l 72 (311)
+.|...+|.++++|+...... ...+.. ....|+..+-...+++++.- .....|++|.+ +|.+|.+..
T Consensus 19 ~pv~~~dG~~avLKl~~p~~~-~~~E~~-g~~~L~~w~G~GaVrll~~d--~~~~AlLLErl~~g~~L~~~~ 86 (253)
T PF04655_consen 19 VPVRRADGTPAVLKLAPPHAE-AEHEAR-GEAALRWWNGRGAVRLLAAD--PERGALLLERLDPGRSLASLP 86 (253)
T ss_pred EEEEcCCCCeEEEEecCCccc-chhhhh-HHhHhheeCCCCceeeeccc--cccchhhhhhccCCCchhhcc
Confidence 456678999999998743321 111111 12457777778889998764 33567888988 555776655
|
Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.06 E-value=0.43 Score=42.99 Aligned_cols=27 Identities=30% Similarity=0.187 Sum_probs=22.9
Q ss_pred eEeeccCCCeEEEcCCCceEEccccccc
Q 021490 109 VIYRDLKCSNILLDRGYHPKLSDFGLAK 136 (311)
Q Consensus 109 i~h~dl~p~nil~~~~~~~~l~df~~~~ 136 (311)
++|.|+.+.||+.+++ .++++||..+.
T Consensus 229 fCHNDL~~gNIL~~~~-~l~lID~EYA~ 255 (383)
T PTZ00384 229 FCHNDLFFTNILDFNQ-GIYFIDFDFAG 255 (383)
T ss_pred eeeccCCcccEEecCC-CEEEEEecccc
Confidence 8999999999987654 59999997654
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.82 E-value=0.049 Score=43.52 Aligned_cols=28 Identities=18% Similarity=0.235 Sum_probs=24.9
Q ss_pred CeEeeccCCCeEEEcCCCceEEccccccc
Q 021490 108 PVIYRDLKCSNILLDRGYHPKLSDFGLAK 136 (311)
Q Consensus 108 ~i~h~dl~p~nil~~~~~~~~l~df~~~~ 136 (311)
..+|+|+.|.|+++++++ ++++||+.+.
T Consensus 78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~ 105 (188)
T PRK10271 78 APLHMDVHAGNLVHSASG-LRLIDWEYAG 105 (188)
T ss_pred eeecCCCCCccEEEECCC-EEEEeCCccc
Confidence 379999999999998887 8999999875
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 311 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 4e-49 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-48 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-43 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-42 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-37 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-37 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-36 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 5e-35 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-24 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 5e-24 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-21 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-21 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-20 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-19 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-19 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-18 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 6e-18 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 8e-18 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 8e-18 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 8e-18 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-17 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-17 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-17 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-17 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-17 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-17 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-17 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-17 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 4e-17 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-17 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-17 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-17 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-17 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 4e-17 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-17 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-17 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 5e-17 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 5e-17 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 5e-17 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 5e-17 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 5e-17 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 5e-17 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 6e-17 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 6e-17 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 6e-17 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 7e-17 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 8e-17 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 8e-17 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-17 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 8e-17 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 9e-17 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 9e-17 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-17 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 9e-17 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-16 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-16 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-16 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-16 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-16 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-16 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-16 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-16 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-16 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-16 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-16 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-16 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-16 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-16 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-16 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-16 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-16 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-16 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-16 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-16 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-16 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-16 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-16 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-16 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-16 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-16 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-16 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-16 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-16 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-16 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-16 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-16 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 4e-16 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-16 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-16 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 4e-16 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-16 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-16 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-16 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 5e-16 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 5e-16 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 5e-16 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 6e-16 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 6e-16 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 6e-16 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-16 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 6e-16 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 6e-16 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 6e-16 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 6e-16 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 7e-16 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 7e-16 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 7e-16 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 9e-16 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-15 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-15 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-15 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-15 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-15 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-15 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-15 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-15 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-15 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-15 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-15 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-15 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-15 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-15 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-15 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-15 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-15 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-15 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-15 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-15 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-15 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-15 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-15 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-15 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-15 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-15 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-15 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-15 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-15 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-15 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-15 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-15 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-15 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-15 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-15 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 4e-15 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-15 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 4e-15 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-15 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-15 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 4e-15 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 5e-15 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 5e-15 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-15 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 6e-15 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 7e-15 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 8e-15 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 9e-15 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 9e-15 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-14 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-14 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-14 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-14 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-14 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-14 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-14 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-14 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-14 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-14 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-14 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-14 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-14 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-14 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-14 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-14 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-14 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-14 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-14 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-14 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-14 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-14 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-14 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-14 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-14 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-14 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-14 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-14 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-14 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-14 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-14 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-14 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-14 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-14 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-14 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-14 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-14 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-14 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-14 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-14 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 4e-14 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 4e-14 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-14 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 5e-14 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 5e-14 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-14 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 5e-14 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 5e-14 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 5e-14 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 6e-14 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 6e-14 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 6e-14 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 7e-14 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 7e-14 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 7e-14 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 7e-14 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 8e-14 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-14 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 8e-14 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 8e-14 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 9e-14 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 9e-14 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-14 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-13 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-13 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-13 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-13 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-13 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-13 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-13 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-13 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-13 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-13 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-13 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-13 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-13 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-13 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-13 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-13 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-13 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-13 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-13 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-13 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-13 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-13 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 3e-13 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-13 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-13 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-13 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 4e-13 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-13 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-13 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 4e-13 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 5e-13 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 5e-13 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 5e-13 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-13 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 5e-13 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-13 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 5e-13 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 5e-13 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 5e-13 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-13 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 5e-13 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 6e-13 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 6e-13 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-13 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 6e-13 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 6e-13 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 6e-13 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 6e-13 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-13 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 6e-13 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 6e-13 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 6e-13 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 7e-13 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 7e-13 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 7e-13 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 7e-13 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 7e-13 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 7e-13 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 7e-13 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 7e-13 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 7e-13 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 7e-13 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 7e-13 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 8e-13 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 8e-13 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 9e-13 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 9e-13 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-12 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-12 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-12 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-12 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-12 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-12 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-12 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-12 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-12 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-12 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-12 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-12 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-12 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-12 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-12 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-12 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-12 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-12 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-12 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-12 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-12 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-12 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-12 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-12 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-12 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-12 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-12 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-12 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-12 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-12 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-12 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-12 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-12 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-12 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-12 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-12 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-12 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-12 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-12 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-12 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-12 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-12 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-12 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-12 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-12 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 4e-12 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-12 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-12 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 4e-12 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 4e-12 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 4e-12 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 4e-12 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 4e-12 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 5e-12 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 5e-12 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 5e-12 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 5e-12 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 5e-12 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 5e-12 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 6e-12 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 6e-12 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 6e-12 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-12 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 6e-12 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 6e-12 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 6e-12 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 6e-12 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 6e-12 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-12 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-12 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 6e-12 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 7e-12 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 7e-12 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 7e-12 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-12 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-12 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 7e-12 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-12 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-12 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-12 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 8e-12 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 8e-12 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-12 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 8e-12 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-12 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 8e-12 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 8e-12 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 8e-12 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 8e-12 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 8e-12 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 8e-12 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 8e-12 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 9e-12 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 9e-12 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 9e-12 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 9e-12 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 9e-12 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-11 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-11 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-11 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-11 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-11 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-11 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-11 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-11 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-11 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-11 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-11 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-11 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-11 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-11 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-11 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-11 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-11 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-11 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-11 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-11 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-11 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-11 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-11 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-11 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-11 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-11 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-11 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-11 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-11 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-11 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-11 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-11 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-11 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 3e-11 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 4e-11 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-11 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-11 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 4e-11 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-11 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-11 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 5e-11 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-11 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-11 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-11 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-11 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-11 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 6e-11 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 6e-11 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 6e-11 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 7e-11 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 7e-11 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 7e-11 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 7e-11 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 8e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-11 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-11 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-10 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-10 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-10 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-10 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-10 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-10 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-10 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-10 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-10 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-10 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-10 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-10 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-10 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-10 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-10 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-10 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-10 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-10 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-10 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-10 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-10 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-10 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-10 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-10 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-10 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-10 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-10 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-10 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-10 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-10 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-10 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-10 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-10 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-10 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-10 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-10 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-10 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-10 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-10 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-10 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-10 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 4e-10 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 4e-10 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-10 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 5e-10 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 5e-10 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-10 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 5e-10 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 5e-10 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 5e-10 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-10 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 6e-10 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 6e-10 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 6e-10 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 6e-10 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 7e-10 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 7e-10 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 7e-10 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 7e-10 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 8e-10 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 8e-10 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-10 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 8e-10 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 8e-10 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 8e-10 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 8e-10 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-10 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 8e-10 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 8e-10 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-10 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 8e-10 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 8e-10 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 8e-10 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 8e-10 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 8e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 9e-10 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-10 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 9e-10 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 9e-10 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 9e-10 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 9e-10 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-10 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-10 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 9e-10 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 9e-10 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 9e-10 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 9e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 9e-10 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 9e-10 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-10 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 9e-10 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 9e-10 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-09 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-09 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-09 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-09 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-09 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-09 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-09 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-09 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-09 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-09 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-09 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-09 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-09 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-09 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-09 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-09 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-09 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-09 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-09 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-09 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-09 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-09 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-09 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-09 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-09 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-09 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-09 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-09 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-09 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-09 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-09 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-09 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-09 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-09 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-09 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-09 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-09 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-09 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-09 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-09 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 4e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 4e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 4e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 5e-09 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 5e-09 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 6e-09 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-09 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 6e-09 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 6e-09 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-09 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 6e-09 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 6e-09 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 6e-09 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 6e-09 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 6e-09 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 6e-09 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 7e-09 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 7e-09 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 7e-09 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 7e-09 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 7e-09 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 7e-09 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 7e-09 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 7e-09 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 7e-09 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-09 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 7e-09 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 7e-09 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 7e-09 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 7e-09 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 8e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 8e-09 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-09 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 9e-09 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 9e-09 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 9e-09 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 9e-09 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-08 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-08 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-08 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-08 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-08 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-08 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-08 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-08 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-08 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-08 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-08 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-08 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-08 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-08 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-08 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-08 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-08 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-08 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-08 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-08 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-08 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-08 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-08 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-08 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-08 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-08 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-08 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-08 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-08 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-08 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-08 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-08 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-08 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-08 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 4e-08 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 4e-08 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-08 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-08 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 4e-08 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-08 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 4e-08 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-08 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 4e-08 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 5e-08 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-08 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-08 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-08 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-08 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 6e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 6e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 7e-08 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 7e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 7e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 7e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 7e-08 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 8e-08 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 9e-08 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-07 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-07 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-07 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-07 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-07 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-07 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-07 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 4e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 5e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 5e-07 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 5e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 6e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 7e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 7e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 7e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 7e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 7e-07 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 8e-07 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 8e-07 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 9e-07 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-06 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-06 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-06 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-06 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-06 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-06 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-06 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-06 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-06 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-06 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-06 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-06 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 3e-06 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 3e-06 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-06 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-06 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-06 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-06 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-06 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 4e-06 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-06 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-06 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-06 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-06 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 5e-06 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 5e-06 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 5e-06 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-06 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 5e-06 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 5e-06 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 5e-06 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 5e-06 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 5e-06 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 5e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 5e-06 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 6e-06 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 6e-06 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 6e-06 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 6e-06 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 6e-06 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 6e-06 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 6e-06 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 6e-06 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 6e-06 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 6e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 6e-06 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 6e-06 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 7e-06 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 7e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 7e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 7e-06 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 7e-06 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 7e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 7e-06 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 7e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 7e-06 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-06 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 7e-06 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 7e-06 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 7e-06 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 7e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 7e-06 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 7e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 7e-06 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 7e-06 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 7e-06 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-06 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 7e-06 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 7e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 7e-06 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 7e-06 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-06 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 7e-06 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 7e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 7e-06 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 7e-06 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-06 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 7e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 8e-06 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 8e-06 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 8e-06 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 8e-06 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 8e-06 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 8e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 8e-06 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 8e-06 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 8e-06 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 8e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 9e-06 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 9e-06 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-05 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-05 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-05 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-05 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-05 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-05 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-05 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-05 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-05 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-05 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-05 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-05 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-05 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-05 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-05 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-05 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-05 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-05 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-05 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-05 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-05 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-05 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-05 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-05 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-05 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-05 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 4e-05 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-05 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 4e-05 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-05 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 5e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 5e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 5e-05 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 5e-05 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 6e-05 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 6e-05 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 6e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 6e-05 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 6e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 6e-05 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 6e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 7e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 7e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 7e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 7e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 7e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 7e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 7e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 7e-05 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 8e-05 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 8e-05 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 8e-05 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 8e-05 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 8e-05 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 8e-05 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 8e-05 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 9e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 9e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 9e-05 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-04 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-04 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-04 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-04 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-04 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-04 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-04 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-04 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-04 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-04 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 2e-04 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-04 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-04 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 3e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 3e-04 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-04 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 4e-04 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 4e-04 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 5e-04 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 6e-04 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-04 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 6e-04 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 6e-04 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 7e-04 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 7e-04 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 459 bits (1184), Expect = e-165
Identities = 97/260 (37%), Positives = 143/260 (55%), Gaps = 12/260 (4%)
Query: 10 QDVAIKQL----DRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPL 65
VA+K+L D + ++F E+ +++ H NLV L+G+ +DGD LVY YMP
Sbjct: 55 TTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPN 114
Query: 66 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY 125
GS+ D L L G PL W+ R KIA GAA G+ +LH+ I+RD+K +NILLD +
Sbjct: 115 GSLLDRLSCL-DGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAF 170
Query: 126 HPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 185
K+SDFGLA+ T +++R++GT Y APE G++T KSD+YSFGVVLLEI++
Sbjct: 171 TAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIIT 229
Query: 186 GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHE 245
G AVD + Q L+ + + D ++ +VA+ C+HE
Sbjct: 230 GLPAVDEHR--EPQLLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHE 286
Query: 246 QPDMRPVIADVVTALAYLAS 265
+ + RP I V L + +
Sbjct: 287 KKNKRPDIKKVQQLLQEMTA 306
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 450 bits (1160), Expect = e-161
Identities = 101/253 (39%), Positives = 140/253 (55%), Gaps = 4/253 (1%)
Query: 10 QDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVE 69
VA+K+ QG EF E+ LS HP+LV+LIG+C + ++ +L+Y+YM G+++
Sbjct: 64 AKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLK 123
Query: 70 DHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKL 129
HL+ + W R++I GAARGL YLH +I+RD+K NILLD + PK+
Sbjct: 124 RHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKI 180
Query: 130 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKA 189
+DFG++K G D TH+ST V GT GY PEY G+LT KSDVYSFGVVL E+L R A
Sbjct: 181 TDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSA 240
Query: 190 VDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDM 249
+ S +L WA + I DP L + P + A C+ +
Sbjct: 241 IVQSLPREMVNLAEWAVESHNNGQLEQ-IVDPNLADKIRPESLRKFGDTAVKCLALSSED 299
Query: 250 RPVIADVVTALAY 262
RP + DV+ L Y
Sbjct: 300 RPSMGDVLWKLEY 312
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 438 bits (1129), Expect = e-156
Identities = 106/254 (41%), Positives = 153/254 (60%), Gaps = 5/254 (1%)
Query: 10 QDVAIKQLDRNGVQGN-REFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSV 68
VA+K+L QG +F EV M+S+ H NL+ L G+C +RLLVY YM GSV
Sbjct: 55 TLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSV 114
Query: 69 EDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK 128
L + + PLDW R +IA G+ARGL YLHD P +I+RD+K +NILLD +
Sbjct: 115 ASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 174
Query: 129 LSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRK 188
+ DFGLAKL D THV+T V GT G+ APEY TG+ + K+DV+ +GV+LLE+++G++
Sbjct: 175 VGDFGLAKLMDYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQR 233
Query: 189 AVDTSKAAAEQS--LVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQ 246
A D ++ A + L+ W + L +++ + + D +LQG Y Q + VA +C
Sbjct: 234 AFDLARLANDDDVMLLDWVKGLLKEK-KLEALVDVDLQGNYKDEEVEQLIQVALLCTQSS 292
Query: 247 PDMRPVIADVVTAL 260
P RP +++VV L
Sbjct: 293 PMERPKMSEVVRML 306
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 248 bits (634), Expect = 3e-81
Identities = 67/278 (24%), Positives = 99/278 (35%), Gaps = 27/278 (9%)
Query: 10 QDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD----QRLLVYEYMPL 65
+ VA+K Q + EV L + H N++ IG G L+ +
Sbjct: 48 EYVAVKIFPIQDKQS-WQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEK 106
Query: 66 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH-------DKAKPPVIYRDLKCSN 118
GS+ D L + WN IA ARGL YLH D KP + +RD+K N
Sbjct: 107 GSLSDFLK-----ANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKN 161
Query: 119 ILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG-----QLTLKSDV 173
+LL ++DFGLA G + + +GT Y APE + L+ D+
Sbjct: 162 VLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDM 221
Query: 174 YSFGVVLLEILSGRKAVDTSKAAAEQSLVA--WARPLFQDRTRHSLI--ADPELQGQYPP 229
Y+ G+VL E+ S A D P +D + P L+ +
Sbjct: 222 YAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQK 281
Query: 230 RGFYQALA-VAAMCVHEQPDMRPVIADVVTALAYLASQ 266
L C + R V + +
Sbjct: 282 HAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 1e-62
Identities = 76/266 (28%), Positives = 114/266 (42%), Gaps = 36/266 (13%)
Query: 10 QDVAIKQLDRNGVQGN--REFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGS 67
DVA+K L EFL EV ++ L HPN+V +G +V EY+ GS
Sbjct: 61 SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGS 120
Query: 68 VEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP 127
+ LH ++ LD R+ +A A+G+ YLH++ PP+++R+LK N+L+D+ Y
Sbjct: 121 LYRLLHKSGA-REQLDERRRLSMAYDVAKGMNYLHNR-NPPIVHRNLKSPNLLVDKKYTV 178
Query: 128 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 187
K+ DFGL++L S GT + APE + KSDVYSFGV+L E+ + +
Sbjct: 179 KVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQ 236
Query: 188 ------KAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALA-VAA 240
A + R PR +A +
Sbjct: 237 QPWGNLNPAQVVAAVGFKCK----RLEI-------------------PRNLNPQVAAIIE 273
Query: 241 MCVHEQPDMRPVIADVVTALAYLASQ 266
C +P RP A ++ L L
Sbjct: 274 GCWTNEPWKRPSFATIMDLLRPLIKS 299
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 9e-62
Identities = 66/304 (21%), Positives = 112/304 (36%), Gaps = 47/304 (15%)
Query: 10 QDVAIKQLDRNGVQGNREFL--VEVLMLSLLHHPNLVNLIGYCADGD-----QRLLVYEY 62
+ VA+K + F+ + + L+ H N+ I + LLV EY
Sbjct: 37 RPVAVKVFSF---ANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEY 93
Query: 63 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH------DKAKPPVIYRDLKC 116
P GS+ +L DW + ++A RGL YLH D KP + +RDL
Sbjct: 94 YPNGSLXKYLS-----LHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNS 148
Query: 117 SNILLDRGYHPKLSDFGLAK------LGPVGDNTHVSTRVMGTYGYCAPEYAK------- 163
N+L+ +SDFGL+ L G+ + + +GT Y APE +
Sbjct: 149 RNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRD 208
Query: 164 TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPEL 223
+ D+Y+ G++ EI + + + + +A+ + T +
Sbjct: 209 XESALKQVDMYALGLIYWEIFMRCTDLFPGE-SVPEYQMAFQTEVGNHPTFEDMQVLVSR 267
Query: 224 QGQYPP---RGFYQALAVAAM------CVHEQPDMRPVIADVVTALAYLASQKYESDAEK 274
+ Q P +LAV ++ C + + R +A L + K
Sbjct: 268 EKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM---IWERNK 324
Query: 275 VQSP 278
SP
Sbjct: 325 SVSP 328
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 2e-60
Identities = 71/267 (26%), Positives = 123/267 (46%), Gaps = 43/267 (16%)
Query: 10 QDVAIKQLDRNGVQGN-------REFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 62
VAIK L +G +EF EV ++S L+HPN+V L G + +V E+
Sbjct: 45 SVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN--PPRMVMEF 102
Query: 63 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD 122
+P G + L D P+ W+ ++++ A G+EY+ ++ PP+++RDL+ NI L
Sbjct: 103 VPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQ 158
Query: 123 -----RGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE--YAKTGQLTLKSDVYS 175
K++DFGL++ + H + ++G + + APE A+ T K+D YS
Sbjct: 159 SLDENAPVCAKVADFGLSQ-----QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYS 213
Query: 176 FGVVLLEILSGRKAVD--TSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFY 233
F ++L IL+G D + +++ ++ R P + PPR
Sbjct: 214 FAMILYTILTGEGPFDEYSYGKIKFINMIR------EEGLR------PTIPEDCPPR--L 259
Query: 234 QALAVAAMCVHEQPDMRPVIADVVTAL 260
+ + +C P RP + +V L
Sbjct: 260 RNV--IELCWSGDPKKRPHFSYIVKEL 284
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 1e-59
Identities = 69/293 (23%), Positives = 116/293 (39%), Gaps = 34/293 (11%)
Query: 10 QDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVE 69
+DVAIKQ++ + + F+VE+ LS ++HPN+V L G C + LV EY GS+
Sbjct: 32 KDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLY 87
Query: 70 DHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD-RGYHPK 128
+ LH P M ++G+ YLH +I+RDLK N+LL G K
Sbjct: 88 NVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLK 146
Query: 129 LSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR- 187
+ DFG A D T G+ + APE + + K DV+S+G++L E+++ R
Sbjct: 147 ICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRK 201
Query: 188 --KAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALA-VAAMCVH 244
+ ++ RP + + + + C
Sbjct: 202 PFDEIGGPAFRIMWAVHNGTRPPL-------------------IKNLPKPIESLMTRCWS 242
Query: 245 EQPDMRPVIADVVTALAYLASQKYESDAEKVQSPCLDPGTPTRTKGDKERKLN 297
+ P RP + ++V + +L +D + +
Sbjct: 243 KDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSLPPGEDGRVEPYVDFA 295
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 6e-59
Identities = 60/190 (31%), Positives = 91/190 (47%), Gaps = 21/190 (11%)
Query: 10 QDVAIKQL----DRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPL 65
+VA+K D + Q E + ++L HPN++ L G C LV E+
Sbjct: 31 DEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARG 90
Query: 66 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY 125
G + L K + + + A ARG+ YLHD+A P+I+RDLK SNIL+ +
Sbjct: 91 GPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKV 145
Query: 126 HP--------KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFG 177
K++DFGLA+ T + G Y + APE + + SDV+S+G
Sbjct: 146 ENGDLSNKILKITDFGLAR---EWHRTTKMSAA-GAYAWMAPEVIRASMFSKGSDVWSYG 201
Query: 178 VVLLEILSGR 187
V+L E+L+G
Sbjct: 202 VLLWELLTGE 211
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 3e-58
Identities = 56/261 (21%), Positives = 102/261 (39%), Gaps = 39/261 (14%)
Query: 10 QDVAIKQLDRNGVQGN--REFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL--VYEYMPL 65
D+ +K L R+F E L + HPN++ ++G C + +MP
Sbjct: 34 NDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPY 93
Query: 66 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY 125
GS+ + LH+ +D + +K A ARG+ +LH +P + L ++++D
Sbjct: 94 GSLYNVLHE--GTNFVVDQSQAVKFALDMARGMAFLHTL-EPLIPRHALNSRSVMIDEDM 150
Query: 126 HPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE---YAKTGQLTLKSDVYSFGVVLLE 182
++S + + S M + APE +D++SF V+L E
Sbjct: 151 TARISMADVKF-------SFQSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWE 203
Query: 183 ILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYP--PRGFYQALA-VA 239
+++ P F D + + L+G P P G ++ +
Sbjct: 204 LVTREV------------------P-FADLSNMEIGMKVALEGLRPTIPPGISPHVSKLM 244
Query: 240 AMCVHEQPDMRPVIADVVTAL 260
+C++E P RP +V L
Sbjct: 245 KICMNEDPAKRPKFDMIVPIL 265
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 2e-55
Identities = 65/289 (22%), Positives = 103/289 (35%), Gaps = 39/289 (13%)
Query: 10 QDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVE 69
+ + +K+L R + R FL EV ++ L HPN++ IG + + EY+ G++
Sbjct: 36 EVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLR 95
Query: 70 DHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKL 129
+ W+ R+ A A G+ YLH +I+RDL N L+ + +
Sbjct: 96 GIIKS---MDSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVV 149
Query: 130 SDFGLAKL------------GPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFG 177
+DFGLA+L + V+G + APE K DV+SFG
Sbjct: 150 ADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFG 209
Query: 178 VVLLEILSGRKA---VDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQ 234
+VL EI+ A ++ + P F+
Sbjct: 210 IVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNC---------------PPSFFP 254
Query: 235 ALAVAAMCVHEQPDMRPVIADVVTALAYLASQKYESDAEKVQSPCLDPG 283
+ C P+ RP + L L Q LD G
Sbjct: 255 ---ITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLGPQLEQLDRG 300
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 2e-55
Identities = 61/281 (21%), Positives = 105/281 (37%), Gaps = 31/281 (11%)
Query: 10 QDVAIKQLDRNGVQGNREFL--VEVLMLSLLHHPNLVNLIGYCADGD----QRLLVYEYM 63
+ VA+K + E+ L+ H N++ I G Q L+ +Y
Sbjct: 61 EKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYH 117
Query: 64 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH-----DKAKPPVIYRDLKCSN 118
GS+ D+L LD + +K+A + GL +LH + KP + +RDLK N
Sbjct: 118 ENGSLYDYLK-----STTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKN 172
Query: 119 ILLDRGYHPKLSDFGLAKLGPVGDNTH--VSTRVMGTYGYCAPE------YAKTGQLTLK 170
IL+ + ++D GLA N +GT Y PE Q +
Sbjct: 173 ILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIM 232
Query: 171 SDVYSFGVVLLEILSGRKAVDTSKA-AAEQSLVAWARPLFQDRTRHSLIAD--PELQGQY 227
+D+YSFG++L E+ + + + + P ++D I P ++
Sbjct: 233 ADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRW 292
Query: 228 PPRGFYQALA-VAAMCVHEQPDMRPVIADVVTALAYLASQK 267
+ + + C P R V LA ++ +
Sbjct: 293 SSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 4e-55
Identities = 54/270 (20%), Positives = 95/270 (35%), Gaps = 47/270 (17%)
Query: 10 QDVAIKQLDRNGVQGN--REFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGS 67
+VAI+ +D + + F EV+ H N+V +G C ++ +
Sbjct: 56 GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRT 115
Query: 68 VEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP 127
+ + D K LD N +IA +G+ YLH K ++++DLK N+ D G
Sbjct: 116 LYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYDNG-KV 168
Query: 128 KLSDFGLAKL---GPVGDNTHVSTRVMGTYGYCAPEYAKTGQL---------TLKSDVYS 175
++DFGL + G G + APE + + SDV++
Sbjct: 169 VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFA 228
Query: 176 FGVVLLEILSGRKAVDTSKAAAEQSLVAWA-----RPLFQDRTRHSLIADPELQGQYPPR 230
G + E+ + T A A + W +P ++ +
Sbjct: 229 LGTIWYELHAREWPFKTQPAEA----IIWQMGTGMKPNL-----------SQIGM---GK 270
Query: 231 GFYQALAVAAMCVHEQPDMRPVIADVVTAL 260
L C + + RP ++ L
Sbjct: 271 EISDIL---LFCWAFEQEERPTFTKLMDML 297
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 5e-55
Identities = 65/258 (25%), Positives = 112/258 (43%), Gaps = 30/258 (11%)
Query: 11 DVAIKQLDRNGVQGN--REFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSV 68
DVA+K L+ + F EV +L H N++ +GY Q +V ++ S+
Sbjct: 48 DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSL 106
Query: 69 EDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK 128
HLH + + + IA ARG++YLH K +I+RDLK +NI L K
Sbjct: 107 YHHLHAS---ETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVK 160
Query: 129 LSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE---YAKTGQLTLKSDVYSFGVVLLEILS 185
+ DFGLA +H ++ G+ + APE + + +SDVY+FG+VL E+++
Sbjct: 161 IGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMT 220
Query: 186 GR---KAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMC 242
G+ ++ E P +++ P + + A C
Sbjct: 221 GQLPYSNINNRDQIIEMVGRGSLSPDL-----------SKVRSNCPK-RMKRLM---AEC 265
Query: 243 VHEQPDMRPVIADVVTAL 260
+ ++ D RP ++ +
Sbjct: 266 LKKKRDERPSFPRILAEI 283
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 4e-53
Identities = 59/281 (20%), Positives = 107/281 (38%), Gaps = 39/281 (13%)
Query: 10 QDVAIKQLDRNGVQGNREFL--VEVLMLSLLHHPNLVNLIGYCADGD----QRLLVYEYM 63
++VA+K + + + E+ +L H N++ I Q L+ Y
Sbjct: 32 ENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYH 88
Query: 64 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH-----DKAKPPVIYRDLKCSN 118
+GS+ D+L LD + ++I A GL +LH + KP + +RDLK N
Sbjct: 89 EMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKN 143
Query: 119 ILLDRGYHPKLSDFGLAKLGPVGDNTHV--STRVMGTYGYCAPE------YAKTGQLTLK 170
IL+ + ++D GLA + N + +GT Y APE +
Sbjct: 144 ILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKR 203
Query: 171 SDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYP-- 228
D+++FG+VL E+ S E + + D + + + Q P
Sbjct: 204 VDIWAFGLVLWEVARR----MVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNI 259
Query: 229 PRGFYQALAVAAM------CVHEQPDMRPVIADVVTALAYL 263
P ++ + ++ C ++ P R + L +
Sbjct: 260 PNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 4e-52
Identities = 63/285 (22%), Positives = 110/285 (38%), Gaps = 39/285 (13%)
Query: 10 QDVAIKQLDRNGVQGNREFL--VEVLMLSLLHHPNLVNLIGYCADGD----QRLLVYEYM 63
++VA+K + R + E+ +L H N++ I + Q LV +Y
Sbjct: 66 EEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYH 122
Query: 64 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH-----DKAKPPVIYRDLKCSN 118
GS+ D+L+ + + +K+A A GL +LH + KP + +RDLK N
Sbjct: 123 EHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKN 177
Query: 119 ILLDRGYHPKLSDFGLAKLGPVGDNTH--VSTRVMGTYGYCAPE------YAKTGQLTLK 170
IL+ + ++D GLA +T +GT Y APE K + +
Sbjct: 178 ILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKR 237
Query: 171 SDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYP-- 228
+D+Y+ G+V EI + E + + + D + + Q P
Sbjct: 238 ADIYAMGLVFWEIARR----CSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNI 293
Query: 229 PRGFYQALAVAAM------CVHEQPDMRPVIADVVTALAYLASQK 267
P + A+ M C + R + L+ L+ Q+
Sbjct: 294 PNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 338
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-37
Identities = 53/179 (29%), Positives = 80/179 (44%), Gaps = 11/179 (6%)
Query: 10 QDVAIKQL-DRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSV 68
VA+K + +FL E +L HPN+V LIG C +V E + G
Sbjct: 140 TLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 199
Query: 69 EDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK 128
L L T +++ AA G+EYL K I+RDL N L+ K
Sbjct: 200 LTFLRT---EGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLK 253
Query: 129 LSDFGLAKLGPVGDNTHVSTRVMGTYGY--CAPEYAKTGQLTLKSDVYSFGVVLLEILS 185
+SDFG+++ D + ++ + APE G+ + +SDV+SFG++L E S
Sbjct: 254 ISDFGMSRE--EADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFS 310
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-37
Identities = 59/181 (32%), Positives = 92/181 (50%), Gaps = 17/181 (9%)
Query: 12 VAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR--LLVYEYMPLGSVE 69
VA+KQL +G R+F E+ +L LH +V G ++ LV EY+P G +
Sbjct: 55 VAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLR 114
Query: 70 DHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKL 129
D L + LD + + ++ +G+EYL + ++RDL NIL++ H K+
Sbjct: 115 DFLQR---HRARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKI 168
Query: 130 SDFGLAKLGPVGDNTHVSTRVMGTYG-----YCAPEYAKTGQLTLKSDVYSFGVVLLEIL 184
+DFGLAKL P+ + +V G + APE + +SDV+SFGVVL E+
Sbjct: 169 ADFGLAKLLPLDKDYYVVR----EPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELF 224
Query: 185 S 185
+
Sbjct: 225 T 225
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 4e-37
Identities = 50/180 (27%), Positives = 91/180 (50%), Gaps = 9/180 (5%)
Query: 11 DVAIKQL-DRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVE 69
VAIK+L + + N+E L E +++ + +P++ L+G C L+ + MP G +
Sbjct: 46 PVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLL 104
Query: 70 DHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKL 129
D++ + K + + A+G+ YL D+ +++RDL N+L+ H K+
Sbjct: 105 DYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKI 158
Query: 130 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRK 188
+DFGLAKL + + + + A E T +SDV+S+GV + E+++ G K
Sbjct: 159 TDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 7e-37
Identities = 58/181 (32%), Positives = 90/181 (49%), Gaps = 17/181 (9%)
Query: 12 VAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR--LLVYEYMPLGSVE 69
VA+K+L + + R+F E+ +L L H N+V G C +R L+ EY+P GS+
Sbjct: 42 VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 101
Query: 70 DHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKL 129
D+L K+ +D ++ + +G+EYL K I+RDL NIL++ K+
Sbjct: 102 DYLQK---HKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKI 155
Query: 130 SDFGLAKLGPVGDNTHVSTRVMGTYG-----YCAPEYAKTGQLTLKSDVYSFGVVLLEIL 184
DFGL K+ P G + APE + ++ SDV+SFGVVL E+
Sbjct: 156 GDFGLTKVLPQDKEFFKVK----EPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELF 211
Query: 185 S 185
+
Sbjct: 212 T 212
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-36
Identities = 58/181 (32%), Positives = 91/181 (50%), Gaps = 17/181 (9%)
Query: 12 VAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR--LLVYEYMPLGSVE 69
VA+K+L + + R+F E+ +L L H N+V G C +R L+ EY+P GS+
Sbjct: 73 VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 132
Query: 70 DHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKL 129
D+L K+ +D ++ + +G+EYL K I+RDL NIL++ K+
Sbjct: 133 DYLQK---HKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKI 186
Query: 130 SDFGLAKLGPVGDNTHVSTRVMGTYG-----YCAPEYAKTGQLTLKSDVYSFGVVLLEIL 184
DFGL K+ P + G + APE + ++ SDV+SFGVVL E+
Sbjct: 187 GDFGLTKVLPQDKEYYKVK----EPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELF 242
Query: 185 S 185
+
Sbjct: 243 T 243
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 2e-35
Identities = 60/182 (32%), Positives = 86/182 (47%), Gaps = 20/182 (10%)
Query: 12 VAIKQL-DRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR--LLVYEYMPLGSV 68
VA+K L G Q + E+ +L L+H +++ G C D LV EY+PLGS+
Sbjct: 63 VAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSL 122
Query: 69 EDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK 128
D+L + + + A G+ YLH + I+RDL N+LLD K
Sbjct: 123 RDYLP-----RHSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVK 174
Query: 129 LSDFGLAKLGPVGDNTHVSTRVMGTYG-----YCAPEYAKTGQLTLKSDVYSFGVVLLEI 183
+ DFGLAK P G + + G + APE K + SDV+SFGV L E+
Sbjct: 175 IGDFGLAKAVPEGHEYYR----VREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYEL 230
Query: 184 LS 185
L+
Sbjct: 231 LT 232
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 3e-35
Identities = 49/182 (26%), Positives = 86/182 (47%), Gaps = 18/182 (9%)
Query: 12 VAIKQL-DRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR--LLVYEYMPLGSV 68
VA+K L +G + E+ +L L+H N+V G C + L+ E++P GS+
Sbjct: 53 VAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSL 112
Query: 69 EDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK 128
+++L K ++ ++K A +G++YL + ++RDL N+L++ + K
Sbjct: 113 KEYLPK---NKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVK 166
Query: 129 LSDFGLAKLGPVGDNTHVSTRVMGTYG-----YCAPEYAKTGQLTLKSDVYSFGVVLLEI 183
+ DFGL K + + APE + + SDV+SFGV L E+
Sbjct: 167 IGDFGLTKAIETDKEYYTVK----DDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHEL 222
Query: 184 LS 185
L+
Sbjct: 223 LT 224
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 3e-35
Identities = 51/177 (28%), Positives = 90/177 (50%), Gaps = 9/177 (5%)
Query: 10 QDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVE 69
VA+K L + EFL E ++ + HPNLV L+G C ++ E+M G++
Sbjct: 246 LTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 304
Query: 70 DHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKL 129
D+L ++ + + +A + +EYL K I+R+L N L+ + K+
Sbjct: 305 DYLR--ECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKV 359
Query: 130 SDFGLAKLGPVGDNTHVSTRVMG-TYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 185
+DFGL++L + +T+ + + APE + ++KSDV++FGV+L EI +
Sbjct: 360 ADFGLSRL--MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 414
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 3e-35
Identities = 52/180 (28%), Positives = 91/180 (50%), Gaps = 9/180 (5%)
Query: 11 DVAIKQL-DRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVE 69
V IK + D++G Q + +L + L H ++V L+G C G LV +Y+PLGS+
Sbjct: 44 PVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLL 102
Query: 70 DHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKL 129
DH+ + L + A+G+ YL + +++R+L N+LL ++
Sbjct: 103 DHVRQ---HRGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQV 156
Query: 130 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRK 188
+DFG+A L P D + + + A E G+ T +SDV+S+GV + E+++ G +
Sbjct: 157 ADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAE 216
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 5e-35
Identities = 50/180 (27%), Positives = 91/180 (50%), Gaps = 9/180 (5%)
Query: 11 DVAIKQL-DRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVE 69
VAIK+L + + N+E L E +++ + +P++ L+G C L+ + MP G +
Sbjct: 46 PVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLL 104
Query: 70 DHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKL 129
D++ + K + + A+G+ YL D+ +++RDL N+L+ H K+
Sbjct: 105 DYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKI 158
Query: 130 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRK 188
+DFGLAKL + + + + A E T +SDV+S+GV + E+++ G K
Sbjct: 159 TDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-34
Identities = 57/182 (31%), Positives = 87/182 (47%), Gaps = 15/182 (8%)
Query: 11 DVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVED 70
VAIK + R G +F+ E ++ L HP LV L G C + LV E+M G + D
Sbjct: 34 KVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSD 92
Query: 71 HLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLS 130
+L + T + + G+ YL + VI+RDL N L+ K+S
Sbjct: 93 YLRT---QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVS 146
Query: 131 DFGLAKLGPVGDNTHVSTRVMGT---YGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-G 186
DFG+ + V D+ + T GT + +PE + + KSDV+SFGV++ E+ S G
Sbjct: 147 DFGMTRF--VLDDQY--TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEG 202
Query: 187 RK 188
+
Sbjct: 203 KI 204
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-34
Identities = 57/185 (30%), Positives = 83/185 (44%), Gaps = 16/185 (8%)
Query: 11 DVAIKQL---DRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGS 67
VA+K L + + +F+ EV + L H NL+ L G +V E PLGS
Sbjct: 48 SVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL-TPPMKMVTELAPLGS 106
Query: 68 VEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP 127
+ D L + T + A A G+ YL K I+RDL N+LL
Sbjct: 107 LLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLV 160
Query: 128 KLSDFGLAKLGPVGDNTHVSTRVMGT---YGYCAPEYAKTGQLTLKSDVYSFGVVLLEIL 184
K+ DFGL + P D+ +V + +CAPE KT + SD + FGV L E+
Sbjct: 161 KIGDFGLMRALPQNDDHYVMQE--HRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMF 218
Query: 185 S-GRK 188
+ G++
Sbjct: 219 TYGQE 223
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-34
Identities = 51/188 (27%), Positives = 85/188 (45%), Gaps = 22/188 (11%)
Query: 11 DVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVED 70
+V +K LD+ + F M+S L H +LV G C GD+ +LV E++ GS++
Sbjct: 42 EVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDT 101
Query: 71 HLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP--- 127
+L K ++ ++++A A + +L + +I+ ++ NILL R
Sbjct: 102 YLKK---NKNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTG 155
Query: 128 -----KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQL-TLKSDVYSFGVVLL 181
KLSD G++ V + R+ PE + + L +D +SFG L
Sbjct: 156 NPPFIKLSDPGISIT--VLPKDILQERIPWV----PPECIENPKNLNLATDKWSFGTTLW 209
Query: 182 EILS-GRK 188
EI S G K
Sbjct: 210 EICSGGDK 217
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 4e-34
Identities = 53/182 (29%), Positives = 88/182 (48%), Gaps = 15/182 (8%)
Query: 11 DVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVED 70
DVA+K + + G EF E + L HP LV G C+ +V EY+ G + +
Sbjct: 34 DVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLN 92
Query: 71 HLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLS 130
+L K L+ + +++ G+ +L I+RDL N L+DR K+S
Sbjct: 93 YLRS---HGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVS 146
Query: 131 DFGLAKLGPVGDNTHVSTRVMGT---YGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-G 186
DFG+ + V D+ + +GT + APE + + KSDV++FG+++ E+ S G
Sbjct: 147 DFGMTRY--VLDDQY--VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLG 202
Query: 187 RK 188
+
Sbjct: 203 KM 204
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 9e-34
Identities = 51/185 (27%), Positives = 83/185 (44%), Gaps = 17/185 (9%)
Query: 10 QDVAIKQLDRNGVQGN--REFLVEVLMLSLLHHPNLVNLIGYCAD---GDQRLLVY-EYM 63
+VA +L + + + F E ML L HPN+V G + +++ E M
Sbjct: 52 VEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELM 111
Query: 64 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR 123
G+++ +L K + +GL++LH + PP+I+RDLKC NI +
Sbjct: 112 TSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITG 166
Query: 124 GY-HPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLE 182
K+ D GLA L + V+GT + APE + DVY+FG+ +LE
Sbjct: 167 PTGSVKIGDLGLATLK----RASFAKAVIGTPEFMAPEMYEEK-YDESVDVYAFGMCMLE 221
Query: 183 ILSGR 187
+ +
Sbjct: 222 MATSE 226
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 9e-34
Identities = 51/178 (28%), Positives = 86/178 (48%), Gaps = 14/178 (7%)
Query: 11 DVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVED 70
DVAIK + + G EF+ E ++ L H LV L G C ++ EYM G + +
Sbjct: 50 DVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLN 108
Query: 71 HLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLS 130
+L + + +++ +EYL K ++RDL N L++ K+S
Sbjct: 109 YLRE---MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVS 162
Query: 131 DFGLAKLGPVGDNTHVSTRVMGT---YGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 185
DFGL++ V D+ + T +G+ + PE + + KSD+++FGV++ EI S
Sbjct: 163 DFGLSRY--VLDDEY--TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 216
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-33
Identities = 53/187 (28%), Positives = 91/187 (48%), Gaps = 22/187 (11%)
Query: 11 DVAIKQLDRNGVQGN--REFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSV 68
DVAIK L + G + E + E ++ L +P +V LIG C + +LV E G +
Sbjct: 39 DVAIKVL-KQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPL 96
Query: 69 EDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK 128
L ++ + + ++ + G++YL +K ++RDL N+LL ++ K
Sbjct: 97 HKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAK 150
Query: 129 LSDFGLAKLGPVGDNTHVSTRVMGTYG------YCAPEYAKTGQLTLKSDVYSFGVVLLE 182
+SDFGL+K D+ + + + APE + + +SDV+S+GV + E
Sbjct: 151 ISDFGLSKALGADDSYYTARS-----AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWE 205
Query: 183 ILS-GRK 188
LS G+K
Sbjct: 206 ALSYGQK 212
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-33
Identities = 53/179 (29%), Positives = 91/179 (50%), Gaps = 13/179 (7%)
Query: 10 QDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVE 69
VA+K L + EFL E ++ + HPNLV L+G C ++ E+M G++
Sbjct: 39 LTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 97
Query: 70 DHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKL 129
D+L ++ + + +A + +EYL K I+RDL N L+ + K+
Sbjct: 98 DYLR--ECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKV 152
Query: 130 SDFGLAKLGPVGDNTHVSTRVMGT---YGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 185
+DFGL++L + +T+ + G + APE + ++KSDV++FGV+L EI +
Sbjct: 153 ADFGLSRL--MTGDTYTAHA--GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-33
Identities = 52/187 (27%), Positives = 90/187 (48%), Gaps = 22/187 (11%)
Query: 11 DVAIKQL--DRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSV 68
VA+K L + N E L E ++ L +P +V +IG C + + +LV E LG +
Sbjct: 46 TVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPL 104
Query: 69 EDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK 128
+L + + +++ + G++YL + ++RDL N+LL ++ K
Sbjct: 105 NKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAK 157
Query: 129 LSDFGLAKLGPVGDNTHVSTRVMGTYG------YCAPEYAKTGQLTLKSDVYSFGVVLLE 182
+SDFGL+K +N + + + APE + + KSDV+SFGV++ E
Sbjct: 158 ISDFGLSKALRADENYYKAQT-----HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 212
Query: 183 ILS-GRK 188
S G+K
Sbjct: 213 AFSYGQK 219
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-33
Identities = 56/181 (30%), Positives = 88/181 (48%), Gaps = 21/181 (11%)
Query: 10 QDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL-LVYEYMPLGSV 68
VA+K + + + FL E +++ L H NLV L+G + L +V EYM GS+
Sbjct: 217 NKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL 274
Query: 69 EDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK 128
D+L S G+ L + +K + +EYL ++RDL N+L+ K
Sbjct: 275 VDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAK 329
Query: 129 LSDFGLAKLGPVGDNTHVSTRV----MGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEIL 184
+SDFGL K +T + ++ APE + + + KSDV+SFG++L EI
Sbjct: 330 VSDFGLTK---EASSTQDTGKLPVKWT------APEALREKKFSTKSDVWSFGILLWEIY 380
Query: 185 S 185
S
Sbjct: 381 S 381
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-33
Identities = 52/187 (27%), Positives = 84/187 (44%), Gaps = 22/187 (11%)
Query: 12 VAIKQLDRNGVQGNR-EFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVED 70
VAIK ++ R EFL E ++ + ++V L+G + G L++ E M G ++
Sbjct: 58 VAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKS 117
Query: 71 HLHDLSP------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG 124
+L L P P + +++A A G+ YL+ ++RDL N ++
Sbjct: 118 YLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 174
Query: 125 YHPKLSDFGLAKLGPVGDNTHVSTRV------MGTYGYCAPEYAKTGQLTLKSDVYSFGV 178
+ K+ DFG+ + D + M +PE K G T SDV+SFGV
Sbjct: 175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM------SPESLKDGVFTTYSDVWSFGV 228
Query: 179 VLLEILS 185
VL EI +
Sbjct: 229 VLWEIAT 235
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 4e-33
Identities = 55/184 (29%), Positives = 86/184 (46%), Gaps = 13/184 (7%)
Query: 10 QDVAIKQLDRNGVQGNR-EFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSV 68
VAIK L + R +FL E ++ HPN++ L G G ++V EYM GS+
Sbjct: 78 VPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSL 137
Query: 69 EDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK 128
+ L + + G G+ YL D ++RDL N+L+D K
Sbjct: 138 DTFLRT---HDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCK 191
Query: 129 LSDFGLAKLGPVGDNTHVSTRVMGT---YGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 185
+SDFGL+++ + D+ + G + APE + SDV+SFGVV+ E+L+
Sbjct: 192 VSDFGLSRV--LEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249
Query: 186 -GRK 188
G +
Sbjct: 250 YGER 253
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 6e-33
Identities = 58/175 (33%), Positives = 85/175 (48%), Gaps = 8/175 (4%)
Query: 11 DVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVED 70
VAIK L + G FL E ++ L H LV L + +V EYM GS+ D
Sbjct: 210 RVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLD 267
Query: 71 HLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLS 130
L K L + +AA A G+ Y+ ++RDL+ +NIL+ K++
Sbjct: 268 FLK--GETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVA 322
Query: 131 DFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 185
DFGLA+L + T + APE A G+ T+KSDV+SFG++L E+ +
Sbjct: 323 DFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 376
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-32
Identities = 55/194 (28%), Positives = 84/194 (43%), Gaps = 27/194 (13%)
Query: 10 QDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVE 69
VA+K L + ++F E +L+ L H ++V G C DGD ++V+EYM G +
Sbjct: 46 MLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLN 105
Query: 70 DHLHDLSP------------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCS 117
L P K L + + IA+ A G+ YL + ++RDL
Sbjct: 106 KFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATR 162
Query: 118 NILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRV------MGTYGYCAPEYAKTGQLTLKS 171
N L+ K+ DFG+++ D V M PE + T +S
Sbjct: 163 NCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM------PPESIMYRKFTTES 216
Query: 172 DVYSFGVVLLEILS 185
DV+SFGV+L EI +
Sbjct: 217 DVWSFGVILWEIFT 230
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-32
Identities = 60/178 (33%), Positives = 92/178 (51%), Gaps = 14/178 (7%)
Query: 11 DVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVED 70
VA+K L + G FL E ++ L H LV L + ++ EYM GS+ D
Sbjct: 39 KVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVD 96
Query: 71 HLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLS 130
L +P L N + +AA A G+ ++ ++ I+RDL+ +NIL+ K++
Sbjct: 97 FLK--TPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIA 151
Query: 131 DFGLAKLGPVGDNTHVSTRVMGT---YGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 185
DFGLA+L + DN + T G + APE G T+KSDV+SFG++L EI++
Sbjct: 152 DFGLARL--IEDNEY--TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 205
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-32
Identities = 56/191 (29%), Positives = 84/191 (43%), Gaps = 26/191 (13%)
Query: 12 VAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDH 71
VA+K L ++F E +L++L H ++V G C +G L+V+EYM G +
Sbjct: 74 VAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRF 133
Query: 72 LHDLSP-----------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNIL 120
L P PL + +A+ A G+ YL ++RDL N L
Sbjct: 134 LRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCL 190
Query: 121 LDRGYHPKLSDFGLAKLGPVGDNTHVSTRV------MGTYGYCAPEYAKTGQLTLKSDVY 174
+ +G K+ DFG+++ D V R M PE + T +SDV+
Sbjct: 191 VGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWM------PPESILYRKFTTESDVW 244
Query: 175 SFGVVLLEILS 185
SFGVVL EI +
Sbjct: 245 SFGVVLWEIFT 255
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-32
Identities = 59/185 (31%), Positives = 91/185 (49%), Gaps = 22/185 (11%)
Query: 10 QDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL-LVYEYMPLGSV 68
VA+K + +N + FL E +++ L H NLV L+G + L +V EYM GS+
Sbjct: 45 NKVAVKCI-KNDAT-AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL 102
Query: 69 EDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK 128
D+L S G+ L + +K + +EYL ++RDL N+L+ K
Sbjct: 103 VDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAK 157
Query: 129 LSDFGLAKLGPVGDNTHVSTRV----MGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEIL 184
+SDFGL K +T + ++ APE + + + KSDV+SFG++L EI
Sbjct: 158 VSDFGLTK---EASSTQDTGKLPVKWT------APEALREKKFSTKSDVWSFGILLWEIY 208
Query: 185 S-GRK 188
S GR
Sbjct: 209 SFGRV 213
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 2e-32
Identities = 54/178 (30%), Positives = 88/178 (49%), Gaps = 14/178 (7%)
Query: 11 DVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVED 70
VA+K + + G FL E ++ L H LV L + ++ E+M GS+ D
Sbjct: 214 KVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLD 271
Query: 71 HLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLS 130
L S + +A A G+ ++ + I+RDL+ +NIL+ K++
Sbjct: 272 FLK--SDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIA 326
Query: 131 DFGLAKLGPVGDNTHVSTRVMGT---YGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 185
DFGLA++ + DN + T G + APE G T+KSDV+SFG++L+EI++
Sbjct: 327 DFGLARV--IEDNEY--TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVT 380
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-32
Identities = 47/186 (25%), Positives = 84/186 (45%), Gaps = 22/186 (11%)
Query: 11 DVAIKQLDRNGVQGNR-EFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVE 69
+VA+K ++ N+ +F+ E +++ L HP++V LIG + + ++ E P G +
Sbjct: 42 NVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGII-EEEPTWIIMELYPYGELG 100
Query: 70 DHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKL 129
+L K L T + + + + YL ++RD+ NIL+ KL
Sbjct: 101 HYLER---NKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKL 154
Query: 130 SDFGLAKLGPVGDNTHVSTRVMGTYG------YCAPEYAKTGQLTLKSDVYSFGVVLLEI 183
DFGL++ + D + + +PE + T SDV+ F V + EI
Sbjct: 155 GDFGLSRY--IEDEDYYKAS-----VTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEI 207
Query: 184 LS-GRK 188
LS G++
Sbjct: 208 LSFGKQ 213
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-32
Identities = 50/184 (27%), Positives = 89/184 (48%), Gaps = 13/184 (7%)
Query: 10 QDVAIKQLDRNGVQGNR-EFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSV 68
VAIK L + R +FL E ++ H N++ L G + +++ EYM G++
Sbjct: 74 VPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGAL 133
Query: 69 EDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK 128
+ L + + + G A G++YL + ++RDL NIL++ K
Sbjct: 134 DKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCK 187
Query: 129 LSDFGLAKLGPVGDNTHVSTRVMGT---YGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 185
+SDFGL+++ + D+ + G + APE + T SDV+SFG+V+ E+++
Sbjct: 188 VSDFGLSRV--LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMT 245
Query: 186 -GRK 188
G +
Sbjct: 246 YGER 249
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 3e-32
Identities = 54/184 (29%), Positives = 87/184 (47%), Gaps = 13/184 (7%)
Query: 10 QDVAIKQLDRNGVQGNR-EFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSV 68
VAIK L + R +FL E ++ HPN++ L G ++V EYM GS+
Sbjct: 74 ISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL 133
Query: 69 EDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK 128
+ L + + G A G++YL D ++RDL NIL++ K
Sbjct: 134 DSFLRK---HDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCK 187
Query: 129 LSDFGLAKLGPVGDNTHVSTRVMGT---YGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 185
+SDFGL ++ + D+ + G + +PE + T SDV+S+G+VL E++S
Sbjct: 188 VSDFGLGRV--LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245
Query: 186 -GRK 188
G +
Sbjct: 246 YGER 249
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-32
Identities = 58/175 (33%), Positives = 85/175 (48%), Gaps = 8/175 (4%)
Query: 11 DVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVED 70
VAIK L + G FL E ++ L H LV L + +V EYM GS+ D
Sbjct: 293 RVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLD 350
Query: 71 HLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLS 130
L K L + +AA A G+ Y+ ++RDL+ +NIL+ K++
Sbjct: 351 FLK--GETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVA 405
Query: 131 DFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 185
DFGLA+L + T + APE A G+ T+KSDV+SFG++L E+ +
Sbjct: 406 DFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 459
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 4e-32
Identities = 55/268 (20%), Positives = 90/268 (33%), Gaps = 46/268 (17%)
Query: 10 QDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR----LLVYEYMPL 65
A+K++ + Q E E M L +HPN++ L+ YC L+ +
Sbjct: 55 HFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKR 114
Query: 66 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY 125
G++ + + L L + + + G RGLE +H +RDLK +NILL
Sbjct: 115 GTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEG 171
Query: 126 HPKLSDFGLAKLGPVGDNTHVSTRVM-------GTYGYCAPE------YAKTGQLTLKSD 172
P L D G + + T Y APE + + ++D
Sbjct: 172 QPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDE---RTD 228
Query: 173 VYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQY---PP 229
V+S G VL ++ G + + +Q Q
Sbjct: 229 VWSLGCVLYAMMFGEGP-------------------YDMVFQKGDSVALAVQNQLSIPQS 269
Query: 230 RGFYQAL-AVAAMCVHEQPDMRPVIADV 256
AL + + P RP I +
Sbjct: 270 PRHSSALWQLLNSMMTVDPHQRPHIPLL 297
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 6e-32
Identities = 51/183 (27%), Positives = 88/183 (48%), Gaps = 14/183 (7%)
Query: 11 DVAIKQL-DRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVE 69
DVAIK L E + E ++ L +P +V LIG C + +LV E G +
Sbjct: 365 DVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLH 423
Query: 70 DHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKL 129
L ++ + + ++ + G++YL +K ++R+L N+LL ++ K+
Sbjct: 424 KFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKI 477
Query: 130 SDFGLAKLGPVGDNTHVSTRVMGT---YGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS- 185
SDFGL+K D+ + + + APE + + +SDV+S+GV + E LS
Sbjct: 478 SDFGLSKALGADDSYYTARS--AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSY 535
Query: 186 GRK 188
G+K
Sbjct: 536 GQK 538
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-31
Identities = 56/195 (28%), Positives = 86/195 (44%), Gaps = 28/195 (14%)
Query: 10 QDVAIKQLDRNGVQGNR-EFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSV 68
Q VAIK L R EF E ++ + L HPN+V L+G +++ Y G +
Sbjct: 40 QAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDL 99
Query: 69 EDHLHDLSPG------------KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKC 116
+ L SP K L+ + + A A G+EYL V+++DL
Sbjct: 100 HEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLAT 156
Query: 117 SNILLDRGYHPKLSDFGLAKLGPVGDNTHVST------RVMGTYGYCAPEYAKTGQLTLK 170
N+L+ + K+SD GL + D + R M APE G+ ++
Sbjct: 157 RNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWM------APEAIMYGKFSID 210
Query: 171 SDVYSFGVVLLEILS 185
SD++S+GVVL E+ S
Sbjct: 211 SDIWSYGVVLWEVFS 225
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-31
Identities = 51/184 (27%), Positives = 88/184 (47%), Gaps = 18/184 (9%)
Query: 10 QDVAIKQLDRNGVQGNR-EFLVEVLMLSLLHHPNLVNLIGYCADGD-QRLLVYEYMPLGS 67
A+K L+R G +FL E +++ HPN+++L+G C + L+V YM G
Sbjct: 54 IHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGD 113
Query: 68 VEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP 127
+ + + + + + A+G++YL K ++RDL N +LD +
Sbjct: 114 LRNFIRNETH---NPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTV 167
Query: 128 KLSDFGLAKLGPVGDNTHVSTRVMG------TYGYCAPEYAKTGQLTLKSDVYSFGVVLL 181
K++DFGLA+ + V + A E +T + T KSDV+SFGV+L
Sbjct: 168 KVADFGLARDMYDKEYYSVHNKTGAKLPVKWM----ALESLQTQKFTTKSDVWSFGVLLW 223
Query: 182 EILS 185
E+++
Sbjct: 224 ELMT 227
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-31
Identities = 54/183 (29%), Positives = 80/183 (43%), Gaps = 10/183 (5%)
Query: 10 QDVAIKQL-DRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSV 68
VA+K L + Q +FL+E L++S +H N+V IG R ++ E M G +
Sbjct: 61 LQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDL 120
Query: 69 EDHLHDLSPG---KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR-- 123
+ L + P L + +A A G +YL + I+RD+ N LL
Sbjct: 121 KSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPG 177
Query: 124 -GYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLE 182
G K+ DFG+A+ M + PE G T K+D +SFGV+L E
Sbjct: 178 PGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWE 237
Query: 183 ILS 185
I S
Sbjct: 238 IFS 240
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 5e-31
Identities = 55/186 (29%), Positives = 87/186 (46%), Gaps = 22/186 (11%)
Query: 10 QDVAIKQLDRNGVQGNR-EFLVEVLMLSLLHHPNLVNLIGYCADGD-QRLLVYEYMPLGS 67
AIK L R FL E L++ L+HPN++ LIG + ++ YM G
Sbjct: 50 IQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGD 109
Query: 68 VEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP 127
+ + ++ + ARG+EYL ++ ++RDL N +LD +
Sbjct: 110 LLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTV 163
Query: 128 KLSDFGLAKLGPVGDNTHVSTRVMG--------TYGYCAPEYAKTGQLTLKSDVYSFGVV 179
K++DFGLA+ + D + S + T A E +T + T KSDV+SFGV+
Sbjct: 164 KVADFGLARD--ILDREYYSVQQHRHARLPVKWT----ALESLQTYRFTTKSDVWSFGVL 217
Query: 180 LLEILS 185
L E+L+
Sbjct: 218 LWELLT 223
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 6e-31
Identities = 54/187 (28%), Positives = 80/187 (42%), Gaps = 24/187 (12%)
Query: 11 DVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSV 68
VAIK +N +FL E L + HP++V LIG + ++ E LG +
Sbjct: 45 AVAIKTC-KNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGEL 102
Query: 69 EDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK 128
L K LD + + A + L YL K ++RD+ N+L+ K
Sbjct: 103 RSFLQV---RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVK 156
Query: 129 LSDFGLAKLGPVGDNTHVSTRVMGTYG------YCAPEYAKTGQLTLKSDVYSFGVVLLE 182
L DFGL++ + D+T+ + APE + T SDV+ FGV + E
Sbjct: 157 LGDFGLSRY--MEDSTYYKAS-----KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWE 209
Query: 183 ILS-GRK 188
IL G K
Sbjct: 210 ILMHGVK 216
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 7e-31
Identities = 49/184 (26%), Positives = 88/184 (47%), Gaps = 18/184 (9%)
Query: 10 QDVAIKQLDRN-GVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD-QRLLVYEYMPLGS 67
A+K L+R + +FL E +++ HPN+++L+G C + L+V YM G
Sbjct: 118 IHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGD 177
Query: 68 VEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP 127
+ + + + + + A+G+++L K ++RDL N +LD +
Sbjct: 178 LRNFIRNETH---NPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTV 231
Query: 128 KLSDFGLAKLGPVGDNTHVSTRVMG------TYGYCAPEYAKTGQLTLKSDVYSFGVVLL 181
K++DFGLA+ + V + A E +T + T KSDV+SFGV+L
Sbjct: 232 KVADFGLARDMYDKEFDSVHNKTGAKLPVKWM----ALESLQTQKFTTKSDVWSFGVLLW 287
Query: 182 EILS 185
E+++
Sbjct: 288 ELMT 291
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-30
Identities = 51/177 (28%), Positives = 77/177 (43%), Gaps = 11/177 (6%)
Query: 11 DVAIKQL-DRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVE 69
VAIK + +FL E L + HP++V LIG + ++ E LG +
Sbjct: 420 AVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELR 478
Query: 70 DHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKL 129
L K LD + + A + L YL K ++RD+ N+L+ KL
Sbjct: 479 SFLQV---RKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKL 532
Query: 130 SDFGLAKLGPVGDNTHVSTRVMGT-YGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 185
DFGL++ + D+T+ + APE + T SDV+ FGV + EIL
Sbjct: 533 GDFGLSRY--MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM 587
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-30
Identities = 59/256 (23%), Positives = 109/256 (42%), Gaps = 31/256 (12%)
Query: 10 QDVAIKQLDRNGV-QGNREFLV-EVLMLSLLHHPNLVNLIGYCADGDQRLL--VYEYMPL 65
+ + K+LD + + ++ LV EV +L L HPN+V D L V EY
Sbjct: 32 KILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEG 91
Query: 66 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPP--VIYRDLKCSNILLDR 123
G + + + ++ LD +++ L+ H ++ V++RDLK +N+ LD
Sbjct: 92 GDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDG 151
Query: 124 GYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEI 183
+ KL DFGLA++ + +T + +GT Y +PE KSD++S G +L E+
Sbjct: 152 KQNVKLGDFGLARI--LNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209
Query: 184 LSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYP--PRGFYQAL-AVAA 240
+ P F ++ L +G++ P + L +
Sbjct: 210 CAL-------------------MPPFTAFSQKELAGKI-REGKFRRIPYRYSDELNEIIT 249
Query: 241 MCVHEQPDMRPVIADV 256
++ + RP + ++
Sbjct: 250 RMLNLKDYHRPSVEEI 265
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-30
Identities = 51/191 (26%), Positives = 83/191 (43%), Gaps = 24/191 (12%)
Query: 10 QDVAIKQL--DRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR-----LLVYEY 62
VA+K + D + + EFL E + HPN++ L+G C + + +++ +
Sbjct: 63 LKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPF 122
Query: 63 MPLGSVEDHL--HDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNIL 120
M G + +L L G K + T +K A G+EYL ++ ++RDL N +
Sbjct: 123 MKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCM 179
Query: 121 LDRGYHPKLSDFGLAKLGPVGDNTHVSTRV------MGTYGYCAPEYAKTGQLTLKSDVY 174
L ++DFGL+K GD + A E T KSDV+
Sbjct: 180 LRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI------AIESLADRVYTSKSDVW 233
Query: 175 SFGVVLLEILS 185
+FGV + EI +
Sbjct: 234 AFGVTMWEIAT 244
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-30
Identities = 53/183 (28%), Positives = 80/183 (43%), Gaps = 10/183 (5%)
Query: 10 QDVAIKQLDRNGVQGNR-EFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSV 68
VA+K L + + +FL+E L++S +H N+V IG R ++ E M G +
Sbjct: 102 LQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDL 161
Query: 69 EDHLHDLSPG---KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR-- 123
+ L + P L + +A A G +YL + I+RD+ N LL
Sbjct: 162 KSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPG 218
Query: 124 -GYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLE 182
G K+ DFG+A+ M + PE G T K+D +SFGV+L E
Sbjct: 219 PGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWE 278
Query: 183 ILS 185
I S
Sbjct: 279 IFS 281
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-30
Identities = 39/201 (19%), Positives = 83/201 (41%), Gaps = 29/201 (14%)
Query: 10 QDVAIKQLDRNGVQGNREFLV-----------------EVLMLSLLHHPNLVNLIGYCAD 52
+ A+K+ +++ ++ R+F E+ +++ + + + G +
Sbjct: 55 KFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITN 114
Query: 53 GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR----GLEYLHDKAKPP 108
D+ ++YEYM S+ K +++ + Y+H++
Sbjct: 115 YDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN-- 172
Query: 109 VIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE--YAKTGQ 166
+ +RD+K SNIL+D+ KLSDFG ++ + + GTY + PE ++
Sbjct: 173 ICHRDVKPSNILMDKNGRVKLSDFGESEYMV---DKKIKG-SRGTYEFMPPEFFSNESSY 228
Query: 167 LTLKSDVYSFGVVLLEILSGR 187
K D++S G+ L +
Sbjct: 229 NGAKVDIWSLGICLYVMFYNV 249
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-30
Identities = 56/182 (30%), Positives = 89/182 (48%), Gaps = 15/182 (8%)
Query: 11 DVAIKQLDRNGVQGNREFLV----EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLG 66
VAIK + + E L EV S L H N+V++I + D LV EY+
Sbjct: 38 KVAIKAI-FIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGP 96
Query: 67 SVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH 126
++ +++ PL +T + G+++ HD +++RD+K NIL+D
Sbjct: 97 TLSEYIES----HGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKT 149
Query: 127 PKLSDFGLAKLGPVGDNTHVST-RVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 185
K+ DFG+AK + + + T V+GT Y +PE AK +D+YS G+VL E+L
Sbjct: 150 LKIFDFGIAKA--LSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLV 207
Query: 186 GR 187
G
Sbjct: 208 GE 209
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-30
Identities = 48/192 (25%), Positives = 77/192 (40%), Gaps = 25/192 (13%)
Query: 10 QDVAIKQL--DRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR------LLVYE 61
VA+K L D EFL E + HP++ L+G + +++
Sbjct: 52 VKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILP 111
Query: 62 YMPLGSVEDHLHDLSPGKKP--LDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNI 119
+M G + L G+ P L T ++ A G+EYL + I+RDL N
Sbjct: 112 FMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNC 168
Query: 120 LLDRGYHPKLSDFGLAKLGPVGDNTHVSTRV------MGTYGYCAPEYAKTGQLTLKSDV 173
+L ++DFGL++ GD + A E T+ SDV
Sbjct: 169 MLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWL------ALESLADNLYTVHSDV 222
Query: 174 YSFGVVLLEILS 185
++FGV + EI++
Sbjct: 223 WAFGVTMWEIMT 234
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-29
Identities = 50/251 (19%), Positives = 78/251 (31%), Gaps = 39/251 (15%)
Query: 12 VAIKQLDRN--GVQGNREFLVEV-LMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSV 68
A+K+ G + L EV + HP V L +G L E S+
Sbjct: 85 YAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELCG-PSL 143
Query: 69 EDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK 128
+ H L L +LH + +++ D+K +NI L K
Sbjct: 144 QQHCEAW---GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCK 197
Query: 129 LSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRK 188
L DFGL +G + G Y APE + G +DV+S G+ +LE+ +
Sbjct: 198 LGDFGLLVE--LGTAGAGEVQE-GDPRYMAPELLQ-GSYGTAADVFSLGLTILEVACNME 253
Query: 189 AVDTSKAAAEQSLVAWARPLFQDRTRHSL---IADPELQGQYPPRGFYQALAVAAMCVHE 245
L PE + +V M +
Sbjct: 254 ------------------LPHGGEGWQQLRQGYLPPEFTAGLSS----ELRSVLVMMLEP 291
Query: 246 QPDMRPVIADV 256
P +R +
Sbjct: 292 DPKLRATAEAL 302
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-29
Identities = 50/194 (25%), Positives = 88/194 (45%), Gaps = 29/194 (14%)
Query: 12 VAIKQLDRNGVQGNR-EFLVEV-LMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVE 69
VA+K L + + + + + E+ +M + H N++NL+G C ++ EY G++
Sbjct: 70 VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 129
Query: 70 DHL------------HDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCS 117
++L ++ + + + ARG+EYL + I+RDL
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAAR 186
Query: 118 NILLDRGYHPKLSDFGLAKLGPVGDNTHVST------RVMGTYGYCAPEYAKTGQLTLKS 171
N+L+ K++DFGLA+ D +T + M APE T +S
Sbjct: 187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWM------APEALFDRVYTHQS 240
Query: 172 DVYSFGVVLLEILS 185
DV+SFGV++ EI +
Sbjct: 241 DVWSFGVLMWEIFT 254
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-29
Identities = 61/196 (31%), Positives = 88/196 (44%), Gaps = 32/196 (16%)
Query: 10 QDVAIKQL-DRNGVQGNREFLVEV-LMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGS 67
D AIK++ + +R+F E+ ++ L HHPN++NL+G C L EY P G+
Sbjct: 53 MDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGN 112
Query: 68 VEDHLHDLSP------------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLK 115
+ D L L + AA ARG++YL K I+RDL
Sbjct: 113 LLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLA 169
Query: 116 CSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST------RVMGTYGYCAPEYAKTGQLTL 169
NIL+ Y K++DFGL++ + T R M A E T
Sbjct: 170 ARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLPVRWM------AIESLNYSVYTT 220
Query: 170 KSDVYSFGVVLLEILS 185
SDV+S+GV+L EI+S
Sbjct: 221 NSDVWSYGVLLWEIVS 236
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-29
Identities = 47/204 (23%), Positives = 83/204 (40%), Gaps = 35/204 (17%)
Query: 10 QDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL------------ 57
+ AIK++ + L EV++L+ L+H +V + +
Sbjct: 32 RYYAIKKIRHTEEK-LSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTL 90
Query: 58 -LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKC 116
+ EY G++ D +H + ++ L Y+H + +I+RDLK
Sbjct: 91 FIQMEYCENGTLYDLIHS---ENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKP 144
Query: 117 SNILLDRGYHPKLSDFGLAKL-------------GPVGDNTHVSTRVMGTYGYCAPE-YA 162
NI +D + K+ DFGLAK G + ++++ + GT Y A E
Sbjct: 145 MNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAI-GTAMYVATEVLD 203
Query: 163 KTGQLTLKSDVYSFGVVLLEILSG 186
TG K D+YS G++ E++
Sbjct: 204 GTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-29
Identities = 52/194 (26%), Positives = 88/194 (45%), Gaps = 29/194 (14%)
Query: 12 VAIKQL-DRNGVQGNREFLVEV-LMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVE 69
VA+K L D + + + E+ +M + H N++NL+G C ++ EY G++
Sbjct: 116 VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 175
Query: 70 DHLHDLSP------------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCS 117
++L P ++ + + + ARG+EYL + I+RDL
Sbjct: 176 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAAR 232
Query: 118 NILLDRGYHPKLSDFGLAKLGPVGDNTHVST------RVMGTYGYCAPEYAKTGQLTLKS 171
N+L+ K++DFGLA+ D +T + M APE T +S
Sbjct: 233 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWM------APEALFDRVYTHQS 286
Query: 172 DVYSFGVVLLEILS 185
DV+SFGV++ EI +
Sbjct: 287 DVWSFGVLMWEIFT 300
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-29
Identities = 54/192 (28%), Positives = 83/192 (43%), Gaps = 27/192 (14%)
Query: 12 VAIKQL-DRNGVQGNREFLVEV-LMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVE 69
VA+K L + E+ +M L H N+VNL+G C G L++ EY G +
Sbjct: 79 VAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLL 138
Query: 70 DHLHDLSP----------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNI 119
+ L S + ++ A+G+ +L K I+RD+ N+
Sbjct: 139 NFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNV 195
Query: 120 LLDRGYHPKLSDFGLAKLGPVGDNTHVST------RVMGTYGYCAPEYAKTGQLTLKSDV 173
LL G+ K+ DFGLA+ N V + M APE T++SDV
Sbjct: 196 LLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWM------APESIFDCVYTVQSDV 249
Query: 174 YSFGVVLLEILS 185
+S+G++L EI S
Sbjct: 250 WSYGILLWEIFS 261
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 3e-29
Identities = 54/181 (29%), Positives = 78/181 (43%), Gaps = 14/181 (7%)
Query: 10 QDVAIKQLDRNGVQGNR---EFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLG 66
+A+K L + ++ + EV + S L HPN++ L GY D + L+ EY PLG
Sbjct: 35 FILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLG 94
Query: 67 SVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH 126
+V L D A L Y H K VI+RD+K N+LL
Sbjct: 95 TVYRELQK----LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGE 147
Query: 127 PKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG 186
K++DFG + P + GT Y PE + K D++S GV+ E L G
Sbjct: 148 LKIADFGWSVHAP--SSRRTDL--CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 203
Query: 187 R 187
+
Sbjct: 204 K 204
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 5e-29
Identities = 55/263 (20%), Positives = 99/263 (37%), Gaps = 50/263 (19%)
Query: 10 QDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL------------ 57
+ IK++ N N + EV L+ L H N+V+ G D
Sbjct: 37 KTYVIKRVKYN----NEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKT 92
Query: 58 ----LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRD 113
+ E+ G++E + + LD +++ +G++Y+H K +I RD
Sbjct: 93 KCLFIQMEFCDKGTLEQWIEKRR--GEKLDKVLALELFEQITKGVDYIHSKK---LINRD 147
Query: 114 LKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDV 173
LK SNI L K+ DFGL N TR GT Y +PE + + D+
Sbjct: 148 LKPSNIFLVDTKQVKIGDFGLVT---SLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDL 204
Query: 174 YSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFY 233
Y+ G++L E+L F+ + + D + +
Sbjct: 205 YALGLILAELLHV------------------CDTAFETSKFFTDLRDGIISDIFDK---- 242
Query: 234 QALAVAAMCVHEQPDMRPVIADV 256
+ + + ++P+ RP +++
Sbjct: 243 KEKTLLQKLLSKKPEDRPNTSEI 265
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 1e-28
Identities = 56/201 (27%), Positives = 87/201 (43%), Gaps = 36/201 (17%)
Query: 12 VAIKQLDRNGVQGNR-EFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVED 70
VA+K L + +F E +++ +PN+V L+G CA G L++EYM G + +
Sbjct: 80 VAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNE 139
Query: 71 HLHDLSP--------------------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVI 110
L +SP G PL ++ IA A G+ YL ++ +
Sbjct: 140 FLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FV 196
Query: 111 YRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRV------MGTYGYCAPEYAKT 164
+RDL N L+ K++DFGL++ D M PE
Sbjct: 197 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWM------PPESIFY 250
Query: 165 GQLTLKSDVYSFGVVLLEILS 185
+ T +SDV+++GVVL EI S
Sbjct: 251 NRYTTESDVWAYGVVLWEIFS 271
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-28
Identities = 56/196 (28%), Positives = 84/196 (42%), Gaps = 31/196 (15%)
Query: 12 VAIKQLDRNGVQGNR-EFLVEV-LMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVE 69
VA+K L + R + E+ ++ L +H N+VNL+G C G L++ EY G +
Sbjct: 56 VAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLL 115
Query: 70 DHLHDLSP--------------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLK 115
+ L + LD + + A+G+ +L K I+RDL
Sbjct: 116 NFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLA 172
Query: 116 CSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST------RVMGTYGYCAPEYAKTGQLTL 169
NILL G K+ DFGLA+ N V + M APE T
Sbjct: 173 ARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWM------APESIFNCVYTF 226
Query: 170 KSDVYSFGVVLLEILS 185
+SDV+S+G+ L E+ S
Sbjct: 227 ESDVWSYGIFLWELFS 242
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-28
Identities = 49/252 (19%), Positives = 104/252 (41%), Gaps = 32/252 (12%)
Query: 10 QDVAIKQLDRNGV-QGNREFLV-EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGS 67
+ IK+++ + + RE EV +L+ + HPN+V + +V +Y G
Sbjct: 50 RQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGD 109
Query: 68 VEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP 127
+ ++ + + L+++HD+ +++RD+K NI L +
Sbjct: 110 LFKRINAQ--KGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTV 164
Query: 128 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 187
+L DFG+A++ + ++ +GT Y +PE + KSD+++ G VL E+ + +
Sbjct: 165 QLGDFGIARV--LNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLK 222
Query: 188 KAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYP--PRGFYQAL-AVAAMCVH 244
A F+ + +L+ + G +P + L ++ +
Sbjct: 223 HA-------------------FEAGSMKNLVLKI-ISGSFPPVSLHYSYDLRSLVSQLFK 262
Query: 245 EQPDMRPVIADV 256
P RP + +
Sbjct: 263 RNPRDRPSVNSI 274
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-28
Identities = 55/254 (21%), Positives = 103/254 (40%), Gaps = 30/254 (11%)
Query: 10 QDVAIKQLDRNGVQGNRE---FLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLG 66
VA+K++ + + + E+ +L L+HPN++ + ++ +V E G
Sbjct: 58 VPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAG 117
Query: 67 SVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH 126
+ + K+ + T K LE++H + V++RD+K +N+ +
Sbjct: 118 DLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGV 174
Query: 127 PKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG 186
KL D GL + T + ++GT Y +PE KSD++S G +L E+ +
Sbjct: 175 VKLGDLGLGRF--FSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAAL 232
Query: 187 RKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYP--PRGFY-QAL-AVAAMC 242
+ P + D+ + Q YP P Y + L + MC
Sbjct: 233 Q------------------SPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMC 274
Query: 243 VHEQPDMRPVIADV 256
++ P+ RP + V
Sbjct: 275 INPDPEKRPDVTYV 288
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-28
Identities = 55/194 (28%), Positives = 88/194 (45%), Gaps = 29/194 (14%)
Query: 12 VAIKQLDRNGVQGNR-EFLVEV-LMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVE 69
VA+K L + + + + + E+ +M + H N++NL+G C ++ EY G++
Sbjct: 104 VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 163
Query: 70 DHLHDLSPGKKPLDWNTR------------MKIAAGAARGLEYLHDKAKPPVIYRDLKCS 117
++L P +N + A ARG+EYL K I+RDL
Sbjct: 164 EYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAAR 220
Query: 118 NILLDRGYHPKLSDFGLAKLGPVGDNTHVST------RVMGTYGYCAPEYAKTGQLTLKS 171
N+L+ K++DFGLA+ D +T + M APE T +S
Sbjct: 221 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWM------APEALFDRIYTHQS 274
Query: 172 DVYSFGVVLLEILS 185
DV+SFGV+L EI +
Sbjct: 275 DVWSFGVLLWEIFT 288
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-28
Identities = 54/201 (26%), Positives = 88/201 (43%), Gaps = 36/201 (17%)
Query: 12 VAIKQLDRNGVQGNR-EFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVED 70
VA+K L N + L E +L ++HP+++ L G C+ LL+ EY GS+
Sbjct: 56 VAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRG 115
Query: 71 HL--------------------HDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVI 110
L P ++ L + A ++G++YL + ++
Sbjct: 116 FLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LV 172
Query: 111 YRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST------RVMGTYGYCAPEYAKT 164
+RDL NIL+ G K+SDFGL++ D+ + + M A E
Sbjct: 173 HRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWM------AIESLFD 226
Query: 165 GQLTLKSDVYSFGVVLLEILS 185
T +SDV+SFGV+L EI++
Sbjct: 227 HIYTTQSDVWSFGVLLWEIVT 247
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-27
Identities = 53/273 (19%), Positives = 96/273 (35%), Gaps = 52/273 (19%)
Query: 10 QDVAIKQLDRNGVQGNRE-FLVEVLMLSLLHHPNLVNLIGYCADGD---------QRLLV 59
+ AIK++ + RE + EV L+ L HP +V + + ++ +
Sbjct: 31 CNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYL 90
Query: 60 Y---EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKC 116
Y + +++D ++ + + + + I A +E+LH K +++RDLK
Sbjct: 91 YIQMQLCRKENLKDWMNG-RCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKP 146
Query: 117 SNILLDRGYHPKLSDFGLAKL----------GPVGDNTHVSTRVMGTYGYCAPEYAKTGQ 166
SNI K+ DFGL T +GT Y +PE
Sbjct: 147 SNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNS 206
Query: 167 LTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQ 226
+ K D++S G++L E+L P R + D +
Sbjct: 207 YSHKVDIFSLGLILFELL---------------------YPFSTQMERVRTLTD-VRNLK 244
Query: 227 YP--PRGFYQALA-VAAMCVHEQPDMRPVIADV 256
+P Y + + P RP ++
Sbjct: 245 FPPLFTQKYPCEYVMVQDMLSPSPMERPEAINI 277
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-27
Identities = 52/197 (26%), Positives = 84/197 (42%), Gaps = 30/197 (15%)
Query: 10 QDVAIKQLDRNGVQGNR-EFLVEV-LMLSLLHHPNLVNLIGYCADGDQ-RLLVYEYMPLG 66
+ VA+K L + E+ +++ + HH N+VNL+G C +++ E+ G
Sbjct: 58 RTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 117
Query: 67 SVEDHL------------HDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDL 114
++ +L K L + + A+G+E+L + I+RDL
Sbjct: 118 NLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 174
Query: 115 KCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST------RVMGTYGYCAPEYAKTGQLT 168
NILL K+ DFGLA+ + + M APE T
Sbjct: 175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM------APETIFDRVYT 228
Query: 169 LKSDVYSFGVVLLEILS 185
++SDV+SFGV+L EI S
Sbjct: 229 IQSDVWSFGVLLWEIFS 245
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 4e-27
Identities = 56/189 (29%), Positives = 96/189 (50%), Gaps = 23/189 (12%)
Query: 11 DVAIKQLDRNGVQGNREFLV----EVLMLSLLHHPNLVNL--IGYCADGDQRLLVY---E 61
DVA+K L R + + F + E + L+HP +V + G A+ L Y E
Sbjct: 39 DVAVKVL-RADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTG-EAETPAGPLPYIVME 96
Query: 62 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL 121
Y+ ++ D +H + P+ +++ A A + L + H +I+RD+K +NI++
Sbjct: 97 YVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMI 149
Query: 122 DRGYHPKLSDFGLAKLGPVGDNTHVSTR---VMGTYGYCAPEYAKTGQLTLKSDVYSFGV 178
K+ DFG+A+ + D+ + T+ V+GT Y +PE A+ + +SDVYS G
Sbjct: 150 SATNAVKVMDFGIAR--AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGC 207
Query: 179 VLLEILSGR 187
VL E+L+G
Sbjct: 208 VLYEVLTGE 216
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 7e-27
Identities = 48/182 (26%), Positives = 76/182 (41%), Gaps = 16/182 (8%)
Query: 10 QDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVE 69
A+K++ + E++ + L P +V L G +G + E + GS
Sbjct: 84 FQCAVKKVRLEVFRVE-----ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGS-- 136
Query: 70 DHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR-GYHPK 128
L L L + + A GLEYLH + +++ D+K N+LL G
Sbjct: 137 --LGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAA 191
Query: 129 LSDFGLAK-LGPVGDNTHVSTR--VMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 185
L DFG A L P G + T + GT + APE K D++S ++L +L+
Sbjct: 192 LCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLN 251
Query: 186 GR 187
G
Sbjct: 252 GC 253
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-26
Identities = 45/179 (25%), Positives = 74/179 (41%), Gaps = 14/179 (7%)
Query: 12 VAIKQLDRNGVQGNR---EFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSV 68
+A+K L ++ ++ + E+ + S L HPN++ + Y D + L+ E+ P G +
Sbjct: 42 MALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGEL 101
Query: 69 EDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK 128
L D A L Y H++ VI+RD+K N+L+ K
Sbjct: 102 YKELQK----HGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELK 154
Query: 129 LSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 187
++DFG + P GT Y PE + K D++ GV+ E L G
Sbjct: 155 IADFGWSVHAP-SLRRRTMC---GTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGM 209
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-26
Identities = 41/182 (22%), Positives = 65/182 (35%), Gaps = 15/182 (8%)
Query: 11 DVAIKQLDRNGVQGNREFLV----EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLG 66
VA+K + + + F E L P++V + + Q + +
Sbjct: 61 IVALKLM-SETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGV 119
Query: 67 SVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH 126
+ L + PL + I L+ H +RD+K NIL+
Sbjct: 120 DLAAMLRR----QGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDF 172
Query: 127 PKLSDFGLAKLGPVGDNTHVST-RVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 185
L DFG+A D +GT Y APE T ++D+Y+ VL E L+
Sbjct: 173 AYLVDFGIASA--TTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLT 230
Query: 186 GR 187
G
Sbjct: 231 GS 232
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-26
Identities = 43/193 (22%), Positives = 70/193 (36%), Gaps = 24/193 (12%)
Query: 10 QDVAIKQLDRNGVQGN--REFLVEVLMLSLLHHPNL--VNLIGYCADGDQRLLVYEYMPL 65
Q AIK ++ + E+ L+ L + + L Y +V E
Sbjct: 53 QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGN- 111
Query: 66 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY 125
+ L KK +D R + +H +++ DLK +N L+ G
Sbjct: 112 IDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDG- 163
Query: 126 HPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE-----------YAKTGQLTLKSDVY 174
KL DFG+A + V +GT Y PE +++ KSDV+
Sbjct: 164 MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVW 223
Query: 175 SFGVVLLEILSGR 187
S G +L + G+
Sbjct: 224 SLGCILYYMTYGK 236
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-26
Identities = 57/203 (28%), Positives = 86/203 (42%), Gaps = 36/203 (17%)
Query: 10 QDVAIKQLDRNGVQGNR-EFLVEV-LMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGS 67
VA+K L R + E+ +M L H N+VNL+G C L++EY G
Sbjct: 76 IQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGD 135
Query: 68 VEDHLHDLSP-------------------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPP 108
+ ++L L + + A A+G+E+L K+
Sbjct: 136 LLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--- 192
Query: 109 VIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST------RVMGTYGYCAPEYA 162
++RDL N+L+ G K+ DFGLA+ N V + M APE
Sbjct: 193 CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWM------APESL 246
Query: 163 KTGQLTLKSDVYSFGVVLLEILS 185
G T+KSDV+S+G++L EI S
Sbjct: 247 FEGIYTIKSDVWSYGILLWEIFS 269
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-26
Identities = 43/193 (22%), Positives = 70/193 (36%), Gaps = 24/193 (12%)
Query: 10 QDVAIKQLDRNGVQGN--REFLVEVLMLSLLHHPNL--VNLIGYCADGDQRLLVYEYMPL 65
Q AIK ++ + E+ L+ L + + L Y +V E
Sbjct: 34 QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGN- 92
Query: 66 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY 125
+ L KK +D R + +H +++ DLK +N L+ G
Sbjct: 93 IDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDG- 144
Query: 126 HPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE-----------YAKTGQLTLKSDVY 174
KL DFG+A + V +GT Y PE +++ KSDV+
Sbjct: 145 MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVW 204
Query: 175 SFGVVLLEILSGR 187
S G +L + G+
Sbjct: 205 SLGCILYYMTYGK 217
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 7e-26
Identities = 30/181 (16%), Positives = 61/181 (33%), Gaps = 24/181 (13%)
Query: 22 VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD--QRLLVYEYM--PLGSVEDHLHDLSP 77
+ + F+ ++ ++ + D R +Y M L + + L S
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198
Query: 78 GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 137
K L + R+++ R L LH +++ L+ +I+LD+ L+ F
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV- 254
Query: 138 GPVGDNTHVSTRVMGTYGYCAPEY-----------AKTGQLTLKSDVYSFGVVLLEILSG 186
G + G+ PE + +T D ++ G+V+ I
Sbjct: 255 -RDGA----RVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA 309
Query: 187 R 187
Sbjct: 310 D 310
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 8e-26
Identities = 42/193 (21%), Positives = 69/193 (35%), Gaps = 24/193 (12%)
Query: 10 QDVAIKQLDRNGVQGN--REFLVEVLMLSLLHHPNL--VNLIGYCADGDQRLLVYEYMPL 65
Q AIK ++ + E+ L+ L + + L Y +V E
Sbjct: 81 QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGN- 139
Query: 66 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY 125
+ L KK +D R + +H +++ DLK +N L+ G
Sbjct: 140 IDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDG- 191
Query: 126 HPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE-----------YAKTGQLTLKSDVY 174
KL DFG+A + V +G Y PE +++ KSDV+
Sbjct: 192 MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVW 251
Query: 175 SFGVVLLEILSGR 187
S G +L + G+
Sbjct: 252 SLGCILYYMTYGK 264
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-25
Identities = 45/179 (25%), Positives = 81/179 (45%), Gaps = 9/179 (5%)
Query: 12 VAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDH 71
+AIK++ + ++ E+ + L H N+V +G ++ + E +P GS+
Sbjct: 50 IAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSAL 109
Query: 72 LHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY-HPKLS 130
L G + T GL+YLHD +++RD+K N+L++ K+S
Sbjct: 110 LRS-KWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKIS 165
Query: 131 DFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQL--TLKSDVYSFGVVLLEILSGR 187
DFG +K + + GT Y APE G +D++S G ++E+ +G+
Sbjct: 166 DFGTSKR--LAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK 222
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-25
Identities = 71/307 (23%), Positives = 121/307 (39%), Gaps = 50/307 (16%)
Query: 10 QDVAIKQLDRNGVQGNREFLVEV-LMLSLLHHPNLVNLIGYCADGDQR-------LLVYE 61
++ A+K+L N + NR + EV M L HPN+V + G + L+
Sbjct: 54 REYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLT 113
Query: 62 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL 121
+ G + + L + + PL +T +KI R ++++H + KPP+I+RDLK N+LL
Sbjct: 114 ELCKGQLVEFLKKMES-RGPLSCDTVLKIFYQTCRAVQHMHRQ-KPPIIHRDLKVENLLL 171
Query: 122 DRGYHPKLSDFGLA---KLGPVGDNTHVSTRVM-------GTYGYCAPE----YAKTGQL 167
KL DFG A P + ++ T Y PE Y+ +
Sbjct: 172 SNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFP-I 230
Query: 168 TLKSDVYSFGVVLLEILSGRKA-VDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQ 226
K D+++ G +L + + D +K + Q HSLI
Sbjct: 231 GEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGKYSIPPHDTQYTVFHSLI-------- 282
Query: 227 YPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQKY---ESDAEKVQSPCLDPG 283
+ P+ R IA+VV L +A+ + +S ++ G
Sbjct: 283 -------------RAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKSPITELLEQNGGYG 329
Query: 284 TPTRTKG 290
+ T ++G
Sbjct: 330 SATLSRG 336
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-25
Identities = 53/194 (27%), Positives = 89/194 (45%), Gaps = 16/194 (8%)
Query: 3 QVILCLLQDV----AIKQLDRNGVQGNREF---LVEVLMLSLLHHPNLVNLIGYCADGDQ 55
+V C ++ A K+L++ ++ + + +VE +L+ +H +V+L Y +
Sbjct: 200 EVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA-YAFETKT 258
Query: 56 RL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAARGLEYLHDKAKPPVIYRD 113
L LV M G + H++++ R A GLE+LH + +IYRD
Sbjct: 259 DLCLVMTIMNGGDIRYHIYNVDEDNPGFQ-EPRAIFYTAQIVSGLEHLHQRN---IIYRD 314
Query: 114 LKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDV 173
LK N+LLD + ++SD GLA G GT G+ APE + D
Sbjct: 315 LKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYA-GTPGFMAPELLLGEEYDFSVDY 372
Query: 174 YSFGVVLLEILSGR 187
++ GV L E+++ R
Sbjct: 373 FALGVTLYEMIAAR 386
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-25
Identities = 55/247 (22%), Positives = 102/247 (41%), Gaps = 21/247 (8%)
Query: 12 VAIKQLDRNGVQGNREFLV-EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVED 70
+A K + R ++ E+ +L + P +V G + + E+M GS++
Sbjct: 61 MARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ 120
Query: 71 HLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLS 130
L + K++ +GL YL +K K +++RD+K SNIL++ KL
Sbjct: 121 VLKK----AGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLC 174
Query: 131 DFGLA-KLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR-- 187
DFG++ +L ++ ++ V GT Y +PE + +++SD++S G+ L+E+ GR
Sbjct: 175 DFGVSGQL----IDSMANSFV-GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 229
Query: 188 ---KAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVH 244
+ + A + PP ++ L V+
Sbjct: 230 IPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELL---DYIVN 286
Query: 245 EQPDMRP 251
E P P
Sbjct: 287 EPPPKLP 293
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 2e-25
Identities = 30/193 (15%), Positives = 61/193 (31%), Gaps = 21/193 (10%)
Query: 10 QDVAIKQLDRNGVQGNREFLVEVLMLSLL---HHPNLVNLIGYCADGDQRLLVYEYMPLG 66
Q +K EF + ++ L + + +LV E G
Sbjct: 96 QKFVLKVQKPANPW---EFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYG 152
Query: 67 SVEDHLHDL-SPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY 125
++ + ++ + +K + + A +E +HD +I+ D+K N +L G+
Sbjct: 153 TLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGF 209
Query: 126 HP-----------KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVY 174
L D G + + + T T G+ E + D +
Sbjct: 210 LEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYF 269
Query: 175 SFGVVLLEILSGR 187
+ +L G
Sbjct: 270 GVAATVYCMLFGT 282
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 4e-25
Identities = 44/186 (23%), Positives = 77/186 (41%), Gaps = 20/186 (10%)
Query: 12 VAIKQLDRNGVQGNREFLVEVLM-----LSLLHHPNLVNLIGYCADGDQRLLVYEYMPLG 66
+A+K++ N + +LM + + P V G + E M
Sbjct: 35 MAVKRIRATV---NSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMD-T 90
Query: 67 SVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH 126
S++ + + + + KIA + LE+LH K VI+RD+K SN+L++
Sbjct: 91 SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQ 148
Query: 127 PKLSDFGL-AKLGPVGDNTHVSTRVMGTYGYCAPE----YAKTGQLTLKSDVYSFGVVLL 181
K+ DFG+ L + G Y APE ++KSD++S G+ ++
Sbjct: 149 VKMCDFGISGYL----VDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMI 204
Query: 182 EILSGR 187
E+ R
Sbjct: 205 ELAILR 210
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 5e-25
Identities = 60/194 (30%), Positives = 93/194 (47%), Gaps = 19/194 (9%)
Query: 3 QVILCLLQDV----AIKQLDRNGVQGNREF---LVEVLMLSLLHHPNLVNLIGYCADGDQ 55
+V C ++ A K+L++ ++ + L E +L ++ +V+L Y +
Sbjct: 199 EVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA-YAYETKD 257
Query: 56 RL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAARGLEYLHDKAKPPVIYRD 113
L LV M G ++ H++ + P R AA GLE LH + ++YRD
Sbjct: 258 ALCLVLTLMNGGDLKFHIYHMGQAGFPEA---RAVFYAAEICCGLEDLHRER---IVYRD 311
Query: 114 LKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDV 173
LK NILLD H ++SD GLA P G RV GT GY APE K + T D
Sbjct: 312 LKPENILLDDHGHIRISDLGLAVHVPEGQTIK--GRV-GTVGYMAPEVVKNERYTFSPDW 368
Query: 174 YSFGVVLLEILSGR 187
++ G +L E+++G+
Sbjct: 369 WALGCLLYEMIAGQ 382
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 7e-25
Identities = 46/187 (24%), Positives = 79/187 (42%), Gaps = 20/187 (10%)
Query: 10 QDVAIKQLDRNGVQG-NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSV 68
+DVA+K++ +RE V++L HPN++ D + + E ++
Sbjct: 49 RDVAVKRILPECFSFADRE--VQLLR-ESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATL 104
Query: 69 EDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL-----DR 123
++++ L+ T ++ GL +LH +++RDLK NIL+
Sbjct: 105 QEYVEQKDFAHLGLEPITLLQ---QTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHG 158
Query: 124 GYHPKLSDFGLAK-LGPVGDNTHVSTRVMGTYGYCAPEY---AKTGQLTLKSDVYSFGVV 179
+SDFGL K L + + V GT G+ APE T D++S G V
Sbjct: 159 KIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCV 218
Query: 180 LLEILSG 186
++S
Sbjct: 219 FYYVISE 225
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-24
Identities = 54/178 (30%), Positives = 83/178 (46%), Gaps = 11/178 (6%)
Query: 10 QDVAIKQLDRNGVQGNREFLV-EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSV 68
+ VAIK +D + E + E+ +LS P + G + ++ EY+ GS
Sbjct: 48 KVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSA 107
Query: 69 EDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK 128
D L PLD I +GL+YLH + K I+RD+K +N+LL K
Sbjct: 108 LDLLE-----PGPLDETQIATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVK 159
Query: 129 LSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG 186
L+DFG+A G + D +GT + APE K K+D++S G+ +E+ G
Sbjct: 160 LADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARG 215
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-24
Identities = 52/180 (28%), Positives = 87/180 (48%), Gaps = 16/180 (8%)
Query: 10 QDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVE 69
Q+VAI+Q++ + E+L++ +PN+VN + GD+ +V EY+ GS+
Sbjct: 46 QEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT 105
Query: 70 DHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKL 129
D + + +D + + LE+LH I+RD+K NILL KL
Sbjct: 106 DVVT-----ETCMDEGQIAAVCRECLQALEFLHSNQV---IHRDIKSDNILLGMDGSVKL 157
Query: 130 SDFGL-AKLGPVGD--NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG 186
+DFG A++ P +T V GT + APE K D++S G++ +E++ G
Sbjct: 158 TDFGFCAQITPEQSKRSTMV-----GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-24
Identities = 43/193 (22%), Positives = 76/193 (39%), Gaps = 22/193 (11%)
Query: 10 QDVAIKQLDRNGVQGNREFLV-EVLMLSLLHHPNLVNLIGYCADGDQRL--LVYEYMPLG 66
AIK + + + E +L L+H N+V L + R L+ E+ P G
Sbjct: 35 DLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCG 94
Query: 67 SVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH 126
S+ L + S L + + + G+ +L + +++R++K NI+ G
Sbjct: 95 SLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGED 150
Query: 127 P----KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQL--------TLKSDVY 174
KL+DFG A+ + D+ + GT Y P+ + L D++
Sbjct: 151 GQSVYKLTDFGAARE--LEDDEQFVSLY-GTEEYLHPDMYERAVLRKDHQKKYGATVDLW 207
Query: 175 SFGVVLLEILSGR 187
S GV +G
Sbjct: 208 SIGVTFYHAATGS 220
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 55/189 (29%), Positives = 83/189 (43%), Gaps = 19/189 (10%)
Query: 10 QDVAIKQLDRNGVQGNREFLV-EVLMLSLLHHPNLVNLI------GYCADGDQRLLVYEY 62
+ VAIKQ + NRE E+ ++ L+HPN+V+ A D LL EY
Sbjct: 40 EQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEY 99
Query: 63 MPLGSVEDHLHDLSPGKK-PLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL 121
G + +L+ L + + + L YLH+ +I+RDLK NI+L
Sbjct: 100 CEGGDLRKYLNQ--FENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVL 154
Query: 122 DRGYHP---KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGV 178
G K+ D G AK + + V GT Y APE + + T+ D +SFG
Sbjct: 155 QPGPQRLIHKIIDLGYAKE--LDQGELCTEFV-GTLQYLAPELLEQKKYTVTVDYWSFGT 211
Query: 179 VLLEILSGR 187
+ E ++G
Sbjct: 212 LAFECITGF 220
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 3e-24
Identities = 55/180 (30%), Positives = 82/180 (45%), Gaps = 16/180 (8%)
Query: 10 QDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVE 69
Q VAIKQ+ +E + E+ ++ P++V G +V EY GSV
Sbjct: 55 QIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVS 112
Query: 70 DHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKL 129
D + K L + I +GLEYLH K I+RD+K NILL+ H KL
Sbjct: 113 DIIRLR---NKTLTEDEIATILQSTLKGLEYLHFMRK---IHRDIKAGNILLNTEGHAKL 166
Query: 130 SDFGL-AKLGPVGD--NTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG 186
+DFG+ +L NT + GT + APE + +D++S G+ +E+ G
Sbjct: 167 ADFGVAGQLTDTMAKRNTVI-----GTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEG 221
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-24
Identities = 41/183 (22%), Positives = 68/183 (37%), Gaps = 23/183 (12%)
Query: 11 DVAIKQLDRNGVQGNRE-FLVEVLMLSLLHHPNLVNLIGYCADGDQRL-----LVYEYMP 64
V +K L +G + + E L+ + HP++V + + D+ +V EY+
Sbjct: 108 PVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVG 167
Query: 65 LGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG 124
S++ L + L YLH ++Y DLK NI+L
Sbjct: 168 GQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE 218
Query: 125 YHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEIL 184
KL D G + + GT G+ APE T+ +D+Y+ G L +
Sbjct: 219 -QLKLIDLGAVS--RINS----FGYLYGTPGFQAPEIV-RTGPTVATDIYTVGRTLAALT 270
Query: 185 SGR 187
Sbjct: 271 LDL 273
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 3e-24
Identities = 45/180 (25%), Positives = 85/180 (47%), Gaps = 16/180 (8%)
Query: 10 QDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVE 69
+ VA+K +D Q EV+++ H N+V + G++ ++ E++ G++
Sbjct: 71 RQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALT 130
Query: 70 DHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKL 129
D + + L+ + + L YLH + I+RD+K +ILL KL
Sbjct: 131 DIVS-----QVRLNEEQIATVCEAVLQALAYLHAQGV---IHRDIKSDSILLTLDGRVKL 182
Query: 130 SDFGL-AKLGPVGDNTHVSTR--VMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG 186
SDFG A++ + V R ++GT + APE + D++S G++++E++ G
Sbjct: 183 SDFGFCAQI-----SKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDG 237
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 99 bits (249), Expect = 5e-24
Identities = 43/194 (22%), Positives = 76/194 (39%), Gaps = 24/194 (12%)
Query: 10 QDVAIKQLDRNGVQGNREFLV-EVLMLSLLHHPNLVNLIGYCADGDQRL--LVYEYMPLG 66
AIK + + + E +L L+H N+V L + R L+ E+ P G
Sbjct: 35 DLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCG 94
Query: 67 SVEDHLHDLSPGKK-PLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY 125
S+ L + P L + + + G+ +L + +++R++K NI+ G
Sbjct: 95 SLYTVLEE--PSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGE 149
Query: 126 HP----KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQL--------TLKSDV 173
KL+DFG A+ + D+ + GT Y P+ + L D+
Sbjct: 150 DGQSVYKLTDFGAARE--LEDDEQFVSLY-GTEEYLHPDMYERAVLRKDHQKKYGATVDL 206
Query: 174 YSFGVVLLEILSGR 187
+S GV +G
Sbjct: 207 WSIGVTFYHAATGS 220
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 99.7 bits (248), Expect = 6e-24
Identities = 27/180 (15%), Positives = 55/180 (30%), Gaps = 23/180 (12%)
Query: 22 VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV----YEYMPLGSVEDHLHDLSP 77
+ + F+ ++ ++ + D L + + L S
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203
Query: 78 GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 137
K L + R+++ R L LH +++ L+ +I+LD+ L+ F
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV- 259
Query: 138 GPVGDNTHVSTRVMGTYGYCAPEY----------AKTGQLTLKSDVYSFGVVLLEILSGR 187
G S G+ PE +T D ++ G+ + I
Sbjct: 260 -RDGA----SAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 8e-24
Identities = 44/185 (23%), Positives = 82/185 (44%), Gaps = 19/185 (10%)
Query: 10 QDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVE 69
A K ++ + +++VE+ +L+ HP +V L+G + ++ E+ P G+V+
Sbjct: 45 ALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVD 104
Query: 70 DHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKL 129
+ +L + L + L +LH K I+RDLK N+L+ +L
Sbjct: 105 AIMLEL---DRGLTEPQIQVVCRQMLEALNFLHSKRI---IHRDLKAGNVLMTLEGDIRL 158
Query: 130 SDFGLAKLGPVGDNTHVSTR---VMGTYGYCAPE-----YAKTGQLTLKSDVYSFGVVLL 181
+DFG++ N + +GT + APE K K+D++S G+ L+
Sbjct: 159 ADFGVS-----AKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLI 213
Query: 182 EILSG 186
E+
Sbjct: 214 EMAQI 218
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 98.8 bits (246), Expect = 9e-24
Identities = 39/190 (20%), Positives = 72/190 (37%), Gaps = 20/190 (10%)
Query: 10 QDVAIKQLD-RNGVQGNREFLV-EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGS 67
+ V +++++ FL E+ + L +HPN+V ++ +V +M GS
Sbjct: 53 EYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGS 112
Query: 68 VEDHLHDLSPGKKPLDWNTRMKIAA---GAARGLEYLHDKAKPPVIYRDLKCSNILLDRG 124
+D + IA G + L+Y+H ++R +K S+IL+
Sbjct: 113 AKDLICTHFMDGMNELA-----IAYILQGVLKALDYIHHMGY---VHRSVKASHILISVD 164
Query: 125 YHPKLSDFG-LAKLGPVGDNTHV----STRVMGTYGYCAPEYAKTGQL--TLKSDVYSFG 177
LS + G V + + +PE + KSD+YS G
Sbjct: 165 GKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVG 224
Query: 178 VVLLEILSGR 187
+ E+ +G
Sbjct: 225 ITACELANGH 234
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 1e-23
Identities = 57/187 (30%), Positives = 92/187 (49%), Gaps = 12/187 (6%)
Query: 10 QDVAIKQLDRNGVQGNREFLV-EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSV 68
+ VAIK+++ Q + + L+ E+ +S HHPN+V+ D+ LV + + GSV
Sbjct: 41 EKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSV 100
Query: 69 EDHLHDLSPGKKPLDWN-TRMKIAA---GAARGLEYLHDKAKPPVIYRDLKCSNILLDRG 124
D + + + IA GLEYLH + I+RD+K NILL
Sbjct: 101 LDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGED 157
Query: 125 YHPKLSDFGL-AKLGPVGDNTHVSTR--VMGTYGYCAPEYAKTGQL-TLKSDVYSFGVVL 180
+++DFG+ A L GD T R +GT + APE + + K+D++SFG+
Sbjct: 158 GSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITA 217
Query: 181 LEILSGR 187
+E+ +G
Sbjct: 218 IELATGA 224
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 98.6 bits (245), Expect = 1e-23
Identities = 25/172 (14%), Positives = 47/172 (27%), Gaps = 14/172 (8%)
Query: 22 VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD--QRLLVYEYMP--LGSVEDHLHDLSP 77
+ R L+ +++ P L D LL+ L + L +
Sbjct: 127 ARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYV 186
Query: 78 GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 137
+ + A R L K +++ N+ + L D
Sbjct: 187 FRGDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALW- 242
Query: 138 GPVGDNTHVSTRVMGTYGYCAPEY--AKTGQLTLKSDVYSFGVVLLEILSGR 187
VG S+ Y E+ A T T + + G+ + +
Sbjct: 243 -KVGTRGPASS---VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 96.8 bits (242), Expect = 1e-23
Identities = 55/181 (30%), Positives = 83/181 (45%), Gaps = 11/181 (6%)
Query: 10 QDVAIKQLDRNGVQGNR---EFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLG 66
+VAIK +D+ + EV + L HP+++ L Y D + LV E G
Sbjct: 37 LEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNG 96
Query: 67 SVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH 126
+ +L + K + R G+ YLH +++RDL SN+LL R +
Sbjct: 97 EMNRYLK--NRVKPFSENEAR-HFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMN 150
Query: 127 PKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG 186
K++DFGLA + H T + GT Y +PE A L+SDV+S G + +L G
Sbjct: 151 IKIADFGLATQLKMPHEKH-YT-LCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIG 208
Query: 187 R 187
R
Sbjct: 209 R 209
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 2e-23
Identities = 48/186 (25%), Positives = 80/186 (43%), Gaps = 19/186 (10%)
Query: 12 VAIKQLDRNGVQGNREFLVEVLM-----LSLLHHPNLVNLIGYCADGDQRLLVYEYMPLG 66
+A+K++ + + ++LM + P +V G + E M
Sbjct: 50 MAVKRIRSTV---DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTS 106
Query: 67 SVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH 126
+ + + S + KI + L +L + K +I+RD+K SNILLDR +
Sbjct: 107 FDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGN 164
Query: 127 PKLSDFGL-AKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQL----TLKSDVYSFGVVLL 181
KL DFG+ +L ++ TR G Y APE ++SDV+S G+ L
Sbjct: 165 IKLCDFGISGQL----VDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLY 220
Query: 182 EILSGR 187
E+ +GR
Sbjct: 221 ELATGR 226
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 8e-23
Identities = 47/182 (25%), Positives = 76/182 (41%), Gaps = 14/182 (7%)
Query: 10 QDVAIKQLDRNGVQGNR---EFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLG 66
+ A K + ++ + + +E+ + L H ++V G+ D D +V E
Sbjct: 41 EVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRR 100
Query: 67 SVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH 126
S L +L +K L G +YLH VI+RDLK N+ L+
Sbjct: 101 S----LLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLE 153
Query: 127 PKLSDFGLAKLGPVGDNTHVSTRVM-GTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 185
K+ DFGLA +V+ GT Y APE + + DV+S G ++ +L
Sbjct: 154 VKIGDFGLATKVEYDGERK---KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLV 210
Query: 186 GR 187
G+
Sbjct: 211 GK 212
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 1e-22
Identities = 47/182 (25%), Positives = 76/182 (41%), Gaps = 14/182 (7%)
Query: 10 QDVAIKQLDRNGVQGNR---EFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLG 66
+ A K + ++ + + +E+ + L H ++V G+ D D +V E
Sbjct: 67 EVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRR 126
Query: 67 SVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH 126
S L +L +K L G +YLH VI+RDLK N+ L+
Sbjct: 127 S----LLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLE 179
Query: 127 PKLSDFGLAKLGPVGDNTHVSTRVM-GTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 185
K+ DFGLA +V+ GT Y APE + + DV+S G ++ +L
Sbjct: 180 VKIGDFGLATKVEYDGERK---KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLV 236
Query: 186 GR 187
G+
Sbjct: 237 GK 238
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 96.1 bits (239), Expect = 3e-22
Identities = 63/198 (31%), Positives = 92/198 (46%), Gaps = 26/198 (13%)
Query: 3 QVILCLLQDV----AIKQLDRNGVQGNREF---LVEVLMLSLLH---HPNLVNLIGYCAD 52
+V C D A+K LD+ ++ + L E +MLSL+ P +V + Y
Sbjct: 204 EVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMS-YAFH 262
Query: 53 GDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAARGLEYLHDKAKPPVI 110
+L + + M G + HL G M+ AA GLE++H++ V+
Sbjct: 263 TPDKLSFILDLMNGGDLHYHLSQH--GVFSEA---DMRFYAAEIILGLEHMHNRF---VV 314
Query: 111 YRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLK 170
YRDLK +NILLD H ++SD GLA H V GT+GY APE + G
Sbjct: 315 YRDLKPANILLDEHGHVRISDLGLACDFS-KKKPH--ASV-GTHGYMAPEVLQKGVAYDS 370
Query: 171 S-DVYSFGVVLLEILSGR 187
S D +S G +L ++L G
Sbjct: 371 SADWFSLGCMLFKLLRGH 388
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 3e-22
Identities = 47/185 (25%), Positives = 80/185 (43%), Gaps = 24/185 (12%)
Query: 13 AIKQLDRNGVQGNREF---LVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVE 69
AIK L++ + + E ++S L HP V L D ++ Y G +
Sbjct: 59 AIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELL 118
Query: 70 DHLHDLSPGKKPLDWNTRMKI-AAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK 128
++ + G + A LEYLH K +I+RDLK NILL+ H +
Sbjct: 119 KYIRKI--GSFDET---CTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQ 170
Query: 129 LSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE------YAKTGQLTLKSDVYSFGVVLLE 182
++DFG AK+ + +GT Y +PE K+ SD+++ G ++ +
Sbjct: 171 ITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKS------SDLWALGCIIYQ 224
Query: 183 ILSGR 187
+++G
Sbjct: 225 LVAGL 229
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 94.5 bits (235), Expect = 5e-22
Identities = 50/208 (24%), Positives = 78/208 (37%), Gaps = 43/208 (20%)
Query: 10 QDVAIKQLDRNGVQG-NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSV 68
+ VA+K++ + E +++L S HPN++ + E +
Sbjct: 40 RPVAVKRMLIDFCDIALME--IKLLTESD-DHPNVIRYYCSETTDRFLYIALELCN-LN- 94
Query: 69 EDHLHDLSPGKKPLDWNTRMKIAAGAAR-------GLEYLHDKAKPPVIYRDLKCSNILL 121
L DL K D N +++ G+ +LH +I+RDLK NIL+
Sbjct: 95 ---LQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILV 148
Query: 122 DRGYHP-------------KLSDFGLAKL---GPVGDNTHVSTRVMGTYGYCAPE----- 160
+SDFGL K G T+++ GT G+ APE
Sbjct: 149 STSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPS-GTSGWRAPELLEES 207
Query: 161 --YAKTGQLTLKSDVYSFGVVLLEILSG 186
+LT D++S G V ILS
Sbjct: 208 NNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 7e-22
Identities = 47/266 (17%), Positives = 85/266 (31%), Gaps = 58/266 (21%)
Query: 12 VAIKQLDRN--GVQGNREFLVEV-LMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSV 68
AIK+ + G + L EV L H ++V A+ D L+ EY GS+
Sbjct: 39 YAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSL 98
Query: 69 EDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP- 127
D + + + RGL Y+H + +++ D+K SNI + R P
Sbjct: 99 ADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPN 155
Query: 128 ------------------KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE-YAKTGQLT 168
K+ D G + V G + A E +
Sbjct: 156 AASEEGDEDDWASNKVMFKIGDLGHVT---RISSPQVEE---GDSRFLANEVLQENYTHL 209
Query: 169 LKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD---PELQG 225
K+D+++ + ++ PL ++ + I P +
Sbjct: 210 PKADIFALALTVVCAAGA-------------------EPLPRNGDQWHEIRQGRLPRIPQ 250
Query: 226 QYPPRGFYQALAVAAMCVHEQPDMRP 251
+ + + +H P+ RP
Sbjct: 251 VLSQ----EFTELLKVMIHPDPERRP 272
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 9e-22
Identities = 56/195 (28%), Positives = 78/195 (40%), Gaps = 32/195 (16%)
Query: 10 QDVAIKQLDRNGVQGNREFLVEVLMLS-LLHHPNLVNLIG-----YCADGDQRL-LVYEY 62
Q AIK +D G E E+ ML HH N+ G D +L LV E+
Sbjct: 50 QLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEF 108
Query: 63 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAA---GAARGLEYLHDKAKPPVIYRDLKCSNI 119
GSV D + + +W IA RGL +LH I+RD+K N+
Sbjct: 109 CGAGSVTDLIKNTKGNTLKEEW-----IAYICREILRGLSHLHQHKV---IHRDIKGQNV 160
Query: 120 LLDRGYHPKLSDFGLAKLGPVGDNTHVSTR---VMGTYGYCAPEYAKTGQLT-----LKS 171
LL KL DFG++ R +GT + APE + KS
Sbjct: 161 LLTENAEVKLVDFGVS-----AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKS 215
Query: 172 DVYSFGVVLLEILSG 186
D++S G+ +E+ G
Sbjct: 216 DLWSLGITAIEMAEG 230
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 91.9 bits (228), Expect = 2e-21
Identities = 34/164 (20%), Positives = 63/164 (38%), Gaps = 14/164 (8%)
Query: 31 EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI 90
++ + N V + + + + +++D + + + + I
Sbjct: 111 KIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKD-WMNRRCSLEDREHGVCLHI 169
Query: 91 AAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAK----------LGPV 140
A +E+LH K +++RDLK SNI K+ DFGL +
Sbjct: 170 FIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 226
Query: 141 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEIL 184
T +GT Y +PE + K D++S G++L E+L
Sbjct: 227 MPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 4e-21
Identities = 47/185 (25%), Positives = 80/185 (43%), Gaps = 20/185 (10%)
Query: 12 VAIKQLDRNGVQGNREFLV---EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSV 68
+A+KQ+ R+G + + ++ +V++ P +V G + E M +
Sbjct: 53 IAVKQMRRSGNKEENKRILMDLDVVL-KSHDCPYIVQCFGTFITNTDVFIAMELMGTCA- 110
Query: 69 EDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK 128
+ P+ K+ + L YL +K VI+RD+K SNILLD K
Sbjct: 111 ---EKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIK 165
Query: 129 LSDFGL-AKLGPVGDNTHVSTRVMGTYGYCAPE-----YAKTGQLTLKSDVYSFGVVLLE 182
L DFG+ +L + R G Y APE +++DV+S G+ L+E
Sbjct: 166 LCDFGISGRL----VDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVE 221
Query: 183 ILSGR 187
+ +G+
Sbjct: 222 LATGQ 226
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 8e-21
Identities = 65/187 (34%), Positives = 87/187 (46%), Gaps = 27/187 (14%)
Query: 10 QDVAIKQLDRNGVQGNREF---LVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLG 66
+ VAIK++ +G Q N ++ + EV L L HPN + G LV EY G
Sbjct: 80 EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-G 138
Query: 67 SVEDHLHDLSPGKKPLDWNTRMKIAA---GAARGLEYLHDKAKPPVIYRDLKCSNILLDR 123
S D L KKPL ++IAA GA +GL YLH I+RD+K NILL
Sbjct: 139 SASD---LLEVHKKPLQ---EVEIAAVTHGALQGLAYLHSHNM---IHRDVKAGNILLSE 189
Query: 124 GYHPKLSDFGL-AKLGPVGDNTHVSTRVMGTYGYCAPE---YAKTGQLTLKSDVYSFGVV 179
KL DFG + + P N+ +GT + APE GQ K DV+S G+
Sbjct: 190 PGLVKLGDFGSASIMAP--ANS-----FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 242
Query: 180 LLEILSG 186
+E+
Sbjct: 243 CIELAER 249
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 3e-20
Identities = 54/185 (29%), Positives = 82/185 (44%), Gaps = 29/185 (15%)
Query: 13 AIKQLDRNGVQGNREF---LVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVE 69
A+K LD+ V ++ L E +L ++ P LV L D +V EY+ G +
Sbjct: 70 AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF 129
Query: 70 DHLHDLSPGKKPLDWNTRMKI-AAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK 128
HL + G+ + AA EYLH +IYRDLK N+L+D+ + +
Sbjct: 130 SHLRRI--GRFS---EPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQ 181
Query: 129 LSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE------YAKTGQLTLKSDVYSFGVVLLE 182
++DFG AK V T + GT APE Y K D ++ GV++ E
Sbjct: 182 VTDFGFAKR--VKGRTWT---LCGTPEALAPEIILSKGYNKA------VDWWALGVLIYE 230
Query: 183 ILSGR 187
+ +G
Sbjct: 231 MAAGY 235
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 3e-20
Identities = 52/183 (28%), Positives = 84/183 (45%), Gaps = 16/183 (8%)
Query: 10 QDVAIKQLDRNGVQGNREFLV--EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGS 67
+ AIK + + V + + EV +L LL HPN++ L + D LV E G
Sbjct: 63 VERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGE 122
Query: 68 VEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL---DRG 124
+ D + + + I G+ YLH +++RDLK N+LL ++
Sbjct: 123 LFDEIIH----RMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKD 175
Query: 125 YHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEIL 184
K+ DFGL+ + + + R+ GT Y APE + + K DV+S GV+L +L
Sbjct: 176 ALIKIVDFGLSAV--FENQKKMKERL-GTAYYIAPEVLR-KKYDEKCDVWSIGVILFILL 231
Query: 185 SGR 187
+G
Sbjct: 232 AGY 234
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 3e-20
Identities = 48/194 (24%), Positives = 77/194 (39%), Gaps = 30/194 (15%)
Query: 10 QDVAIKQLDRNGVQGNREFLV----EVLMLSLLHHPNLVNL--IGYCADGDQRLLVYEYM 63
A+K L + ++ E+ +L L H N++ L + Y + + +V EY
Sbjct: 31 CRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYC 90
Query: 64 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR--------GLEYLHDKAKPPVIYRDLK 115
G E + D P K R + A GLEYLH + ++++D+K
Sbjct: 91 VCGMQE--MLDSVPEK-------RFPVCQ--AHGYFCQLIDGLEYLHSQG---IVHKDIK 136
Query: 116 CSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQL--TLKSDV 173
N+LL G K+S G+A+ G+ + PE A K D+
Sbjct: 137 PGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDI 196
Query: 174 YSFGVVLLEILSGR 187
+S GV L I +G
Sbjct: 197 WSAGVTLYNITTGL 210
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 7e-20
Identities = 51/185 (27%), Positives = 80/185 (43%), Gaps = 19/185 (10%)
Query: 10 QDVAIKQLDRNGVQGNRE-FLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSV 68
+ IK ++++ Q E E+ +L L HPN++ + D +V E G +
Sbjct: 48 LERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGEL 107
Query: 69 EDHLHDLSPGKKPLDWNTRMKIAAGAAR----GLEYLHDKAKPPVIYRDLKCSNILL--- 121
+ + K L A + L Y H + V+++DLK NIL
Sbjct: 108 LERIVSAQARGKALS----EGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDT 160
Query: 122 DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLL 181
K+ DFGLA+L + H + GT Y APE K +T K D++S GVV+
Sbjct: 161 SPHSPIKIIDFGLAEL--FKSDEHSTNAA-GTALYMAPEVFK-RDVTFKCDIWSAGVVMY 216
Query: 182 EILSG 186
+L+G
Sbjct: 217 FLLTG 221
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 8e-20
Identities = 52/184 (28%), Positives = 83/184 (45%), Gaps = 17/184 (9%)
Query: 10 QDVAIKQLDRNGVQGNRE---FLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLG 66
Q+ A+K + + V+ + L EV +L L HPN++ L + D LV E G
Sbjct: 52 QECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGG 111
Query: 67 SVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL---DR 123
+ D + +K +I G+ Y+H +++RDLK N+LL +
Sbjct: 112 ELFDEIIS----RKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSK 164
Query: 124 GYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEI 183
+ ++ DFGL+ + + +GT Y APE G K DV+S GV+L +
Sbjct: 165 DANIRIIDFGLST---HFEASKKMKDKIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYIL 220
Query: 184 LSGR 187
LSG
Sbjct: 221 LSGC 224
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 1e-19
Identities = 59/180 (32%), Positives = 80/180 (44%), Gaps = 15/180 (8%)
Query: 13 AIKQLDRNGVQGNREF---LVEVLMLSLLHHPNLVNLIGYCADGDQRL-LVYEYMPLGSV 68
A+K L + + E L E +L HP L L Y RL V EY G +
Sbjct: 177 AMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK-YSFQTHDRLCFVMEYANGGEL 235
Query: 69 EDHLHDLSPGKKPLDWNTRMKI-AAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP 127
HL D R + A L+YLH + V+YRDLK N++LD+ H
Sbjct: 236 FFHLS--RERVFSED---RARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHI 288
Query: 128 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 187
K++DFGL K G + D + T GT Y APE + D + GVV+ E++ GR
Sbjct: 289 KITDFGLCKEG-IKDGATMKT-FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 1e-19
Identities = 50/183 (27%), Positives = 83/183 (45%), Gaps = 20/183 (10%)
Query: 13 AIKQLDRNGVQGNREF---LVEVLMLSLLHHPNLVNLIGYCADGDQRL-LVYEYMPLGSV 68
A+K +++ E E+ ++ L HP LVNL Y ++ + +V + + G +
Sbjct: 44 AMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW-YSFQDEEDMFMVVDLLLGGDL 102
Query: 69 EDHLHDLSPGKKPLDWNTRMKI-AAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP 127
HL + +K+ L+YL ++ +I+RD+K NILLD H
Sbjct: 103 RYHL-----QQNVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHV 154
Query: 128 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE--YAKTGQLTLKS-DVYSFGVVLLEIL 184
++DF +A + P T + GT Y APE ++ G + D +S GV E+L
Sbjct: 155 HITDFNIAAMLPRETQI---TTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELL 211
Query: 185 SGR 187
GR
Sbjct: 212 RGR 214
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 86.0 bits (214), Expect = 1e-19
Identities = 65/185 (35%), Positives = 93/185 (50%), Gaps = 29/185 (15%)
Query: 13 AIKQLDRNGVQGNREF---LVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVE 69
A+K L + V ++ E LMLS++ HP ++ + G D Q ++ +Y+ G +
Sbjct: 35 AMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELF 94
Query: 70 DHLHDLSPGKKPLDWNTRMKI-AAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK 128
L + P N K AA LEYLH K +IYRDLK NILLD+ H K
Sbjct: 95 SLLRKS--QRFP---NPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIK 146
Query: 129 LSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE------YAKTGQLTLKSDVYSFGVVLLE 182
++DFG AK V D T+ T + GT Y APE Y K+ D +SFG+++ E
Sbjct: 147 ITDFGFAKY--VPDVTY--T-LCGTPDYIAPEVVSTKPYNKS------IDWWSFGILIYE 195
Query: 183 ILSGR 187
+L+G
Sbjct: 196 MLAGY 200
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 2e-19
Identities = 57/187 (30%), Positives = 79/187 (42%), Gaps = 30/187 (16%)
Query: 13 AIKQLDRNGVQGNREF---LVEVLMLSLLHHPNLVNLIGYCADGDQRL-LVYEYMPLGSV 68
A+K L + + E + E +L HP L L Y RL V EY G +
Sbjct: 34 AMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK-YAFQTHDRLCFVMEYANGGEL 92
Query: 69 EDHLHDLSPGKKPLDWNTRMKI-AAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP 127
HL + R + A LEYLH + V+YRD+K N++LD+ H
Sbjct: 93 FFHLSRE--RVFTEE---RARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHI 144
Query: 128 KLSDFGLAKLGPVGDNTHVSTRVM-GTYGYCAPE------YAKTGQLTLKSDVYSFGVVL 180
K++DFGL K G T + GT Y APE Y + D + GVV+
Sbjct: 145 KITDFGLCKEGISDGAT---MKTFCGTPEYLAPEVLEDNDYGRA------VDWWGLGVVM 195
Query: 181 LEILSGR 187
E++ GR
Sbjct: 196 YEMMCGR 202
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 3e-19
Identities = 55/195 (28%), Positives = 83/195 (42%), Gaps = 31/195 (15%)
Query: 10 QDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLI------GYCADGDQRL-LVYEY 62
VAIK++ ++ NRE L + L++LHHPN+V L G D L +V EY
Sbjct: 49 MSVAIKKVIQDPRFRNRE-LQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEY 107
Query: 63 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD 122
+P ++ + + R + LH + V +RD+K N+L++
Sbjct: 108 VPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN-VCHRDIKPHNVLVN 165
Query: 123 RGYHP-KLSDFGLAK-LGPVGDNTH-VSTRVMGTYGYCAPE-------YAKTGQLTLKSD 172
KL DFG AK L P N + +R Y Y APE Y T D
Sbjct: 166 EADGTLKLCDFGSAKKLSPSEPNVAYICSR----Y-YRAPELIFGNQHY------TTAVD 214
Query: 173 VYSFGVVLLEILSGR 187
++S G + E++ G
Sbjct: 215 IWSVGCIFAEMMLGE 229
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 4e-19
Identities = 54/184 (29%), Positives = 79/184 (42%), Gaps = 20/184 (10%)
Query: 13 AIKQLDRNGVQGNRE---FLVEVLMLSLLHHPNLVNLIGYCA--DGDQRLLVYEYMPLGS 67
A+K L + + + F E +++ + P +V L + A D +V EYMP G
Sbjct: 98 AMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL--FYAFQDDRYLYMVMEYMPGG- 154
Query: 68 VEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP 127
D ++ +S P W R A L+ +H I+RD+K N+LLD+ H
Sbjct: 155 --DLVNLMSNYDVPEKW-ARF-YTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHL 207
Query: 128 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE----YAKTGQLTLKSDVYSFGVVLLEI 183
KL+DFG T V GT Y +PE G + D +S GV L E+
Sbjct: 208 KLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEM 266
Query: 184 LSGR 187
L G
Sbjct: 267 LVGD 270
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 4e-19
Identities = 51/188 (27%), Positives = 85/188 (45%), Gaps = 25/188 (13%)
Query: 10 QDVAIKQLDRNGVQGNREFLV-EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSV 68
+ VA+K +D E + E+ + +L+H N+V G+ +G+ + L EY G +
Sbjct: 33 EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL 92
Query: 69 EDHLHDLSPGKKPLDWNTRMKIAAGAAR--------GLEYLHDKAKPPVIYRDLKCSNIL 120
D + + M A+ G+ YLH + +RD+K N+L
Sbjct: 93 FDRIEP----------DIGMPEPD--AQRFFHQLMAGVVYLHGIG---ITHRDIKPENLL 137
Query: 121 LDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE-YAKTGQLTLKSDVYSFGVV 179
LD + K+SDFGLA + + + ++ GT Y APE + DV+S G+V
Sbjct: 138 LDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIV 197
Query: 180 LLEILSGR 187
L +L+G
Sbjct: 198 LTAMLAGE 205
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 86.0 bits (213), Expect = 5e-19
Identities = 47/186 (25%), Positives = 73/186 (39%), Gaps = 21/186 (11%)
Query: 13 AIKQLDRNGVQGNRE---FLVEVLMLSLLHHPNLVNLIGYCA--DGDQRLLVYEYMPLGS 67
A+K L++ + E F E +L + L + A D + LV +Y G
Sbjct: 103 AMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL--HYAFQDDNNLYLVMDYYVGG- 159
Query: 68 VEDHLHDLSPGKKPLDWNTRMKI-AAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH 126
D L LS + L + A ++ +H ++RD+K NIL+D H
Sbjct: 160 --DLLTLLSKFEDRLP-EEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGH 213
Query: 127 PKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKS-----DVYSFGVVLL 181
+L+DFG S V GT Y +PE + + D +S GV +
Sbjct: 214 IRLADFGSCLKLMEDGTVQSSVAV-GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMY 272
Query: 182 EILSGR 187
E+L G
Sbjct: 273 EMLYGE 278
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 84.5 bits (210), Expect = 7e-19
Identities = 54/188 (28%), Positives = 85/188 (45%), Gaps = 33/188 (17%)
Query: 13 AIKQLDRNGVQGNREFLVEVLM----LSLLHHPNLVNLIGYCADGDQRL-LVYEYMPLGS 67
A+K L + ++ V M L ++HP +V L Y + +L L+ +++ G
Sbjct: 56 AMKVLKKATLKVRDR--VRTKMERDILVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGD 112
Query: 68 VEDHLHDLSPGKKPLDWNTRMKI-AAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH 126
+ L + +K A A L++LH +IYRDLK NILLD H
Sbjct: 113 LFTRLSKE--VMFTEE---DVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGH 164
Query: 127 PKLSDFGLAKLGPVGDNTHVSTRVM-GTYGYCAPE------YAKTGQLTLKSDVYSFGVV 179
KL+DFGL+K + GT Y APE + ++ +D +SFGV+
Sbjct: 165 IKLTDFGLSKESIDHEKK---AYSFCGTVEYMAPEVVNRRGHTQS------ADWWSFGVL 215
Query: 180 LLEILSGR 187
+ E+L+G
Sbjct: 216 MFEMLTGT 223
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 8e-19
Identities = 50/200 (25%), Positives = 82/200 (41%), Gaps = 43/200 (21%)
Query: 10 QDVAIKQLDRNGVQGNREFLV--------EVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 61
+ VAI+ + + E+ +L L+HP ++ + + D + +V E
Sbjct: 161 KKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLE 219
Query: 62 YMPLGSVEDHLHDLSPGKKPLDW---NTRM--KIAAGAAR----GLEYLHDKAKPPVIYR 112
M G +L D N R+ ++YLH+ +I+R
Sbjct: 220 LMEGG-------EL------FDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG---IIHR 263
Query: 113 DLKCSNILL---DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE---YAKTGQ 166
DLK N+LL + K++DFG +K+ +G+ + + T GT Y APE T
Sbjct: 264 DLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRTLC-GTPTYLAPEVLVSVGTAG 320
Query: 167 LTLKSDVYSFGVVLLEILSG 186
D +S GV+L LSG
Sbjct: 321 YNRAVDCWSLGVILFICLSG 340
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 8e-19
Identities = 40/187 (21%), Positives = 79/187 (42%), Gaps = 27/187 (14%)
Query: 10 QDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVE 69
+ K ++ E+ +++ LHHP L+NL D + +L+ E++ G +
Sbjct: 77 RVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELF 136
Query: 70 DHL----HDLSPGKKPLDWNTRMKIAAGAAR----GLEYLHDKAKPPVIYRDLKCSNILL 121
D + + +S R GL+++H+ + +++ D+K NI+
Sbjct: 137 DRIAAEDYKMSE-----------AEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMC 182
Query: 122 --DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVV 179
+ K+ DFGLA + + V T + APE + +D+++ GV+
Sbjct: 183 ETKKASSVKIIDFGLATK--LNPDEIVKVTT-ATAEFAAPEIVDREPVGFYTDMWAIGVL 239
Query: 180 LLEILSG 186
+LSG
Sbjct: 240 GYVLLSG 246
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 1e-18
Identities = 63/183 (34%), Positives = 89/183 (48%), Gaps = 21/183 (11%)
Query: 13 AIKQLDRNGVQGNREF---LVE--VLMLSLLHHPNLVNLIGYCADGDQRL-LVYEYMPLG 66
AIK L ++ V + + +VE VL L+ HP L ++ + L V EY+ G
Sbjct: 46 AIKALKKDVVLMDDDVECTMVEKRVLSLAW-EHPFLTHMF-CTFQTKENLFFVMEYLNGG 103
Query: 67 SVEDHLHDLSPGKKPLDWNTRMKI-AAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY 125
+ H+ K L R AA GL++LH K ++YRDLK NILLD+
Sbjct: 104 DLMYHIQSC--HKFDLS---RATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDG 155
Query: 126 HPKLSDFGLAKLGPVGDNTHVSTRVM-GTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEIL 184
H K++DFG+ K +GD T GT Y APE + D +SFGV+L E+L
Sbjct: 156 HIKIADFGMCKENMLGDAK---TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEML 212
Query: 185 SGR 187
G+
Sbjct: 213 IGQ 215
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 1e-18
Identities = 60/189 (31%), Positives = 82/189 (43%), Gaps = 33/189 (17%)
Query: 13 AIKQLDRNGVQGNREF---LVE--VLMLSLLHHPNLVNLIGYCADGDQRL-LVYEYMPLG 66
A+K L + + +E + E VL+ ++ HP LV L + +L V +Y+ G
Sbjct: 67 AVKVLQKKAILKKKEEKHIMSERNVLLKNV-KHPFLVGLH-FSFQTADKLYFVLDYINGG 124
Query: 67 SVEDHLHDLSPGKKPLDWNTRMKI-AAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY 125
+ HL R + AA A L YLH ++YRDLK NILLD
Sbjct: 125 ELFYHLQRE--RCFLEP---RARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQG 176
Query: 126 HPKLSDFGLAKLGPVGDNTHVSTRVM-GTYGYCAPE------YAKTGQLTLKSDVYSFGV 178
H L+DFGL K ++T T GT Y APE Y +T D + G
Sbjct: 177 HIVLTDFGLCKENIEHNST---TSTFCGTPEYLAPEVLHKQPYDRT------VDWWCLGA 227
Query: 179 VLLEILSGR 187
VL E+L G
Sbjct: 228 VLYEMLYGL 236
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-18
Identities = 51/188 (27%), Positives = 85/188 (45%), Gaps = 25/188 (13%)
Query: 10 QDVAIKQLDRNGVQGNREFLV-EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSV 68
+ VA+K +D E + E+ + +L+H N+V G+ +G+ + L EY G +
Sbjct: 33 EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL 92
Query: 69 EDHLHDLSPGKKPLDWNTRMKIAAGAAR--------GLEYLHDKAKPPVIYRDLKCSNIL 120
D + + M A+ G+ YLH + +RD+K N+L
Sbjct: 93 FDRIEP----------DIGMPEPD--AQRFFHQLMAGVVYLHGIG---ITHRDIKPENLL 137
Query: 121 LDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE-YAKTGQLTLKSDVYSFGVV 179
LD + K+SDFGLA + + + ++ GT Y APE + DV+S G+V
Sbjct: 138 LDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIV 197
Query: 180 LLEILSGR 187
L +L+G
Sbjct: 198 LTAMLAGE 205
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 2e-18
Identities = 55/187 (29%), Positives = 85/187 (45%), Gaps = 24/187 (12%)
Query: 10 QDVAIKQLDRNGVQGNREFLV--EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGS 67
Q+ A+K +++ + + EV +L L HPN++ L D +V E G
Sbjct: 48 QEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGE 107
Query: 68 VEDHLHDLSPGKKPLDWNTRMKIAAGAAR----GLEYLHDKAKPPVIYRDLKCSNILL-- 121
+ D + +K AA + G+ Y+H +++RDLK NILL
Sbjct: 108 LFDEIIK----RKRFS----EHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLES 156
Query: 122 -DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVL 180
++ K+ DFGL+ NT + R+ GT Y APE + G K DV+S GV+L
Sbjct: 157 KEKDCDIKIIDFGLSTC--FQQNTKMKDRI-GTAYYIAPEVLR-GTYDEKCDVWSAGVIL 212
Query: 181 LEILSGR 187
+LSG
Sbjct: 213 YILLSGT 219
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 2e-18
Identities = 45/189 (23%), Positives = 77/189 (40%), Gaps = 32/189 (16%)
Query: 10 QDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVE 69
+ A+K + ++ + E+ +L + H N+V L LV + + G
Sbjct: 35 KLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGG--- 91
Query: 70 DHLHDLSPGKKPLDWNTRM-----KIAAGAAR----GLEYLHDKAKPPVIYRDLKCSNIL 120
+L D K A+ + ++YLH+ +++RDLK N+L
Sbjct: 92 ----EL------FDRILERGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLL 138
Query: 121 L---DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFG 177
+ ++DFGL+K + N +ST GT GY APE + D +S G
Sbjct: 139 YLTPEENSKIMITDFGLSK---MEQNGIMSTAC-GTPGYVAPEVLAQKPYSKAVDCWSIG 194
Query: 178 VVLLEILSG 186
V+ +L G
Sbjct: 195 VITYILLCG 203
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 84.1 bits (208), Expect = 3e-18
Identities = 49/185 (26%), Positives = 80/185 (43%), Gaps = 23/185 (12%)
Query: 10 QDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVE 69
+ A K + E+ +S+L HP LVNL D ++ +++YE+M G +
Sbjct: 183 NNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELF 242
Query: 70 DHLHDLSPGKKPLDWNTRM--KIAAGAAR----GLEYLHDKAKPPVIYRDLKCSNILL-- 121
+ + D + +M A R GL ++H+ ++ DLK NI+
Sbjct: 243 EKV---------ADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTT 290
Query: 122 DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLL 181
R KL DFGL + V GT + APE A+ + +D++S GV+
Sbjct: 291 KRSNELKLIDFGLTAH--LDPKQSVKVTT-GTAEFAAPEVAEGKPVGYYTDMWSVGVLSY 347
Query: 182 EILSG 186
+LSG
Sbjct: 348 ILLSG 352
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 3e-18
Identities = 44/187 (23%), Positives = 80/187 (42%), Gaps = 27/187 (14%)
Query: 10 QDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVE 69
+A K + G++ E E+ +++ L H NL+ L + +LV EY+ G +
Sbjct: 115 LKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELF 174
Query: 70 DHL----HDLSPGKKPLDWNTRMKIAAGAAR----GLEYLHDKAKPPVIYRDLKCSNILL 121
D + ++L+ + G+ ++H +++ DLK NIL
Sbjct: 175 DRIIDESYNLTE-----------LDTILFMKQICEGIRHMHQMY---ILHLDLKPENILC 220
Query: 122 -DRGYHP-KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVV 179
+R K+ DFGLA+ + GT + APE ++ +D++S GV+
Sbjct: 221 VNRDAKQIKIIDFGLARR--YKPREKLKVNF-GTPEFLAPEVVNYDFVSFPTDMWSVGVI 277
Query: 180 LLEILSG 186
+LSG
Sbjct: 278 AYMLLSG 284
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 3e-18
Identities = 50/186 (26%), Positives = 80/186 (43%), Gaps = 23/186 (12%)
Query: 10 QDVAIKQLDRNGVQGNREFLV--EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGS 67
++VAIK +D+ + + EV ++ +L+HPN+V L L+ EY G
Sbjct: 41 REVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGE 100
Query: 68 VEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP 127
V D+L + ++Y H K +++RDLK N+LLD +
Sbjct: 101 VFDYLVA----HGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNI 153
Query: 128 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE------YAKTGQLTLKSDVYSFGVVLL 181
K++DFG + + G Y APE Y G + DV+S GV+L
Sbjct: 154 KIADFGFSNE--FTVGGKLDAFC-GAPPYAAPELFQGKKYD--GP---EVDVWSLGVILY 205
Query: 182 EILSGR 187
++SG
Sbjct: 206 TLVSGS 211
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 3e-18
Identities = 50/198 (25%), Positives = 81/198 (40%), Gaps = 35/198 (17%)
Query: 10 QDVAIKQLDRNGVQGNREFLV-------------EVLMLSLLHHPNLVNLIGYCADGDQR 56
+ AIK + ++ R E+ +L L HPN++ L D
Sbjct: 62 SEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYF 121
Query: 57 LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR----GLEYLHDKAKPPVIYR 112
LV E+ G + + + + + D AA + G+ YLH +++R
Sbjct: 122 YLVTEFYEGGELFEQIIN----RHKFD----ECDAANIMKQILSGICYLHKHN---IVHR 170
Query: 113 DLKCSNILL---DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTL 169
D+K NILL + + K+ DFGL+ + +GT Y APE K +
Sbjct: 171 DIKPENILLENKNSLLNIKIVDFGLSS---FFSKDYKLRDRLGTAYYIAPEVLK-KKYNE 226
Query: 170 KSDVYSFGVVLLEILSGR 187
K DV+S GV++ +L G
Sbjct: 227 KCDVWSCGVIMYILLCGY 244
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 4e-18
Identities = 50/152 (32%), Positives = 69/152 (45%), Gaps = 15/152 (9%)
Query: 39 HHPNLVNLIGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAAR 96
P L L C RL V EY+ G + H+ + G+ AA A
Sbjct: 79 KPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQV--GRFKEP---HAVFYAAEIAI 132
Query: 97 GLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVM-GTYG 155
GL +L K +IYRDLK N++LD H K++DFG+ K T T+ GT
Sbjct: 133 GLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT---TKTFCGTPD 186
Query: 156 YCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 187
Y APE D ++FGV+L E+L+G+
Sbjct: 187 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 4e-18
Identities = 49/184 (26%), Positives = 73/184 (39%), Gaps = 22/184 (11%)
Query: 10 QDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVE 69
A K++ + V+ F E+ ++ L HPN++ L D LV E G E
Sbjct: 35 IRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGG--E 92
Query: 70 DHLHDLSPGKKPLDWNTRMKIAAGAAR----GLEYLHDKAKPPVIYRDLKCSNILL---D 122
L + K+ AA + + Y H V +RDLK N L
Sbjct: 93 --LFERVVHKRVFR----ESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDS 143
Query: 123 RGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLE 182
KL DFGLA + T+V GT Y +P+ + G + D +S GV++
Sbjct: 144 PDSPLKLIDFGLAAR--FKPGKMMRTKV-GTPYYVSPQVLE-GLYGPECDEWSAGVMMYV 199
Query: 183 ILSG 186
+L G
Sbjct: 200 LLCG 203
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 4e-18
Identities = 44/187 (23%), Positives = 70/187 (37%), Gaps = 21/187 (11%)
Query: 13 AIKQLDRNGVQGNRE---FLVEVLMLSLLHHPNLVNLIGYCA--DGDQRLLVYEYMPLGS 67
A+K +++ + E F E +L + L + A D + LV EY G
Sbjct: 90 AMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQL--HFAFQDENYLYLVMEYYVGGD 147
Query: 68 VEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP 127
+ L + P + R A ++ +H ++RD+K NILLDR H
Sbjct: 148 LLTLLSKFGE-RIPAEM-ARF-YLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHI 201
Query: 128 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVY-------SFGVVL 180
+L+DFG V GT Y +PE + + Y + GV
Sbjct: 202 RLADFGSCLKLRADGTVRSLVAV-GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFA 260
Query: 181 LEILSGR 187
E+ G+
Sbjct: 261 YEMFYGQ 267
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 82.6 bits (204), Expect = 4e-18
Identities = 52/226 (23%), Positives = 81/226 (35%), Gaps = 52/226 (23%)
Query: 10 QDVAIKQLDRNGVQGNRE-----FLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMP 64
AIK +++N ++ EV ++ LHHPN+ L D LV E
Sbjct: 52 AIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCH 111
Query: 65 LGSVEDHLHDLSPGKKPLDWNTRMKIAAG-----------------------------AA 95
G + D L+ +K +
Sbjct: 112 GGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLIS 171
Query: 96 R-------GLEYLHDKAKPPVIYRDLKCSNILL--DRGYHPKLSDFGLAKL---GPVGDN 143
L YLH++ + +RD+K N L ++ + KL DFGL+K G+
Sbjct: 172 NIMRQIFSALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEY 228
Query: 144 THVSTRVMGTYGYCAPEYAKTGQL--TLKSDVYSFGVVLLEILSGR 187
++T+ GT + APE T K D +S GV+L +L G
Sbjct: 229 YGMTTKA-GTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGA 273
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 4e-18
Identities = 52/185 (28%), Positives = 84/185 (45%), Gaps = 24/185 (12%)
Query: 10 QDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVE 69
+ A+K +D++ E +E+ +L HPN++ L DG +V E M G +
Sbjct: 48 MEFAVKIIDKSKRDPTEE--IEI-LLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELL 104
Query: 70 DHLHDLSPGKKPLDWNTRMKIAAGAAR----GLEYLHDKAKPPVIYRDLKCSNILL-DRG 124
D + +K + A+ +EYLH + V++RDLK SNIL D
Sbjct: 105 DKILR----QKFFS----EREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDES 153
Query: 125 YHP---KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLL 181
+P ++ DFG AK +N + T T + APE + D++S GV+L
Sbjct: 154 GNPESIRICDFGFAKQLR-AENGLLMTPC-YTANFVAPEVLERQGYDAACDIWSLGVLLY 211
Query: 182 EILSG 186
+L+G
Sbjct: 212 TMLTG 216
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 4e-18
Identities = 49/162 (30%), Positives = 70/162 (43%), Gaps = 27/162 (16%)
Query: 35 LSLLHHPNLVNLIGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AA 92
L + HP +V+LI Y +L L+ EY+ G + L G D A
Sbjct: 75 LEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLERE--GIFMED---TACFYLA 128
Query: 93 GAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVM- 151
+ L +LH K +IYRDLK NI+L+ H KL+DFGL K T
Sbjct: 129 EISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTV---THTFC 182
Query: 152 GTYGYCAPE------YAKTGQLTLKSDVYSFGVVLLEILSGR 187
GT Y APE + + D +S G ++ ++L+G
Sbjct: 183 GTIEYMAPEILMRSGHNRA------VDWWSLGALMYDMLTGA 218
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 5e-18
Identities = 55/165 (33%), Positives = 73/165 (44%), Gaps = 28/165 (16%)
Query: 32 VLMLSLLHHPNLVNLIGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI 90
+L L+ +HP L L C RL V E++ G + H+ + R +
Sbjct: 76 ILSLAR-NHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKS--RRFDEA---RARF 128
Query: 91 -AAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTR 149
AA L +LHDK +IYRDLK N+LLD H KL+DFG+ K G T T
Sbjct: 129 YAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT---TA 182
Query: 150 VM-GTYGYCAPE------YAKTGQLTLKSDVYSFGVVLLEILSGR 187
GT Y APE Y D ++ GV+L E+L G
Sbjct: 183 TFCGTPDYIAPEILQEMLYGPA------VDWWAMGVLLYEMLCGH 221
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 8e-18
Identities = 53/165 (32%), Positives = 79/165 (47%), Gaps = 28/165 (16%)
Query: 32 VLMLSLLHHPNLVNLIGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI 90
V + +HP LV L C + RL V EY+ G + H+ K P + +
Sbjct: 62 VFEQAS-NHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEE---HARF 114
Query: 91 -AAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTR 149
+A + L YLH++ +IYRDLK N+LLD H KL+D+G+ K G +T T
Sbjct: 115 YSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TS 168
Query: 150 VM-GTYGYCAPE------YAKTGQLTLKSDVYSFGVVLLEILSGR 187
GT Y APE Y + D ++ GV++ E+++GR
Sbjct: 169 TFCGTPNYIAPEILRGEDYGFS------VDWWALGVLMFEMMAGR 207
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 8e-18
Identities = 56/190 (29%), Positives = 80/190 (42%), Gaps = 34/190 (17%)
Query: 12 VAIKQL----DRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGS 67
VAIK+ D + + L E+ ML L HPNLVNL+ + LV+EY
Sbjct: 31 VAIKKFLESEDDPVI--KKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDH-- 86
Query: 68 VEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP 127
LH+L ++ + + I + + + H I+RD+K NIL+ +
Sbjct: 87 --TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVI 141
Query: 128 KLSDFGLAKL--GPVGDNTH-VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGV------ 178
KL DFG A+L GP V+TR Y +PE L + Y V
Sbjct: 142 KLCDFGFARLLTGPSDYYDDEVATR-----WYRSPE------LLVGDTQYGPPVDVWAIG 190
Query: 179 -VLLEILSGR 187
V E+LSG
Sbjct: 191 CVFAELLSGV 200
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 8e-18
Identities = 58/194 (29%), Positives = 85/194 (43%), Gaps = 35/194 (18%)
Query: 10 QDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGY-CADGDQRL-----LVYEYM 63
+ VAIK++ +Q R E+ ++ L H N+V L + + G+++ LV +Y+
Sbjct: 80 ELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV 135
Query: 64 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR 123
P +V S K+ L R L Y+H + +RD+K N+LLD
Sbjct: 136 PE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDP 191
Query: 124 GYHP-KLSDFGLAK-LGPVGDNTH-VSTRVMGTYGYCAPE-------YAKTGQLTLKSDV 173
KL DFG AK L N + +R Y Y APE Y T DV
Sbjct: 192 DTAVLKLCDFGSAKQLVRGEPNVSYICSR----Y-YRAPELIFGATDY------TSSIDV 240
Query: 174 YSFGVVLLEILSGR 187
+S G VL E+L G+
Sbjct: 241 WSAGCVLAELLLGQ 254
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 8e-18
Identities = 47/155 (30%), Positives = 70/155 (45%), Gaps = 18/155 (11%)
Query: 39 HHPNLVNLIGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAAR 96
P LV L Y + +L L+ +Y+ G + HL + ++I
Sbjct: 117 QSPFLVTLH-YAFQTETKLHLILDYINGGELFTHLSQR--ERFTEH---EVQIYVGEIVL 170
Query: 97 GLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY 156
LE+LH +IYRD+K NILLD H L+DFGL+K + GT Y
Sbjct: 171 ALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC-GTIEY 226
Query: 157 CAPE---YAKTGQLTLKS-DVYSFGVVLLEILSGR 187
AP+ +G K+ D +S GV++ E+L+G
Sbjct: 227 MAPDIVRGGDSGH--DKAVDWWSLGVLMYELLTGA 259
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 82.8 bits (204), Expect = 1e-17
Identities = 50/152 (32%), Positives = 69/152 (45%), Gaps = 15/152 (9%)
Query: 39 HHPNLVNLIGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI-AAGAAR 96
P L L C RL V EY+ G + H+ + G+ AA A
Sbjct: 400 KPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQV--GRFKEP---HAVFYAAEIAI 453
Query: 97 GLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVM-GTYG 155
GL +L K +IYRDLK N++LD H K++DFG+ K T T+ GT
Sbjct: 454 GLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT---TKTFCGTPD 507
Query: 156 YCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 187
Y APE D ++FGV+L E+L+G+
Sbjct: 508 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 1e-17
Identities = 55/191 (28%), Positives = 84/191 (43%), Gaps = 34/191 (17%)
Query: 10 QDVAIKQLDRNGVQGNREFLV--EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGS 67
Q+ A+K +++ + + EV +L L HPN++ L D +V E G
Sbjct: 48 QEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGG- 106
Query: 68 VEDHLHDLSPGKKPLDWNTRM-----KIAAGAAR----GLEYLHDKAKPPVIYRDLKCSN 118
+L D + AA + G+ Y+H +++RDLK N
Sbjct: 107 ------EL------FDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPEN 151
Query: 119 ILL---DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYS 175
ILL ++ K+ DFGL+ NT + R+ GT Y APE + G K DV+S
Sbjct: 152 ILLESKEKDCDIKIIDFGLSTC--FQQNTKMKDRI-GTAYYIAPEVLR-GTYDEKCDVWS 207
Query: 176 FGVVLLEILSG 186
GV+L +LSG
Sbjct: 208 AGVILYILLSG 218
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 1e-17
Identities = 54/192 (28%), Positives = 84/192 (43%), Gaps = 35/192 (18%)
Query: 12 VAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGY-----CADGDQRL-LVYEYMPL 65
VAIK++ +Q R E+ ++ ++ HPN+V+L + + L LV EY+P
Sbjct: 67 VAIKKV----LQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE 122
Query: 66 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY 125
+V + K+ + R L Y+H + +RD+K N+LLD
Sbjct: 123 -TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPS 178
Query: 126 HP-KLSDFGLAK-LGPVGDNTH-VSTRVMGTYGYCAPE-------YAKTGQLTLKSDVYS 175
KL DFG AK L N + +R Y Y APE Y T D++S
Sbjct: 179 GVLKLIDFGSAKILIAGEPNVSYICSR----Y-YRAPELIFGATNY------TTNIDIWS 227
Query: 176 FGVVLLEILSGR 187
G V+ E++ G+
Sbjct: 228 TGCVMAELMQGQ 239
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 1e-17
Identities = 45/191 (23%), Positives = 76/191 (39%), Gaps = 33/191 (17%)
Query: 10 QDVAIKQLDRNGVQGNREFLV--EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGS 67
+ A K ++ + + E + L HPN+V L + LV++ + G
Sbjct: 32 LEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGG- 90
Query: 68 VEDHLHDLSPGKKPLDWNTRM-----KIAAGAAR----GLEYLHDKAKPPVIYRDLKCSN 118
+L + A+ + + Y H +++R+LK N
Sbjct: 91 ------EL------FEDIVAREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPEN 135
Query: 119 ILL---DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYS 175
+LL +G KL+DFGLA V D+ GT GY +PE K + D+++
Sbjct: 136 LLLASKAKGAAVKLADFGLAIE--VNDSEAWHGFA-GTPGYLSPEVLKKDPYSKPVDIWA 192
Query: 176 FGVVLLEILSG 186
GV+L +L G
Sbjct: 193 CGVILYILLVG 203
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-17
Identities = 53/198 (26%), Positives = 89/198 (44%), Gaps = 35/198 (17%)
Query: 10 QDVAIKQLDRNGVQGNREFLVEV-LMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSV 68
Q+ A+K +++ EV ++ H N++ LI + + D+ LV+E M GS+
Sbjct: 39 QEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI 98
Query: 69 EDHLHDLSPGKKPLDWNTRMKIAAGAAR----GLEYLHDKAKPPVIYRDLKCSNILLDRG 124
H+H ++ + A+ + L++LH+K + +RDLK NIL
Sbjct: 99 LSHIHK----RRHFN----ELEASVVVQDVASALDFLHNKG---IAHRDLKPENILC--- 144
Query: 125 YHP------KLSDFGLAK-LGPVGDNTHVSTRVM----GTYGYCAPEYAKTGQLTLKS-- 171
HP K+ DF L + GD + +ST + G+ Y APE +
Sbjct: 145 EHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYD 204
Query: 172 ---DVYSFGVVLLEILSG 186
D++S GV+L +LSG
Sbjct: 205 KRCDLWSLGVILYILLSG 222
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 3e-17
Identities = 53/165 (32%), Positives = 79/165 (47%), Gaps = 28/165 (16%)
Query: 32 VLMLSLLHHPNLVNLIGYCADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI 90
V + +HP LV L C + RL V EY+ G + H+ K P + +
Sbjct: 105 VFEQAS-NHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEE---HARF 157
Query: 91 -AAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTR 149
+A + L YLH++ +IYRDLK N+LLD H KL+D+G+ K G +T T
Sbjct: 158 YSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TS 211
Query: 150 VM-GTYGYCAPE------YAKTGQLTLKSDVYSFGVVLLEILSGR 187
GT Y APE Y + D ++ GV++ E+++GR
Sbjct: 212 TFCGTPNYIAPEILRGEDYGFS------VDWWALGVLMFEMMAGR 250
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 3e-17
Identities = 42/192 (21%), Positives = 78/192 (40%), Gaps = 32/192 (16%)
Query: 10 QDVAIKQLD-RNGVQGNREFLV-EV-LMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLG 66
Q+ A K L R Q R ++ E+ ++ P ++NL + + +L+ EY G
Sbjct: 55 QEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGG 114
Query: 67 S-----VEDHLHDLSPGKKPLDWNTRMKIAAGAAR----GLEYLHDKAKPPVIYRDLKCS 117
+ + +S + G+ YLH +++ DLK
Sbjct: 115 EIFSLCLPELAEMVSE-----------NDVIRLIKQILEGVYYLHQNN---IVHLDLKPQ 160
Query: 118 NILL---DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVY 174
NILL K+ DFG+++ +G + + GT Y APE +T +D++
Sbjct: 161 NILLSSIYPLGDIKIVDFGMSRK--IGHACELREIM-GTPEYLAPEILNYDPITTATDMW 217
Query: 175 SFGVVLLEILSG 186
+ G++ +L+
Sbjct: 218 NIGIIAYMLLTH 229
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 3e-17
Identities = 53/190 (27%), Positives = 77/190 (40%), Gaps = 34/190 (17%)
Query: 12 VAIKQL----DRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGS 67
VAIK+ D V + + E+ +L L H NLVNL+ C + LV+E++
Sbjct: 53 VAIKKFLESDDDKMV--KKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-- 108
Query: 68 VEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP 127
L DL LD+ K G+ + H +I+RD+K NIL+ +
Sbjct: 109 --TILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVV 163
Query: 128 KLSDFGLAKL--GPVGDNTH-VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGV------ 178
KL DFG A+ P V+TR Y APE L + Y V
Sbjct: 164 KLCDFGFARTLAAPGEVYDDEVATR-----WYRAPE------LLVGDVKYGKAVDVWAIG 212
Query: 179 -VLLEILSGR 187
++ E+ G
Sbjct: 213 CLVTEMFMGE 222
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 79.1 bits (196), Expect = 3e-17
Identities = 53/191 (27%), Positives = 83/191 (43%), Gaps = 28/191 (14%)
Query: 10 QDVAIKQLDRNGVQGNR------EFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 63
++ A K + + + +R E EV +L + HPN++ L + +L+ E +
Sbjct: 31 KEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELV 90
Query: 64 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR----GLEYLHDKAKPPVIYRDLKCSNI 119
G E L D K+ L T + A + G+ YLH K + + DLK NI
Sbjct: 91 SGG--E--LFDFLAEKESL---TEDE-ATQFLKQILDGVHYLHSKR---IAHFDLKPENI 139
Query: 120 LLDRGYHP----KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYS 175
+L P KL DFG+A + GT + APE L L++D++S
Sbjct: 140 MLLDKNVPNPRIKLIDFGIAHK--IEAGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWS 196
Query: 176 FGVVLLEILSG 186
GV+ +LSG
Sbjct: 197 IGVITYILLSG 207
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 4e-17
Identities = 50/203 (24%), Positives = 79/203 (38%), Gaps = 46/203 (22%)
Query: 10 QDVAIKQLDR--------NGVQGNREFL---VEVLMLSLLHHPNLVNLIGYCADGDQRLL 58
++ A+K +D VQ RE V++L + HPN++ L L
Sbjct: 43 KEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR-KVSGHPNIIQLKDTYETNTFFFL 101
Query: 59 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRM-----KIAAGAAR----GLEYLHDKAKPPV 109
V++ M G +L D+ T K R + LH +
Sbjct: 102 VFDLMKKG-------EL------FDYLTEKVTLSEKETRKIMRALLEVICALHKLN---I 145
Query: 110 IYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE------YAK 163
++RDLK NILLD + KL+DFG + + + GT Y APE
Sbjct: 146 VHRDLKPENILLDDDMNIKLTDFGFSCQ--LDPGEKLREVC-GTPSYLAPEIIECSMNDN 202
Query: 164 TGQLTLKSDVYSFGVVLLEILSG 186
+ D++S GV++ +L+G
Sbjct: 203 HPGYGKEVDMWSTGVIMYTLLAG 225
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 4e-17
Identities = 49/208 (23%), Positives = 90/208 (43%), Gaps = 53/208 (25%)
Query: 10 QDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIG-YCADGDQRL-LVYEYMPLGS 67
+D A+KQ++ G+ + E+ +L L HPN+++L + + D+++ L+++Y
Sbjct: 49 KDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE--- 103
Query: 68 VEDHLHDLSPGKKPLDWNTRMKIAAGAA---------------RGLEYLHDKAKPPVIYR 112
HDL + ++ K G+ YLH V++R
Sbjct: 104 -----HDL---WHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHR 152
Query: 113 DLKCSNILLDRGYHP----KLSDFGLAKL--GPVGDNTHVSTRVMGTYGYCAPEYAKTGQ 166
DLK +NIL+ K++D G A+L P+ + V+ T+ Y APE
Sbjct: 153 DLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFWYRAPE------ 205
Query: 167 LTLKS-------DVYSFGVVLLEILSGR 187
L L + D+++ G + E+L+
Sbjct: 206 LLLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 4e-17
Identities = 48/162 (29%), Positives = 78/162 (48%), Gaps = 15/162 (9%)
Query: 31 EVLMLSLLHHPNLVNL--IGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRM 88
E+ +L L HPN+V L + + D +V+E + G V + P KPL +
Sbjct: 86 EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME-----VPTLKPLSEDQAR 140
Query: 89 KIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST 148
+G+EYLH + +I+RD+K SN+L+ H K++DFG++ G + +S
Sbjct: 141 FYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNE-FKGSDALLSN 196
Query: 149 RVMGTYGYCAPE---YAKTGQLTLKSDVYSFGVVLLEILSGR 187
V GT + APE + DV++ GV L + G+
Sbjct: 197 TV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 5e-17
Identities = 43/187 (22%), Positives = 71/187 (37%), Gaps = 18/187 (9%)
Query: 10 QDVAIKQLDRNGVQGNREFLV--------EVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 61
++V +K + + V + E+ +LS + H N++ ++ + LV E
Sbjct: 50 KEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVME 109
Query: 62 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL 121
G L LD I + YL K +I+RD+K NI++
Sbjct: 110 KHGSGL---DLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVI 163
Query: 122 DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE-YAKTGQLTLKSDVYSFGVVL 180
+ KL DFG A G + GT YCAPE + +++S GV L
Sbjct: 164 AEDFTIKLIDFGSAAYLERGKLFYTFC---GTIEYCAPEVLMGNPYRGPELEMWSLGVTL 220
Query: 181 LEILSGR 187
++
Sbjct: 221 YTLVFEE 227
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 6e-17
Identities = 51/200 (25%), Positives = 82/200 (41%), Gaps = 43/200 (21%)
Query: 10 QDVAIKQLDRNGVQGNREFLV--------EVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 61
+ VAIK + + E+ +L L+HP ++ + + D + +V E
Sbjct: 36 KKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLE 94
Query: 62 YMPLGSVEDHLHDLSPGKKPLDW---NTRM--KIAAGAAR----GLEYLHDKAKPPVIYR 112
M G +L D N R+ ++YLH+ +I+R
Sbjct: 95 LMEGG-------EL------FDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG---IIHR 138
Query: 113 DLKCSNILL---DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE---YAKTGQ 166
DLK N+LL + K++DFG +K+ +G+ + + T GT Y APE T
Sbjct: 139 DLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRTLC-GTPTYLAPEVLVSVGTAG 195
Query: 167 LTLKSDVYSFGVVLLEILSG 186
D +S GV+L LSG
Sbjct: 196 YNRAVDCWSLGVILFICLSG 215
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 6e-17
Identities = 48/201 (23%), Positives = 79/201 (39%), Gaps = 43/201 (21%)
Query: 10 QDVAIKQLDRNGVQGNREFLVEVL---------MLSLLHHPNLVNLIGYCADGDQRLLVY 60
+ A+K ++ + + E L EV + + HP+++ LI LV+
Sbjct: 120 HEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVF 179
Query: 61 EYMPLGSVEDHLHDLSPGKKPLDWNTRM-----KIAAGAAR----GLEYLHDKAKPPVIY 111
+ M G +L D+ T K R + +LH +++
Sbjct: 180 DLMRKG-------EL------FDYLTEKVALSEKETRSIMRSLLEAVSFLHANN---IVH 223
Query: 112 RDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE------YAKTG 165
RDLK NILLD +LSDFG + + + GT GY APE
Sbjct: 224 RDLKPENILLDDNMQIRLSDFGFSCH--LEPGEKLRELC-GTPGYLAPEILKCSMDETHP 280
Query: 166 QLTLKSDVYSFGVVLLEILSG 186
+ D+++ GV+L +L+G
Sbjct: 281 GYGKEVDLWACGVILFTLLAG 301
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 7e-17
Identities = 45/191 (23%), Positives = 76/191 (39%), Gaps = 33/191 (17%)
Query: 10 QDVAIKQLDRNGVQGNREFLV--EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGS 67
+ A K ++ + + E + L HPN+V L + LV++ + G
Sbjct: 55 LEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGG- 113
Query: 68 VEDHLHDLSPGKKPLDWNTRM-----KIAAGAAR----GLEYLHDKAKPPVIYRDLKCSN 118
+L + A+ + + Y H +++R+LK N
Sbjct: 114 ------EL------FEDIVAREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPEN 158
Query: 119 ILL---DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYS 175
+LL +G KL+DFGLA V D+ GT GY +PE K + D+++
Sbjct: 159 LLLASKAKGAAVKLADFGLAIE--VNDSEAWHGFA-GTPGYLSPEVLKKDPYSKPVDIWA 215
Query: 176 FGVVLLEILSG 186
GV+L +L G
Sbjct: 216 CGVILYILLVG 226
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 8e-17
Identities = 46/189 (24%), Positives = 80/189 (42%), Gaps = 21/189 (11%)
Query: 10 QDVAIKQLDRNGVQGNREFLV-----EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMP 64
Q A+K +D + E + +L HP++V L+ + +V+E+M
Sbjct: 50 QQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMD 109
Query: 65 LGSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR----GLEYLHDKAKPPVIYRDLKCSNIL 120
+ + + ++ + A+ R L Y HD +I+RD+K +L
Sbjct: 110 GADLCFEI--VKRADAGFVYSEAV--ASHYMRQILEALRYCHDNN---IIHRDVKPHCVL 162
Query: 121 L---DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFG 177
L + KL FG+A +G++ V+ +GT + APE K DV+ G
Sbjct: 163 LASKENSAPVKLGGFGVAIQ--LGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCG 220
Query: 178 VVLLEILSG 186
V+L +LSG
Sbjct: 221 VILFILLSG 229
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 8e-17
Identities = 50/185 (27%), Positives = 77/185 (41%), Gaps = 24/185 (12%)
Query: 10 QDVAIKQLDRNGVQGNREFLVEV-LMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSV 68
Q A+K + + ++ E+ + HPN+V L D LV E + G +
Sbjct: 37 QAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL 93
Query: 69 EDHLHDLSPGKKPLDWNTRMKIAAGAAR----GLEYLHDKAKPPVIYRDLKCSNILL--- 121
+ + KK A+ R + ++HD V++RDLK N+L
Sbjct: 94 FERIKK----KKHFS----ETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDE 142
Query: 122 DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLL 181
+ K+ DFG A+L P DN + T T Y APE D++S GV+L
Sbjct: 143 NDNLEIKIIDFGFARLKP-PDNQPLKTPC-FTLHYAAPELLNQNGYDESCDLWSLGVILY 200
Query: 182 EILSG 186
+LSG
Sbjct: 201 TMLSG 205
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 9e-17
Identities = 54/191 (28%), Positives = 82/191 (42%), Gaps = 28/191 (14%)
Query: 10 QDVAIKQLDRNGVQGNR------EFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 63
+ A K + + + +R E EV +L + HPN++ L + +L+ E +
Sbjct: 38 LEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELV 97
Query: 64 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR----GLEYLHDKAKPPVIYRDLKCSNI 119
G E L D K+ L + A + G+ YLH K + + DLK NI
Sbjct: 98 SGG--E--LFDFLAQKESL----SEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENI 146
Query: 120 LLDRGYHP----KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYS 175
+L P KL DFGLA + D GT + APE L L++D++S
Sbjct: 147 MLLDKNIPIPHIKLIDFGLAHE--IEDGVEFKNIF-GTPEFVAPEIVNYEPLGLEADMWS 203
Query: 176 FGVVLLEILSG 186
GV+ +LSG
Sbjct: 204 IGVITYILLSG 214
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-16
Identities = 53/191 (27%), Positives = 81/191 (42%), Gaps = 28/191 (14%)
Query: 10 QDVAIKQLDRNGVQGNR------EFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 63
+ A K + + + +R E EV +L + H N++ L + +L+ E +
Sbjct: 38 LEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELV 97
Query: 64 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR----GLEYLHDKAKPPVIYRDLKCSNI 119
G E L D K+ L + A + G+ YLH K + + DLK NI
Sbjct: 98 SGG--E--LFDFLAQKESL----SEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENI 146
Query: 120 LLDRGYHP----KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYS 175
+L P KL DFGLA + D GT + APE L L++D++S
Sbjct: 147 MLLDKNIPIPHIKLIDFGLAHE--IEDGVEFKNIF-GTPEFVAPEIVNYEPLGLEADMWS 203
Query: 176 FGVVLLEILSG 186
GV+ +LSG
Sbjct: 204 IGVITYILLSG 214
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 2e-16
Identities = 43/168 (25%), Positives = 76/168 (45%), Gaps = 25/168 (14%)
Query: 31 EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMP--LGSVEDHLHDLSPGKKPLDWNTRM 88
E+ ++ L H N+V L ++ LV+E+M L D + + L+ N
Sbjct: 53 EISLMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDS-RTVGNTPRGLELNLVK 111
Query: 89 KIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL--GPVGDNTHV 146
+GL + H+ +++RDLK N+L+++ KL DFGLA+ PV +
Sbjct: 112 YFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSS- 167
Query: 147 STRVMGTYGYCAPEYAKTGQLTLKSDVYSFGV-------VLLEILSGR 187
V+ T Y AP+ + + S YS + +L E+++G+
Sbjct: 168 --EVV-TLWYRAPD------VLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-16
Identities = 29/186 (15%), Positives = 76/186 (40%), Gaps = 26/186 (13%)
Query: 10 QDVAIKQLDRNGVQGNREFLV-EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSV 68
+ K + G ++ + E+ +L++ H N+++L ++ ++++E++
Sbjct: 31 KTYMAKFVKVKGT--DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGL-- 86
Query: 69 EDHLHDLSPGKKPLDWNTRM--KIAAGAAR----GLEYLHDKAKPPVIYRDLKCSNILL- 121
+ + + + + + L++LH + + D++ NI+
Sbjct: 87 D--IFE-----RINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQ 136
Query: 122 -DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVL 180
R K+ +FG A+ + + Y APE + ++ +D++S G ++
Sbjct: 137 TRRSSTIKIIEFGQARQ--LKPGDNFRLLF-TAPEYYAPEVHQHDVVSTATDMWSLGTLV 193
Query: 181 LEILSG 186
+LSG
Sbjct: 194 YVLLSG 199
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 2e-16
Identities = 50/192 (26%), Positives = 86/192 (44%), Gaps = 34/192 (17%)
Query: 10 QDVAIKQLDRNGVQGNREFLV-----EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMP 64
VA+K L+R ++ +V E+ L L HP+++ L + +V EY+
Sbjct: 37 HKVAVKILNRQKIRSLD--VVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVS 94
Query: 65 LGSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR--------GLEYLHDKAKPPVIYRDLKC 116
G + D++ + R++ AR ++Y H V++RDLK
Sbjct: 95 GGELFDYICK----------HGRVEEME--ARRLFQQILSAVDYCHRHM---VVHRDLKP 139
Query: 117 SNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE-YAKTGQLTLKSDVYS 175
N+LLD + K++DFGL+ + G+ S G+ Y APE + + D++S
Sbjct: 140 ENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAPEVISGRLYAGPEVDIWS 196
Query: 176 FGVVLLEILSGR 187
GV+L +L G
Sbjct: 197 CGVILYALLCGT 208
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 2e-16
Identities = 43/191 (22%), Positives = 75/191 (39%), Gaps = 32/191 (16%)
Query: 10 QDVAIKQLDRNGVQGNREFLV--EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGS 67
Q+ A ++ + + E + LL HPN+V L ++ L+++ + G
Sbjct: 37 QEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGG- 95
Query: 68 VEDHLHDLSPGKKPLDWNTRM-----KIAAGAAR----GLEYLHDKAKPPVIYRDLKCSN 118
+L + A+ + + + H V++R+LK N
Sbjct: 96 ------EL------FEDIVAREYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPEN 140
Query: 119 ILL---DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYS 175
+LL +G KL+DFGLA V GT GY +PE + D+++
Sbjct: 141 LLLASKLKGAAVKLADFGLAIE--VEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWA 198
Query: 176 FGVVLLEILSG 186
GV+L +L G
Sbjct: 199 CGVILYILLVG 209
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 76.8 bits (190), Expect = 3e-16
Identities = 48/199 (24%), Positives = 81/199 (40%), Gaps = 48/199 (24%)
Query: 12 VAIKQL----DRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGS 67
VA+K++ D GV L E+ +L L H N+V L + LV+E+
Sbjct: 30 VALKRVRLDDDDEGV--PSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD--- 84
Query: 68 VEDHLHDLSPGKKPLDWNTRMKIAAGAA--------RGLEYLHDKAKPPVIYRDLKCSNI 119
DL KK D + + +GL + H + V++RDLK N+
Sbjct: 85 -----QDL---KKYFD-SCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNL 132
Query: 120 LLDRGYHPKLSDFGLAKL--GPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFG 177
L++R KL++FGLA+ PV + V+ T Y P+ + + +YS
Sbjct: 133 LINRNGELKLANFGLARAFGIPVRCYSA---EVV-TLWYRPPD------VLFGAKLYSTS 182
Query: 178 V-------VLLEILSGRKA 189
+ + E+ + +
Sbjct: 183 IDMWSAGCIFAELANAGRP 201
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 77.3 bits (190), Expect = 3e-16
Identities = 39/126 (30%), Positives = 55/126 (43%), Gaps = 3/126 (2%)
Query: 60 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNI 119
E L VE+ K L + + A+G+E+L + I+RDL NI
Sbjct: 168 VEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNI 224
Query: 120 LLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVV 179
LL K+ DFGLA+ + + APE T++SDV+SFGV+
Sbjct: 225 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVL 284
Query: 180 LLEILS 185
L EI S
Sbjct: 285 LWEIFS 290
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 3e-16
Identities = 48/199 (24%), Positives = 77/199 (38%), Gaps = 44/199 (22%)
Query: 10 QDVAIKQLDRNGVQGNR------EFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 63
A K + + + +R + EV +L + HPN++ L + +L+ E +
Sbjct: 37 LQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELV 96
Query: 64 PLGSVEDHLHDLSPGKKPLDWNTRM--------KIAAGAAR----GLEYLHDKAKPPVIY 111
G E L D + + A + G+ YLH + +
Sbjct: 97 AGG--E--LFD------------FLAEKESLTEEEATEFLKQILNGVYYLHSLQ---IAH 137
Query: 112 RDLKCSNILLDRGYHP----KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQL 167
DLK NI+L P K+ DFGLA + GT + APE L
Sbjct: 138 FDLKPENIMLLDRNVPKPRIKIIDFGLAHK--IDFGNEFKNIF-GTPEFVAPEIVNYEPL 194
Query: 168 TLKSDVYSFGVVLLEILSG 186
L++D++S GV+ +LSG
Sbjct: 195 GLEADMWSIGVITYILLSG 213
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 76.4 bits (189), Expect = 4e-16
Identities = 55/197 (27%), Positives = 90/197 (45%), Gaps = 48/197 (24%)
Query: 12 VAIKQL----DRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGS 67
VA+K++ + G+ + E+ +L LHHPN+V+LI LV+E+M
Sbjct: 48 VALKRIRLDAEDEGI--PSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFME--- 102
Query: 68 VEDHLHDLSPGKKPLDWNTRMKIAAGAA--------RGLEYLHDKAKPPVIYRDLKCSNI 119
DL KK LD + + RG+ + H +++RDLK N+
Sbjct: 103 -----KDL---KKVLD-ENKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNL 150
Query: 120 LLDRGYHPKLSDFGLAKL--GPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKS------ 171
L++ KL+DFGLA+ PV TH V+ T Y AP+ + + S
Sbjct: 151 LINSDGALKLADFGLARAFGIPVRSYTH---EVV-TLWYRAPD------VLMGSKKYSTS 200
Query: 172 -DVYSFGVVLLEILSGR 187
D++S G + E+++G+
Sbjct: 201 VDIWSIGCIFAEMITGK 217
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 4e-16
Identities = 49/191 (25%), Positives = 73/191 (38%), Gaps = 34/191 (17%)
Query: 10 QDVAIKQLDRNGVQGNREFLV--EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGS 67
+ VA+K ++R V E++ L HPN+V ++ EY G
Sbjct: 46 ELVAVKYIERGAAIDEN---VQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGE 102
Query: 68 VEDHLHDLSPGKKPLDWNTRMKIAAGAAR--------GLEYLHDKAKPPVIYRDLKCSNI 119
+ + + + R AR G+ Y H + +RDLK N
Sbjct: 103 LYERICN----------AGRFSEDE--ARFFFQQLLSGVSYCHSMQ---ICHRDLKLENT 147
Query: 120 LLDRGYHP--KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE-YAKTGQLTLKSDVYSF 176
LLD P K+ DFG +K + + V GT Y APE + +DV+S
Sbjct: 148 LLDGSPAPRLKICDFGYSKSSVLHSQPK--STV-GTPAYIAPEVLLRQEYDGKIADVWSC 204
Query: 177 GVVLLEILSGR 187
GV L +L G
Sbjct: 205 GVTLYVMLVGA 215
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 7e-16
Identities = 42/188 (22%), Positives = 75/188 (39%), Gaps = 28/188 (14%)
Query: 10 QDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR----LLVYEYMPL 65
Q A+K L + +E V+ P++V ++ + L++ E M
Sbjct: 55 QKCALKLLYDSPKAR-QE--VD-HHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEG 110
Query: 66 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR----GLEYLHDKAKPPVIYRDLKCSNILL 121
G + + + + + R AA R +++LH + +RD+K N+L
Sbjct: 111 GELFSRIQE----RGDQAFTERE--AAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLY 161
Query: 122 ---DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGV 178
++ KL+DFG AK + T T Y APE + D++S GV
Sbjct: 162 TSKEKDAVLKLTDFGFAK---ETTQNALQTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGV 217
Query: 179 VLLEILSG 186
++ +L G
Sbjct: 218 IMYILLCG 225
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 76.4 bits (188), Expect = 8e-16
Identities = 47/189 (24%), Positives = 83/189 (43%), Gaps = 27/189 (14%)
Query: 10 QDVAIKQLDR---NGVQGNREFLVEVLMLSLLHHPNLVNLIG-YCADGDQRL-----LVY 60
++VAIK+L R N R E++++ ++H N+++L+ + LV
Sbjct: 88 RNVAIKKLSRPFQNQTHAKRA-YRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVM 146
Query: 61 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNIL 120
E M + +L + + LD + G+++LH +I+RDLK SNI+
Sbjct: 147 ELM-----DANLCQVI--QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIV 196
Query: 121 LDRGYHPKLSDFGLAKLGPVGDNT--HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGV 178
+ K+ DFGLA+ +V TR Y APE D++S G
Sbjct: 197 VKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-----YRAPEVILGMGYKENVDIWSVGC 251
Query: 179 VLLEILSGR 187
++ E++ +
Sbjct: 252 IMGEMVRHK 260
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 9e-16
Identities = 51/200 (25%), Positives = 80/200 (40%), Gaps = 50/200 (25%)
Query: 12 VAIKQL----DRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGS 67
VAIK++ + GV + EV +L L H N++ L + L++EY
Sbjct: 62 VAIKRIRLEHEEEGV--PGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAE--- 116
Query: 68 VEDHLHDLSPGKKPLDWNTRMKIAAGAA------RGLEYLHDKAKPPVIYRDLKCSNILL 121
+DL KK +D N + + + G+ + H + ++RDLK N+LL
Sbjct: 117 -----NDL---KKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLL 165
Query: 122 DRGYHP-----KLSDFGLAKL--GPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVY 174
K+ DFGLA+ P+ TH ++ T Y PE + L S Y
Sbjct: 166 SVSDASETPVLKIGDFGLARAFGIPIRQFTH---EII-TLWYRPPE------ILLGSRHY 215
Query: 175 SFGV-------VLLEILSGR 187
S V + E+L
Sbjct: 216 STSVDIWSIACIWAEMLMKT 235
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 1e-15
Identities = 51/197 (25%), Positives = 87/197 (44%), Gaps = 48/197 (24%)
Query: 12 VAIKQL----DRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGS 67
A+K++ + G+ + E+ +L L H N+V L + +LV+E++
Sbjct: 29 FALKKIRLEKEDEGI--PSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLD--- 83
Query: 68 VEDHLHDLSPGKKPLDWNTRMKIAAGAA--------RGLEYLHDKAKPPVIYRDLKCSNI 119
DL KK LD + + A G+ Y HD+ V++RDLK N+
Sbjct: 84 -----QDL---KKLLD-VCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNL 131
Query: 120 LLDRGYHPKLSDFGLAKL--GPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFG 177
L++R K++DFGLA+ PV TH ++ T Y AP+ + + S YS
Sbjct: 132 LINREGELKIADFGLARAFGIPVRKYTH---EIV-TLWYRAPD------VLMGSKKYSTT 181
Query: 178 V-------VLLEILSGR 187
+ + E+++G
Sbjct: 182 IDIWSVGCIFAEMVNGT 198
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 1e-15
Identities = 41/189 (21%), Positives = 79/189 (41%), Gaps = 22/189 (11%)
Query: 10 QDVAIKQLDRNGVQGNREFLV------EVLMLSLLHH--PNLVNLIGYCADGDQRLLVYE 61
VAIK ++++ + E EV++L + ++ L+ + D +L+ E
Sbjct: 69 LPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE 128
Query: 62 Y-MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNIL 120
P+ + D + + + L + + H+ V++RD+K NIL
Sbjct: 129 RPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENIL 181
Query: 121 LDRGYHP-KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLT-LKSDVYSFGV 178
+D KL DFG L +T + GT Y PE+ + + + V+S G+
Sbjct: 182 IDLNRGELKLIDFGSGALLK---DTVYTDFD-GTRVYSPPEWIRYHRYHGRSAAVWSLGI 237
Query: 179 VLLEILSGR 187
+L +++ G
Sbjct: 238 LLYDMVCGD 246
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 1e-15
Identities = 46/168 (27%), Positives = 73/168 (43%), Gaps = 31/168 (18%)
Query: 31 EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRM-- 88
E+ +L L HPN++ L + LV E + G +L D
Sbjct: 98 EIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGG-------EL------FDRIVEKGY 144
Query: 89 ---KIAAGAAR----GLEYLHDKAKPPVIYRDLKCSNILL---DRGYHPKLSDFGLAKLG 138
+ AA A + + YLH+ +++RDLK N+L K++DFGL+K+
Sbjct: 145 YSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKI- 200
Query: 139 PVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG 186
V + T GT GYCAPE + + D++S G++ +L G
Sbjct: 201 -VEHQVLMKTVC-GTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCG 246
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 2e-15
Identities = 51/177 (28%), Positives = 74/177 (41%), Gaps = 48/177 (27%)
Query: 31 EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI 90
E+ +L L HPN++ L+ LV+++M DL + + +
Sbjct: 62 EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME--------TDL---EVIIK---DNSL 107
Query: 91 AAGAA----------RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL--G 138
+ +GLEYLH +++RDLK +N+LLD KL+DFGLAK
Sbjct: 108 VLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGS 164
Query: 139 PVGDNTH-VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGV-------VLLEILSGR 187
P TH V TR Y APE L + +Y GV +L E+L
Sbjct: 165 PNRAYTHQVVTR-----WYRAPE------LLFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 2e-15
Identities = 49/191 (25%), Positives = 81/191 (42%), Gaps = 24/191 (12%)
Query: 10 QDVAIKQLDRNGVQGNREFLV------EVLMLSLLH----HPNLVNLIGYCADGDQRLLV 59
VAIK + RN V G EV +L + HP ++ L+ + + +LV
Sbjct: 57 LQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLV 116
Query: 60 YEY-MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSN 118
E +P + D++ + K PL +++ H + V++RD+K N
Sbjct: 117 LERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDEN 169
Query: 119 ILLDRGYHP-KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLT-LKSDVYSF 176
IL+D KL DFG L + + GT Y PE+ Q L + V+S
Sbjct: 170 ILIDLRRGCAKLIDFGSGALLH---DEPYTDFD-GTRVYSPPEWISRHQYHALPATVWSL 225
Query: 177 GVVLLEILSGR 187
G++L +++ G
Sbjct: 226 GILLYDMVCGD 236
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-15
Identities = 45/170 (26%), Positives = 68/170 (40%), Gaps = 34/170 (20%)
Query: 31 EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLS----PGKKPLDWNT 86
EV +L L H N+V L LV+EY+ DL ++ +
Sbjct: 50 EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD--------KDLKQYLDDCGNIINMHN 101
Query: 87 RMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL--GPVGDNT 144
RGL Y H + V++RDLK N+L++ KL+DFGLA+ P
Sbjct: 102 VKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYD 158
Query: 145 HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGV-------VLLEILSGR 187
+ V+ T Y P+ + L S YS + + E+ +GR
Sbjct: 159 N---EVV-TLWYRPPD------ILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 3e-15
Identities = 50/190 (26%), Positives = 84/190 (44%), Gaps = 30/190 (15%)
Query: 10 QDVAIKQLDRNGVQGNREFLV---EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLG 66
VA+K L+R ++ E+ L L HP+++ L + +V EY+ G
Sbjct: 42 HKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGG 101
Query: 67 SVEDHLHDLSPGKKPLDWNTRMKIAAGAAR--------GLEYLHDKAKPPVIYRDLKCSN 118
+ D++ N R+ +R G++Y H V++RDLK N
Sbjct: 102 ELFDYICK----------NGRLDEKE--SRRLFQQILSGVDYCHRHM---VVHRDLKPEN 146
Query: 119 ILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE-YAKTGQLTLKSDVYSFG 177
+LLD + K++DFGL+ + G+ S G+ Y APE + + D++S G
Sbjct: 147 VLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAPEVISGRLYAGPEVDIWSSG 203
Query: 178 VVLLEILSGR 187
V+L +L G
Sbjct: 204 VILYALLCGT 213
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 4e-15
Identities = 46/187 (24%), Positives = 83/187 (44%), Gaps = 23/187 (12%)
Query: 10 QDVAIKQLDR---NGVQGNREFLVEVLMLSLLHHPNLVNLIG-YCADGDQRL-----LVY 60
++VAIK+L R N R + E++++ ++H N++ L+ + +V
Sbjct: 51 RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVM 109
Query: 61 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNIL 120
E M + +L + + LD + G+++LH +I+RDLK SNI+
Sbjct: 110 ELM-----DANLCQVI--QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIV 159
Query: 121 LDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVL 180
+ K+ DFGLA + + T + T Y APE D++S G ++
Sbjct: 160 VKSDCTLKILDFGLA---RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 216
Query: 181 LEILSGR 187
E++ G
Sbjct: 217 GEMIKGG 223
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 8e-15
Identities = 52/190 (27%), Positives = 84/190 (44%), Gaps = 31/190 (16%)
Query: 10 QDVAIKQLDRNGVQGNREFLV---EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLG 66
Q VA+K + R ++ + + E+ L LL HP+++ L ++V EY G
Sbjct: 35 QKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYAG-G 93
Query: 67 SVEDHLHDLSPGKKPLDWNTRMKIAAGAAR--------GLEYLHDKAKPPVIYRDLKCSN 118
+ D++ + RM R +EY H +++RDLK N
Sbjct: 94 ELFDYIVE----------KKRMTEDE--GRRFFQQIICAIEYCHRHK---IVHRDLKPEN 138
Query: 119 ILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE-YAKTGQLTLKSDVYSFG 177
+LLD + K++DFGL+ + G+ S G+ Y APE + DV+S G
Sbjct: 139 LLLDDNLNVKIADFGLSNIMTDGNFLKTSC---GSPNYAAPEVINGKLYAGPEVDVWSCG 195
Query: 178 VVLLEILSGR 187
+VL +L GR
Sbjct: 196 IVLYVMLVGR 205
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 1e-14
Identities = 56/202 (27%), Positives = 85/202 (42%), Gaps = 51/202 (25%)
Query: 12 VAIKQL----DRNGV--QGNREFLVEVL-MLSLLHHPNLVNLI----GYCADGDQRL-LV 59
VA+K++ G+ RE V VL L HPN+V L D + +L LV
Sbjct: 40 VALKRVRVQTGEEGMPLSTIRE--VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLV 97
Query: 60 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAA--------RGLEYLHDKAKPPVIY 111
+E++ DL LD + RGL++LH V++
Sbjct: 98 FEHVD--------QDL---TTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVH 143
Query: 112 RDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKS 171
RDLK NIL+ KL+DFGLA+ +++ V+ T Y APE + L+S
Sbjct: 144 RDLKPQNILVTSSGQIKLADFGLAR--IYSFQMALTSVVV-TLWYRAPE------VLLQS 194
Query: 172 ------DVYSFGVVLLEILSGR 187
D++S G + E+ +
Sbjct: 195 SYATPVDLWSVGCIFAEMFRRK 216
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 2e-14
Identities = 56/205 (27%), Positives = 87/205 (42%), Gaps = 54/205 (26%)
Query: 12 VAIKQL----DRNGVQGN-----REFLVEVL-MLSLLHHPNLVNLI----GYCADGDQRL 57
VA+K + G G RE V +L L HPN+V L+ D + ++
Sbjct: 37 VALKSVRVPNGGGGGGGLPISTVRE--VALLRRLEAFEHPNVVRLMDVCATSRTDREIKV 94
Query: 58 -LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAA--------RGLEYLHDKAKPP 108
LV+E++ DL + LD + A RGL++LH
Sbjct: 95 TLVFEHVD--------QDL---RTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC--- 140
Query: 109 VIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLT 168
+++RDLK NIL+ G KL+DFGLA+ ++ V+ T Y APE +
Sbjct: 141 IVHRDLKPENILVTSGGTVKLADFGLAR--IYSYQMALTPVVV-TLWYRAPE------VL 191
Query: 169 LKS------DVYSFGVVLLEILSGR 187
L+S D++S G + E+ +
Sbjct: 192 LQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 3e-14
Identities = 45/189 (23%), Positives = 77/189 (40%), Gaps = 29/189 (15%)
Query: 10 QDVAIKQL-DRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR----LLVYEYMP 64
+ A+K L D + RE VE L P++V ++ + L+V E +
Sbjct: 88 EKFALKMLQDCPKAR--RE--VE-LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 142
Query: 65 LGSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR----GLEYLHDKAKPPVIYRDLKCSNIL 120
G + + D + + R A+ + ++YLH + +RD+K N+L
Sbjct: 143 GGELFSRIQD----RGDQAFTERE--ASEIMKSIGEAIQYLHSIN---IAHRDVKPENLL 193
Query: 121 L---DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFG 177
KL+DFG AK + ++T T Y APE + D++S G
Sbjct: 194 YTSKRPNAILKLTDFGFAKE--TTSHNSLTTPC-YTPYYVAPEVLGPEKYDKSCDMWSLG 250
Query: 178 VVLLEILSG 186
V++ +L G
Sbjct: 251 VIMYILLCG 259
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 3e-14
Identities = 46/182 (25%), Positives = 71/182 (39%), Gaps = 46/182 (25%)
Query: 31 EVLMLSLLHHPNLVNLIGYCADGDQRL--------LVYEYMPLGSVEDHLHDLSPGKKPL 82
E+ +L LL H N+VNLI C LV+++ HDL L
Sbjct: 66 EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE--------HDL---AGLL 114
Query: 83 DWNTRMKIAAGAA--------RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGL 134
N +K GL Y+H +++RD+K +N+L+ R KL+DFGL
Sbjct: 115 S-NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL 170
Query: 135 AKL--GPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKS-------DVYSFGVVLLEILS 185
A+ + T + T Y PE L L D++ G ++ E+ +
Sbjct: 171 ARAFSLAKNSQPNRYTNRVVTLWYRPPE------LLLGERDYGPPIDLWGAGCIMAEMWT 224
Query: 186 GR 187
Sbjct: 225 RS 226
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 6e-13
Identities = 49/194 (25%), Positives = 82/194 (42%), Gaps = 37/194 (19%)
Query: 10 QDVAIKQLDR---NGVQGNREFLVEVLMLSLLHHPNLVNLIG-YCADGDQRL-----LVY 60
VAIK+L R + + R E+ +L + H N++ L+ + D LV
Sbjct: 51 AKVAIKKLYRPFQSELFAKRA-YRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVM 109
Query: 61 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNIL 120
+M L L + L + + +GL Y+H +I+RDLK N+
Sbjct: 110 PFM-----GTDLGKLM-KHEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLA 160
Query: 121 LDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE-------YAKTGQLTLKSDV 173
++ K+ DFGLA+ +V TR Y APE Y +T D+
Sbjct: 161 VNEDCELKILDFGLARQADSEMTGYVVTRW-----YRAPEVILNWMRYTQT------VDI 209
Query: 174 YSFGVVLLEILSGR 187
+S G ++ E+++G+
Sbjct: 210 WSVGCIMAEMITGK 223
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 6e-13
Identities = 45/226 (19%), Positives = 86/226 (38%), Gaps = 67/226 (29%)
Query: 10 QDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGY-------------------- 49
+ A+K++ ++ NRE + ++ +L H N++ L+ Y
Sbjct: 33 KRFALKKVLQDPRYKNRE----LDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNK 88
Query: 50 -----------------CADGDQRL-LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIA 91
++ L ++ EY+P ++ L + + N
Sbjct: 89 LGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYI 147
Query: 92 AGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP-KLSDFGLAK-LGPVGDNTH-VST 148
R + ++H + +RD+K N+L++ + KL DFG AK L P + + +
Sbjct: 148 YQLFRAVGFIHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICS 204
Query: 149 RVMGTYGYCAPE-------YAKTGQLTLKSDVYSFGVVLLEILSGR 187
R + Y APE Y T D++S G V E++ G+
Sbjct: 205 R----F-YRAPELMLGATEY------TPSIDLWSIGCVFGELILGK 239
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 1e-12
Identities = 26/180 (14%), Positives = 49/180 (27%), Gaps = 41/180 (22%)
Query: 11 DVAIKQLDRNGVQGN---REFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGS 67
VA+ +D GV + +E L L LS + P + ++ L+V E++ GS
Sbjct: 58 QVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGS 117
Query: 68 VEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP 127
+++ ++ A + H V S + +
Sbjct: 118 LQEVADT------SPSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDV 168
Query: 128 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 187
L+ + D+ G L +L R
Sbjct: 169 VLAYPA----------------------TMPDA-------NPQDDIRGIGASLYALLVNR 199
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 1e-12
Identities = 48/194 (24%), Positives = 81/194 (41%), Gaps = 38/194 (19%)
Query: 10 QDVAIKQLDR---NGVQGNREFLVEVLMLSLLHHPNLVNLI-----GYCADGDQRL-LVY 60
+ VAIK+L R + + R E+L+L + H N++ L+ LV
Sbjct: 50 EKVAIKKLSRPFQSEIFAKRA-YRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVM 108
Query: 61 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNIL 120
+M + L + + +GL+Y+H V++RDLK N+
Sbjct: 109 PFM-----QTDLQKIM--GLKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLA 158
Query: 121 LDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE-------YAKTGQLTLKSDV 173
++ K+ DFGLA+ +V TR Y APE Y +T D+
Sbjct: 159 VNEDCELKILDFGLARHADAEMTGYVVTRW-----YRAPEVILSWMHYNQT------VDI 207
Query: 174 YSFGVVLLEILSGR 187
+S G ++ E+L+G+
Sbjct: 208 WSVGCIMAEMLTGK 221
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 2e-12
Identities = 47/205 (22%), Positives = 78/205 (38%), Gaps = 47/205 (22%)
Query: 10 QDVAIKQLDR--NGVQGNREF---------LVEVLMLSLLHHPNLVNL----IGYCADGD 54
VAIK++ + + L E+ +L+ HHPN++ L + +
Sbjct: 47 IPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAM 106
Query: 55 QRL-LVYEYMPLGSVEDHLHD-LSPGKKPLDWNTRMK-IAAGAARGLEYLHDKAKPPVIY 111
+L LV E M L + + + ++ GL LH+ V++
Sbjct: 107 HKLYLVTELM-----RTDLAQVIHDQRIVIS-PQHIQYFMYHILLGLHVLHEAG---VVH 157
Query: 112 RDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT--HVSTRVMGTYGYCAPE-------YA 162
RDL NILL + DF LA+ N +V+ R Y APE +
Sbjct: 158 RDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRW-----YRAPELVMQFKGFT 212
Query: 163 KTGQLTLKSDVYSFGVVLLEILSGR 187
K D++S G V+ E+ + +
Sbjct: 213 KL------VDMWSAGCVMAEMFNRK 231
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 7e-12
Identities = 57/194 (29%), Positives = 88/194 (45%), Gaps = 33/194 (17%)
Query: 10 QDVAIKQLD--RNGVQGNREFLVEVLMLSLLHHPNLVNLIG----YCADGDQRL-LVYEY 62
VAIK++ + R L E+ +L H N++ + + + + +V +
Sbjct: 53 VRVAIKKISPFEHQTYCQRT-LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDL 111
Query: 63 MPLGSVEDHLHDLSPGKKPLDWNTRMK-IAAGAARGLEYLHDKAKPPVIYRDLKCSNILL 121
M E L+ L + L N + RGL+Y+H A V++RDLK SN+LL
Sbjct: 112 M-----ETDLYKLL-KTQHLS-NDHICYFLYQILRGLKYIHS-AN--VLHRDLKPSNLLL 161
Query: 122 DRGYHPKLSDFGLAK-LGPVGDNTHVSTRVMGTYGYCAPE-------YAKTGQLTLKSDV 173
+ K+ DFGLA+ P D+T T + T Y APE Y K+ D+
Sbjct: 162 NTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKS------IDI 215
Query: 174 YSFGVVLLEILSGR 187
+S G +L E+LS R
Sbjct: 216 WSVGCILAEMLSNR 229
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 8e-12
Identities = 50/194 (25%), Positives = 86/194 (44%), Gaps = 37/194 (19%)
Query: 10 QDVAIKQLDR---NGVQGNREFLVEVLMLSLLHHPNLVNLI-----GYCADGDQRL-LVY 60
VA+K+L R + + R E+ +L + H N++ L+ + + LV
Sbjct: 55 LRVAVKKLSRPFQSIIHAKRT-YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 113
Query: 61 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNIL 120
M L+++ + L + + RGL+Y+H +I+RDLK SN+
Sbjct: 114 HLM-----GADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLA 164
Query: 121 LDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE-------YAKTGQLTLKSDV 173
++ K+ DFGLA+ +V+TR Y APE Y +T D+
Sbjct: 165 VNEDCELKILDFGLARHTADEMTGYVATRW-----YRAPEIMLNWMHYNQT------VDI 213
Query: 174 YSFGVVLLEILSGR 187
+S G ++ E+L+GR
Sbjct: 214 WSVGCIMAELLTGR 227
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 4e-11
Identities = 47/201 (23%), Positives = 81/201 (40%), Gaps = 40/201 (19%)
Query: 10 QDVAIKQLD--RNGVQGNREFLVEVLMLSLLHHPNLVNLIG-YCADGDQRL----LVYEY 62
+ VAIK+++ + R L E+ +L H N++ + D + ++ E
Sbjct: 37 EIVAIKKIEPFDKPLFALRT-LREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQEL 95
Query: 63 MPLGSVEDHLHDLSPGKKPLDWNTRMK-IAAGAARGLEYLHDKAKPPVIYRDLKCSNILL 121
M + LH + + L + ++ R ++ LH + VI+RDLK SN+L+
Sbjct: 96 M-----QTDLHRVISTQ-MLS-DDHIQYFIYQTLRAVKVLHG-SN--VIHRDLKPSNLLI 145
Query: 122 DRGYHPKLSDFGLA----KLGPVGDNTHVSTRVMGTY----GYCAPE-------YAKTGQ 166
+ K+ DFGLA + M + Y APE Y++
Sbjct: 146 NSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRA-- 203
Query: 167 LTLKSDVYSFGVVLLEILSGR 187
DV+S G +L E+ R
Sbjct: 204 ----MDVWSCGCILAELFLRR 220
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 2e-10
Identities = 49/231 (21%), Positives = 86/231 (37%), Gaps = 48/231 (20%)
Query: 10 QDVAIKQLDR---NGVQGNREFLVEVLMLSLLHHPNLVNL----IGYCADGDQRL-LVYE 61
++VAIK+++R + + R L E+ +L+ L ++ L I L +V E
Sbjct: 52 KNVAIKKVNRMFEDLIDCKR-ILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLE 110
Query: 62 YMPLGSVEDHLHDLSPGKKPLDWNTRMK-IAAGAARGLEYLHDKAKPPVIYRDLKCSNIL 120
+ L L L +K I G ++H+ + +I+RDLK +N L
Sbjct: 111 IA-----DSDLKKLFKTPIFLT-EEHIKTILYNLLLGENFIHE-SG--IIHRDLKPANCL 161
Query: 121 LDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLT------------ 168
L++ K+ DFGLA+ +T++ + QLT
Sbjct: 162 LNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPE 221
Query: 169 --LKS-------DVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQ 210
L D++S G + E+L+ ++ PLF
Sbjct: 222 LILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTN--------RFPLFP 264
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 3e-10
Identities = 48/202 (23%), Positives = 83/202 (41%), Gaps = 40/202 (19%)
Query: 10 QDVAIKQLD-RNGVQGNREFLVEVLMLSLLHHPNLVNLIG-YCADGDQRL---------- 57
+ VAIK++ + L E+ ++ L H N+V + G Q
Sbjct: 37 KRVAIKKIVLTDPQSVKHA-LREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELN 95
Query: 58 ---LVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDL 114
+V EYM E L ++ + PL RGL+Y+H V++RDL
Sbjct: 96 SVYIVQEYM-----ETDLANVL-EQGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDL 146
Query: 115 KCSNILLDRG-YHPKLSDFGLAK-LGPVGDNTHVSTRVMGTYGYCAPE-------YAKTG 165
K +N+ ++ K+ DFGLA+ + P + + + T Y +P Y K
Sbjct: 147 KPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKA- 205
Query: 166 QLTLKSDVYSFGVVLLEILSGR 187
D+++ G + E+L+G+
Sbjct: 206 -----IDMWAAGCIFAEMLTGK 222
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 2e-09
Identities = 25/97 (25%), Positives = 49/97 (50%), Gaps = 12/97 (12%)
Query: 96 RGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP-KLSDFGLAKLGPVGD--NTHVSTRVMG 152
+ L+Y H +++RD+K N+++D + +L D+GLA+ G N V++R
Sbjct: 141 KALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY-- 195
Query: 153 TYGYCAPEYAKTGQLTLKS-DVYSFGVVLLEILSGRK 188
+ PE Q+ S D++S G +L ++ ++
Sbjct: 196 ---FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 229
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 3e-09
Identities = 37/133 (27%), Positives = 51/133 (38%), Gaps = 15/133 (11%)
Query: 10 QDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLG-SV 68
+ VAIK L + + + G +V E LG S+
Sbjct: 35 EYVAIKLEPMKSRAPQLHLEYRFYKQ-LGSGDGIPQVYYFGPCGKYNAMVLEL--LGPSL 91
Query: 69 EDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK 128
ED L DL L T + IA +EY+H K +IYRD+K N L+ R +
Sbjct: 92 ED-LFDLCDRTFSL--KTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKT 145
Query: 129 -----LSDFGLAK 136
+ DF LAK
Sbjct: 146 QQVIHIIDFALAK 158
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 2e-08
Identities = 46/235 (19%), Positives = 78/235 (33%), Gaps = 53/235 (22%)
Query: 10 QDVAIKQLDRNGVQGNREF----LVEVLMLSLLHHPNLVNL----IGYCADGDQRL-LVY 60
+ VAIK++ R V + L E+ +L+ L+H ++V + I + L +V
Sbjct: 79 RVVAIKKILR--VFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVL 136
Query: 61 EYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNIL 120
E + L L + G++Y+H A +++RDLK +N L
Sbjct: 137 EIA-----DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHS-AG--ILHRDLKPANCL 188
Query: 121 LDRGYHPKLSDFGLA-----KLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLT------- 168
+++ K+ DFGLA QLT
Sbjct: 189 VNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRW 248
Query: 169 -------LKSDVYSFGV-------VLLEILSGRKAVDTSKAAAEQSLVAWARPLF 209
L + Y+ + + E+L+ K A PLF
Sbjct: 249 YRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHAD--------RGPLF 295
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 2e-08
Identities = 50/189 (26%), Positives = 81/189 (42%), Gaps = 22/189 (11%)
Query: 10 QDVAIKQLDRNGVQGNREFLVEVLMLSLLHH-PNLVNLIGYCADGDQRLLVYEYMPLG-S 67
++VAIK + + +E + ++ + + A+GD ++V E LG S
Sbjct: 35 EEVAIKLECVK--TKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL--LGPS 90
Query: 68 VEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP 127
+ED L + K L T + +A +EY+H K I+RD+K N L+ G
Sbjct: 91 LED-LFNFCSRKFSL--KTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKG 144
Query: 128 K---LSDFGLAKL-GPVGDNTHVSTR----VMGTYGYCAPEYAKTG-QLTLKSDVYSFGV 178
+ DFGLAK + H+ R + GT Y A G + + + D+ S G
Sbjct: 145 NLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY-ASINTHLGIEQSRRDDLESLGY 203
Query: 179 VLLEILSGR 187
VL+ G
Sbjct: 204 VLMYFNLGS 212
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 3e-08
Identities = 56/212 (26%), Positives = 91/212 (42%), Gaps = 52/212 (24%)
Query: 10 QDVAIKQLDR---NGVQGNREFLVEVLMLSLLH-HPNLVNLIG-YCADGDQRL-LVYEYM 63
+ VA+K++ N R E+++L+ L H N+VNL+ AD D+ + LV++YM
Sbjct: 35 EVVAVKKIFDAFQNSTDAQRT-FREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYM 93
Query: 64 PLGSVEDHLH------DLSPG-KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKC 116
E LH L P K+ + + + ++YLH +++RD+K
Sbjct: 94 -----ETDLHAVIRANILEPVHKQYVVYQL--------IKVIKYLHS-GG--LLHRDMKP 137
Query: 117 SNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLT-------- 168
SNILL+ H K++DFGL++ V + + LT
Sbjct: 138 SNILLNAECHVKVADFGLSR-SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWY 196
Query: 169 ------LKS-------DVYSFGVVLLEILSGR 187
L S D++S G +L EIL G+
Sbjct: 197 RAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 52.7 bits (126), Expect = 5e-08
Identities = 51/189 (26%), Positives = 85/189 (44%), Gaps = 22/189 (11%)
Query: 10 QDVAIKQLDRNGVQGNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLVYEYMPLG-S 67
++VAIK + + + L E + +L + N+ + +GD +LV + LG S
Sbjct: 33 EEVAIKLENVK--TKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDL--LGPS 88
Query: 68 VEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP 127
+ED L + K L T + +A +E++H K+ ++RD+K N L+ G
Sbjct: 89 LED-LFNFCSRKLSL--KTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRA 142
Query: 128 K---LSDFGLAKL-GPVGDNTHVSTR----VMGTYGYCAPEYAKTG-QLTLKSDVYSFGV 178
+ DFGLAK + H+ R + GT Y A G + + + D+ S G
Sbjct: 143 NQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY-ASVNTHLGIEQSRRDDLESLGY 201
Query: 179 VLLEILSGR 187
VL+ L G
Sbjct: 202 VLMYFLRGS 210
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 1e-07
Identities = 37/189 (19%), Positives = 65/189 (34%), Gaps = 50/189 (26%)
Query: 10 QDVAIKQLDRNGVQGNREFLVEV-LMLSLLHHPNLVNLIGYCADGDQR----LLVYEYMP 64
+ A+K L EV L P++V ++ + L+V E +
Sbjct: 44 EKFALKMLQDCPKARR-----EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 98
Query: 65 LGSVEDHLHDLSPGKKPLDWNTRMKIAAGAAR----GLEYLHDKAKPPVIYRDLKCSNIL 120
G + + D + + R A+ + ++YLH + +RD+K N+L
Sbjct: 99 GGELFSRIQD----RGDQAFTERE--ASEIMKSIGEAIQYLHSIN---IAHRDVKPENLL 149
Query: 121 L---DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFG 177
KL+DFG AK + Y D++S G
Sbjct: 150 YTSKRPNAILKLTDFGFAK--------ETTGE---KYD-------------KSCDMWSLG 185
Query: 178 VVLLEILSG 186
V++ +L G
Sbjct: 186 VIMYILLCG 194
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 49.9 bits (118), Expect = 4e-07
Identities = 25/137 (18%), Positives = 41/137 (29%), Gaps = 19/137 (13%)
Query: 52 DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIY 111
DQ +V E+ G + + K T I L + +
Sbjct: 133 KDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLTASLAVAEASLR--FEH 185
Query: 112 RDLKCSNILLDRGYHPKLSDFGLAKLGPVGD-------NTHVSTRVM--GTYGYCAPEYA 162
RDL N+LL + KL K + + +R+ G +C
Sbjct: 186 RDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMD 245
Query: 163 K---TGQLTLKSDVYSF 176
+ TG + D+Y
Sbjct: 246 EDLFTGDGDYQFDIYRL 262
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 7e-07
Identities = 23/106 (21%), Positives = 43/106 (40%), Gaps = 11/106 (10%)
Query: 35 LSLLHHPNLVNLIGY-CADGDQRLLVYEYMPLG-SVEDHLHDLSPGKKPLDWNTRMKIAA 92
L + +G+ R LV LG S++ D+S K L + +++A
Sbjct: 111 LYSTPLLAIPTCMGFGVHQDKYRFLVLPS--LGRSLQS-ALDVS-PKHVLSERSVLQVAC 166
Query: 93 GAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK--LSDFGLAK 136
LE+LH+ ++ ++ NI +D + L+ +G A
Sbjct: 167 RLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 8e-07
Identities = 46/189 (24%), Positives = 74/189 (39%), Gaps = 20/189 (10%)
Query: 10 QDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLG-SV 68
Q VAIK R L L + N+ + +G +LV + LG S+
Sbjct: 36 QQVAIKFEPRRSDAPQLRDEYRTYKL-LAGCTGIPNVYYFGQEGLHNVLVIDL--LGPSL 92
Query: 69 EDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK 128
ED L DL K + T A ++ +H+K+ ++YRD+K N L+ R
Sbjct: 93 ED-LLDLCGRKFSV--KTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKN 146
Query: 129 -----LSDFGLAKL-GPVGDNTHVSTR----VMGTYGYCAPEYAKTGQLTLKSDVYSFGV 178
+ DFG+ K H+ R + GT Y + + + + D+ + G
Sbjct: 147 ANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGH 206
Query: 179 VLLEILSGR 187
V + L G
Sbjct: 207 VFMYFLRGS 215
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 3e-05
Identities = 15/41 (36%), Positives = 24/41 (58%), Gaps = 5/41 (12%)
Query: 98 LEYLHDKAKPPVIYRDLKCSNILLDRGYHPK--LSDFGLAK 136
LEY+H+ ++ D+K SN+LL+ + L D+GLA
Sbjct: 165 LEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 3e-05
Identities = 33/180 (18%), Positives = 54/180 (30%), Gaps = 61/180 (33%)
Query: 58 LVYEYMPLG-SVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKC 116
+V+E LG + + + PL KI +GL+YLH K + +I+ D+K
Sbjct: 122 MVFE--VLGHHLLKWIIKSNYQGLPLP--CVKKIIQQVLQGLDYLHTKCR--IIHTDIKP 175
Query: 117 SNILL-------------------------------------------------DRGYHP 127
NILL
Sbjct: 176 ENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKV 235
Query: 128 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 187
K++D G A + TR Y + E +D++S + E+ +G
Sbjct: 236 KIADLGNACWVHKHFTEDIQTRQ-----YRSLEVLIGSGYNTPADIWSTACMAFELATGD 290
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 5e-05
Identities = 13/41 (31%), Positives = 24/41 (58%), Gaps = 5/41 (12%)
Query: 98 LEYLHDKAKPPVIYRDLKCSNILLDRGYHPK--LSDFGLAK 136
LEY+H+ ++ D+K +N+LL + L+D+GL+
Sbjct: 164 LEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 39.7 bits (93), Expect = 7e-04
Identities = 47/203 (23%), Positives = 82/203 (40%), Gaps = 52/203 (25%)
Query: 10 QDVAIKQLDRNGVQGNREFLVEVLMLSLL--------HHPNLVNLIGY-------CADGD 54
+ VAIK + +N + +EV +L L+ ++ +V+L + C
Sbjct: 80 EWVAIKII-KNKKAFLNQAQIEVRLLELMNKHDTEMKYY--IVHLKRHFMFRNHLC---- 132
Query: 55 QRLLVYEYMPLGSVEDHLHDL--SPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYR 112
LV+E + +L+DL + + + N K A L +L + +I+
Sbjct: 133 ---LVFEML-----SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHC 183
Query: 113 DLKCSNILLDRGYHP--KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE------YAKT 164
DLK NILL K+ DFG + ++ +R Y +PE Y
Sbjct: 184 DLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF-----YRSPEVLLGMPY--- 235
Query: 165 GQLTLKSDVYSFGVVLLEILSGR 187
L D++S G +L+E+ +G
Sbjct: 236 ---DLAIDMWSLGCILVEMHTGE 255
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 311 | |||
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.91 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.84 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.69 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.53 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.29 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.13 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.97 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.84 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.54 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.51 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.41 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.34 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.21 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.11 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 98.04 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.91 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.86 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.72 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.64 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.32 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.25 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.14 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.04 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.87 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.84 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.83 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.57 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.53 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.22 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.09 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 94.87 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 92.66 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 92.16 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 83.87 |
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-54 Score=377.85 Aligned_cols=239 Identities=29% Similarity=0.442 Sum_probs=191.6
Q ss_pred CCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCC----------
Q 021490 8 LLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP---------- 77 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------- 77 (311)
+|+.||||+++.......++|.+|+++|.+++|||||++++++.+....|||||||++|+|.+++.....
T Consensus 70 ~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~ 149 (329)
T 4aoj_A 70 DKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGED 149 (329)
T ss_dssp -CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC---------
T ss_pred CCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHHhcCccccccccccc
Confidence 5889999999876666678999999999999999999999999999999999999999999999976321
Q ss_pred -CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccc
Q 021490 78 -GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY 156 (311)
Q Consensus 78 -~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y 156 (311)
....+++.+++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++...............||+.|
T Consensus 150 ~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~y 226 (329)
T 4aoj_A 150 VAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRW 226 (329)
T ss_dssp --CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC----------------CCCCGGG
T ss_pred ccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccc
Confidence 1356999999999999999999999999 999999999999999999999999999764333333334456789999
Q ss_pred cCccccccCCCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHH
Q 021490 157 CAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQA 235 (311)
Q Consensus 157 ~aPE~~~~~~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 235 (311)
+|||++.+..++.++|||||||++|||+| |+.||...........+.... .+ ..|...+.++
T Consensus 227 mAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g~-------------~~----~~p~~~~~~~ 289 (329)
T 4aoj_A 227 MPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGR-------------EL----ERPRACPPEV 289 (329)
T ss_dssp CCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHTC-------------CC----CCCTTCCHHH
T ss_pred cChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-------------CC----CCcccccHHH
Confidence 99999999999999999999999999999 899998766544322221110 01 1223344588
Q ss_pred HHHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 021490 236 LAVAAMCVHEQPDMRPVIADVVTALAYLASQ 266 (311)
Q Consensus 236 ~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~ 266 (311)
.+|+.+||+.||++|||+.||++.|+.+.+.
T Consensus 290 ~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 290 YAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp HHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 9999999999999999999999999988754
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-55 Score=375.95 Aligned_cols=239 Identities=27% Similarity=0.380 Sum_probs=197.5
Q ss_pred CCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccC---------CC
Q 021490 8 LLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLS---------PG 78 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------~~ 78 (311)
+|..||||+++.......++|.+|+++|++|+|||||++++++.++...+||||||++|+|.+++.... ..
T Consensus 42 ~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~ 121 (299)
T 4asz_A 42 DKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNP 121 (299)
T ss_dssp -CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----C
T ss_pred CCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCC
Confidence 578999999987666667899999999999999999999999999999999999999999999997531 12
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccC
Q 021490 79 KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCA 158 (311)
Q Consensus 79 ~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~a 158 (311)
...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...............||+.|+|
T Consensus 122 ~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymA 198 (299)
T 4asz_A 122 PTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMP 198 (299)
T ss_dssp CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCC
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcC
Confidence 357999999999999999999999999 99999999999999999999999999975333222222233468999999
Q ss_pred ccccccCCCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHH
Q 021490 159 PEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALA 237 (311)
Q Consensus 159 PE~~~~~~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 237 (311)
||++.+..++.++|||||||++|||+| |+.||...........+.... . ...|...+.++.+
T Consensus 199 PE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~--------~---------~~~p~~~~~~~~~ 261 (299)
T 4asz_A 199 PESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR--------V---------LQRPRTCPQEVYE 261 (299)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTC--------C---------CCCCTTCCHHHHH
T ss_pred HHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC--------C---------CCCCccchHHHHH
Confidence 999999999999999999999999999 899998766543322221110 0 0123334458899
Q ss_pred HHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 021490 238 VAAMCVHEQPDMRPVIADVVTALAYLASQ 266 (311)
Q Consensus 238 li~~~l~~~p~~Rps~~~vl~~l~~~~~~ 266 (311)
|+.+||+.||++|||+.++.+.|+.+...
T Consensus 262 li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 262 LMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 99999999999999999999999887643
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-53 Score=370.68 Aligned_cols=229 Identities=21% Similarity=0.268 Sum_probs=193.4
Q ss_pred CCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHHH
Q 021490 8 LLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTR 87 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~ 87 (311)
+|+.||||+++.......+.+.+|+.+|+.++|||||+++++|.+++.+|||||||+||+|.+++.. +.+++..+
T Consensus 98 tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~-----~~l~e~~~ 172 (346)
T 4fih_A 98 SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH-----TRMNEEQI 172 (346)
T ss_dssp TCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEHHHHHHH-----SCCCHHHH
T ss_pred CCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHc-----CCCCHHHH
Confidence 6999999999877666778899999999999999999999999999999999999999999999975 46999999
Q ss_pred HHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccCCC
Q 021490 88 MKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQL 167 (311)
Q Consensus 88 ~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 167 (311)
..++.||+.||+|||+++ |+||||||+|||++.+|.+||+|||++...... ........||+.|+|||++.+..|
T Consensus 173 ~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~--~~~~~~~~GTp~YmAPEvl~~~~y 247 (346)
T 4fih_A 173 AAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKSLVGTPYWMAPELISRLPY 247 (346)
T ss_dssp HHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSS--SCCBCCCCSCGGGCCHHHHTTCCB
T ss_pred HHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCC--CCcccccccCcCcCCHHHHCCCCC
Confidence 999999999999999999 999999999999999999999999999754322 222334579999999999999999
Q ss_pred ccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCC
Q 021490 168 TLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQP 247 (311)
Q Consensus 168 ~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p 247 (311)
+.++|||||||++|+|++|..||...........+.... .+. ...+...+.++.+||.+||+.||
T Consensus 248 ~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~-------------~~~--~~~~~~~s~~~~dli~~~L~~dP 312 (346)
T 4fih_A 248 GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL-------------PPR--LKNLHKVSPSLKGFLDRLLVRDP 312 (346)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSS-------------CCC--CSCGGGSCHHHHHHHHHHSCSST
T ss_pred CcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC-------------CCC--CCccccCCHHHHHHHHHHcCCCh
Confidence 999999999999999999999998765544332221100 000 01123345688999999999999
Q ss_pred CCCCCHHHHHHHHH
Q 021490 248 DMRPVIADVVTALA 261 (311)
Q Consensus 248 ~~Rps~~~vl~~l~ 261 (311)
++|||+.|+++.-+
T Consensus 313 ~~R~ta~e~l~Hp~ 326 (346)
T 4fih_A 313 AQRATAAELLKHPF 326 (346)
T ss_dssp TTSCCHHHHTTCGG
T ss_pred hHCcCHHHHhcCHh
Confidence 99999999988643
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-53 Score=368.81 Aligned_cols=236 Identities=27% Similarity=0.373 Sum_probs=193.1
Q ss_pred CCcEEEEEEeecCCC-cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCC---------
Q 021490 8 LLQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP--------- 77 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------- 77 (311)
+++.||||+++.... ...+.|.+|+.++.+++|||||++++++.++...+||||||++|+|.++|.....
T Consensus 55 ~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~ 134 (308)
T 4gt4_A 55 QTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDD 134 (308)
T ss_dssp -CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC----
T ss_pred CCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEEcCCCCcHHHHHHhhCcccccccccc
Confidence 578999999975533 3457899999999999999999999999999999999999999999999965321
Q ss_pred ---CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccc
Q 021490 78 ---GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTY 154 (311)
Q Consensus 78 ---~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~ 154 (311)
....+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++...............||+
T Consensus 135 ~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~ 211 (308)
T 4gt4_A 135 DRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPI 211 (308)
T ss_dssp -CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCG
T ss_pred ccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCCCEEECCcccceeccCCCceeEecccccCC
Confidence 1246999999999999999999999999 9999999999999999999999999997543332223334456899
Q ss_pred cccCccccccCCCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHH
Q 021490 155 GYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFY 233 (311)
Q Consensus 155 ~y~aPE~~~~~~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
.|+|||++.+..++.++|||||||++|||+| |..||.+.........+.. ... ...|...+.
T Consensus 212 ~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~-------~~~----------~~~p~~~~~ 274 (308)
T 4gt4_A 212 RWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRN-------RQV----------LPCPDDCPA 274 (308)
T ss_dssp GGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHT-------TCC----------CCCCTTCCH
T ss_pred cccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-------CCC----------CCCcccchH
Confidence 9999999999999999999999999999998 8999987665433222211 000 112334455
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 021490 234 QALAVAAMCVHEQPDMRPVIADVVTALAYL 263 (311)
Q Consensus 234 ~l~~li~~~l~~~p~~Rps~~~vl~~l~~~ 263 (311)
.+.+|+.+||+.||++|||+.||++.|+.+
T Consensus 275 ~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 275 WVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 788999999999999999999999999754
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-53 Score=363.16 Aligned_cols=238 Identities=27% Similarity=0.434 Sum_probs=185.3
Q ss_pred CcEEEEEEeecCCC--cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHH
Q 021490 9 LQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNT 86 (311)
Q Consensus 9 g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~ 86 (311)
...||||+++.... ...+.|.+|+.+|++++|||||++++++.+ +.++||||||+||+|.+++... ...+++..
T Consensus 58 ~~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~gGsL~~~l~~~---~~~l~~~~ 133 (307)
T 3omv_A 58 HGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEGSSLYKHLHVQ---ETKFQMFQ 133 (307)
T ss_dssp SSEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSSCBHHHHHHTS---CCCCCHHH
T ss_pred CCcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCCCCHHHHHhhc---CCCCCHHH
Confidence 35799999875443 334689999999999999999999998764 5689999999999999999752 46799999
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccccc--
Q 021490 87 RMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT-- 164 (311)
Q Consensus 87 ~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-- 164 (311)
+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||++................||+.|+|||++.+
T Consensus 134 ~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~ 210 (307)
T 3omv_A 134 LIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQD 210 (307)
T ss_dssp HHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCS
T ss_pred HHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccC
Confidence 9999999999999999999 99999999999999999999999999976433333333344579999999999864
Q ss_pred -CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHcc
Q 021490 165 -GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCV 243 (311)
Q Consensus 165 -~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 243 (311)
..++.++|||||||++|||+||..||............ ..... ..|.+ ...+...+..+.+|+.+||
T Consensus 211 ~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~------~~~~~-----~~p~~-~~~~~~~~~~l~~li~~cl 278 (307)
T 3omv_A 211 NNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFM------VGRGY-----ASPDL-SKLYKNCPKAMKRLVADCV 278 (307)
T ss_dssp SCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHH------HHTTC-----CCCCS-TTSCTTSCHHHHHHHHHHT
T ss_pred CCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHH------HhcCC-----CCCCc-ccccccchHHHHHHHHHHc
Confidence 45899999999999999999999999865443221111 11100 01111 1223344558899999999
Q ss_pred ccCCCCCCCHHHHHHHHHHhhh
Q 021490 244 HEQPDMRPVIADVVTALAYLAS 265 (311)
Q Consensus 244 ~~~p~~Rps~~~vl~~l~~~~~ 265 (311)
+.||++|||+.+|++.|+.+..
T Consensus 279 ~~dP~~RPs~~ei~~~Le~l~~ 300 (307)
T 3omv_A 279 KKVKEERPLFPQILSSIELLQH 300 (307)
T ss_dssp CSSSTTSCCHHHHHHHHHHHHT
T ss_pred CCCHhHCcCHHHHHHHHHHHhc
Confidence 9999999999999999988753
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-53 Score=365.48 Aligned_cols=227 Identities=22% Similarity=0.286 Sum_probs=191.8
Q ss_pred cCCcEEEEEEeecCC---CcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCC
Q 021490 7 CLLQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLD 83 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~ 83 (311)
.+|+.||||++++.. ....+.+.+|+++|+.++||||++++++|.++..+|+|||||+||+|.+++.. .+.++
T Consensus 55 ~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy~~gG~L~~~i~~----~~~l~ 130 (311)
T 4aw0_A 55 ATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK----IGSFD 130 (311)
T ss_dssp TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH----HSSCC
T ss_pred CCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHH----cCCCC
Confidence 369999999997642 23457899999999999999999999999999999999999999999999987 57899
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccc
Q 021490 84 WNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 163 (311)
Q Consensus 84 ~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 163 (311)
+..+..++.||+.||+|||+++ |+||||||+|||++.+|.+||+|||++................||+.|+|||++.
T Consensus 131 e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~ 207 (311)
T 4aw0_A 131 ETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 207 (311)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHc
Confidence 9999999999999999999999 9999999999999999999999999998654433333344567999999999999
Q ss_pred cCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHcc
Q 021490 164 TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCV 243 (311)
Q Consensus 164 ~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 243 (311)
+..++.++|||||||++|+|++|..||...+.......+... .. .++...+.++.+||.+||
T Consensus 208 ~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~--------------~~----~~p~~~s~~~~dli~~lL 269 (311)
T 4aw0_A 208 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKL--------------EY----DFPEKFFPKARDLVEKLL 269 (311)
T ss_dssp HSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--------------CC----CCCTTCCHHHHHHHHHHS
T ss_pred CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC--------------CC----CCCcccCHHHHHHHHHHc
Confidence 999999999999999999999999999876544332222111 01 122334457899999999
Q ss_pred ccCCCCCCCHHHHHH
Q 021490 244 HEQPDMRPVIADVVT 258 (311)
Q Consensus 244 ~~~p~~Rps~~~vl~ 258 (311)
+.||++|||++|++.
T Consensus 270 ~~dp~~R~t~~e~~~ 284 (311)
T 4aw0_A 270 VLDATKRLGCEEMEG 284 (311)
T ss_dssp CSSGGGSTTSGGGTC
T ss_pred cCCHhHCcChHHHcC
Confidence 999999999998753
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-53 Score=368.74 Aligned_cols=230 Identities=20% Similarity=0.286 Sum_probs=190.5
Q ss_pred cCCcEEEEEEeecCCC--cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCH
Q 021490 7 CLLQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 84 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~ 84 (311)
.+|+.||||+++.... ...+.|.+|+.+|+.|+|||||++++++.++..+|||||||+||+|.+++... .+..+++
T Consensus 47 ~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg~L~~~i~~~--~~~~~~e 124 (350)
T 4b9d_A 47 EDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQ--KGVLFQE 124 (350)
T ss_dssp TTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHT--TTCCCCH
T ss_pred CCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHHc--CCCCCCH
Confidence 3699999999976543 33468999999999999999999999999999999999999999999999752 2456899
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccccc
Q 021490 85 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT 164 (311)
Q Consensus 85 ~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 164 (311)
..++.++.||+.||+|||++| |+||||||+|||++.+|.+||+|||+++.... .........||+.|+|||++.+
T Consensus 125 ~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~--~~~~~~~~~GT~~YmAPE~l~~ 199 (350)
T 4b9d_A 125 DQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS--TVELARACIGTPYYLSPEICEN 199 (350)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCH--HHHHHHHHHSCCTTCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecC--CcccccccCCCccccCHHHHCC
Confidence 999999999999999999999 99999999999999999999999999975321 1112234569999999999999
Q ss_pred CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccc
Q 021490 165 GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVH 244 (311)
Q Consensus 165 ~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 244 (311)
..++.++|||||||++|+|++|..||...+.......+.. .. .+ ..+...+.++.+||.+||+
T Consensus 200 ~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~------~~-------~~----~~~~~~s~~~~~li~~~L~ 262 (350)
T 4b9d_A 200 KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIIS------GS-------FP----PVSLHYSYDLRSLVSQLFK 262 (350)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH------TC-------CC----CCCTTSCHHHHHHHHHHTC
T ss_pred CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHc------CC-------CC----CCCccCCHHHHHHHHHHcc
Confidence 9999999999999999999999999987655433222211 10 01 1123345588999999999
Q ss_pred cCCCCCCCHHHHHHHH
Q 021490 245 EQPDMRPVIADVVTAL 260 (311)
Q Consensus 245 ~~p~~Rps~~~vl~~l 260 (311)
.||++|||+.|+++.-
T Consensus 263 ~dP~~R~s~~e~l~hp 278 (350)
T 4b9d_A 263 RNPRDRPSVNSILEKG 278 (350)
T ss_dssp SSGGGSCCHHHHHTSH
T ss_pred CChhHCcCHHHHhcCH
Confidence 9999999999998754
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-52 Score=365.17 Aligned_cols=234 Identities=20% Similarity=0.191 Sum_probs=189.2
Q ss_pred cCCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHH
Q 021490 7 CLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNT 86 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~ 86 (311)
.+|+.||||+++.... +.+|+.+++.++|||||++++++.++..+|||||||+||+|.+++.. .+.+++..
T Consensus 81 ~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~----~~~l~e~~ 151 (336)
T 4g3f_A 81 QTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQ----MGCLPEDR 151 (336)
T ss_dssp TTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHH----HSSCCHHH
T ss_pred CCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHHHHH----cCCCCHHH
Confidence 3689999999975432 24699999999999999999999999999999999999999999987 56799999
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCC-ceEEccccccccCCCCCCc---eeeeeccccccccCcccc
Q 021490 87 RMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY-HPKLSDFGLAKLGPVGDNT---HVSTRVMGTYGYCAPEYA 162 (311)
Q Consensus 87 ~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~-~~~l~df~~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~ 162 (311)
+..++.||+.||+|||+++ |+||||||+|||++.+| .+||+|||++......... .......||+.|+|||++
T Consensus 152 ~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~ 228 (336)
T 4g3f_A 152 ALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVV 228 (336)
T ss_dssp HHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHH
T ss_pred HHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHH
Confidence 9999999999999999999 99999999999999887 6999999999764322211 112234699999999999
Q ss_pred ccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHc
Q 021490 163 KTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMC 242 (311)
Q Consensus 163 ~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 242 (311)
.+..++.++|||||||++|+|++|..||...........+... ... ...+++..+..+.+||.+|
T Consensus 229 ~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~------~~~---------~~~~~~~~s~~~~~li~~~ 293 (336)
T 4g3f_A 229 MGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASE------PPP---------IREIPPSCAPLTAQAIQEG 293 (336)
T ss_dssp TTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHS------CCG---------GGGSCTTSCHHHHHHHHHH
T ss_pred CCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcC------CCC---------chhcCccCCHHHHHHHHHH
Confidence 9999999999999999999999999999765433222111110 000 0122344456889999999
Q ss_pred cccCCCCCCCHHHHHHHHHHhhhcc
Q 021490 243 VHEQPDMRPVIADVVTALAYLASQK 267 (311)
Q Consensus 243 l~~~p~~Rps~~~vl~~l~~~~~~~ 267 (311)
|+.||++|||+.|+++.|....+..
T Consensus 294 L~~dP~~R~sa~el~~~l~~~l~~~ 318 (336)
T 4g3f_A 294 LRKEPVHRASAMELRRKVGKALQEV 318 (336)
T ss_dssp TCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred ccCCHhHCcCHHHHHHHHHHHHhhh
Confidence 9999999999999999998766543
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-52 Score=371.46 Aligned_cols=229 Identities=21% Similarity=0.284 Sum_probs=193.3
Q ss_pred cCCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHH
Q 021490 7 CLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNT 86 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~ 86 (311)
.+|+.||||+++.......+.+.+|+.+|+.++|||||+++++|.+++.+|||||||+||+|.+++.. +.+++..
T Consensus 174 ~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L~~~i~~-----~~l~e~~ 248 (423)
T 4fie_A 174 SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH-----TRMNEEQ 248 (423)
T ss_dssp TTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHH-----SCCCHHH
T ss_pred CCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcHHHHHhc-----cCCCHHH
Confidence 36999999999877777778899999999999999999999999999999999999999999999975 5699999
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccCC
Q 021490 87 RMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ 166 (311)
Q Consensus 87 ~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 166 (311)
+..++.||+.||+|||++| |+||||||+|||++.+|.+||+|||++...... ........||+.|+|||++.+..
T Consensus 249 ~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~--~~~~~~~~GTp~YmAPEvl~~~~ 323 (423)
T 4fie_A 249 IAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKSLVGTPYWMAPELISRLP 323 (423)
T ss_dssp HHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSS--CCCBCCCEECTTTCCHHHHTTCC
T ss_pred HHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCC--CccccccccCcCcCCHHHHCCCC
Confidence 9999999999999999999 999999999999999999999999999754322 22234457999999999999999
Q ss_pred CccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccC
Q 021490 167 LTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQ 246 (311)
Q Consensus 167 ~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 246 (311)
|+.++|||||||++|+|++|..||...........+.... .+.+ ..+...+.++.+||.+||..|
T Consensus 324 y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~-------------~~~~--~~~~~~s~~~~dli~~~L~~d 388 (423)
T 4fie_A 324 YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL-------------PPRL--KNLHKVSPSLKGFLDRLLVRD 388 (423)
T ss_dssp BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC-------------CCCC--SCTTSSCHHHHHHHHHHSCSS
T ss_pred CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC-------------CCCC--cccccCCHHHHHHHHHHcCCC
Confidence 9999999999999999999999998765544333221110 0000 112234458899999999999
Q ss_pred CCCCCCHHHHHHHH
Q 021490 247 PDMRPVIADVVTAL 260 (311)
Q Consensus 247 p~~Rps~~~vl~~l 260 (311)
|++|||+.|+++.-
T Consensus 389 P~~R~ta~ell~Hp 402 (423)
T 4fie_A 389 PAQRATAAELLKHP 402 (423)
T ss_dssp TTTSCCHHHHTTCG
T ss_pred hhHCcCHHHHhcCH
Confidence 99999999998864
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-51 Score=349.34 Aligned_cols=226 Identities=23% Similarity=0.276 Sum_probs=179.7
Q ss_pred cCCcEEEEEEeecCCC---cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCC
Q 021490 7 CLLQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLD 83 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~ 83 (311)
.+|+.||||++++... .....+.+|+.+|+.++||||+++++++.++...|+||||| +|+|.+++.+ .+.++
T Consensus 36 ~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~-~g~L~~~l~~----~~~l~ 110 (275)
T 3hyh_A 36 TTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQ----RDKMS 110 (275)
T ss_dssp TTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC-CEEHHHHHHH----SCSCC
T ss_pred CCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeCC-CCCHHHHHHH----cCCCC
Confidence 3699999999976532 33467999999999999999999999999999999999999 6899999987 57899
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccc
Q 021490 84 WNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 163 (311)
Q Consensus 84 ~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 163 (311)
+..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||++..... ........||+.|+|||++.
T Consensus 111 e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~---~~~~~~~~GT~~Y~APE~~~ 184 (275)
T 3hyh_A 111 EQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTD---GNFLKTSCGSPNYAAPEVIS 184 (275)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------------------CTTSCHHHHS
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCC---CCccCCeeECcccCChhhhc
Confidence 9999999999999999999999 99999999999999999999999999975322 22233457999999999998
Q ss_pred cCCC-ccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHc
Q 021490 164 TGQL-TLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMC 242 (311)
Q Consensus 164 ~~~~-~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 242 (311)
+..+ +.++|||||||++|+|++|..||...........+... .. .++...+.++.+|+.+|
T Consensus 185 ~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~--------------~~----~~p~~~s~~~~~li~~~ 246 (275)
T 3hyh_A 185 GKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNG--------------VY----TLPKFLSPGAAGLIKRM 246 (275)
T ss_dssp SSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--------------CC----CCCTTSCHHHHHHHHHH
T ss_pred CCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC--------------CC----CCCCCCCHHHHHHHHHH
Confidence 8776 57999999999999999999999876543332222111 00 11223345788999999
Q ss_pred cccCCCCCCCHHHHHHHHH
Q 021490 243 VHEQPDMRPVIADVVTALA 261 (311)
Q Consensus 243 l~~~p~~Rps~~~vl~~l~ 261 (311)
|+.||++|||+.|+++.-+
T Consensus 247 L~~dP~~R~s~~eil~hpw 265 (275)
T 3hyh_A 247 LIVNPLNRISIHEIMQDDW 265 (275)
T ss_dssp SCSSGGGSCCHHHHHHCHH
T ss_pred ccCChhHCcCHHHHHcCcc
Confidence 9999999999999998754
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-52 Score=358.71 Aligned_cols=225 Identities=25% Similarity=0.291 Sum_probs=180.6
Q ss_pred CCcEEEEEEeecCCC--cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHH
Q 021490 8 LLQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN 85 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~ 85 (311)
.|+.||||+++.... .....+.+|+.+|++++||||+++++++.++..+|+|||||+||+|.+++.. .+.+++.
T Consensus 51 ~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~----~~~l~e~ 126 (304)
T 3ubd_A 51 ARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSK----EVMFTEE 126 (304)
T ss_dssp TTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEEECCCTTCEEHHHHHH----HCCCCHH
T ss_pred CCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEEcCCCCCHHHHHHh----cCCCCHH
Confidence 578999999976532 2345788999999999999999999999999999999999999999999987 5789999
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccC
Q 021490 86 TRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG 165 (311)
Q Consensus 86 ~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 165 (311)
.+..++.||+.||+|||+++ |+||||||+|||++.+|.+||+|||++...... ........||+.|+|||++.+.
T Consensus 127 ~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~--~~~~~~~~GT~~YmAPE~~~~~ 201 (304)
T 3ubd_A 127 DVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDH--EKKAYSFCGTVEYMAPEVVNRR 201 (304)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC-------CCCCSCCCCGGGCCHHHHHTS
T ss_pred HHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceeccCC--CccccccccCcccCCHHHhccC
Confidence 99999999999999999999 999999999999999999999999999753221 1222345799999999999999
Q ss_pred CCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHcccc
Q 021490 166 QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHE 245 (311)
Q Consensus 166 ~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 245 (311)
.++.++|||||||++|+|++|..||...+.......+.. . .+ .+|...+.++.+||.+||+.
T Consensus 202 ~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~------~--------~~----~~p~~~s~~~~~li~~~L~~ 263 (304)
T 3ubd_A 202 GHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILK------A--------KL----GMPQFLSPEAQSLLRMLFKR 263 (304)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------C--------CC----CCCTTSCHHHHHHHHHHTCS
T ss_pred CCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHc------C--------CC----CCCCcCCHHHHHHHHHHccc
Confidence 999999999999999999999999987665443222211 1 01 12233455889999999999
Q ss_pred CCCCCCCH-----HHHHHH
Q 021490 246 QPDMRPVI-----ADVVTA 259 (311)
Q Consensus 246 ~p~~Rps~-----~~vl~~ 259 (311)
||++|||+ +|+++.
T Consensus 264 dP~~R~ta~~~~~~eil~H 282 (304)
T 3ubd_A 264 NPANRLGAGPDGVEEIKRH 282 (304)
T ss_dssp SGGGSTTCSTTTHHHHHTS
T ss_pred CHHHCCCCCcCCHHHHHcC
Confidence 99999984 566654
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-51 Score=349.13 Aligned_cols=228 Identities=26% Similarity=0.400 Sum_probs=181.4
Q ss_pred cCCcEEEEEEeecCCC--cchhHHHHHHHHHhcCCCCcccceeeEeee----CCeeEEEEecCCCCChhhhhcccCCCCC
Q 021490 7 CLLQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCAD----GDQRLLVYEYMPLGSVEDHLHDLSPGKK 80 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 80 (311)
.+|+.||+|++..... ...+.|.+|+++|+.|+|||||+++++|.+ +..+|||||||+||+|.+++.. .+
T Consensus 49 ~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~l~~----~~ 124 (290)
T 3fpq_A 49 ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR----FK 124 (290)
T ss_dssp TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECCCSCBHHHHHHH----HS
T ss_pred CCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCCCCCCHHHHHHh----cC
Confidence 3689999999976533 334689999999999999999999999865 3458999999999999999987 57
Q ss_pred CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEc-CCCceEEccccccccCCCCCCceeeeeccccccccCc
Q 021490 81 PLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD-RGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 159 (311)
Q Consensus 81 ~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aP 159 (311)
.+++..+..++.||+.||+|||+++ ++|+||||||+|||++ .+|.+||+|||++..... .......||+.|+||
T Consensus 125 ~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~----~~~~~~~GTp~YmAP 199 (290)
T 3fpq_A 125 VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA----SFAKAVIGTPEFMAP 199 (290)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT----TSBEESCSSCCCCCG
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC----CccCCcccCccccCH
Confidence 8999999999999999999999874 3499999999999997 478999999999975322 123345799999999
Q ss_pred cccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHH
Q 021490 160 EYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVA 239 (311)
Q Consensus 160 E~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 239 (311)
|++.+ .++.++|||||||++|+|+||..||......... ... +..... .+.+. ...+.++.+||
T Consensus 200 E~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~--~~~----i~~~~~-----~~~~~----~~~~~~~~~li 263 (290)
T 3fpq_A 200 EMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI--YRR----VTSGVK-----PASFD----KVAIPEVKEII 263 (290)
T ss_dssp GGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH--HHH----HTTTCC-----CGGGG----GCCCHHHHHHH
T ss_pred HHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHH--HHH----HHcCCC-----CCCCC----ccCCHHHHHHH
Confidence 99875 6999999999999999999999999764432221 110 111000 01111 12234788999
Q ss_pred HHccccCCCCCCCHHHHHHH
Q 021490 240 AMCVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 240 ~~~l~~~p~~Rps~~~vl~~ 259 (311)
.+||+.||++|||+.|+++.
T Consensus 264 ~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 264 EGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp HHHSCSSGGGSCCHHHHHTS
T ss_pred HHHccCChhHCcCHHHHhcC
Confidence 99999999999999999875
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-51 Score=358.81 Aligned_cols=239 Identities=27% Similarity=0.378 Sum_probs=192.4
Q ss_pred CcEEEEEEeecCCCc-chhHHHHHHHHHhcCCC-CcccceeeEeeeC-CeeEEEEecCCCCChhhhhcccCC--------
Q 021490 9 LQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHH-PNLVNLIGYCADG-DQRLLVYEYMPLGSVEDHLHDLSP-------- 77 (311)
Q Consensus 9 g~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~-------- 77 (311)
++.||||+++..... ..+.|.+|+++|.+++| ||||+++++|.+. ..+++|||||++|+|.+++.....
T Consensus 94 ~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~ 173 (353)
T 4ase_A 94 CRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 173 (353)
T ss_dssp EEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC---
T ss_pred CeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhccccccccccc
Confidence 468999999765443 34679999999999975 8999999998664 568999999999999999975321
Q ss_pred ----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeecccc
Q 021490 78 ----GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT 153 (311)
Q Consensus 78 ----~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~ 153 (311)
....+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++...............||
T Consensus 174 ~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt 250 (353)
T 4ase_A 174 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 250 (353)
T ss_dssp ----CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEEC
T ss_pred chhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccCccceeeCCCCCEEECcchhhhhcccCCCceeecccccc
Confidence 1345899999999999999999999999 999999999999999999999999999865444333344455689
Q ss_pred ccccCccccccCCCccccceeehhHHHHHHHh-CCCccCcchhHHH-HHHHHHhhhhhccccccccccCccccCCCChHh
Q 021490 154 YGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAE-QSLVAWARPLFQDRTRHSLIADPELQGQYPPRG 231 (311)
Q Consensus 154 ~~y~aPE~~~~~~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (311)
+.|+|||++.+..++.++|||||||++|||+| |..||........ ...+. ... ....|...
T Consensus 251 ~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~-------~g~----------~~~~p~~~ 313 (353)
T 4ase_A 251 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK-------EGT----------RMRAPDYT 313 (353)
T ss_dssp GGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHH-------HTC----------CCCCCTTC
T ss_pred ccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHH-------cCC----------CCCCCccC
Confidence 99999999999999999999999999999998 8999986543221 11111 100 01122334
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhcc
Q 021490 232 FYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQK 267 (311)
Q Consensus 232 ~~~l~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~~ 267 (311)
+.++.+++.+||+.||++|||+.++++.|+.+.+..
T Consensus 314 ~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~ 349 (353)
T 4ase_A 314 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 349 (353)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred CHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence 458899999999999999999999999998876543
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=344.12 Aligned_cols=254 Identities=22% Similarity=0.270 Sum_probs=181.3
Q ss_pred cchhccCCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCC----eeEEEEecCCCCChhhhhcccCC
Q 021490 2 MQVILCLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD----QRLLVYEYMPLGSVEDHLHDLSP 77 (311)
Q Consensus 2 ~~~~~~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~ 77 (311)
|++.. +|+.||||+++... .....+..|+..+..++||||+++++++.++. .+|||||||++|+|.+++..
T Consensus 20 y~~~~-~g~~VAvK~l~~~~-~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~--- 94 (303)
T 3hmm_A 20 WRGKW-RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR--- 94 (303)
T ss_dssp EEEEE-TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH---
T ss_pred EEEEE-CCEEEEEEEECccc-hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCCcHHHHHHh---
Confidence 44444 68999999996432 11123334566667889999999999997653 57999999999999999986
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHhhcCC-----CCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCce--eeeec
Q 021490 78 GKKPLDWNTRMKIAAGAARGLEYLHDKA-----KPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH--VSTRV 150 (311)
Q Consensus 78 ~~~~l~~~~~~~~~~~i~~~l~~lh~~~-----~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~--~~~~~ 150 (311)
..+++..+..++.|++.||+|||++. .++|+||||||+|||++.++.+||+|||++.......... .....
T Consensus 95 --~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~ 172 (303)
T 3hmm_A 95 --YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHR 172 (303)
T ss_dssp --CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC----
T ss_pred --CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCCCceeeecccc
Confidence 46999999999999999999999871 1129999999999999999999999999987543322211 12335
Q ss_pred cccccccCccccccC------CCccccceeehhHHHHHHHhCCCccCcchhHHHH--------HHHHHhhhhhccccccc
Q 021490 151 MGTYGYCAPEYAKTG------QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ--------SLVAWARPLFQDRTRHS 216 (311)
Q Consensus 151 ~~~~~y~aPE~~~~~------~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~--------~~~~~~~~~~~~~~~~~ 216 (311)
.||+.|+|||++.+. .++.++|||||||++|||+||..||......... .............
T Consensus 173 ~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~---- 248 (303)
T 3hmm_A 173 VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQ---- 248 (303)
T ss_dssp -CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTS----
T ss_pred cccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHHHHHHhcc----
Confidence 699999999998754 4678999999999999999998877533211000 0000000000000
Q ss_pred cccCccccCC-CChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhcc
Q 021490 217 LIADPELQGQ-YPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQK 267 (311)
Q Consensus 217 ~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~~ 267 (311)
...|.+... .+......+.+|+.+||+.||++|||+.+|++.|+.+.+..
T Consensus 249 -~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~ 299 (303)
T 3hmm_A 249 -KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp -CCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred -cCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHc
Confidence 011111111 12244567889999999999999999999999999887653
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-48 Score=333.90 Aligned_cols=227 Identities=21% Similarity=0.303 Sum_probs=171.5
Q ss_pred cCCcEEEEEEeecCCCc-chhHHHHHHHHHhcCCCCcccceeeEeeeCC------------eeEEEEecCCCCChhhhhc
Q 021490 7 CLLQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGD------------QRLLVYEYMPLGSVEDHLH 73 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------------~~~lv~e~~~~~~L~~~l~ 73 (311)
.+|+.||||+++..... ..+.+.+|+.+|+.|+||||++++++|.+.+ .+|+|||||+||+|.+++.
T Consensus 28 ~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~ 107 (299)
T 4g31_A 28 VDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMN 107 (299)
T ss_dssp TTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CEEEEEEEECCCSCCHHHHHH
T ss_pred CCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHH
Confidence 36999999999765433 3468999999999999999999999986544 3699999999999999998
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCc---------
Q 021490 74 DLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT--------- 144 (311)
Q Consensus 74 ~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~--------- 144 (311)
... .....++..++.++.||+.||+|||+++ |+||||||+|||++.+|.+||+|||++.........
T Consensus 108 ~~~-~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~ 183 (299)
T 4g31_A 108 GRC-TIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183 (299)
T ss_dssp TCC-SGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCCCC------------------
T ss_pred hcC-CCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEccCccceecCCCcccccccccccc
Confidence 632 1233566778999999999999999999 999999999999999999999999999764322111
Q ss_pred -eeeeeccccccccCccccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccc
Q 021490 145 -HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPEL 223 (311)
Q Consensus 145 -~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (311)
.......||+.|+|||++.+..++.++|||||||++|||++ ||....... ...... ..
T Consensus 184 ~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~--~~~~~~----~~------------ 242 (299)
T 4g31_A 184 YARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERV--RTLTDV----RN------------ 242 (299)
T ss_dssp --------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHH--HHHHHH----HT------------
T ss_pred ccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHH--HHHHHH----hc------------
Confidence 11123469999999999999999999999999999999996 775432211 111100 00
Q ss_pred cCCCC---hHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 021490 224 QGQYP---PRGFYQALAVAAMCVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 224 ~~~~~---~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~ 259 (311)
..++ ...+..+.+|+.+||+.||++|||+.|+++.
T Consensus 243 -~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 243 -LKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp -TCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -CCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0111 1223456789999999999999999999875
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-47 Score=339.48 Aligned_cols=247 Identities=23% Similarity=0.259 Sum_probs=186.7
Q ss_pred cCCcEEEEEEeecCCC--cchhHHHHHHHHHhcCCCCcccceeeEeee------CCeeEEEEecCCCCChhhhhcccCCC
Q 021490 7 CLLQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCAD------GDQRLLVYEYMPLGSVEDHLHDLSPG 78 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~~~l~~~~~~ 78 (311)
.+|+.||||+++.... ...+.+.+|+++|+.|+||||+++++++.. ...+|||||||+ |+|.+++..
T Consensus 77 ~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~-g~L~~~i~~---- 151 (398)
T 4b99_A 77 LTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLME-SDLHQIIHS---- 151 (398)
T ss_dssp TTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEECCS-EEHHHHHTS----
T ss_pred CCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEEEeCCC-CCHHHHHHh----
Confidence 3699999999975543 234678899999999999999999998753 357899999996 679999986
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCC--Cceeeeeccccccc
Q 021490 79 KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD--NTHVSTRVMGTYGY 156 (311)
Q Consensus 79 ~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~y 156 (311)
.+.+++..+..++.||+.||+|||++| |+||||||+|||++.+|.+||+|||++....... .........||+.|
T Consensus 152 ~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y 228 (398)
T 4b99_A 152 SQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWY 228 (398)
T ss_dssp SSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCC-------CCCCCSSCCCCTT
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceeeecccCccccccccccceeChHh
Confidence 678999999999999999999999999 9999999999999999999999999997543221 11223345799999
Q ss_pred cCccccccC-CCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhcccccccc---------ccCcccc--
Q 021490 157 CAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSL---------IADPELQ-- 224 (311)
Q Consensus 157 ~aPE~~~~~-~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~-- 224 (311)
+|||++.+. .++.++||||+||++|+|++|.+||.+.+.......+............... ...+...
T Consensus 229 ~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (398)
T 4b99_A 229 RAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPV 308 (398)
T ss_dssp CCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCC
T ss_pred cCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCC
Confidence 999998764 5689999999999999999999999887765554433222111100000000 0000000
Q ss_pred --CCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 021490 225 --GQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 261 (311)
Q Consensus 225 --~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l~ 261 (311)
....+..+.++.+||.+||.+||++|||+.|+++.-.
T Consensus 309 ~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~ 347 (398)
T 4b99_A 309 PWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPF 347 (398)
T ss_dssp CHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGG
T ss_pred CHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHh
Confidence 0001123457889999999999999999999998743
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-46 Score=325.50 Aligned_cols=263 Identities=39% Similarity=0.640 Sum_probs=216.3
Q ss_pred CcchhccCCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCC
Q 021490 1 MMQVILCLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKK 80 (311)
Q Consensus 1 ~~~~~~~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 80 (311)
||.+...+|+.||||++........+.+.+|+.+++.++||||+++++++.+....++||||+++++|.+++........
T Consensus 55 Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 134 (321)
T 2qkw_B 55 VYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTM 134 (321)
T ss_dssp EEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSC
T ss_pred EEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCcc
Confidence 35556668999999998777666678899999999999999999999999999999999999999999999976443345
Q ss_pred CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcc
Q 021490 81 PLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 160 (311)
Q Consensus 81 ~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE 160 (311)
.+++..++.++.|++.||+|||+++ ++||||||+||+++.++.++|+|||++................++..|+|||
T Consensus 135 ~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE 211 (321)
T 2qkw_B 135 SMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPE 211 (321)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHH
T ss_pred ccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecccccccccccccccccccCCCccccCHH
Confidence 6999999999999999999999999 9999999999999999999999999987543322222233445889999999
Q ss_pred ccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHH
Q 021490 161 YAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAA 240 (311)
Q Consensus 161 ~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 240 (311)
++.+..++.++||||||+++|+|++|..||.............|...... ........++.+....++..+..+.+++.
T Consensus 212 ~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 290 (321)
T 2qkw_B 212 YFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN-NGQLEQIVDPNLADKIRPESLRKFGDTAV 290 (321)
T ss_dssp HHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHT-TTCCCSSSSSSCTTCSCHHHHHHHHHHHH
T ss_pred HhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccc-cccHHHhcChhhccccCHHHHHHHHHHHH
Confidence 99888999999999999999999999999976554433333333322211 12223344566666777888899999999
Q ss_pred HccccCCCCCCCHHHHHHHHHHhhhcc
Q 021490 241 MCVHEQPDMRPVIADVVTALAYLASQK 267 (311)
Q Consensus 241 ~~l~~~p~~Rps~~~vl~~l~~~~~~~ 267 (311)
+||+.||++|||+.++++.|+.+....
T Consensus 291 ~~l~~dP~~Rps~~ell~~L~~~l~~~ 317 (321)
T 2qkw_B 291 KCLALSSEDRPSMGDVLWKLEYALRLQ 317 (321)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred HHcCCCcccCcCHHHHHHHHHHHhhcc
Confidence 999999999999999999999887654
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=350.78 Aligned_cols=231 Identities=21% Similarity=0.255 Sum_probs=191.8
Q ss_pred cCCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHH
Q 021490 7 CLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNT 86 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~ 86 (311)
.+|+.||||++........+.+.+|+.+|+.|+||||++++++|.++..+|||||||+||+|.+++.. ..+.+++..
T Consensus 180 ~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L~~~i~~---~~~~l~e~~ 256 (573)
T 3uto_A 180 ATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD---EHNKMSEDE 256 (573)
T ss_dssp TTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCCCBHHHHHTC---TTSCEEHHH
T ss_pred CCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHHH---hCCCCCHHH
Confidence 37999999999776666677899999999999999999999999999999999999999999999865 246799999
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCC--CceEEccccccccCCCCCCceeeeeccccccccCcccccc
Q 021490 87 RMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG--YHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT 164 (311)
Q Consensus 87 ~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~--~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 164 (311)
+..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||++...... .......||+.|+|||++.+
T Consensus 257 ~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~---~~~~~~~GT~~y~APEv~~~ 330 (573)
T 3uto_A 257 AVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK---QSVKVTTGTAEFAAPEVAEG 330 (573)
T ss_dssp HHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT---SEEEEECSSGGGCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC---CceeeeEECccccCHHHhCC
Confidence 9999999999999999999 9999999999999854 89999999999864322 22334579999999999999
Q ss_pred CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccc
Q 021490 165 GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVH 244 (311)
Q Consensus 165 ~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 244 (311)
..++.++|||||||++|+|++|..||...........+.... . .+........+.++.+||.+||+
T Consensus 331 ~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~------~--------~~~~~~~~~~s~~~~dli~~~L~ 396 (573)
T 3uto_A 331 KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCD------W--------NMDDSAFSGISEDGKDFIRKLLL 396 (573)
T ss_dssp CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTC------C--------CCCSGGGTTSCHHHHHHHHTTSC
T ss_pred CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCC------C--------CCCcccccCCCHHHHHHHHHHcc
Confidence 999999999999999999999999998766544332221110 0 00011112334578899999999
Q ss_pred cCCCCCCCHHHHHHHH
Q 021490 245 EQPDMRPVIADVVTAL 260 (311)
Q Consensus 245 ~~p~~Rps~~~vl~~l 260 (311)
.||.+|||+.|+++.-
T Consensus 397 ~dp~~R~t~~e~l~Hp 412 (573)
T 3uto_A 397 ADPNTRMTIHQALEHP 412 (573)
T ss_dssp SSGGGSCCHHHHHHST
T ss_pred CChhHCcCHHHHhcCc
Confidence 9999999999998763
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=325.60 Aligned_cols=241 Identities=21% Similarity=0.219 Sum_probs=177.6
Q ss_pred CCcEEEEEEeecCCCcchhHHHHHHHHHhcC-CCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHH
Q 021490 8 LLQDVAIKQLDRNGVQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNT 86 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~ 86 (311)
.++.||||++.... ...++.+|+++|..+ +||||++++++|.+++..|+|||||+|++|.+++.. +++..
T Consensus 48 ~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~g~~L~~~~~~-------l~~~~ 118 (361)
T 4f9c_A 48 PEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILNS-------LSFQE 118 (361)
T ss_dssp CEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECCCCCCHHHHHTT-------CCHHH
T ss_pred CCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCCCcccHHHHHcC-------CCHHH
Confidence 57899999985543 456788999999998 699999999999999999999999999999999853 89999
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCC-CceEEccccccccCCCCCC----------------------
Q 021490 87 RMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG-YHPKLSDFGLAKLGPVGDN---------------------- 143 (311)
Q Consensus 87 ~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~-~~~~l~df~~~~~~~~~~~---------------------- 143 (311)
+..++.|++.||+|||++| |+||||||+|||++.+ +.+||+|||+++.......
T Consensus 119 ~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (361)
T 4f9c_A 119 VREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSI 195 (361)
T ss_dssp HHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC----------------
T ss_pred HHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccccccccccccccccccccccccc
Confidence 9999999999999999999 9999999999999876 8999999999964322110
Q ss_pred ----ceeeeeccccccccCccccccC-CCccccceeehhHHHHHHHhCCCccCcchhH-HHHHHHHHhh---------hh
Q 021490 144 ----THVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAA-AEQSLVAWAR---------PL 208 (311)
Q Consensus 144 ----~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~-~~~~~~~~~~---------~~ 208 (311)
........||+.|+|||++.+. .++.++||||+||++|+|++|..||...... .....+.... ..
T Consensus 196 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~ 275 (361)
T 4f9c_A 196 CLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKT 275 (361)
T ss_dssp ----------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred cccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhh
Confidence 0111234699999999998775 5899999999999999999999999544322 2111111000 00
Q ss_pred hcccc-c-----------------cccccCccc---------cCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 021490 209 FQDRT-R-----------------HSLIADPEL---------QGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 260 (311)
Q Consensus 209 ~~~~~-~-----------------~~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l 260 (311)
+.... . ......|.+ ........+.++.+|+.+||++||++|||++|+++.-
T Consensus 276 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp 354 (361)
T 4f9c_A 276 FGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHP 354 (361)
T ss_dssp TTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSG
T ss_pred ccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCc
Confidence 00000 0 000000000 0011123356789999999999999999999998753
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=343.69 Aligned_cols=227 Identities=24% Similarity=0.264 Sum_probs=182.1
Q ss_pred CCcEEEEEEeecCCC---cchhHHHH---HHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCC
Q 021490 8 LLQDVAIKQLDRNGV---QGNREFLV---EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKP 81 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~---~~~~~~~~---e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 81 (311)
+|+.||||++++... .....+.+ ++.++..++||||++++++|.+...+|+|||||+||+|.+++.. .+.
T Consensus 213 tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVmEy~~GGdL~~~l~~----~~~ 288 (689)
T 3v5w_A 213 TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ----HGV 288 (689)
T ss_dssp TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH----HCC
T ss_pred CCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEEecCCCCcHHHHHHh----cCC
Confidence 699999999975432 22233444 46677788999999999999999999999999999999999987 578
Q ss_pred CCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccc
Q 021490 82 LDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 161 (311)
Q Consensus 82 l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 161 (311)
+++..+..++.||+.||+|||++| |+||||||+|||++.+|.+||+|||++....... .....||+.|+|||+
T Consensus 289 l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~----~~t~~GTp~YmAPEv 361 (689)
T 3v5w_A 289 FSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEV 361 (689)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSCC----CCSCCSCGGGCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeecCCCC----CCCccCCcCccCHHH
Confidence 999999999999999999999999 9999999999999999999999999997543221 223579999999999
Q ss_pred ccc-CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHH
Q 021490 162 AKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAA 240 (311)
Q Consensus 162 ~~~-~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 240 (311)
+.. ..|+.++|||||||++|+|++|..||..........+..... .. . ..++...+.++.+||.
T Consensus 362 l~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~---~~--------~----~~~p~~~S~~a~dLI~ 426 (689)
T 3v5w_A 362 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL---TM--------A----VELPDSFSPELRSLLE 426 (689)
T ss_dssp HSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHH---HC--------C----CCCCTTSCHHHHHHHH
T ss_pred HhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhc---CC--------C----CCCCccCCHHHHHHHH
Confidence 964 679999999999999999999999997654322222211111 00 0 1223344568899999
Q ss_pred HccccCCCCCCC-----HHHHHHHH
Q 021490 241 MCVHEQPDMRPV-----IADVVTAL 260 (311)
Q Consensus 241 ~~l~~~p~~Rps-----~~~vl~~l 260 (311)
+||+.||.+|++ ++|+++.-
T Consensus 427 ~lL~~dP~~Rl~~~~~ga~ei~~Hp 451 (689)
T 3v5w_A 427 GLLQRDVNRRLGCLGRGAQEVKESP 451 (689)
T ss_dssp HHTCSCGGGCTTCSSSTHHHHTTSG
T ss_pred HHccCCHhHCCCCCCCCHHHHhcCc
Confidence 999999999998 67877653
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=314.39 Aligned_cols=257 Identities=41% Similarity=0.685 Sum_probs=207.9
Q ss_pred CcchhccCCcEEEEEEeecCCCc-chhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCC
Q 021490 1 MMQVILCLLQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGK 79 (311)
Q Consensus 1 ~~~~~~~~g~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~ 79 (311)
||.+...+|+.||||+++..... ....+.+|+.++..++||||+++++++.+....++||||+++++|.+++.......
T Consensus 46 V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~ 125 (326)
T 3uim_A 46 VYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQ 125 (326)
T ss_dssp EEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTC
T ss_pred EEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccC
Confidence 35556668999999999765432 33479999999999999999999999999999999999999999999998765555
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhcC---CCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccc
Q 021490 80 KPLDWNTRMKIAAGAARGLEYLHDK---AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY 156 (311)
Q Consensus 80 ~~l~~~~~~~~~~~i~~~l~~lh~~---~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y 156 (311)
..+++..++.++.|++.||+|||+. + ++||||||+||+++.++.++|+|||++....... ........++..|
T Consensus 126 ~~~~~~~~~~i~~~i~~~l~~lH~~~~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~gt~~y 201 (326)
T 3uim_A 126 PPLDWPKRQRIALGSARGLAYLHDHCDPK---IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD-THVTTAVRGTIGH 201 (326)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHHHHSSSSC---EECCCCSGGGEEECTTCCEEECCCSSCEECCSSS-SCEECCCCSCGGG
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCC---eEeCCCchhhEEECCCCCEEeccCccccccCccc-ccccccccCCcCc
Confidence 6799999999999999999999999 8 9999999999999999999999999997543222 2223334589999
Q ss_pred cCccccccCCCccccceeehhHHHHHHHhCCCccCcchhHH--HHHHHHHhhhhhccccccccccCccccCCCChHhHHH
Q 021490 157 CAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA--EQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQ 234 (311)
Q Consensus 157 ~aPE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
+|||++.+..++.++||||||+++|+|++|..||....... ......|...... ........+..+...++...+..
T Consensus 202 ~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 280 (326)
T 3uim_A 202 IAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK-EKKLEALVDVDLQGNYKDEEVEQ 280 (326)
T ss_dssp CCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTS-SCCSTTSSCTTCTTSCCHHHHHH
T ss_pred cCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhh-chhhhhhcChhhccccCHHHHHH
Confidence 99999988889999999999999999999999997433221 1122233322222 22333445556666778888899
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHHHHH
Q 021490 235 ALAVAAMCVHEQPDMRPVIADVVTALAY 262 (311)
Q Consensus 235 l~~li~~~l~~~p~~Rps~~~vl~~l~~ 262 (311)
+.+++.+||+.||.+|||+.++++.|+.
T Consensus 281 l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 281 LIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp HHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred HHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 9999999999999999999999999975
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-44 Score=307.63 Aligned_cols=229 Identities=24% Similarity=0.333 Sum_probs=191.5
Q ss_pred cCCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHH
Q 021490 7 CLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNT 86 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~ 86 (311)
.+|+.||||++........+.+.+|+.+++.++||||+++++++.++...++||||++|++|.+++.. ..+++..
T Consensus 43 ~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~ 117 (297)
T 3fxz_A 43 ATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQ 117 (297)
T ss_dssp TTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH-----SCCCHHH
T ss_pred CCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCCCHHHHHhh-----cCCCHHH
Confidence 57899999999877766778899999999999999999999999999999999999999999999986 4699999
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccCC
Q 021490 87 RMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ 166 (311)
Q Consensus 87 ~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 166 (311)
+..++.|++.||+|||+++ ++||||||+||+++.++.++|+|||++....... .......++..|+|||++.+..
T Consensus 118 ~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~ 192 (297)
T 3fxz_A 118 IAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSTMVGTPYWMAPEVVTRKA 192 (297)
T ss_dssp HHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT--CCBCCCCSCGGGCCHHHHHCSC
T ss_pred HHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc--cccCCccCCcCccChhhhcCCC
Confidence 9999999999999999999 9999999999999999999999999986533222 2233456899999999999999
Q ss_pred CccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccC
Q 021490 167 LTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQ 246 (311)
Q Consensus 167 ~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 246 (311)
++.++||||||+++|+|++|..||................ .. ....+...+..+.+++.+||+.|
T Consensus 193 ~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~------~~---------~~~~~~~~~~~~~~li~~~l~~d 257 (297)
T 3fxz_A 193 YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG------TP---------ELQNPEKLSAIFRDFLNRCLEMD 257 (297)
T ss_dssp BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHC------SC---------CCSCGGGSCHHHHHHHHHHSCSS
T ss_pred CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC------CC---------CCCCccccCHHHHHHHHHHccCC
Confidence 9999999999999999999999997765443322211110 00 00112334457889999999999
Q ss_pred CCCCCCHHHHHHHH
Q 021490 247 PDMRPVIADVVTAL 260 (311)
Q Consensus 247 p~~Rps~~~vl~~l 260 (311)
|.+|||+.++++..
T Consensus 258 p~~Rps~~ell~h~ 271 (297)
T 3fxz_A 258 VEKRGSAKELLQHQ 271 (297)
T ss_dssp TTTSCCHHHHTTCG
T ss_pred hhHCcCHHHHhhCh
Confidence 99999999999764
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-44 Score=310.38 Aligned_cols=239 Identities=26% Similarity=0.383 Sum_probs=191.6
Q ss_pred cCCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHH
Q 021490 7 CLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNT 86 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~ 86 (311)
.+|..||+|++........+.|.+|++++..++||||+++++++.++...++||||+++++|.+++... ...+++..
T Consensus 33 ~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~ 109 (310)
T 3s95_A 33 ETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSM---DSQYPWSQ 109 (310)
T ss_dssp TTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHC---CTTSCHHH
T ss_pred CCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCcHHHHHHhc---cCCCCHHH
Confidence 368999999997666666789999999999999999999999999999999999999999999999863 46799999
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCce------------eeeeccccc
Q 021490 87 RMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH------------VSTRVMGTY 154 (311)
Q Consensus 87 ~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~------------~~~~~~~~~ 154 (311)
++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.......... ......|++
T Consensus 110 ~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 186 (310)
T 3s95_A 110 RVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNP 186 (310)
T ss_dssp HHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC--------------------CCCCSCG
T ss_pred HHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccccccccccccccccccccccCCCc
Confidence 9999999999999999999 9999999999999999999999999987543222111 011346899
Q ss_pred cccCccccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHH
Q 021490 155 GYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQ 234 (311)
Q Consensus 155 ~y~aPE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
.|+|||++.+..++.++||||||+++|+|++|..||.......... ............++..+..
T Consensus 187 ~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~ 251 (310)
T 3s95_A 187 YWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF---------------GLNVRGFLDRYCPPNCPPS 251 (310)
T ss_dssp GGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS---------------SBCHHHHHHHTCCTTCCTT
T ss_pred ceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH---------------hhhhhccccccCCCCCCHH
Confidence 9999999999999999999999999999999999986532211100 0000000000112223346
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 021490 235 ALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 266 (311)
Q Consensus 235 l~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~ 266 (311)
+.+++.+||+.||.+|||+.++++.|+.+...
T Consensus 252 l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~ 283 (310)
T 3s95_A 252 FFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283 (310)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 88899999999999999999999999988754
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=311.03 Aligned_cols=238 Identities=27% Similarity=0.359 Sum_probs=191.6
Q ss_pred CCcEEEEEEeecCCC-cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHH
Q 021490 8 LLQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNT 86 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~ 86 (311)
.+..||||+++.... ...+.|.+|+.++..++||||+++++++.++...++||||++|++|.+++... ...+++..
T Consensus 76 ~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~ 152 (325)
T 3kul_A 76 RDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTH---DGQFTIMQ 152 (325)
T ss_dssp CCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEECCTTCBHHHHHHTT---TTCSCHHH
T ss_pred CCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeCCCCCcHHHHHHhc---ccCCCHHH
Confidence 455699999976533 33468999999999999999999999999999999999999999999999752 45799999
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCc-eeeeeccccccccCccccccC
Q 021490 87 RMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT-HVSTRVMGTYGYCAPEYAKTG 165 (311)
Q Consensus 87 ~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~ 165 (311)
++.++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++......... .......++..|+|||++.+.
T Consensus 153 ~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~ 229 (325)
T 3kul_A 153 LVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFR 229 (325)
T ss_dssp HHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHC
T ss_pred HHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCC
Confidence 9999999999999999999 999999999999999999999999999764332211 122233457789999999989
Q ss_pred CCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccc
Q 021490 166 QLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVH 244 (311)
Q Consensus 166 ~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 244 (311)
.++.++||||||+++|+|++ |..||...........+... .....+...+..+.+|+.+||.
T Consensus 230 ~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~l~~li~~~l~ 292 (325)
T 3kul_A 230 TFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEG-----------------YRLPAPMGCPHALHQLMLDCWH 292 (325)
T ss_dssp EECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTT-----------------CCCCCCTTCCHHHHHHHHHHTC
T ss_pred CCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC-----------------CCCCCCCCcCHHHHHHHHHHcc
Confidence 99999999999999999999 99999776554332222110 0011222344588899999999
Q ss_pred cCCCCCCCHHHHHHHHHHhhhccC
Q 021490 245 EQPDMRPVIADVVTALAYLASQKY 268 (311)
Q Consensus 245 ~~p~~Rps~~~vl~~l~~~~~~~~ 268 (311)
.||.+|||+.++++.|+.+.....
T Consensus 293 ~dp~~Rps~~eil~~L~~l~~~~~ 316 (325)
T 3kul_A 293 KDRAQRPRFSQIVSVLDALIRSPE 316 (325)
T ss_dssp SSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred CChhhCcCHHHHHHHHHHHHhCcc
Confidence 999999999999999998876543
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=315.98 Aligned_cols=240 Identities=25% Similarity=0.375 Sum_probs=193.8
Q ss_pred CCcEEEEEEeecCCC-cchhHHHHHHHHHhcC-CCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCC--------
Q 021490 8 LLQDVAIKQLDRNGV-QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP-------- 77 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-------- 77 (311)
++..||||+++.... ...+.+.+|+.+++.+ +||||+++++++.+....|+||||+++|+|.+++.....
T Consensus 112 ~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 191 (370)
T 2psq_A 112 EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD 191 (370)
T ss_dssp CEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-------
T ss_pred cceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCcccccccc
Confidence 467899999976533 2346899999999999 899999999999999999999999999999999986421
Q ss_pred ----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeecccc
Q 021490 78 ----GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT 153 (311)
Q Consensus 78 ----~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~ 153 (311)
....+++..++.++.||+.||+|||+++ ++||||||+|||++.++.+||+|||++................++
T Consensus 192 ~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t 268 (370)
T 2psq_A 192 INRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP 268 (370)
T ss_dssp ----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSC
T ss_pred ccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcc
Confidence 1245899999999999999999999999 999999999999999999999999999754332222222234567
Q ss_pred ccccCccccccCCCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhH
Q 021490 154 YGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGF 232 (311)
Q Consensus 154 ~~y~aPE~~~~~~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (311)
..|+|||++.+..++.++|||||||++|+|++ |..||...........+... . ....+...+
T Consensus 269 ~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~-------~----------~~~~~~~~~ 331 (370)
T 2psq_A 269 VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG-------H----------RMDKPANCT 331 (370)
T ss_dssp GGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT-------C----------CCCCCTTSC
T ss_pred cceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC-------C----------CCCCCCCCC
Confidence 88999999999999999999999999999999 99999876543322211100 0 011223344
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhcc
Q 021490 233 YQALAVAAMCVHEQPDMRPVIADVVTALAYLASQK 267 (311)
Q Consensus 233 ~~l~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~~ 267 (311)
..+.+++.+||+.||.+|||+.++++.|+.+....
T Consensus 332 ~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~ 366 (370)
T 2psq_A 332 NELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 366 (370)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 58899999999999999999999999999887654
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-44 Score=311.53 Aligned_cols=227 Identities=24% Similarity=0.329 Sum_probs=188.8
Q ss_pred cCCcEEEEEEeecCCC--cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCH
Q 021490 7 CLLQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 84 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~ 84 (311)
.+|+.||||++..... ...+.+.+|+++++.++||||+++++++.+....|+||||++|++|.+++.. .+.+++
T Consensus 38 ~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~ 113 (328)
T 3fe3_A 38 LTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVA----HGRMKE 113 (328)
T ss_dssp TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHH----HCCCCH
T ss_pred CCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCCCCcHHHHHHH----cCCCCH
Confidence 4799999999976532 3446788999999999999999999999999999999999999999999977 567999
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccccc
Q 021490 85 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT 164 (311)
Q Consensus 85 ~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 164 (311)
..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++....... ......+++.|+|||++.+
T Consensus 114 ~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~ 187 (328)
T 3fe3_A 114 KEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG---KLDAFCGAPPYAAPELFQG 187 (328)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC---GGGTTSSSGGGCCHHHHHT
T ss_pred HHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCCC---ccccccCCcceeCcccccC
Confidence 999999999999999999999 9999999999999999999999999987533221 2233568999999999988
Q ss_pred CCCc-cccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHcc
Q 021490 165 GQLT-LKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCV 243 (311)
Q Consensus 165 ~~~~-~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 243 (311)
..+. .++|||||||++|+|++|..||...........+... . ...+...+..+.+|+.+||
T Consensus 188 ~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~------~------------~~~p~~~s~~~~~li~~~L 249 (328)
T 3fe3_A 188 KKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG------K------------YRIPFYMSTDCENLLKRFL 249 (328)
T ss_dssp CCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------C------------CCCCTTSCHHHHHHHHHHC
T ss_pred CCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------C------------CCCCCCCCHHHHHHHHHHC
Confidence 7764 7899999999999999999999876654433222111 0 0112223457889999999
Q ss_pred ccCCCCCCCHHHHHHHHH
Q 021490 244 HEQPDMRPVIADVVTALA 261 (311)
Q Consensus 244 ~~~p~~Rps~~~vl~~l~ 261 (311)
..||.+|||++++++..+
T Consensus 250 ~~dP~~R~t~~eil~h~~ 267 (328)
T 3fe3_A 250 VLNPIKRGTLEQIMKDRW 267 (328)
T ss_dssp CSSTTTSCCHHHHTTCTT
T ss_pred CCChhHCcCHHHHhcCHh
Confidence 999999999999998743
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=319.34 Aligned_cols=242 Identities=26% Similarity=0.335 Sum_probs=192.9
Q ss_pred cchhcc-CCcEEEEEEeecCCC-cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCC
Q 021490 2 MQVILC-LLQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGK 79 (311)
Q Consensus 2 ~~~~~~-~g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~ 79 (311)
|.+... +|+.||||+++.... ...+.|.+|+.+++.++||||+++++++.++...++||||+++++|.+++... +
T Consensus 131 ~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~ 207 (377)
T 3cbl_A 131 FSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTE---G 207 (377)
T ss_dssp EEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHH---G
T ss_pred EEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHhc---C
Confidence 334443 789999999875432 23357889999999999999999999999999999999999999999999762 3
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCc
Q 021490 80 KPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 159 (311)
Q Consensus 80 ~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aP 159 (311)
..+++..++.++.|++.||+|||+++ ++||||||+|||++.++.+||+|||++................++..|+||
T Consensus 208 ~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aP 284 (377)
T 3cbl_A 208 ARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAP 284 (377)
T ss_dssp GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCH
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCH
Confidence 46999999999999999999999999 999999999999999999999999998753221111111112356789999
Q ss_pred cccccCCCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHH
Q 021490 160 EYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAV 238 (311)
Q Consensus 160 E~~~~~~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 238 (311)
|++.+..++.++||||||+++|+|++ |..||...........+... . ....+...+..+.+|
T Consensus 285 E~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~-------~----------~~~~~~~~~~~l~~l 347 (377)
T 3cbl_A 285 EALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKG-------G----------RLPCPELCPDAVFRL 347 (377)
T ss_dssp HHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTT-------C----------CCCCCTTCCHHHHHH
T ss_pred hHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-------C----------CCCCCCCCCHHHHHH
Confidence 99998899999999999999999998 99999876554332222110 0 011122334578899
Q ss_pred HHHccccCCCCCCCHHHHHHHHHHhhhc
Q 021490 239 AAMCVHEQPDMRPVIADVVTALAYLASQ 266 (311)
Q Consensus 239 i~~~l~~~p~~Rps~~~vl~~l~~~~~~ 266 (311)
+.+||+.||.+|||+.++++.|+.+...
T Consensus 348 i~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 348 MEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 9999999999999999999999988653
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=305.46 Aligned_cols=239 Identities=32% Similarity=0.473 Sum_probs=185.5
Q ss_pred CCcEEEEEEeecCCCc--chhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHH
Q 021490 8 LLQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN 85 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~ 85 (311)
.|..||||++...... ..+.+.+|+.++++++||||+++++++.+....++||||+++++|.+++.... ....+++.
T Consensus 59 ~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~ 137 (309)
T 3p86_A 59 HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSG-AREQLDER 137 (309)
T ss_dssp TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTTCBHHHHHHSTT-HHHHSCHH
T ss_pred CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCCCcHHHHHhhcC-CCCCCCHH
Confidence 6889999999765432 23578999999999999999999999999999999999999999999998621 01239999
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccC
Q 021490 86 TRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG 165 (311)
Q Consensus 86 ~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 165 (311)
.++.++.|++.||+|||+.+ .+++||||||+||+++.++.++|+|||++...... ........++..|+|||++.+.
T Consensus 138 ~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~ 214 (309)
T 3p86_A 138 RRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST--FLSSKSAAGTPEWMAPEVLRDE 214 (309)
T ss_dssp HHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC-------------------CCTTSCHHHHTTC
T ss_pred HHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCcccccc--ccccccCCCCccccChhhhcCC
Confidence 99999999999999999985 45999999999999999999999999998642221 1122335689999999999999
Q ss_pred CCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHcccc
Q 021490 166 QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHE 245 (311)
Q Consensus 166 ~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 245 (311)
.++.++||||||+++|+|++|..||................ . . ...+...+..+.+|+.+||+.
T Consensus 215 ~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~-------~-----~----~~~~~~~~~~l~~li~~~l~~ 278 (309)
T 3p86_A 215 PSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKC-------K-----R----LEIPRNLNPQVAAIIEGCWTN 278 (309)
T ss_dssp CCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSC-------C-----C----CCCCTTSCHHHHHHHHHHTCS
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-------C-----C----CCCCccCCHHHHHHHHHHccC
Confidence 99999999999999999999999998765543322221100 0 0 122333445788999999999
Q ss_pred CCCCCCCHHHHHHHHHHhhhc
Q 021490 246 QPDMRPVIADVVTALAYLASQ 266 (311)
Q Consensus 246 ~p~~Rps~~~vl~~l~~~~~~ 266 (311)
||.+|||+.++++.|+.+...
T Consensus 279 dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 279 EPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp SGGGSCCHHHHHHHHHHHHC-
T ss_pred ChhhCcCHHHHHHHHHHHHHh
Confidence 999999999999999887754
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=300.86 Aligned_cols=239 Identities=26% Similarity=0.389 Sum_probs=194.9
Q ss_pred cchhccCCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCC
Q 021490 2 MQVILCLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKP 81 (311)
Q Consensus 2 ~~~~~~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 81 (311)
|.+...+++.||+|++... ....+.+.+|+.++++++||||+++++++.++...++||||+++++|.+++... ...
T Consensus 27 ~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~ 102 (269)
T 4hcu_A 27 HLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQ---RGL 102 (269)
T ss_dssp EEEEETTTEEEEEEEECTT-SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTT---TTC
T ss_pred EEEEecCCCeEEEEEeccc-ccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHHHHHHhc---Ccc
Confidence 4555668899999999644 345678999999999999999999999999999999999999999999999752 456
Q ss_pred CCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccc
Q 021490 82 LDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 161 (311)
Q Consensus 82 l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 161 (311)
+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++....... ........++..|+|||+
T Consensus 103 ~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~ 178 (269)
T 4hcu_A 103 FAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEV 178 (269)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH-HHSTTSTTCCGGGCCHHH
T ss_pred cCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccc-cccccCcccccccCCHHH
Confidence 999999999999999999999999 9999999999999999999999999987532211 111222345678999999
Q ss_pred cccCCCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHH
Q 021490 162 AKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAA 240 (311)
Q Consensus 162 ~~~~~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 240 (311)
+.+..++.++||||||+++|+|++ |..||...........+... .....+...+..+.+++.
T Consensus 179 ~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~li~ 241 (269)
T 4hcu_A 179 FSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG-----------------FRLYKPRLASTHVYQIMN 241 (269)
T ss_dssp HHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-----------------CCCCCCTTSCHHHHHHHH
T ss_pred hcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC-----------------ccCCCCCcCCHHHHHHHH
Confidence 998999999999999999999999 99999876554332221110 001112223457889999
Q ss_pred HccccCCCCCCCHHHHHHHHHHhhh
Q 021490 241 MCVHEQPDMRPVIADVVTALAYLAS 265 (311)
Q Consensus 241 ~~l~~~p~~Rps~~~vl~~l~~~~~ 265 (311)
+||+.||.+|||+.++++.|+.+..
T Consensus 242 ~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 242 HCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHccCCcccCcCHHHHHHHHHHHHH
Confidence 9999999999999999999998765
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-43 Score=307.34 Aligned_cols=226 Identities=26% Similarity=0.315 Sum_probs=188.3
Q ss_pred CCcEEEEEEeecCC---CcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCH
Q 021490 8 LLQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 84 (311)
Q Consensus 8 ~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~ 84 (311)
+|+.||||++++.. ......+.+|+.++..++||||+++++++.+....|+||||++||+|.+++.. ...+++
T Consensus 29 ~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~ 104 (337)
T 1o6l_A 29 TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR----ERVFTE 104 (337)
T ss_dssp TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH----HSCCCH
T ss_pred CCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHh----cCCCCH
Confidence 68999999997642 23456788999999999999999999999999999999999999999999986 567999
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccccc
Q 021490 85 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT 164 (311)
Q Consensus 85 ~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 164 (311)
..+..++.||+.||+|||+++ |+||||||+|||++.+|.++|+|||++...... ........||+.|+|||++.+
T Consensus 105 ~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~ 179 (337)
T 1o6l_A 105 ERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYLAPEVLED 179 (337)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT--TCCBCCCEECGGGCCGGGGSS
T ss_pred HHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcccC--CCcccccccChhhCChhhhcC
Confidence 999999999999999999999 999999999999999999999999998742221 112233568999999999999
Q ss_pred CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccc
Q 021490 165 GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVH 244 (311)
Q Consensus 165 ~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 244 (311)
..++.++|||||||++|+|++|..||...........+. ... . .++...+..+.+||.+||+
T Consensus 180 ~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~------~~~--------~----~~p~~~s~~~~~li~~lL~ 241 (337)
T 1o6l_A 180 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL------MEE--------I----RFPRTLSPEAKSLLAGLLK 241 (337)
T ss_dssp SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------HCC--------C----CCCTTSCHHHHHHHHHHTC
T ss_pred CCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHH------cCC--------C----CCCCCCCHHHHHHHHHHhh
Confidence 999999999999999999999999998765433322211 110 0 1223344588999999999
Q ss_pred cCCCCCC-----CHHHHHHHH
Q 021490 245 EQPDMRP-----VIADVVTAL 260 (311)
Q Consensus 245 ~~p~~Rp-----s~~~vl~~l 260 (311)
.||.+|| ++.++++.-
T Consensus 242 ~dP~~R~g~~~~~~~ei~~h~ 262 (337)
T 1o6l_A 242 KDPKQRLGGGPSDAKEVMEHR 262 (337)
T ss_dssp SSTTTSTTCSTTTHHHHHTSG
T ss_pred cCHHHhcCCCCCCHHHHHcCC
Confidence 9999999 899998764
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=299.64 Aligned_cols=240 Identities=25% Similarity=0.345 Sum_probs=195.2
Q ss_pred cchhccCCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCC
Q 021490 2 MQVILCLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKP 81 (311)
Q Consensus 2 ~~~~~~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 81 (311)
|.+...++..||+|+++... ...+.+.+|+.++..++||||+++++++.++...++||||+++++|.+++... ...
T Consensus 25 ~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~ 100 (268)
T 3sxs_A 25 KLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSH---GKG 100 (268)
T ss_dssp EEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHH---GGG
T ss_pred EEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCcHHHHHHHc---CCC
Confidence 45566678899999996543 45678999999999999999999999999999999999999999999999762 346
Q ss_pred CCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccc
Q 021490 82 LDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 161 (311)
Q Consensus 82 l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 161 (311)
+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++....... ........++..|+|||+
T Consensus 101 ~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~ 176 (268)
T 3sxs_A 101 LEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ-YVSSVGTKFPVKWSAPEV 176 (268)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTC-EEECCSCCCCGGGCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhh-hhcccCCCcCcccCCHHH
Confidence 999999999999999999999999 9999999999999999999999999987543222 122223446678999999
Q ss_pred cccCCCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHH
Q 021490 162 AKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAA 240 (311)
Q Consensus 162 ~~~~~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 240 (311)
+.+..++.++||||||+++|+|++ |..||................ . ...+...+..+.+++.
T Consensus 177 ~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~----------~-------~~~~~~~~~~l~~li~ 239 (268)
T 3sxs_A 177 FHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGH----------R-------LYRPHLASDTIYQIMY 239 (268)
T ss_dssp HHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC----------C-------CCCCTTSCHHHHHHHH
T ss_pred HhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCC----------C-------CCCCCcChHHHHHHHH
Confidence 998899999999999999999999 999998765543322221110 0 0111222347889999
Q ss_pred HccccCCCCCCCHHHHHHHHHHhhhc
Q 021490 241 MCVHEQPDMRPVIADVVTALAYLASQ 266 (311)
Q Consensus 241 ~~l~~~p~~Rps~~~vl~~l~~~~~~ 266 (311)
+||+.||.+|||+.++++.|+.+..+
T Consensus 240 ~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 240 SCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp HTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred HHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 99999999999999999999887654
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=312.77 Aligned_cols=244 Identities=26% Similarity=0.351 Sum_probs=185.9
Q ss_pred CCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCC----eeEEEEecCCCCChhhhhcccCCCCCCCC
Q 021490 8 LLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD----QRLLVYEYMPLGSVEDHLHDLSPGKKPLD 83 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~l~ 83 (311)
.|+.||||+++... .....+.+|+.++..++||||+++++++.+.. ..++||||+++|+|.+++.. ..++
T Consensus 46 ~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~ 119 (322)
T 3soc_A 46 LNEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA-----NVVS 119 (322)
T ss_dssp TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH-----CCBC
T ss_pred CCCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCCCCHHHHHHh-----cCCC
Confidence 47899999995433 33446667999999999999999999998744 46999999999999999976 4599
Q ss_pred HHHHHHHHHHHHHHHHHhhcC----------CCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeecccc
Q 021490 84 WNTRMKIAAGAARGLEYLHDK----------AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT 153 (311)
Q Consensus 84 ~~~~~~~~~~i~~~l~~lh~~----------~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~ 153 (311)
+..++.++.|++.||+|||+. + ++||||||+|||++.++.+||+|||++................++
T Consensus 120 ~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt 196 (322)
T 3soc_A 120 WNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGT 196 (322)
T ss_dssp HHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCC
T ss_pred HHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEccCCcccccccccCccccccCccC
Confidence 999999999999999999999 8 999999999999999999999999999654333222223335689
Q ss_pred ccccCcccccc-----CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHH----------HHhhhhhccccccccc
Q 021490 154 YGYCAPEYAKT-----GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLV----------AWARPLFQDRTRHSLI 218 (311)
Q Consensus 154 ~~y~aPE~~~~-----~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~ 218 (311)
..|+|||++.+ ..++.++|||||||++|+|++|..||............ ......... .
T Consensus 197 ~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~ 270 (322)
T 3soc_A 197 RRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHK------K 270 (322)
T ss_dssp GGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTS------C
T ss_pred ccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcc------c
Confidence 99999999876 35567899999999999999999999754321111000 000000000 0
Q ss_pred cCccccCC-CChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 021490 219 ADPELQGQ-YPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 266 (311)
Q Consensus 219 ~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~ 266 (311)
..+.+... .....+..+.+|+.+||+.||++|||+.++++.|+.+...
T Consensus 271 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 271 KRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp CCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 01111110 1123456789999999999999999999999999988754
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=303.01 Aligned_cols=236 Identities=20% Similarity=0.264 Sum_probs=193.0
Q ss_pred cchhcc-CCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCC
Q 021490 2 MQVILC-LLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKK 80 (311)
Q Consensus 2 ~~~~~~-~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 80 (311)
|.+... +|+.||||++........+.+.+|+.+++.++||||+++++++......++||||++|++|.+++.. .
T Consensus 62 ~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-----~ 136 (321)
T 2c30_A 62 CLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-----V 136 (321)
T ss_dssp EEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT-----C
T ss_pred EEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh-----c
Confidence 334433 7999999999877766778899999999999999999999999999999999999999999999874 4
Q ss_pred CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcc
Q 021490 81 PLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 160 (311)
Q Consensus 81 ~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE 160 (311)
.+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++....... .......++..|+|||
T Consensus 137 ~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE 211 (321)
T 2c30_A 137 RLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--PKRKSLVGTPYWMAPE 211 (321)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSS--CCBCCCCSCGGGCCHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCcEEEeeeeeeeecccCc--cccccccCCccccCHh
Confidence 6999999999999999999999999 9999999999999999999999999987533221 1223456899999999
Q ss_pred ccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHH
Q 021490 161 YAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAA 240 (311)
Q Consensus 161 ~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 240 (311)
++.+..++.++||||||+++|+|++|..||...........+... . .+.+ ......+..+.+++.
T Consensus 212 ~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~-------~------~~~~--~~~~~~~~~l~~li~ 276 (321)
T 2c30_A 212 VISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS-------P------PPKL--KNSHKVSPVLRDFLE 276 (321)
T ss_dssp HHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS-------S------CCCC--TTGGGSCHHHHHHHH
T ss_pred hhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-------C------CCCc--CccccCCHHHHHHHH
Confidence 999889999999999999999999999999765543322211100 0 0000 011223457889999
Q ss_pred HccccCCCCCCCHHHHHHHHHH
Q 021490 241 MCVHEQPDMRPVIADVVTALAY 262 (311)
Q Consensus 241 ~~l~~~p~~Rps~~~vl~~l~~ 262 (311)
+||+.||++|||+.++++....
T Consensus 277 ~~l~~dp~~Rps~~ell~hp~~ 298 (321)
T 2c30_A 277 RMLVRDPQERATAQELLDHPFL 298 (321)
T ss_dssp HHSCSSTTTSCCHHHHHTSGGG
T ss_pred HHccCChhhCcCHHHHhcChhh
Confidence 9999999999999999987543
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=310.67 Aligned_cols=229 Identities=24% Similarity=0.277 Sum_probs=187.4
Q ss_pred CCcEEEEEEeecCCCc------chhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCC
Q 021490 8 LLQDVAIKQLDRNGVQ------GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKP 81 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 81 (311)
+|+.||+|+++..... ..+.+.+|+.++..++||||+++++++.+....++||||++|++|.+++.. ...
T Consensus 36 ~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~ 111 (361)
T 2yab_A 36 TGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQ----KES 111 (361)
T ss_dssp TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTT----CSC
T ss_pred CCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEEEEcCCCCcHHHHHHh----cCC
Confidence 6899999999765432 346899999999999999999999999999999999999999999999976 567
Q ss_pred CCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCC----ceEEccccccccCCCCCCceeeeecccccccc
Q 021490 82 LDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY----HPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 157 (311)
Q Consensus 82 l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~----~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~ 157 (311)
+++..+..++.|++.||+|||+.| ++||||||+||+++.++ .++|+|||++....... ......|++.|+
T Consensus 112 l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~ 185 (361)
T 2yab_A 112 LSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---EFKNIFGTPEFV 185 (361)
T ss_dssp CBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTTC---CCCCCCSCGGGC
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCCC---ccccCCCCccEE
Confidence 999999999999999999999999 99999999999998877 79999999997543221 223346899999
Q ss_pred CccccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHH
Q 021490 158 APEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALA 237 (311)
Q Consensus 158 aPE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 237 (311)
|||++.+..++.++|||||||++|+|++|..||...........+.... ...++... ...+..+.+
T Consensus 186 aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~----------~~~~~~~~----~~~s~~~~~ 251 (361)
T 2yab_A 186 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVS----------YDFDEEFF----SQTSELAKD 251 (361)
T ss_dssp CHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTC----------CCCCHHHH----TTSCHHHHH
T ss_pred CchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC----------CCCCchhc----cCCCHHHHH
Confidence 9999998899999999999999999999999998765443322211100 00011111 123447889
Q ss_pred HHHHccccCCCCCCCHHHHHHHH
Q 021490 238 VAAMCVHEQPDMRPVIADVVTAL 260 (311)
Q Consensus 238 li~~~l~~~p~~Rps~~~vl~~l 260 (311)
||.+||..||.+|||+.++++..
T Consensus 252 li~~~L~~dP~~R~t~~e~l~hp 274 (361)
T 2yab_A 252 FIRKLLVKETRKRLTIQEALRHP 274 (361)
T ss_dssp HHHHHSCSSTTTSCCHHHHHTST
T ss_pred HHHHHCCCChhHCcCHHHHhcCc
Confidence 99999999999999999998653
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=307.71 Aligned_cols=233 Identities=25% Similarity=0.359 Sum_probs=185.4
Q ss_pred CCcEEEEEEeecCCC-cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHH
Q 021490 8 LLQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNT 86 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~ 86 (311)
+|+.||||++..... ...+.+.+|+.+++.++||||+++++++.++...++||||++|++|.+++.. ...+++..
T Consensus 31 ~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~ 106 (323)
T 3tki_A 31 TEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP----DIGMPEPD 106 (323)
T ss_dssp TCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGSBT----TTBCCHHH
T ss_pred CCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCcHHHHHhh----cCCCCHHH
Confidence 789999999975543 3346788999999999999999999999999999999999999999999986 56799999
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccCC
Q 021490 87 RMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ 166 (311)
Q Consensus 87 ~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 166 (311)
++.++.|++.||+|||+.| ++||||||+||+++.++.++|+|||++................++..|+|||++.+..
T Consensus 107 ~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 183 (323)
T 3tki_A 107 AQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183 (323)
T ss_dssp HHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSS
T ss_pred HHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCC
Confidence 9999999999999999999 9999999999999999999999999987543222222233456899999999998766
Q ss_pred C-ccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHcccc
Q 021490 167 L-TLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHE 245 (311)
Q Consensus 167 ~-~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 245 (311)
+ +.++|||||||++|+|++|..||......... ...+.. .. .. .......+..+.+|+.+||..
T Consensus 184 ~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~~~~~----~~----~~------~~~~~~~~~~~~~li~~~L~~ 248 (323)
T 3tki_A 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDWKE----KK----TY------LNPWKKIDSAPLALLHKILVE 248 (323)
T ss_dssp BCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH-HHHHHT----TC----TT------STTGGGSCHHHHHHHHHHSCS
T ss_pred CCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH-HHHHhc----cc----cc------CCccccCCHHHHHHHHHHccC
Confidence 5 78899999999999999999999765432211 111110 00 00 000122345788999999999
Q ss_pred CCCCCCCHHHHHHHHHH
Q 021490 246 QPDMRPVIADVVTALAY 262 (311)
Q Consensus 246 ~p~~Rps~~~vl~~l~~ 262 (311)
||.+|||+.|+++..+.
T Consensus 249 dP~~R~t~~eil~h~~~ 265 (323)
T 3tki_A 249 NPSARITIPDIKKDRWY 265 (323)
T ss_dssp STTTSCCHHHHTTCTTT
T ss_pred ChhhCcCHHHHhhChhh
Confidence 99999999999987554
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-43 Score=304.51 Aligned_cols=239 Identities=27% Similarity=0.395 Sum_probs=193.4
Q ss_pred CCcEEEEEEeecCCC-cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCC---------
Q 021490 8 LLQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP--------- 77 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------- 77 (311)
+|..||+|+++.... ...+.+.+|+++++.++||||+++++++.+....++||||+++++|.+++.....
T Consensus 52 ~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 131 (314)
T 2ivs_A 52 GYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSG 131 (314)
T ss_dssp SEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC---
T ss_pred CcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCccccc
Confidence 468999999975432 3346889999999999999999999999999999999999999999999986432
Q ss_pred -----------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCcee
Q 021490 78 -----------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHV 146 (311)
Q Consensus 78 -----------~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~ 146 (311)
....+++..++.++.|++.||+|||+++ ++|+||||+||+++.++.++|+|||++...........
T Consensus 132 ~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~ 208 (314)
T 2ivs_A 132 GSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVK 208 (314)
T ss_dssp -------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEEC
T ss_pred ccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---CcccccchheEEEcCCCCEEEcccccccccccccccee
Confidence 1234899999999999999999999999 99999999999999999999999999875433322222
Q ss_pred eeeccccccccCccccccCCCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccC
Q 021490 147 STRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQG 225 (311)
Q Consensus 147 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (311)
.....++..|+|||++.+..++.++||||||+++|+|++ |..||............... . ..
T Consensus 209 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~-------~----------~~ 271 (314)
T 2ivs_A 209 RSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTG-------H----------RM 271 (314)
T ss_dssp SSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT-------C----------CC
T ss_pred ccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHhhcC-------C----------cC
Confidence 333456788999999998889999999999999999999 99999766543332221110 0 01
Q ss_pred CCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 021490 226 QYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 266 (311)
Q Consensus 226 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~ 266 (311)
..+...+..+.+++.+||+.||.+|||+.++++.|+.+...
T Consensus 272 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 272 ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 12233445889999999999999999999999999987654
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-43 Score=311.03 Aligned_cols=237 Identities=25% Similarity=0.349 Sum_probs=182.5
Q ss_pred CCcEEEEEEeecCCC-cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHH
Q 021490 8 LLQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNT 86 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~ 86 (311)
.+..||||+++.... ...+.|.+|+.++.+++||||+++++++.+....++||||+++++|.+++... ...+++..
T Consensus 72 ~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~---~~~~~~~~ 148 (373)
T 2qol_A 72 KEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH---DAQFTVIQ 148 (373)
T ss_dssp CBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTT---TTCSCHHH
T ss_pred CceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEeCCCCCcHHHHHHhC---CCCCCHHH
Confidence 578899999975532 33468999999999999999999999999999999999999999999999762 45799999
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCce-eeeeccccccccCccccccC
Q 021490 87 RMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH-VSTRVMGTYGYCAPEYAKTG 165 (311)
Q Consensus 87 ~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~ 165 (311)
++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++.......... ......++..|+|||++.+.
T Consensus 149 ~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 225 (373)
T 2qol_A 149 LVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225 (373)
T ss_dssp HHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC----------------------CTTSCHHHHHHC
T ss_pred HHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhccC
Confidence 9999999999999999999 9999999999999999999999999987543221111 11122356789999999999
Q ss_pred CCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccc
Q 021490 166 QLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVH 244 (311)
Q Consensus 166 ~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 244 (311)
.++.++||||||+++|+|++ |..||...........+... .....+...+..+.+++.+||+
T Consensus 226 ~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~-----------------~~~~~~~~~~~~l~~li~~cl~ 288 (373)
T 2qol_A 226 KFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG-----------------YRLPPPMDCPAALYQLMLDCWQ 288 (373)
T ss_dssp CCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTT-----------------EECCCCTTCBHHHHHHHHHHTC
T ss_pred CcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-----------------CCCCCCccccHHHHHHHHHHhC
Confidence 99999999999999999998 99999766543332221100 0011122334578899999999
Q ss_pred cCCCCCCCHHHHHHHHHHhhhcc
Q 021490 245 EQPDMRPVIADVVTALAYLASQK 267 (311)
Q Consensus 245 ~~p~~Rps~~~vl~~l~~~~~~~ 267 (311)
.||.+|||+.++++.|+.+....
T Consensus 289 ~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 289 KDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp SSGGGSCCHHHHHHHHHHHHHCG
T ss_pred cChhhCcCHHHHHHHHHHHHhCc
Confidence 99999999999999999887543
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=304.69 Aligned_cols=230 Identities=23% Similarity=0.276 Sum_probs=187.8
Q ss_pred CCcEEEEEEeecCCCc------chhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCC
Q 021490 8 LLQDVAIKQLDRNGVQ------GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKP 81 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 81 (311)
+|+.||+|+++..... ..+.+.+|+.+++.++||||+++++++.+....++||||++|++|.+++.. ...
T Consensus 35 ~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~ 110 (326)
T 2y0a_A 35 TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE----KES 110 (326)
T ss_dssp TCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTT----SSC
T ss_pred CCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEEcCCCCCHHHHHHh----cCC
Confidence 6899999999765432 356899999999999999999999999999999999999999999999976 567
Q ss_pred CCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCC----ceEEccccccccCCCCCCceeeeecccccccc
Q 021490 82 LDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY----HPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 157 (311)
Q Consensus 82 l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~----~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~ 157 (311)
+++..++.++.|++.||+|||+.+ ++||||||+||+++.++ .++|+|||++....... ......+++.|+
T Consensus 111 ~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~ 184 (326)
T 2y0a_A 111 LTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN---EFKNIFGTPEFV 184 (326)
T ss_dssp CBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTTS---CCCCCCSCTTTC
T ss_pred cCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCCC---ccccccCCcCcC
Confidence 999999999999999999999999 99999999999999887 79999999987543221 122346899999
Q ss_pred CccccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHH
Q 021490 158 APEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALA 237 (311)
Q Consensus 158 aPE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 237 (311)
|||++.+..++.++|||||||++|+|++|..||...........+..... . ..... ....+..+.+
T Consensus 185 aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~------~----~~~~~----~~~~~~~~~~ 250 (326)
T 2y0a_A 185 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNY------E----FEDEY----FSNTSALAKD 250 (326)
T ss_dssp CHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCC------C----CCHHH----HTTSCHHHHH
T ss_pred CceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCC------C----cCccc----cccCCHHHHH
Confidence 99999988999999999999999999999999976654333222111100 0 00000 1122347889
Q ss_pred HHHHccccCCCCCCCHHHHHHHHH
Q 021490 238 VAAMCVHEQPDMRPVIADVVTALA 261 (311)
Q Consensus 238 li~~~l~~~p~~Rps~~~vl~~l~ 261 (311)
|+.+||..||.+|||+.++++...
T Consensus 251 li~~~L~~dP~~Rpt~~e~l~hp~ 274 (326)
T 2y0a_A 251 FIRRLLVKDPKKRMTIQDSLQHPW 274 (326)
T ss_dssp HHHHHSCSSGGGSCCHHHHHHSTT
T ss_pred HHHHHccCChhhCCCHHHHhcCCC
Confidence 999999999999999999998643
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-43 Score=301.65 Aligned_cols=239 Identities=26% Similarity=0.323 Sum_probs=188.0
Q ss_pred cCCcEEEEEEeecCCCcc---hhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCC
Q 021490 7 CLLQDVAIKQLDRNGVQG---NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLD 83 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~ 83 (311)
.+|..||+|++....... .+.+.+|+.++..++||||+++++++.++...++||||++|++|.+++.. .+.++
T Consensus 34 ~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~----~~~~~ 109 (294)
T 4eqm_A 34 ILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIES----HGPLS 109 (294)
T ss_dssp TTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH----HCSCC
T ss_pred CCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCCCCCCHHHHHHh----cCCCC
Confidence 368999999986544322 36788999999999999999999999999999999999999999999987 56799
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccc
Q 021490 84 WNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 163 (311)
Q Consensus 84 ~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 163 (311)
+..++.++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++....... ........+++.|+|||++.
T Consensus 110 ~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~ 185 (294)
T 4eqm_A 110 VDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS-LTQTNHVLGTVQYFSPEQAK 185 (294)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--------------CCSSCCHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccccc-ccccCccccCccccCHhHhc
Confidence 9999999999999999999999 9999999999999999999999999987532221 11223346899999999999
Q ss_pred cCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHcc
Q 021490 164 TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCV 243 (311)
Q Consensus 164 ~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 243 (311)
+..++.++||||||+++|+|++|..||............ ..... +......+...+..+.+++.+||
T Consensus 186 ~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~------~~~~~-------~~~~~~~~~~~~~~l~~li~~~l 252 (294)
T 4eqm_A 186 GEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKH------IQDSV-------PNVTTDVRKDIPQSLSNVILRAT 252 (294)
T ss_dssp TCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHH------HSSCC-------CCHHHHSCTTSCHHHHHHHHHHS
T ss_pred CCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH------hhccC-------CCcchhcccCCCHHHHHHHHHHh
Confidence 999999999999999999999999999876543321110 11100 01111112233457889999999
Q ss_pred ccCCCCCC-CHHHHHHHHHHhhhc
Q 021490 244 HEQPDMRP-VIADVVTALAYLASQ 266 (311)
Q Consensus 244 ~~~p~~Rp-s~~~vl~~l~~~~~~ 266 (311)
+.||.+|| ++.++.+.|+.+...
T Consensus 253 ~~dp~~R~~~~~~l~~~l~~~~~~ 276 (294)
T 4eqm_A 253 EKDKANRYKTIQEMKDDLSSVLHE 276 (294)
T ss_dssp CSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred cCCHhHccccHHHHHHHHHHHHhh
Confidence 99999998 889999999866543
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=298.67 Aligned_cols=240 Identities=23% Similarity=0.349 Sum_probs=194.8
Q ss_pred cchhccCCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCC
Q 021490 2 MQVILCLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKP 81 (311)
Q Consensus 2 ~~~~~~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 81 (311)
|.+...++..||+|+++... ...+.+.+|+.++..++||||+++++++.+....++||||+++++|.+++... ...
T Consensus 41 ~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~ 116 (283)
T 3gen_A 41 KYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREM---RHR 116 (283)
T ss_dssp EEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHHHHHHCG---GGC
T ss_pred EEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHHHHHHHh---ccC
Confidence 44556678899999996443 45678999999999999999999999999999999999999999999999762 356
Q ss_pred CCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccc
Q 021490 82 LDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 161 (311)
Q Consensus 82 l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 161 (311)
+++..++.++.|++.||+|||+++ ++|+||||+||+++.++.++|+|||++....... ........++..|+|||+
T Consensus 117 ~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~ 192 (283)
T 3gen_A 117 FQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEV 192 (283)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH-HHSTTSTTSCGGGCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccccc-cccccCCccCcccCCHHH
Confidence 999999999999999999999999 9999999999999999999999999987532211 111122345678999999
Q ss_pred cccCCCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHH
Q 021490 162 AKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAA 240 (311)
Q Consensus 162 ~~~~~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 240 (311)
+.+..++.++||||||+++|+|++ |..||...........+.... ....+...+..+.+++.
T Consensus 193 ~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~l~~li~ 255 (283)
T 3gen_A 193 LMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL-----------------RLYRPHLASEKVYTIMY 255 (283)
T ss_dssp HHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC-----------------CCCCCTTCCHHHHHHHH
T ss_pred hccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhccc-----------------CCCCCCcCCHHHHHHHH
Confidence 998899999999999999999998 999998766543332221110 01112223457889999
Q ss_pred HccccCCCCCCCHHHHHHHHHHhhhc
Q 021490 241 MCVHEQPDMRPVIADVVTALAYLASQ 266 (311)
Q Consensus 241 ~~l~~~p~~Rps~~~vl~~l~~~~~~ 266 (311)
+||+.||.+|||+.++++.|+.+...
T Consensus 256 ~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 256 SCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp HTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHccCChhHCcCHHHHHHHHHHHhhc
Confidence 99999999999999999999887643
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=309.47 Aligned_cols=245 Identities=26% Similarity=0.383 Sum_probs=197.2
Q ss_pred CCcEEEEEEeecCCC-cchhHHHHHHHHHhcC-CCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCC--------
Q 021490 8 LLQDVAIKQLDRNGV-QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP-------- 77 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-------- 77 (311)
.+..||+|+++.... .....+.+|++++..+ +||||+++++++.++...++||||+++++|.+++.....
T Consensus 100 ~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 179 (382)
T 3tt0_A 100 RVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYN 179 (382)
T ss_dssp CEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCC
T ss_pred cceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccc
Confidence 346899999976543 3346889999999999 899999999999999999999999999999999987431
Q ss_pred ----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeecccc
Q 021490 78 ----GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT 153 (311)
Q Consensus 78 ----~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~ 153 (311)
....+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||++................++
T Consensus 180 ~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t 256 (382)
T 3tt0_A 180 PSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLP 256 (382)
T ss_dssp CCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCG
T ss_pred cccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCC
Confidence 1245999999999999999999999999 999999999999999999999999999764433322233334567
Q ss_pred ccccCccccccCCCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhH
Q 021490 154 YGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGF 232 (311)
Q Consensus 154 ~~y~aPE~~~~~~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (311)
..|+|||++.+..++.++|||||||++|+|++ |..||...........+.... ....+...+
T Consensus 257 ~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~ 319 (382)
T 3tt0_A 257 VKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGH-----------------RMDKPSNCT 319 (382)
T ss_dssp GGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC-----------------CCCCCSSCC
T ss_pred cceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-----------------CCCCCccCC
Confidence 88999999999999999999999999999999 999998765543322221110 001122334
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhccCCccc
Q 021490 233 YQALAVAAMCVHEQPDMRPVIADVVTALAYLASQKYESDA 272 (311)
Q Consensus 233 ~~l~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~~~~~~~ 272 (311)
..+.+|+.+||+.||.+|||+.++++.|+.+.........
T Consensus 320 ~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~ 359 (382)
T 3tt0_A 320 NELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEM 359 (382)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC-
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCCC
Confidence 5788999999999999999999999999988866544443
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-43 Score=304.71 Aligned_cols=242 Identities=22% Similarity=0.325 Sum_probs=179.7
Q ss_pred EEEEEEeecCC--CcchhHHHHHHHHHhcCCCCcccceeeEeeeCCee------EEEEecCCCCChhhhhcccC--CCCC
Q 021490 11 DVAIKQLDRNG--VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR------LLVYEYMPLGSVEDHLHDLS--PGKK 80 (311)
Q Consensus 11 ~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~------~lv~e~~~~~~L~~~l~~~~--~~~~ 80 (311)
.||||+++... ....+.+.+|+.+++.++||||+++++++.+.... ++||||+++++|.+++.... ....
T Consensus 53 ~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~ 132 (323)
T 3qup_A 53 KVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPF 132 (323)
T ss_dssp EEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CC
T ss_pred eEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhcccccc
Confidence 79999997653 34457899999999999999999999999877655 99999999999999986532 1123
Q ss_pred CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcc
Q 021490 81 PLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 160 (311)
Q Consensus 81 ~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE 160 (311)
.+++..++.++.|++.||+|||+++ ++||||||+||+++.++.++|+|||++................++..|+|||
T Consensus 133 ~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE 209 (323)
T 3qup_A 133 NLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALE 209 (323)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-----------------CCGGGCCHH
T ss_pred ccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEEEeeccccccccccccccccccccCcccccCch
Confidence 6999999999999999999999999 9999999999999999999999999987543332222233345678899999
Q ss_pred ccccCCCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHH
Q 021490 161 YAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVA 239 (311)
Q Consensus 161 ~~~~~~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 239 (311)
++.+..++.++|||||||++|+|++ |..||............... . ....+...+..+.+|+
T Consensus 210 ~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~------~-----------~~~~~~~~~~~l~~li 272 (323)
T 3qup_A 210 SLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGG------N-----------RLKQPPECMEEVYDLM 272 (323)
T ss_dssp HHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT------C-----------CCCCCTTCCHHHHHHH
T ss_pred hhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcC------C-----------CCCCCCccCHHHHHHH
Confidence 9999999999999999999999999 89999876544332221110 0 0111233445789999
Q ss_pred HHccccCCCCCCCHHHHHHHHHHhhhccCCccc
Q 021490 240 AMCVHEQPDMRPVIADVVTALAYLASQKYESDA 272 (311)
Q Consensus 240 ~~~l~~~p~~Rps~~~vl~~l~~~~~~~~~~~~ 272 (311)
.+||+.||.+|||+.++++.|+.+....+....
T Consensus 273 ~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~ 305 (323)
T 3qup_A 273 YQCWSADPKQRPSFTCLRMELENILGHLSVLST 305 (323)
T ss_dssp HHTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred HHHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence 999999999999999999999998876654443
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-43 Score=307.86 Aligned_cols=240 Identities=26% Similarity=0.397 Sum_probs=191.2
Q ss_pred CCcEEEEEEeecCCC-cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCC--------
Q 021490 8 LLQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPG-------- 78 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-------- 78 (311)
+++.||+|+++.... ...+.|.+|+.++..++||||+++++++.++...++||||+++++|.+++......
T Consensus 76 ~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 155 (343)
T 1luf_A 76 PFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHS 155 (343)
T ss_dssp SEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC---------
T ss_pred CceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccc
Confidence 458999999976543 33468999999999999999999999999999999999999999999999763211
Q ss_pred ------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCcee
Q 021490 79 ------------KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHV 146 (311)
Q Consensus 79 ------------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~ 146 (311)
...+++..++.++.|++.||+|||+++ ++||||||+||+++.++.++|+|||++...........
T Consensus 156 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~ 232 (343)
T 1luf_A 156 DLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKA 232 (343)
T ss_dssp -------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC-
T ss_pred cccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEECCCCeEEEeecCCCcccccCccccc
Confidence 257999999999999999999999999 99999999999999999999999999865322221222
Q ss_pred eeeccccccccCccccccCCCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccC
Q 021490 147 STRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQG 225 (311)
Q Consensus 147 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (311)
.....++..|+|||++.+..++.++||||||+++|+|++ |..||...........+.. . .. .
T Consensus 233 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~-------~-~~---------~ 295 (343)
T 1luf_A 233 DGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRD-------G-NI---------L 295 (343)
T ss_dssp ---CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT-------T-CC---------C
T ss_pred cCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChHHHHHHHhC-------C-Cc---------C
Confidence 233457889999999998899999999999999999999 9999977654332221110 0 00 0
Q ss_pred CCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhcc
Q 021490 226 QYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQK 267 (311)
Q Consensus 226 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~~ 267 (311)
..+...+..+.+++.+||+.||.+|||+.++++.|+.+....
T Consensus 296 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~ 337 (343)
T 1luf_A 296 ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA 337 (343)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence 122233457889999999999999999999999999876543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=312.08 Aligned_cols=242 Identities=27% Similarity=0.383 Sum_probs=191.3
Q ss_pred ccCCcEEEEEEeecCCC-cchhHHHHHHHHHhcC-CCCcccceeeEeeeCC-eeEEEEecCCCCChhhhhcccCCC----
Q 021490 6 LCLLQDVAIKQLDRNGV-QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGD-QRLLVYEYMPLGSVEDHLHDLSPG---- 78 (311)
Q Consensus 6 ~~~g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~---- 78 (311)
..+|+.||||+++.... ...+.+.+|++++..+ +||||+++++++.+.. ..++||||+++|+|.+++......
T Consensus 49 ~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~ 128 (359)
T 3vhe_A 49 TATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY 128 (359)
T ss_dssp TTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSC
T ss_pred cccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhcccccccc
Confidence 34678999999976543 2346799999999999 7899999999987755 489999999999999999764211
Q ss_pred ----------------------------------------------------------CCCCCHHHHHHHHHHHHHHHHH
Q 021490 79 ----------------------------------------------------------KKPLDWNTRMKIAAGAARGLEY 100 (311)
Q Consensus 79 ----------------------------------------------------------~~~l~~~~~~~~~~~i~~~l~~ 100 (311)
...+++..++.++.|++.||+|
T Consensus 129 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~ 208 (359)
T 3vhe_A 129 KTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEF 208 (359)
T ss_dssp C------------------------------------------------------CTTTTCBCHHHHHHHHHHHHHHHHH
T ss_pred ccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHH
Confidence 1228999999999999999999
Q ss_pred hhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccCCCccccceeehhHHH
Q 021490 101 LHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVL 180 (311)
Q Consensus 101 lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~l~ 180 (311)
||+++ ++||||||+|||++.++.++|+|||++................++..|+|||++.+..++.++||||||+++
T Consensus 209 LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il 285 (359)
T 3vhe_A 209 LASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 285 (359)
T ss_dssp HHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred HHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHH
Confidence 99999 999999999999999999999999999764433333344445678899999999999999999999999999
Q ss_pred HHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 021490 181 LEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 181 ~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~ 259 (311)
|+|++ |..||............ ..... ....+...+..+.+++.+||+.||.+|||+.++++.
T Consensus 286 ~ellt~g~~p~~~~~~~~~~~~~------~~~~~----------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 286 WEIFSLGASPYPGVKIDEEFCRR------LKEGT----------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp HHHTTTSCCSSTTCCCSHHHHHH------HHHTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhcCCCCCCccchhHHHHHH------HHcCC----------CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 99998 99999765432221100 00000 011122334578899999999999999999999999
Q ss_pred HHHhhhc
Q 021490 260 LAYLASQ 266 (311)
Q Consensus 260 l~~~~~~ 266 (311)
|+.+...
T Consensus 350 L~~~~~~ 356 (359)
T 3vhe_A 350 LGNLLQA 356 (359)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9987643
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=305.04 Aligned_cols=230 Identities=19% Similarity=0.211 Sum_probs=186.5
Q ss_pred cCCcEEEEEEeecCCC--cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCH
Q 021490 7 CLLQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 84 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~ 84 (311)
.+|+.||+|+++.... ...+.+.+|+.+++.++||||+++++++.++...|+||||++|++|.+++.. ...+++
T Consensus 52 ~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~ 127 (362)
T 2bdw_A 52 TTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA----REFYSE 127 (362)
T ss_dssp TTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTT----CSCCCH
T ss_pred CCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHH----cCCCCH
Confidence 3689999999976543 2346788999999999999999999999999999999999999999999976 567999
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCC---CceEEccccccccCCCCCCceeeeeccccccccCccc
Q 021490 85 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG---YHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 161 (311)
Q Consensus 85 ~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~---~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 161 (311)
..+..++.||+.||+|||+.+ ++||||||+||+++.+ +.+||+|||++...... .......+++.|+|||+
T Consensus 128 ~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~ 201 (362)
T 2bdw_A 128 ADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS---EAWHGFAGTPGYLSPEV 201 (362)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC---CSCCCSCSCTTTCCHHH
T ss_pred HHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceEecCC---cccccCCCCccccCHHH
Confidence 999999999999999999999 9999999999999864 45999999998754322 12233568999999999
Q ss_pred cccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHH
Q 021490 162 AKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAM 241 (311)
Q Consensus 162 ~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 241 (311)
+.+..++.++|||||||++|+|++|..||...........+.... .. ... ......+..+.+|+.+
T Consensus 202 ~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~------~~---~~~-----~~~~~~~~~~~~li~~ 267 (362)
T 2bdw_A 202 LKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA------YD---YPS-----PEWDTVTPEAKSLIDS 267 (362)
T ss_dssp HTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC------CC---CCT-----TGGGGSCHHHHHHHHH
T ss_pred HccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC------CC---CCc-----ccccCCCHHHHHHHHH
Confidence 998899999999999999999999999998765433322221110 00 000 0012234578899999
Q ss_pred ccccCCCCCCCHHHHHHHH
Q 021490 242 CVHEQPDMRPVIADVVTAL 260 (311)
Q Consensus 242 ~l~~~p~~Rps~~~vl~~l 260 (311)
||+.||.+|||+.++++..
T Consensus 268 ~L~~dP~~R~t~~e~l~hp 286 (362)
T 2bdw_A 268 MLTVNPKKRITADQALKVP 286 (362)
T ss_dssp HSCSSGGGSCCHHHHTTSH
T ss_pred HcCCChhhCcCHHHHhcCc
Confidence 9999999999999998664
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=308.00 Aligned_cols=243 Identities=26% Similarity=0.362 Sum_probs=189.7
Q ss_pred cCCcEEEEEEeecCC-CcchhHHHHHHHHHhcC-CCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCC------
Q 021490 7 CLLQDVAIKQLDRNG-VQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPG------ 78 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~------ 78 (311)
.++..||+|+++... ....+.+.+|+.++..+ +||||+++++++.+....++||||+++++|.+++......
T Consensus 73 ~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~ 152 (344)
T 1rjb_A 73 GVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEI 152 (344)
T ss_dssp SCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC-----
T ss_pred CcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEEEecCCCCcHHHHHhhcccccccccc
Confidence 356789999997543 23457899999999999 8999999999999999999999999999999999763211
Q ss_pred -------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCce
Q 021490 79 -------------KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 145 (311)
Q Consensus 79 -------------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~ 145 (311)
...+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++..........
T Consensus 153 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 229 (344)
T 1rjb_A 153 EYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV 229 (344)
T ss_dssp ----------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSE
T ss_pred chhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEEcCCCcEEeCCCccCcccccCccce
Confidence 134899999999999999999999999 9999999999999999999999999997543333333
Q ss_pred eeeeccccccccCccccccCCCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCcccc
Q 021490 146 VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQ 224 (311)
Q Consensus 146 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (311)
......++..|+|||++.+..++.++||||||+++|+|++ |..||............ .... ..
T Consensus 230 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~------~~~~----------~~ 293 (344)
T 1rjb_A 230 VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKL------IQNG----------FK 293 (344)
T ss_dssp EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHH------HHTT----------CC
T ss_pred eccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHHHHH------HhcC----------CC
Confidence 3344557889999999998999999999999999999998 99999765432211100 1100 00
Q ss_pred CCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhccC
Q 021490 225 GQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQKY 268 (311)
Q Consensus 225 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~~~ 268 (311)
...+...+..+.+|+.+||+.||.+|||+.++++.|+.+.....
T Consensus 294 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 337 (344)
T 1rjb_A 294 MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE 337 (344)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence 11122334588899999999999999999999999998775543
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=306.79 Aligned_cols=230 Identities=19% Similarity=0.239 Sum_probs=188.3
Q ss_pred CCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHHH
Q 021490 8 LLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTR 87 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~ 87 (311)
+|+.||+|++..........+.+|+.+++.++||||+++++++.+....++||||++|++|.+++... ...+++..+
T Consensus 75 ~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~---~~~l~~~~~ 151 (387)
T 1kob_A 75 TGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAE---DYKMSEAEV 151 (387)
T ss_dssp TCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCT---TCCBCHHHH
T ss_pred CCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCcHHHHHHhh---cCCCCHHHH
Confidence 68999999997665555668999999999999999999999999999999999999999999998752 357999999
Q ss_pred HHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcC--CCceEEccccccccCCCCCCceeeeeccccccccCccccccC
Q 021490 88 MKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR--GYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG 165 (311)
Q Consensus 88 ~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~--~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 165 (311)
+.++.|++.||+|||+.+ ++||||||+|||++. ++.++|+|||++...... .......++..|+|||++.+.
T Consensus 152 ~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~ 225 (387)
T 1kob_A 152 INYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD---EIVKVTTATAEFAAPEIVDRE 225 (387)
T ss_dssp HHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT---SCEEEECSSGGGCCHHHHTTC
T ss_pred HHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC---cceeeeccCCCccCchhccCC
Confidence 999999999999999999 999999999999974 577999999999754322 122334689999999999999
Q ss_pred CCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHcccc
Q 021490 166 QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHE 245 (311)
Q Consensus 166 ~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 245 (311)
.++.++|||||||++|+|++|..||...........+... .. .+........+..+.+||.+||+.
T Consensus 226 ~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~------~~--------~~~~~~~~~~s~~~~~li~~~L~~ 291 (387)
T 1kob_A 226 PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC------DW--------EFDEDAFSSVSPEAKDFIKNLLQK 291 (387)
T ss_dssp CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHC------CC--------CCCSSTTTTSCHHHHHHHHTTSCS
T ss_pred CCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhC------CC--------CCCccccccCCHHHHHHHHHHcCC
Confidence 9999999999999999999999999876543332211100 00 001111223345788999999999
Q ss_pred CCCCCCCHHHHHHHH
Q 021490 246 QPDMRPVIADVVTAL 260 (311)
Q Consensus 246 ~p~~Rps~~~vl~~l 260 (311)
||.+|||+.++++..
T Consensus 292 dP~~Rpt~~ell~hp 306 (387)
T 1kob_A 292 EPRKRLTVHDALEHP 306 (387)
T ss_dssp SGGGSCCHHHHHTST
T ss_pred ChhHCcCHHHHhhCc
Confidence 999999999999864
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=306.23 Aligned_cols=234 Identities=21% Similarity=0.222 Sum_probs=185.8
Q ss_pred cCCcEEEEEEeecCC-----CcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCC
Q 021490 7 CLLQDVAIKQLDRNG-----VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKP 81 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 81 (311)
.+|+.||||+++... ....+.+.+|+.+++.++||||+++++++.++...|+||||++|++|.+++......+..
T Consensus 47 ~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~ 126 (351)
T 3c0i_A 47 ETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFV 126 (351)
T ss_dssp TTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSSCBHHHHHHHHHHTTCC
T ss_pred CCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCC
Confidence 368999999986432 224578999999999999999999999999999999999999999998887653333456
Q ss_pred CCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCc---eEEccccccccCCCCCCceeeeeccccccccC
Q 021490 82 LDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH---PKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCA 158 (311)
Q Consensus 82 l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~---~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~a 158 (311)
+++..+..++.|++.||+|||+++ ++||||||+||+++.++. ++|+|||++...... ........+++.|+|
T Consensus 127 ~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~--~~~~~~~~gt~~y~a 201 (351)
T 3c0i_A 127 YSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES--GLVAGGRVGTPHFMA 201 (351)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTT--SCBCCCCCSCGGGCC
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcceeEecCC--CeeecCCcCCcCccC
Confidence 899999999999999999999999 999999999999986654 999999999754322 122234568999999
Q ss_pred ccccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHH
Q 021490 159 PEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAV 238 (311)
Q Consensus 159 PE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 238 (311)
||++.+..++.++|||||||++|+|++|..||..........+.. ... ...+... ...+..+.+|
T Consensus 202 PE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~i~~-------~~~----~~~~~~~----~~~s~~~~~l 266 (351)
T 3c0i_A 202 PEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIK-------GKY----KMNPRQW----SHISESAKDL 266 (351)
T ss_dssp HHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHHHHHHHH-------TCC----CCCHHHH----TTSCHHHHHH
T ss_pred HHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHHHHHHHc-------CCC----CCCcccc----ccCCHHHHHH
Confidence 999998899999999999999999999999998754322111111 000 0001000 1223478899
Q ss_pred HHHccccCCCCCCCHHHHHHHH
Q 021490 239 AAMCVHEQPDMRPVIADVVTAL 260 (311)
Q Consensus 239 i~~~l~~~p~~Rps~~~vl~~l 260 (311)
+.+||+.||++|||+.++++..
T Consensus 267 i~~~L~~dP~~R~s~~e~l~hp 288 (351)
T 3c0i_A 267 VRRMLMLDPAERITVYEALNHP 288 (351)
T ss_dssp HHHHTCSSTTTSCCHHHHHTSH
T ss_pred HHHHCCCChhHCcCHHHHhcCh
Confidence 9999999999999999999754
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=301.17 Aligned_cols=231 Identities=15% Similarity=0.172 Sum_probs=188.4
Q ss_pred CCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHHH
Q 021490 8 LLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTR 87 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~ 87 (311)
+|+.||+|+++.. ......+.+|+.+++.++||||+++++++.+....++||||++|++|.+++... ...+++..+
T Consensus 29 ~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~ 104 (321)
T 1tki_A 29 SKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTS---AFELNEREI 104 (321)
T ss_dssp TTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSS---SCCCCHHHH
T ss_pred CCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCHHHHHHhc---CCCCCHHHH
Confidence 6899999998643 345567889999999999999999999999999999999999999999999752 357999999
Q ss_pred HHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcC--CCceEEccccccccCCCCCCceeeeeccccccccCccccccC
Q 021490 88 MKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR--GYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG 165 (311)
Q Consensus 88 ~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~--~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 165 (311)
+.++.|++.||+|||+.+ ++||||||+||+++. ++.++|+|||++...... .......+++.|+|||++.+.
T Consensus 105 ~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~ 178 (321)
T 1tki_A 105 VSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG---DNFRLLFTAPEYYAPEVHQHD 178 (321)
T ss_dssp HHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT---CEEEEEESCGGGSCHHHHTTC
T ss_pred HHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC---CccccccCChhhcCcHHhcCC
Confidence 999999999999999999 999999999999987 789999999999754322 223345689999999999988
Q ss_pred CCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHcccc
Q 021490 166 QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHE 245 (311)
Q Consensus 166 ~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 245 (311)
.++.++||||||+++|+|++|..||...........+.... .. ...... +..+..+.+|+.+||..
T Consensus 179 ~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~------~~----~~~~~~----~~~s~~~~~li~~~L~~ 244 (321)
T 1tki_A 179 VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAE------YT----FDEEAF----KEISIEAMDFVDRLLVK 244 (321)
T ss_dssp EECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC------CC----CCHHHH----TTSCHHHHHHHHTTSCS
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCC------CC----CChhhh----ccCCHHHHHHHHHHcCC
Confidence 88999999999999999999999998765443322221110 00 000000 12245788999999999
Q ss_pred CCCCCCCHHHHHHHHHH
Q 021490 246 QPDMRPVIADVVTALAY 262 (311)
Q Consensus 246 ~p~~Rps~~~vl~~l~~ 262 (311)
||.+|||+.|+++....
T Consensus 245 dp~~Rpt~~e~l~hp~~ 261 (321)
T 1tki_A 245 ERKSRMTASEALQHPWL 261 (321)
T ss_dssp SGGGSCCHHHHHHSHHH
T ss_pred ChhHCcCHHHHhcChhh
Confidence 99999999999987654
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=311.26 Aligned_cols=241 Identities=27% Similarity=0.355 Sum_probs=191.6
Q ss_pred cCCcEEEEEEeecCCC-cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCC---CCCCC
Q 021490 7 CLLQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP---GKKPL 82 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~l 82 (311)
.++..||||+++.... .....+.+|+.++..++||||+++++++.+....++||||++||+|.+++..... ....+
T Consensus 99 ~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 178 (367)
T 3l9p_A 99 PSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSL 178 (367)
T ss_dssp -CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCC
T ss_pred CcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccc
Confidence 3577899999965432 3345788999999999999999999999999999999999999999999976431 22469
Q ss_pred CHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCC---ceEEccccccccCCCCCCceeeeeccccccccCc
Q 021490 83 DWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY---HPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 159 (311)
Q Consensus 83 ~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~---~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aP 159 (311)
++..++.++.|++.||+|||+++ |+||||||+|||++.++ .+||+|||++................++..|+||
T Consensus 179 ~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aP 255 (367)
T 3l9p_A 179 AMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPP 255 (367)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCH
T ss_pred cHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECH
Confidence 99999999999999999999999 99999999999999555 5999999998642111111222234578899999
Q ss_pred cccccCCCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHH
Q 021490 160 EYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAV 238 (311)
Q Consensus 160 E~~~~~~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 238 (311)
|++.+..++.++|||||||++|+|++ |..||...........+.... . ...+...+..+.+|
T Consensus 256 E~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~-------~----------~~~~~~~~~~l~~l 318 (367)
T 3l9p_A 256 EAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG-------R----------MDPPKNCPGPVYRI 318 (367)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC-------C----------CCCCTTCCHHHHHH
T ss_pred HHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-------C----------CCCCccCCHHHHHH
Confidence 99999999999999999999999998 999998766544332221110 0 01122334478899
Q ss_pred HHHccccCCCCCCCHHHHHHHHHHhhhcc
Q 021490 239 AAMCVHEQPDMRPVIADVVTALAYLASQK 267 (311)
Q Consensus 239 i~~~l~~~p~~Rps~~~vl~~l~~~~~~~ 267 (311)
+.+||+.||.+|||+.++++.|+.+.+..
T Consensus 319 i~~~l~~dP~~Rps~~eil~~l~~~~~~~ 347 (367)
T 3l9p_A 319 MTQCWQHQPEDRPNFAIILERIEYCTQDP 347 (367)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred HHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence 99999999999999999999999887654
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=309.46 Aligned_cols=231 Identities=19% Similarity=0.206 Sum_probs=189.0
Q ss_pred cCCcEEEEEEeecCCCc--chhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCH
Q 021490 7 CLLQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 84 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~ 84 (311)
.+|+.||+|++...... ..+.+.+|+.+++.++||||+++++++.++...|+||||++||+|.+++.. ...+++
T Consensus 34 ~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~----~~~~~e 109 (444)
T 3soa_A 34 LAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVA----REYYSE 109 (444)
T ss_dssp TTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCCBCCBHHHHHHH----CSCCCH
T ss_pred CCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeCCCCCHHHHHHH----cCCCCH
Confidence 47899999999765432 345788999999999999999999999999999999999999999999987 577999
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEc---CCCceEEccccccccCCCCCCceeeeeccccccccCccc
Q 021490 85 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD---RGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 161 (311)
Q Consensus 85 ~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~---~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 161 (311)
..+..++.|++.||+|||+++ |+||||||+|||++ .++.+||+|||++...... ........|++.|+|||+
T Consensus 110 ~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~--~~~~~~~~gt~~Y~APE~ 184 (444)
T 3soa_A 110 ADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE--QQAWFGFAGTPGYLSPEV 184 (444)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT--CCBCCCSCSCGGGCCHHH
T ss_pred HHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC--CceeecccCCcccCCHHH
Confidence 999999999999999999999 99999999999998 5678999999999753322 222234568999999999
Q ss_pred cccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHH
Q 021490 162 AKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAM 241 (311)
Q Consensus 162 ~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 241 (311)
+.+..++.++|||||||++|+|++|..||...........+..... .... ......+..+.+|+.+
T Consensus 185 l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~---------~~~~-----~~~~~~s~~~~~li~~ 250 (444)
T 3soa_A 185 LRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAY---------DFPS-----PEWDTVTPEAKDLINK 250 (444)
T ss_dssp HTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC---------CCCT-----TTTTTSCHHHHHHHHH
T ss_pred hcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCC---------CCCc-----cccccCCHHHHHHHHH
Confidence 9988999999999999999999999999977654433322211100 0001 1112234578899999
Q ss_pred ccccCCCCCCCHHHHHHHH
Q 021490 242 CVHEQPDMRPVIADVVTAL 260 (311)
Q Consensus 242 ~l~~~p~~Rps~~~vl~~l 260 (311)
||+.||.+|||+.++++..
T Consensus 251 ~L~~dP~~Rpta~e~L~hp 269 (444)
T 3soa_A 251 MLTINPSKRITAAEALKHP 269 (444)
T ss_dssp HSCSSTTTSCCHHHHHHSC
T ss_pred HcCCChhHCCCHHHHhcCc
Confidence 9999999999999999764
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=307.53 Aligned_cols=226 Identities=28% Similarity=0.354 Sum_probs=183.8
Q ss_pred cCCcEEEEEEeecCC---CcchhHHHHHHHHHhcC-CCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCC
Q 021490 7 CLLQDVAIKQLDRNG---VQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPL 82 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l 82 (311)
.+|+.||||+++... ....+.+.+|..++..+ +||||+++++++.+....|+||||++||+|.+++.. ...+
T Consensus 46 ~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~ 121 (353)
T 3txo_A 46 ETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQK----SRRF 121 (353)
T ss_dssp TTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH----HSSC
T ss_pred CCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHH----cCCC
Confidence 368999999997642 23446788899999988 799999999999999999999999999999999987 5679
Q ss_pred CHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccc
Q 021490 83 DWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 162 (311)
Q Consensus 83 ~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 162 (311)
++..+..++.||+.||+|||+++ |+||||||+|||++.+|.+||+|||++..... .........||+.|+|||++
T Consensus 122 ~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~~--~~~~~~~~~gt~~y~aPE~~ 196 (353)
T 3txo_A 122 DEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC--NGVTTATFCGTPDYIAPEIL 196 (353)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-----------CCGGGCCHHHH
T ss_pred CHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeeccc--CCccccccCCCcCeEChhhc
Confidence 99999999999999999999999 99999999999999999999999999874221 11223345689999999999
Q ss_pred ccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHc
Q 021490 163 KTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMC 242 (311)
Q Consensus 163 ~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 242 (311)
.+..++.++|||||||++|+|++|..||...........+.. .. ..++...+..+.+|+.+|
T Consensus 197 ~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~------~~------------~~~p~~~~~~~~~li~~l 258 (353)
T 3txo_A 197 QEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN------DE------------VVYPTWLHEDATGILKSF 258 (353)
T ss_dssp HHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------CC------------CCCCTTSCHHHHHHHHHH
T ss_pred CCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHc------CC------------CCCCCCCCHHHHHHHHHH
Confidence 988899999999999999999999999987665443222211 10 012233445788999999
Q ss_pred cccCCCCCCCH------HHHHHH
Q 021490 243 VHEQPDMRPVI------ADVVTA 259 (311)
Q Consensus 243 l~~~p~~Rps~------~~vl~~ 259 (311)
|+.||.+||++ .++++.
T Consensus 259 L~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 259 MTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp TCSSGGGSTTSGGGTCTHHHHTS
T ss_pred hhhCHHHccCCcccCCHHHHhhC
Confidence 99999999998 777764
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=296.02 Aligned_cols=250 Identities=19% Similarity=0.224 Sum_probs=186.1
Q ss_pred cchhccCCcEEEEEEeecCCC--cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCC
Q 021490 2 MQVILCLLQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGK 79 (311)
Q Consensus 2 ~~~~~~~g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~ 79 (311)
|.+...+|+.||+|++..... ...+.+.+|+.+++.++||||+++++++.+....++||||+++ +|.+++... .
T Consensus 19 ~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~---~ 94 (288)
T 1ob3_A 19 YKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVC---E 94 (288)
T ss_dssp EEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE-EHHHHHHTS---T
T ss_pred EEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCC-CHHHHHHhc---c
Confidence 455566799999999965543 2246888999999999999999999999999999999999975 899888752 3
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCc
Q 021490 80 KPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 159 (311)
Q Consensus 80 ~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aP 159 (311)
..+++..+..++.|++.||+|||+++ ++||||||+||+++.++.+||+|||++...... ........++..|+||
T Consensus 95 ~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~t~~y~aP 169 (288)
T 1ob3_A 95 GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP--VRKYTHEIVTLWYRAP 169 (288)
T ss_dssp TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----------CCCTTCCH
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcc--ccccccccccccccCc
Confidence 67999999999999999999999999 999999999999999999999999998653211 1122234578999999
Q ss_pred ccccc-CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhh-hhhccc---cccccccCcccc-------CCC
Q 021490 160 EYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWAR-PLFQDR---TRHSLIADPELQ-------GQY 227 (311)
Q Consensus 160 E~~~~-~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~-~~~~~~---~~~~~~~~~~~~-------~~~ 227 (311)
|++.+ ..++.++|||||||++|+|++|..||...........+.... ...... .......++.+. ...
T Consensus 170 E~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (288)
T 1ob3_A 170 DVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESF 249 (288)
T ss_dssp HHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGT
T ss_pred hheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccccccccCccHHHH
Confidence 99875 458999999999999999999999998765544322221110 000000 000000011110 011
Q ss_pred ChHhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 021490 228 PPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 260 (311)
Q Consensus 228 ~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l 260 (311)
....+..+.+|+.+||+.||++|||+.++++..
T Consensus 250 ~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 282 (288)
T 1ob3_A 250 LKGLDESGIDLLSKMLKLDPNQRITAKQALEHA 282 (288)
T ss_dssp CCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred hhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCc
Confidence 123456788999999999999999999998753
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=299.73 Aligned_cols=223 Identities=28% Similarity=0.371 Sum_probs=187.3
Q ss_pred CCcEEEEEEeecCC---CcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCH
Q 021490 8 LLQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 84 (311)
Q Consensus 8 ~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~ 84 (311)
+|+.||+|+++... ....+.+.+|+.++..++||||+++++++.+....|+||||++|++|.+++.. ...+++
T Consensus 30 ~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~ 105 (318)
T 1fot_A 30 NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRK----SQRFPN 105 (318)
T ss_dssp TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH----TSSCCH
T ss_pred CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCCCCCHHHHHHH----cCCCCH
Confidence 79999999997642 23456788999999999999999999999999999999999999999999987 567999
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccccc
Q 021490 85 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT 164 (311)
Q Consensus 85 ~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 164 (311)
..+..++.|++.||+|||+++ ++||||||+||+++.+|.+||+|||++...... .....|++.|+|||++.+
T Consensus 106 ~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~ 177 (318)
T 1fot_A 106 PVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-----TYTLCGTPDYIAPEVVST 177 (318)
T ss_dssp HHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC-----BCCCCSCTTTCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCCc-----cccccCCccccCHhHhcC
Confidence 999999999999999999999 999999999999999999999999998753221 223468999999999999
Q ss_pred CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccc
Q 021490 165 GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVH 244 (311)
Q Consensus 165 ~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 244 (311)
..++.++|||||||++|+|++|..||...........+ .... ..++...+..+.+++.+||.
T Consensus 178 ~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i------~~~~------------~~~p~~~~~~~~~li~~lL~ 239 (318)
T 1fot_A 178 KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI------LNAE------------LRFPPFFNEDVKDLLSRLIT 239 (318)
T ss_dssp CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH------HHCC------------CCCCTTSCHHHHHHHHHHTC
T ss_pred CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH------HhCC------------CCCCCCCCHHHHHHHHHHhc
Confidence 99999999999999999999999999776543332211 1110 01223344588899999999
Q ss_pred cCCCCCC-----CHHHHHHHH
Q 021490 245 EQPDMRP-----VIADVVTAL 260 (311)
Q Consensus 245 ~~p~~Rp-----s~~~vl~~l 260 (311)
.||.+|| +++++++.-
T Consensus 240 ~dp~~R~~~~~~~~~~i~~hp 260 (318)
T 1fot_A 240 RDLSQRLGNLQNGTEDVKNHP 260 (318)
T ss_dssp SCTTTCTTSSTTTTHHHHTSG
T ss_pred cCHHHcCCCcCCCHHHHhcCc
Confidence 9999999 889988664
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=301.82 Aligned_cols=244 Identities=27% Similarity=0.392 Sum_probs=188.8
Q ss_pred cCCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeee--CCeeEEEEecCCCCChhhhhcccCCCCCCCCH
Q 021490 7 CLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCAD--GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 84 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~ 84 (311)
.+|+.||||++........+.+.+|+.++..++||||+++++++.. ....++||||+++++|.+++... ...+++
T Consensus 37 ~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~ 113 (295)
T 3ugc_A 37 NTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH---KERIDH 113 (295)
T ss_dssp SCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEECCTTCBHHHHHHHC---GGGCCH
T ss_pred CCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEEeCCCCCHHHHHHhc---ccccCH
Confidence 4789999999976665566789999999999999999999999854 35689999999999999999862 345999
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCc-eeeeeccccccccCccccc
Q 021490 85 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT-HVSTRVMGTYGYCAPEYAK 163 (311)
Q Consensus 85 ~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~ 163 (311)
..++.++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++......... .......++..|+|||++.
T Consensus 114 ~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 190 (295)
T 3ugc_A 114 IKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLT 190 (295)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC-------------CTTCGGGGCCHHHHH
T ss_pred HHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhc
Confidence 999999999999999999999 999999999999999999999999999754322211 1222334677899999999
Q ss_pred cCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHH---------HHHhhhhhccccccccccCccccCCCChHhHHH
Q 021490 164 TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSL---------VAWARPLFQDRTRHSLIADPELQGQYPPRGFYQ 234 (311)
Q Consensus 164 ~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
+..++.++||||||+++|+|++|..||........... .......... ......+...+..
T Consensus 191 ~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~ 260 (295)
T 3ugc_A 191 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKN----------NGRLPRPDGCPDE 260 (295)
T ss_dssp HCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHT----------TCCCCCCTTCCHH
T ss_pred CCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhc----------cCcCCCCcCcCHH
Confidence 99999999999999999999999999875443211100 0000000000 0011223344568
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 021490 235 ALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 266 (311)
Q Consensus 235 l~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~ 266 (311)
+.+++.+||+.||.+|||+.++++.|+.+...
T Consensus 261 l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 261 IYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 89999999999999999999999999988654
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=293.42 Aligned_cols=239 Identities=26% Similarity=0.374 Sum_probs=194.0
Q ss_pred cchhccCCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCC
Q 021490 2 MQVILCLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKP 81 (311)
Q Consensus 2 ~~~~~~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 81 (311)
|.+...+++.||+|+++... ...+.+.+|+.+++.++||||+++++++.++...++||||+++++|.+++... ...
T Consensus 25 ~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~ 100 (267)
T 3t9t_A 25 HLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQ---RGL 100 (267)
T ss_dssp EEEEETTTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHHT---TTC
T ss_pred EEEEecCCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHHHHhhC---ccc
Confidence 45555678899999996543 45578999999999999999999999999999999999999999999999762 356
Q ss_pred CCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccc
Q 021490 82 LDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 161 (311)
Q Consensus 82 l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 161 (311)
+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++...... .........++..|+|||+
T Consensus 101 ~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~~~y~aPE~ 176 (267)
T 3t9t_A 101 FAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD-QYTSSTGTKFPVKWASPEV 176 (267)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH-HHHSTTSTTCCGGGCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccccc-cccccccccccccccChhh
Confidence 899999999999999999999999 999999999999999999999999998753211 1111122346678999999
Q ss_pred cccCCCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHH
Q 021490 162 AKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAA 240 (311)
Q Consensus 162 ~~~~~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 240 (311)
+.+..++.++||||||+++|+|++ |..||...........+... . ....+...+..+.+++.
T Consensus 177 ~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~-------~----------~~~~~~~~~~~l~~li~ 239 (267)
T 3t9t_A 177 FSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG-------F----------RLYKPRLASTHVYQIMN 239 (267)
T ss_dssp HHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-------C----------CCCCCTTSCHHHHHHHH
T ss_pred hcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcC-------C----------cCCCCccCcHHHHHHHH
Confidence 998899999999999999999999 89999876543322211100 0 00112223457889999
Q ss_pred HccccCCCCCCCHHHHHHHHHHhhh
Q 021490 241 MCVHEQPDMRPVIADVVTALAYLAS 265 (311)
Q Consensus 241 ~~l~~~p~~Rps~~~vl~~l~~~~~ 265 (311)
+||+.||.+|||+.++++.|+.+..
T Consensus 240 ~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 240 HCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHccCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999999998864
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=295.54 Aligned_cols=249 Identities=37% Similarity=0.585 Sum_probs=194.7
Q ss_pred CCcEEEEEEeecCC----CcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCC
Q 021490 8 LLQDVAIKQLDRNG----VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLD 83 (311)
Q Consensus 8 ~g~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~ 83 (311)
+|..||+|++.... ....+.+.+|+.+++.++||||+++++++.+....++||||+++++|.+++.... ....++
T Consensus 53 ~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~ 131 (307)
T 2nru_A 53 NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD-GTPPLS 131 (307)
T ss_dssp SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGG-GCCCCC
T ss_pred CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhcc-CCCCCC
Confidence 68899999986542 1234688999999999999999999999999999999999999999999987532 135699
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccc
Q 021490 84 WNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 163 (311)
Q Consensus 84 ~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 163 (311)
+..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++................++..|+|||++.
T Consensus 132 ~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 208 (307)
T 2nru_A 132 WHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALR 208 (307)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHT
T ss_pred HHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhc
Confidence 9999999999999999999999 9999999999999999999999999987544333333333456899999999886
Q ss_pred cCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHcc
Q 021490 164 TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCV 243 (311)
Q Consensus 164 ~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 243 (311)
+ .++.++||||||+++|+|++|..||...........+. ..............++.+ ...+...+..+.+++.+||
T Consensus 209 ~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl 284 (307)
T 2nru_A 209 G-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIK--EEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCL 284 (307)
T ss_dssp T-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHH--HHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHT
T ss_pred C-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHH--HHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHc
Confidence 4 57889999999999999999999997654322111110 000001111111112222 2345667788999999999
Q ss_pred ccCCCCCCCHHHHHHHHHHhh
Q 021490 244 HEQPDMRPVIADVVTALAYLA 264 (311)
Q Consensus 244 ~~~p~~Rps~~~vl~~l~~~~ 264 (311)
+.||.+|||+.++++.|+.+.
T Consensus 285 ~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 285 HEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp CSSTTTSCCHHHHHHHHHHHC
T ss_pred CCCcccCcCHHHHHHHHHHHh
Confidence 999999999999999998775
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=312.86 Aligned_cols=230 Identities=27% Similarity=0.375 Sum_probs=187.7
Q ss_pred CCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCC-eeEEEEecCCCCChhhhhcccCCCCCCCCHHH
Q 021490 8 LLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD-QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNT 86 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~ 86 (311)
.|+.||||+++... ..+.|.+|+.+|++++||||+++++++.+.. ..++||||+++|+|.+++.... ...+++..
T Consensus 215 ~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~--~~~~~~~~ 290 (450)
T 1k9a_A 215 RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG--RSVLGGDC 290 (450)
T ss_dssp TTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHHC--TTTCCHHH
T ss_pred cCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhcC--CCCCCHHH
Confidence 47899999996543 5678999999999999999999999987665 7899999999999999998632 33479999
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccCC
Q 021490 87 RMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ 166 (311)
Q Consensus 87 ~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 166 (311)
++.++.|++.||+|||+++ ++||||||+|||++.++.+||+|||++...... .....++..|+|||++.+..
T Consensus 291 ~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-----~~~~~~~~~y~aPE~~~~~~ 362 (450)
T 1k9a_A 291 LLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----QDTGKLPVKWTAPEALREKK 362 (450)
T ss_dssp HHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC-----------CCCTTTSCHHHHHSSC
T ss_pred HHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc-----ccCCCCCcceeCHHHhcCCC
Confidence 9999999999999999999 999999999999999999999999998743211 11234678899999999999
Q ss_pred CccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHcccc
Q 021490 167 LTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHE 245 (311)
Q Consensus 167 ~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 245 (311)
++.++||||||+++|+|++ |..||...........+.. . .....+...+..+.+|+.+||+.
T Consensus 363 ~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~-------~----------~~~~~p~~~~~~l~~li~~cl~~ 425 (450)
T 1k9a_A 363 FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK-------G----------YKMDAPDGCPPAVYDVMKNCWHL 425 (450)
T ss_dssp CCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHT-------T----------CCCCCCTTCCHHHHHHHHHHTCS
T ss_pred CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-------C----------CCCCCCCcCCHHHHHHHHHHcCC
Confidence 9999999999999999998 9999976554332221110 0 00112233445889999999999
Q ss_pred CCCCCCCHHHHHHHHHHhhhc
Q 021490 246 QPDMRPVIADVVTALAYLASQ 266 (311)
Q Consensus 246 ~p~~Rps~~~vl~~l~~~~~~ 266 (311)
||.+|||+.++++.|+.+...
T Consensus 426 dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 426 DAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp SGGGSCCHHHHHHHHHHHHHT
T ss_pred ChhHCcCHHHHHHHHHHHHHh
Confidence 999999999999999988754
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=306.51 Aligned_cols=232 Identities=21% Similarity=0.227 Sum_probs=189.2
Q ss_pred cCCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHH
Q 021490 7 CLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNT 86 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~ 86 (311)
.+|+.||+|+++.......+.+.+|+.++..++||||+++++++.+....++||||+++++|.+++... ...+++..
T Consensus 112 ~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~---~~~l~~~~ 188 (373)
T 2x4f_A 112 ATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDE---SYNLTELD 188 (373)
T ss_dssp TTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEHHHHHHT---GGGCCHHH
T ss_pred CCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHhc---CCCCCHHH
Confidence 468999999998766566778999999999999999999999999999999999999999999988752 35699999
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEE--cCCCceEEccccccccCCCCCCceeeeeccccccccCcccccc
Q 021490 87 RMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL--DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT 164 (311)
Q Consensus 87 ~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~--~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 164 (311)
++.++.|++.||+|||+.+ ++||||||+|||+ +.++.++|+|||++....... ......+++.|+|||++.+
T Consensus 189 ~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~ 262 (373)
T 2x4f_A 189 TILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---KLKVNFGTPEFLAPEVVNY 262 (373)
T ss_dssp HHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC---BCCCCCSSCTTCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc---ccccccCCCcEeChhhccC
Confidence 9999999999999999999 9999999999999 567899999999987543222 1223458999999999998
Q ss_pred CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccc
Q 021490 165 GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVH 244 (311)
Q Consensus 165 ~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 244 (311)
..++.++|||||||++|+|++|..||...........+... .... .... ....+..+.+|+.+||+
T Consensus 263 ~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~------~~~~----~~~~----~~~~~~~~~~li~~~L~ 328 (373)
T 2x4f_A 263 DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILAC------RWDL----EDEE----FQDISEEAKEFISKLLI 328 (373)
T ss_dssp CBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT------CCCS----CSGG----GTTSCHHHHHHHHTTSC
T ss_pred CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc------cCCC----Chhh----hccCCHHHHHHHHHHcC
Confidence 89999999999999999999999999876544332211110 0000 0001 11234578899999999
Q ss_pred cCCCCCCCHHHHHHHHH
Q 021490 245 EQPDMRPVIADVVTALA 261 (311)
Q Consensus 245 ~~p~~Rps~~~vl~~l~ 261 (311)
.||.+|||+.++++...
T Consensus 329 ~dp~~Rps~~e~l~hp~ 345 (373)
T 2x4f_A 329 KEKSWRISASEALKHPW 345 (373)
T ss_dssp SSGGGSCCHHHHHHSHH
T ss_pred CChhhCCCHHHHhcCcC
Confidence 99999999999998643
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=319.20 Aligned_cols=234 Identities=25% Similarity=0.388 Sum_probs=192.0
Q ss_pred CCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHHH
Q 021490 8 LLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTR 87 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~ 87 (311)
.|..||||+++... ...+.|.+|+.+|++++||||+++++++.+....++||||+++|+|.+++.... ...+++..+
T Consensus 244 ~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~--~~~~~~~~~ 320 (495)
T 1opk_A 244 YSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN--RQEVSAVVL 320 (495)
T ss_dssp GTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSC--TTTSCHHHH
T ss_pred CCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhcC--cCCCCHHHH
Confidence 48899999996543 456889999999999999999999999999999999999999999999997632 456999999
Q ss_pred HHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccCCC
Q 021490 88 MKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQL 167 (311)
Q Consensus 88 ~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 167 (311)
+.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++...... .........++..|+|||++....+
T Consensus 321 ~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~ 396 (495)
T 1opk_A 321 LYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYNKF 396 (495)
T ss_dssp HHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTC-CEECCTTCCCCGGGCCHHHHHHCEE
T ss_pred HHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCC-ceeecCCCcCCcceeCHhHHhcCCC
Confidence 999999999999999999 999999999999999999999999998754221 1112223345678999999998999
Q ss_pred ccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccC
Q 021490 168 TLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQ 246 (311)
Q Consensus 168 ~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 246 (311)
+.++|||||||++|+|++ |..||...........+.. ......+...+..+.+|+.+||+.|
T Consensus 397 ~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~l~~li~~cl~~d 459 (495)
T 1opk_A 397 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK-----------------DYRMERPEGCPEKVYELMRACWQWN 459 (495)
T ss_dssp CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT-----------------TCCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred CcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-----------------CCCCCCCCCCCHHHHHHHHHHcCcC
Confidence 999999999999999999 9999987654332222110 0011223334458889999999999
Q ss_pred CCCCCCHHHHHHHHHHhhh
Q 021490 247 PDMRPVIADVVTALAYLAS 265 (311)
Q Consensus 247 p~~Rps~~~vl~~l~~~~~ 265 (311)
|.+|||+.++++.|+.+..
T Consensus 460 P~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 460 PSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp GGGSCCHHHHHHHHHTSCS
T ss_pred hhHCcCHHHHHHHHHHHHh
Confidence 9999999999999987653
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=299.32 Aligned_cols=251 Identities=20% Similarity=0.217 Sum_probs=185.9
Q ss_pred CcchhccCCcEEEEEEeecCCCc--chhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCC
Q 021490 1 MMQVILCLLQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPG 78 (311)
Q Consensus 1 ~~~~~~~~g~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~ 78 (311)
||.+...+|+.||+|+++..... ....+.+|+.+++.++||||+++++++.++...++||||++ ++|.+++...
T Consensus 37 V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~--- 112 (311)
T 3niz_A 37 VYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFME-KDLKKVLDEN--- 112 (311)
T ss_dssp EEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCS-EEHHHHHHTC---
T ss_pred EEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCC-CCHHHHHHhc---
Confidence 35566668999999999654332 24678899999999999999999999999999999999997 5788877652
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccC
Q 021490 79 KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCA 158 (311)
Q Consensus 79 ~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~a 158 (311)
...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++...... ........++..|+|
T Consensus 113 ~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~~~t~~y~a 187 (311)
T 3niz_A 113 KTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIP--VRSYTHEVVTLWYRA 187 (311)
T ss_dssp TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSC--CC---CCCCCCTTCC
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCC--cccccCCcccCCcCC
Confidence 456999999999999999999999999 999999999999999999999999999753222 122233467999999
Q ss_pred cccccc-CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhh-hhccccc-----------cccccCccccC
Q 021490 159 PEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARP-LFQDRTR-----------HSLIADPELQG 225 (311)
Q Consensus 159 PE~~~~-~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~-----------~~~~~~~~~~~ 225 (311)
||++.+ ..++.++|||||||++|+|++|..||...........+..... ....... ...........
T Consensus 188 PE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (311)
T 3niz_A 188 PDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWS 267 (311)
T ss_dssp HHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHH
T ss_pred HHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHH
Confidence 999876 5689999999999999999999999976654433222211100 0000000 00000000000
Q ss_pred CCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 021490 226 QYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 260 (311)
Q Consensus 226 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l 260 (311)
...+..+.++.+|+.+||+.||++|||+.|+++.-
T Consensus 268 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 302 (311)
T 3niz_A 268 SIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHP 302 (311)
T ss_dssp HHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSG
T ss_pred HhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCc
Confidence 01122345788999999999999999999999753
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=301.94 Aligned_cols=243 Identities=25% Similarity=0.363 Sum_probs=193.2
Q ss_pred cCCcEEEEEEeecCCC-cchhHHHHHHHHHhcC-CCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCC------
Q 021490 7 CLLQDVAIKQLDRNGV-QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPG------ 78 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~------ 78 (311)
.++..||+|+++.... ...+.+.+|+.+++.+ +||||+++++++.+....++||||+++++|.+++......
T Consensus 65 ~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 144 (334)
T 2pvf_A 65 KEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 144 (334)
T ss_dssp ---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC
T ss_pred ccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccc
Confidence 3578899999975533 3346789999999999 8999999999999999999999999999999999864211
Q ss_pred ------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccc
Q 021490 79 ------KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMG 152 (311)
Q Consensus 79 ------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~ 152 (311)
...+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++................+
T Consensus 145 ~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~ 221 (334)
T 2pvf_A 145 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRL 221 (334)
T ss_dssp --------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCC
T ss_pred cccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCc
Confidence 234899999999999999999999999 99999999999999999999999999875433322222333456
Q ss_pred cccccCccccccCCCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHh
Q 021490 153 TYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRG 231 (311)
Q Consensus 153 ~~~y~aPE~~~~~~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (311)
+..|+|||++.+..++.++||||||+++|+|++ |..||...........+... . . ...+...
T Consensus 222 ~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~-------~------~----~~~~~~~ 284 (334)
T 2pvf_A 222 PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG-------H------R----MDKPANC 284 (334)
T ss_dssp CGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHT-------C------C----CCCCTTC
T ss_pred ccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHHHhcC-------C------C----CCCCccC
Confidence 788999999988889999999999999999999 99999876544332221110 0 0 0112233
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhccCC
Q 021490 232 FYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQKYE 269 (311)
Q Consensus 232 ~~~l~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~~~~ 269 (311)
+..+.+++.+||+.||.+|||+.++++.|+.+......
T Consensus 285 ~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~ 322 (334)
T 2pvf_A 285 TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322 (334)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcccc
Confidence 45788999999999999999999999999988876544
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=298.57 Aligned_cols=241 Identities=19% Similarity=0.141 Sum_probs=190.8
Q ss_pred cCCcEEEEEEeecCCCcchhHHHHHHHHHhcC-CCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHH
Q 021490 7 CLLQDVAIKQLDRNGVQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN 85 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~ 85 (311)
.+|+.||||++.... ..+.+.+|+.+++.+ +||||+++++++.++...++||||+ +++|.+++... ...+++.
T Consensus 32 ~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~---~~~~~~~ 105 (330)
T 2izr_A 32 YTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLC---DRTFSLK 105 (330)
T ss_dssp TTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CCBHHHHHHHT---TTCCCHH
T ss_pred CCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CCCHHHHHHHc---CCCCCHH
Confidence 578999999986543 345788999999999 9999999999999999999999999 89999999863 4679999
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCc-----eEEccccccccCCCCCCce-----eeeecccccc
Q 021490 86 TRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH-----PKLSDFGLAKLGPVGDNTH-----VSTRVMGTYG 155 (311)
Q Consensus 86 ~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~-----~~l~df~~~~~~~~~~~~~-----~~~~~~~~~~ 155 (311)
.++.++.|++.||+|||+.+ ++||||||+|||++.++. ++|+|||++.......... ......|+..
T Consensus 106 ~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~ 182 (330)
T 2izr_A 106 TVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTAR 182 (330)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTT
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCcc
Confidence 99999999999999999999 999999999999998887 9999999997543322111 1234568999
Q ss_pred ccCccccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHH
Q 021490 156 YCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQA 235 (311)
Q Consensus 156 y~aPE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 235 (311)
|+|||++.+..++.++|||||||++|+|++|..||...................... . ...+ ....+ .+
T Consensus 183 y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~-~-----~~~~----~~~~p-~~ 251 (330)
T 2izr_A 183 YMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT-P-----IEVL----CENFP-EM 251 (330)
T ss_dssp TCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS-C-----HHHH----TTTCH-HH
T ss_pred ccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC-C-----HHHH----hccCh-HH
Confidence 999999999999999999999999999999999998654322221111110000000 0 0000 01122 78
Q ss_pred HHHHHHccccCCCCCCCHHHHHHHHHHhhhcc
Q 021490 236 LAVAAMCVHEQPDMRPVIADVVTALAYLASQK 267 (311)
Q Consensus 236 ~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~~ 267 (311)
.+++..||+.||.+||++.++.+.|+.+....
T Consensus 252 ~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~ 283 (330)
T 2izr_A 252 ATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK 283 (330)
T ss_dssp HHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence 88999999999999999999999998877553
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=295.53 Aligned_cols=249 Identities=17% Similarity=0.174 Sum_probs=189.5
Q ss_pred CCcEEEEEEeecCC-CcchhHHHHHHHHHhcCCCCcccceeeEeeeCC--eeEEEEecCCCCChhhhhcccCCCCCCCCH
Q 021490 8 LLQDVAIKQLDRNG-VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD--QRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 84 (311)
Q Consensus 8 ~g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~ 84 (311)
+|+.||||+++... ....+.+.+|+++++.++||||+++++++.... ..++||||+++++|.+++..... ...+++
T Consensus 33 ~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~ 111 (319)
T 4euu_A 33 TGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSN-AYGLPE 111 (319)
T ss_dssp TCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTTCBHHHHHHSGGG-TTCCCH
T ss_pred CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCCCCCHHHHHHHhcc-ccCCCH
Confidence 58999999997544 244578889999999999999999999987655 77999999999999999986321 234999
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEE----cCCCceEEccccccccCCCCCCceeeeeccccccccCcc
Q 021490 85 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL----DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 160 (311)
Q Consensus 85 ~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~----~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE 160 (311)
..++.++.|++.||+|||+.+ ++||||||+||++ +.++.+||+|||++....... ......++..|+|||
T Consensus 112 ~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE 185 (319)
T 4euu_A 112 SEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE---QFVSLYGTEEYLHPD 185 (319)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTC---CBCCCCSCGGGCCHH
T ss_pred HHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCceecCCCC---ceeecccCCCccCHH
Confidence 999999999999999999999 9999999999999 788889999999997543322 122346899999999
Q ss_pred ccc--------cCCCccccceeehhHHHHHHHhCCCccCcchhHHH-HHHHHHhh-hhhcccc-------cccccc--Cc
Q 021490 161 YAK--------TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE-QSLVAWAR-PLFQDRT-------RHSLIA--DP 221 (311)
Q Consensus 161 ~~~--------~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~-~~~~~~~~-~~~~~~~-------~~~~~~--~~ 221 (311)
++. +..++.++|||||||++|+|++|..||........ ........ ....... ...... ..
T Consensus 186 ~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 265 (319)
T 4euu_A 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDM 265 (319)
T ss_dssp HHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSC
T ss_pred HhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccC
Confidence 886 46789999999999999999999999964432221 11111111 0000000 000000 01
Q ss_pred cccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 021490 222 ELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYL 263 (311)
Q Consensus 222 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l~~~ 263 (311)
.....++......+.+++.+||+.||++|||+.|+++.....
T Consensus 266 ~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 266 PVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp CTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred CcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 112244567778899999999999999999999999998643
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-43 Score=305.10 Aligned_cols=247 Identities=28% Similarity=0.381 Sum_probs=192.9
Q ss_pred ccCCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEee--eCCeeEEEEecCCCCChhhhhcccCCCCCCCC
Q 021490 6 LCLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA--DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLD 83 (311)
Q Consensus 6 ~~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~ 83 (311)
..+|+.||||++........+.+.+|+.+++.++||||+++++++. +....++||||+++++|.+++... ...++
T Consensus 49 ~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~ 125 (327)
T 3lxl_A 49 DNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRH---RARLD 125 (327)
T ss_dssp SSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEECCTTCBHHHHHHHH---GGGCC
T ss_pred CCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEeecCCCCHHHHHHhc---ccCCC
Confidence 3578999999997766666678999999999999999999999886 456789999999999999999762 34699
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCce-eeeeccccccccCcccc
Q 021490 84 WNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH-VSTRVMGTYGYCAPEYA 162 (311)
Q Consensus 84 ~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~ 162 (311)
+..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.......... ......++..|+|||++
T Consensus 126 ~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 202 (327)
T 3lxl_A 126 ASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESL 202 (327)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceecccCCccceeeccCCccccccCHHHh
Confidence 9999999999999999999999 9999999999999999999999999997643332221 12234577889999999
Q ss_pred ccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHH--------HHHhhhhhccccccccccCccccCCCChHhHHH
Q 021490 163 KTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSL--------VAWARPLFQDRTRHSLIADPELQGQYPPRGFYQ 234 (311)
Q Consensus 163 ~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
.+..++.++||||||+++|+|++|..||........... ........ ........+...+..
T Consensus 203 ~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~ 272 (327)
T 3lxl_A 203 SDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL----------EEGQRLPAPPACPAE 272 (327)
T ss_dssp HHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHH----------HTTCCCCCCTTCCHH
T ss_pred ccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHh----------hcccCCCCCCcccHH
Confidence 999999999999999999999999999976543221100 00000000 011111223445568
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHHHHHhhhccC
Q 021490 235 ALAVAAMCVHEQPDMRPVIADVVTALAYLASQKY 268 (311)
Q Consensus 235 l~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~~~ 268 (311)
+.+|+.+||+.||.+|||+.++++.|+.+.....
T Consensus 273 l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 306 (327)
T 3lxl_A 273 VHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR 306 (327)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHC-----
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 8999999999999999999999999987765543
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=316.89 Aligned_cols=240 Identities=24% Similarity=0.355 Sum_probs=193.0
Q ss_pred cchhccCCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCC
Q 021490 2 MQVILCLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKP 81 (311)
Q Consensus 2 ~~~~~~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 81 (311)
|.+...++..||||+++... ...+.|.+|+.+|+.++||||+++++++. ....++||||+++|+|.+++.... ...
T Consensus 205 ~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~--~~~ 280 (454)
T 1qcf_A 205 WMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDE--GSK 280 (454)
T ss_dssp EEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHHSHH--HHT
T ss_pred EEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHHHHhcc--CCC
Confidence 45556678899999996543 56789999999999999999999999986 567899999999999999997521 236
Q ss_pred CCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccc
Q 021490 82 LDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 161 (311)
Q Consensus 82 l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 161 (311)
+++..++.++.|++.||+|||+++ ++||||||+|||++.++.+||+|||++....... ........++..|+|||+
T Consensus 281 ~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~-~~~~~~~~~~~~y~aPE~ 356 (454)
T 1qcf_A 281 QPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPEA 356 (454)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH-HHTTCSSSSCGGGSCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc-eeccCCCcccccccCHHH
Confidence 899999999999999999999999 9999999999999999999999999997532211 111122345778999999
Q ss_pred cccCCCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHH
Q 021490 162 AKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAA 240 (311)
Q Consensus 162 ~~~~~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 240 (311)
+....++.++||||||+++|+|++ |..||...........+... .. ...+...+..+.+|+.
T Consensus 357 ~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~-------~~----------~~~~~~~~~~l~~li~ 419 (454)
T 1qcf_A 357 INFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG-------YR----------MPRPENCPEELYNIMM 419 (454)
T ss_dssp HHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHT-------CC----------CCCCTTSCHHHHHHHH
T ss_pred hccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-------CC----------CCCCCCCCHHHHHHHH
Confidence 998999999999999999999999 99999876544332222110 00 0112233457889999
Q ss_pred HccccCCCCCCCHHHHHHHHHHhhhc
Q 021490 241 MCVHEQPDMRPVIADVVTALAYLASQ 266 (311)
Q Consensus 241 ~~l~~~p~~Rps~~~vl~~l~~~~~~ 266 (311)
+||+.||.+|||+.++++.|+.+...
T Consensus 420 ~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 420 RCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred HHccCChhHCcCHHHHHHHHHHHHhc
Confidence 99999999999999999999877543
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=302.45 Aligned_cols=232 Identities=26% Similarity=0.414 Sum_probs=184.0
Q ss_pred EEEEEEeecCC-CcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHHHHH
Q 021490 11 DVAIKQLDRNG-VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMK 89 (311)
Q Consensus 11 ~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~ 89 (311)
+||+|.++... ....+.|.+|+.++..++||||+++++++.++. .++|++++.+|+|.+++... ...+++..++.
T Consensus 46 ~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v~e~~~~g~L~~~l~~~---~~~~~~~~~~~ 121 (327)
T 3poz_A 46 PVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREH---KDNIGSQYLLN 121 (327)
T ss_dssp EEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEEEECCTTCBHHHHHHHS---TTSCCHHHHHH
T ss_pred EEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEEEEecCCCcHHHHHHhc---CCCCCHHHHHH
Confidence 46888875443 345578999999999999999999999998754 78999999999999999763 46799999999
Q ss_pred HHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccCCCcc
Q 021490 90 IAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTL 169 (311)
Q Consensus 90 ~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 169 (311)
++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||++................++..|+|||++.+..++.
T Consensus 122 ~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 198 (327)
T 3poz_A 122 WCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH 198 (327)
T ss_dssp HHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCH
T ss_pred HHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCc
Confidence 9999999999999999 9999999999999999999999999987643333333333445678999999999999999
Q ss_pred ccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCC
Q 021490 170 KSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPD 248 (311)
Q Consensus 170 ~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~ 248 (311)
++||||||+++|+|++ |..||...........+.... ....+...+..+.+++.+||+.||.
T Consensus 199 ~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~li~~~l~~~p~ 261 (327)
T 3poz_A 199 QSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE-----------------RLPQPPICTIDVYMIMVKCWMIDAD 261 (327)
T ss_dssp HHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-----------------CCCCCTTBCHHHHHHHHHHTCSCGG
T ss_pred hhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCC-----------------CCCCCccCCHHHHHHHHHHcCCChh
Confidence 9999999999999999 999998765443322221110 0112233445788999999999999
Q ss_pred CCCCHHHHHHHHHHhhhc
Q 021490 249 MRPVIADVVTALAYLASQ 266 (311)
Q Consensus 249 ~Rps~~~vl~~l~~~~~~ 266 (311)
+|||+.++++.|+.+...
T Consensus 262 ~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 262 SRPKFRELIIEFSKMARD 279 (327)
T ss_dssp GSCCHHHHHHHHHHHHTS
T ss_pred hCCCHHHHHHHHHHHHhh
Confidence 999999999999988754
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=300.85 Aligned_cols=241 Identities=27% Similarity=0.376 Sum_probs=193.8
Q ss_pred cCCcEEEEEEeecCCC-cchhHHHHHHHHHhcC-CCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCC-------
Q 021490 7 CLLQDVAIKQLDRNGV-QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP------- 77 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~------- 77 (311)
.+++.||+|+++.... ...+.+.+|+.++..+ +||||+++++++.++...++||||+++++|.+++.....
T Consensus 51 ~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 130 (313)
T 1t46_A 51 DAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKT 130 (313)
T ss_dssp TCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC-----
T ss_pred chhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccc
Confidence 4678999999975543 3346899999999999 999999999999999999999999999999999986321
Q ss_pred -------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeec
Q 021490 78 -------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRV 150 (311)
Q Consensus 78 -------~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~ 150 (311)
....+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++...............
T Consensus 131 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 207 (313)
T 1t46_A 131 SPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 207 (313)
T ss_dssp ---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSS
T ss_pred cccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEcCCCCEEEccccccccccccccceeccCC
Confidence 1225899999999999999999999999 999999999999999999999999999765444333333345
Q ss_pred cccccccCccccccCCCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCCh
Q 021490 151 MGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPP 229 (311)
Q Consensus 151 ~~~~~y~aPE~~~~~~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (311)
.++..|+|||++.+..++.++||||||+++|+|++ |..||............ . .... ....+.
T Consensus 208 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~--~----~~~~----------~~~~~~ 271 (313)
T 1t46_A 208 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM--I----KEGF----------RMLSPE 271 (313)
T ss_dssp EECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHH--H----HHTC----------CCCCCT
T ss_pred CCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHHH--h----ccCC----------CCCCcc
Confidence 57788999999998999999999999999999999 99999765432211100 0 0000 001122
Q ss_pred HhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 021490 230 RGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 266 (311)
Q Consensus 230 ~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~ 266 (311)
..+..+.+++.+||+.||.+|||+.++++.|+.+...
T Consensus 272 ~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 308 (313)
T 1t46_A 272 HAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (313)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 3345788999999999999999999999999877654
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=297.46 Aligned_cols=248 Identities=19% Similarity=0.237 Sum_probs=187.5
Q ss_pred CCcEEEEEEeecCCC-cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccC--CCCCCCCH
Q 021490 8 LLQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLS--PGKKPLDW 84 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~l~~ 84 (311)
+|+.||+|+++.... ...+.+.+|+.+++.++||||+++++++.++...++||||++ ++|.+++.... .....+++
T Consensus 29 ~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~ 107 (317)
T 2pmi_A 29 TGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLEL 107 (317)
T ss_dssp SCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCH
T ss_pred CCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC-CCHHHHHHhccccccccCCCH
Confidence 689999999976543 334688899999999999999999999999999999999997 69999886532 12246999
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccccc
Q 021490 85 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT 164 (311)
Q Consensus 85 ~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 164 (311)
..+..++.|++.||+|||+.| ++||||||+||+++.++.+||+|||++....... .......++..|+|||++.+
T Consensus 108 ~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~ 182 (317)
T 2pmi_A 108 NLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPV--NTFSSEVVTLWYRAPDVLMG 182 (317)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETTSCC--CCCCCCCSCCTTCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecCCCc--ccCCCCcccccccCchHhhC
Confidence 999999999999999999999 9999999999999999999999999987543221 12233467899999999876
Q ss_pred -CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccc----cccccccCcccc------------CCC
Q 021490 165 -GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDR----TRHSLIADPELQ------------GQY 227 (311)
Q Consensus 165 -~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~------------~~~ 227 (311)
..++.++|||||||++|+|++|..||...........+.......... ........+.+. ...
T Consensus 183 ~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (317)
T 2pmi_A 183 SRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHT 262 (317)
T ss_dssp CCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGC
T ss_pred CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccc
Confidence 468999999999999999999999998766544433222111000000 000000000000 001
Q ss_pred ChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 021490 228 PPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 261 (311)
Q Consensus 228 ~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l~ 261 (311)
....+..+.+|+.+||+.||++|||+.++++.-.
T Consensus 263 ~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~ 296 (317)
T 2pmi_A 263 KEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPW 296 (317)
T ss_dssp SSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGG
T ss_pred cccCCHHHHHHHHHHCCCCcccCCCHHHHhCChh
Confidence 1123457899999999999999999999997643
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=302.39 Aligned_cols=234 Identities=21% Similarity=0.272 Sum_probs=177.4
Q ss_pred CCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHHH
Q 021490 8 LLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTR 87 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~ 87 (311)
+|+.||||++.... ...+.+.+|+.+++.++||||+++++++.+....++||||++|++|.+++.. .+.+++..+
T Consensus 44 ~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~ 118 (361)
T 3uc3_A 44 TKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICN----AGRFSEDEA 118 (361)
T ss_dssp TCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHH
T ss_pred CCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCHHHHHHh----cCCCCHHHH
Confidence 68999999996543 3457788999999999999999999999999999999999999999999976 567999999
Q ss_pred HHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCc--eEEccccccccCCCCCCceeeeeccccccccCccccccC
Q 021490 88 MKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH--PKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG 165 (311)
Q Consensus 88 ~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~--~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 165 (311)
+.++.|++.||+|||++| ++||||||+||+++.++. +||+|||++..... ........+++.|+|||++.+.
T Consensus 119 ~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~ 192 (361)
T 3uc3_A 119 RFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL---HSQPKSTVGTPAYIAPEVLLRQ 192 (361)
T ss_dssp HHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC------------------CTTSCHHHHHCS
T ss_pred HHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccccc---cCCCCCCcCCCCcCChhhhcCC
Confidence 999999999999999999 999999999999987665 99999999863211 1222334689999999999887
Q ss_pred CCccc-cceeehhHHHHHHHhCCCccCcchhHHHH-HHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHcc
Q 021490 166 QLTLK-SDVYSFGVVLLEILSGRKAVDTSKAAAEQ-SLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCV 243 (311)
Q Consensus 166 ~~~~~-~DiwslG~l~~~ll~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 243 (311)
.++.+ +|||||||++|+|++|..||......... ..... ........ ......+..+.+|+.+||
T Consensus 193 ~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~---~~~~~~~~----------~~~~~~s~~~~~li~~~L 259 (361)
T 3uc3_A 193 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQR---ILSVKYSI----------PDDIRISPECCHLISRIF 259 (361)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHH---HHTTCCCC----------CTTSCCCHHHHHHHHHHS
T ss_pred CCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHH---HhcCCCCC----------CCcCCCCHHHHHHHHHHc
Confidence 77555 89999999999999999999765432211 11111 11100000 001123457889999999
Q ss_pred ccCCCCCCCHHHHHHHHHHhhh
Q 021490 244 HEQPDMRPVIADVVTALAYLAS 265 (311)
Q Consensus 244 ~~~p~~Rps~~~vl~~l~~~~~ 265 (311)
+.||.+|||+.++++.-.+...
T Consensus 260 ~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 260 VADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp CSCTTTSCCHHHHHTSHHHHTT
T ss_pred cCChhHCcCHHHHHhCcchhcC
Confidence 9999999999999988766443
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=293.53 Aligned_cols=228 Identities=24% Similarity=0.305 Sum_probs=180.0
Q ss_pred cCCcEEEEEEeecCCCc--------------------------chhHHHHHHHHHhcCCCCcccceeeEeee--CCeeEE
Q 021490 7 CLLQDVAIKQLDRNGVQ--------------------------GNREFLVEVLMLSLLHHPNLVNLIGYCAD--GDQRLL 58 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~--------------------------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 58 (311)
.+|+.||||++...... ..+.+.+|+.+++.++||||+++++++.+ ....++
T Consensus 36 ~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 115 (298)
T 2zv2_A 36 NDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYM 115 (298)
T ss_dssp TTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCCCTTBCCEEEEEECSSSSEEEE
T ss_pred CCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCCCEEEE
Confidence 36899999999764321 23578899999999999999999999986 568899
Q ss_pred EEecCCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccC
Q 021490 59 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLG 138 (311)
Q Consensus 59 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~ 138 (311)
||||+++++|.+++. ...+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++...
T Consensus 116 v~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 187 (298)
T 2zv2_A 116 VFELVNQGPVMEVPT-----LKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEF 187 (298)
T ss_dssp EEECCTTCBSCCSSC-----SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEecCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCCEEEecCCCcccc
Confidence 999999999988764 357999999999999999999999999 999999999999999999999999998754
Q ss_pred CCCCCceeeeeccccccccCccccccCC---CccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhcccccc
Q 021490 139 PVGDNTHVSTRVMGTYGYCAPEYAKTGQ---LTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRH 215 (311)
Q Consensus 139 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 215 (311)
... ........++..|+|||++.+.. .+.++||||||+++|+|++|..||...........+.. ....
T Consensus 188 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~------~~~~- 258 (298)
T 2zv2_A 188 KGS--DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKS------QALE- 258 (298)
T ss_dssp SSS--SCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------CCCC-
T ss_pred ccc--cccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHHHHHhc------ccCC-
Confidence 322 12233456899999999987654 37789999999999999999999976554322211110 0000
Q ss_pred ccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 021490 216 SLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 260 (311)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l 260 (311)
.+ ..+..+..+.+++.+||+.||++|||+.++++.-
T Consensus 259 ----~~-----~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp 294 (298)
T 2zv2_A 259 ----FP-----DQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHP 294 (298)
T ss_dssp ----CC-----SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCH
T ss_pred ----CC-----CccccCHHHHHHHHHHhhcChhhCCCHHHHhcCc
Confidence 00 0122344788999999999999999999998653
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=300.62 Aligned_cols=232 Identities=25% Similarity=0.422 Sum_probs=184.8
Q ss_pred EEEEEeecCC-CcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHHHHHH
Q 021490 12 VAIKQLDRNG-VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKI 90 (311)
Q Consensus 12 vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~ 90 (311)
||+|.+.... ......+.+|+.++..++||||+++++++. +...++||||+.+++|.+++... ...+++..++.+
T Consensus 45 v~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~ 120 (325)
T 3kex_A 45 VCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQH---RGALGPQLLLNW 120 (325)
T ss_dssp EEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEECCTTCBSHHHHHSS---GGGSCTTHHHHH
T ss_pred EEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEEeCCCCCHHHHHHHc---cccCCHHHHHHH
Confidence 7888875443 234467889999999999999999999986 45689999999999999999762 357999999999
Q ss_pred HHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccCCCccc
Q 021490 91 AAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLK 170 (311)
Q Consensus 91 ~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 170 (311)
+.|++.||+|||+.+ ++||||||+|||++.++.++|+|||++................++..|+|||++.+..++.+
T Consensus 121 ~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 197 (325)
T 3kex_A 121 GVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQ 197 (325)
T ss_dssp HHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHH
T ss_pred HHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChh
Confidence 999999999999999 99999999999999999999999999987544443333444567889999999998999999
Q ss_pred cceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCC
Q 021490 171 SDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDM 249 (311)
Q Consensus 171 ~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~ 249 (311)
+||||||+++|+|++ |..||...........+..... ...+...+..+.+++.+||..||.+
T Consensus 198 ~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~li~~~l~~dp~~ 260 (325)
T 3kex_A 198 SDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGER-----------------LAQPQICTIDVYMVMVKCWMIDENI 260 (325)
T ss_dssp HHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCB-----------------CCCCTTBCTTTTHHHHHHTCSCTTT
T ss_pred hHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC-----------------CCCCCcCcHHHHHHHHHHcCCChhh
Confidence 999999999999999 9999987654433322221100 0111112235677999999999999
Q ss_pred CCCHHHHHHHHHHhhhcc
Q 021490 250 RPVIADVVTALAYLASQK 267 (311)
Q Consensus 250 Rps~~~vl~~l~~~~~~~ 267 (311)
|||+.++++.|+.+....
T Consensus 261 Rps~~el~~~l~~~~~~~ 278 (325)
T 3kex_A 261 RPTFKELANEFTRMARDP 278 (325)
T ss_dssp SCCHHHHHHHHHHHTTSH
T ss_pred CcCHHHHHHHHHHHHhcc
Confidence 999999999999886543
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-42 Score=304.08 Aligned_cols=226 Identities=25% Similarity=0.361 Sum_probs=184.0
Q ss_pred CCcEEEEEEeecCC---CcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCH
Q 021490 8 LLQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 84 (311)
Q Consensus 8 ~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~ 84 (311)
+|+.||+|+++... ....+.+.+|+.++..++||||+++++++.+....|+||||+.||+|.+++.. ...+++
T Consensus 39 ~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~l~~ 114 (384)
T 4fr4_A 39 TKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQ----NVHFKE 114 (384)
T ss_dssp TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHT----TCCCCH
T ss_pred CCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCcHHHHHHh----cCCCCH
Confidence 58899999997543 23456888999999999999999999999999999999999999999999987 567999
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccccc
Q 021490 85 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT 164 (311)
Q Consensus 85 ~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 164 (311)
..+..++.|++.||+|||+.| |+||||||+|||++.+|.++|+|||++...... .......||+.|+|||++..
T Consensus 115 ~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~---~~~~~~~gt~~Y~aPE~~~~ 188 (384)
T 4fr4_A 115 ETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE---TQITTMAGTKPYMAPEMFSS 188 (384)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT---CCBCCCCSCGGGCCGGGTCC
T ss_pred HHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCC---CceeccCCCccccCCeeecc
Confidence 999999999999999999999 999999999999999999999999999754322 22234568999999999864
Q ss_pred ---CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHH
Q 021490 165 ---GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAM 241 (311)
Q Consensus 165 ---~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 241 (311)
..++.++|||||||++|+|++|..||................. . ...++...+..+.+||.+
T Consensus 189 ~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~---~------------~~~~p~~~s~~~~~li~~ 253 (384)
T 4fr4_A 189 RKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET---T------------VVTYPSAWSQEMVSLLKK 253 (384)
T ss_dssp CSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH---C------------CCCCCTTSCHHHHHHHHH
T ss_pred CCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh---c------------ccCCCCcCCHHHHHHHHH
Confidence 4589999999999999999999999975443322222221111 0 011233345588999999
Q ss_pred ccccCCCCCCC-HHHHHH
Q 021490 242 CVHEQPDMRPV-IADVVT 258 (311)
Q Consensus 242 ~l~~~p~~Rps-~~~vl~ 258 (311)
||+.||.+||+ +++++.
T Consensus 254 lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 254 LLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp HSCSSGGGSCCSHHHHHT
T ss_pred HhcCCHhHhcccHHHHHc
Confidence 99999999998 566554
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=294.41 Aligned_cols=236 Identities=25% Similarity=0.384 Sum_probs=194.0
Q ss_pred CCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHHH
Q 021490 8 LLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTR 87 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~ 87 (311)
+|..||+|+++. .....+.+.+|+.+++.++||||+++++++.++...++||||++|++|.+++.... ...+++..+
T Consensus 37 ~~~~vaiK~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~--~~~~~~~~~ 113 (288)
T 3kfa_A 37 YSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN--RQEVSAVVL 113 (288)
T ss_dssp GTEEEEEEEECS-CSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHCC--TTTSCHHHH
T ss_pred CCEEEEEEecCc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcHHHHHHhcc--cCCccHhHH
Confidence 488999999964 34456789999999999999999999999999999999999999999999997632 456999999
Q ss_pred HHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccCCC
Q 021490 88 MKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQL 167 (311)
Q Consensus 88 ~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 167 (311)
+.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++....... ........++..|+|||++.+..+
T Consensus 114 ~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~ 189 (288)
T 3kfa_A 114 LYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKF 189 (288)
T ss_dssp HHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS-SEEETTEEECGGGCCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCCc-cccccCCccccCcCChhhhccCCC
Confidence 999999999999999999 9999999999999999999999999987543222 222333456788999999998999
Q ss_pred ccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccC
Q 021490 168 TLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQ 246 (311)
Q Consensus 168 ~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 246 (311)
+.++||||||+++|+|++ |..||............... .....+...+..+.+++.+||..|
T Consensus 190 ~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~l~~li~~~l~~d 252 (288)
T 3kfa_A 190 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-----------------YRMERPEGCPEKVYELMRACWQWN 252 (288)
T ss_dssp CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT-----------------CCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcc-----------------CCCCCCCCCCHHHHHHHHHHhCCC
Confidence 999999999999999999 99999776543332222110 011122333457889999999999
Q ss_pred CCCCCCHHHHHHHHHHhhhcc
Q 021490 247 PDMRPVIADVVTALAYLASQK 267 (311)
Q Consensus 247 p~~Rps~~~vl~~l~~~~~~~ 267 (311)
|.+|||+.++++.|+.+....
T Consensus 253 p~~Rps~~~~~~~l~~~~~~~ 273 (288)
T 3kfa_A 253 PSDRPSFAEIHQAFETMFQES 273 (288)
T ss_dssp GGGSCCHHHHHHHHHHHHHHH
T ss_pred hhhCcCHHHHHHHHHHHHHhc
Confidence 999999999999998777543
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=300.64 Aligned_cols=223 Identities=23% Similarity=0.238 Sum_probs=187.0
Q ss_pred CCcEEEEEEeecCC---CcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCH
Q 021490 8 LLQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 84 (311)
Q Consensus 8 ~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~ 84 (311)
+|+.||||+++... ....+.+.+|+.++..++||||+++++++.+....|+||||++|++|.+++.. .+.+++
T Consensus 65 ~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~ 140 (350)
T 1rdq_E 65 SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR----IGRFSE 140 (350)
T ss_dssp TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH----HCCCCH
T ss_pred CCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHH----cCCCCH
Confidence 68999999997643 23456888999999999999999999999999999999999999999999987 467999
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccccc
Q 021490 85 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT 164 (311)
Q Consensus 85 ~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 164 (311)
..+..++.|++.||+|||++| |+||||||+|||++.+|.++|+|||++...... .....|++.|+|||++.+
T Consensus 141 ~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~-----~~~~~gt~~y~aPE~~~~ 212 (350)
T 1rdq_E 141 PHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWTLCGTPEALAPEIILS 212 (350)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC-----BCCCEECGGGCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCC-----cccccCCccccCHHHhcC
Confidence 999999999999999999999 999999999999999999999999998753221 123468999999999999
Q ss_pred CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccc
Q 021490 165 GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVH 244 (311)
Q Consensus 165 ~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 244 (311)
..++.++|||||||++|+|++|..||...........+.. .. . .++...+..+.++|.+||+
T Consensus 213 ~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~------~~--------~----~~p~~~~~~~~~li~~lL~ 274 (350)
T 1rdq_E 213 KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS------GK--------V----RFPSHFSSDLKDLLRNLLQ 274 (350)
T ss_dssp CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------CC--------C----CCCTTCCHHHHHHHHHHSC
T ss_pred CCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHc------CC--------C----CCCCCCCHHHHHHHHHHhh
Confidence 9999999999999999999999999987654333221111 10 0 1223344578999999999
Q ss_pred cCCCCCCC-----HHHHHHHH
Q 021490 245 EQPDMRPV-----IADVVTAL 260 (311)
Q Consensus 245 ~~p~~Rps-----~~~vl~~l 260 (311)
.||.+||+ ++++++.-
T Consensus 275 ~dp~~R~~~~~~~~~ei~~h~ 295 (350)
T 1rdq_E 275 VDLTKRFGNLKNGVNDIKNHK 295 (350)
T ss_dssp SCTTTCTTSSTTTTHHHHTSG
T ss_pred cCHHhccCCccCCHHHHHhCc
Confidence 99999998 88888664
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=302.21 Aligned_cols=227 Identities=25% Similarity=0.323 Sum_probs=185.5
Q ss_pred cCCcEEEEEEeecCC---CcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCC
Q 021490 7 CLLQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLD 83 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~ 83 (311)
.+|+.||+|++.... ......+.+|+.+++.++||||+++++++.+....++||||+ +|+|.+++.. .+.++
T Consensus 32 ~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~g~l~~~l~~----~~~l~ 106 (336)
T 3h4j_B 32 KTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVE----KKRMT 106 (336)
T ss_dssp TTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC-CEEHHHHHHH----HCSCC
T ss_pred CCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC-CCcHHHHHHH----cCCCC
Confidence 478999999987542 233467899999999999999999999999999999999999 6899998876 56799
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccc
Q 021490 84 WNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 163 (311)
Q Consensus 84 ~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 163 (311)
+..++.++.|++.||+|||+.| ++||||||+||+++.++.+||+|||++...... .......|++.|+|||++.
T Consensus 107 ~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~---~~~~~~~gt~~y~aPE~~~ 180 (336)
T 3h4j_B 107 EDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG---NFLKTSCGSPNYAAPEVIN 180 (336)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS---BTTCCCTTSTTTSCGGGSC
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCC---cccccccCCcCcCCHHHHc
Confidence 9999999999999999999999 999999999999999999999999998753322 2223346899999999998
Q ss_pred cCCC-ccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHc
Q 021490 164 TGQL-TLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMC 242 (311)
Q Consensus 164 ~~~~-~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 242 (311)
+..+ +.++||||||+++|+|++|..||........ ... .. ......+...+..+.+|+.+|
T Consensus 181 ~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~----------~~~-i~-------~~~~~~p~~~s~~~~~li~~~ 242 (336)
T 3h4j_B 181 GKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL----------FKK-VN-------SCVYVMPDFLSPGAQSLIRRM 242 (336)
T ss_dssp CSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC----------BCC-CC-------SSCCCCCTTSCHHHHHHHHTT
T ss_pred CCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH----------HHH-HH-------cCCCCCcccCCHHHHHHHHHH
Confidence 8776 6899999999999999999999976432110 000 00 001122334456888999999
Q ss_pred cccCCCCCCCHHHHHHHHHH
Q 021490 243 VHEQPDMRPVIADVVTALAY 262 (311)
Q Consensus 243 l~~~p~~Rps~~~vl~~l~~ 262 (311)
|+.||.+|||+.|+++..+.
T Consensus 243 L~~dP~~Rpt~~eil~hp~~ 262 (336)
T 3h4j_B 243 IVADPMQRITIQEIRRDPWF 262 (336)
T ss_dssp SCSSGGGSCCHHHHTTCHHH
T ss_pred cCCChhHCcCHHHHHhChhh
Confidence 99999999999999988654
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-42 Score=290.82 Aligned_cols=230 Identities=30% Similarity=0.432 Sum_probs=177.9
Q ss_pred CCcEEEEEEeecCCC----cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCC
Q 021490 8 LLQDVAIKQLDRNGV----QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLD 83 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~ 83 (311)
.|..||+|+++.... ...+.+.+|+.+++.++||||+++++++.++...++||||+++++|.+++.. ..++
T Consensus 29 ~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~ 103 (271)
T 3dtc_A 29 IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSG-----KRIP 103 (271)
T ss_dssp TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECCTTEEHHHHHTS-----SCCC
T ss_pred cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcCCCCCHHHHhhc-----CCCC
Confidence 488999999865433 2246788999999999999999999999999999999999999999999864 5799
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcC--------CCceEEccccccccCCCCCCceeeeecccccc
Q 021490 84 WNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR--------GYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG 155 (311)
Q Consensus 84 ~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~--------~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~ 155 (311)
+..++.++.|++.||+|||+++..+++|+||||+||+++. ++.++|+|||++....... .....++..
T Consensus 104 ~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~ 179 (271)
T 3dtc_A 104 PDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT----KMSAAGAYA 179 (271)
T ss_dssp HHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC-----------------CCGG
T ss_pred HHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCccccccccc----ccCCCCccc
Confidence 9999999999999999999987445789999999999986 7789999999986432211 223468899
Q ss_pred ccCccccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHH
Q 021490 156 YCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQA 235 (311)
Q Consensus 156 y~aPE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 235 (311)
|+|||++.+..++.++||||||+++|+|++|..||............. .. ......+...+..+
T Consensus 180 y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~------~~----------~~~~~~~~~~~~~~ 243 (271)
T 3dtc_A 180 WMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVA------MN----------KLALPIPSTCPEPF 243 (271)
T ss_dssp GSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHH------TS----------CCCCCCCTTCCHHH
T ss_pred eeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhh------cC----------CCCCCCCcccCHHH
Confidence 999999999999999999999999999999999998765433221111 00 00111223344578
Q ss_pred HHHHHHccccCCCCCCCHHHHHHHHHH
Q 021490 236 LAVAAMCVHEQPDMRPVIADVVTALAY 262 (311)
Q Consensus 236 ~~li~~~l~~~p~~Rps~~~vl~~l~~ 262 (311)
.+++.+||+.||.+|||+.++++.|+.
T Consensus 244 ~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 244 AKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred HHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 899999999999999999999999974
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=313.78 Aligned_cols=239 Identities=28% Similarity=0.360 Sum_probs=188.7
Q ss_pred cchhccCCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCC
Q 021490 2 MQVILCLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKP 81 (311)
Q Consensus 2 ~~~~~~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 81 (311)
|.+...++..||||+++... ...+.|.+|+.+|+.++||||+++++++.+ ...++||||+++|+|.+++.... +..
T Consensus 201 y~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~~--~~~ 276 (452)
T 1fmk_A 201 WMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGET--GKY 276 (452)
T ss_dssp EEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHH--HTT
T ss_pred EEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHHHHHHhcC--CCC
Confidence 45555667889999996543 456789999999999999999999999876 67899999999999999997521 356
Q ss_pred CCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccc
Q 021490 82 LDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 161 (311)
Q Consensus 82 l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 161 (311)
+++..++.++.|++.||+|||+++ ++||||||+|||++.++.+||+|||++....... ........++..|+|||+
T Consensus 277 ~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-~~~~~~~~~~~~y~aPE~ 352 (452)
T 1fmk_A 277 LRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEA 352 (452)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---------------CCGGGSCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCc-eecccCCcccccccCHhH
Confidence 999999999999999999999999 9999999999999999999999999997543211 112223446788999999
Q ss_pred cccCCCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHH
Q 021490 162 AKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAA 240 (311)
Q Consensus 162 ~~~~~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 240 (311)
+....++.++||||||+++|+|++ |..||...........+... .....+...+..+.+|+.
T Consensus 353 ~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~-----------------~~~~~~~~~~~~l~~li~ 415 (452)
T 1fmk_A 353 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-----------------YRMPCPPECPESLHDLMC 415 (452)
T ss_dssp HHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-----------------CCCCCCTTSCHHHHHHHH
T ss_pred HhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-----------------CCCCCCCCCCHHHHHHHH
Confidence 998999999999999999999999 99999876543332211100 001122334557889999
Q ss_pred HccccCCCCCCCHHHHHHHHHHhhh
Q 021490 241 MCVHEQPDMRPVIADVVTALAYLAS 265 (311)
Q Consensus 241 ~~l~~~p~~Rps~~~vl~~l~~~~~ 265 (311)
+||+.||++|||+.++++.|+.+..
T Consensus 416 ~cl~~dP~~Rpt~~~l~~~L~~~~~ 440 (452)
T 1fmk_A 416 QCWRKEPEERPTFEYLQAFLEDYFT 440 (452)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred HHccCChhhCcCHHHHHHHHHHHhc
Confidence 9999999999999999999987653
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=291.62 Aligned_cols=244 Identities=18% Similarity=0.198 Sum_probs=182.4
Q ss_pred CCcEEEEEEeecCCCc--chhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHH
Q 021490 8 LLQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN 85 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~ 85 (311)
+|+.||+|+++..... ....+.+|+.+++.++||||+++++++.++...++||||+++ +|.+.+... ...+++.
T Consensus 26 ~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~---~~~l~~~ 101 (292)
T 3o0g_A 26 THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSC---NGDLDPE 101 (292)
T ss_dssp TCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHT---TTCCCHH
T ss_pred CCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCCC-CHHHHHHhC---CCCCCHH
Confidence 6899999999765432 236788999999999999999999999999999999999975 565555442 4679999
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccC
Q 021490 86 TRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG 165 (311)
Q Consensus 86 ~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 165 (311)
.++.++.|++.||+|||++| ++||||||+||+++.++.++|+|||++...... ........++..|+|||++.+.
T Consensus 102 ~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~ 176 (292)
T 3o0g_A 102 IVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP--VRCYSAEVVTLWYRPPDVLFGA 176 (292)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSC--CSCCCSCCSCGGGCCHHHHTTC
T ss_pred HHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCc--cccccCCccccCCcChHHHcCC
Confidence 99999999999999999999 999999999999999999999999999753221 1222334678999999998775
Q ss_pred C-CccccceeehhHHHHHHHhCCCcc-CcchhHHHHHHHHHhhhhhc-ccc-c---------cccccCccccCCCChHhH
Q 021490 166 Q-LTLKSDVYSFGVVLLEILSGRKAV-DTSKAAAEQSLVAWARPLFQ-DRT-R---------HSLIADPELQGQYPPRGF 232 (311)
Q Consensus 166 ~-~~~~~DiwslG~l~~~ll~g~~pf-~~~~~~~~~~~~~~~~~~~~-~~~-~---------~~~~~~~~~~~~~~~~~~ 232 (311)
. ++.++|||||||++|+|++|..|| ...........+........ ... . ..............+..+
T Consensus 177 ~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (292)
T 3o0g_A 177 KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLN 256 (292)
T ss_dssp SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCC
T ss_pred CCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccC
Confidence 5 799999999999999999988775 44333322221111100000 000 0 000000001112223455
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHH
Q 021490 233 YQALAVAAMCVHEQPDMRPVIADVVTAL 260 (311)
Q Consensus 233 ~~l~~li~~~l~~~p~~Rps~~~vl~~l 260 (311)
..+.+|+.+||+.||++|||++|+++.-
T Consensus 257 ~~~~~li~~~L~~dP~~R~t~~e~l~hp 284 (292)
T 3o0g_A 257 ATGRDLLQNLLKCNPVQRISAEEALQHP 284 (292)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred hHHHHHHHHHhccChhhCCCHHHHhcCc
Confidence 6888999999999999999999999753
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=308.01 Aligned_cols=231 Identities=24% Similarity=0.347 Sum_probs=182.6
Q ss_pred CCcEEEEEEeecCCC---cchhHHHHHHHHHhcC-CCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCC
Q 021490 8 LLQDVAIKQLDRNGV---QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLD 83 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~ 83 (311)
+|+.||+|++++... ...+.+.+|..++.++ +||||+++++++.+....|+||||++||+|..++.. ...++
T Consensus 76 ~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~----~~~l~ 151 (396)
T 4dc2_A 76 TDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR----QRKLP 151 (396)
T ss_dssp TTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH----HSSCC
T ss_pred CCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcCCCCcHHHHHHH----cCCCC
Confidence 688999999976532 2335688899999887 899999999999999999999999999999999987 56799
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccc
Q 021490 84 WNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 163 (311)
Q Consensus 84 ~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 163 (311)
+..+..++.||+.||+|||+++ |+||||||+|||++.+|.+||+|||++..... .........||+.|+|||++.
T Consensus 152 ~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~~--~~~~~~~~~gt~~Y~aPE~l~ 226 (396)
T 4dc2_A 152 EEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR--PGDTTSTFCGTPNYIAPEILR 226 (396)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC--TTCCBCCCCBCGGGCCHHHHT
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeeccc--CCCccccccCCcccCCchhhc
Confidence 9999999999999999999999 99999999999999999999999999874221 112233456899999999999
Q ss_pred cCCCccccceeehhHHHHHHHhCCCccCcchhHHHH---HHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHH
Q 021490 164 TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ---SLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAA 240 (311)
Q Consensus 164 ~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 240 (311)
+..++.++|||||||++|+|++|..||......... ............ . ..++...+..+.+||.
T Consensus 227 ~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~--------~----~~~p~~~s~~~~~li~ 294 (396)
T 4dc2_A 227 GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK--------Q----IRIPRSLSVKAASVLK 294 (396)
T ss_dssp TCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHC--------C----CCCCTTSCHHHHHHHH
T ss_pred CCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcc--------c----cCCCCcCCHHHHHHHH
Confidence 999999999999999999999999999643221110 000000001111 0 1223344558899999
Q ss_pred HccccCCCCCCCH------HHHHHH
Q 021490 241 MCVHEQPDMRPVI------ADVVTA 259 (311)
Q Consensus 241 ~~l~~~p~~Rps~------~~vl~~ 259 (311)
+||+.||.+||++ +++++.
T Consensus 295 ~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 295 SFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp HHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred HHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 9999999999995 566654
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-42 Score=298.99 Aligned_cols=227 Identities=25% Similarity=0.290 Sum_probs=178.6
Q ss_pred cCCcEEEEEEeecCCC----cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCC
Q 021490 7 CLLQDVAIKQLDRNGV----QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPL 82 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l 82 (311)
.+|+.||+|+++.... .....+.+|+.+++.++||||+++++++.++...|+||||++|++|.+++.. ...+
T Consensus 43 ~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~ 118 (327)
T 3a62_A 43 NTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLER----EGIF 118 (327)
T ss_dssp TTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEEEEEECCTTEEHHHHHHH----HSSC
T ss_pred CCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEEEEeCCCCCcHHHHHHh----CCCC
Confidence 4789999999976532 2345678899999999999999999999999999999999999999999986 5679
Q ss_pred CHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccc
Q 021490 83 DWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 162 (311)
Q Consensus 83 ~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 162 (311)
++..+..++.|++.||+|||+++ ++||||||+||+++.++.++|+|||++...... ........|+..|+|||++
T Consensus 119 ~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~ 193 (327)
T 3a62_A 119 MEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHD--GTVTHTFCGTIEYMAPEIL 193 (327)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC------------CTTSSCCTTSCHHHH
T ss_pred CHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCcccccccC--CccccccCCCcCccCHhhC
Confidence 99999999999999999999999 999999999999999999999999998642211 1122334689999999999
Q ss_pred ccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHc
Q 021490 163 KTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMC 242 (311)
Q Consensus 163 ~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 242 (311)
.+..++.++||||||+++|+|++|..||...........+. ... ..+++..+..+.+++.+|
T Consensus 194 ~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~------~~~------------~~~p~~~~~~~~~li~~~ 255 (327)
T 3a62_A 194 MRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKIL------KCK------------LNLPPYLTQEARDLLKKL 255 (327)
T ss_dssp TTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH------HTC------------CCCCTTSCHHHHHHHHHH
T ss_pred cCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHH------hCC------------CCCCCCCCHHHHHHHHHH
Confidence 98889999999999999999999999998765433322111 100 012233445888999999
Q ss_pred cccCCCCCC-----CHHHHHHHH
Q 021490 243 VHEQPDMRP-----VIADVVTAL 260 (311)
Q Consensus 243 l~~~p~~Rp-----s~~~vl~~l 260 (311)
|+.||.+|| ++.++++..
T Consensus 256 L~~dp~~R~~~~~~~~~e~l~hp 278 (327)
T 3a62_A 256 LKRNAASRLGAGPGDAGEVQAHP 278 (327)
T ss_dssp SCSCGGGSTTSSTTTHHHHHHSG
T ss_pred HhcCHhhccCCCCCCHHHHHcCC
Confidence 999999999 778888764
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-42 Score=295.96 Aligned_cols=243 Identities=24% Similarity=0.345 Sum_probs=188.8
Q ss_pred ccCCcEEEEEEeecCCC-cchhHHHHHHHHHhcCCCCcccceeeEeeeC--CeeEEEEecCCCCChhhhhcccCCCCCCC
Q 021490 6 LCLLQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADG--DQRLLVYEYMPLGSVEDHLHDLSPGKKPL 82 (311)
Q Consensus 6 ~~~g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~l 82 (311)
..+|+.||+|+++.... ...+.+.+|+.+++.++||||+++++++.+. ...++||||+++++|.+++... ...+
T Consensus 47 ~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~ 123 (302)
T 4e5w_A 47 DNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKN---KNKI 123 (302)
T ss_dssp SSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEEEEECCTTCBHHHHHHHH---TTTC
T ss_pred CccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEEEEEeCCCCcHHHHHHhc---cccC
Confidence 34789999999975542 3457899999999999999999999999876 6689999999999999999652 4569
Q ss_pred CHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCc-eeeeeccccccccCccc
Q 021490 83 DWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT-HVSTRVMGTYGYCAPEY 161 (311)
Q Consensus 83 ~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~ 161 (311)
++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++......... .......++..|+|||+
T Consensus 124 ~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 200 (302)
T 4e5w_A 124 NLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPEC 200 (302)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHH
T ss_pred CHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccccccCCCcceeccCCCCCCccccCCee
Confidence 99999999999999999999999 999999999999999999999999999764333221 22333557888999999
Q ss_pred cccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHH--------HHHHhhhhhccccccccccCccccCCCChHhHH
Q 021490 162 AKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQS--------LVAWARPLFQDRTRHSLIADPELQGQYPPRGFY 233 (311)
Q Consensus 162 ~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
+.+..++.++||||||+++|+|++|..|+.......... .......... .......+...+.
T Consensus 201 ~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~ 270 (302)
T 4e5w_A 201 LMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLK----------EGKRLPCPPNCPD 270 (302)
T ss_dssp HHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHH----------TTCCCCCCTTCCH
T ss_pred ecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHh----------ccCCCCCCCCCCH
Confidence 999999999999999999999999999875433211100 0000000000 0011122334456
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHHHHHhh
Q 021490 234 QALAVAAMCVHEQPDMRPVIADVVTALAYLA 264 (311)
Q Consensus 234 ~l~~li~~~l~~~p~~Rps~~~vl~~l~~~~ 264 (311)
.+.+|+.+||+.||.+|||+.++++.|+.+.
T Consensus 271 ~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 271 EVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 8899999999999999999999999998764
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=292.59 Aligned_cols=236 Identities=25% Similarity=0.353 Sum_probs=191.0
Q ss_pred CCcEEEEEEeecCCC-cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHH
Q 021490 8 LLQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNT 86 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~ 86 (311)
.++.||+|+++.... ...+.+.+|+.++..++||||+++++++ .....++||||+++++|.+++.. ....+++..
T Consensus 36 ~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~ 111 (287)
T 1u59_A 36 KQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG---KREEIPVSN 111 (287)
T ss_dssp CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHTT---CTTTSCHHH
T ss_pred CcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCCCHHHHHHh---CCccCCHHH
Confidence 688899999976533 3456899999999999999999999999 45678999999999999999975 246699999
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCce-eeeeccccccccCccccccC
Q 021490 87 RMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH-VSTRVMGTYGYCAPEYAKTG 165 (311)
Q Consensus 87 ~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~ 165 (311)
++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.......... ......++..|+|||++.+.
T Consensus 112 ~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 188 (287)
T 1u59_A 112 VAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 188 (287)
T ss_dssp HHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHC
T ss_pred HHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeeccCcceeeccccccccccccCHHHhccC
Confidence 9999999999999999999 9999999999999999999999999987643222211 11223457889999999888
Q ss_pred CCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccc
Q 021490 166 QLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVH 244 (311)
Q Consensus 166 ~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 244 (311)
.++.++||||||+++|+|++ |..||...........+... . ....+...+..+.+++.+||+
T Consensus 189 ~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~-------~----------~~~~~~~~~~~l~~li~~~l~ 251 (287)
T 1u59_A 189 KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG-------K----------RMECPPECPPELYALMSDCWI 251 (287)
T ss_dssp EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTT-------C----------CCCCCTTCCHHHHHHHHHTTC
T ss_pred CCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcC-------C----------cCCCCCCcCHHHHHHHHHHcC
Confidence 89999999999999999998 99999776543332211110 0 011233445588999999999
Q ss_pred cCCCCCCCHHHHHHHHHHhhhcc
Q 021490 245 EQPDMRPVIADVVTALAYLASQK 267 (311)
Q Consensus 245 ~~p~~Rps~~~vl~~l~~~~~~~ 267 (311)
.||.+|||+.++++.|+.+....
T Consensus 252 ~~p~~Rps~~~l~~~l~~~~~~~ 274 (287)
T 1u59_A 252 YKWEDRPDFLTVEQRMRACYYSL 274 (287)
T ss_dssp SSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CChhhCcCHHHHHHHHHHHHHhc
Confidence 99999999999999998876543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=303.34 Aligned_cols=239 Identities=23% Similarity=0.293 Sum_probs=183.8
Q ss_pred CcchhccCCcEEEEEEeecCCCc--chhHHHHHHHHHhcCCC--CcccceeeEeeeCCeeEEEEecCCCCChhhhhcccC
Q 021490 1 MMQVILCLLQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHH--PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLS 76 (311)
Q Consensus 1 ~~~~~~~~g~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 76 (311)
||.+...+|+.||||+++..... ..+.+.+|+.++..++| |||+++++++.++...++||| +.+++|.+++..
T Consensus 25 Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~-- 101 (343)
T 3dbq_A 25 VFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKK-- 101 (343)
T ss_dssp EEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC-CCSEEHHHHHHH--
T ss_pred EEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEe-CCCCCHHHHHHh--
Confidence 35566678999999999765432 33678999999999976 999999999999999999999 557899999987
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccc
Q 021490 77 PGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY 156 (311)
Q Consensus 77 ~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y 156 (311)
...+++..+..++.|++.||+|||+.+ |+||||||+|||++ ++.+||+|||++................|++.|
T Consensus 102 --~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y 175 (343)
T 3dbq_A 102 --KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNY 175 (343)
T ss_dssp --SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC------------CCCCSS
T ss_pred --cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCcccccccCCCCcCCcCc
Confidence 567999999999999999999999999 99999999999997 578999999999764333222233345689999
Q ss_pred cCcccccc-----------CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccC
Q 021490 157 CAPEYAKT-----------GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQG 225 (311)
Q Consensus 157 ~aPE~~~~-----------~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (311)
+|||++.+ ..++.++|||||||++|+|++|..||......... .. ... ++....
T Consensus 176 ~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-~~----~~~----------~~~~~~ 240 (343)
T 3dbq_A 176 MPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK-LH----AII----------DPNHEI 240 (343)
T ss_dssp CCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH-HH----HHH----------CTTSCC
T ss_pred CCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHH-HH----HHh----------cCCccc
Confidence 99999865 67889999999999999999999999754322111 00 001 111111
Q ss_pred CCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 021490 226 QYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYL 263 (311)
Q Consensus 226 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l~~~ 263 (311)
.++...+..+.+|+.+||+.||.+|||+.++++....-
T Consensus 241 ~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~ 278 (343)
T 3dbq_A 241 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 278 (343)
T ss_dssp CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred CCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccc
Confidence 22333345788999999999999999999999886543
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=295.53 Aligned_cols=244 Identities=20% Similarity=0.281 Sum_probs=184.3
Q ss_pred cCCcEEEEEEeecCCC---cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCC
Q 021490 7 CLLQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLD 83 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~ 83 (311)
.+|+.||+|+++.... .....+.+|+.+++.++||||+++++++.++...++||||+++++|.+++.........++
T Consensus 55 ~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 134 (310)
T 2wqm_A 55 LDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIP 134 (310)
T ss_dssp TTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCSCBHHHHHHHHHHTTCCCC
T ss_pred CCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEecCCCCCHHHHHHHhcccccCCC
Confidence 4789999999975332 3346788999999999999999999999999999999999999999999875433356799
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccc
Q 021490 84 WNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 163 (311)
Q Consensus 84 ~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 163 (311)
+..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++...... ........++..|+|||++.
T Consensus 135 ~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~ 209 (310)
T 2wqm_A 135 ERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK--TTAAHSLVGTPYYMSPERIH 209 (310)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC--------------------CCSSCCHHHHT
T ss_pred HHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeecCC--CccccccCCCeeEeChHHhC
Confidence 9999999999999999999999 999999999999999999999999998653221 11222345888999999999
Q ss_pred cCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHcc
Q 021490 164 TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCV 243 (311)
Q Consensus 164 ~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 243 (311)
+..++.++||||||+++|+|++|..||......... ..... ... . .+. ......+..+.+++.+||
T Consensus 210 ~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~----~~~-~-----~~~---~~~~~~~~~l~~li~~~l 275 (310)
T 2wqm_A 210 ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS-LCKKI----EQC-D-----YPP---LPSDHYSEELRQLVNMCI 275 (310)
T ss_dssp TCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHH-HHHHH----HTT-C-----SCC---CCTTTSCHHHHHHHHHHT
T ss_pred CCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHH-HHHHh----hcc-c-----CCC---CcccccCHHHHHHHHHHc
Confidence 889999999999999999999999999754321111 11100 000 0 000 011223447889999999
Q ss_pred ccCCCCCCCHHHHHHHHHHhhhccCC
Q 021490 244 HEQPDMRPVIADVVTALAYLASQKYE 269 (311)
Q Consensus 244 ~~~p~~Rps~~~vl~~l~~~~~~~~~ 269 (311)
..||.+|||+.++++.|+.+......
T Consensus 276 ~~dp~~Rps~~~il~~l~~l~~~~~~ 301 (310)
T 2wqm_A 276 NPDPEKRPDVTYVYDVAKRMHACTAS 301 (310)
T ss_dssp CSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred CCChhhCCCHHHHHHHHHHHHHhhhh
Confidence 99999999999999999988866543
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=296.91 Aligned_cols=235 Identities=25% Similarity=0.348 Sum_probs=184.6
Q ss_pred cEEEEEEeecCCC-cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHHHH
Q 021490 10 QDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRM 88 (311)
Q Consensus 10 ~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~ 88 (311)
..||+|+++.... .....+.+|+.++..++||||+++++++.+....++||||+++++|.+++... ...+++..++
T Consensus 74 ~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~ 150 (333)
T 1mqb_A 74 VPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREK---DGEFSVLQLV 150 (333)
T ss_dssp EEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHT---TTCSCHHHHH
T ss_pred ccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCCCCCcHHHHHHhC---CCCCCHHHHH
Confidence 4699999975543 23457899999999999999999999999999999999999999999999762 4679999999
Q ss_pred HHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCc-eeeeeccccccccCccccccCCC
Q 021490 89 KIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT-HVSTRVMGTYGYCAPEYAKTGQL 167 (311)
Q Consensus 89 ~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~ 167 (311)
.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++......... .......++..|+|||++.+..+
T Consensus 151 ~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 227 (333)
T 1mqb_A 151 GMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKF 227 (333)
T ss_dssp HHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCC
T ss_pred HHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccCCC
Confidence 99999999999999999 999999999999999999999999998754322111 11122345778999999998899
Q ss_pred ccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccC
Q 021490 168 TLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQ 246 (311)
Q Consensus 168 ~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 246 (311)
+.++||||||+++|+|++ |..||...........+. .... ...+...+..+.+++.+||+.|
T Consensus 228 ~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~-------~~~~----------~~~~~~~~~~l~~li~~~l~~~ 290 (333)
T 1mqb_A 228 TSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN-------DGFR----------LPTPMDCPSAIYQLMMQCWQQE 290 (333)
T ss_dssp CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-------TTCC----------CCCCTTCBHHHHHHHHHHTCSS
T ss_pred CchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH-------CCCc----------CCCcccCCHHHHHHHHHHcCCC
Confidence 999999999999999999 999997665433222111 0000 0112233457889999999999
Q ss_pred CCCCCCHHHHHHHHHHhhhcc
Q 021490 247 PDMRPVIADVVTALAYLASQK 267 (311)
Q Consensus 247 p~~Rps~~~vl~~l~~~~~~~ 267 (311)
|.+|||+.++++.|+.+....
T Consensus 291 p~~Rps~~~l~~~L~~~~~~~ 311 (333)
T 1mqb_A 291 RARRPKFADIVSILDKLIRAP 311 (333)
T ss_dssp TTTSCCHHHHHHHHHHHHHSG
T ss_pred hhhCcCHHHHHHHHHHHHhcc
Confidence 999999999999999887544
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=296.44 Aligned_cols=229 Identities=24% Similarity=0.269 Sum_probs=187.1
Q ss_pred CCcEEEEEEeecCCCc------chhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCC
Q 021490 8 LLQDVAIKQLDRNGVQ------GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKP 81 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 81 (311)
+|+.||+|+++..... ..+.+.+|+.++..++||||+++++++.+....++||||+++++|.+++.. ...
T Consensus 36 ~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~ 111 (321)
T 2a2a_A 36 TGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQ----KES 111 (321)
T ss_dssp TCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHT----CSC
T ss_pred CCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEEcCCCCcHHHHHHh----cCC
Confidence 6899999999765432 356799999999999999999999999999999999999999999999986 567
Q ss_pred CCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCC----ceEEccccccccCCCCCCceeeeecccccccc
Q 021490 82 LDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY----HPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 157 (311)
Q Consensus 82 l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~----~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~ 157 (311)
+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++ .++|+|||++....... ......++..|+
T Consensus 112 ~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~ 185 (321)
T 2a2a_A 112 LSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---EFKNIFGTPEFV 185 (321)
T ss_dssp EEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTTC---CCCCCCSCGGGC
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCccceecCccc---cccccCCCCCcc
Confidence 999999999999999999999999 99999999999999888 79999999987543221 123345899999
Q ss_pred CccccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHH
Q 021490 158 APEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALA 237 (311)
Q Consensus 158 aPE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 237 (311)
|||++.+..++.++||||||+++|+|++|..||...........+... .....+... ...+..+.+
T Consensus 186 aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~----------~~~~~~~~~----~~~~~~~~~ 251 (321)
T 2a2a_A 186 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV----------SYDFDEEFF----SHTSELAKD 251 (321)
T ss_dssp CHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTT----------CCCCCHHHH----TTCCHHHHH
T ss_pred CcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc----------ccccChhhh----cccCHHHHH
Confidence 999999889999999999999999999999999776543332211110 000011111 122347889
Q ss_pred HHHHccccCCCCCCCHHHHHHHH
Q 021490 238 VAAMCVHEQPDMRPVIADVVTAL 260 (311)
Q Consensus 238 li~~~l~~~p~~Rps~~~vl~~l 260 (311)
++.+||..||.+|||+.++++..
T Consensus 252 li~~~l~~dp~~Rps~~e~l~hp 274 (321)
T 2a2a_A 252 FIRKLLVKETRKRLTIQEALRHP 274 (321)
T ss_dssp HHHTTSCSSTTTSCCHHHHHHST
T ss_pred HHHHHcCCChhhCcCHHHHhcCc
Confidence 99999999999999999999764
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=300.56 Aligned_cols=225 Identities=26% Similarity=0.326 Sum_probs=185.0
Q ss_pred CCcEEEEEEeecCC---CcchhHHHHHHHHHhcC-CCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCC
Q 021490 8 LLQDVAIKQLDRNG---VQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLD 83 (311)
Q Consensus 8 ~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~ 83 (311)
+|+.||||+++... ....+.+.+|..++..+ +||||+++++++.+....|+||||++||+|.+++.. .+.++
T Consensus 44 ~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~ 119 (353)
T 2i0e_A 44 TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ----VGRFK 119 (353)
T ss_dssp EEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH----HSSCC
T ss_pred CCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHh----cCCCC
Confidence 47899999997642 23456788999999988 799999999999999999999999999999999986 46799
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccc
Q 021490 84 WNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 163 (311)
Q Consensus 84 ~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 163 (311)
+..++.++.|++.||+|||++| |+||||||+|||++.+|.++|+|||++...... ........|++.|+|||++.
T Consensus 120 ~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~ 194 (353)
T 2i0e_A 120 EPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD--GVTTKTFCGTPDYIAPEIIA 194 (353)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT--TCCBCCCCSCGGGCCHHHHT
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccccccC--CcccccccCCccccChhhhc
Confidence 9999999999999999999999 999999999999999999999999998742211 12233456899999999999
Q ss_pred cCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHcc
Q 021490 164 TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCV 243 (311)
Q Consensus 164 ~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 243 (311)
+..++.++|||||||++|+|++|..||...........+. ... . .++...+..+.+|+.+||
T Consensus 195 ~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~------~~~--------~----~~p~~~s~~~~~li~~lL 256 (353)
T 2i0e_A 195 YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM------EHN--------V----AYPKSMSKEAVAICKGLM 256 (353)
T ss_dssp TCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------HCC--------C----CCCTTSCHHHHHHHHHHT
T ss_pred CCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHH------hCC--------C----CCCCCCCHHHHHHHHHHh
Confidence 9999999999999999999999999998765433322111 110 0 122334558899999999
Q ss_pred ccCCCCCCC-----HHHHHHH
Q 021490 244 HEQPDMRPV-----IADVVTA 259 (311)
Q Consensus 244 ~~~p~~Rps-----~~~vl~~ 259 (311)
+.||.+||+ ++++++.
T Consensus 257 ~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 257 TKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp CSCTTSCTTCSTTHHHHHHTS
T ss_pred hcCHHHcCCCCCCCHHHHhcC
Confidence 999999995 4677655
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=291.15 Aligned_cols=235 Identities=26% Similarity=0.380 Sum_probs=188.1
Q ss_pred CCcEEEEEEeecCCCc--chhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHH
Q 021490 8 LLQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN 85 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~ 85 (311)
+++.||||+++..... ..+.+.+|+.++..++||||+++++++ .....++||||+++++|.+++.. ...+++.
T Consensus 43 ~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~ 117 (291)
T 1xbb_A 43 VVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ----NRHVKDK 117 (291)
T ss_dssp SEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHHH----CTTCCHH
T ss_pred ceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEeCCCCCHHHHHHh----CcCCCHH
Confidence 5789999999765432 246899999999999999999999999 56678999999999999999987 5679999
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCce-eeeeccccccccCcccccc
Q 021490 86 TRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH-VSTRVMGTYGYCAPEYAKT 164 (311)
Q Consensus 86 ~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~ 164 (311)
.++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.......... ......++..|+|||++.+
T Consensus 118 ~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 194 (291)
T 1xbb_A 118 NIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 194 (291)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhcc
Confidence 99999999999999999999 9999999999999999999999999987543322211 1122345688999999998
Q ss_pred CCCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHcc
Q 021490 165 GQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCV 243 (311)
Q Consensus 165 ~~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 243 (311)
..++.++||||||+++|+|++ |..||...........+... . . ...+...+..+.+++.+||
T Consensus 195 ~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~-------~------~----~~~~~~~~~~l~~li~~~l 257 (291)
T 1xbb_A 195 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG-------E------R----MGCPAGCPREMYDLMNLCW 257 (291)
T ss_dssp CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-------C------C----CCCCTTCCHHHHHHHHHHT
T ss_pred CCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-------C------C----CCCCCCCCHHHHHHHHHHc
Confidence 889999999999999999999 99999876554332222110 0 0 1122334458899999999
Q ss_pred ccCCCCCCCHHHHHHHHHHhhhcc
Q 021490 244 HEQPDMRPVIADVVTALAYLASQK 267 (311)
Q Consensus 244 ~~~p~~Rps~~~vl~~l~~~~~~~ 267 (311)
+.||.+|||+.++++.|+.+....
T Consensus 258 ~~dp~~Rps~~~l~~~L~~~~~~~ 281 (291)
T 1xbb_A 258 TYDVENRPGFAAVELRLRNYYYDV 281 (291)
T ss_dssp CSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred CCChhhCcCHHHHHHHHHHHHHHH
Confidence 999999999999999998876543
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=302.52 Aligned_cols=225 Identities=29% Similarity=0.395 Sum_probs=185.7
Q ss_pred CCcEEEEEEeecCC---CcchhHHHHHHHHHhcC-CCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCC
Q 021490 8 LLQDVAIKQLDRNG---VQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLD 83 (311)
Q Consensus 8 ~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~ 83 (311)
+|+.||||+++... ....+.+..|..++..+ +||||+++++++.+....|+||||++||+|.+++.. ...++
T Consensus 41 ~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~ 116 (345)
T 1xjd_A 41 TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS----CHKFD 116 (345)
T ss_dssp TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH----HSSCC
T ss_pred CCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCCCCCcHHHHHHH----cCCCC
Confidence 68999999997642 23456788899999877 999999999999999999999999999999999987 46799
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccc
Q 021490 84 WNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 163 (311)
Q Consensus 84 ~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 163 (311)
+..+..++.|++.||+|||++| ++||||||+||+++.+|.++|+|||++...... ........|++.|+|||++.
T Consensus 117 ~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~ 191 (345)
T 1xjd_A 117 LSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLG--DAKTNTFCGTPDYIAPEILL 191 (345)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT--TCCBCCCCSCGGGCCHHHHT
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhhcccC--CCcccCCCCCcccCChhhhc
Confidence 9999999999999999999999 999999999999999999999999998743221 11233456899999999999
Q ss_pred cCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHcc
Q 021490 164 TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCV 243 (311)
Q Consensus 164 ~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 243 (311)
+..++.++|||||||++|+|++|..||...+.......+... .+ .++...+..+.+|+.+||
T Consensus 192 ~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~--------------~~----~~p~~~s~~~~~li~~lL 253 (345)
T 1xjd_A 192 GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--------------NP----FYPRWLEKEAKDLLVKLF 253 (345)
T ss_dssp TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--------------CC----CCCTTSCHHHHHHHHHHS
T ss_pred CCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhC--------------CC----CCCcccCHHHHHHHHHHh
Confidence 999999999999999999999999999876554332222110 01 122234457889999999
Q ss_pred ccCCCCCCCHH-HHHHH
Q 021490 244 HEQPDMRPVIA-DVVTA 259 (311)
Q Consensus 244 ~~~p~~Rps~~-~vl~~ 259 (311)
..||.+||++. ++++.
T Consensus 254 ~~dp~~R~~~~~~i~~h 270 (345)
T 1xjd_A 254 VREPEKRLGVRGDIRQH 270 (345)
T ss_dssp CSSGGGSBTTBSCGGGS
T ss_pred cCCHhHcCCChHHHHcC
Confidence 99999999997 66644
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=298.92 Aligned_cols=236 Identities=24% Similarity=0.324 Sum_probs=178.0
Q ss_pred cCCcEEEEEEeecCCCcc---hhHHHHHHHHHhcCCCCcccceeeEeeeCCe----eEEEEecCCCCChhhhhcccCCCC
Q 021490 7 CLLQDVAIKQLDRNGVQG---NREFLVEVLMLSLLHHPNLVNLIGYCADGDQ----RLLVYEYMPLGSVEDHLHDLSPGK 79 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~~lv~e~~~~~~L~~~l~~~~~~~ 79 (311)
.+|+.||||+++...... ...+.+|+.++..++||||+++++++..... .|+||||++|++|.+++.. .
T Consensus 35 ~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~----~ 110 (311)
T 3ork_A 35 RDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT----E 110 (311)
T ss_dssp TTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEEECCCEEEHHHHHHH----H
T ss_pred CCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEEecCCCCCHHHHHHh----c
Confidence 578999999997654333 3578899999999999999999999876543 4999999999999999986 4
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCc-eeeeeccccccccC
Q 021490 80 KPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT-HVSTRVMGTYGYCA 158 (311)
Q Consensus 80 ~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~y~a 158 (311)
..+++..++.++.|++.||+|||+++ ++||||||+||+++.++.++|+|||++......... .......++..|+|
T Consensus 111 ~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~a 187 (311)
T 3ork_A 111 GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 187 (311)
T ss_dssp CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC------------------CCTTCC
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcccccccccccccccccCcCcccCC
Confidence 67999999999999999999999999 999999999999999999999999998753322111 12223458999999
Q ss_pred ccccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHH
Q 021490 159 PEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAV 238 (311)
Q Consensus 159 PE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 238 (311)
||++.+..++.++||||||+++|+|++|..||............ ....... .... ....+..+.++
T Consensus 188 PE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~------~~~~~~~----~~~~----~~~~~~~l~~l 253 (311)
T 3ork_A 188 PEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQH------VREDPIP----PSAR----HEGLSADLDAV 253 (311)
T ss_dssp HHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH------HHCCCCC----HHHH----STTCCHHHHHH
T ss_pred HHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH------hcCCCCC----cccc----cCCCCHHHHHH
Confidence 99999999999999999999999999999999876543322111 0000000 0000 11233478899
Q ss_pred HHHccccCCCCCCCHHHHH-HHHHHh
Q 021490 239 AAMCVHEQPDMRPVIADVV-TALAYL 263 (311)
Q Consensus 239 i~~~l~~~p~~Rps~~~vl-~~l~~~ 263 (311)
+.+||+.||.+||++.+++ ..+..+
T Consensus 254 i~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 254 VLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp HHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred HHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 9999999999999777665 444443
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=290.83 Aligned_cols=242 Identities=20% Similarity=0.162 Sum_probs=190.5
Q ss_pred cCCcEEEEEEeecCCCcchhHHHHHHHHHhcC-CCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHH
Q 021490 7 CLLQDVAIKQLDRNGVQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN 85 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~ 85 (311)
.+|+.||||++.... ..+.+.+|+.++..+ +|+|++++++++.++...++||||+ +++|.+++... +..+++.
T Consensus 33 ~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~---~~~~~~~ 106 (298)
T 1csn_A 33 LNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLC---GRKFSVK 106 (298)
T ss_dssp TTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHT---TTCCCHH
T ss_pred CCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CCCHHHHHHHh---ccCCCHH
Confidence 579999999986443 445788999999999 7999999999999999999999999 89999999862 3569999
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCc-----eEEccccccccCCCCCCc-----eeeeecccccc
Q 021490 86 TRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH-----PKLSDFGLAKLGPVGDNT-----HVSTRVMGTYG 155 (311)
Q Consensus 86 ~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~-----~~l~df~~~~~~~~~~~~-----~~~~~~~~~~~ 155 (311)
.++.++.|++.||+|||+.+ ++||||||+||+++.++. ++|+|||++......... .......++..
T Consensus 107 ~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~ 183 (298)
T 1csn_A 107 TVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 183 (298)
T ss_dssp HHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTT
T ss_pred HHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcc
Confidence 99999999999999999999 999999999999987765 999999999764332221 11234568999
Q ss_pred ccCccccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHH
Q 021490 156 YCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQA 235 (311)
Q Consensus 156 y~aPE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 235 (311)
|+|||++.+..++.++||||||+++|+|++|..||...................... ..+.+.. ..+..+
T Consensus 184 y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~----~~~~~l 253 (298)
T 1csn_A 184 YMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST------PLRELCA----GFPEEF 253 (298)
T ss_dssp TCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS------CHHHHTT----TSCHHH
T ss_pred cCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc------cHHHHHh----hCcHHH
Confidence 999999999899999999999999999999999998743222211111110000000 0011111 223478
Q ss_pred HHHHHHccccCCCCCCCHHHHHHHHHHhhhcc
Q 021490 236 LAVAAMCVHEQPDMRPVIADVVTALAYLASQK 267 (311)
Q Consensus 236 ~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~~ 267 (311)
.+++.+||+.||.+|||+.++++.|+.+....
T Consensus 254 ~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~ 285 (298)
T 1csn_A 254 YKYMHYARNLAFDATPDYDYLQGLFSKVLERL 285 (298)
T ss_dssp HHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HHHHHHHhcCCcccCCCHHHHHHHHHHHHHhc
Confidence 89999999999999999999999999887654
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-42 Score=305.87 Aligned_cols=248 Identities=17% Similarity=0.217 Sum_probs=183.5
Q ss_pred CCcEEEEEEeecCCC--cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHH
Q 021490 8 LLQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN 85 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~ 85 (311)
+|+.||||+++.... ...+.+.+|+.+++.++||||+++++++.++...++||||+++++|.+++.... ...+++.
T Consensus 51 ~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~ 128 (389)
T 3gni_B 51 TGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHF--MDGMNEL 128 (389)
T ss_dssp TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTC--TTCCCHH
T ss_pred CCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEEccCCCCHHHHHhhhc--ccCCCHH
Confidence 699999999976543 233678889999999999999999999999999999999999999999997632 3669999
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCC-----ceeeeeccccccccCcc
Q 021490 86 TRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN-----THVSTRVMGTYGYCAPE 160 (311)
Q Consensus 86 ~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-----~~~~~~~~~~~~y~aPE 160 (311)
.+..++.||+.||+|||+++ |+||||||+|||++.++.++|+|||.+........ ........++..|+|||
T Consensus 129 ~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 205 (389)
T 3gni_B 129 AIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPE 205 (389)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHH
T ss_pred HHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeeccccccccccccccccccccccccCHH
Confidence 99999999999999999999 99999999999999999999999998754211110 01112236788999999
Q ss_pred cccc--CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHH-HHHhhhhhccccc-------------------cccc
Q 021490 161 YAKT--GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSL-VAWARPLFQDRTR-------------------HSLI 218 (311)
Q Consensus 161 ~~~~--~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~-------------------~~~~ 218 (311)
++.+ ..++.++|||||||++|+|++|..||........... .....+....... ....
T Consensus 206 ~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (389)
T 3gni_B 206 VLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSL 285 (389)
T ss_dssp HHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC------------------------------------
T ss_pred HHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccccccccccccccccccccccccccccc
Confidence 9987 5789999999999999999999999976443222110 0000000000000 0000
Q ss_pred --------cCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 021490 219 --------ADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 260 (311)
Q Consensus 219 --------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l 260 (311)
.........+...+..+.+|+.+||+.||++|||+.|+++..
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp 335 (389)
T 3gni_B 286 TTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHS 335 (389)
T ss_dssp --------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSG
T ss_pred ccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCH
Confidence 000000112233456789999999999999999999999764
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=289.76 Aligned_cols=241 Identities=27% Similarity=0.371 Sum_probs=192.2
Q ss_pred cchhccCCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCC
Q 021490 2 MQVILCLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKP 81 (311)
Q Consensus 2 ~~~~~~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 81 (311)
|.+...++..||+|+++... ...+.+.+|+++++.++||||+++++++.+ ...++||||+++++|.+++.... +..
T Consensus 30 y~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~--~~~ 105 (279)
T 1qpc_A 30 WMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPS--GIK 105 (279)
T ss_dssp EEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTSHH--HHT
T ss_pred EEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecCCCCCHHHHHhcCC--CCC
Confidence 45556678899999996443 456789999999999999999999999864 56899999999999999997521 236
Q ss_pred CCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccc
Q 021490 82 LDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 161 (311)
Q Consensus 82 l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 161 (311)
+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++....... ........++..|+|||+
T Consensus 106 ~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~ 181 (279)
T 1qpc_A 106 LTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPEA 181 (279)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-EECCTTCCCCTTTSCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCcc-cccccCCCCccCccChhh
Confidence 999999999999999999999999 9999999999999999999999999987543221 111222345778999999
Q ss_pred cccCCCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHH
Q 021490 162 AKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAA 240 (311)
Q Consensus 162 ~~~~~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 240 (311)
+.+..++.++||||||+++|+|++ |..||.............. .. . ...+...+..+.+++.
T Consensus 182 ~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~-------~~------~----~~~~~~~~~~l~~li~ 244 (279)
T 1qpc_A 182 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER-------GY------R----MVRPDNCPEELYQLMR 244 (279)
T ss_dssp HHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT-------TC------C----CCCCTTCCHHHHHHHH
T ss_pred hccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhc-------cc------C----CCCcccccHHHHHHHH
Confidence 988889999999999999999999 8999977654332221110 00 0 0112233458889999
Q ss_pred HccccCCCCCCCHHHHHHHHHHhhhcc
Q 021490 241 MCVHEQPDMRPVIADVVTALAYLASQK 267 (311)
Q Consensus 241 ~~l~~~p~~Rps~~~vl~~l~~~~~~~ 267 (311)
+||+.||.+|||+.++++.|+.+....
T Consensus 245 ~~l~~~p~~Rps~~~l~~~l~~~~~~~ 271 (279)
T 1qpc_A 245 LCWKERPEDRPTFDYLRSVLEDFFTAT 271 (279)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred HHhccChhhCCCHHHHHHHHHHHHHhc
Confidence 999999999999999999999877543
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=299.23 Aligned_cols=231 Identities=25% Similarity=0.346 Sum_probs=182.8
Q ss_pred CCcEEEEEEeecCCCc---chhHHHHHHHHHhcC-CCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCC
Q 021490 8 LLQDVAIKQLDRNGVQ---GNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLD 83 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~ 83 (311)
+|+.||||+++..... ..+.+.+|..++..+ +||||+++++++.+....|+||||++|++|.+++.. ...++
T Consensus 33 ~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~l~ 108 (345)
T 3a8x_A 33 TDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR----QRKLP 108 (345)
T ss_dssp TTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH----HSSCC
T ss_pred CCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHH----cCCCC
Confidence 6899999999765432 235688899999988 899999999999999999999999999999999986 46799
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccc
Q 021490 84 WNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 163 (311)
Q Consensus 84 ~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 163 (311)
+..++.++.|++.||+|||+++ |+||||||+|||++.+|.++|+|||++...... ........|++.|+|||++.
T Consensus 109 ~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~ 183 (345)
T 3a8x_A 109 EEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP--GDTTSTFCGTPNYIAPEILR 183 (345)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT--TCCBCCCCSCGGGCCHHHHT
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccCC--CCcccccCCCccccCccccC
Confidence 9999999999999999999999 999999999999999999999999998742211 12233456899999999999
Q ss_pred cCCCccccceeehhHHHHHHHhCCCccCcchhHHHH---HHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHH
Q 021490 164 TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ---SLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAA 240 (311)
Q Consensus 164 ~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 240 (311)
+..++.++|||||||++|+|++|..||......... ............. ..++...+..+.+|+.
T Consensus 184 ~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~------------~~~p~~~s~~~~~li~ 251 (345)
T 3a8x_A 184 GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ------------IRIPRSLSVKAASVLK 251 (345)
T ss_dssp TCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC------------CCCCTTSCHHHHHHHH
T ss_pred CCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC------------CCCCCCCCHHHHHHHH
Confidence 999999999999999999999999999653211100 0000000001100 1123344558899999
Q ss_pred HccccCCCCCCCH------HHHHHH
Q 021490 241 MCVHEQPDMRPVI------ADVVTA 259 (311)
Q Consensus 241 ~~l~~~p~~Rps~------~~vl~~ 259 (311)
+||+.||.+||++ .++++.
T Consensus 252 ~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 252 SFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp HHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred HHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 9999999999996 566654
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=295.23 Aligned_cols=240 Identities=24% Similarity=0.332 Sum_probs=181.4
Q ss_pred CCcEEEEEEeecCCC--cchhHHHHHHHHHhcCCCCcccceeeEeeeCC-----eeEEEEecCCCCChhhhhcccC--CC
Q 021490 8 LLQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGD-----QRLLVYEYMPLGSVEDHLHDLS--PG 78 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~--~~ 78 (311)
.+..||+|+++.... ...+.+.+|+.+++.++||||+++++++.+.. ..++||||+++++|.+++.... ..
T Consensus 61 ~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~ 140 (313)
T 3brb_A 61 TSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETG 140 (313)
T ss_dssp CEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTS
T ss_pred ceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcC
Confidence 456899999875533 23467899999999999999999999997654 3499999999999999984321 23
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccC
Q 021490 79 KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCA 158 (311)
Q Consensus 79 ~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~a 158 (311)
...+++..++.++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++................++..|+|
T Consensus 141 ~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a 217 (313)
T 3brb_A 141 PKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA 217 (313)
T ss_dssp CCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEEECSCSCC----------------CCGGGSC
T ss_pred CccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccC
Confidence 467999999999999999999999999 99999999999999999999999999875433222222233456789999
Q ss_pred ccccccCCCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHH
Q 021490 159 PEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALA 237 (311)
Q Consensus 159 PE~~~~~~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 237 (311)
||++.+..++.++||||||+++|+|++ |..||............... . . ...+...+..+.+
T Consensus 218 PE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-------~------~----~~~~~~~~~~l~~ 280 (313)
T 3brb_A 218 IESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHG-------H------R----LKQPEDCLDELYE 280 (313)
T ss_dssp HHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT-------C------C----CCCBTTCCHHHHH
T ss_pred chhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcC-------C------C----CCCCccccHHHHH
Confidence 999999999999999999999999999 88999765543322211100 0 0 0112233457899
Q ss_pred HHHHccccCCCCCCCHHHHHHHHHHhhhcc
Q 021490 238 VAAMCVHEQPDMRPVIADVVTALAYLASQK 267 (311)
Q Consensus 238 li~~~l~~~p~~Rps~~~vl~~l~~~~~~~ 267 (311)
++.+||..||.+|||+.++++.|+.+....
T Consensus 281 li~~~l~~dp~~Rps~~~l~~~L~~l~~~l 310 (313)
T 3brb_A 281 IMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310 (313)
T ss_dssp HHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred HHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 999999999999999999999999887543
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=300.10 Aligned_cols=234 Identities=23% Similarity=0.279 Sum_probs=165.4
Q ss_pred cCCcEEEEEEeecCCCcchhHHHHHHHHHhcCC-CCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHH
Q 021490 7 CLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN 85 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~ 85 (311)
.+|+.||||++... ....+.+|+.++..+. ||||+++++++.++...|+||||++|++|.+++.. ...+++.
T Consensus 34 ~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~ 106 (325)
T 3kn6_A 34 KSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKK----KKHFSET 106 (325)
T ss_dssp TTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH----CSCCCHH
T ss_pred CCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHHHHh----cCCCCHH
Confidence 36899999999643 4467788999999996 99999999999999999999999999999999987 5789999
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCC---ceEEccccccccCCCCCCceeeeeccccccccCcccc
Q 021490 86 TRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY---HPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 162 (311)
Q Consensus 86 ~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~---~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 162 (311)
.+..++.|++.||+|||+++ ++||||||+||+++.++ .++|+|||++...... ........++..|+|||++
T Consensus 107 ~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~~~t~~y~aPE~~ 181 (325)
T 3kn6_A 107 EASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD--NQPLKTPCFTLHYAAPELL 181 (325)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC----------------------
T ss_pred HHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCC--CCcccccCCCcCccCHHHh
Confidence 99999999999999999999 99999999999998765 8999999998753222 1222334578999999999
Q ss_pred ccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHH-HHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHH
Q 021490 163 KTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQS-LVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAM 241 (311)
Q Consensus 163 ~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 241 (311)
.+..++.++||||||+++|+|++|..||.......... ............. .+........+..+.+|+.+
T Consensus 182 ~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~--------~~~~~~~~~~s~~~~~li~~ 253 (325)
T 3kn6_A 182 NQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDF--------SFEGEAWKNVSQEAKDLIQG 253 (325)
T ss_dssp --CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCC--------CCCSHHHHTSCHHHHHHHHH
T ss_pred cCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCC--------CCCcccccCCCHHHHHHHHH
Confidence 99999999999999999999999999997654321110 0000111110000 00000012234578899999
Q ss_pred ccccCCCCCCCHHHHHHHH
Q 021490 242 CVHEQPDMRPVIADVVTAL 260 (311)
Q Consensus 242 ~l~~~p~~Rps~~~vl~~l 260 (311)
||+.||.+|||+.++++.-
T Consensus 254 ~L~~dP~~Rpt~~ell~h~ 272 (325)
T 3kn6_A 254 LLTVDPNKRLKMSGLRYNE 272 (325)
T ss_dssp HHCCCTTTCCCTTTSTTCG
T ss_pred HCCCChhHCCCHHHHhcCh
Confidence 9999999999999998664
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=310.56 Aligned_cols=227 Identities=26% Similarity=0.319 Sum_probs=179.1
Q ss_pred cCCcEEEEEEeecC---CCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCC
Q 021490 7 CLLQDVAIKQLDRN---GVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLD 83 (311)
Q Consensus 7 ~~g~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~ 83 (311)
.+|+.||||+++.. .......+.+|+.++..++||||+++++++.+....++||||++|++|.+++.. ...++
T Consensus 171 ~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~ 246 (446)
T 4ejn_A 171 ATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSR----ERVFS 246 (446)
T ss_dssp TTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECCCSSCBHHHHHHH----HSCCC
T ss_pred CCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeCCCCcHHHHHHh----cCCCC
Confidence 46899999999764 223446788899999999999999999999999999999999999999999987 56799
Q ss_pred HHHHHHHHHHHHHHHHHhhc-CCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccc
Q 021490 84 WNTRMKIAAGAARGLEYLHD-KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 162 (311)
Q Consensus 84 ~~~~~~~~~~i~~~l~~lh~-~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 162 (311)
+..+..++.|++.||+|||+ .| |+||||||+|||++.++.+||+|||++..... .........||+.|+|||++
T Consensus 247 ~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~--~~~~~~~~~gt~~y~aPE~~ 321 (446)
T 4ejn_A 247 EDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIK--DGATMKTFCGTPEYLAPEVL 321 (446)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-------CCSSSCGGGCCHHHH
T ss_pred HHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceeccC--CCcccccccCCccccCHhhc
Confidence 99999999999999999998 88 99999999999999999999999999874221 12223345689999999999
Q ss_pred ccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHc
Q 021490 163 KTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMC 242 (311)
Q Consensus 163 ~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 242 (311)
.+..++.++|||||||++|+|++|..||...........+.. .. ..++...+..+.+||.+|
T Consensus 322 ~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~------~~------------~~~p~~~~~~~~~li~~~ 383 (446)
T 4ejn_A 322 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM------EE------------IRFPRTLGPEAKSLLSGL 383 (446)
T ss_dssp HTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------CC------------CCCCTTSCHHHHHHHHHH
T ss_pred CCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHh------CC------------CCCCccCCHHHHHHHHHH
Confidence 999999999999999999999999999987655433322211 00 012233445788999999
Q ss_pred cccCCCCCC-----CHHHHHHHH
Q 021490 243 VHEQPDMRP-----VIADVVTAL 260 (311)
Q Consensus 243 l~~~p~~Rp-----s~~~vl~~l 260 (311)
|+.||.+|| |+.++++..
T Consensus 384 L~~dP~~R~~~~~~t~~ell~hp 406 (446)
T 4ejn_A 384 LKKDPKQRLGGGSEDAKEIMQHR 406 (446)
T ss_dssp TCSSTTTSTTCSTTTHHHHHTSG
T ss_pred cccCHHHhCCCCCCCHHHHHhCc
Confidence 999999999 999999764
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=293.56 Aligned_cols=244 Identities=26% Similarity=0.294 Sum_probs=183.1
Q ss_pred CCcEEEEEEeecCCCcc--hhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHH
Q 021490 8 LLQDVAIKQLDRNGVQG--NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN 85 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~ 85 (311)
+|+.||+|++....... .+.+.+|+.+++.++||||+++++++.+....++||||+++++|.+++.. ...+++.
T Consensus 27 ~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~ 102 (311)
T 4agu_A 27 TGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRY----QRGVPEH 102 (311)
T ss_dssp TCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHT----SSCCCHH
T ss_pred CCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCCchHHHHHhh----hcCCCHH
Confidence 58999999986554322 36788999999999999999999999999999999999999999998876 5679999
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccccc-
Q 021490 86 TRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT- 164 (311)
Q Consensus 86 ~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~- 164 (311)
.+..++.|++.||+|||+.| ++|+||||+||+++.++.++|+|||++...... ........++..|+|||++.+
T Consensus 103 ~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~ 177 (311)
T 4agu_A 103 LVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGP--SDYYDDEVATRWYRSPELLVGD 177 (311)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC--------------GGGCCHHHHHTC
T ss_pred HHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCc--ccccCCCcCCccccChHHHhcC
Confidence 99999999999999999999 999999999999999999999999998753321 122233468899999999876
Q ss_pred CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhh--------hhhcccccc--ccccCccccCC---CChHh
Q 021490 165 GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWAR--------PLFQDRTRH--SLIADPELQGQ---YPPRG 231 (311)
Q Consensus 165 ~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~--------~~~~~~~~~--~~~~~~~~~~~---~~~~~ 231 (311)
..++.++||||||+++|+|++|..||................ ..+...... ....++..... ..+..
T Consensus 178 ~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (311)
T 4agu_A 178 TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNI 257 (311)
T ss_dssp SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTC
T ss_pred CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccc
Confidence 677999999999999999999999998776554433222110 000000000 00001100000 00233
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 021490 232 FYQALAVAAMCVHEQPDMRPVIADVVTAL 260 (311)
Q Consensus 232 ~~~l~~li~~~l~~~p~~Rps~~~vl~~l 260 (311)
+..+.+|+.+||+.||.+|||++++++.-
T Consensus 258 ~~~~~~li~~~L~~dP~~Rpt~~ell~hp 286 (311)
T 4agu_A 258 SYPALGLLKGCLHMDPTERLTCEQLLHHP 286 (311)
T ss_dssp CHHHHHHHHHHCCSSTTTSCCHHHHHTSG
T ss_pred cHHHHHHHHHHccCChhhcCCHHHHhcCh
Confidence 45788999999999999999999999764
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=288.55 Aligned_cols=231 Identities=29% Similarity=0.499 Sum_probs=182.4
Q ss_pred cCCcEEEEEEeecCCCcch-------hHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCC
Q 021490 7 CLLQDVAIKQLDRNGVQGN-------REFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGK 79 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~ 79 (311)
.+|+.||+|++........ +.+.+|+.+++.++||||+++++++.+.. ++||||+++++|.+++... .
T Consensus 42 ~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~lv~e~~~~~~L~~~l~~~---~ 116 (287)
T 4f0f_A 42 KDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDK---A 116 (287)
T ss_dssp TTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--EEEEECCTTCBHHHHHHCT---T
T ss_pred CCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--eEEEEecCCCCHHHHHhcc---c
Confidence 4789999999865443221 67889999999999999999999987654 7999999999999888652 4
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCc-----eEEccccccccCCCCCCceeeeeccccc
Q 021490 80 KPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH-----PKLSDFGLAKLGPVGDNTHVSTRVMGTY 154 (311)
Q Consensus 80 ~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~-----~~l~df~~~~~~~~~~~~~~~~~~~~~~ 154 (311)
..+++..++.++.|++.||+|||+.+ .+++|+||||+||+++.++. ++|+|||++..... ......++.
T Consensus 117 ~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~g~~ 190 (287)
T 4f0f_A 117 HPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH-----SVSGLLGNF 190 (287)
T ss_dssp SCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSS-----CEECCCCCC
T ss_pred CCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCCCCccccccc-----cccccCCCc
Confidence 67999999999999999999999985 45999999999999988776 99999999864221 233456899
Q ss_pred cccCccccc--cCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhH
Q 021490 155 GYCAPEYAK--TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGF 232 (311)
Q Consensus 155 ~y~aPE~~~--~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (311)
.|+|||++. ...++.++||||||+++|+|++|..||................ . ......+...+
T Consensus 191 ~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~----~----------~~~~~~~~~~~ 256 (287)
T 4f0f_A 191 QWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIRE----E----------GLRPTIPEDCP 256 (287)
T ss_dssp TTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHH----S----------CCCCCCCTTSC
T ss_pred cccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhc----c----------CCCCCCCcccC
Confidence 999999983 4567889999999999999999999997654332211111000 0 01112233344
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 021490 233 YQALAVAAMCVHEQPDMRPVIADVVTALAY 262 (311)
Q Consensus 233 ~~l~~li~~~l~~~p~~Rps~~~vl~~l~~ 262 (311)
..+.+++.+||+.||.+|||+.++++.|+.
T Consensus 257 ~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 257 PRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred HHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 588999999999999999999999999975
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=318.30 Aligned_cols=235 Identities=25% Similarity=0.352 Sum_probs=187.5
Q ss_pred CCcEEEEEEeecCCC-cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHH
Q 021490 8 LLQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNT 86 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~ 86 (311)
++..||||+++.... ...+.|.+|+++|+.++||||+++++++.. +..++||||+++|+|.+++... ...+++..
T Consensus 362 ~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~---~~~l~~~~ 437 (613)
T 2ozo_A 362 KQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGK---REEIPVSN 437 (613)
T ss_dssp CEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCBHHHHHTTC---TTTSCHHH
T ss_pred CcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCcHHHHHhhc---cCCCCHHH
Confidence 567899999976543 356789999999999999999999999976 5689999999999999999752 46699999
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCc-eeeeeccccccccCccccccC
Q 021490 87 RMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT-HVSTRVMGTYGYCAPEYAKTG 165 (311)
Q Consensus 87 ~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~ 165 (311)
++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++......... .......++..|+|||++.+.
T Consensus 438 ~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~ 514 (613)
T 2ozo_A 438 VAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 514 (613)
T ss_dssp HHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------------CCTTSCHHHHHHC
T ss_pred HHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCC
Confidence 9999999999999999999 999999999999999999999999999754322111 111223356789999999989
Q ss_pred CCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccc
Q 021490 166 QLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVH 244 (311)
Q Consensus 166 ~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 244 (311)
.++.++|||||||++|||++ |..||...........+... . ....+...+..+.+|+.+||+
T Consensus 515 ~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~-------~----------~~~~p~~~~~~l~~li~~cl~ 577 (613)
T 2ozo_A 515 KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG-------K----------RMECPPECPPELYALMSDCWI 577 (613)
T ss_dssp CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTT-------C----------CCCCCTTCCHHHHHHHHHTTC
T ss_pred CCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC-------C----------CCCCCCcCCHHHHHHHHHHcC
Confidence 99999999999999999998 99999876554332222110 0 012233345588999999999
Q ss_pred cCCCCCCCHHHHHHHHHHhhhc
Q 021490 245 EQPDMRPVIADVVTALAYLASQ 266 (311)
Q Consensus 245 ~~p~~Rps~~~vl~~l~~~~~~ 266 (311)
.||.+|||+.++++.|+.+...
T Consensus 578 ~dP~~RPs~~~l~~~L~~~~~~ 599 (613)
T 2ozo_A 578 YKWEDRPDFLTVEQRMRACYYS 599 (613)
T ss_dssp SSTTTSCCHHHHHHHHHHHHHH
T ss_pred CChhHCcCHHHHHHHHHHHHHH
Confidence 9999999999999999876543
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=294.70 Aligned_cols=225 Identities=27% Similarity=0.392 Sum_probs=182.7
Q ss_pred cEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHHHHH
Q 021490 10 QDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMK 89 (311)
Q Consensus 10 ~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~ 89 (311)
..||+|++........+.+.+|+.+++.++||||+++++++.++...++||||++|++|.+++... ...+++..++.
T Consensus 41 ~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~ 117 (289)
T 4fvq_A 41 TEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKN---KNCINILWKLE 117 (289)
T ss_dssp EEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEEEEECCTTCBHHHHHHHT---GGGCCHHHHHH
T ss_pred hhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEEEEECCCCCCHHHHHHhC---CCCCCHHHHHH
Confidence 579999997766666788999999999999999999999999999999999999999999999872 34499999999
Q ss_pred HHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCc--------eEEccccccccCCCCCCceeeeeccccccccCccc
Q 021490 90 IAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH--------PKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 161 (311)
Q Consensus 90 ~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~--------~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 161 (311)
++.|++.||+|||+++ ++||||||+||+++.++. ++|+|||++..... .....++..|+|||+
T Consensus 118 i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~------~~~~~~~~~y~aPE~ 188 (289)
T 4fvq_A 118 VAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP------KDILQERIPWVPPEC 188 (289)
T ss_dssp HHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSC------HHHHHHTTTTSCHHH
T ss_pred HHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceeeeccCcccccccC------ccccCCcCcccCHHH
Confidence 9999999999999999 999999999999998877 99999999864211 123457888999999
Q ss_pred ccc-CCCccccceeehhHHHHHHHhCC-CccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHH
Q 021490 162 AKT-GQLTLKSDVYSFGVVLLEILSGR-KAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVA 239 (311)
Q Consensus 162 ~~~-~~~~~~~DiwslG~l~~~ll~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 239 (311)
+.+ ..++.++||||||+++|+|++|. +||.............. .. ..+...+..+.+++
T Consensus 189 ~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~-------~~------------~~~~~~~~~l~~li 249 (289)
T 4fvq_A 189 IENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYED-------RH------------QLPAPKAAELANLI 249 (289)
T ss_dssp HHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT-------TC------------CCCCCSSCTTHHHH
T ss_pred hCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhc-------cC------------CCCCCCCHHHHHHH
Confidence 987 67899999999999999999954 55554443322221110 00 01111123577899
Q ss_pred HHccccCCCCCCCHHHHHHHHHHhhh
Q 021490 240 AMCVHEQPDMRPVIADVVTALAYLAS 265 (311)
Q Consensus 240 ~~~l~~~p~~Rps~~~vl~~l~~~~~ 265 (311)
.+||+.||.+|||+.++++.|+.+..
T Consensus 250 ~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 250 NNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp HHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred HHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 99999999999999999999986654
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=292.19 Aligned_cols=237 Identities=20% Similarity=0.199 Sum_probs=181.7
Q ss_pred CCcEEEEEEeecCCCcc---hhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCH
Q 021490 8 LLQDVAIKQLDRNGVQG---NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 84 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~ 84 (311)
+|+.||+|+++...... .+.+.+|+.++..++||||+++++++.++...++||||++|++|.+++.. ...+++
T Consensus 58 ~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~ 133 (309)
T 2h34_A 58 RERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRR----QGPLAP 133 (309)
T ss_dssp TTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCCCEEHHHHHHH----HCSCCH
T ss_pred CCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEecCCCCHHHHHHh----cCCCCH
Confidence 68999999987553322 36788999999999999999999999999999999999999999999987 467999
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccccc
Q 021490 85 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT 164 (311)
Q Consensus 85 ~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 164 (311)
..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++....... ........++..|+|||++.+
T Consensus 134 ~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~ 209 (309)
T 2h34_A 134 PRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTDEK-LTQLGNTVGTLYYMAPERFSE 209 (309)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC-----------------CCGGGCCGGGTCC
T ss_pred HHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccccccc-cccccccCCCcCccCHHHHcC
Confidence 999999999999999999999 9999999999999999999999999986532221 112223458899999999998
Q ss_pred CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccc
Q 021490 165 GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVH 244 (311)
Q Consensus 165 ~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 244 (311)
..++.++||||||+++|+|++|..||............. ..... .. ..++..+..+.+++.+||+
T Consensus 210 ~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-------~~~~~----~~----~~~~~~~~~l~~li~~~l~ 274 (309)
T 2h34_A 210 SHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHIN-------QAIPR----PS----TVRPGIPVAFDAVIARGMA 274 (309)
T ss_dssp ----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHH-------SCCCC----GG----GTSTTCCTHHHHHHHHHTC
T ss_pred CCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhc-------cCCCC----cc----ccCCCCCHHHHHHHHHhcc
Confidence 899999999999999999999999998765432211111 10000 00 1122233478889999999
Q ss_pred cCCCCCC-CHHHHHHHHHHhhhcc
Q 021490 245 EQPDMRP-VIADVVTALAYLASQK 267 (311)
Q Consensus 245 ~~p~~Rp-s~~~vl~~l~~~~~~~ 267 (311)
.||.+|| |++++++.|+.+....
T Consensus 275 ~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 275 KNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp SSGGGSCSSHHHHHHHHHHTCC--
T ss_pred CCHHHHHHhHHHHHHHHHHHHHhh
Confidence 9999999 9999999998765443
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=291.87 Aligned_cols=233 Identities=25% Similarity=0.348 Sum_probs=178.2
Q ss_pred CcEEEEEEeecCCC-cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHHH
Q 021490 9 LQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTR 87 (311)
Q Consensus 9 g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~ 87 (311)
+..||+|+++.... ...+.+.+|+.+++.++||||+++++++. +...++||||+++++|.+++... ...+++..+
T Consensus 43 ~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~ 118 (281)
T 1mp8_A 43 ALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVR---KYSLDLASL 118 (281)
T ss_dssp CEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHHT---TTTSCHHHH
T ss_pred ceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEEEecCCCCCHHHHHHhc---CCCCCHHHH
Confidence 56799999865433 33467899999999999999999999985 45689999999999999999862 356999999
Q ss_pred HHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccCCC
Q 021490 88 MKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQL 167 (311)
Q Consensus 88 ~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 167 (311)
+.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++........ .......++..|+|||++.+..+
T Consensus 119 ~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~ 194 (281)
T 1mp8_A 119 ILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY-YKASKGKLPIKWMAPESINFRRF 194 (281)
T ss_dssp HHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------------------CCGGGCCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccCcccc-cccccCCCcccccChhhcccCCC
Confidence 999999999999999999 99999999999999999999999999875432211 11223346778999999998899
Q ss_pred ccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccC
Q 021490 168 TLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQ 246 (311)
Q Consensus 168 ~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 246 (311)
+.++||||||+++|+|++ |..||...........+... . ....+...+..+.+++.+||+.|
T Consensus 195 ~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~-------~----------~~~~~~~~~~~l~~li~~~l~~~ 257 (281)
T 1mp8_A 195 TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG-------E----------RLPMPPNCPPTLYSLMTKCWAYD 257 (281)
T ss_dssp SHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT-------C----------CCCCCTTCCHHHHHHHHHHTCSS
T ss_pred CCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcC-------C----------CCCCCCCCCHHHHHHHHHHccCC
Confidence 999999999999999997 99999765543322211100 0 01122334458889999999999
Q ss_pred CCCCCCHHHHHHHHHHhhhc
Q 021490 247 PDMRPVIADVVTALAYLASQ 266 (311)
Q Consensus 247 p~~Rps~~~vl~~l~~~~~~ 266 (311)
|.+|||+.++++.|+.+...
T Consensus 258 p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 258 PSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp GGGSCCHHHHHHHHHHHHHH
T ss_pred hhhCcCHHHHHHHHHHHHHH
Confidence 99999999999999987654
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=293.91 Aligned_cols=238 Identities=29% Similarity=0.408 Sum_probs=187.4
Q ss_pred CCcE--EEEEEeecCC-CcchhHHHHHHHHHhcC-CCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccC-------
Q 021490 8 LLQD--VAIKQLDRNG-VQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLS------- 76 (311)
Q Consensus 8 ~g~~--vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------- 76 (311)
+|.. ||+|.++... ....+.+.+|+.++..+ +||||+++++++.+....++||||+++++|.+++....
T Consensus 49 ~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 128 (327)
T 1fvr_A 49 DGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPA 128 (327)
T ss_dssp TTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHH
T ss_pred CCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecCCCCCHHHHHHhccccccccc
Confidence 4554 4999987543 33456899999999999 89999999999999999999999999999999997632
Q ss_pred -----CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeecc
Q 021490 77 -----PGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVM 151 (311)
Q Consensus 77 -----~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~ 151 (311)
.....+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++..... ........
T Consensus 129 ~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~---~~~~~~~~ 202 (327)
T 1fvr_A 129 FAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEV---YVKKTMGR 202 (327)
T ss_dssp HHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEESSCE---ECCC----
T ss_pred ccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeEEEcccCcCccccc---cccccCCC
Confidence 12347999999999999999999999999 99999999999999999999999999863211 11122234
Q ss_pred ccccccCccccccCCCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChH
Q 021490 152 GTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPR 230 (311)
Q Consensus 152 ~~~~y~aPE~~~~~~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (311)
++..|+|||++.+..++.++||||||+++|+|++ |..||...........+ ... .....+..
T Consensus 203 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~-------~~~----------~~~~~~~~ 265 (327)
T 1fvr_A 203 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL-------PQG----------YRLEKPLN 265 (327)
T ss_dssp CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHG-------GGT----------CCCCCCTT
T ss_pred CCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHh-------hcC----------CCCCCCCC
Confidence 6788999999998889999999999999999998 99999776543321111 000 00112233
Q ss_pred hHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhccC
Q 021490 231 GFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQKY 268 (311)
Q Consensus 231 ~~~~l~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~~~ 268 (311)
.+..+.+|+.+||..||.+|||+.++++.|+.+.....
T Consensus 266 ~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 303 (327)
T 1fvr_A 266 CDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 303 (327)
T ss_dssp BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence 44578899999999999999999999999998886543
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=308.66 Aligned_cols=226 Identities=24% Similarity=0.343 Sum_probs=186.7
Q ss_pred CCcEEEEEEeecCCC---cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCH
Q 021490 8 LLQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 84 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~ 84 (311)
+|+.||||+++.... .....+.+|+.+++.++||||+++++++.+....++||||++|++|.+++.. .+.+++
T Consensus 40 ~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~l~~ 115 (476)
T 2y94_A 40 TGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICK----NGRLDE 115 (476)
T ss_dssp TCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSSEEHHHHTTS----SSSCCH
T ss_pred CCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHh----cCCCCH
Confidence 799999999975432 3346789999999999999999999999999999999999999999999976 567999
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccccc
Q 021490 85 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT 164 (311)
Q Consensus 85 ~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 164 (311)
..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++...... .......|++.|+|||++.+
T Consensus 116 ~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~ 189 (476)
T 2y94_A 116 KESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG---EFLRTSCGSPNYAAPEVISG 189 (476)
T ss_dssp HHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTT---CCBCCCCSCSTTCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcccc---ccccccCCCcCeEChhhccC
Confidence 999999999999999999999 999999999999999999999999999754322 12233468999999999987
Q ss_pred CCC-ccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHcc
Q 021490 165 GQL-TLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCV 243 (311)
Q Consensus 165 ~~~-~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 243 (311)
..+ +.++|||||||++|+|++|..||...........+. ... . ..+...+..+.+|+.+||
T Consensus 190 ~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~------~~~-----~-------~~p~~~s~~~~~Li~~~L 251 (476)
T 2y94_A 190 RLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKIC------DGI-----F-------YTPQYLNPSVISLLKHML 251 (476)
T ss_dssp CCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHH------TTC-----C-------CCCTTCCHHHHHHHHHHT
T ss_pred CCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHh------cCC-----c-------CCCccCCHHHHHHHHHHc
Confidence 765 689999999999999999999998655433222111 100 0 112223447889999999
Q ss_pred ccCCCCCCCHHHHHHHHH
Q 021490 244 HEQPDMRPVIADVVTALA 261 (311)
Q Consensus 244 ~~~p~~Rps~~~vl~~l~ 261 (311)
+.||.+|||+.++++.-.
T Consensus 252 ~~dP~~Rpt~~eil~hp~ 269 (476)
T 2y94_A 252 QVDPMKRATIKDIREHEW 269 (476)
T ss_dssp CSSTTTSCCHHHHHTCHH
T ss_pred CCCchhCcCHHHHHhCHH
Confidence 999999999999997644
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=302.99 Aligned_cols=231 Identities=22% Similarity=0.230 Sum_probs=186.0
Q ss_pred CCcEEEEEEeecCC---CcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCH
Q 021490 8 LLQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 84 (311)
Q Consensus 8 ~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~ 84 (311)
+|+.||+|++++.. ......+.+|+.++..++||||+++++++.+....|+||||++||+|.+++.. ..+++
T Consensus 93 ~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~-----~~~~e 167 (410)
T 3v8s_A 93 TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN-----YDVPE 167 (410)
T ss_dssp TCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH-----CCCCH
T ss_pred CCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHc-----CCCCH
Confidence 58999999997532 23345688999999999999999999999999999999999999999999975 46899
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccccc
Q 021490 85 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT 164 (311)
Q Consensus 85 ~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 164 (311)
..+..++.|++.||+|||+.+ |+||||||+|||++.+|.+||+|||++....... ........||+.|+|||++.+
T Consensus 168 ~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~-~~~~~~~~gt~~Y~APE~l~~ 243 (410)
T 3v8s_A 168 KWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG-MVRCDTAVGTPDYISPEVLKS 243 (410)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTS-EEECCSCCSCGGGCCHHHHHT
T ss_pred HHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccceeEeeccCC-cccccCCcCCccccCHHHhhc
Confidence 999999999999999999999 9999999999999999999999999997543221 112234569999999999976
Q ss_pred CC----CccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHH
Q 021490 165 GQ----LTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAA 240 (311)
Q Consensus 165 ~~----~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 240 (311)
.. ++.++|||||||++|+|++|..||...+.......+......+. .| .....+..+.+||.
T Consensus 244 ~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~---------~p-----~~~~~s~~~~~li~ 309 (410)
T 3v8s_A 244 QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLT---------FP-----DDNDISKEAKNLIC 309 (410)
T ss_dssp TTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCC---------CC-----TTCCCCHHHHHHHH
T ss_pred cCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcccccc---------CC-----CcccccHHHHHHHH
Confidence 55 78999999999999999999999987665443322211110000 00 01123457889999
Q ss_pred HccccCCCC--CCCHHHHHHHHH
Q 021490 241 MCVHEQPDM--RPVIADVVTALA 261 (311)
Q Consensus 241 ~~l~~~p~~--Rps~~~vl~~l~ 261 (311)
+||+.+|.+ ||+++|+++...
T Consensus 310 ~lL~~~~~rlgR~~~~ei~~Hp~ 332 (410)
T 3v8s_A 310 AFLTDREVRLGRNGVEEIKRHLF 332 (410)
T ss_dssp HHSSCGGGCTTSSCHHHHHTSGG
T ss_pred HHccChhhhCCCCCHHHHhcCcc
Confidence 999999988 999999998753
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=298.72 Aligned_cols=228 Identities=21% Similarity=0.273 Sum_probs=170.8
Q ss_pred CCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHHH
Q 021490 8 LLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTR 87 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~ 87 (311)
+|+.||||+++... ..+.+.+|+.++..++||||+++++++.+....++||||+++++|.+++.. ...+++..+
T Consensus 77 ~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~ 150 (349)
T 2w4o_A 77 TQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVE----KGYYSERDA 150 (349)
T ss_dssp TCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTT----CSSCCHHHH
T ss_pred CCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCCHHHHHHh----cCCCCHHHH
Confidence 57899999997543 446788999999999999999999999999999999999999999999976 567999999
Q ss_pred HHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcC---CCceEEccccccccCCCCCCceeeeeccccccccCcccccc
Q 021490 88 MKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR---GYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT 164 (311)
Q Consensus 88 ~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~---~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 164 (311)
+.++.|++.||+|||+.+ ++||||||+||+++. ++.++|+|||++...... .......++..|+|||++.+
T Consensus 151 ~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~ 224 (349)
T 2w4o_A 151 ADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ---VLMKTVCGTPGYCAPEILRG 224 (349)
T ss_dssp HHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC-------------------CGGGSCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccCcc---cccccccCCCCccCHHHhcC
Confidence 999999999999999999 999999999999975 889999999998753221 12233468999999999998
Q ss_pred CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccc
Q 021490 165 GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVH 244 (311)
Q Consensus 165 ~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 244 (311)
..++.++|||||||++|+|++|..||......... .. ....... ..........+..+.+|+.+||+
T Consensus 225 ~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~--~~---~i~~~~~--------~~~~~~~~~~~~~~~~li~~~L~ 291 (349)
T 2w4o_A 225 CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFM--FR---RILNCEY--------YFISPWWDEVSLNAKDLVRKLIV 291 (349)
T ss_dssp CCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHH--HH---HHHTTCC--------CCCTTTTTTSCHHHHHHHHTTSC
T ss_pred CCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHH--HH---HHHhCCC--------ccCCchhhhCCHHHHHHHHHHcc
Confidence 89999999999999999999999999765433211 00 0010000 00011122344578899999999
Q ss_pred cCCCCCCCHHHHHHHH
Q 021490 245 EQPDMRPVIADVVTAL 260 (311)
Q Consensus 245 ~~p~~Rps~~~vl~~l 260 (311)
.||++|||+.++++.-
T Consensus 292 ~dP~~Rpt~~e~l~hp 307 (349)
T 2w4o_A 292 LDPKKRLTTFQALQHP 307 (349)
T ss_dssp SSGGGSCCHHHHHHST
T ss_pred CChhhCcCHHHHhcCc
Confidence 9999999999999864
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=290.86 Aligned_cols=239 Identities=28% Similarity=0.439 Sum_probs=176.7
Q ss_pred CCcEEEEEEeecCCC--cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHH
Q 021490 8 LLQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN 85 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~ 85 (311)
.+..||+|+++.... ...+.|.+|+.+++.++||||++++++. .....++||||+++++|.+++... ...+++.
T Consensus 45 ~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~ 120 (289)
T 3og7_A 45 WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHAS---ETKFEMK 120 (289)
T ss_dssp SSSEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCCEEEHHHHHTTC------CCHH
T ss_pred EcCceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEecCCCcHHHHHhhc---cCCCCHH
Confidence 345799999865543 2346789999999999999999999965 456789999999999999999652 4679999
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccc--
Q 021490 86 TRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK-- 163 (311)
Q Consensus 86 ~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-- 163 (311)
.++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++................++..|+|||++.
T Consensus 121 ~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 197 (289)
T 3og7_A 121 KLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 197 (289)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC------------------CCCTTCCHHHHC--
T ss_pred HHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccccccccccccccCCCccccCchhhccc
Confidence 99999999999999999999 9999999999999999999999999987543322223333456899999999986
Q ss_pred -cCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHc
Q 021490 164 -TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMC 242 (311)
Q Consensus 164 -~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 242 (311)
+..++.++||||||+++|+|++|..||............ .. .... .+.+ .......+..+.+|+.+|
T Consensus 198 ~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~--~~----~~~~-----~~~~-~~~~~~~~~~l~~li~~~ 265 (289)
T 3og7_A 198 DSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEM--VG----RGSL-----SPDL-SKVRSNCPKRMKRLMAEC 265 (289)
T ss_dssp --CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHH--HH----HTSC-----CCCT-TSSCTTSCHHHHHHHHHH
T ss_pred CCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHH--hc----cccc-----Ccch-hhccccCCHHHHHHHHHH
Confidence 567888999999999999999999999765443221111 00 0000 0000 111223345889999999
Q ss_pred cccCCCCCCCHHHHHHHHHHhhh
Q 021490 243 VHEQPDMRPVIADVVTALAYLAS 265 (311)
Q Consensus 243 l~~~p~~Rps~~~vl~~l~~~~~ 265 (311)
|+.||.+|||+.++++.|+.+..
T Consensus 266 l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 266 LKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp TCSSGGGSCCHHHHHHHHHHTTC
T ss_pred ccCChhhCCCHHHHHHHHHHHhh
Confidence 99999999999999999988764
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=295.66 Aligned_cols=242 Identities=27% Similarity=0.393 Sum_probs=191.1
Q ss_pred CCcEEEEEEeecCCC-cchhHHHHHHHHHhcCCCCcccceeeEeeeC--CeeEEEEecCCCCChhhhhcccCCCCCCCCH
Q 021490 8 LLQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADG--DQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 84 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~ 84 (311)
+|+.||||+++.... ...+.+.+|+++++.++||||+++++++.+. ...++||||+++++|.+++.. ..+++
T Consensus 59 ~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-----~~~~~ 133 (318)
T 3lxp_A 59 TGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPR-----HSIGL 133 (318)
T ss_dssp CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGG-----SCCCH
T ss_pred CCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEEEecccCCcHHHHHhh-----CCCCH
Confidence 789999999976543 3346789999999999999999999999874 678999999999999999976 45999
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCc-eeeeeccccccccCccccc
Q 021490 85 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT-HVSTRVMGTYGYCAPEYAK 163 (311)
Q Consensus 85 ~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~ 163 (311)
..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++......... .......++..|+|||++.
T Consensus 134 ~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 210 (318)
T 3lxp_A 134 AQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLK 210 (318)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccccccccccccccccccCCCCCceeeChHHhc
Confidence 999999999999999999999 999999999999999999999999999765433222 1223345778899999999
Q ss_pred cCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHH--------HHHhhhhhccccccccccCccccCCCChHhHHHH
Q 021490 164 TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSL--------VAWARPLFQDRTRHSLIADPELQGQYPPRGFYQA 235 (311)
Q Consensus 164 ~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 235 (311)
+..++.++||||||+++|+|++|..||........... ......... .......+...+..+
T Consensus 211 ~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~l 280 (318)
T 3lxp_A 211 EYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE----------RGERLPRPDKCPAEV 280 (318)
T ss_dssp HCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHH----------TTCCCCCCTTCCHHH
T ss_pred CCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHh----------cccCCCCCccccHHH
Confidence 98999999999999999999999999976543211100 000000000 011112233445589
Q ss_pred HHHHHHccccCCCCCCCHHHHHHHHHHhhhcc
Q 021490 236 LAVAAMCVHEQPDMRPVIADVVTALAYLASQK 267 (311)
Q Consensus 236 ~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~~ 267 (311)
.+|+.+||+.||.+|||+.++++.|+.+...-
T Consensus 281 ~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 312 (318)
T 3lxp_A 281 YHLMKNCWETEASFRPTFENLIPILKTVHEKY 312 (318)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHcCCCcccCcCHHHHHHHHHHHHHhh
Confidence 99999999999999999999999999876543
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=288.26 Aligned_cols=231 Identities=25% Similarity=0.356 Sum_probs=185.4
Q ss_pred CCcEEEEEEeecCCC-cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHH
Q 021490 8 LLQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNT 86 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~ 86 (311)
+|+.||+|+++.... ...+.+.+|+.+++.++||||+++++++.++...++||||+++++|.+++.. ...+++..
T Consensus 31 ~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~ 106 (276)
T 2yex_A 31 TEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP----DIGMPEPD 106 (276)
T ss_dssp TCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBT----TTBCCHHH
T ss_pred CCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCCCcHHHHHhh----ccCCCHHH
Confidence 789999999975543 3457889999999999999999999999999999999999999999999976 56799999
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccCC
Q 021490 87 RMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ 166 (311)
Q Consensus 87 ~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 166 (311)
++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||.+................++..|+|||++.+..
T Consensus 107 ~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 183 (276)
T 2yex_A 107 AQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183 (276)
T ss_dssp HHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSS
T ss_pred HHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCC
Confidence 9999999999999999999 9999999999999999999999999986533222222233456889999999998766
Q ss_pred C-ccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHcccc
Q 021490 167 L-TLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHE 245 (311)
Q Consensus 167 ~-~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 245 (311)
+ +.++||||||+++|+|++|..||......... ...+.. .. .. .......+..+.+++.+||+.
T Consensus 184 ~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~----~~-~~---------~~~~~~~~~~~~~li~~~l~~ 248 (276)
T 2yex_A 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDWKE----KK-TY---------LNPWKKIDSAPLALLHKILVE 248 (276)
T ss_dssp BCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH-HHHHHT----TC-TT---------STTGGGSCHHHHHHHHHHSCS
T ss_pred CCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH-HHHhhh----cc-cc---------cCchhhcCHHHHHHHHHHCCC
Confidence 5 78899999999999999999999765432111 111110 00 00 001123345788999999999
Q ss_pred CCCCCCCHHHHHHHH
Q 021490 246 QPDMRPVIADVVTAL 260 (311)
Q Consensus 246 ~p~~Rps~~~vl~~l 260 (311)
||.+|||+.++++..
T Consensus 249 ~p~~Rps~~~il~~~ 263 (276)
T 2yex_A 249 NPSARITIPDIKKDR 263 (276)
T ss_dssp STTTSCCHHHHTTCT
T ss_pred CchhCCCHHHHhcCc
Confidence 999999999998753
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=304.70 Aligned_cols=238 Identities=22% Similarity=0.289 Sum_probs=183.2
Q ss_pred CcchhccCCcEEEEEEeecCCC--cchhHHHHHHHHHhcCC--CCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccC
Q 021490 1 MMQVILCLLQDVAIKQLDRNGV--QGNREFLVEVLMLSLLH--HPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLS 76 (311)
Q Consensus 1 ~~~~~~~~g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 76 (311)
||.+...+|+.||||++..... ...+.+.+|+.++..++ ||||+++++++..+...|+||| +.+++|.+++..
T Consensus 72 Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-~~~~~L~~~l~~-- 148 (390)
T 2zmd_A 72 VFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKK-- 148 (390)
T ss_dssp EEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-CCSEEHHHHHHH--
T ss_pred EEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-cCCCCHHHHHHh--
Confidence 3556666799999999976543 33468899999999996 5999999999999999999999 568899999987
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccc
Q 021490 77 PGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY 156 (311)
Q Consensus 77 ~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y 156 (311)
...+++..+..++.||+.||+|||+.+ |+||||||+|||++ ++.+||+|||++................|++.|
T Consensus 149 --~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y 222 (390)
T 2zmd_A 149 --KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNY 222 (390)
T ss_dssp --CSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC---------CCSCCCGGG
T ss_pred --cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCCCccccCCCCCcCCCc
Confidence 567999999999999999999999999 99999999999995 578999999999754332222223345699999
Q ss_pred cCcccccc-----------CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccC
Q 021490 157 CAPEYAKT-----------GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQG 225 (311)
Q Consensus 157 ~aPE~~~~-----------~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (311)
+|||++.+ ..++.++|||||||++|+|++|..||......... +. .... +....
T Consensus 223 ~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~-~~----~~~~----------~~~~~ 287 (390)
T 2zmd_A 223 MPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK-LH----AIID----------PNHEI 287 (390)
T ss_dssp CCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH-HH----HHHC----------TTSCC
T ss_pred cChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHH-HH----HHhC----------ccccC
Confidence 99999865 36889999999999999999999999764321110 00 0011 11111
Q ss_pred CCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 021490 226 QYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAY 262 (311)
Q Consensus 226 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l~~ 262 (311)
.++...+..+.+|+.+||..||.+|||+.++++....
T Consensus 288 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~ 324 (390)
T 2zmd_A 288 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 324 (390)
T ss_dssp CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred CCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCc
Confidence 1222224578899999999999999999999987654
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=291.38 Aligned_cols=229 Identities=19% Similarity=0.263 Sum_probs=185.0
Q ss_pred CCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHHH
Q 021490 8 LLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTR 87 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~ 87 (311)
+|+.||+|+++.......+.+.+|+.++..++||||+++++++.+....++||||+++++|.+++.. .+.+++..+
T Consensus 33 ~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~ 108 (304)
T 2jam_A 33 TGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILE----RGVYTEKDA 108 (304)
T ss_dssp TCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH----HSCCCHHHH
T ss_pred CCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCCCccHHHHHHH----cCCCCHHHH
Confidence 7899999999866555567889999999999999999999999999999999999999999999876 467999999
Q ss_pred HHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEE---cCCCceEEccccccccCCCCCCceeeeeccccccccCcccccc
Q 021490 88 MKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL---DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT 164 (311)
Q Consensus 88 ~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 164 (311)
+.++.|++.||+|||+.+ ++|+||+|+||++ +.++.++|+|||++...... ......++..|+|||++.+
T Consensus 109 ~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~ 181 (304)
T 2jam_A 109 SLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG----IMSTACGTPGYVAPEVLAQ 181 (304)
T ss_dssp HHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB----TTHHHHSCCCBCCTTTBSS
T ss_pred HHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC----ccccccCCCCccChHHhcc
Confidence 999999999999999999 9999999999999 78889999999998642211 1223458899999999998
Q ss_pred CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccc
Q 021490 165 GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVH 244 (311)
Q Consensus 165 ~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 244 (311)
..++.++||||||+++|+|++|..||...........+... .. .+........+..+.+++.+||.
T Consensus 182 ~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~------~~--------~~~~~~~~~~~~~~~~li~~~l~ 247 (304)
T 2jam_A 182 KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEG------YY--------EFESPFWDDISESAKDFICHLLE 247 (304)
T ss_dssp CSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHC------CC--------CCCTTTTTTSCHHHHHHHHHHHC
T ss_pred CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC------CC--------CCCccccccCCHHHHHHHHHHcC
Confidence 89999999999999999999999999766543322211110 00 00111222344588899999999
Q ss_pred cCCCCCCCHHHHHHHHH
Q 021490 245 EQPDMRPVIADVVTALA 261 (311)
Q Consensus 245 ~~p~~Rps~~~vl~~l~ 261 (311)
.||.+|||+.++++...
T Consensus 248 ~dp~~Rps~~~~l~h~~ 264 (304)
T 2jam_A 248 KDPNERYTCEKALSHPW 264 (304)
T ss_dssp SSTTTSCCHHHHHTSHH
T ss_pred CChhHCcCHHHHhcCcc
Confidence 99999999999998654
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=298.59 Aligned_cols=242 Identities=24% Similarity=0.301 Sum_probs=188.1
Q ss_pred cCCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeee----CCeeEEEEecCCCCChhhhhcccCCCCCCC
Q 021490 7 CLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCAD----GDQRLLVYEYMPLGSVEDHLHDLSPGKKPL 82 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l 82 (311)
.+|+.||||++........+.+.+|+.+++.++||||+++++++.. ....++||||+++++|.+++.........+
T Consensus 52 ~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 131 (317)
T 2buj_A 52 HDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFL 131 (317)
T ss_dssp TTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCC
T ss_pred CCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCC
Confidence 5789999999977666667789999999999999999999999862 347899999999999999988654446789
Q ss_pred CHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCce-------eeeecccccc
Q 021490 83 DWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH-------VSTRVMGTYG 155 (311)
Q Consensus 83 ~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~-------~~~~~~~~~~ 155 (311)
++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.......... ......++..
T Consensus 132 ~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 208 (317)
T 2buj_A 132 TEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTIS 208 (317)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGG
T ss_pred CHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhcccccccccccccccccccccCCcc
Confidence 99999999999999999999999 9999999999999999999999999876421110000 0012346889
Q ss_pred ccCccccccCC---CccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhH
Q 021490 156 YCAPEYAKTGQ---LTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGF 232 (311)
Q Consensus 156 y~aPE~~~~~~---~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (311)
|+|||++.+.. ++.++||||||+++|+|++|..||......... ..... .... ....+...+
T Consensus 209 y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~~~~----~~~~----------~~~~~~~~~ 273 (317)
T 2buj_A 209 YRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS-VALAV----QNQL----------SIPQSPRHS 273 (317)
T ss_dssp GCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC-HHHHH----HCC------------CCCCTTSC
T ss_pred cCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch-hhHHh----hccC----------CCCccccCC
Confidence 99999987543 688999999999999999999999643221110 00000 0000 001112334
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 021490 233 YQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 266 (311)
Q Consensus 233 ~~l~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~ 266 (311)
..+.+++.+||+.||.+|||+.++++.|+.+...
T Consensus 274 ~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 307 (317)
T 2buj_A 274 SALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP 307 (317)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCC
T ss_pred HHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCC
Confidence 5788999999999999999999999999877543
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=288.86 Aligned_cols=231 Identities=25% Similarity=0.320 Sum_probs=182.4
Q ss_pred cCCcEEEEEEeecCC-CcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHH
Q 021490 7 CLLQDVAIKQLDRNG-VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN 85 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~ 85 (311)
.+|..||+|++.... ....+.+.+|+++++.++||||+++++++.+....++||||+++++|.+++.........+++.
T Consensus 45 ~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 124 (285)
T 3is5_A 45 SSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEG 124 (285)
T ss_dssp TTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHH
T ss_pred cCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHH
Confidence 368999999987654 3455789999999999999999999999999999999999999999999886533234679999
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEE---cCCCceEEccccccccCCCCCCceeeeeccccccccCcccc
Q 021490 86 TRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL---DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 162 (311)
Q Consensus 86 ~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 162 (311)
.++.++.|++.||+|||+.+ ++|+||||+||++ +.++.++|+|||++...... .......++..|+|||++
T Consensus 125 ~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~~t~~y~aPE~~ 198 (285)
T 3is5_A 125 YVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD---EHSTNAAGTALYMAPEVF 198 (285)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-------------CTTGGGCCHHHH
T ss_pred HHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceecCCc---ccCcCcccccCcCChHHh
Confidence 99999999999999999999 9999999999999 45678999999998753221 222345689999999988
Q ss_pred ccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHc
Q 021490 163 KTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMC 242 (311)
Q Consensus 163 ~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 242 (311)
. ..++.++||||||+++|+|++|..||................... . .. ....+..+.+|+.+|
T Consensus 199 ~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~------~-----~~----~~~~~~~~~~li~~~ 262 (285)
T 3is5_A 199 K-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNY------A-----VE----CRPLTPQAVDLLKQM 262 (285)
T ss_dssp T-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC------C-----C------CCCCHHHHHHHHHH
T ss_pred c-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCccc------c-----cc----cCcCCHHHHHHHHHH
Confidence 6 568899999999999999999999998766544332222111000 0 00 011234788999999
Q ss_pred cccCCCCCCCHHHHHHH
Q 021490 243 VHEQPDMRPVIADVVTA 259 (311)
Q Consensus 243 l~~~p~~Rps~~~vl~~ 259 (311)
|+.||.+|||+.|+++.
T Consensus 263 L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 263 LTKDPERRPSAAQVLHH 279 (285)
T ss_dssp TCSCTTTSCCHHHHHTS
T ss_pred ccCChhhCcCHHHHhcC
Confidence 99999999999999865
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=296.88 Aligned_cols=232 Identities=26% Similarity=0.413 Sum_probs=181.6
Q ss_pred EEEEEEeecCC-CcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHHHHH
Q 021490 11 DVAIKQLDRNG-VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMK 89 (311)
Q Consensus 11 ~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~ 89 (311)
+||+|.+.... ....+.+.+|+.++..++||||+++++++.++. .++|++++.+++|.+++... ...+++..++.
T Consensus 46 kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~~~~~~g~L~~~l~~~---~~~~~~~~~~~ 121 (327)
T 3lzb_A 46 PVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREH---KDNIGSQYLLN 121 (327)
T ss_dssp EEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEECCCSSCBHHHHHHHT---TTCCCHHHHHH
T ss_pred EEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEEEecCCCcHHHHHHhc---CCCCCHHHHHH
Confidence 35777775433 345678999999999999999999999998754 78999999999999999763 45799999999
Q ss_pred HHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccCCCcc
Q 021490 90 IAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTL 169 (311)
Q Consensus 90 ~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 169 (311)
++.|++.||+|||+++ ++||||||+||+++.++.++|+|||++................++..|+|||++.+..++.
T Consensus 122 i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 198 (327)
T 3lzb_A 122 WCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH 198 (327)
T ss_dssp HHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----------------CCCGGGSCHHHHHHCCCCH
T ss_pred HHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCCh
Confidence 9999999999999999 9999999999999999999999999997643333333333345678899999999999999
Q ss_pred ccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCC
Q 021490 170 KSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPD 248 (311)
Q Consensus 170 ~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~ 248 (311)
++||||||+++|+|++ |..||...........+.... ....+...+..+.+++.+||+.||.
T Consensus 199 ~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~l~~li~~~l~~dp~ 261 (327)
T 3lzb_A 199 QSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE-----------------RLPQPPICTIDVYMIMRKCWMIDAD 261 (327)
T ss_dssp HHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-----------------CCCCCTTBCHHHHHHHHHHTCSSGG
T ss_pred HHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC-----------------CCCCCccCCHHHHHHHHHHcCCChh
Confidence 9999999999999999 999998765543332221110 0112233445788999999999999
Q ss_pred CCCCHHHHHHHHHHhhhc
Q 021490 249 MRPVIADVVTALAYLASQ 266 (311)
Q Consensus 249 ~Rps~~~vl~~l~~~~~~ 266 (311)
+|||+.++++.|+.+...
T Consensus 262 ~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 262 SRPKFRELIIEFSKMARD 279 (327)
T ss_dssp GSCCHHHHHHHHHHHHTS
T ss_pred HCcCHHHHHHHHHHHHhC
Confidence 999999999999988754
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-41 Score=286.43 Aligned_cols=232 Identities=19% Similarity=0.205 Sum_probs=187.3
Q ss_pred cCCcEEEEEEeecCCC--cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCH
Q 021490 7 CLLQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 84 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~ 84 (311)
.+|+.||+|++..... ...+.+.+|+.+++.++||||+++++++.+....++||||+++++|.+++.. ...+++
T Consensus 29 ~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~----~~~~~~ 104 (284)
T 3kk8_A 29 TTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA----REFYSE 104 (284)
T ss_dssp TTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH----HSSCCH
T ss_pred CCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCCCCCHHHHHHh----cCCCCH
Confidence 3689999999976543 2346788999999999999999999999999999999999999999998876 567999
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCc---eEEccccccccCCCCCCceeeeeccccccccCccc
Q 021490 85 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH---PKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 161 (311)
Q Consensus 85 ~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~---~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 161 (311)
..+..++.|++.||+|||+.+ ++|+||+|+||+++.++. ++|+|||++...... .......++..|+|||+
T Consensus 105 ~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~ 178 (284)
T 3kk8_A 105 ADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS---EAWHGFAGTPGYLSPEV 178 (284)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS---CBCCCSCSCGGGCCHHH
T ss_pred HHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC---ccccCCCCCcCCcCchh
Confidence 999999999999999999999 999999999999986655 999999998653322 12233468999999999
Q ss_pred cccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHH
Q 021490 162 AKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAM 241 (311)
Q Consensus 162 ~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 241 (311)
+.+..++.++||||||+++|+|++|..||................ .. ... ......+..+.+++.+
T Consensus 179 ~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~------~~---~~~-----~~~~~~~~~~~~li~~ 244 (284)
T 3kk8_A 179 LKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA------YD---YPS-----PEWDTVTPEAKSLIDS 244 (284)
T ss_dssp HTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC------CC---CCT-----TTTTTSCHHHHHHHHH
T ss_pred hcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhcc------cc---CCc-----hhhcccCHHHHHHHHH
Confidence 999999999999999999999999999997765443322221110 00 000 0112234478899999
Q ss_pred ccccCCCCCCCHHHHHHHHHH
Q 021490 242 CVHEQPDMRPVIADVVTALAY 262 (311)
Q Consensus 242 ~l~~~p~~Rps~~~vl~~l~~ 262 (311)
||+.||.+|||+.++++....
T Consensus 245 ~l~~dp~~Rps~~~~l~h~~~ 265 (284)
T 3kk8_A 245 MLTVNPKKRITADQALKVPWI 265 (284)
T ss_dssp HSCSSTTTSCCHHHHTTSHHH
T ss_pred HcccChhhCCCHHHHhcCccc
Confidence 999999999999999987543
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=298.17 Aligned_cols=242 Identities=28% Similarity=0.387 Sum_probs=191.2
Q ss_pred cCCcEEEEEEeecCCCc-chhHHHHHHHHHhcC-CCCcccceeeEeeeCC-eeEEEEecCCCCChhhhhcccCCC-----
Q 021490 7 CLLQDVAIKQLDRNGVQ-GNREFLVEVLMLSLL-HHPNLVNLIGYCADGD-QRLLVYEYMPLGSVEDHLHDLSPG----- 78 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~----- 78 (311)
.+|+.||||+++..... ..+.+.+|+.++..+ +||||+++++++.... ..++||||+++++|.+++......
T Consensus 55 ~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 134 (316)
T 2xir_A 55 ATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 134 (316)
T ss_dssp TCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-
T ss_pred ccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhccccccccc
Confidence 46789999999765432 346789999999999 7899999999987654 589999999999999999873221
Q ss_pred -------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeecc
Q 021490 79 -------KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVM 151 (311)
Q Consensus 79 -------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~ 151 (311)
...+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++................
T Consensus 135 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 211 (316)
T 2xir_A 135 VAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 211 (316)
T ss_dssp ------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEE
T ss_pred ccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEECCCccccccccCccceeccCCC
Confidence 123899999999999999999999999 9999999999999999999999999997644333333333455
Q ss_pred ccccccCccccccCCCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChH
Q 021490 152 GTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPR 230 (311)
Q Consensus 152 ~~~~y~aPE~~~~~~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (311)
++..|+|||++.+..++.++||||||+++|+|++ |..||............ . ..... ...+..
T Consensus 212 ~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~--~----~~~~~----------~~~~~~ 275 (316)
T 2xir_A 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR--L----KEGTR----------MRAPDY 275 (316)
T ss_dssp ECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHH--H----HHTCC----------CCCCTT
T ss_pred cceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHH--h----ccCcc----------CCCCCC
Confidence 7889999999999999999999999999999998 99999765432211100 0 00000 011222
Q ss_pred hHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhcc
Q 021490 231 GFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQK 267 (311)
Q Consensus 231 ~~~~l~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~~ 267 (311)
.+..+.+++.+||+.||.+|||+.++++.|+.+.+..
T Consensus 276 ~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 312 (316)
T 2xir_A 276 TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 312 (316)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 3447889999999999999999999999999887543
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=286.77 Aligned_cols=229 Identities=21% Similarity=0.204 Sum_probs=187.3
Q ss_pred CCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHHH
Q 021490 8 LLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTR 87 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~ 87 (311)
++..||+|++........+.+.+|+++++.++||||+++++++.++...++||||+++++|.+++.. ...+++..+
T Consensus 33 ~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~ 108 (277)
T 3f3z_A 33 TRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVH----KRVFRESDA 108 (277)
T ss_dssp TCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH----HCSCCHHHH
T ss_pred CCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCCCcHHHHHHH----cCCCCHHHH
Confidence 5789999999877667778999999999999999999999999999999999999999999999877 567999999
Q ss_pred HHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEE---cCCCceEEccccccccCCCCCCceeeeeccccccccCcccccc
Q 021490 88 MKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL---DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT 164 (311)
Q Consensus 88 ~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 164 (311)
+.++.|++.||+|||+++ ++|+||+|+||++ +.++.++|+|||++....... ......++..|+|||++.+
T Consensus 109 ~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~ 182 (277)
T 3f3z_A 109 ARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK---MMRTKVGTPYYVSPQVLEG 182 (277)
T ss_dssp HHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc---chhccCCCCCccChHHhcc
Confidence 999999999999999999 9999999999999 788999999999987533221 2233468899999999865
Q ss_pred CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccc
Q 021490 165 GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVH 244 (311)
Q Consensus 165 ~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 244 (311)
. ++.++||||||+++|+|++|..||...........+..... .. ..... ...+..+.+++.+||+
T Consensus 183 ~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~------~~----~~~~~----~~~~~~~~~li~~~l~ 247 (277)
T 3f3z_A 183 L-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTF------TF----PEKDW----LNVSPQAESLIRRLLT 247 (277)
T ss_dssp C-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC------CC----CHHHH----TTSCHHHHHHHHHHTC
T ss_pred c-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC------CC----Cchhh----hcCCHHHHHHHHHHcc
Confidence 4 89999999999999999999999987654433222211100 00 00000 0123478899999999
Q ss_pred cCCCCCCCHHHHHHHHH
Q 021490 245 EQPDMRPVIADVVTALA 261 (311)
Q Consensus 245 ~~p~~Rps~~~vl~~l~ 261 (311)
.||.+|||+.++++.-.
T Consensus 248 ~dp~~R~s~~~~l~h~~ 264 (277)
T 3f3z_A 248 KSPKQRITSLQALEHEW 264 (277)
T ss_dssp SSTTTSCCHHHHTTSHH
T ss_pred CChhhCcCHHHHhcCHH
Confidence 99999999999997644
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=288.84 Aligned_cols=235 Identities=24% Similarity=0.287 Sum_probs=186.5
Q ss_pred cchhcc-CCcEEEEEEeecCCCc------chhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcc
Q 021490 2 MQVILC-LLQDVAIKQLDRNGVQ------GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHD 74 (311)
Q Consensus 2 ~~~~~~-~g~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 74 (311)
|.+... +|+.||+|+++..... ..+.+.+|+.+++.++||||+++++++.+....++||||+++++|.+++..
T Consensus 22 ~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 101 (283)
T 3bhy_A 22 RKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAE 101 (283)
T ss_dssp EEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH
T ss_pred EEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEEEEeecCCCcHHHHHHh
Confidence 334333 6899999998765332 357899999999999999999999999999999999999999999999976
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCC----ceEEccccccccCCCCCCceeeeec
Q 021490 75 LSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY----HPKLSDFGLAKLGPVGDNTHVSTRV 150 (311)
Q Consensus 75 ~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~----~~~l~df~~~~~~~~~~~~~~~~~~ 150 (311)
...+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++ .++|+|||++....... .....
T Consensus 102 ----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~---~~~~~ 171 (283)
T 3bhy_A 102 ----KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN---EFKNI 171 (283)
T ss_dssp ----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC-----------
T ss_pred ----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecccceeccCCC---ccccc
Confidence 567999999999999999999999999 99999999999998877 89999999987532221 12234
Q ss_pred cccccccCccccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChH
Q 021490 151 MGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPR 230 (311)
Q Consensus 151 ~~~~~y~aPE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (311)
.++..|+|||++.+..++.++||||||+++|+|++|..||...........+.... ....+... ..
T Consensus 172 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~----------~~~~~~~~----~~ 237 (283)
T 3bhy_A 172 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVN----------YDFDEEYF----SN 237 (283)
T ss_dssp CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC----------CCCCHHHH----TT
T ss_pred CCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcc----------cCCcchhc----cc
Confidence 58899999999998899999999999999999999999998765433322111100 00001111 12
Q ss_pred hHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 021490 231 GFYQALAVAAMCVHEQPDMRPVIADVVTAL 260 (311)
Q Consensus 231 ~~~~l~~li~~~l~~~p~~Rps~~~vl~~l 260 (311)
.+..+.+++.+||..||.+|||+.++++..
T Consensus 238 ~~~~~~~li~~~l~~dp~~Rps~~~~l~h~ 267 (283)
T 3bhy_A 238 TSELAKDFIRRLLVKDPKRRMTIAQSLEHS 267 (283)
T ss_dssp CCHHHHHHHHTTSCSSGGGSCCHHHHHHCH
T ss_pred CCHHHHHHHHHHccCCHhHCcCHHHHHhCH
Confidence 234788999999999999999999999753
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=293.62 Aligned_cols=239 Identities=23% Similarity=0.303 Sum_probs=178.7
Q ss_pred CCcEEEEEEeecCCCcchhHHHHHHHHHhc--CCCCcccceeeEeee----CCeeEEEEecCCCCChhhhhcccCCCCCC
Q 021490 8 LLQDVAIKQLDRNGVQGNREFLVEVLMLSL--LHHPNLVNLIGYCAD----GDQRLLVYEYMPLGSVEDHLHDLSPGKKP 81 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 81 (311)
+|+.||||++... ....+..|.+++.. ++||||+++++++.+ ....++||||+++++|.+++.. ..
T Consensus 30 ~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~ 101 (301)
T 3q4u_A 30 QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL-----TT 101 (301)
T ss_dssp TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHHHTT-----CC
T ss_pred CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhccCCCHHHHHhh-----cc
Confidence 6899999998543 34566667777766 799999999998654 2457999999999999999964 57
Q ss_pred CCHHHHHHHHHHHHHHHHHhh--------cCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCcee--eeecc
Q 021490 82 LDWNTRMKIAAGAARGLEYLH--------DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHV--STRVM 151 (311)
Q Consensus 82 l~~~~~~~~~~~i~~~l~~lh--------~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~--~~~~~ 151 (311)
+++..++.++.|++.||+||| +.+ ++||||||+|||++.++.+||+|||++........... .....
T Consensus 102 ~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~ 178 (301)
T 3q4u_A 102 LDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV 178 (301)
T ss_dssp BCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCC
T ss_pred cCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEeeCCCeeecccccccccccccccc
Confidence 999999999999999999999 888 99999999999999999999999999865332222111 12236
Q ss_pred ccccccCccccccC------CCccccceeehhHHHHHHHhC----------CCccCcchhHHHHHHHHHhhhhhcccccc
Q 021490 152 GTYGYCAPEYAKTG------QLTLKSDVYSFGVVLLEILSG----------RKAVDTSKAAAEQSLVAWARPLFQDRTRH 215 (311)
Q Consensus 152 ~~~~y~aPE~~~~~------~~~~~~DiwslG~l~~~ll~g----------~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 215 (311)
++..|+|||++.+. .++.++||||||+++|+|++| ..||............ ...........
T Consensus 179 gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~--~~~~~~~~~~~ 256 (301)
T 3q4u_A 179 GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFED--MRKVVCVDQQR 256 (301)
T ss_dssp CCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHH--HHHHHTTSCCC
T ss_pred cccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcchhh--hhHHHhccCCC
Confidence 89999999999776 556799999999999999999 7787543221110000 00000000000
Q ss_pred ccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 021490 216 SLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYL 263 (311)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l~~~ 263 (311)
... .....+...+..+.+|+.+||+.||.+|||+.++++.|+.+
T Consensus 257 ~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 257 PNI----PNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp CCC----CGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CCC----ChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 000 00112234567899999999999999999999999999865
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=320.00 Aligned_cols=233 Identities=26% Similarity=0.385 Sum_probs=187.6
Q ss_pred CCcEEEEEEeecCCC--cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHH
Q 021490 8 LLQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN 85 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~ 85 (311)
.++.||||+++.... ...+.|.+|+.+|..++||||+++++++.. ...++||||+++|+|.+++.. ...+++.
T Consensus 395 ~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~----~~~l~~~ 469 (635)
T 4fl3_A 395 VVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQ----NRHVKDK 469 (635)
T ss_dssp CEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHHH----CTTCCHH
T ss_pred cceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCCCCHHHHHhh----CCCCCHH
Confidence 568899999976533 335789999999999999999999999864 568999999999999999986 5679999
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCc-eeeeeccccccccCcccccc
Q 021490 86 TRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT-HVSTRVMGTYGYCAPEYAKT 164 (311)
Q Consensus 86 ~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~ 164 (311)
.++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++......... .......++..|+|||++.+
T Consensus 470 ~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~ 546 (635)
T 4fl3_A 470 NIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 546 (635)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------------CGGGSCHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcC
Confidence 99999999999999999999 999999999999999999999999998754332211 12223346788999999999
Q ss_pred CCCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHcc
Q 021490 165 GQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCV 243 (311)
Q Consensus 165 ~~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 243 (311)
..++.++|||||||++|+|++ |..||...........+.... ....+...+..+.+|+.+||
T Consensus 547 ~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~-----------------~~~~p~~~~~~l~~li~~cl 609 (635)
T 4fl3_A 547 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE-----------------RMGCPAGCPREMYDLMNLCW 609 (635)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-----------------CCCCCTTCCHHHHHHHHHHT
T ss_pred CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-----------------CCCCCCCCCHHHHHHHHHHc
Confidence 999999999999999999998 999998766544333221110 01123334458899999999
Q ss_pred ccCCCCCCCHHHHHHHHHHhhh
Q 021490 244 HEQPDMRPVIADVVTALAYLAS 265 (311)
Q Consensus 244 ~~~p~~Rps~~~vl~~l~~~~~ 265 (311)
+.||++|||+.++++.|+.+..
T Consensus 610 ~~dP~~RPs~~~l~~~L~~~~~ 631 (635)
T 4fl3_A 610 TYDVENRPGFAAVELRLRNYYY 631 (635)
T ss_dssp CSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCHhHCcCHHHHHHHHHHHHH
Confidence 9999999999999999987653
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=285.65 Aligned_cols=237 Identities=22% Similarity=0.340 Sum_probs=187.5
Q ss_pred cchhccCCcEEEEEEeecCCC--cchhHHHHHHHHHhcCCCCcccceeeEeeeC--CeeEEEEecCCCCChhhhhcccCC
Q 021490 2 MQVILCLLQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADG--DQRLLVYEYMPLGSVEDHLHDLSP 77 (311)
Q Consensus 2 ~~~~~~~g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~ 77 (311)
|.+.. .|..||+|+++.... ...+.|.+|+.+++.++||||+++++++.+. ...++||||+++++|.+++....
T Consensus 27 ~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~- 104 (271)
T 3kmu_A 27 WKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGT- 104 (271)
T ss_dssp EEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHSCS-
T ss_pred EEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccCCCcHHHHHhhcc-
Confidence 33443 488999999976543 3346799999999999999999999999877 77899999999999999998621
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeecccccccc
Q 021490 78 GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 157 (311)
Q Consensus 78 ~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~ 157 (311)
...+++..++.++.|++.||+|||+.+ .+++|+||||+||+++.++.++|+|||+...... ....+++.|+
T Consensus 105 -~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~-------~~~~~t~~y~ 175 (271)
T 3kmu_A 105 -NFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS-------PGRMYAPAWV 175 (271)
T ss_dssp -SCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC-------TTCBSCGGGS
T ss_pred -cCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeecc-------cCccCCcccc
Confidence 336999999999999999999999874 4599999999999999999999998887653211 1235788999
Q ss_pred CccccccCCCcc---ccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHH
Q 021490 158 APEYAKTGQLTL---KSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQ 234 (311)
Q Consensus 158 aPE~~~~~~~~~---~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
|||++.+...+. ++||||||+++|+|++|..||............. ... .....+...+..
T Consensus 176 aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~------~~~----------~~~~~~~~~~~~ 239 (271)
T 3kmu_A 176 APEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVA------LEG----------LRPTIPPGISPH 239 (271)
T ss_dssp CHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHH------HSC----------CCCCCCTTCCHH
T ss_pred ChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHH------hcC----------CCCCCCCCCCHH
Confidence 999998765544 7999999999999999999998765433321111 000 011122334457
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHHHHHhhh
Q 021490 235 ALAVAAMCVHEQPDMRPVIADVVTALAYLAS 265 (311)
Q Consensus 235 l~~li~~~l~~~p~~Rps~~~vl~~l~~~~~ 265 (311)
+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus 240 ~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 240 VSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 8999999999999999999999999988753
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=296.29 Aligned_cols=222 Identities=21% Similarity=0.261 Sum_probs=183.9
Q ss_pred ccCCcEEEEEEeecCCCc--------chhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCC-ChhhhhcccC
Q 021490 6 LCLLQDVAIKQLDRNGVQ--------GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLG-SVEDHLHDLS 76 (311)
Q Consensus 6 ~~~g~~vaiK~~~~~~~~--------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~-~L~~~l~~~~ 76 (311)
..+|+.||||+++..... ....+.+|+.+++.++||||+++++++.+....++||||+.+| +|.+++..
T Consensus 46 ~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~-- 123 (335)
T 3dls_A 46 KEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDR-- 123 (335)
T ss_dssp TTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTSCBHHHHHHT--
T ss_pred CCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEEEEEEeCCCCccHHHHHHh--
Confidence 347899999999765421 3346788999999999999999999999999999999998666 99999986
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccc
Q 021490 77 PGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY 156 (311)
Q Consensus 77 ~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y 156 (311)
...+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++....... ......++..|
T Consensus 124 --~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~---~~~~~~gt~~y 195 (335)
T 3dls_A 124 --HPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK---LFYTFCGTIEY 195 (335)
T ss_dssp --CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTTC---CBCEECSCGGG
T ss_pred --cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecccceECCCCC---ceeccCCCccc
Confidence 567999999999999999999999999 9999999999999999999999999997543322 22234689999
Q ss_pred cCccccccCCC-ccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHH
Q 021490 157 CAPEYAKTGQL-TLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQA 235 (311)
Q Consensus 157 ~aPE~~~~~~~-~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 235 (311)
+|||++.+..+ +.++||||||+++|+|++|..||...... .... ...+...+..+
T Consensus 196 ~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------------~~~~------------~~~~~~~~~~l 251 (335)
T 3dls_A 196 CAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------------VEAA------------IHPPYLVSKEL 251 (335)
T ss_dssp CCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------------TTTC------------CCCSSCCCHHH
T ss_pred cChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------------Hhhc------------cCCCcccCHHH
Confidence 99999988776 78999999999999999999999763221 0000 01112234578
Q ss_pred HHHHHHccccCCCCCCCHHHHHHHHH
Q 021490 236 LAVAAMCVHEQPDMRPVIADVVTALA 261 (311)
Q Consensus 236 ~~li~~~l~~~p~~Rps~~~vl~~l~ 261 (311)
.+|+.+||+.||.+|||+.++++...
T Consensus 252 ~~li~~~L~~dP~~Rps~~ell~hp~ 277 (335)
T 3dls_A 252 MSLVSGLLQPVPERRTTLEKLVTDPW 277 (335)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHCTT
T ss_pred HHHHHHHccCChhhCcCHHHHhcCcc
Confidence 89999999999999999999998754
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=296.50 Aligned_cols=244 Identities=19% Similarity=0.205 Sum_probs=177.0
Q ss_pred cCCcEEEEEEeecCCCc--chhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCH
Q 021490 7 CLLQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 84 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~ 84 (311)
.+|+.||||+++..... ..+.+.+|+.+++.++||||+++++++.++...++||||++ ++|.+++.. ...+++
T Consensus 57 ~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~ 131 (329)
T 3gbz_A 57 VTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAE-NDLKKYMDK----NPDVSM 131 (329)
T ss_dssp TTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHH----CTTCCH
T ss_pred CCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecCC-CCHHHHHhh----cCCCCH
Confidence 47899999999655432 24577899999999999999999999999999999999997 599999987 567999
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEE-----cCCCceEEccccccccCCCCCCceeeeeccccccccCc
Q 021490 85 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL-----DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 159 (311)
Q Consensus 85 ~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~-----~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aP 159 (311)
..++.++.|++.||+|||+++ ++||||||+|||+ +.++.++|+|||++...... ........++..|+||
T Consensus 132 ~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~~~t~~y~aP 206 (329)
T 3gbz_A 132 RVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP--IRQFTHEIITLWYRPP 206 (329)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-------------CCTTCCH
T ss_pred HHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCCccccCCc--ccccCCCcCCccccCH
Confidence 999999999999999999999 9999999999999 45556999999998653221 1222334578999999
Q ss_pred cccccC-CCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCC------------
Q 021490 160 EYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQ------------ 226 (311)
Q Consensus 160 E~~~~~-~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------ 226 (311)
|++.+. .++.++|||||||++|+|++|..||...........+..................+.....
T Consensus 207 E~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (329)
T 3gbz_A 207 EILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRV 286 (329)
T ss_dssp HHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHH
T ss_pred HHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhh
Confidence 998764 5899999999999999999999999876654433222111110100000000000000000
Q ss_pred CChHhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 021490 227 YPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 260 (311)
Q Consensus 227 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l 260 (311)
.+...+..+.+|+.+||+.||.+|||+.|+++.-
T Consensus 287 ~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 320 (329)
T 3gbz_A 287 LGALLDDEGLDLLTAMLEMDPVKRISAKNALEHP 320 (329)
T ss_dssp HGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred cccccCHHHHHHHHHHccCChhhCCCHHHHhCCc
Confidence 1111346788999999999999999999998753
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=296.30 Aligned_cols=238 Identities=24% Similarity=0.367 Sum_probs=189.6
Q ss_pred CCcEEEEEEeecCCC-cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccC------CCCC
Q 021490 8 LLQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLS------PGKK 80 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~ 80 (311)
.++.||+|+++.... .....+.+|+.+++.++||||+++++++.++...++||||+++++|.+++.... ....
T Consensus 54 ~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 133 (322)
T 1p4o_A 54 PETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLA 133 (322)
T ss_dssp EEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCC
T ss_pred CceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCC
Confidence 478899999975432 334578999999999999999999999999999999999999999999987521 1124
Q ss_pred CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcc
Q 021490 81 PLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 160 (311)
Q Consensus 81 ~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE 160 (311)
.+++..++.++.|++.||+|||+++ ++||||||+||+++.++.++|+|||++................++..|+|||
T Consensus 134 ~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 210 (322)
T 1p4o_A 134 PPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE 210 (322)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHH
T ss_pred CcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChh
Confidence 6789999999999999999999999 9999999999999999999999999987532222112222334678899999
Q ss_pred ccccCCCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHH
Q 021490 161 YAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVA 239 (311)
Q Consensus 161 ~~~~~~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 239 (311)
++.+..++.++||||||+++|+|++ |..||...........+.. .. . ...+...+..+.+++
T Consensus 211 ~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~------~~-~----------~~~~~~~~~~l~~li 273 (322)
T 1p4o_A 211 SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME------GG-L----------LDKPDNCPDMLFELM 273 (322)
T ss_dssp HHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHT------TC-C----------CCCCTTCCHHHHHHH
T ss_pred hhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHc------CC-c----------CCCCCCCCHHHHHHH
Confidence 9998899999999999999999999 8999987654333221110 00 0 011223345788999
Q ss_pred HHccccCCCCCCCHHHHHHHHHHhhh
Q 021490 240 AMCVHEQPDMRPVIADVVTALAYLAS 265 (311)
Q Consensus 240 ~~~l~~~p~~Rps~~~vl~~l~~~~~ 265 (311)
.+||+.||.+|||+.++++.|+.+..
T Consensus 274 ~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 274 RMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 99999999999999999999976543
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-41 Score=286.15 Aligned_cols=228 Identities=28% Similarity=0.385 Sum_probs=165.7
Q ss_pred cCCcEEEEEEeecCCC---cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCC
Q 021490 7 CLLQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLD 83 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~ 83 (311)
.+|+.||+|++..... ...+.+.+|+.++..++||||+++++++.+....++||||+++++|.+++... ...++
T Consensus 34 ~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~ 110 (278)
T 3cok_A 34 HTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNR---VKPFS 110 (278)
T ss_dssp TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHTC---SSCCC
T ss_pred cCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCCCCcHHHHHhhc---cCCCC
Confidence 4789999999965432 23467899999999999999999999999999999999999999999999862 36799
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccc
Q 021490 84 WNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 163 (311)
Q Consensus 84 ~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 163 (311)
+..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++....... .......++..|+|||++.
T Consensus 111 ~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~ 185 (278)
T 3cok_A 111 ENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH--EKHYTLCGTPNYISPEIAT 185 (278)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC------------------------
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccCCC--CcceeccCCCCcCCcchhc
Confidence 9999999999999999999999 9999999999999999999999999987533221 1122345789999999999
Q ss_pred cCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHcc
Q 021490 164 TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCV 243 (311)
Q Consensus 164 ~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 243 (311)
+..++.++||||||+++|+|++|..||......... ... ...+. ..+...+..+.+++.+||
T Consensus 186 ~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~----------~~~----~~~~~----~~~~~~~~~~~~li~~~l 247 (278)
T 3cok_A 186 RSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL----------NKV----VLADY----EMPSFLSIEAKDLIHQLL 247 (278)
T ss_dssp ------CTHHHHHHHHHHHHHHSSCSSCCCSCC---------------C----CSSCC----CCCTTSCHHHHHHHHHHS
T ss_pred CCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH----------HHH----hhccc----CCccccCHHHHHHHHHHc
Confidence 888999999999999999999999999764321110 000 00011 122334457889999999
Q ss_pred ccCCCCCCCHHHHHHHH
Q 021490 244 HEQPDMRPVIADVVTAL 260 (311)
Q Consensus 244 ~~~p~~Rps~~~vl~~l 260 (311)
+.||++|||+.++++..
T Consensus 248 ~~dp~~Rps~~~~l~h~ 264 (278)
T 3cok_A 248 RRNPADRLSLSSVLDHP 264 (278)
T ss_dssp CSSGGGSCCHHHHTTST
T ss_pred ccCHhhCCCHHHHhcCc
Confidence 99999999999998753
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=288.77 Aligned_cols=232 Identities=22% Similarity=0.290 Sum_probs=185.4
Q ss_pred cchhcc-CCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeee----------------CCeeEEEEecCC
Q 021490 2 MQVILC-LLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCAD----------------GDQRLLVYEYMP 64 (311)
Q Consensus 2 ~~~~~~-~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~~~~~lv~e~~~ 64 (311)
|.+... +|+.||+|+++... +.+.+|++++..++||||+++++++.. ....++||||++
T Consensus 28 ~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~ 103 (284)
T 2a19_B 28 FKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCD 103 (284)
T ss_dssp EEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCC
T ss_pred EEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccccCcceEEEEEeccC
Confidence 334443 79999999996543 467789999999999999999998854 345799999999
Q ss_pred CCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCc
Q 021490 65 LGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT 144 (311)
Q Consensus 65 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~ 144 (311)
+++|.+++.... ...+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 104 ~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 176 (284)
T 2a19_B 104 KGTLEQWIEKRR--GEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG-- 176 (284)
T ss_dssp SCBHHHHHHHGG--GSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEESSCCS--
T ss_pred CCCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCCEEECcchhheeccccc--
Confidence 999999997632 357999999999999999999999999 9999999999999999999999999987543321
Q ss_pred eeeeeccccccccCccccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCcccc
Q 021490 145 HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQ 224 (311)
Q Consensus 145 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (311)
......++..|+|||++.+..++.++||||||+++|+|++|..||...... ... ... .
T Consensus 177 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~-----~~~----~~~---------~--- 234 (284)
T 2a19_B 177 -KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKF-----FTD----LRD---------G--- 234 (284)
T ss_dssp -CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHHH-----HHH----HHT---------T---
T ss_pred -cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHHH-----HHH----hhc---------c---
Confidence 122345889999999999888999999999999999999999887532211 000 000 0
Q ss_pred CCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhcc
Q 021490 225 GQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQK 267 (311)
Q Consensus 225 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~~ 267 (311)
..+...+..+.+++.+||+.||.+|||+.++++.|+.+....
T Consensus 235 -~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~ 276 (284)
T 2a19_B 235 -IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276 (284)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC--
T ss_pred -cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCC
Confidence 011223346788999999999999999999999999876443
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=293.88 Aligned_cols=236 Identities=23% Similarity=0.290 Sum_probs=180.9
Q ss_pred cCCcEEEEEEeecCCCcchhHHHHHHHHHhcC-CCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHH
Q 021490 7 CLLQDVAIKQLDRNGVQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN 85 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~ 85 (311)
.+|+.||||+++.........+.+|+.++.++ +||||+++++++.++...++||||++|++|.+++.. ...+++.
T Consensus 36 ~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~ 111 (316)
T 2ac3_A 36 ITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHK----RRHFNEL 111 (316)
T ss_dssp SSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH----HSSCCHH
T ss_pred CCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcHHHHHhc----cCCCCHH
Confidence 36899999999877666678899999999985 799999999999999999999999999999999987 4679999
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCc---eEEccccccccCCCCCC-----ceeeeecccccccc
Q 021490 86 TRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH---PKLSDFGLAKLGPVGDN-----THVSTRVMGTYGYC 157 (311)
Q Consensus 86 ~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~---~~l~df~~~~~~~~~~~-----~~~~~~~~~~~~y~ 157 (311)
.+..++.|++.||+|||+++ ++||||||+||+++.++. ++|+|||++........ ........++..|+
T Consensus 112 ~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 188 (316)
T 2ac3_A 112 EASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYM 188 (316)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------------------CCSGGGC
T ss_pred HHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccccccccccccccCCcCcc
Confidence 99999999999999999999 999999999999998776 99999999865322111 11112345899999
Q ss_pred Ccccccc-----CCCccccceeehhHHHHHHHhCCCccCcchhHH------------HHHHHHHhhhhhccccccccccC
Q 021490 158 APEYAKT-----GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA------------EQSLVAWARPLFQDRTRHSLIAD 220 (311)
Q Consensus 158 aPE~~~~-----~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~ 220 (311)
|||++.. ..++.++|||||||++|+|++|..||....... ...+.... ...... . .
T Consensus 189 aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i---~~~~~~---~-~ 261 (316)
T 2ac3_A 189 APEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESI---QEGKYE---F-P 261 (316)
T ss_dssp CHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHH---HHCCCC---C-C
T ss_pred ChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHH---hccCcc---c-C
Confidence 9999875 457889999999999999999999997643211 00011100 000000 0 0
Q ss_pred ccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 021490 221 PELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 260 (311)
Q Consensus 221 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l 260 (311)
.... ...+..+.+|+.+||+.||.+|||+.++++..
T Consensus 262 ~~~~----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp 297 (316)
T 2ac3_A 262 DKDW----AHISCAAKDLISKLLVRDAKQRLSAAQVLQHP 297 (316)
T ss_dssp HHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHST
T ss_pred chhc----ccCCHHHHHHHHHHhhCChhhCCCHHHHhcCh
Confidence 0000 11234788999999999999999999999864
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=316.38 Aligned_cols=239 Identities=28% Similarity=0.358 Sum_probs=192.0
Q ss_pred cchhccCCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCC
Q 021490 2 MQVILCLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKP 81 (311)
Q Consensus 2 ~~~~~~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 81 (311)
|.+....+..||||+++... ...+.|.+|+.+|+.++||||+++++++.+ ...++||||+++|+|.+++.... +..
T Consensus 284 y~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~--~~~ 359 (535)
T 2h8h_A 284 WMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGET--GKY 359 (535)
T ss_dssp EEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHHHHSHHH--HTT
T ss_pred EEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHHHHHhhcC--CCC
Confidence 45556667889999996544 456789999999999999999999999876 67899999999999999997521 356
Q ss_pred CCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccc
Q 021490 82 LDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 161 (311)
Q Consensus 82 l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 161 (311)
+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++...... .........++..|+|||+
T Consensus 360 l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-~~~~~~~~~~~~~y~aPE~ 435 (535)
T 2h8h_A 360 LRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN-EYTARQGAKFPIKWTAPEA 435 (535)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH-HHHTTCSTTSCGGGSCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCC-ceecccCCcCcccccCHHH
Confidence 899999999999999999999999 999999999999999999999999998753211 0111122346778999999
Q ss_pred cccCCCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHH
Q 021490 162 AKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAA 240 (311)
Q Consensus 162 ~~~~~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 240 (311)
+....++.++||||||+++|+|++ |..||...........+... .....+...+..+.+||.
T Consensus 436 ~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~-----------------~~~~~~~~~~~~l~~li~ 498 (535)
T 2h8h_A 436 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-----------------YRMPCPPECPESLHDLMC 498 (535)
T ss_dssp HHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTT-----------------CCCCCCTTCCHHHHHHHH
T ss_pred hccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-----------------CCCCCCCCCCHHHHHHHH
Confidence 998999999999999999999999 99999876543332221100 001122334457889999
Q ss_pred HccccCCCCCCCHHHHHHHHHHhhh
Q 021490 241 MCVHEQPDMRPVIADVVTALAYLAS 265 (311)
Q Consensus 241 ~~l~~~p~~Rps~~~vl~~l~~~~~ 265 (311)
+||+.||++|||+.++++.|+.+..
T Consensus 499 ~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 499 QCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred HHcCCChhHCcCHHHHHHHHHHHhh
Confidence 9999999999999999999987653
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-41 Score=292.87 Aligned_cols=231 Identities=20% Similarity=0.241 Sum_probs=184.4
Q ss_pred CCcEEEEEEeecCCC--cchhHHHHHHHHHhcC-CCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCH
Q 021490 8 LLQDVAIKQLDRNGV--QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 84 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~ 84 (311)
+|+.||+|+++.... .....+.+|+.++..+ .||||+++++++.+....++||||+++++|.+++... ....+++
T Consensus 53 ~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~ 130 (327)
T 3lm5_A 53 TGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPE--LAEMVSE 130 (327)
T ss_dssp TCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSC--C-CCCCH
T ss_pred CCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHh--cccCCCH
Confidence 689999999976432 3357889999999999 5699999999999999999999999999999998652 2467999
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcC---CCceEEccccccccCCCCCCceeeeeccccccccCccc
Q 021490 85 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR---GYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 161 (311)
Q Consensus 85 ~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~---~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 161 (311)
..++.++.|++.||+|||+.+ ++||||||+||+++. ++.++|+|||++...... .......+++.|+|||+
T Consensus 131 ~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~ 204 (327)
T 3lm5_A 131 NDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA---CELREIMGTPEYLAPEI 204 (327)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEECCGGGCEEC------------CCCGGGCCHHH
T ss_pred HHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEeeCccccccCCc---cccccccCCcCccCCee
Confidence 999999999999999999999 999999999999987 789999999999754322 11233468999999999
Q ss_pred cccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHH
Q 021490 162 AKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAM 241 (311)
Q Consensus 162 ~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 241 (311)
+.+..++.++||||||+++|+|++|..||...........+.... ...........+..+.+++.+
T Consensus 205 ~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~--------------~~~~~~~~~~~~~~~~~li~~ 270 (327)
T 3lm5_A 205 LNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVN--------------VDYSEETFSSVSQLATDFIQS 270 (327)
T ss_dssp HTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC--------------CCCCTTTTTTSCHHHHHHHHH
T ss_pred ecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcc--------------cccCchhhcccCHHHHHHHHH
Confidence 999999999999999999999999999998765543322221110 000111122334578899999
Q ss_pred ccccCCCCCCCHHHHHHHH
Q 021490 242 CVHEQPDMRPVIADVVTAL 260 (311)
Q Consensus 242 ~l~~~p~~Rps~~~vl~~l 260 (311)
||+.||.+|||+.++++..
T Consensus 271 ~L~~dP~~Rpt~~~ll~h~ 289 (327)
T 3lm5_A 271 LLVKNPEKRPTAEICLSHS 289 (327)
T ss_dssp HSCSSGGGSCCHHHHTTCG
T ss_pred HcCCChhhCcCHHHHhCCH
Confidence 9999999999999998764
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=296.00 Aligned_cols=231 Identities=24% Similarity=0.294 Sum_probs=182.4
Q ss_pred CCcEEEEEEeecCCCcchhHHHHHHHHHhcC-CCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHH
Q 021490 8 LLQDVAIKQLDRNGVQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNT 86 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~ 86 (311)
+|+.||||+++.... .+.+|++++..+ +||||+++++++.++...|+||||++||+|.+++.. .+.+++..
T Consensus 46 ~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~i~~----~~~~~~~~ 117 (342)
T 2qr7_A 46 TNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILR----QKFFSERE 117 (342)
T ss_dssp TTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHT----CTTCCHHH
T ss_pred CCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHH
Confidence 689999999975542 345688888888 799999999999999999999999999999999986 56799999
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCC----CceEEccccccccCCCCCCceeeeeccccccccCcccc
Q 021490 87 RMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG----YHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 162 (311)
Q Consensus 87 ~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~----~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 162 (311)
+..++.|++.||+|||+.| ++||||||+|||+..+ +.++|+|||++....... .......++..|+|||++
T Consensus 118 ~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~ 192 (342)
T 2qr7_A 118 ASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN--GLLMTPCYTANFVAPEVL 192 (342)
T ss_dssp HHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTT--CCBCCSSCCSSCCCHHHH
T ss_pred HHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCC--CceeccCCCccccCHHHh
Confidence 9999999999999999999 9999999999998543 359999999987543222 122334679999999999
Q ss_pred ccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHc
Q 021490 163 KTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMC 242 (311)
Q Consensus 163 ~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 242 (311)
.+..++.++|||||||++|+|++|..||..........+...... . ...+........+..+.+|+.+|
T Consensus 193 ~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~---~--------~~~~~~~~~~~~s~~~~~li~~~ 261 (342)
T 2qr7_A 193 ERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGS---G--------KFSLSGGYWNSVSDTAKDLVSKM 261 (342)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHH---C--------CCCCCSTTTTTSCHHHHHHHHHH
T ss_pred cCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHcc---C--------CcccCccccccCCHHHHHHHHHH
Confidence 888899999999999999999999999976432222222111110 0 00111122234456889999999
Q ss_pred cccCCCCCCCHHHHHHHHHH
Q 021490 243 VHEQPDMRPVIADVVTALAY 262 (311)
Q Consensus 243 l~~~p~~Rps~~~vl~~l~~ 262 (311)
|+.||++|||+.++++....
T Consensus 262 L~~dP~~R~t~~~il~hp~~ 281 (342)
T 2qr7_A 262 LHVDPHQRLTAALVLRHPWI 281 (342)
T ss_dssp TCSSTTTSCCHHHHTTSHHH
T ss_pred CCCChhHCcCHHHHhcCCee
Confidence 99999999999999987654
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=288.58 Aligned_cols=231 Identities=27% Similarity=0.388 Sum_probs=180.9
Q ss_pred CCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeC-CeeEEEEecCCCCChhhhhcccCCCCCCCCHHH
Q 021490 8 LLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADG-DQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNT 86 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~ 86 (311)
.|+.||+|+++.. ...+.+.+|+.++..++||||+++++++.+. ...++||||+++++|.+++.... ...+++..
T Consensus 43 ~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~ 118 (278)
T 1byg_A 43 RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG--RSVLGGDC 118 (278)
T ss_dssp TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHH--HHHCCHHH
T ss_pred cCCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHHHHHHhcc--cccCCHHH
Confidence 5889999998644 3567899999999999999999999987544 47899999999999999997621 12389999
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccCC
Q 021490 87 RMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ 166 (311)
Q Consensus 87 ~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 166 (311)
++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++...... .....++..|+|||++.+..
T Consensus 119 ~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~ 190 (278)
T 1byg_A 119 LLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----QDTGKLPVKWTAPEALREKK 190 (278)
T ss_dssp HHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-----------------CCTTTSCHHHHHHCC
T ss_pred HHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc-----ccCCCccccccCHHHhCCCC
Confidence 9999999999999999999 999999999999999999999999998643221 12234678899999999889
Q ss_pred CccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHcccc
Q 021490 167 LTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHE 245 (311)
Q Consensus 167 ~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 245 (311)
++.++||||||+++|+|++ |..||...........+ ... .....+...+..+.+++.+||+.
T Consensus 191 ~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~-------~~~----------~~~~~~~~~~~~l~~li~~~l~~ 253 (278)
T 1byg_A 191 FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV-------EKG----------YKMDAPDGCPPAVYEVMKNCWHL 253 (278)
T ss_dssp CCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHH-------TTT----------CCCCCCTTCCHHHHHHHHHHTCS
T ss_pred CCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-------hcC----------CCCCCcccCCHHHHHHHHHHhcC
Confidence 9999999999999999998 99999765443221111 000 00112233445888999999999
Q ss_pred CCCCCCCHHHHHHHHHHhhhcc
Q 021490 246 QPDMRPVIADVVTALAYLASQK 267 (311)
Q Consensus 246 ~p~~Rps~~~vl~~l~~~~~~~ 267 (311)
||.+|||+.++++.|+.+....
T Consensus 254 ~p~~Rps~~~l~~~L~~i~~~~ 275 (278)
T 1byg_A 254 DAAMRPSFLQLREQLEHIKTHE 275 (278)
T ss_dssp SGGGSCCHHHHHHHHHHHHHHC
T ss_pred ChhhCCCHHHHHHHHHHHHhhh
Confidence 9999999999999999887543
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-42 Score=299.56 Aligned_cols=238 Identities=26% Similarity=0.382 Sum_probs=189.5
Q ss_pred cEEEEEEeecCCC-cchhHHHHHHHHHhcC-CCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCC----------
Q 021490 10 QDVAIKQLDRNGV-QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP---------- 77 (311)
Q Consensus 10 ~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------- 77 (311)
..||+|+++.... ...+.+.+|+.++..+ +||||+++++++.+....++||||+++++|.+++.....
T Consensus 77 ~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 156 (333)
T 2i1m_A 77 LKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAI 156 (333)
T ss_dssp CEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-----
T ss_pred hHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccc
Confidence 5799999976543 3346789999999999 899999999999999999999999999999999875310
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeecccccccc
Q 021490 78 GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 157 (311)
Q Consensus 78 ~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~ 157 (311)
....+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++................++..|+
T Consensus 157 ~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~ 233 (333)
T 2i1m_A 157 ANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWM 233 (333)
T ss_dssp --CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGS
T ss_pred cccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECCCCeEEECccccccccccccceeecCCCCCCcccc
Confidence 1346899999999999999999999999 9999999999999999999999999997543333333333445678899
Q ss_pred CccccccCCCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHH
Q 021490 158 APEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQAL 236 (311)
Q Consensus 158 aPE~~~~~~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 236 (311)
|||++.+..++.++||||||+++|+|++ |..||............ ..... ....+...+..+.
T Consensus 234 aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~------~~~~~----------~~~~~~~~~~~l~ 297 (333)
T 2i1m_A 234 APESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKL------VKDGY----------QMAQPAFAPKNIY 297 (333)
T ss_dssp CHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHH------HHHTC----------CCCCCTTCCHHHH
T ss_pred CHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHH------HhcCC----------CCCCCCCCCHHHH
Confidence 9999998899999999999999999998 89999765432221110 00000 0011222345788
Q ss_pred HHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 021490 237 AVAAMCVHEQPDMRPVIADVVTALAYLASQ 266 (311)
Q Consensus 237 ~li~~~l~~~p~~Rps~~~vl~~l~~~~~~ 266 (311)
+++.+||+.||.+|||+.++++.|+.+...
T Consensus 298 ~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 327 (333)
T 2i1m_A 298 SIMQACWALEPTHRPTFQQICSFLQEQAQE 327 (333)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence 999999999999999999999999877654
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=284.60 Aligned_cols=227 Identities=27% Similarity=0.374 Sum_probs=185.9
Q ss_pred cCCcEEEEEEeecCCC---cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCC
Q 021490 7 CLLQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLD 83 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~ 83 (311)
.+|..||+|++..... .....+.+|+.+++.++||||+++++++.+....++||||+++++|.+++.. ...++
T Consensus 32 ~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~----~~~~~ 107 (279)
T 3fdn_A 32 QSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFD 107 (279)
T ss_dssp TTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH----HSSCC
T ss_pred cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecCCCCcHHHHHHh----cCCCC
Confidence 3578999999865432 2346788999999999999999999999999999999999999999999987 46799
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccc
Q 021490 84 WNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 163 (311)
Q Consensus 84 ~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 163 (311)
+..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++...... ......++..|+|||++.
T Consensus 108 ~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~ 180 (279)
T 3fdn_A 108 EQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTDLCGTLDYLPPEMIE 180 (279)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC------------CCCCTTCCHHHHT
T ss_pred HHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCcc----cccccCCCCCccCHhHhc
Confidence 9999999999999999999999 999999999999999999999999988542221 123346889999999999
Q ss_pred cCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHcc
Q 021490 164 TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCV 243 (311)
Q Consensus 164 ~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 243 (311)
+..++.++||||||+++|+|++|..||...........+.... ...+...+..+.+|+.+||
T Consensus 181 ~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~li~~~l 242 (279)
T 3fdn_A 181 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE------------------FTFPDFVTEGARDLISRLL 242 (279)
T ss_dssp TCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC------------------CCCCTTSCHHHHHHHHHHC
T ss_pred cCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCC------------------CCCCCcCCHHHHHHHHHHh
Confidence 9899999999999999999999999998765543332221110 1122233457889999999
Q ss_pred ccCCCCCCCHHHHHHHHHH
Q 021490 244 HEQPDMRPVIADVVTALAY 262 (311)
Q Consensus 244 ~~~p~~Rps~~~vl~~l~~ 262 (311)
+.||.+|||+.++++....
T Consensus 243 ~~~p~~Rps~~e~l~h~~~ 261 (279)
T 3fdn_A 243 KHNPSQRPMLREVLEHPWI 261 (279)
T ss_dssp CSSGGGSCCHHHHHHCHHH
T ss_pred ccChhhCCCHHHHhhCccc
Confidence 9999999999999988654
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=287.10 Aligned_cols=245 Identities=23% Similarity=0.240 Sum_probs=184.1
Q ss_pred cCCcEEEEEEeecCCC-----cchhHHHHHHHHHhcCC---CCcccceeeEeeeCC-----eeEEEEecCCCCChhhhhc
Q 021490 7 CLLQDVAIKQLDRNGV-----QGNREFLVEVLMLSLLH---HPNLVNLIGYCADGD-----QRLLVYEYMPLGSVEDHLH 73 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~-----~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~ 73 (311)
.+|+.||||+++.... .....+.+|+.+++.++ ||||+++++++.... ..++||||++ ++|.+++.
T Consensus 32 ~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~ 110 (308)
T 3g33_A 32 HSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLD 110 (308)
T ss_dssp TTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHH
T ss_pred CCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCceeEEEEehhhh-cCHHHHHh
Confidence 4689999999875432 12356778888887775 999999999997765 5799999997 69999998
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeecccc
Q 021490 74 DLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT 153 (311)
Q Consensus 74 ~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~ 153 (311)
... ...+++..++.++.|++.||+|||+++ ++||||||+||+++.++.++|+|||++...... .......++
T Consensus 111 ~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt 182 (308)
T 3g33_A 111 KAP--PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQ---MALTPVVVT 182 (308)
T ss_dssp TCC--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEECSCSCTTTSTTC---CCSGGGGCC
T ss_pred hcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEEeeCccccccCCC---cccCCcccc
Confidence 732 345999999999999999999999999 999999999999999999999999998753322 222345689
Q ss_pred ccccCccccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhc-cccccc-cccCccccC------
Q 021490 154 YGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQ-DRTRHS-LIADPELQG------ 225 (311)
Q Consensus 154 ~~y~aPE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~------ 225 (311)
..|+|||++.+..++.++|||||||++|+|++|..||...........+........ ...... ......+..
T Consensus 183 ~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (308)
T 3g33_A 183 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPV 262 (308)
T ss_dssp CSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCH
T ss_pred ccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhhccccccCCCCCCcH
Confidence 999999999989999999999999999999999999987665544332221111110 000000 000000000
Q ss_pred -CCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 021490 226 -QYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 260 (311)
Q Consensus 226 -~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l 260 (311)
...+..+..+.+|+.+||+.||++|||+.++++.-
T Consensus 263 ~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~ 298 (308)
T 3g33_A 263 QSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHS 298 (308)
T ss_dssp HHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTST
T ss_pred HHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCc
Confidence 01123346788999999999999999999999763
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=295.17 Aligned_cols=245 Identities=24% Similarity=0.334 Sum_probs=184.0
Q ss_pred CCcEEEEEEeecCCCcc--hhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHH
Q 021490 8 LLQDVAIKQLDRNGVQG--NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN 85 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~ 85 (311)
+|+.||+|++....... .+.+.+|+.+++.++||||+++++++.+....++||||+++++|.+++.. ...+++.
T Consensus 49 ~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~ 124 (331)
T 4aaa_A 49 TGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELF----PNGLDYQ 124 (331)
T ss_dssp TCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHS----TTCCCHH
T ss_pred CCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCcchHHHHHhh----ccCCCHH
Confidence 58999999986554322 35688999999999999999999999999999999999999999888765 5679999
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccC
Q 021490 86 TRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG 165 (311)
Q Consensus 86 ~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 165 (311)
.++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++...... ........++..|+|||++.+.
T Consensus 125 ~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~ 199 (331)
T 4aaa_A 125 VVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP--GEVYDDEVATRWYRAPELLVGD 199 (331)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC--------------CCCCCTTCCHHHHTTC
T ss_pred HHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCC--ccccCCCcCCccccCcccccCC
Confidence 99999999999999999999 999999999999999999999999998653221 1222334688999999998765
Q ss_pred -CCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHh-h-------hhhccccccccccCccccCCC-----ChHh
Q 021490 166 -QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWA-R-------PLFQDRTRHSLIADPELQGQY-----PPRG 231 (311)
Q Consensus 166 -~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~-~-------~~~~~~~~~~~~~~~~~~~~~-----~~~~ 231 (311)
.++.++||||||+++|+|++|..||............... . ..+...........+.+.... .+..
T Consensus 200 ~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (331)
T 4aaa_A 200 VKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKL 279 (331)
T ss_dssp TTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTS
T ss_pred CCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccch
Confidence 7899999999999999999999999876654432211110 0 000000000111111111111 1233
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 021490 232 FYQALAVAAMCVHEQPDMRPVIADVVTALA 261 (311)
Q Consensus 232 ~~~l~~li~~~l~~~p~~Rps~~~vl~~l~ 261 (311)
+..+.+|+.+||+.||.+|||+.|+++.-.
T Consensus 280 ~~~l~~li~~~L~~dP~~Rpt~~ell~hp~ 309 (331)
T 4aaa_A 280 SEVVIDLAKKCLHIDPDKRPFCAELLHHDF 309 (331)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCGGGGGGSHH
T ss_pred hHHHHHHHHHHhccCcccCCCHHHHhcCch
Confidence 568899999999999999999999997643
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=294.63 Aligned_cols=241 Identities=27% Similarity=0.364 Sum_probs=189.4
Q ss_pred cCCcEEEEEEeecCCC-cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCC---CCCC
Q 021490 7 CLLQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPG---KKPL 82 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~---~~~l 82 (311)
.+|..||||++..... .....+.+|+.+++.++||||+++++++.+....++||||+++++|.+++...... ...+
T Consensus 58 ~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 137 (327)
T 2yfx_A 58 PSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSL 137 (327)
T ss_dssp --CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSC
T ss_pred CccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccc
Confidence 4678899999965432 34468899999999999999999999999999999999999999999999874311 2458
Q ss_pred CHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcC---CCceEEccccccccCCCCCCceeeeeccccccccCc
Q 021490 83 DWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR---GYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 159 (311)
Q Consensus 83 ~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~---~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aP 159 (311)
++..++.++.|++.||+|||+.+ ++||||+|+||+++. +..++|+|||++................++..|+||
T Consensus 138 ~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 214 (327)
T 2yfx_A 138 AMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 214 (327)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCH
T ss_pred cHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCH
Confidence 99999999999999999999999 999999999999984 446999999998643222222222334578899999
Q ss_pred cccccCCCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHH
Q 021490 160 EYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAV 238 (311)
Q Consensus 160 E~~~~~~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 238 (311)
|++.+..++.++||||||+++|+|++ |..||...........+... . .+ ..+...+..+.++
T Consensus 215 E~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~-------~------~~----~~~~~~~~~l~~l 277 (327)
T 2yfx_A 215 EAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG-------G------RM----DPPKNCPGPVYRI 277 (327)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT-------C------CC----CCCTTCCHHHHHH
T ss_pred hHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcC-------C------CC----CCCCCCCHHHHHH
Confidence 99988899999999999999999998 99999876543332221110 0 00 1122334578899
Q ss_pred HHHccccCCCCCCCHHHHHHHHHHhhhcc
Q 021490 239 AAMCVHEQPDMRPVIADVVTALAYLASQK 267 (311)
Q Consensus 239 i~~~l~~~p~~Rps~~~vl~~l~~~~~~~ 267 (311)
+.+||+.||.+|||+.++++.|+.+....
T Consensus 278 i~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 306 (327)
T 2yfx_A 278 MTQCWQHQPEDRPNFAIILERIEYCTQDP 306 (327)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred HHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence 99999999999999999999999887654
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=287.26 Aligned_cols=236 Identities=31% Similarity=0.419 Sum_probs=181.2
Q ss_pred CCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHHH
Q 021490 8 LLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTR 87 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~ 87 (311)
.|+.||+|++... ...+.|.+|+++++.++||||+++++++.+ ..++||||++|++|.+++.... ....+++..+
T Consensus 30 ~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~ 104 (307)
T 2eva_A 30 RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAE-PLPYYTAAHA 104 (307)
T ss_dssp TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTTCBHHHHHHCSS-SEECCCHHHH
T ss_pred CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCCCCHHHHHhccC-CCCccCHHHH
Confidence 4789999998533 355789999999999999999999998874 4799999999999999998632 1235789999
Q ss_pred HHHHHHHHHHHHHhhc---CCCCCeEeeccCCCeEEEcCCCc-eEEccccccccCCCCCCceeeeeccccccccCccccc
Q 021490 88 MKIAAGAARGLEYLHD---KAKPPVIYRDLKCSNILLDRGYH-PKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 163 (311)
Q Consensus 88 ~~~~~~i~~~l~~lh~---~~~~~i~h~dl~p~nil~~~~~~-~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 163 (311)
+.++.|++.||+|||+ ++ ++||||||+||+++.++. +||+|||++...... .....++..|+|||++.
T Consensus 105 ~~~~~qi~~~l~~LH~~~~~~---ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~ 176 (307)
T 2eva_A 105 MSWCLQCSQGVAYLHSMQPKA---LIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-----MTNNKGSAAWMAPEVFE 176 (307)
T ss_dssp HHHHHHHHHHHHHHHTCSSSC---CCCCCCSGGGEEEETTTTEEEECCCCC-----------------CCTTSSCHHHHT
T ss_pred HHHHHHHHHHHHHHHhCCCCC---eecCCCChhHEEEeCCCCEEEEcccccccccccc-----cccCCCCCceEChhhhC
Confidence 9999999999999999 77 999999999999998886 799999998643211 22335899999999999
Q ss_pred cCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHcc
Q 021490 164 TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCV 243 (311)
Q Consensus 164 ~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 243 (311)
+..++.++||||||+++|+|++|..||............ .. ... . .+.. +...+..+.+++.+||
T Consensus 177 ~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~-~~----~~~-~-----~~~~----~~~~~~~l~~li~~~l 241 (307)
T 2eva_A 177 GSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMW-AV----HNG-T-----RPPL----IKNLPKPIESLMTRCW 241 (307)
T ss_dssp CCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHH-HH----HTT-C-----CCCC----BTTCCHHHHHHHHHHT
T ss_pred CCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHH-HH----hcC-C-----CCCc----ccccCHHHHHHHHHHh
Confidence 889999999999999999999999999754322111100 00 000 0 1111 1223347889999999
Q ss_pred ccCCCCCCCHHHHHHHHHHhhhccCCcc
Q 021490 244 HEQPDMRPVIADVVTALAYLASQKYESD 271 (311)
Q Consensus 244 ~~~p~~Rps~~~vl~~l~~~~~~~~~~~ 271 (311)
+.||.+|||+.++++.|+.+........
T Consensus 242 ~~dp~~Rps~~ell~~L~~~~~~~~~~~ 269 (307)
T 2eva_A 242 SKDPSQRPSMEEIVKIMTHLMRYFPGAD 269 (307)
T ss_dssp CSSGGGSCCHHHHHHHHHHHGGGCCCTT
T ss_pred cCChhhCcCHHHHHHHHHHHHHhccCCC
Confidence 9999999999999999999876654433
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=295.53 Aligned_cols=245 Identities=27% Similarity=0.386 Sum_probs=191.2
Q ss_pred ccCCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCC--eeEEEEecCCCCChhhhhcccCCCCCCCC
Q 021490 6 LCLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD--QRLLVYEYMPLGSVEDHLHDLSPGKKPLD 83 (311)
Q Consensus 6 ~~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~l~ 83 (311)
..+|+.||+|++........+.+.+|+.+++.++||||+++++++.... ..++||||+++++|.+++... ...++
T Consensus 67 ~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~ 143 (326)
T 2w1i_A 67 DNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH---KERID 143 (326)
T ss_dssp SSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEECCCTTCBHHHHHHHS---TTSSC
T ss_pred CCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEEECCCCCCHHHHHHhc---ccCCC
Confidence 3479999999997766666678999999999999999999999986543 689999999999999999862 35699
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCce-eeeeccccccccCcccc
Q 021490 84 WNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH-VSTRVMGTYGYCAPEYA 162 (311)
Q Consensus 84 ~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~ 162 (311)
+..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.......... ......++..|+|||++
T Consensus 144 ~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 220 (326)
T 2w1i_A 144 HIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESL 220 (326)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhhccccccccccccCCCCceeEECchhh
Confidence 9999999999999999999999 9999999999999999999999999987643322211 11223467789999999
Q ss_pred ccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHH---------HHHHhhhhhccccccccccCccccCCCChHhHH
Q 021490 163 KTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQS---------LVAWARPLFQDRTRHSLIADPELQGQYPPRGFY 233 (311)
Q Consensus 163 ~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
.+..++.++||||||+++|+|++|..||.......... ............ .....+...+.
T Consensus 221 ~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~ 290 (326)
T 2w1i_A 221 TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN----------GRLPRPDGCPD 290 (326)
T ss_dssp HHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTT----------CCCCCCTTCCH
T ss_pred cCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcC----------CCCCCCCcccH
Confidence 98889999999999999999999999987543211100 000000001000 00112233445
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 021490 234 QALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 266 (311)
Q Consensus 234 ~l~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~ 266 (311)
.+.+++.+||+.||.+|||+.++++.|+.+...
T Consensus 291 ~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 291 EIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 889999999999999999999999999988643
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=295.42 Aligned_cols=238 Identities=25% Similarity=0.198 Sum_probs=181.6
Q ss_pred cCCcEEEEEEeecC-----CCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCC---
Q 021490 7 CLLQDVAIKQLDRN-----GVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPG--- 78 (311)
Q Consensus 7 ~~g~~vaiK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~--- 78 (311)
.+|..||+|++... .....+.+.+|+.+++.++||||+++++++.+....++||||++|++|.+++......
T Consensus 49 ~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~ 128 (345)
T 3hko_A 49 QTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTG 128 (345)
T ss_dssp TTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTT
T ss_pred CCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEEEeCCCCCcHHHHHHHhhccccc
Confidence 46889999998654 2344578999999999999999999999999999999999999999999998631100
Q ss_pred ---------------------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCC
Q 021490 79 ---------------------------------KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY 125 (311)
Q Consensus 79 ---------------------------------~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~ 125 (311)
...+++..++.++.|++.||+|||+.+ ++||||||+||+++.++
T Consensus 129 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~ 205 (345)
T 3hko_A 129 KCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG---ICHRDIKPENFLFSTNK 205 (345)
T ss_dssp EEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSS
T ss_pred ccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEecCC
Confidence 123467788999999999999999999 99999999999998776
Q ss_pred --ceEEccccccccCCCCCC--ceeeeeccccccccCcccccc--CCCccccceeehhHHHHHHHhCCCccCcchhHHHH
Q 021490 126 --HPKLSDFGLAKLGPVGDN--THVSTRVMGTYGYCAPEYAKT--GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ 199 (311)
Q Consensus 126 --~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~ 199 (311)
.++|+|||++........ ........+++.|+|||++.+ ..++.++||||||+++|+|++|..||.........
T Consensus 206 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~ 285 (345)
T 3hko_A 206 SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTI 285 (345)
T ss_dssp SCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred CceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHH
Confidence 899999999875322111 112334568999999999865 67889999999999999999999999876654332
Q ss_pred HHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 021490 200 SLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 261 (311)
Q Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l~ 261 (311)
..... .... ...+. ....+..+.+|+.+||+.||.+|||+.++++...
T Consensus 286 ~~~~~------~~~~---~~~~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~ 333 (345)
T 3hko_A 286 SQVLN------KKLC---FENPN-----YNVLSPLARDLLSNLLNRNVDERFDAMRALQHPW 333 (345)
T ss_dssp HHHHH------CCCC---TTSGG-----GGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHH
T ss_pred HHHHh------cccc---cCCcc-----cccCCHHHHHHHHHHcCCChhHCCCHHHHhcChh
Confidence 22111 1000 00010 1123457889999999999999999999998643
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=287.39 Aligned_cols=232 Identities=25% Similarity=0.342 Sum_probs=190.6
Q ss_pred cCCcEEEEEEeecCCC-cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHH
Q 021490 7 CLLQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN 85 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~ 85 (311)
.+|+.||||+++.... ...+.+.+|+.++..++||||+++++++.++...++||||+++++|.+++.. ..+++.
T Consensus 45 ~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~ 119 (303)
T 3a7i_A 45 RTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-----GPLDET 119 (303)
T ss_dssp TTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHTT-----SCCCHH
T ss_pred CCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCcHHHHHhc-----CCCCHH
Confidence 4689999999976543 4457899999999999999999999999999999999999999999999874 569999
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccC
Q 021490 86 TRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG 165 (311)
Q Consensus 86 ~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 165 (311)
.++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++....... .......++..|+|||++.+.
T Consensus 120 ~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~ 194 (303)
T 3a7i_A 120 QIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--IKRNTFVGTPFWMAPEVIKQS 194 (303)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB--CCBCCCCSCGGGCCHHHHTTC
T ss_pred HHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc--cccCccCCCcCccCHHHHhcC
Confidence 99999999999999999999 9999999999999999999999999986533221 122334688999999999988
Q ss_pred CCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHcccc
Q 021490 166 QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHE 245 (311)
Q Consensus 166 ~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 245 (311)
.++.++||||||+++|+|++|..||...........+.. .. .+.+ +...+..+.+|+.+||+.
T Consensus 195 ~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-------~~------~~~~----~~~~~~~l~~li~~~l~~ 257 (303)
T 3a7i_A 195 AYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPK-------NN------PPTL----EGNYSKPLKEFVEACLNK 257 (303)
T ss_dssp CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH-------SC------CCCC----CSSCCHHHHHHHHHHCCS
T ss_pred CCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhc-------CC------CCCC----ccccCHHHHHHHHHHcCC
Confidence 999999999999999999999999986654332221110 00 1111 222334788999999999
Q ss_pred CCCCCCCHHHHHHHHHHhhh
Q 021490 246 QPDMRPVIADVVTALAYLAS 265 (311)
Q Consensus 246 ~p~~Rps~~~vl~~l~~~~~ 265 (311)
||.+|||+.++++.......
T Consensus 258 dp~~Rps~~~ll~~~~~~~~ 277 (303)
T 3a7i_A 258 EPSFRPTAKELLKHKFILRN 277 (303)
T ss_dssp SGGGSCCHHHHTTCHHHHHH
T ss_pred ChhhCcCHHHHhhChhhhcC
Confidence 99999999999987665443
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=291.88 Aligned_cols=228 Identities=23% Similarity=0.301 Sum_probs=188.0
Q ss_pred CCcEEEEEEeecCCC---cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCH
Q 021490 8 LLQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 84 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~ 84 (311)
+|+.||+|++..... ...+.+.+|+.+++.++||||+++++++.+....++||||+++++|.+++.. ...+++
T Consensus 65 ~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~l~~ 140 (335)
T 2owb_A 65 TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKR----RKALTE 140 (335)
T ss_dssp TCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHH----HCSCCH
T ss_pred CCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCCCCCHHHHHhc----cCCCCH
Confidence 578999999876532 3346788999999999999999999999999999999999999999999876 467999
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccccc
Q 021490 85 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT 164 (311)
Q Consensus 85 ~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 164 (311)
..++.++.|++.||+|||+++ ++|+||+|+||+++.++.++|+|||++....... .......++..|+|||++.+
T Consensus 141 ~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~ 215 (335)
T 2owb_A 141 PEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG--ERKKVLCGTPNYIAPEVLSK 215 (335)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCSTT--CCBCCCCSCCSSCCHHHHHT
T ss_pred HHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecccCc--ccccccCCCccccCHHHhcc
Confidence 999999999999999999999 9999999999999999999999999987543221 12233468899999999998
Q ss_pred CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccc
Q 021490 165 GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVH 244 (311)
Q Consensus 165 ~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 244 (311)
..++.++||||||+++|+|++|..||...........+... . . ..+...+..+.+|+.+||+
T Consensus 216 ~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~------~--------~----~~~~~~~~~~~~li~~~l~ 277 (335)
T 2owb_A 216 KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN------E--------Y----SIPKHINPVAASLIQKMLQ 277 (335)
T ss_dssp SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT------C--------C----CCCTTSCHHHHHHHHHHTC
T ss_pred CCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcC------C--------C----CCCccCCHHHHHHHHHHcc
Confidence 88999999999999999999999999876543332211110 0 0 1122233478889999999
Q ss_pred cCCCCCCCHHHHHHHHHH
Q 021490 245 EQPDMRPVIADVVTALAY 262 (311)
Q Consensus 245 ~~p~~Rps~~~vl~~l~~ 262 (311)
.||.+|||+.++++....
T Consensus 278 ~dp~~Rps~~ell~~~~~ 295 (335)
T 2owb_A 278 TDPTARPTINELLNDEFF 295 (335)
T ss_dssp SSGGGSCCGGGGGGSHHH
T ss_pred CChhHCcCHHHHhcCccc
Confidence 999999999999987543
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=293.09 Aligned_cols=235 Identities=21% Similarity=0.272 Sum_probs=180.1
Q ss_pred cchhcc-CCcEEEEEEeecCCC-cchhHHHHHHHHHhcCCCCcccceeeEeeeCC-------------------------
Q 021490 2 MQVILC-LLQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGD------------------------- 54 (311)
Q Consensus 2 ~~~~~~-~g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------------------------- 54 (311)
|.+... +|+.||||+++.... ...+.+.+|+.+++.++||||+++++++.+..
T Consensus 23 ~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 102 (332)
T 3qd2_B 23 FEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSP 102 (332)
T ss_dssp EEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC---------------
T ss_pred EEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhhccccccccccCC
Confidence 444444 799999999975443 34578999999999999999999999986543
Q ss_pred --------------------------------eeEEEEecCCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHhh
Q 021490 55 --------------------------------QRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH 102 (311)
Q Consensus 55 --------------------------------~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh 102 (311)
..++|||||+|++|.+++..... ....++..++.++.|++.||+|||
T Consensus 103 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH 181 (332)
T 3qd2_B 103 SPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS-LEDREHGVCLHIFIQIAEAVEFLH 181 (332)
T ss_dssp -----------------------------CCCEEEEEEECCCSSCHHHHHHTCCS-GGGSCHHHHHHHHHHHHHHHHHHH
T ss_pred CcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC-ccchhhHHHHHHHHHHHHHHHHHH
Confidence 37999999999999999987432 244667789999999999999999
Q ss_pred cCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCc----------eeeeeccccccccCccccccCCCccccc
Q 021490 103 DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT----------HVSTRVMGTYGYCAPEYAKTGQLTLKSD 172 (311)
Q Consensus 103 ~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~----------~~~~~~~~~~~y~aPE~~~~~~~~~~~D 172 (311)
+++ ++||||||+||+++.++.++|+|||++......... .......++..|+|||++.+..++.++|
T Consensus 182 ~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 258 (332)
T 3qd2_B 182 SKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVD 258 (332)
T ss_dssp HTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCHHHHHCCCCCTHHH
T ss_pred hCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccChHHhcCCCCcchhh
Confidence 999 999999999999999999999999998764332211 1122346899999999999999999999
Q ss_pred eeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCC
Q 021490 173 VYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPV 252 (311)
Q Consensus 173 iwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps 252 (311)
|||||+++|+|++|..|+...... ..... .. . .+ ......+..+.+++.+||+.||.+|||
T Consensus 259 i~slG~il~el~~~~~~~~~~~~~-----~~~~~----~~-~-----~~----~~~~~~~~~~~~li~~~l~~~p~~Rps 319 (332)
T 3qd2_B 259 IFSLGLILFELLYSFSTQMERVRI-----ITDVR----NL-K-----FP----LLFTQKYPQEHMMVQDMLSPSPTERPE 319 (332)
T ss_dssp HHHHHHHHHHHHSCCCCHHHHHHH-----HHHHH----TT-C-----CC----HHHHHHCHHHHHHHHHHHCSSGGGSCC
T ss_pred HHHHHHHHHHHHHcCCChhHHHHH-----HHHhh----cc-C-----CC----cccccCChhHHHHHHHHccCCCCcCCC
Confidence 999999999999987775332111 00000 00 0 00 001223346788999999999999999
Q ss_pred HHHHHHH
Q 021490 253 IADVVTA 259 (311)
Q Consensus 253 ~~~vl~~ 259 (311)
+.++++.
T Consensus 320 ~~~~l~~ 326 (332)
T 3qd2_B 320 ATDIIEN 326 (332)
T ss_dssp HHHHHHS
T ss_pred HHHHhhc
Confidence 9999875
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=305.84 Aligned_cols=230 Identities=25% Similarity=0.301 Sum_probs=185.6
Q ss_pred CCcEEEEEEeecCC--CcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHH
Q 021490 8 LLQDVAIKQLDRNG--VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN 85 (311)
Q Consensus 8 ~g~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~ 85 (311)
+|+.||||+++... ......+.+|+.+++.++||||+++++++.+....++|||||.|++|.+++.. ...+++.
T Consensus 46 ~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~ 121 (486)
T 3mwu_A 46 TQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIK----RKRFSEH 121 (486)
T ss_dssp TCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH----HSSCCHH
T ss_pred CCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcCCCCcHHHHHHh----cCCCCHH
Confidence 68999999986542 34567899999999999999999999999999999999999999999999876 4679999
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEc---CCCceEEccccccccCCCCCCceeeeeccccccccCcccc
Q 021490 86 TRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD---RGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 162 (311)
Q Consensus 86 ~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~---~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 162 (311)
.+..++.|++.||+|||+++ |+||||||+||+++ .++.+||+|||++...... .......+++.|+|||++
T Consensus 122 ~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~ 195 (486)
T 3mwu_A 122 DAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN---TKMKDRIGTAYYIAPEVL 195 (486)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-------CCTTGGGGCCGGGG
T ss_pred HHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC---CccCCCcCCCCCCCHHHh
Confidence 99999999999999999999 99999999999995 4567999999998753222 222345689999999998
Q ss_pred ccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHc
Q 021490 163 KTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMC 242 (311)
Q Consensus 163 ~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 242 (311)
.+ .++.++|||||||++|+|++|..||...........+......+ ..+ .....+..+.+|+.+|
T Consensus 196 ~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~---------~~~-----~~~~~s~~~~~li~~~ 260 (486)
T 3mwu_A 196 RG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAF---------DLP-----QWRTISDDAKDLIRKM 260 (486)
T ss_dssp GS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCS---------CSG-----GGGGSCHHHHHHHHHH
T ss_pred CC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC---------CCc-----ccCCCCHHHHHHHHHH
Confidence 75 58999999999999999999999998766544332221110000 000 0122345788999999
Q ss_pred cccCCCCCCCHHHHHHHHHH
Q 021490 243 VHEQPDMRPVIADVVTALAY 262 (311)
Q Consensus 243 l~~~p~~Rps~~~vl~~l~~ 262 (311)
|+.||.+|||+.++++..+.
T Consensus 261 L~~dp~~R~t~~~~l~hp~~ 280 (486)
T 3mwu_A 261 LTFHPSLRITATQCLEHPWI 280 (486)
T ss_dssp TCSSTTTSCCHHHHHHCHHH
T ss_pred cCCChhhCcCHHHHhcCHhh
Confidence 99999999999999987543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=285.60 Aligned_cols=228 Identities=23% Similarity=0.312 Sum_probs=188.0
Q ss_pred CCcEEEEEEeecCCC---cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCH
Q 021490 8 LLQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 84 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~ 84 (311)
+|+.||+|++..... ...+.+.+|+.+++.++||||+++++++.++...++||||+++++|.+++.. ...+++
T Consensus 39 ~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~ 114 (294)
T 2rku_A 39 TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKR----RKALTE 114 (294)
T ss_dssp TCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH----HCSCCH
T ss_pred CCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCCCCCHHHHHHh----cCCCCH
Confidence 578999999876532 2346788999999999999999999999999999999999999999999876 567999
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccccc
Q 021490 85 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT 164 (311)
Q Consensus 85 ~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 164 (311)
..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++....... .......++..|+|||++.+
T Consensus 115 ~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~ 189 (294)
T 2rku_A 115 PEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG--ERKKVLCGTPNYIAPEVLSK 189 (294)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCSTT--CCBCCCCSCCSSCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecccCc--cccccccCCCCcCCcchhcc
Confidence 999999999999999999999 9999999999999999999999999987533221 12233458899999999988
Q ss_pred CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccc
Q 021490 165 GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVH 244 (311)
Q Consensus 165 ~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 244 (311)
..++.++||||||+++|+|++|..||............. ... . ..+...+..+.+++.+||+
T Consensus 190 ~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~------~~~--------~----~~~~~~~~~~~~li~~~l~ 251 (294)
T 2rku_A 190 KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK------KNE--------Y----SIPKHINPVAASLIQKMLQ 251 (294)
T ss_dssp SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH------TTC--------C----CCCTTSCHHHHHHHHHHTC
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh------hcc--------C----CCccccCHHHHHHHHHHcc
Confidence 889999999999999999999999998765433221111 000 0 1122334478889999999
Q ss_pred cCCCCCCCHHHHHHHHHH
Q 021490 245 EQPDMRPVIADVVTALAY 262 (311)
Q Consensus 245 ~~p~~Rps~~~vl~~l~~ 262 (311)
.||++|||+.++++....
T Consensus 252 ~~p~~Rps~~~ll~~~~~ 269 (294)
T 2rku_A 252 TDPTARPTINELLNDEFF 269 (294)
T ss_dssp SSGGGSCCGGGGGGSHHH
T ss_pred cChhhCcCHHHHhhChhe
Confidence 999999999999987554
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=293.52 Aligned_cols=246 Identities=24% Similarity=0.231 Sum_probs=183.3
Q ss_pred CCcEEEEEEeecCCCc-----chhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCC
Q 021490 8 LLQDVAIKQLDRNGVQ-----GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPL 82 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l 82 (311)
+|+.||||+++..... ..+.+.+|+.++..++||||+++++++.+....++||||+++ +|.+++.. ....+
T Consensus 34 ~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~ 109 (346)
T 1ua2_A 34 TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKD---NSLVL 109 (346)
T ss_dssp CCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSE-EHHHHHTT---CCSSC
T ss_pred CCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEEEcCCC-CHHHHHHh---cCcCC
Confidence 5899999998654321 135788999999999999999999999999999999999975 88888875 24578
Q ss_pred CHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccc
Q 021490 83 DWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 162 (311)
Q Consensus 83 ~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 162 (311)
++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++...... ........++..|+|||++
T Consensus 110 ~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~~~t~~y~aPE~~ 184 (346)
T 1ua2_A 110 TPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP--NRAYTHQVVTRWYRAPELL 184 (346)
T ss_dssp CSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC--CCCCCCSCCCCTTCCHHHH
T ss_pred CHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccceeccCC--cccCCcccccccccCchHh
Confidence 99999999999999999999999 999999999999999999999999998754222 1222335689999999998
Q ss_pred cc-CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhh-hcccc-ccccccCccccC---CCC-----hHh
Q 021490 163 KT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPL-FQDRT-RHSLIADPELQG---QYP-----PRG 231 (311)
Q Consensus 163 ~~-~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~~~~~~---~~~-----~~~ 231 (311)
.+ ..++.++|||||||++|+|++|.+||...........+...... ..... ......+..... ..+ ...
T Consensus 185 ~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (346)
T 1ua2_A 185 FGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAA 264 (346)
T ss_dssp TTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTC
T ss_pred hCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccC
Confidence 65 45789999999999999999999999876654433222111100 00000 000000000000 011 233
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 021490 232 FYQALAVAAMCVHEQPDMRPVIADVVTALAY 262 (311)
Q Consensus 232 ~~~l~~li~~~l~~~p~~Rps~~~vl~~l~~ 262 (311)
+..+.+|+.+||+.||.+|||+.|+++....
T Consensus 265 ~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f 295 (346)
T 1ua2_A 265 GDDLLDLIQGLFLFNPCARITATQALKMKYF 295 (346)
T ss_dssp CHHHHHHHHHHHCSSTTTSCCHHHHHTSGGG
T ss_pred CHHHHHHHHHHhccChhhCCCHHHHhcChhh
Confidence 4688999999999999999999999987543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=295.45 Aligned_cols=246 Identities=22% Similarity=0.279 Sum_probs=180.5
Q ss_pred CCcEEEEEEeecCCCcc-hhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHH
Q 021490 8 LLQDVAIKQLDRNGVQG-NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNT 86 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~ 86 (311)
+|+.||+|+++...... ...+.+|+.+++.++||||+++++++.+....++||||++ ++|.+++... +..+++..
T Consensus 26 ~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~---~~~~~~~~ 101 (324)
T 3mtl_A 26 TDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDC---GNIINMHN 101 (324)
T ss_dssp TCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS-EEHHHHHHHT---TTCCCHHH
T ss_pred CCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc-cCHHHHHHhc---CCCCCHHH
Confidence 78999999996554322 2356679999999999999999999999999999999997 5898888762 45699999
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccccc-C
Q 021490 87 RMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT-G 165 (311)
Q Consensus 87 ~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~ 165 (311)
+..++.|++.||+|||+.| ++||||||+||+++.++.++|+|||++...... ........++..|+|||++.+ .
T Consensus 102 ~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~ 176 (324)
T 3mtl_A 102 VKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIP--TKTYDNEVVTLWYRPPDILLGST 176 (324)
T ss_dssp HHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC--------------CGGGCCHHHHTTCC
T ss_pred HHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCC--ccccccccCcccccChhhhcCCC
Confidence 9999999999999999999 999999999999999999999999998643221 222233467899999999876 5
Q ss_pred CCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccC--------cccc----CCCChHhHH
Q 021490 166 QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD--------PELQ----GQYPPRGFY 233 (311)
Q Consensus 166 ~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~----~~~~~~~~~ 233 (311)
.++.++|||||||++|+|++|..||...........+.................. +... ....+..+.
T Consensus 177 ~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (324)
T 3mtl_A 177 DYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDS 256 (324)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCH
T ss_pred CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCH
Confidence 6899999999999999999999999877655443332221110000000000000 0000 001122345
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 021490 234 QALAVAAMCVHEQPDMRPVIADVVTALAY 262 (311)
Q Consensus 234 ~l~~li~~~l~~~p~~Rps~~~vl~~l~~ 262 (311)
.+.+|+.+||+.||.+|||++|+++.-.+
T Consensus 257 ~~~~li~~~L~~dP~~R~t~~e~l~hp~f 285 (324)
T 3mtl_A 257 DGADLLTKLLQFEGRNRISAEDAMKHPFF 285 (324)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHTTSGGG
T ss_pred HHHHHHHHHcCcCcccCCCHHHHhcChhh
Confidence 78899999999999999999999987544
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=287.17 Aligned_cols=234 Identities=23% Similarity=0.332 Sum_probs=185.3
Q ss_pred CcEEEEEEeecCCC-cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHHH
Q 021490 9 LQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTR 87 (311)
Q Consensus 9 g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~ 87 (311)
+..||+|+++.... ...+.+.+|+.+++.++||||+++++++.+ ...++||||+++++|.+++... ...+++..+
T Consensus 40 ~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~ 115 (281)
T 3cc6_A 40 KINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIMELYPYGELGHYLERN---KNSLKVLTL 115 (281)
T ss_dssp EEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHHH---TTTCCHHHH
T ss_pred cceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEEEecCCCCCHHHHHHhc---cccCCHHHH
Confidence 34699999876532 345789999999999999999999999865 4568999999999999999762 356999999
Q ss_pred HHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccCCC
Q 021490 88 MKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQL 167 (311)
Q Consensus 88 ~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 167 (311)
+.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++........ .......++..|+|||++.+..+
T Consensus 116 ~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~ 191 (281)
T 3cc6_A 116 VLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY-YKASVTRLPIKWMSPESINFRRF 191 (281)
T ss_dssp HHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC----------CCCCCGGGCCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCcccccccc-cccccCCCCcceeCchhhccCCC
Confidence 999999999999999999 99999999999999999999999999875332211 11223346778999999998899
Q ss_pred ccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccC
Q 021490 168 TLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQ 246 (311)
Q Consensus 168 ~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 246 (311)
+.++||||||+++|+|++ |..||................ . ...+...+..+.+++.+||+.|
T Consensus 192 ~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~-------~----------~~~~~~~~~~l~~li~~~l~~~ 254 (281)
T 3cc6_A 192 TTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGD-------R----------LPKPDLCPPVLYTLMTRCWDYD 254 (281)
T ss_dssp CHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTC-------C----------CCCCTTCCHHHHHHHHHHTCSS
T ss_pred CchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCC-------C----------CCCCCCCCHHHHHHHHHHccCC
Confidence 999999999999999998 999997554433322221110 0 0112223457889999999999
Q ss_pred CCCCCCHHHHHHHHHHhhhcc
Q 021490 247 PDMRPVIADVVTALAYLASQK 267 (311)
Q Consensus 247 p~~Rps~~~vl~~l~~~~~~~ 267 (311)
|.+|||+.++++.|+.+.+..
T Consensus 255 p~~Rps~~ell~~L~~~~~~~ 275 (281)
T 3cc6_A 255 PSDRPRFTELVCSLSDVYQME 275 (281)
T ss_dssp GGGSCCHHHHHHHHHHHHHHH
T ss_pred chhCcCHHHHHHHHHHHHHhh
Confidence 999999999999999887544
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=287.04 Aligned_cols=235 Identities=26% Similarity=0.395 Sum_probs=184.0
Q ss_pred cEEEEEEeecCCC-cchhHHHHHHHHHhcCCCCcccceeeEe-eeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHHH
Q 021490 10 QDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYC-ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTR 87 (311)
Q Consensus 10 ~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~ 87 (311)
..||+|.++.... ...+.+.+|+.++++++||||+++++++ ..+...++||||+++++|.+++.. ....+++..+
T Consensus 54 ~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~ 130 (298)
T 3f66_A 54 IHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDL 130 (298)
T ss_dssp EEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEECCTTCBHHHHHHC---TTCCCCHHHH
T ss_pred eEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeCCCCCCHHHHHHh---cccCCCHHHH
Confidence 4689999865433 3346899999999999999999999985 455678999999999999999975 2466899999
Q ss_pred HHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCC--ceeeeeccccccccCccccccC
Q 021490 88 MKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN--THVSTRVMGTYGYCAPEYAKTG 165 (311)
Q Consensus 88 ~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~ 165 (311)
+.++.|++.||+|||+++ ++||||||+||+++.++.++|+|||++........ ........++..|+|||++.+.
T Consensus 131 ~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 207 (298)
T 3f66_A 131 IGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 207 (298)
T ss_dssp HHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHC
T ss_pred HHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCC
Confidence 999999999999999999 99999999999999999999999999875432211 1122334567889999999999
Q ss_pred CCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccc
Q 021490 166 QLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVH 244 (311)
Q Consensus 166 ~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 244 (311)
.++.++||||||+++|+|++ |.+||............... . . ...+...+..+.+++.+||+
T Consensus 208 ~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~------~-------~----~~~~~~~~~~l~~li~~~l~ 270 (298)
T 3f66_A 208 KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG------R-------R----LLQPEYCPDPLYEVMLKCWH 270 (298)
T ss_dssp CCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTT------C-------C----CCCCTTCCHHHHHHHHHHTC
T ss_pred CCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcC------C-------C----CCCCccCCHHHHHHHHHHcC
Confidence 99999999999999999999 56666654433222111100 0 0 01112233478899999999
Q ss_pred cCCCCCCCHHHHHHHHHHhhhcc
Q 021490 245 EQPDMRPVIADVVTALAYLASQK 267 (311)
Q Consensus 245 ~~p~~Rps~~~vl~~l~~~~~~~ 267 (311)
.||.+|||+.++++.|+.+...-
T Consensus 271 ~~p~~Rps~~ell~~L~~~~~~~ 293 (298)
T 3f66_A 271 PKAEMRPSFSELVSRISAIFSTF 293 (298)
T ss_dssp SSGGGSCCHHHHHHHHHHHHHTS
T ss_pred CChhhCcCHHHHHHHHHHHHHhh
Confidence 99999999999999999887643
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=308.36 Aligned_cols=230 Identities=25% Similarity=0.296 Sum_probs=188.1
Q ss_pred CCcEEEEEEeecCC---CcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCH
Q 021490 8 LLQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 84 (311)
Q Consensus 8 ~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~ 84 (311)
+|+.||||++.... ....+.+.+|+.+++.++||||+++++++.+....++||||+.|++|.+++.. ...+++
T Consensus 50 ~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~ 125 (484)
T 3nyv_A 50 TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIIS----RKRFSE 125 (484)
T ss_dssp TCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHT----CSCCBH
T ss_pred CCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCCHHHHHHh----cCCCCH
Confidence 78999999997653 23457899999999999999999999999999999999999999999999976 567999
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEE---cCCCceEEccccccccCCCCCCceeeeeccccccccCccc
Q 021490 85 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL---DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 161 (311)
Q Consensus 85 ~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 161 (311)
..+..++.|++.||+|||+++ ++||||||+||++ +.++.++|+|||++....... ......+++.|+|||+
T Consensus 126 ~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~ 199 (484)
T 3nyv_A 126 VDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK---KMKDKIGTAYYIAPEV 199 (484)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCC---SHHHHTTGGGTCCHHH
T ss_pred HHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccccc---ccccCCCCccccCcee
Confidence 999999999999999999999 9999999999999 567899999999987543222 2233468999999999
Q ss_pred cccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHH
Q 021490 162 AKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAM 241 (311)
Q Consensus 162 ~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 241 (311)
+.+ .++.++|||||||++|+|++|..||...........+..... . ...+ .....+..+.+|+.+
T Consensus 200 ~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~------~---~~~~-----~~~~~s~~~~~li~~ 264 (484)
T 3nyv_A 200 LHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKY------T---FELP-----QWKKVSESAKDLIRK 264 (484)
T ss_dssp HHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC------C---CCSG-----GGGGSCHHHHHHHHH
T ss_pred ecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCC------C---CCCc-----ccccCCHHHHHHHHH
Confidence 875 689999999999999999999999987665443322211100 0 0000 112234578899999
Q ss_pred ccccCCCCCCCHHHHHHHHHH
Q 021490 242 CVHEQPDMRPVIADVVTALAY 262 (311)
Q Consensus 242 ~l~~~p~~Rps~~~vl~~l~~ 262 (311)
||+.||.+|||+.++++..+.
T Consensus 265 ~L~~dp~~R~s~~e~l~h~~~ 285 (484)
T 3nyv_A 265 MLTYVPSMRISARDALDHEWI 285 (484)
T ss_dssp HTCSSGGGSCCHHHHHTSHHH
T ss_pred HCCCChhHCcCHHHHhhChhh
Confidence 999999999999999987543
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=297.86 Aligned_cols=237 Identities=26% Similarity=0.389 Sum_probs=179.1
Q ss_pred cEEEEEEeecCC-CcchhHHHHHHHHHhcCCCCcccceeeEee-eCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHHH
Q 021490 10 QDVAIKQLDRNG-VQGNREFLVEVLMLSLLHHPNLVNLIGYCA-DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTR 87 (311)
Q Consensus 10 ~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~ 87 (311)
..||+|.++... ....+.|.+|+.+++.++||||+++++++. .+...++||||+++++|.+++... ...+++..+
T Consensus 118 ~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~ 194 (373)
T 3c1x_A 118 IHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE---THNPTVKDL 194 (373)
T ss_dssp EEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEECCTTCBHHHHHHCT---TCCCBHHHH
T ss_pred EEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEECCCCCCHHHHHhhc---ccCCCHHHH
Confidence 468999986543 234578999999999999999999999865 455789999999999999999762 456899999
Q ss_pred HHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCc--eeeeeccccccccCccccccC
Q 021490 88 MKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT--HVSTRVMGTYGYCAPEYAKTG 165 (311)
Q Consensus 88 ~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~ 165 (311)
+.++.|++.||+|||+++ ++||||||+||+++.++.+||+|||++......... .......++..|+|||++.+.
T Consensus 195 ~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 271 (373)
T 3c1x_A 195 IGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 271 (373)
T ss_dssp HHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---------------------CCGGGSCHHHHHHC
T ss_pred HHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcCC
Confidence 999999999999999999 999999999999999999999999998753222111 112234567889999999999
Q ss_pred CCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccc
Q 021490 166 QLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVH 244 (311)
Q Consensus 166 ~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 244 (311)
.++.++||||||+++|+|++ |.+||............... .. ...+...+..+.+++.+||+
T Consensus 272 ~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~--------~~---------~~~p~~~~~~l~~li~~cl~ 334 (373)
T 3c1x_A 272 KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG--------RR---------LLQPEYCPDPLYEVMLKCWH 334 (373)
T ss_dssp CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTT--------CC---------CCCCTTCCHHHHHHHHHHTC
T ss_pred CCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcC--------CC---------CCCCCCCCHHHHHHHHHHcC
Confidence 99999999999999999999 67788665433222111100 00 01122234578899999999
Q ss_pred cCCCCCCCHHHHHHHHHHhhhccCC
Q 021490 245 EQPDMRPVIADVVTALAYLASQKYE 269 (311)
Q Consensus 245 ~~p~~Rps~~~vl~~l~~~~~~~~~ 269 (311)
.||.+|||+.++++.|+.+......
T Consensus 335 ~dp~~RPs~~ell~~L~~i~~~~~~ 359 (373)
T 3c1x_A 335 PKAEMRPSFSELVSRISAIFSTFIG 359 (373)
T ss_dssp SSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred CChhhCcCHHHHHHHHHHHHHhccc
Confidence 9999999999999999988765443
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=285.82 Aligned_cols=235 Identities=27% Similarity=0.353 Sum_probs=185.7
Q ss_pred cEEEEEEeecCCC-cchhHHHHHHHHHhcCCCCcccceeeEeeeCCee-EEEEecCCCCChhhhhcccCCCCCCCCHHHH
Q 021490 10 QDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR-LLVYEYMPLGSVEDHLHDLSPGKKPLDWNTR 87 (311)
Q Consensus 10 ~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~-~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~ 87 (311)
..||+|+++.... ...+.+.+|+.+++.++||||+++++++.+.... ++||||+.+++|.+++.. ....+++..+
T Consensus 50 ~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~ 126 (298)
T 3pls_A 50 IQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRS---PQRNPTVKDL 126 (298)
T ss_dssp EEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCCTTCBHHHHHHC---TTCCCBHHHH
T ss_pred eeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecccCCCHHHHHhc---cccCCCHHHH
Confidence 4799999865443 3346889999999999999999999999766655 999999999999999976 2467899999
Q ss_pred HHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCC--CceeeeeccccccccCccccccC
Q 021490 88 MKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD--NTHVSTRVMGTYGYCAPEYAKTG 165 (311)
Q Consensus 88 ~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~ 165 (311)
+.++.|++.||+|||+++ ++||||||+||+++.++.++|+|||++....... .........++..|+|||.+.+.
T Consensus 127 ~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 203 (298)
T 3pls_A 127 ISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTY 203 (298)
T ss_dssp HHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTC
T ss_pred HHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccC
Confidence 999999999999999999 9999999999999999999999999987532211 11122234578899999999999
Q ss_pred CCccccceeehhHHHHHHHhCC-CccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccc
Q 021490 166 QLTLKSDVYSFGVVLLEILSGR-KAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVH 244 (311)
Q Consensus 166 ~~~~~~DiwslG~l~~~ll~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 244 (311)
.++.++||||||+++|+|++|. +||................ ....+...+..+.+++.+||+
T Consensus 204 ~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~l~~li~~~l~ 266 (298)
T 3pls_A 204 RFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGR-----------------RLPQPEYCPDSLYQVMQQCWE 266 (298)
T ss_dssp CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTC-----------------CCCCCTTCCHHHHHHHHHHTC
T ss_pred CCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCC-----------------CCCCCccchHHHHHHHHHHcc
Confidence 9999999999999999999955 4455443332222111110 001122234578899999999
Q ss_pred cCCCCCCCHHHHHHHHHHhhhcc
Q 021490 245 EQPDMRPVIADVVTALAYLASQK 267 (311)
Q Consensus 245 ~~p~~Rps~~~vl~~l~~~~~~~ 267 (311)
.||.+|||+.++++.|+.+....
T Consensus 267 ~~p~~Rps~~~ll~~l~~~~~~l 289 (298)
T 3pls_A 267 ADPAVRPTFRVLVGEVEQIVSAL 289 (298)
T ss_dssp SSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CChhhCcCHHHHHHHHHHHHHHH
Confidence 99999999999999999887654
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=308.28 Aligned_cols=232 Identities=24% Similarity=0.334 Sum_probs=186.4
Q ss_pred CCcEEEEEEeecCCC---cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCH
Q 021490 8 LLQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 84 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~ 84 (311)
+|+.||||+++.... .....+.+|+.++..++||||+++++++.+....|+||||++||+|.+++.........+++
T Consensus 209 tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e 288 (543)
T 3c4z_A 209 TGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQE 288 (543)
T ss_dssp TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCH
T ss_pred CCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccCCCHHHHHHHhhcccccccH
Confidence 699999999976432 33467889999999999999999999999999999999999999999999765434567999
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccccc
Q 021490 85 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT 164 (311)
Q Consensus 85 ~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 164 (311)
..++.++.||+.||+|||+++ |+||||||+|||++.+|.+||+|||++....... .......||+.|+|||++.+
T Consensus 289 ~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~--~~~~~~~GT~~Y~APE~l~~ 363 (543)
T 3c4z_A 289 PRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ--TKTKGYAGTPGFMAPELLLG 363 (543)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCTTC--CCBCCCCSCTTTSCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeeccCCC--cccccccCCccccChhhhcC
Confidence 999999999999999999999 9999999999999999999999999997543221 11223468999999999999
Q ss_pred CCCccccceeehhHHHHHHHhCCCccCcchhHHH-HHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHcc
Q 021490 165 GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE-QSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCV 243 (311)
Q Consensus 165 ~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 243 (311)
..++.++|||||||++|+|++|..||........ ..+.. ...... ..++...+..+.+||.+||
T Consensus 364 ~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~---~i~~~~------------~~~p~~~s~~~~~li~~lL 428 (543)
T 3c4z_A 364 EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ---RVLEQA------------VTYPDKFSPASKDFCEALL 428 (543)
T ss_dssp CCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHH---HHHHCC------------CCCCTTSCHHHHHHHHHHS
T ss_pred CCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHH---HHhhcc------------cCCCcccCHHHHHHHHHhc
Confidence 9999999999999999999999999976432111 11111 011110 1123334558889999999
Q ss_pred ccCCCCCCCH-----HHHHHH
Q 021490 244 HEQPDMRPVI-----ADVVTA 259 (311)
Q Consensus 244 ~~~p~~Rps~-----~~vl~~ 259 (311)
+.||.+||++ .+++..
T Consensus 429 ~~dP~~R~~~~~~~a~ei~~H 449 (543)
T 3c4z_A 429 QKDPEKRLGFRDGSCDGLRTH 449 (543)
T ss_dssp CSSGGGSCCCBTTBSHHHHTS
T ss_pred cCCHhHCCCCcccCHHHHHcC
Confidence 9999999975 566644
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-41 Score=300.54 Aligned_cols=233 Identities=19% Similarity=0.223 Sum_probs=175.1
Q ss_pred CCcEEEEEEeecCCCcchhHHHHHHHHHh-cCCCCcccceeeEeee----CCeeEEEEecCCCCChhhhhcccCCCCCCC
Q 021490 8 LLQDVAIKQLDRNGVQGNREFLVEVLMLS-LLHHPNLVNLIGYCAD----GDQRLLVYEYMPLGSVEDHLHDLSPGKKPL 82 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l 82 (311)
+|+.||||+++ ....+.+|+.++. ..+||||+++++++.. ....|+||||++||+|.+++.... ...+
T Consensus 86 ~~~~vAiK~~~-----~~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~l 158 (400)
T 1nxk_A 86 TQEKFALKMLQ-----DCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRG--DQAF 158 (400)
T ss_dssp TCCEEEEEEEE-----CSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHCC-----CC
T ss_pred CCCEEEEEEeC-----cchhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHHhC--CCCC
Confidence 68999999995 2356778888874 4589999999999875 567899999999999999998621 3469
Q ss_pred CHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcC---CCceEEccccccccCCCCCCceeeeeccccccccCc
Q 021490 83 DWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR---GYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 159 (311)
Q Consensus 83 ~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~---~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aP 159 (311)
++..+..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||++...... .......++..|+||
T Consensus 159 ~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~---~~~~~~~gt~~y~aP 232 (400)
T 1nxk_A 159 TEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH---NSLTTPCYTPYYVAP 232 (400)
T ss_dssp BHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTCEECC--------------CTTCCG
T ss_pred CHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccccccCCC---CccccCCCCCCccCH
Confidence 99999999999999999999999 999999999999997 789999999998753221 122345679999999
Q ss_pred cccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHH-HHHHHhhhhhccccccccccCccccCCCChHhHHHHHHH
Q 021490 160 EYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ-SLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAV 238 (311)
Q Consensus 160 E~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 238 (311)
|++.+..++.++|||||||++|+|++|..||......... ....... ... .. +........+..+.+|
T Consensus 233 E~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~---~~~---~~-----~~~~~~~~~s~~~~~l 301 (400)
T 1nxk_A 233 EVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR---MGQ---YE-----FPNPEWSEVSEEVKML 301 (400)
T ss_dssp GGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH---HTC---CC-----CCTTTTTTSCHHHHHH
T ss_pred hhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH---cCc---cc-----CCCcccccCCHHHHHH
Confidence 9999999999999999999999999999999764432110 0000000 000 00 0001112334578999
Q ss_pred HHHccccCCCCCCCHHHHHHHHHHhh
Q 021490 239 AAMCVHEQPDMRPVIADVVTALAYLA 264 (311)
Q Consensus 239 i~~~l~~~p~~Rps~~~vl~~l~~~~ 264 (311)
|.+||+.||.+|||+.++++......
T Consensus 302 i~~~L~~dP~~Rpt~~eil~hp~~~~ 327 (400)
T 1nxk_A 302 IRNLLKTEPTQRMTITEFMNHPWIMQ 327 (400)
T ss_dssp HHTTSCSSGGGSCCHHHHHHSHHHHT
T ss_pred HHHHCCCChhHCcCHHHHhcCccccC
Confidence 99999999999999999998866543
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=299.26 Aligned_cols=253 Identities=17% Similarity=0.171 Sum_probs=191.5
Q ss_pred CCcEEEEEEeecCCC-cchhHHHHHHHHHhcCCCCcccceeeEeeeCC--eeEEEEecCCCCChhhhhcccCCCCCCCCH
Q 021490 8 LLQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGD--QRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 84 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~ 84 (311)
+|+.||||+++.... ...+.+.+|+++++.++||||+++++++.+.. ..++||||++|++|.+++..... ...+++
T Consensus 33 ~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-~~~l~~ 111 (396)
T 4eut_A 33 TGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSN-AYGLPE 111 (396)
T ss_dssp TCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCTTEEHHHHTTSGGG-TTCCCH
T ss_pred CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCCCCCHHHHHHhhhc-ccCCCH
Confidence 589999999976442 34577889999999999999999999997655 77999999999999999986321 234999
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEE----cCCCceEEccccccccCCCCCCceeeeeccccccccCcc
Q 021490 85 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL----DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 160 (311)
Q Consensus 85 ~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~----~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE 160 (311)
..++.++.|++.||+|||+.+ ++||||||+||++ +.++.+||+|||++...... .......++..|+|||
T Consensus 112 ~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~---~~~~~~~gt~~y~aPE 185 (396)
T 4eut_A 112 SEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD---EQFVSLYGTEEYLHPD 185 (396)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCG---GGSSCSSSCCTTCCHH
T ss_pred HHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCceEccCC---CccccccCCccccCHH
Confidence 999999999999999999999 9999999999999 77888999999999753222 1222346899999999
Q ss_pred cccc--------CCCccccceeehhHHHHHHHhCCCccCcchhHHH-HHHHHHh-hhhhccc-------ccc--ccccCc
Q 021490 161 YAKT--------GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE-QSLVAWA-RPLFQDR-------TRH--SLIADP 221 (311)
Q Consensus 161 ~~~~--------~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~-~~~~~~~-~~~~~~~-------~~~--~~~~~~ 221 (311)
++.+ ..++.++|||||||++|+|++|..||........ ....... ....... ... .-..+.
T Consensus 186 ~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 265 (396)
T 4eut_A 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDM 265 (396)
T ss_dssp HHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSC
T ss_pred HhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcccchhheeccCCCcccCccC
Confidence 8865 5678899999999999999999999965332111 1111111 0000000 000 000011
Q ss_pred cccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhcc
Q 021490 222 ELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQK 267 (311)
Q Consensus 222 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~~ 267 (311)
.....++......+.+++.+||+.||++|||+.++++.++.+....
T Consensus 266 ~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~~ 311 (396)
T 4eut_A 266 PVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRM 311 (396)
T ss_dssp CTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTCE
T ss_pred CcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhce
Confidence 1122345667788889999999999999999999999998877653
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=283.83 Aligned_cols=226 Identities=23% Similarity=0.301 Sum_probs=178.7
Q ss_pred CCcEEEEEEeecCC---CcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCH
Q 021490 8 LLQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 84 (311)
Q Consensus 8 ~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~ 84 (311)
+|+.||||+++... ....+.+.+|+.+++.++||||+++++++.+....++||||+++++|.+++.. ...+++
T Consensus 35 ~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~ 110 (276)
T 2h6d_A 35 TGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICK----HGRVEE 110 (276)
T ss_dssp TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH----HCSCCH
T ss_pred CCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEeccCCCcHHHHHhc----cCCCCH
Confidence 78999999996543 23456888999999999999999999999999999999999999999999986 467999
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccccc
Q 021490 85 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT 164 (311)
Q Consensus 85 ~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 164 (311)
..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++...... .......++..|+|||++.+
T Consensus 111 ~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~ 184 (276)
T 2h6d_A 111 MEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG---EFLRTSCGSPNYAAPEVISG 184 (276)
T ss_dssp HHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC----------------CCTGGGTT
T ss_pred HHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCCC---cceecccCCccccCHHHHcC
Confidence 999999999999999999999 999999999999999999999999998753222 12223457889999999987
Q ss_pred CCC-ccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHcc
Q 021490 165 GQL-TLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCV 243 (311)
Q Consensus 165 ~~~-~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 243 (311)
..+ +.++||||||+++|+|++|..||...........+... . . ..+...+..+.+++.+||
T Consensus 185 ~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~------~--------~----~~~~~~~~~l~~li~~~l 246 (276)
T 2h6d_A 185 RLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGG------V--------F----YIPEYLNRSVATLLMHML 246 (276)
T ss_dssp SCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------C--------C----CCCTTSCHHHHHHHHHHT
T ss_pred CCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC------c--------c----cCchhcCHHHHHHHHHHc
Confidence 665 68999999999999999999999875543322211110 0 0 112223447889999999
Q ss_pred ccCCCCCCCHHHHHHHHH
Q 021490 244 HEQPDMRPVIADVVTALA 261 (311)
Q Consensus 244 ~~~p~~Rps~~~vl~~l~ 261 (311)
+.||.+|||+.++++.-.
T Consensus 247 ~~~p~~Rps~~~~l~h~~ 264 (276)
T 2h6d_A 247 QVDPLKRATIKDIREHEW 264 (276)
T ss_dssp CSSGGGSCCHHHHHHSHH
T ss_pred cCChhhCCCHHHHHhChh
Confidence 999999999999998644
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=295.45 Aligned_cols=234 Identities=22% Similarity=0.324 Sum_probs=185.7
Q ss_pred cchhcc-CCcEEEEEEeecCCCc--------chhHHHHHHHHHhcC-CCCcccceeeEeeeCCeeEEEEecCCCCChhhh
Q 021490 2 MQVILC-LLQDVAIKQLDRNGVQ--------GNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDH 71 (311)
Q Consensus 2 ~~~~~~-~g~~vaiK~~~~~~~~--------~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 71 (311)
|.+... +|+.||||++...... ..+.+.+|+.++..+ +||||+++++++......++||||++|++|.++
T Consensus 111 y~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~ 190 (365)
T 2y7j_A 111 RRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDY 190 (365)
T ss_dssp EEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEEEECCCTTCBHHHH
T ss_pred EEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEEEEEeCCCCcHHHH
Confidence 445553 7999999998765421 135678899999999 799999999999999999999999999999999
Q ss_pred hcccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeecc
Q 021490 72 LHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVM 151 (311)
Q Consensus 72 l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~ 151 (311)
+.. ...+++..+..++.|++.||.|||+.| ++|+||+|+||+++.++.++|+|||++....... ......
T Consensus 191 l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~~---~~~~~~ 260 (365)
T 2y7j_A 191 LTE----KVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE---KLRELC 260 (365)
T ss_dssp HHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECCTTC---CBCCCC
T ss_pred HHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEEecCcccccCCCc---ccccCC
Confidence 986 567999999999999999999999999 9999999999999999999999999987543221 123356
Q ss_pred ccccccCcccccc------CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccC
Q 021490 152 GTYGYCAPEYAKT------GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQG 225 (311)
Q Consensus 152 ~~~~y~aPE~~~~------~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (311)
+++.|+|||++.+ ..++.++|||||||++|+|++|..||...........+.... ... ..+..
T Consensus 261 gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~------~~~---~~~~~-- 329 (365)
T 2y7j_A 261 GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQ------YQF---SSPEW-- 329 (365)
T ss_dssp SCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC------CCC---CHHHH--
T ss_pred CCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC------CCC---CCccc--
Confidence 8999999998863 357889999999999999999999997655433222211100 000 00000
Q ss_pred CCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 021490 226 QYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 226 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~ 259 (311)
...+..+.+++.+||+.||++|||+.++++.
T Consensus 330 ---~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 330 ---DDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp ---SSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ---ccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1123468889999999999999999999875
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=299.07 Aligned_cols=221 Identities=27% Similarity=0.292 Sum_probs=173.9
Q ss_pred CCcEEEEEEeecCCC---cchhHHHHHHHH-HhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCC
Q 021490 8 LLQDVAIKQLDRNGV---QGNREFLVEVLM-LSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLD 83 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~---~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~ 83 (311)
+|+.||||++++... .....+.+|..+ ++.++||||+++++++.+....|+||||++||+|.+++.. ...++
T Consensus 62 ~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~ 137 (373)
T 2r5t_A 62 EEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQR----ERCFL 137 (373)
T ss_dssp TCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH----HSSCC
T ss_pred CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCCCCCcHHHHHHh----cCCCC
Confidence 588999999976543 223466677776 5678999999999999999999999999999999999987 56799
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccc
Q 021490 84 WNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 163 (311)
Q Consensus 84 ~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 163 (311)
+..+..++.||+.||+|||++| |+||||||+|||++.+|.+||+|||++...... ........||+.|+|||++.
T Consensus 138 ~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~ 212 (373)
T 2r5t_A 138 EPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH--NSTTSTFCGTPEYLAPEVLH 212 (373)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC--CCCCCSBSCCCCCCCHHHHT
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccccC--CCccccccCCccccCHHHhC
Confidence 9999999999999999999999 999999999999999999999999998742221 11223456899999999999
Q ss_pred cCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHcc
Q 021490 164 TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCV 243 (311)
Q Consensus 164 ~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 243 (311)
+..++.++|||||||++|+|++|..||...........+. ... ..+++..+..+.+||.+||
T Consensus 213 ~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~------~~~------------~~~~~~~~~~~~~li~~lL 274 (373)
T 2r5t_A 213 KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL------NKP------------LQLKPNITNSARHLLEGLL 274 (373)
T ss_dssp TCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHH------HSC------------CCCCSSSCHHHHHHHHHHT
T ss_pred CCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH------hcc------------cCCCCCCCHHHHHHHHHHc
Confidence 9999999999999999999999999998765443322211 110 0122334457889999999
Q ss_pred ccCCCCCCCHHH
Q 021490 244 HEQPDMRPVIAD 255 (311)
Q Consensus 244 ~~~p~~Rps~~~ 255 (311)
+.||.+||++.+
T Consensus 275 ~~dp~~R~~~~~ 286 (373)
T 2r5t_A 275 QKDRTKRLGAKD 286 (373)
T ss_dssp CSSGGGSTTTTT
T ss_pred ccCHHhCCCCCC
Confidence 999999999853
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=284.33 Aligned_cols=226 Identities=23% Similarity=0.315 Sum_probs=187.4
Q ss_pred CCcEEEEEEeecCC---CcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCH
Q 021490 8 LLQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 84 (311)
Q Consensus 8 ~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~ 84 (311)
+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+....++||||+++++|.+++.. ...+++
T Consensus 38 ~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~ 113 (284)
T 2vgo_A 38 NKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQK----HGRFDE 113 (284)
T ss_dssp TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH----HSSCCH
T ss_pred CCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeCCCCcHHHHHHh----cCCCCH
Confidence 67899999986542 22346789999999999999999999999999999999999999999999987 467999
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccccc
Q 021490 85 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT 164 (311)
Q Consensus 85 ~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 164 (311)
..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++....... .....++..|+|||++.+
T Consensus 114 ~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~ 186 (284)
T 2vgo_A 114 QRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR----RRTMCGTLDYLPPEMIEG 186 (284)
T ss_dssp HHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSSSC----BCCCCSCGGGCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcccc----cccccCCCCcCCHHHhcc
Confidence 999999999999999999999 9999999999999999999999999886432211 223458899999999998
Q ss_pred CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccc
Q 021490 165 GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVH 244 (311)
Q Consensus 165 ~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 244 (311)
..++.++||||||+++|+|++|..||...........+. .. + ..++...+..+.+++.+||+
T Consensus 187 ~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~------~~--------~----~~~~~~~~~~~~~li~~~l~ 248 (284)
T 2vgo_A 187 KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIV------NV--------D----LKFPPFLSDGSKDLISKLLR 248 (284)
T ss_dssp CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH------TT--------C----CCCCTTSCHHHHHHHHHHSC
T ss_pred CCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHh------cc--------c----cCCCCcCCHHHHHHHHHHhh
Confidence 899999999999999999999999998765433322111 00 0 11223344578899999999
Q ss_pred cCCCCCCCHHHHHHHHHH
Q 021490 245 EQPDMRPVIADVVTALAY 262 (311)
Q Consensus 245 ~~p~~Rps~~~vl~~l~~ 262 (311)
.||.+|||+.++++....
T Consensus 249 ~~p~~Rps~~~ll~h~~~ 266 (284)
T 2vgo_A 249 YHPPQRLPLKGVMEHPWV 266 (284)
T ss_dssp SSGGGSCCHHHHHTCHHH
T ss_pred cCHhhCCCHHHHhhCHHH
Confidence 999999999999986543
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=294.00 Aligned_cols=240 Identities=15% Similarity=0.116 Sum_probs=183.2
Q ss_pred CCcEEEEEEeecCCCc-----------chhHHHHHHHHHhcCCCCcccceeeEeee----CCeeEEEEecCCCCChhhhh
Q 021490 8 LLQDVAIKQLDRNGVQ-----------GNREFLVEVLMLSLLHHPNLVNLIGYCAD----GDQRLLVYEYMPLGSVEDHL 72 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l 72 (311)
++..||+|++...... ....+.+|+..+..++||||+++++++.+ ....++||||+ |++|.+++
T Consensus 64 ~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l 142 (345)
T 2v62_A 64 KDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKIS 142 (345)
T ss_dssp GGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHC
T ss_pred ccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecccccccCCCcEEEEEEecc-CCCHHHHH
Confidence 6788999998765422 12346678899999999999999999987 67899999999 99999999
Q ss_pred cccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCC--ceEEccccccccCCCCCCc-----e
Q 021490 73 HDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY--HPKLSDFGLAKLGPVGDNT-----H 145 (311)
Q Consensus 73 ~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~--~~~l~df~~~~~~~~~~~~-----~ 145 (311)
.. ...+++..++.++.|++.||+|||+.+ ++||||||+|||++.++ .++|+|||++......... .
T Consensus 143 ~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~ 215 (345)
T 2v62_A 143 GQ----NGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQEN 215 (345)
T ss_dssp BG----GGBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCC
T ss_pred Hh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhc
Confidence 87 458999999999999999999999999 99999999999998877 9999999999653221111 1
Q ss_pred eeeeccccccccCccccccCCCccccceeehhHHHHHHHhCCCccCcchhH--HHHHHHHHhhhhhccccccccccCccc
Q 021490 146 VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAA--AEQSLVAWARPLFQDRTRHSLIADPEL 223 (311)
Q Consensus 146 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (311)
......++..|+|||++.+..++.++|||||||++|+|++|..||...... ............+..... ...
T Consensus 216 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~ 289 (345)
T 2v62_A 216 PRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDELPQSVL------KWA 289 (345)
T ss_dssp GGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHHHHHHHTTTHHHH------HHS
T ss_pred cccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHHHHhhcccccHHHH------hhc
Confidence 113346899999999999989999999999999999999999999643221 111111111110000000 000
Q ss_pred cCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhh
Q 021490 224 QGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLA 264 (311)
Q Consensus 224 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l~~~~ 264 (311)
. ....+..+.+++.+||+.||++|||+.++++.|+.+.
T Consensus 290 -~--~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 290 -P--SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp -C--TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred -c--ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 0 0123347889999999999999999999999997544
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=283.75 Aligned_cols=233 Identities=24% Similarity=0.344 Sum_probs=183.3
Q ss_pred cCCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHH
Q 021490 7 CLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNT 86 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~ 86 (311)
.+|+.||+|+++.......+.+.+|+.+++.++||||+++++++.+....++||||+++++|.+++.... ....+++..
T Consensus 45 ~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~ 123 (295)
T 2clq_A 45 SNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKW-GPLKDNEQT 123 (295)
T ss_dssp TTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHHHHHHHTT-CCCTTCHHH
T ss_pred CCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHHHHHHhhc-cCCCccHHH
Confidence 4688999999987766667889999999999999999999999999999999999999999999997632 124567899
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcC-CCceEEccccccccCCCCCCceeeeeccccccccCccccccC
Q 021490 87 RMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR-GYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG 165 (311)
Q Consensus 87 ~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 165 (311)
+..++.|++.||+|||+.+ ++|+||+|+||+++. ++.++|+|||++....... .......++..|+|||++.+.
T Consensus 124 ~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~ 198 (295)
T 2clq_A 124 IGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN--PCTETFTGTLQYMAPEIIDKG 198 (295)
T ss_dssp HHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC-------CCCCCCGGGCCHHHHHHG
T ss_pred HHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCC--CcccccCCCccccChhhhcCC
Confidence 9999999999999999999 999999999999987 8999999999987533221 112334688999999998764
Q ss_pred C--CccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHcc
Q 021490 166 Q--LTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCV 243 (311)
Q Consensus 166 ~--~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 243 (311)
. ++.++||||||+++|+|++|..||............. .... ..+ ..+...+..+.+++.+||
T Consensus 199 ~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~---~~~~--------~~~----~~~~~~~~~~~~li~~~l 263 (295)
T 2clq_A 199 PRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKV---GMFK--------VHP----EIPESMSAEAKAFILKCF 263 (295)
T ss_dssp GGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHH---HHHC--------CCC----CCCTTSCHHHHHHHHHTT
T ss_pred CCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhh---cccc--------ccc----cccccCCHHHHHHHHHHc
Confidence 3 7899999999999999999999997543322111100 0000 011 122334458889999999
Q ss_pred ccCCCCCCCHHHHHHHH
Q 021490 244 HEQPDMRPVIADVVTAL 260 (311)
Q Consensus 244 ~~~p~~Rps~~~vl~~l 260 (311)
+.||++|||+.++++.-
T Consensus 264 ~~dp~~Rps~~~ll~~~ 280 (295)
T 2clq_A 264 EPDPDKRACANDLLVDE 280 (295)
T ss_dssp CSSTTTSCCHHHHHTSG
T ss_pred cCChhhCCCHHHHhcCh
Confidence 99999999999998753
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=295.25 Aligned_cols=246 Identities=13% Similarity=0.097 Sum_probs=182.6
Q ss_pred CcEEEEEEeecCCCcc-----------hhHHHHHHHHHhcCCCCcccceeeEeeeC----CeeEEEEecCCCCChhhhhc
Q 021490 9 LQDVAIKQLDRNGVQG-----------NREFLVEVLMLSLLHHPNLVNLIGYCADG----DQRLLVYEYMPLGSVEDHLH 73 (311)
Q Consensus 9 g~~vaiK~~~~~~~~~-----------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~ 73 (311)
++.||||++....... ...+..|+..+..++||||+++++++.+. ...++||||+ |++|.+++.
T Consensus 65 ~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~ 143 (364)
T 3op5_A 65 DAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYE 143 (364)
T ss_dssp TCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHH
T ss_pred ccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHH
Confidence 5889999986554211 12344566677788899999999998764 4589999999 999999998
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEc--CCCceEEccccccccCCCCCCc-----ee
Q 021490 74 DLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD--RGYHPKLSDFGLAKLGPVGDNT-----HV 146 (311)
Q Consensus 74 ~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~--~~~~~~l~df~~~~~~~~~~~~-----~~ 146 (311)
.. ...+++..++.++.|++.||+|||+.+ ++||||||+|||++ .++.++|+|||++......... ..
T Consensus 144 ~~---~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~ 217 (364)
T 3op5_A 144 AN---AKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADP 217 (364)
T ss_dssp HT---TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCS
T ss_pred hc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCc
Confidence 62 467999999999999999999999999 99999999999999 8899999999999653221111 11
Q ss_pred eeeccccccccCccccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCC
Q 021490 147 STRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQ 226 (311)
Q Consensus 147 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (311)
.....+|..|+|||++.+..++.++|||||||++|+|++|..||............ ....... ......++.+.
T Consensus 218 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~--~~~~~~~--~~~~~~~~~~~-- 291 (364)
T 3op5_A 218 KRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRD--SKIRYRE--NIASLMDKCFP-- 291 (364)
T ss_dssp SCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHH--HHHHHHH--CHHHHHHHHSC--
T ss_pred ccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHHHH--HHHHhhh--hHHHHHHHhcc--
Confidence 12345899999999999989999999999999999999999999853322111100 0000000 00000011110
Q ss_pred CChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhccC
Q 021490 227 YPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQKY 268 (311)
Q Consensus 227 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~~~ 268 (311)
....+..+.+++..||+.||.+|||+.++++.|+.+.....
T Consensus 292 -~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~ 332 (364)
T 3op5_A 292 -AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIG 332 (364)
T ss_dssp -TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred -cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Confidence 01223478889999999999999999999999988876543
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=284.33 Aligned_cols=232 Identities=21% Similarity=0.258 Sum_probs=182.5
Q ss_pred cCCcEEEEEEeecCC----CcchhHHHHHHHHHhcCCCCcccceeeEe--eeCCeeEEEEecCCCCChhhhhcccCCCCC
Q 021490 7 CLLQDVAIKQLDRNG----VQGNREFLVEVLMLSLLHHPNLVNLIGYC--ADGDQRLLVYEYMPLGSVEDHLHDLSPGKK 80 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 80 (311)
.+|+.||+|+++... ......+.+|+.+++.++||||+++++++ .+....++||||++++ |.+++.... ..
T Consensus 28 ~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~--~~ 104 (305)
T 2wtk_C 28 ETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVP--EK 104 (305)
T ss_dssp TTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEEECCSEE-HHHHHHHST--TC
T ss_pred CCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEehhccCC-HHHHHHhCc--cc
Confidence 368999999997543 23457899999999999999999999998 4456789999999866 777776532 46
Q ss_pred CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcc
Q 021490 81 PLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 160 (311)
Q Consensus 81 ~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE 160 (311)
.+++..++.++.|++.||+|||+++ ++|+||+|+||+++.++.++|+|||++................++..|+|||
T Consensus 105 ~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 181 (305)
T 2wtk_C 105 RFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPE 181 (305)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHH
T ss_pred ccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccccCccccccccccCCCCCCCcChh
Confidence 7999999999999999999999999 9999999999999999999999999987644333333334456899999999
Q ss_pred ccccCC--CccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHH
Q 021490 161 YAKTGQ--LTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAV 238 (311)
Q Consensus 161 ~~~~~~--~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 238 (311)
++.+.. .+.++||||||+++|+|++|..||...........+... . . ..+...+..+.++
T Consensus 182 ~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~------~--------~----~~~~~~~~~l~~l 243 (305)
T 2wtk_C 182 IANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKG------S--------Y----AIPGDCGPPLSDL 243 (305)
T ss_dssp HHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC------C--------C----CCCSSSCHHHHHH
T ss_pred hccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcC------C--------C----CCCCccCHHHHHH
Confidence 987644 377999999999999999999999876543332211110 0 0 1122234478899
Q ss_pred HHHccccCCCCCCCHHHHHHHHHH
Q 021490 239 AAMCVHEQPDMRPVIADVVTALAY 262 (311)
Q Consensus 239 i~~~l~~~p~~Rps~~~vl~~l~~ 262 (311)
+.+||..||.+|||+.++++....
T Consensus 244 i~~~l~~dp~~Rps~~~ll~~~~~ 267 (305)
T 2wtk_C 244 LKGMLEYEPAKRFSIRQIRQHSWF 267 (305)
T ss_dssp HHHHTCSSTTTSCCHHHHHHSHHH
T ss_pred HHHHccCChhhCCCHHHHhcCccc
Confidence 999999999999999999987543
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=309.17 Aligned_cols=230 Identities=27% Similarity=0.345 Sum_probs=186.7
Q ss_pred CCcEEEEEEeecCC---CcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCH
Q 021490 8 LLQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 84 (311)
Q Consensus 8 ~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~ 84 (311)
+|+.||||++.... ......+.+|+.+|..++||||+++++++.+....|+||||++||+|.+++.... ...+++
T Consensus 208 tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~--~~~l~e 285 (576)
T 2acx_A 208 TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMG--QAGFPE 285 (576)
T ss_dssp TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHSSS--SCCCCH
T ss_pred CCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcC--CCCCCH
Confidence 79999999997642 2344678899999999999999999999999999999999999999999997632 345999
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccccc
Q 021490 85 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT 164 (311)
Q Consensus 85 ~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 164 (311)
..++.++.||+.||+|||+++ |+||||||+|||++.+|.+||+|||++....... ......||+.|+|||++.+
T Consensus 286 ~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APEvl~~ 359 (576)
T 2acx_A 286 ARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGRVGTVGYMAPEVVKN 359 (576)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCTTC---CEECCCSCGGGCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecccCc---cccccCCCccccCHHHHcC
Confidence 999999999999999999999 9999999999999999999999999997543221 2233478999999999998
Q ss_pred CCCccccceeehhHHHHHHHhCCCccCcchhHHH-HHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHcc
Q 021490 165 GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE-QSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCV 243 (311)
Q Consensus 165 ~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 243 (311)
..++.++|||||||++|+|++|..||........ ..+..... .. ...++...+..+.+||.+||
T Consensus 360 ~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~---~~------------~~~~p~~~s~~~~dLI~~lL 424 (576)
T 2acx_A 360 ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK---EV------------PEEYSERFSPQARSLCSQLL 424 (576)
T ss_dssp CEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHH---HC------------CCCCCTTSCHHHHHHHHHHT
T ss_pred CCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhh---cc------------cccCCccCCHHHHHHHHHhc
Confidence 8999999999999999999999999976532111 11111110 00 01122334558899999999
Q ss_pred ccCCCCCC-----CHHHHHHHH
Q 021490 244 HEQPDMRP-----VIADVVTAL 260 (311)
Q Consensus 244 ~~~p~~Rp-----s~~~vl~~l 260 (311)
+.||.+|| ++.|+++.-
T Consensus 425 ~~dP~~R~g~~~~sa~eil~Hp 446 (576)
T 2acx_A 425 CKDPAERLGCRGGSAREVKEHP 446 (576)
T ss_dssp CSSGGGSTTCSSSHHHHHHTSG
T ss_pred cCCHHHcCCCCCCCHHHHHhCh
Confidence 99999999 788888663
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=304.88 Aligned_cols=229 Identities=25% Similarity=0.307 Sum_probs=184.4
Q ss_pred CCcEEEEEEeecCC--CcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHH
Q 021490 8 LLQDVAIKQLDRNG--VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN 85 (311)
Q Consensus 8 ~g~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~ 85 (311)
+|..||+|+++... ......+.+|+.+++.++||||+++++++.+....++|||||+||+|.+++.. ...+++.
T Consensus 61 ~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~----~~~~~~~ 136 (494)
T 3lij_A 61 THVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIH----RMKFNEV 136 (494)
T ss_dssp TCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH----HSSCCHH
T ss_pred CCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCcHHHHHHH----cCCCCHH
Confidence 68899999997654 23457899999999999999999999999999999999999999999998876 5679999
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcC---CCceEEccccccccCCCCCCceeeeeccccccccCcccc
Q 021490 86 TRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR---GYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 162 (311)
Q Consensus 86 ~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~---~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 162 (311)
.+..++.|++.||+|||+.+ ++||||||+||+++. ++.+||+|||++...... .......+++.|+|||++
T Consensus 137 ~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~l 210 (494)
T 3lij_A 137 DAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ---KKMKERLGTAYYIAPEVL 210 (494)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT---BCBCCCCSCTTTCCHHHH
T ss_pred HHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC---ccccccCCCcCeeCHHHH
Confidence 99999999999999999999 999999999999976 445999999998754322 222335689999999998
Q ss_pred ccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHc
Q 021490 163 KTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMC 242 (311)
Q Consensus 163 ~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 242 (311)
. ..++.++|||||||++|+|++|..||...........+...... ...+. ....+..+.+|+.+|
T Consensus 211 ~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~---------~~~~~-----~~~~s~~~~~li~~~ 275 (494)
T 3lij_A 211 R-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYT---------FDSPE-----WKNVSEGAKDLIKQM 275 (494)
T ss_dssp T-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC---------CCSGG-----GTTSCHHHHHHHHHH
T ss_pred c-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC---------CCchh-----cccCCHHHHHHHHHH
Confidence 6 56899999999999999999999999876654433322211100 00111 012344788999999
Q ss_pred cccCCCCCCCHHHHHHHHH
Q 021490 243 VHEQPDMRPVIADVVTALA 261 (311)
Q Consensus 243 l~~~p~~Rps~~~vl~~l~ 261 (311)
|+.||.+|||+.++++..+
T Consensus 276 L~~dp~~R~s~~e~l~hp~ 294 (494)
T 3lij_A 276 LQFDSQRRISAQQALEHPW 294 (494)
T ss_dssp TCSSTTTSCCHHHHHTCHH
T ss_pred CCCChhhCccHHHHhcCcc
Confidence 9999999999999997644
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=299.95 Aligned_cols=234 Identities=21% Similarity=0.177 Sum_probs=186.6
Q ss_pred CCcEEEEEEeecCCC---cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCH
Q 021490 8 LLQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 84 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~ 84 (311)
+|+.||+|++++... .....+.+|+.++..++||||+++++++.+....|+||||++||+|.+++... ...+++
T Consensus 98 ~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~---~~~l~e 174 (437)
T 4aw2_A 98 ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKF---EDRLPE 174 (437)
T ss_dssp TTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTT---TTCCCH
T ss_pred CCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCCCCcHHHHHHHc---cCCCCH
Confidence 578999999975321 23345889999999999999999999999999999999999999999999762 467999
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccc-
Q 021490 85 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK- 163 (311)
Q Consensus 85 ~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~- 163 (311)
..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++....... ........||+.|+|||++.
T Consensus 175 ~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~-~~~~~~~~GT~~Y~APE~l~~ 250 (437)
T 4aw2_A 175 EMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG-TVQSSVAVGTPDYISPEILQA 250 (437)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTS-CEECCSCCSCGGGCCHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchhhhhhcccCC-CcccccccCCcCeeChHHHhh
Confidence 999999999999999999999 9999999999999999999999999986533221 22223356999999999987
Q ss_pred ----cCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHH
Q 021490 164 ----TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVA 239 (311)
Q Consensus 164 ----~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 239 (311)
...++.++|||||||++|+|++|..||...+.......+......+ ..|.. ....+..+.+||
T Consensus 251 ~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~---------~~p~~----~~~~s~~~~dLi 317 (437)
T 4aw2_A 251 MEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERF---------QFPTQ----VTDVSENAKDLI 317 (437)
T ss_dssp HHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC---------CCCSS----CCCSCHHHHHHH
T ss_pred cccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccc---------cCCcc----cccCCHHHHHHH
Confidence 4678999999999999999999999998766544332221110000 00111 112345788999
Q ss_pred HHccccCCCC--CCCHHHHHHHHH
Q 021490 240 AMCVHEQPDM--RPVIADVVTALA 261 (311)
Q Consensus 240 ~~~l~~~p~~--Rps~~~vl~~l~ 261 (311)
.+||..+|+. ||+++|+++.-.
T Consensus 318 ~~lL~~~~~r~~r~~~~eil~Hpf 341 (437)
T 4aw2_A 318 RRLICSREHRLGQNGIEDFKKHPF 341 (437)
T ss_dssp HTTSSCGGGCTTTTTTHHHHTSGG
T ss_pred HHHhcccccccCCCCHHHHhCCCc
Confidence 9999988888 999999998743
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=293.69 Aligned_cols=243 Identities=17% Similarity=0.174 Sum_probs=184.3
Q ss_pred CCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccc---------------eeeEeee-CCeeEEEEecCCCCChhhh
Q 021490 8 LLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVN---------------LIGYCAD-GDQRLLVYEYMPLGSVEDH 71 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~---------------~~~~~~~-~~~~~lv~e~~~~~~L~~~ 71 (311)
+|+.||+|++... +.+.+|+.+++.++||||++ +++++.. +...++||||+ +++|.++
T Consensus 74 ~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~ 147 (352)
T 2jii_A 74 QKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSA 147 (352)
T ss_dssp ---CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHH
T ss_pred cCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHH
Confidence 4899999998643 57889999999999999988 5666665 67889999999 9999999
Q ss_pred hcccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCC--ceEEccccccccCCCCCCc-----
Q 021490 72 LHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY--HPKLSDFGLAKLGPVGDNT----- 144 (311)
Q Consensus 72 l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~--~~~l~df~~~~~~~~~~~~----- 144 (311)
+.... ...+++..++.++.|++.||+|||+++ ++||||||+||+++.++ .++|+|||++.........
T Consensus 148 l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 222 (352)
T 2jii_A 148 LDVSP--KHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVE 222 (352)
T ss_dssp HHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCT
T ss_pred HHhCC--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccc
Confidence 98721 367999999999999999999999999 99999999999999998 8999999999753321111
Q ss_pred eeeeeccccccccCccccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCcccc
Q 021490 145 HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQ 224 (311)
Q Consensus 145 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (311)
.......++..|+|||++.+..++.++||||||+++|+|++|..||......... +........... ..+....
T Consensus 223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~-~~~~~~~~~~~~---~~~~~~~-- 296 (352)
T 2jii_A 223 GSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTED-IMKQKQKFVDKP---GPFVGPC-- 296 (352)
T ss_dssp TSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHH-HHHHHHHHHHSC---CCEECTT--
T ss_pred cccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHH-HHHHHHhccCCh---hhhhhhc--
Confidence 1112346899999999999889999999999999999999999999865421111 111111111110 0000000
Q ss_pred CCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhccC
Q 021490 225 GQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQKY 268 (311)
Q Consensus 225 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~~~ 268 (311)
......+..+.+|+.+||..||.+|||+.++++.|+.+.....
T Consensus 297 -~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 339 (352)
T 2jii_A 297 -GHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR 339 (352)
T ss_dssp -SCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred -cccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence 0001223578899999999999999999999999998876653
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=304.37 Aligned_cols=242 Identities=21% Similarity=0.235 Sum_probs=174.2
Q ss_pred CCcEEEEEEeecCCC--cchhHHHHHHHHHhcCCCCcccceeeEeee-----CCeeEEEEecCCCCChhhhhcccCCCCC
Q 021490 8 LLQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCAD-----GDQRLLVYEYMPLGSVEDHLHDLSPGKK 80 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 80 (311)
+|+.||||++..... ...+.+.+|+.+|+.++||||+++++++.. ....|+||||+ +++|.+++.. ..
T Consensus 77 ~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~----~~ 151 (458)
T 3rp9_A 77 EKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRT----PV 151 (458)
T ss_dssp --CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEECCC-SEEHHHHHHS----SC
T ss_pred CCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEEecc-ccchhhhccc----CC
Confidence 789999999965432 334688999999999999999999999843 35689999998 5789999976 56
Q ss_pred CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCc----------------
Q 021490 81 PLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT---------------- 144 (311)
Q Consensus 81 ~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~---------------- 144 (311)
.+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.........
T Consensus 152 ~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (458)
T 3rp9_A 152 YLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLV 228 (458)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC-----------
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccchhccCccccccccccCccccccccc
Confidence 7999999999999999999999999 999999999999999999999999999764321110
Q ss_pred ---------eeeeeccccccccCcccc-ccCCCccccceeehhHHHHHHHh-----------CCCccCcchh--------
Q 021490 145 ---------HVSTRVMGTYGYCAPEYA-KTGQLTLKSDVYSFGVVLLEILS-----------GRKAVDTSKA-------- 195 (311)
Q Consensus 145 ---------~~~~~~~~~~~y~aPE~~-~~~~~~~~~DiwslG~l~~~ll~-----------g~~pf~~~~~-------- 195 (311)
.......+|..|+|||++ ....++.++|||||||++|||++ |.++|.+...
T Consensus 229 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~ 308 (458)
T 3rp9_A 229 TFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQK 308 (458)
T ss_dssp ----------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC------------
T ss_pred cccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccccccccCCCCcccccccccc
Confidence 112335679999999976 55679999999999999999998 6677755431
Q ss_pred ------------HHHHHHHHHhhhhhccccc-----------------cccccCccccCCCChHhHHHHHHHHHHccccC
Q 021490 196 ------------AAEQSLVAWARPLFQDRTR-----------------HSLIADPELQGQYPPRGFYQALAVAAMCVHEQ 246 (311)
Q Consensus 196 ------------~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 246 (311)
......+. ..++.... ........+ ....+..+..+.+||.+||..|
T Consensus 309 ~~~~~~~~~~~~~~~l~~i~---~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dLl~~mL~~d 384 (458)
T 3rp9_A 309 AGNDFKFHTRGNRDQLNVIF---NILGTPSEEDIEALEKEDAKRYIRIFPKREGTDL-AERFPASSADAIHLLKRMLVFN 384 (458)
T ss_dssp --------CHHHHHHHHHHH---HHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCG-GGGSTTSCHHHHHHHHHHSCSS
T ss_pred ccccccccccCCHHHHHHHH---HHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCH-HHHCCCCCHHHHHHHHHHhccC
Confidence 01111000 00000000 000000000 0111233568899999999999
Q ss_pred CCCCCCHHHHHHHHH
Q 021490 247 PDMRPVIADVVTALA 261 (311)
Q Consensus 247 p~~Rps~~~vl~~l~ 261 (311)
|++|||++|+++.-.
T Consensus 385 P~~R~t~~e~L~Hp~ 399 (458)
T 3rp9_A 385 PNKRITINECLAHPF 399 (458)
T ss_dssp TTTSCCHHHHHHSGG
T ss_pred ccccCCHHHHhcCHh
Confidence 999999999998753
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=294.81 Aligned_cols=241 Identities=21% Similarity=0.219 Sum_probs=184.2
Q ss_pred cCCcEEEEEEeecCCCcchhHHHHHHHHHhcCC-----CCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCC
Q 021490 7 CLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLH-----HPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKP 81 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-----h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 81 (311)
.+|+.||||+++. .......+..|+.+++.++ ||||+++++++......++||||+ +++|.+++.... ...
T Consensus 58 ~~~~~vavK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~~~ 133 (360)
T 3llt_A 58 DNKKYYAVKVVRN-IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNN--YNG 133 (360)
T ss_dssp TTCCEEEEEEECS-CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTT--TCC
T ss_pred CCCeEEEEEEecc-chhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhcC--CCC
Confidence 3689999999953 3344567788999999996 999999999999999999999999 899999998732 346
Q ss_pred CCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcC-------------------------CCceEEccccccc
Q 021490 82 LDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR-------------------------GYHPKLSDFGLAK 136 (311)
Q Consensus 82 l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~-------------------------~~~~~l~df~~~~ 136 (311)
+++..+..++.||+.||+|||+.+ ++||||||+|||++. ++.++|+|||++.
T Consensus 134 ~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~ 210 (360)
T 3llt_A 134 FHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCAT 210 (360)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCE
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCce
Confidence 999999999999999999999999 999999999999975 7889999999987
Q ss_pred cCCCCCCceeeeeccccccccCccccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhcccc---
Q 021490 137 LGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRT--- 213 (311)
Q Consensus 137 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--- 213 (311)
..... .....++..|+|||++.+..++.++|||||||++|+|++|..||...........+......+....
T Consensus 211 ~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~ 285 (360)
T 3llt_A 211 FKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYE 285 (360)
T ss_dssp ETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHH
T ss_pred ecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhh
Confidence 53221 2234689999999999999999999999999999999999999987665544333322111000000
Q ss_pred -----ccccccCccccCCCC--------------------hHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 021490 214 -----RHSLIADPELQGQYP--------------------PRGFYQALAVAAMCVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 214 -----~~~~~~~~~~~~~~~--------------------~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~ 259 (311)
..............+ ......+.+|+.+||+.||++|||+.|+++.
T Consensus 286 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 356 (360)
T 3llt_A 286 ATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKH 356 (360)
T ss_dssp HTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred hhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000000000000000 0112567799999999999999999999864
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=300.82 Aligned_cols=249 Identities=20% Similarity=0.239 Sum_probs=188.5
Q ss_pred CCcEEEEEEeecCCC-cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHH
Q 021490 8 LLQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNT 86 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~ 86 (311)
+|+.||+|+++.... ...+.+.+|+.++..++||||+++++++.++...++||||++|++|.+++.. ...+++..
T Consensus 57 ~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~ 132 (360)
T 3eqc_A 57 SGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQI 132 (360)
T ss_dssp TCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHH----HSSCCHHH
T ss_pred CCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCCHHHHHHH----cCCCCHHH
Confidence 689999999976533 3346889999999999999999999999999999999999999999999987 46799999
Q ss_pred HHHHHHHHHHHHHHhhcC-CCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccC
Q 021490 87 RMKIAAGAARGLEYLHDK-AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG 165 (311)
Q Consensus 87 ~~~~~~~i~~~l~~lh~~-~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 165 (311)
+..++.+++.||+|||+. + ++|+||||+||+++.++.++|+|||++..... .......++..|+|||++.+.
T Consensus 133 ~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~----~~~~~~~gt~~y~aPE~~~~~ 205 (360)
T 3eqc_A 133 LGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMSPERLQGT 205 (360)
T ss_dssp HHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH----HC----CCCCTTCCHHHHTTC
T ss_pred HHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCccccc----ccccCCCCCCCeECHHHHcCC
Confidence 999999999999999996 8 99999999999999999999999998853211 112234688999999999999
Q ss_pred CCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhh-----hhhcccc---cc------------------cccc
Q 021490 166 QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWAR-----PLFQDRT---RH------------------SLIA 219 (311)
Q Consensus 166 ~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~-----~~~~~~~---~~------------------~~~~ 219 (311)
.++.++||||||+++|+|++|..||................ ....... .. ....
T Consensus 206 ~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (360)
T 3eqc_A 206 HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIV 285 (360)
T ss_dssp CCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------------------CCCHHHHHHHHH
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHh
Confidence 99999999999999999999999998765543322110000 0000000 00 0000
Q ss_pred CccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhcc
Q 021490 220 DPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQK 267 (311)
Q Consensus 220 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~~ 267 (311)
............+..+.+|+.+||+.||.+|||+.++++....-....
T Consensus 286 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 333 (360)
T 3eqc_A 286 NEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDA 333 (360)
T ss_dssp HSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHH
T ss_pred ccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchH
Confidence 000000011123457889999999999999999999998765544333
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=298.72 Aligned_cols=238 Identities=21% Similarity=0.184 Sum_probs=186.4
Q ss_pred cCCcEEEEEEeecCCC---cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCC
Q 021490 7 CLLQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLD 83 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~ 83 (311)
.+|+.||||++++... ...+.+.+|..++..++||||+++++++.+....|+||||++||+|.+++... +..++
T Consensus 84 ~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~---~~~l~ 160 (412)
T 2vd5_A 84 QTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKF---GERIP 160 (412)
T ss_dssp TTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH---SSCCC
T ss_pred CCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCCCCcHHHHHHhc---CCCCC
Confidence 3699999999975322 23356889999999999999999999999999999999999999999999762 34799
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccc
Q 021490 84 WNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 163 (311)
Q Consensus 84 ~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 163 (311)
+..+..++.|++.||+|||+.+ |+||||||+|||++.+|.+||+|||++....... ........||+.|+|||++.
T Consensus 161 ~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~-~~~~~~~~Gt~~Y~APE~l~ 236 (412)
T 2vd5_A 161 AEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG-TVRSLVAVGTPDYLSPEILQ 236 (412)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTS-CEECSSCCSCGGGCCHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeechhheeccCCC-ccccceeccccCcCCHHHHh
Confidence 9999999999999999999999 9999999999999999999999999997543221 11222346899999999987
Q ss_pred -------cCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHH
Q 021490 164 -------TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQAL 236 (311)
Q Consensus 164 -------~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 236 (311)
...++.++|||||||++|+|++|..||...........+....... ..|.. +...+.++.
T Consensus 237 ~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~---------~~p~~----~~~~s~~~~ 303 (412)
T 2vd5_A 237 AVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHL---------SLPLV----DEGVPEEAR 303 (412)
T ss_dssp HHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC---------CCC--------CCCHHHH
T ss_pred hcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCc---------CCCcc----ccCCCHHHH
Confidence 3568999999999999999999999998766544322221110000 01111 122345889
Q ss_pred HHHHHccccCCCCC---CCHHHHHHHHHHhhhc
Q 021490 237 AVAAMCVHEQPDMR---PVIADVVTALAYLASQ 266 (311)
Q Consensus 237 ~li~~~l~~~p~~R---ps~~~vl~~l~~~~~~ 266 (311)
+||.+||. +|.+| |+++|+++.- ++...
T Consensus 304 dli~~lL~-~p~~Rlgr~~~~ei~~Hp-ff~~i 334 (412)
T 2vd5_A 304 DFIQRLLC-PPETRLGRGGAGDFRTHP-FFFGL 334 (412)
T ss_dssp HHHHTTSS-CGGGCTTTTTHHHHHTSG-GGTTC
T ss_pred HHHHHHcC-ChhhcCCCCCHHHHhcCC-CcCCC
Confidence 99999999 99998 5899998764 34433
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=288.38 Aligned_cols=228 Identities=21% Similarity=0.181 Sum_probs=175.6
Q ss_pred cchhcc-CCcEEEEEEeecCCCc--chhHHHHHHHHHhcC-CCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCC
Q 021490 2 MQVILC-LLQDVAIKQLDRNGVQ--GNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP 77 (311)
Q Consensus 2 ~~~~~~-~g~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 77 (311)
|.+... +|+.||||++...... ....+..|+..+..+ +||||+++++++.++...++||||+ +++|.+++...
T Consensus 74 y~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~-~~~L~~~~~~~-- 150 (311)
T 3p1a_A 74 FKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAW-- 150 (311)
T ss_dssp EEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHH--
T ss_pred EEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEecc-CCCHHHHHHhc--
Confidence 344444 7999999998654332 233555666666555 8999999999999999999999999 67998888763
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeecccccccc
Q 021490 78 GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 157 (311)
Q Consensus 78 ~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~ 157 (311)
+..+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||++...... .......|+..|+
T Consensus 151 -~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~---~~~~~~~gt~~y~ 223 (311)
T 3p1a_A 151 -GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA---GAGEVQEGDPRYM 223 (311)
T ss_dssp -CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC---------CCCCCGGGC
T ss_pred -CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecccC---CCCcccCCCcccc
Confidence 456999999999999999999999999 999999999999999999999999998653222 2223345899999
Q ss_pred CccccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHH
Q 021490 158 APEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALA 237 (311)
Q Consensus 158 aPE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 237 (311)
|||++.+ .++.++|||||||++|+|++|..||........ +... ...+.+. ...+..+.+
T Consensus 224 aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~----------~~~~-----~~~~~~~----~~~~~~l~~ 283 (311)
T 3p1a_A 224 APELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQ----------LRQG-----YLPPEFT----AGLSSELRS 283 (311)
T ss_dssp CGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHH----------HTTT-----CCCHHHH----TTSCHHHHH
T ss_pred CHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH----------Hhcc-----CCCcccc----cCCCHHHHH
Confidence 9999875 789999999999999999999776654332111 0000 0011111 123457889
Q ss_pred HHHHccccCCCCCCCHHHHHHH
Q 021490 238 VAAMCVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 238 li~~~l~~~p~~Rps~~~vl~~ 259 (311)
++.+||+.||++|||+.++++.
T Consensus 284 li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 284 VLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp HHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHcCCChhhCcCHHHHHhC
Confidence 9999999999999999999975
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=284.09 Aligned_cols=229 Identities=25% Similarity=0.306 Sum_probs=187.0
Q ss_pred CCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHHH
Q 021490 8 LLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTR 87 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~ 87 (311)
+|+.||+|++... ...+.+.+|+.++..++||||+++++++.+....++||||+++++|.+++... ...+++..+
T Consensus 53 ~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~ 127 (314)
T 3com_A 53 TGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLR---NKTLTEDEI 127 (314)
T ss_dssp TCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHH---TCCCCHHHH
T ss_pred CCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCCCHHHHHHhc---CCCCCHHHH
Confidence 5899999999654 34578899999999999999999999999999999999999999999998742 467999999
Q ss_pred HHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccCCC
Q 021490 88 MKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQL 167 (311)
Q Consensus 88 ~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 167 (311)
+.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++...... ........++..|+|||++.+..+
T Consensus 128 ~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~ 202 (314)
T 3com_A 128 ATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT--MAKRNTVIGTPFWMAPEVIQEIGY 202 (314)
T ss_dssp HHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTT--BSCBCCCCSCGGGCCHHHHSSSCB
T ss_pred HHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhh--ccccCccCCCCCccChhhcCCCCC
Confidence 999999999999999999 999999999999999999999999998653222 112233468899999999998889
Q ss_pred ccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCC
Q 021490 168 TLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQP 247 (311)
Q Consensus 168 ~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p 247 (311)
+.++||||||+++|+|++|..||.............. . .... ...+...+..+.+++.+||..||
T Consensus 203 ~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------~--~~~~-------~~~~~~~~~~l~~li~~~l~~dp 267 (314)
T 3com_A 203 NCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPT------N--PPPT-------FRKPELWSDNFTDFVKQCLVKSP 267 (314)
T ss_dssp CTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH------S--CCCC-------CSSGGGSCHHHHHHHHHHTCSCT
T ss_pred CccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhc------C--CCcc-------cCCcccCCHHHHHHHHHHccCCh
Confidence 9999999999999999999999986554332211100 0 0000 01122234578899999999999
Q ss_pred CCCCCHHHHHHHHH
Q 021490 248 DMRPVIADVVTALA 261 (311)
Q Consensus 248 ~~Rps~~~vl~~l~ 261 (311)
.+|||+.++++...
T Consensus 268 ~~Rpt~~~ll~~~~ 281 (314)
T 3com_A 268 EQRATATQLLQHPF 281 (314)
T ss_dssp TTSCCHHHHTTSHH
T ss_pred hhCcCHHHHHhCHH
Confidence 99999999998644
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=293.00 Aligned_cols=228 Identities=31% Similarity=0.388 Sum_probs=183.8
Q ss_pred cCCcEEEEEEeecCCCcc---hhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCC
Q 021490 7 CLLQDVAIKQLDRNGVQG---NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLD 83 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~ 83 (311)
.+|+.||||++....... .+.+.+|+.++..++||||+++++++.++...++||||+. |+|.+++... ...++
T Consensus 77 ~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~-g~l~~~l~~~---~~~l~ 152 (348)
T 1u5q_A 77 RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVH---KKPLQ 152 (348)
T ss_dssp TTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHHH---TSCCC
T ss_pred cCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCC-CCHHHHHHHh---cCCCC
Confidence 578999999997554322 3578899999999999999999999999999999999997 6788877542 46799
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccc
Q 021490 84 WNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 163 (311)
Q Consensus 84 ~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 163 (311)
+..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++..... .....+++.|+|||++.
T Consensus 153 ~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~------~~~~~gt~~y~aPE~~~ 223 (348)
T 1u5q_A 153 EVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVGTPYWMAPEVIL 223 (348)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS------BCCCCSCGGGCCHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC------CCcccCCcceeCHhhhc
Confidence 9999999999999999999999 99999999999999999999999999875322 12346899999999884
Q ss_pred ---cCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHH
Q 021490 164 ---TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAA 240 (311)
Q Consensus 164 ---~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 240 (311)
...++.++|||||||++|+|++|..||............. ... .+.. .+...+..+.+|+.
T Consensus 224 ~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~------~~~-------~~~~---~~~~~~~~l~~li~ 287 (348)
T 1u5q_A 224 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA------QNE-------SPAL---QSGHWSEYFRNFVD 287 (348)
T ss_dssp TTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH------HSC-------CCCC---CCTTSCHHHHHHHH
T ss_pred cccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH------hcC-------CCCC---CCCCCCHHHHHHHH
Confidence 5678999999999999999999999997665433221111 100 0000 11223447888999
Q ss_pred HccccCCCCCCCHHHHHHHHHHh
Q 021490 241 MCVHEQPDMRPVIADVVTALAYL 263 (311)
Q Consensus 241 ~~l~~~p~~Rps~~~vl~~l~~~ 263 (311)
+||+.||++|||+.++++.....
T Consensus 288 ~~l~~dP~~Rps~~~ll~h~~~~ 310 (348)
T 1u5q_A 288 SCLQKIPQDRPTSEVLLKHRFVL 310 (348)
T ss_dssp HHTCSSGGGSCCHHHHTTCHHHH
T ss_pred HHcccChhhCcCHHHHhhChhhh
Confidence 99999999999999999876543
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=288.84 Aligned_cols=242 Identities=24% Similarity=0.294 Sum_probs=178.9
Q ss_pred CCcEEEEEEeecCCCcchhHHHHHHHHHhcC--CCCcccceeeEeeeC----CeeEEEEecCCCCChhhhhcccCCCCCC
Q 021490 8 LLQDVAIKQLDRNGVQGNREFLVEVLMLSLL--HHPNLVNLIGYCADG----DQRLLVYEYMPLGSVEDHLHDLSPGKKP 81 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l--~h~~i~~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 81 (311)
.|..||||++... ....+..|.+++..+ +||||+++++++.+. ...++||||+++++|.+++.. ..
T Consensus 59 ~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~ 130 (337)
T 3mdy_A 59 RGEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKS-----TT 130 (337)
T ss_dssp TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHH-----CC
T ss_pred CCceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhc-----cC
Confidence 4899999998533 334555566666555 899999999999877 688999999999999999975 46
Q ss_pred CCHHHHHHHHHHHHHHHHHhhcC--------CCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCce--eeeecc
Q 021490 82 LDWNTRMKIAAGAARGLEYLHDK--------AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH--VSTRVM 151 (311)
Q Consensus 82 l~~~~~~~~~~~i~~~l~~lh~~--------~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~--~~~~~~ 151 (311)
+++..++.++.|++.||+|||+. + ++||||||+||+++.++.+||+|||++.......... ......
T Consensus 131 ~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~ 207 (337)
T 3mdy_A 131 LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRV 207 (337)
T ss_dssp BCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEECTTSCEEECCCTTCEECC---------CCSSC
T ss_pred CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCc
Confidence 99999999999999999999998 8 9999999999999999999999999986532222111 112346
Q ss_pred ccccccCccccccCCCccc------cceeehhHHHHHHHhC----------CCccCcchhHHHHHHHHHhhhhhcccccc
Q 021490 152 GTYGYCAPEYAKTGQLTLK------SDVYSFGVVLLEILSG----------RKAVDTSKAAAEQSLVAWARPLFQDRTRH 215 (311)
Q Consensus 152 ~~~~y~aPE~~~~~~~~~~------~DiwslG~l~~~ll~g----------~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 215 (311)
++..|+|||++.+...+.. +|||||||++|+|++| ..||............ .........
T Consensus 208 gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~--~~~~~~~~~-- 283 (337)
T 3mdy_A 208 GTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYED--MREIVCIKK-- 283 (337)
T ss_dssp SCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHH--HHHHHTTSC--
T ss_pred cCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCchhh--hHHHHhhhc--
Confidence 8999999999987666554 9999999999999999 5565432211100000 000000000
Q ss_pred ccccCccccCC-CChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhcc
Q 021490 216 SLIADPELQGQ-YPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQK 267 (311)
Q Consensus 216 ~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~~ 267 (311)
..+.+... .+...+..+.+|+.+||+.||.+|||+.++++.|+.+....
T Consensus 284 ---~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 284 ---LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp ---CCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred ---cCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence 01111100 11255678999999999999999999999999999888654
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=288.60 Aligned_cols=235 Identities=22% Similarity=0.266 Sum_probs=184.3
Q ss_pred CCcEEEEEEeecCCC--cchhHHHHHHHHHhcCCCCcccceeeEee--eCCeeEEEEecCCCCChhhhhcccCCCCCCCC
Q 021490 8 LLQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCA--DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLD 83 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~ 83 (311)
+|+.||+|++..... ...+.+.+|+.+++.++||||+++++++. .+...++||||+++++|.+++.........++
T Consensus 30 ~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 109 (279)
T 2w5a_A 30 DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLD 109 (279)
T ss_dssp TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCC
T ss_pred CCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCC
Confidence 789999999976543 33467899999999999999999999874 45789999999999999999976433345699
Q ss_pred HHHHHHHHHHHHHHHHHhhcCC--CCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccc
Q 021490 84 WNTRMKIAAGAARGLEYLHDKA--KPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 161 (311)
Q Consensus 84 ~~~~~~~~~~i~~~l~~lh~~~--~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 161 (311)
+..++.++.|++.||+|||+.+ +.+++|+||+|+||+++.++.++|+|||++...... ........++..|+|||+
T Consensus 110 ~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~ 187 (279)
T 2w5a_A 110 EEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD--TSFAKTFVGTPYYMSPEQ 187 (279)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHHC-----CHHHHHHHSCCTTCCHHH
T ss_pred HHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchheeeccc--cccccccCCCccccChHH
Confidence 9999999999999999999875 234999999999999999999999999998653221 111223457899999999
Q ss_pred cccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHH
Q 021490 162 AKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAM 241 (311)
Q Consensus 162 ~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 241 (311)
+.+..++.++||||||+++|+|++|..||...........+... . .+ ..+...+..+.+++.+
T Consensus 188 ~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~------~-------~~----~~~~~~~~~l~~li~~ 250 (279)
T 2w5a_A 188 MNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG------K-------FR----RIPYRYSDELNEIITR 250 (279)
T ss_dssp HHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT------C-------CC----CCCTTSCHHHHHHHHH
T ss_pred hccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhc------c-------cc----cCCcccCHHHHHHHHH
Confidence 99888999999999999999999999999876543322211110 0 00 1222334578899999
Q ss_pred ccccCCCCCCCHHHHHHHHH
Q 021490 242 CVHEQPDMRPVIADVVTALA 261 (311)
Q Consensus 242 ~l~~~p~~Rps~~~vl~~l~ 261 (311)
||+.||.+|||+.++++.++
T Consensus 251 ~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 251 MLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp HTCSSGGGSCCHHHHHTSTT
T ss_pred HcCCCcccCCCHHHHHhChh
Confidence 99999999999999998764
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=296.81 Aligned_cols=245 Identities=22% Similarity=0.265 Sum_probs=181.0
Q ss_pred cCCcEEEEEEeecCC--CcchhHHHHHHHHHhcCC-CCcccceeeEeeeCC--eeEEEEecCCCCChhhhhcccCCCCCC
Q 021490 7 CLLQDVAIKQLDRNG--VQGNREFLVEVLMLSLLH-HPNLVNLIGYCADGD--QRLLVYEYMPLGSVEDHLHDLSPGKKP 81 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~ 81 (311)
.+|+.||||++.... ......+.+|+.++..+. ||||+++++++.... ..|+||||++ ++|..++.. ..
T Consensus 32 ~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~ 105 (388)
T 3oz6_A 32 RTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIRA-----NI 105 (388)
T ss_dssp TTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECCS-EEHHHHHHH-----TC
T ss_pred CCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEecccC-cCHHHHHHc-----CC
Confidence 468999999986543 234467889999999997 999999999997544 6899999997 689998875 46
Q ss_pred CCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCC-------------------
Q 021490 82 LDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD------------------- 142 (311)
Q Consensus 82 l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~------------------- 142 (311)
+++..+..++.|++.||+|||+.| |+||||||+|||++.++.+||+|||++.......
T Consensus 106 ~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (388)
T 3oz6_A 106 LEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDD 182 (388)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC--------
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccccccccccccccccccccccccccccc
Confidence 999999999999999999999999 9999999999999999999999999987532210
Q ss_pred CceeeeeccccccccCcccccc-CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhcccc------c-
Q 021490 143 NTHVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRT------R- 214 (311)
Q Consensus 143 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~------~- 214 (311)
.........+|..|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+........... .
T Consensus 183 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~ 262 (388)
T 3oz6_A 183 DQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPF 262 (388)
T ss_dssp -------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSS
T ss_pred ccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHH
Confidence 1112233568999999999876 6789999999999999999999999987765544332221110000000 0
Q ss_pred ----------cccccCccccCC------------CChHhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 021490 215 ----------HSLIADPELQGQ------------YPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 260 (311)
Q Consensus 215 ----------~~~~~~~~~~~~------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l 260 (311)
............ .....+..+.+|+.+||+.||++|||+.|+++..
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~Hp 330 (388)
T 3oz6_A 263 AKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHP 330 (388)
T ss_dssp HHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTST
T ss_pred HHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHHhCCH
Confidence 000000000000 0012345788999999999999999999999874
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=283.77 Aligned_cols=224 Identities=21% Similarity=0.233 Sum_probs=179.6
Q ss_pred CCcEEEEEEeecCCC--cchhHHHHHHHHHhcC-CCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCH
Q 021490 8 LLQDVAIKQLDRNGV--QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 84 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~ 84 (311)
+|+.||+|+++.... .....+.+|+..+..+ +||||+++++++.+....++||||++|++|.+++.........+++
T Consensus 35 ~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 114 (289)
T 1x8b_A 35 DGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKE 114 (289)
T ss_dssp TCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCH
T ss_pred CCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecCCCcHHHHHHhhcccccCCCH
Confidence 799999999976533 3346788999999999 9999999999999999999999999999999999763322367999
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCC-------------------CceEEccccccccCCCCCCce
Q 021490 85 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG-------------------YHPKLSDFGLAKLGPVGDNTH 145 (311)
Q Consensus 85 ~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~-------------------~~~~l~df~~~~~~~~~~~~~ 145 (311)
..++.++.|++.||+|||+++ ++|+||||+||+++.+ ..++|+|||.+.......
T Consensus 115 ~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~--- 188 (289)
T 1x8b_A 115 AELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ--- 188 (289)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC--------------------CCCEEECCCTTCEETTCSC---
T ss_pred HHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCcc---
Confidence 999999999999999999999 9999999999999844 479999999987543221
Q ss_pred eeeeccccccccCccccccC-CCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCcccc
Q 021490 146 VSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQ 224 (311)
Q Consensus 146 ~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (311)
...++..|+|||++.+. .++.++||||||+++|+|++|.+++........ + ... . .+
T Consensus 189 ---~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~--~-------~~~--~-----~~--- 246 (289)
T 1x8b_A 189 ---VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHE--I-------RQG--R-----LP--- 246 (289)
T ss_dssp ---CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHHHH--H-------HTT--C-----CC---
T ss_pred ---ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHHHH--H-------HcC--C-----CC---
Confidence 23488999999998765 667899999999999999999987755432111 0 000 0 01
Q ss_pred CCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 021490 225 GQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 260 (311)
Q Consensus 225 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l 260 (311)
..+...+..+.+++.+||+.||.+|||+.++++..
T Consensus 247 -~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~ 281 (289)
T 1x8b_A 247 -RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHS 281 (289)
T ss_dssp -CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCT
T ss_pred -CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhCh
Confidence 12223345788999999999999999999998764
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-40 Score=288.99 Aligned_cols=249 Identities=22% Similarity=0.244 Sum_probs=184.6
Q ss_pred cCCcEEEEEEeecCCC--cchhHHHHHHHHHhcCCCCcccceeeEeee--------CCeeEEEEecCCCCChhhhhcccC
Q 021490 7 CLLQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCAD--------GDQRLLVYEYMPLGSVEDHLHDLS 76 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~~ 76 (311)
.+|+.||||++..... .....+.+|+.+++.++||||+++++++.+ ....++||||+++ +|.+.+...
T Consensus 40 ~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~- 117 (351)
T 3mi9_A 40 KTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNV- 117 (351)
T ss_dssp TTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEEEEEECCSE-EHHHHHHCT-
T ss_pred CCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEEEEEeccCC-CHHHHHhhc-
Confidence 4789999999865543 224578899999999999999999999977 3468999999974 777777652
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCC--ceeeeeccccc
Q 021490 77 PGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN--THVSTRVMGTY 154 (311)
Q Consensus 77 ~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~ 154 (311)
...+++..++.++.|++.||+|||+.| ++||||||+||+++.++.++|+|||++........ ........++.
T Consensus 118 --~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~ 192 (351)
T 3mi9_A 118 --LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTL 192 (351)
T ss_dssp --TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCG
T ss_pred --cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchhcccccccccccccccCCccccc
Confidence 456999999999999999999999999 99999999999999999999999999875432211 11223346799
Q ss_pred cccCcccccc-CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhcccccc-----ccccCccccCCCC
Q 021490 155 GYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRH-----SLIADPELQGQYP 228 (311)
Q Consensus 155 ~y~aPE~~~~-~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~ 228 (311)
.|+|||++.+ ..++.++|||||||++|+|++|..||...........+............. .............
T Consensus 193 ~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (351)
T 3mi9_A 193 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQK 272 (351)
T ss_dssp GGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCC
T ss_pred CccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchhhcccccccccc
Confidence 9999998876 567999999999999999999999998776655443332221111100000 0000000000000
Q ss_pred --h-------HhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 021490 229 --P-------RGFYQALAVAAMCVHEQPDMRPVIADVVTALAY 262 (311)
Q Consensus 229 --~-------~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l~~ 262 (311)
. ..+..+.+|+.+||+.||++|||+.|+++.-..
T Consensus 273 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f 315 (351)
T 3mi9_A 273 RKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 315 (351)
T ss_dssp CCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred cCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCc
Confidence 0 013457899999999999999999999987543
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=292.61 Aligned_cols=240 Identities=20% Similarity=0.227 Sum_probs=184.4
Q ss_pred cCCcEEEEEEeecCCC--cchhHHHHHHHHHhcCCCCcccceeeEeeeCC------eeEEEEecCCCCChhhhhcccCCC
Q 021490 7 CLLQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGD------QRLLVYEYMPLGSVEDHLHDLSPG 78 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~ 78 (311)
.+|+.||||++..... ...+.+.+|+.+++.++||||+++++++.... ..|+||||+ +++|.+++..
T Consensus 48 ~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---- 122 (367)
T 1cm8_A 48 RTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH---- 122 (367)
T ss_dssp TTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHH----
T ss_pred CCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEEecC-CCCHHHHHhc----
Confidence 4689999999865432 23467889999999999999999999997653 459999999 7899999875
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccC
Q 021490 79 KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCA 158 (311)
Q Consensus 79 ~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~a 158 (311)
..+++..+..++.|++.||+|||+.| ++||||||+||+++.++.+||+|||++...... .....++..|+|
T Consensus 123 -~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~a 193 (367)
T 1cm8_A 123 -EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSE-----MTGYVVTRWYRA 193 (367)
T ss_dssp -CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCSS-----CCSSCSCGGGCC
T ss_pred -CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecccccccc-----cCcCcCCCCcCC
Confidence 46999999999999999999999999 999999999999999999999999999753221 223467899999
Q ss_pred cccccc-CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhcc----cc----------ccccccCccc
Q 021490 159 PEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQD----RT----------RHSLIADPEL 223 (311)
Q Consensus 159 PE~~~~-~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~----~~----------~~~~~~~~~~ 223 (311)
||++.+ ..++.++|||||||++|+|++|..||.+.+.......+......... .. .........+
T Consensus 194 PE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (367)
T 1cm8_A 194 PEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDF 273 (367)
T ss_dssp THHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCG
T ss_pred HHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCH
Confidence 999877 67899999999999999999999999877654433222111000000 00 0000000001
Q ss_pred cCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 021490 224 QGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 261 (311)
Q Consensus 224 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l~ 261 (311)
....+..+..+.+|+.+||..||.+|||+.++++.-.
T Consensus 274 -~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~ 310 (367)
T 1cm8_A 274 -ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPY 310 (367)
T ss_dssp -GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred -HHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChH
Confidence 1122334568899999999999999999999998643
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=284.02 Aligned_cols=234 Identities=27% Similarity=0.379 Sum_probs=181.6
Q ss_pred cEEEEEEeecCC---CcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHH
Q 021490 10 QDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNT 86 (311)
Q Consensus 10 ~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~ 86 (311)
..||+|+++... ....+.+.+|+.++..++||||+++++++.+.. .++||||+++++|.+++... ...+++..
T Consensus 47 ~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~~---~~~~~~~~ 122 (291)
T 1u46_A 47 VSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKH---QGHFLLGT 122 (291)
T ss_dssp EEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEEEECCTTCBHHHHHHHH---GGGSCHHH
T ss_pred eEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceeeEecccCCCHHHHHHhc---cCCcCHHH
Confidence 369999987543 234578899999999999999999999998754 89999999999999999762 35699999
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCce-eeeeccccccccCccccccC
Q 021490 87 RMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH-VSTRVMGTYGYCAPEYAKTG 165 (311)
Q Consensus 87 ~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~ 165 (311)
++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.......... ......++..|+|||++.+.
T Consensus 123 ~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 199 (291)
T 1u46_A 123 LSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 199 (291)
T ss_dssp HHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHC
T ss_pred HHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCC
Confidence 9999999999999999999 9999999999999999999999999987643332221 12234567789999999988
Q ss_pred CCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccc
Q 021490 166 QLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVH 244 (311)
Q Consensus 166 ~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 244 (311)
.++.++||||||+++|+|++ |..||...........+. ..... ...+...+..+.+++.+||+
T Consensus 200 ~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~------~~~~~----------~~~~~~~~~~l~~li~~~l~ 263 (291)
T 1u46_A 200 TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID------KEGER----------LPRPEDCPQDIYNVMVQCWA 263 (291)
T ss_dssp EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH------TSCCC----------CCCCTTCCHHHHHHHHHHTC
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHH------ccCCC----------CCCCcCcCHHHHHHHHHHcc
Confidence 89999999999999999999 999998765433222111 00000 01122334578899999999
Q ss_pred cCCCCCCCHHHHHHHHHHhhhc
Q 021490 245 EQPDMRPVIADVVTALAYLASQ 266 (311)
Q Consensus 245 ~~p~~Rps~~~vl~~l~~~~~~ 266 (311)
.||.+|||+.++++.|+.+...
T Consensus 264 ~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 264 HKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp SSGGGSCCHHHHHHHHHHHC--
T ss_pred CCcccCcCHHHHHHHHHHhCcc
Confidence 9999999999999999877643
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=292.08 Aligned_cols=247 Identities=18% Similarity=0.198 Sum_probs=186.6
Q ss_pred cchhccCCcEEEEEEeecCCCcch-----------------hHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCC
Q 021490 2 MQVILCLLQDVAIKQLDRNGVQGN-----------------REFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMP 64 (311)
Q Consensus 2 ~~~~~~~g~~vaiK~~~~~~~~~~-----------------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 64 (311)
|.+.. +|+.||||++........ +.+.+|+.++..++||||+++++++.+....++||||++
T Consensus 48 ~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 126 (348)
T 2pml_X 48 ILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYME 126 (348)
T ss_dssp EEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEEEESSSEEEEEEECCT
T ss_pred EEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeccC
Confidence 44444 899999999876432211 789999999999999999999999999999999999999
Q ss_pred CCChhhh------hcccCCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCeEeeccCCCeEEEcCCCceEEcccccccc
Q 021490 65 LGSVEDH------LHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD-KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 137 (311)
Q Consensus 65 ~~~L~~~------l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~ 137 (311)
+++|.++ +... ....+++..++.++.|++.||+|||+ .| ++|+||+|+||+++.++.++|+|||++..
T Consensus 127 ~~~L~~~~~~~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 201 (348)
T 2pml_X 127 NDSILKFDEYFFVLDKN--YTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNILMDKNGRVKLSDFGESEY 201 (348)
T ss_dssp TCBSSEESSSEESSCSS--SCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred CCcHHHHHHHhhhhhhc--cccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEEEcCCCcEEEeccccccc
Confidence 9999998 5431 24679999999999999999999999 98 99999999999999999999999999875
Q ss_pred CCCCCCceeeeeccccccccCccccccC-CCcc-ccceeehhHHHHHHHhCCCccCcchh-HHHHHHHHHhhhhhccccc
Q 021490 138 GPVGDNTHVSTRVMGTYGYCAPEYAKTG-QLTL-KSDVYSFGVVLLEILSGRKAVDTSKA-AAEQSLVAWARPLFQDRTR 214 (311)
Q Consensus 138 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~-~~DiwslG~l~~~ll~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~ 214 (311)
.... ......++..|+|||++.+. .++. ++||||||+++|+|++|..||..... ......+......+.. .
T Consensus 202 ~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~~~~~~~~--~ 275 (348)
T 2pml_X 202 MVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPL--D 275 (348)
T ss_dssp CBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTSCCCCCCC--S
T ss_pred cccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCcCCcc--c
Confidence 3222 23345689999999999876 6666 99999999999999999999986544 2221111100000000 0
Q ss_pred cccccCcc---ccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 021490 215 HSLIADPE---LQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 260 (311)
Q Consensus 215 ~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l 260 (311)
......+. .........+..+.+|+.+||+.||.+|||+.++++.-
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp 324 (348)
T 2pml_X 276 RNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHE 324 (348)
T ss_dssp SSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSG
T ss_pred hhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCc
Confidence 00000000 00011133455889999999999999999999999753
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=282.85 Aligned_cols=228 Identities=25% Similarity=0.284 Sum_probs=183.8
Q ss_pred CCcEEEEEEeecCCC---------cchhHHHHHHHHHhcCC-CCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCC
Q 021490 8 LLQDVAIKQLDRNGV---------QGNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP 77 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~---------~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 77 (311)
+|+.||||+++.... ...+.+.+|+.++..+. ||||+++++++.++...++||||+++++|.+++..
T Consensus 41 ~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--- 117 (298)
T 1phk_A 41 TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE--- 117 (298)
T ss_dssp TTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH---
T ss_pred cCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEEEEEeccCCCcHHHHHhc---
Confidence 689999999976542 12356789999999995 99999999999999999999999999999999987
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeecccccccc
Q 021490 78 GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 157 (311)
Q Consensus 78 ~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~ 157 (311)
...+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++....... ......++..|+
T Consensus 118 -~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~ 190 (298)
T 1phk_A 118 -KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPSYL 190 (298)
T ss_dssp -HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECCTTC---CBCCCCSCGGGC
T ss_pred -cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecccchhhcCCCc---ccccccCCcccc
Confidence 567999999999999999999999999 9999999999999999999999999987533221 223345889999
Q ss_pred Cccccc------cCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHh
Q 021490 158 APEYAK------TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRG 231 (311)
Q Consensus 158 aPE~~~------~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (311)
|||++. ...++.++||||||+++|+|++|..||...........+... ... .........
T Consensus 191 aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~------~~~--------~~~~~~~~~ 256 (298)
T 1phk_A 191 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG------NYQ--------FGSPEWDDY 256 (298)
T ss_dssp CHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT------CCC--------CCTTTGGGS
T ss_pred CHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcC------Ccc--------cCccccccc
Confidence 999885 456788999999999999999999999766543332221111 000 000111233
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 021490 232 FYQALAVAAMCVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 232 ~~~l~~li~~~l~~~p~~Rps~~~vl~~ 259 (311)
+..+.+++.+||+.||.+|||+.++++.
T Consensus 257 ~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 257 SDTVKDLVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp CHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred CHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence 4578899999999999999999999875
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=304.06 Aligned_cols=230 Identities=23% Similarity=0.288 Sum_probs=185.4
Q ss_pred CCcEEEEEEeecCCC-------------cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcc
Q 021490 8 LLQDVAIKQLDRNGV-------------QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHD 74 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 74 (311)
+|+.||+|+++.... ...+.+.+|+.+++.++||||+++++++.+....++|||||+|++|.+++..
T Consensus 60 ~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~ 139 (504)
T 3q5i_A 60 GHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIIN 139 (504)
T ss_dssp TCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH
T ss_pred CCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHH
Confidence 588999999976432 2346788999999999999999999999999999999999999999999876
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCC---ceEEccccccccCCCCCCceeeeecc
Q 021490 75 LSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY---HPKLSDFGLAKLGPVGDNTHVSTRVM 151 (311)
Q Consensus 75 ~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~---~~~l~df~~~~~~~~~~~~~~~~~~~ 151 (311)
...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++ .++|+|||++...... .......
T Consensus 140 ----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~ 209 (504)
T 3q5i_A 140 ----RHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD---YKLRDRL 209 (504)
T ss_dssp ----HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTT---SCBCCCC
T ss_pred ----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCC---Ccccccc
Confidence 567999999999999999999999999 99999999999998776 6999999999754322 1223346
Q ss_pred ccccccCccccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHh
Q 021490 152 GTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRG 231 (311)
Q Consensus 152 ~~~~y~aPE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (311)
+++.|+|||++. ..++.++|||||||++|+|++|..||...........+......+ ..... ...
T Consensus 210 gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~----------~~~~~----~~~ 274 (504)
T 3q5i_A 210 GTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYF----------DFNDW----KNI 274 (504)
T ss_dssp SCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC----------CHHHH----TTS
T ss_pred CCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC----------Ccccc----CCC
Confidence 899999999987 468999999999999999999999998766544333222110000 00000 122
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 021490 232 FYQALAVAAMCVHEQPDMRPVIADVVTALAY 262 (311)
Q Consensus 232 ~~~l~~li~~~l~~~p~~Rps~~~vl~~l~~ 262 (311)
+..+.+|+.+||+.||.+|||+.++++..+.
T Consensus 275 s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~ 305 (504)
T 3q5i_A 275 SDEAKELIKLMLTYDYNKRCTAEEALNSRWI 305 (504)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred CHHHHHHHHHHcCCChhHCCCHHHHhcCHhh
Confidence 3578899999999999999999999987543
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=289.46 Aligned_cols=242 Identities=23% Similarity=0.308 Sum_probs=184.5
Q ss_pred CCcEEEEEEeecCCCcchhHHHHHHHHHhc--CCCCcccceeeEeeeCC----eeEEEEecCCCCChhhhhcccCCCCCC
Q 021490 8 LLQDVAIKQLDRNGVQGNREFLVEVLMLSL--LHHPNLVNLIGYCADGD----QRLLVYEYMPLGSVEDHLHDLSPGKKP 81 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~ 81 (311)
.|+.||||+++.. ....+.+|++++.. ++||||+++++++.... ..++||||+++++|.+++.. ..
T Consensus 64 ~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~ 135 (342)
T 1b6c_B 64 RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-----YT 135 (342)
T ss_dssp TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHH-----CC
T ss_pred cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEeecCCCcHHHHHhc-----cC
Confidence 5899999998543 34677889998887 78999999999998776 78999999999999999975 46
Q ss_pred CCHHHHHHHHHHHHHHHHHhh--------cCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCce--eeeecc
Q 021490 82 LDWNTRMKIAAGAARGLEYLH--------DKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH--VSTRVM 151 (311)
Q Consensus 82 l~~~~~~~~~~~i~~~l~~lh--------~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~--~~~~~~ 151 (311)
+++..++.++.|++.||+||| +.+ ++|+||||+||+++.++.++|+|||++.......... ......
T Consensus 136 ~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~ 212 (342)
T 1b6c_B 136 VTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV 212 (342)
T ss_dssp BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCC
T ss_pred ccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCCEEEEECCCceeccccccccccccccCC
Confidence 999999999999999999999 888 9999999999999999999999999986533322211 123346
Q ss_pred ccccccCccccccC------CCccccceeehhHHHHHHHhC----------CCccCcchhHHHHHHHHHhhhhhcccccc
Q 021490 152 GTYGYCAPEYAKTG------QLTLKSDVYSFGVVLLEILSG----------RKAVDTSKAAAEQSLVAWARPLFQDRTRH 215 (311)
Q Consensus 152 ~~~~y~aPE~~~~~------~~~~~~DiwslG~l~~~ll~g----------~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 215 (311)
++..|+|||++.+. .++.++||||||+++|+|++| ..||......... ...+... .....
T Consensus 213 gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~-~~~~~~~-~~~~~-- 288 (342)
T 1b6c_B 213 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS-VEEMRKV-VCEQK-- 288 (342)
T ss_dssp CCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCC-HHHHHHH-HTTSC--
T ss_pred cCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCccc-HHHHHHH-HHHHH--
Confidence 89999999998765 334789999999999999999 6777543221100 0000000 00000
Q ss_pred ccccCccccCC-CChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhcc
Q 021490 216 SLIADPELQGQ-YPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQK 267 (311)
Q Consensus 216 ~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~~ 267 (311)
..+.+... ........+.+|+.+||+.||++|||+.++++.|+.+....
T Consensus 289 ---~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~ 338 (342)
T 1b6c_B 289 ---LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 338 (342)
T ss_dssp ---CCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred ---hCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHh
Confidence 01111111 12355678899999999999999999999999999887654
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=313.55 Aligned_cols=225 Identities=26% Similarity=0.330 Sum_probs=186.8
Q ss_pred CCcEEEEEEeecCC---CcchhHHHHHHHHHhcC-CCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCC
Q 021490 8 LLQDVAIKQLDRNG---VQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLD 83 (311)
Q Consensus 8 ~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~ 83 (311)
+|+.||||+++... ....+.+..|..++..+ +||||+.+++++.+...+|+||||++||+|.+++.. .+.++
T Consensus 365 ~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~----~~~~~ 440 (674)
T 3pfq_A 365 TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ----VGRFK 440 (674)
T ss_dssp SCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECCCSCBHHHHHHH----HSSCC
T ss_pred CCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCcCCCcHHHHHHh----cCCCC
Confidence 68889999997542 23456788899999988 799999999999999999999999999999999987 56799
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccc
Q 021490 84 WNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 163 (311)
Q Consensus 84 ~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 163 (311)
+..++.++.||+.||+|||+.+ |+||||||+|||++.+|.+||+|||++...... ........||+.|+|||++.
T Consensus 441 ~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~--~~~~~~~~GT~~Y~APE~l~ 515 (674)
T 3pfq_A 441 EPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD--GVTTKTFCGTPDYIAPEIIA 515 (674)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEECCCT--TCCBCCCCSCSSSCCHHHHT
T ss_pred HHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeeccccC--CcccccccCCCcccCHhhhc
Confidence 9999999999999999999999 999999999999999999999999998752221 12233456899999999999
Q ss_pred cCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHcc
Q 021490 164 TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCV 243 (311)
Q Consensus 164 ~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 243 (311)
+..++.++||||||+++|||++|..||...+.......+ .... ..++...+.++.+||.+||
T Consensus 516 ~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i------~~~~------------~~~p~~~s~~~~~li~~lL 577 (674)
T 3pfq_A 516 YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI------MEHN------------VAYPKSMSKEAVAICKGLM 577 (674)
T ss_dssp CCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HSSC------------CCCCTTSCHHHHHHHHHHS
T ss_pred CCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHH------HhCC------------CCCCccCCHHHHHHHHHHc
Confidence 999999999999999999999999999876554332222 1110 1223344568999999999
Q ss_pred ccCCCCCCCH-----HHHHHH
Q 021490 244 HEQPDMRPVI-----ADVVTA 259 (311)
Q Consensus 244 ~~~p~~Rps~-----~~vl~~ 259 (311)
+.||.+||++ +|+++.
T Consensus 578 ~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 578 TKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp CSSSTTCTTCSTTHHHHHHSS
T ss_pred cCCHHHCCCCCCCcHHHHhcC
Confidence 9999999997 666654
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=296.29 Aligned_cols=229 Identities=23% Similarity=0.296 Sum_probs=172.1
Q ss_pred cCCcEEEEEEeecCCC--------cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCC
Q 021490 7 CLLQDVAIKQLDRNGV--------QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPG 78 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~--------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~ 78 (311)
.+|+.||||++..... .....+.+|+.+|+.++||||+++++++. ....++||||+++++|.+++..
T Consensus 158 ~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~---- 232 (419)
T 3i6u_A 158 KTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVVG---- 232 (419)
T ss_dssp TTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SSEEEEEEECCTTCBGGGGTSS----
T ss_pred CCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCceEEEEEcCCCCcHHHHHhc----
Confidence 3689999999976421 12246889999999999999999999975 4568999999999999999876
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCC---ceEEccccccccCCCCCCceeeeecccccc
Q 021490 79 KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY---HPKLSDFGLAKLGPVGDNTHVSTRVMGTYG 155 (311)
Q Consensus 79 ~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~---~~~l~df~~~~~~~~~~~~~~~~~~~~~~~ 155 (311)
...+++..+..++.|++.||+|||+++ ++||||||+|||++.++ .+||+|||++..... ........+++.
T Consensus 233 ~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~---~~~~~~~~gt~~ 306 (419)
T 3i6u_A 233 NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE---TSLMRTLCGTPT 306 (419)
T ss_dssp SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC--------------CT
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEeecccceecCC---CccccccCCCCC
Confidence 577999999999999999999999999 99999999999997544 599999999975332 222234568999
Q ss_pred ccCcccccc---CCCccccceeehhHHHHHHHhCCCccCcchhHHHH-HHHHHhhhhhccccccccccCccccCCCChHh
Q 021490 156 YCAPEYAKT---GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ-SLVAWARPLFQDRTRHSLIADPELQGQYPPRG 231 (311)
Q Consensus 156 y~aPE~~~~---~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (311)
|+|||++.+ ..++.++|||||||++|+|++|..||......... ..+. ... ....+... ...
T Consensus 307 y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~-------~~~---~~~~~~~~----~~~ 372 (419)
T 3i6u_A 307 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT-------SGK---YNFIPEVW----AEV 372 (419)
T ss_dssp TCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHH-------TTC---CCCCHHHH----TTS
T ss_pred ccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHh-------cCC---CCCCchhh----ccc
Confidence 999999853 67789999999999999999999999754322111 1010 000 00001111 123
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 021490 232 FYQALAVAAMCVHEQPDMRPVIADVVTAL 260 (311)
Q Consensus 232 ~~~l~~li~~~l~~~p~~Rps~~~vl~~l 260 (311)
+..+.+|+.+||+.||.+|||+.++++.-
T Consensus 373 ~~~~~~li~~~L~~dP~~Rps~~e~l~hp 401 (419)
T 3i6u_A 373 SEKALDLVKKLLVVDPKARFTTEEALRHP 401 (419)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhCCc
Confidence 45788999999999999999999999764
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=299.79 Aligned_cols=238 Identities=22% Similarity=0.256 Sum_probs=177.9
Q ss_pred cCCcEEEEEEeecCC--CcchhHHHHHHHHHhcCCCCcccceeeEeeeC------CeeEEEEecCCCCChhhhhcccCCC
Q 021490 7 CLLQDVAIKQLDRNG--VQGNREFLVEVLMLSLLHHPNLVNLIGYCADG------DQRLLVYEYMPLGSVEDHLHDLSPG 78 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~ 78 (311)
.+|+.||||++.... ....+.+.+|+.+++.++||||+++++++... ...|+||||+++ +|.+.+..
T Consensus 85 ~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~-~l~~~~~~---- 159 (464)
T 3ttj_A 85 VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQM---- 159 (464)
T ss_dssp TTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSE-EHHHHHTS----
T ss_pred CCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEEEeCCCC-CHHHHHhh----
Confidence 368999999997542 23456888999999999999999999999654 357999999975 56666643
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccC
Q 021490 79 KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCA 158 (311)
Q Consensus 79 ~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~a 158 (311)
.+++..+..++.|++.||+|||+.| |+||||||+|||++.++.+||+|||++...... .......+|..|+|
T Consensus 160 --~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~---~~~~~~~gt~~y~a 231 (464)
T 3ttj_A 160 --ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRA 231 (464)
T ss_dssp --CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC-----C---CCC----CCCTTCC
T ss_pred --cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEeeeecCCC---cccCCCcccccccC
Confidence 4899999999999999999999999 999999999999999999999999999753221 12334568999999
Q ss_pred ccccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhh----------------hhccccccccccCcc
Q 021490 159 PEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARP----------------LFQDRTRHSLIADPE 222 (311)
Q Consensus 159 PE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~ 222 (311)
||++.+..++.++|||||||++|+|++|..||.+.+..+....+..... ......... ...
T Consensus 232 PE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~---~~~ 308 (464)
T 3ttj_A 232 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYA---GLT 308 (464)
T ss_dssp HHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCC---CCC
T ss_pred HHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccC---CCC
Confidence 9999999999999999999999999999999988765544332211100 000000000 000
Q ss_pred ccCCCC-----------hHhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 021490 223 LQGQYP-----------PRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 260 (311)
Q Consensus 223 ~~~~~~-----------~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l 260 (311)
+...++ ...+..+.+|+.+||..||++|||++|+++.-
T Consensus 309 ~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp 357 (464)
T 3ttj_A 309 FPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 357 (464)
T ss_dssp HHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTST
T ss_pred hHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcCh
Confidence 000000 11256789999999999999999999999764
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=281.51 Aligned_cols=241 Identities=21% Similarity=0.228 Sum_probs=185.6
Q ss_pred cCCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEe-eeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHH
Q 021490 7 CLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYC-ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN 85 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~ 85 (311)
.+|+.||||++.... ..+.+.+|+.+++.++|++++..+..+ .++...++||||+ +++|.+++... ...+++.
T Consensus 32 ~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~---~~~~~~~ 105 (296)
T 3uzp_A 32 AAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFC---SRKFSLK 105 (296)
T ss_dssp TTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHT---TTCCCHH
T ss_pred CCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CCCHHHHHHhh---ccCCCHH
Confidence 579999999986543 345789999999999988766655554 6677889999999 89999999752 4579999
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEc---CCCceEEccccccccCCCCCCce-----eeeecccccccc
Q 021490 86 TRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD---RGYHPKLSDFGLAKLGPVGDNTH-----VSTRVMGTYGYC 157 (311)
Q Consensus 86 ~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~---~~~~~~l~df~~~~~~~~~~~~~-----~~~~~~~~~~y~ 157 (311)
.++.++.|++.||+|||+++ ++||||||+||+++ .++.++|+|||++.......... ......++..|+
T Consensus 106 ~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 182 (296)
T 3uzp_A 106 TVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 182 (296)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTC
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccccccccccccccccccccC
Confidence 99999999999999999999 99999999999994 78899999999987643332211 123356899999
Q ss_pred CccccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHH-hhhhhccccccccccCccccCCCChHhHHHHH
Q 021490 158 APEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAW-ARPLFQDRTRHSLIADPELQGQYPPRGFYQAL 236 (311)
Q Consensus 158 aPE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 236 (311)
|||++.+..++.++||||||+++|+|++|..||.............. ........ .+.+.. ..+..+.
T Consensus 183 aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~----~~~~~l~ 251 (296)
T 3uzp_A 183 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP-------IEVLCK----GYPSEFA 251 (296)
T ss_dssp CHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC-------HHHHTT----TSCHHHH
T ss_pred ChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc-------hHHHHh----hCCHHHH
Confidence 99999998999999999999999999999999976432211111100 00000000 000111 2234788
Q ss_pred HHHHHccccCCCCCCCHHHHHHHHHHhhhcc
Q 021490 237 AVAAMCVHEQPDMRPVIADVVTALAYLASQK 267 (311)
Q Consensus 237 ~li~~~l~~~p~~Rps~~~vl~~l~~~~~~~ 267 (311)
+++.+||+.||.+|||+.++++.|+.+....
T Consensus 252 ~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 282 (296)
T 3uzp_A 252 TYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp HHHHHHHTSCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HHHHHHHhcCcCcCCCHHHHHHHHHHHHHhc
Confidence 9999999999999999999999999887654
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=285.99 Aligned_cols=235 Identities=21% Similarity=0.313 Sum_probs=181.9
Q ss_pred cchhcc-CCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCC
Q 021490 2 MQVILC-LLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKK 80 (311)
Q Consensus 2 ~~~~~~-~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 80 (311)
|.+... +|+.||+|++........+.+.+|+.++..++||||+++++++.++...++||||+++++|.+++... ..
T Consensus 36 ~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~---~~ 112 (302)
T 2j7t_A 36 YKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLEL---DR 112 (302)
T ss_dssp EEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTEEHHHHHHHH---TS
T ss_pred EEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcHHHHHHhh---cc
Confidence 334333 58999999997776677789999999999999999999999999999999999999999999988752 45
Q ss_pred CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcc
Q 021490 81 PLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 160 (311)
Q Consensus 81 ~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE 160 (311)
.+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++..... .........++..|+|||
T Consensus 113 ~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~~~~~y~aPE 187 (302)
T 2j7t_A 113 GLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK--TLQKRDSFIGTPYWMAPE 187 (302)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHH--HHHC-----CCGGGCCHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccc--cccccccccCChhhcCCe
Confidence 6999999999999999999999999 99999999999999999999999998642100 001122345889999999
Q ss_pred cc-----ccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHH
Q 021490 161 YA-----KTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQA 235 (311)
Q Consensus 161 ~~-----~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 235 (311)
++ .+..++.++||||||+++|+|++|..||............. ... ... ...+...+..+
T Consensus 188 ~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~------~~~-~~~--------~~~~~~~~~~l 252 (302)
T 2j7t_A 188 VVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA------KSD-PPT--------LLTPSKWSVEF 252 (302)
T ss_dssp HHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH------HSC-CCC--------CSSGGGSCHHH
T ss_pred eeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHh------ccC-Ccc--------cCCccccCHHH
Confidence 88 35678899999999999999999999998765433221111 000 000 01122334578
Q ss_pred HHHHHHccccCCCCCCCHHHHHHH
Q 021490 236 LAVAAMCVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 236 ~~li~~~l~~~p~~Rps~~~vl~~ 259 (311)
.+++.+||+.||.+|||+.++++.
T Consensus 253 ~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 253 RDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp HHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred HHHHHHHcccChhhCCCHHHHhcC
Confidence 899999999999999999999875
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-40 Score=282.02 Aligned_cols=241 Identities=21% Similarity=0.228 Sum_probs=184.5
Q ss_pred cCCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEe-eeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHH
Q 021490 7 CLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYC-ADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN 85 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~ 85 (311)
.+|+.||||++.... ..+.+.+|+.++..++|++++..+..+ .+....++||||+ +++|.+++... ...+++.
T Consensus 32 ~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~---~~~~~~~ 105 (296)
T 4hgt_A 32 AAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFC---SRKFSLK 105 (296)
T ss_dssp TTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHT---TSCCCHH
T ss_pred CCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-CCCHHHHHHHh---cCCCCHH
Confidence 578999999875443 335688999999999988766666554 6777889999999 89999999852 4569999
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEE---cCCCceEEccccccccCCCCCCc-----eeeeecccccccc
Q 021490 86 TRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL---DRGYHPKLSDFGLAKLGPVGDNT-----HVSTRVMGTYGYC 157 (311)
Q Consensus 86 ~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~---~~~~~~~l~df~~~~~~~~~~~~-----~~~~~~~~~~~y~ 157 (311)
.++.++.|++.||+|||+++ ++||||||+||++ +.++.++|+|||++......... .......++..|+
T Consensus 106 ~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~ 182 (296)
T 4hgt_A 106 TVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 182 (296)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGC
T ss_pred HHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCcccc
Confidence 99999999999999999999 9999999999999 78899999999999764333221 1123456899999
Q ss_pred CccccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHH-hhhhhccccccccccCccccCCCChHhHHHHH
Q 021490 158 APEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAW-ARPLFQDRTRHSLIADPELQGQYPPRGFYQAL 236 (311)
Q Consensus 158 aPE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 236 (311)
|||++.+..++.++|||||||++|+|++|..||.............. ........ .+.+... .+..+.
T Consensus 183 aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~----~~~~l~ 251 (296)
T 4hgt_A 183 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP-------IEVLCKG----YPSEFA 251 (296)
T ss_dssp CHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC-------HHHHTTT----SCHHHH
T ss_pred chHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch-------hhhhhcc----CCHHHH
Confidence 99999999999999999999999999999999976443221111110 00000000 0001111 234788
Q ss_pred HHHHHccccCCCCCCCHHHHHHHHHHhhhcc
Q 021490 237 AVAAMCVHEQPDMRPVIADVVTALAYLASQK 267 (311)
Q Consensus 237 ~li~~~l~~~p~~Rps~~~vl~~l~~~~~~~ 267 (311)
+++.+||+.||++|||+.++++.|+.+....
T Consensus 252 ~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~ 282 (296)
T 4hgt_A 252 TYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp HHHHHHHTSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHhcCCCCCCCHHHHHHHHHHHHHHh
Confidence 9999999999999999999999999887654
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=299.78 Aligned_cols=176 Identities=25% Similarity=0.297 Sum_probs=145.3
Q ss_pred cCCcEEEEEEeecCCC--cchhHHHHHHHHHhcCCCCcccceeeEeeeC-----CeeEEEEecCCCCChhhhhcccCCCC
Q 021490 7 CLLQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADG-----DQRLLVYEYMPLGSVEDHLHDLSPGK 79 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~ 79 (311)
.+|+.||||+++.... ...+.+.+|+.+|+.++||||+++++++... ...|+||||++ ++|.+++.. .
T Consensus 49 ~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~----~ 123 (432)
T 3n9x_A 49 NTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFKT----P 123 (432)
T ss_dssp TTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEECCS-EEHHHHHHS----S
T ss_pred CCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEEecCC-cCHHHHHhc----c
Confidence 3688999999975432 3346889999999999999999999999766 57899999996 699999986 5
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCc---------------
Q 021490 80 KPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT--------------- 144 (311)
Q Consensus 80 ~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~--------------- 144 (311)
..+++..+..++.||+.||+|||+.| ++||||||+|||++.++.+||+|||++.........
T Consensus 124 ~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~ 200 (432)
T 3n9x_A 124 IFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPH 200 (432)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC---------------------
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCccccccccccccccccccccccccc
Confidence 67999999999999999999999999 999999999999999999999999999764322111
Q ss_pred -----eeeeeccccccccCcccc-ccCCCccccceeehhHHHHHHHhCCCcc
Q 021490 145 -----HVSTRVMGTYGYCAPEYA-KTGQLTLKSDVYSFGVVLLEILSGRKAV 190 (311)
Q Consensus 145 -----~~~~~~~~~~~y~aPE~~-~~~~~~~~~DiwslG~l~~~ll~g~~pf 190 (311)
.......+|..|+|||++ ....++.++|||||||++|+|++|..||
T Consensus 201 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 201 NKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp ----------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred ccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 112445689999999986 5567899999999999999999854433
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=301.37 Aligned_cols=226 Identities=15% Similarity=0.139 Sum_probs=170.2
Q ss_pred cchhc-cCCcEEEEEEeecC---CCcchhHHHHHH---HHHhcCCCCccccee-------eEeeeCC-------------
Q 021490 2 MQVIL-CLLQDVAIKQLDRN---GVQGNREFLVEV---LMLSLLHHPNLVNLI-------GYCADGD------------- 54 (311)
Q Consensus 2 ~~~~~-~~g~~vaiK~~~~~---~~~~~~~~~~e~---~~l~~l~h~~i~~~~-------~~~~~~~------------- 54 (311)
|.+.. .+|+.||||+++.. .....+.+.+|+ ++++.++||||++++ +++.+..
T Consensus 90 ~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (377)
T 3byv_A 90 LEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERD 169 (377)
T ss_dssp EEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC------
T ss_pred EEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCCccccccccCCCc
Confidence 34443 46999999999754 223457889999 455556799999998 6555443
Q ss_pred ----eeEEEEecCCCCChhhhhcccC---CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCce
Q 021490 55 ----QRLLVYEYMPLGSVEDHLHDLS---PGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP 127 (311)
Q Consensus 55 ----~~~lv~e~~~~~~L~~~l~~~~---~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~ 127 (311)
..|+||||+ +|+|.+++.... .....+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+
T Consensus 170 ~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~ 245 (377)
T 3byv_A 170 MWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGV 245 (377)
T ss_dssp CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCE
T ss_pred eEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCE
Confidence 278999999 589999998621 11123345888899999999999999999 9999999999999999999
Q ss_pred EEccccccccCCCCCCceeeeeccccccccCccccccC-----------CCccccceeehhHHHHHHHhCCCccCcchhH
Q 021490 128 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG-----------QLTLKSDVYSFGVVLLEILSGRKAVDTSKAA 196 (311)
Q Consensus 128 ~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----------~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~ 196 (311)
||+|||++.... .......| ..|+|||++.+. .++.++|||||||++|+|++|..||......
T Consensus 246 kL~DFG~a~~~~-----~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~ 319 (377)
T 3byv_A 246 FLTGFEHLVRDG-----ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAAL 319 (377)
T ss_dssp EECCGGGCEETT-----CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred EEEechhheecC-----CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccc
Confidence 999999987421 12333456 899999999877 8899999999999999999999999754321
Q ss_pred HHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 021490 197 AEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~ 259 (311)
.... ... ......+..+.+|+.+||+.||.+|||+.++++.
T Consensus 320 ~~~~------~~~----------------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 360 (377)
T 3byv_A 320 GGSE------WIF----------------RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 360 (377)
T ss_dssp CCSG------GGG----------------SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred cchh------hhh----------------hhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence 1100 000 0011233478899999999999999999999974
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=289.45 Aligned_cols=234 Identities=14% Similarity=0.102 Sum_probs=187.8
Q ss_pred ccCCcEEEEEEeecCCCcchhHHHHHHHHHhcCC---CCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCC-CCCC
Q 021490 6 LCLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLH---HPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP-GKKP 81 (311)
Q Consensus 6 ~~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~ 81 (311)
..+|+.||||+++.. ....+.+|+.++..++ |+||+.+++++..+...++||||++||+|.+++..... ....
T Consensus 92 ~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~ 168 (365)
T 3e7e_A 92 AKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKV 168 (365)
T ss_dssp --CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCS
T ss_pred cccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccC
Confidence 457899999998643 4557788888888887 89999999999999999999999999999999975321 2467
Q ss_pred CCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcC-----------CCceEEccccccccCCCCCCceeeeec
Q 021490 82 LDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR-----------GYHPKLSDFGLAKLGPVGDNTHVSTRV 150 (311)
Q Consensus 82 l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~-----------~~~~~l~df~~~~~~~~~~~~~~~~~~ 150 (311)
+++..++.++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||++...............
T Consensus 169 l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~ 245 (365)
T 3e7e_A 169 MPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAK 245 (365)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCS
T ss_pred CCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeee
Confidence 999999999999999999999999 999999999999988 899999999999654333334444556
Q ss_pred cccccccCccccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChH
Q 021490 151 MGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPR 230 (311)
Q Consensus 151 ~~~~~y~aPE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (311)
.||..|+|||++.+..++.++|||||||++|+|++|..||........ . ....+. .. .
T Consensus 246 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~---------------~----~~~~~~-~~--~ 303 (365)
T 3e7e_A 246 CETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC---------------K----PEGLFR-RL--P 303 (365)
T ss_dssp SCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE---------------E----ECSCCT-TC--S
T ss_pred cCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce---------------e----echhcc-cc--C
Confidence 799999999999999999999999999999999999999965432100 0 001111 11 1
Q ss_pred hHHHHHHHHHHccccCCCCC-CCHHHHHHHHHHhhhcc
Q 021490 231 GFYQALAVAAMCVHEQPDMR-PVIADVVTALAYLASQK 267 (311)
Q Consensus 231 ~~~~l~~li~~~l~~~p~~R-ps~~~vl~~l~~~~~~~ 267 (311)
....+.+++..||..+|.+| |++.++.+.|+.+....
T Consensus 304 ~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~ 341 (365)
T 3e7e_A 304 HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH 341 (365)
T ss_dssp SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence 24467789999999999998 67888888888776554
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=288.88 Aligned_cols=245 Identities=23% Similarity=0.296 Sum_probs=176.8
Q ss_pred CCcEEEEEEeecCCCcchhHHHHHHHH--HhcCCCCcccceeeEeee-----CCeeEEEEecCCCCChhhhhcccCCCCC
Q 021490 8 LLQDVAIKQLDRNGVQGNREFLVEVLM--LSLLHHPNLVNLIGYCAD-----GDQRLLVYEYMPLGSVEDHLHDLSPGKK 80 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~~~~~~~~e~~~--l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 80 (311)
+|+.||||+++.. ....+..|.++ +..++||||+++++.+.. ....++||||+++|+|.+++.. .
T Consensus 35 ~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~ 106 (336)
T 3g2f_A 35 DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL-----H 106 (336)
T ss_dssp TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHH-----C
T ss_pred CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEecCCCCcHHHHHhh-----c
Confidence 6899999999643 33445555555 445899999999985532 2357899999999999999976 4
Q ss_pred CCCHHHHHHHHHHHHHHHHHhhcC---------CCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCC------ce
Q 021490 81 PLDWNTRMKIAAGAARGLEYLHDK---------AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN------TH 145 (311)
Q Consensus 81 ~l~~~~~~~~~~~i~~~l~~lh~~---------~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~------~~ 145 (311)
.+++..++.++.|++.||+|||+. + ++||||||+|||++.++.+||+|||++........ ..
T Consensus 107 ~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~ 183 (336)
T 3g2f_A 107 TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDN 183 (336)
T ss_dssp CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC-------
T ss_pred ccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEEEeeccceeecccccccCcccccc
Confidence 458999999999999999999999 8 99999999999999999999999999975432211 11
Q ss_pred eeeeccccccccCcccccc-------CCCccccceeehhHHHHHHHhCCCccCcchhHHHH-HH----------HHHhhh
Q 021490 146 VSTRVMGTYGYCAPEYAKT-------GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ-SL----------VAWARP 207 (311)
Q Consensus 146 ~~~~~~~~~~y~aPE~~~~-------~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~-~~----------~~~~~~ 207 (311)
......++..|+|||++.+ ..++.++|||||||++|+|++|..||......... .. ......
T Consensus 184 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (336)
T 3g2f_A 184 AAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQV 263 (336)
T ss_dssp --CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHH
T ss_pred ccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHh
Confidence 1223468999999999876 45678899999999999999997776432221100 00 000000
Q ss_pred hhccccccccccCccccCC--CChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhccC
Q 021490 208 LFQDRTRHSLIADPELQGQ--YPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQKY 268 (311)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~~~ 268 (311)
...... ..+.+... .....+..+.+|+.+||+.||++|||+.++++.|+.+...-.
T Consensus 264 ~~~~~~-----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~ 321 (336)
T 3g2f_A 264 LVSREK-----QRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWE 321 (336)
T ss_dssp HHTTSC-----CCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCC
T ss_pred hhcccc-----cCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHH
Confidence 000000 01111111 123456689999999999999999999999999998885543
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=291.55 Aligned_cols=250 Identities=23% Similarity=0.228 Sum_probs=179.4
Q ss_pred CcchhccCCcEEEEEEeecCCCcc-----------hhHHHHHHHHHhcCCCCcccceeeEeee-----CCeeEEEEecCC
Q 021490 1 MMQVILCLLQDVAIKQLDRNGVQG-----------NREFLVEVLMLSLLHHPNLVNLIGYCAD-----GDQRLLVYEYMP 64 (311)
Q Consensus 1 ~~~~~~~~g~~vaiK~~~~~~~~~-----------~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~ 64 (311)
||.+...+|..||||++....... .+.+.+|+++++.++||||+++++++.. ....++||||++
T Consensus 38 V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~ 117 (362)
T 3pg1_A 38 VCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR 117 (362)
T ss_dssp EEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCS
T ss_pred EEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEeccCCCcceEEEEEccCC
Confidence 355556679999999986543321 2678999999999999999999999844 336899999997
Q ss_pred CCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCc
Q 021490 65 LGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT 144 (311)
Q Consensus 65 ~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~ 144 (311)
++|.+++.. ....+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++..... .
T Consensus 118 -~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~---~ 187 (362)
T 3pg1_A 118 -TDLAQVIHD---QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTA---D 187 (362)
T ss_dssp -EEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCTTC----------
T ss_pred -CCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEEcCCCCEEEEecCccccccc---c
Confidence 688888775 2457999999999999999999999999 99999999999999999999999999864222 1
Q ss_pred eeeeeccccccccCcccccc-CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHH-hhhh------------hc
Q 021490 145 HVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAW-ARPL------------FQ 210 (311)
Q Consensus 145 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~-~~~~------------~~ 210 (311)
.......++..|+|||++.+ ..++.++|||||||++|+|++|..||...........+.. .... ..
T Consensus 188 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 267 (362)
T 3pg1_A 188 ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSAR 267 (362)
T ss_dssp --------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHH
T ss_pred cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhh
Confidence 22233468889999998876 6789999999999999999999999987654433222111 0000 00
Q ss_pred ccccccc-ccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 021490 211 DRTRHSL-IADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 260 (311)
Q Consensus 211 ~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l 260 (311)
....... ...........+..+..+.+|+.+||+.||.+|||+.++++..
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 318 (362)
T 3pg1_A 268 DYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHP 318 (362)
T ss_dssp HHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred HHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCc
Confidence 0000000 0000000011122345788999999999999999999999864
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=294.98 Aligned_cols=233 Identities=24% Similarity=0.316 Sum_probs=183.2
Q ss_pred cCCcEEEEEEeecCC----CcchhHHHHHHHHHhcC-CCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCC
Q 021490 7 CLLQDVAIKQLDRNG----VQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKP 81 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 81 (311)
.+|+.||||+++... ....+.+.+|+.++..+ .||||+++++++.+....++||||+++++|.+++.. ...
T Consensus 80 ~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~ 155 (355)
T 1vzo_A 80 DTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQ----RER 155 (355)
T ss_dssp TTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHH----HSC
T ss_pred CCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEEEEeecCCCCCHHHHHHH----cCC
Confidence 478999999986543 23346777899999999 699999999999999999999999999999999987 467
Q ss_pred CCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccc
Q 021490 82 LDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 161 (311)
Q Consensus 82 l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 161 (311)
+++..+..++.|++.||+|||+.+ ++||||||+|||++.++.++|+|||++....... ........++..|+|||+
T Consensus 156 ~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~~~~~gt~~y~aPE~ 231 (355)
T 1vzo_A 156 FTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE-TERAYDFCGTIEYMAPDI 231 (355)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEECCGGG-GGGGCGGGSCCTTCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCeecccCC-CCcccCcccCcCccChhh
Confidence 999999999999999999999999 9999999999999999999999999986532211 112223468999999999
Q ss_pred ccc--CCCccccceeehhHHHHHHHhCCCccCcchhHHHH-HHHHHhhhhhccccccccccCccccCCCChHhHHHHHHH
Q 021490 162 AKT--GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ-SLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAV 238 (311)
Q Consensus 162 ~~~--~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 238 (311)
+.+ ..++.++|||||||++|+|++|..||......... .+.... ... .+ .++...+..+.+|
T Consensus 232 ~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~---~~~--------~~----~~~~~~~~~~~~l 296 (355)
T 1vzo_A 232 VRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI---LKS--------EP----PYPQEMSALAKDL 296 (355)
T ss_dssp HTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH---HHC--------CC----CCCTTSCHHHHHH
T ss_pred hcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHH---hcc--------CC----CCCcccCHHHHHH
Confidence 875 35788999999999999999999999754321111 111110 100 11 1223344578899
Q ss_pred HHHccccCCCCCC-----CHHHHHHHHHH
Q 021490 239 AAMCVHEQPDMRP-----VIADVVTALAY 262 (311)
Q Consensus 239 i~~~l~~~p~~Rp-----s~~~vl~~l~~ 262 (311)
+.+||..||.+|| |+.++++...+
T Consensus 297 i~~~L~~dP~~R~~~~~~s~~ell~h~~f 325 (355)
T 1vzo_A 297 IQRLLMKDPKKRLGCGPRDADEIKEHLFF 325 (355)
T ss_dssp HHHHTCSSGGGSTTSSTTTHHHHHTSGGG
T ss_pred HHHHhhhCHHHhcCCCCCCHHHHHcCcch
Confidence 9999999999999 99999987643
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=286.97 Aligned_cols=241 Identities=27% Similarity=0.389 Sum_probs=170.5
Q ss_pred CCcEEEEEEeecCC-CcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccC----CCCCCC
Q 021490 8 LLQDVAIKQLDRNG-VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLS----PGKKPL 82 (311)
Q Consensus 8 ~g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~l 82 (311)
+|+.||||++.... ....+.+.+|+.++..++||||+++++++......++||||++|++|.+++.... .....+
T Consensus 39 ~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 118 (303)
T 2vwi_A 39 KKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVL 118 (303)
T ss_dssp --CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSS
T ss_pred CCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccCCchHHHHHHHhhccccccCCC
Confidence 68999999986543 2345678899999999999999999999999999999999999999999986421 124569
Q ss_pred CHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCC---ceeeeeccccccccCc
Q 021490 83 DWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN---THVSTRVMGTYGYCAP 159 (311)
Q Consensus 83 ~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~y~aP 159 (311)
++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++........ ........++..|+||
T Consensus 119 ~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aP 195 (303)
T 2vwi_A 119 DESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAP 195 (303)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHHHCC---------------CCCTTCCH
T ss_pred CHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCH
Confidence 99999999999999999999999 99999999999999999999999998865332211 1112234688999999
Q ss_pred ccccc-CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhcccc-ccccccCccccCCCChHhHHHHHH
Q 021490 160 EYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRT-RHSLIADPELQGQYPPRGFYQALA 237 (311)
Q Consensus 160 E~~~~-~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~ 237 (311)
|++.+ ..++.++||||||+++|+|++|..||............. ..... ......++.... ..+..+.+
T Consensus 196 E~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~----~~~~~~~~ 266 (303)
T 2vwi_A 196 EVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTL-----QNDPPSLETGVQDKEMLK----KYGKSFRK 266 (303)
T ss_dssp HHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHH-----TSSCCCTTC-----CCCC----CCCHHHHH
T ss_pred HHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHh-----ccCCCccccccccchhhh----hhhHHHHH
Confidence 99865 568999999999999999999999997655433221110 00000 001111111222 23347889
Q ss_pred HHHHccccCCCCCCCHHHHHHHH
Q 021490 238 VAAMCVHEQPDMRPVIADVVTAL 260 (311)
Q Consensus 238 li~~~l~~~p~~Rps~~~vl~~l 260 (311)
++.+||+.||.+|||+.++++.-
T Consensus 267 li~~~l~~dp~~Rps~~~ll~h~ 289 (303)
T 2vwi_A 267 MISLCLQKDPEKRPTAAELLRHK 289 (303)
T ss_dssp HHHHHCCSSGGGSCCHHHHHTST
T ss_pred HHHHHccCChhhCcCHHHHhhCh
Confidence 99999999999999999999753
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-40 Score=292.40 Aligned_cols=243 Identities=19% Similarity=0.247 Sum_probs=180.8
Q ss_pred cCCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeee----------------------------------
Q 021490 7 CLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCAD---------------------------------- 52 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---------------------------------- 52 (311)
.+|+.||||++.... ....+|+.+++.++||||+++++++..
T Consensus 30 ~~~~~vAiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 105 (383)
T 3eb0_A 30 ESGKRFALKKVLQDP----RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIV 105 (383)
T ss_dssp TTCCEEEEEEEECCT----TSCCHHHHHHTTCCCTTBCCEEEEEEEC---------------------------------
T ss_pred CCCCEEEEEEEecCc----chHHHHHHHHHHcCCCCccchhheeeecCcccccccccccccccccccccccccccccccc
Confidence 478999999986443 223469999999999999999999843
Q ss_pred ----CCeeEEEEecCCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEc-CCCce
Q 021490 53 ----GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD-RGYHP 127 (311)
Q Consensus 53 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~-~~~~~ 127 (311)
+...++||||++ ++|.+.+......+..+++..+..++.|++.||+|||+.| ++||||||+||+++ .++.+
T Consensus 106 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---i~H~Dikp~Nil~~~~~~~~ 181 (383)
T 3eb0_A 106 NPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG---ICHRDIKPQNLLVNSKDNTL 181 (383)
T ss_dssp ----CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEEETTTTEE
T ss_pred cCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCc---CccCccCHHHEEEcCCCCcE
Confidence 334889999997 5887777654334678999999999999999999999999 99999999999997 68899
Q ss_pred EEccccccccCCCCCCceeeeeccccccccCccccccC-CCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHh-
Q 021490 128 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWA- 205 (311)
Q Consensus 128 ~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~- 205 (311)
+|+|||++....... ......++..|+|||++.+. .++.++||||+||++|+|++|..||......+....+...
T Consensus 182 kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~ 258 (383)
T 3eb0_A 182 KLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIM 258 (383)
T ss_dssp EECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred EEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence 999999997532221 22234578899999988764 5899999999999999999999999876654433222111
Q ss_pred hhh-------hcc---ccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 021490 206 RPL-------FQD---RTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 260 (311)
Q Consensus 206 ~~~-------~~~---~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l 260 (311)
... +.. ...........+...++...+..+.+|+.+||+.||.+|||+.|+++.-
T Consensus 259 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 323 (383)
T 3eb0_A 259 GTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHP 323 (383)
T ss_dssp CCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSG
T ss_pred CCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCH
Confidence 000 000 0000001111111123334456789999999999999999999999653
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=285.65 Aligned_cols=238 Identities=24% Similarity=0.300 Sum_probs=181.5
Q ss_pred CcchhccCCcEEEEEEeecCCC--cchhHHHHHHHHHhcCC--CCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccC
Q 021490 1 MMQVILCLLQDVAIKQLDRNGV--QGNREFLVEVLMLSLLH--HPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLS 76 (311)
Q Consensus 1 ~~~~~~~~g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 76 (311)
||.+...+|+.||+|++..... ...+.+.+|+.++..++ ||||+++++++.++...++||| +.+++|.+++..
T Consensus 44 Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~-- 120 (313)
T 3cek_A 44 VFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKK-- 120 (313)
T ss_dssp EEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-CCSEEHHHHHHH--
T ss_pred EEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-cCCCcHHHHHHh--
Confidence 3556667899999999975543 23468899999999997 5999999999999999999999 557899999987
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccc
Q 021490 77 PGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY 156 (311)
Q Consensus 77 ~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y 156 (311)
...+++..++.++.|++.||+|||+.+ ++|+||+|+||++++ +.++|+|||++................++..|
T Consensus 121 --~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y 194 (313)
T 3cek_A 121 --KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNY 194 (313)
T ss_dssp --CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSCC--------------CCGGG
T ss_pred --cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeeccccccccCccccccccCCCCCCCc
Confidence 567999999999999999999999999 999999999999965 89999999998754332222222344689999
Q ss_pred cCcccccc-----------CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccC
Q 021490 157 CAPEYAKT-----------GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQG 225 (311)
Q Consensus 157 ~aPE~~~~-----------~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (311)
+|||++.+ ..++.++||||||+++|+|++|..||......... ... .. ++....
T Consensus 195 ~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~-~~~----~~----------~~~~~~ 259 (313)
T 3cek_A 195 MPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK-LHA----II----------DPNHEI 259 (313)
T ss_dssp CCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH-HHH----HH----------CTTSCC
T ss_pred CCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHH-HHH----HH----------hccccc
Confidence 99999865 46788999999999999999999999764322111 000 01 111111
Q ss_pred CCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 021490 226 QYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAY 262 (311)
Q Consensus 226 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l~~ 262 (311)
.++...+..+.+++.+||+.||.+|||+.++++....
T Consensus 260 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~ 296 (313)
T 3cek_A 260 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 296 (313)
T ss_dssp CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred CCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccc
Confidence 1222234578899999999999999999999987543
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=283.06 Aligned_cols=250 Identities=22% Similarity=0.238 Sum_probs=185.6
Q ss_pred cchhc--cCCcEEEEEEeecCCC--cchhHHHHHHHHHhcC---CCCcccceeeEee-----eCCeeEEEEecCCCCChh
Q 021490 2 MQVIL--CLLQDVAIKQLDRNGV--QGNREFLVEVLMLSLL---HHPNLVNLIGYCA-----DGDQRLLVYEYMPLGSVE 69 (311)
Q Consensus 2 ~~~~~--~~g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~ 69 (311)
|.+.. .+|+.||+|+++.... .....+.+|+.+++.+ +||||+++++++. .....++||||++ ++|.
T Consensus 28 ~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~ 106 (326)
T 1blx_A 28 FKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLT 106 (326)
T ss_dssp EEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCS-CBHH
T ss_pred EEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEEEEEecCC-CCHH
Confidence 44443 4688999999875432 2234677888887766 8999999999987 4567899999997 6999
Q ss_pred hhhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeee
Q 021490 70 DHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTR 149 (311)
Q Consensus 70 ~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~ 149 (311)
+++.... ...+++..++.++.|++.||+|||+.| ++|+||+|+||+++.++.++|+|||++..... ......
T Consensus 107 ~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~---~~~~~~ 178 (326)
T 1blx_A 107 TYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTS 178 (326)
T ss_dssp HHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCCSCCCCCG---GGGGCC
T ss_pred HHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEecCcccccccC---CCCccc
Confidence 9987632 345999999999999999999999999 99999999999999999999999999875321 112233
Q ss_pred ccccccccCccccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhh-ccccccc-c-----c--cC
Q 021490 150 VMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLF-QDRTRHS-L-----I--AD 220 (311)
Q Consensus 150 ~~~~~~y~aPE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~-~-----~--~~ 220 (311)
..++..|+|||++.+..++.++||||||+++|+|++|..||...........+....... ....... . . ..
T Consensus 179 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (326)
T 1blx_A 179 VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKS 258 (326)
T ss_dssp CCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCC
T ss_pred cccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccccchhhhcccC
Confidence 467899999999998899999999999999999999999998766544332221110000 0000000 0 0 00
Q ss_pred ccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 021490 221 PELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 260 (311)
Q Consensus 221 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l 260 (311)
......+....+..+.+|+.+||..||.+|||+.++++.-
T Consensus 259 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 298 (326)
T 1blx_A 259 AQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHP 298 (326)
T ss_dssp CCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred cchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCc
Confidence 0001112233456788999999999999999999999753
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=283.85 Aligned_cols=230 Identities=26% Similarity=0.318 Sum_probs=177.9
Q ss_pred cCCcEEEEEEeecCCCcchhHHHHHHHHHhcC-CCCcccceeeEeee------CCeeEEEEecCCCCChhhhhcccCCCC
Q 021490 7 CLLQDVAIKQLDRNGVQGNREFLVEVLMLSLL-HHPNLVNLIGYCAD------GDQRLLVYEYMPLGSVEDHLHDLSPGK 79 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~~~l~~~~~~~ 79 (311)
.+|+.||||++... ....+.+.+|+.++..+ +||||+++++++.. ....++||||+++++|.+++.... .
T Consensus 47 ~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~ 123 (326)
T 2x7f_A 47 KTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK--G 123 (326)
T ss_dssp TTCCEEEEEEEECC-SSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSG--G
T ss_pred CCCCeEEEEEEecC-cccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhcc--c
Confidence 47899999999644 34567889999999999 79999999999976 467899999999999999998632 3
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCc
Q 021490 80 KPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 159 (311)
Q Consensus 80 ~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aP 159 (311)
..+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++...... ........++..|+||
T Consensus 124 ~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~~~y~aP 198 (326)
T 2x7f_A 124 NTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT--VGRRNTFIGTPYWMAP 198 (326)
T ss_dssp GCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCTTTC---------------CCGGGCCH
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEeeCcCceecCcC--ccccccccCCccccCh
Confidence 57999999999999999999999999 999999999999999999999999998653221 1112334688999999
Q ss_pred cccc-----cCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHH
Q 021490 160 EYAK-----TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQ 234 (311)
Q Consensus 160 E~~~-----~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
|++. +..++.++||||||+++|+|++|..||...........+. ... .+. ..+...+..
T Consensus 199 E~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~------~~~-------~~~---~~~~~~~~~ 262 (326)
T 2x7f_A 199 EVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP------RNP-------APR---LKSKKWSKK 262 (326)
T ss_dssp HHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH------HSC-------CCC---CSCSCSCHH
T ss_pred hhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhh------cCc-------ccc---CCccccCHH
Confidence 9986 4678899999999999999999999997655433221110 000 000 011223347
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHHH
Q 021490 235 ALAVAAMCVHEQPDMRPVIADVVTAL 260 (311)
Q Consensus 235 l~~li~~~l~~~p~~Rps~~~vl~~l 260 (311)
+.+++.+||..||.+|||+.++++..
T Consensus 263 l~~li~~~l~~dp~~Rps~~~ll~hp 288 (326)
T 2x7f_A 263 FQSFIESCLVKNHSQRPATEQLMKHP 288 (326)
T ss_dssp HHHHHHHHCCSSGGGSCCHHHHHTSH
T ss_pred HHHHHHHHhccChhhCCCHHHHhhCh
Confidence 88999999999999999999999864
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=288.71 Aligned_cols=243 Identities=21% Similarity=0.246 Sum_probs=176.0
Q ss_pred cCCcEEEEEEeecCCC--cchhHHHHHHHHHhcCCCCcccceeeEeeeCC------eeEEEEecCCCCChhhhhcccCCC
Q 021490 7 CLLQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGD------QRLLVYEYMPLGSVEDHLHDLSPG 78 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~ 78 (311)
.+|+.||||++..... ...+.+.+|+.+++.++||||+++++++.... ..++||||++ ++|.+++..
T Consensus 48 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---- 122 (371)
T 2xrw_A 48 ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQM---- 122 (371)
T ss_dssp TTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEEECCS-EEHHHHHHS----
T ss_pred CCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEEEEEcCC-CCHHHHHhh----
Confidence 3689999999975432 33467889999999999999999999997654 7899999997 578888753
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccC
Q 021490 79 KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCA 158 (311)
Q Consensus 79 ~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~a 158 (311)
.+++..+..++.|++.||+|||+++ ++||||||+||+++.++.+||+|||++...... .......++..|+|
T Consensus 123 --~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~a 194 (371)
T 2xrw_A 123 --ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRA 194 (371)
T ss_dssp --CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-------------------CTTCC
T ss_pred --ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecccccccc---cccCCceecCCccC
Confidence 4899999999999999999999999 999999999999999999999999998753221 12233468899999
Q ss_pred ccccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHh----------------hhhhccccccccc----
Q 021490 159 PEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWA----------------RPLFQDRTRHSLI---- 218 (311)
Q Consensus 159 PE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~---- 218 (311)
||++.+..++.++|||||||++|+|++|..||...+.......+... .............
T Consensus 195 PE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (371)
T 2xrw_A 195 PEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEK 274 (371)
T ss_dssp HHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHH
T ss_pred HHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhh
Confidence 99999989999999999999999999999999876654332211100 0000000000000
Q ss_pred cCccc--cC--CCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 021490 219 ADPEL--QG--QYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAY 262 (311)
Q Consensus 219 ~~~~~--~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l~~ 262 (311)
..+.. .. ..+...+..+.+|+.+||..||.+|||+.++++.-..
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~ 322 (371)
T 2xrw_A 275 LFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 322 (371)
T ss_dssp HSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHH
T ss_pred hcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcch
Confidence 00000 00 0011235678999999999999999999999987653
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-40 Score=286.78 Aligned_cols=238 Identities=24% Similarity=0.313 Sum_probs=169.8
Q ss_pred cCCcEEEEEEeecCCCcchhHHHHHHHHHhcCC-CCcccceeeEee--------eCCeeEEEEecCCCCChhhhhcccCC
Q 021490 7 CLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLH-HPNLVNLIGYCA--------DGDQRLLVYEYMPLGSVEDHLHDLSP 77 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--------~~~~~~lv~e~~~~~~L~~~l~~~~~ 77 (311)
.+|+.||||++........+.+.+|+.++..+. ||||+++++++. .....++||||++ |+|.+++....
T Consensus 51 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~- 128 (337)
T 3ll6_A 51 GSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKME- 128 (337)
T ss_dssp TTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHH-
T ss_pred CCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEEEEEecC-CCHHHHHHHhh-
Confidence 378999999997766666678999999999996 999999999984 3345799999996 78988886532
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCce----------ee
Q 021490 78 GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH----------VS 147 (311)
Q Consensus 78 ~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~----------~~ 147 (311)
....+++..++.++.|++.||+|||+.+ .+++|+||||+|||++.++.++|+|||++.......... ..
T Consensus 129 ~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~ 207 (337)
T 3ll6_A 129 SRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEE 207 (337)
T ss_dssp TTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC---------------
T ss_pred ccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCccceeccccCcccccccccccchhh
Confidence 1356999999999999999999999874 349999999999999999999999999997643322111 11
Q ss_pred eeccccccccCcccc---ccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCcccc
Q 021490 148 TRVMGTYGYCAPEYA---KTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQ 224 (311)
Q Consensus 148 ~~~~~~~~y~aPE~~---~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (311)
....++..|+|||++ .+..++.++||||||+++|+|++|..||......... .....
T Consensus 208 ~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~----------~~~~~---------- 267 (337)
T 3ll6_A 208 ITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIV----------NGKYS---------- 267 (337)
T ss_dssp ----------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------------------CC----------
T ss_pred ccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhh----------cCccc----------
Confidence 134588999999998 5667889999999999999999999999754321110 00000
Q ss_pred CCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhcc
Q 021490 225 GQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQK 267 (311)
Q Consensus 225 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~~ 267 (311)
.......+..+.+|+.+||+.||.+|||+.++++.|+.+....
T Consensus 268 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~ 310 (337)
T 3ll6_A 268 IPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR 310 (337)
T ss_dssp CCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred CCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 0001111235778999999999999999999999999887644
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=288.75 Aligned_cols=240 Identities=21% Similarity=0.228 Sum_probs=171.2
Q ss_pred cCCcEEEEEEeecCCC--cchhHHHHHHHHHhcCCCCcccceeeEeeeC------CeeEEEEecCCCCChhhhhcccCCC
Q 021490 7 CLLQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADG------DQRLLVYEYMPLGSVEDHLHDLSPG 78 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~ 78 (311)
.+|+.||||++..... ...+.+.+|+.+++.++||||+++++++... ...++|+|++ +++|.+++..
T Consensus 52 ~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---- 126 (367)
T 2fst_X 52 KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC---- 126 (367)
T ss_dssp TTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECC-CEECC---------
T ss_pred CCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEeccc-CCCHHHHHhc----
Confidence 4789999999865432 3346888999999999999999999998654 5679999999 6899988864
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccC
Q 021490 79 KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCA 158 (311)
Q Consensus 79 ~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~a 158 (311)
..+++..+..++.|++.||+|||+.| ++||||||+||+++.++.+||+|||++..... ......++..|+|
T Consensus 127 -~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~a 197 (367)
T 2fst_X 127 -QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTAD-----EMTGYVATRWYRA 197 (367)
T ss_dssp -CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC--------------------CCCTTCC
T ss_pred -CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeeccccccccc-----cCCCcCcCcCccC
Confidence 56999999999999999999999999 99999999999999999999999999875321 1233468999999
Q ss_pred cccccc-CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhh-----ccccc---------cccccCccc
Q 021490 159 PEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLF-----QDRTR---------HSLIADPEL 223 (311)
Q Consensus 159 PE~~~~-~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-----~~~~~---------~~~~~~~~~ 223 (311)
||++.+ ..++.++|||||||++|+|++|..||.+.+.......+....... ..... ........+
T Consensus 198 PE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (367)
T 2fst_X 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNF 277 (367)
T ss_dssp HHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCH
T ss_pred hHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCH
Confidence 999876 678999999999999999999999998776544433221110000 00000 000000000
Q ss_pred cCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 021490 224 QGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 261 (311)
Q Consensus 224 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l~ 261 (311)
. ...+..+..+.+|+.+||+.||.+|||+.++++...
T Consensus 278 ~-~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~ 314 (367)
T 2fst_X 278 A-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 314 (367)
T ss_dssp H-HHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred H-HHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChh
Confidence 0 001122457889999999999999999999998743
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=282.47 Aligned_cols=228 Identities=25% Similarity=0.311 Sum_probs=175.1
Q ss_pred cCCcEEEEEEeecCCC--------cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCC
Q 021490 7 CLLQDVAIKQLDRNGV--------QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPG 78 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~--------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~ 78 (311)
.+|+.||||++..... .....+.+|+.+++.++||||+++++++..+. .++||||+++++|.+++..
T Consensus 33 ~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~---- 107 (322)
T 2ycf_A 33 KTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVG---- 107 (322)
T ss_dssp TTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-EEEEEECCTTEETHHHHST----
T ss_pred CCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-eEEEEecCCCCcHHHHHhc----
Confidence 3689999999865421 22346889999999999999999999987654 8999999999999999876
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCc---eEEccccccccCCCCCCceeeeecccccc
Q 021490 79 KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH---PKLSDFGLAKLGPVGDNTHVSTRVMGTYG 155 (311)
Q Consensus 79 ~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~---~~l~df~~~~~~~~~~~~~~~~~~~~~~~ 155 (311)
...+++..++.++.|++.||+|||+++ ++|+||||+||+++.++. ++|+|||++..... ........++..
T Consensus 108 ~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~---~~~~~~~~gt~~ 181 (322)
T 2ycf_A 108 NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE---TSLMRTLCGTPT 181 (322)
T ss_dssp TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCCTTCEECCC---CHHHHHHHSCCT
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccCccceeccc---ccccccccCCcC
Confidence 567999999999999999999999999 999999999999987654 99999999875322 111223458899
Q ss_pred ccCccccc---cCCCccccceeehhHHHHHHHhCCCccCcchhHHH-HHHHHHhhhhhccccccccccCccccCCCChHh
Q 021490 156 YCAPEYAK---TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE-QSLVAWARPLFQDRTRHSLIADPELQGQYPPRG 231 (311)
Q Consensus 156 y~aPE~~~---~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (311)
|+|||++. ...++.++||||||+++|+|++|..||........ ...+... . ....+... ...
T Consensus 182 y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~------~----~~~~~~~~----~~~ 247 (322)
T 2ycf_A 182 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG------K----YNFIPEVW----AEV 247 (322)
T ss_dssp TCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHT------C----CCCCHHHH----TTS
T ss_pred ccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhC------c----cccCchhh----hhc
Confidence 99999874 46788999999999999999999999975443211 1111000 0 00001111 122
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 021490 232 FYQALAVAAMCVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 232 ~~~l~~li~~~l~~~p~~Rps~~~vl~~ 259 (311)
+..+.+++.+||+.||.+|||+.++++.
T Consensus 248 ~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 248 SEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 4478899999999999999999999864
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=277.47 Aligned_cols=228 Identities=25% Similarity=0.301 Sum_probs=182.6
Q ss_pred CCcEEEEEEeecCC--CcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHH
Q 021490 8 LLQDVAIKQLDRNG--VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN 85 (311)
Q Consensus 8 ~g~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~ 85 (311)
+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+....++||||+++++|.+++.. ...+++.
T Consensus 46 ~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~ 121 (287)
T 2wei_A 46 TQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIK----RKRFSEH 121 (287)
T ss_dssp TCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH----HSSCCHH
T ss_pred CCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEccCCCCHHHHHHh----cCCCCHH
Confidence 78999999987643 24457899999999999999999999999999999999999999999998876 4679999
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCC---CceEEccccccccCCCCCCceeeeeccccccccCcccc
Q 021490 86 TRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG---YHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 162 (311)
Q Consensus 86 ~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~---~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 162 (311)
.++.++.|++.||+|||+.+ ++|+||+|+||+++.+ +.++|+|||++....... ......++..|+|||++
T Consensus 122 ~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~ 195 (287)
T 2wei_A 122 DAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT---KMKDRIGTAYYIAPEVL 195 (287)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCS---SCSCHHHHHTTCCHHHH
T ss_pred HHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcceeecCCC---ccccccCcccccChHHh
Confidence 99999999999999999999 9999999999999754 469999999987532221 12234578899999998
Q ss_pred ccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHc
Q 021490 163 KTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMC 242 (311)
Q Consensus 163 ~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 242 (311)
.+ .++.++||||||+++|+|++|..||...........+... .... ..+. ....+..+.+++.+|
T Consensus 196 ~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~------~~~~---~~~~-----~~~~~~~~~~li~~~ 260 (287)
T 2wei_A 196 RG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETG------KYAF---DLPQ-----WRTISDDAKDLIRKM 260 (287)
T ss_dssp TT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------CCCC---CSGG-----GTTSCHHHHHHHHHH
T ss_pred cC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC------CCCC---Cchh-----hhhcCHHHHHHHHHH
Confidence 75 4889999999999999999999999876544332221110 0000 0000 012234788999999
Q ss_pred cccCCCCCCCHHHHHHHH
Q 021490 243 VHEQPDMRPVIADVVTAL 260 (311)
Q Consensus 243 l~~~p~~Rps~~~vl~~l 260 (311)
|+.||.+|||+.++++..
T Consensus 261 l~~dp~~Rps~~ell~hp 278 (287)
T 2wei_A 261 LTFHPSLRITATQCLEHP 278 (287)
T ss_dssp TCSSGGGSCCHHHHHHSH
T ss_pred cccChhhCcCHHHHhcCH
Confidence 999999999999999854
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=280.07 Aligned_cols=238 Identities=16% Similarity=0.173 Sum_probs=179.9
Q ss_pred cCCcEEEEEEeecCCCcchhHHHHHHHHHhcCC-CCcccceeeEeee--CCeeEEEEecCCCCChhhhhcccCCCCCCCC
Q 021490 7 CLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLH-HPNLVNLIGYCAD--GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLD 83 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~ 83 (311)
.+|+.||||+++. ...+.+.+|+.+++.++ ||||+++++++.+ ....++||||+++++|.+++.. ++
T Consensus 59 ~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-------~~ 128 (330)
T 3nsz_A 59 TNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-------LT 128 (330)
T ss_dssp TTCCEEEEEEECS---CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGGG-------CC
T ss_pred CCCcEEEEEEecc---cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHHh-------CC
Confidence 4789999999863 34578899999999997 9999999999987 6678999999999999998864 88
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCC-ceEEccccccccCCCCCCceeeeeccccccccCcccc
Q 021490 84 WNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY-HPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 162 (311)
Q Consensus 84 ~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 162 (311)
+..+..++.|++.||+|||+.+ ++||||||+|||++.++ .++|+|||++....... ......++..|+|||++
T Consensus 129 ~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~ 202 (330)
T 3nsz_A 129 DYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ---EYNVRVASRYFKGPELL 202 (330)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC---CCCSCCSCGGGCCHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC---ccccccccccccChhhh
Confidence 9999999999999999999999 99999999999999776 89999999997543222 12334688899999998
Q ss_pred cc-CCCccccceeehhHHHHHHHhCCCccCcchhHHH-HH-HHHHhh-----hhhcccc-------------ccccccCc
Q 021490 163 KT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE-QS-LVAWAR-----PLFQDRT-------------RHSLIADP 221 (311)
Q Consensus 163 ~~-~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~-~~-~~~~~~-----~~~~~~~-------------~~~~~~~~ 221 (311)
.+ ..++.++|||||||++|+|++|..||........ .. ...... ..+.... ........
T Consensus 203 ~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (330)
T 3nsz_A 203 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWER 282 (330)
T ss_dssp TTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGG
T ss_pred cCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhh
Confidence 76 6789999999999999999999999954332211 11 000000 0000000 00000000
Q ss_pred cccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 021490 222 ELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 260 (311)
Q Consensus 222 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l 260 (311)
......+...+..+.+|+.+||+.||.+|||++++++.-
T Consensus 283 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp 321 (330)
T 3nsz_A 283 FVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHP 321 (330)
T ss_dssp GCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSG
T ss_pred hccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCc
Confidence 111112223456889999999999999999999999863
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-40 Score=281.10 Aligned_cols=234 Identities=21% Similarity=0.253 Sum_probs=169.6
Q ss_pred cCCcEEEEEEeecCCCcc-h-hHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCH
Q 021490 7 CLLQDVAIKQLDRNGVQG-N-REFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 84 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~~-~-~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~ 84 (311)
.+|+.||+|+++...... . +.+.++...++.++||||+++++++.++...++||||++ ++|.+++.........+++
T Consensus 30 ~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~ 108 (290)
T 3fme_A 30 PSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPE 108 (290)
T ss_dssp TTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCS-EEHHHHHHHHHHTTCCCCH
T ss_pred CCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhc-cchHHHHHHHHhcCCCCCH
Confidence 478999999997653322 2 334455556888899999999999999999999999997 5888877654333578999
Q ss_pred HHHHHHHHHHHHHHHHhhcC-CCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccc-
Q 021490 85 NTRMKIAAGAARGLEYLHDK-AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA- 162 (311)
Q Consensus 85 ~~~~~~~~~i~~~l~~lh~~-~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~- 162 (311)
..++.++.|++.||+|||++ + ++|+||||+||+++.++.++|+|||++...... .......++..|+|||++
T Consensus 109 ~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~ 182 (290)
T 3fme_A 109 DILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLVDD---VAKDIDAGCKPYMAPERIN 182 (290)
T ss_dssp HHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC------------------CCCCCCSCHHHHS
T ss_pred HHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccccc---ccccccCCCccccChhhcC
Confidence 99999999999999999998 9 999999999999999999999999998653222 122234588999999996
Q ss_pred ---ccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHH
Q 021490 163 ---KTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVA 239 (311)
Q Consensus 163 ---~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 239 (311)
.+..++.++||||||+++|+|++|..||.......... ... ..... +. ..+...+..+.+++
T Consensus 183 ~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-~~~----~~~~~-------~~---~~~~~~~~~~~~li 247 (290)
T 3fme_A 183 PELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQL-KQV----VEEPS-------PQ---LPADKFSAEFVDFT 247 (290)
T ss_dssp CCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHH-HHH----HHSCC-------CC---CCTTTSCHHHHHHH
T ss_pred hhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHH-HHH----hccCC-------CC---cccccCCHHHHHHH
Confidence 45678899999999999999999999997533221111 000 00000 00 01122345788999
Q ss_pred HHccccCCCCCCCHHHHHHHHHH
Q 021490 240 AMCVHEQPDMRPVIADVVTALAY 262 (311)
Q Consensus 240 ~~~l~~~p~~Rps~~~vl~~l~~ 262 (311)
.+||+.||++|||+.++++...+
T Consensus 248 ~~~l~~~p~~Rpt~~e~l~hp~f 270 (290)
T 3fme_A 248 SQCLKKNSKERPTYPELMQHPFF 270 (290)
T ss_dssp HHHTCSSGGGSCCHHHHTTSHHH
T ss_pred HHHhhcChhhCcCHHHHHhCccc
Confidence 99999999999999999986543
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=292.30 Aligned_cols=249 Identities=25% Similarity=0.256 Sum_probs=179.8
Q ss_pred cchhcc-CCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeC------CeeEEEEecCCCCChhhhhcc
Q 021490 2 MQVILC-LLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADG------DQRLLVYEYMPLGSVEDHLHD 74 (311)
Q Consensus 2 ~~~~~~-~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~ 74 (311)
|.+... +|+.||||++.... ..+.+|+++|+.++||||+++++++... ...++||||+++ +|.+.+..
T Consensus 71 y~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~ 145 (420)
T 1j1b_A 71 YQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARH 145 (420)
T ss_dssp EEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCCE-EHHHHHHH
T ss_pred EEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhcccc-cHHHHHHH
Confidence 444443 68999999986432 2334799999999999999999988432 236799999975 66666554
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCC-CceEEccccccccCCCCCCceeeeecccc
Q 021490 75 LSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG-YHPKLSDFGLAKLGPVGDNTHVSTRVMGT 153 (311)
Q Consensus 75 ~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~ 153 (311)
.......+++..++.++.||+.||+|||+.+ |+||||||+|||++.+ +.+||+|||++....... ......++
T Consensus 146 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~---~~~~~~~t 219 (420)
T 1j1b_A 146 YSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE---PNVSYICS 219 (420)
T ss_dssp HHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC---CCCSCCSC
T ss_pred HhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhhhcccCC---CceeeeeC
Confidence 3223577999999999999999999999999 9999999999999954 678999999997532221 12234679
Q ss_pred ccccCccccccC-CCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHh-hh----hhcc-ccccccccCcccc--
Q 021490 154 YGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWA-RP----LFQD-RTRHSLIADPELQ-- 224 (311)
Q Consensus 154 ~~y~aPE~~~~~-~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~-~~----~~~~-~~~~~~~~~~~~~-- 224 (311)
..|+|||++.+. .++.++|||||||++|+|++|..||......+....+... .. .+.. .........+.+.
T Consensus 220 ~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~ 299 (420)
T 1j1b_A 220 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAH 299 (420)
T ss_dssp TTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCC
T ss_pred CCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCC
Confidence 999999998764 7899999999999999999999999876654332221111 00 0000 0000011111111
Q ss_pred ---CCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 021490 225 ---GQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 261 (311)
Q Consensus 225 ---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l~ 261 (311)
..+++..+.++.+|+.+||..||.+|||+.|+++...
T Consensus 300 ~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~ 339 (420)
T 1j1b_A 300 PWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 339 (420)
T ss_dssp CHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred CHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHh
Confidence 1122334568999999999999999999999997644
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=293.67 Aligned_cols=240 Identities=21% Similarity=0.234 Sum_probs=186.3
Q ss_pred cCCcEEEEEEeecCCCcchhHHHHHHHHHhcCCC-CcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHH
Q 021490 7 CLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHH-PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN 85 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~ 85 (311)
.+|+.||||+++... ...++.+|++++..|+| +++..+..++.+....++||||+ +++|.+++... ...+++.
T Consensus 30 ~~~~~vAvK~~~~~~--~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~sL~~ll~~~---~~~l~~~ 103 (483)
T 3sv0_A 30 QTNEEVAIKLENVKT--KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC---SRKLSLK 103 (483)
T ss_dssp TTCCEEEEEEEETTC--SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHT---TTCCCHH
T ss_pred CCCcEEEEEEecccc--ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CCCHHHHHHhh---cCCCCHH
Confidence 469999999886543 34568899999999987 55666666777888899999999 89999999853 4579999
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEE---cCCCceEEccccccccCCCCCCce-----eeeecccccccc
Q 021490 86 TRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL---DRGYHPKLSDFGLAKLGPVGDNTH-----VSTRVMGTYGYC 157 (311)
Q Consensus 86 ~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~---~~~~~~~l~df~~~~~~~~~~~~~-----~~~~~~~~~~y~ 157 (311)
.++.++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||++.......... ......++..|+
T Consensus 104 ~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 180 (483)
T 3sv0_A 104 TVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180 (483)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTC
T ss_pred HHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCcccc
Confidence 99999999999999999999 9999999999999 588999999999997643322211 122456899999
Q ss_pred CccccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHh-hhhhccccccccccCccccCCCChHhHHHHH
Q 021490 158 APEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWA-RPLFQDRTRHSLIADPELQGQYPPRGFYQAL 236 (311)
Q Consensus 158 aPE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 236 (311)
|||++.+..++.++|||||||++|+|++|..||............... ....... ...+...+ +.++.
T Consensus 181 aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~-------~~~l~~~~----p~~l~ 249 (483)
T 3sv0_A 181 SVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATS-------IEALCRGY----PTEFA 249 (483)
T ss_dssp CHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSC-------HHHHHTTS----CHHHH
T ss_pred CHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccccc-------HHHHhcCC----cHHHH
Confidence 999999999999999999999999999999999765432222211111 1000000 00011122 34788
Q ss_pred HHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 021490 237 AVAAMCVHEQPDMRPVIADVVTALAYLASQ 266 (311)
Q Consensus 237 ~li~~~l~~~p~~Rps~~~vl~~l~~~~~~ 266 (311)
+|+..||+.||.+||++.+|++.|+.+...
T Consensus 250 ~li~~cl~~dP~~RPs~~el~~~L~~l~~~ 279 (483)
T 3sv0_A 250 SYFHYCRSLRFDDKPDYSYLKRLFRDLFIR 279 (483)
T ss_dssp HHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred HHHHHHhcCChhhCcCHHHHHHHHHHHHHH
Confidence 999999999999999999999999887653
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-39 Score=275.27 Aligned_cols=228 Identities=26% Similarity=0.393 Sum_probs=179.9
Q ss_pred cCCcEEEEEEeecCCC--cchhHHHHHHHHHhcCCCCcccceeeEeee----CCeeEEEEecCCCCChhhhhcccCCCCC
Q 021490 7 CLLQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCAD----GDQRLLVYEYMPLGSVEDHLHDLSPGKK 80 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 80 (311)
.++..||+|++..... ...+.+.+|+.+++.++||||+++++++.. ....++||||+++++|.+++.. ..
T Consensus 49 ~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~ 124 (290)
T 1t4h_A 49 ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR----FK 124 (290)
T ss_dssp TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHH----HS
T ss_pred CCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEecCCCCHHHHHHH----cc
Confidence 4688999999876532 334678999999999999999999998865 4568999999999999999986 46
Q ss_pred CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEc-CCCceEEccccccccCCCCCCceeeeeccccccccCc
Q 021490 81 PLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD-RGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 159 (311)
Q Consensus 81 ~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aP 159 (311)
.+++..++.++.|++.||+|||+.+ .+++|+||+|+||+++ .++.++|+|||++...... ......++..|+||
T Consensus 125 ~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~----~~~~~~~t~~y~aP 199 (290)
T 1t4h_A 125 VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAP 199 (290)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT----SBEESCSSCCCCCG
T ss_pred CCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccccccc----ccccccCCcCcCCH
Confidence 7999999999999999999999974 3499999999999998 7899999999998643222 12334689999999
Q ss_pred cccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHH
Q 021490 160 EYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVA 239 (311)
Q Consensus 160 E~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 239 (311)
|++. ..++.++||||||+++|+|++|..||............ ...... ...+ +...+..+.+++
T Consensus 200 E~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~------~~~~~~-----~~~~----~~~~~~~l~~li 263 (290)
T 1t4h_A 200 EMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR------VTSGVK-----PASF----DKVAIPEVKEII 263 (290)
T ss_dssp GGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHH------HTTTCC-----CGGG----GGCCCHHHHHHH
T ss_pred HHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHH------HhccCC-----cccc----CCCCCHHHHHHH
Confidence 9887 45899999999999999999999999764432221110 000000 0111 111224788999
Q ss_pred HHccccCCCCCCCHHHHHHH
Q 021490 240 AMCVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 240 ~~~l~~~p~~Rps~~~vl~~ 259 (311)
.+||+.||.+|||+.++++.
T Consensus 264 ~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 264 EGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp HHHSCSSGGGSCCHHHHHTS
T ss_pred HHHccCChhhCCCHHHHhhC
Confidence 99999999999999999875
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=284.15 Aligned_cols=251 Identities=21% Similarity=0.285 Sum_probs=184.0
Q ss_pred cchhcc-CCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEee--------------eCCeeEEEEecCCCC
Q 021490 2 MQVILC-LLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCA--------------DGDQRLLVYEYMPLG 66 (311)
Q Consensus 2 ~~~~~~-~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--------------~~~~~~lv~e~~~~~ 66 (311)
|.+... +|+.||+|++........+.+.+|+.+++.++||||+++++++. +....++||||++ +
T Consensus 28 ~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~ 106 (320)
T 2i6l_A 28 FSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-T 106 (320)
T ss_dssp EEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECCS-E
T ss_pred EEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccccCceeEEeeccC-C
Confidence 334433 48999999997666566678999999999999999999999873 3467899999997 6
Q ss_pred ChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEc-CCCceEEccccccccCCCCCC-c
Q 021490 67 SVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD-RGYHPKLSDFGLAKLGPVGDN-T 144 (311)
Q Consensus 67 ~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~-~~~~~~l~df~~~~~~~~~~~-~ 144 (311)
+|.+++.. +.+++..++.++.|++.||+|||+++ ++|+||||+||+++ +++.++|+|||++........ .
T Consensus 107 ~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~ 178 (320)
T 2i6l_A 107 DLANVLEQ-----GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHK 178 (320)
T ss_dssp EHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEEECCCTTCBCC-------
T ss_pred CHHHHhhc-----CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEEEccCccccccCCCcccc
Confidence 99999864 56999999999999999999999999 99999999999997 567999999999875422111 1
Q ss_pred eeeeeccccccccCcccccc-CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhcccccc--------
Q 021490 145 HVSTRVMGTYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRH-------- 215 (311)
Q Consensus 145 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-------- 215 (311)
.......++..|+|||++.+ ..++.++||||||+++|+|++|..||...........+....+........
T Consensus 179 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (320)
T 2i6l_A 179 GHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPV 258 (320)
T ss_dssp -CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCH
T ss_pred cccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcc
Confidence 11223456889999998865 678999999999999999999999998766543322221110000000000
Q ss_pred ---ccccCccc-cCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 021490 216 ---SLIADPEL-QGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 261 (311)
Q Consensus 216 ---~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l~ 261 (311)
.....+.. .....+..+..+.+++.+||+.||.+|||+.++++...
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 308 (320)
T 2i6l_A 259 YIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPY 308 (320)
T ss_dssp HHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHH
T ss_pred cccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcc
Confidence 00000000 00011223457899999999999999999999998644
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=294.99 Aligned_cols=242 Identities=19% Similarity=0.211 Sum_probs=182.8
Q ss_pred CCcEEEEEEeecCCCcchhHHHHHHHHHhcC------CCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCC
Q 021490 8 LLQDVAIKQLDRNGVQGNREFLVEVLMLSLL------HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKP 81 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 81 (311)
+|+.||||+++. .......+.+|+.+++.+ +|+||+.+++++......++||||+. ++|.+++.... ...
T Consensus 121 ~~~~vAvK~~~~-~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~ 196 (429)
T 3kvw_A 121 VHQHVALKMVRN-EKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLS-MNLYELIKKNK--FQG 196 (429)
T ss_dssp TTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEECCCC-CBHHHHHHHTT--TCC
T ss_pred CCcEEEEEEECC-ccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEeccC-CCHHHHHHhcc--CCC
Confidence 589999999964 333446778888888877 57799999999999999999999996 69999987732 345
Q ss_pred CCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCc--eEEccccccccCCCCCCceeeeeccccccccCc
Q 021490 82 LDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH--PKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 159 (311)
Q Consensus 82 l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~--~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aP 159 (311)
+++..+..++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||++...... .....++..|+||
T Consensus 197 ~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~~-----~~~~~gt~~y~aP 268 (429)
T 3kvw_A 197 FSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR-----VYTYIQSRFYRAP 268 (429)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTCEETTCC-----CCSSCSCGGGCCH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccceecCCc-----ccccCCCCCccCh
Confidence 999999999999999999999999 999999999999999887 999999998653221 2234688999999
Q ss_pred cccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhh---------------hccccccc-----ccc
Q 021490 160 EYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPL---------------FQDRTRHS-----LIA 219 (311)
Q Consensus 160 E~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~---------------~~~~~~~~-----~~~ 219 (311)
|++.+..++.++|||||||++|+|++|..||...........+...... +....... ...
T Consensus 269 E~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (429)
T 3kvw_A 269 EVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLS 348 (429)
T ss_dssp HHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCC
T ss_pred HHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccc
Confidence 9999989999999999999999999999999877655443222111000 00000000 000
Q ss_pred C-----------------c----cccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 021490 220 D-----------------P----ELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 261 (311)
Q Consensus 220 ~-----------------~----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l~ 261 (311)
+ + .+...++......+.+||.+||+.||++|||+.|+++.-+
T Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~Hpw 411 (429)
T 3kvw_A 349 DGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPW 411 (429)
T ss_dssp C--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTT
T ss_pred cccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhCChh
Confidence 0 0 0000011112457889999999999999999999998744
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=291.36 Aligned_cols=249 Identities=22% Similarity=0.258 Sum_probs=179.7
Q ss_pred CcchhccCCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCC------eeEEEEecCCCCChhhhhcc
Q 021490 1 MMQVILCLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD------QRLLVYEYMPLGSVEDHLHD 74 (311)
Q Consensus 1 ~~~~~~~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~ 74 (311)
||.+....+..||+|++..... ...+|+.+++.++||||+++++++.... ..++||||++++ +...+..
T Consensus 56 V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~ 130 (394)
T 4e7w_A 56 VFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPET-VYRASRH 130 (394)
T ss_dssp EEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSEE-HHHHHHH
T ss_pred EEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccCcc-HHHHHHH
Confidence 3555666777799999864432 2236999999999999999999985433 378999999764 4443332
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEc-CCCceEEccccccccCCCCCCceeeeecccc
Q 021490 75 LSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD-RGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT 153 (311)
Q Consensus 75 ~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~ 153 (311)
.......+++..+..++.|++.||+|||+.+ ++||||||+|||++ .++.+||+|||++....... ......++
T Consensus 131 ~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~---~~~~~~~t 204 (394)
T 4e7w_A 131 YAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE---PNVSYICS 204 (394)
T ss_dssp HHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC---CCCSSCSC
T ss_pred HHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCC---CCcccccC
Confidence 2122567999999999999999999999999 99999999999999 79999999999997532221 12234678
Q ss_pred ccccCccccccC-CCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhh--------hhcccc---ccccccCc
Q 021490 154 YGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARP--------LFQDRT---RHSLIADP 221 (311)
Q Consensus 154 ~~y~aPE~~~~~-~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~--------~~~~~~---~~~~~~~~ 221 (311)
..|+|||++.+. .++.++|||||||++|+|++|..||.+.........+..... ...... ........
T Consensus 205 ~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~ 284 (394)
T 4e7w_A 205 RYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPH 284 (394)
T ss_dssp GGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCC
T ss_pred cCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCC
Confidence 999999998664 589999999999999999999999987765443322211100 000000 00000000
Q ss_pred cccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 021490 222 ELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 260 (311)
Q Consensus 222 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l 260 (311)
.+...+++..+.++.+|+.+||+.||.+|||+.++++.-
T Consensus 285 ~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 323 (394)
T 4e7w_A 285 PFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHP 323 (394)
T ss_dssp CHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSG
T ss_pred cHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcCh
Confidence 111112233456899999999999999999999999764
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=284.72 Aligned_cols=246 Identities=22% Similarity=0.242 Sum_probs=182.7
Q ss_pred cCCcEEEEEEeecCCC-cchhHHHHHHHHHhcCCCCcccceeeEeeeC-----CeeEEEEecCCCCChhhhhcccCCCCC
Q 021490 7 CLLQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADG-----DQRLLVYEYMPLGSVEDHLHDLSPGKK 80 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~ 80 (311)
.+|+.||||++..... ...+.+.+|++++..++||||+++++++... ...++||||++ ++|.+++.. .
T Consensus 50 ~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~-----~ 123 (364)
T 3qyz_A 50 LNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKT-----Q 123 (364)
T ss_dssp TTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCS-EEHHHHHHH-----C
T ss_pred CCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEcccC-cCHHHHHHh-----C
Confidence 3688999999975432 3346889999999999999999999998654 36899999997 599999875 4
Q ss_pred CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCc-eeeeeccccccccCc
Q 021490 81 PLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT-HVSTRVMGTYGYCAP 159 (311)
Q Consensus 81 ~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~y~aP 159 (311)
.+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++......... .......++..|+||
T Consensus 124 ~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aP 200 (364)
T 3qyz_A 124 HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 200 (364)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCC
Confidence 6999999999999999999999999 999999999999999999999999998753322111 112334689999999
Q ss_pred cccc-cCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhh-hhhcccc--------cc--ccccCc--cccC
Q 021490 160 EYAK-TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWAR-PLFQDRT--------RH--SLIADP--ELQG 225 (311)
Q Consensus 160 E~~~-~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~--------~~--~~~~~~--~~~~ 225 (311)
|++. ...++.++|||||||++|+|++|..||...........+.... ....... .. .....+ ....
T Consensus 201 E~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (364)
T 3qyz_A 201 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWN 280 (364)
T ss_dssp HHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHH
T ss_pred HHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHH
Confidence 9865 4568999999999999999999999998766544332221110 0000000 00 000000 0000
Q ss_pred CCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 021490 226 QYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 261 (311)
Q Consensus 226 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l~ 261 (311)
...+..+..+.+|+.+||+.||.+|||+.++++.-.
T Consensus 281 ~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 316 (364)
T 3qyz_A 281 RLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 316 (364)
T ss_dssp HHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGG
T ss_pred HhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcc
Confidence 011223457889999999999999999999998743
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=281.68 Aligned_cols=241 Identities=18% Similarity=0.213 Sum_probs=185.2
Q ss_pred cCCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCc------ccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCC
Q 021490 7 CLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPN------LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKK 80 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~------i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 80 (311)
.+|+.||||+++.. ....+.+.+|+.++..++|++ ++++++++.+....++||||+ +++|.+++.... ..
T Consensus 38 ~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~--~~ 113 (339)
T 1z57_A 38 AGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENG--FL 113 (339)
T ss_dssp TTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTT--TC
T ss_pred CCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEEEcCC-CCCHHHHHHhcC--CC
Confidence 36899999999533 344567889999999887654 999999999999999999999 899999998632 34
Q ss_pred CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcC-------------------CCceEEccccccccCCCC
Q 021490 81 PLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR-------------------GYHPKLSDFGLAKLGPVG 141 (311)
Q Consensus 81 ~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~-------------------~~~~~l~df~~~~~~~~~ 141 (311)
.+++..++.++.|++.||+|||+++ ++||||||+||+++. ++.++|+|||++......
T Consensus 114 ~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~ 190 (339)
T 1z57_A 114 PFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH 190 (339)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSC
T ss_pred CCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCccc
Confidence 6899999999999999999999999 999999999999987 668999999998753221
Q ss_pred CCceeeeeccccccccCccccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhcc-----ccccc
Q 021490 142 DNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQD-----RTRHS 216 (311)
Q Consensus 142 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-----~~~~~ 216 (311)
.....++..|+|||++.+..++.++|||||||++|+|++|..||...+................. .....
T Consensus 191 -----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~ 265 (339)
T 1z57_A 191 -----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRK 265 (339)
T ss_dssp -----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGG
T ss_pred -----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchh
Confidence 22346899999999999889999999999999999999999999876655443332221110000 00000
Q ss_pred ccc--------------------Cc-cccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 021490 217 LIA--------------------DP-ELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 217 ~~~--------------------~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~ 259 (311)
... .+ ..........+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 329 (339)
T 1z57_A 266 YFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKH 329 (339)
T ss_dssp GEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred HHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhcC
Confidence 000 00 00011233456789999999999999999999999875
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=304.54 Aligned_cols=233 Identities=25% Similarity=0.347 Sum_probs=185.1
Q ss_pred CcEEEEEEeecCCC-cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHHH
Q 021490 9 LQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTR 87 (311)
Q Consensus 9 g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~ 87 (311)
+..||+|+++.... ...+.|.+|+.+++.++||||+++++++. +...++||||+++|+|.+++... ...+++..+
T Consensus 418 ~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv~E~~~~g~L~~~l~~~---~~~l~~~~~ 493 (656)
T 2j0j_A 418 AMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVR---KFSLDLASL 493 (656)
T ss_dssp CEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHHHHT---TTTCCHHHH
T ss_pred cEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEEEEcCCCCcHHHHHHhc---cCCCCHHHH
Confidence 56799999865433 23468999999999999999999999985 45689999999999999999862 356999999
Q ss_pred HHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccCCC
Q 021490 88 MKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQL 167 (311)
Q Consensus 88 ~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 167 (311)
+.++.|++.||+|||+++ ++||||||+|||++.++.+||+|||++........ .......++..|+|||++.+..+
T Consensus 494 ~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~ 569 (656)
T 2j0j_A 494 ILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY-YKASKGKLPIKWMAPESINFRRF 569 (656)
T ss_dssp HHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSCCC-----------CCGGGCCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeecCCCcc-eeccCCCCCcceeCHHHhcCCCC
Confidence 999999999999999999 99999999999999999999999999975432211 11223346788999999998999
Q ss_pred ccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccC
Q 021490 168 TLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQ 246 (311)
Q Consensus 168 ~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 246 (311)
+.++||||||+++|+|++ |..||...........+... . ....++..+..+.+|+.+||..|
T Consensus 570 ~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~-------~----------~~~~~~~~~~~l~~li~~~l~~d 632 (656)
T 2j0j_A 570 TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG-------E----------RLPMPPNCPPTLYSLMTKCWAYD 632 (656)
T ss_dssp CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHT-------C----------CCCCCTTCCHHHHHHHHHHTCSS
T ss_pred CchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC-------C----------CCCCCccccHHHHHHHHHHcCCC
Confidence 999999999999999997 99999876554332222110 0 00122334458889999999999
Q ss_pred CCCCCCHHHHHHHHHHhhhc
Q 021490 247 PDMRPVIADVVTALAYLASQ 266 (311)
Q Consensus 247 p~~Rps~~~vl~~l~~~~~~ 266 (311)
|.+|||+.++++.|+.+...
T Consensus 633 P~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 633 PSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp GGGSCCHHHHHHHHHHHHHH
T ss_pred hhHCcCHHHHHHHHHHHHHH
Confidence 99999999999999987643
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=289.71 Aligned_cols=233 Identities=10% Similarity=0.013 Sum_probs=162.7
Q ss_pred cCCcEEEEEEeecCCC---cchhHHHHHHHHHhcC--CCCccccee-------eEeeeC-----------------CeeE
Q 021490 7 CLLQDVAIKQLDRNGV---QGNREFLVEVLMLSLL--HHPNLVNLI-------GYCADG-----------------DQRL 57 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l--~h~~i~~~~-------~~~~~~-----------------~~~~ 57 (311)
.+|+.||||+++.... ...+.+.+|+.++..| +||||++++ +++... ...|
T Consensus 85 ~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (371)
T 3q60_A 85 ERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYL 164 (371)
T ss_dssp TTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEETTSCSSSBCSCC---CCEEEEE
T ss_pred CCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCCCCCeeeccCCcccceeeeEE
Confidence 3789999999987553 2235677785544444 699988755 444332 3379
Q ss_pred EEEecCCCCChhhhhcccCCCCCCCCHHHH------HHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEcc
Q 021490 58 LVYEYMPLGSVEDHLHDLSPGKKPLDWNTR------MKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSD 131 (311)
Q Consensus 58 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~------~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~d 131 (311)
+||||++ ++|.+++... +..+++..+ +.++.|++.||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 165 lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~D 237 (371)
T 3q60_A 165 LLMPAAS-VDLELLFSTL---DFVYVFRGDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGD 237 (371)
T ss_dssp EEECCCS-EEHHHHHHHH---HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGGGEEECTTSCEEECC
T ss_pred EEecCCC-CCHHHHHHHh---ccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---CccCcCCHHHEEECCCCCEEEEe
Confidence 9999998 8999999863 233455555 677899999999999999 99999999999999999999999
Q ss_pred ccccccCCCCCCceeeeeccccccccCcccccc--CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhh
Q 021490 132 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT--GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLF 209 (311)
Q Consensus 132 f~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 209 (311)
||++.... .......++..|+|||++.+ ..++.++|||||||++|+|++|..||......... .+
T Consensus 238 FG~a~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~--------~~ 304 (371)
T 3q60_A 238 VSALWKVG-----TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKG--------SW 304 (371)
T ss_dssp GGGEEETT-----CEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTT--------CC
T ss_pred cceeeecC-----CCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCccccc--------ch
Confidence 99987532 11224456799999999987 67899999999999999999999999765321110 00
Q ss_pred ccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 021490 210 QDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 260 (311)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l 260 (311)
.. ................+..+..+.+|+.+||+.||++|||+.++++.-
T Consensus 305 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 354 (371)
T 3q60_A 305 KR-PSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETP 354 (371)
T ss_dssp CB-CCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSH
T ss_pred hh-hhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCH
Confidence 00 000000011111111224456889999999999999999999998654
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=281.55 Aligned_cols=252 Identities=19% Similarity=0.173 Sum_probs=183.4
Q ss_pred cchhc-cCCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCe-------eEEEEecCCCCChhhhhc
Q 021490 2 MQVIL-CLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ-------RLLVYEYMPLGSVEDHLH 73 (311)
Q Consensus 2 ~~~~~-~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-------~~lv~e~~~~~~L~~~l~ 73 (311)
|.+.. .+|+.||||++... ......+.++++.+..++||||+++++++..... .++||||+++ +|...+.
T Consensus 40 ~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~ 117 (360)
T 3e3p_A 40 QLGKEKSTGMSVAIKKVIQD-PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCR 117 (360)
T ss_dssp EEEEETTTCCEEEEEEEECC-TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEECCSC-BHHHHHH
T ss_pred EEEEECCCCCEEEEEEEecC-ccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEeecccc-cHHHHHH
Confidence 34443 36899999998543 3445567788999999999999999999865333 7899999975 5555444
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHHHHHHhh--cCCCCCeEeeccCCCeEEEcC-CCceEEccccccccCCCCCCceeeeec
Q 021490 74 DLSPGKKPLDWNTRMKIAAGAARGLEYLH--DKAKPPVIYRDLKCSNILLDR-GYHPKLSDFGLAKLGPVGDNTHVSTRV 150 (311)
Q Consensus 74 ~~~~~~~~l~~~~~~~~~~~i~~~l~~lh--~~~~~~i~h~dl~p~nil~~~-~~~~~l~df~~~~~~~~~~~~~~~~~~ 150 (311)
........+++..+..++.|++.||.||| +.+ ++||||||+|||++. ++.++|+|||++....... .....
T Consensus 118 ~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~---~~~~~ 191 (360)
T 3e3p_A 118 NYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE---PNVAY 191 (360)
T ss_dssp HHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTTS---CCCST
T ss_pred HHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcEEEeeCCCceecCCCC---Ccccc
Confidence 32223677999999999999999999999 898 999999999999996 8999999999997543221 22334
Q ss_pred cccccccCccccccC-CCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhh-h-------hhccccccccccC-
Q 021490 151 MGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWAR-P-------LFQDRTRHSLIAD- 220 (311)
Q Consensus 151 ~~~~~y~aPE~~~~~-~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~-~-------~~~~~~~~~~~~~- 220 (311)
.++..|+|||++.+. .++.++|||||||++|+|++|..||...........+.... . .+..........+
T Consensus 192 ~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (360)
T 3e3p_A 192 ICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNS 271 (360)
T ss_dssp TSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCC
T ss_pred cCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhcccccc
Confidence 678999999998654 48999999999999999999999998766544332221110 0 0000000000000
Q ss_pred -----ccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 021490 221 -----PELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 261 (311)
Q Consensus 221 -----~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l~ 261 (311)
.......+...+..+.+|+.+||+.||.+|||+.|+++...
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 317 (360)
T 3e3p_A 272 KGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPY 317 (360)
T ss_dssp CCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGG
T ss_pred ccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCcc
Confidence 00111222335678999999999999999999999998754
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=275.98 Aligned_cols=231 Identities=22% Similarity=0.318 Sum_probs=174.1
Q ss_pred cCCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeee-------------CCeeEEEEecCCCCChhhhhc
Q 021490 7 CLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCAD-------------GDQRLLVYEYMPLGSVEDHLH 73 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-------------~~~~~lv~e~~~~~~L~~~l~ 73 (311)
.+|+.||||+++.. ....+.+.+|+.+++.++||||+++++++.+ ....++||||+++++|.+++.
T Consensus 29 ~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 107 (303)
T 1zy4_A 29 LDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIH 107 (303)
T ss_dssp TTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHH
T ss_pred CCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhh
Confidence 47899999999543 3445788999999999999999999998865 346799999999999999998
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCC----------
Q 021490 74 DLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN---------- 143 (311)
Q Consensus 74 ~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~---------- 143 (311)
.. ...+++..++.++.|++.||+|||+++ ++|+||+|+||+++.++.++|+|||++........
T Consensus 108 ~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 181 (303)
T 1zy4_A 108 SE---NLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181 (303)
T ss_dssp HS---CGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCCCSCTTC-------------
T ss_pred cc---ccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEeeCcchhhcccccchhcccccccc
Confidence 62 456888999999999999999999999 99999999999999999999999999875332110
Q ss_pred --ceeeeeccccccccCccccccC-CCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccC
Q 021490 144 --THVSTRVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD 220 (311)
Q Consensus 144 --~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (311)
........++..|+|||++.+. .++.++||||||+++|+|++ ||....... ....... .. .
T Consensus 182 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~--~~~~~~~---~~--------~ 245 (303)
T 1zy4_A 182 GSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERV--NILKKLR---SV--------S 245 (303)
T ss_dssp ------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHH--HHHHHHH---ST--------T
T ss_pred ccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHH--HHHHhcc---cc--------c
Confidence 1112234588999999998764 68999999999999999998 554322211 1111110 00 1
Q ss_pred ccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 021490 221 PELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 260 (311)
Q Consensus 221 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l 260 (311)
..+...++...+..+.+++.+||+.||.+|||+.++++..
T Consensus 246 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~ 285 (303)
T 1zy4_A 246 IEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSG 285 (303)
T ss_dssp CCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSS
T ss_pred cccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCC
Confidence 1112233444455788999999999999999999999764
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=283.90 Aligned_cols=245 Identities=20% Similarity=0.213 Sum_probs=181.3
Q ss_pred CCcEEEEEEeecCCC-cchhHHHHHHHHHhcCCCCcccceeeEeeeC-----CeeEEEEecCCCCChhhhhcccCCCCCC
Q 021490 8 LLQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADG-----DQRLLVYEYMPLGSVEDHLHDLSPGKKP 81 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 81 (311)
+|+.||||+++.... .....+.+|+.+++.++||||+++++++... ...++||||++ ++|.+++.. ..
T Consensus 35 ~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~ 108 (353)
T 2b9h_A 35 TGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVIST-----QM 108 (353)
T ss_dssp TTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECCCS-EEHHHHHHH-----CC
T ss_pred CCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEeccC-ccHHHHHhh-----cC
Confidence 689999999965432 2345788999999999999999999987654 67899999997 689999875 46
Q ss_pred CCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCce--------eeeecccc
Q 021490 82 LDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH--------VSTRVMGT 153 (311)
Q Consensus 82 l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~--------~~~~~~~~ 153 (311)
+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++.......... ......++
T Consensus 109 ~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt 185 (353)
T 2b9h_A 109 LSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVAT 185 (353)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC----------------CCCCCC
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccccccccccccCccccccchhhcccc
Confidence 999999999999999999999999 9999999999999999999999999987543221111 11224578
Q ss_pred ccccCcccccc-CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccC----------cc
Q 021490 154 YGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD----------PE 222 (311)
Q Consensus 154 ~~y~aPE~~~~-~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~ 222 (311)
..|+|||++.. ..++.++|||||||++|+|++|..||...........+.................. +.
T Consensus 186 ~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (353)
T 2b9h_A 186 RWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPM 265 (353)
T ss_dssp GGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCC
T ss_pred ccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccC
Confidence 99999998754 67899999999999999999999999877654433222111000000000000000 00
Q ss_pred cc----CCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 021490 223 LQ----GQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 261 (311)
Q Consensus 223 ~~----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l~ 261 (311)
.. ....+..+..+.+|+.+||+.||++|||+.++++...
T Consensus 266 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 308 (353)
T 2b9h_A 266 YPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPY 308 (353)
T ss_dssp CCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred CCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCcc
Confidence 00 0011233457889999999999999999999998643
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-39 Score=287.25 Aligned_cols=241 Identities=18% Similarity=0.192 Sum_probs=180.1
Q ss_pred cCCcEEEEEEeecCCCcchhHHHHHHHHHhcCC--------CCcccceeeEee----eCCeeEEEEecCCCCChhhhhcc
Q 021490 7 CLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLH--------HPNLVNLIGYCA----DGDQRLLVYEYMPLGSVEDHLHD 74 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~--------h~~i~~~~~~~~----~~~~~~lv~e~~~~~~L~~~l~~ 74 (311)
.+|+.||||+++.. ....+.+.+|+.+++.++ |+||+++++++. +....++||||+ +++|.+++..
T Consensus 60 ~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~ 137 (397)
T 1wak_A 60 QGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIK 137 (397)
T ss_dssp TTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHH
T ss_pred CCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceEEEEEecc-CccHHHHHHh
Confidence 46899999999633 344578889999999985 788999999987 556889999999 5667666654
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCCeEeeccCCCeEEEcCCC----------------------------
Q 021490 75 LSPGKKPLDWNTRMKIAAGAARGLEYLHDK-AKPPVIYRDLKCSNILLDRGY---------------------------- 125 (311)
Q Consensus 75 ~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~-~~~~i~h~dl~p~nil~~~~~---------------------------- 125 (311)
. ....+++..++.++.||+.||+|||++ + |+||||||+|||++.++
T Consensus 138 ~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 212 (397)
T 1wak_A 138 S--NYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVST 212 (397)
T ss_dssp T--TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHHHHHHHC-----------------
T ss_pred c--ccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCcccc
Confidence 2 235799999999999999999999998 8 99999999999999775
Q ss_pred ---------------------ceEEccccccccCCCCCCceeeeeccccccccCccccccCCCccccceeehhHHHHHHH
Q 021490 126 ---------------------HPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEIL 184 (311)
Q Consensus 126 ---------------------~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~l~~~ll 184 (311)
.++|+|||++...... .....++..|+|||++.+..++.++|||||||++|+|+
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 287 (397)
T 1wak_A 213 APATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELA 287 (397)
T ss_dssp ----CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHH
T ss_pred CCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHh
Confidence 7999999998753221 22346899999999999989999999999999999999
Q ss_pred hCCCccCcchhHH------HHH-HHHHhhh--------------hhccccccccccCcc---------ccCCCChHhHHH
Q 021490 185 SGRKAVDTSKAAA------EQS-LVAWARP--------------LFQDRTRHSLIADPE---------LQGQYPPRGFYQ 234 (311)
Q Consensus 185 ~g~~pf~~~~~~~------~~~-~~~~~~~--------------~~~~~~~~~~~~~~~---------~~~~~~~~~~~~ 234 (311)
+|..||....... ... +...... .+..........+.. -....+...+..
T Consensus 288 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (397)
T 1wak_A 288 TGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAG 367 (397)
T ss_dssp HSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHH
T ss_pred hCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHH
Confidence 9999997544211 111 1110000 000000000000000 011235566778
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHH
Q 021490 235 ALAVAAMCVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 235 l~~li~~~l~~~p~~Rps~~~vl~~ 259 (311)
+.+|+.+||+.||++|||+.|+++.
T Consensus 368 ~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 368 FTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp HHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHhccChhhcCCHHHHhhC
Confidence 9999999999999999999999875
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=282.11 Aligned_cols=236 Identities=22% Similarity=0.293 Sum_probs=179.4
Q ss_pred CcEEEEEEeecCCC--cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHH
Q 021490 9 LQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNT 86 (311)
Q Consensus 9 g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~ 86 (311)
+..||+|+++.... ...+.+.+|+.+++.++||||+++++++.+....++||||++|++|.+++... ...+++..
T Consensus 55 ~~~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~---~~~~~~~~ 131 (319)
T 2y4i_B 55 HGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDA---KIVLDVNK 131 (319)
T ss_dssp SSSEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCSEEHHHHTTSS---CCCCCSHH
T ss_pred cCeEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccCCcHHHHHHhc---CCCCCHHH
Confidence 34699999865432 33467888999999999999999999999999999999999999999999762 34799999
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCC---CceeeeeccccccccCccccc
Q 021490 87 RMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD---NTHVSTRVMGTYGYCAPEYAK 163 (311)
Q Consensus 87 ~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~ 163 (311)
++.++.|++.||+|||+.+ ++|+||+|+||+++ ++.++|+|||++....... .........++..|+|||++.
T Consensus 132 ~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 207 (319)
T 2y4i_B 132 TRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIR 207 (319)
T ss_dssp HHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHS
T ss_pred HHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccccccccccccccccccCCCcccccChHHhh
Confidence 9999999999999999999 99999999999998 6799999999876432111 111222345889999999886
Q ss_pred c---------CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHH
Q 021490 164 T---------GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQ 234 (311)
Q Consensus 164 ~---------~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
. ..++.++||||||+++|+|++|..||............... . .+... ....+..
T Consensus 208 ~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-------~------~~~~~---~~~~~~~ 271 (319)
T 2y4i_B 208 QLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTG-------M------KPNLS---QIGMGKE 271 (319)
T ss_dssp CBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTT-------C------CCCCC---CSSCCTT
T ss_pred hccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccC-------C------CCCCC---cCCCCHH
Confidence 4 35788999999999999999999999876544332211100 0 00000 0112236
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHHHHHhhhcc
Q 021490 235 ALAVAAMCVHEQPDMRPVIADVVTALAYLASQK 267 (311)
Q Consensus 235 l~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~~ 267 (311)
+.+++.+||..||.+|||+.++++.|+.+....
T Consensus 272 l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 272 ISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp HHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred HHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 788999999999999999999999998776543
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=278.96 Aligned_cols=239 Identities=22% Similarity=0.279 Sum_probs=163.9
Q ss_pred cCCcEEEEEEeecCCC-cchhHHHHHHH-HHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccC-CCCCCCC
Q 021490 7 CLLQDVAIKQLDRNGV-QGNREFLVEVL-MLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLS-PGKKPLD 83 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~-~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~l~ 83 (311)
.+|+.||||+++.... .....+..|+. +++.++||||+++++++.+....++||||+++ +|.+++.... .....++
T Consensus 45 ~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~ 123 (327)
T 3aln_A 45 PSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIP 123 (327)
T ss_dssp TTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCC
T ss_pred CCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecCC-ChHHHHHHHHhhhcccCc
Confidence 3689999999976543 23345666666 67778999999999999999999999999974 7877765311 1246799
Q ss_pred HHHHHHHHHHHHHHHHHhhcC-CCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccc
Q 021490 84 WNTRMKIAAGAARGLEYLHDK-AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 162 (311)
Q Consensus 84 ~~~~~~~~~~i~~~l~~lh~~-~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 162 (311)
+..+..++.|++.||.|||+. + ++|+||+|+||+++.++.++|+|||++...... .......++..|+|||++
T Consensus 124 ~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~---~~~~~~~gt~~y~aPE~~ 197 (327)
T 3aln_A 124 EEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS---IAKTRDAGCRPYMAPERI 197 (327)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-------------------------
T ss_pred HHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceecccc---cccccCCCCccccCceee
Confidence 999999999999999999998 9 999999999999999999999999998753221 122233588999999998
Q ss_pred ----ccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHH
Q 021490 163 ----KTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAV 238 (311)
Q Consensus 163 ----~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 238 (311)
.+..++.++||||||+++|+|++|..||......... ...... ...+.+........+..+.+|
T Consensus 198 ~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---------~~~~~~---~~~~~~~~~~~~~~~~~l~~l 265 (327)
T 3aln_A 198 DPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ---------LTQVVK---GDPPQLSNSEEREFSPSFINF 265 (327)
T ss_dssp --------CCSHHHHHHHHHHHHHHHHSCCCSSCC----------------CCCCC---SCCCCCCCCSSCCCCHHHHHH
T ss_pred ccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH---------HHHHhc---CCCCCCCCcccccCCHHHHHH
Confidence 4567889999999999999999999999764321110 000000 001111111222344588999
Q ss_pred HHHccccCCCCCCCHHHHHHHHHHhh
Q 021490 239 AAMCVHEQPDMRPVIADVVTALAYLA 264 (311)
Q Consensus 239 i~~~l~~~p~~Rps~~~vl~~l~~~~ 264 (311)
+.+||+.||.+|||+.++++......
T Consensus 266 i~~~l~~dp~~Rps~~ell~hp~~~~ 291 (327)
T 3aln_A 266 VNLCLTKDESKRPKYKELLKHPFILM 291 (327)
T ss_dssp HHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred HHHHhhCChhhCcCHHHHHhChHHHH
Confidence 99999999999999999998655443
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=280.45 Aligned_cols=239 Identities=22% Similarity=0.265 Sum_probs=179.2
Q ss_pred cCCcEEEEEEeecCCCc--chhHHHHHHHHHhcCCCCcccceeeEeeeCCee------EEEEecCCCCChhhhhcccCCC
Q 021490 7 CLLQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR------LLVYEYMPLGSVEDHLHDLSPG 78 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~------~lv~e~~~~~~L~~~l~~~~~~ 78 (311)
.+|+.||||++...... ..+.+.+|+.+++.++||||+++++++...... ++||||+. ++|.+.+.
T Consensus 65 ~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~----- 138 (371)
T 4exu_A 65 RSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMG----- 138 (371)
T ss_dssp TTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEEECCC-EEHHHHTT-----
T ss_pred CCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEEEcccc-ccHHHHhh-----
Confidence 36899999999764332 246888999999999999999999999877654 99999997 68888774
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccC
Q 021490 79 KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCA 158 (311)
Q Consensus 79 ~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~a 158 (311)
..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++..... ......++..|+|
T Consensus 139 -~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~-----~~~~~~~t~~y~a 209 (371)
T 4exu_A 139 -MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADA-----EMTGYVVTRWYRA 209 (371)
T ss_dssp -SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC-------------CTTCCCTTSC
T ss_pred -cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCccccccc-----CcCCcccCccccC
Confidence 34999999999999999999999999 99999999999999999999999999874321 1233467899999
Q ss_pred cccccc-CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhcc----ccc----------cccccCccc
Q 021490 159 PEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQD----RTR----------HSLIADPEL 223 (311)
Q Consensus 159 PE~~~~-~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~----~~~----------~~~~~~~~~ 223 (311)
||++.+ ..++.++|||||||++|+|++|..||...........+......... ... ........+
T Consensus 210 PE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (371)
T 4exu_A 210 PEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDF 289 (371)
T ss_dssp HHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCH
T ss_pred HHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhH
Confidence 999877 67899999999999999999999999876654432221110000000 000 000000000
Q ss_pred cCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 021490 224 QGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 261 (311)
Q Consensus 224 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l~ 261 (311)
....+..+..+.+|+.+||+.||.+|||+.++++.-.
T Consensus 290 -~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 326 (371)
T 4exu_A 290 -TQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPF 326 (371)
T ss_dssp -HHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGG
T ss_pred -HHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcc
Confidence 0011233558899999999999999999999998754
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-39 Score=284.36 Aligned_cols=243 Identities=15% Similarity=0.194 Sum_probs=180.4
Q ss_pred cCCcEEEEEEeecCCCcchhHHHHHHHHHhcCC-----------CCcccceeeEeeeCC----eeEEEEecCCCCChhhh
Q 021490 7 CLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLH-----------HPNLVNLIGYCADGD----QRLLVYEYMPLGSVEDH 71 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~ 71 (311)
.+|+.||||++.. .....+.+.+|+.++..++ ||||+++++++.... ..++|||++ +++|.++
T Consensus 42 ~~~~~vaiK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~ 119 (373)
T 1q8y_A 42 VNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLAL 119 (373)
T ss_dssp TTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHH
T ss_pred CCCcEEEEEEecC-CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCCceEEEEEecC-CCCHHHH
Confidence 4789999999963 3334567889999999886 889999999987654 789999999 8999999
Q ss_pred hcccCCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCCeEeeccCCCeEEEc------CCCceEEccccccccCCCCCCc
Q 021490 72 LHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK-AKPPVIYRDLKCSNILLD------RGYHPKLSDFGLAKLGPVGDNT 144 (311)
Q Consensus 72 l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~-~~~~i~h~dl~p~nil~~------~~~~~~l~df~~~~~~~~~~~~ 144 (311)
+.... ...+++..++.++.||+.||+|||++ + ++||||||+|||++ ..+.++|+|||++......
T Consensus 120 ~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~--- 191 (373)
T 1q8y_A 120 IKKYE--HRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH--- 191 (373)
T ss_dssp HHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC---
T ss_pred HHHhh--ccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCCcCcceEEEcccccccccCCC---
Confidence 98632 45699999999999999999999998 9 99999999999994 4458999999998753221
Q ss_pred eeeeeccccccccCccccccCCCccccceeehhHHHHHHHhCCCccCcchhHHH-------HHHHHHhhh----------
Q 021490 145 HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAE-------QSLVAWARP---------- 207 (311)
Q Consensus 145 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~-------~~~~~~~~~---------- 207 (311)
.....++..|+|||++.+..++.++|||||||++|+|++|..||........ ..+......
T Consensus 192 --~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 269 (373)
T 1q8y_A 192 --YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGK 269 (373)
T ss_dssp --CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCT
T ss_pred --CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccc
Confidence 2234689999999999999999999999999999999999999976542211 111110000
Q ss_pred ----hhccccccccccCc---------cccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 021490 208 ----LFQDRTRHSLIADP---------ELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 261 (311)
Q Consensus 208 ----~~~~~~~~~~~~~~---------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l~ 261 (311)
.+............ .....++...+..+.+||.+||+.||.+|||+.++++...
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 336 (373)
T 1q8y_A 270 YTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPW 336 (373)
T ss_dssp THHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGG
T ss_pred hhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhChh
Confidence 00000000000000 0012345677888999999999999999999999998754
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=289.86 Aligned_cols=234 Identities=22% Similarity=0.265 Sum_probs=171.5
Q ss_pred ccCCcEEEEEEeecCCCcchhHHHHHHHHHhcC-CCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCC---
Q 021490 6 LCLLQDVAIKQLDRNGVQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKP--- 81 (311)
Q Consensus 6 ~~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~--- 81 (311)
..+|+.||||++... ..+.+.+|+.++..+ +||||+++++++.++...++|||||+ |+|.+++.........
T Consensus 36 ~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~ 111 (434)
T 2rio_A 36 SFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKL 111 (434)
T ss_dssp ESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEHHHHHHTC---------
T ss_pred EECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCHHHHHhccCCCchhhhh
Confidence 447999999998643 345678899999876 89999999999999999999999996 6999999863211111
Q ss_pred CCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCC-------------CceEEccccccccCCCCCCc--ee
Q 021490 82 LDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG-------------YHPKLSDFGLAKLGPVGDNT--HV 146 (311)
Q Consensus 82 l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~-------------~~~~l~df~~~~~~~~~~~~--~~ 146 (311)
.++..++.++.|++.||+|||+.+ |+||||||+|||++.+ +.++|+|||++......... ..
T Consensus 112 ~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~ 188 (434)
T 2rio_A 112 QKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTN 188 (434)
T ss_dssp ---CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------
T ss_pred ccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceee
Confidence 133346789999999999999999 9999999999999754 48999999999764332211 11
Q ss_pred eeeccccccccCcccccc-------CCCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccc
Q 021490 147 STRVMGTYGYCAPEYAKT-------GQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLI 218 (311)
Q Consensus 147 ~~~~~~~~~y~aPE~~~~-------~~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 218 (311)
.....|+..|+|||++.+ ..++.++|||||||++|+|++ |..||........ .+.. ....
T Consensus 189 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~-~i~~-------~~~~---- 256 (434)
T 2rio_A 189 LNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES-NIIR-------GIFS---- 256 (434)
T ss_dssp ------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHH-HHHH-------TCCC----
T ss_pred ecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHH-HHhc-------CCCC----
Confidence 223468999999999865 568899999999999999999 9999975433221 1111 0000
Q ss_pred cCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 021490 219 ADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 219 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~ 259 (311)
.+......+...+.++.+|+.+||+.||.+|||+.++++.
T Consensus 257 -~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 257 -LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp -CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 0111112234566789999999999999999999999864
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=288.04 Aligned_cols=250 Identities=19% Similarity=0.198 Sum_probs=172.3
Q ss_pred CCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeee--CCeeEEEEecCCCCChhhhhcccC-----CCCC
Q 021490 8 LLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCAD--GDQRLLVYEYMPLGSVEDHLHDLS-----PGKK 80 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~ 80 (311)
+++.||||+++... ....+.+|+.+|+.++||||+++++++.. +...++||||++ ++|.+++.... ....
T Consensus 47 ~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~ 123 (405)
T 3rgf_A 47 DDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPV 123 (405)
T ss_dssp CCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS-EEHHHHHHHHHHHC------
T ss_pred CCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC-CCHHHHHHHhcccccccccc
Confidence 57899999996442 34578899999999999999999999954 678999999996 58887775321 1123
Q ss_pred CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEE----cCCCceEEccccccccCCCCCC-ceeeeecccccc
Q 021490 81 PLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL----DRGYHPKLSDFGLAKLGPVGDN-THVSTRVMGTYG 155 (311)
Q Consensus 81 ~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~----~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~ 155 (311)
.+++..++.++.||+.||+|||+.+ |+||||||+|||+ +.++.++|+|||++........ ........++..
T Consensus 124 ~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~ 200 (405)
T 3rgf_A 124 QLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 200 (405)
T ss_dssp -CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCT
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCc
Confidence 5999999999999999999999999 9999999999999 6788999999999975432211 122233568999
Q ss_pred ccCcccccc-CCCccccceeehhHHHHHHHhCCCccCcchhHH---------HH-HHHHHhhhhhccccc-ccc------
Q 021490 156 YCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA---------EQ-SLVAWARPLFQDRTR-HSL------ 217 (311)
Q Consensus 156 y~aPE~~~~-~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~---------~~-~~~~~~~~~~~~~~~-~~~------ 217 (311)
|+|||++.+ ..++.++|||||||++|+|++|..||....... .. .+............. ...
T Consensus 201 y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~ 280 (405)
T 3rgf_A 201 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHST 280 (405)
T ss_dssp TCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHH
T ss_pred ccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhh
Confidence 999999877 458999999999999999999999997544311 10 111100000000000 000
Q ss_pred ----ccCcccc--------CCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 021490 218 ----IADPELQ--------GQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYL 263 (311)
Q Consensus 218 ----~~~~~~~--------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l~~~ 263 (311)
....... .......+..+.+||.+||+.||.+|||++|+++.-.+.
T Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~ 338 (405)
T 3rgf_A 281 LMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFL 338 (405)
T ss_dssp HHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred hhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhc
Confidence 0000000 000001134678999999999999999999999886543
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=278.95 Aligned_cols=232 Identities=18% Similarity=0.177 Sum_probs=155.5
Q ss_pred CCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeee----CCeeEEEEecCCCCChhhhhcccCCCCCCCC
Q 021490 8 LLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCAD----GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLD 83 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~ 83 (311)
+|+.||||++... .....+....++.++||||+++++++.. +...++||||++|++|.+++.... ...++
T Consensus 53 ~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~l~ 126 (336)
T 3fhr_A 53 TGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERG--DQAFT 126 (336)
T ss_dssp TCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC---CCCCB
T ss_pred CCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhcC--CCCCC
Confidence 6899999999542 1222223344567799999999999876 445899999999999999998632 35799
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcC---CCceEEccccccccCCCCCCceeeeeccccccccCcc
Q 021490 84 WNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR---GYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 160 (311)
Q Consensus 84 ~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~---~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE 160 (311)
+..++.++.|++.||+|||+++ ++||||||+||+++. ++.++|+|||++...... ......+++.|+|||
T Consensus 127 ~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~~~t~~y~aPE 199 (336)
T 3fhr_A 127 EREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN----ALQTPCYTPYYVAPE 199 (336)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC----------------------
T ss_pred HHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccccceecccc----ccccCCCCcCccChh
Confidence 9999999999999999999999 999999999999976 455999999998753221 122345789999999
Q ss_pred ccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHH
Q 021490 161 YAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAA 240 (311)
Q Consensus 161 ~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 240 (311)
++.+..++.++||||||+++|+|++|..||............. ..+.. . ...+........+..+.+|+.
T Consensus 200 ~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~---~~~~~--~-----~~~~~~~~~~~~~~~~~~li~ 269 (336)
T 3fhr_A 200 VLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMK---RRIRL--G-----QYGFPNPEWSEVSEDAKQLIR 269 (336)
T ss_dssp ----CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------------CCCTTTSTTCCHHHHHHHH
T ss_pred hhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHH---Hhhhc--c-----ccccCchhhccCCHHHHHHHH
Confidence 9988889999999999999999999999997654322110000 00000 0 000111111234457889999
Q ss_pred HccccCCCCCCCHHHHHHHHHH
Q 021490 241 MCVHEQPDMRPVIADVVTALAY 262 (311)
Q Consensus 241 ~~l~~~p~~Rps~~~vl~~l~~ 262 (311)
+||+.||.+|||+.++++....
T Consensus 270 ~~L~~dP~~Rpt~~ell~hp~~ 291 (336)
T 3fhr_A 270 LLLKTDPTERLTITQFMNHPWI 291 (336)
T ss_dssp HHSCSSGGGSCCHHHHHHSHHH
T ss_pred HHCCCChhHCcCHHHHhcCccc
Confidence 9999999999999999987654
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=278.21 Aligned_cols=239 Identities=22% Similarity=0.269 Sum_probs=179.3
Q ss_pred cCCcEEEEEEeecCCCc--chhHHHHHHHHHhcCCCCcccceeeEeeeCCe------eEEEEecCCCCChhhhhcccCCC
Q 021490 7 CLLQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ------RLLVYEYMPLGSVEDHLHDLSPG 78 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~------~~lv~e~~~~~~L~~~l~~~~~~ 78 (311)
.+|+.||||++...... ..+.+.+|+.+++.++||||+++++++..... .++||||++ ++|.+++.
T Consensus 47 ~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~----- 120 (353)
T 3coi_A 47 RSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMG----- 120 (353)
T ss_dssp TTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCS-EEGGGTTT-----
T ss_pred CCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEEecccc-CCHHHHhc-----
Confidence 36999999999654322 24678899999999999999999999977654 499999997 68887774
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccC
Q 021490 79 KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCA 158 (311)
Q Consensus 79 ~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~a 158 (311)
..+++..+..++.|++.||+|||++| ++||||+|+||+++.++.++|+|||++..... ......++..|+|
T Consensus 121 -~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~-----~~~~~~~t~~y~a 191 (353)
T 3coi_A 121 -LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADA-----EMTGYVVTRWYRA 191 (353)
T ss_dssp -SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCTTC-------------CCSBCCSC
T ss_pred -CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccccCCCC-----CccccccCcCcCC
Confidence 34999999999999999999999999 99999999999999999999999999874321 1223467899999
Q ss_pred cccccc-CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhh-----hcccc---------ccccccCccc
Q 021490 159 PEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPL-----FQDRT---------RHSLIADPEL 223 (311)
Q Consensus 159 PE~~~~-~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~-----~~~~~---------~~~~~~~~~~ 223 (311)
||++.+ ..++.++||||||+++|+|++|..||...........+...... ..... .......+.+
T Consensus 192 PE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (353)
T 3coi_A 192 PEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDF 271 (353)
T ss_dssp HHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCT
T ss_pred HHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccH
Confidence 999876 67899999999999999999999999876654332211110000 00000 0000000001
Q ss_pred cCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 021490 224 QGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 261 (311)
Q Consensus 224 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l~ 261 (311)
....+..+..+.+|+.+||..||.+|||+.++++.-.
T Consensus 272 -~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~ 308 (353)
T 3coi_A 272 -TQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPF 308 (353)
T ss_dssp -TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGG
T ss_pred -HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcc
Confidence 1222344568999999999999999999999997644
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=279.62 Aligned_cols=240 Identities=17% Similarity=0.185 Sum_probs=181.2
Q ss_pred CcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCc------ccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCC
Q 021490 9 LQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPN------LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPL 82 (311)
Q Consensus 9 g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~------i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l 82 (311)
++.||+|+++. .....+.+.+|+.+++.++|++ ++.+++++......++||||+ +++|.+++... ....+
T Consensus 45 ~~~vavK~~~~-~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~--~~~~~ 120 (355)
T 2eu9_A 45 KSQVALKIIRN-VGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKEN--NFQPY 120 (355)
T ss_dssp TEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHT--TTCCC
T ss_pred ceEEEEEEEcc-cccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEEEecc-CCChHHHHHhc--cCCCC
Confidence 37899999953 3344567888999999997765 899999999999999999999 56777777652 13579
Q ss_pred CHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEE-------------------cCCCceEEccccccccCCCCCC
Q 021490 83 DWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL-------------------DRGYHPKLSDFGLAKLGPVGDN 143 (311)
Q Consensus 83 ~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~-------------------~~~~~~~l~df~~~~~~~~~~~ 143 (311)
++..++.++.|++.||+|||+++ ++||||||+|||+ +.++.++|+|||++......
T Consensus 121 ~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-- 195 (355)
T 2eu9_A 121 PLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH-- 195 (355)
T ss_dssp CHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC--
T ss_pred CHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCcccccccc--
Confidence 99999999999999999999999 9999999999999 56789999999998753222
Q ss_pred ceeeeeccccccccCccccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhcc-----ccccccc
Q 021490 144 THVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQD-----RTRHSLI 218 (311)
Q Consensus 144 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~ 218 (311)
.....++..|+|||++.+..++.++|||||||++|+|++|..||..................... .......
T Consensus 196 ---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~ 272 (355)
T 2eu9_A 196 ---HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYF 272 (355)
T ss_dssp ---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGE
T ss_pred ---ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhh
Confidence 22346899999999999889999999999999999999999999876654433222211100000 0000000
Q ss_pred cCc---------------------cccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 021490 219 ADP---------------------ELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 260 (311)
Q Consensus 219 ~~~---------------------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l 260 (311)
... ..........+..+.+|+.+||+.||.+|||+.++++.-
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp 335 (355)
T 2eu9_A 273 YKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHP 335 (355)
T ss_dssp ETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSG
T ss_pred cccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 000 000111233456888999999999999999999999764
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=280.25 Aligned_cols=241 Identities=20% Similarity=0.187 Sum_probs=180.3
Q ss_pred CCcEEEEEEeecCCCcchhHHHHHHHHHhcCC-CC-----cccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCC
Q 021490 8 LLQDVAIKQLDRNGVQGNREFLVEVLMLSLLH-HP-----NLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKP 81 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~-----~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 81 (311)
+|+.||||+++.. ......+.+|+.++..++ |+ +|+.+++++......++||||++ ++|.+++.... ...
T Consensus 78 ~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~ 153 (382)
T 2vx3_A 78 EQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLS-YNLYDLLRNTN--FRG 153 (382)
T ss_dssp TTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEECCC-CBHHHHHHHTT--TSC
T ss_pred CCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEecCC-CCHHHHHhhcC--cCC
Confidence 6889999999633 234567778999988885 55 49999999999999999999996 59999998732 356
Q ss_pred CCHHHHHHHHHHHHHHHHHhhc--CCCCCeEeeccCCCeEEEc--CCCceEEccccccccCCCCCCceeeeecccccccc
Q 021490 82 LDWNTRMKIAAGAARGLEYLHD--KAKPPVIYRDLKCSNILLD--RGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 157 (311)
Q Consensus 82 l~~~~~~~~~~~i~~~l~~lh~--~~~~~i~h~dl~p~nil~~--~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~ 157 (311)
+++..+..++.|++.||+|||+ .+ |+||||||+|||++ .++.+||+|||++...... .....++..|+
T Consensus 154 ~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~ 225 (382)
T 2vx3_A 154 VSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR-----IYQYIQSRFYR 225 (382)
T ss_dssp CCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTSCCEEECCCTTCEETTCC-----CCSSCSCGGGC
T ss_pred CCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCCCCcEEEEeccCceecccc-----cccccCCcccc
Confidence 9999999999999999999994 57 99999999999995 4778999999999754221 22346889999
Q ss_pred CccccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhh---------------hccccc----cc--
Q 021490 158 APEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPL---------------FQDRTR----HS-- 216 (311)
Q Consensus 158 aPE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~---------------~~~~~~----~~-- 216 (311)
|||++.+..++.++|||||||++|+|++|..||...........+...... +..... ..
T Consensus 226 aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (382)
T 2vx3_A 226 SPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKT 305 (382)
T ss_dssp CHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCC
T ss_pred ChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHHHHHHHhccccccccccc
Confidence 999999989999999999999999999999999876654433222111100 000000 00
Q ss_pred -----cccCccc--------------------cCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 021490 217 -----LIADPEL--------------------QGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 260 (311)
Q Consensus 217 -----~~~~~~~--------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l 260 (311)
....+.. ...........+.+||.+||+.||++|||+.|+++.-
T Consensus 306 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~e~L~hp 374 (382)
T 2vx3_A 306 KDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHS 374 (382)
T ss_dssp CTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHHHHTTSG
T ss_pred cccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCCHHHHhcCc
Confidence 0000000 0011122345789999999999999999999998763
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-39 Score=278.97 Aligned_cols=219 Identities=21% Similarity=0.307 Sum_probs=179.9
Q ss_pred cCCcEEEEEEeecCCCc------chhHHHHHHHHHhcCC--CCcccceeeEeeeCCeeEEEEecCCC-CChhhhhcccCC
Q 021490 7 CLLQDVAIKQLDRNGVQ------GNREFLVEVLMLSLLH--HPNLVNLIGYCADGDQRLLVYEYMPL-GSVEDHLHDLSP 77 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~ 77 (311)
.+|+.||||+++..... ....+.+|+.+++.++ |+||+++++++.+....++|||++.+ ++|.+++..
T Consensus 66 ~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~--- 142 (320)
T 3a99_A 66 SDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE--- 142 (320)
T ss_dssp TTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHH---
T ss_pred CCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEEEEEEcCCCCccHHHHHhc---
Confidence 47899999999765432 2356778999999996 59999999999999999999999976 899999987
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEc-CCCceEEccccccccCCCCCCceeeeeccccccc
Q 021490 78 GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD-RGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY 156 (311)
Q Consensus 78 ~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y 156 (311)
...+++..++.++.|++.||+|||+.+ ++||||||+||+++ +++.++|+|||++...... ......++..|
T Consensus 143 -~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~----~~~~~~gt~~y 214 (320)
T 3a99_A 143 -RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVY 214 (320)
T ss_dssp -HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCSS----CBCCCCSCGGG
T ss_pred -cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEeeCccccccccc----cccCCCCCccC
Confidence 567999999999999999999999999 99999999999999 7899999999998754322 12234588999
Q ss_pred cCccccccCCC-ccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHH
Q 021490 157 CAPEYAKTGQL-TLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQA 235 (311)
Q Consensus 157 ~aPE~~~~~~~-~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 235 (311)
+|||++.+..+ +.++||||||+++|+|++|..||....... ... .. .+...+..+
T Consensus 215 ~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~------------~~~--------~~----~~~~~~~~~ 270 (320)
T 3a99_A 215 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII------------RGQ--------VF----FRQRVSSEC 270 (320)
T ss_dssp SCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHH------------HCC--------CC----CSSCCCHHH
T ss_pred CChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhhh------------ccc--------cc----ccccCCHHH
Confidence 99999877665 788999999999999999999997643210 000 00 112233478
Q ss_pred HHHHHHccccCCCCCCCHHHHHHHH
Q 021490 236 LAVAAMCVHEQPDMRPVIADVVTAL 260 (311)
Q Consensus 236 ~~li~~~l~~~p~~Rps~~~vl~~l 260 (311)
.+|+.+||+.||.+|||+.++++..
T Consensus 271 ~~li~~~l~~dp~~Rps~~~ll~hp 295 (320)
T 3a99_A 271 QHLIRWCLALRPSDRPTFEEIQNHP 295 (320)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred HHHHHHHccCChhhCcCHHHHhcCH
Confidence 8999999999999999999999864
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=276.31 Aligned_cols=220 Identities=25% Similarity=0.378 Sum_probs=174.9
Q ss_pred cCCcEEEEEEeecCCCc------chhHHHHHHHHHhcC----CCCcccceeeEeeeCCeeEEEEec-CCCCChhhhhccc
Q 021490 7 CLLQDVAIKQLDRNGVQ------GNREFLVEVLMLSLL----HHPNLVNLIGYCADGDQRLLVYEY-MPLGSVEDHLHDL 75 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l----~h~~i~~~~~~~~~~~~~~lv~e~-~~~~~L~~~l~~~ 75 (311)
.+|+.||||+++..... ....+.+|+.++..+ +||||+++++++.+....++|||+ +.+++|.+++..
T Consensus 54 ~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~- 132 (312)
T 2iwi_A 54 TDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITE- 132 (312)
T ss_dssp TTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-----CEEEEECCSSEEEHHHHHHH-
T ss_pred cCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHh-
Confidence 47899999999665432 234566799999988 899999999999999999999999 789999999987
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEc-CCCceEEccccccccCCCCCCceeeeeccccc
Q 021490 76 SPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD-RGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTY 154 (311)
Q Consensus 76 ~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~ 154 (311)
...+++..++.++.|++.||+|||+.+ ++|+||+|+||+++ .++.++|+|||++....... .....++.
T Consensus 133 ---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~ 202 (312)
T 2iwi_A 133 ---KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP----YTDFDGTR 202 (312)
T ss_dssp ---HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEEECCCSSCEECCSSC----BCCCCSCT
T ss_pred ---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEEEEEcchhhhcccCc----ccccCCcc
Confidence 467999999999999999999999999 99999999999999 88999999999987543221 22345889
Q ss_pred cccCccccccCCC-ccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHH
Q 021490 155 GYCAPEYAKTGQL-TLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFY 233 (311)
Q Consensus 155 ~y~aPE~~~~~~~-~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
.|+|||++.+..+ +.++||||||+++|+|++|..||....... ... ..++...+.
T Consensus 203 ~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------------~~~------------~~~~~~~~~ 258 (312)
T 2iwi_A 203 VYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEIL------------EAE------------LHFPAHVSP 258 (312)
T ss_dssp TTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHH------------HTC------------CCCCTTSCH
T ss_pred cccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHHh------------hhc------------cCCcccCCH
Confidence 9999999877665 458999999999999999999997643210 000 011223345
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHHHH
Q 021490 234 QALAVAAMCVHEQPDMRPVIADVVTALA 261 (311)
Q Consensus 234 ~l~~li~~~l~~~p~~Rps~~~vl~~l~ 261 (311)
.+.+++.+||+.||++|||+.++++...
T Consensus 259 ~~~~li~~~l~~~p~~Rps~~e~l~~~~ 286 (312)
T 2iwi_A 259 DCCALIRRCLAPKPSSRPSLEEILLDPW 286 (312)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHHSTT
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 7889999999999999999999998643
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=283.80 Aligned_cols=229 Identities=23% Similarity=0.251 Sum_probs=170.0
Q ss_pred ccCCcEEEEEEeecCCCcchhHHHHHHHHHhcC-CCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCH
Q 021490 6 LCLLQDVAIKQLDRNGVQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 84 (311)
Q Consensus 6 ~~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~ 84 (311)
..+|+.||||++.... ...+.+|+.+++.+ +||||+++++++.+....|+|||||+ ++|.+++... ...+.+
T Consensus 45 ~~~~~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L~~~l~~~---~~~~~~ 117 (432)
T 3p23_A 45 MFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQK---DFAHLG 117 (432)
T ss_dssp ESSSSEEEEEEECTTT---EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHSS---SCCCCS
T ss_pred EeCCeEEEEEEECHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CCHHHHHHhc---CCCccc
Confidence 3478999999996533 23466899999999 79999999999999999999999996 6999999763 234555
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcC-----CCceEEccccccccCCCCCCc-eeeeeccccccccC
Q 021490 85 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR-----GYHPKLSDFGLAKLGPVGDNT-HVSTRVMGTYGYCA 158 (311)
Q Consensus 85 ~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~-----~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~y~a 158 (311)
..++.++.|++.||+|||+.+ |+||||||+||+++. ...++|+|||++......... .......||..|+|
T Consensus 118 ~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~A 194 (432)
T 3p23_A 118 LEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIA 194 (432)
T ss_dssp SCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCC
T ss_pred hhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccC
Confidence 667899999999999999999 999999999999953 235789999998754322111 22233568999999
Q ss_pred ccccc---cCCCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHH
Q 021490 159 PEYAK---TGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQ 234 (311)
Q Consensus 159 PE~~~---~~~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
||++. ...++.++|||||||++|+|++ |..||........... ...... .. ..........
T Consensus 195 PE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~-------~~~~~~--~~------~~~~~~~~~~ 259 (432)
T 3p23_A 195 PEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANIL-------LGACSL--DC------LHPEKHEDVI 259 (432)
T ss_dssp GGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHH-------TTCCCC--TT------SCTTCHHHHH
T ss_pred hhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHH-------hccCCc--cc------cCccccccHH
Confidence 99987 4567789999999999999999 8999965433221110 000000 00 0112234556
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHH
Q 021490 235 ALAVAAMCVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 235 l~~li~~~l~~~p~~Rps~~~vl~~ 259 (311)
+.+|+.+||+.||.+|||+.++++.
T Consensus 260 ~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 260 ARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 7889999999999999999999954
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=270.20 Aligned_cols=230 Identities=25% Similarity=0.319 Sum_probs=166.8
Q ss_pred CCcEEEEEEeecCCCcc-h-hHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHH
Q 021490 8 LLQDVAIKQLDRNGVQG-N-REFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN 85 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~~-~-~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~ 85 (311)
+|+.||||++....... . +.+.++..+++.++||||+++++++.++...++||||+ ++.+..+.... ...+++.
T Consensus 49 ~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~~~~l~~~~---~~~~~~~ 124 (318)
T 2dyl_A 49 TGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRM---QGPIPER 124 (318)
T ss_dssp TCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-SEEHHHHHHHH---TSCCCHH
T ss_pred CCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-CCcHHHHHHHh---ccCCCHH
Confidence 68999999997654322 2 34445556788889999999999999999999999999 55665555431 4679999
Q ss_pred HHHHHHHHHHHHHHHhhcC-CCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccc-
Q 021490 86 TRMKIAAGAARGLEYLHDK-AKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK- 163 (311)
Q Consensus 86 ~~~~~~~~i~~~l~~lh~~-~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~- 163 (311)
.++.++.|++.||+|||++ + ++|+||+|+||+++.++.++|+|||++...... .......++..|+|||++.
T Consensus 125 ~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~ 198 (318)
T 2dyl_A 125 ILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVDD---KAKDRSAGCAAYMAPERIDP 198 (318)
T ss_dssp HHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC-----------------CCTTCCHHHHC-
T ss_pred HHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccCC---ccccccCCCccccChhhccc
Confidence 9999999999999999995 8 999999999999999999999999998643221 1222345889999999984
Q ss_pred ----cCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHH
Q 021490 164 ----TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVA 239 (311)
Q Consensus 164 ----~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 239 (311)
...++.++||||||+++|+|++|..||......... .... ..... +.+. .....+..+.+++
T Consensus 199 ~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~---~~~~~-------~~~~--~~~~~~~~l~~li 264 (318)
T 2dyl_A 199 PDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEV--LTKV---LQEEP-------PLLP--GHMGFSGDFQSFV 264 (318)
T ss_dssp -------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH--HHHH---HHSCC-------CCCC--SSSCCCHHHHHHH
T ss_pred ccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHH--HHHH---hccCC-------CCCC--ccCCCCHHHHHHH
Confidence 456788999999999999999999999764322111 0000 11100 0000 0112334788999
Q ss_pred HHccccCCCCCCCHHHHHHHHH
Q 021490 240 AMCVHEQPDMRPVIADVVTALA 261 (311)
Q Consensus 240 ~~~l~~~p~~Rps~~~vl~~l~ 261 (311)
.+||..||.+|||+.++++...
T Consensus 265 ~~~l~~dp~~Rps~~~ll~h~~ 286 (318)
T 2dyl_A 265 KDCLTKDHRKRPKYNKLLEHSF 286 (318)
T ss_dssp HHHTCSCTTTSCCHHHHTTSHH
T ss_pred HHHccCChhHCcCHHHHhhCHH
Confidence 9999999999999999997543
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=291.38 Aligned_cols=249 Identities=24% Similarity=0.289 Sum_probs=187.4
Q ss_pred cCCcEEEEEEeecCC-CcchhHHHHHHHHHhcCCCCcccceeeEeee------CCeeEEEEecCCCCChhhhhcccCCCC
Q 021490 7 CLLQDVAIKQLDRNG-VQGNREFLVEVLMLSLLHHPNLVNLIGYCAD------GDQRLLVYEYMPLGSVEDHLHDLSPGK 79 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~~~l~~~~~~~ 79 (311)
.+|+.||||+++... ....+.+.+|+.++..++||||+++++++.. +...++||||++|++|.+++.... ..
T Consensus 37 ~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~-~~ 115 (676)
T 3qa8_A 37 DTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFE-NC 115 (676)
T ss_dssp TTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSS-CT
T ss_pred CCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcc-cC
Confidence 468999999986543 2334679999999999999999999998765 667899999999999999998632 13
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCc---eEEccccccccCCCCCCceeeeeccccccc
Q 021490 80 KPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH---PKLSDFGLAKLGPVGDNTHVSTRVMGTYGY 156 (311)
Q Consensus 80 ~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~---~~l~df~~~~~~~~~~~~~~~~~~~~~~~y 156 (311)
..+++..++.++.|++.||+|||+.| ++||||+|+||+++.++. ++|+|||++....... ......++..|
T Consensus 116 ~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~---~~~~~~gt~~Y 189 (676)
T 3qa8_A 116 CGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE---LCTEFVGTLQY 189 (676)
T ss_dssp TCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCC---CCCCCCSCCTT
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccccccccccccc---ccccccCCccc
Confidence 46999999999999999999999999 999999999999997664 8999999997543222 22335689999
Q ss_pred cCccccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhh---------hccccccc--cccCccccC
Q 021490 157 CAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPL---------FQDRTRHS--LIADPELQG 225 (311)
Q Consensus 157 ~aPE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~---------~~~~~~~~--~~~~~~~~~ 225 (311)
+|||++.+..++.++||||||+++|+|++|..||........ |.... ........ .........
T Consensus 190 ~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~-----~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~ 264 (676)
T 3qa8_A 190 LAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQ-----WHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPN 264 (676)
T ss_dssp CSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHH-----SSTTCC------CCSCCCCSSSCCCCSSSCCSC
T ss_pred CChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhh-----hhhhhhcccchhhhhhhhhccccccccccCCch
Confidence 999999999999999999999999999999999976432211 11000 00000000 000111123
Q ss_pred CCChHhHHHHHHHHHHccccCCCCCCCHHH-----HHHHHHHhhhcc
Q 021490 226 QYPPRGFYQALAVAAMCVHEQPDMRPVIAD-----VVTALAYLASQK 267 (311)
Q Consensus 226 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~-----vl~~l~~~~~~~ 267 (311)
.+....+..+.+++.+||..||++|||+.+ +.+.+..+....
T Consensus 265 ~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~k 311 (676)
T 3qa8_A 265 HLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLK 311 (676)
T ss_dssp CCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCCC
T ss_pred hhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhcc
Confidence 445567889999999999999999999988 446666555543
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=265.48 Aligned_cols=211 Identities=18% Similarity=0.161 Sum_probs=163.9
Q ss_pred CCcEEEEEEeecCCCcc---hhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCH
Q 021490 8 LLQDVAIKQLDRNGVQG---NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 84 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~ 84 (311)
+|+.||||++....... .+.|.+|+..+..++||||+++++++.++...|+||||++|++|.+++.. + ...
T Consensus 55 ~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~-----~-~~~ 128 (286)
T 3uqc_A 55 LDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADT-----S-PSP 128 (286)
T ss_dssp TTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCEEEHHHHHTT-----C-CCH
T ss_pred CCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEecCCCCHHHHHhc-----C-CCh
Confidence 48999999997654432 36889999999999999999999999999999999999999999999964 2 356
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccccc
Q 021490 85 NTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT 164 (311)
Q Consensus 85 ~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 164 (311)
..+..++.|++.||+|||++| ++||||||+||+++.+|.++|++++ |++
T Consensus 129 ~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~----------------------~~~------ 177 (286)
T 3uqc_A 129 VGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA----------------------TMP------ 177 (286)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC----------------------CCT------
T ss_pred HHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc----------------------ccC------
Confidence 678999999999999999999 9999999999999999999998543 222
Q ss_pred CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccc
Q 021490 165 GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVH 244 (311)
Q Consensus 165 ~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 244 (311)
.++.++|||||||++|+|++|..||.......... . ....... .+.......+..+..+.+++.+||+
T Consensus 178 -~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~------~-~~~~~~~----~~~~~~~~~~~~~~~l~~li~~~l~ 245 (286)
T 3uqc_A 178 -DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA------P-AERDTAG----QPIEPADIDRDIPFQISAVAARSVQ 245 (286)
T ss_dssp -TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE------E-CCBCTTS----CBCCHHHHCTTSCHHHHHHHHHHHC
T ss_pred -CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH------H-HHHHhcc----CCCChhhcccCCCHHHHHHHHHHcc
Confidence 36889999999999999999999998654211000 0 0000000 0000001112334578899999999
Q ss_pred cCCCCCCCHHHHHHHHHHhhhccC
Q 021490 245 EQPDMRPVIADVVTALAYLASQKY 268 (311)
Q Consensus 245 ~~p~~Rps~~~vl~~l~~~~~~~~ 268 (311)
.||++| |+.++++.|+.+.....
T Consensus 246 ~dP~~R-s~~el~~~L~~~~~~~~ 268 (286)
T 3uqc_A 246 GDGGIR-SASTLLNLMQQATAVAD 268 (286)
T ss_dssp TTSSCC-CHHHHHHHHHHHHC---
T ss_pred cCCccC-CHHHHHHHHHHHhccCC
Confidence 999999 99999999998876543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=262.09 Aligned_cols=209 Identities=20% Similarity=0.278 Sum_probs=162.6
Q ss_pred cCCcEEEEEEeecCCCcchhHHHHHHHHH-hcCCCCcccceeeEeee----CCeeEEEEecCCCCChhhhhcccCCCCCC
Q 021490 7 CLLQDVAIKQLDRNGVQGNREFLVEVLML-SLLHHPNLVNLIGYCAD----GDQRLLVYEYMPLGSVEDHLHDLSPGKKP 81 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l-~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 81 (311)
.+|+.||+|+++. ...+.+|+.++ +.++||||+++++++.+ ....++||||++|++|.+++.... ...
T Consensus 41 ~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~ 113 (299)
T 3m2w_A 41 RTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRG--DQA 113 (299)
T ss_dssp TTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHHCT--TCC
T ss_pred CCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHhcc--CCC
Confidence 4689999999953 35677899888 55699999999999876 667899999999999999998732 347
Q ss_pred CCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcC---CCceEEccccccccCCCCCCceeeeeccccccccC
Q 021490 82 LDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR---GYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCA 158 (311)
Q Consensus 82 l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~---~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~a 158 (311)
+++..++.++.|++.||+|||+.+ ++|+||||+||+++. ++.++|+|||++...
T Consensus 114 ~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~-------------------- 170 (299)
T 3m2w_A 114 FTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKET-------------------- 170 (299)
T ss_dssp CBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEEC--------------------
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEecccccccc--------------------
Confidence 999999999999999999999999 999999999999998 788999999987531
Q ss_pred ccccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCC----hHhHHH
Q 021490 159 PEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYP----PRGFYQ 234 (311)
Q Consensus 159 PE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~ 234 (311)
.+..++.++|||||||++|+|++|..||.......... ........ . ....+ ...+..
T Consensus 171 ----~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~-------~~~~~~~~-----~--~~~~~~~~~~~~~~~ 232 (299)
T 3m2w_A 171 ----TGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP-------GMKTRIRM-----G--QYEFPNPEWSEVSEE 232 (299)
T ss_dssp ----TTCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------C-------CSCCSSCT-----T--CCSSCHHHHTTSCHH
T ss_pred ----ccccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhH-------HHHHHHhh-----c--cccCCchhcccCCHH
Confidence 12457889999999999999999999997644321100 00000000 0 00111 123457
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 021490 235 ALAVAAMCVHEQPDMRPVIADVVTALAYL 263 (311)
Q Consensus 235 l~~li~~~l~~~p~~Rps~~~vl~~l~~~ 263 (311)
+.+++.+||+.||.+|||+.++++.....
T Consensus 233 ~~~li~~~l~~dP~~Rps~~e~l~hp~~~ 261 (299)
T 3m2w_A 233 VKMLIRNLLKTEPTQRMTITEFMNHPWIM 261 (299)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred HHHHHHHHcccChhhCCCHHHHhcChhhc
Confidence 89999999999999999999999875543
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-37 Score=291.90 Aligned_cols=216 Identities=21% Similarity=0.285 Sum_probs=170.3
Q ss_pred CCcEEEEEEeecCCC-cchhHHHHHHHHHhcCCCCcccceeeEeeeCCe-----eEEEEecCCCCChhhhhcccCCCCCC
Q 021490 8 LLQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ-----RLLVYEYMPLGSVEDHLHDLSPGKKP 81 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-----~~lv~e~~~~~~L~~~l~~~~~~~~~ 81 (311)
+|+.||||++..... .....+.+|+.++..++||||+++++++.+... .|+||||++|++|.+++.. .
T Consensus 105 ~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~------~ 178 (681)
T 2pzi_A 105 NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ------K 178 (681)
T ss_dssp TTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC----C------C
T ss_pred CCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHhC------C
Confidence 689999999865432 334678899999999999999999999987655 7999999999999887643 6
Q ss_pred CCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccc
Q 021490 82 LDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 161 (311)
Q Consensus 82 l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 161 (311)
+++..++.++.||+.||+|||++| |+||||||+|||++.+ .+||+|||++...... ....||+.|+|||+
T Consensus 179 l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~------~~~~gt~~y~aPE~ 248 (681)
T 2pzi_A 179 LPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF------GYLYGTPGFQAPEI 248 (681)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCEETTCC------SCCCCCTTTSCTTH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccchhcccC------CccCCCccccCHHH
Confidence 999999999999999999999999 9999999999999885 8999999998754322 23468999999999
Q ss_pred cccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHH
Q 021490 162 AKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAM 241 (311)
Q Consensus 162 ~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 241 (311)
+.+.. +.++|||||||++|+|++|..||...... ... . .......+..+.+||.+
T Consensus 249 ~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~---------------~~~-----~----~~~~~~~~~~l~~li~~ 303 (681)
T 2pzi_A 249 VRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVD---------------GLP-----E----DDPVLKTYDSYGRLLRR 303 (681)
T ss_dssp HHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECS---------------SCC-----T----TCHHHHHCHHHHHHHHH
T ss_pred HcCCC-CCceehhhhHHHHHHHHhCCCCCcccccc---------------ccc-----c----cccccccCHHHHHHHhh
Confidence 87654 88999999999999999999888652110 000 0 00011223578889999
Q ss_pred ccccCCCCCCC-HHHHHHHHHHhh
Q 021490 242 CVHEQPDMRPV-IADVVTALAYLA 264 (311)
Q Consensus 242 ~l~~~p~~Rps-~~~vl~~l~~~~ 264 (311)
||+.||.+||+ ++++...|..+.
T Consensus 304 ~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 304 AIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp HTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred hccCChhhCCCHHHHHHHHHHHHH
Confidence 99999999995 556666665544
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=272.25 Aligned_cols=226 Identities=17% Similarity=0.156 Sum_probs=164.4
Q ss_pred cchh-ccCCcEEEEEEeecCCC---cchhHHHHHHHHHhcCCC-Ccccce---------e------------eEeee---
Q 021490 2 MQVI-LCLLQDVAIKQLDRNGV---QGNREFLVEVLMLSLLHH-PNLVNL---------I------------GYCAD--- 52 (311)
Q Consensus 2 ~~~~-~~~g~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h-~~i~~~---------~------------~~~~~--- 52 (311)
|.+. ..+|+.||||+++.... ...+.|.+|+.++..++| +|...+ . .++..
T Consensus 95 y~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (413)
T 3dzo_A 95 LEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERD 174 (413)
T ss_dssp EEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC-------------
T ss_pred EEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCCCccccccCCCcc
Confidence 4444 44699999999874433 235789999999999987 322111 1 11111
Q ss_pred --CCeeEEEEecCCCCChhhhhccc---CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCce
Q 021490 53 --GDQRLLVYEYMPLGSVEDHLHDL---SPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP 127 (311)
Q Consensus 53 --~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~ 127 (311)
....+++|+++ +++|.+++... ......+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+
T Consensus 175 ~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---iiHrDiKp~NILl~~~~~~ 250 (413)
T 3dzo_A 175 MWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGV 250 (413)
T ss_dssp --CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCE
T ss_pred ccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcccceEEEecCCeE
Confidence 12457888876 68999888522 122456888899999999999999999999 9999999999999999999
Q ss_pred EEccccccccCCCCCCceeeeeccccccccCcccc----------ccCCCccccceeehhHHHHHHHhCCCccCcchhHH
Q 021490 128 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA----------KTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAA 197 (311)
Q Consensus 128 ~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~ 197 (311)
||+|||++..... ......| ..|+|||++ ....++.++|||||||++|+|++|..||.......
T Consensus 251 kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~ 324 (413)
T 3dzo_A 251 FLTGFEHLVRDGA-----SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALG 324 (413)
T ss_dssp EECCGGGCEETTE-----EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGS
T ss_pred EEEeccceeecCC-----ccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9999999864221 1333456 899999998 55567889999999999999999999997654321
Q ss_pred HHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 021490 198 EQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~ 259 (311)
... ..+.. ....+..+.+|+.+||+.||.+|||+.++++.
T Consensus 325 ~~~------~~~~~----------------~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~ 364 (413)
T 3dzo_A 325 GSE------WIFRS----------------CKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 364 (413)
T ss_dssp CSG------GGGSS----------------CCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred hHH------HHHhh----------------cccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 100 00000 01123578899999999999999998887643
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-36 Score=263.00 Aligned_cols=226 Identities=16% Similarity=0.097 Sum_probs=165.7
Q ss_pred cchhccCCcEEEEEEeecCCC--------cchhHHHHHHHHHhcCC---------CCcccce-----------------e
Q 021490 2 MQVILCLLQDVAIKQLDRNGV--------QGNREFLVEVLMLSLLH---------HPNLVNL-----------------I 47 (311)
Q Consensus 2 ~~~~~~~g~~vaiK~~~~~~~--------~~~~~~~~e~~~l~~l~---------h~~i~~~-----------------~ 47 (311)
|.+.. +|+.||||+++.... ...+.+.+|+.+++.++ ||||+++ +
T Consensus 37 ~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~~~~~~hp~iv~~~ 115 (336)
T 2vuw_A 37 FQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAW 115 (336)
T ss_dssp EEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEEEEESSCCHHHHHHH
T ss_pred EEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcceeEecCCCcHHHHHHH
Confidence 34443 689999999976542 23378899999999886 5555554 4
Q ss_pred eEeee-------------CCeeEEEEecCCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHhh-cCCCCCeEeec
Q 021490 48 GYCAD-------------GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH-DKAKPPVIYRD 113 (311)
Q Consensus 48 ~~~~~-------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh-~~~~~~i~h~d 113 (311)
+++.+ ....|+||||+++|++.+.+.. ..+++..+..++.||+.||+||| +.+ |+|||
T Consensus 116 ~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivHrD 187 (336)
T 2vuw_A 116 DHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLTASLAVAEASLR---FEHRD 187 (336)
T ss_dssp HHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHHHHHHHHHHHHHHC---CBCSC
T ss_pred HHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHhCC---EeECC
Confidence 44443 6789999999999987777643 56899999999999999999999 899 99999
Q ss_pred cCCCeEEEcCCC--------------------ceEEccccccccCCCCCCceeeeeccccccccCccccccCCCccccce
Q 021490 114 LKCSNILLDRGY--------------------HPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDV 173 (311)
Q Consensus 114 l~p~nil~~~~~--------------------~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 173 (311)
|||+|||++.++ .+||+|||++..... ....||+.|+|||++.+.. +.++||
T Consensus 188 lKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y~aPE~~~g~~-~~~~Di 259 (336)
T 2vuw_A 188 LHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVSMDEDLFTGDG-DYQFDI 259 (336)
T ss_dssp CCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCCTTCSGGGCCCS-SHHHHH
T ss_pred CCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeecccChhhhcCCC-ccceeh
Confidence 999999999887 899999999975322 1236899999999998766 889999
Q ss_pred eehhHH-HHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCCCCCC
Q 021490 174 YSFGVV-LLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPV 252 (311)
Q Consensus 174 wslG~l-~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps 252 (311)
||+|++ .+++++|..||........ ... ........ ............+.++.+||.+||+.| |
T Consensus 260 wsl~~~~~~~~~~g~~p~~~~~~~~~--~~~---~~~~~~~~-----~~~~~~~~~~~~s~~~~dli~~~L~~d-----s 324 (336)
T 2vuw_A 260 YRLMKKENNNRWGEYHPYSNVLWLHY--LTD---KMLKQMTF-----KTKCNTPAMKQIKRKIQEFHRTMLNFS-----S 324 (336)
T ss_dssp HHHHHHHHTTCTTSCCTHHHHHHHHH--HHH---HHHHTCCC-----SSCCCSHHHHHHHHHHHHHHHHGGGSS-----S
T ss_pred hhhhCCCCcccccccCCCcchhhhhH--HHH---hhhhhhcc-----CcccchhhhhhcCHHHHHHHHHHhccC-----C
Confidence 998777 7778999999854321110 000 00100000 000011123456778999999999977 9
Q ss_pred HHHHH-HH
Q 021490 253 IADVV-TA 259 (311)
Q Consensus 253 ~~~vl-~~ 259 (311)
+.|++ +.
T Consensus 325 a~e~l~~H 332 (336)
T 2vuw_A 325 ATDLLCQH 332 (336)
T ss_dssp HHHHHHHC
T ss_pred HHHHHhcC
Confidence 99988 53
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.6e-33 Score=258.38 Aligned_cols=169 Identities=18% Similarity=0.148 Sum_probs=127.1
Q ss_pred CcEEEEEEeecCCC----------cchhHHHHHHHHHhcC-CCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCC
Q 021490 9 LQDVAIKQLDRNGV----------QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP 77 (311)
Q Consensus 9 g~~vaiK~~~~~~~----------~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 77 (311)
|+.+++|++..... ...++|.+|+++|+++ .|+||++++++++++...||||||++|++|.+++..
T Consensus 259 g~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~--- 335 (569)
T 4azs_A 259 GEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAA--- 335 (569)
T ss_dssp CSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHT---
T ss_pred cceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHh---
Confidence 78899999976432 1235799999999999 799999999999999999999999999999999987
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeecccccccc
Q 021490 78 GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 157 (311)
Q Consensus 78 ~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~ 157 (311)
.+.++.. .++.||+.||+|+|++| |+||||||+|||++.+|.+||+|||+++..... ........||+.|+
T Consensus 336 -~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~--~~~~~t~vGTp~Ym 406 (569)
T 4azs_A 336 -GEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD--CSWPTNLVQSFFVF 406 (569)
T ss_dssp -TCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC-----CCSHHHHHHHHHH
T ss_pred -CCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCC--CccccCceechhhc
Confidence 5667764 47899999999999999 999999999999999999999999998753222 12233457999999
Q ss_pred CccccccCCCccccceeehhHHHHHHHhCCCcc
Q 021490 158 APEYAKTGQLTLKSDVYSFGVVLLEILSGRKAV 190 (311)
Q Consensus 158 aPE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf 190 (311)
|||++.+ .+..++|+||+|++++.+.++..++
T Consensus 407 APE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 407 VNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp HHHHC------------------CCCCTTHHHH
T ss_pred cHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 9999975 4567899999999988877665443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.7e-25 Score=206.29 Aligned_cols=167 Identities=22% Similarity=0.243 Sum_probs=134.0
Q ss_pred cCCcEEEEEEeecCCCcc--------hhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCC
Q 021490 7 CLLQDVAIKQLDRNGVQG--------NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPG 78 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~~--------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~ 78 (311)
..+..+++|+........ .+++.+|++++++++||||+.+..++......|+||||++|++|.+++..
T Consensus 357 ~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE~~~ggsL~~~l~~---- 432 (540)
T 3en9_A 357 YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIED---- 432 (540)
T ss_dssp CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEECCCSEEHHHHSTT----
T ss_pred ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEECCCCCCHHHHHHH----
Confidence 367889999875533211 24588999999999999999666666677788999999999999999974
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCce-----eeeecccc
Q 021490 79 KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH-----VSTRVMGT 153 (311)
Q Consensus 79 ~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~-----~~~~~~~~ 153 (311)
+..++.|++.||+|||+++ |+||||||+|||++. .+||+|||++.......... ......+|
T Consensus 433 --------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT 499 (540)
T 3en9_A 433 --------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLST 499 (540)
T ss_dssp --------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHH
T ss_pred --------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCCccccccchhhhhhhhcCC
Confidence 5689999999999999999 999999999999998 99999999998643211111 11235689
Q ss_pred ccccCcccccc--CCCccccceeehhHHHHHHHhCCCcc
Q 021490 154 YGYCAPEYAKT--GQLTLKSDVYSFGVVLLEILSGRKAV 190 (311)
Q Consensus 154 ~~y~aPE~~~~--~~~~~~~DiwslG~l~~~ll~g~~pf 190 (311)
+.|+|||++.. ..|+..+|+|+..+-..+.+.++.+|
T Consensus 500 ~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 500 HHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp CGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred CCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 99999999986 67788899999888777777666555
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=1.2e-21 Score=167.36 Aligned_cols=129 Identities=11% Similarity=0.011 Sum_probs=101.0
Q ss_pred cchhccCCcEEEEEEeecCCC------------------cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecC
Q 021490 2 MQVILCLLQDVAIKQLDRNGV------------------QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 63 (311)
Q Consensus 2 ~~~~~~~g~~vaiK~~~~~~~------------------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 63 (311)
|.+...+|+.||||+++.... .....+.+|+.++..++ | +++.+++.. ...++||||+
T Consensus 107 y~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~~~-~~~~lvmE~~ 182 (282)
T 1zar_A 107 FNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVYAW-EGNAVLMELI 182 (282)
T ss_dssp EEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEEEE-ETTEEEEECC
T ss_pred EEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEEec-cceEEEEEec
Confidence 445556799999999964322 12456889999999999 4 666665544 4569999999
Q ss_pred CCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCC
Q 021490 64 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN 143 (311)
Q Consensus 64 ~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~ 143 (311)
+|++|.+ +.. .....++.|++.||+|||+.| ++||||||+|||++ ++.++|+|||++..
T Consensus 183 ~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~-~~~vkl~DFG~a~~------ 241 (282)
T 1zar_A 183 DAKELYR-VRV----------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS-EEGIWIIDFPQSVE------ 241 (282)
T ss_dssp CCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE-TTEEEECCCTTCEE------
T ss_pred CCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE-CCcEEEEECCCCeE------
Confidence 9999988 432 124579999999999999999 99999999999999 99999999999852
Q ss_pred ceeeeeccccccccCcccccc
Q 021490 144 THVSTRVMGTYGYCAPEYAKT 164 (311)
Q Consensus 144 ~~~~~~~~~~~~y~aPE~~~~ 164 (311)
+..+.|||.+..
T Consensus 242 ---------~~~~~a~e~l~r 253 (282)
T 1zar_A 242 ---------VGEEGWREILER 253 (282)
T ss_dssp ---------TTSTTHHHHHHH
T ss_pred ---------CCCCCHHHHHHH
Confidence 345788887753
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.69 E-value=3.5e-17 Score=137.91 Aligned_cols=120 Identities=14% Similarity=0.023 Sum_probs=89.6
Q ss_pred cchhc-cCCcE--EEEEEeecCCCcc------------------------hhHHHHHHHHHhcCCCCcc--cceeeEeee
Q 021490 2 MQVIL-CLLQD--VAIKQLDRNGVQG------------------------NREFLVEVLMLSLLHHPNL--VNLIGYCAD 52 (311)
Q Consensus 2 ~~~~~-~~g~~--vaiK~~~~~~~~~------------------------~~~~~~e~~~l~~l~h~~i--~~~~~~~~~ 52 (311)
|.+.. .+|+. ||||+++...... ...+.+|+..|..+.|+++ ..+++.
T Consensus 64 y~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~--- 140 (258)
T 1zth_A 64 FYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEAGVSVPQPYTY--- 140 (258)
T ss_dssp EEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHTTCCCCCEEEE---
T ss_pred EEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhCCCCCCeEEEc---
Confidence 44555 57888 9999975432110 1267889999999988764 333332
Q ss_pred CCeeEEEEecCCC-C----ChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHhh-cCCCCCeEeeccCCCeEEEcCCCc
Q 021490 53 GDQRLLVYEYMPL-G----SVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLH-DKAKPPVIYRDLKCSNILLDRGYH 126 (311)
Q Consensus 53 ~~~~~lv~e~~~~-~----~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh-~~~~~~i~h~dl~p~nil~~~~~~ 126 (311)
...++||||+.+ | +|.+.... .++..+..++.|++.+|.+|| +.| ++||||||+|||++. .
T Consensus 141 -~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~g---ivHrDlkp~NILl~~--~ 207 (258)
T 1zth_A 141 -MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEAE---LVHADLSEYNIMYID--K 207 (258)
T ss_dssp -ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTSC---EECSSCSTTSEEESS--S
T ss_pred -CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEEcC--c
Confidence 356899999942 3 66665432 235567899999999999999 999 999999999999998 8
Q ss_pred eEEcccccccc
Q 021490 127 PKLSDFGLAKL 137 (311)
Q Consensus 127 ~~l~df~~~~~ 137 (311)
++|+|||++..
T Consensus 208 ~~liDFG~a~~ 218 (258)
T 1zth_A 208 VYFIDMGQAVT 218 (258)
T ss_dssp EEECCCTTCEE
T ss_pred EEEEECccccc
Confidence 99999999864
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.53 E-value=2.7e-15 Score=131.89 Aligned_cols=122 Identities=12% Similarity=0.057 Sum_probs=82.0
Q ss_pred CcchhccCCcEEEEEEeecCCC-----c---------chhHH--------HHHHHHHhcCCCCcccceeeEeeeCCeeEE
Q 021490 1 MMQVILCLLQDVAIKQLDRNGV-----Q---------GNREF--------LVEVLMLSLLHHPNLVNLIGYCADGDQRLL 58 (311)
Q Consensus 1 ~~~~~~~~g~~vaiK~~~~~~~-----~---------~~~~~--------~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 58 (311)
||.+...+|+.||||+++.... . ..... .+|...|.++.+.++.-..-+... ..+|
T Consensus 111 VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~vp~p~~~~--~~~L 188 (397)
T 4gyi_A 111 IMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFPVPEPIAQS--RHTI 188 (397)
T ss_dssp EEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCSCCCEEEEE--TTEE
T ss_pred EEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCCCCeeeecc--CceE
Confidence 4667778999999999754211 0 00112 234555555533332211111111 2379
Q ss_pred EEecCCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCC----------ceE
Q 021490 59 VYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY----------HPK 128 (311)
Q Consensus 59 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~----------~~~ 128 (311)
||||++|++|..+... .....++.|++.+|.+||+.| |+||||||.|||++++| .+.
T Consensus 189 VME~i~G~~L~~l~~~----------~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~dgd~~d~~~~~~~~~ 255 (397)
T 4gyi_A 189 VMSLVDALPMRQVSSV----------PDPASLYADLIALILRLAKHG---LIHGDFNEFNILIREEKDAEDPSSITLTPI 255 (397)
T ss_dssp EEECCSCEEGGGCCCC----------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEEEECSSCTTSEEEEEE
T ss_pred EEEecCCccHhhhccc----------HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeCCCCcccccccccceE
Confidence 9999999888665432 124567899999999999999 99999999999998776 389
Q ss_pred Ecccccccc
Q 021490 129 LSDFGLAKL 137 (311)
Q Consensus 129 l~df~~~~~ 137 (311)
|+||+.+..
T Consensus 256 iID~~Q~V~ 264 (397)
T 4gyi_A 256 IIXFPQMVS 264 (397)
T ss_dssp ECCCTTCEE
T ss_pred EEEeCCccc
Confidence 999997653
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.29 E-value=7.2e-12 Score=105.42 Aligned_cols=120 Identities=16% Similarity=0.081 Sum_probs=92.8
Q ss_pred CCcEEEEEEeecCCCcchhHHHHHHHHHhcCC-CCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHH
Q 021490 8 LLQDVAIKQLDRNGVQGNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNT 86 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~ 86 (311)
.|+.+++|+...........+.+|+.+++.+. +..+.++++++.+....|+||||++|.+|.+.+.. ...
T Consensus 36 ~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~~---------~~~ 106 (263)
T 3tm0_A 36 ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYED---------EQS 106 (263)
T ss_dssp SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHCCT---------TTC
T ss_pred CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehhhccCC---------ccc
Confidence 47889999986533234457889999999984 66788899999888899999999999999876421 112
Q ss_pred HHHHHHHHHHHHHHhhcCC--------------------------------------------------------CCCeE
Q 021490 87 RMKIAAGAARGLEYLHDKA--------------------------------------------------------KPPVI 110 (311)
Q Consensus 87 ~~~~~~~i~~~l~~lh~~~--------------------------------------------------------~~~i~ 110 (311)
...++.+++.+|+.||+.. ...++
T Consensus 107 ~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~ 186 (263)
T 3tm0_A 107 PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFS 186 (263)
T ss_dssp HHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEE
T ss_pred HHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEE
Confidence 3467889999999999810 02289
Q ss_pred eeccCCCeEEEcCCCceEEccccccc
Q 021490 111 YRDLKCSNILLDRGYHPKLSDFGLAK 136 (311)
Q Consensus 111 h~dl~p~nil~~~~~~~~l~df~~~~ 136 (311)
|+|++|.||++++++.+.|+||+.+.
T Consensus 187 HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 187 HGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred CCCCCcCcEEEECCcEEEEEEchhcc
Confidence 99999999999876666799998764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.13 E-value=8.8e-11 Score=98.37 Aligned_cols=120 Identities=16% Similarity=0.103 Sum_probs=87.6
Q ss_pred cchhccCCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCc--ccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCC
Q 021490 2 MQVILCLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPN--LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGK 79 (311)
Q Consensus 2 ~~~~~~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~ 79 (311)
|.+...+|..+++|+.... ....+.+|+.+++.+.+.+ +.+++++...+...++||||++|.+|. ...
T Consensus 37 ~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~~~----- 106 (264)
T 1nd4_A 37 FRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--SSH----- 106 (264)
T ss_dssp EEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--TSC-----
T ss_pred EEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--cCc-----
Confidence 4454556788999987543 3356788999999985444 456888887777889999999998884 221
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhcCC------------------------------------------------------
Q 021490 80 KPLDWNTRMKIAAGAARGLEYLHDKA------------------------------------------------------ 105 (311)
Q Consensus 80 ~~l~~~~~~~~~~~i~~~l~~lh~~~------------------------------------------------------ 105 (311)
.. ...++.+++..|+.||+..
T Consensus 107 --~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 181 (264)
T 1nd4_A 107 --LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDG 181 (264)
T ss_dssp --CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSS
T ss_pred --CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCC
Confidence 11 1256677778888888642
Q ss_pred -CCCeEeeccCCCeEEEcCCCceEEccccccc
Q 021490 106 -KPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 136 (311)
Q Consensus 106 -~~~i~h~dl~p~nil~~~~~~~~l~df~~~~ 136 (311)
...++|+|++|.||++++++.+.|+||+.+.
T Consensus 182 ~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 182 EDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp CCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred CCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 0119999999999999877667799999764
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.97 E-value=1.7e-09 Score=95.18 Aligned_cols=123 Identities=13% Similarity=0.189 Sum_probs=90.1
Q ss_pred CcEEEEEEee--cCC-CcchhHHHHHHHHHhcCCC--CcccceeeEeeeC---CeeEEEEecCCCCChhhhhcccCCCCC
Q 021490 9 LQDVAIKQLD--RNG-VQGNREFLVEVLMLSLLHH--PNLVNLIGYCADG---DQRLLVYEYMPLGSVEDHLHDLSPGKK 80 (311)
Q Consensus 9 g~~vaiK~~~--~~~-~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~ 80 (311)
+..+++|+.. ... ......+.+|+.+++.|.. ..+.+++.++.+. ...++||||++|.++.+.. ..
T Consensus 61 ~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~~~------~~ 134 (359)
T 3dxp_A 61 GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEFVSGRVLWDQS------LP 134 (359)
T ss_dssp SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEECCCCBCCCCTT------CT
T ss_pred CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEecCCeecCCCc------cc
Confidence 4678888764 222 1234578889999999973 4577888887665 3479999999988775422 23
Q ss_pred CCCHHHHHHHHHHHHHHHHHhhcCC-------------------------------------------------------
Q 021490 81 PLDWNTRMKIAAGAARGLEYLHDKA------------------------------------------------------- 105 (311)
Q Consensus 81 ~l~~~~~~~~~~~i~~~l~~lh~~~------------------------------------------------------- 105 (311)
.++......++.+++..|+.||+..
T Consensus 135 ~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 214 (359)
T 3dxp_A 135 GMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDAD 214 (359)
T ss_dssp TCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSS
T ss_pred cCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCC
Confidence 4778888999999999999999721
Q ss_pred CCCeEeeccCCCeEEEcCCCc--eEEcccccccc
Q 021490 106 KPPVIYRDLKCSNILLDRGYH--PKLSDFGLAKL 137 (311)
Q Consensus 106 ~~~i~h~dl~p~nil~~~~~~--~~l~df~~~~~ 137 (311)
...++|+|+++.||+++.++. +.|+||+.+..
T Consensus 215 ~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 215 LTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred CceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 123999999999999987653 68999998753
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.84 E-value=2e-09 Score=92.41 Aligned_cols=172 Identities=18% Similarity=0.208 Sum_probs=106.9
Q ss_pred cEEEEEEeecCCCcchhHHHHHHHHHhcCC-CCc--ccceeeEeeeCC---eeEEEEecCCCCChhhhhcccCCCCCCCC
Q 021490 10 QDVAIKQLDRNGVQGNREFLVEVLMLSLLH-HPN--LVNLIGYCADGD---QRLLVYEYMPLGSVEDHLHDLSPGKKPLD 83 (311)
Q Consensus 10 ~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~--i~~~~~~~~~~~---~~~lv~e~~~~~~L~~~l~~~~~~~~~l~ 83 (311)
..+++|+.... .....+.+|+++++.+. +.. +..++....... ..|+||++++|.+|.+... ..++
T Consensus 41 ~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~~l~~~~~------~~l~ 112 (304)
T 3sg8_A 41 RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGVPLTPLLL------NNLP 112 (304)
T ss_dssp TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCEECCHHHH------HTSC
T ss_pred CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCeECCcccc------ccCC
Confidence 56888875322 34567889999998883 333 334444333322 3489999999988865432 2367
Q ss_pred HHHHHHHHHHHHHHHHHhhcCC-------------------------------------------------------CCC
Q 021490 84 WNTRMKIAAGAARGLEYLHDKA-------------------------------------------------------KPP 108 (311)
Q Consensus 84 ~~~~~~~~~~i~~~l~~lh~~~-------------------------------------------------------~~~ 108 (311)
..+...++.+++..++.||+.. ...
T Consensus 113 ~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~ 192 (304)
T 3sg8_A 113 KQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPC 192 (304)
T ss_dssp HHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCE
T ss_pred HHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCce
Confidence 7777888888888888888511 123
Q ss_pred eEeeccCCCeEEEcC--CCceEEccccccccCCCCCCceeee------------eccccccccC-ccccccCCCccccce
Q 021490 109 VIYRDLKCSNILLDR--GYHPKLSDFGLAKLGPVGDNTHVST------------RVMGTYGYCA-PEYAKTGQLTLKSDV 173 (311)
Q Consensus 109 i~h~dl~p~nil~~~--~~~~~l~df~~~~~~~~~~~~~~~~------------~~~~~~~y~a-PE~~~~~~~~~~~Di 173 (311)
++|+|+++.||++++ ++.+.|+||+.+............. .......... |+.... ...-.+.
T Consensus 193 ~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r--~~~~~~~ 270 (304)
T 3sg8_A 193 LIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEK--YRMKEKY 270 (304)
T ss_dssp EECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHH--HHHHHHH
T ss_pred eEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCCcHHHHHH--HHHHHHH
Confidence 799999999999998 5567899999876421110000000 0000001111 221111 1223588
Q ss_pred eehhHHHHHHHhCCCccC
Q 021490 174 YSFGVVLLEILSGRKAVD 191 (311)
Q Consensus 174 wslG~l~~~ll~g~~pf~ 191 (311)
|+++.++|.+.+|..+|-
T Consensus 271 ~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 271 WSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HHHHHHHHHHHTTCHHHH
T ss_pred HHHHHHHHHHHcCCHHHH
Confidence 999999999999998764
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.51 E-value=6.8e-07 Score=75.08 Aligned_cols=118 Identities=18% Similarity=0.155 Sum_probs=85.4
Q ss_pred CCcEEEEEEeecCCCcchhHHHHHHHHHhcCC-CCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHH
Q 021490 8 LLQDVAIKQLDRNGVQGNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNT 86 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~ 86 (311)
++..+++|+-.. .....+.+|+..|+.+. +-.+.+++.++.+.+..++|||+++|.++.+..... ...
T Consensus 49 ~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~--------~~~ 117 (272)
T 4gkh_A 49 NAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEY--------PDS 117 (272)
T ss_dssp TCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHHHHC--------GGG
T ss_pred CCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccccccCC--------HHH
Confidence 456788887542 23567888999999884 333667888888889999999999998887765431 122
Q ss_pred HHHHHHHHHHHHHHhhcCC-------------------------------------------------------CCCeEe
Q 021490 87 RMKIAAGAARGLEYLHDKA-------------------------------------------------------KPPVIY 111 (311)
Q Consensus 87 ~~~~~~~i~~~l~~lh~~~-------------------------------------------------------~~~i~h 111 (311)
...+..+++..|+.||+.. ...++|
T Consensus 118 ~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~H 197 (272)
T 4gkh_A 118 GENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTH 197 (272)
T ss_dssp HHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEEC
T ss_pred HHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEc
Confidence 3345666677777777431 001799
Q ss_pred eccCCCeEEEcCCCceEEccccccc
Q 021490 112 RDLKCSNILLDRGYHPKLSDFGLAK 136 (311)
Q Consensus 112 ~dl~p~nil~~~~~~~~l~df~~~~ 136 (311)
+|+++.||+++.++.+-|+||+.+.
T Consensus 198 GDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 198 GDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp SCCCTTSEEEETTEEEEECCCTTCE
T ss_pred CCCCCCeEEEECCeEEEEEECcccc
Confidence 9999999999988777899998764
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.41 E-value=1.2e-06 Score=75.10 Aligned_cols=120 Identities=19% Similarity=0.158 Sum_probs=79.7
Q ss_pred CcEEEEEEeecCCCcchhHHHHHHHHHhcCCCC---cccceeeEee-eCCeeEEEEecCCCCChhhhhcccCCCCCCCCH
Q 021490 9 LQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHP---NLVNLIGYCA-DGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDW 84 (311)
Q Consensus 9 g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~---~i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~ 84 (311)
|..+++|+- ........+.+|+++|+.|.+. .+..++.+.. .....++||++++|.+|....- ..++.
T Consensus 39 g~~~VlR~~--~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l~~~~~------~~l~~ 110 (306)
T 3tdw_A 39 NGDWVFRFP--KSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQILGEDGM------AVLPD 110 (306)
T ss_dssp TTTEEEEEE--SSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEECHHHHH------TTSCH
T ss_pred CCEEEEEec--CCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeECchhhh------hhCCH
Confidence 567888874 2223456788999999999642 2455555553 3455789999999988876321 12344
Q ss_pred HHHHHHHHHHHHHHHHhhcCC---------------------------------------------------------CC
Q 021490 85 NTRMKIAAGAARGLEYLHDKA---------------------------------------------------------KP 107 (311)
Q Consensus 85 ~~~~~~~~~i~~~l~~lh~~~---------------------------------------------------------~~ 107 (311)
.....++.+++..|+.||+.. ..
T Consensus 111 ~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~ 190 (306)
T 3tdw_A 111 DAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTP 190 (306)
T ss_dssp HHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCC
T ss_pred HHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHHHHHhCcccccCCC
Confidence 455555555555555555421 11
Q ss_pred CeEeeccCCCeEEEcC---CCc-eEEccccccc
Q 021490 108 PVIYRDLKCSNILLDR---GYH-PKLSDFGLAK 136 (311)
Q Consensus 108 ~i~h~dl~p~nil~~~---~~~-~~l~df~~~~ 136 (311)
.++|+|+++.||+++. ++. +.|+||+.+.
T Consensus 191 ~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~ 223 (306)
T 3tdw_A 191 RLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAA 223 (306)
T ss_dssp EEECSCCSGGGEEECTTCSSCCEEEECCCTTCE
T ss_pred eeEeCCCCcccEEEecCCCCCceEEEEehhhcC
Confidence 2699999999999987 355 4899998765
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.21 E-value=1.5e-06 Score=76.18 Aligned_cols=62 Identities=10% Similarity=0.039 Sum_probs=41.5
Q ss_pred CcEEEEEEeecCC---CcchhHHHHHHHHHhcCC-C--CcccceeeEeeeC---CeeEEEEecCCCCChhh
Q 021490 9 LQDVAIKQLDRNG---VQGNREFLVEVLMLSLLH-H--PNLVNLIGYCADG---DQRLLVYEYMPLGSVED 70 (311)
Q Consensus 9 g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~-h--~~i~~~~~~~~~~---~~~~lv~e~~~~~~L~~ 70 (311)
|..+++|+-.... ......+.+|+.+++.|. + -.+.+++.+..+. ...++|||+++|.++.+
T Consensus 52 ~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 52 QQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp EEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTSSCEEEEECCCCBCCCB
T ss_pred CceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccCCceEEEEecCCCChhh
Confidence 6778888754322 112356788999998884 3 2466677776554 34689999999877653
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=98.04 E-value=1.4e-05 Score=63.79 Aligned_cols=101 Identities=15% Similarity=0.096 Sum_probs=67.6
Q ss_pred CChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCce
Q 021490 66 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH 145 (311)
Q Consensus 66 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~ 145 (311)
-||.+.|+.. +.++++.++|.++.|.+.+|.-+-.... -...-+.|..|++..+|.|-+.+ +.+.
T Consensus 33 vSL~eIL~~~---~~PlsEEqaWALc~Qc~~~L~~~~~~~~--~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------- 97 (229)
T 2yle_A 33 LSLEEILRLY---NQPINEEQAWAVCYQCCGSLRAAARRRQ--PRHRVRSAAQIRVWRDGAVTLAP-AADD--------- 97 (229)
T ss_dssp EEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTTC--CCCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred ccHHHHHHHc---CCCcCHHHHHHHHHHHHHHHHhhhhccc--CCceecCCcceEEecCCceeccc-cccc---------
Confidence 4688888874 6899999999999999999887732110 12344567999999999888764 1110
Q ss_pred eeeeccccccccCccccccCCCccccceeehhHHHHHHHhCC
Q 021490 146 VSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 187 (311)
Q Consensus 146 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~l~~~ll~g~ 187 (311)
.....+.+||... ...+.+.-|||||+++|.-+--.
T Consensus 98 -----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDyg 133 (229)
T 2yle_A 98 -----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYG 133 (229)
T ss_dssp --------------CCSS-SSSCHHHHHHHHHHHHHHHHTTT
T ss_pred -----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcC
Confidence 0123467888763 45577889999999999988633
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.91 E-value=3.7e-05 Score=65.13 Aligned_cols=64 Identities=20% Similarity=0.210 Sum_probs=45.1
Q ss_pred CcchhccCCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCC---cccceeeEeeeCCeeEEEEecCCCCCh
Q 021490 1 MMQVILCLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHP---NLVNLIGYCADGDQRLLVYEYMPLGSV 68 (311)
Q Consensus 1 ~~~~~~~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~---~i~~~~~~~~~~~~~~lv~e~~~~~~L 68 (311)
+|++.+.||++|++|+-..........|..|++.|+.|.-. .+.+++.+. ..++||||++++..
T Consensus 31 vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l~~~~~ 97 (288)
T 3f7w_A 31 LYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWVDERPP 97 (288)
T ss_dssp EEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECCCCCCC
T ss_pred EEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEeecccCC
Confidence 47788899999999987555545556788999999988422 234444432 24789999987653
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.86 E-value=7.5e-05 Score=64.58 Aligned_cols=28 Identities=18% Similarity=0.165 Sum_probs=25.7
Q ss_pred eEeeccCCCeEEEcCCCceEEccccccc
Q 021490 109 VIYRDLKCSNILLDRGYHPKLSDFGLAK 136 (311)
Q Consensus 109 i~h~dl~p~nil~~~~~~~~l~df~~~~ 136 (311)
++|+|+++.||+++.++.+.|+||+.+.
T Consensus 224 l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 224 LCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp EECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred eecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 9999999999999888889999998764
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.72 E-value=0.0001 Score=65.43 Aligned_cols=57 Identities=19% Similarity=0.052 Sum_probs=35.2
Q ss_pred CCcEEEEEEeecCCC-------cchhHHHHHHHHHhcCCC--Cccc-ceeeEeeeCCeeEEEEecCCCC
Q 021490 8 LLQDVAIKQLDRNGV-------QGNREFLVEVLMLSLLHH--PNLV-NLIGYCADGDQRLLVYEYMPLG 66 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~-------~~~~~~~~e~~~l~~l~h--~~i~-~~~~~~~~~~~~~lv~e~~~~~ 66 (311)
+|+.++||....... ...+++..|++++..+.. +..+ +++.+ +....++|||+++|.
T Consensus 54 ~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lvmE~l~g~ 120 (397)
T 2olc_A 54 HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTVMEDLSHL 120 (397)
T ss_dssp --CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEEECCCTTS
T ss_pred CCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEEEEeCCCc
Confidence 468899998643211 234567789999988742 4433 44433 345578999999764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.64 E-value=0.00023 Score=60.90 Aligned_cols=58 Identities=22% Similarity=0.192 Sum_probs=45.3
Q ss_pred CCcEEEEEEeecCCCcchhHHHHHHHHHhcCC---CCcccceeeEeeeCCeeEEEEecCCCCCh
Q 021490 8 LLQDVAIKQLDRNGVQGNREFLVEVLMLSLLH---HPNLVNLIGYCADGDQRLLVYEYMPLGSV 68 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 68 (311)
++..+++|+.... ....|..|++.|+.|. ...+.+++.+.......++||||++|..+
T Consensus 58 ~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 58 EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN 118 (312)
T ss_dssp SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence 5678899986532 3567888999999884 25677888888777889999999998765
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.32 E-value=0.002 Score=55.40 Aligned_cols=29 Identities=31% Similarity=0.343 Sum_probs=25.7
Q ss_pred eEeeccCCCeEEEcCC----CceEEcccccccc
Q 021490 109 VIYRDLKCSNILLDRG----YHPKLSDFGLAKL 137 (311)
Q Consensus 109 i~h~dl~p~nil~~~~----~~~~l~df~~~~~ 137 (311)
++|||+++.||+++.+ +.+.|+||+.+..
T Consensus 185 lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 185 FVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp EECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred eEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 9999999999999874 6789999998764
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.25 E-value=0.00099 Score=58.56 Aligned_cols=124 Identities=19% Similarity=0.230 Sum_probs=73.2
Q ss_pred CCcEEEEEEeecCCCcchhHHHHHHHHHhcCC-CCcccceeeEeeeCCeeEEEEecCCCCChhhh--------------h
Q 021490 8 LLQDVAIKQLDRNGVQGNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLVYEYMPLGSVEDH--------------L 72 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~--------------l 72 (311)
+++.+++|+.- ........+.+|+++++.|. +.-..++++.+.+ .+||||++|.+|... |
T Consensus 81 ~~~~~vlR~~g-~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~i~G~~l~~~~l~~p~~~~~ia~~L 155 (379)
T 3feg_A 81 EPREVLLRLYG-AILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQYIPSRPLKTQELREPVLSAAIATKM 155 (379)
T ss_dssp CCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEECCSEEECCGGGGGCHHHHHHHHHHH
T ss_pred CCCeEEEEECC-CccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEEecCccCChhHhCCHHHHHHHHHHH
Confidence 35789998852 22334567778999998884 3333556655543 299999998665311 1
Q ss_pred ---cccC-CCCCCC--CHHHHHHHHHHHHH-------------------HHHHh----hcCC-CCCeEeeccCCCeEEEc
Q 021490 73 ---HDLS-PGKKPL--DWNTRMKIAAGAAR-------------------GLEYL----HDKA-KPPVIYRDLKCSNILLD 122 (311)
Q Consensus 73 ---~~~~-~~~~~l--~~~~~~~~~~~i~~-------------------~l~~l----h~~~-~~~i~h~dl~p~nil~~ 122 (311)
++.. ..+... -+.++..|..++.. .+..| ...+ ...++|+|+.+.||+++
T Consensus 156 a~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~ 235 (379)
T 3feg_A 156 AQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLL 235 (379)
T ss_dssp HHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEE
T ss_pred HHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEc
Confidence 1111 011112 23455555544422 12222 2211 12389999999999998
Q ss_pred CC----CceEEccccccc
Q 021490 123 RG----YHPKLSDFGLAK 136 (311)
Q Consensus 123 ~~----~~~~l~df~~~~ 136 (311)
.+ +.+.++||..+.
T Consensus 236 ~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 236 SEPENADSLMLVDFEYSS 253 (379)
T ss_dssp SCC---CCEEECCCTTCE
T ss_pred CCCCccCcEEEEecccCC
Confidence 76 789999998764
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.14 E-value=0.0035 Score=53.68 Aligned_cols=66 Identities=9% Similarity=-0.023 Sum_probs=40.6
Q ss_pred cchhccCCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCc--ccceeeE-----eeeCCeeEEEEecCCCCCh
Q 021490 2 MQVILCLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPN--LVNLIGY-----CADGDQRLLVYEYMPLGSV 68 (311)
Q Consensus 2 ~~~~~~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~-----~~~~~~~~lv~e~~~~~~L 68 (311)
|.+...+|+.+++|+..... .....+..|..+++.|.... +..++.. ...++..+++|++++|.++
T Consensus 42 y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~G~~~ 114 (328)
T 1zyl_A 42 YQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF 114 (328)
T ss_dssp EEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred EEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecCCCCC
Confidence 44555567789999985332 24456777888887774212 3333332 2234566889999987543
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.04 E-value=0.0015 Score=55.43 Aligned_cols=27 Identities=26% Similarity=0.345 Sum_probs=23.4
Q ss_pred eEeeccCCCeEEEcCCCceEEccccccc
Q 021490 109 VIYRDLKCSNILLDRGYHPKLSDFGLAK 136 (311)
Q Consensus 109 i~h~dl~p~nil~~~~~~~~l~df~~~~ 136 (311)
++|+|+.+.||+ ..++.+.++||..+.
T Consensus 175 l~HgDl~~~Nil-~~~~~~~lID~e~a~ 201 (301)
T 3dxq_A 175 ACHCDPLCENFL-DTGERMWIVDWEYSG 201 (301)
T ss_dssp EECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred eeccCCCcCCEE-ECCCCEEEEeccccc
Confidence 899999999999 556678999998765
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.87 E-value=0.0079 Score=51.32 Aligned_cols=28 Identities=32% Similarity=0.243 Sum_probs=24.6
Q ss_pred eEeeccCCCeEEEcCCCceEEccccccc
Q 021490 109 VIYRDLKCSNILLDRGYHPKLSDFGLAK 136 (311)
Q Consensus 109 i~h~dl~p~nil~~~~~~~~l~df~~~~ 136 (311)
++|+|+++.||+++.++.+.++||+.+.
T Consensus 189 liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 189 VIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp EECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cCCCCCCccCEEEeCCceEEEecchhcc
Confidence 9999999999999887666899998764
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.84 E-value=0.0016 Score=58.28 Aligned_cols=54 Identities=19% Similarity=0.311 Sum_probs=35.1
Q ss_pred CcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcc-cceeeEeeeCCeeEEEEecCCCCCh
Q 021490 9 LQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNL-VNLIGYCADGDQRLLVYEYMPLGSV 68 (311)
Q Consensus 9 g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~~~~L 68 (311)
+..+++|+.... ...+.+.+|+.++..|...++ .++++.+.+ .+|++|++|.+|
T Consensus 105 ~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~l~G~~l 159 (429)
T 1nw1_A 105 PNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRPL 159 (429)
T ss_dssp CSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEEC
T ss_pred CceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEEeCCccc
Confidence 578999987332 122566689999988853333 556665432 389999987444
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.83 E-value=0.0068 Score=52.39 Aligned_cols=28 Identities=14% Similarity=0.210 Sum_probs=25.5
Q ss_pred eEeeccCCCeEEEcCCCceEEccccccc
Q 021490 109 VIYRDLKCSNILLDRGYHPKLSDFGLAK 136 (311)
Q Consensus 109 i~h~dl~p~nil~~~~~~~~l~df~~~~ 136 (311)
++|+|+.+.||+++.++.+.++||+.+.
T Consensus 208 ~~HgD~~~~N~l~~~~~~~~~iD~e~~~ 235 (339)
T 3i1a_A 208 LCHSDIHAGNVLVGNEESIYIIDWDEPM 235 (339)
T ss_dssp EECSCCCGGGEEECGGGCEEECCCSSCE
T ss_pred eEeCCCCcCCEEEeCCCeEEEEECCCCe
Confidence 9999999999999988889999998664
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.57 E-value=0.0055 Score=53.51 Aligned_cols=27 Identities=26% Similarity=0.310 Sum_probs=23.1
Q ss_pred eEeeccCCCeEEEcCCCceEEccccccc
Q 021490 109 VIYRDLKCSNILLDRGYHPKLSDFGLAK 136 (311)
Q Consensus 109 i~h~dl~p~nil~~~~~~~~l~df~~~~ 136 (311)
++|+|+++.||++++++ +.++||..+.
T Consensus 214 l~HgDl~~~Nil~~~~~-~~lID~e~a~ 240 (369)
T 3c5i_A 214 FCHNDLQENNIINTNKC-LRLIDFEYSG 240 (369)
T ss_dssp EECSCCCGGGEEECC-C-EEECCCTTCE
T ss_pred EEeCCCCcccEEecCCc-EEEEEecCCC
Confidence 89999999999998655 8999998764
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.53 E-value=0.0074 Score=54.40 Aligned_cols=55 Identities=11% Similarity=0.038 Sum_probs=34.3
Q ss_pred CcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcc-cceeeEeeeCCeeEEEEecCCCCCh
Q 021490 9 LQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNL-VNLIGYCADGDQRLLVYEYMPLGSV 68 (311)
Q Consensus 9 g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~~~~L 68 (311)
+..+++|+..... .......+|+.++..|...++ .++++.+. . .+|++|++|.+|
T Consensus 133 ~~~~vLRi~g~~~-~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 133 QAKYLIRLYGPKT-DEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL 188 (458)
T ss_dssp TEEEEEEEECC-C-CSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred CceEEEEECCCCh-hhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence 4788898864322 222223579999998865444 45666652 2 359999987554
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.09 E-value=0.066 Score=47.63 Aligned_cols=27 Identities=19% Similarity=0.327 Sum_probs=24.5
Q ss_pred eEeeccCCCeEEEcCCCceEEccccccc
Q 021490 109 VIYRDLKCSNILLDRGYHPKLSDFGLAK 136 (311)
Q Consensus 109 i~h~dl~p~nil~~~~~~~~l~df~~~~ 136 (311)
++|+|+.+.||+ +.++.+.++||..+.
T Consensus 264 ~~H~D~~~~N~l-~~~~~~~~IDwe~a~ 290 (424)
T 3mes_A 264 FAHNDLQENNLL-QTQNNIRMIDYEYSA 290 (424)
T ss_dssp EECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred EECCCCCcccee-cCCCcEEEEecccCC
Confidence 899999999999 778889999998764
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=94.87 E-value=0.029 Score=49.85 Aligned_cols=32 Identities=16% Similarity=0.270 Sum_probs=27.6
Q ss_pred hcCCCCCeEeeccCCCeEEEcCCCceEEcccccccc
Q 021490 102 HDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKL 137 (311)
Q Consensus 102 h~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~ 137 (311)
+... ++|||+++.||+++.++ +.++||+.+..
T Consensus 230 ~~~~---liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 230 RAQA---LIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp BCCE---EECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred CCCe---EEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 4556 99999999999998876 99999988764
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=92.66 E-value=0.52 Score=37.56 Aligned_cols=84 Identities=11% Similarity=0.070 Sum_probs=60.4
Q ss_pred CCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHH-HhhcCCCCCeEeeccCCC
Q 021490 39 HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLE-YLHDKAKPPVIYRDLKCS 117 (311)
Q Consensus 39 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~-~lh~~~~~~i~h~dl~p~ 117 (311)
.||+. -..+-.+++.+.+.++.-+++.=...+. .++....+.++.+|+.... ++++ -+|--|+|+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~-------~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~ 113 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR-------KTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPE 113 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH-------TSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH-------hcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCc
Confidence 57777 4455567777777777543332233343 3788899999999988655 4433 578899999
Q ss_pred eEEEcCCCceEEccccccc
Q 021490 118 NILLDRGYHPKLSDFGLAK 136 (311)
Q Consensus 118 nil~~~~~~~~l~df~~~~ 136 (311)
|++++.++.+++.-.|+..
T Consensus 114 NL~f~~~~~p~i~hRGi~~ 132 (219)
T 4ano_A 114 NLMFNRALEPFFLHVGVKE 132 (219)
T ss_dssp GEEECTTCCEEESCCEETT
T ss_pred eEEEeCCCcEEEEEcCCcc
Confidence 9999999999999888643
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=92.16 E-value=0.59 Score=37.13 Aligned_cols=117 Identities=12% Similarity=0.138 Sum_probs=75.4
Q ss_pred CCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCe
Q 021490 39 HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSN 118 (311)
Q Consensus 39 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~n 118 (311)
.||+.+.. .+-.+++.+.+.++.-+.+.=...+. .++....+.++.+|+....++++ -+|--|+|+|
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik-------~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~N 109 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIK-------SFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDE 109 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGG-------GSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGG
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHH-------hcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecce
Confidence 57888766 45566666666665433221122233 37889999999999887754443 4788999999
Q ss_pred EEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccCCCccccceeehhHHHHHHHhCCCccCc
Q 021490 119 ILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDT 192 (311)
Q Consensus 119 il~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~ 192 (311)
++++.++.+++.-.|+... ++|.- .+...=.-.+=|++..+++++..|+.
T Consensus 110 L~f~~~~~p~i~~RGik~~-------------------l~P~~-----~~ee~fL~qyKAliiall~~K~~Fe~ 159 (215)
T 4ann_A 110 LFFTRDGLPIAKTRGLQNV-------------------VDPLP-----VSEAEFLTRYKALVICAFNEKQSFDA 159 (215)
T ss_dssp EEECTTSCEEESCCEETTT-------------------BSCCC-----CCHHHHHHHHHHHHHHHHCTTCCHHH
T ss_pred EEEcCCCCEEEEEccCccC-------------------CCCCC-----CCHHHHHHHHHHHHHHHHcCCCCHHH
Confidence 9999999999998876432 12211 11111112456678888888877754
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=83.87 E-value=0.55 Score=41.31 Aligned_cols=28 Identities=29% Similarity=0.291 Sum_probs=24.0
Q ss_pred eEeeccCCCeEEE------cCCCceEEccccccc
Q 021490 109 VIYRDLKCSNILL------DRGYHPKLSDFGLAK 136 (311)
Q Consensus 109 i~h~dl~p~nil~------~~~~~~~l~df~~~~ 136 (311)
++|+|+.+.||++ ++++.+.++||..+.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 6799999999999 456779999998765
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 311 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-66 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-57 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-55 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-55 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-55 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 5e-55 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 6e-55 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 8e-55 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 9e-55 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-54 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-54 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 5e-54 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 9e-54 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-53 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 6e-53 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-52 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-52 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-51 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-51 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-51 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-51 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-51 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 7e-51 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-50 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 9e-50 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 7e-49 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-48 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 7e-48 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 5e-46 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 6e-46 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-45 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-45 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 6e-44 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-43 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-42 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-41 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-41 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 7e-41 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-39 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 8e-39 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 9e-39 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 8e-37 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-36 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 5e-36 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 5e-36 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-35 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-35 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-35 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-34 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 5e-34 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-33 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-32 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-32 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-30 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-30 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-30 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 6e-30 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-26 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-26 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-24 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 8e-23 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-22 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-10 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (530), Expect = 1e-66
Identities = 66/260 (25%), Positives = 118/260 (45%), Gaps = 24/260 (9%)
Query: 10 QDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGS 67
DVA+K L+ Q + F EV +L H N++ +GY Q +V ++ S
Sbjct: 31 GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSS 89
Query: 68 VEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP 127
+ HLH + + + + IA A+G++YLH K +I+RDLK +NI L
Sbjct: 90 LYHHLHII---ETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTV 143
Query: 128 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT---GQLTLKSDVYSFGVVLLEIL 184
K+ DFGLA + +H ++ G+ + APE + + +SDVY+FG+VL E++
Sbjct: 144 KIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELM 203
Query: 185 SGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVH 244
+G+ + + L D ++ ++ + A C+
Sbjct: 204 TGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMK------------RLMAECLK 251
Query: 245 EQPDMRPVIADVVTALAYLA 264
++ D RP+ ++ ++ LA
Sbjct: 252 KKRDERPLFPQILASIELLA 271
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 1e-57
Identities = 69/264 (26%), Positives = 112/264 (42%), Gaps = 33/264 (12%)
Query: 3 QVILCLLQD---VAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 59
+V + VA+K L + G FL E ++ L H LV L + ++
Sbjct: 28 EVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYII 85
Query: 60 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNI 119
EYM GS+ D L P L N + +AA A G+ ++ ++ I+RDL+ +NI
Sbjct: 86 TEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANI 140
Query: 120 LLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVV 179
L+ K++DFGLA+L + + APE G T+KSDV+SFG++
Sbjct: 141 LVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGIL 199
Query: 180 LLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFY---QAL 236
L EI++ R + T +I + E +G R +
Sbjct: 200 LTEIVTHG------------------RIPYPGMTNPEVIQNLE-RGYRMVRPDNCPEELY 240
Query: 237 AVAAMCVHEQPDMRPVIADVVTAL 260
+ +C E+P+ RP + + L
Sbjct: 241 QLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 1e-55
Identities = 58/253 (22%), Positives = 99/253 (39%), Gaps = 28/253 (11%)
Query: 10 QDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVE 69
DVAIK + + G EF+ E ++ L H LV L G C ++ EYM G +
Sbjct: 29 YDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLL 87
Query: 70 DHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKL 129
++L + +++ +EYL K ++RDL N L++ K+
Sbjct: 88 NYLR---EMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKV 141
Query: 130 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKA 189
SDFGL++ D S + PE + + KSD+++FGV++ EI S
Sbjct: 142 SDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS---- 196
Query: 190 VDTSKAAAEQSLVAWARPLFQDRTRHSLIA--DPELQGQYPPRGFYQALAVAAMCVHEQP 247
+ ++ T L+ P + + C HE+
Sbjct: 197 --------------LGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKA 242
Query: 248 DMRPVIADVVTAL 260
D RP +++ +
Sbjct: 243 DERPTFKILLSNI 255
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 1e-55
Identities = 58/279 (20%), Positives = 109/279 (39%), Gaps = 27/279 (9%)
Query: 10 QDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD----QRLLVYEYMPL 65
++VA+K + + E+ +L H N++ I + Q LV +Y
Sbjct: 27 EEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEH 85
Query: 66 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKA-----KPPVIYRDLKCSNIL 120
GS+ D+L+ + + +K+A A GL +LH + KP + +RDLK NIL
Sbjct: 86 GSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNIL 140
Query: 121 LDRGYHPKLSDFGLAKLGPVGDNT--HVSTRVMGTYGYCAPEY------AKTGQLTLKSD 172
+ + ++D GLA +T +GT Y APE K + ++D
Sbjct: 141 VKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRAD 200
Query: 173 VYSFGVVLLEILSGRKAVDTSKAAAEQ-SLVAWARPLFQDRTRHSL--IADPELQGQYPP 229
+Y+ G+V EI + + + P ++ + P + ++
Sbjct: 201 IYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQS 260
Query: 230 RGFYQALA-VAAMCVHEQPDMRPVIADVVTALAYLASQK 267
+ +A + C + R + L+ L+ Q+
Sbjct: 261 CEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 179 bits (454), Expect = 2e-55
Identities = 62/264 (23%), Positives = 112/264 (42%), Gaps = 27/264 (10%)
Query: 10 QDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVE 69
VA+K L + ++ EFL E ++ + HPNLV L+G C ++ E+M G++
Sbjct: 43 LTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 101
Query: 70 DHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKL 129
D+L + ++ + + +A + +EYL K I+RDL N L+ + K+
Sbjct: 102 DYLRE--CNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKV 156
Query: 130 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKA 189
+DFGL++L GD + APE + ++KSDV++FGV+L EI +
Sbjct: 157 ADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGM- 214
Query: 190 VDTSKAAAEQSLVAWARPLFQDRTRHSL--IADPELQGQYPPRGFYQALAVAAMCVHEQP 247
+ + + + + + + P + + C P
Sbjct: 215 -----------------SPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNP 257
Query: 248 DMRPVIADVVTALAYLASQKYESD 271
RP A++ A + + SD
Sbjct: 258 SDRPSFAEIHQAFETMFQESSISD 281
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (451), Expect = 5e-55
Identities = 66/265 (24%), Positives = 105/265 (39%), Gaps = 41/265 (15%)
Query: 10 QDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL-LVYEYMPLGSV 68
VA+K + + + FL E +++ L H NLV L+G + L +V EYM GS+
Sbjct: 31 NKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL 88
Query: 69 EDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK 128
D+L S G+ L + +K + +EYL ++RDL N+L+ K
Sbjct: 89 VDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAK 143
Query: 129 LSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRK 188
+SDFGL K +T + APE + + + KSDV+SFG++L EI S
Sbjct: 144 VSDFGLTKEASSTQDT-----GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFG- 197
Query: 189 AVDTSKAAAEQSLVAWARPLFQDRTRHSLIA------DPELQGQYPPRGFYQALAVAAMC 242
R + ++ + PP V C
Sbjct: 198 -----------------RVPYPRIPLKDVVPRVEKGYKMDAPDGCPP----AVYEVMKNC 236
Query: 243 VHEQPDMRPVIADVVTALAYLASQK 267
H MRP + L ++ + +
Sbjct: 237 WHLDAAMRPSFLQLREQLEHIKTHE 261
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 6e-55
Identities = 45/179 (25%), Positives = 83/179 (46%), Gaps = 11/179 (6%)
Query: 10 QDVAIKQLDRNGVQGNRE-FLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSV 68
+A K + R + E+ +L + P +V G + + E+M GS+
Sbjct: 32 LVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL 91
Query: 69 EDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK 128
+ L + K++ +GL YL +K K +++RD+K SNIL++ K
Sbjct: 92 DQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIK 145
Query: 129 LSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 187
L DFG++ ++ +GT Y +PE + +++SD++S G+ L+E+ GR
Sbjct: 146 LCDFGVSGQLI----DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 8e-55
Identities = 62/274 (22%), Positives = 100/274 (36%), Gaps = 45/274 (16%)
Query: 12 VAIKQLDRNGVQGNRE-FLVEV-LMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVE 69
VA+K L RE + E+ +M L H N+VNL+G C L++EY G +
Sbjct: 70 VAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLL 129
Query: 70 DHLH-------------------DLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVI 110
++L + L + + A A+G+E+L K +
Sbjct: 130 NYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCV 186
Query: 111 YRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLK 170
+RDL N+L+ G K+ DFGLA+ N V + APE G T+K
Sbjct: 187 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIK 246
Query: 171 SDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSL---IADPELQGQY 227
SDV+S+G++L EI S + + + +
Sbjct: 247 SDVWSYGILLWEIFSLG------------------VNPYPGIPVDANFYKLIQNGFKMDQ 288
Query: 228 PPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 261
P + + C RP ++ + L
Sbjct: 289 PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 178 bits (452), Expect = 9e-55
Identities = 62/275 (22%), Positives = 101/275 (36%), Gaps = 46/275 (16%)
Query: 10 QDVAIKQLDRNGVQGNR-EFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSV 68
VA+K L + +F E +++ +PN+V L+G CA G L++EYM G +
Sbjct: 44 TMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDL 103
Query: 69 EDHLHD--------------------LSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPP 108
+ L SPG PL ++ IA A G+ YL +
Sbjct: 104 NEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERK 160
Query: 109 VIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLT 168
++RDL N L+ K++DFGL++ D + PE + T
Sbjct: 161 FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYT 220
Query: 169 LKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSL---IADPELQG 225
+SDV+++GVVL EI S + + + D +
Sbjct: 221 TESDVWAYGVVLWEIFSYG------------------LQPYYGMAHEEVIYYVRDGNIL- 261
Query: 226 QYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 260
P + + +C + P RP + L
Sbjct: 262 ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRIL 296
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 2e-54
Identities = 69/265 (26%), Positives = 113/265 (42%), Gaps = 27/265 (10%)
Query: 3 QVILCLLQD---VAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 59
V L + VAIK + R G +F+ E ++ L HP LV L G C + LV
Sbjct: 20 LVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 78
Query: 60 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNI 119
+E+M G + D+L + T + + G+ YL + VI+RDL N
Sbjct: 79 FEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNC 132
Query: 120 LLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVV 179
L+ K+SDFG+ + D ST + +PE + + KSDV+SFGV+
Sbjct: 133 LVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVL 191
Query: 180 LLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVA 239
+ E+ S K +++ +E + +D + + P L +
Sbjct: 192 MWEVFSEGKIPYENRSNSE---------VVEDISTGFRLYKPRLAST-------HVYQIM 235
Query: 240 AMCVHEQPDMRPVIADVVTALAYLA 264
C E+P+ RP + ++ LA +A
Sbjct: 236 NHCWKERPEDRPAFSRLLRQLAEIA 260
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 2e-54
Identities = 64/272 (23%), Positives = 115/272 (42%), Gaps = 33/272 (12%)
Query: 10 QDVAIKQLDRNGVQGNRE-FLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSV 68
DVAIK L + + + E + E ++ L +P +V LIG C + +LV E G +
Sbjct: 37 IDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPL 95
Query: 69 EDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK 128
L ++ + + ++ + G++YL +K ++RDL N+LL ++ K
Sbjct: 96 HKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAK 149
Query: 129 LSDFGLAK-LGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 187
+SDFGL+K LG + + APE + + +SDV+S+GV + E LS
Sbjct: 150 ISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYG 209
Query: 188 KAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA--DPELQGQYPPRGFYQALAVAAMCVHE 245
+ ++ ++A + + + PP + A+ + C
Sbjct: 210 ------------------QKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIY 251
Query: 246 QPDMRPVIADVVTALAYLASQKYESDAEKVQS 277
+ + RP V + Y S A KV+
Sbjct: 252 KWEDRPDFLTVEQRM----RACYYSLASKVEG 279
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 5e-54
Identities = 69/274 (25%), Positives = 121/274 (44%), Gaps = 26/274 (9%)
Query: 12 VAIKQLDRNGVQGN-REFLVEVLMLSLLHHPNLVNLIGYCADGDQR-LLVYEYMPLGSVE 69
A+K L+R G +FL E +++ HPN+++L+G C + L+V YM G +
Sbjct: 58 CAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR 117
Query: 70 DHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKL 129
+ + + A+G+++L K ++RDL N +LD + K+
Sbjct: 118 NFIR---NETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKV 171
Query: 130 SDFGLAKL--GPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 187
+DFGLA+ D+ H T + A E +T + T KSDV+SFGV+L E+++
Sbjct: 172 ADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRG 231
Query: 188 KAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQP 247
+ + L Q R LQ +Y P Y+ V C H +
Sbjct: 232 APPY-----PDVNTFDITVYLLQGR--------RLLQPEYCPDPLYE---VMLKCWHPKA 275
Query: 248 DMRPVIADVVTALAYLASQKYESDAEKVQSPCLD 281
+MRP +++V+ ++ + S V + ++
Sbjct: 276 EMRPSFSELVSRISAIFSTFIGEHYVHVNATYVN 309
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 9e-54
Identities = 55/260 (21%), Positives = 103/260 (39%), Gaps = 37/260 (14%)
Query: 10 QDVAIKQLDRNGVQGN--REFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL--VYEYMPL 65
+ + K+LD + + + EV +L L HPN+V D L V EY
Sbjct: 30 KILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEG 89
Query: 66 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDK--AKPPVIYRDLKCSNILLDR 123
G + + + ++ LD +++ L+ H + V++RDLK +N+ LD
Sbjct: 90 GDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDG 149
Query: 124 GYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEI 183
+ KL DFGLA++ + +T + +GT Y +PE KSD++S G +L E+
Sbjct: 150 KQNVKLGDFGLARI--LNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 207
Query: 184 LSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA------DPELQGQYPPRGFYQALA 237
+ P F ++ L + +Y +
Sbjct: 208 CAL-------------------MPPFTAFSQKELAGKIREGKFRRIPYRYSD----ELNE 244
Query: 238 VAAMCVHEQPDMRPVIADVV 257
+ ++ + RP + +++
Sbjct: 245 IITRMLNLKDYHRPSVEEIL 264
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 2e-53
Identities = 64/267 (23%), Positives = 100/267 (37%), Gaps = 34/267 (12%)
Query: 10 QDVAIKQLDRNGVQGNRE-FLVEVLMLS-LLHHPNLVNLIGYCADGDQRLLVYEYMPLGS 67
VA+K L + RE + E+ +LS L +H N+VNL+G C G L++ EY G
Sbjct: 54 MTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGD 113
Query: 68 VEDHLHD--------------LSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRD 113
+ + L + + LD + + A+G+ +L K I+RD
Sbjct: 114 LLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRD 170
Query: 114 LKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDV 173
L NILL G K+ DFGLA+ N V + APE T +SDV
Sbjct: 171 LAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDV 230
Query: 174 YSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFY 233
+S+G+ L E+ S + + + + P
Sbjct: 231 WSYGIFLWELFSLGSSPYPGMPVDSKFY---------------KMIKEGFRMLSPEHAPA 275
Query: 234 QALAVAAMCVHEQPDMRPVIADVVTAL 260
+ + C P RP +V +
Sbjct: 276 EMYDIMKTCWDADPLKRPTFKQIVQLI 302
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 6e-53
Identities = 59/249 (23%), Positives = 103/249 (41%), Gaps = 24/249 (9%)
Query: 10 QDVAIKQLD-RNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSV 68
+ VA+K +D + V E+ + +L+H N+V G+ +G+ + L EY G +
Sbjct: 31 EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL 90
Query: 69 EDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK 128
D + + + G+ YLH + +RD+K N+LLD + K
Sbjct: 91 FDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLK 143
Query: 129 LSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQL-TLKSDVYSFGVVLLEILSGR 187
+SDFGLA + + + ++ GT Y APE K + DV+S G+VL +L+G
Sbjct: 144 ISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 203
Query: 188 KAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQP 247
D + ++ + + + + D LA+ + E P
Sbjct: 204 LPWDQPSDSCQEYSDWKEKKTYLNPWKK---IDSA------------PLALLHKILVENP 248
Query: 248 DMRPVIADV 256
R I D+
Sbjct: 249 SARITIPDI 257
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 4e-52
Identities = 58/256 (22%), Positives = 103/256 (40%), Gaps = 31/256 (12%)
Query: 10 QDVAIKQLDRNGVQGN--REFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGS 67
+ VA+K L E L E ++ L +P +V +IG C + + +LV E LG
Sbjct: 35 KTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGP 93
Query: 68 VEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP 127
+ +L + + +++ + G++YL + ++RDL N+LL ++
Sbjct: 94 LNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYA 146
Query: 128 KLSDFGLAK-LGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG 186
K+SDFGL+K L + T + APE + + KSDV+SFGV++ E S
Sbjct: 147 KISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSY 206
Query: 187 RKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA--DPELQGQYPPRGFYQALAVAAMCVH 244
+ ++ + A + + P + + +C
Sbjct: 207 G------------------QKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWT 248
Query: 245 EQPDMRPVIADVVTAL 260
+ RP A V L
Sbjct: 249 YDVENRPGFAAVELRL 264
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 5e-52
Identities = 53/257 (20%), Positives = 96/257 (37%), Gaps = 38/257 (14%)
Query: 10 QDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVE 69
A K +D + +++VE+ +L+ HPN+V L+ + ++ E+ G+V+
Sbjct: 38 VLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVD 97
Query: 70 DHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKL 129
+ +L ++PL + + L YLHD +I+RDLK NIL KL
Sbjct: 98 AVMLEL---ERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKL 151
Query: 130 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA-----KTGQLTLKSDVYSFGVVLLEIL 184
+DFG++ +GT + APE K K+DV+S G+ L+E+
Sbjct: 152 ADFGVSAKNT--RTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMA 209
Query: 185 SGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFY-----QALAVA 239
P + ++ + + P
Sbjct: 210 EI-------------------EPPHHELNPMRVLLK-IAKSEPPTLAQPSRWSSNFKDFL 249
Query: 240 AMCVHEQPDMRPVIADV 256
C+ + D R + +
Sbjct: 250 KKCLEKNVDARWTTSQL 266
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 1e-51
Identities = 70/276 (25%), Positives = 110/276 (39%), Gaps = 40/276 (14%)
Query: 8 LLQDVAIKQLDRNGV-QGNREFLVEV-LMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPL 65
L D AIK++ +R+F E+ ++ L HHPN++NL+G C L EY P
Sbjct: 36 LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 95
Query: 66 GSVEDHLHD------------LSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRD 113
G++ D L + L + AA ARG++YL + I+RD
Sbjct: 96 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRD 152
Query: 114 LKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDV 173
L NIL+ Y K++DFGL++ V T + A E T SDV
Sbjct: 153 LAARNILVGENYVAKIADFGLSRGQEVYVKK---TMGRLPVRWMAIESLNYSVYTTNSDV 209
Query: 174 YSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA--DPELQGQYPPRG 231
+S+GV+L EI+S + T L + + P
Sbjct: 210 WSYGVLLWEIVSLG------------------GTPYCGMTCAELYEKLPQGYRLEKPLNC 251
Query: 232 FYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQK 267
+ + C E+P RP A ++ +L + ++
Sbjct: 252 DDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 169 bits (430), Expect = 2e-51
Identities = 59/258 (22%), Positives = 104/258 (40%), Gaps = 30/258 (11%)
Query: 12 VAIKQLDRNGVQGN-REFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVED 70
VAIK L + R+FL E ++ HPN+++L G +++ E+M GS++
Sbjct: 57 VAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDS 116
Query: 71 HLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLS 130
L + + G A G++YL D ++RDL NIL++ K+S
Sbjct: 117 FLRQ---NDGQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVS 170
Query: 131 DFGLAKLGPVGDNTHVSTRV---MGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 187
DFGL++ + T + APE + + T SDV+S+G+V+ E++S
Sbjct: 171 DFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS-- 228
Query: 188 KAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA--DPELQGQYPPRGFYQALAVAAMCVHE 245
+ + D T +I + + + P + C +
Sbjct: 229 ----------------YGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQK 272
Query: 246 QPDMRPVIADVVTALAYL 263
+ RP +V L +
Sbjct: 273 DRNHRPKFGQIVNTLDKM 290
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 2e-51
Identities = 59/256 (23%), Positives = 108/256 (42%), Gaps = 28/256 (10%)
Query: 12 VAIKQLDRNGVQGNR-EFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVED 70
VAIK L + R +FL E ++ H N++ L G + +++ EYM G+++
Sbjct: 39 VAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDK 98
Query: 71 HLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLS 130
L + + + G A G++YL ++RDL NIL++ K+S
Sbjct: 99 FLRE---KDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVS 152
Query: 131 DFGLAK-LGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKA 189
DFGL++ L + T+ ++ + APE + T SDV+SFG+V+ E+++
Sbjct: 153 DFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYG-- 210
Query: 190 VDTSKAAAEQSLVAWARPLFQDRTRHSLIA--DPELQGQYPPRGFYQALAVAAMCVHEQP 247
+ + + H ++ + + P + C ++
Sbjct: 211 ----------------ERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQER 254
Query: 248 DMRPVIADVVTALAYL 263
RP AD+V+ L L
Sbjct: 255 ARRPKFADIVSILDKL 270
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 2e-51
Identities = 59/255 (23%), Positives = 101/255 (39%), Gaps = 32/255 (12%)
Query: 10 QDVAIKQLDRNGVQGN--REFLVEVLMLSLLHHPNLVNLIGYCADGDQR----LLVYEYM 63
+VA +L + + + F E ML L HPN+V + +LV E M
Sbjct: 35 VEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELM 94
Query: 64 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL-D 122
G+++ +L K + +GL++LH + PP+I+RDLKC NI +
Sbjct: 95 TSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITG 149
Query: 123 RGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLE 182
K+ D GLA L + V+GT + APE + + DVY+FG+ +LE
Sbjct: 150 PTGSVKIGDLGLATL----KRASFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLE 204
Query: 183 ILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMC 242
+ + + AA+ + + + + + C
Sbjct: 205 MATSEYPYSECQNAAQI---------------YRRVTSGVKPASFDKVAIPEVKEIIEGC 249
Query: 243 VHEQPDMRPVIADVV 257
+ + D R I D++
Sbjct: 250 IRQNKDERYSIKDLL 264
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (425), Expect = 4e-51
Identities = 64/252 (25%), Positives = 100/252 (39%), Gaps = 34/252 (13%)
Query: 10 QDVAIKQLDRNGVQGN---REFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLG 66
+A+K L + ++ + EV + S L HPN++ L GY D + L+ EY PLG
Sbjct: 32 FILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLG 91
Query: 67 SVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH 126
+V L D A L Y H K VI+RD+K N+LL
Sbjct: 92 TVYRELQK----LSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGE 144
Query: 127 PKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG 186
K++DFG + P + T + GT Y PE + K D++S GV+ E L G
Sbjct: 145 LKIADFGWSVHAP----SSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 200
Query: 187 RKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD-PELQGQYPPRGFYQALAVAAMCVHE 245
+P F+ T ++ +P A + + +
Sbjct: 201 -------------------KPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKH 241
Query: 246 QPDMRPVIADVV 257
P RP++ +V+
Sbjct: 242 NPSQRPMLREVL 253
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (425), Expect = 7e-51
Identities = 66/263 (25%), Positives = 105/263 (39%), Gaps = 31/263 (11%)
Query: 3 QVILCLLQD---VAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 59
+V + VAIK L + G FL E ++ L H LV L + +V
Sbjct: 32 EVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIV 89
Query: 60 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNI 119
EYM GS+ D L K L + +AA A G+ Y+ ++RDL+ +NI
Sbjct: 90 TEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANI 144
Query: 120 LLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVV 179
L+ K++DFGLA+L + + APE A G+ T+KSDV+SFG++
Sbjct: 145 LVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGIL 203
Query: 180 LLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA--DPELQGQYPPRGFYQALA 237
L E+ + R + ++ + + PP
Sbjct: 204 LTELTTKG------------------RVPYPGMVNREVLDQVERGYRMPCPPECPESLHD 245
Query: 238 VAAMCVHEQPDMRPVIADVVTAL 260
+ C ++P+ RP + L
Sbjct: 246 LMCQCWRKEPEERPTFEYLQAFL 268
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 167 bits (424), Expect = 2e-50
Identities = 67/260 (25%), Positives = 98/260 (37%), Gaps = 47/260 (18%)
Query: 10 QDVAIKQLDRNGVQGN---REFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLG 66
+ VAIK++ +G Q N ++ + EV L L HPN + G LV EY
Sbjct: 41 EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGS 100
Query: 67 SVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH 126
+ + KKPL + GA +GL YLH +I+RD+K NILL
Sbjct: 101 ASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGL 153
Query: 127 PKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA---KTGQLTLKSDVYSFGVVLLEI 183
KL DFG A + + +GT + APE GQ K DV+S G+ +E+
Sbjct: 154 VKLGDFGSASI------MAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
Query: 184 LSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLI------ADPELQGQYPPRGFYQALA 237
+P + S + P LQ + F
Sbjct: 208 AER-------------------KPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRN--- 245
Query: 238 VAAMCVHEQPDMRPVIADVV 257
C+ + P RP ++
Sbjct: 246 FVDSCLQKIPQDRPTSEVLL 265
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 9e-50
Identities = 55/258 (21%), Positives = 107/258 (41%), Gaps = 28/258 (10%)
Query: 12 VAIKQLDR-NGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVED 70
VAIK+L + N+E L E +++ + +P++ L+G C +L + + MP G + D
Sbjct: 41 VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLD 99
Query: 71 HLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLS 130
++ + K + + A+G+ YL D+ +++RDL N+L+ H K++
Sbjct: 100 YVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKIT 153
Query: 131 DFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAV 190
DFGLAKL + + + + A E T +SDV+S+GV + E+++
Sbjct: 154 DFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFG--- 210
Query: 191 DTSKAAAEQSLVAWARPLFQDRTRHSLIA--DPELQGQYPPRGFYQALAVAAMCVHEQPD 248
+ + + + + PP + C D
Sbjct: 211 ---------------SKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDAD 255
Query: 249 MRPVIADVVTALAYLASQ 266
RP +++ + +A
Sbjct: 256 SRPKFRELIIEFSKMARD 273
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 7e-49
Identities = 65/258 (25%), Positives = 101/258 (39%), Gaps = 32/258 (12%)
Query: 10 QDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLG 66
VA+K L + + + +F+ EV + L H NL+ L G ++ V E PLG
Sbjct: 37 VSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLG 95
Query: 67 SVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH 126
S+ D L + T + A A G+ YL K I+RDL N+LL
Sbjct: 96 SLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDL 149
Query: 127 PKLSDFGLAKLGPVGDNTHV-STRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 185
K+ DFGL + P D+ +V + +CAPE KT + SD + FGV L E+ +
Sbjct: 150 VKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 209
Query: 186 GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFY---QALAVAAMC 242
+ + ++ + +G+ PR V C
Sbjct: 210 YG------------------QEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQC 251
Query: 243 VHEQPDMRPVIADVVTAL 260
+P+ RP + L
Sbjct: 252 WAHKPEDRPTFVALRDFL 269
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 2e-48
Identities = 60/261 (22%), Positives = 107/261 (40%), Gaps = 32/261 (12%)
Query: 10 QDVAIKQLDRNGVQGNR-EFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSV 68
VAIK ++ R EFL E ++ + ++V L+G + G L++ E M G +
Sbjct: 51 TRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDL 110
Query: 69 EDHLHDL------SPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD 122
+ +L L +P P + +++A A G+ YL+ ++RDL N ++
Sbjct: 111 KSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVA 167
Query: 123 RGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLE 182
+ K+ DFG+ + D + + + +PE K G T SDV+SFGVVL E
Sbjct: 168 EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWE 227
Query: 183 ILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSL---IADPELQGQYPPRGFYQALAVA 239
I + +Q + + + + L P +
Sbjct: 228 IATLA------------------EQPYQGLSNEQVLRFVMEGGLL-DKPDNCPDMLFELM 268
Query: 240 AMCVHEQPDMRPVIADVVTAL 260
MC P MRP ++++++
Sbjct: 269 RMCWQYNPKMRPSFLEIISSI 289
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 7e-48
Identities = 54/251 (21%), Positives = 101/251 (40%), Gaps = 33/251 (13%)
Query: 10 QDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVE 69
Q+VAI+Q++ + E+L++ +PN+VN + GD+ +V EY+ GS+
Sbjct: 46 QEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT 105
Query: 70 DHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKL 129
D + + +D + + LE+LH VI+RD+K NILL KL
Sbjct: 106 DVVT-----ETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKL 157
Query: 130 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKA 189
+DFG + + ++GT + APE K D++S G++ +E++ G
Sbjct: 158 TDFGFCAQ--ITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG--- 212
Query: 190 VDTSKAAAEQSLVAWARPLFQDRTR----HSLIADPELQGQYPPRGFYQALAVAAMCVHE 245
P + + + + + + Q P + C+
Sbjct: 213 ----------------EPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDM 256
Query: 246 QPDMRPVIADV 256
+ R ++
Sbjct: 257 DVEKRGSAKEL 267
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 5e-46
Identities = 53/259 (20%), Positives = 96/259 (37%), Gaps = 30/259 (11%)
Query: 10 QDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLG 66
++ AIK L++ + E ++S L HP V L D ++ Y G
Sbjct: 34 REYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNG 93
Query: 67 SVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH 126
+ ++ D A LEYLH +I+RDLK NILL+ H
Sbjct: 94 ELLKYIRK----IGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMH 146
Query: 127 PKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG 186
+++DFG AK+ + +GT Y +PE SD+++ G ++ ++++G
Sbjct: 147 IQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 206
Query: 187 RKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIAD-PELQGQYPPRGFYQALAVAAMCVHE 245
P F+ + + +L+ +P + F +A + +
Sbjct: 207 -------------------LPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVL 247
Query: 246 QPDMRPVIADVVTALAYLA 264
R ++ A
Sbjct: 248 DATKRLGCEEMEGYGPLKA 266
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 6e-46
Identities = 59/257 (22%), Positives = 94/257 (36%), Gaps = 25/257 (9%)
Query: 12 VAIKQLDRNGVQGNRE-FLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVED 70
VAIK RE FL E L + HP++V LIG + + ++ E LG +
Sbjct: 38 VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRS 96
Query: 71 HLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLS 130
L K LD + + A + L YL K ++RD+ N+L+ KL
Sbjct: 97 FLQV---RKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLG 150
Query: 131 DFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAV 190
DFGL++ + +++ + APE + T SDV+ FGV + EIL
Sbjct: 151 DFGLSRYME-DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 209
Query: 191 DTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPDMR 250
R + PP ++ C P R
Sbjct: 210 F------------QGVKNNDVIGRIENGERLPMPPNCPP----TLYSLMTKCWAYDPSRR 253
Query: 251 PVIADVVTALAYLASQK 267
P ++ L+ + ++
Sbjct: 254 PRFTELKAQLSTILEEE 270
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 1e-45
Identities = 63/270 (23%), Positives = 105/270 (38%), Gaps = 37/270 (13%)
Query: 12 VAIKQLDRNGVQGN-REFLVEV-LMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVE 69
VA+K L + + + + + E+ +M + H N++NL+G C ++ EY G++
Sbjct: 48 VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 107
Query: 70 DHLHDLSPG------------KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCS 117
++L P ++ L + A ARG+EYL K I+RDL
Sbjct: 108 EYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAAR 164
Query: 118 NILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFG 177
N+L+ K++DFGLA+ D +T + APE T +SDV+SFG
Sbjct: 165 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFG 224
Query: 178 VVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSL--IADPELQGQYPPRGFYQA 235
V+L EI + + L + + P +
Sbjct: 225 VLLWEIFTLG------------------GSPYPGVPVEELFKLLKEGHRMDKPSNCTNEL 266
Query: 236 LAVAAMCVHEQPDMRPVIADVVTALAYLAS 265
+ C H P RP +V L + +
Sbjct: 267 YMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 2e-45
Identities = 64/269 (23%), Positives = 106/269 (39%), Gaps = 33/269 (12%)
Query: 10 QDVAIKQLDRNGVQG-NREFLVEV-LMLSLLHHPNLVNLIGYCA-DGDQRLLVYEYMPLG 66
+ VA+K L +R + E+ +++ + HH N+VNL+G C G +++ E+ G
Sbjct: 44 RTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 103
Query: 67 SVEDHLHD------------LSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDL 114
++ +L K L + + A+G+E+L + I+RDL
Sbjct: 104 NLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDL 160
Query: 115 KCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVY 174
NILL K+ DFGLA+ + + APE T++SDV+
Sbjct: 161 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVW 220
Query: 175 SFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQ 234
SFGV+L EI S + + ++ TR P +
Sbjct: 221 SFGVLLWEIFSLGASPY-----PGVKIDEEFCRRLKEGTR------MRAPDYTTP----E 265
Query: 235 ALAVAAMCVHEQPDMRPVIADVVTALAYL 263
C H +P RP +++V L L
Sbjct: 266 MYQTMLDCWHGEPSQRPTFSELVEHLGNL 294
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 151 bits (382), Expect = 6e-44
Identities = 51/254 (20%), Positives = 88/254 (34%), Gaps = 35/254 (13%)
Query: 10 QDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVE 69
+ A K + E+ +S+L HP LVNL D ++ +++YE+M G +
Sbjct: 52 NNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELF 111
Query: 70 DHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL--DRGYHP 127
+ + D + + ++ +GL ++H+ ++ DLK NI+ R
Sbjct: 112 EKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNEL 165
Query: 128 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 187
KL DFGL D GT + APE A+ + +D++S GV+ +LSG
Sbjct: 166 KLIDFGLTAH---LDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG- 221
Query: 188 KAVDTSKAAAEQSLVAWARPLFQDRTRHSLI-----ADPELQGQYPPRGFYQALAVAAMC 242
F + D +
Sbjct: 222 ------------------LSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKL 263
Query: 243 VHEQPDMRPVIADV 256
+ P+ R I
Sbjct: 264 LLADPNTRMTIHQA 277
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 150 bits (379), Expect = 2e-43
Identities = 45/254 (17%), Positives = 90/254 (35%), Gaps = 35/254 (13%)
Query: 10 QDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVE 69
+ K ++ E+ +++ LHHP L+NL D + +L+ E++ G +
Sbjct: 55 RVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELF 114
Query: 70 DHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD--RGYHP 127
D + + + A GL+++H+ +++ D+K NI+ + +
Sbjct: 115 DRIAA---EDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSV 168
Query: 128 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 187
K+ DFGLA + + T + APE + +D+++ GV+ +LSG
Sbjct: 169 KIIDFGLAT---KLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG- 224
Query: 188 KAVDTSKAAAEQSLVAWARPLFQDRTRHSLI-----ADPELQGQYPPRGFYQALAVAAMC 242
F + D E +A
Sbjct: 225 ------------------LSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNL 266
Query: 243 VHEQPDMRPVIADV 256
+ ++P R + D
Sbjct: 267 LQKEPRKRLTVHDA 280
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 4e-42
Identities = 71/278 (25%), Positives = 112/278 (40%), Gaps = 37/278 (13%)
Query: 10 QDVAIKQLDRNGVQGNRE---FLVEVLMLSL-LHHPNLVNLIGYCADGDQRLLVYEYMPL 65
Q AIK L ++ V + + +VE +LSL HP L ++ + V EY+
Sbjct: 28 QFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNG 87
Query: 66 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY 125
G + H+ D + AA GL++LH K ++YRDLK NILLD+
Sbjct: 88 GDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDG 140
Query: 126 HPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 185
H K++DFG+ K +GD GT Y APE + D +SFGV+L E+L
Sbjct: 141 HIKIADFGMCKENMLGDAKT--NTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLI 198
Query: 186 GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGF-YQALAVAAMCVH 244
G + F + L + + PR +A +
Sbjct: 199 G-------------------QSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFV 239
Query: 245 EQPDMRPVIADVVTALAYLASQKYESDAEKVQSPCLDP 282
+P+ R + + E + E+++ +DP
Sbjct: 240 REPEKRLGVRGDIRQHPLFR----EINWEELERKEIDP 273
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 143 bits (361), Expect = 3e-41
Identities = 54/253 (21%), Positives = 86/253 (33%), Gaps = 32/253 (12%)
Query: 10 QDVAIKQLDRNGVQGNRE-FLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSV 68
+ VAIK + + ++G E+ +L + HPN+V L G L+ + + G +
Sbjct: 35 KLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGEL 94
Query: 69 EDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK 128
D + + K ++ ++YLHD + LD
Sbjct: 95 FDRIVE----KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIM 150
Query: 129 LSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRK 188
+SDFGL+K+ D V + GT GY APE + D +S GV+ +L G
Sbjct: 151 ISDFGLSKME---DPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG-- 205
Query: 189 AVDTSKAAAEQSLVAWARPLFQDRTRHSLI-----ADPELQGQYPPRGFYQALAVAAMCV 243
P F D L A+ E Y A +
Sbjct: 206 -----------------YPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLM 248
Query: 244 HEQPDMRPVIADV 256
+ P+ R
Sbjct: 249 EKDPEKRFTCEQA 261
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 142 bits (358), Expect = 3e-41
Identities = 63/261 (24%), Positives = 112/261 (42%), Gaps = 39/261 (14%)
Query: 10 QDVAIKQLDRNGVQGN---REFLVEVLMLSLLHHPNLVNLIGYCAD----GDQRLLVYEY 62
+DVA+K L + + F E + L+HP +V + G +V EY
Sbjct: 33 RDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEY 92
Query: 63 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD 122
+ ++ D +H + P+ +++ A A + L + H +I+RD+K +NI++
Sbjct: 93 VDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMIS 145
Query: 123 RGYHPKLSDFGLAK-LGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLL 181
K+ DFG+A+ + G++ + V+GT Y +PE A+ + +SDVYS G VL
Sbjct: 146 ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLY 205
Query: 182 EILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQAL----- 236
E+L+G P F + S+ + PP ++ L
Sbjct: 206 EVLTG-------------------EPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLD 246
Query: 237 AVAAMCVHEQPDMRPVIADVV 257
AV + + P+ R A +
Sbjct: 247 AVVLKALAKNPENRYQTAAEM 267
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 7e-41
Identities = 39/254 (15%), Positives = 93/254 (36%), Gaps = 36/254 (14%)
Query: 10 QDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVE 69
+ K + G E+ +L++ H N+++L ++ ++++E++ +
Sbjct: 31 KTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIF 89
Query: 70 DHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD--RGYHP 127
+ ++ L+ + L++LH + + D++ NI+ R
Sbjct: 90 ERINT---SAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTI 143
Query: 128 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 187
K+ +FG A+ GDN + + Y APE + ++ +D++S G ++ +LSG
Sbjct: 144 KIIEFGQARQLKPGDNFRL---LFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSG- 199
Query: 188 KAVDTSKAAAEQSLVAWARPLFQDRTRHSLI-----ADPELQGQYPPRGFYQALAVAAMC 242
F T +I A+ + +A+
Sbjct: 200 ------------------INPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRL 241
Query: 243 VHEQPDMRPVIADV 256
+ ++ R ++
Sbjct: 242 LVKERKSRMTASEA 255
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 139 bits (352), Expect = 2e-39
Identities = 63/249 (25%), Positives = 100/249 (40%), Gaps = 33/249 (13%)
Query: 10 QDVAIKQLDRNGV---QGNREFLVEVLMLSLLH---HPNLVNLIGYCADGDQRLLVYEYM 63
+ A+K LD+ + QG L E +MLSL+ P +V + D+ + + M
Sbjct: 30 KMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLM 89
Query: 64 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR 123
G + HL AA GLE++H++ V+YRDLK +NILLD
Sbjct: 90 NGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDE 142
Query: 124 GYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ-LTLKSDVYSFGVVLLE 182
H ++SD GLA +GT+GY APE + G +D +S G +L +
Sbjct: 143 HGHVRISDLGLACDFS----KKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFK 198
Query: 183 ILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMC 242
+L G K + + R +L EL + P + ++
Sbjct: 199 LLRGHSPFRQHKTKDKHEID-----------RMTLTMAVELPDSFSP----ELRSLLEGL 243
Query: 243 VHEQPDMRP 251
+ + R
Sbjct: 244 LQRDVNRRL 252
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 137 bits (345), Expect = 8e-39
Identities = 59/182 (32%), Positives = 86/182 (47%), Gaps = 15/182 (8%)
Query: 10 QDVAIKQLDRNGVQGNRE---FLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLG 66
+ A+K L + V ++ E LMLS++ HP ++ + G D Q ++ +Y+
Sbjct: 30 RYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIE-- 87
Query: 67 SVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH 126
L L + AA LEYLH K +IYRDLK NILLD+ H
Sbjct: 88 --GGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGH 142
Query: 127 PKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG 186
K++DFG AK P V+ + GT Y APE T D +SFG+++ E+L+G
Sbjct: 143 IKITDFGFAKYVP-----DVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAG 197
Query: 187 RK 188
Sbjct: 198 YT 199
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 135 bits (342), Expect = 9e-39
Identities = 57/268 (21%), Positives = 96/268 (35%), Gaps = 50/268 (18%)
Query: 10 QDVAIKQLDRNGV---------QGNREFLVEV-LMLSLLHHPNLVNLIGYCADGDQRLLV 59
++ A+K +D G + L EV ++ + HPN++ L LV
Sbjct: 29 KEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLV 88
Query: 60 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNI 119
++ M G + D+L + K L KI + LH +++RDLK NI
Sbjct: 89 FDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENI 141
Query: 120 LLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQL------TLKSDV 173
LLD + KL+DFG + D V GT Y APE + + D+
Sbjct: 142 LLDDDMNIKLTDFGFSCQ---LDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDM 198
Query: 174 YSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLI-----ADPELQGQYP 228
+S GV++ +L+G P F R + ++ + +
Sbjct: 199 WSTGVIMYTLLAG-------------------SPPFWHRKQMLMLRMIMSGNYQFGSPEW 239
Query: 229 PRGFYQALAVAAMCVHEQPDMRPVIADV 256
+ + + QP R +
Sbjct: 240 DDYSDTVKDLVSRFLVVQPQKRYTAEEA 267
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 8e-37
Identities = 57/262 (21%), Positives = 93/262 (35%), Gaps = 44/262 (16%)
Query: 10 QDVAIKQLDRNGVQGNR------EFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 63
A K + + + +R + EV +L + HPN++ L + +L+ E +
Sbjct: 36 LQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELV 95
Query: 64 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR 123
L D K+ L + G+ YLH + + DLK NI+L
Sbjct: 96 A----GGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLD 148
Query: 124 ----GYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVV 179
K+ DFGLA D + + GT + APE L L++D++S GV+
Sbjct: 149 RNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 205
Query: 180 LLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIA-----DPELQGQYPPRGFYQ 234
+LSG F T+ +A + E + +Y
Sbjct: 206 TYILLSG-------------------ASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 246
Query: 235 ALAVAAMCVHEQPDMRPVIADV 256
A + + P R I D
Sbjct: 247 AKDFIRRLLVKDPKKRMTIQDS 268
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 2e-36
Identities = 61/263 (23%), Positives = 97/263 (36%), Gaps = 25/263 (9%)
Query: 10 QDVAIKQLDRNGVQG-----NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMP 64
Q VAIK++ NR L E+ +L L HPN++ L+ LV+++M
Sbjct: 24 QIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME 83
Query: 65 LGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG 124
D + L + +GLEYLH +++RDLK +N+LLD
Sbjct: 84 ----TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDEN 136
Query: 125 YHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQL-TLKSDVYSFGVVLLEI 183
KL+DFGLAK G T + T Y APE ++ + D+++ G +L E+
Sbjct: 137 GVLKLADFGLAK--SFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAEL 194
Query: 184 LSGRKAV--DTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFY-------- 233
L + D+ + P + + D +P +
Sbjct: 195 LLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGD 254
Query: 234 QALAVAAMCVHEQPDMRPVIADV 256
L + P R
Sbjct: 255 DLLDLIQGLFLFNPCARITATQA 277
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 5e-36
Identities = 53/181 (29%), Positives = 82/181 (45%), Gaps = 7/181 (3%)
Query: 10 QDVAIKQLDRNGVQGNRE-FLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSV 68
VAIK++ Q + L E+ +L H N++ + + Y+ +
Sbjct: 34 VRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLM 93
Query: 69 EDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPK 128
L+ L + L + RGL+Y+H V++RDLK SN+LL+ K
Sbjct: 94 GADLYKLLK-TQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLK 149
Query: 129 LSDFGLAK-LGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKS-DVYSFGVVLLEILSG 186
+ DFGLA+ P D+T T + T Y APE + KS D++S G +L E+LS
Sbjct: 150 ICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 209
Query: 187 R 187
R
Sbjct: 210 R 210
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 129 bits (324), Expect = 5e-36
Identities = 50/274 (18%), Positives = 82/274 (29%), Gaps = 31/274 (11%)
Query: 10 QDVAIKQLDRNGVQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPLGSV 68
Q VAIK R + E LL + N+ + +G +LV + +
Sbjct: 31 QQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLG---- 84
Query: 69 EDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP- 127
L + T A ++ +H+K ++YRD+K N L+ R
Sbjct: 85 PSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKN 141
Query: 128 ----KLSDFGLAKLGPVGDNT-----HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGV 178
+ DFG+ K + GT Y + + + + D+ + G
Sbjct: 142 ANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGH 201
Query: 179 VLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAV 238
V + L G KAA + Q L A P FY+
Sbjct: 202 VFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAG-------FPEEFYK---Y 251
Query: 239 AAMCVHEQPDMRPVIADVVTALA-YLASQKYESD 271
+ D P + + L D
Sbjct: 252 MHYARNLAFDATPDYDYLQGLFSKVLERLNTTED 285
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 128 bits (322), Expect = 1e-35
Identities = 51/272 (18%), Positives = 93/272 (34%), Gaps = 29/272 (10%)
Query: 10 QDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYC-ADGDQRLLVYEYMPLGSV 68
++VAIK + + +E + ++ + I +C A+GD ++V E +
Sbjct: 33 EEVAIKLECVK--TKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLE 90
Query: 69 EDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNIL---LDRGY 125
+ + T + +A +EY+H K I+RD+K N L +G
Sbjct: 91 DLFNFC----SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGN 143
Query: 126 HPKLSDFGLAKLGPVGDNT-----HVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVL 180
+ DFGLAK + + GT Y + + + + D+ S G VL
Sbjct: 144 LVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVL 203
Query: 181 LEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAA 240
+ G KAA ++ + + L YP +
Sbjct: 204 MYFNLGSLPWQGLKAATKRQKY------ERISEKKMSTPIEVLCKGYPS----EFATYLN 253
Query: 241 MCVHEQPDMRPVIADVVTALA-YLASQKYESD 271
C + D +P + + Q + D
Sbjct: 254 FCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYD 285
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 2e-35
Identities = 49/185 (26%), Positives = 75/185 (40%), Gaps = 17/185 (9%)
Query: 10 QDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR------LLVYEYM 63
+ VAIK++ ++ NRE + ++ L H N+V L + ++ LV +Y+
Sbjct: 46 ELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV 101
Query: 64 PLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR 123
P H S K+ L R L Y+H + +RD+K N+LLD
Sbjct: 102 PETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDP 157
Query: 124 -GYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLE 182
KL DFG AK + + + Y T DV+S G VL E
Sbjct: 158 DTAVLKLCDFGSAKQ--LVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAE 215
Query: 183 ILSGR 187
+L G+
Sbjct: 216 LLLGQ 220
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (321), Expect = 2e-35
Identities = 53/263 (20%), Positives = 89/263 (33%), Gaps = 22/263 (8%)
Query: 10 QDVAIKQLDRNGVQGN--REFLVEVLMLSLL---HHPNLVNLIGYCADGDQRLLVYEYMP 64
+ VA+K++ + + EV +L L HPN+V L C +
Sbjct: 34 RFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLV 93
Query: 65 LGSV--EDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD 122
V + + + + T + RGL++LH V++RDLK NIL+
Sbjct: 94 FEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVT 150
Query: 123 RGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLE 182
KL+DFGLA++ T V+ T Y APE D++S G + E
Sbjct: 151 SSGQIKLADFGLARIY---SFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAE 207
Query: 183 ILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQ---------GQYPPRGFY 233
+ + S + + L + +A P ++
Sbjct: 208 MFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDE 267
Query: 234 QALAVAAMCVHEQPDMRPVIADV 256
+ C+ P R
Sbjct: 268 LGKDLLLKCLTFNPAKRISAYSA 290
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 2e-34
Identities = 47/254 (18%), Positives = 86/254 (33%), Gaps = 29/254 (11%)
Query: 10 QDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYC----ADGDQRLLVYEYMPL 65
+ A+K L ++ + RE L P++V ++ A L+V E +
Sbjct: 38 EKFALKML-QDCPKARREV---ELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG 93
Query: 66 GSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY 125
G + + D G + +I ++YLH + +RD+K N+L
Sbjct: 94 GELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKR 148
Query: 126 ---HPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLE 182
KL+DFG AK ++ T Y APE + D++S GV++
Sbjct: 149 PNAILKLTDFGFAKETTSHNSLT---TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYI 205
Query: 183 ILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMC 242
+L G ++ A + + E + +
Sbjct: 206 LLCGYPPFYSNHGLA----------ISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNL 255
Query: 243 VHEQPDMRPVIADV 256
+ +P R I +
Sbjct: 256 LKTEPTQRMTITEF 269
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 5e-34
Identities = 47/257 (18%), Positives = 90/257 (35%), Gaps = 44/257 (17%)
Query: 10 QDVAIKQLDRNGVQGNRE------FLVEVLMLSLLH--HPNLVNLIGYCADGDQRLLVYE 61
VAIK ++++ + E +EV++L + ++ L+ + D +L+ E
Sbjct: 30 LPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE 89
Query: 62 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL 121
L D + L + + H+ V++RD+K NIL+
Sbjct: 90 RPEPVQ---DLFDFITERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILI 143
Query: 122 DR-GYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQL-TLKSDVYSFGVV 179
D KL DFG L V T GT Y PE+ + + + V+S G++
Sbjct: 144 DLNRGELKLIDFGSGAL----LKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGIL 199
Query: 180 LLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVA 239
L +++ G F+ + + + + +
Sbjct: 200 LYDMVCG-------------------DIPFEHDE-EIIRGQVFFRQRVSS----ECQHLI 235
Query: 240 AMCVHEQPDMRPVIADV 256
C+ +P RP ++
Sbjct: 236 RWCLALRPSDRPTFEEI 252
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 3e-33
Identities = 45/260 (17%), Positives = 94/260 (36%), Gaps = 20/260 (7%)
Query: 10 QDVAIKQL--DRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGS 67
+ VA+K++ D + E+ +L L+HPN+V L+ ++ LV+E++
Sbjct: 28 EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDL 87
Query: 68 VEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP 127
+ + +GL + H V++RDLK N+L++
Sbjct: 88 ---KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAI 141
Query: 128 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 187
KL+DFGLA+ V + V+ + + D++S G + E+++ R
Sbjct: 142 KLADFGLARAFGV-PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200
Query: 188 KAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYP-----------PRGFYQAL 236
+ + + + + P+ + +P P
Sbjct: 201 ALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGR 260
Query: 237 AVAAMCVHEQPDMRPVIADV 256
++ + +H P+ R
Sbjct: 261 SLLSQMLHYDPNKRISAKAA 280
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 1e-32
Identities = 53/181 (29%), Positives = 76/181 (41%), Gaps = 12/181 (6%)
Query: 10 QDVAIKQLDRNGVQGNRE---FLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLG 66
+ A+K L + + E + E +L HP L L D+ V EY G
Sbjct: 31 RYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 90
Query: 67 SVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH 126
+ HL ++ A LEYLH + V+YRD+K N++LD+ H
Sbjct: 91 ELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGH 143
Query: 127 PKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG 186
K++DFGL K G T GT Y APE + D + GVV+ E++ G
Sbjct: 144 IKITDFGLCKEGISDGATM--KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 201
Query: 187 R 187
R
Sbjct: 202 R 202
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 119 bits (298), Expect = 2e-32
Identities = 43/260 (16%), Positives = 97/260 (37%), Gaps = 21/260 (8%)
Query: 10 QDVAIKQL--DRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGS 67
+ A+K++ ++ + E+ +L L H N+V L + +LV+E++
Sbjct: 27 ETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLD--- 83
Query: 68 VEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP 127
+D L + L+ T G+ Y HD+ V++RDLK N+L++R
Sbjct: 84 -QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGEL 139
Query: 128 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 187
K++DFGLA+ + + ++ + + + + D++S G + E+++G
Sbjct: 140 KIADFGLARAFGIPVRKYT-HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
Query: 188 KAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFY-----------QAL 236
A + + + ++ P+ + +
Sbjct: 199 PLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGI 258
Query: 237 AVAAMCVHEQPDMRPVIADV 256
+ + + P+ R
Sbjct: 259 DLLSKMLKLDPNQRITAKQA 278
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 116 bits (291), Expect = 1e-30
Identities = 56/246 (22%), Positives = 85/246 (34%), Gaps = 35/246 (14%)
Query: 10 QDVAIKQLDRNGVQGNRE---FLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLG 66
A+K LD+ V ++ L E +L ++ P LV L D +V EY+ G
Sbjct: 67 NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG 126
Query: 67 SVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYH 126
+ HL AA EYLH +IYRDLK N+L+D+ +
Sbjct: 127 EMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGY 179
Query: 127 PKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG 186
+++DFG AK T + GT APE + D ++ GV++ E+ +G
Sbjct: 180 IQVTDFGFAKRVKGRTWT-----LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
Query: 187 RKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQAL-AVAAMCVHE 245
P F + P F L + +
Sbjct: 235 -------------------YPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQV 275
Query: 246 QPDMRP 251
R
Sbjct: 276 DLTKRF 281
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (287), Expect = 1e-30
Identities = 46/261 (17%), Positives = 88/261 (33%), Gaps = 22/261 (8%)
Query: 10 QDVAIKQL--DRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGS 67
+ VA+K++ D + L E+ +L L H N+V L + LV+E+
Sbjct: 28 EIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD--- 84
Query: 68 VEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP 127
+D LD +GL + H + V++RDLK N+L++R
Sbjct: 85 -QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGEL 140
Query: 128 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 187
KL++FGLA+ + S V+ + + D++S G + E+ +
Sbjct: 141 KLANFGLARAFGI-PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAG 199
Query: 188 KAVDTSKAAAEQ------------SLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQA 235
+ + +Q + D + + P+
Sbjct: 200 RPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATG 259
Query: 236 LAVAAMCVHEQPDMRPVIADV 256
+ + P R +
Sbjct: 260 RDLLQNLLKCNPVQRISAEEA 280
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 2e-30
Identities = 45/191 (23%), Positives = 81/191 (42%), Gaps = 20/191 (10%)
Query: 10 QDVAIKQLDRNGVQGN--REFLVEVLMLSLLHHPNLVNLIGYCADGDQR--------LLV 59
Q VA+K++ + L E+ +L LL H N+VNLI C LV
Sbjct: 36 QKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLV 95
Query: 60 YEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNI 119
+++ + L + ++ GL Y+H + +++RD+K +N+
Sbjct: 96 FDFCEHDLAGLLSNVL----VKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANV 148
Query: 120 LLDRGYHPKLSDFGLAKLGPVGDNTHVS--TRVMGTYGYCAPEYAKTGQL-TLKSDVYSF 176
L+ R KL+DFGLA+ + N+ + T + T Y PE + D++
Sbjct: 149 LITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGA 208
Query: 177 GVVLLEILSGR 187
G ++ E+ +
Sbjct: 209 GCIMAEMWTRS 219
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (285), Expect = 6e-30
Identities = 35/180 (19%), Positives = 74/180 (41%), Gaps = 9/180 (5%)
Query: 10 QDVAIKQLDRNGVQGN--REFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGS 67
VAIK+L R + E+ +L + H N++ L+ + ++ +
Sbjct: 44 AKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMP 103
Query: 68 VEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP 127
+ L + + +GL Y+H +I+RDLK N+ ++
Sbjct: 104 FMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCEL 160
Query: 128 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 187
K+ DFGLA+ ++ ++ V+ + + T D++S G ++ E+++G+
Sbjct: 161 KILDFGLARQA----DSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 216
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 104 bits (259), Expect = 2e-26
Identities = 34/182 (18%), Positives = 68/182 (37%), Gaps = 19/182 (10%)
Query: 10 QDVAIKQLDRNGVQGNREFLVEV-LMLSLLHHPNLVNLIGYCADGDQRL--LVYEYMPLG 66
+ V +K L + + E+ ++ +L PN++ L D R LV+E++
Sbjct: 61 EKVVVKILKPVKKK---KIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNT 117
Query: 67 SVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR-GY 125
+ + L + L+Y H +++RD+K N+++D
Sbjct: 118 DFKQLY-------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHR 167
Query: 126 HPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS 185
+L D+GLA+ + RV Y D++S G +L ++
Sbjct: 168 KLRLIDWGLAEF--YHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIF 225
Query: 186 GR 187
+
Sbjct: 226 RK 227
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (258), Expect = 3e-26
Identities = 51/185 (27%), Positives = 79/185 (42%), Gaps = 15/185 (8%)
Query: 10 QDVAIKQLDRNGV----QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMP 64
+ A+K L + + + E +L + P LV L + L+ +Y+
Sbjct: 53 KLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYIN 112
Query: 65 LGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG 124
G + HL ++ + LE+LH +IYRD+K NILLD
Sbjct: 113 GGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSN 165
Query: 125 YHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQ--LTLKSDVYSFGVVLLE 182
H L+DFGL+K V D T + GT Y AP+ + G D +S GV++ E
Sbjct: 166 GHVVLTDFGLSKE-FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYE 224
Query: 183 ILSGR 187
+L+G
Sbjct: 225 LLTGA 229
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99 bits (248), Expect = 1e-24
Identities = 37/180 (20%), Positives = 73/180 (40%), Gaps = 9/180 (5%)
Query: 10 QDVAIKQLDRN--GVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGS 67
VA+K+L R + + E+ +L + H N++ L+ + +
Sbjct: 44 LRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTH 103
Query: 68 VEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHP 127
+ + + L + + RGL+Y+H +I+RDLK SN+ ++
Sbjct: 104 LMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCEL 160
Query: 128 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR 187
K+ DFGLA+ + ++ V + D++S G ++ E+L+GR
Sbjct: 161 KILDFGLARH----TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.6 bits (234), Expect = 8e-23
Identities = 43/186 (23%), Positives = 80/186 (43%), Gaps = 21/186 (11%)
Query: 10 QDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCA------DGDQRLLVYE 61
++VAIK+L R + E++++ ++H N+++L+ + LV E
Sbjct: 43 RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME 102
Query: 62 YMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILL 121
M + + LD + G+++LH +I+RDLK SNI++
Sbjct: 103 LMDANLCQVI-------QMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVV 152
Query: 122 DRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLL 181
K+ DFGLA+ + + T + T Y APE D++S G ++
Sbjct: 153 KSDCTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 209
Query: 182 EILSGR 187
E++ +
Sbjct: 210 EMVRHK 215
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 93.2 bits (230), Expect = 3e-22
Identities = 32/191 (16%), Positives = 68/191 (35%), Gaps = 16/191 (8%)
Query: 10 QDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY------- 62
VA+K + + V E+ +L ++ + A+ +LL +
Sbjct: 39 THVAMKIVRGDKVYTEA-AEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGV 97
Query: 63 -----MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCS 117
+ + + +I+ GL+Y+H + +I+ D+K
Sbjct: 98 HVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPE 155
Query: 118 NILLDR-GYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSF 176
N+L++ L +A LG T + T Y +PE +D++S
Sbjct: 156 NVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWST 215
Query: 177 GVVLLEILSGR 187
++ E+++G
Sbjct: 216 ACLIFELITGD 226
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 57.5 bits (138), Expect = 1e-10
Identities = 14/141 (9%), Positives = 36/141 (25%), Gaps = 29/141 (20%)
Query: 10 QDVAIKQLDRNGV----------QGNREFLVEVLMLSLLHHPNLVNLIGYCA----DGDQ 55
+ +K G+ F V + + L L G +
Sbjct: 25 GECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWEG 84
Query: 56 RLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLK 115
++ E + + ++ + + + +++ DL
Sbjct: 85 NAVLMELIDAKELYRV-----------RVENPDEVLDMILEEVAKFYHR---GIVHGDLS 130
Query: 116 CSNILLDRGYHPKLSDFGLAK 136
N+L+ + DF +
Sbjct: 131 QYNVLVS-EEGIWIIDFPQSV 150
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 311 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.79 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.51 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.22 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.66 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.47 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.59 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 92.37 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-52 Score=349.50 Aligned_cols=236 Identities=24% Similarity=0.310 Sum_probs=187.7
Q ss_pred cchhc-cCCcEEEEEEeecCCC-cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCC
Q 021490 2 MQVIL-CLLQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGK 79 (311)
Q Consensus 2 ~~~~~-~~g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~ 79 (311)
|.+.. .+|+.||||+++.... ...+.+.+|+.+|+.++||||+++++++.++...|+|||||+||+|.+++.. .
T Consensus 22 ~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~l~~----~ 97 (271)
T d1nvra_ 22 QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP----D 97 (271)
T ss_dssp EEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBT----T
T ss_pred EEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCCCcHHHHHhc----C
Confidence 34443 4699999999976543 3446899999999999999999999999999999999999999999999976 5
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCc
Q 021490 80 KPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 159 (311)
Q Consensus 80 ~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aP 159 (311)
..+++..+..++.|++.||+|||++| |+||||||+|||+++++.+||+|||++................||+.|+||
T Consensus 98 ~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~AP 174 (271)
T d1nvra_ 98 IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 174 (271)
T ss_dssp TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCT
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCccccccceeeCcCccCH
Confidence 68999999999999999999999999 999999999999999999999999999764333333333446799999999
Q ss_pred cccccCCC-ccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHH
Q 021490 160 EYAKTGQL-TLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAV 238 (311)
Q Consensus 160 E~~~~~~~-~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 238 (311)
|++.+..+ +.++|||||||++|+|++|..||............... ... ........+.++.+|
T Consensus 175 E~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~------~~~---------~~~~~~~~s~~~~~l 239 (271)
T d1nvra_ 175 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE------KKT---------YLNPWKKIDSAPLAL 239 (271)
T ss_dssp HHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHT------TCT---------TSTTGGGSCHHHHHH
T ss_pred hHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhc------CCC---------CCCccccCCHHHHHH
Confidence 99988776 67899999999999999999999765432221111000 000 001112334578899
Q ss_pred HHHccccCCCCCCCHHHHHHH
Q 021490 239 AAMCVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 239 i~~~l~~~p~~Rps~~~vl~~ 259 (311)
+.+||+.||++|||++|+++.
T Consensus 240 i~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 240 LHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp HHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHcCCChhHCcCHHHHhcC
Confidence 999999999999999999875
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-51 Score=349.41 Aligned_cols=233 Identities=24% Similarity=0.338 Sum_probs=193.6
Q ss_pred cchhc-cCCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCC
Q 021490 2 MQVIL-CLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKK 80 (311)
Q Consensus 2 ~~~~~-~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 80 (311)
|.+.. .+|+.||||+++.......+.+.+|+.+++.++||||+++++++.++...|+|||||+||+|.+++.. +
T Consensus 37 y~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~~~~-----~ 111 (293)
T d1yhwa1 37 YTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-----T 111 (293)
T ss_dssp EEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH-----S
T ss_pred EEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcHHHHhhc-----c
Confidence 34433 46999999999877666778899999999999999999999999999999999999999999998875 4
Q ss_pred CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcc
Q 021490 81 PLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 160 (311)
Q Consensus 81 ~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE 160 (311)
.+++..+..++.||+.||+|||++| |+||||||+|||++.+|.+||+|||++...... ........||+.|+|||
T Consensus 112 ~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~--~~~~~~~~gt~~Y~aPE 186 (293)
T d1yhwa1 112 CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGTPYWMAPE 186 (293)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCST--TCCBCCCCSCGGGCCHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccc--cccccccccCCCccChh
Confidence 6999999999999999999999999 999999999999999999999999999764322 22234456999999999
Q ss_pred ccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHH
Q 021490 161 YAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAA 240 (311)
Q Consensus 161 ~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 240 (311)
++.+..++.++|||||||++|+|++|..||............... .. + ....+...+..+.+||.
T Consensus 187 ~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~------~~-------~--~~~~~~~~s~~~~~li~ 251 (293)
T d1yhwa1 187 VVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN------GT-------P--ELQNPEKLSAIFRDFLN 251 (293)
T ss_dssp HHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHH------CS-------C--CCSSGGGSCHHHHHHHH
T ss_pred hhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhC------CC-------C--CCCCcccCCHHHHHHHH
Confidence 999999999999999999999999999999776544332211100 00 0 01122334568899999
Q ss_pred HccccCCCCCCCHHHHHHH
Q 021490 241 MCVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 241 ~~l~~~p~~Rps~~~vl~~ 259 (311)
+||+.||.+|||+.|+++.
T Consensus 252 ~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 252 RCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp HHTCSSTTTSCCHHHHTTC
T ss_pred HHccCChhHCcCHHHHhcC
Confidence 9999999999999999875
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-51 Score=346.92 Aligned_cols=240 Identities=25% Similarity=0.381 Sum_probs=187.5
Q ss_pred CcchhccCCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCC
Q 021490 1 MMQVILCLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKK 80 (311)
Q Consensus 1 ~~~~~~~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 80 (311)
||.+.+.+++.||||+++. .....++|.+|+++++.++||||+++++++.++...++||||+++|+|.+++... ..
T Consensus 21 Vy~~~~~~~~~vAvK~i~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~~l~~~---~~ 96 (263)
T d1sm2a_ 21 VHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQ---RG 96 (263)
T ss_dssp EEEEEETTTEEEEEEECCS-SSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTT---TT
T ss_pred EEEEEECCCCEEEEEEECC-CcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcHHHHhhcc---cc
Confidence 4566777899999999964 4455678999999999999999999999999999999999999999999998752 46
Q ss_pred CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcc
Q 021490 81 PLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 160 (311)
Q Consensus 81 ~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE 160 (311)
.+++..++.++.|++.||+|||+++ ++||||||+|||+++++.+||+|||++........ .......+|..|+|||
T Consensus 97 ~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE 172 (263)
T d1sm2a_ 97 LFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPE 172 (263)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC-------------------CTTSCCHH
T ss_pred CCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCc-eeecceecCcccCChH
Confidence 7899999999999999999999999 99999999999999999999999999875432221 2223356889999999
Q ss_pred ccccCCCccccceeehhHHHHHHHhC-CCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHH
Q 021490 161 YAKTGQLTLKSDVYSFGVVLLEILSG-RKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVA 239 (311)
Q Consensus 161 ~~~~~~~~~~~DiwslG~l~~~ll~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 239 (311)
++.+..++.++|||||||++|||+|+ .+||...........+... . . ...|...+.++.+|+
T Consensus 173 ~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~-------~------~----~~~p~~~~~~l~~li 235 (263)
T d1sm2a_ 173 VFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG-------F------R----LYKPRLASTHVYQIM 235 (263)
T ss_dssp HHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHT-------C------C----CCCCTTSCHHHHHHH
T ss_pred HhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhc-------C------C----CCCccccCHHHHHHH
Confidence 99999999999999999999999995 5666554433322222111 0 0 011223345788999
Q ss_pred HHccccCCCCCCCHHHHHHHHHHhhh
Q 021490 240 AMCVHEQPDMRPVIADVVTALAYLAS 265 (311)
Q Consensus 240 ~~~l~~~p~~Rps~~~vl~~l~~~~~ 265 (311)
.+||+.||++|||++++++.|+.+.+
T Consensus 236 ~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 236 NHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 99999999999999999999998753
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-51 Score=343.84 Aligned_cols=230 Identities=27% Similarity=0.368 Sum_probs=192.0
Q ss_pred cchhc-cCCcEEEEEEeecCC---CcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCC
Q 021490 2 MQVIL-CLLQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP 77 (311)
Q Consensus 2 ~~~~~-~~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 77 (311)
|.+.. .+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.++...|+|||||+||+|.+++..
T Consensus 23 y~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy~~~g~L~~~l~~--- 99 (263)
T d2j4za1 23 YLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK--- 99 (263)
T ss_dssp EEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH---
T ss_pred EEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHhh---
Confidence 34443 368999999987542 23456889999999999999999999999999999999999999999999987
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeecccccccc
Q 021490 78 GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 157 (311)
Q Consensus 78 ~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~ 157 (311)
...+++..+..++.|++.||+|||++| |+||||||+|||++.++.+||+|||++...... ......||+.|+
T Consensus 100 -~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~----~~~~~~Gt~~Y~ 171 (263)
T d2j4za1 100 -LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLDYL 171 (263)
T ss_dssp -HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC----CCEETTEEGGGC
T ss_pred -cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC----cccccCCCCccc
Confidence 567999999999999999999999999 999999999999999999999999999753322 223456999999
Q ss_pred CccccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHH
Q 021490 158 APEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALA 237 (311)
Q Consensus 158 aPE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 237 (311)
|||++.+..++.++|||||||++|+|++|..||...........+... .+ .++...+.++.+
T Consensus 172 APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~--------------~~----~~p~~~s~~~~~ 233 (263)
T d2j4za1 172 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--------------EF----TFPDFVTEGARD 233 (263)
T ss_dssp CHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT--------------CC----CCCTTSCHHHHH
T ss_pred CHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcC--------------CC----CCCccCCHHHHH
Confidence 999999999999999999999999999999999876544332222110 01 122334558889
Q ss_pred HHHHccccCCCCCCCHHHHHHHH
Q 021490 238 VAAMCVHEQPDMRPVIADVVTAL 260 (311)
Q Consensus 238 li~~~l~~~p~~Rps~~~vl~~l 260 (311)
|+.+||+.||++|||+.|+++.-
T Consensus 234 li~~~L~~dp~~R~t~~eil~hp 256 (263)
T d2j4za1 234 LISRLLKHNPSQRPMLREVLEHP 256 (263)
T ss_dssp HHHHHTCSSGGGSCCHHHHHTCH
T ss_pred HHHHHccCCHhHCcCHHHHHcCc
Confidence 99999999999999999999764
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-51 Score=345.21 Aligned_cols=238 Identities=28% Similarity=0.445 Sum_probs=184.7
Q ss_pred CcEEEEEEeecCC--CcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHH
Q 021490 9 LQDVAIKQLDRNG--VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNT 86 (311)
Q Consensus 9 g~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~ 86 (311)
+..||||+++... ....+.|.+|+.+|.+++||||+++++++.+ ...++|||||+||+|.+++... ...+++..
T Consensus 30 ~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~~~g~L~~~l~~~---~~~~~~~~ 105 (276)
T d1uwha_ 30 HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHII---ETKFEMIK 105 (276)
T ss_dssp SSEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCCEEEHHHHHHTS---CCCCCHHH
T ss_pred CCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecCCCCCHHHHHhhc---cCCCCHHH
Confidence 4569999986553 3345789999999999999999999998754 5689999999999999999752 45699999
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccccc--
Q 021490 87 RMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKT-- 164 (311)
Q Consensus 87 ~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-- 164 (311)
+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++................||+.|+|||++.+
T Consensus 106 ~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~ 182 (276)
T d1uwha_ 106 LIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182 (276)
T ss_dssp HHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCS
T ss_pred HHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhccc
Confidence 9999999999999999999 99999999999999999999999999976443333333344578999999999864
Q ss_pred -CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHcc
Q 021490 165 -GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCV 243 (311)
Q Consensus 165 -~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 243 (311)
..++.++|||||||++|||+||..||............... ... .|.+ ...+...+..+.+|+.+||
T Consensus 183 ~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~------~~~-----~p~~-~~~~~~~~~~l~~li~~cl 250 (276)
T d1uwha_ 183 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGR------GYL-----SPDL-SKVRSNCPKAMKRLMAECL 250 (276)
T ss_dssp SCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHH------TSC-----CCCG-GGSCTTCCHHHHHHHHHHT
T ss_pred CCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhc------CCC-----CCcc-hhccccchHHHHHHHHHHc
Confidence 35789999999999999999999999865543322111100 000 0100 1122233458889999999
Q ss_pred ccCCCCCCCHHHHHHHHHHhhh
Q 021490 244 HEQPDMRPVIADVVTALAYLAS 265 (311)
Q Consensus 244 ~~~p~~Rps~~~vl~~l~~~~~ 265 (311)
+.||++|||+.++++.|+.+.+
T Consensus 251 ~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 251 KKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp CSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCHhHCcCHHHHHHHHHHHHH
Confidence 9999999999999999998875
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-51 Score=348.28 Aligned_cols=233 Identities=21% Similarity=0.266 Sum_probs=189.4
Q ss_pred cchhc-cCCcEEEEEEeecCC---CcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCC
Q 021490 2 MQVIL-CLLQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP 77 (311)
Q Consensus 2 ~~~~~-~~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 77 (311)
|.+.. .+|+.||||+++... ....+.+.+|+++|++++||||+++++++.++...|+|||||+||+|.+++..
T Consensus 25 y~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~~~~--- 101 (288)
T d1uu3a_ 25 VLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK--- 101 (288)
T ss_dssp EEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH---
T ss_pred EEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEccCCCCHHHhhhc---
Confidence 44443 468999999997542 23456899999999999999999999999999999999999999999999887
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeecccccccc
Q 021490 78 GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 157 (311)
Q Consensus 78 ~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~ 157 (311)
.+.+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||++................||+.|+
T Consensus 102 -~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~ 177 (288)
T d1uu3a_ 102 -IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 177 (288)
T ss_dssp -HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC----------CCCCGGGC
T ss_pred -cCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccCCcccccccccCCcccc
Confidence 578999999999999999999999999 9999999999999999999999999997654333333334457999999
Q ss_pred CccccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHH
Q 021490 158 APEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALA 237 (311)
Q Consensus 158 aPE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 237 (311)
|||++.+..++.++|||||||++|+|++|..||...+.......+. .. .. .++...+.++.+
T Consensus 178 APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~------~~--------~~----~~p~~~s~~~~~ 239 (288)
T d1uu3a_ 178 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII------KL--------EY----DFPEKFFPKARD 239 (288)
T ss_dssp CHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------TT--------CC----CCCTTCCHHHHH
T ss_pred CceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHH------cC--------CC----CCCccCCHHHHH
Confidence 9999999999999999999999999999999998765433322111 11 01 122334457899
Q ss_pred HHHHccccCCCCCCCHHHHHHH
Q 021490 238 VAAMCVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 238 li~~~l~~~p~~Rps~~~vl~~ 259 (311)
||.+||+.||.+|||++|++..
T Consensus 240 li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 240 LVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp HHHTTSCSSGGGSTTSGGGTCH
T ss_pred HHHHHccCCHhHCcCHHHHcCC
Confidence 9999999999999999997654
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.1e-50 Score=344.56 Aligned_cols=241 Identities=24% Similarity=0.367 Sum_probs=194.4
Q ss_pred cchhcc-CCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCC
Q 021490 2 MQVILC-LLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKK 80 (311)
Q Consensus 2 ~~~~~~-~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 80 (311)
|.+... +|+.||||+++.. ....++|.+|+.+|+.++||||+++++++.++...++|||||++|+|.+++.... ..
T Consensus 34 y~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~~~--~~ 110 (287)
T d1opja_ 34 YEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN--RQ 110 (287)
T ss_dssp EEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSC--TT
T ss_pred EEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCcchHHHhhhcc--cc
Confidence 444443 5889999999644 4566789999999999999999999999999999999999999999999987632 46
Q ss_pred CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcc
Q 021490 81 PLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 160 (311)
Q Consensus 81 ~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE 160 (311)
.+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||++...... .........++..|+|||
T Consensus 111 ~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~-~~~~~~~~~g~~~y~aPE 186 (287)
T d1opja_ 111 EVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPE 186 (287)
T ss_dssp TSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS-SSEEETTEEECGGGCCHH
T ss_pred chHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCC-CceeeccccccccccChH
Confidence 7999999999999999999999999 999999999999999999999999999764332 222333345788999999
Q ss_pred ccccCCCccccceeehhHHHHHHHhCCCcc-CcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHH
Q 021490 161 YAKTGQLTLKSDVYSFGVVLLEILSGRKAV-DTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVA 239 (311)
Q Consensus 161 ~~~~~~~~~~~DiwslG~l~~~ll~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 239 (311)
++.+..++.++|||||||++|||++|..|| ...+.......+. .. .....+...+..+.+|+
T Consensus 187 ~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~-------~~----------~~~~~~~~~~~~l~~li 249 (287)
T d1opja_ 187 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-------KD----------YRMERPEGCPEKVYELM 249 (287)
T ss_dssp HHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-------TT----------CCCCCCTTCCHHHHHHH
T ss_pred HHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHh-------cC----------CCCCCCccchHHHHHHH
Confidence 999999999999999999999999976665 4433322222111 00 01122333445889999
Q ss_pred HHccccCCCCCCCHHHHHHHHHHhhhc
Q 021490 240 AMCVHEQPDMRPVIADVVTALAYLASQ 266 (311)
Q Consensus 240 ~~~l~~~p~~Rps~~~vl~~l~~~~~~ 266 (311)
.+||+.||++|||+.++++.|+.+.+.
T Consensus 250 ~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 250 RACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred HHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 999999999999999999999876543
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-50 Score=345.57 Aligned_cols=235 Identities=23% Similarity=0.311 Sum_probs=190.9
Q ss_pred cchhc-cCCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCC
Q 021490 2 MQVIL-CLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKK 80 (311)
Q Consensus 2 ~~~~~-~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 80 (311)
|.+.. .+|+.||||+++.......+.|.+|+++|++++||||+++++++.++...++|||||+||+|.+++.+. ..
T Consensus 29 y~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~~~~~~~---~~ 105 (288)
T d2jfla1 29 YKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLEL---ER 105 (288)
T ss_dssp EEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHH---TS
T ss_pred EEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcHHHHHHhc---CC
Confidence 34443 368999999998777777789999999999999999999999999999999999999999999987652 46
Q ss_pred CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcc
Q 021490 81 PLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 160 (311)
Q Consensus 81 ~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE 160 (311)
.+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++..... .........||+.|+|||
T Consensus 106 ~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~--~~~~~~~~~Gt~~y~APE 180 (288)
T d2jfla1 106 PLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTR--TIQRRDSFIGTPYWMAPE 180 (288)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHH--HHHHHTCCCSCCTTCCHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCC--CcccccccccccccCCHH
Confidence 7999999999999999999999999 99999999999999999999999999864211 111122356899999999
Q ss_pred ccc-----cCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHH
Q 021490 161 YAK-----TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQA 235 (311)
Q Consensus 161 ~~~-----~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 235 (311)
++. ...++.++|||||||++|+|++|..||...........+... . . + ....+...+.++
T Consensus 181 ~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~------~--~-----~--~~~~~~~~s~~~ 245 (288)
T d2jfla1 181 VVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKS------E--P-----P--TLAQPSRWSSNF 245 (288)
T ss_dssp HHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHS------C--C-----C--CCSSGGGSCHHH
T ss_pred HHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC------C--C-----C--CCCccccCCHHH
Confidence 984 456789999999999999999999999876543332211100 0 0 0 011123445688
Q ss_pred HHHHHHccccCCCCCCCHHHHHHH
Q 021490 236 LAVAAMCVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 236 ~~li~~~l~~~p~~Rps~~~vl~~ 259 (311)
.+||.+||+.||++|||+.|+++.
T Consensus 246 ~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 246 KDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HHHHHHHccCChhHCcCHHHHhcC
Confidence 999999999999999999999875
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-50 Score=340.74 Aligned_cols=231 Identities=26% Similarity=0.389 Sum_probs=185.9
Q ss_pred CCcEEEEEEeecCCC--cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHH
Q 021490 8 LLQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN 85 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~ 85 (311)
.++.||||+++.... ...+.|.+|+.+|++++||||+++++++.+ +..++|||||++|+|.+++.. ...+++.
T Consensus 33 ~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~g~L~~~l~~----~~~l~~~ 107 (277)
T d1xbba_ 33 VVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQ----NRHVKDK 107 (277)
T ss_dssp SEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHHH----CTTCCHH
T ss_pred cCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCCCcHHHHHhh----ccCCCHH
Confidence 357899999965432 234689999999999999999999999865 457899999999999999987 6779999
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCce-eeeeccccccccCcccccc
Q 021490 86 TRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH-VSTRVMGTYGYCAPEYAKT 164 (311)
Q Consensus 86 ~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~ 164 (311)
.++.++.||+.||+|||+++ ++||||||+|||++.++.+||+|||++.......... ......+|+.|+|||++.+
T Consensus 108 ~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~ 184 (277)
T d1xbba_ 108 NIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184 (277)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHH
T ss_pred HHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccccccccCCCceecCchhhcC
Confidence 99999999999999999999 9999999999999999999999999997643332222 2233568899999999999
Q ss_pred CCCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHcc
Q 021490 165 GQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCV 243 (311)
Q Consensus 165 ~~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 243 (311)
..++.++|||||||++|||++ |..||...........+... . ....+...+.++.+|+.+||
T Consensus 185 ~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~-------~----------~~~~p~~~~~~~~~li~~cl 247 (277)
T d1xbba_ 185 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG-------E----------RMGCPAGCPREMYDLMNLCW 247 (277)
T ss_dssp CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-------C----------CCCCCTTCCHHHHHHHHHHT
T ss_pred CCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcC-------C----------CCCCCcccCHHHHHHHHHHc
Confidence 999999999999999999998 89999876544332222110 0 01122334458889999999
Q ss_pred ccCCCCCCCHHHHHHHHHHh
Q 021490 244 HEQPDMRPVIADVVTALAYL 263 (311)
Q Consensus 244 ~~~p~~Rps~~~vl~~l~~~ 263 (311)
+.||++|||+++|++.|+..
T Consensus 248 ~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 248 TYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp CSSTTTSCCHHHHHHHHHHH
T ss_pred CCCHhHCcCHHHHHHHhhCH
Confidence 99999999999999888754
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.1e-50 Score=345.65 Aligned_cols=228 Identities=23% Similarity=0.299 Sum_probs=174.3
Q ss_pred CCcEEEEEEeecCCC-cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHH
Q 021490 8 LLQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNT 86 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~ 86 (311)
+|+.||||++..... .....+.+|+.+|+.++||||+++++++.++...|+|||||+||+|.+++.. .+.+++..
T Consensus 33 ~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~L~~~l~~----~~~l~e~~ 108 (307)
T d1a06a_ 33 TQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVE----KGFYTERD 108 (307)
T ss_dssp TCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHT----CSCCCHHH
T ss_pred CCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHhhhc----ccCCCHHH
Confidence 689999999976543 3345788999999999999999999999999999999999999999999986 67899999
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEc---CCCceEEccccccccCCCCCCceeeeeccccccccCccccc
Q 021490 87 RMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD---RGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 163 (311)
Q Consensus 87 ~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~---~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 163 (311)
+..++.|++.||+|||+++ ++||||||+||++. +++.+||+|||++..... ........||+.|+|||++.
T Consensus 109 ~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~---~~~~~~~~GT~~y~APE~~~ 182 (307)
T d1a06a_ 109 ASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP---GSVLSTACGTPGYVAPEVLA 182 (307)
T ss_dssp HHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC---------------------CTTSCHHHHT
T ss_pred HHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEccC---CCeeeeeeeCccccCcHHHc
Confidence 9999999999999999999 99999999999995 578999999999975322 22233456999999999999
Q ss_pred cCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHcc
Q 021490 164 TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCV 243 (311)
Q Consensus 164 ~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 243 (311)
+..++.++|||||||++|+|++|..||...........+. .. ...+.....+..+.++.+|+.+||
T Consensus 183 ~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~------~~--------~~~~~~~~~~~~s~~~~~li~~~L 248 (307)
T d1a06a_ 183 QKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQIL------KA--------EYEFDSPYWDDISDSAKDFIRHLM 248 (307)
T ss_dssp TCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH------TT--------CCCCCTTTTTTSCHHHHHHHHHHS
T ss_pred CCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHh------cc--------CCCCCCccccCCCHHHHHHHHHHc
Confidence 9999999999999999999999999998765443322211 11 011111222334558899999999
Q ss_pred ccCCCCCCCHHHHHHH
Q 021490 244 HEQPDMRPVIADVVTA 259 (311)
Q Consensus 244 ~~~p~~Rps~~~vl~~ 259 (311)
+.||++|||+.|+++.
T Consensus 249 ~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 249 EKDPEKRFTCEQALQH 264 (307)
T ss_dssp CSSGGGSCCHHHHHHS
T ss_pred cCCHhHCcCHHHHhcC
Confidence 9999999999999886
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.8e-50 Score=344.28 Aligned_cols=232 Identities=24% Similarity=0.352 Sum_probs=181.3
Q ss_pred EEEEEEeecCCC-cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHHHHH
Q 021490 11 DVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMK 89 (311)
Q Consensus 11 ~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~ 89 (311)
.||||++..... ...+.|.+|+.+|++++||||+++++++.++...++|||||++|+|.+++... .+.+++..+..
T Consensus 56 ~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~---~~~l~~~~~~~ 132 (299)
T d1jpaa_ 56 FVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQN---DGQFTVIQLVG 132 (299)
T ss_dssp EEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTT---TTCSCHHHHHH
T ss_pred EEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccc---cCCCCHHHHHH
Confidence 589998865443 34468999999999999999999999999999999999999999999988762 45799999999
Q ss_pred HHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCce---eeeeccccccccCccccccCC
Q 021490 90 IAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH---VSTRVMGTYGYCAPEYAKTGQ 166 (311)
Q Consensus 90 ~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~ 166 (311)
++.||+.||+|||+++ ++||||||+|||++.++.+||+|||++.......... ......+++.|+|||++.+..
T Consensus 133 i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~ 209 (299)
T d1jpaa_ 133 MLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRK 209 (299)
T ss_dssp HHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-----------------------CGGGSCHHHHHSCC
T ss_pred HHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCC
Confidence 9999999999999999 9999999999999999999999999997643322211 112245788999999999999
Q ss_pred CccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHcccc
Q 021490 167 LTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHE 245 (311)
Q Consensus 167 ~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 245 (311)
++.++|||||||++|||+| |..||...........+... . ....+...+..+.+|+.+||+.
T Consensus 210 ~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~-------~----------~~~~~~~~~~~l~~li~~cl~~ 272 (299)
T d1jpaa_ 210 FTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQD-------Y----------RLPPPMDCPSALHQLMLDCWQK 272 (299)
T ss_dssp CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-------C----------CCCCCTTCCHHHHHHHHHHTCS
T ss_pred CCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-------C----------CCCCCccchHHHHHHHHHHcCC
Confidence 9999999999999999998 89999876554332222110 0 0112233455788999999999
Q ss_pred CCCCCCCHHHHHHHHHHhhh
Q 021490 246 QPDMRPVIADVVTALAYLAS 265 (311)
Q Consensus 246 ~p~~Rps~~~vl~~l~~~~~ 265 (311)
||++|||+.++++.|+.+.+
T Consensus 273 ~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 273 DRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp STTTSCCHHHHHHHHHHHHH
T ss_pred CHhHCcCHHHHHHHHHHHhc
Confidence 99999999999999988765
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-50 Score=341.75 Aligned_cols=233 Identities=26% Similarity=0.358 Sum_probs=189.4
Q ss_pred CCcEEEEEEeecCCC-cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHH
Q 021490 8 LLQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNT 86 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~ 86 (311)
++..||||+++.... ...+.|.+|+++|.+++||||+++++++.+ +..|+|||||++|+|.+++... ...+++..
T Consensus 35 ~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~L~~~l~~~---~~~l~~~~ 110 (285)
T d1u59a_ 35 KQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGK---REEIPVSN 110 (285)
T ss_dssp CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHTTC---TTTSCHHH
T ss_pred CcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCcHHHHhhcc---ccCCCHHH
Confidence 456899999975543 345789999999999999999999999865 4689999999999999987652 46799999
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCce-eeeeccccccccCccccccC
Q 021490 87 RMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH-VSTRVMGTYGYCAPEYAKTG 165 (311)
Q Consensus 87 ~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~ 165 (311)
+..++.|++.||+|||+++ ++||||||+||+++.++.+||+|||++.......... ......+|+.|+|||++.+.
T Consensus 111 ~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 187 (285)
T d1u59a_ 111 VAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 187 (285)
T ss_dssp HHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHC
T ss_pred HHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccccccccccccccccCccccChHHHhCC
Confidence 9999999999999999999 9999999999999999999999999997654332221 12234578999999999999
Q ss_pred CCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccc
Q 021490 166 QLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVH 244 (311)
Q Consensus 166 ~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 244 (311)
.++.++|||||||++|||+| |..||......+....+... . ....++..+.++.+|+.+||+
T Consensus 188 ~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~-------~----------~~~~p~~~~~~l~~li~~cl~ 250 (285)
T d1u59a_ 188 KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG-------K----------RMECPPECPPELYALMSDCWI 250 (285)
T ss_dssp EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTT-------C----------CCCCCTTCCHHHHHHHHHTTC
T ss_pred CCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-------C----------CCCCCCcCCHHHHHHHHHHcC
Confidence 99999999999999999998 89999876544332222110 0 012233444588999999999
Q ss_pred cCCCCCCCHHHHHHHHHHhh
Q 021490 245 EQPDMRPVIADVVTALAYLA 264 (311)
Q Consensus 245 ~~p~~Rps~~~vl~~l~~~~ 264 (311)
.||++|||+.++++.|+.+.
T Consensus 251 ~~p~~RPs~~~i~~~L~~~~ 270 (285)
T d1u59a_ 251 YKWEDRPDFLTVEQRMRACY 270 (285)
T ss_dssp SSGGGSCCHHHHHHHHHHHH
T ss_pred CCHhHCcCHHHHHHHHHHHH
Confidence 99999999999999987554
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-50 Score=339.84 Aligned_cols=239 Identities=26% Similarity=0.359 Sum_probs=190.6
Q ss_pred CcchhccCCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCC
Q 021490 1 MMQVILCLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKK 80 (311)
Q Consensus 1 ~~~~~~~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 80 (311)
||.+.+.+++.||||+++.. ....+.|.+|+.++.+++||||+++++++.+ ...++||||+++|+|.+++.... ..
T Consensus 29 Vy~~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~L~~~~~~~~--~~ 104 (272)
T d1qpca_ 29 VWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPS--GI 104 (272)
T ss_dssp EEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTSHH--HH
T ss_pred EEEEEECCCCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCCCcHHHHHhhcC--CC
Confidence 46677778899999999644 3556789999999999999999999998754 56799999999999999876521 34
Q ss_pred CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcc
Q 021490 81 PLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 160 (311)
Q Consensus 81 ~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE 160 (311)
.+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||++...... .........++..|+|||
T Consensus 105 ~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~-~~~~~~~~~gt~~y~APE 180 (272)
T d1qpca_ 105 KLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDN-EYTAREGAKFPIKWTAPE 180 (272)
T ss_dssp TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSS-CEECCTTCCCCTTTSCHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCC-ccccccccCCcccccChH
Confidence 6999999999999999999999999 999999999999999999999999999764322 122233456888999999
Q ss_pred ccccCCCccccceeehhHHHHHHHhCCC-ccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHH
Q 021490 161 YAKTGQLTLKSDVYSFGVVLLEILSGRK-AVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVA 239 (311)
Q Consensus 161 ~~~~~~~~~~~DiwslG~l~~~ll~g~~-pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 239 (311)
++.+..++.++|||||||++|||+||.. ||...........+.. .. .+ ..+...+.++.+|+
T Consensus 181 ~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~-------~~------~~----~~p~~~~~~l~~li 243 (272)
T d1qpca_ 181 AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER-------GY------RM----VRPDNCPEELYQLM 243 (272)
T ss_dssp HHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT-------TC------CC----CCCTTCCHHHHHHH
T ss_pred HHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHh-------cC------CC----CCcccChHHHHHHH
Confidence 9998999999999999999999999654 4554433322221110 00 01 11223445789999
Q ss_pred HHccccCCCCCCCHHHHHHHHHHhh
Q 021490 240 AMCVHEQPDMRPVIADVVTALAYLA 264 (311)
Q Consensus 240 ~~~l~~~p~~Rps~~~vl~~l~~~~ 264 (311)
.+||+.||++|||+.++++.|+.+-
T Consensus 244 ~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 244 RLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHcCCCHhHCcCHHHHHHHhhhhh
Confidence 9999999999999999999998654
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-49 Score=334.38 Aligned_cols=237 Identities=24% Similarity=0.356 Sum_probs=195.4
Q ss_pred CcchhccCCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCC
Q 021490 1 MMQVILCLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKK 80 (311)
Q Consensus 1 ~~~~~~~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 80 (311)
||.+...+++.||||+++... ...+.|.+|+.++.+++||||+++++++.++...++||||+++|+|.+++... ..
T Consensus 20 Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~~~~~~---~~ 95 (258)
T d1k2pa_ 20 VKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREM---RH 95 (258)
T ss_dssp EEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHHHHHHSG---GG
T ss_pred EEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHHHhhhcc---cc
Confidence 355556788899999997544 45678999999999999999999999999999999999999999999987652 46
Q ss_pred CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcc
Q 021490 81 PLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 160 (311)
Q Consensus 81 ~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE 160 (311)
.+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++....... ........++..|+|||
T Consensus 96 ~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~-~~~~~~~~~t~~y~aPE 171 (258)
T d1k2pa_ 96 RFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPE 171 (258)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS-CCCCCCSCCCGGGCCHH
T ss_pred CCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCC-ceeecccCCCCCcCCcH
Confidence 7999999999999999999999999 9999999999999999999999999997543322 22233356889999999
Q ss_pred ccccCCCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHH
Q 021490 161 YAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVA 239 (311)
Q Consensus 161 ~~~~~~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 239 (311)
++.+..++.++|||||||++|||+| |..||......+....+... .. ...|...+..+.+|+
T Consensus 172 ~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~-------~~----------~~~p~~~~~~l~~li 234 (258)
T d1k2pa_ 172 VLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG-------LR----------LYRPHLASEKVYTIM 234 (258)
T ss_dssp HHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTT-------CC----------CCCCTTCCHHHHHHH
T ss_pred HhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhC-------CC----------CCCcccccHHHHHHH
Confidence 9999999999999999999999998 89999877654433222111 00 011223335788999
Q ss_pred HHccccCCCCCCCHHHHHHHHHH
Q 021490 240 AMCVHEQPDMRPVIADVVTALAY 262 (311)
Q Consensus 240 ~~~l~~~p~~Rps~~~vl~~l~~ 262 (311)
.+||+.||++|||+.++++.|..
T Consensus 235 ~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 235 YSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp HHTTCSSGGGSCCHHHHHHHHHC
T ss_pred HHHccCCHhHCcCHHHHHHHhhC
Confidence 99999999999999999998853
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.1e-49 Score=347.16 Aligned_cols=235 Identities=19% Similarity=0.251 Sum_probs=193.7
Q ss_pred cchhc-cCCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCC
Q 021490 2 MQVIL-CLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKK 80 (311)
Q Consensus 2 ~~~~~-~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 80 (311)
|.+.. .+|+.||||+++.........+.+|+.+|+.++||||++++++|.++...|+|||||+||+|.+++.. .+.
T Consensus 46 ~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~~~~---~~~ 122 (352)
T d1koba_ 46 HRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAA---EDY 122 (352)
T ss_dssp EEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTC---TTC
T ss_pred EEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCChHHHHHHh---cCC
Confidence 34443 47999999999876656667889999999999999999999999999999999999999999988765 245
Q ss_pred CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEc--CCCceEEccccccccCCCCCCceeeeeccccccccC
Q 021490 81 PLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD--RGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCA 158 (311)
Q Consensus 81 ~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~--~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~a 158 (311)
.+++..++.++.||+.||+|||++| |+||||||+|||++ .++.+||+|||++...... .......+++.|+|
T Consensus 123 ~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~---~~~~~~~gt~~y~a 196 (352)
T d1koba_ 123 KMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD---EIVKVTTATAEFAA 196 (352)
T ss_dssp CBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT---SCEEEECSSGGGCC
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCC---CceeeccCcccccC
Confidence 7999999999999999999999999 99999999999997 6789999999999764332 22344568999999
Q ss_pred ccccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHH
Q 021490 159 PEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAV 238 (311)
Q Consensus 159 PE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 238 (311)
||++.+..++.++|||||||++|+|++|..||.+.........+... +..+........+.++.+|
T Consensus 197 PE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~--------------~~~~~~~~~~~~s~~~~~l 262 (352)
T d1koba_ 197 PEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC--------------DWEFDEDAFSSVSPEAKDF 262 (352)
T ss_dssp HHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHC--------------CCCCCSSTTTTSCHHHHHH
T ss_pred HHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--------------CCCCCcccccCCCHHHHHH
Confidence 99999999999999999999999999999999876654432222111 0111112223345588999
Q ss_pred HHHccccCCCCCCCHHHHHHH
Q 021490 239 AAMCVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 239 i~~~l~~~p~~Rps~~~vl~~ 259 (311)
|.+||+.||.+|||+.|+++.
T Consensus 263 i~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 263 IKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp HHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHccCChhHCcCHHHHhcC
Confidence 999999999999999999875
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.6e-49 Score=347.58 Aligned_cols=235 Identities=21% Similarity=0.260 Sum_probs=192.6
Q ss_pred cchhc-cCCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCC
Q 021490 2 MQVIL-CLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKK 80 (311)
Q Consensus 2 ~~~~~-~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 80 (311)
|.+.. .+|+.||||++........+.+.+|+.+|+.++||||+++++++.++...|+|||||+||+|.+++... .+
T Consensus 43 y~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~l~~~---~~ 119 (350)
T d1koaa2 43 HRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADE---HN 119 (350)
T ss_dssp EEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTCT---TS
T ss_pred EEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCCHHHHHHhh---cC
Confidence 44443 469999999997766666678999999999999999999999999999999999999999999998652 46
Q ss_pred CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEc--CCCceEEccccccccCCCCCCceeeeeccccccccC
Q 021490 81 PLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD--RGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCA 158 (311)
Q Consensus 81 ~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~--~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~a 158 (311)
.+++..+..++.||+.||+|||++| ++||||||+|||++ .++.+||+|||++...... .......||+.|+|
T Consensus 120 ~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~---~~~~~~~gT~~Y~a 193 (350)
T d1koaa2 120 KMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK---QSVKVTTGTAEFAA 193 (350)
T ss_dssp CBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT---SCEEEECSCTTTCC
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccc---cccceecCcccccC
Confidence 7999999999999999999999999 99999999999996 4678999999999754322 22334568999999
Q ss_pred ccccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHH
Q 021490 159 PEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAV 238 (311)
Q Consensus 159 PE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 238 (311)
||++.+..++.++|||||||++|+|++|..||.+.........+.... .. +........+..+.+|
T Consensus 194 PEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~------~~--------~~~~~~~~~s~~~~~l 259 (350)
T d1koaa2 194 PEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCD------WN--------MDDSAFSGISEDGKDF 259 (350)
T ss_dssp HHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC------CC--------SCCGGGGGCCHHHHHH
T ss_pred HHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC------CC--------CCcccccCCCHHHHHH
Confidence 999999999999999999999999999999998765543322221110 00 0011112344578999
Q ss_pred HHHccccCCCCCCCHHHHHHH
Q 021490 239 AAMCVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 239 i~~~l~~~p~~Rps~~~vl~~ 259 (311)
|.+||+.||++|||++|+++.
T Consensus 260 i~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 260 IRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp HHHHCCSSGGGSCCHHHHHHS
T ss_pred HHHHccCChhHCcCHHHHhcC
Confidence 999999999999999999886
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-50 Score=341.59 Aligned_cols=239 Identities=22% Similarity=0.271 Sum_probs=179.6
Q ss_pred cchhc-cCCcEEEEEEeecCCCc--chhHHHHHHHHHhcCCCCcccceeeEeee--CCeeEEEEecCCCCChhhhhcccC
Q 021490 2 MQVIL-CLLQDVAIKQLDRNGVQ--GNREFLVEVLMLSLLHHPNLVNLIGYCAD--GDQRLLVYEYMPLGSVEDHLHDLS 76 (311)
Q Consensus 2 ~~~~~-~~g~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~ 76 (311)
|.+.. .+|+.||+|+++..... ..+.+.+|++++++++||||+++++++.+ +..+|+|||||+||+|.+++....
T Consensus 21 y~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~ 100 (269)
T d2java1 21 QKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGT 100 (269)
T ss_dssp EEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECCTTEEHHHHHHHHH
T ss_pred EEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCCCcHHHHHHhcc
Confidence 44443 46899999999765432 23578899999999999999999999864 456899999999999999987543
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHhhcCC--CCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccc
Q 021490 77 PGKKPLDWNTRMKIAAGAARGLEYLHDKA--KPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTY 154 (311)
Q Consensus 77 ~~~~~l~~~~~~~~~~~i~~~l~~lh~~~--~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~ 154 (311)
.....+++..++.++.|++.||+|||+++ ..+|+||||||+|||++.++.+||+|||++...... ........||+
T Consensus 101 ~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~--~~~~~~~~gt~ 178 (269)
T d2java1 101 KERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD--TSFAKAFVGTP 178 (269)
T ss_dssp HHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC-------------CCC
T ss_pred ccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccC--CCccccCCCCc
Confidence 33567999999999999999999999864 234999999999999999999999999999764322 22233456899
Q ss_pred cccCccccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHH
Q 021490 155 GYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQ 234 (311)
Q Consensus 155 ~y~aPE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+... . .+ ..+...+.+
T Consensus 179 ~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~--------~-----~~----~~~~~~s~~ 241 (269)
T d2java1 179 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG--------K-----FR----RIPYRYSDE 241 (269)
T ss_dssp SCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT--------C-----CC----CCCTTSCHH
T ss_pred ccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcC--------C-----CC----CCCcccCHH
Confidence 999999999999999999999999999999999999876554332221110 0 01 122334458
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHH
Q 021490 235 ALAVAAMCVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 235 l~~li~~~l~~~p~~Rps~~~vl~~ 259 (311)
+.+|+.+||+.||.+|||+.|+++.
T Consensus 242 l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 242 LNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHcCCChhHCcCHHHHHhC
Confidence 8999999999999999999999864
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-49 Score=341.18 Aligned_cols=234 Identities=24% Similarity=0.282 Sum_probs=189.8
Q ss_pred cchhc-cCCcEEEEEEeecCCC------cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcc
Q 021490 2 MQVIL-CLLQDVAIKQLDRNGV------QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHD 74 (311)
Q Consensus 2 ~~~~~-~~g~~vaiK~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 74 (311)
|.+.. .+|+.||||++++... ...+.|.+|+.+|++++||||+++++++.++...|+|||||+||+|.+++..
T Consensus 27 y~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~gg~L~~~i~~ 106 (293)
T d1jksa_ 27 KKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE 106 (293)
T ss_dssp EEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH
T ss_pred EEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCccccchhcc
Confidence 44443 4799999999976432 2346899999999999999999999999999999999999999999999987
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCC----ceEEccccccccCCCCCCceeeeec
Q 021490 75 LSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY----HPKLSDFGLAKLGPVGDNTHVSTRV 150 (311)
Q Consensus 75 ~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~----~~~l~df~~~~~~~~~~~~~~~~~~ 150 (311)
.+.+++..+..++.|++.||+|||+++ ++||||||+||+++.++ .+|++|||++....... .....
T Consensus 107 ----~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~---~~~~~ 176 (293)
T d1jksa_ 107 ----KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN---EFKNI 176 (293)
T ss_dssp ----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSC---BCSCC
T ss_pred ----ccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchhhhhhcCCCc---ccccc
Confidence 567999999999999999999999999 99999999999998776 49999999987543222 22334
Q ss_pred cccccccCccccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChH
Q 021490 151 MGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPR 230 (311)
Q Consensus 151 ~~~~~y~aPE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (311)
.+++.|+|||++.+..++.++|||||||++|+|++|..||.+.........+... ... ..+. .++.
T Consensus 177 ~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~------~~~----~~~~----~~~~ 242 (293)
T d1jksa_ 177 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV------NYE----FEDE----YFSN 242 (293)
T ss_dssp CCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTT------CCC----CCHH----HHTT
T ss_pred CCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhc------CCC----CCch----hcCC
Confidence 6889999999999999999999999999999999999999876544332221111 000 0001 1122
Q ss_pred hHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 021490 231 GFYQALAVAAMCVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 231 ~~~~l~~li~~~l~~~p~~Rps~~~vl~~ 259 (311)
.+..+.+||.+||+.||.+|||++|+++.
T Consensus 243 ~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 243 TSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 34578899999999999999999999875
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-50 Score=347.21 Aligned_cols=249 Identities=20% Similarity=0.231 Sum_probs=187.9
Q ss_pred cchhc-cCCcEEEEEEeecCCC-cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCC
Q 021490 2 MQVIL-CLLQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGK 79 (311)
Q Consensus 2 ~~~~~-~~g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~ 79 (311)
|.+.. .+|+.||+|+++.... .....+.+|+.+|+.++||||++++++|.++...|+|||||+||+|.+++.+ .
T Consensus 23 ~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~l~~----~ 98 (322)
T d1s9ja_ 23 FKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK----A 98 (322)
T ss_dssp EEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHH----H
T ss_pred EEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHhh----c
Confidence 34443 4789999999976543 3346899999999999999999999999999999999999999999999987 5
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhc-CCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccC
Q 021490 80 KPLDWNTRMKIAAGAARGLEYLHD-KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCA 158 (311)
Q Consensus 80 ~~l~~~~~~~~~~~i~~~l~~lh~-~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~a 158 (311)
+.+++..+..++.|++.||+|||+ ++ |+||||||+|||++.+|.+||+|||++..... .......||+.|+|
T Consensus 99 ~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~----~~~~~~~GT~~Y~A 171 (322)
T d1s9ja_ 99 GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMS 171 (322)
T ss_dssp SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH----HTC---CCSSCCCC
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCC----CccccccCCccccC
Confidence 679999999999999999999997 48 99999999999999999999999999875321 11223579999999
Q ss_pred ccccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHh-hhhhcc---------ccccccc----------
Q 021490 159 PEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWA-RPLFQD---------RTRHSLI---------- 218 (311)
Q Consensus 159 PE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~-~~~~~~---------~~~~~~~---------- 218 (311)
||++.+..++.++||||+||++|+|++|+.||...+........... ...... .......
T Consensus 172 PEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (322)
T d1s9ja_ 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIF 251 (322)
T ss_dssp HHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------------------CCCCHH
T ss_pred chHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccccccccchhHH
Confidence 99999999999999999999999999999999765433221110000 000000 0000000
Q ss_pred ------cCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 021490 219 ------ADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 261 (311)
Q Consensus 219 ------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l~ 261 (311)
.............+.++.+|+.+||..||.+|||++|+++.-.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf 300 (322)
T d1s9ja_ 252 ELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF 300 (322)
T ss_dssp HHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred HHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHh
Confidence 0000000001123457889999999999999999999998643
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-49 Score=333.94 Aligned_cols=233 Identities=25% Similarity=0.387 Sum_probs=182.8
Q ss_pred cchhc-cCCcEEEEEEeecCCC--cchhHHHHHHHHHhcCCCCcccceeeEeee----CCeeEEEEecCCCCChhhhhcc
Q 021490 2 MQVIL-CLLQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCAD----GDQRLLVYEYMPLGSVEDHLHD 74 (311)
Q Consensus 2 ~~~~~-~~g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~ 74 (311)
|.+.. .+|+.||+|++..... ...+.|.+|+++|++++||||+++++++.+ +...|+|||||+||+|.+++..
T Consensus 26 y~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~ 105 (270)
T d1t4ha_ 26 YKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR 105 (270)
T ss_dssp EEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHH
T ss_pred EEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCCCCCcHHHHHhc
Confidence 44443 3688999999876543 334679999999999999999999999865 3467999999999999999987
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEc-CCCceEEccccccccCCCCCCceeeeecccc
Q 021490 75 LSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLD-RGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT 153 (311)
Q Consensus 75 ~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~ 153 (311)
...+++..+..++.||+.||+|||+++ .+|+||||||+|||++ +++.+||+|||++...... ......||
T Consensus 106 ----~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~----~~~~~~GT 176 (270)
T d1t4ha_ 106 ----FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGT 176 (270)
T ss_dssp ----HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT----SBEESCSS
T ss_pred ----cccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC----ccCCcccC
Confidence 567999999999999999999999874 3499999999999997 5789999999999753221 22345799
Q ss_pred ccccCccccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHH
Q 021490 154 YGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFY 233 (311)
Q Consensus 154 ~~y~aPE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
+.|+|||++.+ .++.++|||||||++|+|++|..||.......... .. +..... .+.+... .+.
T Consensus 177 ~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~--~~----i~~~~~-----~~~~~~~----~~~ 240 (270)
T d1t4ha_ 177 PEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY--RR----VTSGVK-----PASFDKV----AIP 240 (270)
T ss_dssp CCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHH--HH----HTTTCC-----CGGGGGC----CCH
T ss_pred ccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHH--HH----HHcCCC-----CcccCcc----CCH
Confidence 99999999875 58999999999999999999999997654322211 10 100000 1111112 234
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHH
Q 021490 234 QALAVAAMCVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 234 ~l~~li~~~l~~~p~~Rps~~~vl~~ 259 (311)
++.+|+.+||+.||++|||++|+++.
T Consensus 241 ~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 241 EVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 68899999999999999999999864
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.1e-49 Score=338.91 Aligned_cols=230 Identities=28% Similarity=0.347 Sum_probs=186.6
Q ss_pred cchh-ccCCcEEEEEEeecCCCcc---hhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCC
Q 021490 2 MQVI-LCLLQDVAIKQLDRNGVQG---NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP 77 (311)
Q Consensus 2 ~~~~-~~~g~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 77 (311)
|.+. ..+|+.||||+++...... .+.+.+|+.+|++++||||+++++++.++...|+|||||.||+|..++..
T Consensus 32 y~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~~~~--- 108 (309)
T d1u5ra_ 32 YFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVH--- 108 (309)
T ss_dssp EEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHH---
T ss_pred EEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEecCCCchHHHHHh---
Confidence 4443 3478999999997654332 35788999999999999999999999999999999999999999877765
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeecccccccc
Q 021490 78 GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 157 (311)
Q Consensus 78 ~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~ 157 (311)
.+.+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||++..... .....||+.|+
T Consensus 109 -~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~------~~~~~GT~~Y~ 178 (309)
T d1u5ra_ 109 -KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVGTPYWM 178 (309)
T ss_dssp -TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS------BCCCCSCGGGC
T ss_pred -CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC------CCccccCcccc
Confidence 578999999999999999999999999 99999999999999999999999999975322 22346999999
Q ss_pred Ccccccc---CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHH
Q 021490 158 APEYAKT---GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQ 234 (311)
Q Consensus 158 aPE~~~~---~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
|||++.+ ..++.++|||||||++|+|++|..||...........+. ... .+.+ .+...+..
T Consensus 179 APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~------~~~-------~~~~---~~~~~s~~ 242 (309)
T d1u5ra_ 179 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA------QNE-------SPAL---QSGHWSEY 242 (309)
T ss_dssp CHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH------HSC-------CCCC---SCTTSCHH
T ss_pred CHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHH------hCC-------CCCC---CCCCCCHH
Confidence 9999864 468899999999999999999999997655433221111 000 0000 11223457
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHHH
Q 021490 235 ALAVAAMCVHEQPDMRPVIADVVTAL 260 (311)
Q Consensus 235 l~~li~~~l~~~p~~Rps~~~vl~~l 260 (311)
+.+|+.+||+.||.+|||+.|+++.-
T Consensus 243 ~~~li~~~L~~dP~~Rpt~~ell~Hp 268 (309)
T d1u5ra_ 243 FRNFVDSCLQKIPQDRPTSEVLLKHR 268 (309)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred HHHHHHHHCcCChhHCcCHHHHHhCH
Confidence 88999999999999999999998753
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-48 Score=339.22 Aligned_cols=226 Identities=26% Similarity=0.318 Sum_probs=190.4
Q ss_pred cCCcEEEEEEeecCC---CcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCC
Q 021490 7 CLLQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLD 83 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~ 83 (311)
.+|+.||||++++.. ....+.+.+|+.+|+.++||||+++++++.++..+|+|||||+||+|.+++.. ...++
T Consensus 28 ~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~gg~L~~~~~~----~~~~~ 103 (337)
T d1o6la_ 28 ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR----ERVFT 103 (337)
T ss_dssp TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH----HSCCC
T ss_pred CCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceeccCCCchhhhhhc----ccCCc
Confidence 479999999997642 23457889999999999999999999999999999999999999999999987 67899
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccc
Q 021490 84 WNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 163 (311)
Q Consensus 84 ~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 163 (311)
+..+..++.|++.||+|||++| |+||||||+|||++.+|.+||+|||++...... ........||+.|+|||++.
T Consensus 104 e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~--~~~~~~~~GT~~Y~aPE~~~ 178 (337)
T d1o6la_ 104 EERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYLAPEVLE 178 (337)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT--TCCBCCCEECGGGCCGGGGS
T ss_pred HHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccC--CcccccceeCHHHhhhhhcc
Confidence 9999999999999999999999 999999999999999999999999999753222 22233457999999999999
Q ss_pred cCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHcc
Q 021490 164 TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCV 243 (311)
Q Consensus 164 ~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 243 (311)
+..++.++|||||||++|+|++|..||...+.......+... .. .+|...+.++.+||.+||
T Consensus 179 ~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~--------------~~----~~p~~~s~~~~dli~~~L 240 (337)
T d1o6la_ 179 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME--------------EI----RFPRTLSPEAKSLLAGLL 240 (337)
T ss_dssp SSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--------------CC----CCCTTSCHHHHHHHHHHT
T ss_pred CCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcC--------------CC----CCCccCCHHHHHHHHhhc
Confidence 999999999999999999999999999877654432222111 01 123334557899999999
Q ss_pred ccCCCCCCC-----HHHHHHH
Q 021490 244 HEQPDMRPV-----IADVVTA 259 (311)
Q Consensus 244 ~~~p~~Rps-----~~~vl~~ 259 (311)
+.||.+|++ ++++++.
T Consensus 241 ~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 241 KKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp CSSTTTSTTCSTTTHHHHHTS
T ss_pred cCCchhhcccccccHHHHHcC
Confidence 999999995 8888875
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-49 Score=343.30 Aligned_cols=232 Identities=27% Similarity=0.398 Sum_probs=186.1
Q ss_pred cEEEEEEeecCC-CcchhHHHHHHHHHhcC-CCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCC----------
Q 021490 10 QDVAIKQLDRNG-VQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP---------- 77 (311)
Q Consensus 10 ~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------- 77 (311)
..||+|++.... ......|.+|+.+|.++ +||||+++++++.+....++|||||++|+|.+++.....
T Consensus 68 ~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~ 147 (325)
T d1rjba_ 68 IQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYE 147 (325)
T ss_dssp EEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC--------
T ss_pred eEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhc
Confidence 369999986543 34456899999999998 899999999999999999999999999999999976321
Q ss_pred ---------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeee
Q 021490 78 ---------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVST 148 (311)
Q Consensus 78 ---------~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~ 148 (311)
....+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++............
T Consensus 148 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~ 224 (325)
T d1rjba_ 148 NQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRG 224 (325)
T ss_dssp -------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEET
T ss_pred cccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCchhccccccCCeEEEeeccccccccCCCceeeec
Confidence 1245899999999999999999999999 9999999999999999999999999997654444333444
Q ss_pred eccccccccCccccccCCCccccceeehhHHHHHHHh-CCCccCcchhHHHH-HHHHHhhhhhccccccccccCccccCC
Q 021490 149 RVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQ-SLVAWARPLFQDRTRHSLIADPELQGQ 226 (311)
Q Consensus 149 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (311)
...+|+.|+|||++.+..++.++|||||||++|||+| |..||......... ..+. .. ....
T Consensus 225 ~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~-------~~----------~~~~ 287 (325)
T d1rjba_ 225 NARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQ-------NG----------FKMD 287 (325)
T ss_dssp TEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHH-------TT----------CCCC
T ss_pred cccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHHHHHHHh-------cC----------CCCC
Confidence 5568999999999999999999999999999999998 89999765432221 1111 10 0112
Q ss_pred CChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 021490 227 YPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALA 261 (311)
Q Consensus 227 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l~ 261 (311)
.+...+.++.+||.+||+.||++|||++||++.|.
T Consensus 288 ~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 288 QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 23344558999999999999999999999999985
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-48 Score=330.89 Aligned_cols=234 Identities=24% Similarity=0.327 Sum_probs=181.9
Q ss_pred cEEEEEEeecCCCc-chhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHHHH
Q 021490 10 QDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRM 88 (311)
Q Consensus 10 ~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~ 88 (311)
..||||+++..... ....|.+|++++.+++||||+++++++.+....++||||+.++++.+++... ...+++..+.
T Consensus 37 ~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~~~~~~l~~~~~~~---~~~~~~~~~~ 113 (283)
T d1mqba_ 37 VPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREK---DGEFSVLQLV 113 (283)
T ss_dssp EEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHT---TTCSCHHHHH
T ss_pred EEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEecccCcchhhhhcc---cccccHHHHH
Confidence 47999999655433 3357999999999999999999999999999999999999999999887762 4679999999
Q ss_pred HHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCC-ceeeeeccccccccCccccccCCC
Q 021490 89 KIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN-THVSTRVMGTYGYCAPEYAKTGQL 167 (311)
Q Consensus 89 ~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~ 167 (311)
.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++....... ........||..|+|||++.+..+
T Consensus 114 ~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~ 190 (283)
T d1mqba_ 114 GMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKF 190 (283)
T ss_dssp HHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCC
T ss_pred HHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCC
Confidence 99999999999999999 99999999999999999999999999975432221 122233457899999999999999
Q ss_pred ccccceeehhHHHHHHHhCCCcc-CcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccC
Q 021490 168 TLKSDVYSFGVVLLEILSGRKAV-DTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQ 246 (311)
Q Consensus 168 ~~~~DiwslG~l~~~ll~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 246 (311)
+.++|||||||++|||++|..|| ...........+. ... ....+...+..+.+|+.+||+.|
T Consensus 191 ~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~-------~~~----------~~~~~~~~~~~l~~li~~cl~~~ 253 (283)
T d1mqba_ 191 TSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN-------DGF----------RLPTPMDCPSAIYQLMMQCWQQE 253 (283)
T ss_dssp CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-------TTC----------CCCCCTTCBHHHHHHHHHHTCSS
T ss_pred CCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHh-------ccC----------CCCCchhhHHHHHHHHHHHCcCC
Confidence 99999999999999999965554 4333322221111 110 11122334457889999999999
Q ss_pred CCCCCCHHHHHHHHHHhhhc
Q 021490 247 PDMRPVIADVVTALAYLASQ 266 (311)
Q Consensus 247 p~~Rps~~~vl~~l~~~~~~ 266 (311)
|++|||+.+|++.|+.+.+.
T Consensus 254 p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 254 RARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp TTTSCCHHHHHHHHHHHHHS
T ss_pred HhHCcCHHHHHHHHHHHhhC
Confidence 99999999999999877653
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-48 Score=329.91 Aligned_cols=239 Identities=27% Similarity=0.348 Sum_probs=186.4
Q ss_pred CcchhccCCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCC
Q 021490 1 MMQVILCLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKK 80 (311)
Q Consensus 1 ~~~~~~~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 80 (311)
||.+...+++.||||+++.. ....+.|.+|+.++.+++||||+++++++.+ +..++||||+++|+|..++.... ..
T Consensus 33 Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~g~l~~~~~~~~--~~ 108 (285)
T d1fmka3 33 VWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGET--GK 108 (285)
T ss_dssp EEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHH--HT
T ss_pred EEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCCCchhhhhhhcc--cc
Confidence 45667778889999999644 4556789999999999999999999999854 56899999999999998886521 35
Q ss_pred CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcc
Q 021490 81 PLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 160 (311)
Q Consensus 81 ~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE 160 (311)
.+++..++.++.||+.||+|||+++ ++||||||+|||++.++.+||+|||++....... ........+++.|+|||
T Consensus 109 ~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE 184 (285)
T d1fmka3 109 YLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPE 184 (285)
T ss_dssp TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---------------CCGGGSCHH
T ss_pred cchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCC-ceeeccccccccccChH
Confidence 6999999999999999999999999 9999999999999999999999999997542221 22233456899999999
Q ss_pred ccccCCCccccceeehhHHHHHHHhCCCcc-CcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHH
Q 021490 161 YAKTGQLTLKSDVYSFGVVLLEILSGRKAV-DTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVA 239 (311)
Q Consensus 161 ~~~~~~~~~~~DiwslG~l~~~ll~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 239 (311)
++....++.++|||||||++|||++|..|| ...........+... .....+...+.++.+|+
T Consensus 185 ~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~-----------------~~~~~~~~~~~~l~~li 247 (285)
T d1fmka3 185 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-----------------YRMPCPPECPESLHDLM 247 (285)
T ss_dssp HHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-----------------CCCCCCTTSCHHHHHHH
T ss_pred HHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhc-----------------CCCCCCcccCHHHHHHH
Confidence 999999999999999999999999965554 444333222222110 01112333455889999
Q ss_pred HHccccCCCCCCCHHHHHHHHHHhh
Q 021490 240 AMCVHEQPDMRPVIADVVTALAYLA 264 (311)
Q Consensus 240 ~~~l~~~p~~Rps~~~vl~~l~~~~ 264 (311)
.+||+.||++|||+.+|++.|+...
T Consensus 248 ~~cl~~dP~~Rps~~~i~~~L~~~~ 272 (285)
T d1fmka3 248 CQCWRKEPEERPTFEYLQAFLEDYF 272 (285)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred HHHcccCHhHCcCHHHHHHHHhhhh
Confidence 9999999999999999999887544
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.3e-47 Score=331.30 Aligned_cols=229 Identities=28% Similarity=0.350 Sum_probs=191.4
Q ss_pred cchhc-cCCcEEEEEEeecCC---CcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCC
Q 021490 2 MQVIL-CLLQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP 77 (311)
Q Consensus 2 ~~~~~-~~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 77 (311)
|.+.. .+|+.||||+++... ....+.+.+|+.+++.++||||+++++++.++...|+|||||+||+|..++..
T Consensus 21 y~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~l~~~~~~--- 97 (316)
T d1fota_ 21 HLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRK--- 97 (316)
T ss_dssp EEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH---
T ss_pred EEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeeecCCccccccccc---
Confidence 44443 469999999997542 23457899999999999999999999999999999999999999999999987
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeecccccccc
Q 021490 78 GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 157 (311)
Q Consensus 78 ~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~ 157 (311)
...+++..+..++.||+.||+|||++| |+||||||+|||++.+|.+||+|||++...... .....||+.|+
T Consensus 98 -~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~-----~~~~~Gt~~Y~ 168 (316)
T d1fota_ 98 -SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-----TYTLCGTPDYI 168 (316)
T ss_dssp -TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC-----BCCCCSCTTTC
T ss_pred -cccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc-----cccccCccccc
Confidence 678999999999999999999999999 999999999999999999999999999764322 22356999999
Q ss_pred CccccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHH
Q 021490 158 APEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALA 237 (311)
Q Consensus 158 aPE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 237 (311)
|||++.+..++.++|||||||++|+|++|..||...+.......+... . ..+++..+.++.+
T Consensus 169 APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~--------------~----~~~p~~~s~~~~~ 230 (316)
T d1fota_ 169 APEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA--------------E----LRFPPFFNEDVKD 230 (316)
T ss_dssp CHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC--------------C----CCCCTTSCHHHHH
T ss_pred CHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcC--------------C----CCCCCCCCHHHHH
Confidence 999999999999999999999999999999999876554332222110 0 1123334457889
Q ss_pred HHHHccccCCCCCC-----CHHHHHHHH
Q 021490 238 VAAMCVHEQPDMRP-----VIADVVTAL 260 (311)
Q Consensus 238 li~~~l~~~p~~Rp-----s~~~vl~~l 260 (311)
++.+||..||.+|+ |++++++.-
T Consensus 231 li~~~L~~dp~~R~~~~r~t~~~il~Hp 258 (316)
T d1fota_ 231 LLSRLITRDLSQRLGNLQNGTEDVKNHP 258 (316)
T ss_dssp HHHHHTCSCTTTCTTSSTTTTHHHHTSG
T ss_pred HHHHHhhhCHHhccccchhhHHHHHcCc
Confidence 99999999999996 899998753
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=8.3e-48 Score=327.43 Aligned_cols=242 Identities=24% Similarity=0.316 Sum_probs=185.7
Q ss_pred cchhc-cCCcEEEEEEeecCCCcc---hhHHHHHHHHHhcCCCCcccceeeEeeeCC----eeEEEEecCCCCChhhhhc
Q 021490 2 MQVIL-CLLQDVAIKQLDRNGVQG---NREFLVEVLMLSLLHHPNLVNLIGYCADGD----QRLLVYEYMPLGSVEDHLH 73 (311)
Q Consensus 2 ~~~~~-~~g~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~ 73 (311)
|.+.. .+|+.||||+++...... ...|.+|+.+++.++||||+++++++.... ..|+|||||+|++|.+++.
T Consensus 24 y~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~ 103 (277)
T d1o6ya_ 24 HLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH 103 (277)
T ss_dssp EEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEEECCCEEEHHHHHH
T ss_pred EEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEEECCCCCEehhhhc
Confidence 44443 479999999997654433 357899999999999999999999987643 4799999999999999988
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCC-ceeeeeccc
Q 021490 74 DLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDN-THVSTRVMG 152 (311)
Q Consensus 74 ~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~ 152 (311)
. .+.+++..+..++.||+.||+|||++| ++||||||+|||++.++.++++|||.+........ ........|
T Consensus 104 ~----~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~G 176 (277)
T d1o6ya_ 104 T----EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIG 176 (277)
T ss_dssp H----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCEECC--------------
T ss_pred c----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhhhhccccccccccccccC
Confidence 7 567999999999999999999999999 99999999999999999999999998864322221 122334568
Q ss_pred cccccCccccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhH
Q 021490 153 TYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGF 232 (311)
Q Consensus 153 ~~~y~aPE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (311)
|+.|+|||++.+..++.++|||||||++|+|+||..||............ ....... .....+..+
T Consensus 177 t~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~------~~~~~~~--------~~~~~~~~s 242 (277)
T d1o6ya_ 177 TAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQH------VREDPIP--------PSARHEGLS 242 (277)
T ss_dssp --TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH------HHCCCCC--------GGGTSSSCC
T ss_pred cccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHH------HhcCCCC--------CchhccCCC
Confidence 99999999999999999999999999999999999999876543322111 1111000 011112234
Q ss_pred HHHHHHHHHccccCCCCCC-CHHHHHHHHHHhh
Q 021490 233 YQALAVAAMCVHEQPDMRP-VIADVVTALAYLA 264 (311)
Q Consensus 233 ~~l~~li~~~l~~~p~~Rp-s~~~vl~~l~~~~ 264 (311)
..+.++|.+||+.||++|| |++++++.|..+.
T Consensus 243 ~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 243 ADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred HHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 5888999999999999999 8999999887654
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-48 Score=326.74 Aligned_cols=235 Identities=28% Similarity=0.378 Sum_probs=183.2
Q ss_pred cchhccCCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeee-CCeeEEEEecCCCCChhhhhcccCCCCC
Q 021490 2 MQVILCLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCAD-GDQRLLVYEYMPLGSVEDHLHDLSPGKK 80 (311)
Q Consensus 2 ~~~~~~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 80 (311)
|++.. .|..||||+++.. ...+.|.+|++++++++||||+++++++.+ +...++||||+++|+|.+++... ...
T Consensus 24 y~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~--~~~ 98 (262)
T d1byga_ 24 MLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRS 98 (262)
T ss_dssp EEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHH--HHH
T ss_pred EEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHHHHHHhc--CCC
Confidence 44444 5789999999643 355789999999999999999999999854 45689999999999999998652 124
Q ss_pred CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcc
Q 021490 81 PLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 160 (311)
Q Consensus 81 ~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE 160 (311)
.+++..++.++.||+.||+|||+.+ ++||||||+||+++.++.++++|||++..... ......++..|+|||
T Consensus 99 ~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~-----~~~~~~~~~~y~aPE 170 (262)
T d1byga_ 99 VLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS-----TQDTGKLPVKWTAPE 170 (262)
T ss_dssp HCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-----------------CCTTTSCHH
T ss_pred CCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCC-----CCccccccccCCChH
Confidence 5899999999999999999999999 99999999999999999999999999874322 122335788999999
Q ss_pred ccccCCCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHH
Q 021490 161 YAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVA 239 (311)
Q Consensus 161 ~~~~~~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 239 (311)
++.+..++.++|||||||++|||+| |.+||...........+. .. ..+ ..++..+..+.+|+
T Consensus 171 ~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~-------~~------~~~----~~~~~~~~~~~~li 233 (262)
T d1byga_ 171 ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-------KG------YKM----DAPDGCPPAVYEVM 233 (262)
T ss_dssp HHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHT-------TT------CCC----CCCTTCCHHHHHHH
T ss_pred HHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-------cC------CCC----CCCccCCHHHHHHH
Confidence 9999999999999999999999998 688887654433222110 00 011 22334445888999
Q ss_pred HHccccCCCCCCCHHHHHHHHHHhhhc
Q 021490 240 AMCVHEQPDMRPVIADVVTALAYLASQ 266 (311)
Q Consensus 240 ~~~l~~~p~~Rps~~~vl~~l~~~~~~ 266 (311)
.+||..||++|||+.++++.|+.+...
T Consensus 234 ~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 234 KNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence 999999999999999999999987653
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.8e-47 Score=324.42 Aligned_cols=229 Identities=24% Similarity=0.281 Sum_probs=187.4
Q ss_pred cCCcEEEEEEeecCCCcc---------hhHHHHHHHHHhcCC-CCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccC
Q 021490 7 CLLQDVAIKQLDRNGVQG---------NREFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLS 76 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~~---------~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 76 (311)
.+|+.||||+++...... .+.+.+|+.++++++ ||||+++++++.++...|+|||||+||+|.+++..
T Consensus 26 ~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~-- 103 (277)
T d1phka_ 26 PTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE-- 103 (277)
T ss_dssp TTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH--
T ss_pred CCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcceEEEEEcCCCchHHHHHHh--
Confidence 478999999997654322 236889999999997 99999999999999999999999999999999987
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccc
Q 021490 77 PGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY 156 (311)
Q Consensus 77 ~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y 156 (311)
.+.+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++....... ......||..|
T Consensus 104 --~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y 175 (277)
T d1phka_ 104 --KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPSY 175 (277)
T ss_dssp --HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECCTTC---CBCCCCSCGGG
T ss_pred --cCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchheeEccCCC---ceeeeeccCCC
Confidence 568999999999999999999999999 9999999999999999999999999997643322 22335689999
Q ss_pred cCcccccc------CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChH
Q 021490 157 CAPEYAKT------GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPR 230 (311)
Q Consensus 157 ~aPE~~~~------~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (311)
+|||.+.+ ..++.++||||+||++|+|++|+.||...........+... ... ........
T Consensus 176 ~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~------~~~--------~~~~~~~~ 241 (277)
T d1phka_ 176 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG------NYQ--------FGSPEWDD 241 (277)
T ss_dssp CCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT------CCC--------CCTTTGGG
T ss_pred CCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhC------CCC--------CCCccccc
Confidence 99998853 35688999999999999999999999877654433222111 000 01111223
Q ss_pred hHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 021490 231 GFYQALAVAAMCVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 231 ~~~~l~~li~~~l~~~p~~Rps~~~vl~~ 259 (311)
.+.++.+|+.+||+.||.+|||+.|+++.
T Consensus 242 ~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 242 YSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp SCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 45689999999999999999999999865
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-47 Score=327.27 Aligned_cols=249 Identities=22% Similarity=0.176 Sum_probs=185.4
Q ss_pred cchhc-cCCcEEEEEEeecCCCcc-----hhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhccc
Q 021490 2 MQVIL-CLLQDVAIKQLDRNGVQG-----NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDL 75 (311)
Q Consensus 2 ~~~~~-~~g~~vaiK~~~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 75 (311)
|.+.. .+|+.||||+++...... .+.+.+|+.++++++||||+++++++.++...|+||||+.|+++..+...
T Consensus 15 y~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~~~~~~~~~~~- 93 (299)
T d1ua2a_ 15 YKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDN- 93 (299)
T ss_dssp EEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSEEHHHHHTTC-
T ss_pred EEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhcchHHhhhhhc-
Confidence 44443 369999999986543322 35788999999999999999999999999999999999998877766654
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeecccccc
Q 021490 76 SPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYG 155 (311)
Q Consensus 76 ~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~ 155 (311)
...+++..+..++.||+.||+|||++| ++||||||+|||++.++.+||+|||++....... .......+|+.
T Consensus 94 ---~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~--~~~~~~~gt~~ 165 (299)
T d1ua2a_ 94 ---SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN--RAYTHQVVTRW 165 (299)
T ss_dssp ---CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC--CCCCCSCCCCT
T ss_pred ---ccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCc--ccccceecChh
Confidence 577999999999999999999999999 9999999999999999999999999997533221 22233568999
Q ss_pred ccCcccccc-CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccc-c-ccccccCcccc---CCC--
Q 021490 156 YCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDR-T-RHSLIADPELQ---GQY-- 227 (311)
Q Consensus 156 y~aPE~~~~-~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~---~~~-- 227 (311)
|+|||++.. ..++.++|||||||++|+|++|..||......+....+.......... . ........... ...
T Consensus 166 y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (299)
T d1ua2a_ 166 YRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPL 245 (299)
T ss_dssp TCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCH
T ss_pred hccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCCCCCh
Confidence 999998865 467999999999999999999999998766554433222111000000 0 00000000000 001
Q ss_pred ---ChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 021490 228 ---PPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 228 ---~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~ 259 (311)
.+..+..+.+|+.+||+.||++|||++|+++.
T Consensus 246 ~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 246 HHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp HHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred HHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 11234678999999999999999999999875
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-47 Score=324.78 Aligned_cols=233 Identities=25% Similarity=0.346 Sum_probs=179.6
Q ss_pred CcEEEEEEeecCCCc-chhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHHH
Q 021490 9 LQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTR 87 (311)
Q Consensus 9 g~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~ 87 (311)
+..||||+++..... ..+.|.+|+.++++++||||+++++++. +...++||||+++|+|.+++... ...+++..+
T Consensus 35 ~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~E~~~~g~l~~~~~~~---~~~l~~~~~ 110 (273)
T d1mp8a_ 35 ALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVR---KYSLDLASL 110 (273)
T ss_dssp CEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHHT---TTTSCHHHH
T ss_pred eEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEEEeccCCcHHhhhhcc---CCCCCHHHH
Confidence 457899988654433 3467999999999999999999999986 45789999999999999987652 467999999
Q ss_pred HHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccCCC
Q 021490 88 MKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQL 167 (311)
Q Consensus 88 ~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 167 (311)
+.++.||+.||+|||+++ ++||||||+||+++.++.+||+|||++....... ........+|+.|+|||++.+..+
T Consensus 111 ~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~-~~~~~~~~gt~~y~apE~l~~~~~ 186 (273)
T d1mp8a_ 111 ILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST-YYKASKGKLPIKWMAPESINFRRF 186 (273)
T ss_dssp HHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------------------CCGGGCCHHHHHHCCC
T ss_pred HHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheeccCCc-ceeccceecCcccchhhHhccCCC
Confidence 999999999999999999 9999999999999999999999999997543221 122233567899999999999999
Q ss_pred ccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccC
Q 021490 168 TLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQ 246 (311)
Q Consensus 168 ~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 246 (311)
+.++|||||||++|||++ |.+||...........+... . . ...++..+..+.+||.+||+.|
T Consensus 187 ~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~-------~------~----~~~~~~~~~~~~~li~~cl~~d 249 (273)
T d1mp8a_ 187 TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG-------E------R----LPMPPNCPPTLYSLMTKCWAYD 249 (273)
T ss_dssp SHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT-------C------C----CCCCTTCCHHHHHHHHHHTCSS
T ss_pred CCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-------C------C----CCCCCCCCHHHHHHHHHHcCCC
Confidence 999999999999999998 89999876554332221110 0 0 1123344568999999999999
Q ss_pred CCCCCCHHHHHHHHHHhhhc
Q 021490 247 PDMRPVIADVVTALAYLASQ 266 (311)
Q Consensus 247 p~~Rps~~~vl~~l~~~~~~ 266 (311)
|++|||+.+|++.|+.+.+.
T Consensus 250 p~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 250 PSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp GGGSCCHHHHHHHHHHHHHH
T ss_pred HhHCcCHHHHHHHHHHHHHH
Confidence 99999999999999877644
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.7e-47 Score=329.22 Aligned_cols=237 Identities=26% Similarity=0.399 Sum_probs=190.1
Q ss_pred CCcEEEEEEeecCCCc-chhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccC----------
Q 021490 8 LLQDVAIKQLDRNGVQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLS---------- 76 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------- 76 (311)
++..||||+++..... ..++|.+|+++|+.++||||+++++++.+....++||||+++|+|.+++....
T Consensus 42 ~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~ 121 (301)
T d1lufa_ 42 PFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHS 121 (301)
T ss_dssp SEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC---------
T ss_pred CCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEEEecCCCcHHHHHHhcCcccccccccc
Confidence 5688999999765433 34689999999999999999999999999999999999999999999986521
Q ss_pred ----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCcee
Q 021490 77 ----------PGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHV 146 (311)
Q Consensus 77 ----------~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~ 146 (311)
.....+++..++.++.|++.||+|||+++ ++||||||+|||++.++.+||+|||++...........
T Consensus 122 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~ 198 (301)
T d1lufa_ 122 DLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKA 198 (301)
T ss_dssp -------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC-
T ss_pred ccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEcccceEECCCCcEEEccchhheeccCCccccc
Confidence 11345899999999999999999999999 99999999999999999999999999875333222233
Q ss_pred eeeccccccccCccccccCCCccccceeehhHHHHHHHhCC-CccCcchhHHHHHHHHHhhhhhccccccccccCccccC
Q 021490 147 STRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGR-KAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQG 225 (311)
Q Consensus 147 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~l~~~ll~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (311)
.....+++.|+|||.+.+..++.++|||||||++|||++|. +||......+....+... . .+
T Consensus 199 ~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~~-------~------~~---- 261 (301)
T d1lufa_ 199 DGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDG-------N------IL---- 261 (301)
T ss_dssp ---CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT-------C------CC----
T ss_pred cCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHHHHHHHHcC-------C------CC----
Confidence 33456888999999999999999999999999999999985 677766554432222110 0 01
Q ss_pred CCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhh
Q 021490 226 QYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLA 264 (311)
Q Consensus 226 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l~~~~ 264 (311)
..+...+.++.+|+.+||+.||++|||+.+|++.|+.+.
T Consensus 262 ~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 262 ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 122333457889999999999999999999999998775
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-47 Score=329.71 Aligned_cols=232 Identities=26% Similarity=0.414 Sum_probs=185.3
Q ss_pred EEEEEEeecCC-CcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHHHHH
Q 021490 11 DVAIKQLDRNG-VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRMK 89 (311)
Q Consensus 11 ~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~ 89 (311)
+||+|.++... ....+.|.+|+.++++++||||+++++++.++ ..+++++++.+++|.+++... ...+++..++.
T Consensus 40 ~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~e~~~~~~l~~~~~~~---~~~~~~~~~~~ 115 (317)
T d1xkka_ 40 PVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREH---KDNIGSQYLLN 115 (317)
T ss_dssp EEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECCTTCBHHHHHHHT---SSSCCHHHHHH
T ss_pred EEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEEEeccCCccccccccc---ccCCCHHHHHH
Confidence 68999886543 34567899999999999999999999999865 567888999999999888762 56799999999
Q ss_pred HHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccccCCCcc
Q 021490 90 IAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAKTGQLTL 169 (311)
Q Consensus 90 ~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 169 (311)
++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++................||..|+|||++.+..++.
T Consensus 116 i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~ 192 (317)
T d1xkka_ 116 WCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH 192 (317)
T ss_dssp HHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCH
T ss_pred HHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecccccccccccccccCccccChHHHhcCCCCh
Confidence 9999999999999999 9999999999999999999999999998654433333334456899999999999999999
Q ss_pred ccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccCCC
Q 021490 170 KSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQPD 248 (311)
Q Consensus 170 ~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~ 248 (311)
++|||||||++|||+| |..||...........+.... ....++..+..+.+|+.+||+.||.
T Consensus 193 ~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~-----------------~~~~p~~~~~~~~~li~~cl~~dP~ 255 (317)
T d1xkka_ 193 QSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE-----------------RLPQPPICTIDVYMIMVKCWMIDAD 255 (317)
T ss_dssp HHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTC-----------------CCCCCTTBCHHHHHHHHHHTCSSGG
T ss_pred hhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC-----------------CCCCCcccCHHHHHHHHHhCCCChh
Confidence 9999999999999998 789987765443332222110 0112333445789999999999999
Q ss_pred CCCCHHHHHHHHHHhhhc
Q 021490 249 MRPVIADVVTALAYLASQ 266 (311)
Q Consensus 249 ~Rps~~~vl~~l~~~~~~ 266 (311)
+|||+.++++.|+.+...
T Consensus 256 ~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 256 SRPKFRELIIEFSKMARD 273 (317)
T ss_dssp GSCCHHHHHHHHHHHHHS
T ss_pred hCcCHHHHHHHHHHHHhC
Confidence 999999999999887643
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-47 Score=328.66 Aligned_cols=236 Identities=14% Similarity=0.173 Sum_probs=189.3
Q ss_pred cchhc-cCCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCC
Q 021490 2 MQVIL-CLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKK 80 (311)
Q Consensus 2 ~~~~~-~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 80 (311)
|.+.. .+|+.||||+++... .....+.+|+++|+.++||||++++++|.++..+|+|||||+||+|.+++... +.
T Consensus 22 y~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~~~i~~~---~~ 97 (321)
T d1tkia_ 22 HRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTS---AF 97 (321)
T ss_dssp EEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSS---SC
T ss_pred EEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCcHHHHHHhc---CC
Confidence 34443 368999999996543 34467889999999999999999999999999999999999999999999762 34
Q ss_pred CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcC--CCceEEccccccccCCCCCCceeeeeccccccccC
Q 021490 81 PLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR--GYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCA 158 (311)
Q Consensus 81 ~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~--~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~a 158 (311)
.+++.++..++.||+.||+|||++| |+||||||+|||++. .+.++|+|||++..... ........+++.|+|
T Consensus 98 ~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~---~~~~~~~~~t~~y~a 171 (321)
T d1tkia_ 98 ELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP---GDNFRLLFTAPEYYA 171 (321)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT---TCEEEEEESCGGGSC
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhcccc---CCccccccccccccc
Confidence 7999999999999999999999999 999999999999985 45899999999875422 222334568899999
Q ss_pred ccccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHH
Q 021490 159 PEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAV 238 (311)
Q Consensus 159 PE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 238 (311)
||.+.+..++.++|||||||++|+|++|..||...........+... .... +... .+..+.++.+|
T Consensus 172 pe~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~------~~~~----~~~~----~~~~s~~~~~l 237 (321)
T d1tkia_ 172 PEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNA------EYTF----DEEA----FKEISIEAMDF 237 (321)
T ss_dssp HHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT------CCCC----CHHH----HTTSCHHHHHH
T ss_pred chhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------CCCC----Chhh----ccCCCHHHHHH
Confidence 99999999999999999999999999999999876654332222111 0000 0000 11234478899
Q ss_pred HHHccccCCCCCCCHHHHHHHHH
Q 021490 239 AAMCVHEQPDMRPVIADVVTALA 261 (311)
Q Consensus 239 i~~~l~~~p~~Rps~~~vl~~l~ 261 (311)
+.+||..||.+|||+.|+++.-.
T Consensus 238 i~~~L~~dp~~R~s~~eil~hp~ 260 (321)
T d1tkia_ 238 VDRLLVKERKSRMTASEALQHPW 260 (321)
T ss_dssp HHTTSCSSGGGSCCHHHHHHSHH
T ss_pred HHHHccCChhHCcCHHHHhcCHh
Confidence 99999999999999999998643
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-47 Score=321.79 Aligned_cols=231 Identities=28% Similarity=0.389 Sum_probs=181.0
Q ss_pred cEEEEEEeecCCC---cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHHH
Q 021490 10 QDVAIKQLDRNGV---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNT 86 (311)
Q Consensus 10 ~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~ 86 (311)
..||||+++.... ...+.|.+|+.+|++++||||+++++++.+ ...++|||||++++|.+++... .+.+++..
T Consensus 37 ~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv~e~~~~~~l~~~~~~~---~~~l~~~~ 112 (273)
T d1u46a_ 37 VSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKH---QGHFLLGT 112 (273)
T ss_dssp EEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHHH---GGGSCHHH
T ss_pred EEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchheeeeeecCcchhhhhhcc---cCCCCHHH
Confidence 4799999876432 334689999999999999999999999965 4678999999999999887652 45699999
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCcee-eeeccccccccCccccccC
Q 021490 87 RMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHV-STRVMGTYGYCAPEYAKTG 165 (311)
Q Consensus 87 ~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~ 165 (311)
+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++........... .....++..|+|||++.+.
T Consensus 113 ~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~ 189 (273)
T d1u46a_ 113 LSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 189 (273)
T ss_dssp HHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHC
T ss_pred HHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCC
Confidence 9999999999999999999 99999999999999999999999999986543333222 2334578899999999999
Q ss_pred CCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccc
Q 021490 166 QLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVH 244 (311)
Q Consensus 166 ~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 244 (311)
.++.++||||||+++|||+| |..||...........+. .... .+ ..+...+..+.+|+.+||.
T Consensus 190 ~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~------~~~~------~~----~~~~~~~~~l~~li~~cl~ 253 (273)
T d1u46a_ 190 TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID------KEGE------RL----PRPEDCPQDIYNVMVQCWA 253 (273)
T ss_dssp EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH------TSCC------CC----CCCTTCCHHHHHHHHHHTC
T ss_pred CCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHH------hCCC------CC----CCcccccHHHHHHHHHHcC
Confidence 99999999999999999998 899998765544322111 1100 01 1122334578899999999
Q ss_pred cCCCCCCCHHHHHHHHHHh
Q 021490 245 EQPDMRPVIADVVTALAYL 263 (311)
Q Consensus 245 ~~p~~Rps~~~vl~~l~~~ 263 (311)
.||++|||+.+|.+.|.+.
T Consensus 254 ~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 254 HKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp SSGGGSCCHHHHHHHHHHH
T ss_pred CChhHCcCHHHHHHHHHhc
Confidence 9999999999999988754
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1e-46 Score=329.90 Aligned_cols=228 Identities=23% Similarity=0.236 Sum_probs=189.7
Q ss_pred cchhc-cCCcEEEEEEeecCC---CcchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCC
Q 021490 2 MQVIL-CLLQDVAIKQLDRNG---VQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP 77 (311)
Q Consensus 2 ~~~~~-~~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 77 (311)
|.+.. .+|+.||||+++... ....+.+.+|+.+|+.++||||+++++++.+....++||||+.||+|..++..
T Consensus 58 y~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~l~~--- 134 (350)
T d1rdqe_ 58 MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR--- 134 (350)
T ss_dssp EEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH---
T ss_pred EEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccccccccchhhhHhh---
Confidence 44443 369999999997542 23456889999999999999999999999999999999999999999999987
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeecccccccc
Q 021490 78 GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 157 (311)
Q Consensus 78 ~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~ 157 (311)
.+.+++..+..++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||++...... .....||+.|+
T Consensus 135 -~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~-----~~~~~Gt~~Y~ 205 (350)
T d1rdqe_ 135 -IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWTLCGTPEAL 205 (350)
T ss_dssp -HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC-----BCCCEECGGGC
T ss_pred -cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc-----cccccCccccC
Confidence 567999999999999999999999999 999999999999999999999999999764322 22346899999
Q ss_pred CccccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHH
Q 021490 158 APEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALA 237 (311)
Q Consensus 158 aPE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 237 (311)
|||++.+..++.++|||||||++|+|++|..||...........+... . + ..+...+.++.+
T Consensus 206 APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~------~--------~----~~p~~~s~~~~~ 267 (350)
T d1rdqe_ 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG------K--------V----RFPSHFSSDLKD 267 (350)
T ss_dssp CHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------C--------C----CCCTTCCHHHHH
T ss_pred CHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcC------C--------C----CCCccCCHHHHH
Confidence 999999999999999999999999999999999876543332222111 0 0 112234458899
Q ss_pred HHHHccccCCCCCC-----CHHHHHHH
Q 021490 238 VAAMCVHEQPDMRP-----VIADVVTA 259 (311)
Q Consensus 238 li~~~l~~~p~~Rp-----s~~~vl~~ 259 (311)
||.+||..||.+|+ |++++++.
T Consensus 268 li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 268 LLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp HHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHHHHhhhCHHhccccccccHHHHHcC
Confidence 99999999999994 89999875
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-47 Score=330.07 Aligned_cols=237 Identities=20% Similarity=0.231 Sum_probs=182.4
Q ss_pred cchhc-cCCcEEEEEEeecCCCcchhHHHHHHHHHhcC-CCCcccceeeEeee----CCeeEEEEecCCCCChhhhhccc
Q 021490 2 MQVIL-CLLQDVAIKQLDRNGVQGNREFLVEVLMLSLL-HHPNLVNLIGYCAD----GDQRLLVYEYMPLGSVEDHLHDL 75 (311)
Q Consensus 2 ~~~~~-~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~ 75 (311)
|.+.. .+|+.||||+++ ....+.+|+.++.++ +||||++++++|.+ +..+|+|||||+||+|.+++...
T Consensus 29 y~a~~~~~~~~vAiK~i~-----~~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~ 103 (335)
T d2ozaa1 29 LQIFNKRTQEKFALKMLQ-----DCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDR 103 (335)
T ss_dssp EEEEETTTCCEEEEEEEE-----CSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHSC
T ss_pred EEEEECCCCCEEEEEEEC-----CcHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCCCcHHHHHHhc
Confidence 44443 468999999995 345678899987654 89999999999865 45689999999999999999762
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcC---CCceEEccccccccCCCCCCceeeeeccc
Q 021490 76 SPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR---GYHPKLSDFGLAKLGPVGDNTHVSTRVMG 152 (311)
Q Consensus 76 ~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~---~~~~~l~df~~~~~~~~~~~~~~~~~~~~ 152 (311)
....+++..+..++.||+.||+|||++| |+||||||+|||++. ++.+||+|||++....... ......|
T Consensus 104 --~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~---~~~~~~g 175 (335)
T d2ozaa1 104 --GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCY 175 (335)
T ss_dssp --SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCC---CCCCCSC
T ss_pred --CCCCcCHHHHHHHHHHHHHHHHHHHHcC---CccccccccccccccccccccccccccceeeeccCCC---ccccccC
Confidence 2357999999999999999999999999 999999999999985 5679999999997543322 2334569
Q ss_pred cccccCccccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhH
Q 021490 153 TYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGF 232 (311)
Q Consensus 153 ~~~y~aPE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (311)
|+.|+|||++.+..++.++|||||||++|+|++|..||............ ... .... ...+........+
T Consensus 176 t~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~------~~~-i~~~---~~~~~~~~~~~~s 245 (335)
T d2ozaa1 176 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM------KTR-IRMG---QYEFPNPEWSEVS 245 (335)
T ss_dssp CCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------------C-CCSC---SSSCCTTHHHHSC
T ss_pred CcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHH------HHH-HhcC---CCCCCCcccccCC
Confidence 99999999999999999999999999999999999999765432211100 000 0000 0011111112345
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 021490 233 YQALAVAAMCVHEQPDMRPVIADVVTALA 261 (311)
Q Consensus 233 ~~l~~li~~~l~~~p~~Rps~~~vl~~l~ 261 (311)
.++.+||.+||+.||++|||+.|+++.-.
T Consensus 246 ~~~~~li~~~L~~dP~~R~s~~eil~hp~ 274 (335)
T d2ozaa1 246 EEVKMLIRNLLKTEPTQRMTITEFMNHPW 274 (335)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHHSHH
T ss_pred HHHHHHHHHHccCChhHCcCHHHHHcCHH
Confidence 68999999999999999999999998643
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-47 Score=329.63 Aligned_cols=224 Identities=29% Similarity=0.391 Sum_probs=185.5
Q ss_pred CCcEEEEEEeecCC---CcchhHHHHHHHHHh-cCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCC
Q 021490 8 LLQDVAIKQLDRNG---VQGNREFLVEVLMLS-LLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLD 83 (311)
Q Consensus 8 ~g~~vaiK~~~~~~---~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~ 83 (311)
+|+.||||++++.. ....+.+.+|..++. .++||||+++++++.++...|+|||||+||+|.+++.. ...++
T Consensus 26 t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~~g~L~~~i~~----~~~~~ 101 (320)
T d1xjda_ 26 TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS----CHKFD 101 (320)
T ss_dssp TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH----HSSCC
T ss_pred CCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeecCCCcHHHHhhc----cCCCC
Confidence 69999999997542 234466777777765 68999999999999999999999999999999999987 57799
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCccccc
Q 021490 84 WNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAK 163 (311)
Q Consensus 84 ~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 163 (311)
+..+..++.||+.||+|||+++ ++||||||+|||++.++.+||+|||++...... ........||+.|+|||++.
T Consensus 102 e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~ 176 (320)
T d1xjda_ 102 LSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLG--DAKTNTFCGTPDYIAPEILL 176 (320)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT--TCCBCCCCSCGGGCCHHHHT
T ss_pred HHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhcccc--cccccccCCCCCcCCHHHHc
Confidence 9999999999999999999999 999999999999999999999999999753322 22233456899999999999
Q ss_pred cCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHcc
Q 021490 164 TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCV 243 (311)
Q Consensus 164 ~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 243 (311)
+..++.++|||||||++|+|++|..||.+.........+... .+ .++...+.++.+||.+||
T Consensus 177 ~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~--------------~~----~~p~~~s~~~~dli~~~L 238 (320)
T d1xjda_ 177 GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--------------NP----FYPRWLEKEAKDLLVKLF 238 (320)
T ss_dssp TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--------------CC----CCCTTSCHHHHHHHHHHS
T ss_pred CCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--------------CC----CCCccCCHHHHHHHHHhc
Confidence 999999999999999999999999999876654432222111 11 122233457899999999
Q ss_pred ccCCCCCCCHH-HHHH
Q 021490 244 HEQPDMRPVIA-DVVT 258 (311)
Q Consensus 244 ~~~p~~Rps~~-~vl~ 258 (311)
..||.+|||+. ++++
T Consensus 239 ~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 239 VREPEKRLGVRGDIRQ 254 (320)
T ss_dssp CSSGGGSBTTBSCGGG
T ss_pred ccCCCCCcCHHHHHHh
Confidence 99999999996 6764
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-46 Score=321.85 Aligned_cols=239 Identities=27% Similarity=0.396 Sum_probs=193.9
Q ss_pred CCcEEEEEEeecCCC-cchhHHHHHHHHHhcC-CCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCC--------
Q 021490 8 LLQDVAIKQLDRNGV-QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP-------- 77 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-------- 77 (311)
.+..||||+++.... .....+.+|+..+.++ +||||+++++++.++...++|||||++|+|.+++.....
T Consensus 44 ~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~ 123 (299)
T d1fgka_ 44 RVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYN 123 (299)
T ss_dssp CEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC-------
T ss_pred CceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccc
Confidence 345799999976554 3346888899999888 899999999999999999999999999999999975321
Q ss_pred ----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeecccc
Q 021490 78 ----GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT 153 (311)
Q Consensus 78 ----~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~ 153 (311)
....+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||++................++
T Consensus 124 ~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 200 (299)
T d1fgka_ 124 PSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLP 200 (299)
T ss_dssp -----CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCG
T ss_pred cccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceeecCCCCeEeccchhhccccccccccccccCCCC
Confidence 1356899999999999999999999999 999999999999999999999999999765443333333445688
Q ss_pred ccccCccccccCCCccccceeehhHHHHHHHh-CCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhH
Q 021490 154 YGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGF 232 (311)
Q Consensus 154 ~~y~aPE~~~~~~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (311)
+.|+|||.+.+..++.++||||||+++|+|++ |.+||...........+. ... .+ ..+...+
T Consensus 201 ~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i~-------~~~------~~----~~p~~~~ 263 (299)
T d1fgka_ 201 VKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK-------EGH------RM----DKPSNCT 263 (299)
T ss_dssp GGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-------TTC------CC----CCCSSCC
T ss_pred hhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHHHH-------cCC------CC----CCCccch
Confidence 99999999999999999999999999999998 688887665543322211 110 01 1222344
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 021490 233 YQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 266 (311)
Q Consensus 233 ~~l~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~ 266 (311)
..+.+|+.+||+.||.+|||+.||++.|+.+.+.
T Consensus 264 ~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~ 297 (299)
T d1fgka_ 264 NELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297 (299)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence 5789999999999999999999999999887643
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-46 Score=320.78 Aligned_cols=250 Identities=19% Similarity=0.231 Sum_probs=184.5
Q ss_pred cchhc-cCCcEEEEEEeecCCC--cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCC
Q 021490 2 MQVIL-CLLQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPG 78 (311)
Q Consensus 2 ~~~~~-~~g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~ 78 (311)
|.+.. .+|+.||||+++.... ...+++.+|+++|++++||||+++++++.++...|+||||+.+ ++.+++... .
T Consensus 19 y~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~-~~~~~~~~~--~ 95 (298)
T d1gz8a_ 19 YKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDAS--A 95 (298)
T ss_dssp EEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHT--T
T ss_pred EEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCC-chhhhhhhh--c
Confidence 44443 5799999999965432 2357899999999999999999999999999999999999975 444444332 2
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccC
Q 021490 79 KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCA 158 (311)
Q Consensus 79 ~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~a 158 (311)
...+++..+..++.|++.||+|||++| |+||||||+|||++.++.+||+|||.+...... ........+++.|+|
T Consensus 96 ~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~--~~~~~~~~gt~~y~a 170 (298)
T d1gz8a_ 96 LTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--VRTYTHEVVTLWYRA 170 (298)
T ss_dssp TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC--SBCTTCCBCCCTTCC
T ss_pred ccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCC--cccceeecccceeee
Confidence 567999999999999999999999999 999999999999999999999999998753221 222334568999999
Q ss_pred ccccccCC-CccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCC-----------
Q 021490 159 PEYAKTGQ-LTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQ----------- 226 (311)
Q Consensus 159 PE~~~~~~-~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------- 226 (311)
||++.... ++.++|||||||++|+|++|..||...+.......+..................+.....
T Consensus 171 pE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (298)
T d1gz8a_ 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSK 250 (298)
T ss_dssp HHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHH
T ss_pred hhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccccccccccchhh
Confidence 99877655 578999999999999999999999876654433222111100000000000001111000
Q ss_pred CChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 021490 227 YPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 227 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~ 259 (311)
..+..+.++.+|+.+||..||++|||+.|+++.
T Consensus 251 ~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 251 VVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp HSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 012334678899999999999999999999976
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-46 Score=320.83 Aligned_cols=234 Identities=26% Similarity=0.416 Sum_probs=185.3
Q ss_pred EEEEEEeecC-CCcchhHHHHHHHHHhcCCCCcccceeeEeee-CCeeEEEEecCCCCChhhhhcccCCCCCCCCHHHHH
Q 021490 11 DVAIKQLDRN-GVQGNREFLVEVLMLSLLHHPNLVNLIGYCAD-GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWNTRM 88 (311)
Q Consensus 11 ~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~ 88 (311)
.||||+++.. .....++|.+|+++|.+++||||+++++++.+ +...++|||||++++|.+++... ...+++..++
T Consensus 57 ~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~~g~l~~~~~~~---~~~~~~~~~~ 133 (311)
T d1r0pa_ 57 HCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE---THNPTVKDLI 133 (311)
T ss_dssp EEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECCTTCBHHHHHHCT---TCCCBHHHHH
T ss_pred EEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEeecCchhhhhccc---cccchHHHHH
Confidence 6899999754 33445789999999999999999999999865 45889999999999999998762 4568889999
Q ss_pred HHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCc--eeeeeccccccccCccccccCC
Q 021490 89 KIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT--HVSTRVMGTYGYCAPEYAKTGQ 166 (311)
Q Consensus 89 ~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~ 166 (311)
.++.|++.||.|||+.+ ++||||||+|||+++++.+||+|||++......... .......++..|+|||.+....
T Consensus 134 ~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 210 (311)
T d1r0pa_ 134 GFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK 210 (311)
T ss_dssp HHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCC
T ss_pred HHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccccceecccccccccccChHHHhcCC
Confidence 99999999999999999 999999999999999999999999999764332211 1222346889999999999999
Q ss_pred CccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHHHccccC
Q 021490 167 LTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAAMCVHEQ 246 (311)
Q Consensus 167 ~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 246 (311)
++.++||||||+++|||++|..||........ +.... ... .. + ..+...+..+.+|+.+||+.|
T Consensus 211 ~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~--~~~~i---~~g-~~------~----~~p~~~~~~l~~li~~cl~~d 274 (311)
T d1r0pa_ 211 FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--ITVYL---LQG-RR------L----LQPEYCPDPLYEVMLKCWHPK 274 (311)
T ss_dssp CCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHH---HTT-CC------C----CCCTTCCHHHHHHHHHHTCSS
T ss_pred CCChhHhhhhHHHHHHHHHCCCCCCCCCCHHH--HHHHH---HcC-CC------C----CCcccCcHHHHHHHHHHcCCC
Confidence 99999999999999999998877754332111 11111 100 00 0 112233457889999999999
Q ss_pred CCCCCCHHHHHHHHHHhhhc
Q 021490 247 PDMRPVIADVVTALAYLASQ 266 (311)
Q Consensus 247 p~~Rps~~~vl~~l~~~~~~ 266 (311)
|++|||+.||++.|+.+...
T Consensus 275 P~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 275 AEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp GGGSCCHHHHHHHHHHHHHT
T ss_pred HhHCcCHHHHHHHHHHHHHh
Confidence 99999999999999988754
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-46 Score=321.10 Aligned_cols=234 Identities=30% Similarity=0.417 Sum_probs=185.2
Q ss_pred EEEEEEeecCC-CcchhHHHHHHHHHhcC-CCCcccceeeEeeeCCeeEEEEecCCCCChhhhhccc------------C
Q 021490 11 DVAIKQLDRNG-VQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDL------------S 76 (311)
Q Consensus 11 ~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~------------~ 76 (311)
.||||+++... ....+.|.+|+++|.++ +||||+++++++.++...++||||++||+|.+++... .
T Consensus 39 ~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~ 118 (309)
T d1fvra_ 39 DAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 118 (309)
T ss_dssp EEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHT
T ss_pred EEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccc
Confidence 57888886543 34557899999999999 7999999999999999999999999999999998753 1
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccc
Q 021490 77 PGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY 156 (311)
Q Consensus 77 ~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y 156 (311)
.....+++..++.++.||+.||.|||+++ ++||||||+|||++.++.+||+|||++...... .......++..|
T Consensus 119 ~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~---~~~~~~~gt~~y 192 (309)
T d1fvra_ 119 STASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVY---VKKTMGRLPVRW 192 (309)
T ss_dssp TBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEESSCEE---CCC----CCTTT
T ss_pred cccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCceEEcccccccccccc---ccccceecCCcc
Confidence 23467999999999999999999999999 999999999999999999999999998642211 112234588999
Q ss_pred cCccccccCCCccccceeehhHHHHHHHhCC-CccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHH
Q 021490 157 CAPEYAKTGQLTLKSDVYSFGVVLLEILSGR-KAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQA 235 (311)
Q Consensus 157 ~aPE~~~~~~~~~~~DiwslG~l~~~ll~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 235 (311)
+|||.+.+..++.++|||||||++|||++|. +||...........+ .... . ...+...+.++
T Consensus 193 ~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i-------~~~~------~----~~~~~~~~~~~ 255 (309)
T d1fvra_ 193 MAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL-------PQGY------R----LEKPLNCDDEV 255 (309)
T ss_dssp CCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHG-------GGTC------C----CCCCTTBCHHH
T ss_pred cchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHH-------HhcC------C----CCCCccCCHHH
Confidence 9999999999999999999999999999965 567655433321111 0100 1 12233345589
Q ss_pred HHHHHHccccCCCCCCCHHHHHHHHHHhhhcc
Q 021490 236 LAVAAMCVHEQPDMRPVIADVVTALAYLASQK 267 (311)
Q Consensus 236 ~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~~ 267 (311)
.+||.+||+.||++|||+.++++.|+.+.+..
T Consensus 256 ~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 256 YDLMRQCWREKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred HHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 99999999999999999999999999887543
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.6e-46 Score=328.12 Aligned_cols=232 Identities=24% Similarity=0.255 Sum_probs=183.3
Q ss_pred cchhc-cCCcEEEEEEeecCCC---cchhHHHH---HHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcc
Q 021490 2 MQVIL-CLLQDVAIKQLDRNGV---QGNREFLV---EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHD 74 (311)
Q Consensus 2 ~~~~~-~~g~~vaiK~~~~~~~---~~~~~~~~---e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 74 (311)
|.+.. .+|+.||||++..... .....+.+ ++.+++.++||||+++++++.++...|+|||||+||+|.+++..
T Consensus 21 y~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE~~~gg~L~~~l~~ 100 (364)
T d1omwa3 21 YGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ 100 (364)
T ss_dssp EEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH
T ss_pred EEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEEEEecCCCcHHHHHHh
Confidence 44443 3699999999865432 22233444 46777788899999999999999999999999999999999987
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccc
Q 021490 75 LSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTY 154 (311)
Q Consensus 75 ~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~ 154 (311)
...+++..++.++.||+.||+|||+++ ++||||||+|||++.+|.+||+|||++....... .....||+
T Consensus 101 ----~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~----~~~~~GT~ 169 (364)
T d1omwa3 101 ----HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTH 169 (364)
T ss_dssp ----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEECSSSC----CCSCCSCG
T ss_pred ----cccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeecCCCc----cccccccc
Confidence 577999999999999999999999999 9999999999999999999999999997543221 22346999
Q ss_pred cccCcccccc-CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHH
Q 021490 155 GYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFY 233 (311)
Q Consensus 155 ~y~aPE~~~~-~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
.|+|||++.. ..++.++|||||||++|+|++|..||..........+.... ... . ...+...+.
T Consensus 170 ~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~---~~~--------~----~~~~~~~s~ 234 (364)
T d1omwa3 170 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT---LTM--------A----VELPDSFSP 234 (364)
T ss_dssp GGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHS---SSC--------C----CCCCSSSCH
T ss_pred ccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc---ccC--------C----CCCCCCCCH
Confidence 9999999864 57899999999999999999999999765433222211111 000 1 112233445
Q ss_pred HHHHHHHHccccCCCCCCC-----HHHHHHH
Q 021490 234 QALAVAAMCVHEQPDMRPV-----IADVVTA 259 (311)
Q Consensus 234 ~l~~li~~~l~~~p~~Rps-----~~~vl~~ 259 (311)
++.+||.+||+.||++||| ++|+++.
T Consensus 235 ~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 235 ELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp HHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred HHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 8899999999999999999 6888865
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-46 Score=323.74 Aligned_cols=238 Identities=26% Similarity=0.385 Sum_probs=192.5
Q ss_pred cCCcEEEEEEeecCCC-cchhHHHHHHHHHhcC-CCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCC-------
Q 021490 7 CLLQDVAIKQLDRNGV-QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSP------- 77 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~------- 77 (311)
.+++.||||+++.... .....|.+|+.++..+ +||||+++++++.+....++|||||++|+|.+++.....
T Consensus 51 ~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~ 130 (311)
T d1t46a_ 51 DAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKT 130 (311)
T ss_dssp TCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC-----
T ss_pred CCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhcccccccccc
Confidence 4578999999976543 3345799999999999 699999999999999999999999999999999876321
Q ss_pred -------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeec
Q 021490 78 -------GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRV 150 (311)
Q Consensus 78 -------~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~ 150 (311)
....+++..+..++.||+.||+|||+++ ++||||||+||+++.++.++++|||++...............
T Consensus 131 ~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~ 207 (311)
T d1t46a_ 131 SPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 207 (311)
T ss_dssp ---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSS
T ss_pred ccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccccccCcccccccchheeccCCCcceEeeec
Confidence 2346899999999999999999999999 999999999999999999999999999875544444444556
Q ss_pred cccccccCccccccCCCccccceeehhHHHHHHHh-CCCccCcchhHHH-HHHHHHhhhhhccccccccccCccccCCCC
Q 021490 151 MGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILS-GRKAVDTSKAAAE-QSLVAWARPLFQDRTRHSLIADPELQGQYP 228 (311)
Q Consensus 151 ~~~~~y~aPE~~~~~~~~~~~DiwslG~l~~~ll~-g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (311)
.+++.|+|||++.+..++.++|||||||++|||+| |.+||........ ..++... .....+
T Consensus 208 ~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~-----------------~~~~~~ 270 (311)
T d1t46a_ 208 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEG-----------------FRMLSP 270 (311)
T ss_dssp EECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHT-----------------CCCCCC
T ss_pred ccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC-----------------CCCCCc
Confidence 78999999999999999999999999999999999 5565655443222 1222111 011122
Q ss_pred hHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhh
Q 021490 229 PRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLA 264 (311)
Q Consensus 229 ~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l~~~~ 264 (311)
...+..+.+||.+||+.||.+|||+.++++.|+.+.
T Consensus 271 ~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i 306 (311)
T d1t46a_ 271 EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (311)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhh
Confidence 234457899999999999999999999999998654
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-46 Score=323.74 Aligned_cols=238 Identities=27% Similarity=0.369 Sum_probs=178.5
Q ss_pred CCcEEEEEEeecCCC-cchhHHHHHHHHHhcC-CCCcccceeeEeeeC-CeeEEEEecCCCCChhhhhcccCC-------
Q 021490 8 LLQDVAIKQLDRNGV-QGNREFLVEVLMLSLL-HHPNLVNLIGYCADG-DQRLLVYEYMPLGSVEDHLHDLSP------- 77 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~------- 77 (311)
+++.||||+++.... ...+.+.+|...+.++ +|+||+.+++++.+. ...++|||||++|+|.+++.....
T Consensus 42 ~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~ 121 (299)
T d1ywna1 42 TCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKV 121 (299)
T ss_dssp CEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC---
T ss_pred CCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhcccccccccc
Confidence 457899999975443 3346788888888877 688999999987654 568999999999999999875311
Q ss_pred -----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccc
Q 021490 78 -----GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMG 152 (311)
Q Consensus 78 -----~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~ 152 (311)
....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...............|
T Consensus 122 ~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~g 198 (299)
T d1ywna1 122 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 198 (299)
T ss_dssp --------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCC
T ss_pred chhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeECCCCcEEEccCcchhhccccccccccCceee
Confidence 1345899999999999999999999999 99999999999999999999999999976443333333344568
Q ss_pred cccccCccccccCCCccccceeehhHHHHHHHhC-CCccCcchhHHHH-HHHHHhhhhhccccccccccCccccCCCChH
Q 021490 153 TYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSG-RKAVDTSKAAAEQ-SLVAWARPLFQDRTRHSLIADPELQGQYPPR 230 (311)
Q Consensus 153 ~~~y~aPE~~~~~~~~~~~DiwslG~l~~~ll~g-~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (311)
|+.|+|||++.+..++.++|||||||++|||++| .+||......... ..+. ... .+ ..+..
T Consensus 199 t~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~-------~~~------~~----~~~~~ 261 (299)
T d1ywna1 199 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK-------EGT------RM----RAPDY 261 (299)
T ss_dssp GGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHH-------HTC------CC----CCCTT
T ss_pred CccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHh-------cCC------CC----CCCcc
Confidence 9999999999999999999999999999999986 5678655432211 1111 100 01 12233
Q ss_pred hHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhh
Q 021490 231 GFYQALAVAAMCVHEQPDMRPVIADVVTALAYLAS 265 (311)
Q Consensus 231 ~~~~l~~li~~~l~~~p~~Rps~~~vl~~l~~~~~ 265 (311)
.+.++.+++.+||+.||++|||+.|+++.|+.+.+
T Consensus 262 ~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 262 TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 34578999999999999999999999999987753
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.5e-45 Score=315.01 Aligned_cols=250 Identities=19% Similarity=0.189 Sum_probs=188.2
Q ss_pred CcchhccCCcEEEEEEeecCCC--cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCC
Q 021490 1 MMQVILCLLQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPG 78 (311)
Q Consensus 1 ~~~~~~~~g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~ 78 (311)
||.+...+|+.||||+++.... ...+.+.+|+.+|+.++||||+++++++.++...+++|+++.++.+..+...
T Consensus 18 Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~~~~~~~---- 93 (286)
T d1ob3a_ 18 VYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVC---- 93 (286)
T ss_dssp EEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHHTS----
T ss_pred EEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhhhHHHHHhh----
Confidence 4666677899999999966543 2347899999999999999999999999999999999999987766666654
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccC
Q 021490 79 KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCA 158 (311)
Q Consensus 79 ~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~a 158 (311)
.+.+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+|++|||.+...... ........+++.|+|
T Consensus 94 ~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~--~~~~~~~~~~~~y~~ 168 (286)
T d1ob3a_ 94 EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP--VRKYTHEIVTLWYRA 168 (286)
T ss_dssp TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----------CCCTTCC
T ss_pred cCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccC--ccccceecccchhhh
Confidence 578999999999999999999999999 999999999999999999999999998753222 122233458899999
Q ss_pred cccccc-CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhcc-----cccc------ccccCccccCC
Q 021490 159 PEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQD-----RTRH------SLIADPELQGQ 226 (311)
Q Consensus 159 PE~~~~-~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-----~~~~------~~~~~~~~~~~ 226 (311)
||.+.+ ..++.++|||||||++|+|++|+.||......+....+......... .... .....+.....
T Consensus 169 pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (286)
T d1ob3a_ 169 PDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWES 248 (286)
T ss_dssp HHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGG
T ss_pred HHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhh
Confidence 999865 45689999999999999999999999876554433222111100000 0000 00000100111
Q ss_pred CChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 021490 227 YPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 227 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~ 259 (311)
..+..+..+.+|+.+||+.||++|||++|+++.
T Consensus 249 ~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 249 FLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp TCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 223345688899999999999999999999864
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-46 Score=318.15 Aligned_cols=249 Identities=23% Similarity=0.287 Sum_probs=181.0
Q ss_pred cchhccCCcEEEEEEeecCCCcchhHHHH--HHHHHhcCCCCcccceeeEeeeCC----eeEEEEecCCCCChhhhhccc
Q 021490 2 MQVILCLLQDVAIKQLDRNGVQGNREFLV--EVLMLSLLHHPNLVNLIGYCADGD----QRLLVYEYMPLGSVEDHLHDL 75 (311)
Q Consensus 2 ~~~~~~~g~~vaiK~~~~~~~~~~~~~~~--e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~ 75 (311)
|.+.. +|+.||||+++.. ..+.+.. |+..+..++||||+++++++.+.. .+++|||||++|+|.+++++
T Consensus 20 y~~~~-~g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~- 94 (303)
T d1vjya_ 20 WRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR- 94 (303)
T ss_dssp EEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH-
T ss_pred EEEEE-CCEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCCCHHHHHhc-
Confidence 44443 6899999998643 2334444 455556789999999999997654 57999999999999999986
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHhhc--------CCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCce--
Q 021490 76 SPGKKPLDWNTRMKIAAGAARGLEYLHD--------KAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTH-- 145 (311)
Q Consensus 76 ~~~~~~l~~~~~~~~~~~i~~~l~~lh~--------~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~-- 145 (311)
..+++..++.++.+++.||+|||+ ++ |+||||||+|||++.++.+||+|||++..........
T Consensus 95 ----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~---IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~ 167 (303)
T d1vjya_ 95 ----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDI 167 (303)
T ss_dssp ----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC
T ss_pred ----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---eeccccCccceEEcCCCCeEEEecCccccccCCCcceec
Confidence 469999999999999999999997 46 9999999999999999999999999987643332221
Q ss_pred eeeeccccccccCccccccCC------CccccceeehhHHHHHHHhCCCccCcchhHHHH--H------HHHHhhhhhcc
Q 021490 146 VSTRVMGTYGYCAPEYAKTGQ------LTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ--S------LVAWARPLFQD 211 (311)
Q Consensus 146 ~~~~~~~~~~y~aPE~~~~~~------~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~--~------~~~~~~~~~~~ 211 (311)
......||+.|+|||++.+.. ++.++|||||||++|||+||..||......... . ...........
T Consensus 168 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (303)
T d1vjya_ 168 APNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCE 247 (303)
T ss_dssp ----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTT
T ss_pred cccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHHHHHHhc
Confidence 223457899999999987642 577899999999999999998887432211000 0 00000000000
Q ss_pred ccccccccCccccCCC-ChHhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhcc
Q 021490 212 RTRHSLIADPELQGQY-PPRGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQK 267 (311)
Q Consensus 212 ~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~~ 267 (311)
....|.+.... +......+.+|+.+||+.||++|||+.||++.|+++.+..
T Consensus 248 -----~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 299 (303)
T d1vjya_ 248 -----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp -----SCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -----cccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhc
Confidence 00111111111 2234567889999999999999999999999999887654
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-45 Score=315.74 Aligned_cols=236 Identities=25% Similarity=0.369 Sum_probs=189.3
Q ss_pred CCcEEEEEEeecCCC-cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccC------CCCC
Q 021490 8 LLQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLS------PGKK 80 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~ 80 (311)
.+..||||+++.... .....|.+|+.++.+++||||+++++++..+...++||||+++|+|.+++.... ....
T Consensus 49 ~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~ 128 (308)
T d1p4oa_ 49 PETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLA 128 (308)
T ss_dssp EEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCC
T ss_pred CCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccC
Confidence 357899999975433 333578999999999999999999999999999999999999999999876421 1124
Q ss_pred CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcc
Q 021490 81 PLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 160 (311)
Q Consensus 81 ~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE 160 (311)
.+++..+..++.|++.||.|||+++ |+||||||+|||+++++++||+|||++................+++.|+|||
T Consensus 129 ~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe 205 (308)
T d1p4oa_ 129 PPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE 205 (308)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEeecccceeccCCcceeeccceecccccCCHH
Confidence 5789999999999999999999999 9999999999999999999999999997543333323333446889999999
Q ss_pred ccccCCCccccceeehhHHHHHHHhC-CCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHH
Q 021490 161 YAKTGQLTLKSDVYSFGVVLLEILSG-RKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVA 239 (311)
Q Consensus 161 ~~~~~~~~~~~DiwslG~l~~~ll~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 239 (311)
.+.+..++.++||||||+++|||+|| ..||...........+. ... . ...+...+..+.+|+
T Consensus 206 ~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~-------~~~------~----~~~p~~~~~~l~~li 268 (308)
T d1p4oa_ 206 SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM-------EGG------L----LDKPDNCPDMLFELM 268 (308)
T ss_dssp HHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH-------TTC------C----CCCCTTCCHHHHHHH
T ss_pred HHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------hCC------C----CCCcccchHHHHHHH
Confidence 99999999999999999999999998 47777655443322221 000 0 111223345899999
Q ss_pred HHccccCCCCCCCHHHHHHHHHHh
Q 021490 240 AMCVHEQPDMRPVIADVVTALAYL 263 (311)
Q Consensus 240 ~~~l~~~p~~Rps~~~vl~~l~~~ 263 (311)
.+||+.||.+|||+.+|++.|+..
T Consensus 269 ~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 269 RMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred HHHcCCChhHCcCHHHHHHHHHHh
Confidence 999999999999999999998654
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-45 Score=312.97 Aligned_cols=249 Identities=21% Similarity=0.197 Sum_probs=184.0
Q ss_pred cchhc-cC-CcEEEEEEeecCCC--cchhHHHHHHHHHhcC---CCCcccceeeEeee-----CCeeEEEEecCCCCChh
Q 021490 2 MQVIL-CL-LQDVAIKQLDRNGV--QGNREFLVEVLMLSLL---HHPNLVNLIGYCAD-----GDQRLLVYEYMPLGSVE 69 (311)
Q Consensus 2 ~~~~~-~~-g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~ 69 (311)
|.+.. .+ |+.||||+++.... .....+.+|+.+|+.| +||||++++++|.. ....+++||+++++.+.
T Consensus 24 ~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~ 103 (305)
T d1blxa_ 24 FKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTT 103 (305)
T ss_dssp EEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHH
T ss_pred EEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEEEEEEeccCCchh
Confidence 44443 33 67799999876432 2334677888887766 79999999999853 34679999999887665
Q ss_pred hhhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeee
Q 021490 70 DHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTR 149 (311)
Q Consensus 70 ~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~ 149 (311)
..... ....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++.... .......
T Consensus 104 ~~~~~---~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~---~~~~~~~ 174 (305)
T d1blxa_ 104 YLDKV---PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYS---FQMALTS 174 (305)
T ss_dssp HHHHS---CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCCSCCCCC---GGGGGCC
T ss_pred hhhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecchhhhhhhc---ccccCCC
Confidence 44443 2567999999999999999999999999 9999999999999999999999999987422 2223344
Q ss_pred ccccccccCccccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhc-cccccc-c-------ccC
Q 021490 150 VMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQ-DRTRHS-L-------IAD 220 (311)
Q Consensus 150 ~~~~~~y~aPE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~-~-------~~~ 220 (311)
..||+.|+|||++.+..++.++||||+||++|+|++|..||......+....+........ ...... . ...
T Consensus 175 ~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (305)
T d1blxa_ 175 VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKS 254 (305)
T ss_dssp CCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCC
T ss_pred cccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccchhhhhcccc
Confidence 5799999999999999999999999999999999999999987765544333222111000 000000 0 000
Q ss_pred ccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 021490 221 PELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 221 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~ 259 (311)
......+....+..+.+|+.+||+.||++|||+.|+++.
T Consensus 255 ~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 255 AQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp CCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000111223345678899999999999999999999876
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=313.11 Aligned_cols=218 Identities=21% Similarity=0.315 Sum_probs=178.0
Q ss_pred cCCcEEEEEEeecCCCc------chhHHHHHHHHHhcCC--CCcccceeeEeeeCCeeEEEEecCCC-CChhhhhcccCC
Q 021490 7 CLLQDVAIKQLDRNGVQ------GNREFLVEVLMLSLLH--HPNLVNLIGYCADGDQRLLVYEYMPL-GSVEDHLHDLSP 77 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~ 77 (311)
.+|+.||||+++..... ...++.+|+.++++++ ||||+++++++.+....++||||+.+ +++.+++..
T Consensus 27 ~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~--- 103 (273)
T d1xwsa_ 27 SDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE--- 103 (273)
T ss_dssp TTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHH---
T ss_pred CCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEEEEeccCcchHHHHHhc---
Confidence 47999999999764322 2245778999999996 89999999999999999999999976 577888876
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcC-CCceEEccccccccCCCCCCceeeeeccccccc
Q 021490 78 GKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR-GYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY 156 (311)
Q Consensus 78 ~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y 156 (311)
...+++..+..++.|++.||+|||+++ ++||||||+|||++. ++.+||+|||++...... ......||+.|
T Consensus 104 -~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~~----~~~~~~GT~~y 175 (273)
T d1xwsa_ 104 -RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVY 175 (273)
T ss_dssp -HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECCSS----CBCCCCSCGGG
T ss_pred -cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccccceecccc----cccccccCCCc
Confidence 567999999999999999999999999 999999999999985 579999999999753222 22345689999
Q ss_pred cCccccccCCC-ccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHH
Q 021490 157 CAPEYAKTGQL-TLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQA 235 (311)
Q Consensus 157 ~aPE~~~~~~~-~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 235 (311)
+|||++.+..+ +.++|||||||++|+|++|..||...... . .. .. .++...+.++
T Consensus 176 ~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i-----~-------~~--------~~----~~~~~~s~~~ 231 (273)
T d1xwsa_ 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI-----I-------RG--------QV----FFRQRVSSEC 231 (273)
T ss_dssp SCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH-----H-------HC--------CC----CCSSCCCHHH
T ss_pred CCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHH-----h-------hc--------cc----CCCCCCCHHH
Confidence 99999987655 67799999999999999999999764321 0 00 00 1122234578
Q ss_pred HHHHHHccccCCCCCCCHHHHHHH
Q 021490 236 LAVAAMCVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 236 ~~li~~~l~~~p~~Rps~~~vl~~ 259 (311)
.+|+.+||+.||++|||++|+++.
T Consensus 232 ~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 232 QHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHccCCHhHCcCHHHHhcC
Confidence 999999999999999999999875
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-43 Score=303.64 Aligned_cols=253 Identities=21% Similarity=0.197 Sum_probs=182.6
Q ss_pred cchhc-cCCcEEEEEEeecCCC--cchhHHHHHHHHHhcCCCCcccceeeEeee--------CCeeEEEEecCCCCChhh
Q 021490 2 MQVIL-CLLQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCAD--------GDQRLLVYEYMPLGSVED 70 (311)
Q Consensus 2 ~~~~~-~~g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--------~~~~~lv~e~~~~~~L~~ 70 (311)
|.+.. .+|+.||||++..... .....+.+|+.+|+.++||||+++++++.. +...++||||+.++.+..
T Consensus 27 y~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~ 106 (318)
T d3blha1 27 FKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGL 106 (318)
T ss_dssp EEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEEEEEECCCEEHHHH
T ss_pred EEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEEEEEeccCCCccch
Confidence 44443 4799999999865533 334688999999999999999999999855 345799999998776665
Q ss_pred hhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCc--eeee
Q 021490 71 HLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT--HVST 148 (311)
Q Consensus 71 ~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~ 148 (311)
.... ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.++|+|||++......... ....
T Consensus 107 ~~~~----~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 179 (318)
T d3blha1 107 LSNV----LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYT 179 (318)
T ss_dssp HTCT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCC-----CCCCC
T ss_pred hhhc----ccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecceeeeccccccccccccc
Confidence 5544 577999999999999999999999999 999999999999999999999999999654322211 1222
Q ss_pred eccccccccCccccccC-CCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccc---cCc--c
Q 021490 149 RVMGTYGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLI---ADP--E 222 (311)
Q Consensus 149 ~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~--~ 222 (311)
...+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.........+......+......... ... .
T Consensus 180 ~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (318)
T d3blha1 180 NRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLE 259 (318)
T ss_dssp SCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------
T ss_pred ceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhc
Confidence 34689999999998754 68999999999999999999999998766554443332221111111000000 000 0
Q ss_pred ccCC--CCh-------HhHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 021490 223 LQGQ--YPP-------RGFYQALAVAAMCVHEQPDMRPVIADVVTALA 261 (311)
Q Consensus 223 ~~~~--~~~-------~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l~ 261 (311)
.... ... .....+.+||.+||+.||++|||++|+++.-.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpf 307 (318)
T d3blha1 260 LVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF 307 (318)
T ss_dssp CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred ccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChh
Confidence 0000 000 11346778999999999999999999998753
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-43 Score=306.58 Aligned_cols=243 Identities=19% Similarity=0.231 Sum_probs=184.4
Q ss_pred cchhc-cCCcEEEEEEeecCCC--cchhHHHHHHHHHhcCCCCcccceeeEeeeCC------eeEEEEecCCCCChhhhh
Q 021490 2 MQVIL-CLLQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGD------QRLLVYEYMPLGSVEDHL 72 (311)
Q Consensus 2 ~~~~~-~~g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~l 72 (311)
|.+.. .+|+.||||+++.... ...+.+.+|+.+|+.++||||++++++|.... ..|+||||+ +.+|...+
T Consensus 35 ~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~ 113 (346)
T d1cm8a_ 35 CSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLM 113 (346)
T ss_dssp EEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHH
T ss_pred EEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEEecc-cccHHHHH
Confidence 44443 4699999999975433 22467889999999999999999999997654 569999999 57787777
Q ss_pred cccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccc
Q 021490 73 HDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMG 152 (311)
Q Consensus 73 ~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~ 152 (311)
.. ..+++..+..++.|++.||+|||++| |+||||||+|||++.++.++++|||++...... .....+
T Consensus 114 ~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~ 180 (346)
T d1cm8a_ 114 KH-----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSE-----MTGYVV 180 (346)
T ss_dssp HH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCSS-----CCSSCS
T ss_pred Hh-----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccceeccCCc-----cccccc
Confidence 64 57999999999999999999999999 999999999999999999999999999754322 234568
Q ss_pred cccccCcccccc-CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhcc----c----------ccccc
Q 021490 153 TYGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQD----R----------TRHSL 217 (311)
Q Consensus 153 ~~~y~aPE~~~~-~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~----~----------~~~~~ 217 (311)
++.|+|||++.+ ..++.++||||+||++|+|++|..||...+................. . .....
T Consensus 181 t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (346)
T d1cm8a_ 181 TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPE 260 (346)
T ss_dssp CGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCC
T ss_pred cccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCc
Confidence 999999999876 45689999999999999999999999877654443222111100000 0 00000
Q ss_pred ccCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 021490 218 IADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 218 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~ 259 (311)
.....+ .......+..+.+||.+||..||++|||+.|+++.
T Consensus 261 ~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 261 LEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp CCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ccccch-HHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000000 11122334578899999999999999999999986
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-43 Score=306.29 Aligned_cols=247 Identities=24% Similarity=0.214 Sum_probs=178.6
Q ss_pred cchhc-cCCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCcccceeeEeeeC------CeeEEEEecCCCCChhhhhcc
Q 021490 2 MQVIL-CLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPNLVNLIGYCADG------DQRLLVYEYMPLGSVEDHLHD 74 (311)
Q Consensus 2 ~~~~~-~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~ 74 (311)
|.+.. .+|+.||||+++.... .+.+|+++|++++||||++++++|... ...++|||||+++. .+.+..
T Consensus 37 y~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~~-~~~l~~ 111 (350)
T d1q5ka_ 37 YQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETV-YRVARH 111 (350)
T ss_dssp EEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEEH-HHHHHH
T ss_pred EEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccCCcc-HHHHHh
Confidence 44443 3699999999965432 234799999999999999999998542 35789999997654 333322
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCC-ceEEccccccccCCCCCCceeeeecccc
Q 021490 75 LSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGY-HPKLSDFGLAKLGPVGDNTHVSTRVMGT 153 (311)
Q Consensus 75 ~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~ 153 (311)
.......+++..+..++.||+.||+|||++| |+||||||+|||++.++ .+||+|||++....... ......++
T Consensus 112 ~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt 185 (350)
T d1q5ka_ 112 YSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE---PNVSYICS 185 (350)
T ss_dssp HHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEECCTTS---CCCSCCSC
T ss_pred hhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhccCCc---cccccccc
Confidence 2222567999999999999999999999999 99999999999999775 89999999987543222 22334689
Q ss_pred ccccCcccccc-CCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhh---------hhhcccc--ccccccCc
Q 021490 154 YGYCAPEYAKT-GQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWAR---------PLFQDRT--RHSLIADP 221 (311)
Q Consensus 154 ~~y~aPE~~~~-~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~---------~~~~~~~--~~~~~~~~ 221 (311)
..|+|||.+.+ ..++.++||||+||++|+|++|..||......+....+.... ....... ........
T Consensus 186 ~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (350)
T d1q5ka_ 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAH 265 (350)
T ss_dssp TTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCC
T ss_pred ccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccC
Confidence 99999998765 578999999999999999999999998766544332221110 0000000 00000000
Q ss_pred cccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 021490 222 ELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 222 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~ 259 (311)
.......+..+.++.+|+.+||..||++|||+.|+++.
T Consensus 266 ~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 266 PWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp CGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred chhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11112223445688999999999999999999999975
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-43 Score=306.49 Aligned_cols=250 Identities=22% Similarity=0.241 Sum_probs=182.8
Q ss_pred cchh-ccCCcEEEEEEeecCCC-cchhHHHHHHHHHhcCCCCcccceeeEeeeCC-----eeEEEEecCCCCChhhhhcc
Q 021490 2 MQVI-LCLLQDVAIKQLDRNGV-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGD-----QRLLVYEYMPLGSVEDHLHD 74 (311)
Q Consensus 2 ~~~~-~~~g~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~ 74 (311)
|.+. ..+|+.||||+++.... ...+.+++|+.+|+.++||||+++++++.... ..|++ +++.||+|.+++..
T Consensus 25 y~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~-~~~~~g~L~~~l~~ 103 (345)
T d1pmea_ 25 CSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLV-THLMGADLYKLLKT 103 (345)
T ss_dssp EEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEE-EECCCEEHHHHHHH
T ss_pred EEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEE-EeecCCchhhhhhc
Confidence 4443 34799999999975443 33468899999999999999999999986543 34555 45668999999975
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCc-eeeeecccc
Q 021490 75 LSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNT-HVSTRVMGT 153 (311)
Q Consensus 75 ~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~ 153 (311)
..+++..+..++.|++.||+|||++| |+||||||+|||++.++.+||+|||++......... .......++
T Consensus 104 -----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt 175 (345)
T d1pmea_ 104 -----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 175 (345)
T ss_dssp -----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSC
T ss_pred -----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeeccCCCccceeecccccc
Confidence 46999999999999999999999999 999999999999999999999999998753222111 122345689
Q ss_pred ccccCccccc-cCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhcccc---------ccccccCccc
Q 021490 154 YGYCAPEYAK-TGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRT---------RHSLIADPEL 223 (311)
Q Consensus 154 ~~y~aPE~~~-~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~ 223 (311)
+.|+|||++. ...++.++||||+||++|+|++|..||......+................ .......+..
T Consensus 176 ~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (345)
T d1pmea_ 176 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHK 255 (345)
T ss_dssp GGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCC
T ss_pred ceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCcc
Confidence 9999999984 45678899999999999999999999987665443322211110000000 0000000000
Q ss_pred c----CCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 021490 224 Q----GQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 260 (311)
Q Consensus 224 ~----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l 260 (311)
. ....+..+.++.+|+.+||..||.+|||+.|+++.-
T Consensus 256 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hp 296 (345)
T d1pmea_ 256 NKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 296 (345)
T ss_dssp CCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred CCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCH
Confidence 0 001112335788999999999999999999999763
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-42 Score=295.11 Aligned_cols=249 Identities=17% Similarity=0.161 Sum_probs=187.9
Q ss_pred cchhc-cCCcEEEEEEeecCCC--cchhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCC
Q 021490 2 MQVIL-CLLQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPG 78 (311)
Q Consensus 2 ~~~~~-~~g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~ 78 (311)
|.+.. .+|+.||||+++.... ....++.+|+.+|+.++||||+++++++.+....++|++++.|++|..++..
T Consensus 19 ~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~l~~~~~~---- 94 (292)
T d1unla_ 19 FKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSC---- 94 (292)
T ss_dssp EEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSEEHHHHHHHT----
T ss_pred EEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeecccccccccccc----
Confidence 34443 4789999999976543 2346899999999999999999999999999999999999999998888876
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccC
Q 021490 79 KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCA 158 (311)
Q Consensus 79 ~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~a 158 (311)
.+.+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.+....... .......++..|.|
T Consensus 95 ~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~--~~~~~~~~~~~~~~ 169 (292)
T d1unla_ 95 NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV--RCYSAEVVTLWYRP 169 (292)
T ss_dssp TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC--SCCCSCCSCGGGCC
T ss_pred ccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC--ccceeeccccchhh
Confidence 678999999999999999999999999 9999999999999999999999999997643322 22223456788999
Q ss_pred ccccccCC-CccccceeehhHHHHHHHhCCCccCcchh-HHHHHHHHHhhhhhcccc-----------ccccccCccccC
Q 021490 159 PEYAKTGQ-LTLKSDVYSFGVVLLEILSGRKAVDTSKA-AAEQSLVAWARPLFQDRT-----------RHSLIADPELQG 225 (311)
Q Consensus 159 PE~~~~~~-~~~~~DiwslG~l~~~ll~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~ 225 (311)
||++.... ++.++|||||||++|+|++|..||..... ......+........... ............
T Consensus 170 pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (292)
T d1unla_ 170 PDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLV 249 (292)
T ss_dssp HHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCT
T ss_pred hhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhh
Confidence 99887654 68999999999999999999988644332 222221111110000000 000000011111
Q ss_pred CCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 021490 226 QYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 226 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~ 259 (311)
...+..+..+.+|+.+||+.||.+|||++|+++.
T Consensus 250 ~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 250 NVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 2233445678899999999999999999999875
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-43 Score=304.11 Aligned_cols=230 Identities=24% Similarity=0.308 Sum_probs=182.5
Q ss_pred CCcEEEEEEeecCCC----cchhHHHHHHHHHhcCCC-CcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCC
Q 021490 8 LLQDVAIKQLDRNGV----QGNREFLVEVLMLSLLHH-PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPL 82 (311)
Q Consensus 8 ~g~~vaiK~~~~~~~----~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l 82 (311)
+|+.||||+++.... ...+.+.+|++++++++| |||+++++++.+....++||||+.|++|.+++.. .+.+
T Consensus 51 ~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~----~~~~ 126 (322)
T d1vzoa_ 51 TGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQ----RERF 126 (322)
T ss_dssp TTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHH----HSCC
T ss_pred CCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCceeeeeecccccHHHHHHHh----cccc
Confidence 589999999865432 345678899999999976 8999999999999999999999999999999987 5678
Q ss_pred CHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccCcccc
Q 021490 83 DWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 162 (311)
Q Consensus 83 ~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 162 (311)
++..+..++.|++.||+|||+++ ++||||||+||+++.+|.++|+|||++....... ........+++.|++||.+
T Consensus 127 ~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~~-~~~~~~~~g~~~~~~pe~~ 202 (322)
T d1vzoa_ 127 TEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE-TERAYDFCGTIEYMAPDIV 202 (322)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEECCGGG-GGGGCGGGSCCTTCCHHHH
T ss_pred cHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchhhhcccc-cccccccccccccchhHHh
Confidence 89999999999999999999999 9999999999999999999999999986532221 2223345689999999998
Q ss_pred ccC--CCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCChHhHHHHHHHHH
Q 021490 163 KTG--QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPPRGFYQALAVAA 240 (311)
Q Consensus 163 ~~~--~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 240 (311)
.+. .++.++|||||||++|+|++|..||...........+..... .. . ..++...+.++.+|+.
T Consensus 203 ~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~--~~--------~----~~~~~~~s~~~~~li~ 268 (322)
T d1vzoa_ 203 RGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL--KS--------E----PPYPQEMSALAKDLIQ 268 (322)
T ss_dssp TTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH--HC--------C----CCCCTTSCHHHHHHHH
T ss_pred hcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcc--cC--------C----CCCcccCCHHHHHHHH
Confidence 654 467899999999999999999999976543322221111100 00 0 1123344568999999
Q ss_pred HccccCCCCCCC-----HHHHHHH
Q 021490 241 MCVHEQPDMRPV-----IADVVTA 259 (311)
Q Consensus 241 ~~l~~~p~~Rps-----~~~vl~~ 259 (311)
+||.+||++||| ++|+++.
T Consensus 269 ~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 269 RLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp HHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred HHcccCHHHcCCCCcccHHHHHcC
Confidence 999999999995 7888764
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.5e-41 Score=295.53 Aligned_cols=238 Identities=17% Similarity=0.198 Sum_probs=176.5
Q ss_pred cCCcEEEEEEeecCCCcchhHHHHHHHHHhcCC-CCcccceeeEeee--CCeeEEEEecCCCCChhhhhcccCCCCCCCC
Q 021490 7 CLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLH-HPNLVNLIGYCAD--GDQRLLVYEYMPLGSVEDHLHDLSPGKKPLD 83 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~ 83 (311)
.+|+.||||+++.. ..+++.+|+.+|+.++ ||||++++++|.. ....++|||||.+++|.... +.++
T Consensus 58 ~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~-------~~l~ 127 (328)
T d3bqca1 58 TNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-------QTLT 127 (328)
T ss_dssp TTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGTT-------TSCC
T ss_pred CCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHHh-------cCCC
Confidence 47999999998643 4568899999999995 9999999999874 35689999999999987654 3599
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCC-CceEEccccccccCCCCCCceeeeeccccccccCcccc
Q 021490 84 WNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRG-YHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA 162 (311)
Q Consensus 84 ~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 162 (311)
+..+..++.||+.||+|||++| |+||||||+|||++.+ +.++|+|||++....... ......+|..|+|||.+
T Consensus 128 e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~---~~~~~~~t~~y~aPE~~ 201 (328)
T d3bqca1 128 DYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ---EYNVRVASRYFKGPELL 201 (328)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC---CCCSCCSCGGGCCHHHH
T ss_pred HHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccCCC---cccccccCccccCcccc
Confidence 9999999999999999999999 9999999999999865 469999999997543222 22334688999999998
Q ss_pred ccC-CCccccceeehhHHHHHHHhCCCccCcchhHHHHH--HHH---------Hhhhh-hcccccccccc--------Cc
Q 021490 163 KTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQS--LVA---------WARPL-FQDRTRHSLIA--------DP 221 (311)
Q Consensus 163 ~~~-~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~--~~~---------~~~~~-~~~~~~~~~~~--------~~ 221 (311)
.+. .++.++||||+||++|+|++|..||.......... +.. +.... ........... ..
T Consensus 202 ~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (328)
T d3bqca1 202 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWER 281 (328)
T ss_dssp TTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGG
T ss_pred cCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhh
Confidence 764 57999999999999999999999996554322211 100 00000 00000000000 00
Q ss_pred cccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 021490 222 ELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 260 (311)
Q Consensus 222 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l 260 (311)
..........+.++.+||.+||.+||++|||++|+++.-
T Consensus 282 ~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp 320 (328)
T d3bqca1 282 FVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHP 320 (328)
T ss_dssp GCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred cccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence 011111123456789999999999999999999998753
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.8e-42 Score=293.61 Aligned_cols=239 Identities=21% Similarity=0.208 Sum_probs=179.0
Q ss_pred cCCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCc-ccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHH
Q 021490 7 CLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPN-LVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN 85 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~ 85 (311)
.+|+.||||++.... ..+.+..|+++++.++|+| |+.+.+++.++...++||||+ +++|...+... ...+++.
T Consensus 30 ~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-~~~l~~~~~~~---~~~~~~~ 103 (299)
T d1ckia_ 30 AAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFC---SRKFSLK 103 (299)
T ss_dssp TTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHT---TTCCCHH
T ss_pred CCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-CCchhhhhhhc---cCCCcHH
Confidence 468999999986543 3456889999999998766 555566667888999999999 46676666542 5679999
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcC---CCceEEccccccccCCCCCCc-----eeeeecccccccc
Q 021490 86 TRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR---GYHPKLSDFGLAKLGPVGDNT-----HVSTRVMGTYGYC 157 (311)
Q Consensus 86 ~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~---~~~~~l~df~~~~~~~~~~~~-----~~~~~~~~~~~y~ 157 (311)
.+..++.|++.||+|||+++ |+||||||+|||++. +..++|+|||++......... .......||+.|+
T Consensus 104 ~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~ 180 (299)
T d1ckia_ 104 TVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180 (299)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSC
T ss_pred HHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCcccc
Confidence 99999999999999999999 999999999999864 457999999999764332211 1223456999999
Q ss_pred CccccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHH-HHhhhhhccccccccccCccccCCCChHhHHHHH
Q 021490 158 APEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLV-AWARPLFQDRTRHSLIADPELQGQYPPRGFYQAL 236 (311)
Q Consensus 158 aPE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 236 (311)
|||++.+..++.++|||||||++|||++|..||............ ......... ..+.+...+ +.++.
T Consensus 181 aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~----p~~~~ 249 (299)
T d1ckia_ 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST-------PIEVLCKGY----PSEFA 249 (299)
T ss_dssp CHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS-------CHHHHTTTS----CHHHH
T ss_pred CHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCC-------ChhHhccCC----CHHHH
Confidence 999999999999999999999999999999999765543332211 111110000 001111122 34788
Q ss_pred HHHHHccccCCCCCCCHHHHHHHHHHhhh
Q 021490 237 AVAAMCVHEQPDMRPVIADVVTALAYLAS 265 (311)
Q Consensus 237 ~li~~~l~~~p~~Rps~~~vl~~l~~~~~ 265 (311)
+++..||+.||.+||++.++.+.|+.+..
T Consensus 250 ~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 250 TYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp HHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred HHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 99999999999999999999988876643
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=4.7e-41 Score=287.60 Aligned_cols=246 Identities=20% Similarity=0.185 Sum_probs=188.5
Q ss_pred cchhc-cCCcEEEEEEeecCCCcchhHHHHHHHHHhcCCC-CcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCC
Q 021490 2 MQVIL-CLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHH-PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGK 79 (311)
Q Consensus 2 ~~~~~-~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~ 79 (311)
|.+.. .+|+.||||+++... ..+.+.+|++.+..|+| +|++.+++++.++...++||||+ +++|.+++... +
T Consensus 22 y~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~~l~~~~~~~---~ 95 (293)
T d1csna_ 22 FEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLC---G 95 (293)
T ss_dssp EEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHT---T
T ss_pred EEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-CCCHHHHHHhh---c
Confidence 44443 368999999986543 34567889999999965 89999999999999999999999 68999988762 4
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcC-----CCceEEccccccccCCCCCCc-----eeeee
Q 021490 80 KPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDR-----GYHPKLSDFGLAKLGPVGDNT-----HVSTR 149 (311)
Q Consensus 80 ~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~-----~~~~~l~df~~~~~~~~~~~~-----~~~~~ 149 (311)
..++...+..++.|++.||+|||++| |+||||||+|||++. ++.++|+|||++......... .....
T Consensus 96 ~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~ 172 (293)
T d1csna_ 96 RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKN 172 (293)
T ss_dssp TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCC
T ss_pred cchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEEcccCccccceeecccCc
Confidence 57999999999999999999999999 999999999999974 578999999999764332211 12233
Q ss_pred ccccccccCccccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccccccccCccccCCCCh
Q 021490 150 VMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTRHSLIADPELQGQYPP 229 (311)
Q Consensus 150 ~~~~~~y~aPE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (311)
..||+.|+|||++.+..++.++|||||||++|+|++|..||................... .. ...+.+...+|
T Consensus 173 ~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~-~~-----~~~~~l~~~~p- 245 (293)
T d1csna_ 173 LSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK-QS-----TPLRELCAGFP- 245 (293)
T ss_dssp CCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH-HH-----SCHHHHTTTSC-
T ss_pred eEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhcc-CC-----CChHHhcCCCC-
Confidence 569999999999999999999999999999999999999997544332221111110000 00 00011112233
Q ss_pred HhHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 021490 230 RGFYQALAVAAMCVHEQPDMRPVIADVVTALAYLASQ 266 (311)
Q Consensus 230 ~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l~~~~~~ 266 (311)
.++.+++..|+..+|++||+++.+.+.|+.+...
T Consensus 246 ---~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~ 279 (293)
T d1csna_ 246 ---EEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 279 (293)
T ss_dssp ---HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred ---HHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHH
Confidence 4788899999999999999999999888776543
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-41 Score=298.62 Aligned_cols=241 Identities=22% Similarity=0.238 Sum_probs=174.7
Q ss_pred cCCcEEEEEEeecCCC--cchhHHHHHHHHHhcCCCCcccceeeEeee------CCeeEEEEecCCCCChhhhhcccCCC
Q 021490 7 CLLQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCAD------GDQRLLVYEYMPLGSVEDHLHDLSPG 78 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~~~l~~~~~~ 78 (311)
.+|+.||||+++.... ....++.+|+.+++.++||||++++++|.. ...+|+|||||.++ +.+.+.
T Consensus 40 ~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~~-l~~~~~----- 113 (355)
T d2b1pa1 40 VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVIQ----- 113 (355)
T ss_dssp TTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEE-HHHHHT-----
T ss_pred CCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEEeccchH-HHHhhh-----
Confidence 3699999999976543 233578899999999999999999999953 36789999999765 444443
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeeccccccccC
Q 021490 79 KKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCA 158 (311)
Q Consensus 79 ~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~a 158 (311)
..+++..++.++.||+.||+|||++| |+||||||+|||++.++.++++|||++..... ........+|..|+|
T Consensus 114 -~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~---~~~~~~~~~t~~y~a 186 (355)
T d2b1pa1 114 -MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYRA 186 (355)
T ss_dssp -SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC------------------CCTTCC
T ss_pred -cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhhcccc---ccccccccccccccC
Confidence 35899999999999999999999999 99999999999999999999999999875322 222334568999999
Q ss_pred ccccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhh----------------hhhcccccccc-----
Q 021490 159 PEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWAR----------------PLFQDRTRHSL----- 217 (311)
Q Consensus 159 PE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~----- 217 (311)
||++.+..++.++||||+||++|+|++|..||.+.+.......+.... ...........
T Consensus 187 PE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (355)
T d2b1pa1 187 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPK 266 (355)
T ss_dssp HHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHH
T ss_pred hhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCcccccccccc
Confidence 999999999999999999999999999999997665443322111000 00000000000
Q ss_pred -ccCcccc--CCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 021490 218 -IADPELQ--GQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 260 (311)
Q Consensus 218 -~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l 260 (311)
..+.... .......+.++.+|+.+||..||++|||++|+++.-
T Consensus 267 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hp 312 (355)
T d2b1pa1 267 LFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 312 (355)
T ss_dssp HSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTST
T ss_pred ccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCc
Confidence 0000000 011123467889999999999999999999999774
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-41 Score=294.14 Aligned_cols=244 Identities=19% Similarity=0.202 Sum_probs=178.3
Q ss_pred cchh-ccCCcEEEEEEeecCCC--cchhHHHHHHHHHhcCCCCcccceeeEeeeC-----CeeEEEEecCCCCChhhhhc
Q 021490 2 MQVI-LCLLQDVAIKQLDRNGV--QGNREFLVEVLMLSLLHHPNLVNLIGYCADG-----DQRLLVYEYMPLGSVEDHLH 73 (311)
Q Consensus 2 ~~~~-~~~g~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~ 73 (311)
|.+. ..+|+.||||+++.... ...+.+.+|+.+|+.++||||+++++++... ...+++++++.||+|.+++.
T Consensus 35 y~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~ 114 (348)
T d2gfsa1 35 CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 114 (348)
T ss_dssp EEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHT
T ss_pred EEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEEEeecCCchhhhcc
Confidence 4444 34799999999975543 2345788999999999999999999998533 33466667778999999986
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCCCceeeeecccc
Q 021490 74 DLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGDNTHVSTRVMGT 153 (311)
Q Consensus 74 ~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~ 153 (311)
. +.+++..+..++.||+.||+|||++| |+||||||+|||++.++.++++|||++.... .......++
T Consensus 115 ~-----~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~~~~-----~~~~~~~g~ 181 (348)
T d2gfsa1 115 C-----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTD-----DEMTGYVAT 181 (348)
T ss_dssp T-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----CCT-----GGGSSSCHH
T ss_pred c-----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhcccC-----ccccccccc
Confidence 4 56999999999999999999999999 9999999999999999999999999986422 122334688
Q ss_pred ccccCccccccC-CCccccceeehhHHHHHHHhCCCccCcchhHHHHHHHHHhhhhhccccc--------------cccc
Q 021490 154 YGYCAPEYAKTG-QLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQSLVAWARPLFQDRTR--------------HSLI 218 (311)
Q Consensus 154 ~~y~aPE~~~~~-~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~ 218 (311)
..|+|||++.+. .++.++|||||||++|+|++|..||.+.+.......+............ ....
T Consensus 182 ~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (348)
T d2gfsa1 182 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM 261 (348)
T ss_dssp HHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCC
T ss_pred ccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccC
Confidence 999999987664 5688999999999999999999999877655443332211110000000 0000
Q ss_pred cCccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 021490 219 ADPELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTA 259 (311)
Q Consensus 219 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~ 259 (311)
....+. ......+..+.+||.+||..||.+|||+.|+++.
T Consensus 262 ~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 262 PKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp CCCCHH-HHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCcchh-hhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 000000 0011234578899999999999999999999986
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=9e-36 Score=262.34 Aligned_cols=249 Identities=16% Similarity=0.149 Sum_probs=172.0
Q ss_pred cchhc-cCCcEEEEEEeecCCCcchhHHHHHHHHHhcCC-----------CCcccceeeEeee--CCeeEEEEecCCCCC
Q 021490 2 MQVIL-CLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLH-----------HPNLVNLIGYCAD--GDQRLLVYEYMPLGS 67 (311)
Q Consensus 2 ~~~~~-~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~i~~~~~~~~~--~~~~~lv~e~~~~~~ 67 (311)
|.+.. .+|+.||||+++... ...+.+.+|+.+++.++ |+||+++++++.. ....++++.++..+.
T Consensus 30 y~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~ 108 (362)
T d1q8ya_ 30 WLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGE 108 (362)
T ss_dssp EEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCCCE
T ss_pred EEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccccceeeeeeeccccc
Confidence 44443 479999999996443 33467888999988775 5789999988754 345667777665444
Q ss_pred hhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCeEeeccCCCeEEEcCCC------ceEEccccccccCCC
Q 021490 68 VEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHD-KAKPPVIYRDLKCSNILLDRGY------HPKLSDFGLAKLGPV 140 (311)
Q Consensus 68 L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~~~~i~h~dl~p~nil~~~~~------~~~l~df~~~~~~~~ 140 (311)
........ .....+++..+..++.|++.||+|||+ .| |+||||||+|||++.++ .++++|||.+.....
T Consensus 109 ~~~~~~~~-~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~ 184 (362)
T d1q8ya_ 109 NLLALIKK-YEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE 184 (362)
T ss_dssp EHHHHHHH-TTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTB
T ss_pred cccccccc-ccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCcccccceeeEeeccccccccc
Confidence 33222211 225778999999999999999999997 88 99999999999998655 389999999864322
Q ss_pred CCCceeeeeccccccccCccccccCCCccccceeehhHHHHHHHhCCCccCcchhHHHH----HHHHHhh----------
Q 021490 141 GDNTHVSTRVMGTYGYCAPEYAKTGQLTLKSDVYSFGVVLLEILSGRKAVDTSKAAAEQ----SLVAWAR---------- 206 (311)
Q Consensus 141 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~l~~~ll~g~~pf~~~~~~~~~----~~~~~~~---------- 206 (311)
......+++.|+|||++....++.++||||+||++++|++|+.||......... .+.....
T Consensus 185 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~ 259 (362)
T d1q8ya_ 185 -----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLL 259 (362)
T ss_dssp -----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHH
T ss_pred -----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHh
Confidence 223346899999999999999999999999999999999999999755432111 0000000
Q ss_pred -------hhhccccccccccC---------ccccCCCChHhHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 021490 207 -------PLFQDRTRHSLIAD---------PELQGQYPPRGFYQALAVAAMCVHEQPDMRPVIADVVTAL 260 (311)
Q Consensus 207 -------~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~vl~~l 260 (311)
..+........... ...........+..+.+|+.+||.+||.+|||+.|+++.-
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp 329 (362)
T d1q8ya_ 260 RNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHP 329 (362)
T ss_dssp HHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCG
T ss_pred hcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 00000000000000 0012234456678899999999999999999999998753
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.79 E-value=2.1e-20 Score=148.66 Aligned_cols=150 Identities=9% Similarity=-0.005 Sum_probs=104.9
Q ss_pred CcchhccCCcEEEEEEeecCCCc------------------chhHHHHHHHHHhcCCCCcccceeeEeeeCCeeEEEEec
Q 021490 1 MMQVILCLLQDVAIKQLDRNGVQ------------------GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 62 (311)
Q Consensus 1 ~~~~~~~~g~~vaiK~~~~~~~~------------------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 62 (311)
||.+...+|+.||||+++..... ......+|...+.++.|.+++..+++. ..+++|||
T Consensus 16 Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~----~~~lvme~ 91 (191)
T d1zara2 16 VFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE----GNAVLMEL 91 (191)
T ss_dssp EEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE----TTEEEEEC
T ss_pred EEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec----CCEEEEEe
Confidence 46777789999999987532110 012344688899999999998887653 23799999
Q ss_pred CCCCChhhhhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeeccCCCeEEEcCCCceEEccccccccCCCCC
Q 021490 63 MPLGSVEDHLHDLSPGKKPLDWNTRMKIAAGAARGLEYLHDKAKPPVIYRDLKCSNILLDRGYHPKLSDFGLAKLGPVGD 142 (311)
Q Consensus 63 ~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dl~p~nil~~~~~~~~l~df~~~~~~~~~~ 142 (311)
+++..+.. ++...+..++.|++.+|+|||++| ++||||||+|||+++++ ++|+|||++.......
T Consensus 92 ~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~~-~~liDFG~a~~~~~~~ 156 (191)
T d1zara2 92 IDAKELYR-----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEG 156 (191)
T ss_dssp CCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETTE-EEECCCTTCEETTSTT
T ss_pred eccccccc-----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCCC-EEEEECCCcccCCCCC
Confidence 98765432 333446788999999999999999 99999999999999764 8999999986432211
Q ss_pred CceeeeeccccccccCcc-----ccccCCCccccceeehhHH
Q 021490 143 NTHVSTRVMGTYGYCAPE-----YAKTGQLTLKSDVYSFGVV 179 (311)
Q Consensus 143 ~~~~~~~~~~~~~y~aPE-----~~~~~~~~~~~DiwslG~l 179 (311)
.. .|.... .+..+.++.++|+||+.--
T Consensus 157 ~~----------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 157 WR----------EILERDVRNIITYFSRTYRTEKDINSAIDR 188 (191)
T ss_dssp HH----------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHH
T ss_pred cH----------HHHHHHHHHHHHHHcCCCCCcccHHHHHHH
Confidence 11 111110 0113567888999997643
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.51 E-value=3.2e-07 Score=74.70 Aligned_cols=121 Identities=16% Similarity=0.082 Sum_probs=85.2
Q ss_pred cCCcEEEEEEeecCCCcchhHHHHHHHHHhcCC-CCcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCCCCCCHH
Q 021490 7 CLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGKKPLDWN 85 (311)
Q Consensus 7 ~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~ 85 (311)
.+|+.+++|+...........+.+|+..+..+. +--+.+++.+..++...++||++++|.++.+.... . .
T Consensus 35 ~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~----~--~--- 105 (263)
T d1j7la_ 35 GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYED----E--Q--- 105 (263)
T ss_dssp CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTT----C--S---
T ss_pred eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccccccc----c--c---
Confidence 467778899886655555567788999888774 33356777888888889999999999887655432 0 1
Q ss_pred HHHHHHHHHHHHHHHhhcCCCC--------------------------------------------------------Ce
Q 021490 86 TRMKIAAGAARGLEYLHDKAKP--------------------------------------------------------PV 109 (311)
Q Consensus 86 ~~~~~~~~i~~~l~~lh~~~~~--------------------------------------------------------~i 109 (311)
....++.+++..++.||+.... .+
T Consensus 106 ~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l 185 (263)
T d1j7la_ 106 SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVF 185 (263)
T ss_dssp CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEE
T ss_pred cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEE
Confidence 1223455566666666643200 17
Q ss_pred EeeccCCCeEEEcCCCceEEccccccc
Q 021490 110 IYRDLKCSNILLDRGYHPKLSDFGLAK 136 (311)
Q Consensus 110 ~h~dl~p~nil~~~~~~~~l~df~~~~ 136 (311)
+|+|+.|.||++++++.+.|+||+.+.
T Consensus 186 ~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 186 SHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp ECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred EEeeccCcceeecCCceEEEeechhcc
Confidence 899999999999987767799998764
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.22 E-value=4.2e-06 Score=67.46 Aligned_cols=120 Identities=16% Similarity=0.085 Sum_probs=77.7
Q ss_pred cchhccCCcEEEEEEeecCCCcchhHHHHHHHHHhcCCC--CcccceeeEeeeCCeeEEEEecCCCCChhhhhcccCCCC
Q 021490 2 MQVILCLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHH--PNLVNLIGYCADGDQRLLVYEYMPLGSVEDHLHDLSPGK 79 (311)
Q Consensus 2 ~~~~~~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~ 79 (311)
|.+...+|..+++|..... ....+..|+..++.+.. -.+.+++.+..++...++||++++|.++.+..
T Consensus 28 ~r~~~~~~~~~vlK~~~~~---~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~~~~------- 97 (255)
T d1nd4a_ 28 FRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLSSH------- 97 (255)
T ss_dssp EEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETTTSC-------
T ss_pred EEEEeCCCCEEEEEeCCcc---CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccccccc-------
Confidence 4556667888899876433 23456778888877743 23566777777778889999999986654311
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhcCC------------------------------------------------------
Q 021490 80 KPLDWNTRMKIAAGAARGLEYLHDKA------------------------------------------------------ 105 (311)
Q Consensus 80 ~~l~~~~~~~~~~~i~~~l~~lh~~~------------------------------------------------------ 105 (311)
.... ..+.+++..|+.||+..
T Consensus 98 --~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 172 (255)
T d1nd4a_ 98 --LAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDG 172 (255)
T ss_dssp --CCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSS
T ss_pred --ccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCcc
Confidence 1111 11223334444444211
Q ss_pred -CCCeEeeccCCCeEEEcCCCceEEccccccc
Q 021490 106 -KPPVIYRDLKCSNILLDRGYHPKLSDFGLAK 136 (311)
Q Consensus 106 -~~~i~h~dl~p~nil~~~~~~~~l~df~~~~ 136 (311)
...++|+|+.|.||+++++..+-|+||+.+.
T Consensus 173 ~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 173 EDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp CCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred CCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 0017999999999999987767899998764
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.66 E-value=8.7e-05 Score=63.65 Aligned_cols=28 Identities=25% Similarity=0.226 Sum_probs=24.7
Q ss_pred eEeeccCCCeEEEcCCCceEEcccccccc
Q 021490 109 VIYRDLKCSNILLDRGYHPKLSDFGLAKL 137 (311)
Q Consensus 109 i~h~dl~p~nil~~~~~~~~l~df~~~~~ 137 (311)
++|||+++.|||+++++ ++|+||..+..
T Consensus 225 LiHGDl~~gNIlv~~~~-~~vID~E~a~~ 252 (392)
T d2pula1 225 LIHGDLHTGSIFASEHE-TKVIDPEFAFY 252 (392)
T ss_dssp EECSCCCGGGEEECSSC-EEECCCTTCEE
T ss_pred eeccCCcCCceeEcCCc-eEEechhhccc
Confidence 99999999999998765 89999987753
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.47 E-value=0.00046 Score=57.34 Aligned_cols=66 Identities=9% Similarity=-0.054 Sum_probs=44.0
Q ss_pred CcchhccCCcEEEEEEeecCCCcchhHHHHHHHHHhcCCCCc--cccee-----eEeeeCCeeEEEEecCCCCC
Q 021490 1 MMQVILCLLQDVAIKQLDRNGVQGNREFLVEVLMLSLLHHPN--LVNLI-----GYCADGDQRLLVYEYMPLGS 67 (311)
Q Consensus 1 ~~~~~~~~g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~-----~~~~~~~~~~lv~e~~~~~~ 67 (311)
||+|.+.+|..+++|+.... -.+.+++..|...+..|.... +...+ ..+..+...+.++++++|..
T Consensus 38 vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~ 110 (325)
T d1zyla1 38 VYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ 110 (325)
T ss_dssp EEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred eEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence 47788899999999987543 345677888888888774221 11111 12345567889999998744
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.59 E-value=0.0021 Score=54.72 Aligned_cols=54 Identities=19% Similarity=0.250 Sum_probs=35.0
Q ss_pred CcEEEEEEeecCCCcchhHHHHHHHHHhcCC-CCcccceeeEeeeCCeeEEEEecCCCCCh
Q 021490 9 LQDVAIKQLDRNGVQGNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLVYEYMPLGSV 68 (311)
Q Consensus 9 g~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 68 (311)
+..|++++.- . ........+|..+++.+. +.-..++++++.+ .+|++|++|.+|
T Consensus 74 ~~~vllRi~g-~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi~g~~l 128 (395)
T d1nw1a_ 74 PNKVLLRVYF-N-PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRPL 128 (395)
T ss_dssp CSEEEEEEEC-S-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEEC
T ss_pred CCcEEEEecC-C-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEEeccccC
Confidence 3567777663 2 234445667999998884 4334466666642 689999987554
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=92.37 E-value=0.02 Score=46.57 Aligned_cols=28 Identities=32% Similarity=0.243 Sum_probs=25.5
Q ss_pred eEeeccCCCeEEEcCCCceEEccccccc
Q 021490 109 VIYRDLKCSNILLDRGYHPKLSDFGLAK 136 (311)
Q Consensus 109 i~h~dl~p~nil~~~~~~~~l~df~~~~ 136 (311)
++|+|+.+.|++++.+...-++||+.+.
T Consensus 185 iIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 185 VIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccCCcchhhhhcccccceeEecccccc
Confidence 9999999999999988877899999764
|